ID   B4DKQ6_HUMAN            Unreviewed;       258 AA.
AC   B4DKQ6;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-MAR-2018, entry version 39.
DE   SubName: Full=cDNA FLJ54269, highly similar to Docking protein 2 (Downstream of tyrosine kinase 2) {ECO:0000313|EMBL:BAG59268.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG59268.1};
RN   [1] {ECO:0000313|EMBL:BAG59268.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cord blood {ECO:0000313|EMBL:BAG59268.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK296671; BAG59268.1; -; mRNA.
DR   RefSeq; NP_958728.1; NM_201349.2.
DR   UniGene; Hs.71215; -.
DR   iPTMnet; B4DKQ6; -.
DR   PeptideAtlas; B4DKQ6; -.
DR   GeneID; 9046; -.
DR   CTD; 9046; -.
DR   eggNOG; KOG4047; Eukaryota.
DR   eggNOG; ENOG410XS2S; LUCA.
DR   HOVERGEN; HBG018962; -.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   CDD; cd01203; PTB_DOK1_DOK2_DOK3; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR037751; Dok1/2/3_PTB.
DR   InterPro; IPR002404; IRS_PTB.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   Pfam; PF02174; IRS; 1.
DR   SMART; SM00310; PTBI; 1.
DR   PROSITE; PS51064; IRS_PTB; 1.
PE   2: Evidence at transcript level;
KW   Kinase {ECO:0000313|EMBL:BAG59268.1};
KW   Transferase {ECO:0000313|EMBL:BAG59268.1}.
FT   DOMAIN        1     98       IRS-type PTB.
FT                                {ECO:0000259|PROSITE:PS51064}.
SQ   SEQUENCE   258 AA;  28486 MW;  70DED1F772FCA11D CRC64;
     MRPTEASERC HLRGSYTLRA GESALELWGG PEPGTQLYDW PYRFLRRFGR DKVTFSFEAG
     RRCVSGEGNF EFETRQGNEI FLALEEAISA QKNAAPATPQ PQPATIPASL PRPDSPYSRP
     HDSLPPPSPT TPVPAPRPRG QEGEYAVPFD AVARSLGKNF RGILAVPPQL LADPLYDSIE
     ETLPPRPDHI YDEPEGVAAL FLYDSPQEPR GEAWRRQATA DRDPAGLQHV QPAGQDFSAS
     GWQPGTEYDN VVLKKGPK
//
ID   DOK2_HUMAN              Reviewed;         412 AA.
AC   O60496; Q8N5A4;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 2.
DT   23-MAY-2018, entry version 154.
DE   RecName: Full=Docking protein 2;
DE   AltName: Full=Downstream of tyrosine kinase 2;
DE   AltName: Full=p56(dok-2);
GN   Name=DOK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 8-21; 30-49; 59-89 AND
RP   128-149, TISSUE SPECIFICITY, INTERACTION WITH RASGAP, AND VARIANT
RP   PRO-152.
RX   PubMed=9478921; DOI=10.1074/jbc.273.9.4827;
RA   Di Cristofano A., Carpino N., Dunant N., Friedland G., Kobayashi R.,
RA   Strife A., Wisniewski D., Clarkson B., Pandolfi P.P., Resh M.D.;
RT   "Molecular cloning and characterization of p56dok-2 defines a new
RT   family of RasGAP-binding proteins.";
RL   J. Biol. Chem. 273:4827-4830(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-299, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-299, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-299, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-299, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   INTERACTION WITH HERPES SIMPLEX VIRUS 1 PROTEIN UL46.
RX   PubMed=28841444; DOI=10.1016/j.virol.2017.08.018;
RA   Lahmidi S., Strunk U., Smiley J.R., Pearson A., Duplay P.;
RT   "Herpes simplex virus 1 infection of T cells causes VP11/12-dependent
RT   phosphorylation and degradation of the cellular protein Dok-2.";
RL   Virology 511:66-73(2017).
RN   [8]
RP   STRUCTURE BY NMR OF 1-247.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the PH and IRS domains of human docking protein
RT   2, isoform A.";
RL   Submitted (OCT-2006) to the PDB data bank.
CC   -!- FUNCTION: DOK proteins are enzymatically inert adaptor or
CC       scaffolding proteins. They provide a docking platform for the
CC       assembly of multimolecular signaling complexes. DOK2 may modulate
CC       the cellular proliferation induced by IL-4, as well as IL-2 and
CC       IL-3. May be involved in modulating Bcr-Abl signaling. Attenuates
CC       EGF-stimulated MAP kinase activation (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with phosphorylated RASGAP and EGFR. Interacts
CC       with RET and NCK. Interacts (via PH domain) with TEK/TIE2
CC       (tyrosine phosphorylated) (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Herpes simplex virus
CC       1 (HHV-1) protein UL46; this interaction induces DOK2
CC       phosphorylation and subsequent degradation.
CC       {ECO:0000269|PubMed:28841444}.
CC   -!- INTERACTION:
CC       Q9NUX5:POT1; NbExp=2; IntAct=EBI-1046024, EBI-752420;
CC   -!- TISSUE SPECIFICITY: Highly expressed in peripheral blood
CC       leukocytes, lymph nodes and spleen. Lower expression in thymus,
CC       bone marrow and fetal liver. {ECO:0000269|PubMed:9478921}.
CC   -!- DOMAIN: PTB domain mediates receptor interaction.
CC   -!- PTM: On immunoreceptor stimulation, phosphorylated on C-terminal
CC       tyrosine residues. Phosphorylation on Tyr-345 is required for
CC       binding to the SH2 domain of NCK. Phosphorylation on both Tyr-271
CC       and Tyr-299 is required for interaction with RASGAP.
CC       Phosphorylated on tyrosine residues by TEK/TIE2 (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the DOK family. Type A subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF034970; AAC13265.1; -; mRNA.
DR   EMBL; BC032623; AAH32623.1; -; mRNA.
DR   CCDS; CCDS6016.1; -.
DR   RefSeq; NP_003965.2; NM_003974.3.
DR   UniGene; Hs.71215; -.
DR   PDB; 2D9W; NMR; -; A=1-114.
DR   PDB; 2DLW; NMR; -; A=148-247.
DR   PDBsum; 2D9W; -.
DR   PDBsum; 2DLW; -.
DR   ProteinModelPortal; O60496; -.
DR   SMR; O60496; -.
DR   BioGrid; 114508; 37.
DR   IntAct; O60496; 8.
DR   MINT; O60496; -.
DR   STRING; 9606.ENSP00000276420; -.
DR   iPTMnet; O60496; -.
DR   PhosphoSitePlus; O60496; -.
DR   BioMuta; DOK2; -.
DR   OGP; O60496; -.
DR   MaxQB; O60496; -.
DR   PaxDb; O60496; -.
DR   PeptideAtlas; O60496; -.
DR   PRIDE; O60496; -.
DR   DNASU; 9046; -.
DR   Ensembl; ENST00000276420; ENSP00000276420; ENSG00000147443.
DR   GeneID; 9046; -.
DR   KEGG; hsa:9046; -.
DR   UCSC; uc003wzy.2; human.
DR   CTD; 9046; -.
DR   DisGeNET; 9046; -.
DR   EuPathDB; HostDB:ENSG00000147443.12; -.
DR   GeneCards; DOK2; -.
DR   HGNC; HGNC:2991; DOK2.
DR   HPA; CAB004379; -.
DR   MIM; 604997; gene.
DR   neXtProt; NX_O60496; -.
DR   OpenTargets; ENSG00000147443; -.
DR   PharmGKB; PA27457; -.
DR   eggNOG; KOG4047; Eukaryota.
DR   eggNOG; ENOG410XS2S; LUCA.
DR   GeneTree; ENSGT00730000110348; -.
DR   HOGENOM; HOG000112245; -.
DR   HOVERGEN; HBG018962; -.
DR   InParanoid; O60496; -.
DR   KO; K20234; -.
DR   OMA; EYAVPFD; -.
DR   OrthoDB; EOG091G075T; -.
DR   PhylomeDB; O60496; -.
DR   TreeFam; TF324994; -.
DR   Reactome; R-HSA-210993; Tie2 Signaling.
DR   Reactome; R-HSA-8853659; RET signaling.
DR   SignaLink; O60496; -.
DR   SIGNOR; O60496; -.
DR   ChiTaRS; DOK2; human.
DR   EvolutionaryTrace; O60496; -.
DR   GeneWiki; DOK2; -.
DR   GenomeRNAi; 9046; -.
DR   PRO; PR:O60496; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000147443; -.
DR   CleanEx; HS_DOK2; -.
DR   ExpressionAtlas; O60496; baseline and differential.
DR   Genevisible; O60496; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005057; F:signal transducer activity, downstream of receptor; IEA:Ensembl.
DR   GO; GO:0005068; F:transmembrane receptor protein tyrosine kinase adaptor activity; IEA:Ensembl.
DR   GO; GO:0007411; P:axon guidance; TAS:Reactome.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0007265; P:Ras protein signal transduction; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   CDD; cd01203; PTB_DOK1_DOK2_DOK3; 1.
DR   Gene3D; 2.30.29.30; -; 2.
DR   InterPro; IPR037751; Dok1/2/3_PTB.
DR   InterPro; IPR002404; IRS_PTB.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   Pfam; PF02174; IRS; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00310; PTBI; 1.
DR   PROSITE; PS51064; IRS_PTB; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    412       Docking protein 2.
FT                                /FTId=PRO_0000187270.
FT   DOMAIN        4    114       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   DOMAIN      147    252       IRS-type PTB. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00389}.
FT   COMPBIAS    250    292       Pro-rich.
FT   COMPBIAS    321    363       Pro-rich.
FT   MOD_RES     271    271       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:O70469}.
FT   MOD_RES     299    299       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15144186,
FT                                ECO:0000244|PubMed:15592455,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     345    345       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:O70469}.
FT   VARIANT     152    152       A -> P (in dbSNP:rs1140295).
FT                                {ECO:0000269|PubMed:9478921}.
FT                                /FTId=VAR_030951.
FT   VARIANT     274    274       P -> L (in dbSNP:rs34215892).
FT                                /FTId=VAR_053068.
FT   VARIANT     394    394       S -> A (in dbSNP:rs2242241).
FT                                /FTId=VAR_030952.
FT   CONFLICT    166    166       L -> R (in Ref. 1; AAC13265).
FT                                {ECO:0000305}.
FT   CONFLICT    178    178       A -> S (in Ref. 1; AAC13265).
FT                                {ECO:0000305}.
FT   CONFLICT    347    347       E -> K (in Ref. 1; AAC13265).
FT                                {ECO:0000305}.
FT   CONFLICT    374    374       A -> R (in Ref. 1; AAC13265).
FT                                {ECO:0000305}.
FT   STRAND        5     13       {ECO:0000244|PDB:2D9W}.
FT   STRAND       17     20       {ECO:0000244|PDB:2D9W}.
FT   STRAND       25     31       {ECO:0000244|PDB:2D9W}.
FT   STRAND       34     37       {ECO:0000244|PDB:2D9W}.
FT   STRAND       40     44       {ECO:0000244|PDB:2D9W}.
FT   STRAND       50     52       {ECO:0000244|PDB:2D9W}.
FT   STRAND       57     60       {ECO:0000244|PDB:2D9W}.
FT   HELIX        62     64       {ECO:0000244|PDB:2D9W}.
FT   STRAND       65     70       {ECO:0000244|PDB:2D9W}.
FT   STRAND       75     77       {ECO:0000244|PDB:2D9W}.
FT   STRAND       82     90       {ECO:0000244|PDB:2D9W}.
FT   STRAND       92     97       {ECO:0000244|PDB:2D9W}.
FT   HELIX        99    113       {ECO:0000244|PDB:2D9W}.
FT   STRAND      151    155       {ECO:0000244|PDB:2DLW}.
FT   HELIX       159    164       {ECO:0000244|PDB:2DLW}.
FT   STRAND      168    174       {ECO:0000244|PDB:2DLW}.
FT   STRAND      176    180       {ECO:0000244|PDB:2DLW}.
FT   STRAND      184    187       {ECO:0000244|PDB:2DLW}.
FT   HELIX       196    198       {ECO:0000244|PDB:2DLW}.
FT   STRAND      202    205       {ECO:0000244|PDB:2DLW}.
FT   STRAND      208    213       {ECO:0000244|PDB:2DLW}.
FT   STRAND      221    226       {ECO:0000244|PDB:2DLW}.
FT   HELIX       231    247       {ECO:0000244|PDB:2DLW}.
SQ   SEQUENCE   412 AA;  45379 MW;  EFAEDBA68439757F CRC64;
     MGDGAVKQGF LYLQQQQTFG KKWRRFGASL YGGSDCALAR LELQEGPEKP RRCEAARKVI
     RLSDCLRVAE AGGEASSPRD TSAFFLETKE RLYLLAAPAA ERGDWVQAIC LLAFPGQRKE
     LSGPEGKQSR PCMEENELYS SAVTVGPHKE FAVTMRPTEA SERCHLRGSY TLRAGESALE
     LWGGPEPGTQ LYDWPYRFLR RFGRDKVTFS FEAGRRCVSG EGNFEFETRQ GNEIFLALEE
     AISAQKNAAP ATPQPQPATI PASLPRPDSP YSRPHDSLPP PSPTTPVPAP RPRGQEGEYA
     VPFDAVARSL GKNFRGILAV PPQLLADPLY DSIEETLPPR PDHIYDEPEG VAALSLYDSP
     QEPRGEAWRR QATADRDPAG LQHVQPAGQD FSASGWQPGT EYDNVVLKKG PK
//
ID   DJB11_HUMAN             Reviewed;         358 AA.
AC   Q9UBS4; Q542Y5; Q542Y9; Q6IAQ8; Q96JC6;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   23-MAY-2018, entry version 168.
DE   RecName: Full=DnaJ homolog subfamily B member 11;
DE   AltName: Full=APOBEC1-binding protein 2;
DE            Short=ABBP-2;
DE   AltName: Full=DnaJ protein homolog 9;
DE   AltName: Full=ER-associated DNAJ;
DE   AltName: Full=ER-associated Hsp40 co-chaperone;
DE   AltName: Full=Endoplasmic reticulum DNA J domain-containing protein 3;
DE            Short=ER-resident protein ERdj3;
DE            Short=ERdj3;
DE            Short=ERj3p;
DE   AltName: Full=HEDJ;
DE   AltName: Full=Human DnaJ protein 9;
DE            Short=hDj-9;
DE   AltName: Full=PWP1-interacting protein 4;
DE   Flags: Precursor;
GN   Name=DNAJB11; Synonyms=EDJ, ERJ3, HDJ9;
GN   ORFNames=PSEC0121, UNQ537/PRO1080;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11147971; DOI=10.1379/1466-1268(2000)005<0098:MHDHCO>2.0.CO;2;
RA   Ohtsuka K., Hata M.;
RT   "Mammalian HSP40/DNAJ homologs: cloning of novel cDNAs and a proposal
RT   for their classification and nomenclature.";
RL   Cell Stress Chaperones 5:98-112(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION,
RP   INTERACTION WITH HSPA5, TISSUE SPECIFICITY, AND GLYCOSYLATION.
RC   TISSUE=Skeletal muscle;
RX   PubMed=10827079; DOI=10.1074/jbc.M000739200;
RA   Yu M., Haslam R.H.A., Haslam D.B.;
RT   "HEDJ, an Hsp40 co-chaperone localized to the endoplasmic reticulum of
RT   human cells.";
RL   J. Biol. Chem. 275:24984-24992(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND GLYCOSYLATION.
RC   TISSUE=Placenta;
RX   PubMed=15195998; DOI=10.1515/BC.2004.043;
RA   Bies C., Blum R., Dudek J., Nastainczyk W., Oberhauser S., Jung M.,
RA   Zimmermann R.;
RT   "Characterization of pancreatic ERj3p, a homolog of yeast DnaJ-like
RT   protein Scj1p.";
RL   Biol. Chem. 385:389-395(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-264.
RC   TISSUE=Tonsil;
RA   Honore B.;
RT   "hPWP1-interacting protein 4.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-264.
RC   TISSUE=Placenta, and Retinoblastoma;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=11584023; DOI=10.1074/jbc.M109215200;
RA   Lau P.P., Villanueva H., Kobayashi K., Nakamuta M., Chang B.H.-J.,
RA   Chan L.;
RT   "A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein
RT   B mRNA editing.";
RL   J. Biol. Chem. 276:46445-46452(2001).
RN   [12]
RP   COMPONENT OF A CHAPERONE COMPLEX.
RX   PubMed=12475965; DOI=10.1091/mbc.E02-05-0311;
RA   Meunier L., Usherwood Y.-K., Chung K.T., Hendershot L.M.;
RT   "A subset of chaperones and folding enzymes form multiprotein
RT   complexes in endoplasmic reticulum to bind nascent proteins.";
RL   Mol. Biol. Cell 13:4456-4469(2002).
RN   [13]
RP   SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=15544163; DOI=10.1379/CSC-52.1;
RA   Nakanishi K., Kamiguchi K., Torigoe T., Nabeta C., Hirohashi Y.,
RA   Asanuma H., Tobioka H., Koge N., Harada O., Tamura Y., Nagano H.,
RA   Yano S., Chiba S., Matsumoto H., Sato N.;
RT   "Localization and function in endoplasmic reticulum stress tolerance
RT   of ERdj3, a new member of Hsp40 family protein.";
RL   Cell Stress Chaperones 9:253-264(2004).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, INDUCTION, TISSUE SPECIFICITY,
RP   GLYCOSYLATION, INTERACTION WITH DENATURED SUBSTRATES, AND MUTAGENESIS
RP   OF HIS-53.
RX   PubMed=15525676; DOI=10.1091/mbc.E04-05-0434;
RA   Shen Y., Hendershot L.M.;
RT   "ERdj3, a stress-inducible endoplasmic reticulum DnaJ homologue,
RT   serves as a cofactor for BiP's interactions with unfolded
RT   substrates.";
RL   Mol. Biol. Cell 16:40-50(2005).
RN   [15]
RP   MUTAGENESIS OF CYS-169; CYS-171; CYS-193 AND CYS-196, AND INTERACTION
RP   WITH DENATURED SUBSTRATES.
RX   PubMed=17976514; DOI=10.1016/j.abb.2007.10.001;
RA   Marcus N.Y., Marcus R.A., Schmidt B.Z., Haslam D.B.;
RT   "Contribution of the HEDJ/ERdj3 cysteine-rich domain to substrate
RT   interactions.";
RL   Arch. Biochem. Biophys. 468:147-158(2007).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-188, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [17]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-261.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Serves as a co-chaperone for HSPA5. Binds directly to
CC       both unfolded proteins that are substrates for ERAD and nascent
CC       unfolded peptide chains, but dissociates from the HSPA5-unfolded
CC       protein complex before folding is completed. May help recruiting
CC       HSPA5 and other chaperones to the substrate. Stimulates HSPA5
CC       ATPase activity. {ECO:0000269|PubMed:10827079,
CC       ECO:0000269|PubMed:15525676}.
CC   -!- SUBUNIT: Part of a large chaperone multiprotein complex comprising
CC       DNAJB11, HSP90B1, HSPA5, HYOU, PDIA2, PDIA4, PDIA6, PPIB, SDF2L1,
CC       UGT1A1 and very small amounts of ERP29, but not, or at very low
CC       levels, CALR nor CANX. Binds to denatured substrates in an ATP-
CC       independent manner. Interacts via the J domain with HSPA5 in an
CC       ATP-dependent manner. {ECO:0000269|PubMed:10827079,
CC       ECO:0000269|PubMed:15525676, ECO:0000269|PubMed:17976514}.
CC   -!- INTERACTION:
CC       P11021:HSPA5; NbExp=3; IntAct=EBI-713113, EBI-354921;
CC       Q8ZQQ2:slrP (xeno); NbExp=4; IntAct=EBI-713113, EBI-10712653;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000269|PubMed:10827079, ECO:0000269|PubMed:15195998,
CC       ECO:0000269|PubMed:15525676, ECO:0000269|PubMed:15544163}.
CC       Note=Associated with the ER membrane in a C-terminally epitope-
CC       tagged construct.
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:10827079, ECO:0000269|PubMed:11584023,
CC       ECO:0000269|PubMed:15525676}.
CC   -!- INDUCTION: By endoplasmic reticulum stress-inducing agents such as
CC       thapsigargin and tunicamycin. {ECO:0000269|PubMed:15525676,
CC       ECO:0000269|PubMed:15544163}.
CC   -!- PTM: Contains high-mannose Endo H-sensitive carbohydrates.
CC   -!- PTM: Cys-169, Cys-171, Cys-193 and Cys-196 form intramolecular
CC       disulfide bonds. The preferential partner for each Cys is not
CC       known.
CC   -!- PTM: Thr-188 was reported to be phosphorylated upon DNA damage by
CC       ATM or ATR; however as this position has been shown to be in the
CC       ER lumen, the in vivo relevance is not proven.
CC   -!- CAUTION: PubMed:11584023 reported a cytosolic, as well as nuclear
CC       subcellular location. This result was obtained using an N-
CC       terminally GFP-tagged construct which most probably affected
CC       signal peptide-driven targeting to the ER. As a consequence, the
CC       in vivo revelance of the observed interaction with APOBEC1, a
CC       nuclear protein, is dubious. This holds true for the interaction
CC       with PWP1. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB028859; BAA88307.1; -; mRNA.
DR   EMBL; AF228505; AAF61711.1; -; mRNA.
DR   EMBL; AJ250137; CAB65118.1; -; mRNA.
DR   EMBL; AF277317; AAK69110.1; -; mRNA.
DR   EMBL; AY359043; AAQ89402.1; -; mRNA.
DR   EMBL; AK075300; BAC11533.1; -; mRNA.
DR   EMBL; AK075430; BAC11617.1; -; mRNA.
DR   EMBL; BT007063; AAP35712.1; -; mRNA.
DR   EMBL; CR457096; CAG33377.1; -; mRNA.
DR   EMBL; CH471052; EAW78190.1; -; Genomic_DNA.
DR   EMBL; BC001144; AAH01144.1; -; mRNA.
DR   CCDS; CCDS3277.1; -.
DR   PIR; T52073; T52073.
DR   RefSeq; NP_057390.1; NM_016306.5.
DR   UniGene; Hs.317192; -.
DR   UniGene; Hs.712822; -.
DR   ProteinModelPortal; Q9UBS4; -.
DR   SMR; Q9UBS4; -.
DR   BioGrid; 119699; 90.
DR   DIP; DIP-29678N; -.
DR   IntAct; Q9UBS4; 49.
DR   MINT; Q9UBS4; -.
DR   STRING; 9606.ENSP00000265028; -.
DR   iPTMnet; Q9UBS4; -.
DR   PhosphoSitePlus; Q9UBS4; -.
DR   BioMuta; DNAJB11; -.
DR   DMDM; 18203497; -.
DR   OGP; Q9UBS4; -.
DR   REPRODUCTION-2DPAGE; IPI00008454; -.
DR   EPD; Q9UBS4; -.
DR   MaxQB; Q9UBS4; -.
DR   PaxDb; Q9UBS4; -.
DR   PeptideAtlas; Q9UBS4; -.
DR   PRIDE; Q9UBS4; -.
DR   TopDownProteomics; Q9UBS4; -.
DR   DNASU; 51726; -.
DR   Ensembl; ENST00000265028; ENSP00000265028; ENSG00000090520.
DR   Ensembl; ENST00000439351; ENSP00000414398; ENSG00000090520.
DR   GeneID; 51726; -.
DR   KEGG; hsa:51726; -.
DR   UCSC; uc003fqi.4; human.
DR   CTD; 51726; -.
DR   DisGeNET; 51726; -.
DR   EuPathDB; HostDB:ENSG00000090520.10; -.
DR   GeneCards; DNAJB11; -.
DR   HGNC; HGNC:14889; DNAJB11.
DR   HPA; HPA010814; -.
DR   HPA; HPA017051; -.
DR   MIM; 611341; gene.
DR   neXtProt; NX_Q9UBS4; -.
DR   OpenTargets; ENSG00000090520; -.
DR   PharmGKB; PA27413; -.
DR   eggNOG; KOG0713; Eukaryota.
DR   eggNOG; COG0484; LUCA.
DR   GeneTree; ENSGT00860000133716; -.
DR   HOGENOM; HOG000226718; -.
DR   HOVERGEN; HBG066727; -.
DR   InParanoid; Q9UBS4; -.
DR   KO; K09517; -.
DR   OMA; KEGMMDH; -.
DR   OrthoDB; EOG091G0GWF; -.
DR   PhylomeDB; Q9UBS4; -.
DR   TreeFam; TF105144; -.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   ChiTaRS; DNAJB11; human.
DR   GeneWiki; DNAJB11; -.
DR   GenomeRNAi; 51726; -.
DR   PRO; PR:Q9UBS4; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000090520; -.
DR   CleanEx; HS_DNAJB11; -.
DR   Genevisible; Q9UBS4; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:AgBase.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0032781; P:positive regulation of ATPase activity; IDA:AgBase.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   CDD; cd06257; DnaJ; 1.
DR   Gene3D; 1.10.287.110; -; 1.
DR   InterPro; IPR002939; DnaJ_C.
DR   InterPro; IPR001623; DnaJ_domain.
DR   InterPro; IPR018253; DnaJ_domain_CS.
DR   InterPro; IPR008971; HSP40/DnaJ_pept-bd.
DR   InterPro; IPR036869; J_dom_sf.
DR   Pfam; PF00226; DnaJ; 1.
DR   Pfam; PF01556; DnaJ_C; 1.
DR   PRINTS; PR00625; JDOMAIN.
DR   SMART; SM00271; DnaJ; 1.
DR   SUPFAM; SSF46565; SSF46565; 1.
DR   SUPFAM; SSF49493; SSF49493; 3.
DR   PROSITE; PS00636; DNAJ_1; 1.
DR   PROSITE; PS50076; DNAJ_2; 1.
PE   1: Evidence at protein level;
KW   Chaperone; Complete proteome; Disulfide bond; Endoplasmic reticulum;
KW   Glycoprotein; Phosphoprotein; Polymorphism; Reference proteome;
KW   Signal.
FT   SIGNAL        1     22       {ECO:0000250}.
FT   CHAIN        23    358       DnaJ homolog subfamily B member 11.
FT                                /FTId=PRO_0000007260.
FT   DOMAIN       25     90       J. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00286}.
FT   MOD_RES     188    188       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   CARBOHYD    261    261       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   VARIANT     264    264       I -> V (in dbSNP:rs8147).
FT                                {ECO:0000269|PubMed:16303743,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_016092.
FT   MUTAGEN      53     53       H->Q: Loss of HSPA5-binding, but no
FT                                effect on interaction with denatured
FT                                substrates.
FT                                {ECO:0000269|PubMed:15525676}.
FT   MUTAGEN     169    169       C->S: Drastic loss of interaction with
FT                                denatured substrates.
FT                                {ECO:0000269|PubMed:17976514}.
FT   MUTAGEN     171    171       C->S: Drastic loss of interaction with
FT                                denatured substrates.
FT                                {ECO:0000269|PubMed:17976514}.
FT   MUTAGEN     193    193       C->S: Drastic loss of interaction with
FT                                denatured substrates.
FT                                {ECO:0000269|PubMed:17976514}.
FT   MUTAGEN     196    196       C->S: Drastic loss of interaction with
FT                                denatured substrates.
FT                                {ECO:0000269|PubMed:17976514}.
FT   CONFLICT    247    247       K -> R (in Ref. 8; CAG33377).
FT                                {ECO:0000305}.
SQ   SEQUENCE   358 AA;  40514 MW;  580CC4D66A06B734 CRC64;
     MAPQNLSTFC LLLLYLIGAV IAGRDFYKIL GVPRSASIKD IKKAYRKLAL QLHPDRNPDD
     PQAQEKFQDL GAAYEVLSDS EKRKQYDTYG EEGLKDGHQS SHGDIFSHFF GDFGFMFGGT
     PRQQDRNIPR GSDIIVDLEV TLEEVYAGNF VEVVRNKPVA RQAPGKRKCN CRQEMRTTQL
     GPGRFQMTQE VVCDECPNVK LVNEERTLEV EIEPGVRDGM EYPFIGEGEP HVDGEPGDLR
     FRIKVVKHPI FERRGDDLYT NVTISLVESL VGFEMDITHL DGHKVHISRD KITRPGAKLW
     KKGEGLPNFD NNNIKGSLII TFDVDFPKEQ LTEEAREGIK QLLKQGSVQK VYNGLQGY
//
ID   A0A1U9X7A6_HUMAN        Unreviewed;      1126 AA.
AC   A0A1U9X7A6;
DT   07-JUN-2017, integrated into UniProtKB/TrEMBL.
DT   07-JUN-2017, sequence version 1.
DT   23-MAY-2018, entry version 10.
DE   SubName: Full=BAG6 {ECO:0000313|EMBL:AQY76674.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AQY76674.1};
RN   [1] {ECO:0000313|EMBL:AQY76674.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Norman P.J., Norberg S.J., Nemat-Gorgani N., Ronaghi M., Parham P.;
RT   "CDS alleles of MHC region genes derived from homozygous
RT   individuals.";
RL   Submitted (MAR-2017) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KY500163; AQY76667.1; -; Genomic_DNA.
DR   EMBL; KY500166; AQY76670.1; -; Genomic_DNA.
DR   EMBL; KY500168; AQY76672.1; -; Genomic_DNA.
DR   EMBL; KY500170; AQY76674.1; -; Genomic_DNA.
DR   RefSeq; NP_001092004.1; NM_001098534.1.
DR   RefSeq; NP_542433.1; NM_080702.2.
DR   RefSeq; NP_542434.1; NM_080703.2.
DR   UniGene; Hs.440900; -.
DR   SMR; A0A1U9X7A6; -.
DR   GeneID; 7917; -.
DR   CTD; 7917; -.
DR   ExpressionAtlas; A0A1U9X7A6; baseline and differential.
DR   InterPro; IPR021925; BAG6.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR019954; Ubiquitin_CS.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   Pfam; PF12057; DUF3538; 1.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00299; UBIQUITIN_1; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   4: Predicted;
FT   DOMAIN       17     77       Ubiquitin-like.
FT                                {ECO:0000259|PROSITE:PS50053}.
SQ   SEQUENCE   1126 AA;  118693 MW;  8A67290BC8176ABA CRC64;
     MEPNDSTSTA VEEPDSLEVL VKTLDSQTRT FIVGAQMNVK EFKEHIAASV SIPSEKQRLI
     YQGRVLQDDK KLQEYNVGGK VIHLVERAPP QTHLPSGASS GTGSASATHG GGSPPGTRGP
     GASVHDRNAN SYVMVGTFNL PSDGSAVDVH INMEQAPIQS EPRVRLVMAQ HMIRDIQTLL
     SRMECRGGPQ PQHSQPPPQP PAVTPEPVAL SSQTSEPVES EAPPREPMEA EEVEERAPAQ
     NPELTPGPAP AGPTPAPETN APNHPSPAEY VEVLQELQRL ESRLQPFLQR YYEVLGAAAT
     TDYNNNHEGR EEDQRLINLV GESLRLLGNT FVALSDLRCN LACTPPRHLH VVRPMSHYTT
     PMVLQQAAIP IQINVGTTVT MTGNGTRPPP TPNAEAPPPG PGQASSVAPS STNVESSAEG
     APPPGPAPPP ATSHPRVIRI SHQSVEPVVM MHMNIQDSGT QPGGVPSAPT GPLGPPGHGQ
     TLGQQVPGFP TAPTRVVIAR PTPPQARPSH PGGPPVSGTL QGAGLGTNAS LAQMVSGLVG
     QLLMQPVLVA QGTPGMAPPP APATASASAG TTNTATTAGP APGGPAQPPP TPQPSMADLQ
     FSQLLGNLLG PAGPGAGGSG VASPTITVAM PGVPAFLQGM TDFLQATQTA PPPPPPPPPP
     PPAPEQQTMP PPGSPSGGAG SPGGLGLESL SPEFFTSVVQ GVLSSLLGSL GARAGSSESI
     AAFIQRLSGS SNIFEPGADG ALGFFGALLS LLCQNFSMVD VVMLLHGHFQ PLQRLQPQLR
     SFFHQHYLGG QEPTPSNIRM ATHTLITGLE EYVRESFSLV QVQPGVDIIR TNLEFLQEQF
     NSIAAHVLHC TDSGFGARLL ELCNQGLFEC LALNLHCLGG QQMELAAVIN GRIRRMSRGV
     NPSLVSWLTT MMGLRLQVVL EHMPVGPDAI LRYVRRVGDP PQPLPEEPME VQGAERASPE
     PQRENASPAP GTTAEEAMSR GPPPAPEGGS RDEQDGASAE TEPWAAAVPP EWVPIIQQDI
     QSQRKVKPQP PLSDAYLSGM PAKRRKTMQG EGPQLLLSEA VSRAAKAAGA RPLTSPESLS
     RDLEAPEVQE SYRQQLRSDI QKRLQEDPNY SPQRFPNAQR AFADDP
//
ID   BAG6_HUMAN              Reviewed;        1132 AA.
AC   P46379; A2ADJ7; A3KQ42; A3KQ44; A6NGY6; A6PWF7; B0UX84; B4DZ12;
AC   B4E3V4; E7EMZ4; F8VXY4; O95874; Q5HYL9; Q5SQ35; Q5SQ36; Q5SQ37;
AC   Q5SQ41; Q5SRP8; Q5SRP9; Q5STC1; Q5STX1; Q5STX3; Q96SA6; Q9BCN4;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2005, sequence version 2.
DT   23-MAY-2018, entry version 175.
DE   RecName: Full=Large proline-rich protein BAG6 {ECO:0000305};
DE   AltName: Full=BAG family molecular chaperone regulator 6;
DE   AltName: Full=BCL2-associated athanogene 6 {ECO:0000312|HGNC:HGNC:13919};
DE            Short=BAG-6;
DE   AltName: Full=HLA-B-associated transcript 3 {ECO:0000303|PubMed:2156268};
DE   AltName: Full=Protein G3;
DE   AltName: Full=Protein Scythe {ECO:0000303|PubMed:17403783};
GN   Name=BAG6 {ECO:0000312|HGNC:HGNC:13919};
GN   Synonyms=BAT3 {ECO:0000303|PubMed:2156268}, G3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), VARIANT PRO-625,
RP   AND REPEAT.
RC   TISSUE=T-cell;
RX   PubMed=2156268; DOI=10.1073/pnas.87.6.2374;
RA   Banerji J., Sands J., Strominger J.L., Spies T.;
RT   "A gene pair from the human major histocompatibility complex encodes
RT   large proline-rich proteins with multiple repeated motifs and a single
RT   ubiquitin-like domain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2374-2378(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Endometrium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 5), AND VARIANT
RP   PRO-625.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14656967; DOI=10.1101/gr.1736803;
RA   Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S.,
RA   Campbell R.D., Hood L.;
RT   "Analysis of the gene-dense major histocompatibility complex class III
RT   region and its comparison to mouse.";
RL   Genome Res. 13:2621-2636(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PRO-625.
RA   Hirakawa M., Yamaguchi H., Imai K., Shimada J., Shiina S., Tamiya G.,
RA   Oka A., Inoko H.;
RT   "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PRO-625.
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PRO-625.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH RICIN A CHAIN,
RP   MUTAGENESIS OF ASP-1001, AND CLEAVAGE BY CASP3.
RX   PubMed=14960581; DOI=10.1074/jbc.M307049200;
RA   Wu Y.-H., Shih S.-F., Lin J.-Y.;
RT   "Ricin triggers apoptotic morphological changes through caspase-3
RT   cleavage of BAT3.";
RL   J. Biol. Chem. 279:19264-19275(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1117, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH EP300.
RX   PubMed=17403783; DOI=10.1101/gad.1534107;
RA   Sasaki T., Gan E.C., Wakeham A., Kornbluth S., Mak T.W., Okada H.;
RT   "HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-
RT   mediated acetylation of p53.";
RL   Genes Dev. 21:848-861(2007).
RN   [13]
RP   FUNCTION IN NK CELL ACTIVATION, AND SUBCELLULAR LOCATION.
RX   PubMed=18055229; DOI=10.1016/j.immuni.2007.10.010;
RA   Pogge von Strandmann E., Simhadri V.R., von Tresckow B., Sasse S.,
RA   Reiners K.S., Hansen H.P., Rothe A., Boll B., Simhadri V.L.,
RA   Borchmann P., McKinnon P.J., Hallek M., Engert A.;
RT   "Human leukocyte antigen-B-associated transcript 3 is released from
RT   tumor cells and engages the NKp30 receptor on natural killer cells.";
RL   Immunity 27:965-974(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-973, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH CTCFL.
RX   PubMed=18765639; DOI=10.1128/MCB.00568-08;
RA   Nguyen P., Bar-Sela G., Sun L., Bisht K.S., Cui H., Kohn E.,
RA   Feinberg A.P., Gius D.;
RT   "BAT3 and SET1A form a complex with CTCFL/BORIS to modulate H3K4
RT   histone dimethylation and gene expression.";
RL   Mol. Cell. Biol. 28:6720-6729(2008).
RN   [17]
RP   FUNCTION IN NK CELL ACTIVATION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=18852879; DOI=10.1371/journal.pone.0003377;
RA   Simhadri V.R., Reiners K.S., Hansen H.P., Topolar D., Simhadri V.L.,
RA   Nohroudi K., Kufer T.A., Engert A., Pogge von Strandmann E.;
RT   "Dendritic cells release HLA-B-associated transcript-3 positive
RT   exosomes to regulate natural killer function.";
RL   PLoS ONE 3:E3377-E3377(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-973; SER-1081
RP   AND SER-1117, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-832
RP   (ISOFORM 4), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-964 AND SER-973, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   UBIQUITINATION IN CASE OF INFECTION BY L.PNEUMOPHILA (MICROBIAL
RP   INFECTION), AND INTERACTION WITH LPG2160 AND LEGU1 (MICROBIAL
RP   INFECTION).
RX   PubMed=20547746; DOI=10.1128/IAI.00344-10;
RA   Ensminger A.W., Isberg R.R.;
RT   "E3 ubiquitin ligase activity and targeting of BAT3 by multiple
RT   Legionella pneumophila translocated substrates.";
RL   Infect. Immun. 78:3905-3919(2010).
RN   [22]
RP   FUNCTION.
RX   PubMed=20516149; DOI=10.1242/jcs.066738;
RA   Leznicki P., Clancy A., Schwappach B., High S.;
RT   "Bat3 promotes the membrane integration of tail-anchored proteins.";
RL   J. Cell Sci. 123:2170-2178(2010).
RN   [23]
RP   FUNCTION, SUBCELLULAR LOCATION, RIBOSOME-BINDING, IDENTIFICATION BY
RP   MASS SPECTROMETRY, AND IDENTIFICATION IN THE BAG6/BAT3 COMPLEX.
RX   PubMed=20676083; DOI=10.1038/nature09296;
RA   Mariappan M., Li X., Stefanovic S., Sharma A., Mateja A., Keenan R.J.,
RA   Hegde R.S.;
RT   "A ribosome-associating factor chaperones tail-anchored membrane
RT   proteins.";
RL   Nature 466:1120-1124(2010).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-350; SER-964; SER-973
RP   AND SER-1117, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [26]
RP   FUNCTION, INTERACTION WITH AMFR; SYVN1 AND VCP, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=21636303; DOI=10.1016/j.molcel.2011.05.010;
RA   Wang Q., Liu Y., Soetandyo N., Baek K., Hegde R., Ye Y.;
RT   "A ubiquitin ligase-associated chaperone holdase maintains
RT   polypeptides in soluble states for proteasome degradation.";
RL   Mol. Cell 42:758-770(2011).
RN   [27]
RP   FUNCTION, AND DOMAIN.
RX   PubMed=21743475; DOI=10.1038/nature10181;
RA   Hessa T., Sharma A., Mariappan M., Eshleman H.D., Gutierrez E.,
RA   Hegde R.S.;
RT   "Protein targeting and degradation are coupled for elimination of
RT   mislocalized proteins.";
RL   Nature 475:394-397(2011).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-964 AND SER-973, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [29]
RP   FUNCTION, AND INTERACTION WITH SGTA.
RX   PubMed=23129660; DOI=10.1073/pnas.1209997109;
RA   Leznicki P., High S.;
RT   "SGTA antagonizes BAG6-mediated protein triage.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:19214-19219(2012).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-964; SER-973;
RP   THR-1053; SER-1081 AND SER-1117, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [31]
RP   INTERACTION WITH ZFAND2B.
RX   PubMed=24160817; DOI=10.1042/BJ20130710;
RA   Glinka T., Alter J., Braunstein I., Tzach L., Wei Sheng C.,
RA   Geifman S., Edelmann M.J., Kessler B.M., Stanhill A.;
RT   "Signal-peptide-mediated translocation is regulated by a p97-AIRAPL
RT   complex.";
RL   Biochem. J. 457:253-261(2014).
RN   [32]
RP   INTERACTION WITH SGTA AND USP13.
RX   PubMed=24424410; DOI=10.7554/eLife.01369;
RA   Liu Y., Soetandyo N., Lee J.G., Liu L., Xu Y., Clemons W.M. Jr.,
RA   Ye Y.;
RT   "USP13 antagonizes gp78 to maintain functionality of a chaperone in
RT   ER-associated degradation.";
RL   Elife 3:E01369-E01369(2014).
RN   [33]
RP   FUNCTION, AND INTERACTION WITH SGTA.
RX   PubMed=25179605; DOI=10.1242/jcs.155648;
RA   Wunderley L., Leznicki P., Payapilly A., High S.;
RT   "SGTA regulates the cytosolic quality control of hydrophobic
RT   substrates.";
RL   J. Cell Sci. 127:4728-4739(2014).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96 AND THR-117, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [35]
RP   FUNCTION, INTERACTION WITH RNF126, AND DOMAIN.
RX   PubMed=24981174; DOI=10.1016/j.molcel.2014.05.025;
RA   Rodrigo-Brenni M.C., Gutierrez E., Hegde R.S.;
RT   "Cytosolic quality control of mislocalized proteins requires RNF126
RT   recruitment to Bag6.";
RL   Mol. Cell 55:227-237(2014).
RN   [36]
RP   FUNCTION.
RX   PubMed=26565908; DOI=10.1016/j.celrep.2015.09.047;
RA   Kadowaki H., Nagai A., Maruyama T., Takami Y., Satrimafitrah P.,
RA   Kato H., Honda A., Hatta T., Natsume T., Sato T., Kai H., Ichijo H.,
RA   Nishitoh H.;
RT   "Pre-emptive quality control protects the ER from protein overload via
RT   the proximity of ERAD components and SRP.";
RL   Cell Rep. 13:944-956(2015).
RN   [37]
RP   INTERACTION WITH ZFAND2B.
RX   PubMed=26337389; DOI=10.1091/mbc.E15-02-0085;
RA   Braunstein I., Zach L., Allan S., Kalies K.U., Stanhill A.;
RT   "Proteasomal degradation of preemptive quality control (pQC)
RT   substrates is mediated by an AIRAPL-p97 complex.";
RL   Mol. Biol. Cell 26:3719-3727(2015).
RN   [38]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [39]
RP   FUNCTION.
RX   PubMed=26692333; DOI=10.1038/nm.4013;
RA   Osorio F.G., Soria-Valles C., Santiago-Fernandez O., Bernal T.,
RA   Mittelbrunn M., Colado E., Rodriguez F., Bonzon-Kulichenko E.,
RA   Vazquez J., Porta-de-la-Riva M., Ceron J., Fueyo A., Li J.,
RA   Green A.R., Freije J.M., Lopez-Otin C.;
RT   "Loss of the proteostasis factor AIRAPL causes myeloid transformation
RT   by deregulating IGF-1 signaling.";
RL   Nat. Med. 22:91-96(2016).
RN   [40]
RP   FUNCTION, DOMAIN, AND REGION.
RX   PubMed=28104892; DOI=10.1126/science.aah6130;
RA   Shao S., Rodrigo-Brenni M.C., Kivlen M.H., Hegde R.S.;
RT   "Mechanistic basis for a molecular triage reaction.";
RL   Science 355:298-302(2017).
RN   [41]
RP   STRUCTURE BY NMR OF 17-89.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the N-terminal ubiquitin-like domain in the
RT   human BAT3 protein.";
RL   Submitted (JUL-2005) to the PDB data bank.
RN   [42]
RP   STRUCTURE BY NMR OF 17-101 IN COMPLEX WITH RNF126, FUNCTION,
RP   INTERACTION WITH RNF126 AND SGTA, AND DOMAIN.
RX   PubMed=27193484; DOI=10.1038/srep26433;
RA   Krysztofinska E.M., Martinez-Lumbreras S., Thapaliya A., Evans N.J.,
RA   High S., Isaacson R.L.;
RT   "Structural and functional insights into the E3 ligase, RNF126.";
RL   Sci. Rep. 6:26433-26433(2016).
CC   -!- FUNCTION: ATP-independent molecular chaperone preventing the
CC       aggregation of misfolded and hydrophobic patches-containing
CC       proteins (PubMed:21636303). Functions as part of a cytosolic
CC       protein quality control complex, the BAG6/BAT3 complex, which
CC       maintains these client proteins in a soluble state and
CC       participates to their proper delivery to the endoplasmic reticulum
CC       or alternatively can promote their sorting to the proteasome where
CC       they undergo degradation (PubMed:20516149, PubMed:21636303,
CC       PubMed:21743475, PubMed:28104892). The BAG6/BAT3 complex is
CC       involved in the post-translational delivery of tail-anchored/type
CC       II transmembrane proteins to the endoplasmic reticulum membrane.
CC       Recruited to ribosomes, it interacts with the transmembrane region
CC       of newly synthesized tail-anchored proteins and together with SGTA
CC       and ASNA1 mediates their delivery to the endoplasmic reticulum
CC       (PubMed:20516149, PubMed:20676083, PubMed:28104892). Client
CC       proteins that cannot be properly delivered to the endoplasmic
CC       reticulum are ubiquitinated by RNF126, an E3 ubiquitin-protein
CC       ligase associated with BAG6 and are sorted to the proteasome
CC       (PubMed:24981174, PubMed:28104892, PubMed:27193484). SGTA which
CC       prevents the recruitment of RNF126 to BAG6 may negatively regulate
CC       the ubiquitination and the proteasomal degradation of client
CC       proteins (PubMed:23129660, PubMed:25179605, PubMed:27193484).
CC       Similarly, the BAG6/BAT3 complex also functions as a sorting
CC       platform for proteins of the secretory pathway that are
CC       mislocalized to the cytosol either delivering them to the
CC       proteasome for degradation or to the endoplasmic reticulum
CC       (PubMed:21743475). The BAG6/BAT3 complex also plays a role in the
CC       endoplasmic reticulum-associated degradation (ERAD), a quality
CC       control mechanism that eliminates unwanted proteins of the
CC       endoplasmic reticulum through their retrotranslocation to the
CC       cytosol and their targeting to the proteasome. It maintains these
CC       retrotranslocated proteins in an unfolded yet soluble state
CC       condition in the cytosol to ensure their proper delivery to the
CC       proteasome (PubMed:21636303). BAG6 is also required for selective
CC       ubiquitin-mediated degradation of defective nascent chain
CC       polypeptides by the proteasome. In this context, it may
CC       participate to the production of antigenic peptides and play a
CC       role in antigen presentation in immune response (By similarity).
CC       BAG6 is also involved in endoplasmic reticulum stress-induced pre-
CC       emptive quality control, a mechanism that selectively attenuates
CC       the translocation of newly synthesized proteins into the
CC       endoplasmic reticulum and reroutes them to the cytosol for
CC       proteasomal degradation. BAG6 may ensure the proper degradation of
CC       these proteins and thereby protects the endoplasmic reticulum from
CC       protein overload upon stress (PubMed:26565908). By inhibiting the
CC       polyubiquitination and subsequent proteasomal degradation of HSPA2
CC       it may also play a role in the assembly of the synaptonemal
CC       complex during spermatogenesis (By similarity). Also positively
CC       regulates apoptosis by interacting with and stabilizing the
CC       proapoptotic factor AIFM1 (By similarity). By controlling the
CC       steady-state expression of the IGF1R receptor, indirectly
CC       regulates the insulin-like growth factor receptor signaling
CC       pathway (PubMed:26692333). {ECO:0000250|UniProtKB:Q9Z1R2,
CC       ECO:0000269|PubMed:20516149, ECO:0000269|PubMed:20676083,
CC       ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:21743475,
CC       ECO:0000269|PubMed:23129660, ECO:0000269|PubMed:24981174,
CC       ECO:0000269|PubMed:25179605, ECO:0000269|PubMed:26565908,
CC       ECO:0000269|PubMed:26692333, ECO:0000269|PubMed:27193484,
CC       ECO:0000269|PubMed:28104892}.
CC   -!- FUNCTION: Involved in DNA damage-induced apoptosis: following DNA
CC       damage, accumulates in the nucleus and forms a complex with
CC       p300/EP300, enhancing p300/EP300-mediated p53/TP53 acetylation
CC       leading to increase p53/TP53 transcriptional activity
CC       (PubMed:17403783). When nuclear, may also act as a component of
CC       some chromatin regulator complex that regulates histone 3 'Lys-4'
CC       dimethylation (H3K4me2) (PubMed:18765639).
CC       {ECO:0000269|PubMed:17403783, ECO:0000269|PubMed:18765639}.
CC   -!- FUNCTION: Released extracellularly via exosomes, it is a ligand of
CC       the natural killer/NK cells receptor NCR3 and stimulates NK cells
CC       cytotoxicity. It may thereby trigger NK cells cytotoxicity against
CC       neighboring tumor cells and immature myeloid dendritic cells (DC).
CC       {ECO:0000269|PubMed:18055229, ECO:0000269|PubMed:18852879}.
CC   -!- FUNCTION: Mediates ricin-induced apoptosis.
CC       {ECO:0000269|PubMed:14960581}.
CC   -!- SUBUNIT: Component of the BAG6/BAT3 complex, also named BAT3
CC       complex, at least composed of BAG6, UBL4A and GET4/TRC35
CC       (PubMed:20676083). Interacts with GET4; the interaction is direct
CC       and localizes BAG6 in the cytosol (PubMed:21636303). Interacts
CC       with AIFM1 (By similarity). Interacts with HSPA2 (By similarity).
CC       Interacts with CTCFL (PubMed:18765639). Interacts with p300/EP300
CC       (PubMed:17403783). Interacts (via ubiquitin-like domain) with
CC       RNF126; required for BAG6-dependent ubiquitination of proteins
CC       mislocalized to the cytosol (PubMed:24981174, PubMed:27193484).
CC       Interacts (via ubiquitin-like domain) with SGTA; SGTA competes
CC       with RNF126 by binding the same region of BAG6, thereby promoting
CC       deubiquitination of BAG6-target proteins and rescuing them from
CC       degradation (PubMed:23129660, PubMed:24424410, PubMed:25179605,
CC       PubMed:27193484). Interacts with ricin A chain (PubMed:14960581).
CC       Interacts with VCP and AMFR; both form the VCP/p97-AMFR/gp78
CC       complex (PubMed:21636303). Interacts with SYVN1 (PubMed:21636303).
CC       Interacts with USP13; the interaction is direct and may mediate
CC       UBL4A deubiquitination (PubMed:24424410). Interacts with ZFAND2B
CC       (PubMed:24160817, PubMed:26337389). {ECO:0000250|UniProtKB:Q9Z1R2,
CC       ECO:0000269|PubMed:14960581, ECO:0000269|PubMed:17403783,
CC       ECO:0000269|PubMed:18765639, ECO:0000269|PubMed:20676083,
CC       ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:23129660,
CC       ECO:0000269|PubMed:24160817, ECO:0000269|PubMed:24424410,
CC       ECO:0000269|PubMed:24981174, ECO:0000269|PubMed:25179605,
CC       ECO:0000269|PubMed:26337389, ECO:0000269|PubMed:27193484}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with L. pneumophila
CC       Lpg2160 and LegU1 proteins. {ECO:0000269|PubMed:20547746}.
CC   -!- INTERACTION:
CC       Q12805:EFEMP1; NbExp=3; IntAct=EBI-347552, EBI-536772;
CC       Q8IZU0:FAM9B; NbExp=3; IntAct=EBI-347552, EBI-10175124;
CC       Q53G59:KLHL12; NbExp=4; IntAct=EBI-347552, EBI-740929;
CC       Q7Z434:MAVS; NbExp=2; IntAct=EBI-347552, EBI-995373;
CC       O14931:NCR3; NbExp=6; IntAct=EBI-347552, EBI-14989262;
CC       O14931-1:NCR3; NbExp=5; IntAct=EBI-9640181, EBI-15013584;
CC       Q9BV68:RNF126; NbExp=4; IntAct=EBI-347552, EBI-357322;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-347552, EBI-347996;
CC       Q12800:TFCP2; NbExp=3; IntAct=EBI-347552, EBI-717422;
CC       Q9UHD9:UBQLN2; NbExp=4; IntAct=EBI-10988864, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:17403783, ECO:0000269|PubMed:20676083,
CC       ECO:0000269|PubMed:21636303}. Nucleus
CC       {ECO:0000269|PubMed:14960581, ECO:0000269|PubMed:17403783,
CC       ECO:0000269|PubMed:21636303}. Secreted, exosome
CC       {ECO:0000269|PubMed:18055229, ECO:0000269|PubMed:18852879}.
CC       Note=Normally localized in cytosol and nucleus, it can also be
CC       released extracellularly, in exosomes, by tumor and myeloid
CC       dendritic cells. {ECO:0000269|PubMed:18055229,
CC       ECO:0000269|PubMed:18852879}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P46379-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P46379-2; Sequence=VSP_015695;
CC       Name=3;
CC         IsoId=P46379-3; Sequence=VSP_015695, VSP_030519;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=P46379-4; Sequence=VSP_015695, VSP_045910, VSP_045911,
CC                                  VSP_045912, VSP_045913;
CC         Note=No experimental confirmation available. Contains a
CC         phosphoserine at position 832.;
CC       Name=5;
CC         IsoId=P46379-5; Sequence=VSP_015695, VSP_045913;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed by immature dendritic cells (at
CC       protein level). {ECO:0000269|PubMed:18852879}.
CC   -!- DOMAIN: The ubiquitin-like domain mediates interaction with the E3
CC       ubiquitin-protein ligase RNF126 which is responsible for the BAG6-
CC       dependent ubiquitination of client proteins (PubMed:21743475,
CC       PubMed:24981174, PubMed:28104892, PubMed:27193484). SGTA also
CC       binds this domain and competes with RNF126 to antagonize client
CC       protein ubiquitination and degradation (PubMed:28104892). The
CC       ubiquitin-like domain also mediates the interaction with USP13
CC       (PubMed:24424410). {ECO:0000269|PubMed:21743475,
CC       ECO:0000269|PubMed:24424410, ECO:0000269|PubMed:24981174,
CC       ECO:0000269|PubMed:27193484, ECO:0000269|PubMed:28104892}.
CC   -!- PTM: Ricin can induce a cleavage by the caspase CASP3. The
CC       released C-terminal peptide induces apoptosis.
CC       {ECO:0000269|PubMed:14960581}.
CC   -!- PTM: (Microbial infection) In case of infection by L.pneumophila,
CC       ubiquitinated by the SCF(LegU1) complex.
CC       {ECO:0000269|PubMed:20547746}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD18085.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAB63390.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAI18318.2; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M33519; AAA35587.1; -; mRNA.
DR   EMBL; M33521; AAA35588.1; -; Genomic_DNA.
DR   EMBL; M33520; AAA35588.1; JOINED; Genomic_DNA.
DR   EMBL; BX647244; CAI46045.1; -; mRNA.
DR   EMBL; AK302695; BAG63924.1; -; mRNA.
DR   EMBL; AK304879; BAG65616.1; -; mRNA.
DR   EMBL; AF129756; AAD18085.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BA000025; BAB63390.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AL662801; CAI18314.1; -; Genomic_DNA.
DR   EMBL; AL662801; CAI18315.1; -; Genomic_DNA.
DR   EMBL; AL662801; CAI18316.2; -; Genomic_DNA.
DR   EMBL; AL662801; CAI18318.2; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL662847; CAI17658.1; -; Genomic_DNA.
DR   EMBL; AL670886; CAI17658.1; JOINED; Genomic_DNA.
DR   EMBL; AL662847; CAI17659.1; -; Genomic_DNA.
DR   EMBL; AL670886; CAI17659.1; JOINED; Genomic_DNA.
DR   EMBL; AL670886; CAI17784.1; -; Genomic_DNA.
DR   EMBL; AL662847; CAI17784.1; JOINED; Genomic_DNA.
DR   EMBL; AL670886; CAI17785.1; -; Genomic_DNA.
DR   EMBL; AL662847; CAI17785.1; JOINED; Genomic_DNA.
DR   EMBL; AL670886; CAI17786.1; -; Genomic_DNA.
DR   EMBL; AL662847; CAI17786.1; JOINED; Genomic_DNA.
DR   EMBL; AL805934; CAI18501.1; -; Genomic_DNA.
DR   EMBL; AL805934; CAI18504.1; -; Genomic_DNA.
DR   EMBL; AL805934; CAI18508.2; -; Genomic_DNA.
DR   EMBL; AL805934; CAI18509.1; -; Genomic_DNA.
DR   EMBL; AL670886; CAM25014.1; -; Genomic_DNA.
DR   EMBL; AL662847; CAM25014.1; JOINED; Genomic_DNA.
DR   EMBL; BX511262; CAM45799.1; -; Genomic_DNA.
DR   EMBL; BX511262; CAM45800.1; -; Genomic_DNA.
DR   EMBL; BX511262; CAM45801.1; -; Genomic_DNA.
DR   EMBL; AL662847; CAO72072.1; -; Genomic_DNA.
DR   EMBL; AL670886; CAO72072.1; JOINED; Genomic_DNA.
DR   EMBL; CR753842; CAQ06558.1; -; Genomic_DNA.
DR   EMBL; CR753892; CAQ06558.1; JOINED; Genomic_DNA.
DR   EMBL; CR753892; CAQ06931.1; -; Genomic_DNA.
DR   EMBL; CR753842; CAQ06931.1; JOINED; Genomic_DNA.
DR   EMBL; CR354443; CAQ06977.1; -; Genomic_DNA.
DR   EMBL; CR759761; CAQ10854.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03455.1; -; Genomic_DNA.
DR   EMBL; BC003133; AAH03133.1; -; mRNA.
DR   CCDS; CCDS4709.1; -. [P46379-2]
DR   CCDS; CCDS47403.1; -. [P46379-1]
DR   CCDS; CCDS56414.1; -. [P46379-4]
DR   CCDS; CCDS56415.1; -. [P46379-5]
DR   PIR; A35098; A35098.
DR   RefSeq; NP_001092004.1; NM_001098534.1. [P46379-2]
DR   RefSeq; NP_001186626.1; NM_001199697.1. [P46379-4]
DR   RefSeq; NP_001186627.1; NM_001199698.1. [P46379-5]
DR   RefSeq; NP_004630.3; NM_004639.3. [P46379-1]
DR   RefSeq; NP_542433.1; NM_080702.2. [P46379-2]
DR   RefSeq; NP_542434.1; NM_080703.2. [P46379-2]
DR   RefSeq; XP_016866776.1; XM_017011287.1. [P46379-3]
DR   UniGene; Hs.440900; -.
DR   PDB; 1WX9; NMR; -; A=17-89.
DR   PDB; 2N9P; NMR; -; C=17-101.
DR   PDB; 4DWF; X-ray; 1.80 A; A/B=13-101.
DR   PDB; 4EEW; X-ray; 1.30 A; A/B=1-87.
DR   PDB; 4WWR; X-ray; 2.00 A; A/C/E/G=1060-1111.
DR   PDB; 4X86; X-ray; 1.85 A; B=1048-1123.
DR   PDB; 6AU8; X-ray; 1.80 A; C=1008-1050.
DR   PDBsum; 1WX9; -.
DR   PDBsum; 2N9P; -.
DR   PDBsum; 4DWF; -.
DR   PDBsum; 4EEW; -.
DR   PDBsum; 4WWR; -.
DR   PDBsum; 4X86; -.
DR   PDBsum; 6AU8; -.
DR   ProteinModelPortal; P46379; -.
DR   SMR; P46379; -.
DR   BioGrid; 113647; 294.
DR   CORUM; P46379; -.
DR   DIP; DIP-31191N; -.
DR   IntAct; P46379; 260.
DR   MINT; P46379; -.
DR   STRING; 9606.ENSP00000365131; -.
DR   iPTMnet; P46379; -.
DR   PhosphoSitePlus; P46379; -.
DR   SwissPalm; P46379; -.
DR   BioMuta; BAG6; -.
DR   DMDM; 76800648; -.
DR   EPD; P46379; -.
DR   MaxQB; P46379; -.
DR   PaxDb; P46379; -.
DR   PeptideAtlas; P46379; -.
DR   PRIDE; P46379; -.
DR   Ensembl; ENST00000211379; ENSP00000211379; ENSG00000204463. [P46379-2]
DR   Ensembl; ENST00000361076; ENSP00000354368; ENSG00000096155. [P46379-1]
DR   Ensembl; ENST00000362049; ENSP00000354875; ENSG00000204463. [P46379-5]
DR   Ensembl; ENST00000375964; ENSP00000365131; ENSG00000204463. [P46379-1]
DR   Ensembl; ENST00000375976; ENSP00000365143; ENSG00000204463. [P46379-2]
DR   Ensembl; ENST00000383446; ENSP00000372938; ENSG00000096155. [P46379-2]
DR   Ensembl; ENST00000383448; ENSP00000372940; ENSG00000096155. [P46379-2]
DR   Ensembl; ENST00000417144; ENSP00000412110; ENSG00000229524. [P46379-2]
DR   Ensembl; ENST00000419847; ENSP00000389121; ENSG00000233348. [P46379-2]
DR   Ensembl; ENST00000439687; ENSP00000402856; ENSG00000204463. [P46379-4]
DR   Ensembl; ENST00000442479; ENSP00000413698; ENSG00000229524. [P46379-2]
DR   Ensembl; ENST00000443182; ENSP00000410156; ENSG00000233348. [P46379-2]
DR   Ensembl; ENST00000449450; ENSP00000397894; ENSG00000229524. [P46379-1]
DR   Ensembl; ENST00000451932; ENSP00000390966; ENSG00000233348. [P46379-1]
DR   Ensembl; ENST00000551350; ENSP00000447546; ENSG00000229524. [P46379-5]
DR   Ensembl; ENST00000552116; ENSP00000447946; ENSG00000233348. [P46379-5]
DR   Ensembl; ENST00000552605; ENSP00000446525; ENSG00000096155. [P46379-5]
DR   Ensembl; ENST00000613474; ENSP00000478966; ENSG00000227761. [P46379-4]
DR   Ensembl; ENST00000615143; ENSP00000482413; ENSG00000229524. [P46379-4]
DR   Ensembl; ENST00000615224; ENSP00000477951; ENSG00000228760. [P46379-4]
DR   Ensembl; ENST00000615725; ENSP00000479238; ENSG00000233348. [P46379-4]
DR   Ensembl; ENST00000617635; ENSP00000484238; ENSG00000096155. [P46379-4]
DR   Ensembl; ENST00000621056; ENSP00000477867; ENSG00000234651. [P46379-4]
DR   GeneID; 7917; -.
DR   KEGG; hsa:7917; -.
DR   UCSC; uc003nvf.4; human. [P46379-1]
DR   CTD; 7917; -.
DR   DisGeNET; 7917; -.
DR   EuPathDB; HostDB:ENSG00000204463.12; -.
DR   GeneCards; BAG6; -.
DR   H-InvDB; HIX0165051; -.
DR   H-InvDB; HIX0166179; -.
DR   H-InvDB; HIX0166289; -.
DR   H-InvDB; HIX0166578; -.
DR   H-InvDB; HIX0166832; -.
DR   H-InvDB; HIX0167081; -.
DR   H-InvDB; HIX0167222; -.
DR   H-InvDB; HIX0167321; -.
DR   H-InvDB; HIX0167461; -.
DR   H-InvDB; HIX0167568; -.
DR   HGNC; HGNC:13919; BAG6.
DR   HPA; CAB020704; -.
DR   HPA; HPA045116; -.
DR   HPA; HPA053291; -.
DR   MIM; 142590; gene.
DR   neXtProt; NX_P46379; -.
DR   OpenTargets; ENSG00000204463; -.
DR   PharmGKB; PA25264; -.
DR   eggNOG; KOG4248; Eukaryota.
DR   eggNOG; ENOG410XS9P; LUCA.
DR   GeneTree; ENSGT00390000016199; -.
DR   HOVERGEN; HBG002193; -.
DR   InParanoid; P46379; -.
DR   OMA; PMVAPNA; -.
DR   OrthoDB; EOG091G0XSR; -.
DR   PhylomeDB; P46379; -.
DR   TreeFam; TF328437; -.
DR   ChiTaRS; BAG6; human.
DR   EvolutionaryTrace; P46379; -.
DR   GeneWiki; HLA-B_associated_transcript_3; -.
DR   GenomeRNAi; 7917; -.
DR   PMAP-CutDB; B0UX84; -.
DR   PRO; PR:P46379; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000204463; -.
DR   ExpressionAtlas; P46379; baseline and differential.
DR   Genevisible; P46379; HS.
DR   GO; GO:0071818; C:BAT3 complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0030544; F:Hsp70 protein binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0051787; F:misfolded protein binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0031593; F:polyubiquitin modification-dependent protein binding; ISS:UniProtKB.
DR   GO; GO:0070628; F:proteasome binding; ISS:UniProtKB.
DR   GO; GO:0043022; F:ribosome binding; IDA:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:1990381; F:ubiquitin-specific protease binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0006915; P:apoptotic process; IDA:UniProtKB.
DR   GO; GO:0007420; P:brain development; ISS:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0009790; P:embryo development; ISS:UniProtKB.
DR   GO; GO:0061857; P:endoplasmic reticulum stress-induced pre-emptive quality control; IMP:UniProtKB.
DR   GO; GO:0071712; P:ER-associated misfolded protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0002429; P:immune response-activating cell surface receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0018393; P:internal peptidyl-lysine acetylation; IDA:UniProtKB.
DR   GO; GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:UniProtKB.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; ISS:UniProtKB.
DR   GO; GO:0030324; P:lung development; ISS:UniProtKB.
DR   GO; GO:1904378; P:maintenance of unfolded protein involved in ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0030101; P:natural killer cell activation; IDA:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0045861; P:negative regulation of proteolysis; ISS:UniProtKB.
DR   GO; GO:1904294; P:positive regulation of ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0010498; P:proteasomal protein catabolic process; IMP:UniProtKB.
DR   GO; GO:1904379; P:protein localization to cytosolic proteasome complex involved in ERAD pathway; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0050821; P:protein stabilization; ISS:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB.
DR   GO; GO:0007130; P:synaptonemal complex assembly; ISS:UniProtKB.
DR   GO; GO:0071816; P:tail-anchored membrane protein insertion into ER membrane; IDA:UniProtKB.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IDA:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   InterPro; IPR021925; BAG6.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR019954; Ubiquitin_CS.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   Pfam; PF12057; DUF3538; 1.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00299; UBIQUITIN_1; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis; Chaperone;
KW   Chromatin regulator; Complete proteome; Cytoplasm; Differentiation;
KW   Immunity; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Secreted; Spermatogenesis; Transport; Ubl conjugation.
FT   CHAIN         1   1132       Large proline-rich protein BAG6.
FT                                /FTId=PRO_0000114897.
FT   DOMAIN       17     92       Ubiquitin-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   REPEAT      242    270       1. {ECO:0000303|PubMed:2156268}.
FT   REPEAT      415    443       2. {ECO:0000303|PubMed:2156268}.
FT   REPEAT      574    602       3. {ECO:0000303|PubMed:2156268}.
FT   REPEAT      608    636       4. {ECO:0000303|PubMed:2156268}.
FT   REGION      242    636       4 X 29 AA approximate repeats.
FT                                {ECO:0000303|PubMed:2156268}.
FT   REGION     1022   1132       Mediates interaction with UBL4A and GET4
FT                                and is sufficient for the delivery of
FT                                client proteins to the endoplasmic
FT                                reticulum. {ECO:0000269|PubMed:28104892}.
FT   COMPBIAS    195    273       Pro-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00015}.
FT   COMPBIAS    394    681       Pro-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00015}.
FT   SITE       1001   1002       Cleavage; by CASP3.
FT                                {ECO:0000269|PubMed:14960581}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      96     96       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     113    113       Phosphoserine.
FT                                {ECO:0000244|PubMed:17924679,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     117    117       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     350    350       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     964    964       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     973    973       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1053   1053       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1081   1081       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1117   1117       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     185    190       Missing (in isoform 2, isoform 3, isoform
FT                                4 and isoform 5).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_015695.
FT   VAR_SEQ     489    489       G -> GSTLIQLPSLPPEFMHAVAHQITHQAMVAAVASAAA
FT                                G (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_030519.
FT   VAR_SEQ     527    527       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045910.
FT   VAR_SEQ     561    685       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045911.
FT   VAR_SEQ     969   1016       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045912.
FT   VAR_SEQ    1053   1101       Missing (in isoform 4 and isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045913.
FT   VARIANT     625    625       S -> P (in dbSNP:rs1052486).
FT                                {ECO:0000269|PubMed:14574404,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:2156268,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.7}.
FT                                /FTId=VAR_023531.
FT   VARIANT     728    728       A -> V (in dbSNP:rs11548856).
FT                                /FTId=VAR_037150.
FT   MUTAGEN    1001   1001       D->A: Abolishes cleavage by the caspase
FT                                CASP3. {ECO:0000269|PubMed:14960581}.
FT   CONFLICT     43     43       K -> R (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT     47     47       A -> R (in Ref. 1; AAA35587).
FT                                {ECO:0000305}.
FT   CONFLICT    150    150       H -> D (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    511    511       Q -> R (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    561    561       G -> D (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    617    617       P -> L (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    679    679       G -> R (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    839    839       L -> R (in Ref. 3; BAG63924).
FT                                {ECO:0000305}.
FT   CONFLICT    842    842       L -> P (in Ref. 3; BAG63924).
FT                                {ECO:0000305}.
FT   CONFLICT    853    853       V -> M (in Ref. 2; CAI46045).
FT                                {ECO:0000305}.
FT   CONFLICT    854    854       L -> Q (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    927    927       E -> D (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   STRAND       16     23       {ECO:0000244|PDB:4EEW}.
FT   STRAND       28     34       {ECO:0000244|PDB:4EEW}.
FT   STRAND       35     37       {ECO:0000244|PDB:2N9P}.
FT   HELIX        39     50       {ECO:0000244|PDB:4EEW}.
FT   HELIX        54     56       {ECO:0000244|PDB:4EEW}.
FT   STRAND       57     61       {ECO:0000244|PDB:4EEW}.
FT   STRAND       64     66       {ECO:0000244|PDB:2N9P}.
FT   STRAND       68     71       {ECO:0000244|PDB:1WX9}.
FT   HELIX        72     75       {ECO:0000244|PDB:4EEW}.
FT   STRAND       80     86       {ECO:0000244|PDB:4EEW}.
FT   TURN         91     93       {ECO:0000244|PDB:2N9P}.
FT   HELIX      1009   1013       {ECO:0000244|PDB:6AU8}.
FT   HELIX      1016   1018       {ECO:0000244|PDB:6AU8}.
FT   HELIX      1019   1028       {ECO:0000244|PDB:6AU8}.
FT   HELIX      1040   1043       {ECO:0000244|PDB:6AU8}.
FT   HELIX      1063   1074       {ECO:0000244|PDB:4X86}.
FT   HELIX      1082   1089       {ECO:0000244|PDB:4X86}.
FT   HELIX      1092   1110       {ECO:0000244|PDB:4X86}.
SQ   SEQUENCE   1132 AA;  119409 MW;  625B5F86321367ED CRC64;
     MEPNDSTSTA VEEPDSLEVL VKTLDSQTRT FIVGAQMNVK EFKEHIAASV SIPSEKQRLI
     YQGRVLQDDK KLQEYNVGGK VIHLVERAPP QTHLPSGASS GTGSASATHG GGSPPGTRGP
     GASVHDRNAN SYVMVGTFNL PSDGSAVDVH INMEQAPIQS EPRVRLVMAQ HMIRDIQTLL
     SRMETLPYLQ CRGGPQPQHS QPPPQPPAVT PEPVALSSQT SEPVESEAPP REPMEAEEVE
     ERAPAQNPEL TPGPAPAGPT PAPETNAPNH PSPAEYVEVL QELQRLESRL QPFLQRYYEV
     LGAAATTDYN NNHEGREEDQ RLINLVGESL RLLGNTFVAL SDLRCNLACT PPRHLHVVRP
     MSHYTTPMVL QQAAIPIQIN VGTTVTMTGN GTRPPPTPNA EAPPPGPGQA SSVAPSSTNV
     ESSAEGAPPP GPAPPPATSH PRVIRISHQS VEPVVMMHMN IQDSGTQPGG VPSAPTGPLG
     PPGHGQTLGQ QVPGFPTAPT RVVIARPTPP QARPSHPGGP PVSGTLQGAG LGTNASLAQM
     VSGLVGQLLM QPVLVAQGTP GMAPPPAPAT ASASAGTTNT ATTAGPAPGG PAQPPPTPQP
     SMADLQFSQL LGNLLGPAGP GAGGSGVASP TITVAMPGVP AFLQGMTDFL QATQTAPPPP
     PPPPPPPPAP EQQTMPPPGS PSGGAGSPGG LGLESLSPEF FTSVVQGVLS SLLGSLGARA
     GSSESIAAFI QRLSGSSNIF EPGADGALGF FGALLSLLCQ NFSMVDVVML LHGHFQPLQR
     LQPQLRSFFH QHYLGGQEPT PSNIRMATHT LITGLEEYVR ESFSLVQVQP GVDIIRTNLE
     FLQEQFNSIA AHVLHCTDSG FGARLLELCN QGLFECLALN LHCLGGQQME LAAVINGRIR
     RMSRGVNPSL VSWLTTMMGL RLQVVLEHMP VGPDAILRYV RRVGDPPQPL PEEPMEVQGA
     ERASPEPQRE NASPAPGTTA EEAMSRGPPP APEGGSRDEQ DGASAETEPW AAAVPPEWVP
     IIQQDIQSQR KVKPQPPLSD AYLSGMPAKR RKTMQGEGPQ LLLSEAVSRA AKAAGARPLT
     SPESLSRDLE APEVQESYRQ QLRSDIQKRL QEDPNYSPQR FPNAQRAFAD DP
//
ID   A0A024R778_HUMAN        Unreviewed;       168 AA.
AC   A0A024R778;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 30.
DE   SubName: Full=Pleiotrophin (Heparin binding growth factor 8, neurite growth-promoting factor 1), isoform CRA_a {ECO:0000313|EMBL:EAW83872.1};
GN   Name=PTN {ECO:0000313|EMBL:EAW83872.1};
GN   ORFNames=hCG_18946 {ECO:0000313|EMBL:EAW83872.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW83872.1};
RN   [1] {ECO:0000313|EMBL:EAW83872.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW83872.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471070; EAW83872.1; -; Genomic_DNA.
DR   RefSeq; NP_001308315.1; NM_001321386.2.
DR   RefSeq; NP_002816.1; NM_002825.6.
DR   UniGene; Hs.371249; -.
DR   ProteinModelPortal; A0A024R778; -.
DR   SMR; A0A024R778; -.
DR   GeneID; 5764; -.
DR   KEGG; hsa:5764; -.
DR   CTD; 5764; -.
DR   EuPathDB; HostDB:ENSG00000105894.11; -.
DR   eggNOG; ENOG410IWNA; Eukaryota.
DR   eggNOG; ENOG4111ZWP; LUCA.
DR   KO; K16642; -.
DR   OMA; GEDICNS; -.
DR   OrthoDB; EOG091G0VCN; -.
DR   PhylomeDB; A0A024R778; -.
DR   ChiTaRS; PTN; human.
DR   GenomeRNAi; 5764; -.
DR   Bgee; ENSG00000105894; -.
DR   ExpressionAtlas; A0A024R778; baseline and differential.
DR   GO; GO:0005604; C:basement membrane; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; IEA:Ensembl.
DR   GO; GO:0031594; C:neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0008083; F:growth factor activity; IEA:Ensembl.
DR   GO; GO:1904399; F:heparan sulfate binding; IEA:Ensembl.
DR   GO; GO:0008201; F:heparin binding; IEA:Ensembl.
DR   GO; GO:0030282; P:bone mineralization; IEA:Ensembl.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEA:Ensembl.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0034644; P:cellular response to UV; IEA:Ensembl.
DR   GO; GO:0071305; P:cellular response to vitamin D; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0045446; P:endothelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0044849; P:estrous cycle; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0007612; P:learning; IEA:Ensembl.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl.
DR   GO; GO:0030336; P:negative regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; IEA:Ensembl.
DR   GO; GO:0045837; P:negative regulation of membrane potential; IEA:Ensembl.
DR   GO; GO:0072201; P:negative regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:1904397; P:negative regulation of neuromuscular junction development; IEA:Ensembl.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl.
DR   GO; GO:2000347; P:positive regulation of hepatocyte proliferation; IEA:Ensembl.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:1904395; P:positive regulation of skeletal muscle acetylcholine-gated channel clustering; IEA:Ensembl.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:Ensembl.
DR   GO; GO:0014823; P:response to activity; IEA:Ensembl.
DR   GO; GO:1904391; P:response to ciliary neurotrophic factor; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:1904373; P:response to kainic acid; IEA:Ensembl.
DR   GO; GO:1990089; P:response to nerve growth factor; IEA:Ensembl.
DR   GO; GO:0032570; P:response to progesterone; IEA:Ensembl.
DR   GO; GO:0060221; P:retinal rod cell differentiation; IEA:Ensembl.
DR   GO; GO:1904389; P:rod bipolar cell differentiation; IEA:Ensembl.
DR   GO; GO:0021510; P:spinal cord development; IEA:Ensembl.
DR   GO; GO:0021794; P:thalamus development; IEA:Ensembl.
DR   Gene3D; 2.20.60.10; -; 1.
DR   Gene3D; 2.30.90.10; -; 1.
DR   InterPro; IPR000762; Midkine_heparin-bd_GF.
DR   InterPro; IPR020090; PTN/MK_C_dom.
DR   InterPro; IPR038130; PTN/MK_C_dom_sf.
DR   InterPro; IPR020091; PTN/MK_diS_sf.
DR   InterPro; IPR020089; PTN/MK_N_dom.
DR   InterPro; IPR037122; PTN/MK_N_dom_sf.
DR   InterPro; IPR020092; PTN_MK_heparin-bd_GF_CS.
DR   PANTHER; PTHR13850; PTHR13850; 1.
DR   Pfam; PF01091; PTN_MK_C; 1.
DR   Pfam; PF05196; PTN_MK_N; 1.
DR   PRINTS; PR00269; PTNMIDKINE.
DR   ProDom; PD005592; PTN_MK_hepar_bd; 1.
DR   SMART; SM00193; PTN; 1.
DR   SUPFAM; SSF57288; SSF57288; 2.
DR   PROSITE; PS00619; PTN_MK_1; 1.
DR   PROSITE; PS00620; PTN_MK_2; 1.
PE   4: Predicted;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     32       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        33    168       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001533626.
FT   DOMAIN       34     95       PTN_MK_N. {ECO:0000259|Pfam:PF05196}.
FT   DOMAIN       96    158       PTN_MK_C. {ECO:0000259|Pfam:PF01091}.
SQ   SEQUENCE   168 AA;  18942 MW;  0359C08B6497B579 CRC64;
     MQAQQYQQQR RKFAAAFLAF IFILAAVDTA EAGKKEKPEK KVKKSDCGEW QWSVCVPTSG
     DCGLGTREGT RTGAECKQTM KTQRCKIPCN WKKQFGAECK YQFQAWGECD LNTALKTRTG
     SLKRALHNAE CQKTVTISKP CGKLTKPKPQ AESKKKKKEG KKQEKMLD
//
ID   PTN_HUMAN               Reviewed;         168 AA.
AC   P21246; Q5U0B0; Q6ICQ5; Q9UCC6;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1991, sequence version 1.
DT   23-MAY-2018, entry version 171.
DE   RecName: Full=Pleiotrophin;
DE            Short=PTN;
DE   AltName: Full=Heparin-binding brain mitogen;
DE            Short=HBBM;
DE   AltName: Full=Heparin-binding growth factor 8;
DE            Short=HBGF-8;
DE   AltName: Full=Heparin-binding growth-associated molecule;
DE            Short=HB-GAM;
DE   AltName: Full=Heparin-binding neurite outgrowth-promoting factor 1;
DE            Short=HBNF-1;
DE   AltName: Full=Osteoblast-specific factor 1;
DE            Short=OSF-1;
DE   Flags: Precursor;
GN   Name=PTN; Synonyms=HBNF1, NEGF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1701634; DOI=10.1016/S0006-291X(05)81048-4;
RA   Tezuka K.I., Takeshita S., Hakeda Y., Kumegawa M., Kikuno R.,
RA   Hashimoto-Gotoh T.;
RT   "Isolation of mouse and human cDNA clones encoding a protein expressed
RT   specifically in osteoblasts and brain tissues.";
RL   Biochem. Biophys. Res. Commun. 173:246-251(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=2270483; DOI=10.1126/science.2270483;
RA   Li Y.-S., Milner P.G., Chauhan A.K., Watson M.A., Hoffman R.M.,
RA   Kodner C.M., Milbrandt J., Deuel T.F.;
RT   "Cloning and expression of a developmentally regulated protein that
RT   induces mitogenic and neurite outgrowth activity.";
RL   Science 250:1690-1694(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND INDUCTION.
RX   PubMed=1768439; DOI=10.3109/08977199109000275;
RA   Kretschmer P.J., Fairhurst J.L., Decker M.M., Chan C.P., Gluzman Y.,
RA   Boehlen P., Kovesdi I.;
RT   "Cloning, characterization and developmental regulation of two members
RT   of a novel human gene family of neurite outgrowth-promoting
RT   proteins.";
RL   Growth Factors 5:99-114(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1457401; DOI=10.1021/bi00163a009;
RA   Milner P.G., Shah D., Veile R., Donis-Keller H., Kumar B.V.;
RT   "Cloning, nucleotide sequence, and chromosome localization of the
RT   human pleiotrophin gene.";
RL   Biochemistry 31:12023-12028(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8484754; DOI=10.1006/bbrc.1993.1432;
RA   Kretschmer P.J., Fairhurst J.L., Hulmes J.D., Popjes M.L., Boehlen P.,
RA   Kovesdi I.;
RT   "Genomic organization of the human HBNF gene and characterization of
RT   an HBNF variant protein as a splice mutant.";
RL   Biochem. Biophys. Res. Commun. 192:420-429(1993).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9299545; DOI=10.1006/bbrc.1997.7188;
RA   Masuda H., Tsujimura A., Yoshioka M., Arai Y., Kuboki Y., Mukai T.,
RA   Nakamura T., Tsuji H., Nakagawa M., Hashimoto-Gotoh T.;
RT   "Bone mass loss due to estrogen deficiency is compensated in
RT   transgenic mice overexpressing human osteoblast stimulating factor-
RT   1.";
RL   Biochem. Biophys. Res. Commun. 238:528-533(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   PROTEIN SEQUENCE OF 33-58.
RC   TISSUE=Brain;
RX   PubMed=2388713; DOI=10.1007/BF00969930;
RA   Huber D., Gautschi-Sova P., Bohlen P.;
RT   "Amino-terminal sequences of a novel heparin-binding protein from
RT   human, bovine, rat, and chick brain: high interspecies homology.";
RL   Neurochem. Res. 15:435-439(1990).
RN   [14]
RP   PROTEIN SEQUENCE OF 33-52, SUBCELLULAR LOCATION, HEPARIN-BINDING, AND
RP   FUNCTION.
RX   PubMed=1733956;
RA   Wellsein A., Fang W., Khatri A., Lu Y., Swain S.S., Dickson R.B.,
RA   Sasse J., Riegel A.T., Lippman M.E.;
RT   "A heparin-binding growth factor secreted from breast cancer cells
RT   homologous to a developmentally regulated cytokine.";
RL   J. Biol. Chem. 267:2582-2587(1992).
RN   [15]
RP   PROTEIN SEQUENCE OF 33-49, INDUCTION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Plasma;
RX   PubMed=8241100;
RA   Novotny W.F., Maffi T., Mehta R.L., Milner P.G.;
RT   "Identification of novel heparin-releasable proteins, as well as the
RT   cytokines midkine and pleiotrophin, in human postheparin plasma.";
RL   Arterioscler. Thromb. 13:1798-1805(1993).
RN   [16]
RP   DISULFIDE BONDS.
RX   PubMed=8484780; DOI=10.1006/bbrc.1993.1476;
RA   Hulmes J.D., Seddon A.P., Decker M.M., Bohlen P.;
RT   "Comparison of the disulfide bond arrangements of human recombinant
RT   and bovine brain heparin binding neurite-promoting factors.";
RL   Biochem. Biophys. Res. Commun. 192:738-746(1993).
RN   [17]
RP   INTERACTION WITH ALK, AND FUNCTION.
RX   PubMed=11278720; DOI=10.1074/jbc.M010660200;
RA   Stoica G.E., Kuo A., Aigner A., Sunitha I., Souttou B., Malerczyk C.,
RA   Caughey D.J., Wen D., Karavanov A., Riegel A.T., Wellstein A.;
RT   "Identification of anaplastic lymphoma kinase as a receptor for the
RT   growth factor pleiotrophin.";
RL   J. Biol. Chem. 276:16772-16779(2001).
RN   [18]
RP   FUNCTION, AND INTERACTION WITH PTPRZ1.
RX   PubMed=16814777; DOI=10.1016/j.febslet.2006.06.041;
RA   Fukada M., Fujikawa A., Chow J.P., Ikematsu S., Sakuma S., Noda M.;
RT   "Protein tyrosine phosphatase receptor type Z is inactivated by
RT   ligand-induced oligomerization.";
RL   FEBS Lett. 580:4051-4056(2006).
RN   [19]
RP   INTERACTION WITH NEK6, AND PHOSPHORYLATION BY NEK6.
RX   PubMed=20873783; DOI=10.1021/pr100562w;
RA   Vaz Meirelles G., Ferreira Lanza D.C., da Silva J.C.,
RA   Santana Bernachi J., Paes Leme A.F., Kobarg J.;
RT   "Characterization of hNek6 interactome reveals an important role for
RT   its short N-terminal domain and colocalization with proteins at the
RT   centrosome.";
RL   J. Proteome Res. 9:6298-6316(2010).
RN   [20] {ECO:0000244|PDB:2N6F}
RP   STRUCTURE BY NMR OF 33-168, FUNCTION, SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=26896299; DOI=10.1111/febs.13686;
RA   Ryan E., Shen D., Wang X.;
RT   "Structural studies reveal an important role for the pleiotrophin C-
RT   terminus in mediating interactions with chondroitin sulfate.";
RL   FEBS J. 283:1488-1503(2016).
CC   -!- FUNCTION: Secreted growth factor that induces neurite outgrowth
CC       and which is mitogenic for fibroblasts, epithelial, and
CC       endothelial cells (PubMed:1768439, PubMed:1733956). Binds
CC       anaplastic lymphoma kinase (ALK) which induces MAPK pathway
CC       activation, an important step in the anti-apoptotic signaling of
CC       PTN and regulation of cell proliferation (PubMed:11278720). Binds
CC       to cell-surface target proteins via their chondroitin sulfate
CC       groups (PubMed:26896299). Down-regulates PTPRZ1 activity
CC       (PubMed:16814777). {ECO:0000269|PubMed:11278720,
CC       ECO:0000269|PubMed:16814777, ECO:0000269|PubMed:1768439,
CC       ECO:0000269|PubMed:26896299}.
CC   -!- SUBUNIT: Interacts with ALK and NEK6 (PubMed:11278720,
CC       PubMed:20873783). Interacts with PTPRZ1 (probably via chondroitin
CC       sulfate groups) (PubMed:16814777, PubMed:26896299).
CC       {ECO:0000269|PubMed:11278720, ECO:0000269|PubMed:16814777,
CC       ECO:0000269|PubMed:20873783, ECO:0000305|PubMed:26896299}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:1733956,
CC       ECO:0000269|PubMed:8241100}.
CC   -!- TISSUE SPECIFICITY: Osteoblast and brain.
CC   -!- INDUCTION: By heparin and retinoic acid.
CC       {ECO:0000269|PubMed:1768439, ECO:0000269|PubMed:8241100}.
CC   -!- PTM: Phosphorylated by NEK6. {ECO:0000269|PubMed:20873783}.
CC   -!- SIMILARITY: Belongs to the pleiotrophin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Pleiotrophin entry;
CC       URL="https://en.wikipedia.org/wiki/Pleiotrophin";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PTNID41904ch7q33.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D90226; BAA14261.1; -; mRNA.
DR   EMBL; X52946; CAA37121.1; -; mRNA.
DR   EMBL; M57399; AAA35961.1; -; mRNA.
DR   EMBL; S50409; AAB24425.1; -; Genomic_DNA.
DR   EMBL; S50405; AAB24425.1; JOINED; Genomic_DNA.
DR   EMBL; S50408; AAB24425.1; JOINED; Genomic_DNA.
DR   EMBL; S50394; AAB24425.1; JOINED; Genomic_DNA.
DR   EMBL; S60110; AAB26456.1; -; Genomic_DNA.
DR   EMBL; S59641; AAB26456.1; JOINED; Genomic_DNA.
DR   EMBL; S60111; AAB26456.1; JOINED; Genomic_DNA.
DR   EMBL; S60736; AAB26456.1; JOINED; Genomic_DNA.
DR   EMBL; AB004306; BAA22944.1; -; Genomic_DNA.
DR   EMBL; AK290488; BAF83177.1; -; mRNA.
DR   EMBL; AK313424; BAG36216.1; -; mRNA.
DR   EMBL; CR450338; CAG29334.1; -; mRNA.
DR   EMBL; BT019692; AAV38498.1; -; mRNA.
DR   EMBL; CH236950; EAL24052.1; -; Genomic_DNA.
DR   EMBL; CH471070; EAW83869.1; -; Genomic_DNA.
DR   EMBL; BC005916; AAH05916.1; -; mRNA.
DR   CCDS; CCDS5844.1; -.
DR   PIR; JN0474; C37780.
DR   RefSeq; NP_001308315.1; NM_001321386.2.
DR   RefSeq; NP_001308316.1; NM_001321387.2.
DR   RefSeq; NP_002816.1; NM_002825.6.
DR   UniGene; Hs.371249; -.
DR   PDB; 2N6F; NMR; -; A=33-168.
DR   PDBsum; 2N6F; -.
DR   DisProt; DP00887; -.
DR   ProteinModelPortal; P21246; -.
DR   SMR; P21246; -.
DR   BioGrid; 111731; 94.
DR   DIP; DIP-5953N; -.
DR   IntAct; P21246; 91.
DR   MINT; P21246; -.
DR   STRING; 9606.ENSP00000341170; -.
DR   iPTMnet; P21246; -.
DR   PhosphoSitePlus; P21246; -.
DR   BioMuta; PTN; -.
DR   DMDM; 131553; -.
DR   PaxDb; P21246; -.
DR   PeptideAtlas; P21246; -.
DR   PRIDE; P21246; -.
DR   DNASU; 5764; -.
DR   Ensembl; ENST00000348225; ENSP00000341170; ENSG00000105894.
DR   GeneID; 5764; -.
DR   KEGG; hsa:5764; -.
DR   UCSC; uc003vtq.4; human.
DR   CTD; 5764; -.
DR   DisGeNET; 5764; -.
DR   EuPathDB; HostDB:ENSG00000105894.11; -.
DR   GeneCards; PTN; -.
DR   HGNC; HGNC:9630; PTN.
DR   HPA; CAB017685; -.
DR   MIM; 162095; gene.
DR   neXtProt; NX_P21246; -.
DR   OpenTargets; ENSG00000105894; -.
DR   PharmGKB; PA33974; -.
DR   eggNOG; ENOG410IWNA; Eukaryota.
DR   eggNOG; ENOG4111ZWP; LUCA.
DR   GeneTree; ENSGT00390000007640; -.
DR   HOGENOM; HOG000231473; -.
DR   HOVERGEN; HBG008317; -.
DR   InParanoid; P21246; -.
DR   KO; K16642; -.
DR   OMA; GEDICNS; -.
DR   OrthoDB; EOG091G0VCN; -.
DR   PhylomeDB; P21246; -.
DR   TreeFam; TF332376; -.
DR   SignaLink; P21246; -.
DR   SIGNOR; P21246; -.
DR   ChiTaRS; PTN; human.
DR   GeneWiki; Pleiotrophin; -.
DR   GenomeRNAi; 5764; -.
DR   PMAP-CutDB; P21246; -.
DR   PRO; PR:P21246; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000105894; -.
DR   CleanEx; HS_PTN; -.
DR   ExpressionAtlas; P21246; baseline and differential.
DR   Genevisible; P21246; HS.
DR   GO; GO:0005604; C:basement membrane; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:LIFEdb.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IEA:Ensembl.
DR   GO; GO:0031594; C:neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0035374; F:chondroitin sulfate binding; IDA:UniProtKB.
DR   GO; GO:0008083; F:growth factor activity; IDA:UniProtKB.
DR   GO; GO:1904399; F:heparan sulfate binding; IEA:Ensembl.
DR   GO; GO:0008201; F:heparin binding; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004864; F:protein phosphatase inhibitor activity; TAS:ProtInc.
DR   GO; GO:0030282; P:bone mineralization; IEA:Ensembl.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEA:Ensembl.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0034644; P:cellular response to UV; IEA:Ensembl.
DR   GO; GO:0071305; P:cellular response to vitamin D; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0045446; P:endothelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0044849; P:estrous cycle; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0007612; P:learning; IEA:Ensembl.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl.
DR   GO; GO:0030336; P:negative regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; IEA:Ensembl.
DR   GO; GO:0045837; P:negative regulation of membrane potential; IEA:Ensembl.
DR   GO; GO:0072201; P:negative regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:1904397; P:negative regulation of neuromuscular junction development; IEA:Ensembl.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl.
DR   GO; GO:2000347; P:positive regulation of hepatocyte proliferation; IEA:Ensembl.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:1904395; P:positive regulation of skeletal muscle acetylcholine-gated channel clustering; IEA:Ensembl.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:Ensembl.
DR   GO; GO:0014823; P:response to activity; IEA:Ensembl.
DR   GO; GO:1904391; P:response to ciliary neurotrophic factor; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:1904373; P:response to kainic acid; IEA:Ensembl.
DR   GO; GO:1990089; P:response to nerve growth factor; IEA:Ensembl.
DR   GO; GO:0032570; P:response to progesterone; IEA:Ensembl.
DR   GO; GO:0060221; P:retinal rod cell differentiation; IEA:Ensembl.
DR   GO; GO:1904389; P:rod bipolar cell differentiation; IEA:Ensembl.
DR   GO; GO:0021510; P:spinal cord development; IEA:Ensembl.
DR   GO; GO:0021794; P:thalamus development; IEA:Ensembl.
DR   GO; GO:0007185; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; TAS:ProtInc.
DR   Gene3D; 2.20.60.10; -; 1.
DR   Gene3D; 2.30.90.10; -; 1.
DR   InterPro; IPR000762; Midkine_heparin-bd_GF.
DR   InterPro; IPR020090; PTN/MK_C_dom.
DR   InterPro; IPR038130; PTN/MK_C_dom_sf.
DR   InterPro; IPR020091; PTN/MK_diS_sf.
DR   InterPro; IPR020089; PTN/MK_N_dom.
DR   InterPro; IPR037122; PTN/MK_N_dom_sf.
DR   InterPro; IPR020092; PTN_MK_heparin-bd_GF_CS.
DR   PANTHER; PTHR13850; PTHR13850; 1.
DR   Pfam; PF01091; PTN_MK_C; 1.
DR   Pfam; PF05196; PTN_MK_N; 1.
DR   PRINTS; PR00269; PTNMIDKINE.
DR   ProDom; PD005592; PTN_MK_hepar_bd; 1.
DR   SMART; SM00193; PTN; 1.
DR   SUPFAM; SSF57288; SSF57288; 2.
DR   PROSITE; PS00619; PTN_MK_1; 1.
DR   PROSITE; PS00620; PTN_MK_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Growth factor; Heparin-binding; Mitogen;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     32       {ECO:0000269|PubMed:1733956,
FT                                ECO:0000269|PubMed:2388713,
FT                                ECO:0000269|PubMed:8241100}.
FT   CHAIN        33    168       Pleiotrophin.
FT                                /FTId=PRO_0000024659.
FT   REGION       92     99       Chondroitin sulfate binding.
FT                                {ECO:0000269|PubMed:26896299}.
FT   REGION      123    131       Chondroitin sulfate binding.
FT                                {ECO:0000269|PubMed:26896299}.
FT   REGION      147    168       Chondroitin sulfate A binding.
FT                                {ECO:0000269|PubMed:26896299}.
FT   DISULFID     47     76       {ECO:0000244|PDB:2N6F,
FT                                ECO:0000269|PubMed:26896299,
FT                                ECO:0000269|PubMed:8484780}.
FT   DISULFID     55     85       {ECO:0000244|PDB:2N6F,
FT                                ECO:0000269|PubMed:26896299,
FT                                ECO:0000269|PubMed:8484780}.
FT   DISULFID     62     89       {ECO:0000244|PDB:2N6F,
FT                                ECO:0000269|PubMed:26896299,
FT                                ECO:0000269|PubMed:8484780}.
FT   DISULFID     99    131       {ECO:0000244|PDB:2N6F,
FT                                ECO:0000269|PubMed:26896299,
FT                                ECO:0000269|PubMed:8484780}.
FT   DISULFID    109    141       {ECO:0000244|PDB:2N6F,
FT                                ECO:0000269|PubMed:26896299,
FT                                ECO:0000269|PubMed:8484780}.
FT   CONFLICT     42     42       V -> K (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     47     47       C -> D (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     75     75       E -> G (in Ref. 9; AAV38498).
FT                                {ECO:0000305}.
FT   STRAND       48     52       {ECO:0000244|PDB:2N6F}.
FT   STRAND       60     62       {ECO:0000244|PDB:2N6F}.
FT   STRAND       66     72       {ECO:0000244|PDB:2N6F}.
FT   STRAND       78     84       {ECO:0000244|PDB:2N6F}.
FT   STRAND       97    104       {ECO:0000244|PDB:2N6F}.
FT   TURN        111    114       {ECO:0000244|PDB:2N6F}.
FT   STRAND      115    124       {ECO:0000244|PDB:2N6F}.
FT   STRAND      133    142       {ECO:0000244|PDB:2N6F}.
FT   TURN        163    166       {ECO:0000244|PDB:2N6F}.
SQ   SEQUENCE   168 AA;  18942 MW;  0359C08B6497B579 CRC64;
     MQAQQYQQQR RKFAAAFLAF IFILAAVDTA EAGKKEKPEK KVKKSDCGEW QWSVCVPTSG
     DCGLGTREGT RTGAECKQTM KTQRCKIPCN WKKQFGAECK YQFQAWGECD LNTALKTRTG
     SLKRALHNAE CQKTVTISKP CGKLTKPKPQ AESKKKKKEG KKQEKMLD
//
ID   UBR1_HUMAN              Reviewed;        1749 AA.
AC   Q8IWV7; O60708; O75492; Q14D45; Q68DN9; Q8IWY6; Q96JY4;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   25-APR-2018, entry version 136.
DE   RecName: Full=E3 ubiquitin-protein ligase UBR1;
DE            EC=2.3.2.27;
DE   AltName: Full=N-recognin-1;
DE   AltName: Full=RING-type E3 ubiquitin transferase UBR1;
DE   AltName: Full=Ubiquitin-protein ligase E3-alpha-1;
DE   AltName: Full=Ubiquitin-protein ligase E3-alpha-I;
GN   Name=UBR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   FUNCTION.
RX   PubMed=15548684; DOI=10.1158/0008-5472.CAN-04-2102;
RA   Kwak K.S., Zhou X., Solomon V., Baracos V.E., Davis J., Bannon A.W.,
RA   Boyle W.J., Lacey D.L., Han H.Q.;
RT   "Regulation of protein catabolism by muscle-specific and cytokine-
RT   inducible ubiquitin ligase E3alpha-II during cancer cachexia.";
RL   Cancer Res. 64:8193-8198(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 18-1727 (ISOFORM 1).
RC   TISSUE=Erythroid cell;
RX   PubMed=12434312; DOI=10.1086/344781;
RA   Dgany O., Avidan N., Delaunay J., Krasnov T., Shalmon L., Shalev H.,
RA   Eidelitz-Markus T., Kapelushnik J., Cattan D., Pariente A.,
RA   Tulliez M., Cretien A., Schischmanoff P.-O., Iolascon A., Fibach E.,
RA   Koren A., Roessler J., Le Merrer M., Yaniv I., Zaizov R.,
RA   Ben-Asher E., Olender T., Lancet D., Beckmann J.S., Tamary H.;
RT   "Congenital dyserythropoietic anemia type I is caused by mutations in
RT   codanin-1.";
RL   Am. J. Hum. Genet. 71:1467-1474(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 166-1014 (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 656-1749 (ISOFORM 2).
RC   TISSUE=Heart;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 702-1034 (ISOFORM 1), AND
RP   TISSUE SPECIFICITY.
RX   PubMed=9653112; DOI=10.1073/pnas.95.14.7898;
RA   Kwon Y.T., Reiss Y., Fried V.A., Hershko A., Yoon J.K., Gonda D.K.,
RA   Sangan P., Copeland N.G., Jenkins N.A., Varshavsky A.;
RT   "The mouse and human genes encoding the recognition component of the
RT   N-end rule pathway.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:7898-7903(1998).
RN   [7]
RP   INTERACTION WITH RECQL4, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15317757; DOI=10.1093/hmg/ddh269;
RA   Yin J., Kwon Y.T., Varshavsky A., Wang W.;
RT   "RECQL4, mutated in the Rothmund-Thomson and RAPADILINO syndromes,
RT   interacts with ubiquitin ligases UBR1 and UBR2 of the N-end rule
RT   pathway.";
RL   Hum. Mol. Genet. 13:2421-2430(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1179, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-21, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT THR-21, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-21, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   FUNCTION.
RX   PubMed=20298436; DOI=10.1111/j.1365-2443.2010.01385.x;
RA   Kume K., Iizumi Y., Shimada M., Ito Y., Kishi T., Yamaguchi Y.,
RA   Handa H.;
RT   "Role of N-end rule ubiquitin ligases UBR1 and UBR2 in regulating the
RT   leucine-mTOR signaling pathway.";
RL   Genes Cells 15:339-349(2010).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-21, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-21, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 98-167 ALONE AND IN COMPLEX
RP   WITH N-END RULE PEPTIDE, UBR-TYPE ZINC-FINGER, FUNCTION, AND VARIANT
RP   JB5 ARG-136.
RX   PubMed=20835242; DOI=10.1038/nsmb.1894;
RA   Matta-Camacho E., Kozlov G., Li F.F., Gehring K.;
RT   "Structural basis of substrate recognition and specificity in the N-
RT   end rule pathway.";
RL   Nat. Struct. Mol. Biol. 17:1182-1187(2010).
RN   [16]
RP   VARIANTS JBS ARG-136 AND SER-1279, FUNCTION, DISEASE, TISSUE
RP   SPECIFICITY, SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=16311597; DOI=10.1038/ng1681;
RA   Zenker M., Mayerle J., Lerch M.M., Tagariello A., Zerres K.,
RA   Durie P.R., Beier M., Hulskamp G., Guzman C., Rehder H., Beemer F.A.,
RA   Hamel B.C.J., Vanlieferinghen P., Gershoni-Baruch R., Vieira M.W.,
RA   Dumic M., Auslender R., Gil-da-Silva-Lopes V.L., Steinlicht S.,
RA   Rauh M., Shalev S.A., Thiel C., Winterpacht A., Kwon Y.T.,
RA   Varshavsky A., Reis A.;
RT   "Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway,
RT   causes pancreatic dysfunction, malformations and mental retardation
RT   (Johanson-Blizzard syndrome).";
RL   Nat. Genet. 37:1345-1350(2005).
RN   [17]
RP   VARIANTS JBS LEU-122; ARG-136 AND GLU-1102, AND CHARACTERIZATION OF
RP   VARIANTS JBS LEU-122; ARG-136 AND GLU-1102.
RX   PubMed=21931868; DOI=10.1371/journal.pone.0024925;
RA   Hwang C.S., Sukalo M., Batygin O., Addor M.C., Brunner H., Aytes A.P.,
RA   Mayerle J., Song H.K., Varshavsky A., Zenker M.;
RT   "Ubiquitin ligases of the N-end rule pathway: assessment of mutations
RT   in UBR1 that cause the Johanson-Blizzard syndrome.";
RL   PLoS ONE 6:E24925-E24925(2011).
RN   [18]
RP   VARIANT JBS PRO-700.
RX   PubMed=22072859; DOI=10.3748/wjg.v17.i37.4247;
RA   Almashraki N., Abdulnabee M.Z., Sukalo M., Alrajoudi A.,
RA   Sharafadeen I., Zenker M.;
RT   "Johanson-Blizzard syndrome.";
RL   World J. Gastroenterol. 17:4247-4250(2011).
RN   [19]
RP   VARIANTS JBS LEU-122; PHE-127; ARG-136; ARG-166; ARG-217; ARG-286;
RP   PRO-317; 389-ALA--PHE-392 DEL; ASP-563; VAL-660 DEL; PRO-700; CYS-754;
RP   HIS-754; GLU-1102; GLY-1242; SER-1279; LEU-1426; PHE-1427; PRO-1431
RP   AND ARG-1661.
RX   PubMed=24599544; DOI=10.1002/humu.22538;
RA   Sukalo M., Fiedler A., Guzman C., Spranger S., Addor M.C.,
RA   McHeik J.N., Oltra Benavent M., Cobben J.M., Gillis L.A., Shealy A.G.,
RA   Deshpande C., Bozorgmehr B., Everman D.B., Stattin E.L., Liebelt J.,
RA   Keller K.M., Bertola D.R., van Karnebeek C.D., Bergmann C., Liu Z.,
RA   Dueker G., Rezaei N., Alkuraya F.S., Ogur G., Alrajoudi A.,
RA   Venegas-Vega C.A., Verbeek N.E., Richmond E.J., Kirbiyik O.,
RA   Ranganath P., Singh A., Godbole K., Ali F.A., Alves C., Mayerle J.,
RA   Lerch M.M., Witt H., Zenker M.;
RT   "Mutations in the human UBR1 gene and the associated phenotypic
RT   spectrum.";
RL   Hum. Mutat. 35:521-531(2014).
RN   [20]
RP   VARIANT JBS ARG-427.
RX   PubMed=26149651; DOI=10.1016/j.gene.2015.06.082;
RA   Atik T., Karakoyun M., Sukalo M., Zenker M., Ozkinay F., Aydogdu S.;
RT   "Two novel UBR1 gene mutations in a patient with Johanson Blizzard
RT   Syndrome: A mild phenotype without mental retardation.";
RL   Gene 570:153-155(2015).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase which is a component of the
CC       N-end rule pathway. Recognizes and binds to proteins bearing
CC       specific N-terminal residues that are destabilizing according to
CC       the N-end rule, leading to their ubiquitination and subsequent
CC       degradation. May be involved in pancreatic homeostasis. Binds
CC       leucine and is a negative regulator of the leucine-mTOR signaling
CC       pathway, thereby controlling cell growth.
CC       {ECO:0000269|PubMed:15548684, ECO:0000269|PubMed:16311597,
CC       ECO:0000269|PubMed:20298436, ECO:0000269|PubMed:20835242}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with RECQL4. {ECO:0000269|PubMed:15317757,
CC       ECO:0000269|PubMed:20835242}.
CC   -!- INTERACTION:
CC       P63146:UBE2B; NbExp=2; IntAct=EBI-711736, EBI-712629;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:16311597}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8IWV7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IWV7-2; Sequence=VSP_015164, VSP_015165;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Broadly expressed, with highest levels in
CC       skeletal muscle, kidney and pancreas. Present in acinar cells of
CC       the pancreas (at protein level). {ECO:0000269|PubMed:15548684,
CC       ECO:0000269|PubMed:16311597, ECO:0000269|PubMed:9653112}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal pancreas.
CC       {ECO:0000269|PubMed:16311597}.
CC   -!- DOMAIN: The RING-H2 zinc finger is an atypical RING finger with a
CC       His ligand in place of the fourth Cys of the classical motif.
CC   -!- DOMAIN: The UBR-type zinc finger forms a pocket that mediates
CC       recognition of type 1 N-degrons. It exhibits preference for
CC       Arginine in first position, has poor affinity for histidine, and
CC       doesn't bind acetylated peptides.
CC   -!- DISEASE: Johanson-Blizzard syndrome (JBS) [MIM:243800]: This
CC       disorder includes congenital exocrine pancreatic insufficiency,
CC       multiple malformations such as nasal wing aplasia, and frequent
CC       mental retardation. Pancreas of individuals with JBS do not
CC       express UBR1 and show intrauterine-onset destructive pancreatitis.
CC       {ECO:0000269|PubMed:16311597, ECO:0000269|PubMed:21931868,
CC       ECO:0000269|PubMed:22072859, ECO:0000269|PubMed:24599544,
CC       ECO:0000269|PubMed:26149651}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the UBR1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB55380.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY061886; AAL32103.1; -; mRNA.
DR   EMBL; BC113505; AAI13506.1; -; mRNA.
DR   EMBL; BC113507; AAI13508.1; -; mRNA.
DR   EMBL; AF525401; AAO14997.1; -; mRNA.
DR   EMBL; AK027803; BAB55380.1; ALT_INIT; mRNA.
DR   EMBL; CR749326; CAH18181.1; -; mRNA.
DR   EMBL; AF061556; AAC39845.1; -; mRNA.
DR   EMBL; AH006181; AAC23677.1; -; Genomic_DNA.
DR   CCDS; CCDS10091.1; -. [Q8IWV7-1]
DR   RefSeq; NP_777576.1; NM_174916.2. [Q8IWV7-1]
DR   UniGene; Hs.591121; -.
DR   PDB; 3NY1; X-ray; 2.08 A; A/B=97-168.
DR   PDB; 5TDC; X-ray; 1.61 A; A/C=98-168.
DR   PDBsum; 3NY1; -.
DR   PDBsum; 5TDC; -.
DR   ProteinModelPortal; Q8IWV7; -.
DR   SMR; Q8IWV7; -.
DR   BioGrid; 128238; 104.
DR   DIP; DIP-47033N; -.
DR   IntAct; Q8IWV7; 32.
DR   MINT; Q8IWV7; -.
DR   STRING; 9606.ENSP00000290650; -.
DR   iPTMnet; Q8IWV7; -.
DR   PhosphoSitePlus; Q8IWV7; -.
DR   BioMuta; UBR1; -.
DR   DMDM; 73622071; -.
DR   EPD; Q8IWV7; -.
DR   MaxQB; Q8IWV7; -.
DR   PaxDb; Q8IWV7; -.
DR   PeptideAtlas; Q8IWV7; -.
DR   PRIDE; Q8IWV7; -.
DR   Ensembl; ENST00000290650; ENSP00000290650; ENSG00000159459. [Q8IWV7-1]
DR   GeneID; 197131; -.
DR   KEGG; hsa:197131; -.
DR   UCSC; uc001zqq.4; human. [Q8IWV7-1]
DR   CTD; 197131; -.
DR   DisGeNET; 197131; -.
DR   EuPathDB; HostDB:ENSG00000159459.11; -.
DR   GeneCards; UBR1; -.
DR   HGNC; HGNC:16808; UBR1.
DR   HPA; HPA038838; -.
DR   MalaCards; UBR1; -.
DR   MIM; 243800; phenotype.
DR   MIM; 605981; gene.
DR   neXtProt; NX_Q8IWV7; -.
DR   OpenTargets; ENSG00000159459; -.
DR   Orphanet; 2315; Johanson-Blizzard syndrome.
DR   PharmGKB; PA38187; -.
DR   eggNOG; KOG1140; Eukaryota.
DR   eggNOG; ENOG410XPQU; LUCA.
DR   GeneTree; ENSGT00530000063055; -.
DR   HOVERGEN; HBG080426; -.
DR   InParanoid; Q8IWV7; -.
DR   KO; K10625; -.
DR   OMA; ILLMFQE; -.
DR   OrthoDB; EOG091G009K; -.
DR   PhylomeDB; Q8IWV7; -.
DR   TreeFam; TF323875; -.
DR   BioCyc; MetaCyc:ENSG00000159459-MONOMER; -.
DR   BRENDA; 3.4.17.20; 2681.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SIGNOR; Q8IWV7; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; UBR1; human.
DR   EvolutionaryTrace; Q8IWV7; -.
DR   GeneWiki; UBR1; -.
DR   GenomeRNAi; 197131; -.
DR   PRO; PR:Q8IWV7; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000159459; -.
DR   CleanEx; HS_UBR1; -.
DR   ExpressionAtlas; Q8IWV7; baseline and differential.
DR   Genevisible; Q8IWV7; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0000502; C:proteasome complex; IEA:Ensembl.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0070728; F:leucine binding; IDA:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0071233; P:cellular response to leucine; IDA:UniProtKB.
DR   GO; GO:0032007; P:negative regulation of TOR signaling; IMP:UniProtKB.
DR   GO; GO:0071596; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway; IBA:GO_Central.
DR   Gene3D; 3.30.1390.10; -; 1.
DR   InterPro; IPR003769; ClpS_core.
DR   InterPro; IPR014719; Ribosomal_L7/12_C/ClpS-like.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   InterPro; IPR003126; Znf_UBR.
DR   Pfam; PF02617; ClpS; 1.
DR   Pfam; PF02207; zf-UBR; 1.
DR   SMART; SM00396; ZnF_UBR1; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF54736; SSF54736; 1.
DR   PROSITE; PS51157; ZF_UBR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Disease mutation; Metal-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transferase;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19369195}.
FT   CHAIN         2   1749       E3 ubiquitin-protein ligase UBR1.
FT                                /FTId=PRO_0000056136.
FT   ZN_FING      97    168       UBR-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00508}.
FT   ZN_FING    1098   1201       RING-type; atypical.
FT   COMPBIAS    864    869       Poly-Pro.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES      21     21       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1179   1179       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   VAR_SEQ     795    803       NNETGLENV -> TRCIRPWSL (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_015164.
FT   VAR_SEQ     804   1749       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_015165.
FT   VARIANT     122    122       V -> L (in JBS; decreased, but detectable
FT                                activity in a yeast-based assay).
FT                                {ECO:0000269|PubMed:21931868,
FT                                ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075179.
FT   VARIANT     127    127       C -> F (in JBS).
FT                                {ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075180.
FT   VARIANT     136    136       H -> R (in JBS; prevents proper folding
FT                                of the UBR-type zinc finger; may decrease
FT                                protein stability; loss of activity in a
FT                                yeast-based assay; dbSNP:rs119477054).
FT                                {ECO:0000269|PubMed:16311597,
FT                                ECO:0000269|PubMed:20835242,
FT                                ECO:0000269|PubMed:21931868,
FT                                ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_024741.
FT   VARIANT     166    166       H -> R (in JBS).
FT                                {ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075181.
FT   VARIANT     217    217       L -> R (in JBS).
FT                                {ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075182.
FT   VARIANT     286    286       I -> R (in JBS).
FT                                {ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075183.
FT   VARIANT     317    317       L -> P (in JBS).
FT                                {ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075184.
FT   VARIANT     389    392       Missing (in JBS).
FT                                {ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075185.
FT   VARIANT     427    427       L -> R (in JBS; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:26149651}.
FT                                /FTId=VAR_075186.
FT   VARIANT     563    563       A -> D (in JBS; dbSNP:rs768686147).
FT                                {ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075187.
FT   VARIANT     596    596       K -> M (in dbSNP:rs34568456).
FT                                /FTId=VAR_034467.
FT   VARIANT     660    660       Missing (in JBS).
FT                                {ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075188.
FT   VARIANT     700    700       S -> P (in JBS).
FT                                {ECO:0000269|PubMed:22072859,
FT                                ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075189.
FT   VARIANT     754    754       R -> C (in JBS).
FT                                {ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075190.
FT   VARIANT     754    754       R -> H (in JBS).
FT                                {ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075191.
FT   VARIANT     899    899       I -> V (in dbSNP:rs35069201).
FT                                /FTId=VAR_052116.
FT   VARIANT    1102   1102       Q -> E (in JBS; strong decrease in
FT                                activity in a yeast-based assay).
FT                                {ECO:0000269|PubMed:21931868,
FT                                ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075192.
FT   VARIANT    1242   1242       R -> G (in JBS).
FT                                {ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075193.
FT   VARIANT    1279   1279       G -> S (in JBS).
FT                                {ECO:0000269|PubMed:16311597,
FT                                ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_024742.
FT   VARIANT    1426   1426       P -> L (in JBS).
FT                                {ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075194.
FT   VARIANT    1427   1427       S -> F (in JBS).
FT                                {ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075195.
FT   VARIANT    1431   1431       S -> P (in JBS; dbSNP:rs140972409).
FT                                {ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075196.
FT   VARIANT    1548   1548       T -> A (in dbSNP:rs3917223).
FT                                /FTId=VAR_061822.
FT   VARIANT    1661   1661       G -> R (in JBS).
FT                                {ECO:0000269|PubMed:24599544}.
FT                                /FTId=VAR_075197.
FT   CONFLICT    201    201       V -> A (in Ref. 4). {ECO:0000305}.
FT   CONFLICT    900    900       D -> N (in Ref. 6; AAC39845).
FT                                {ECO:0000305}.
FT   CONFLICT    973    973       D -> T (in Ref. 3; AAO14997).
FT                                {ECO:0000305}.
FT   CONFLICT    993    993       C -> S (in Ref. 6; AAC23677).
FT                                {ECO:0000305}.
FT   CONFLICT   1710   1719       LSRERYRKLH -> FLVSGTEAP (in Ref. 3).
FT                                {ECO:0000305}.
FT   CONFLICT   1722   1722       W -> R (in Ref. 3). {ECO:0000305}.
FT   STRAND      108    112       {ECO:0000244|PDB:5TDC}.
FT   TURN        113    115       {ECO:0000244|PDB:5TDC}.
FT   STRAND      116    118       {ECO:0000244|PDB:5TDC}.
FT   HELIX       125    129       {ECO:0000244|PDB:5TDC}.
FT   HELIX       132    135       {ECO:0000244|PDB:5TDC}.
FT   STRAND      138    142       {ECO:0000244|PDB:5TDC}.
FT   TURN        154    156       {ECO:0000244|PDB:5TDC}.
FT   STRAND      157    159       {ECO:0000244|PDB:5TDC}.
FT   TURN        164    166       {ECO:0000244|PDB:5TDC}.
SQ   SEQUENCE   1749 AA;  200211 MW;  3AE0E1A749884971 CRC64;
     MADEEAGGTE RMEISAELPQ TPQRLASWWD QQVDFYTAFL HHLAQLVPEI YFAEMDPDLE
     KQEESVQMSI FTPLEWYLFG EDPDICLEKL KHSGAFQLCG RVFKSGETTY SCRDCAIDPT
     CVLCMDCFQD SVHKNHRYKM HTSTGGGFCD CGDTEAWKTG PFCVNHEPGR AGTIKENSRC
     PLNEEVIVQA RKIFPSVIKY VVEMTIWEEE KELPPELQIR EKNERYYCVL FNDEHHSYDH
     VIYSLQRALD CELAEAQLHT TAIDKEGRRA VKAGAYAACQ EAKEDIKSHS ENVSQHPLHV
     EVLHSEIMAH QKFALRLGSW MNKIMSYSSD FRQIFCQACL REEPDSENPC LISRLMLWDA
     KLYKGARKIL HELIFSSFFM EMEYKKLFAM EFVKYYKQLQ KEYISDDHDR SISITALSVQ
     MFTVPTLARH LIEEQNVISV ITETLLEVLP EYLDRNNKFN FQGYSQDKLG RVYAVICDLK
     YILISKPTIW TERLRMQFLE GFRSFLKILT CMQGMEEIRR QVGQHIEVDP DWEAAIAIQM
     QLKNILLMFQ EWCACDEELL LVAYKECHKA VMRCSTSFIS SSKTVVQSCG HSLETKSYRV
     SEDLVSIHLP LSRTLAGLHV RLSRLGAVSR LHEFVSFEDF QVEVLVEYPL RCLVLVAQVV
     AEMWRRNGLS LISQVFYYQD VKCREEMYDK DIIMLQIGAS LMDPNKFLLL VLQRYELAEA
     FNKTISTKDQ DLIKQYNTLI EEMLQVLIYI VGERYVPGVG NVTKEEVTMR EIIHLLCIEP
     MPHSAIAKNL PENENNETGL ENVINKVATF KKPGVSGHGV YELKDESLKD FNMYFYHYSK
     TQHSKAEHMQ KKRRKQENKD EALPPPPPPE FCPAFSKVIN LLNCDIMMYI LRTVFERAID
     TDSNLWTEGM LQMAFHILAL GLLEEKQQLQ KAPEEEVTFD FYHKASRLGS SAMNIQMLLE
     KLKGIPQLEG QKDMITWILQ MFDTVKRLRE KSCLIVATTS GSESIKNDEI THDKEKAERK
     RKAEAARLHR QKIMAQMSAL QKNFIETHKL MYDNTSEMPG KEDSIMEEES TPAVSDYSRI
     ALGPKRGPSV TEKEVLTCIL CQEEQEVKIE NNAMVLSACV QKSTALTQHR GKPIELSGEA
     LDPLFMDPDL AYGTYTGSCG HVMHAVCWQK YFEAVQLSSQ QRIHVDLFDL ESGEYLCPLC
     KSLCNTVIPI IPLQPQKINS ENADALAQLL TLARWIQTVL ARISGYNIRH AKGENPIPIF
     FNQGMGDSTL EFHSILSFGV ESSIKYSNSI KEMVILFATT IYRIGLKVPP DERDPRVPML
     TWSTCAFTIQ AIENLLGDEG KPLFGALQNR QHNGLKALMQ FAVAQRITCP QVLIQKHLVR
     LLSVVLPNIK SEDTPCLLSI DLFHVLVGAV LAFPSLYWDD PVDLQPSSVS SSYNHLYLFH
     LITMAHMLQI LLTVDTGLPL AQVQEDSEEA HSASSFFAEI SQYTSGSIGC DIPGWYLWVS
     LKNGITPYLR CAALFFHYLL GVTPPEELHT NSAEGEYSAL CSYLSLPTNL FLLFQEYWDT
     VRPLLQRWCA DPALLNCLKQ KNTVVRYPRK RNSLIELPDD YSCLLNQASH FRCPRSADDE
     RKHPVLCLFC GAILCSQNIC CQEIVNGEEV GACIFHALHC GAGVCIFLKI RECRVVLVEG
     KARGCAYPAP YLDEYGETDP GLKRGNPLHL SRERYRKLHL VWQQHCIIEE IARSQETNQM
     LFGFNWQLL
//
ID   ABEC1_HUMAN             Reviewed;         236 AA.
AC   P41238; Q9UE64; Q9UM71;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 3.
DT   23-MAY-2018, entry version 163.
DE   RecName: Full=C->U-editing enzyme APOBEC-1;
DE            EC=3.5.4.36 {ECO:0000269|PubMed:11727199};
DE   AltName: Full=Apolipoprotein B mRNA-editing enzyme 1;
DE   AltName: Full=HEPR;
DE   AltName: Full=mRNA(cytosine(6666)) deaminase 1;
GN   Name=APOBEC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ILE-80.
RC   TISSUE=Intestine;
RX   PubMed=8208612; DOI=10.1093/nar/22.10.1874;
RA   Hadjiagapiou C., Giannoni F., Funahashi T., Skarosi S.F.,
RA   Davidson N.O.;
RT   "Molecular cloning of a human small intestinal apolipoprotein B mRNA
RT   editing protein.";
RL   Nucleic Acids Res. 22:1874-1879(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND VARIANT ILE-80.
RC   TISSUE=Small intestine;
RX   PubMed=8078915; DOI=10.1073/pnas.91.18.8522;
RA   Lau P.P., Zhu H.-J., Baldini A., Charnsangavej C., Chan L.;
RT   "Dimeric structure of a human apolipoprotein B mRNA editing protein
RT   and cloning and chromosomal localization of its gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:8522-8526(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ILE-80.
RC   TISSUE=Osteosarcoma;
RX   PubMed=9186903;
RA   Hirano K., Min J., Funahashi T., Baunoch D.A., Davidson N.O.;
RT   "Characterization of the human apobec-1 gene: expression in
RT   gastrointestinal tissues determined by alternative splicing with
RT   production of a novel truncated peptide.";
RL   J. Lipid Res. 38:847-859(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ILE-80.
RC   TISSUE=Peripheral blood leukocyte;
RX   PubMed=9479499; DOI=10.1006/geno.1997.5110;
RA   Fujino T., Navaratnam N., Scott J.;
RT   "Human apolipoprotein B RNA editing deaminase gene (APOBEC1).";
RL   Genomics 47:266-275(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 16-147.
RA   Hong S.H., Kim J.Q., Lee C.C.;
RT   "A novel mutation in exon 3 of the human apoB editing protein gene.";
RL   Submitted (NOV-1996) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   INTERACTION WITH HNRPAB.
RX   PubMed=8999813; DOI=10.1074/jbc.272.3.1452;
RA   Lau P.P., Zhu H.J., Nakamuta M., Chan L.;
RT   "Cloning of an Apobec-1-binding protein that also interacts with
RT   apolipoprotein B mRNA and evidence for its involvement in RNA
RT   editing.";
RL   J. Biol. Chem. 272:1452-1455(1997).
RN   [7]
RP   INTERACTION WITH SYNCRIP.
RX   PubMed=11352648; DOI=10.1006/bbrc.2001.4679;
RA   Lau P.P., Chang B.-H., Chan L.;
RT   "Two-hybrid cloning identifies an RNA-binding protein, GRY-RBP, as a
RT   component of apobec-1 editosome.";
RL   Biochem. Biophys. Res. Commun. 282:977-983(2001).
RN   [8]
RP   FUNCTION IN NF1 EDITING, AND CATALYTIC ACTIVITY.
RX   PubMed=11727199; DOI=10.1086/337952;
RA   Mukhopadhyay D., Anant S., Lee R.M., Kennedy S., Viskochil D.,
RA   Davidson N.O.;
RT   "C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that
RT   express both the type II transcript and apobec-1, the catalytic
RT   subunit of the apolipoprotein B mRNA-editing enzyme.";
RL   Am. J. Hum. Genet. 70:38-50(2002).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=22580899; DOI=10.1161/ATVBAHA.112.250043;
RA   Sun H., Samarghandi A., Zhang N., Yao Z., Xiong M., Teng B.B.;
RT   "Proprotein convertase subtilisin/kexin type 9 interacts with
RT   apolipoprotein B and prevents its intracellular degradation,
RT   irrespective of the low-density lipoprotein receptor.";
RL   Arterioscler. Thromb. Vasc. Biol. 32:1585-1595(2012).
CC   -!- FUNCTION: Catalytic component of the apolipoprotein B mRNA editing
CC       enzyme complex which is responsible for the postranscriptional
CC       editing of a CAA codon for Gln to a UAA codon for stop in the APOB
CC       mRNA. Also involved in CGA (Arg) to UGA (Stop) editing in the NF1
CC       mRNA. May also play a role in the epigenetic regulation of gene
CC       expression by participating in DNA demethylation.
CC       {ECO:0000269|PubMed:11727199}.
CC   -!- CATALYTIC ACTIVITY: Cytosine(6666) in apolipoprotein B mRNA +
CC       H(2)O = uracil(6666) in apolipoprotein B mRNA + NH(3).
CC       {ECO:0000269|PubMed:11727199}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y235};
CC       Note=Binds 1 Zn(2+) ion per subunit.
CC       {ECO:0000250|UniProtKB:Q9Y235};
CC   -!- SUBUNIT: Homodimer. Part of the apolipoprotein B mRNA editing
CC       complex with A1CF. Found in a complex with CELF2/CUGBP2 and A1CF.
CC       Interacts with HNRPAB and SYNCRIP. {ECO:0000269|PubMed:11352648,
CC       ECO:0000269|PubMed:8999813}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:22580899}.
CC   -!- TISSUE SPECIFICITY: Expressed exclusively in the small intestine.
CC   -!- SIMILARITY: Belongs to the cytidine and deoxycytidylate deaminase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L25877; AAA86766.1; -; mRNA.
DR   EMBL; L26234; AAA64230.1; -; mRNA.
DR   EMBL; U72891; AAD00185.1; -; mRNA.
DR   EMBL; AB009426; BAA23882.1; -; Genomic_DNA.
DR   EMBL; U78720; AAD10701.1; -; mRNA.
DR   CCDS; CCDS8579.1; -.
DR   PIR; I59323; I59323.
DR   RefSeq; NP_001291495.1; NM_001304566.1.
DR   RefSeq; NP_001635.2; NM_001644.4.
DR   RefSeq; NP_005880.2; NM_005889.3.
DR   UniGene; Hs.560; -.
DR   ProteinModelPortal; P41238; -.
DR   SMR; P41238; -.
DR   BioGrid; 106836; 9.
DR   IntAct; P41238; 4.
DR   STRING; 9606.ENSP00000229304; -.
DR   iPTMnet; P41238; -.
DR   PhosphoSitePlus; P41238; -.
DR   BioMuta; APOBEC1; -.
DR   DMDM; 152013530; -.
DR   PaxDb; P41238; -.
DR   PRIDE; P41238; -.
DR   Ensembl; ENST00000229304; ENSP00000229304; ENSG00000111701.
DR   GeneID; 339; -.
DR   KEGG; hsa:339; -.
DR   UCSC; uc001qtb.4; human.
DR   CTD; 339; -.
DR   DisGeNET; 339; -.
DR   EuPathDB; HostDB:ENSG00000111701.6; -.
DR   GeneCards; APOBEC1; -.
DR   HGNC; HGNC:604; APOBEC1.
DR   MIM; 600130; gene.
DR   neXtProt; NX_P41238; -.
DR   OpenTargets; ENSG00000111701; -.
DR   PharmGKB; PA24889; -.
DR   eggNOG; ENOG410IKDF; Eukaryota.
DR   eggNOG; ENOG4111BJA; LUCA.
DR   GeneTree; ENSGT00530000062933; -.
DR   HOGENOM; HOG000033766; -.
DR   HOVERGEN; HBG050445; -.
DR   KO; K16932; -.
DR   OMA; NFVNYPP; -.
DR   OrthoDB; EOG091G0PT8; -.
DR   PhylomeDB; P41238; -.
DR   TreeFam; TF331356; -.
DR   BRENDA; 3.5.4.36; 2681.
DR   BRENDA; 3.5.4.37; 2681.
DR   Reactome; R-HSA-72200; mRNA Editing: C to U Conversion.
DR   Reactome; R-HSA-75094; Formation of the Editosome.
DR   GeneWiki; APOBEC1; -.
DR   GenomeRNAi; 339; -.
DR   PRO; PR:P41238; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000111701; -.
DR   CleanEx; HS_APOBEC1; -.
DR   ExpressionAtlas; P41238; baseline and differential.
DR   Genevisible; P41238; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0017091; F:AU-rich element binding; IEA:Ensembl.
DR   GO; GO:0004126; F:cytidine deaminase activity; TAS:Reactome.
DR   GO; GO:0004131; F:cytosine deaminase activity; IEA:Ensembl.
DR   GO; GO:0008047; F:enzyme activator activity; IEA:Ensembl.
DR   GO; GO:0003729; F:mRNA binding; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; TAS:ProtInc.
DR   GO; GO:0008270; F:zinc ion binding; TAS:ProtInc.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl.
DR   GO; GO:0016554; P:cytidine to uridine editing; TAS:Reactome.
DR   GO; GO:0051607; P:defense response to virus; IEA:Ensembl.
DR   GO; GO:0070383; P:DNA cytosine deamination; IEA:Ensembl.
DR   GO; GO:0080111; P:DNA demethylation; ISS:UniProtKB.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   GO; GO:0042158; P:lipoprotein biosynthetic process; IEA:Ensembl.
DR   GO; GO:0042953; P:lipoprotein transport; IEA:Ensembl.
DR   GO; GO:0016556; P:mRNA modification; IEA:Ensembl.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0048255; P:mRNA stabilization; IEA:Ensembl.
DR   GO; GO:0090310; P:negative regulation of methylation-dependent chromatin silencing; ISS:UniProtKB.
DR   GO; GO:0090209; P:negative regulation of triglyceride metabolic process; IEA:Ensembl.
DR   GO; GO:0090366; P:positive regulation of mRNA modification; IEA:Ensembl.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0051592; P:response to calcium ion; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0010332; P:response to gamma radiation; IEA:Ensembl.
DR   GO; GO:0006970; P:response to osmotic stress; IEA:Ensembl.
DR   GO; GO:0010043; P:response to zinc ion; IEA:Ensembl.
DR   GO; GO:0006396; P:RNA processing; TAS:ProtInc.
DR   GO; GO:0006641; P:triglyceride metabolic process; IEA:Ensembl.
DR   InterPro; IPR016192; APOBEC/CMP_deaminase_Zn-bd.
DR   InterPro; IPR013158; APOBEC_N.
DR   InterPro; IPR002125; CMP_dCMP_dom.
DR   InterPro; IPR016193; Cytidine_deaminase-like.
DR   Pfam; PF08210; APOBEC_N; 1.
DR   SUPFAM; SSF53927; SSF53927; 1.
DR   PROSITE; PS00903; CYT_DCMP_DEAMINASES_1; 1.
DR   PROSITE; PS51747; CYT_DCMP_DEAMINASES_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; Hydrolase; Metal-binding;
KW   mRNA processing; Polymorphism; Reference proteome; Zinc.
FT   CHAIN         1    236       C->U-editing enzyme APOBEC-1.
FT                                /FTId=PRO_0000171742.
FT   DOMAIN       10    134       CMP/dCMP-type deaminase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01083}.
FT   COMPBIAS    180    193       Leu-rich.
FT   ACT_SITE     63     63       Proton donor.
FT                                {ECO:0000250|UniProtKB:Q9Y235}.
FT   METAL        61     61       Zinc; catalytic.
FT                                {ECO:0000250|UniProtKB:Q9Y235}.
FT   METAL        93     93       Zinc; catalytic.
FT                                {ECO:0000250|UniProtKB:Q9Y235}.
FT   METAL        96     96       Zinc; catalytic.
FT                                {ECO:0000250|UniProtKB:Q9Y235}.
FT   VARIANT      80     80       M -> I (in dbSNP:rs2302515).
FT                                {ECO:0000269|PubMed:8078915,
FT                                ECO:0000269|PubMed:8208612,
FT                                ECO:0000269|PubMed:9186903,
FT                                ECO:0000269|PubMed:9479499}.
FT                                /FTId=VAR_013779.
FT   VARIANT     236    236       R -> K (in dbSNP:rs12820011).
FT                                /FTId=VAR_048720.
FT   CONFLICT     53     53       S -> T (in Ref. 5; AAD10701).
FT                                {ECO:0000305}.
FT   CONFLICT     83     83       S -> T (in Ref. 5; AAD10701).
FT                                {ECO:0000305}.
SQ   SEQUENCE   236 AA;  28192 MW;  28466B43F7FD82F7 CRC64;
     MTSEKGPSTG DPTLRRRIEP WEFDVFYDPR ELRKEACLLY EIKWGMSRKI WRSSGKNTTN
     HVEVNFIKKF TSERDFHPSM SCSITWFLSW SPCWECSQAI REFLSRHPGV TLVIYVARLF
     WHMDQQNRQG LRDLVNSGVT IQIMRASEYY HCWRNFVNYP PGDEAHWPQY PPLWMMLYAL
     ELHCIILSLP PCLKISRRWQ NHLTFFRLHL QNCHYQTIPP HILLATGLIH PSVAWR
//
ID   TERF2_HUMAN             Reviewed;         542 AA.
AC   Q15554;
DT   20-JUN-2002, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 3.
DT   23-MAY-2018, entry version 191.
DE   RecName: Full=Telomeric repeat-binding factor 2;
DE   AltName: Full=TTAGGG repeat-binding factor 2;
DE   AltName: Full=Telomeric DNA-binding protein;
GN   Name=TERF2; Synonyms=TRBF2, TRF2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Adrenal cortex;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 6-542 (ISOFORM 1).
RC   TISSUE=Mammary carcinoma;
RX   PubMed=9326950; DOI=10.1038/ng1097-231;
RA   Broccoli D., Smogorzewska A., Chong L., de Lange T.;
RT   "Human telomeres contain two distinct Myb-related proteins, TRF1 and
RT   TRF2.";
RL   Nat. Genet. 17:231-235(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 83-542 (ISOFORM 1).
RC   TISSUE=Cervix carcinoma;
RX   PubMed=9326951; DOI=10.1038/ng1097-236;
RA   Bilaud T., Brun C., Ancelin K., Koering C.E., Larouche T., Gilson E.;
RT   "Telomeric localization of TRF2, a novel human telobox protein.";
RL   Nat. Genet. 17:236-239(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 480-542 (ISOFORM 1).
RC   TISSUE=Cervix carcinoma;
RX   PubMed=8614633; DOI=10.1093/nar/24.7.1294;
RA   Bilaud T., Koering C.E., Binet-Brasselet E., Ancelin K., Pollice A.,
RA   Gasser S.M., Gilson E.;
RT   "The telobox, a Myb-related telomeric DNA binding motif found in
RT   proteins from yeast, plants and human.";
RL   Nucleic Acids Res. 24:1294-1303(1996).
RN   [6]
RP   FUNCTION.
RX   PubMed=9476899; DOI=10.1016/S0092-8674(00)80932-0;
RA   van Steensel B., Smogorzewska A., de Lange T.;
RT   "TRF2 protects human telomeres from end-to-end fusions.";
RL   Cell 92:401-413(1998).
RN   [7]
RP   INTERACTION WITH NBN.
RX   PubMed=10888888; DOI=10.1038/77139;
RA   Zhu X.-D., Kuester B., Mann M., Petrini J.H.J., de Lange T.;
RT   "Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and
RT   human telomeres.";
RL   Nat. Genet. 25:347-352(2000).
RN   [8]
RP   IDENTIFICATION IN THE SHELTERIN COMPLEX.
RX   PubMed=15316005; DOI=10.1074/jbc.M409047200;
RA   Ye J.Z.-S., Donigian J.R., van Overbeek M., Loayza D., Luo Y.,
RA   Krutchinsky A.N., Chait B.T., de Lange T.;
RT   "TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2
RT   complex on telomeres.";
RL   J. Biol. Chem. 279:47264-47271(2004).
RN   [9]
RP   IDENTIFICATION IN THE SHELTERIN COMPLEX.
RX   PubMed=15383534; DOI=10.1074/jbc.M409293200;
RA   Liu D., O'Connor M.S., Qin J., Songyang Z.;
RT   "Telosome, a mammalian telomere-associated complex formed by multiple
RT   telomeric proteins.";
RL   J. Biol. Chem. 279:51338-51342(2004).
RN   [10]
RP   FUNCTION OF THE SHELTERIN COMPLEX.
RX   PubMed=16166375; DOI=10.1101/gad.1346005;
RA   de Lange T.;
RT   "Shelterin: the protein complex that shapes and safeguards human
RT   telomeres.";
RL   Genes Dev. 19:2100-2110(2005).
RN   [11]
RP   PHOSPHORYLATION AT THR-230 BY ATM.
RX   PubMed=16223874; DOI=10.1073/pnas.0507915102;
RA   Tanaka H., Mendonca M.S., Bradshaw P.S., Hoelz D.J., Malkas L.H.,
RA   Meyn M.S., Gilley D.;
RT   "DNA damage-induced phosphorylation of the human telomere-associated
RT   protein TRF2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:15539-15544(2005).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-365, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [13]
RP   INTERACTION WITH DCLRE1B.
RX   PubMed=16730176; DOI=10.1016/j.cub.2006.05.022;
RA   van Overbeek M., de Lange T.;
RT   "Apollo, an Artemis-related nuclease, interacts with TRF2 and protects
RT   human telomeres in S phase.";
RL   Curr. Biol. 16:1295-1302(2006).
RN   [14]
RP   INTERACTION WITH DCLRE1B.
RX   PubMed=16730175; DOI=10.1016/j.cub.2006.05.021;
RA   Lenain C., Bauwens S., Amiard S., Brunori M., Giraud-Panis M.J.,
RA   Gilson E.;
RT   "The Apollo 5' exonuclease functions together with TRF2 to protect
RT   telomeres from DNA repair.";
RL   Curr. Biol. 16:1303-1310(2006).
RN   [15]
RP   INTERACTION WITH DCLRE1B.
RX   PubMed=16606622; DOI=10.1074/jbc.C600038200;
RA   Freibaum B.D., Counter C.M.;
RT   "hSnm1B is a novel telomere-associated protein.";
RL   J. Biol. Chem. 281:15033-15036(2006).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-365, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [17]
RP   INTERACTION WITH DCLRE1B.
RX   PubMed=18468965; DOI=10.1016/j.dnarep.2008.03.020;
RA   Demuth I., Bradshaw P.S., Lindner A., Anders M., Heinrich S.,
RA   Kallenbach J., Schmelz K., Digweed M., Meyn M.S., Concannon P.;
RT   "Endogenous hSNM1B/Apollo interacts with TRF2 and stimulates ATM in
RT   response to ionizing radiation.";
RL   DNA Repair 7:1192-1201(2008).
RN   [18]
RP   INTERACTION WITH DCLRE1B.
RX   PubMed=18593705; DOI=10.1074/jbc.M800388200;
RA   Freibaum B.D., Counter C.M.;
RT   "The protein hSnm1B is stabilized when bound to the telomere-binding
RT   protein TRF2.";
RL   J. Biol. Chem. 283:23671-23676(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-365, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [21]
RP   INTERACTION WITH SLX4.
RX   PubMed=19596235; DOI=10.1016/j.cell.2009.06.030;
RA   Svendsen J.M., Smogorzewska A., Sowa M.E., O'Connell B.C., Gygi S.P.,
RA   Elledge S.J., Harper J.W.;
RT   "Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is
RT   required for DNA repair.";
RL   Cell 138:63-77(2009).
RN   [22]
RP   METHYLATION AT ARG-59 AND ARG-60 BY PRMT1.
RX   PubMed=19596784; DOI=10.1128/MCB.00009-09;
RA   Mitchell T.R., Glenfield K., Jeyanthan K., Zhu X.D.;
RT   "Arginine methylation regulates telomere length and stability.";
RL   Mol. Cell. Biol. 29:4918-4934(2009).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-365, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [24]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH DCLRE1B, AND
RP   DNA-BINDING.
RX   PubMed=20655466; DOI=10.1016/j.cell.2010.05.032;
RA   Ye J., Lenain C., Bauwens S., Rizzo A., Saint-Leger A., Poulet A.,
RA   Benarroch D., Magdinier F., Morere J., Amiard S., Verhoeyen E.,
RA   Britton S., Calsou P., Salles B., Bizard A., Nadal M., Salvati E.,
RA   Sabatier L., Wu Y., Biroccio A., Londono-Vallejo A.,
RA   Giraud-Panis M.J., Gilson E.;
RT   "TRF2 and Apollo cooperate with topoisomerase 2alpha to protect human
RT   telomeres from replicative damage.";
RL   Cell 142:230-242(2010).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-365, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-365, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-365, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-365, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [30]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-287; LYS-335; LYS-353;
RP   LYS-369; LYS-375 AND LYS-452, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS).
RX   PubMed=11545737; DOI=10.1016/S1097-2765(01)00321-5;
RA   Fairall L., Chapman L., Moss H., de Lange T., Rhodes D.;
RT   "Structure of the TRFH dimerization domain of the human telomeric
RT   proteins TRF1 and TRF2.";
RL   Mol. Cell 8:351-361(2001).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 488-542 IN COMPLEX WITH
RP   TELOMERIC DNA, AND SUBUNIT.
RX   PubMed=15608617; DOI=10.1038/sj.embor.7400314;
RA   Court R., Chapman L., Fairall L., Rhodes D.;
RT   "How the human telomeric proteins TRF1 and TRF2 recognize telomeric
RT   DNA: a view from high-resolution crystal structures.";
RL   EMBO Rep. 6:39-45(2005).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 84-318 IN COMPLEX WITH TINF2
RP   AND DCLRE1B, AND DOMAIN TRFH DIMERIZATION.
RX   PubMed=18202258; DOI=10.1126/science.1151804;
RA   Chen Y., Yang Y., van Overbeek M., Donigian J.R., Baciu P.,
RA   de Lange T., Lei M.;
RT   "A shared docking motif in TRF1 and TRF2 used for differential
RT   recruitment of telomeric proteins.";
RL   Science 319:1092-1096(2008).
CC   -!- FUNCTION: Binds the telomeric double-stranded 5'-TTAGGG-3' repeat
CC       and plays a central role in telomere maintenance and protection
CC       against end-to-end fusion of chromosomes. In addition to its
CC       telomeric DNA-binding role, required to recruit a number of
CC       factors and enzymes required for telomere protection, including
CC       the shelterin complex, TERF2IP/RAP1 and DCLRE1B/Apollo. Component
CC       of the shelterin complex (telosome) that is involved in the
CC       regulation of telomere length and protection. Shelterin associates
CC       with arrays of double-stranded 5'-TTAGGG-3' repeats added by
CC       telomerase and protects chromosome ends; without its protective
CC       activity, telomeres are no longer hidden from the DNA damage
CC       surveillance and chromosome ends are inappropriately processed by
CC       DNA repair pathways. Together with DCLRE1B/Apollo, plays a key
CC       role in telomeric loop (T loop) formation by generating 3' single-
CC       stranded overhang at the leading end telomeres: T loops have been
CC       proposed to protect chromosome ends from degradation and repair.
CC       Required both to recruit DCLRE1B/Apollo to telomeres and activate
CC       the exonuclease activity of DCLRE1B/Apollo. Preferentially binds
CC       to positive supercoiled DNA. Together with DCLRE1B/Apollo,
CC       required to control the amount of DNA topoisomerase (TOP1, TOP2A
CC       and TOP2B) needed for telomere replication during fork passage and
CC       prevent aberrant telomere topology. Recruits TERF2IP/RAP1 to
CC       telomeres, thereby participating in to repressing homology-
CC       directed repair (HDR), which can affect telomere length.
CC       {ECO:0000269|PubMed:16166375, ECO:0000269|PubMed:20655466,
CC       ECO:0000269|PubMed:9476899}.
CC   -!- SUBUNIT: Homodimer. Component of the shelterin complex (telosome)
CC       composed of TERF1, TERF2, TINF2, TERF2IP/RAP1, ACD and POT1.
CC       Interacts with TERF2IP. Interacts with NBN. Interacts with
CC       SLX4/BTBD12. Interacts with DCLRE1B/Apollo and TERF2IP/RAP1; the
CC       interaction is direct. {ECO:0000269|PubMed:10888888,
CC       ECO:0000269|PubMed:15316005, ECO:0000269|PubMed:15383534,
CC       ECO:0000269|PubMed:15608617, ECO:0000269|PubMed:16606622,
CC       ECO:0000269|PubMed:16730175, ECO:0000269|PubMed:16730176,
CC       ECO:0000269|PubMed:18202258, ECO:0000269|PubMed:18468965,
CC       ECO:0000269|PubMed:18593705, ECO:0000269|PubMed:19596235,
CC       ECO:0000269|PubMed:20655466}.
CC   -!- INTERACTION:
CC       Q13315:ATM; NbExp=2; IntAct=EBI-706637, EBI-495465;
CC       P54132:BLM; NbExp=8; IntAct=EBI-706637, EBI-621372;
CC       Q6PK04:CCDC137; NbExp=2; IntAct=EBI-706637, EBI-714654;
CC       Q9H816:DCLRE1B; NbExp=9; IntAct=EBI-706637, EBI-3508943;
CC       Q9NR30:DDX21; NbExp=2; IntAct=EBI-706637, EBI-357942;
CC       P03211:EBNA1 (xeno); NbExp=3; IntAct=EBI-706637, EBI-996522;
CC       P16104:H2AFX; NbExp=4; IntAct=EBI-706637, EBI-494830;
CC       Q7Z4V5:HDGFL2; NbExp=2; IntAct=EBI-706637, EBI-1049136;
CC       O94992:HEXIM1; NbExp=2; IntAct=EBI-706637, EBI-2832510;
CC       P05204:HMGN2; NbExp=2; IntAct=EBI-706637, EBI-1758689;
CC       Q8NEM0:MCPH1; NbExp=5; IntAct=EBI-706637, EBI-1565483;
CC       Q69YI7:NAIF1; NbExp=2; IntAct=EBI-706637, EBI-10249231;
CC       Q13415:ORC1; NbExp=2; IntAct=EBI-706637, EBI-374847;
CC       Q13416:ORC2; NbExp=3; IntAct=EBI-706637, EBI-374957;
CC       Q9NUX5:POT1; NbExp=6; IntAct=EBI-706637, EBI-752420;
CC       Q80W00:Ppp1r10 (xeno); NbExp=3; IntAct=EBI-706637, EBI-2553719;
CC       P26373:RPL13; NbExp=2; IntAct=EBI-706637, EBI-356849;
CC       Q8IY92:SLX4; NbExp=5; IntAct=EBI-706637, EBI-2370740;
CC       Q9NYB0:TERF2IP; NbExp=36; IntAct=EBI-706637, EBI-750109;
CC       Q9BSI4:TINF2; NbExp=11; IntAct=EBI-706637, EBI-717399;
CC       Q9BSI4-3:TINF2; NbExp=4; IntAct=EBI-706637, EBI-717418;
CC       Q14191:WRN; NbExp=8; IntAct=EBI-706637, EBI-368417;
CC       Q86VM9:ZC3H18; NbExp=2; IntAct=EBI-706637, EBI-1045965;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00625, ECO:0000269|PubMed:20655466}. Chromosome,
CC       telomere {ECO:0000269|PubMed:20655466}. Note=Colocalizes with
CC       telomeric DNA in interphase cells and is located at chromosome
CC       ends during metaphase.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15554-3; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15554-4; Sequence=VSP_003304, VSP_003305;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in spleen,
CC       thymus, prostate, uterus, testis, small intestine, colon and
CC       peripheral blood leukocytes.
CC   -!- DOMAIN: The TRFH dimerization region mediates the interaction with
CC       DCLRE1B/Apollo but not TINF2. {ECO:0000269|PubMed:18202258}.
CC   -!- DOMAIN: The HTH domain is an independent structural unit and
CC       mediates binding to telomeric DNA. {ECO:0000269|PubMed:18202258}.
CC   -!- PTM: Phosphorylated upon DNA damage, most probably by ATM.
CC       Phosphorylated TERF2 is not bound to telomeric DNA, and rapidly
CC       localizes to damage sites. {ECO:0000269|PubMed:16223874}.
CC   -!- PTM: Methylated by PRMT1 at multiple arginines within the N-
CC       terminal Arg-rich region. Methylation may control association with
CC       telomeres. {ECO:0000269|PubMed:19596784}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB81135.1; Type=Frameshift; Positions=36; Evidence={ECO:0000305};
CC       Sequence=AAB81135.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. The N-terminus may be contaminated with vector sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH24890.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC026464; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC024890; AAH24890.1; ALT_INIT; mRNA.
DR   EMBL; AF002999; AAB81135.1; ALT_SEQ; mRNA.
DR   EMBL; U95970; AAD00821.1; -; mRNA.
DR   EMBL; X93512; CAA63769.1; -; mRNA.
DR   CCDS; CCDS10879.2; -. [Q15554-3]
DR   PIR; S67923; S67923.
DR   RefSeq; NP_005643.2; NM_005652.4. [Q15554-3]
DR   UniGene; Hs.63335; -.
DR   PDB; 1H6P; X-ray; 2.20 A; A/B=85-287.
DR   PDB; 1VF9; NMR; -; A=480-542.
DR   PDB; 1VFC; NMR; -; A=480-542.
DR   PDB; 1W0U; X-ray; 1.80 A; A/B=488-542.
DR   PDB; 1XG1; NMR; -; A=480-542.
DR   PDB; 3BU8; X-ray; 2.15 A; A/B=84-318.
DR   PDB; 3BUA; X-ray; 2.50 A; A/B/C/D=84-287.
DR   PDB; 3K6G; X-ray; 1.95 A; D/E/F=317-358.
DR   PDB; 3SJM; X-ray; 1.35 A; A/B=483-542.
DR   PDB; 4M7C; X-ray; 2.05 A; A/B=87-286.
DR   PDB; 4RQI; X-ray; 2.44 A; A/B/C/D=85-287.
DR   PDB; 5WQD; X-ray; 3.00 A; A/B/C/D/E/F/G=84-287.
DR   PDB; 5XYF; X-ray; 2.20 A; C=392-408.
DR   PDBsum; 1H6P; -.
DR   PDBsum; 1VF9; -.
DR   PDBsum; 1VFC; -.
DR   PDBsum; 1W0U; -.
DR   PDBsum; 1XG1; -.
DR   PDBsum; 3BU8; -.
DR   PDBsum; 3BUA; -.
DR   PDBsum; 3K6G; -.
DR   PDBsum; 3SJM; -.
DR   PDBsum; 4M7C; -.
DR   PDBsum; 4RQI; -.
DR   PDBsum; 5WQD; -.
DR   PDBsum; 5XYF; -.
DR   ProteinModelPortal; Q15554; -.
DR   SMR; Q15554; -.
DR   BioGrid; 112873; 270.
DR   CORUM; Q15554; -.
DR   DIP; DIP-34052N; -.
DR   ELM; Q15554; -.
DR   IntAct; Q15554; 76.
DR   MINT; Q15554; -.
DR   STRING; 9606.ENSP00000254942; -.
DR   iPTMnet; Q15554; -.
DR   PhosphoSitePlus; Q15554; -.
DR   DMDM; 21542277; -.
DR   EPD; Q15554; -.
DR   PaxDb; Q15554; -.
DR   PeptideAtlas; Q15554; -.
DR   PRIDE; Q15554; -.
DR   Ensembl; ENST00000254942; ENSP00000254942; ENSG00000132604. [Q15554-3]
DR   Ensembl; ENST00000567296; ENSP00000454955; ENSG00000132604. [Q15554-4]
DR   GeneID; 7014; -.
DR   KEGG; hsa:7014; -.
DR   UCSC; uc002exd.5; human. [Q15554-3]
DR   CTD; 7014; -.
DR   DisGeNET; 7014; -.
DR   EuPathDB; HostDB:ENSG00000132604.10; -.
DR   GeneCards; TERF2; -.
DR   HGNC; HGNC:11729; TERF2.
DR   HPA; CAB010451; -.
DR   HPA; HPA001907; -.
DR   HPA; HPA002735; -.
DR   MIM; 602027; gene.
DR   neXtProt; NX_Q15554; -.
DR   OpenTargets; ENSG00000132604; -.
DR   PharmGKB; PA36446; -.
DR   eggNOG; ENOG410IJXM; Eukaryota.
DR   eggNOG; ENOG4111KJ3; LUCA.
DR   GeneTree; ENSGT00530000063796; -.
DR   HOGENOM; HOG000154547; -.
DR   HOVERGEN; HBG108560; -.
DR   InParanoid; Q15554; -.
DR   KO; K11111; -.
DR   OMA; NPKVPKG; -.
DR   OrthoDB; EOG091G04CC; -.
DR   TreeFam; TF333209; -.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   ChiTaRS; TERF2; human.
DR   EvolutionaryTrace; Q15554; -.
DR   GeneWiki; TERF2; -.
DR   GenomeRNAi; 7014; -.
DR   PRO; PR:Q15554; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000132604; -.
DR   CleanEx; HS_TERF2; -.
DR   ExpressionAtlas; Q15554; baseline and differential.
DR   Genevisible; Q15554; HS.
DR   GO; GO:0000781; C:chromosome, telomeric region; IDA:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; IDA:BHF-UCL.
DR   GO; GO:0000783; C:nuclear telomere cap complex; IDA:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0070187; C:shelterin complex; IDA:BHF-UCL.
DR   GO; GO:0003691; F:double-stranded telomeric DNA binding; IDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0098505; F:G-rich strand telomeric DNA binding; IDA:BHF-UCL.
DR   GO; GO:0008022; F:protein C-terminus binding; IPI:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:BHF-UCL.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISM:NTNU_SB.
DR   GO; GO:0042162; F:telomeric DNA binding; IDA:UniProtKB.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0090398; P:cellular senescence; NAS:BHF-UCL.
DR   GO; GO:1903770; P:negative regulation of beta-galactosidase activity; IDA:BHF-UCL.
DR   GO; GO:2000773; P:negative regulation of cellular senescence; IMP:BHF-UCL.
DR   GO; GO:1905778; P:negative regulation of exonuclease activity; IDA:BHF-UCL.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:BHF-UCL.
DR   GO; GO:1904430; P:negative regulation of t-circle formation; IMP:BHF-UCL.
DR   GO; GO:1904354; P:negative regulation of telomere capping; IMP:BHF-UCL.
DR   GO; GO:0032205; P:negative regulation of telomere maintenance; IDA:UniProtKB.
DR   GO; GO:0032208; P:negative regulation of telomere maintenance via recombination; IMP:BHF-UCL.
DR   GO; GO:0032214; P:negative regulation of telomere maintenance via semi-conservative replication; NAS:BHF-UCL.
DR   GO; GO:0032211; P:negative regulation of telomere maintenance via telomerase; IDA:BHF-UCL.
DR   GO; GO:1904357; P:negative regulation of telomere maintenance via telomere lengthening; IMP:BHF-UCL.
DR   GO; GO:1903824; P:negative regulation of telomere single strand break repair; NAS:BHF-UCL.
DR   GO; GO:1905839; P:negative regulation of telomeric D-loop disassembly; IDA:BHF-UCL.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL.
DR   GO; GO:0051000; P:positive regulation of nitric-oxide synthase activity; IMP:BHF-UCL.
DR   GO; GO:0031848; P:protection from non-homologous end joining at telomere; IMP:BHF-UCL.
DR   GO; GO:0070198; P:protein localization to chromosome, telomeric region; IMP:BHF-UCL.
DR   GO; GO:0032204; P:regulation of telomere maintenance; IMP:CACAO.
DR   GO; GO:0032210; P:regulation of telomere maintenance via telomerase; IDA:BHF-UCL.
DR   GO; GO:0006278; P:RNA-dependent DNA biosynthetic process; IEA:GOC.
DR   GO; GO:0016233; P:telomere capping; IMP:BHF-UCL.
DR   GO; GO:0000723; P:telomere maintenance; IMP:UniProtKB.
DR   GO; GO:0061820; P:telomeric D-loop disassembly; IGI:BHF-UCL.
DR   GO; GO:0031627; P:telomeric loop formation; IDA:BHF-UCL.
DR   CDD; cd11654; TRF2_RBM; 1.
DR   Gene3D; 1.25.40.210; -; 1.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR017930; Myb_dom.
DR   InterPro; IPR001005; SANT/Myb.
DR   InterPro; IPR013867; Telomere_rpt-bd_fac_dimer_dom.
DR   InterPro; IPR036507; Telomere_rpt-bd_fac_dimer_sf.
DR   InterPro; IPR017357; TERF1/2.
DR   InterPro; IPR030657; TERF2.
DR   InterPro; IPR031902; TERF2_RBM.
DR   PANTHER; PTHR21717:SF13; PTHR21717:SF13; 1.
DR   Pfam; PF00249; Myb_DNA-binding; 1.
DR   Pfam; PF16772; TERF2_RBM; 1.
DR   Pfam; PF08558; TRF; 1.
DR   PIRSF; PIRSF038016; Telomere_bd-1_Pin2; 1.
DR   ProDom; PD014243; Telomere_repeat-bd_fac_dimer; 1.
DR   SMART; SM00717; SANT; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF63600; SSF63600; 1.
DR   PROSITE; PS51294; HTH_MYB; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle; Chromosome;
KW   Complete proteome; DNA-binding; Isopeptide bond; Methylation; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Telomere;
KW   Ubl conjugation.
FT   CHAIN         1    542       Telomeric repeat-binding factor 2.
FT                                /FTId=PRO_0000197131.
FT   DOMAIN      484    541       HTH myb-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00625}.
FT   DNA_BIND    512    537       H-T-H motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00625}.
FT   REGION       84    287       TRFH dimerization.
FT   MOTIF       371    375       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   COMPBIAS     55     72       Arg-rich (basic).
FT   MOD_RES      59     59       Asymmetric dimethylarginine; by PRMT1.
FT                                {ECO:0000269|PubMed:19596784}.
FT   MOD_RES      60     60       Omega-N-methylarginine.
FT                                {ECO:0000269|PubMed:19596784}.
FT   MOD_RES     230    230       Phosphothreonine; by ATM.
FT                                {ECO:0000269|PubMed:16223874}.
FT   MOD_RES     365    365       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   CROSSLNK    287    287       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    335    335       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    353    353       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    369    369       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    375    375       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    452    452       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     281    293       MAKKALKSESAAS -> VRLGPSPITMVCP (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_003304.
FT   VAR_SEQ     294    542       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_003305.
FT   VARIANT     455    455       S -> G (in dbSNP:rs35874485).
FT                                /FTId=VAR_050196.
FT   TURN         87     89       {ECO:0000244|PDB:3BU8}.
FT   HELIX        90    111       {ECO:0000244|PDB:4M7C}.
FT   HELIX       115    128       {ECO:0000244|PDB:4M7C}.
FT   HELIX       137    153       {ECO:0000244|PDB:4M7C}.
FT   TURN        154    156       {ECO:0000244|PDB:4M7C}.
FT   STRAND      163    165       {ECO:0000244|PDB:3BU8}.
FT   HELIX       170    184       {ECO:0000244|PDB:4M7C}.
FT   HELIX       189    209       {ECO:0000244|PDB:4M7C}.
FT   HELIX       213    223       {ECO:0000244|PDB:4M7C}.
FT   HELIX       228    230       {ECO:0000244|PDB:3BU8}.
FT   HELIX       231    243       {ECO:0000244|PDB:4M7C}.
FT   TURN        244    246       {ECO:0000244|PDB:1H6P}.
FT   HELIX       249    252       {ECO:0000244|PDB:4M7C}.
FT   HELIX       256    268       {ECO:0000244|PDB:4M7C}.
FT   HELIX       277    285       {ECO:0000244|PDB:4M7C}.
FT   TURN        286    288       {ECO:0000244|PDB:3BU8}.
FT   HELIX       327    338       {ECO:0000244|PDB:3K6G}.
FT   HELIX       343    352       {ECO:0000244|PDB:3K6G}.
FT   HELIX       401    406       {ECO:0000244|PDB:5XYF}.
FT   TURN        482    485       {ECO:0000244|PDB:1VF9}.
FT   STRAND      487    489       {ECO:0000244|PDB:1XG1}.
FT   HELIX       494    507       {ECO:0000244|PDB:3SJM}.
FT   HELIX       512    518       {ECO:0000244|PDB:3SJM}.
FT   HELIX       526    538       {ECO:0000244|PDB:3SJM}.
SQ   SEQUENCE   542 AA;  59594 MW;  3A278AC6B594C43A CRC64;
     MAAGAGTAGP ASGPGVVRDP AASQPRKRPG REGGEGARRS DTMAGGGGSS DGSGRAAGRR
     ASRSSGRARR GRHEPGLGGP AERGAGEARL EEAVNRWVLK FYFHEALRAF RGSRYGDFRQ
     IRDIMQALLV RPLGKEHTVS RLLRVMQCLS RIEEGENLDC SFDMEAELTP LESAINVLEM
     IKTEFTLTEA VVESSRKLVK EAAVIICIKN KEFEKASKIL KKHMSKDPTT QKLRNDLLNI
     IREKNLAHPV IQNFSYETFQ QKMLRFLESH LDDAEPYLLT MAKKALKSES AASSTGKEDK
     QPAPGPVEKP PREPARQLRN PPTTIGMMTL KAAFKTLSGA QDSEAAFAKL DQKDLVLPTQ
     ALPASPALKN KRPRKDENES SAPADGEGGS ELQPKNKRMT ISRLVLEEDS QSTEPSAGLN
     SSQEAASAPP SKPTVLNQPL PGEKNPKVPK GKWNSSNGVE EKETWVEEDE LFQVQAAPDE
     DSTTNITKKQ KWTVEESEWV KAGVQKYGEG NWAAISKNYP FVNRTAVMIK DRWRTMKRLG
     MN
//
ID   A0A024R739_HUMAN        Unreviewed;       634 AA.
AC   A0A024R739;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 24.
DE   SubName: Full=POT1 protection of telomeres 1 homolog (S. pombe), isoform CRA_b {ECO:0000313|EMBL:EAW83617.1};
GN   Name=POT1 {ECO:0000313|EMBL:EAW83617.1};
GN   ORFNames=hCG_32923 {ECO:0000313|EMBL:EAW83617.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW83617.1};
RN   [1] {ECO:0000313|EMBL:EAW83617.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW83617.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471070; EAW83617.1; -; Genomic_DNA.
DR   RefSeq; NP_056265.2; NM_015450.2.
DR   RefSeq; XP_006715980.1; XM_006715917.3.
DR   UniGene; Hs.31968; -.
DR   ProteinModelPortal; A0A024R739; -.
DR   SMR; A0A024R739; -.
DR   GeneID; 25913; -.
DR   KEGG; hsa:25913; -.
DR   CTD; 25913; -.
DR   EuPathDB; HostDB:ENSG00000128513.14; -.
DR   eggNOG; KOG4757; Eukaryota.
DR   eggNOG; ENOG410Z1J0; LUCA.
DR   KO; K11109; -.
DR   OMA; DKTSWIP; -.
DR   OrthoDB; EOG091G01T8; -.
DR   PhylomeDB; A0A024R739; -.
DR   ChiTaRS; POT1; human.
DR   GenomeRNAi; 25913; -.
DR   Bgee; ENSG00000128513; -.
DR   ExpressionAtlas; A0A024R739; baseline and differential.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0043047; F:single-stranded telomeric DNA binding; IEA:InterPro.
DR   GO; GO:0000723; P:telomere maintenance; IEA:InterPro.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR028389; POT1.
DR   InterPro; IPR032042; POT1PC.
DR   InterPro; IPR011564; Telomer_end-bd_POT1/Cdc13.
DR   PANTHER; PTHR14513; PTHR14513; 1.
DR   Pfam; PF02765; POT1; 1.
DR   Pfam; PF16686; POT1PC; 1.
DR   SMART; SM00976; Telo_bind; 1.
DR   SUPFAM; SSF50249; SSF50249; 2.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN       11    141       Telo_bind. {ECO:0000259|SMART:SM00976}.
FT   COILED      285    305       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   634 AA;  71442 MW;  123A12CABE708C91 CRC64;
     MSLVPATNYI YTPLNQLKGG TIVNVYGVVK FFKPPYLSKG TDYCSVVTIV DQTNVKLTCL
     LFSGNYEALP IIYKNGDIVR FHRLKIQVYK KETQGITSSG FASLTFEGTL GAPIIPRTSS
     KYFNFTTEDH KMVEALRVWA STHMSPSWTL LKLCDVQPMQ YFDLTCQLLG KAEVDGASFL
     LKVWDGTRTP FPSWRVLIQD LVLEGDLSHI HRLQNLTIDI LVYDNHVHVA RSLKVGSFLR
     IYSLHTKLQS MNSENQTMLS LEFHLHGGTS YGRGIRVLPE SNSDVDQLKK DLESANLTAN
     QHSDVICQSE PDDSFPSSGS VSLYEVERCQ QLSATILTDH QYLERTPLCA ILKQKAPQQY
     RIRAKLRSYK PRRLFQSVKL HCPKCHLLQE VPHEGDLDII FQDGATKTPD VKLQNTSLYD
     SKIWTTKNQK GRKVAVHFVK NNGILPLSNE CLLLIEGGTL SEICKLSNKF NSVIPVRSGH
     EDLELLDLSA PFLIQGTIHH YGCKQCSSLR SIQNLNSLVD KTSWIPSSVA EALGIVPLQY
     VFVMTFTLDD GTGVLEAYLM DSDKFFQIPA SEVLMDDDLQ KSVDMIMDMF CPPGIKIDAY
     PWLECFIKSY NVTNGTDNQI CYQIFDTTVA EDVI
//
ID   A8MTK3_HUMAN            Unreviewed;       503 AA.
AC   A8MTK3;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   23-MAY-2018, entry version 88.
DE   SubName: Full=POT1 protection of telomeres 1 homolog (S. pombe), isoform CRA_a {ECO:0000313|EMBL:EAW83615.1};
DE   SubName: Full=Protection of telomeres protein 1 {ECO:0000313|Ensembl:ENSP00000377002};
GN   Name=POT1 {ECO:0000313|EMBL:EAW83615.1,
GN   ECO:0000313|Ensembl:ENSP00000377002};
GN   ORFNames=hCG_32923 {ECO:0000313|EMBL:EAW83615.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000377002, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW83615.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000377002, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3] {ECO:0000313|EMBL:EAW83615.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|Ensembl:ENSP00000377002}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC004925; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC096665; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110791; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471070; EAW83615.1; -; Genomic_DNA.
DR   RefSeq; NP_001036059.1; NM_001042594.1.
DR   RefSeq; XP_011514308.1; XM_011516006.1.
DR   RefSeq; XP_011514309.1; XM_011516007.1.
DR   RefSeq; XP_016867431.1; XM_017011942.1.
DR   UniGene; Hs.31968; -.
DR   DNASU; 25913; -.
DR   Ensembl; ENST00000393329; ENSP00000377002; ENSG00000128513.
DR   GeneID; 25913; -.
DR   UCSC; uc003vlo.4; human.
DR   CTD; 25913; -.
DR   EuPathDB; HostDB:ENSG00000128513.14; -.
DR   HGNC; HGNC:17284; POT1.
DR   OpenTargets; ENSG00000128513; -.
DR   PharmGKB; PA134934904; -.
DR   eggNOG; KOG4757; Eukaryota.
DR   eggNOG; ENOG410Z1J0; LUCA.
DR   GeneTree; ENSGT00390000018285; -.
DR   HOGENOM; HOG000015271; -.
DR   HOVERGEN; HBG053641; -.
DR   ChiTaRS; POT1; human.
DR   GenomeRNAi; 25913; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000128513; -.
DR   GO; GO:0043047; F:single-stranded telomeric DNA binding; IEA:InterPro.
DR   GO; GO:0000723; P:telomere maintenance; IEA:InterPro.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR028389; POT1.
DR   InterPro; IPR032042; POT1PC.
DR   PANTHER; PTHR14513; PTHR14513; 1.
DR   Pfam; PF16686; POT1PC; 1.
DR   SUPFAM; SSF50249; SSF50249; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A8MTK3,
KW   ECO:0000213|MaxQB:A8MTK3, ECO:0000213|PeptideAtlas:A8MTK3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       21    165       POT1PC. {ECO:0000259|Pfam:PF16686}.
FT   COILED      154    174       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   503 AA;  56817 MW;  2CF6B188449D8AE3 CRC64;
     MVEALRVWAS THMSPSWTLL KLCDVQPMQY FDLTCQLLGK AEVDGASFLL KVWDGTRTPF
     PSWRVLIQDL VLEGDLSHIH RLQNLTIDIL VYDNHVHVAR SLKVGSFLRI YSLHTKLQSM
     NSENQTMLSL EFHLHGGTSY GRGIRVLPES NSDVDQLKKD LESANLTANQ HSDVICQSEP
     DDSFPSSGSV SLYEVERCQQ LSATILTDHQ YLERTPLCAI LKQKAPQQYR IRAKLRSYKP
     RRLFQSVKLH CPKCHLLQEV PHEGDLDIIF QDGATKTPDV KLQNTSLYDS KIWTTKNQKG
     RKVAVHFVKN NGILPLSNEC LLLIEGGTLS EICKLSNKFN SVIPVRSGHE DLELLDLSAP
     FLIQGTIHHY GCKQCSSLRS IQNLNSLVDK TSWIPSSVAE ALGIVPLQYV FVMTFTLDDG
     TGVLEAYLMD SDKFFQIPAS EVLMDDDLQK SVDMIMDMFC PPGIKIDAYP WLECFIKSYN
     VTNGTDNQIC YQIFDTTVAE DVI
//
ID   Q5MJ33_HUMAN            Unreviewed;        45 AA.
AC   Q5MJ33;
DT   01-FEB-2005, integrated into UniProtKB/TrEMBL.
DT   01-FEB-2005, sequence version 1.
DT   23-MAY-2018, entry version 103.
DE   SubName: Full=Protection of telomeres protein 1 {ECO:0000313|Ensembl:ENSP00000403088};
DE   SubName: Full=Protection of telomeres protein 1 variant 4 {ECO:0000313|EMBL:AAW22616.1};
GN   Name=POT1 {ECO:0000313|Ensembl:ENSP00000403088};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAW22616.1};
RN   [1] {ECO:0000313|EMBL:AAW22616.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Ovary {ECO:0000313|EMBL:AAW22616.1};
RX   PubMed=12391173; DOI=10.1128/MCB.22.22.8079-8087.2002;
RA   Baumann P., Podell E., Cech T.R.;
RT   "Human Pot1 (protection of telomeres) protein: cytolocalization, gene
RT   structure, and alternative splicing.";
RL   Mol. Cell. Biol. 22:8079-8087(2002).
RN   [2] {ECO:0000313|Ensembl:ENSP00000403088, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3] {ECO:0000313|EMBL:AAW22616.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Ovary {ECO:0000313|EMBL:AAW22616.1};
RA   Baumann P., Cech T.R.;
RL   Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|Ensembl:ENSP00000403088}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC004925; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC096665; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110791; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AY823523; AAW22616.1; -; mRNA.
DR   RefSeq; NP_001036059.1; NM_001042594.1.
DR   UniGene; Hs.31968; -.
DR   DNASU; 25913; -.
DR   Ensembl; ENST00000429326; ENSP00000403088; ENSG00000128513.
DR   GeneID; 25913; -.
DR   UCSC; uc064hqi.1; human.
DR   CTD; 25913; -.
DR   EuPathDB; HostDB:ENSG00000128513.14; -.
DR   HGNC; HGNC:17284; POT1.
DR   OpenTargets; ENSG00000128513; -.
DR   PharmGKB; PA134934904; -.
DR   eggNOG; KOG4757; Eukaryota.
DR   eggNOG; ENOG410Z1J0; LUCA.
DR   GeneTree; ENSGT00390000018285; -.
DR   ChiTaRS; POT1; human.
DR   GenomeRNAi; 25913; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000128513; -.
DR   GO; GO:0043047; F:single-stranded telomeric DNA binding; IEA:InterPro.
DR   GO; GO:0000723; P:telomere maintenance; IEA:InterPro.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR028389; POT1.
DR   PANTHER; PTHR14513; PTHR14513; 1.
DR   SUPFAM; SSF50249; SSF50249; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:Q5MJ33};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   45 AA;  4923 MW;  841205B2DC134228 CRC64;
     MSLVPATNYI YTPLNQLKGG TIVNVYGVVK FFKPPYLSKG TDSSI
//
ID   POTE1_HUMAN             Reviewed;         634 AA.
AC   Q9NUX5; O95018; Q5MJ36; Q9H662; Q9NW19; Q9UG95;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-FEB-2018, entry version 170.
DE   RecName: Full=Protection of telomeres protein 1;
DE            Short=hPot1;
DE   AltName: Full=POT1-like telomere end-binding protein;
GN   Name=POT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   SINGLE-STRANDED TELOMERE DNA-BINDING.
RC   TISSUE=Ovary;
RX   PubMed=11349150; DOI=10.1126/science.1060036;
RA   Baumann P., Cech T.R.;
RT   "Pot1, the putative telomere end-binding protein in fission yeast and
RT   humans.";
RL   Science 292:1171-1175(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING (ISOFORMS
RP   1 AND 2), TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND
RP   SINGLE-STRANDED TELOMERE DNA-BINDING.
RX   PubMed=12391173; DOI=10.1128/MCB.22.22.8079-8087.2002;
RA   Baumann P., Podell E., Cech T.R.;
RT   "Human Pot1 (protection of telomeres) protein: cytolocalization, gene
RT   structure, and alternative splicing.";
RL   Mol. Cell. Biol. 22:8079-8087(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta, Small intestine, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 499-634 (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   FUNCTION IN TELOMERE REGULATION, ALTERNATIVE SPLICING (ISOFORMS 1 AND
RP   2), AND SINGLE-STRANDED TELOMERE DNA-BINDING.
RX   PubMed=12781132; DOI=10.1016/S0960-9822(03)00339-7;
RA   Colgin L.M., Baran K., Baumann P., Cech T.R., Reddel R.R.;
RT   "Human POT1 facilitates telomere elongation by telomerase.";
RL   Curr. Biol. 13:942-946(2003).
RN   [9]
RP   FUNCTION IN TELOMERE REGULATION, IDENTIFICATION IN A COMPLEX WITH
RP   TERF1; TINF2 AND TNKS1, AND INTERACTION WITH TNKS1.
RX   PubMed=12768206; DOI=10.1038/nature01688;
RA   Loayza D., De Lange T.;
RT   "POT1 as a terminal transducer of TRF1 telomere length control.";
RL   Nature 423:1013-1018(2003).
RN   [10]
RP   SINGLE-STRANDED TELOMERE DNA-BINDING.
RX   PubMed=14715659; DOI=10.1074/jbc.M312309200;
RA   Loayza D., Parsons H., Donigian J., Hoke K., de Lange T.;
RT   "DNA binding features of human POT1: a nonamer 5'-TAGGGTTAG-3' minimal
RT   binding site, sequence specificity, and internal binding to multimeric
RT   sites.";
RL   J. Biol. Chem. 279:13241-13248(2004).
RN   [11]
RP   INTERACTION WITH ACD.
RX   PubMed=15231715; DOI=10.1101/gad.1215404;
RA   Ye J.Z.-S., Hockemeyer D., Krutchinsky A.N., Loayza D., Hooper S.M.,
RA   Chait B.T., de Lange T.;
RT   "POT1-interacting protein PIP1: a telomere length regulator that
RT   recruits POT1 to the TIN2/TRF1 complex.";
RL   Genes Dev. 18:1649-1654(2004).
RN   [12]
RP   IDENTIFICATION IN THE SHELTERIN COMPLEX.
RX   PubMed=15316005; DOI=10.1074/jbc.M409047200;
RA   Ye J.Z.-S., Donigian J.R., van Overbeek M., Loayza D., Luo Y.,
RA   Krutchinsky A.N., Chait B.T., de Lange T.;
RT   "TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2
RT   complex on telomeres.";
RL   J. Biol. Chem. 279:47264-47271(2004).
RN   [13]
RP   IDENTIFICATION IN THE SHELTERIN COMPLEX.
RX   PubMed=15383534; DOI=10.1074/jbc.M409293200;
RA   Liu D., O'Connor M.S., Qin J., Songyang Z.;
RT   "Telosome, a mammalian telomere-associated complex formed by multiple
RT   telomeric proteins.";
RL   J. Biol. Chem. 279:51338-51342(2004).
RN   [14]
RP   FUNCTION OF THE SHELTERIN COMPLEX.
RX   PubMed=16166375; DOI=10.1101/gad.1346005;
RA   de Lange T.;
RT   "Shelterin: the protein complex that shapes and safeguards human
RT   telomeres.";
RL   Genes Dev. 19:2100-2110(2005).
RN   [15]
RP   FUNCTION, SUBUNIT, AND IDENTIFICATION IN A COMPLEX WITH ACD AND
RP   SINGLE-STRANDED TELOMERIC DNA.
RX   PubMed=17237768; DOI=10.1038/nature05454;
RA   Wang F., Podell E.R., Zaug A.J., Yang Y., Baciu P., Cech T.R., Lei M.;
RT   "The POT1-TPP1 telomere complex is a telomerase processivity factor.";
RL   Nature 445:506-510(2007).
RN   [16]
RP   IDENTIFICATION IN THE TELOMERASE HOLOENZYME COMPLEX.
RX   PubMed=19179534; DOI=10.1126/science.1165357;
RA   Venteicher A.S., Abreu E.B., Meng Z., McCann K.E., Terns R.M.,
RA   Veenstra T.D., Terns M.P., Artandi S.E.;
RT   "A human telomerase holoenzyme protein required for Cajal body
RT   localization and telomere synthesis.";
RL   Science 323:644-648(2009).
RN   [17]
RP   FUNCTION.
RX   PubMed=20231318; DOI=10.1101/gad.1881810;
RA   Zaug A.J., Podell E.R., Nandakumar J., Cech T.R.;
RT   "Functional interaction between telomere protein TPP1 and
RT   telomerase.";
RL   Genes Dev. 24:613-622(2010).
RN   [18]
RP   INVOLVEMENT IN GLM9, AND VARIANT GLM9 CYS-95.
RX   PubMed=25482530; DOI=10.1093/jnci/dju384;
RG   Gliogene Consortium;
RA   Bainbridge M.N., Armstrong G.N., Gramatges M.M., Bertuch A.A.,
RA   Jhangiani S.N., Doddapaneni H., Lewis L., Tombrello J.,
RA   Tsavachidis S., Liu Y., Jalali A., Plon S.E., Lau C.C., Parsons D.W.,
RA   Claus E.B., Barnholtz-Sloan J., Il'yasova D., Schildkraut J.,
RA   Ali-Osman F., Sadetzki S., Johansen C., Houlston R.S., Jenkins R.B.,
RA   Lachance D., Olson S.H., Bernstein J.L., Merrell R.T., Wrensch M.R.,
RA   Walsh K.M., Davis F.G., Lai R., Shete S., Aldape K., Amos C.I.,
RA   Thompson P.A., Muzny D.M., Gibbs R.A., Melin B.S., Bondy M.L.;
RT   "Germline mutations in shelterin complex genes are associated with
RT   familial glioma.";
RL   J. Natl. Cancer Inst. 107:384-384(2015).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.73 ANGSTROMS) OF 6-299 IN COMPLEX WITH
RP   SINGLE-STRANDED TELOMERIC DNA.
RX   PubMed=15558049; DOI=10.1038/nsmb867;
RA   Lei M., Podell E.R., Cech T.R.;
RT   "Structure of human POT1 bound to telomeric single-stranded DNA
RT   provides a model for chromosome end-protection.";
RL   Nat. Struct. Mol. Biol. 11:1223-1229(2004).
RN   [20]
RP   INVOLVEMENT IN CMM10, VARIANTS CMM10 CYS-89; GLU-94 AND LEU-273, AND
RP   CHARACTERIZATION OF VARIANTS CMM10 CYS-89; GLU-94 AND LEU-273.
RX   PubMed=24686849; DOI=10.1038/ng.2947;
RA   Robles-Espinoza C.D., Harland M., Ramsay A.J., Aoude L.G., Quesada V.,
RA   Ding Z., Pooley K.A., Pritchard A.L., Tiffen J.C., Petljak M.,
RA   Palmer J.M., Symmons J., Johansson P., Stark M.S., Gartside M.G.,
RA   Snowden H., Montgomery G.W., Martin N.G., Liu J.Z., Choi J.,
RA   Makowski M., Brown K.M., Dunning A.M., Keane T.M., Lopez-Otin C.,
RA   Gruis N.A., Hayward N.K., Bishop D.T., Newton-Bishop J.A., Adams D.J.;
RT   "POT1 loss-of-function variants predispose to familial melanoma.";
RL   Nat. Genet. 46:478-481(2014).
RN   [21]
RP   VARIANTS CMM10 HIS-137; ASN-224; ASN-270; PRO-532 AND HIS-623, AND
RP   CHARACTERIZATION OF VARIANTS CMM10 HIS-137; ASN-270 AND HIS-623.
RX   PubMed=24686846; DOI=10.1038/ng.2941;
RA   Shi J., Yang X.R., Ballew B., Rotunno M., Calista D., Fargnoli M.C.,
RA   Ghiorzo P., Bressac-de Paillerets B., Nagore E., Avril M.F.,
RA   Caporaso N.E., McMaster M.L., Cullen M., Wang Z., Zhang X., Bruno W.,
RA   Pastorino L., Queirolo P., Banuls-Roca J., Garcia-Casado Z.,
RA   Vaysse A., Mohamdi H., Riazalhosseini Y., Foglio M., Jouenne F.,
RA   Hua X., Hyland P.L., Yin J., Vallabhaneni H., Chai W., Minghetti P.,
RA   Pellegrini C., Ravichandran S., Eggermont A., Lathrop M., Peris K.,
RA   Scarra G.B., Landi G., Savage S.A., Sampson J.N., He J., Yeager M.,
RA   Goldin L.R., Demenais F., Chanock S.J., Tucker M.A., Goldstein A.M.,
RA   Liu Y., Landi M.T.;
RT   "Rare missense variants in POT1 predispose to familial cutaneous
RT   malignant melanoma.";
RL   Nat. Genet. 46:482-486(2014).
CC   -!- FUNCTION: Component of the telomerase ribonucleoprotein (RNP)
CC       complex that is essential for the replication of chromosome
CC       termini. Is a component of the double-stranded telomeric DNA-
CC       binding TRF1 complex which is involved in the regulation of
CC       telomere length by cis-inhibition of telomerase. Also acts as a
CC       single-stranded telomeric DNA-binding protein and thus may act as
CC       a downstream effector of the TRF1 complex and may transduce
CC       information about telomere maintenance and/or length to the
CC       telomere terminus. Component of the shelterin complex (telosome)
CC       that is involved in the regulation of telomere length and
CC       protection. Shelterin associates with arrays of double-stranded
CC       TTAGGG repeats added by telomerase and protects chromosome ends;
CC       without its protective activity, telomeres are no longer hidden
CC       from the DNA damage surveillance and chromosome ends are
CC       inappropriately processed by DNA repair pathways. Binds to two or
CC       more telomeric single-stranded 5'-TTAGGG-3' repeats (G-strand) and
CC       with high specificity to a minimal telomeric single-stranded 5'-
CC       TAGGGTTAG-3' sequence. Binds telomeric single-stranded sequences
CC       internally or at proximity of a 3'-end. Its activity is TERT
CC       dependent but it does not increase TERT activity by itself. In
CC       contrast, the ACD-POT1 heterodimer enhances telomere elongation by
CC       increasing telomerase processivity. {ECO:0000269|PubMed:12768206,
CC       ECO:0000269|PubMed:12781132, ECO:0000269|PubMed:16166375,
CC       ECO:0000269|PubMed:17237768, ECO:0000269|PubMed:20231318}.
CC   -!- SUBUNIT: Homodimer or homooligomer. Component of the shelterin
CC       complex (telosome) composed of TERF1, TERF2, TINF2, TERF2IP, ACD
CC       and POT1. Binds single-stranded telomeric DNA as a monomer (By
CC       similarity). Component of the telomerase holoenzyme complex at
CC       least composed of TERT, DKC1, WRAP53/TCAB1, NOP10, NHP2, GAR1,
CC       TEP1, EST1A, POT1 and a telomerase RNA template component (TERC).
CC       Found in a complex with TERF1, TINF2 and TNKS1. Interacts with
CC       TNKS1. Forms heterodimers with ACD. Identified in a complex with
CC       ACD and single-stranded telomeric DNA. {ECO:0000250,
CC       ECO:0000269|PubMed:12768206, ECO:0000269|PubMed:15231715,
CC       ECO:0000269|PubMed:15316005, ECO:0000269|PubMed:15383534,
CC       ECO:0000269|PubMed:15558049, ECO:0000269|PubMed:17237768,
CC       ECO:0000269|PubMed:19179534}.
CC   -!- INTERACTION:
CC       Q96AP0:ACD; NbExp=7; IntAct=EBI-752420, EBI-717666;
CC       P30838:ALDH3A1; NbExp=2; IntAct=EBI-752420, EBI-3905126;
CC       P07355:ANXA2; NbExp=2; IntAct=EBI-752420, EBI-352622;
CC       Q9BV29:CCDC32; NbExp=2; IntAct=EBI-752420, EBI-2874058;
CC       Q549N0:CFL2; NbExp=3; IntAct=EBI-752420, EBI-10201319;
CC       O95833:CLIC3; NbExp=2; IntAct=EBI-752420, EBI-10192241;
CC       Q6PJW8:CNST; NbExp=2; IntAct=EBI-752420, EBI-750390;
CC       O60496:DOK2; NbExp=2; IntAct=EBI-752420, EBI-1046024;
CC       O94808:GFPT2; NbExp=2; IntAct=EBI-752420, EBI-6916534;
CC       Q99795:GPA33; NbExp=2; IntAct=EBI-752420, EBI-4289554;
CC       P46952:HAAO; NbExp=2; IntAct=EBI-752420, EBI-743215;
CC       P50747:HLCS; NbExp=2; IntAct=EBI-752420, EBI-3915568;
CC       P09601:HMOX1; NbExp=2; IntAct=EBI-752420, EBI-2806151;
CC       P0DMV8:HSPA1A; NbExp=2; IntAct=EBI-752420, EBI-11052499;
CC       Q9NPH2:ISYNA1; NbExp=2; IntAct=EBI-752420, EBI-720563;
CC       Q96A73:KIAA1191; NbExp=2; IntAct=EBI-752420, EBI-725897;
CC       Q8WXG6:MADD; NbExp=2; IntAct=EBI-752420, EBI-310528;
CC       P43358:MAGEA4; NbExp=2; IntAct=EBI-752420, EBI-743122;
CC       Q12851:MAP4K2; NbExp=2; IntAct=EBI-752420, EBI-49783;
CC       Q03426:MVK; NbExp=2; IntAct=EBI-752420, EBI-740630;
CC       Q9BY11:PACSIN1; NbExp=2; IntAct=EBI-752420, EBI-721769;
CC       Q96GU1:PAGE5; NbExp=2; IntAct=EBI-752420, EBI-11305258;
CC       Q01064:PDE1B; NbExp=2; IntAct=EBI-752420, EBI-7413304;
CC       Q5SRE7:PHYHD1; NbExp=2; IntAct=EBI-752420, EBI-2623130;
CC       Q8IUZ5:PHYKPL; NbExp=2; IntAct=EBI-752420, EBI-751947;
CC       Q9P0Z9:PIPOX; NbExp=2; IntAct=EBI-752420, EBI-725582;
CC       Q86WR7:PROSER2; NbExp=2; IntAct=EBI-752420, EBI-2880603;
CC       Q9BRP8:PYM1; NbExp=2; IntAct=EBI-752420, EBI-2352802;
CC       Q9BWH6:RPAP1; NbExp=2; IntAct=EBI-752420, EBI-1048085;
CC       O43704:SULT1B1; NbExp=2; IntAct=EBI-752420, EBI-10179062;
CC       Q9BR01:SULT4A1; NbExp=2; IntAct=EBI-752420, EBI-6690555;
CC       Q96A49:SYAP1; NbExp=2; IntAct=EBI-752420, EBI-10770179;
CC       Q15554:TERF2; NbExp=6; IntAct=EBI-752420, EBI-706637;
CC       Q9BSI4:TINF2; NbExp=3; IntAct=EBI-752420, EBI-717399;
CC       P63313:TMSB10; NbExp=2; IntAct=EBI-752420, EBI-2688673;
CC       Q9Y4P8:WIPI2; NbExp=2; IntAct=EBI-752420, EBI-719396;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12391173}.
CC       Chromosome, telomere {ECO:0000269|PubMed:12391173}.
CC       Note=Colocalizes with telomeric DNA.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=A number of isoforms are produced.;
CC       Name=1; Synonyms=Variant 1;
CC         IsoId=Q9NUX5-1; Sequence=Displayed;
CC       Name=2; Synonyms=Variant 3;
CC         IsoId=Q9NUX5-2; Sequence=VSP_010846, VSP_010847;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11349150,
CC       ECO:0000269|PubMed:12391173}.
CC   -!- DISEASE: Melanoma, cutaneous malignant 10 (CMM10) [MIM:615848]: A
CC       malignant neoplasm of melanocytes, arising de novo or from a pre-
CC       existing benign nevus, which occurs most often in the skin but
CC       also may involve other sites. {ECO:0000269|PubMed:24686846,
CC       ECO:0000269|PubMed:24686849}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Glioma 9 (GLM9) [MIM:616568]: Gliomas are benign or
CC       malignant central nervous system neoplasms derived from glial
CC       cells. They comprise astrocytomas and glioblastoma multiforme that
CC       are derived from astrocytes, oligodendrogliomas derived from
CC       oligodendrocytes and ependymomas derived from ependymocytes.
CC       {ECO:0000269|PubMed:25482530}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the telombin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15404.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY823520; AAW22613.1; -; mRNA.
DR   EMBL; AK001230; BAA91568.1; -; mRNA.
DR   EMBL; AK001935; BAA91988.1; -; mRNA.
DR   EMBL; AK022580; BAB14110.1; -; mRNA.
DR   EMBL; AK026234; BAB15404.1; ALT_INIT; mRNA.
DR   EMBL; AC004925; AAD08852.1; -; Genomic_DNA.
DR   EMBL; AC096665; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110791; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471070; EAW83616.1; -; Genomic_DNA.
DR   EMBL; BC002923; AAH02923.1; -; mRNA.
DR   EMBL; AL050120; CAB43281.1; -; mRNA.
DR   CCDS; CCDS5793.1; -. [Q9NUX5-1]
DR   PIR; T08766; T08766.
DR   RefSeq; NP_001036059.1; NM_001042594.1.
DR   RefSeq; NP_056265.2; NM_015450.2. [Q9NUX5-1]
DR   RefSeq; XP_006715980.1; XM_006715917.3. [Q9NUX5-1]
DR   UniGene; Hs.31968; -.
DR   PDB; 1XJV; X-ray; 1.73 A; A=6-299.
DR   PDB; 3KJO; X-ray; 1.80 A; A=1-299.
DR   PDB; 3KJP; X-ray; 1.80 A; A=1-299.
DR   PDB; 5H65; X-ray; 2.10 A; A=341-634.
DR   PDB; 5UN7; X-ray; 2.10 A; A=330-634.
DR   PDBsum; 1XJV; -.
DR   PDBsum; 3KJO; -.
DR   PDBsum; 3KJP; -.
DR   PDBsum; 5H65; -.
DR   PDBsum; 5UN7; -.
DR   ProteinModelPortal; Q9NUX5; -.
DR   SMR; Q9NUX5; -.
DR   BioGrid; 117417; 213.
DR   CORUM; Q9NUX5; -.
DR   DIP; DIP-29610N; -.
DR   IntAct; Q9NUX5; 181.
DR   STRING; 9606.ENSP00000350249; -.
DR   BindingDB; Q9NUX5; -.
DR   ChEMBL; CHEMBL5908; -.
DR   iPTMnet; Q9NUX5; -.
DR   PhosphoSitePlus; Q9NUX5; -.
DR   BioMuta; POT1; -.
DR   DMDM; 50401179; -.
DR   EPD; Q9NUX5; -.
DR   MaxQB; Q9NUX5; -.
DR   PaxDb; Q9NUX5; -.
DR   PeptideAtlas; Q9NUX5; -.
DR   PRIDE; Q9NUX5; -.
DR   DNASU; 25913; -.
DR   Ensembl; ENST00000357628; ENSP00000350249; ENSG00000128513. [Q9NUX5-1]
DR   GeneID; 25913; -.
DR   KEGG; hsa:25913; -.
DR   UCSC; uc003vlm.4; human. [Q9NUX5-1]
DR   CTD; 25913; -.
DR   DisGeNET; 25913; -.
DR   EuPathDB; HostDB:ENSG00000128513.14; -.
DR   GeneCards; POT1; -.
DR   HGNC; HGNC:17284; POT1.
DR   HPA; HPA068538; -.
DR   MalaCards; POT1; -.
DR   MIM; 606478; gene.
DR   MIM; 615848; phenotype.
DR   MIM; 616568; phenotype.
DR   neXtProt; NX_Q9NUX5; -.
DR   OpenTargets; ENSG00000128513; -.
DR   Orphanet; 67038; B-cell chronic lymphocytic leukemia.
DR   Orphanet; 618; Familial melanoma.
DR   PharmGKB; PA134934904; -.
DR   eggNOG; KOG4757; Eukaryota.
DR   eggNOG; ENOG410Z1J0; LUCA.
DR   GeneTree; ENSGT00390000018285; -.
DR   HOGENOM; HOG000015271; -.
DR   HOVERGEN; HBG053641; -.
DR   InParanoid; Q9NUX5; -.
DR   KO; K11109; -.
DR   OMA; DKTSWIP; -.
DR   OrthoDB; EOG091G01T8; -.
DR   PhylomeDB; Q9NUX5; -.
DR   TreeFam; TF328398; -.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   SIGNOR; Q9NUX5; -.
DR   ChiTaRS; POT1; human.
DR   EvolutionaryTrace; Q9NUX5; -.
DR   GeneWiki; POT1; -.
DR   GenomeRNAi; 25913; -.
DR   PRO; PR:Q9NUX5; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000128513; -.
DR   CleanEx; HS_POT1; -.
DR   ExpressionAtlas; Q9NUX5; baseline and differential.
DR   Genevisible; Q9NUX5; HS.
DR   GO; GO:0000781; C:chromosome, telomeric region; IDA:UniProtKB.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; IDA:BHF-UCL.
DR   GO; GO:0000783; C:nuclear telomere cap complex; IDA:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0070187; C:shelterin complex; IDA:BHF-UCL.
DR   GO; GO:1905773; F:8-hydroxy-2'-deoxyguanosine DNA binding; IDA:BHF-UCL.
DR   GO; GO:0017151; F:DEAD/H-box RNA helicase binding; IPI:BHF-UCL.
DR   GO; GO:1990955; F:G-rich single-stranded DNA binding; IDA:BHF-UCL.
DR   GO; GO:0098505; F:G-rich strand telomeric DNA binding; IDA:BHF-UCL.
DR   GO; GO:0043047; F:single-stranded telomeric DNA binding; IDA:BHF-UCL.
DR   GO; GO:0010521; F:telomerase inhibitor activity; IDA:BHF-UCL.
DR   GO; GO:0061821; F:telomeric D-loop binding; IDA:BHF-UCL.
DR   GO; GO:0042162; F:telomeric DNA binding; IDA:BHF-UCL.
DR   GO; GO:0032508; P:DNA duplex unwinding; IDA:BHF-UCL.
DR   GO; GO:0070200; P:establishment of protein localization to telomere; IMP:BHF-UCL.
DR   GO; GO:0051974; P:negative regulation of telomerase activity; IDA:BHF-UCL.
DR   GO; GO:0032211; P:negative regulation of telomere maintenance via telomerase; IGI:BHF-UCL.
DR   GO; GO:1905776; P:positive regulation of DNA helicase activity; IDA:BHF-UCL.
DR   GO; GO:0060383; P:positive regulation of DNA strand elongation; IDA:BHF-UCL.
DR   GO; GO:0051096; P:positive regulation of helicase activity; IDA:BHF-UCL.
DR   GO; GO:0051973; P:positive regulation of telomerase activity; IDA:BHF-UCL.
DR   GO; GO:0032212; P:positive regulation of telomere maintenance via telomerase; IDA:BHF-UCL.
DR   GO; GO:1905774; P:regulation of DNA helicase activity; IDA:BHF-UCL.
DR   GO; GO:0032210; P:regulation of telomere maintenance via telomerase; IGI:BHF-UCL.
DR   GO; GO:0032202; P:telomere assembly; IDA:BHF-UCL.
DR   GO; GO:0016233; P:telomere capping; IMP:BHF-UCL.
DR   GO; GO:0007004; P:telomere maintenance via telomerase; IDA:UniProtKB.
DR   GO; GO:0061820; P:telomeric D-loop disassembly; IGI:BHF-UCL.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR028389; POT1.
DR   InterPro; IPR032042; POT1PC.
DR   InterPro; IPR011564; Telomer_end-bd_POT1/Cdc13.
DR   PANTHER; PTHR14513; PTHR14513; 1.
DR   Pfam; PF02765; POT1; 1.
DR   Pfam; PF16686; POT1PC; 1.
DR   SMART; SM00976; Telo_bind; 1.
DR   SUPFAM; SSF50249; SSF50249; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosome; Complete proteome;
KW   Disease mutation; DNA-binding; Nucleus; Polymorphism;
KW   Reference proteome; Telomere.
FT   CHAIN         1    634       Protection of telomeres protein 1.
FT                                /FTId=PRO_0000121728.
FT   REGION       33     48       DNA binding.
FT   REGION      270    273       DNA binding.
FT   SITE        243    243       DNA binding.
FT   VAR_SEQ     532    538       ALGIVPL -> DVNSVLV (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_010846.
FT   VAR_SEQ     539    634       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_010847.
FT   VARIANT      89     89       Y -> C (in CMM10; complete abolition of
FT                                POT1-DNA complex formation, thus
FT                                disrupting the interaction with telomeres
FT                                and leading to elongated telomeres;
FT                                dbSNP:rs587777472).
FT                                {ECO:0000269|PubMed:24686849}.
FT                                /FTId=VAR_071390.
FT   VARIANT      94     94       Q -> E (in CMM10; complete abolition of
FT                                POT1-DNA complex formation, thus
FT                                disrupting the interaction with telomeres
FT                                and leading to elongated telomeres;
FT                                dbSNP:rs587777474).
FT                                {ECO:0000269|PubMed:24686849}.
FT                                /FTId=VAR_071391.
FT   VARIANT      95     95       G -> C (in GLM9; dbSNP:rs797045168).
FT                                {ECO:0000269|PubMed:25482530}.
FT                                /FTId=VAR_075717.
FT   VARIANT     137    137       R -> H (in CMM10; increased telomere
FT                                intensity signals and telomere fragility;
FT                                dbSNP:rs587777475).
FT                                {ECO:0000269|PubMed:24686846}.
FT                                /FTId=VAR_071392.
FT   VARIANT     224    224       D -> N (in CMM10; dbSNP:rs202187871).
FT                                {ECO:0000269|PubMed:24686846}.
FT                                /FTId=VAR_071393.
FT   VARIANT     270    270       S -> N (in CMM10; significantly increased
FT                                telomere length and numbers of fragile
FT                                telomeres; dbSNP:rs587777477).
FT                                {ECO:0000269|PubMed:24686846}.
FT                                /FTId=VAR_071394.
FT   VARIANT     273    273       R -> L (in CMM10; complete abolition of
FT                                POT1-DNA complex formation, thus
FT                                disrupting the interaction with telomeres
FT                                and leading to elongated telomeres;
FT                                dbSNP:rs587777476).
FT                                {ECO:0000269|PubMed:24686849}.
FT                                /FTId=VAR_071395.
FT   VARIANT     529    529       V -> M (in dbSNP:rs34973253).
FT                                /FTId=VAR_034393.
FT   VARIANT     532    532       A -> P (in CMM10).
FT                                {ECO:0000269|PubMed:24686846}.
FT                                /FTId=VAR_071396.
FT   VARIANT     623    623       Q -> H (in CMM10; increased telomere
FT                                intensity signals and telomere fragility;
FT                                dbSNP:rs587777478).
FT                                {ECO:0000269|PubMed:24686846}.
FT                                /FTId=VAR_071397.
FT   CONFLICT    410    410       D -> V (in Ref. 3; BAA91568).
FT                                {ECO:0000305}.
FT   CONFLICT    412    412       K -> Q (in Ref. 3; BAB15404).
FT                                {ECO:0000305}.
FT   CONFLICT    499    499       H -> D (in Ref. 7; CAB43281).
FT                                {ECO:0000305}.
FT   HELIX        14     16       {ECO:0000244|PDB:1XJV}.
FT   STRAND       19     37       {ECO:0000244|PDB:1XJV}.
FT   STRAND       39     50       {ECO:0000244|PDB:1XJV}.
FT   STRAND       56     65       {ECO:0000244|PDB:1XJV}.
FT   HELIX        66     68       {ECO:0000244|PDB:1XJV}.
FT   STRAND       78     89       {ECO:0000244|PDB:1XJV}.
FT   STRAND       92    106       {ECO:0000244|PDB:1XJV}.
FT   HELIX       127    143       {ECO:0000244|PDB:1XJV}.
FT   HELIX       153    155       {ECO:0000244|PDB:1XJV}.
FT   STRAND      161    173       {ECO:0000244|PDB:1XJV}.
FT   STRAND      175    184       {ECO:0000244|PDB:1XJV}.
FT   TURN        200    202       {ECO:0000244|PDB:3KJP}.
FT   HELIX       207    213       {ECO:0000244|PDB:1XJV}.
FT   HELIX       214    216       {ECO:0000244|PDB:1XJV}.
FT   STRAND      217    223       {ECO:0000244|PDB:1XJV}.
FT   HELIX       226    232       {ECO:0000244|PDB:1XJV}.
FT   STRAND      238    251       {ECO:0000244|PDB:1XJV}.
FT   STRAND      257    265       {ECO:0000244|PDB:1XJV}.
FT   HELIX       270    272       {ECO:0000244|PDB:1XJV}.
FT   STRAND      274    278       {ECO:0000244|PDB:1XJV}.
FT   HELIX       283    297       {ECO:0000244|PDB:1XJV}.
FT   STRAND      334    339       {ECO:0000244|PDB:5UN7}.
FT   HELIX       348    352       {ECO:0000244|PDB:5H65}.
FT   STRAND      359    370       {ECO:0000244|PDB:5H65}.
FT   HELIX       374    377       {ECO:0000244|PDB:5H65}.
FT   STRAND      378    381       {ECO:0000244|PDB:5H65}.
FT   TURN        383    385       {ECO:0000244|PDB:5H65}.
FT   STRAND      388    390       {ECO:0000244|PDB:5H65}.
FT   HELIX       394    404       {ECO:0000244|PDB:5H65}.
FT   HELIX       411    413       {ECO:0000244|PDB:5H65}.
FT   STRAND      417    425       {ECO:0000244|PDB:5H65}.
FT   STRAND      427    429       {ECO:0000244|PDB:5H65}.
FT   STRAND      433    439       {ECO:0000244|PDB:5H65}.
FT   HELIX       448    450       {ECO:0000244|PDB:5H65}.
FT   STRAND      452    457       {ECO:0000244|PDB:5H65}.
FT   HELIX       460    469       {ECO:0000244|PDB:5H65}.
FT   STRAND      470    478       {ECO:0000244|PDB:5H65}.
FT   STRAND      480    486       {ECO:0000244|PDB:5H65}.
FT   STRAND      492    495       {ECO:0000244|PDB:5H65}.
FT   STRAND      498    500       {ECO:0000244|PDB:5H65}.
FT   TURN        504    506       {ECO:0000244|PDB:5H65}.
FT   HELIX       512    517       {ECO:0000244|PDB:5H65}.
FT   STRAND      521    523       {ECO:0000244|PDB:5H65}.
FT   HELIX       526    532       {ECO:0000244|PDB:5H65}.
FT   STRAND      539    549       {ECO:0000244|PDB:5H65}.
FT   STRAND      554    563       {ECO:0000244|PDB:5H65}.
FT   TURN        564    566       {ECO:0000244|PDB:5H65}.
FT   HELIX       570    573       {ECO:0000244|PDB:5H65}.
FT   HELIX       577    590       {ECO:0000244|PDB:5H65}.
FT   STRAND      593    595       {ECO:0000244|PDB:5H65}.
FT   HELIX       597    599       {ECO:0000244|PDB:5H65}.
FT   STRAND      603    611       {ECO:0000244|PDB:5H65}.
FT   STRAND      620    626       {ECO:0000244|PDB:5H65}.
FT   TURN        630    632       {ECO:0000244|PDB:5H65}.
SQ   SEQUENCE   634 AA;  71442 MW;  123A12CABE708C91 CRC64;
     MSLVPATNYI YTPLNQLKGG TIVNVYGVVK FFKPPYLSKG TDYCSVVTIV DQTNVKLTCL
     LFSGNYEALP IIYKNGDIVR FHRLKIQVYK KETQGITSSG FASLTFEGTL GAPIIPRTSS
     KYFNFTTEDH KMVEALRVWA STHMSPSWTL LKLCDVQPMQ YFDLTCQLLG KAEVDGASFL
     LKVWDGTRTP FPSWRVLIQD LVLEGDLSHI HRLQNLTIDI LVYDNHVHVA RSLKVGSFLR
     IYSLHTKLQS MNSENQTMLS LEFHLHGGTS YGRGIRVLPE SNSDVDQLKK DLESANLTAN
     QHSDVICQSE PDDSFPSSGS VSLYEVERCQ QLSATILTDH QYLERTPLCA ILKQKAPQQY
     RIRAKLRSYK PRRLFQSVKL HCPKCHLLQE VPHEGDLDII FQDGATKTPD VKLQNTSLYD
     SKIWTTKNQK GRKVAVHFVK NNGILPLSNE CLLLIEGGTL SEICKLSNKF NSVIPVRSGH
     EDLELLDLSA PFLIQGTIHH YGCKQCSSLR SIQNLNSLVD KTSWIPSSVA EALGIVPLQY
     VFVMTFTLDD GTGVLEAYLM DSDKFFQIPA SEVLMDDDLQ KSVDMIMDMF CPPGIKIDAY
     PWLECFIKSY NVTNGTDNQI CYQIFDTTVA EDVI
//
ID   AGO4_HUMAN              Reviewed;         861 AA.
AC   Q9HCK5; A7MD27;
DT   14-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   14-NOV-2003, sequence version 2.
DT   23-MAY-2018, entry version 135.
DE   RecName: Full=Protein argonaute-4 {ECO:0000255|HAMAP-Rule:MF_03033};
DE            Short=Argonaute4 {ECO:0000255|HAMAP-Rule:MF_03033};
DE            Short=hAgo4;
DE   AltName: Full=Argonaute RISC catalytic component 4;
DE   AltName: Full=Eukaryotic translation initiation factor 2C 4 {ECO:0000255|HAMAP-Rule:MF_03033};
DE            Short=eIF-2C 4 {ECO:0000255|HAMAP-Rule:MF_03033};
DE            Short=eIF2C 4 {ECO:0000255|HAMAP-Rule:MF_03033};
GN   Name=AGO4; Synonyms=EIF2C4, KIAA1567;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes.
RT   XVIII. The complete sequences of 100 new cDNA clones from brain which
RT   code for large proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   ASSOCIATION WITH MIRNA.
RX   PubMed=15260970; DOI=10.1016/j.molcel.2004.07.007;
RA   Meister G., Landthaler M., Patkaniowska A., Dorsett Y., Teng G.,
RA   Tuschl T.;
RT   "Human Argonaute2 mediates RNA cleavage targeted by miRNAs and
RT   siRNAs.";
RL   Mol. Cell 15:185-197(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=15337849; DOI=10.1261/rna.7131604;
RA   Pillai R.S., Artus C.G., Filipowicz W.;
RT   "Tethering of human Ago proteins to mRNA mimics the miRNA-mediated
RT   repression of protein synthesis.";
RL   RNA 10:1518-1525(2004).
RN   [7]
RP   INTERACTION WITH ZFP36.
RX   PubMed=15766526; DOI=10.1016/j.cell.2004.12.038;
RA   Jing Q., Huang S., Guth S., Zarubin T., Motoyama A., Chen J.,
RA   Di Padova F., Lin S.C., Gram H., Han J.;
RT   "Involvement of microRNA in AU-rich element-mediated mRNA
RT   instability.";
RL   Cell 120:623-634(2005).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16081698; DOI=10.1126/science.1115079;
RA   Pillai R.S., Bhattacharyya S.N., Artus C.G., Zoller T., Cougot N.,
RA   Basyuk E., Bertrand E., Filipowicz W.;
RT   "Inhibition of translational initiation by Let-7 MicroRNA in human
RT   cells.";
RL   Science 309:1573-1576(2005).
RN   [9]
RP   FUNCTION.
RX   PubMed=18771919; DOI=10.1016/j.cub.2008.07.072;
RA   Wu L., Fan J., Belasco J.G.;
RT   "Importance of translation and nonnucleolytic ago proteins for on-
RT   target RNA interference.";
RL   Curr. Biol. 18:1327-1332(2008).
RN   [10]
RP   FUNCTION.
RX   PubMed=18552826; DOI=10.1038/nsmb.1440;
RA   Haussecker D., Cao D., Huang Y., Parameswaran P., Fire A.Z., Kay M.A.;
RT   "Capped small RNAs and MOV10 in human hepatitis delta virus
RT   replication.";
RL   Nat. Struct. Mol. Biol. 15:714-721(2008).
RN   [11]
RP   INTERACTION WITH EIF4B; IMP8; PRMT5; TNRC6A AND TNRC6B, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=19167051; DOI=10.1016/j.cell.2008.12.023;
RA   Weinmann L., Hoeck J., Ivacevic T., Ohrt T., Muetze J., Schwille P.,
RA   Kremmer E., Benes V., Urlaub H., Meister G.;
RT   "Importin 8 is a gene silencing factor that targets argonaute proteins
RT   to distinct mRNAs.";
RL   Cell 136:496-507(2009).
CC   -!- FUNCTION: Required for RNA-mediated gene silencing (RNAi). Binds
CC       to short RNAs such as microRNAs (miRNAs) and represses the
CC       translation of mRNAs which are complementary to them. Lacks
CC       endonuclease activity and does not appear to cleave target mRNAs.
CC       Also required for RNA-directed transcription and replication of
CC       the human hapatitis delta virus (HDV). {ECO:0000255|HAMAP-
CC       Rule:MF_03033, ECO:0000269|PubMed:15337849,
CC       ECO:0000269|PubMed:18552826, ECO:0000269|PubMed:18771919}.
CC   -!- SUBUNIT: Interacts with EIF4B, IMP8, PRMT5, TNRC6A and TNRC6B
CC       (PubMed:19167051). Interacts with ZFP36 (PubMed:15766526).
CC       {ECO:0000255|HAMAP-Rule:MF_03033, ECO:0000269|PubMed:15766526,
CC       ECO:0000269|PubMed:19167051}.
CC   -!- INTERACTION:
CC       O15397:IPO8; NbExp=3; IntAct=EBI-2269696, EBI-358808;
CC       Q8NDV7:TNRC6A; NbExp=4; IntAct=EBI-2269696, EBI-2269715;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000255|HAMAP-
CC       Rule:MF_03033, ECO:0000269|PubMed:16081698,
CC       ECO:0000269|PubMed:19167051}.
CC   -!- SIMILARITY: Belongs to the argonaute family. Ago subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03033}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB13393.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB046787; BAB13393.1; ALT_INIT; mRNA.
DR   EMBL; AL359186; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL354864; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07400.1; -; Genomic_DNA.
DR   EMBL; BC152450; AAI52451.1; -; mRNA.
DR   CCDS; CCDS397.1; -.
DR   RefSeq; NP_060099.2; NM_017629.3.
DR   UniGene; Hs.744858; -.
DR   ProteinModelPortal; Q9HCK5; -.
DR   SMR; Q9HCK5; -.
DR   BioGrid; 128178; 69.
DR   CORUM; Q9HCK5; -.
DR   IntAct; Q9HCK5; 75.
DR   STRING; 9606.ENSP00000362306; -.
DR   iPTMnet; Q9HCK5; -.
DR   PhosphoSitePlus; Q9HCK5; -.
DR   BioMuta; AGO4; -.
DR   DMDM; 38372393; -.
DR   EPD; Q9HCK5; -.
DR   MaxQB; Q9HCK5; -.
DR   PaxDb; Q9HCK5; -.
DR   PeptideAtlas; Q9HCK5; -.
DR   PRIDE; Q9HCK5; -.
DR   DNASU; 192670; -.
DR   Ensembl; ENST00000373210; ENSP00000362306; ENSG00000134698.
DR   GeneID; 192670; -.
DR   KEGG; hsa:192670; -.
DR   UCSC; uc001bzj.3; human.
DR   CTD; 192670; -.
DR   DisGeNET; 192670; -.
DR   EuPathDB; HostDB:ENSG00000134698.10; -.
DR   GeneCards; AGO4; -.
DR   HGNC; HGNC:18424; AGO4.
DR   HPA; CAB012179; -.
DR   HPA; HPA068896; -.
DR   MIM; 607356; gene.
DR   neXtProt; NX_Q9HCK5; -.
DR   OpenTargets; ENSG00000134698; -.
DR   PharmGKB; PA38330; -.
DR   eggNOG; KOG1041; Eukaryota.
DR   eggNOG; ENOG410XP07; LUCA.
DR   GeneTree; ENSGT00760000119148; -.
DR   HOGENOM; HOG000116043; -.
DR   InParanoid; Q9HCK5; -.
DR   KO; K11593; -.
DR   OMA; IQWVSVV; -.
DR   OrthoDB; EOG091G020J; -.
DR   PhylomeDB; Q9HCK5; -.
DR   TreeFam; TF101510; -.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-203927; MicroRNA (miRNA) biogenesis.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559585; Oncogene Induced Senescence.
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   Reactome; R-HSA-426486; Small interfering RNA (siRNA) biogenesis.
DR   Reactome; R-HSA-426496; Post-transcriptional silencing by small RNAs.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-8934593; Regulation of RUNX1 Expression and Activity.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8943723; Regulation of PTEN mRNA translation.
DR   Reactome; R-HSA-8948700; Competing endogenous RNAs (ceRNAs) regulate PTEN translation.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   ChiTaRS; AGO4; human.
DR   GenomeRNAi; 192670; -.
DR   PRO; PR:Q9HCK5; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000134698; -.
DR   CleanEx; HS_EIF2C4; -.
DR   Genevisible; Q9HCK5; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0035068; C:micro-ribonucleoprotein complex; IEA:Ensembl.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000932; C:P-body; IEA:UniProtKB-SubCell.
DR   GO; GO:0016442; C:RISC complex; IDA:BHF-UCL.
DR   GO; GO:0070578; C:RISC-loading complex; IDA:BHF-UCL.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:BHF-UCL.
DR   GO; GO:0035198; F:miRNA binding; IDA:BHF-UCL.
DR   GO; GO:0003727; F:single-stranded RNA binding; IDA:BHF-UCL.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0007140; P:male meiotic nuclear division; IEA:Ensembl.
DR   GO; GO:0035280; P:miRNA loading onto RISC involved in gene silencing by miRNA; IDA:BHF-UCL.
DR   GO; GO:0035278; P:miRNA mediated inhibition of translation; IDA:UniProtKB.
DR   GO; GO:0010586; P:miRNA metabolic process; IEA:Ensembl.
DR   GO; GO:0006402; P:mRNA catabolic process; IDA:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0035194; P:posttranscriptional gene silencing by RNA; TAS:Reactome.
DR   GO; GO:0031054; P:pre-miRNA processing; IDA:BHF-UCL.
DR   GO; GO:0035196; P:production of miRNAs involved in gene silencing by miRNA; IMP:BHF-UCL.
DR   GO; GO:0022604; P:regulation of cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0045652; P:regulation of megakaryocyte differentiation; TAS:Reactome.
DR   GO; GO:0010501; P:RNA secondary structure unwinding; IDA:BHF-UCL.
DR   GO; GO:0007130; P:synaptonemal complex assembly; IEA:Ensembl.
DR   GO; GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; TAS:Reactome.
DR   Gene3D; 3.30.420.10; -; 1.
DR   HAMAP; MF_03033; AGO4; 1.
DR   InterPro; IPR028604; AGO4.
DR   InterPro; IPR014811; ArgoL1.
DR   InterPro; IPR032472; ArgoL2.
DR   InterPro; IPR032473; Argonaute_Mid_dom.
DR   InterPro; IPR032474; Argonaute_N.
DR   InterPro; IPR003100; PAZ_dom.
DR   InterPro; IPR036085; PAZ_dom_sf.
DR   InterPro; IPR003165; Piwi.
DR   InterPro; IPR012337; RNaseH-like_sf.
DR   InterPro; IPR036397; RNaseH_sf.
DR   Pfam; PF08699; ArgoL1; 1.
DR   Pfam; PF16488; ArgoL2; 1.
DR   Pfam; PF16487; ArgoMid; 1.
DR   Pfam; PF16486; ArgoN; 1.
DR   Pfam; PF02170; PAZ; 1.
DR   Pfam; PF02171; Piwi; 1.
DR   SMART; SM01163; DUF1785; 1.
DR   SMART; SM00949; PAZ; 1.
DR   SMART; SM00950; Piwi; 1.
DR   SUPFAM; SSF101690; SSF101690; 1.
DR   SUPFAM; SSF53098; SSF53098; 1.
DR   PROSITE; PS50821; PAZ; 1.
DR   PROSITE; PS50822; PIWI; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; Reference proteome; Ribonucleoprotein;
KW   RNA-binding; RNA-mediated gene silencing; Translation regulation.
FT   CHAIN         1    861       Protein argonaute-4.
FT                                /FTId=PRO_0000194063.
FT   DOMAIN      225    338       PAZ. {ECO:0000255|HAMAP-Rule:MF_03033}.
FT   DOMAIN      509    820       Piwi. {ECO:0000255|HAMAP-Rule:MF_03033}.
SQ   SEQUENCE   861 AA;  97097 MW;  F236FF05047534C1 CRC64;
     MEALGPGPPA SLFQPPRRPG LGTVGKPIRL LANHFQVQIP KIDVYHYDVD IKPEKRPRRV
     NREVVDTMVR HFKMQIFGDR QPGYDGKRNM YTAHPLPIGR DRVDMEVTLP GEGKDQTFKV
     SVQWVSVVSL QLLLEALAGH LNEVPDDSVQ ALDVITRHLP SMRYTPVGRS FFSPPEGYYH
     PLGGGREVWF GFHQSVRPAM WNMMLNIDVS ATAFYRAQPI IEFMCEVLDI QNINEQTKPL
     TDSQRVKFTK EIRGLKVEVT HCGQMKRKYR VCNVTRRPAS HQTFPLQLEN GQAMECTVAQ
     YFKQKYSLQL KYPHLPCLQV GQEQKHTYLP LEVCNIVAGQ RCIKKLTDNQ TSTMIKATAR
     SAPDRQEEIS RLVKSNSMVG GPDPYLKEFG IVVHNEMTEL TGRVLPAPML QYGGRNKTVA
     TPNQGVWDMR GKQFYAGIEI KVWAVACFAP QKQCREDLLK SFTDQLRKIS KDAGMPIQGQ
     PCFCKYAQGA DSVEPMFKHL KMTYVGLQLI VVILPGKTPV YAEVKRVGDT LLGMATQCVQ
     VKNVVKTSPQ TLSNLCLKIN AKLGGINNVL VPHQRPSVFQ QPVIFLGADV THPPAGDGKK
     PSIAAVVGSM DGHPSRYCAT VRVQTSRQEI SQELLYSQEV IQDLTNMVRE LLIQFYKSTR
     FKPTRIIYYR GGVSEGQMKQ VAWPELIAIR KACISLEEDY RPGITYIVVQ KRHHTRLFCA
     DKTERVGKSG NVPAGTTVDS TITHPSEFDF YLCSHAGIQG TSRPSHYQVL WDDNCFTADE
     LQLLTYQLCH TYVRCTRSVS IPAPAYYARL VAFRARYHLV DKDHDSAEGS HVSGQSNGRD
     PQALAKAVQI HHDTQHTMYF A
//
ID   HDAC5_HUMAN             Reviewed;        1122 AA.
AC   Q9UQL6; C9JFV9; O60340; O60528; Q96DY4;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   23-MAY-2018, entry version 191.
DE   RecName: Full=Histone deacetylase 5;
DE            Short=HD5;
DE            EC=3.5.1.98;
DE   AltName: Full=Antigen NY-CO-9;
GN   Name=HDAC5; Synonyms=KIAA0600;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10220385; DOI=10.1073/pnas.96.9.4868;
RA   Grozinger C.M., Hassig C.A., Schreiber S.L.;
RT   "Three proteins define a class of human histone deacetylases related
RT   to yeast Hda1p.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:4868-4873(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-176 (ISOFORM 3).
RC   TISSUE=Neuroblastoma;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 189-1122 (ISOFORM 1).
RC   TISSUE=Colon carcinoma;
RX   PubMed=9610721;
RX   DOI=10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.0.CO;2-P;
RA   Scanlan M.J., Chen Y.-T., Williamson B., Gure A.O., Stockert E.,
RA   Gordan J.D., Tuereci O., Sahin U., Pfreundschuh M., Old L.J.;
RT   "Characterization of human colon cancer antigens recognized by
RT   autologous antibodies.";
RL   Int. J. Cancer 76:652-658(1998).
RN   [8]
RP   GENE ORGANIZATION.
RX   PubMed=11018260; DOI=10.1016/S0167-4781(00)00191-3;
RA   Mahlknecht U., Schnittger S., Ottmann O.G., Schoch C., Mosebach M.,
RA   Hiddemann W., Hoelzer D.;
RT   "Chromosomal organization and localization of the human histone
RT   deacetylase 5 gene (HDAC5).";
RL   Biochim. Biophys. Acta 1493:342-348(2000).
RN   [9]
RP   INTERACTION WITH BCOR.
RX   PubMed=10898795;
RA   Huynh K.D., Fischle W., Verdin E., Bardwell V.J.;
RT   "BCoR, a novel corepressor involved in BCL-6 repression.";
RL   Genes Dev. 14:1810-1823(2000).
RN   [10]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION, AND MUTAGENESIS OF SER-259;
RP   SER-279; SER-498; SER-661 AND SER-713.
RX   PubMed=11081517; DOI=10.1038/35040593;
RA   McKinsey T.A., Zhang C.-L., Lu J., Olson E.N.;
RT   "Signal-dependent nuclear export of a histone deacetylase regulates
RT   muscle differentiation.";
RL   Nature 408:106-111(2000).
RN   [11]
RP   INTERACTION WITH 14-3-3, AND PHOSPHORYLATION AT SER-259 AND SER-498.
RX   PubMed=11114197; DOI=10.1073/pnas.260501497;
RA   McKinsey T.A., Zhang C.-L., Olson E.N.;
RT   "Activation of the myocyte enhancer factor-2 transcription factor by
RT   calcium/calmodulin-dependent protein kinase-stimulated binding of 14-
RT   3-3 to histone deacetylase 5.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:14400-14405(2000).
RN   [12]
RP   NUCLEAR EXPORT SIGNAL, AND MUTAGENESIS OF VAL-1086 AND LEU-1092.
RX   PubMed=11509672; DOI=10.1128/MCB.21.18.6312-6321.2001;
RA   McKinsey T.A., Zhang C.-L., Olson E.N.;
RT   "Identification of a signal-responsive nuclear export sequence in
RT   class II histone deacetylases.";
RL   Mol. Cell. Biol. 21:6312-6321(2001).
RN   [13]
RP   UBIQUITINATION.
RX   PubMed=12354939; DOI=10.1073/pnas.172511699;
RA   Hook S.S., Orian A., Cowley S.M., Eisenman R.N.;
RT   "Histone deacetylase 6 binds polyubiquitin through its zinc finger
RT   (PAZ domain) and copurifies with deubiquitinating enzymes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:13425-13430(2002).
RN   [14]
RP   INTERACTION WITH BCL6.
RX   PubMed=12504096; DOI=10.1016/S0006-291X(02)02873-5;
RA   Mascle X., Albagli O., Lemercier C.;
RT   "Point mutations in BCL6 DNA-binding domain reveal distinct roles for
RT   the six zinc fingers.";
RL   Biochem. Biophys. Res. Commun. 300:391-396(2003).
RN   [15]
RP   INTERACTION WITH KDM5B.
RX   PubMed=17373667; DOI=10.1002/ijc.22673;
RA   Barrett A., Santangelo S., Tan K., Catchpole S., Roberts K.,
RA   Spencer-Dene B., Hall D., Scibetta A., Burchell J., Verdin E.,
RA   Freemont P., Taylor-Papadimitriou J.;
RT   "Breast cancer associated transcriptional repressor PLU-1/JARID1B
RT   interacts directly with histone deacetylases.";
RL   Int. J. Cancer 121:265-275(2007).
RN   [16]
RP   INTERACTION WITH DDIT3.
RX   PubMed=17872950; DOI=10.1074/jbc.M703735200;
RA   Ohoka N., Hattori T., Kitagawa M., Onozaki K., Hayashi H.;
RT   "Critical and functional regulation of CHOP (C/EBP homologous protein)
RT   through the N-terminal portion.";
RL   J. Biol. Chem. 282:35687-35694(2007).
RN   [17]
RP   PHOSPHORYLATION AT SER-259 AND SER-498, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF SER-259 AND SER-498.
RX   PubMed=18184930; DOI=10.2337/db07-0843;
RA   McGee S.L., van Denderen B.J., Howlett K.F., Mollica J.,
RA   Schertzer J.D., Kemp B.E., Hargreaves M.;
RT   "AMP-activated protein kinase regulates GLUT4 transcription by
RT   phosphorylating histone deacetylase 5.";
RL   Diabetes 57:860-867(2008).
RN   [18]
RP   PHOSPHORYLATION AT SER-259 AND SER-498.
RX   PubMed=18332134; DOI=10.1074/jbc.M800264200;
RA   Ha C.H., Wang W., Jhun B.S., Wong C., Hausser A., Pfizenmaier K.,
RA   McKinsey T.A., Olson E.N., Jin Z.G.;
RT   "Protein kinase D-dependent phosphorylation and nuclear export of
RT   histone deacetylase 5 mediates vascular endothelial growth factor-
RT   induced gene expression and angiogenesis.";
RL   J. Biol. Chem. 283:14590-14599(2008).
RN   [19]
RP   INTERACTION WITH BAHD1.
RX   PubMed=19666599; DOI=10.1073/pnas.0901259106;
RA   Bierne H., Tham T.N., Batsche E., Dumay A., Leguillou M.,
RA   Kerneis-Golsteyn S., Regnault B., Seeler J.S., Muchardt C.,
RA   Feunteun J., Cossart P.;
RT   "Human BAHD1 promotes heterochromatic gene silencing.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:13826-13831(2009).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-533, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [21]
RP   PHOSPHORYLATION AT THR-292, AND MUTAGENESIS OF SER-259; SER-291 AND
RP   THR-292.
RX   PubMed=20188095; DOI=10.1016/j.febslet.2010.02.057;
RA   Harrison B.C., Huynh K., Lundgaard G.L., Helmke S.M., Perryman M.B.,
RA   McKinsey T.A.;
RT   "Protein kinase C-related kinase targets nuclear localization signals
RT   in a subset of class IIa histone deacetylases.";
RL   FEBS Lett. 584:1103-1110(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   INTERACTION WITH ANKRA2.
RX   PubMed=22649097; DOI=10.1126/scisignal.2002979;
RA   Xu C., Jin J., Bian C., Lam R., Tian R., Weist R., You L., Nie J.,
RA   Bochkarev A., Tempel W., Tan C.S., Wasney G.A., Vedadi M., Gish G.D.,
RA   Arrowsmith C.H., Pawson T., Yang X.J., Min J.;
RT   "Sequence-specific recognition of a PxLPxI/L motif by an ankyrin
RT   repeat tumbler lock.";
RL   Sci. Signal. 5:RA39-RA39(2012).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-611; SER-661 AND
RP   SER-1108, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [25]
RP   FUNCTION, AND INTERACTION WITH EP300.
RX   PubMed=24413532; DOI=10.1158/0008-5472.CAN-13-2020;
RA   Kang H.J., Lee M.H., Kang H.L., Kim S.H., Ahn J.R., Na H., Na T.Y.,
RA   Kim Y.N., Seong J.K., Lee M.O.;
RT   "Differential regulation of estrogen receptor alpha expression in
RT   breast cancer cells by metastasis-associated protein 1.";
RL   Cancer Res. 74:1484-1494(2014).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [27]
RP   INTERACTION WITH CUL7.
RX   PubMed=25752541; DOI=10.1016/j.str.2015.02.001;
RA   Nie J., Xu C., Jin J., Aka J.A., Tempel W., Nguyen V., You L.,
RA   Weist R., Min J., Pawson T., Yang X.J.;
RT   "Ankyrin repeats of ANKRA2 recognize a PxLPxL motif on the 3M syndrome
RT   protein CCDC8.";
RL   Structure 23:700-712(2015).
RN   [28]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-35, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Responsible for the deacetylation of lysine residues on
CC       the N-terminal part of the core histones (H2A, H2B, H3 and H4).
CC       Histone deacetylation gives a tag for epigenetic repression and
CC       plays an important role in transcriptional regulation, cell cycle
CC       progression and developmental events. Histone deacetylases act via
CC       the formation of large multiprotein complexes. Involved in muscle
CC       maturation by repressing transcription of myocyte enhancer MEF2C.
CC       During muscle differentiation, it shuttles into the cytoplasm,
CC       allowing the expression of myocyte enhancer factors. Involved in
CC       the MTA1-mediated epigenetic regulation of ESR1 expression in
CC       breast cancer. {ECO:0000269|PubMed:24413532}.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of an N(6)-acetyl-lysine residue of
CC       a histone to yield a deacetylated histone.
CC   -!- SUBUNIT: Interacts with AHRR, BAHD1, BCOR, HDAC7, HDAC9, CTBP1,
CC       MEF2C, NCOR2, NRIP1, PHB2 and a 14-3-3 chaperone protein.
CC       Interacts with BCL6, DDIT3/CHOP, GRK5, KDM5B and MYOCD. Interacts
CC       with EP300 in the presence of TFAP2C. Interacts with ANKRA2.
CC       Interacts with CUL7 (as part of the 3M complex); negatively
CC       regulated by ANKRA2. Interacts with ZBTB7B; the interaction allows
CC       the recruitment of HDAC4 on CD8 loci for deacetylation and
CC       possible inhibition of CD8 genes expression (By similarity).
CC       {ECO:0000250|UniProtKB:Q9Z2V6, ECO:0000269|PubMed:10898795,
CC       ECO:0000269|PubMed:11114197, ECO:0000269|PubMed:12504096,
CC       ECO:0000269|PubMed:17373667, ECO:0000269|PubMed:17872950,
CC       ECO:0000269|PubMed:19666599, ECO:0000269|PubMed:22649097,
CC       ECO:0000269|PubMed:24413532, ECO:0000269|PubMed:25752541}.
CC   -!- INTERACTION:
CC       Q9HCU9:BRMS1; NbExp=2; IntAct=EBI-715576, EBI-714781;
CC       P23771:GATA3; NbExp=4; IntAct=EBI-715576, EBI-6664760;
CC       Q8VEB1:Grk5 (xeno); NbExp=2; IntAct=EBI-715576, EBI-8367081;
CC       P08393:ICP0 (xeno); NbExp=3; IntAct=EBI-715576, EBI-6148881;
CC       P25791-3:LMO2; NbExp=6; IntAct=EBI-715576, EBI-11959475;
CC       Q13761:RUNX3; NbExp=5; IntAct=EBI-715576, EBI-925990;
CC       P31947:SFN; NbExp=3; IntAct=EBI-715576, EBI-476295;
CC       P63104:YWHAZ; NbExp=2; IntAct=EBI-715576, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Shuttles between
CC       the nucleus and the cytoplasm. In muscle cells, it shuttles into
CC       the cytoplasm during myocyte differentiation. The export to
CC       cytoplasm depends on the interaction with a 14-3-3 chaperone
CC       protein and is due to its phosphorylation at Ser-259 and Ser-498
CC       by AMPK, CaMK1 and SIK1.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UQL6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UQL6-2; Sequence=VSP_002081;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9UQL6-3; Sequence=VSP_039180;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DOMAIN: The nuclear export sequence mediates the shuttling between
CC       the nucleus and the cytoplasm. {ECO:0000250}.
CC   -!- PTM: Phosphorylated by AMPK, CaMK1, SIK1 and PRKD1 at Ser-259 and
CC       Ser-498. The phosphorylation is required for the export to the
CC       cytoplasm and inhibition. Phosphorylated by the PKC kinases PKN1
CC       and PKN2, impairing nuclear import. Phosphorylated by GRK5,
CC       leading to nuclear export of HDAC5 and allowing MEF2-mediated
CC       transcription (By similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated. Polyubiquitination however does not lead to
CC       its degradation. {ECO:0000269|PubMed:12354939}.
CC   -!- SIMILARITY: Belongs to the histone deacetylase family. HD type 2
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC18040.1; Type=Frameshift; Positions=1085; Evidence={ECO:0000305};
CC       Sequence=BAA25526.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF132608; AAD29047.1; -; mRNA.
DR   EMBL; AB011172; BAA25526.2; ALT_INIT; mRNA.
DR   EMBL; AC023855; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC013140; AAH13140.1; ALT_TERM; mRNA.
DR   EMBL; BC051824; AAH51824.1; -; mRNA.
DR   EMBL; BX458255; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AF039691; AAC18040.1; ALT_FRAME; mRNA.
DR   EMBL; BK000028; DAA00017.1; -; Genomic_DNA.
DR   CCDS; CCDS32663.1; -. [Q9UQL6-3]
DR   CCDS; CCDS45696.1; -. [Q9UQL6-1]
DR   RefSeq; NP_001015053.1; NM_001015053.1. [Q9UQL6-3]
DR   RefSeq; NP_005465.2; NM_005474.4. [Q9UQL6-1]
DR   RefSeq; XP_005256963.1; XM_005256906.4. [Q9UQL6-1]
DR   UniGene; Hs.438782; -.
DR   PDB; 5UWI; X-ray; 2.14 A; D=1078-1095.
DR   PDBsum; 5UWI; -.
DR   ProteinModelPortal; Q9UQL6; -.
DR   SMR; Q9UQL6; -.
DR   BioGrid; 115331; 352.
DR   CORUM; Q9UQL6; -.
DR   DIP; DIP-38260N; -.
DR   ELM; Q9UQL6; -.
DR   IntAct; Q9UQL6; 33.
DR   MINT; Q9UQL6; -.
DR   STRING; 9606.ENSP00000225983; -.
DR   BindingDB; Q9UQL6; -.
DR   ChEMBL; CHEMBL2563; -.
DR   DrugBank; DB05015; Belinostat.
DR   DrugBank; DB06603; Panobinostat.
DR   GuidetoPHARMACOLOGY; 2660; -.
DR   iPTMnet; Q9UQL6; -.
DR   PhosphoSitePlus; Q9UQL6; -.
DR   BioMuta; HDAC5; -.
DR   DMDM; 296434519; -.
DR   EPD; Q9UQL6; -.
DR   PaxDb; Q9UQL6; -.
DR   PeptideAtlas; Q9UQL6; -.
DR   PRIDE; Q9UQL6; -.
DR   Ensembl; ENST00000225983; ENSP00000225983; ENSG00000108840. [Q9UQL6-3]
DR   Ensembl; ENST00000336057; ENSP00000337290; ENSG00000108840. [Q9UQL6-2]
DR   Ensembl; ENST00000586802; ENSP00000468004; ENSG00000108840. [Q9UQL6-1]
DR   GeneID; 10014; -.
DR   KEGG; hsa:10014; -.
DR   UCSC; uc002ifd.2; human. [Q9UQL6-1]
DR   CTD; 10014; -.
DR   DisGeNET; 10014; -.
DR   EuPathDB; HostDB:ENSG00000108840.15; -.
DR   GeneCards; HDAC5; -.
DR   H-InvDB; HIX0013862; -.
DR   HGNC; HGNC:14068; HDAC5.
DR   HPA; CAB019400; -.
DR   HPA; HPA030991; -.
DR   MIM; 605315; gene.
DR   neXtProt; NX_Q9UQL6; -.
DR   OpenTargets; ENSG00000108840; -.
DR   PharmGKB; PA29230; -.
DR   eggNOG; KOG1343; Eukaryota.
DR   eggNOG; COG0123; LUCA.
DR   GeneTree; ENSGT00530000062809; -.
DR   HOGENOM; HOG000232065; -.
DR   HOVERGEN; HBG057100; -.
DR   InParanoid; Q9UQL6; -.
DR   KO; K11406; -.
DR   OMA; LGPYDSR; -.
DR   OrthoDB; EOG091G0EQO; -.
DR   PhylomeDB; Q9UQL6; -.
DR   TreeFam; TF106174; -.
DR   Reactome; R-HSA-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-8943724; Regulation of PTEN gene transcription.
DR   SIGNOR; Q9UQL6; -.
DR   ChiTaRS; HDAC5; human.
DR   GeneWiki; Histone_deacetylase_5; -.
DR   GenomeRNAi; 10014; -.
DR   PRO; PR:Q9UQL6; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000108840; -.
DR   CleanEx; HS_HDAC5; -.
DR   ExpressionAtlas; Q9UQL6; baseline and differential.
DR   Genevisible; Q9UQL6; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0000118; C:histone deacetylase complex; TAS:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0001047; F:core promoter binding; IDA:UniProtKB.
DR   GO; GO:0004407; F:histone deacetylase activity; IDA:BHF-UCL.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC.
DR   GO; GO:0033558; F:protein deacetylase activity; IMP:UniProtKB.
DR   GO; GO:0005080; F:protein kinase C binding; IPI:UniProtKB.
DR   GO; GO:0070491; F:repressing transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0001085; F:RNA polymerase II transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0042113; P:B cell activation; TAS:UniProtKB.
DR   GO; GO:0030183; P:B cell differentiation; TAS:UniProtKB.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; NAS:BHF-UCL.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0006325; P:chromatin organization; TAS:UniProtKB.
DR   GO; GO:0006338; P:chromatin remodeling; TAS:ProtInc.
DR   GO; GO:0006342; P:chromatin silencing; TAS:ProtInc.
DR   GO; GO:0016575; P:histone deacetylation; IDA:BHF-UCL.
DR   GO; GO:0006954; P:inflammatory response; TAS:UniProtKB.
DR   GO; GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; IMP:BHF-UCL.
DR   GO; GO:0010832; P:negative regulation of myotube differentiation; IMP:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:MGI.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; TAS:UniProtKB.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0051091; P:positive regulation of DNA binding transcription factor activity; IMP:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:BHF-UCL.
DR   GO; GO:0006476; P:protein deacetylation; IMP:UniProtKB.
DR   GO; GO:0040029; P:regulation of gene expression, epigenetic; IMP:UniProtKB.
DR   GO; GO:0010830; P:regulation of myotube differentiation; ISS:UniProtKB.
DR   GO; GO:0043393; P:regulation of protein binding; IMP:BHF-UCL.
DR   GO; GO:0014823; P:response to activity; IEA:Ensembl.
DR   GO; GO:0042220; P:response to cocaine; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.800.20; -; 1.
DR   InterPro; IPR000286; His_deacetylse.
DR   InterPro; IPR023801; His_deacetylse_dom.
DR   InterPro; IPR037138; His_deacetylse_dom_sf.
DR   InterPro; IPR024643; Hist_deacetylase_Gln_rich_N.
DR   InterPro; IPR017320; Histone_deAcase_II_euk.
DR   InterPro; IPR030703; Histone_deacetylase_5.
DR   InterPro; IPR023696; Ureohydrolase_dom_sf.
DR   PANTHER; PTHR10625; PTHR10625; 1.
DR   PANTHER; PTHR10625:SF57; PTHR10625:SF57; 1.
DR   Pfam; PF12203; HDAC4_Gln; 1.
DR   Pfam; PF00850; Hist_deacetyl; 1.
DR   PIRSF; PIRSF037911; HDAC_II_euk; 1.
DR   PRINTS; PR01270; HDASUPER.
DR   SUPFAM; SSF52768; SSF52768; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromatin regulator;
KW   Complete proteome; Cytoplasm; Hydrolase; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc.
FT   CHAIN         1   1122       Histone deacetylase 5.
FT                                /FTId=PRO_0000114701.
FT   REGION      684   1028       Histone deacetylase.
FT   MOTIF      1081   1122       Nuclear export signal.
FT   COMPBIAS     47     52       Poly-Gly.
FT   COMPBIAS     85     92       Poly-Gln.
FT   COMPBIAS    596    599       Poly-Glu.
FT   COMPBIAS   1099   1104       Poly-Ala.
FT   ACT_SITE    833    833       {ECO:0000250}.
FT   METAL       696    696       Zinc. {ECO:0000250}.
FT   METAL       698    698       Zinc. {ECO:0000250}.
FT   METAL       704    704       Zinc. {ECO:0000250}.
FT   METAL       781    781       Zinc. {ECO:0000250}.
FT   MOD_RES     259    259       Phosphoserine; by AMPK, CaMK1, SIK1 and
FT                                PKD/PRKD1. {ECO:0000269|PubMed:11114197,
FT                                ECO:0000269|PubMed:18184930,
FT                                ECO:0000269|PubMed:18332134}.
FT   MOD_RES     292    292       Phosphothreonine; by PKC.
FT                                {ECO:0000269|PubMed:20188095}.
FT   MOD_RES     498    498       Phosphoserine; by AMPK, CaMK1, SIK1 and
FT                                PKD/PRKD1. {ECO:0000269|PubMed:11114197,
FT                                ECO:0000269|PubMed:18184930,
FT                                ECO:0000269|PubMed:18332134}.
FT   MOD_RES     533    533       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     611    611       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     661    661       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1108   1108       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK     35     35       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       7      7       S -> SA (in isoform 3).
FT                                {ECO:0000303|Ref.6}.
FT                                /FTId=VSP_039180.
FT   VAR_SEQ     684    768       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9628581}.
FT                                /FTId=VSP_002081.
FT   VARIANT     137    137       R -> Q (in dbSNP:rs438096).
FT                                /FTId=VAR_055903.
FT   VARIANT     565    565       G -> A (in dbSNP:rs33916560).
FT                                /FTId=VAR_055904.
FT   MUTAGEN     259    259       S->A: Reduces AMPK- and caMK-dependent
FT                                phosphorylation and the subsequent
FT                                nuclear export. Abolishes nuclear export;
FT                                when associated with A-498. Does not
FT                                affect phosphorylation by PKN1 and PKN2.
FT                                {ECO:0000269|PubMed:11081517,
FT                                ECO:0000269|PubMed:18184930,
FT                                ECO:0000269|PubMed:20188095}.
FT   MUTAGEN     279    279       S->A: No effect.
FT                                {ECO:0000269|PubMed:11081517}.
FT   MUTAGEN     291    291       S->A: Does not affect phosphorylation by
FT                                PKC. {ECO:0000269|PubMed:20188095}.
FT   MUTAGEN     292    292       T->A: Abolishes phosphorylation by PKC.
FT                                {ECO:0000269|PubMed:20188095}.
FT   MUTAGEN     498    498       S->A: Reduces AMPK- and CaMK-dependent
FT                                phosphorylation and the subsequent
FT                                nuclear export. Abolishes nuclear export;
FT                                when associated with A-259.
FT                                {ECO:0000269|PubMed:11081517,
FT                                ECO:0000269|PubMed:18184930}.
FT   MUTAGEN     661    661       S->A: No effect.
FT                                {ECO:0000269|PubMed:11081517}.
FT   MUTAGEN     713    713       S->A: No effect.
FT                                {ECO:0000269|PubMed:11081517}.
FT   MUTAGEN    1086   1086       V->A: Reduces CaMK-dependent nuclear
FT                                export. {ECO:0000269|PubMed:11509672}.
FT   MUTAGEN    1092   1092       L->A: Reduces CaMK-dependent nuclear
FT                                export. {ECO:0000269|PubMed:11509672}.
FT   CONFLICT     37     37       V -> L (in Ref. 6; BX458255).
FT                                {ECO:0000305}.
FT   CONFLICT    139    139       Q -> R (in Ref. 6; BX458255).
FT                                {ECO:0000305}.
FT   CONFLICT    147    147       R -> G (in Ref. 6; BX458255).
FT                                {ECO:0000305}.
FT   CONFLICT    593    593       D -> E (in Ref. 1; AAD29047, 5; AAH51824
FT                                and 7; AAC18040). {ECO:0000305}.
FT   CONFLICT    671    671       S -> N (in Ref. 7; AAC18040).
FT                                {ECO:0000305}.
FT   CONFLICT    684    684       G -> S (in Ref. 7; AAC18040).
FT                                {ECO:0000305}.
FT   CONFLICT   1026   1026       E -> K (in Ref. 7; AAC18040).
FT                                {ECO:0000305}.
FT   CONFLICT   1074   1074       E -> G (in Ref. 7; AAC18040).
FT                                {ECO:0000305}.
FT   CONFLICT   1093   1093       S -> L (in Ref. 7; AAC18040).
FT                                {ECO:0000305}.
FT   HELIX      1083   1090       {ECO:0000244|PDB:5UWI}.
SQ   SEQUENCE   1122 AA;  121978 MW;  CF4BE774E3588FEC CRC64;
     MNSPNESDGM SGREPSLEIL PRTSLHSIPV TVEVKPVLPR AMPSSMGGGG GGSPSPVELR
     GALVGSVDPT LREQQLQQEL LALKQQQQLQ KQLLFAEFQK QHDHLTRQHE VQLQKHLKQQ
     QEMLAAKQQQ EMLAAKRQQE LEQQRQREQQ RQEELEKQRL EQQLLILRNK EKSKESAIAS
     TEVKLRLQEF LLSKSKEPTP GGLNHSLPQH PKCWGAHHAS LDQSSPPQSG PPGTPPSYKL
     PLPGPYDSRD DFPLRKTASE PNLKVRSRLK QKVAERRSSP LLRRKDGTVI STFKKRAVEI
     TGAGPGASSV CNSAPGSGPS SPNSSHSTIA ENGFTGSVPN IPTEMLPQHR ALPLDSSPNQ
     FSLYTSPSLP NISLGLQATV TVTNSHLTAS PKLSTQQEAE RQALQSLRQG GTLTGKFMST
     SSIPGCLLGV ALEGDGSPHG HASLLQHVLL LEQARQQSTL IAVPLHGQSP LVTGERVATS
     MRTVGKLPRH RPLSRTQSSP LPQSPQALQQ LVMQQQHQQF LEKQKQQQLQ LGKILTKTGE
     LPRQPTTHPE ETEEELTEQQ EVLLGEGALT MPREGSTESE STQEDLEEED EEDDGEEEED
     CIQVKDEEGE SGAEEGPDLE EPGAGYKKLF SDAQPLQPLQ VYQAPLSLAT VPHQALGRTQ
     SSPAAPGGMK SPPDQPVKHL FTTGVVYDTF MLKHQCMCGN THVHPEHAGR IQSIWSRLQE
     TGLLSKCERI RGRKATLDEI QTVHSEYHTL LYGTSPLNRQ KLDSKKLLGP ISQKMYAVLP
     CGGIGVDSDT VWNEMHSSSA VRMAVGCLLE LAFKVAAGEL KNGFAIIRPP GHHAEESTAM
     GFCFFNSVAI TAKLLQQKLN VGKVLIVDWD IHHGNGTQQA FYNDPSVLYI SLHRYDNGNF
     FPGSGAPEEV GGGPGVGYNV NVAWTGGVDP PIGDVEYLTA FRTVVMPIAH EFSPDVVLVS
     AGFDAVEGHL SPLGGYSVTA RCFGHLTRQL MTLAGGRVVL ALEGGHDLTA ICDASEACVS
     ALLSVELQPL DEAVLQQKPN INAVATLEKV IEIQSKHWSC VQKFAAGLGR SLREAQAGET
     EEAETVSAMA LLSVGAEQAQ AAAAREHSPR PAEEPMEQEP AL
//
ID   B0LPF3_HUMAN            Unreviewed;       217 AA.
AC   B0LPF3;
DT   18-MAR-2008, integrated into UniProtKB/TrEMBL.
DT   18-MAR-2008, sequence version 1.
DT   23-MAY-2018, entry version 102.
DE   SubName: Full=Growth factor receptor-bound protein 2 {ECO:0000313|EMBL:ABY87532.1};
DE   SubName: Full=Growth factor receptor-bound protein 2, isoform CRA_a {ECO:0000313|EMBL:EAW89270.1};
DE   SubName: Full=cDNA, FLJ96637, Homo sapiens growth factor receptor-bound protein 2 (GRB2), mRNA {ECO:0000313|EMBL:BAG37940.1};
GN   Name=GRB2 {ECO:0000313|EMBL:ABY87532.1};
GN   ORFNames=hCG_27179 {ECO:0000313|EMBL:EAW89270.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABY87532.1};
RN   [1] {ECO:0000313|EMBL:EAW89270.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW89270.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ABY87532.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Rieder M.J., Johanson E.J., da Ponte S.H., Stanaway I.S., Ahearn M.O.,
RA   Bertucci C.B., Wong M.W., Yi Q., Nickerson D.A.;
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAG37940.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAG37940.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:AGC09591.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Rieder M.J., Bertucci C., Stanaway I.B., Johnson E.J., Swanson J.E.,
RA   Siegel D.L., da Ponte S.H., Igartua C., Patterson K., Nickerson D.A.;
RL   Submitted (AUG-2012) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU332843; ABY87532.1; -; Genomic_DNA.
DR   EMBL; JX512444; AGC09591.1; -; Genomic_DNA.
DR   EMBL; AK315565; BAG37940.1; -; mRNA.
DR   EMBL; CH471099; EAW89270.1; -; Genomic_DNA.
DR   RefSeq; NP_002077.1; NM_002086.4.
DR   UniGene; Hs.444356; -.
DR   SMR; B0LPF3; -.
DR   PRIDE; B0LPF3; -.
DR   DNASU; 2885; -.
DR   GeneID; 2885; -.
DR   KEGG; hsa:2885; -.
DR   CTD; 2885; -.
DR   EuPathDB; HostDB:ENSG00000177885.13; -.
DR   PharmGKB; PA28962; -.
DR   eggNOG; KOG3601; Eukaryota.
DR   eggNOG; ENOG410XR1G; LUCA.
DR   HOVERGEN; HBG005404; -.
DR   KO; K04364; -.
DR   OMA; HWWHGEI; -.
DR   OrthoDB; EOG091G0HWS; -.
DR   ChiTaRS; GRB2; human.
DR   GenomeRNAi; 2885; -.
DR   Bgee; ENSG00000177885; -.
DR   ExpressionAtlas; B0LPF3; baseline and differential.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0008180; C:COP9 signalosome; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0012506; C:vesicle membrane; IEA:Ensembl.
DR   GO; GO:0046875; F:ephrin receptor binding; IEA:Ensembl.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0019903; F:protein phosphatase binding; IEA:Ensembl.
DR   GO; GO:0005070; F:SH3/SH2 adaptor activity; IEA:Ensembl.
DR   GO; GO:0048646; P:anatomical structure formation involved in morphogenesis; IEA:Ensembl.
DR   GO; GO:0060670; P:branching involved in labyrinthine layer morphogenesis; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IEA:Ensembl.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; IEA:Ensembl.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0007265; P:Ras protein signal transduction; IEA:InterPro.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IEA:Ensembl.
DR   CDD; cd11949; SH3_GRB2_C; 1.
DR   CDD; cd11946; SH3_GRB2_N; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR030219; Grb2.
DR   InterPro; IPR035643; GRB2_C_SH3.
DR   InterPro; IPR035641; GRB2_N_SH3.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR24418:SF290; PTHR24418:SF290; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 2.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 2.
DR   SUPFAM; SSF50044; SSF50044; 2.
DR   SUPFAM; SSF55550; SSF55550; 2.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 2.
PE   2: Evidence at transcript level;
KW   Receptor {ECO:0000313|EMBL:ABY87532.1};
KW   SH2 domain {ECO:0000256|PROSITE-ProRule:PRU00191};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192,
KW   ECO:0000256|SAAS:SAAS01042643}.
FT   DOMAIN        1     58       SH3. {ECO:0000259|PROSITE:PS50002}.
FT   DOMAIN       60    152       SH2. {ECO:0000259|PROSITE:PS50001}.
FT   DOMAIN      156    215       SH3. {ECO:0000259|PROSITE:PS50002}.
SQ   SEQUENCE   217 AA;  25206 MW;  83A4B0BA1B248DC4 CRC64;
     MEAIAKYDFK ATADDELSFK RGDILKVLNE ECDQNWYKAE LNGKDGFIPK NYIEMKPHPW
     FFGKIPRAKA EEMLSKQRHD GAFLIRESES APGDFSLSVK FGNDVQHFKV LRDGAGKYFL
     WVVKFNSLNE LVDYHRSTSV SRNQQIFLRD IEQVPQQPTY VQALFDFDPQ EDGELGFRRG
     DFIHVMDNSD PNWWKGACHG QTGMFPRNYV TPVNRNV
//
ID   GRB2_HUMAN              Reviewed;         217 AA.
AC   P62993; P29354; Q14450; Q63057; Q63059;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   31-AUG-2004, sequence version 1.
DT   23-MAY-2018, entry version 182.
DE   RecName: Full=Growth factor receptor-bound protein 2;
DE   AltName: Full=Adapter protein GRB2;
DE   AltName: Full=Protein Ash;
DE   AltName: Full=SH2/SH3 adapter GRB2;
GN   Name=GRB2; Synonyms=ASH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND MUTAGENESIS OF
RP   PRO-49 AND GLY-203.
RC   TISSUE=Brain;
RX   PubMed=1322798; DOI=10.1016/0092-8674(92)90167-B;
RA   Lowenstein E.J., Daly R.J., Batzer A.G., Li W., Margolis B.,
RA   Lammers R., Ullrich A., Skolnik E.Y., Bar-Sagi D., Schlessinger J.;
RT   "The SH2 and SH3 domain-containing protein GRB2 links receptor
RT   tyrosine kinases to ras signaling.";
RL   Cell 70:431-442(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal lung;
RX   PubMed=1384039; DOI=10.1073/pnas.89.19.9015;
RA   Matuoka K., Yamakawa A., Shibata M., Takenawa T.;
RT   "Cloning of ASH, a ubiquitous protein composed of one Src homology
RT   region (SH) 2 and two SH3 domains, from human and rat cDNA
RT   libraries.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:9015-9019(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND FUNCTION.
RC   TISSUE=Placenta;
RX   PubMed=8178156; DOI=10.1126/science.8178156;
RA   Fath I., Schweighoffer F., Rey I., Multon M.-C., Boiziau J.,
RA   Duchesne M., Tocque B.;
RT   "Cloning of a Grb2 isoform with apoptotic properties.";
RL   Science 264:971-974(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Epidermis;
RX   PubMed=10051406; DOI=10.1006/geno.1998.5692;
RA   Bochmann H., Gehrisch S., Jaross W.;
RT   "The gene structure of the human growth factor bound protein GRB2.";
RL   Genomics 56:203-207(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 11-20; 27-38; 77-109; 118-136; 143-149 AND
RP   179-195, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   INTERACTION WITH CSF1R.
RX   PubMed=8262059;
RA   van der Geer P., Hunter T.;
RT   "Mutation of Tyr697, a GRB2-binding site, and Tyr721, a PI 3-kinase
RT   binding site, abrogates signal transduction by the murine CSF-1
RT   receptor expressed in Rat-2 fibroblasts.";
RL   EMBO J. 12:5161-5172(1993).
RN   [11]
RP   INTERACTION WITH IRS1.
RX   PubMed=8388384;
RA   Tobe K., Matuoka K., Tamemoto H., Ueki K., Kaburagi Y., Asai S.,
RA   Noguchi T., Matsuda M., Tanaka S., Hattori S., Fukui Y., Akanuma Y.,
RA   Yazaki Y., Takenawa T., Kadowaki T.;
RT   "Insulin stimulates association of insulin receptor substrate-1 with
RT   the protein abundant Src homology/growth factor receptor-bound protein
RT   2.";
RL   J. Biol. Chem. 268:11167-11171(1993).
RN   [12]
RP   INTERACTION WITH IRS1 AND SHC.
RX   PubMed=8491186;
RA   Skolnik E.Y., Lee C.-H., Batzer A.G., Vicentini L.M., Zhou M.,
RA   Daly R.J., Myers M.J. Jr., Backer J.M., Ullrich A., White M.F.,
RA   Schlessinger J.;
RT   "The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-
RT   phosphorylated IRS1 and Shc: implications for insulin control of ras
RT   signalling.";
RL   EMBO J. 12:1929-1936(1993).
RN   [13]
RP   INTERACTION WITH SOS1, AND MUTAGENESIS OF PRO-49; GLU-89; SER-90 AND
RP   GLY-203.
RC   TISSUE=Brain;
RX   PubMed=8493579; DOI=10.1126/science.8493579;
RA   Chardin P., Camonis J.H., Gale N.W., van Aelst L., Wigler M.H.,
RA   Bar-Sagi D.;
RT   "Human Sos1: a guanine nucleotide exchange factor for Ras that binds
RT   to GRB2.";
RL   Science 260:1338-1343(1993).
RN   [14]
RP   IDENTIFICATION IN A COMPLEX WITH MUC1 AND SOS1, AND INTERACTION WITH
RP   MUC1 AND SOS1.
RX   PubMed=7664271;
RA   Pandey P., Kharbanda S., Kufe D.;
RT   "Association of the DF3/MUC1 breast cancer antigen with Grb2 and the
RT   Sos/Ras exchange protein.";
RL   Cancer Res. 55:4000-4003(1995).
RN   [15]
RP   INTERACTION WITH INPP5D.
RX   PubMed=8723348; DOI=10.1016/S0960-9822(02)00511-0;
RA   Kavanaugh W.M., Pot D.A., Chin S.M., Deuter-Reinhard M.,
RA   Jefferson A.B., Norris F.A., Masiarz F.R., Cousens L.S., Majerus P.W.,
RA   Williams L.T.;
RT   "Multiple forms of an inositol polyphosphate 5-phosphatase form
RT   signaling complexes with Shc and Grb2.";
RL   Curr. Biol. 6:438-445(1996).
RN   [16]
RP   INTERACTION WITH EPHB1.
RX   PubMed=8798570; DOI=10.1074/jbc.271.38.23588;
RA   Stein E., Cerretti D.P., Daniel T.O.;
RT   "Ligand activation of ELK receptor tyrosine kinase promotes its
RT   association with Grb10 and Grb2 in vascular endothelial cells.";
RL   J. Biol. Chem. 271:23588-23593(1996).
RN   [17]
RP   INTERACTION WITH INPP5D.
RX   PubMed=9108392;
RA   Odai H., Sasaki K., Iwamatsu A., Nakamoto T., Ueno H., Yamagata T.,
RA   Mitani K., Yazaki Y., Hirai H.;
RT   "Purification and molecular cloning of SH2- and SH3-containing
RT   inositol polyphosphate-5-phosphatase, which is involved in the
RT   signaling pathway of granulocyte-macrophage colony-stimulating factor,
RT   erythropoietin, and Bcr-Abl.";
RL   Blood 89:2745-2756(1997).
RN   [18]
RP   INTERACTION WITH PTK2/FAK1.
RX   PubMed=9148935; DOI=10.1074/jbc.272.20.13189;
RA   Schlaepfer D.D., Hunter T.;
RT   "Focal adhesion kinase overexpression enhances ras-dependent integrin
RT   signaling to ERK2/mitogen-activated protein kinase through
RT   interactions with and activation of c-Src.";
RL   J. Biol. Chem. 272:13189-13195(1997).
RN   [19]
RP   INTERACTION WITH PTPNS1.
RX   PubMed=9062191; DOI=10.1038/386181a0;
RA   Kharitonenkov A., Chen Z., Sures I., Wang H., Schilling J.,
RA   Ullrich A.;
RT   "A family of proteins that inhibit signalling through tyrosine kinase
RT   receptors.";
RL   Nature 386:181-186(1997).
RN   [20]
RP   INTERACTION WITH AXL.
RX   PubMed=9178760; DOI=10.1038/sj.onc.1201123;
RA   Braunger J., Schleithoff L., Schulz A.S., Kessler H., Lammers R.,
RA   Ullrich A., Bartram C.R., Janssen J.W.;
RT   "Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is
RT   mediated mainly by a multi-substrate docking-site.";
RL   Oncogene 14:2619-2631(1997).
RN   [21]
RP   INTERACTION WITH SH2B2.
RX   PubMed=9233773; DOI=10.1038/sj.onc.1201163;
RA   Yokouchi M., Suzuki R., Masuhara M., Komiya S., Inoue A.,
RA   Yoshimura A.;
RT   "Cloning and characterization of APS, an adaptor molecule containing
RT   PH and SH2 domains that is tyrosine phosphorylated upon B-cell
RT   receptor stimulation.";
RL   Oncogene 15:7-15(1997).
RN   [22]
RP   INTERACTION WITH LAT.
RX   PubMed=9489702; DOI=10.1016/S0092-8674(00)80901-0;
RA   Zhang W., Sloan-Lancaster J., Kitchen J., Trible R.P., Samelson L.E.;
RT   "LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor
RT   to cellular activation.";
RL   Cell 92:83-92(1998).
RN   [23]
RP   INTERACTION WITH REPS2.
RX   PubMed=9422736; DOI=10.1074/jbc.273.2.814;
RA   Ikeda M., Ishida O., Hinoi T., Kishida S., Kikuchi A.;
RT   "Identification and characterization of a novel protein interacting
RT   with Ral-binding protein 1, a putative effector protein of Ral.";
RL   J. Biol. Chem. 273:814-821(1998).
RN   [24]
RP   INTERACTION WITH IRS4.
RX   PubMed=9553137; DOI=10.1074/jbc.273.17.10726;
RA   Fantin V.R., Sparling J.D., Slot J.W., Keller S.R., Lienhard G.E.,
RA   Lavan B.E.;
RT   "Characterization of insulin receptor substrate 4 in human embryonic
RT   kidney 293 cells.";
RL   J. Biol. Chem. 273:10726-10732(1998).
RN   [25]
RP   INTERACTION WITH SHB, AND MUTAGENESIS OF PRO-49 AND PRO-206.
RX   PubMed=9484780; DOI=10.1038/sj.onc.1201607;
RA   Welsh M., Songyang Z., Frantz J.D., Trueb T., Reedquist K.A.,
RA   Karlsson T., Miyazaki M., Cantley L.C., Band H., Shoelson S.E.;
RT   "Stimulation through the T cell receptor leads to interactions between
RT   SHB and several signaling proteins.";
RL   Oncogene 16:891-901(1998).
RN   [26]
RP   INTERACTION WITH EGFR.
RX   PubMed=10026169; DOI=10.1074/jbc.274.9.5542;
RA   Braverman L.E., Quilliam L.A.;
RT   "Identification of Grb4/Nckbeta, a src homology 2 and 3 domain-
RT   containing adapter protein having similar binding and biological
RT   properties to Nck.";
RL   J. Biol. Chem. 274:5542-5549(1999).
RN   [27]
RP   INTERACTION WITH CBLB.
RX   PubMed=10022120; DOI=10.1038/sj.onc.1202411;
RA   Elly C., Witte S., Zhang Z., Rosnet O., Lipkowitz S., Altman A.,
RA   Liu Y.-C.;
RT   "Tyrosine phosphorylation and complex formation of Cbl-b upon T cell
RT   receptor stimulation.";
RL   Oncogene 18:1147-1156(1999).
RN   [28]
RP   INTERACTION WITH CBL AND CBLB.
RX   PubMed=10086340; DOI=10.1038/sj.onc.1202499;
RA   Ettenberg S.A., Keane M.M., Nau M.M., Frankel M., Wang L.-M.,
RA   Pierce J.H., Lipkowitz S.;
RT   "cbl-b inhibits epidermal growth factor receptor signaling.";
RL   Oncogene 18:1855-1866(1999).
RN   [29]
RP   INTERACTION WITH HCV NS5A.
RX   PubMed=10318918; DOI=10.1073/pnas.96.10.5533;
RA   Tan S.-L., Nakao H., He Y., Vijaysri S., Neddermann P., Jacobs B.L.,
RA   Mayer B.J., Katze M.G.;
RT   "NS5A, a nonstructural protein of hepatitis C virus, binds growth
RT   factor receptor-bound protein 2 adaptor protein in a Src homology 3
RT   domain/ligand-dependent manner and perturbs mitogenic signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:5533-5538(1999).
RN   [30]
RP   INTERACTION WITH RALGPS1.
RX   PubMed=10747847; DOI=10.1074/jbc.C000085200;
RA   Rebhun J.F., Chen H., Quilliam L.A.;
RT   "Identification and characterization of a new family of guanine
RT   nucleotide exchange factors for the ras-related GTPase Ral.";
RL   J. Biol. Chem. 275:13406-13410(2000).
RN   [31]
RP   INTERACTION WITH ERBB4.
RX   PubMed=10867024; DOI=10.1074/jbc.C901015199;
RA   Sweeney C., Lai C., Riese D.J. II, Diamonti A.J., Cantley L.C.,
RA   Carraway K.L. III;
RT   "Ligand discrimination in signaling through an ErbB4 receptor
RT   homodimer.";
RL   J. Biol. Chem. 275:19803-19807(2000).
RN   [32]
RP   INTERACTION WITH SKAP2.
RX   PubMed=10942756; DOI=10.1074/jbc.M001439200;
RA   Asazuma N., Wilde J.I., Berlanga O., Leduc M., Leo A.,
RA   Schweighoffer E., Tybulewicz V., Bon C., Liu S.K., McGlade C.J.,
RA   Schraven B., Watson S.P.;
RT   "Interaction of linker for activation of T cells with multiple adapter
RT   proteins in platelets activated by the glycoprotein VI-selective
RT   ligand, convulxin.";
RL   J. Biol. Chem. 275:33427-33434(2000).
RN   [33]
RP   INTERACTION WITH PTPRE.
RX   PubMed=10980613; DOI=10.1038/sj.onc.1203790;
RA   Gil-Henn H., Volohonsky G., Toledano-Katchalski H., Gandre S.,
RA   Elson A.;
RT   "Generation of novel cytoplasmic forms of protein tyrosine phosphatase
RT   epsilon by proteolytic processing and translational control.";
RL   Oncogene 19:4375-4384(2000).
RN   [34]
RP   INTERACTION WITH SIT1.
RX   PubMed=11433379;
RX   DOI=10.1002/1521-4141(200106)31:6<1825::AID-IMMU1825>3.0.CO;2-V;
RA   Pfrepper K.-I., Marie-Cardine A., Simeoni L., Kuramitsu Y., Leo A.,
RA   Spicka J., Hilgert I., Scherer J., Schraven B.;
RT   "Structural and functional dissection of the cytoplasmic domain of the
RT   transmembrane adaptor protein SIT (SHP2-interacting transmembrane
RT   adaptor protein).";
RL   Eur. J. Immunol. 31:1825-1836(2001).
RN   [35]
RP   INTERACTION WITH HEV ORF3 PROTEIN.
RX   PubMed=11518702; DOI=10.1074/jbc.M101546200;
RA   Korkaya H., Jameel S., Gupta D., Tyagi S., Kumar R., Zafrullah M.,
RA   Mazumdar M., Lal S.K., Xiaofang L., Sehgal D., Das S.R., Sahal D.;
RT   "The ORF3 protein of hepatitis E virus binds to Src homology 3 domains
RT   and activates MAPK.";
RL   J. Biol. Chem. 276:42389-42400(2001).
RN   [36]
RP   IDENTIFICATION IN A COMPLEX WITH PIK3C2B AND EGFR, AND INTERACTION
RP   WITH PIK3C2B.
RX   PubMed=11533253; DOI=10.1128/MCB.21.19.6660-6667.2001;
RA   Wheeler M., Domin J.;
RT   "Recruitment of the class II phosphoinositide 3-kinase C2beta to the
RT   epidermal growth factor receptor: role of Grb2.";
RL   Mol. Cell. Biol. 21:6660-6667(2001).
RN   [37]
RP   INTERACTION WITH NISCH.
RX   PubMed=11912194; DOI=10.1074/jbc.M111838200;
RA   Sano H., Liu S.C.H., Lane W.S., Piletz J.E., Lienhard G.E.;
RT   "Insulin receptor substrate 4 associates with the protein IRAS.";
RL   J. Biol. Chem. 277:19439-19447(2002).
RN   [38]
RP   INTERACTION WITH SKAP1.
RX   PubMed=12171928; DOI=10.1074/jbc.M206023200;
RA   Wu L., Yu Z., Shen S.-H.;
RT   "SKAP55 recruits to lipid rafts and positively mediates the MAPK
RT   pathway upon T cell receptor activation.";
RL   J. Biol. Chem. 277:40420-40427(2002).
RN   [39]
RP   INTERACTION WITH LAX1.
RX   PubMed=12359715; DOI=10.1074/jbc.M208946200;
RA   Zhu M., Janssen E., Leung K., Zhang W.;
RT   "Molecular cloning of a novel gene encoding a membrane-associated
RT   adaptor protein (LAX) in lymphocyte signaling.";
RL   J. Biol. Chem. 277:46151-46158(2002).
RN   [40]
RP   INTERACTION WITH LAT2.
RX   PubMed=12486104; DOI=10.1084/jem.20021405;
RA   Brdicka T., Imrich M., Angelisova P., Brdickova N., Horvath O.,
RA   Spicka J., Hilgert I., Luskova P., Draber P., Novak P., Engels N.,
RA   Wienands J., Simeoni L., Oesterreicher J., Aguado E., Malissen M.,
RA   Schraven B., Horejsi V.;
RT   "Non-T cell activation linker (NTAL): a transmembrane adaptor protein
RT   involved in immunoreceptor signaling.";
RL   J. Exp. Med. 196:1617-1626(2002).
RN   [41]
RP   INTERACTION WITH PTPRJ.
RX   PubMed=12475979; DOI=10.1074/jbc.M210656200;
RA   Palka H.L., Park M., Tonks N.K.;
RT   "Hepatocyte growth factor receptor tyrosine kinase met is a substrate
RT   of the receptor protein-tyrosine phosphatase DEP-1.";
RL   J. Biol. Chem. 278:5728-5735(2003).
RN   [42]
RP   INTERACTION WITH EPHB1 AND SHC1.
RX   PubMed=12925710; DOI=10.1083/jcb.200302073;
RA   Vindis C., Cerretti D.P., Daniel T.O., Huynh-Do U.;
RT   "EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote
RT   chemotaxis.";
RL   J. Cell Biol. 162:661-671(2003).
RN   [43]
RP   INTERACTION WITH LAT2.
RX   PubMed=12514734; DOI=10.1038/ni882;
RA   Janssen E., Zhu M., Zhang W., Koonpaew S., Zhang W.;
RT   "LAB: a new membrane-associated adaptor molecule in B cell
RT   activation.";
RL   Nat. Immunol. 4:117-123(2003).
RN   [44]
RP   INTERACTION WITH NTRK1.
RX   PubMed=15488758; DOI=10.1016/j.ccr.2004.09.011;
RA   Tacconelli A., Farina A.R., Cappabianca L., Desantis G., Tessitore A.,
RA   Vetuschi A., Sferra R., Rucci N., Argenti B., Screpanti I., Gulino A.,
RA   Mackay A.R.;
RT   "TrkA alternative splicing: a regulated tumor-promoting switch in
RT   human neuroblastoma.";
RL   Cancer Cell 6:347-360(2004).
RN   [45]
RP   INTERACTION WITH FLT4.
RX   PubMed=15102829; DOI=10.1074/jbc.M314015200;
RA   Wang J.F., Zhang X., Groopman J.E.;
RT   "Activation of vascular endothelial growth factor receptor-3 and its
RT   downstream signaling promote cell survival under oxidative stress.";
RL   J. Biol. Chem. 279:27088-27097(2004).
RN   [46]
RP   REVIEW ON INTERACTION WITH KIT AND ROLE IN KIT SIGNALING.
RX   PubMed=15526160; DOI=10.1007/s00018-004-4189-6;
RA   Ronnstrand L.;
RT   "Signal transduction via the stem cell factor receptor/c-Kit.";
RL   Cell. Mol. Life Sci. 61:2535-2548(2004).
RN   [47]
RP   INTERACTION WITH BCR.
RX   PubMed=15302586; DOI=10.1016/j.yexcr.2004.05.010;
RA   Laurent C.E., Smithgall T.E.;
RT   "The c-Fes tyrosine kinase cooperates with the breakpoint cluster
RT   region protein (Bcr) to induce neurite extension in a Rac- and Cdc42-
RT   dependent manner.";
RL   Exp. Cell Res. 299:188-198(2004).
RN   [48]
RP   REVIEW ON ROLE IN KIT SIGNALING.
RX   PubMed=16129412; DOI=10.1016/j.bbrc.2005.08.055;
RA   Roskoski R. Jr.;
RT   "Signaling by Kit protein-tyrosine kinase--the stem cell factor
RT   receptor.";
RL   Biochem. Biophys. Res. Commun. 337:1-13(2005).
RN   [49]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [50]
RP   INTERACTION WITH HCST.
RX   PubMed=16582911; DOI=10.1038/ni1325;
RA   Upshaw J.L., Arneson L.N., Schoon R.A., Dick C.J., Billadeau D.D.,
RA   Leibson P.J.;
RT   "NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1
RT   intermediate and phosphatidylinositol-3-kinase in human natural killer
RT   cells.";
RL   Nat. Immunol. 7:524-532(2006).
RN   [51]
RP   INTERACTION WITH GAPT.
RX   PubMed=18559951; DOI=10.1189/jlb.0208087;
RA   Liu Y., Zhang W.;
RT   "Identification of a new transmembrane adaptor protein that
RT   constitutively binds Grb2 in B cells.";
RL   J. Leukoc. Biol. 84:842-851(2008).
RN   [52]
RP   INTERACTION WITH ADAM15.
RX   PubMed=18296648; DOI=10.1158/1541-7786.MCR-07-2028;
RA   Zhong J.L., Poghosyan Z., Pennington C.J., Scott X., Handsley M.M.,
RA   Warn A., Gavrilovic J., Honert K., Kruger A., Span P.N., Sweep F.C.,
RA   Edwards D.R.;
RT   "Distinct functions of natural ADAM-15 cytoplasmic domain variants in
RT   human mammary carcinoma.";
RL   Mol. Cancer Res. 6:383-394(2008).
RN   [53]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-211, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [54]
RP   INTERACTION WITH EGFR.
RX   PubMed=19836242; DOI=10.1016/j.cub.2009.09.048;
RA   Tarcic G., Boguslavsky S.K., Wakim J., Kiuchi T., Liu A., Reinitz F.,
RA   Nathanson D., Takahashi T., Mischel P.S., Ng T., Yarden Y.;
RT   "An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase
RT   controlling EGFR endocytosis.";
RL   Curr. Biol. 19:1788-1798(2009).
RN   [55]
RP   INTERACTION WITH AXL; LTK; PDGFRL AND TNK2, AND FUNCTION.
RX   PubMed=19815557; DOI=10.1074/jbc.M109.072660;
RA   Pao-Chun L., Chan P.M., Chan W., Manser E.;
RT   "Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases
RT   is mediated by Grb2: an analysis of ACK1 effects on Axl signaling.";
RL   J. Biol. Chem. 284:34954-34963(2009).
RN   [56]
RP   INTERACTION WITH KIF26A.
RX   PubMed=19914172; DOI=10.1016/j.cell.2009.10.023;
RA   Zhou R., Niwa S., Homma N., Takei Y., Hirokawa N.;
RT   "KIF26A is an unconventional kinesin and regulates GDNF-Ret signaling
RT   in enteric neuronal development.";
RL   Cell 139:802-813(2009).
RN   [57]
RP   INTERACTION WITH GAREM1.
RX   PubMed=19509291; DOI=10.1074/jbc.M109.021139;
RA   Tashiro K., Tsunematsu T., Okubo H., Ohta T., Sano E., Yamauchi E.,
RA   Taniguchi H., Konishi H.;
RT   "GAREM, a novel adaptor protein for growth factor receptor-bound
RT   protein 2, contributes to cellular transformation through the
RT   activation of extracellular signal-regulated kinase signaling.";
RL   J. Biol. Chem. 284:20206-20214(2009).
RN   [58]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [59]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-6; LYS-50 AND LYS-109, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [60]
RP   INTERACTION WITH PTK2B/PYK2.
RX   PubMed=20521079; DOI=10.1007/s00018-010-0411-x;
RA   Shen X., Xi G., Radhakrishnan Y., Clemmons D.R.;
RT   "Recruitment of Pyk2 to SHPS-1 signaling complex is required for IGF-
RT   I-dependent mitogenic signaling in vascular smooth muscle cells.";
RL   Cell. Mol. Life Sci. 67:3893-3903(2010).
RN   [61]
RP   INTERACTION WITH PTPN23, AND SUBCELLULAR LOCATION.
RX   PubMed=21179510; DOI=10.1371/journal.pone.0014339;
RA   Tanase C.A.;
RT   "Histidine domain-protein tyrosine phosphatase interacts with Grb2 and
RT   GrpL.";
RL   PLoS ONE 5:E14339-E14339(2010).
RN   [62]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [63]
RP   INTERACTION WITH FCRL6.
RX   PubMed=20933011; DOI=10.1016/j.imlet.2010.09.023;
RA   Kulemzin S.V., Zamoshnikova A.Y., Yurchenko M.Y., Vitak N.Y.,
RA   Najakshin A.M., Fayngerts S.A., Chikaev N.A., Reshetnikova E.S.,
RA   Kashirina N.M., Peclo M.M., Rutkevich P.N., Shevelev A.Y.,
RA   Yanushevskaya E.V., Baranov K.O., Mamonkin M., Vlasik T.N.,
RA   Sidorenko S.P., Taranin A.V., Mechetina L.V.;
RT   "FCRL6 receptor: expression and associated proteins.";
RL   Immunol. Lett. 134:174-182(2011).
RN   [64]
RP   INTERACTION WITH ASAP3.
RX   PubMed=22027826; DOI=10.1074/jbc.M111.278770;
RA   Yu X., Wang F., Liu H., Adams G., Aikhionbare F., Liu D., Cao X.,
RA   Fan L., Hu G., Chen Y., Frost A., Partridge E., Ding X., Yao X.;
RT   "ACAP4 protein cooperates with Grb2 protein to orchestrate epidermal
RT   growth factor-stimulated integrin beta1 recycling in cell migration.";
RL   J. Biol. Chem. 286:43735-43747(2011).
RN   [65]
RP   INTERACTION WITH SCIMP.
RX   PubMed=21930792; DOI=10.1128/MCB.05817-11;
RA   Draber P., Vonkova I., Stepanek O., Hrdinka M., Kucova M.,
RA   Skopcova T., Otahal P., Angelisova P., Horejsi V., Yeung M., Weiss A.,
RA   Brdicka T.;
RT   "SCIMP, a transmembrane adapter protein involved in major
RT   histocompatibility complex class II signaling.";
RL   Mol. Cell. Biol. 31:4550-4562(2011).
RN   [66]
RP   INTERACTION WITH TESPA1.
RC   TISSUE=Thymocyte;
RX   PubMed=22561606; DOI=10.1038/ni.2301;
RA   Wang D., Zheng M., Lei L., Ji J., Yao Y., Qiu Y., Ma L., Lou J.,
RA   Ouyang C., Zhang X., He Y., Chi J., Wang L., Kuang Y., Wang J.,
RA   Cao X., Lu L.;
RT   "Tespa1 is involved in late thymocyte development through the
RT   regulation of TCR-mediated signaling.";
RL   Nat. Immunol. 13:560-568(2012).
RN   [67]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [68]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [69]
RP   INTERACTION WITH HERPES SIMPLEX VIRUS 1 UL46.
RX   PubMed=23946459; DOI=10.1128/JVI.01702-13;
RA   Strunk U., Saffran H.A., Wu F.W., Smiley J.R.;
RT   "Role of herpes simplex virus VP11/12 tyrosine-based motifs in binding
RT   and activation of the Src family kinase Lck and recruitment of p85,
RT   Grb2, and Shc.";
RL   J. Virol. 87:11276-11286(2013).
RN   [70]
RP   INTERACTION WITH RHEX.
RX   PubMed=25092874; DOI=10.1084/jem.20130624;
RA   Verma R., Su S., McCrann D.J., Green J.M., Leu K., Young P.R.,
RA   Schatz P.J., Silva J.C., Stokes M.P., Wojchowski D.M.;
RT   "RHEX, a novel regulator of human erythroid progenitor cell expansion
RT   and erythroblast development.";
RL   J. Exp. Med. 211:1715-1722(2014).
RN   [71]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [72]
RP   INTERACTION WITH PRR14.
RX   PubMed=27041574; DOI=10.1038/onc.2016.93;
RA   Yang M., Lewinska M., Fan X., Zhu J., Yuan Z.M.;
RT   "PRR14 is a novel activator of the PI3K pathway promoting lung
RT   carcinogenesis.";
RL   Oncogene 35:5527-5538(2016).
RN   [73]
RP   STRUCTURE BY NMR OF 58-164.
RX   PubMed=8794768; DOI=10.1021/bi952615s;
RA   Thornton K.H., Mueller W.T., McConnell P., Zhu G., Saltiel A.R.,
RA   Thanabal V.;
RT   "Nuclear magnetic resonance solution structure of the growth factor
RT   receptor-bound protein 2 Src homology 2 domain.";
RL   Biochemistry 35:11852-11864(1996).
RN   [74]
RP   STRUCTURE BY NMR OF 52-163.
RA   Senior M.M., Frederick A.F., Black S., Murgolo N.J., Perkins L.M.,
RA   Wilson O., Snow M.E., Wang Y.-S.;
RT   "The three-dimensional solution structure of the Src homology domain-2
RT   of the growth factor receptor-bound protein-2.";
RL   J. Biomol. NMR 11:153-164(1998).
RN   [75]
RP   STRUCTURE BY NMR OF 157-215.
RX   PubMed=7881903; DOI=10.1016/S0969-2126(94)00106-5;
RA   Kohda D., Terasawa H., Ichikawa S., Ogura K., Hatanaka H.,
RA   Mandiyan V., Ullrich A., Schlessinger J., Inagaki F.;
RT   "Solution structure and ligand-binding site of the carboxy-terminal
RT   SH3 domain of GRB2.";
RL   Structure 2:1029-1040(1994).
RN   [76]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS).
RX   PubMed=7716522; DOI=10.1126/science.7716522;
RA   Maignan S., Guilloteau J.-P., Fromage N., Arnoux B., Becquart J.,
RA   Ducruix A.;
RT   "Crystal structure of the mammalian Grb2 adaptor.";
RL   Science 268:291-293(1995).
RN   [77]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 56-153.
RX   PubMed=9642078; DOI=10.1006/jmbi.1998.1790;
RA   Rahuel J., Garcia-Echeverria C., Furet P., Strauss A., Caravatti G.,
RA   Fretz H., Schoepfer J., Gay B.;
RT   "Structural basis for the high affinity of amino-aromatic SH2
RT   phosphopeptide ligands.";
RL   J. Mol. Biol. 279:1013-1022(1998).
RN   [78]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 47-163.
RX   PubMed=10090780; DOI=10.1021/jm9811007;
RA   Ettmayer P., France D., Gounarides J., Jarosinski M., Martin M.-S.,
RA   Rondeau J.-M., Sabio M., Topiol S., Weidmann B., Zurini M., Bair K.W.;
RT   "Structural and conformational requirements for high-affinity binding
RT   to the SH2 domain of Grb2(1).";
RL   J. Med. Chem. 42:971-980(1999).
RN   [79]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 57-152.
RX   PubMed=10395476; DOI=10.1021/jm991013u;
RA   Furet P., Garcia-Echeverria C., Gay B., Schoepfer J., Zeller M.,
RA   Rahuel J.;
RT   "Structure-based design, synthesis, and X-ray crystallography of a
RT   high- affinity antagonist of the Grb2-SH2 domain containing an
RT   asparagine mimetic.";
RL   J. Med. Chem. 42:2358-2363(1999).
RN   [80]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 52-160 IN COMPLEX WITH MET.
RX   PubMed=11063574; DOI=10.1021/bi0012336;
RA   Schiering N., Casale E., Caccia P., Giordano P., Battistini C.;
RT   "Dimer formation through domain swapping in the crystal structure of
RT   the Grb2-SH2-Ac-pYVNV complex.";
RL   Biochemistry 39:13376-13382(2000).
RN   [81]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 56-151 IN COMPLEX WITH THE
RP   TYROSINE PHOSPHORYLATED PEPTIDE TYR-VAL-ASN-VAL-GLN-ASN AND IN COMPLEX
RP   WITH A PEPTIDE INHIBITOR.
RX   PubMed=11827484; DOI=10.1006/jmbi.2001.5299;
RA   Nioche P., Liu W.-Q., Broutin I., Charbonnier F., Latreille M.-T.,
RA   Vidal M., Roques B., Garbay C., Ducruix A.;
RT   "Crystal structures of the SH2 domain of Grb2: highlight on the
RT   binding of a new high-affinity inhibitor.";
RL   J. Mol. Biol. 315:1167-1177(2002).
RN   [82]
RP   X-RAY CRYSTALLOGRAPHY (1.58 ANGSTROMS) OF 158-211 IN COMPLEX WITH
RP   GAB2.
RX   PubMed=19523899; DOI=10.1016/j.str.2009.03.017;
RA   Harkiolaki M., Tsirka T., Lewitzky M., Simister P.C., Joshi D.,
RA   Bird L.E., Jones E.Y., O'Reilly N., Feller S.M.;
RT   "Distinct binding modes of two epitopes in Gab2 that interact with the
RT   SH3C domain of Grb2.";
RL   Structure 17:809-822(2009).
RN   [83]
RP   X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) OF 60-152 IN COMPLEX WITH CD28,
RP   AND INTERACTION WITH CD28.
RX   PubMed=24098653; DOI=10.1371/journal.pone.0074482;
RA   Higo K., Ikura T., Oda M., Morii H., Takahashi J., Abe R., Ito N.;
RT   "High resolution crystal structure of the Grb2 SH2 domain with a
RT   phosphopeptide derived from CD28.";
RL   PLoS ONE 8:E74482-E74482(2013).
CC   -!- FUNCTION: Adapter protein that provides a critical link between
CC       cell surface growth factor receptors and the Ras signaling
CC       pathway.
CC   -!- FUNCTION: Isoform 2 does not bind to phosphorylated epidermal
CC       growth factor receptor (EGFR) but inhibits EGF-induced
CC       transactivation of a RAS-responsive element. Isoform 2 acts as a
CC       dominant negative protein over GRB2 and by suppressing
CC       proliferative signals, may trigger active programmed cell death.
CC   -!- SUBUNIT: Associates (via SH2 domain) with activated EGF and PDGF
CC       receptors (tyrosine phosphorylated) (PubMed:10026169,
CC       PubMed:19836242). Interacts with PDGFRA (tyrosine phosphorylated);
CC       the interaction may be indirect (By similarity). Also associates
CC       to other cellular Tyr-phosphorylated proteins such as SIT1, IRS1,
CC       IRS4, SHC and LNK; probably via the concerted action of both its
CC       SH2 and SH3 domains (PubMed:8388384, PubMed:8491186,
CC       PubMed:9553137, PubMed:11433379). It also seems to interact with
CC       RAS in the signaling pathway leading to DNA synthesis. Interacts
CC       with SOS1 (PubMed:8493579, PubMed:7664271). Forms a complex with
CC       MUC1 and SOS1, through interaction of the SH3 domains with SOS1
CC       and the SH2 domain with phosphorylated MUC1 (PubMed:7664271).
CC       Interacts with phosphorylated MET (PubMed:11063574,
CC       PubMed:11827484). Interacts with phosphorylated TOM1L1 (By
CC       similarity). Interacts with the phosphorylated C-terminus of SH2B2
CC       (PubMed:9233773). Interacts with phosphorylated SIT1, LAX1, LAT,
CC       LAT2 and LIME1 upon TCR and/or BCR activation (By similarity)
CC       (PubMed:9489702, PubMed:12359715, PubMed:12486104,
CC       PubMed:12514734). Interacts with NISCH, PTPNS1 and REPS2
CC       (PubMed:9062191, PubMed:9422736, PubMed:11912194). Interacts with
CC       syntrophin SNTA1 (By similarity). Interacts (via SH3 domains) with
CC       REPS1 (By similarity). Interacts (via SH3 domains) with PIK3C2B
CC       (PubMed:11533253). Interacts with CBL and CBLB (PubMed:10022120,
CC       PubMed:10086340). Interacts with AJUBA and CLNK (By similarity).
CC       Interacts (via SH2 domain) with TEK/TIE2 (tyrosine phosphorylated)
CC       (By similarity). Interacts with SHB, INPP5D/SHIP1, SKAP1 and SKAP2
CC       (PubMed:8723348, PubMed:9108392, PubMed:9484780, PubMed:10942756,
CC       PubMed:12171928). Interacts with PTPN11 (By similarity). Interacts
CC       with PRNP (By similarity). Interacts with RALGPS1
CC       (PubMed:10747847). Interacts with HCST (PubMed:16582911).
CC       Interacts with KDR (By similarity). Interacts with FLT1 (tyrosine-
CC       phosphorylated) (By similarity). Interacts with GAPT and PTPRE
CC       (PubMed:10980613, PubMed:18559951). Interacts (via SH2 domain)
CC       with KIF26A (PubMed:19914172). Interacts (via SH3 2) with GAB2
CC       (PubMed:19523899). Interacts with ADAM15 (PubMed:18296648).
CC       Interacts with THEMIS2 (By similarity). Interacts (via SH2 domain)
CC       with AXL (phosphorylated) (PubMed:9178760, PubMed:19815557).
CC       Interacts (via SH2 domain) with KIT (phosphorylated)
CC       (PubMed:15526160, PubMed:16129412). Interacts with PTPRJ and BCR
CC       (PubMed:12475979, PubMed:15302586). Interacts with PTPN23
CC       (PubMed:21179510). Interacts with FLT4 (tyrosine phosphorylated)
CC       (PubMed:15102829). Interacts with EPHB1 and SHC1; activates the
CC       MAPK/ERK cascade to regulate cell migration (PubMed:8798570,
CC       PubMed:12925710). Part of a complex including TNK2, GRB2, LTK and
CC       one receptor tyrosine kinase (RTK) such as AXL and PDGFRL, in
CC       which GRB2 promotes RTK recruitment by TNK2 (PubMed:9178760,
CC       PubMed:19815557). Interacts (via SH2 domain) with CSF1R (tyrosine
CC       phosphorylated) (PubMed:8262059). Interacts with ERBB4
CC       (PubMed:10867024). Interacts with NTRK1 (phosphorylated upon
CC       ligand-binding) (PubMed:15488758). Interacts with PTK2/FAK1
CC       (tyrosine phosphorylated) (PubMed:9148935). Interacts with
CC       PTK2B/PYK2 (tyrosine phosphorylated) (PubMed:20521079). Isoform 1
CC       interacts with SCIMP (PubMed:21930792). Interacts (via SH3
CC       domains) with GAREM1 isoform 1 (via proline-rich domain and
CC       tyrosine phosphorylated); the interaction occurs upon EGF
CC       stimulation (PubMed:19509291). Interacts with DAB2 (By
CC       similarity). Interacts with TESPA1 (PubMed:22561606). Interacts
CC       with PLCG1, LAT and THEMIS upon TCR activation in thymocytes; the
CC       association is weaker in the absence of TESPA1 (By similarity).
CC       Interacts with CD28 (PubMed:24098653). Interacts with RAB13; may
CC       recruit RAB13 to the leading edge of migrating endothelial cells
CC       where it can activate RHOA (By similarity). Interacts with ASAP3
CC       (phosphorylated form) (PubMed:22027826). Interacts (via SH3
CC       domain) with HEV ORF3 protein (PubMed:11518702). Interacts with
CC       HCV NS5A via its SH3 domains (PubMed:10318918). Interacts with
CC       herpes simplex virus 1 UL46 (PubMed:23946459). Interacts (via SH2
CC       domain) with PTPRH (phosphorylated form) (By similarity).
CC       Interacts with PTPRO (phosphorylated form) (By similarity).
CC       Interacts with PTPRB (phosphorylated form) (By similarity).
CC       Interacts (via SH3 domain 2) with PRR14 (via proline-rich region)
CC       (PubMed:27041574). Interacts with FCRL6 (tyrosine phosphorylated
CC       form) (PubMed:20933011). Interacts with RHEX (via tyrosine-
CC       phosphorylated form) (PubMed:25092874).
CC       {ECO:0000250|UniProtKB:Q60631, ECO:0000269|PubMed:10022120,
CC       ECO:0000269|PubMed:10026169, ECO:0000269|PubMed:10086340,
CC       ECO:0000269|PubMed:10318918, ECO:0000269|PubMed:10747847,
CC       ECO:0000269|PubMed:10867024, ECO:0000269|PubMed:10942756,
CC       ECO:0000269|PubMed:10980613, ECO:0000269|PubMed:11063574,
CC       ECO:0000269|PubMed:11433379, ECO:0000269|PubMed:11518702,
CC       ECO:0000269|PubMed:11533253, ECO:0000269|PubMed:11827484,
CC       ECO:0000269|PubMed:11912194, ECO:0000269|PubMed:12171928,
CC       ECO:0000269|PubMed:12359715, ECO:0000269|PubMed:12475979,
CC       ECO:0000269|PubMed:12486104, ECO:0000269|PubMed:12514734,
CC       ECO:0000269|PubMed:12925710, ECO:0000269|PubMed:15102829,
CC       ECO:0000269|PubMed:15302586, ECO:0000269|PubMed:15488758,
CC       ECO:0000269|PubMed:16582911, ECO:0000269|PubMed:18296648,
CC       ECO:0000269|PubMed:18559951, ECO:0000269|PubMed:19509291,
CC       ECO:0000269|PubMed:19523899, ECO:0000269|PubMed:19815557,
CC       ECO:0000269|PubMed:19836242, ECO:0000269|PubMed:19914172,
CC       ECO:0000269|PubMed:20521079, ECO:0000269|PubMed:20933011,
CC       ECO:0000269|PubMed:21179510, ECO:0000269|PubMed:21930792,
CC       ECO:0000269|PubMed:22027826, ECO:0000269|PubMed:22561606,
CC       ECO:0000269|PubMed:23946459, ECO:0000269|PubMed:24098653,
CC       ECO:0000269|PubMed:25092874, ECO:0000269|PubMed:27041574,
CC       ECO:0000269|PubMed:7664271, ECO:0000269|PubMed:8262059,
CC       ECO:0000269|PubMed:8388384, ECO:0000269|PubMed:8491186,
CC       ECO:0000269|PubMed:8493579, ECO:0000269|PubMed:8723348,
CC       ECO:0000269|PubMed:8798570, ECO:0000269|PubMed:9062191,
CC       ECO:0000269|PubMed:9108392, ECO:0000269|PubMed:9148935,
CC       ECO:0000269|PubMed:9178760, ECO:0000269|PubMed:9233773,
CC       ECO:0000269|PubMed:9422736, ECO:0000269|PubMed:9484780,
CC       ECO:0000269|PubMed:9489702, ECO:0000269|PubMed:9553137}.
CC   -!- INTERACTION:
CC       Self; NbExp=5; IntAct=EBI-401755, EBI-401755;
CC       O92972:- (xeno); NbExp=2; IntAct=EBI-401755, EBI-710506;
CC       P26662:- (xeno); NbExp=3; IntAct=EBI-401755, EBI-9099462;
CC       P27958:- (xeno); NbExp=3; IntAct=EBI-401755, EBI-706378;
CC       Q9P2A4:ABI3; NbExp=3; IntAct=EBI-401755, EBI-742038;
CC       P42684:ABL2; NbExp=2; IntAct=EBI-401755, EBI-1102694;
CC       Q15027:ACAP1; NbExp=3; IntAct=EBI-401755, EBI-751746;
CC       Q13444:ADAM15; NbExp=3; IntAct=EBI-401755, EBI-77818;
CC       Q08117:AES; NbExp=3; IntAct=EBI-401755, EBI-717810;
CC       Q15109:AGER; NbExp=2; IntAct=EBI-401755, EBI-1646426;
CC       Q01484:ANK2; NbExp=2; IntAct=EBI-401755, EBI-941975;
CC       Q9BRR9:ARHGAP9; NbExp=3; IntAct=EBI-401755, EBI-750254;
CC       Q12774:ARHGEF5; NbExp=4; IntAct=EBI-401755, EBI-602199;
CC       Q66PJ3-4:ARL6IP4; NbExp=2; IntAct=EBI-401755, EBI-5280499;
CC       Q9ULH1:ASAP1; NbExp=7; IntAct=EBI-401755, EBI-346622;
CC       O43150:ASAP2; NbExp=3; IntAct=EBI-401755, EBI-310968;
CC       P30530:AXL; NbExp=3; IntAct=EBI-401755, EBI-2850927;
CC       P11274:BCR; NbExp=8; IntAct=EBI-401755, EBI-712838;
CC       Q8WV28:BLNK; NbExp=4; IntAct=EBI-401755, EBI-2623522;
CC       O60885:BRD4; NbExp=2; IntAct=EBI-401755, EBI-723869;
CC       Q6P1W5:C1orf94; NbExp=3; IntAct=EBI-401755, EBI-946029;
CC       P22681:CBL; NbExp=10; IntAct=EBI-401755, EBI-518228;
CC       Q13191:CBLB; NbExp=10; IntAct=EBI-401755, EBI-744027;
CC       Q9Y5K6:CD2AP; NbExp=3; IntAct=EBI-401755, EBI-298152;
CC       P98082:DAB2; NbExp=2; IntAct=EBI-401755, EBI-1171238;
CC       P98078:Dab2 (xeno); NbExp=4; IntAct=EBI-401755, EBI-1391846;
CC       P14868:DARS; NbExp=2; IntAct=EBI-401755, EBI-358730;
CC       Q16643:DBN1; NbExp=4; IntAct=EBI-401755, EBI-351394;
CC       Q92841:DDX17; NbExp=3; IntAct=EBI-401755, EBI-746012;
CC       O14490:DLGAP1; NbExp=3; IntAct=EBI-401755, EBI-1753207;
CC       Q9P1A6:DLGAP2; NbExp=2; IntAct=EBI-401755, EBI-1753397;
CC       Q9Y2H0:DLGAP4; NbExp=2; IntAct=EBI-401755, EBI-722139;
CC       Q05193:DNM1; NbExp=3; IntAct=EBI-401755, EBI-713135;
CC       P50570:DNM2; NbExp=6; IntAct=EBI-401755, EBI-346547;
CC       Q14185:DOCK1; NbExp=2; IntAct=EBI-401755, EBI-446740;
CC       Q7L190:DPPA4; NbExp=3; IntAct=EBI-401755, EBI-710457;
CC       Q8N9I9:DTX3; NbExp=4; IntAct=EBI-401755, EBI-2340258;
CC       P00533:EGFR; NbExp=36; IntAct=EBI-401755, EBI-297353;
CC       P54762:EPHB1; NbExp=2; IntAct=EBI-401755, EBI-80252;
CC       Q12929:EPS8; NbExp=3; IntAct=EBI-401755, EBI-375576;
CC       P04626:ERBB2; NbExp=4; IntAct=EBI-401755, EBI-641062;
CC       P21860:ERBB3; NbExp=3; IntAct=EBI-401755, EBI-720706;
CC       Q9UJM3:ERRFI1; NbExp=12; IntAct=EBI-401755, EBI-2941912;
CC       B7ZLH0:FAM22F; NbExp=5; IntAct=EBI-401755, EBI-10220102;
CC       O15360:FANCA; NbExp=2; IntAct=EBI-401755, EBI-81570;
CC       P21802:FGFR2; NbExp=5; IntAct=EBI-401755, EBI-1028658;
CC       P21333:FLNA; NbExp=2; IntAct=EBI-401755, EBI-350432;
CC       O75369:FLNB; NbExp=2; IntAct=EBI-401755, EBI-352089;
CC       Q14315:FLNC; NbExp=2; IntAct=EBI-401755, EBI-489954;
CC       Q13480:GAB1; NbExp=5; IntAct=EBI-401755, EBI-517684;
CC       Q9UQC2:GAB2; NbExp=10; IntAct=EBI-401755, EBI-975200;
CC       Q9UQC2-1:GAB2; NbExp=3; IntAct=EBI-15787932, EBI-15787947;
CC       Q9H706:GAREM1; NbExp=8; IntAct=EBI-401755, EBI-3440103;
CC       P61978:HNRNPK; NbExp=9; IntAct=EBI-401755, EBI-304185;
CC       Q8IX15-3:HOMEZ; NbExp=3; IntAct=EBI-401755, EBI-10172004;
CC       Q9UKT9:IKZF3; NbExp=7; IntAct=EBI-401755, EBI-747204;
CC       Q0VD86:INCA1; NbExp=3; IntAct=EBI-401755, EBI-6509505;
CC       P35570:Irs1 (xeno); NbExp=5; IntAct=EBI-401755, EBI-520230;
CC       Q07666:KHDRBS1; NbExp=8; IntAct=EBI-401755, EBI-1364;
CC       P10721:KIT; NbExp=6; IntAct=EBI-401755, EBI-1379503;
CC       P05787:KRT8; NbExp=3; IntAct=EBI-401755, EBI-297852;
CC       O43561:LAT; NbExp=7; IntAct=EBI-401755, EBI-1222766;
CC       O43561-2:LAT; NbExp=3; IntAct=EBI-15787932, EBI-8070286;
CC       Q13094:LCP2; NbExp=14; IntAct=EBI-401755, EBI-346946;
CC       P48357:LEPR; NbExp=3; IntAct=EBI-401755, EBI-518596;
CC       P25791:LMO2; NbExp=3; IntAct=EBI-401755, EBI-739696;
CC       Q8TE12:LMX1A; NbExp=3; IntAct=EBI-401755, EBI-10692065;
CC       Q8TBB1:LNX1; NbExp=3; IntAct=EBI-401755, EBI-739832;
CC       Q9BRK4:LZTS2; NbExp=3; IntAct=EBI-401755, EBI-741037;
CC       Q13163:MAP2K5; NbExp=2; IntAct=EBI-401755, EBI-307294;
CC       Q92918:MAP4K1; NbExp=8; IntAct=EBI-401755, EBI-881;
CC       Q8IVH8:MAP4K3; NbExp=2; IntAct=EBI-401755, EBI-1758170;
CC       Q9Y4K4:MAP4K5; NbExp=4; IntAct=EBI-401755, EBI-1279;
CC       Q9H204:MED28; NbExp=3; IntAct=EBI-401755, EBI-514199;
CC       P35579:MYH9; NbExp=3; IntAct=EBI-401755, EBI-350338;
CC       Q8WX92:NELFB; NbExp=2; IntAct=EBI-401755, EBI-347721;
CC       Q9GZT8:NIF3L1; NbExp=3; IntAct=EBI-401755, EBI-740897;
CC       Q13177:PAK2; NbExp=2; IntAct=EBI-401755, EBI-1045887;
CC       Q9NPB6-2:PARD6A; NbExp=3; IntAct=EBI-401755, EBI-10693102;
CC       O00750:PIK3C2B; NbExp=2; IntAct=EBI-401755, EBI-641107;
CC       P27986:PIK3R1; NbExp=4; IntAct=EBI-401755, EBI-79464;
CC       O00459:PIK3R2; NbExp=4; IntAct=EBI-401755, EBI-346930;
CC       P19174:PLCG1; NbExp=2; IntAct=EBI-401755, EBI-79387;
CC       O14939:PLD2; NbExp=4; IntAct=EBI-401755, EBI-1053996;
CC       Q5SXH7:PLEKHS1; NbExp=3; IntAct=EBI-401755, EBI-10691507;
CC       Q96PV4:PNMA5; NbExp=3; IntAct=EBI-401755, EBI-10171633;
CC       Q07869:PPARA; NbExp=3; IntAct=EBI-401755, EBI-78615;
CC       Q08209:PPP3CA; NbExp=3; IntAct=EBI-401755, EBI-352922;
CC       Q9Y478:PRKAB1; NbExp=2; IntAct=EBI-401755, EBI-719769;
CC       P34152:Ptk2 (xeno); NbExp=3; IntAct=EBI-401755, EBI-77070;
CC       P18031:PTPN1; NbExp=2; IntAct=EBI-401755, EBI-968788;
CC       Q06124:PTPN11; NbExp=6; IntAct=EBI-401755, EBI-297779;
CC       P35235:Ptpn11 (xeno); NbExp=7; IntAct=EBI-401755, EBI-397236;
CC       Q9Y2R2:PTPN22; NbExp=2; IntAct=EBI-401755, EBI-1211241;
CC       Q9H3S7:PTPN23; NbExp=6; IntAct=EBI-401755, EBI-724478;
CC       P29350:PTPN6; NbExp=3; IntAct=EBI-401755, EBI-78260;
CC       P18433:PTPRA; NbExp=8; IntAct=EBI-401755, EBI-2609645;
CC       O14522:PTPRT; NbExp=2; IntAct=EBI-401755, EBI-728180;
CC       P06400:RB1; NbExp=4; IntAct=EBI-401755, EBI-491274;
CC       Q04864:REL; NbExp=3; IntAct=EBI-401755, EBI-307352;
CC       Q8NFH8-2:REPS2; NbExp=8; IntAct=EBI-401755, EBI-8029141;
CC       Q15427:SF3B4; NbExp=2; IntAct=EBI-401755, EBI-348469;
CC       Q9H788:SH2D4A; NbExp=3; IntAct=EBI-401755, EBI-747035;
CC       Q9UPX8:SHANK2; NbExp=2; IntAct=EBI-401755, EBI-1570571;
CC       Q9BYB0:SHANK3; NbExp=2; IntAct=EBI-401755, EBI-1752330;
CC       P29353:SHC1; NbExp=23; IntAct=EBI-401755, EBI-78835;
CC       P29353-1:SHC1; NbExp=3; IntAct=EBI-401755, EBI-8160716;
CC       Q8WXH5:SOCS4; NbExp=3; IntAct=EBI-401755, EBI-3942425;
CC       Q07889:SOS1; NbExp=22; IntAct=EBI-401755, EBI-297487;
CC       Q62245:Sos1 (xeno); NbExp=4; IntAct=EBI-401755, EBI-1693;
CC       Q07890:SOS2; NbExp=8; IntAct=EBI-401755, EBI-298181;
CC       O43597:SPRY2; NbExp=3; IntAct=EBI-401755, EBI-742487;
CC       O43295:SRGAP3; NbExp=2; IntAct=EBI-401755, EBI-368166;
CC       O95630:STAMBP; NbExp=9; IntAct=EBI-401755, EBI-396676;
CC       O15056:SYNJ2; NbExp=2; IntAct=EBI-401755, EBI-310513;
CC       Q8N1K5:THEMIS; NbExp=10; IntAct=EBI-401755, EBI-2873538;
CC       Q8N1K5-1:THEMIS; NbExp=10; IntAct=EBI-401755, EBI-15102259;
CC       Q5BJH2-2:TMEM128; NbExp=3; IntAct=EBI-401755, EBI-10694905;
CC       Q92973:TNPO1; NbExp=2; IntAct=EBI-401755, EBI-286693;
CC       O75674:TOM1L1; NbExp=2; IntAct=EBI-401755, EBI-712991;
CC       Q13625-3:TP53BP2; NbExp=3; IntAct=EBI-401755, EBI-10175039;
CC       Q9ULW0:TPX2; NbExp=2; IntAct=EBI-401755, EBI-1037322;
CC       P14373:TRIM27; NbExp=3; IntAct=EBI-401755, EBI-719493;
CC       O60636:TSPAN2; NbExp=6; IntAct=EBI-401755, EBI-3914288;
CC       Q16851:UGP2; NbExp=2; IntAct=EBI-401755, EBI-743729;
CC       P15498:VAV1; NbExp=2; IntAct=EBI-401755, EBI-625518;
CC       Q9UKW4:VAV3; NbExp=7; IntAct=EBI-401755, EBI-297568;
CC       P55072:VCP; NbExp=3; IntAct=EBI-401755, EBI-355164;
CC       O00401:WASL; NbExp=8; IntAct=EBI-401755, EBI-957615;
CC       Q9Y2W2:WBP11; NbExp=4; IntAct=EBI-401755, EBI-714455;
CC       O43516:WIPF1; NbExp=3; IntAct=EBI-401755, EBI-346356;
CC       Q8TF74:WIPF2; NbExp=3; IntAct=EBI-401755, EBI-2850112;
CC       O15156:ZBTB7B; NbExp=3; IntAct=EBI-401755, EBI-740434;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21179510}.
CC       Cytoplasm {ECO:0000269|PubMed:21179510}. Endosome
CC       {ECO:0000269|PubMed:21179510}. Golgi apparatus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=Ash-L;
CC         IsoId=P62993-1, P29354-1;
CC         Sequence=Displayed;
CC       Name=2; Synonyms=GRB3-3;
CC         IsoId=P62993-2, P29354-2;
CC         Sequence=VSP_001839;
CC   -!- DOMAIN: The SH3 domains mediate interaction with RALGPS1 and SHB.
CC   -!- SIMILARITY: Belongs to the GRB2/sem-5/DRK family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GRB2ID386ch17q25.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M96995; AAA58448.1; -; mRNA.
DR   EMBL; X62852; CAA44664.1; -; mRNA.
DR   EMBL; L29511; AAC37549.1; -; mRNA.
DR   EMBL; AF063618; AAC72075.1; -; Genomic_DNA.
DR   EMBL; AF063614; AAC72075.1; JOINED; Genomic_DNA.
DR   EMBL; AF063615; AAC72075.1; JOINED; Genomic_DNA.
DR   EMBL; AF063616; AAC72075.1; JOINED; Genomic_DNA.
DR   EMBL; AF063617; AAC72075.1; JOINED; Genomic_DNA.
DR   EMBL; AF498925; AAM21073.1; -; mRNA.
DR   EMBL; CR541942; CAG46740.1; -; mRNA.
DR   EMBL; AC011933; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000631; AAH00631.1; -; mRNA.
DR   CCDS; CCDS11721.1; -.
DR   CCDS; CCDS11722.1; -. [P62993-2]
DR   PIR; A43321; A43321.
DR   RefSeq; NP_002077.1; NM_002086.4. [P62993-1]
DR   RefSeq; NP_987102.1; NM_203506.2. [P62993-2]
DR   UniGene; Hs.444356; -.
DR   PDB; 1AZE; NMR; -; A=1-56.
DR   PDB; 1BM2; X-ray; 2.10 A; A=49-163.
DR   PDB; 1BMB; X-ray; 1.80 A; A=49-168.
DR   PDB; 1CJ1; X-ray; 3.00 A; A/B/C/D/E/F/G/H/I/J/K/L=57-152.
DR   PDB; 1FHS; NMR; -; A=53-163.
DR   PDB; 1FYR; X-ray; 2.40 A; A/B/C/D=50-161.
DR   PDB; 1GCQ; X-ray; 1.68 A; A/B=159-217.
DR   PDB; 1GFC; NMR; -; A=159-215.
DR   PDB; 1GFD; NMR; -; A=159-215.
DR   PDB; 1GHU; NMR; -; A=60-158.
DR   PDB; 1GRI; X-ray; 3.10 A; A/B=1-217.
DR   PDB; 1IO6; NMR; -; A=159-215.
DR   PDB; 1JYQ; X-ray; 2.00 A; A/B=60-151.
DR   PDB; 1JYR; X-ray; 1.55 A; A=60-151.
DR   PDB; 1JYU; X-ray; 2.75 A; A=60-151.
DR   PDB; 1QG1; NMR; -; E=58-159.
DR   PDB; 1TZE; X-ray; 2.10 A; E=55-152.
DR   PDB; 1X0N; NMR; -; A=58-159.
DR   PDB; 1ZFP; X-ray; 1.80 A; E=56-153.
DR   PDB; 2AOA; X-ray; 1.99 A; A/B=55-153.
DR   PDB; 2AOB; X-ray; 1.80 A; A/B/C/D=55-153.
DR   PDB; 2H46; X-ray; 1.90 A; E=53-162.
DR   PDB; 2H5K; X-ray; 3.25 A; A/B=53-162.
DR   PDB; 2HUW; X-ray; 1.90 A; A/B=53-162.
DR   PDB; 2VVK; X-ray; 1.60 A; A=161-214.
DR   PDB; 2VWF; X-ray; 1.58 A; A=159-214.
DR   PDB; 2W0Z; X-ray; 1.70 A; A=159-214.
DR   PDB; 3C7I; X-ray; 1.70 A; A=53-162.
DR   PDB; 3IMD; X-ray; 2.00 A; A/B=53-163.
DR   PDB; 3IMJ; X-ray; 2.02 A; A/B=53-163.
DR   PDB; 3IN7; X-ray; 2.00 A; A/C=53-163.
DR   PDB; 3IN8; X-ray; 1.70 A; A=53-163.
DR   PDB; 3KFJ; X-ray; 2.02 A; A=53-163.
DR   PDB; 3MXC; X-ray; 2.00 A; A=55-152.
DR   PDB; 3MXY; X-ray; 2.30 A; A=55-152.
DR   PDB; 3N7Y; X-ray; 2.02 A; A/B/C=55-152.
DR   PDB; 3N84; X-ray; 2.00 A; A/B/C/D/E/F=53-163.
DR   PDB; 3N8M; X-ray; 2.00 A; A=53-163.
DR   PDB; 3OV1; X-ray; 1.60 A; A=53-163.
DR   PDB; 3OVE; X-ray; 1.82 A; A=53-163.
DR   PDB; 3S8L; X-ray; 1.71 A; A=53-163.
DR   PDB; 3S8N; X-ray; 1.71 A; A=53-163.
DR   PDB; 3S8O; X-ray; 1.85 A; A=53-163.
DR   PDB; 3WA4; X-ray; 1.35 A; A=60-152.
DR   PDB; 4P9V; X-ray; 1.64 A; A=53-163.
DR   PDB; 4P9Z; X-ray; 1.80 A; A=53-163.
DR   PDB; 5CDW; X-ray; 2.60 A; A/B/C/E/G/H/K/L/O/P/U/V/Y/Z/c/d=54-153.
DR   PDBsum; 1AZE; -.
DR   PDBsum; 1BM2; -.
DR   PDBsum; 1BMB; -.
DR   PDBsum; 1CJ1; -.
DR   PDBsum; 1FHS; -.
DR   PDBsum; 1FYR; -.
DR   PDBsum; 1GCQ; -.
DR   PDBsum; 1GFC; -.
DR   PDBsum; 1GFD; -.
DR   PDBsum; 1GHU; -.
DR   PDBsum; 1GRI; -.
DR   PDBsum; 1IO6; -.
DR   PDBsum; 1JYQ; -.
DR   PDBsum; 1JYR; -.
DR   PDBsum; 1JYU; -.
DR   PDBsum; 1QG1; -.
DR   PDBsum; 1TZE; -.
DR   PDBsum; 1X0N; -.
DR   PDBsum; 1ZFP; -.
DR   PDBsum; 2AOA; -.
DR   PDBsum; 2AOB; -.
DR   PDBsum; 2H46; -.
DR   PDBsum; 2H5K; -.
DR   PDBsum; 2HUW; -.
DR   PDBsum; 2VVK; -.
DR   PDBsum; 2VWF; -.
DR   PDBsum; 2W0Z; -.
DR   PDBsum; 3C7I; -.
DR   PDBsum; 3IMD; -.
DR   PDBsum; 3IMJ; -.
DR   PDBsum; 3IN7; -.
DR   PDBsum; 3IN8; -.
DR   PDBsum; 3KFJ; -.
DR   PDBsum; 3MXC; -.
DR   PDBsum; 3MXY; -.
DR   PDBsum; 3N7Y; -.
DR   PDBsum; 3N84; -.
DR   PDBsum; 3N8M; -.
DR   PDBsum; 3OV1; -.
DR   PDBsum; 3OVE; -.
DR   PDBsum; 3S8L; -.
DR   PDBsum; 3S8N; -.
DR   PDBsum; 3S8O; -.
DR   PDBsum; 3WA4; -.
DR   PDBsum; 4P9V; -.
DR   PDBsum; 4P9Z; -.
DR   PDBsum; 5CDW; -.
DR   DisProt; DP00210; -.
DR   ProteinModelPortal; P62993; -.
DR   SMR; P62993; -.
DR   BioGrid; 109142; 542.
DR   CORUM; P62993; -.
DR   DIP; DIP-29229N; -.
DR   ELM; P62993; -.
DR   IntAct; P62993; 775.
DR   MINT; P62993; -.
DR   STRING; 9606.ENSP00000339007; -.
DR   BindingDB; P62993; -.
DR   ChEMBL; CHEMBL3663; -.
DR   DrugBank; DB00061; Pegademase bovine.
DR   iPTMnet; P62993; -.
DR   PhosphoSitePlus; P62993; -.
DR   BioMuta; GRB2; -.
DR   DMDM; 51702266; -.
DR   OGP; P62993; -.
DR   SWISS-2DPAGE; P62993; -.
DR   EPD; P62993; -.
DR   MaxQB; P62993; -.
DR   PaxDb; P62993; -.
DR   PeptideAtlas; P62993; -.
DR   PRIDE; P62993; -.
DR   TopDownProteomics; P62993-1; -. [P62993-1]
DR   TopDownProteomics; P62993-2; -. [P62993-2]
DR   DNASU; 2885; -.
DR   Ensembl; ENST00000316615; ENSP00000317360; ENSG00000177885. [P62993-2]
DR   Ensembl; ENST00000316804; ENSP00000339007; ENSG00000177885. [P62993-1]
DR   Ensembl; ENST00000392562; ENSP00000376345; ENSG00000177885. [P62993-1]
DR   Ensembl; ENST00000392563; ENSP00000376346; ENSG00000177885. [P62993-2]
DR   Ensembl; ENST00000392564; ENSP00000376347; ENSG00000177885. [P62993-1]
DR   GeneID; 2885; -.
DR   KEGG; hsa:2885; -.
DR   UCSC; uc002jnx.5; human.
DR   CTD; 2885; -.
DR   DisGeNET; 2885; -.
DR   EuPathDB; HostDB:ENSG00000177885.13; -.
DR   GeneCards; GRB2; -.
DR   HGNC; HGNC:4566; GRB2.
DR   HPA; CAB002589; -.
DR   HPA; HPA030749; -.
DR   HPA; HPA030750; -.
DR   MIM; 108355; gene.
DR   neXtProt; NX_P62993; -.
DR   OpenTargets; ENSG00000177885; -.
DR   PharmGKB; PA28962; -.
DR   eggNOG; KOG3601; Eukaryota.
DR   eggNOG; ENOG410XR1G; LUCA.
DR   GeneTree; ENSGT00820000126999; -.
DR   HOGENOM; HOG000251625; -.
DR   HOVERGEN; HBG005404; -.
DR   InParanoid; P62993; -.
DR   KO; K04364; -.
DR   OMA; HWWHGEI; -.
DR   OrthoDB; EOG091G0HWS; -.
DR   PhylomeDB; P62993; -.
DR   TreeFam; TF354288; -.
DR   Reactome; R-HSA-109704; PI3K Cascade.
DR   Reactome; R-HSA-112412; SOS-mediated signalling.
DR   Reactome; R-HSA-1236382; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants.
DR   Reactome; R-HSA-1250196; SHC1 events in ERBB2 signaling.
DR   Reactome; R-HSA-1250347; SHC1 events in ERBB4 signaling.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-1295596; Spry regulation of FGF signaling.
DR   Reactome; R-HSA-1433557; Signaling by SCF-KIT.
DR   Reactome; R-HSA-1433559; Regulation of KIT signaling.
DR   Reactome; R-HSA-167044; Signalling to RAS.
DR   Reactome; R-HSA-179812; GRB2 events in EGFR signaling.
DR   Reactome; R-HSA-180292; GAB1 signalosome.
DR   Reactome; R-HSA-180336; SHC1 events in EGFR signaling.
DR   Reactome; R-HSA-182971; EGFR downregulation.
DR   Reactome; R-HSA-1839117; Signaling by cytosolic FGFR1 fusion mutants.
DR   Reactome; R-HSA-186763; Downstream signal transduction.
DR   Reactome; R-HSA-1963640; GRB2 events in ERBB2 signaling.
DR   Reactome; R-HSA-1963642; PI3K events in ERBB2 signaling.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-210993; Tie2 Signaling.
DR   Reactome; R-HSA-2179392; EGFR Transactivation by Gastrin.
DR   Reactome; R-HSA-2219530; Constitutive Signaling by Aberrant PI3K in Cancer.
DR   Reactome; R-HSA-2424491; DAP12 signaling.
DR   Reactome; R-HSA-2428933; SHC-related events triggered by IGF1R.
DR   Reactome; R-HSA-2730905; Role of LAT2/NTAL/LAB on calcium mobilization.
DR   Reactome; R-HSA-2871796; FCERI mediated MAPK activation.
DR   Reactome; R-HSA-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-HSA-354194; GRB2:SOS provides linkage to MAPK signaling for Integrins.
DR   Reactome; R-HSA-375165; NCAM signaling for neurite out-growth.
DR   Reactome; R-HSA-388841; Costimulation by the CD28 family.
DR   Reactome; R-HSA-389359; CD28 dependent Vav1 pathway.
DR   Reactome; R-HSA-391160; Signal regulatory protein family interactions.
DR   Reactome; R-HSA-392451; G beta:gamma signalling through PI3Kgamma.
DR   Reactome; R-HSA-512988; Interleukin-3, 5 and GM-CSF signaling.
DR   Reactome; R-HSA-5637810; Constitutive Signaling by EGFRvIII.
DR   Reactome; R-HSA-5654688; SHC-mediated cascade:FGFR1.
DR   Reactome; R-HSA-5654689; PI-3K cascade:FGFR1.
DR   Reactome; R-HSA-5654693; FRS-mediated FGFR1 signaling.
DR   Reactome; R-HSA-5654695; PI-3K cascade:FGFR2.
DR   Reactome; R-HSA-5654699; SHC-mediated cascade:FGFR2.
DR   Reactome; R-HSA-5654700; FRS-mediated FGFR2 signaling.
DR   Reactome; R-HSA-5654704; SHC-mediated cascade:FGFR3.
DR   Reactome; R-HSA-5654706; FRS-mediated FGFR3 signaling.
DR   Reactome; R-HSA-5654710; PI-3K cascade:FGFR3.
DR   Reactome; R-HSA-5654712; FRS-mediated FGFR4 signaling.
DR   Reactome; R-HSA-5654719; SHC-mediated cascade:FGFR4.
DR   Reactome; R-HSA-5654720; PI-3K cascade:FGFR4.
DR   Reactome; R-HSA-5654726; Negative regulation of FGFR1 signaling.
DR   Reactome; R-HSA-5654727; Negative regulation of FGFR2 signaling.
DR   Reactome; R-HSA-5654732; Negative regulation of FGFR3 signaling.
DR   Reactome; R-HSA-5654733; Negative regulation of FGFR4 signaling.
DR   Reactome; R-HSA-5655253; Signaling by FGFR2 in disease.
DR   Reactome; R-HSA-5655291; Signaling by FGFR4 in disease.
DR   Reactome; R-HSA-5655302; Signaling by FGFR1 in disease.
DR   Reactome; R-HSA-5663213; RHO GTPases Activate WASPs and WAVEs.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-HSA-6807004; Negative regulation of MET activity.
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-HSA-74749; Signal attenuation.
DR   Reactome; R-HSA-74751; Insulin receptor signalling cascade.
DR   Reactome; R-HSA-8851805; MET activates RAS signaling.
DR   Reactome; R-HSA-8851907; MET activates PI3K/AKT signaling.
DR   Reactome; R-HSA-8853334; Signaling by FGFR3 fusions in cancer.
DR   Reactome; R-HSA-8853338; Signaling by FGFR3 point mutants in cancer.
DR   Reactome; R-HSA-8853659; RET signaling.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8865999; MET activates PTPN11.
DR   Reactome; R-HSA-8875360; InlB-mediated entry of Listeria monocytogenes into host cell.
DR   Reactome; R-HSA-8875555; MET activates RAP1 and RAC1.
DR   Reactome; R-HSA-8875656; MET receptor recycling.
DR   Reactome; R-HSA-8983432; Interleukin-15 signaling.
DR   Reactome; R-HSA-9026519; Activated NTRK2 signals through RAS.
DR   Reactome; R-HSA-9028335; Activated NTRK2 signals through PI3K.
DR   Reactome; R-HSA-9028731; Activated NTRK2 signals through FRS2 and FRS3.
DR   Reactome; R-HSA-912526; Interleukin receptor SHC signaling.
DR   Reactome; R-HSA-912631; Regulation of signaling by CBL.
DR   Reactome; R-HSA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   SignaLink; P62993; -.
DR   SIGNOR; P62993; -.
DR   ChiTaRS; GRB2; human.
DR   EvolutionaryTrace; P62993; -.
DR   GeneWiki; GRB2; -.
DR   GenomeRNAi; 2885; -.
DR   PRO; PR:P62993; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000177885; -.
DR   CleanEx; HS_GRB2; -.
DR   ExpressionAtlas; P62993; baseline and differential.
DR   Genevisible; P62993; HS.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0008180; C:COP9 signalosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:HGNC.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0070436; C:Grb2-EGFR complex; IDA:BHF-UCL.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0012506; C:vesicle membrane; IEA:Ensembl.
DR   GO; GO:0016303; F:1-phosphatidylinositol-3-kinase activity; TAS:Reactome.
DR   GO; GO:0046875; F:ephrin receptor binding; IPI:UniProtKB.
DR   GO; GO:0005154; F:epidermal growth factor receptor binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0043560; F:insulin receptor substrate binding; IPI:UniProtKB.
DR   GO; GO:0005168; F:neurotrophin TRKA receptor binding; IPI:UniProtKB.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0046934; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; TAS:Reactome.
DR   GO; GO:0001784; F:phosphotyrosine residue binding; IPI:CAFA.
DR   GO; GO:0019901; F:protein kinase binding; IPI:BHF-UCL.
DR   GO; GO:0019903; F:protein phosphatase binding; IEA:Ensembl.
DR   GO; GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; IDA:UniProtKB.
DR   GO; GO:0005070; F:SH3/SH2 adaptor activity; TAS:UniProtKB.
DR   GO; GO:0048646; P:anatomical structure formation involved in morphogenesis; IEA:Ensembl.
DR   GO; GO:0007411; P:axon guidance; TAS:Reactome.
DR   GO; GO:0060670; P:branching involved in labyrinthine layer morphogenesis; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0016477; P:cell migration; IBA:GO_Central.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:UniProtKB.
DR   GO; GO:0071479; P:cellular response to ionizing radiation; IMP:BHF-UCL.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0035635; P:entry of bacterium into host cell; TAS:Reactome.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:UniProtKB.
DR   GO; GO:0038128; P:ERBB2 signaling pathway; TAS:Reactome.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; IPI:UniProtKB.
DR   GO; GO:0035723; P:interleukin-15-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IBA:GO_Central.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; IEA:Ensembl.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; TAS:Reactome.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IMP:BHF-UCL.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0007265; P:Ras protein signal transduction; TAS:UniProtKB.
DR   GO; GO:0031623; P:receptor internalization; IMP:BHF-UCL.
DR   GO; GO:0042127; P:regulation of cell proliferation; IBA:GO_Central.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IEA:Ensembl.
DR   GO; GO:0042770; P:signal transduction in response to DNA damage; IMP:BHF-UCL.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd11949; SH3_GRB2_C; 1.
DR   CDD; cd11946; SH3_GRB2_N; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR030219; Grb2.
DR   InterPro; IPR035643; GRB2_C_SH3.
DR   InterPro; IPR035641; GRB2_N_SH3.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR24418:SF290; PTHR24418:SF290; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 2.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 2.
DR   SUPFAM; SSF50044; SSF50044; 2.
DR   SUPFAM; SSF55550; SSF55550; 2.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Endosome; Golgi apparatus;
KW   Host-virus interaction; Nucleus; Phosphoprotein; Reference proteome;
KW   Repeat; SH2 domain; SH3 domain.
FT   CHAIN         1    217       Growth factor receptor-bound protein 2.
FT                                /FTId=PRO_0000088198.
FT   DOMAIN        1     58       SH3 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   DOMAIN       60    152       SH2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00191}.
FT   DOMAIN      156    215       SH3 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES       6      6       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      50     50       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     109    109       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     211    211       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VAR_SEQ      60    100       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:8178156}.
FT                                /FTId=VSP_001839.
FT   MUTAGEN      49     49       P->L: Ineffective in DNA synthesis.
FT                                Abolishes interaction with SHB; when
FT                                associated with L-206. Abolishes
FT                                interaction with SOS1.
FT                                {ECO:0000269|PubMed:1322798,
FT                                ECO:0000269|PubMed:8493579,
FT                                ECO:0000269|PubMed:9484780}.
FT   MUTAGEN      89     89       E->K: No effect on the interaction with
FT                                SOS1. {ECO:0000269|PubMed:8493579}.
FT   MUTAGEN      90     90       S->N: No effect on the interaction with
FT                                SOS1. {ECO:0000269|PubMed:8493579}.
FT   MUTAGEN     203    203       G->R: Ineffective in DNA synthesis.
FT                                Abolishes interaction with SOS1.
FT                                {ECO:0000269|PubMed:1322798,
FT                                ECO:0000269|PubMed:8493579}.
FT   MUTAGEN     206    206       P->L: Abolishes interaction with SHB;
FT                                when associated with L-49.
FT                                {ECO:0000269|PubMed:9484780}.
FT   STRAND        2      5       {ECO:0000244|PDB:1GRI}.
FT   STRAND       13     15       {ECO:0000244|PDB:1GRI}.
FT   STRAND       24     26       {ECO:0000244|PDB:1GRI}.
FT   STRAND       36     43       {ECO:0000244|PDB:1GRI}.
FT   STRAND       45     49       {ECO:0000244|PDB:1GRI}.
FT   HELIX        50     52       {ECO:0000244|PDB:1GRI}.
FT   STRAND       61     64       {ECO:0000244|PDB:3IMD}.
FT   HELIX        67     75       {ECO:0000244|PDB:3WA4}.
FT   STRAND       78     80       {ECO:0000244|PDB:1FHS}.
FT   STRAND       82     87       {ECO:0000244|PDB:3WA4}.
FT   TURN         89     93       {ECO:0000244|PDB:3WA4}.
FT   STRAND       95    101       {ECO:0000244|PDB:3WA4}.
FT   STRAND      104    112       {ECO:0000244|PDB:3WA4}.
FT   STRAND      114    116       {ECO:0000244|PDB:1GRI}.
FT   STRAND      118    122       {ECO:0000244|PDB:3WA4}.
FT   STRAND      124    127       {ECO:0000244|PDB:3WA4}.
FT   HELIX       128    134       {ECO:0000244|PDB:3WA4}.
FT   TURN        135    137       {ECO:0000244|PDB:3WA4}.
FT   STRAND      142    144       {ECO:0000244|PDB:3WA4}.
FT   STRAND      149    152       {ECO:0000244|PDB:1FHS}.
FT   STRAND      155    157       {ECO:0000244|PDB:1QG1}.
FT   STRAND      160    165       {ECO:0000244|PDB:2VWF}.
FT   STRAND      171    174       {ECO:0000244|PDB:1IO6}.
FT   STRAND      182    187       {ECO:0000244|PDB:2VWF}.
FT   STRAND      190    198       {ECO:0000244|PDB:2VWF}.
FT   STRAND      201    206       {ECO:0000244|PDB:2VWF}.
FT   HELIX       207    209       {ECO:0000244|PDB:2VWF}.
FT   STRAND      210    212       {ECO:0000244|PDB:2VWF}.
SQ   SEQUENCE   217 AA;  25206 MW;  83A4B0BA1B248DC4 CRC64;
     MEAIAKYDFK ATADDELSFK RGDILKVLNE ECDQNWYKAE LNGKDGFIPK NYIEMKPHPW
     FFGKIPRAKA EEMLSKQRHD GAFLIRESES APGDFSLSVK FGNDVQHFKV LRDGAGKYFL
     WVVKFNSLNE LVDYHRSTSV SRNQQIFLRD IEQVPQQPTY VQALFDFDPQ EDGELGFRRG
     DFIHVMDNSD PNWWKGACHG QTGMFPRNYV TPVNRNV
//
ID   B4DZF6_HUMAN            Unreviewed;       581 AA.
AC   B4DZF6;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-NOV-2017, entry version 49.
DE   SubName: Full=cDNA FLJ54206, highly similar to Ubiquilin-4 {ECO:0000313|EMBL:BAG64068.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG64068.1};
RN   [1] {ECO:0000313|EMBL:BAG64068.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:BAG64068.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK302895; BAG64068.1; -; mRNA.
DR   RefSeq; NP_001291271.1; NM_001304342.1.
DR   UniGene; Hs.283739; -.
DR   ProteinModelPortal; B4DZF6; -.
DR   PeptideAtlas; B4DZF6; -.
DR   PRIDE; B4DZF6; -.
DR   GeneID; 56893; -.
DR   CTD; 56893; -.
DR   HOVERGEN; HBG064537; -.
DR   GenomeRNAi; 56893; -.
DR   InterPro; IPR006636; STI1_HS-bd.
DR   InterPro; IPR015940; UBA.
DR   InterPro; IPR009060; UBA-like_sf.
DR   InterPro; IPR015496; Ubiquilin.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   PANTHER; PTHR10677; PTHR10677; 1.
DR   Pfam; PF00627; UBA; 1.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00727; STI1; 4.
DR   SMART; SM00165; UBA; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50030; UBA; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       13     87       Ubiquitin-like.
FT                                {ECO:0000259|PROSITE:PS50053}.
FT   DOMAIN      533    578       UBA. {ECO:0000259|PROSITE:PS50030}.
SQ   SEQUENCE   581 AA;  62185 MW;  A786637F8276CD26 CRC64;
     MAEPSGAETR PPIRVTVKTP KDKEEIVICD RASVKEFKEE ISRRFKAQQD QLVLIFAGKI
     LKDGDTLNQH GIKDGLTVHL VIKTPQKAQD PAAATASSPS TPDPASAPST TPASPATPAQ
     PSTSGSASSD AGSGSRRSSA GFGGILGLGS LGLGSANFME LQQQMQRQLM SNPEMLSQIM
     ENPLVQDMMS NPDLMRHMIM ANPQMQQLME RNPEISHMLN NPELMRQTME LARNPAMMQE
     MMRNQDRALS NLESIPGGYN ALRRMYTDIQ EPMFSAAREQ FGNNPFSSLA GNSDSSSSQP
     LRTENREPLP NPWSPSPPTS QAPGSGGEGT GGSGTSQVHP TVSNPFGINA ASLGSGMFNS
     PEMQALLQQI SENPQLMQNV ISAPYMRSMM QTLAQNPDFA AQMMVNVPLF AGNPQLQEQL
     RLQLPVFLQQ MQNPESLSIL TNPRAMQALL QIQQGLQTLQ TEAPGLVPSL GSFGISRTPA
     PSAGSNAGST PEAPTSSPAT PATSSPTGAS SAQQQLMQQM IQLLAGSGNS QVQTPEVRFQ
     QQLEQLNSMG FINREANLQA LIATGGDINA AIERLLGSQL S
//
ID   Q59F94_HUMAN            Unreviewed;       600 AA.
AC   Q59F94;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   28-FEB-2018, entry version 67.
DE   SubName: Full=Ataxin-1 ubiquitin-like interacting protein variant {ECO:0000313|EMBL:BAD92803.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD92803.1};
RN   [1] {ECO:0000313|EMBL:BAD92803.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAD92803.1};
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RT   "Homo sapiens protein coding cDNA.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB209566; BAD92803.1; -; mRNA.
DR   RefSeq; NP_001291271.1; NM_001304342.1.
DR   UniGene; Hs.283739; -.
DR   PeptideAtlas; Q59F94; -.
DR   PRIDE; Q59F94; -.
DR   GeneID; 56893; -.
DR   CTD; 56893; -.
DR   eggNOG; KOG0010; Eukaryota.
DR   eggNOG; COG5272; LUCA.
DR   HOVERGEN; HBG064537; -.
DR   GenomeRNAi; 56893; -.
DR   InterPro; IPR006636; STI1_HS-bd.
DR   InterPro; IPR015940; UBA.
DR   InterPro; IPR009060; UBA-like_sf.
DR   InterPro; IPR015496; Ubiquilin.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   PANTHER; PTHR10677; PTHR10677; 1.
DR   Pfam; PF00627; UBA; 1.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00727; STI1; 4.
DR   SMART; SM00165; UBA; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50030; UBA; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       12     86       Ubiquitin-like.
FT                                {ECO:0000259|PROSITE:PS50053}.
FT   DOMAIN      552    597       UBA. {ECO:0000259|PROSITE:PS50030}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAD92803.1}.
SQ   SEQUENCE   600 AA;  63740 MW;  DFBA259E8A40BACD CRC64;
     AEPSGAETRP PIRVTVKTPK DKEEIVICDR ASVKEFKEEI SRRFKAQQDQ LVLIFAGKIL
     KDGDTLNQHG IKDGLTVHLV IKTPQKAQDP AAATASSPST PDPASAPSTT PASPATPAQP
     STSGSASSDA GSGSRRSSGG GPSPGAGEGS PSATASILSG FGGILGLGSL GLGSANFMEL
     QQQMQRQLMS NPEMLSQIME NPLVQDMMSN PDLMRHMIMA NPQMQQLMER NPEISHMLNN
     PELMRQTMEL ARNPAMMQEM MRNQDRALSN LESIPGGYNA LRRMYTDIQE PMFSAAREQF
     GNNPFSSLAG NSDSSSSQPL RTENREPLPN PWSPSPPTSQ APGSGGEGTG GSGTSQVHPT
     VSNPFGINAA SLGSGMFNSP EMQALLQQIS ENPQLMQNVI SAPYMRSMMQ TLAQNPDFAA
     QMMVNVPLFA GNPQLQEQLR LQLPVFLQQM QNPESLSILT NPRAMQALLQ IQQGLQTLQT
     EAPGLVPSLG SFGMSRTPAP SAGSNAGSTP EAPTSSPATP ATSSPTGASS AQQQLMQQMI
     QLLAGSGNSQ VQTPEVRFQQ QLEQLNSMGF INREANLQAL IATGGDINAA IERLLGSQLS
//
ID   UBQL4_HUMAN             Reviewed;         601 AA.
AC   Q9NRR5; A6ND44; B2RAY7; Q5VYA0; Q5VYA1; Q9BR98; Q9UHX4;
DT   15-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2004, sequence version 2.
DT   28-MAR-2018, entry version 153.
DE   RecName: Full=Ubiquilin-4;
DE   AltName: Full=Ataxin-1 interacting ubiquitin-like protein;
DE            Short=A1Up;
DE   AltName: Full=Ataxin-1 ubiquitin-like-interacting protein A1U;
DE   AltName: Full=Connexin43-interacting protein of 75 kDa;
DE            Short=CIP75;
GN   Name=UBQLN4; Synonyms=C1orf6, CIP75, UBIN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION,
RP   INTERACTION WITH ATXN1/SCA1, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=11001934; DOI=10.1093/oxfordjournals.hmg.a018922;
RA   Davidson J.D., Riley B., Burright E.N., Duvick L.A., Zoghbi H.Y.,
RA   Orr H.T.;
RT   "Identification and characterization of an ataxin-1-interacting
RT   protein: A1Up, a ubiquitin-like nuclear protein.";
RL   Hum. Mol. Genet. 9:2305-2312(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   MET-495.
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, Colon, and PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 161-601 (ISOFORM 1), AND VARIANT
RP   MET-495.
RX   PubMed=10575211;
RA   Fogli A., Giglio S., Lo Nigro C., Zollo M., Viggiano L., Rocchi M.,
RA   Archidiacono N., Zuffardi O., Carrozzo R.;
RT   "Identification of two paralogous regions mapping to the short and
RT   long arms of human chromosome 2 comprising LIS1 pseudogenes.";
RL   Cytogenet. Cell Genet. 86:225-232(1999).
RN   [6]
RP   FUNCTION, INTERACTION WITH UBIQUITIN; ATXN1 AND PSMD4, SUBUNIT,
RP   SUBCELLULAR LOCATION, AND UBIQUITINATION.
RX   PubMed=15280365; DOI=10.1074/jbc.M406284200;
RA   Riley B.E., Xu Y., Zoghbi H.Y., Orr H.T.;
RT   "The effects of the polyglutamine repeat protein ataxin-1 on the UbL-
RT   UBA protein A1Up.";
RL   J. Biol. Chem. 279:42290-42301(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [8]
RP   INTERACTION WITH HERPUD1.
RX   PubMed=18307982; DOI=10.1016/j.bbrc.2008.02.086;
RA   Kim T.Y., Kim E., Yoon S.K., Yoon J.B.;
RT   "Herp enhances ER-associated protein degradation by recruiting
RT   ubiquilins.";
RL   Biochem. Biophys. Res. Commun. 369:741-746(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, SUBCELLULAR LOCATION,
RP   INTERACTION WITH UBQLN1; UBQLN2 AND MAP1LC3A/B/C, AND MUTAGENESIS OF
RP   ILE-55.
RX   PubMed=23459205; DOI=10.1038/embor.2013.22;
RA   Lee D.Y., Arnott D., Brown E.J.;
RT   "Ubiquilin4 is an adaptor protein that recruits Ubiquilin1 to the
RT   autophagy machinery.";
RL   EMBO Rep. 14:373-381(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-287, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   REVIEW.
RX   PubMed=24674348; DOI=10.1186/1471-2148-14-63;
RA   Marin I.;
RT   "The ubiquilin gene family: evolutionary patterns and functional
RT   insights.";
RL   BMC Evol. Biol. 14:63-63(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-23 AND LYS-62, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Plays a role in the regulation of protein degradation
CC       via the ubiquitin-proteasome system (UPS). Mediates the
CC       proteasomal targeting of misfolded or accumulated proteins for
CC       degradation by binding (via UBA domain) to their polyubiquitin
CC       chains and by interacting (via ubiquitin-like domain) with the
CC       subunits of the proteasome (Ref. 6). Plays a role in the
CC       regulation of the proteasomal degradation of non-ubiquitinated
CC       GJA1 (By similarity). Acts as an adapter protein that recruits
CC       UBQLN1 to the autophagy machinery. Mediates the association of
CC       UBQLN1 with autophagosomes and the autophagy-related protein LC3
CC       (MAP1LC3A/B/C) and may assist in the maturation of autophagosomes
CC       to autolysosomes by mediating autophagosome-lysosome fusion
CC       (PubMed:23459205). {ECO:0000250|UniProtKB:Q99NB8,
CC       ECO:0000269|PubMed:15280365, ECO:0000269|PubMed:23459205}.
CC   -!- SUBUNIT: Homooligomer (Ref. 6). Binds signal sequences of proteins
CC       that are targeted to the endoplasmic reticulum. Interacts (via UBA
CC       domain) with GJA1 (not ubiquitinated) and with ubiquitin; both
CC       compete for the same binding site. Interacts (via UBA domain) with
CC       ubiquitin and with polyubiquitin chains. Interacts with PSMD2 (By
CC       similarity). Interacts (via ubiquitin-like domain) with PSMD4, a
CC       regulatory subunit of the 26S proteasome. Interacts with
CC       ATXN1/SCA1. Interaction with ATXN1 inhibits polyubiquitination of
CC       UBQLN4 and interferes with PSMD4 binding. Interacts with HERPUD1.
CC       Interacts (via ubiquitin-like domain) with UBQLN1 (via UBA
CC       domain). Interacts (via STI1 1 and 2 domains) with MAP1LC3A/B/C.
CC       Interacts with UBQLN2. {ECO:0000250|UniProtKB:Q99NB8,
CC       ECO:0000269|PubMed:11001934, ECO:0000269|PubMed:15280365,
CC       ECO:0000269|PubMed:18307982, ECO:0000269|PubMed:23459205}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-711226, EBI-711226;
CC       P54253:ATXN1; NbExp=6; IntAct=EBI-711226, EBI-930964;
CC       P26885:FKBP2; NbExp=2; IntAct=EBI-711226, EBI-719873;
CC       P08050:Gja1 (xeno); NbExp=2; IntAct=EBI-711226, EBI-476947;
CC       Q9H492:MAP1LC3A; NbExp=3; IntAct=EBI-711226, EBI-720768;
CC       P55198:MLLT6; NbExp=2; IntAct=EBI-711226, EBI-740216;
CC       Q9NR12:PDLIM7; NbExp=2; IntAct=EBI-711226, EBI-350517;
CC       Q9Y5P3:RAI2; NbExp=3; IntAct=EBI-711226, EBI-746228;
CC       Q13049:TRIM32; NbExp=3; IntAct=EBI-711226, EBI-742790;
CC       Q9UMX0:UBQLN1; NbExp=8; IntAct=EBI-711226, EBI-741480;
CC       O95201:ZNF205; NbExp=2; IntAct=EBI-711226, EBI-747343;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11001934,
CC       ECO:0000269|PubMed:15280365}. Cytoplasm
CC       {ECO:0000269|PubMed:15280365}. Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:Q99NB8}. Cytoplasm, perinuclear region
CC       {ECO:0000250|UniProtKB:Q99NB8}. Cytoplasmic vesicle, autophagosome
CC       {ECO:0000269|PubMed:23459205}. Note=Colocalizes with the
CC       proteasome, both in nucleus and cytoplasm.
CC       {ECO:0000269|PubMed:15280365}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NRR5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NRR5-2; Sequence=VSP_041187, VSP_041188;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in pancreas, kidney, skeletal
CC       muscle, heart and throughout the brain, and at lower levels in
CC       placenta, lung and liver. {ECO:0000269|PubMed:11001934}.
CC   -!- PTM: Ubiquitinated; this does not lead to proteasomal degradation.
CC       May undergo both 'Lys-48'- and 'Lys-63'-linked polyubiquitination.
CC       {ECO:0000269|PubMed:15280365}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF19084.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAH06410.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF188240; AAF80171.1; -; mRNA.
DR   EMBL; AK098368; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK314413; BAG37034.1; -; mRNA.
DR   EMBL; AL355388; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC006410; AAH06410.1; ALT_INIT; mRNA.
DR   EMBL; BC018403; AAH18403.1; -; mRNA.
DR   EMBL; BC063841; AAH63841.1; -; mRNA.
DR   EMBL; AF113544; AAF19084.1; ALT_INIT; mRNA.
DR   CCDS; CCDS1127.1; -. [Q9NRR5-1]
DR   RefSeq; NP_001291271.1; NM_001304342.1.
DR   RefSeq; NP_064516.2; NM_020131.4. [Q9NRR5-1]
DR   UniGene; Hs.283739; -.
DR   ProteinModelPortal; Q9NRR5; -.
DR   SMR; Q9NRR5; -.
DR   BioGrid; 121223; 192.
DR   IntAct; Q9NRR5; 159.
DR   MINT; Q9NRR5; -.
DR   STRING; 9606.ENSP00000357292; -.
DR   TCDB; 8.A.52.1.1; the ubiquitin-related protein degradation (upd) family.
DR   iPTMnet; Q9NRR5; -.
DR   PhosphoSitePlus; Q9NRR5; -.
DR   BioMuta; UBQLN4; -.
DR   DMDM; 45476982; -.
DR   EPD; Q9NRR5; -.
DR   MaxQB; Q9NRR5; -.
DR   PaxDb; Q9NRR5; -.
DR   PeptideAtlas; Q9NRR5; -.
DR   PRIDE; Q9NRR5; -.
DR   TopDownProteomics; Q9NRR5-2; -. [Q9NRR5-2]
DR   Ensembl; ENST00000368309; ENSP00000357292; ENSG00000160803. [Q9NRR5-1]
DR   GeneID; 56893; -.
DR   KEGG; hsa:56893; -.
DR   UCSC; uc001fna.4; human. [Q9NRR5-1]
DR   CTD; 56893; -.
DR   DisGeNET; 56893; -.
DR   EuPathDB; HostDB:ENSG00000160803.7; -.
DR   GeneCards; UBQLN4; -.
DR   HGNC; HGNC:1237; UBQLN4.
DR   HPA; HPA061797; -.
DR   MIM; 605440; gene.
DR   neXtProt; NX_Q9NRR5; -.
DR   OpenTargets; ENSG00000160803; -.
DR   PharmGKB; PA25619; -.
DR   eggNOG; KOG0010; Eukaryota.
DR   eggNOG; COG5272; LUCA.
DR   GeneTree; ENSGT00390000005720; -.
DR   HOVERGEN; HBG064537; -.
DR   InParanoid; Q9NRR5; -.
DR   KO; K04523; -.
DR   OMA; LVIKTAH; -.
DR   OrthoDB; EOG091G08WB; -.
DR   PhylomeDB; Q9NRR5; -.
DR   TreeFam; TF314412; -.
DR   ChiTaRS; UBQLN4; human.
DR   GenomeRNAi; 56893; -.
DR   PRO; PR:Q9NRR5; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000160803; -.
DR   CleanEx; HS_UBQLN4; -.
DR   Genevisible; Q9NRR5; HS.
DR   GO; GO:0005776; C:autophagosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0031593; F:polyubiquitin modification-dependent protein binding; IDA:UniProtKB.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:1901097; P:negative regulation of autophagosome maturation; IMP:UniProtKB.
DR   GO; GO:0032434; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   InterPro; IPR006636; STI1_HS-bd.
DR   InterPro; IPR015940; UBA.
DR   InterPro; IPR009060; UBA-like_sf.
DR   InterPro; IPR015496; Ubiquilin.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   PANTHER; PTHR10677; PTHR10677; 1.
DR   Pfam; PF00627; UBA; 1.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00727; STI1; 4.
DR   SMART; SM00165; UBA; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50030; UBA; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Autophagy; Complete proteome; Cytoplasm;
KW   Cytoplasmic vesicle; Endoplasmic reticulum; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Ubl conjugation.
FT   CHAIN         1    601       Ubiquilin-4.
FT                                /FTId=PRO_0000211015.
FT   DOMAIN       13     87       Ubiquitin-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      192    229       STI1 1. {ECO:0000255}.
FT   DOMAIN      230    261       STI1 2. {ECO:0000255}.
FT   DOMAIN      393    440       STI1 3. {ECO:0000255}.
FT   DOMAIN      444    476       STI1 4. {ECO:0000255}.
FT   DOMAIN      553    598       UBA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00212}.
FT   MOD_RES      98     98       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     287    287       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK     23     23       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK     62     62       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ      93    226       AATASSPSTPDPASAPSTTPASPATPAQPSTSGSASSDAGS
FT                                GSRRSSGGGPSPGAGEGSPSATASILSGFGGILGLGSLGLG
FT                                SANFMELQQQMQRQLMSNPEMLSQIMENPLVQDMMSNPDLM
FT                                RHMIMANPQMQ -> PPAAPSLPAADAEPRVTLHPYQSPSH
FT                                AGIAADPAGTTDLADRGPWAGTQPWLLWDIPDPSTLSRQQR
FT                                RVYARGPHFLTSHASHIFSNRGFQRPAATHAADDPAFGWKW
FT                                KLTGADARSEISAAAGAAQLHGLHQS (in isoform
FT                                2). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041187.
FT   VAR_SEQ     227    601       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041188.
FT   VARIANT     495    495       I -> M (in dbSNP:rs2297792).
FT                                {ECO:0000269|PubMed:10575211,
FT                                ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_052685.
FT   MUTAGEN      55     55       I->A: Loss of interaction with UBQLN1.
FT   CONFLICT    188    189       QL -> HV (in Ref. 1; AAF80171).
FT                                {ECO:0000305}.
FT   CONFLICT    298    298       R -> Q (in Ref. 1; AAF80171).
FT                                {ECO:0000305}.
SQ   SEQUENCE   601 AA;  63853 MW;  E57B9FFEF90793FE CRC64;
     MAEPSGAETR PPIRVTVKTP KDKEEIVICD RASVKEFKEE ISRRFKAQQD QLVLIFAGKI
     LKDGDTLNQH GIKDGLTVHL VIKTPQKAQD PAAATASSPS TPDPASAPST TPASPATPAQ
     PSTSGSASSD AGSGSRRSSG GGPSPGAGEG SPSATASILS GFGGILGLGS LGLGSANFME
     LQQQMQRQLM SNPEMLSQIM ENPLVQDMMS NPDLMRHMIM ANPQMQQLME RNPEISHMLN
     NPELMRQTME LARNPAMMQE MMRNQDRALS NLESIPGGYN ALRRMYTDIQ EPMFSAAREQ
     FGNNPFSSLA GNSDSSSSQP LRTENREPLP NPWSPSPPTS QAPGSGGEGT GGSGTSQVHP
     TVSNPFGINA ASLGSGMFNS PEMQALLQQI SENPQLMQNV ISAPYMRSMM QTLAQNPDFA
     AQMMVNVPLF AGNPQLQEQL RLQLPVFLQQ MQNPESLSIL TNPRAMQALL QIQQGLQTLQ
     TEAPGLVPSL GSFGISRTPA PSAGSNAGST PEAPTSSPAT PATSSPTGAS SAQQQLMQQM
     IQLLAGSGNS QVQTPEVRFQ QQLEQLNSMG FINREANLQA LIATGGDINA AIERLLGSQL
     S
//
ID   SPRE1_HUMAN             Reviewed;         444 AA.
AC   Q7Z699; B2RPJ8; Q05D53; Q8N256;
DT   04-JAN-2005, integrated into UniProtKB/Swiss-Prot.
DT   04-JAN-2005, sequence version 2.
DT   28-MAR-2018, entry version 135.
DE   RecName: Full=Sprouty-related, EVH1 domain-containing protein 1;
DE            Short=Spred-1;
DE            Short=hSpred1;
GN   Name=SPRED1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH SPRED2.
RC   TISSUE=Glioblastoma;
RX   PubMed=15683364; DOI=10.1042/BJ20041284;
RA   King J.A.J., Straffon A.F.L., D'Abaco G.M., Poon C.L.C., I S.T.T.,
RA   Smith C.M., Buchert M., Corcoran N.M., Hall N.E., Callus B.A.,
RA   Sarcevic B., Martin D., Lock P., Hovens C.M.;
RT   "Distinct requirements for the Sprouty domain for functional activity
RT   of Spred proteins.";
RL   Biochem. J. 388:445-454(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=15580519; DOI=10.1007/s00418-004-0725-6;
RA   Engelhardt C.M., Bundschu K., Messerschmitt M., Renne T., Walter U.,
RA   Reinhard M., Schuh K.;
RT   "Expression and subcellular localization of Spred proteins in mouse
RT   and human tissues.";
RL   Histochem. Cell Biol. 122:527-538(2004).
RN   [6]
RP   INTERACTION WITH CAV1, AND SUBCELLULAR LOCATION.
RX   PubMed=16115197; DOI=10.1111/j.1365-2443.2005.00886.x;
RA   Nonami A., Taketomi T., Kimura A., Saeki K., Takaki H., Sanada T.,
RA   Taniguchi K., Harada M., Kato R., Yoshimura A.;
RT   "The Sprouty-related protein, Spred-1, localizes in a lipid
RT   raft/caveola and inhibits ERK activation in collaboration with
RT   caveolin-1.";
RL   Genes Cells 10:887-895(2005).
RN   [7]
RP   INVOLVEMENT IN NFLS.
RX   PubMed=17704776; DOI=10.1038/ng2113;
RA   Brems H., Chmara M., Sahbatou M., Denayer E., Taniguchi K., Kato R.,
RA   Somers R., Messiaen L., De Schepper S., Fryns J.-P., Cools J.,
RA   Marynen P., Thomas G., Yoshimura A., Legius E.;
RT   "Germline loss-of-function mutations in SPRED1 cause a
RT   neurofibromatosis 1-like phenotype.";
RL   Nat. Genet. 39:1120-1126(2007).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-238 AND SER-308, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT LYS-224, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [11]
RP   VARIANT NFLS ASP-44.
RX   PubMed=19443465; DOI=10.1136/jmg.2008.065474;
RA   Spurlock G., Bennett E., Chuzhanova N., Thomas N., Jim H.P., Side L.,
RA   Davies S., Haan E., Kerr B., Huson S.M., Upadhyaya M.;
RT   "SPRED1 mutations (Legius syndrome): another clinically useful
RT   genotype for dissecting the neurofibromatosis type 1 phenotype.";
RL   J. Med. Genet. 46:431-437(2009).
RN   [12]
RP   VARIANT NFLS ASP-44.
RX   PubMed=20108422;
RA   Jim H.P., Upadhyaya M.;
RT   "Novel human pathological mutations. Gene symbol: SPRED1. Disease:
RT   Legius syndrome.";
RL   Hum. Genet. 127:112-112(2010).
RN   [13]
RP   VARIANT NFLS CYS-31.
RX   PubMed=21089071; DOI=10.1002/humu.21404;
RA   Denayer E., Chmara M., Brems H., Kievit A.M., van Bever Y.,
RA   Van den Ouweland A.M., Van Minkelen R., de Goede-Bolder A.,
RA   Oostenbrink R., Lakeman P., Beert E., Ishizaki T., Mori T.,
RA   Keymolen K., Van den Ende J., Mangold E., Peltonen S., Brice G.,
RA   Rankin J., Van Spaendonck-Zwarts K.Y., Yoshimura A., Legius E.;
RT   "Legius syndrome in fourteen families.";
RL   Hum. Mutat. 32:E1985-E1998(2011).
CC   -!- FUNCTION: Tyrosine kinase substrate that inhibits growth-factor-
CC       mediated activation of MAP kinase. Negatively regulates
CC       hematopoiesis of bone marrow (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with Ras. Interacts with TAOK2 and TESK1 (By
CC       similarity). Homodimer and heterodimer. Interacts with CAV1. Able
CC       to interact with SPRED2 to form heterodimers. {ECO:0000250,
CC       ECO:0000269|PubMed:15683364, ECO:0000269|PubMed:16115197}.
CC   -!- INTERACTION:
CC       Q8WWB5:PIH1D2; NbExp=8; IntAct=EBI-5235340, EBI-10232538;
CC       P62136:PPP1CA; NbExp=4; IntAct=EBI-5235340, EBI-357253;
CC       Q8IUH5:ZDHHC17; NbExp=3; IntAct=EBI-5235340, EBI-524753;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16115197};
CC       Peripheral membrane protein {ECO:0000269|PubMed:16115197}.
CC       Membrane, caveola {ECO:0000269|PubMed:16115197}; Peripheral
CC       membrane protein {ECO:0000269|PubMed:16115197}. Nucleus
CC       {ECO:0000269|PubMed:16115197}. Note=Localized in cholesterol-rich
CC       membrane raft/caveola fractions.
CC   -!- TISSUE SPECIFICITY: Weakly expressed in embryonic cell line
CC       HEK293. {ECO:0000269|PubMed:15580519}.
CC   -!- PTM: Phosphorylated on tyrosine. {ECO:0000250}.
CC   -!- DISEASE: Neurofibromatosis 1-like syndrome (NFLS) [MIM:611431]: A
CC       disorder characterized mainly by cafe au lait macules without
CC       neurofibromas or other tumor manifestations of neurofibromatosis
CC       type 1, axillary freckling, and macrocephaly. Additional clinical
CC       manifestations include Noonan-like facial dysmorphism, lipomas,
CC       learning disabilities and attention deficit-hyperactivity.
CC       {ECO:0000269|PubMed:17704776, ECO:0000269|PubMed:19443465,
CC       ECO:0000269|PubMed:20108422, ECO:0000269|PubMed:21089071}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH18015.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY299089; AAP59414.1; -; mRNA.
DR   EMBL; AK091222; BAC03614.1; -; mRNA.
DR   EMBL; CH471125; EAW92368.1; -; Genomic_DNA.
DR   EMBL; BC018015; AAH18015.1; ALT_SEQ; mRNA.
DR   EMBL; BC137480; AAI37481.1; -; mRNA.
DR   EMBL; BC137481; AAI37482.1; -; mRNA.
DR   CCDS; CCDS32193.1; -.
DR   RefSeq; NP_689807.1; NM_152594.2.
DR   UniGene; Hs.525781; -.
DR   PDB; 3SYX; X-ray; 2.45 A; A=13-131.
DR   PDBsum; 3SYX; -.
DR   ProteinModelPortal; Q7Z699; -.
DR   SMR; Q7Z699; -.
DR   BioGrid; 127800; 17.
DR   IntAct; Q7Z699; 38.
DR   MINT; Q7Z699; -.
DR   STRING; 9606.ENSP00000299084; -.
DR   iPTMnet; Q7Z699; -.
DR   PhosphoSitePlus; Q7Z699; -.
DR   SwissPalm; Q7Z699; -.
DR   BioMuta; SPRED1; -.
DR   DMDM; 57013078; -.
DR   EPD; Q7Z699; -.
DR   MaxQB; Q7Z699; -.
DR   PaxDb; Q7Z699; -.
DR   PeptideAtlas; Q7Z699; -.
DR   PRIDE; Q7Z699; -.
DR   Ensembl; ENST00000299084; ENSP00000299084; ENSG00000166068.
DR   GeneID; 161742; -.
DR   KEGG; hsa:161742; -.
DR   UCSC; uc001zka.5; human.
DR   CTD; 161742; -.
DR   DisGeNET; 161742; -.
DR   EuPathDB; HostDB:ENSG00000166068.12; -.
DR   GeneCards; SPRED1; -.
DR   GeneReviews; SPRED1; -.
DR   HGNC; HGNC:20249; SPRED1.
DR   HPA; HPA042193; -.
DR   HPA; HPA061805; -.
DR   MalaCards; SPRED1; -.
DR   MIM; 609291; gene.
DR   MIM; 611431; phenotype.
DR   neXtProt; NX_Q7Z699; -.
DR   OpenTargets; ENSG00000166068; -.
DR   Orphanet; 137605; Legius syndrome.
DR   PharmGKB; PA134897382; -.
DR   eggNOG; ENOG410IQ20; Eukaryota.
DR   eggNOG; ENOG4112CZ7; LUCA.
DR   GeneTree; ENSGT00730000110272; -.
DR   HOGENOM; HOG000220886; -.
DR   HOVERGEN; HBG057556; -.
DR   InParanoid; Q7Z699; -.
DR   KO; K04703; -.
DR   OMA; ISQGCPA; -.
DR   OrthoDB; EOG091G0OE8; -.
DR   PhylomeDB; Q7Z699; -.
DR   TreeFam; TF321411; -.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-5658623; FGFRL1 modulation of FGFR1 signaling.
DR   Reactome; R-HSA-6802949; Signaling by RAS mutants.
DR   ChiTaRS; SPRED1; human.
DR   GeneWiki; SPRED1; -.
DR   GenomeRNAi; 161742; -.
DR   PRO; PR:Q7Z699; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000166068; -.
DR   CleanEx; HS_SPRED1; -.
DR   ExpressionAtlas; Q7Z699; baseline and differential.
DR   Genevisible; Q7Z699; HS.
DR   GO; GO:0005901; C:caveola; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:ARUK-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0019902; F:phosphatase binding; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:ARUK-UCL.
DR   GO; GO:0030291; F:protein serine/threonine kinase inhibitor activity; ISS:BHF-UCL.
DR   GO; GO:0005173; F:stem cell factor receptor binding; ISS:UniProtKB.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0000188; P:inactivation of MAPK activity; ISS:UniProtKB.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IMP:BHF-UCL.
DR   GO; GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; IEA:Ensembl.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IEA:Ensembl.
DR   GO; GO:0043409; P:negative regulation of MAPK cascade; IMP:BHF-UCL.
DR   GO; GO:0010801; P:negative regulation of peptidyl-threonine phosphorylation; IMP:BHF-UCL.
DR   GO; GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IDA:ARUK-UCL.
DR   GO; GO:0043517; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; ISS:BHF-UCL.
DR   GO; GO:0043408; P:regulation of MAPK cascade; TAS:ARUK-UCL.
DR   GO; GO:0090311; P:regulation of protein deacetylation; ISS:BHF-UCL.
DR   GO; GO:0060979; P:vasculogenesis involved in coronary vascular morphogenesis; IMP:BHF-UCL.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR023337; KBD.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR007875; Sprouty.
DR   InterPro; IPR000697; WH1/EVH1_dom.
DR   Pfam; PF05210; Sprouty; 1.
DR   Pfam; PF00568; WH1; 1.
DR   SMART; SM00461; WH1; 1.
DR   PROSITE; PS51488; KBD; 1.
DR   PROSITE; PS51227; SPR; 1.
DR   PROSITE; PS50229; WH1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell membrane; Complete proteome;
KW   Disease mutation; Membrane; Methylation; Nucleus; Phosphoprotein;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    444       Sprouty-related, EVH1 domain-containing
FT                                protein 1.
FT                                /FTId=PRO_0000076907.
FT   DOMAIN        6    123       WH1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00410}.
FT   DOMAIN      233    285       KBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00821}.
FT   DOMAIN      334    442       SPR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00572}.
FT   COMPBIAS    147    150       Poly-Ser.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     224    224       N6-methyllysine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     238    238       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     308    308       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT      31     31       W -> C (in NFLS).
FT                                {ECO:0000269|PubMed:21089071}.
FT                                /FTId=VAR_064827.
FT   VARIANT      44     44       V -> D (in NFLS; dbSNP:rs121434318).
FT                                {ECO:0000269|PubMed:19443465,
FT                                ECO:0000269|PubMed:20108422}.
FT                                /FTId=VAR_064828.
FT   CONFLICT      6      7       AT -> GL (in Ref. 1; AAP59414).
FT                                {ECO:0000305}.
FT   STRAND       13     24       {ECO:0000244|PDB:3SYX}.
FT   STRAND       26     29       {ECO:0000244|PDB:3SYX}.
FT   STRAND       31     37       {ECO:0000244|PDB:3SYX}.
FT   STRAND       40     51       {ECO:0000244|PDB:3SYX}.
FT   STRAND       54     64       {ECO:0000244|PDB:3SYX}.
FT   TURN         65     67       {ECO:0000244|PDB:3SYX}.
FT   STRAND       70     75       {ECO:0000244|PDB:3SYX}.
FT   STRAND       81     86       {ECO:0000244|PDB:3SYX}.
FT   STRAND       89     94       {ECO:0000244|PDB:3SYX}.
FT   STRAND       97    105       {ECO:0000244|PDB:3SYX}.
FT   HELIX       106    121       {ECO:0000244|PDB:3SYX}.
FT   HELIX       122    124       {ECO:0000244|PDB:3SYX}.
SQ   SEQUENCE   444 AA;  50477 MW;  6FFDECCE590DB311 CRC64;
     MSEETATSDN DNSYARVRAV VMTRDDSSGG WLPLGGSGLS SVTVFKVPHQ EENGCADFFI
     RGERLRDKMV VLECMLKKDL IYNKVTPTFH HWKIDDKKFG LTFQSPADAR AFDRGIRRAI
     EDISQGCPES KNEAEGADDL QANEEDSSSS LVKDHLFQQE TVVTSEPYRS SNIRPSPFED
     LNARRVYMQS QANQITFGQP GLDIQSRSME YVQRQISKEC GSLKSQNRVP LKSIRHVSFQ
     DEDEIVRINP RDILIRRYAD YRHPDMWKND LERDDADSSI QFSKPDSKKS DYLYSCGDET
     KLSSPKDSVV FKTQPSSLKI KKSKRRKEDG ERSRCVYCQE RFNHEENVRG KCQDAPDPIK
     RCIYQVSCML CAESMLYHCM SDSEGDFSDP CSCDTSDDKF CLRWLALVAL SFIVPCMCCY
     VPLRMCHRCG EACGCCGGKH KAAG
//
ID   ZZZ3_HUMAN              Reviewed;         903 AA.
AC   Q8IYH5; B7WPC6; Q6N004; Q6N070; Q8IYP0; Q8IYR1; Q8TEK4; Q9Y4U0;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   23-MAY-2018, entry version 154.
DE   RecName: Full=ZZ-type zinc finger-containing protein 3;
GN   Name=ZZZ3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 84-903 (ISOFORM 2).
RC   TISSUE=Adipose tissue, Colon endothelium, and Rectum tumor;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 286-903 (ISOFORM 2).
RC   TISSUE=Brain, Lymph, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 161-903 (ISOFORM 4).
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-130; SER-131 AND
RP   SER-135, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   FUNCTION, AND IDENTIFICATION IN ATAC COMPLEX.
RX   PubMed=19103755; DOI=10.1128/MCB.01599-08;
RA   Guelman S., Kozuka K., Mao Y., Pham V., Solloway M.J., Wang J., Wu J.,
RA   Lill J.R., Zha J.;
RT   "The double-histone-acetyltransferase complex ATAC is essential for
RT   mammalian development.";
RL   Mol. Cell. Biol. 29:1176-1188(2009).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-701, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-89; SER-113;
RP   SER-135 AND SER-606, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-647 AND LYS-708, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [13]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-276; LYS-647 AND LYS-708,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [14]
RP   STRUCTURE BY NMR OF 807-875 IN COMPLEX WITH ZINC IONS.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the ZZ domain of ZZZ3 protein.";
RL   Submitted (JUN-2006) to the PDB data bank.
RN   [15]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-456.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Component of the ATAC complex, a complex with histone
CC       acetyltransferase activity on histones H3 and H4.
CC       {ECO:0000269|PubMed:19103755}.
CC   -!- SUBUNIT: Component of the ADA2A-containing complex (ATAC),
CC       composed of KAT14, KAT2A, TADA2L, TADA3L, ZZ3, MBIP, WDR5, YEATS2,
CC       CCDC101 and DR1. {ECO:0000269|PubMed:19103755,
CC       ECO:0000269|Ref.14}.
CC   -!- INTERACTION:
CC       Q86V42:FAM124A; NbExp=3; IntAct=EBI-2795524, EBI-744506;
CC       P09022:Hoxa1 (xeno); NbExp=3; IntAct=EBI-2795524, EBI-3957603;
CC       Q92830:KAT2A; NbExp=2; IntAct=EBI-2795524, EBI-477622;
CC       Q96KQ4:PPP1R13B; NbExp=4; IntAct=EBI-2795524, EBI-1105153;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00625}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8IYH5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IYH5-2; Sequence=VSP_025511;
CC       Name=3;
CC         IsoId=Q8IYH5-3; Sequence=VSP_025509, VSP_025510;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q8IYH5-4; Sequence=VSP_025512, VSP_025513;
CC         Note=No experimental confirmation available.;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL080063; CAB45694.1; -; mRNA.
DR   EMBL; BX641001; CAE46004.1; -; mRNA.
DR   EMBL; BX640658; CAE45800.1; -; mRNA.
DR   EMBL; BX640766; CAE45870.1; -; mRNA.
DR   EMBL; AC093575; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06376.1; -; Genomic_DNA.
DR   EMBL; BC035397; AAH35397.1; -; mRNA.
DR   EMBL; BC035079; AAH35079.1; -; mRNA.
DR   EMBL; BC035818; AAH35818.1; -; mRNA.
DR   EMBL; AK074119; BAB84945.1; -; mRNA.
DR   CCDS; CCDS677.1; -. [Q8IYH5-1]
DR   CCDS; CCDS76172.1; -. [Q8IYH5-3]
DR   PIR; T12463; T12463.
DR   RefSeq; NP_001295166.1; NM_001308237.1. [Q8IYH5-3]
DR   RefSeq; NP_056349.1; NM_015534.5. [Q8IYH5-1]
DR   RefSeq; XP_005270782.1; XM_005270725.3. [Q8IYH5-1]
DR   RefSeq; XP_005270783.1; XM_005270726.3. [Q8IYH5-1]
DR   RefSeq; XP_005270784.1; XM_005270727.3. [Q8IYH5-2]
DR   RefSeq; XP_005270786.1; XM_005270729.4. [Q8IYH5-3]
DR   RefSeq; XP_016856459.1; XM_017000970.1. [Q8IYH5-2]
DR   UniGene; Hs.480506; -.
DR   PDB; 2FC7; NMR; -; A=807-886.
DR   PDB; 2YUM; NMR; -; A=652-713.
DR   PDBsum; 2FC7; -.
DR   PDBsum; 2YUM; -.
DR   ProteinModelPortal; Q8IYH5; -.
DR   SMR; Q8IYH5; -.
DR   BioGrid; 117482; 52.
DR   CORUM; Q8IYH5; -.
DR   DIP; DIP-47289N; -.
DR   IntAct; Q8IYH5; 22.
DR   MINT; Q8IYH5; -.
DR   STRING; 9606.ENSP00000359837; -.
DR   MEROPS; A22.007; -.
DR   iPTMnet; Q8IYH5; -.
DR   PhosphoSitePlus; Q8IYH5; -.
DR   BioMuta; ZZZ3; -.
DR   DMDM; 74762495; -.
DR   EPD; Q8IYH5; -.
DR   MaxQB; Q8IYH5; -.
DR   PaxDb; Q8IYH5; -.
DR   PeptideAtlas; Q8IYH5; -.
DR   PRIDE; Q8IYH5; -.
DR   DNASU; 26009; -.
DR   Ensembl; ENST00000370798; ENSP00000359834; ENSG00000036549. [Q8IYH5-3]
DR   Ensembl; ENST00000370801; ENSP00000359837; ENSG00000036549. [Q8IYH5-1]
DR   GeneID; 26009; -.
DR   KEGG; hsa:26009; -.
DR   UCSC; uc001dhq.4; human. [Q8IYH5-1]
DR   CTD; 26009; -.
DR   DisGeNET; 26009; -.
DR   EuPathDB; HostDB:ENSG00000036549.12; -.
DR   GeneCards; ZZZ3; -.
DR   HGNC; HGNC:24523; ZZZ3.
DR   HPA; HPA053663; -.
DR   HPA; HPA054913; -.
DR   HPA; HPA066197; -.
DR   neXtProt; NX_Q8IYH5; -.
DR   OpenTargets; ENSG00000036549; -.
DR   PharmGKB; PA134873184; -.
DR   eggNOG; ENOG410IHEM; Eukaryota.
DR   eggNOG; ENOG410ZINA; LUCA.
DR   GeneTree; ENSGT00390000005307; -.
DR   HOVERGEN; HBG062668; -.
DR   InParanoid; Q8IYH5; -.
DR   OMA; RACRCLI; -.
DR   OrthoDB; EOG091G0H07; -.
DR   PhylomeDB; Q8IYH5; -.
DR   TreeFam; TF106396; -.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   ChiTaRS; ZZZ3; human.
DR   EvolutionaryTrace; Q8IYH5; -.
DR   GeneWiki; ZZZ3; -.
DR   GenomeRNAi; 26009; -.
DR   PRO; PR:Q8IYH5; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000036549; -.
DR   CleanEx; HS_ZZZ3; -.
DR   ExpressionAtlas; Q8IYH5; baseline and differential.
DR   Genevisible; Q8IYH5; HS.
DR   GO; GO:0005671; C:Ada2/Gcn5/Ada3 transcription activator complex; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISM:NTNU_SB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00167; SANT; 1.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR017930; Myb_dom.
DR   InterPro; IPR001005; SANT/Myb.
DR   InterPro; IPR000433; Znf_ZZ.
DR   InterPro; IPR037830; ZZZ3.
DR   PANTHER; PTHR22705:SF0; PTHR22705:SF0; 1.
DR   Pfam; PF00249; Myb_DNA-binding; 1.
DR   Pfam; PF00569; ZZ; 1.
DR   SMART; SM00717; SANT; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS51294; HTH_MYB; 1.
DR   PROSITE; PS01357; ZF_ZZ_1; 1.
DR   PROSITE; PS50135; ZF_ZZ_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   DNA-binding; Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1    903       ZZ-type zinc finger-containing protein 3.
FT                                /FTId=PRO_0000287495.
FT   DOMAIN      647    707       HTH myb-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00625}.
FT   DNA_BIND    680    703       H-T-H motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00625}.
FT   ZN_FING     817    867       ZZ-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00228}.
FT   MOD_RES      82     82       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      89     89       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     113    113       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     130    130       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     131    131       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     135    135       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     394    394       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q6KAQ7}.
FT   MOD_RES     606    606       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     701    701       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   CROSSLNK    276    276       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    647    647       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    708    708       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1    494       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_025509.
FT   VAR_SEQ     495    502       VALKHNKD -> MIDLWLYS (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_025510.
FT   VAR_SEQ     598    598       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_025511.
FT   VAR_SEQ     661    683       KKLEQLLIKYPPEEVESRRWQKI -> VINISKSCRLKKTS
FT                                KQLTSESVL (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_025512.
FT   VAR_SEQ     684    903       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_025513.
FT   VARIANT     456    456       P -> S (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035718.
FT   CONFLICT    596    596       D -> G (in Ref. 4; AAH35079).
FT                                {ECO:0000305}.
FT   CONFLICT    655    655       W -> G (in Ref. 1; CAB45694).
FT                                {ECO:0000305}.
FT   CONFLICT    698    698       R -> Q (in Ref. 4; AAH35079).
FT                                {ECO:0000305}.
FT   CONFLICT    721    721       Y -> C (in Ref. 4; AAH35079).
FT                                {ECO:0000305}.
FT   CONFLICT    807    807       Q -> R (in Ref. 1; CAE45800).
FT                                {ECO:0000305}.
FT   CONFLICT    877    877       T -> A (in Ref. 1; CAE45870).
FT                                {ECO:0000305}.
FT   HELIX       657    669       {ECO:0000244|PDB:2YUM}.
FT   HELIX       676    687       {ECO:0000244|PDB:2YUM}.
FT   STRAND      688    690       {ECO:0000244|PDB:2YUM}.
FT   HELIX       692    703       {ECO:0000244|PDB:2YUM}.
FT   HELIX       704    706       {ECO:0000244|PDB:2YUM}.
FT   STRAND      807    809       {ECO:0000244|PDB:2FC7}.
FT   STRAND      817    820       {ECO:0000244|PDB:2FC7}.
FT   STRAND      824    826       {ECO:0000244|PDB:2FC7}.
FT   STRAND      829    833       {ECO:0000244|PDB:2FC7}.
FT   STRAND      835    841       {ECO:0000244|PDB:2FC7}.
FT   STRAND      843    845       {ECO:0000244|PDB:2FC7}.
FT   STRAND      848    850       {ECO:0000244|PDB:2FC7}.
FT   HELIX       851    853       {ECO:0000244|PDB:2FC7}.
FT   STRAND      865    867       {ECO:0000244|PDB:2FC7}.
FT   STRAND      869    872       {ECO:0000244|PDB:2FC7}.
SQ   SEQUENCE   903 AA;  102023 MW;  16ED137C0A8202EA CRC64;
     MAASRSTRVT RSTVGLNGLD ESFCGRTLRN RSIAHPEEIS SNSQVRSRSP KKRPEPVPIQ
     KGNNNGRTTD LKQQSTRESW VSPRKRGLSS SEKDNIERQA IENCERRQTE PVSPVLKRIK
     RCLRSEAPNS SEEDSPIKSD KESVEQRSTV VDNDADFQGT KRACRCLILD DCEKREIKKV
     NVSEEGPLNS AVVEEITGYL AVNGVDDSDS AVINCDDCQP DGNTKQNSIG SYVLQEKSVA
     ENGDTDTQTS MFLDSRKEDS YIDHKVPCTD SQVQVKLEDH KIVTACLPVE HVNQLTTEPA
     TGPFSETQSS LRDSEEEVDV VGDSSASKEQ CKENTNNELD TSLESMPASG EPEPSPVLDC
     VSAQMMSLSE PQEHRYTLRT SPRRAAPTRG SPTKNSSPYR ENGQFEENNL SPNETNATVS
     DNVSQSPTNP GEISQNEKGI CCDSQNNGSE GVSKPPSEAR LNIGHLPSAK ESASQHITEE
     EDDDPDVYYF ESDHVALKHN KDYQRLLQTI AVLEAQRSQA VQDLESLGRH QREALKNPIG
     FVEKLQKKAD IGLPYPQRVV QLPEIVWDQY THSLGNFERE FKNRKRHTRR VKLVFDKVGL
     PARPKSPLDP KKDGESLSYS MLPLSDGPEG SSSRPQMIRG RLCDDTKPET FNQLWTVEEQ
     KKLEQLLIKY PPEEVESRRW QKIADELGNR TAKQVASRVQ KYFIKLTKAG IPVPGRTPNL
     YIYSKKSSTS RRQHPLNKHL FKPSTFMTSH EPPVYMDEDD DRSCFHSHMN TAVEDASDDE
     SIPIMYRNLP EYKELLQFKK LKKQKLQQMQ AESGFVQHVG FKCDNCGIEP IQGVRWHCQD
     CPPEMSLDFC DSCSDCLHET DIHKEDHQLE PIYRSETFLD RDYCVSQGTS YNYLDPNYFP
     ANR
//
ID   A0A140VJG2_HUMAN        Unreviewed;       597 AA.
AC   A0A140VJG2;
DT   08-JUN-2016, integrated into UniProtKB/TrEMBL.
DT   08-JUN-2016, sequence version 1.
DT   23-MAY-2018, entry version 13.
DE   SubName: Full=Testicular tissue protein Li 36 {ECO:0000313|EMBL:AEE60949.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEE60949.1};
RN   [1] {ECO:0000313|EMBL:AEE60949.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human testis protein.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM005349; AEE60949.1; -; mRNA.
DR   RefSeq; NP_001307527.1; NM_001320598.1.
DR   RefSeq; NP_077817.2; NM_024491.3.
DR   RefSeq; XP_016862764.1; XM_017007275.1.
DR   UniGene; Hs.531962; -.
DR   ProteinModelPortal; A0A140VJG2; -.
DR   SMR; A0A140VJG2; -.
DR   PRIDE; A0A140VJG2; -.
DR   GeneID; 80321; -.
DR   KEGG; hsa:80321; -.
DR   CTD; 80321; -.
DR   KO; K16802; -.
DR   OMA; NVLLMMH; -.
DR   PhylomeDB; A0A140VJG2; -.
DR   ExpressionAtlas; A0A140VJG2; baseline and differential.
DR   GO; GO:0005813; C:centrosome; IEA:InterPro.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0043015; F:gamma-tubulin binding; IEA:InterPro.
DR   GO; GO:0060271; P:cilium assembly; IEA:InterPro.
DR   GO; GO:0070507; P:regulation of microtubule cytoskeleton organization; IEA:InterPro.
DR   InterPro; IPR037692; CEP70.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR019734; TPR_repeat.
DR   PANTHER; PTHR14594; PTHR14594; 1.
DR   PROSITE; PS50005; TPR; 1.
DR   PROSITE; PS50293; TPR_REGION; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   TPR repeat {ECO:0000256|PROSITE-ProRule:PRU00339}.
FT   REPEAT      483    516       TPR. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00339}.
FT   DOMAIN      483    516       TPR_REGION.
FT                                {ECO:0000259|PROSITE:PS50293}.
FT   COILED       77    132       {ECO:0000256|SAM:Coils}.
FT   COILED      144    178       {ECO:0000256|SAM:Coils}.
FT   COILED      259    286       {ECO:0000256|SAM:Coils}.
FT   COILED      296    326       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   597 AA;  69752 MW;  345EEEB9B1F0D6C7 CRC64;
     MFPVAPKPQD SSQPSDRLMT EKQQEEAEWE SINVLLMMHG LKPLSLVKRT DLKDLIIFDK
     QSSQRMRQNL KLLVEETSCQ QNMIQELIET NQQLRNELQL EQSRAANQEQ RANDLEQIME
     SVKSKIGELE DESLSRACHQ QNKIKDLQKE QKTLQVKCQH YKKKRTEQEE TIASLQMEVC
     RLKKEEEDRI VTQNRVFAYL CKRVPHTVLD RQLLCLIDYY ESKIRKIHTQ RQYKEDESQS
     EEENDYRNLD ASPTYKGLLM SLQNQLKESK SKIDALSSEK LNLQKDLETR PTQHELRLYK
     QQVKKLEKAL KKNVKLQELI NHKKAEDTEK KDEPSKYNQQ QALIDQRYFQ VLCSINSIIH
     NPRAPVIIYK QTKGGVQNFN KDLVQDCGFE HLVPVIEMWA DQLTSLKDLY KSLKTLSAEL
     VPWLNLKKQD ENEGIKVEDL LFIVDTMLEE VENKEKDSNM PHFQTLQAIV SHFQKLFDVP
     SLNGVYPRMN EVYTRLGEMN NAVRNLQELL ELDSSSSLCV LVSTVGKLCR LINEDVNEQV
     MQVLGPEDLQ SIIYKLEEHE EFFPAFQAFT NDLLEILEID DLDAIVPAVK KLKVLSY
//
ID   B7Z2D2_HUMAN            Unreviewed;       445 AA.
AC   B7Z2D2;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   23-MAY-2018, entry version 75.
DE   SubName: Full=Centrosomal protein of 70 kDa {ECO:0000313|Ensembl:ENSP00000417821};
DE   SubName: Full=cDNA FLJ60498, highly similar to Centrosomal protein of 70 kDa {ECO:0000313|EMBL:BAH11818.1};
GN   Name=CEP70 {ECO:0000313|Ensembl:ENSP00000417821};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH11818.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000417821, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [2] {ECO:0000313|EMBL:BAH11818.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAH11818.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000417821}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC020890; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022497; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC072045; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK294587; BAH11818.1; -; mRNA.
DR   RefSeq; NP_001275896.1; NM_001288967.1.
DR   UniGene; Hs.531962; -.
DR   Ensembl; ENST00000489254; ENSP00000417821; ENSG00000114107.
DR   GeneID; 80321; -.
DR   UCSC; uc011bmm.4; human.
DR   CTD; 80321; -.
DR   EuPathDB; HostDB:ENSG00000114107.8; -.
DR   HGNC; HGNC:29972; CEP70.
DR   OpenTargets; ENSG00000114107; -.
DR   eggNOG; ENOG410IFWI; Eukaryota.
DR   eggNOG; ENOG4111V7R; LUCA.
DR   GeneTree; ENSGT00390000009029; -.
DR   HOGENOM; HOG000290163; -.
DR   HOVERGEN; HBG050899; -.
DR   ChiTaRS; CEP70; human.
DR   GenomeRNAi; 80321; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000114107; -.
DR   GO; GO:0005813; C:centrosome; IEA:InterPro.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0043015; F:gamma-tubulin binding; IEA:InterPro.
DR   GO; GO:0060271; P:cilium assembly; IEA:InterPro.
DR   GO; GO:0070507; P:regulation of microtubule cytoskeleton organization; IEA:InterPro.
DR   InterPro; IPR037692; CEP70.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR019734; TPR_repeat.
DR   PANTHER; PTHR14594; PTHR14594; 1.
DR   PROSITE; PS50005; TPR; 1.
DR   PROSITE; PS50293; TPR_REGION; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:B7Z2D2};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   TPR repeat {ECO:0000256|PROSITE-ProRule:PRU00339}.
FT   REPEAT      331    364       TPR. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00339}.
FT   DOMAIN      331    364       TPR_REGION.
FT                                {ECO:0000259|PROSITE:PS50293}.
FT   COILED        6     26       {ECO:0000256|SAM:Coils}.
FT   COILED      107    134       {ECO:0000256|SAM:Coils}.
FT   COILED      144    174       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   445 AA;  52014 MW;  ABB654A8EB945E70 CRC64;
     MTEVKCQHYK KKRTEQEETI ASLQMEVCRL KKEEEDRIVT QNRVFAYLCK RVPHTVLDRQ
     LLCLIDYYES KIRKIHTQRQ YKEDESQSEE ENDYRNLDAS PTYKGLLMSL QNQLKESKSK
     IDALSSEKLN LQKDLETRPT QHELRLYKQQ VKKLEKALKK NVKLQELINH KKAEDTEKKD
     EPSKYNQQQA LIDQRYFQVL CSINSIIHNP RAPVIIYKQT KGGVQNFNKD LVQDCGFEHL
     VPVIEMWADQ LTSLKDLYKS LKTLSAELVP WLNLKKQDEN EGIKVEDLLF IVDTMLEEVE
     NKEKDSNMPH FQTLQAIVSH FQKLFDVPSL NGVYPRMNEV YTRLGEMNNA VRNLQELLEL
     DSSSSLCVLV STVGKLCRLI NEDVNEQVMQ VLGPEDLQSI IYKLEEHEEF FPAFQAFTND
     LLEILEIDDL DAIVPAVKKL KVLSY
//
ID   CEP70_HUMAN             Reviewed;         597 AA.
AC   Q8NHQ1; B7Z5I8; B7Z7E8; D3DNE9; F5GZX8; Q96B31; Q9H2C3; Q9H2Z1;
AC   Q9H940;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 2.
DT   23-MAY-2018, entry version 137.
DE   RecName: Full=Centrosomal protein of 70 kDa;
DE            Short=Cep70;
DE   AltName: Full=p10-binding protein;
GN   Name=CEP70; Synonyms=BITE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Chronic myeloid leukemia cell;
RA   Tschan M.P., Cajot J.-F., Grob T.J., Fey M.F., Tobler A.;
RT   "Cloning and characterization of BITE: a binding partner of the cell
RT   cycle inhibitor p10.";
RL   Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORMS 1; 4 AND 5),
RP   AND VARIANT ASN-135.
RC   TISSUE=Teratocarcinoma, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ASN-135.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORMS 1 AND 3), AND
RP   VARIANT ASN-135.
RC   TISSUE=Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A.,
RA   Mann M.;
RT   "Proteomic characterization of the human centrosome by protein
RT   correlation profiling.";
RL   Nature 426:570-574(2003).
RN   [7]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH TUBULIN-GAMMA.
RX   PubMed=21795687; DOI=10.1074/jbc.M111.252262;
RA   Shi X., Sun X., Liu M., Li D., Aneja R., Zhou J.;
RT   "CEP70 protein interacts with gamma-tubulin to localize at the
RT   centrosome and is critical for mitotic spindle assembly.";
RL   J. Biol. Chem. 286:33401-33408(2011).
CC   -!- FUNCTION: Plays a role in the organization of both preexisting and
CC       nascent microtubules in interphase cells. During mitosis, required
CC       for the organization and orientation of the mitotic spindle.
CC   -!- SUBUNIT: Directly interacts with tubulin-gamma; this interaction
CC       determines centrosomal localization.
CC       {ECO:0000269|PubMed:21795687}.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-739624, EBI-739624;
CC       Q9ULW3:ABT1; NbExp=5; IntAct=EBI-739624, EBI-2602396;
CC       Q02040:AKAP17A; NbExp=5; IntAct=EBI-739624, EBI-1042725;
CC       Q02040-3:AKAP17A; NbExp=3; IntAct=EBI-739624, EBI-10222656;
CC       Q9NR81:ARHGEF3; NbExp=5; IntAct=EBI-739624, EBI-10312733;
CC       P48047:ATP5O; NbExp=5; IntAct=EBI-739624, EBI-355815;
CC       A0AVN2:BARD1; NbExp=3; IntAct=EBI-739624, EBI-9977322;
CC       Q99728:BARD1; NbExp=3; IntAct=EBI-739624, EBI-473181;
CC       Q9BXY8:BEX2; NbExp=5; IntAct=EBI-739624, EBI-745073;
CC       O95696:BRD1; NbExp=4; IntAct=EBI-739624, EBI-714754;
CC       Q9HCU9:BRMS1; NbExp=3; IntAct=EBI-739624, EBI-714781;
CC       Q13895:BYSL; NbExp=7; IntAct=EBI-739624, EBI-358049;
CC       Q9H7E9:C8orf33; NbExp=4; IntAct=EBI-739624, EBI-715389;
CC       Q9H257:CARD9; NbExp=3; IntAct=EBI-739624, EBI-751319;
CC       Q9BW85:CCDC94; NbExp=5; IntAct=EBI-739624, EBI-10300345;
CC       Q6P1J9:CDC73; NbExp=9; IntAct=EBI-739624, EBI-930143;
CC       Q96GN5:CDCA7L; NbExp=5; IntAct=EBI-739624, EBI-5278764;
CC       Q8IYX8:CEP57L1; NbExp=3; IntAct=EBI-739624, EBI-1104570;
CC       Q8IYX8-2:CEP57L1; NbExp=3; IntAct=EBI-739624, EBI-10181988;
CC       Q8NHQ1-3:CEP70; NbExp=3; IntAct=EBI-739624, EBI-11526150;
CC       Q96M91:CFAP53; NbExp=3; IntAct=EBI-739624, EBI-742422;
CC       Q9H078:CLPB; NbExp=3; IntAct=EBI-739624, EBI-2107221;
CC       P38432:COIL; NbExp=3; IntAct=EBI-739624, EBI-945751;
CC       Q9UJV9:DDX41; NbExp=3; IntAct=EBI-739624, EBI-1046350;
CC       P26196:DDX6; NbExp=5; IntAct=EBI-739624, EBI-351257;
CC       Q68CQ4:DIEXF; NbExp=5; IntAct=EBI-739624, EBI-747711;
CC       Q14241:ELOA; NbExp=3; IntAct=EBI-739624, EBI-742350;
CC       P50402:EMD; NbExp=6; IntAct=EBI-739624, EBI-489887;
CC       P54849:EMP1; NbExp=3; IntAct=EBI-739624, EBI-4319440;
CC       Q9H0I2:ENKD1; NbExp=4; IntAct=EBI-739624, EBI-744099;
CC       P19447:ERCC3; NbExp=3; IntAct=EBI-739624, EBI-1183307;
CC       Q86V42:FAM124A; NbExp=3; IntAct=EBI-739624, EBI-744506;
CC       Q8N9E0:FAM133A; NbExp=5; IntAct=EBI-739624, EBI-10268158;
CC       Q8NE31:FAM13C; NbExp=3; IntAct=EBI-739624, EBI-751248;
CC       Q3B820:FAM161A; NbExp=7; IntAct=EBI-739624, EBI-719941;
CC       Q7L5A3:FAM214B; NbExp=3; IntAct=EBI-739624, EBI-745689;
CC       Q8WXI9:GATAD2B; NbExp=3; IntAct=EBI-739624, EBI-923440;
CC       Q96CN9:GCC1; NbExp=5; IntAct=EBI-739624, EBI-746252;
CC       Q8IVS8:GLYCTK; NbExp=4; IntAct=EBI-739624, EBI-748515;
CC       Q9NWQ4:GPATCH2L; NbExp=3; IntAct=EBI-739624, EBI-5666657;
CC       Q5T3I0:GPATCH4; NbExp=5; IntAct=EBI-739624, EBI-2372076;
CC       Q96SL4:GPX7; NbExp=3; IntAct=EBI-739624, EBI-749411;
CC       Q96CS2:HAUS1; NbExp=3; IntAct=EBI-739624, EBI-2514791;
CC       Q96CS2-2:HAUS1; NbExp=3; IntAct=EBI-739624, EBI-11742270;
CC       Q6NSH1:HMGB4; NbExp=3; IntAct=EBI-739624, EBI-10250889;
CC       Q8WW32:HMGB4; NbExp=5; IntAct=EBI-739624, EBI-10277297;
CC       P10809:HSPD1; NbExp=6; IntAct=EBI-739624, EBI-352528;
CC       Q13123:IK; NbExp=3; IntAct=EBI-739624, EBI-713456;
CC       Q15735:INPP5J; NbExp=4; IntAct=EBI-739624, EBI-10236940;
CC       Q63ZY3:KANK2; NbExp=5; IntAct=EBI-739624, EBI-2556193;
CC       Q7Z3B3:KANSL1; NbExp=4; IntAct=EBI-739624, EBI-740244;
CC       O60341:KDM1A; NbExp=2; IntAct=EBI-739624, EBI-710124;
CC       Q15323:KRT31; NbExp=3; IntAct=EBI-739624, EBI-948001;
CC       A0A0C4DGV4:LAMTOR5; NbExp=5; IntAct=EBI-739624, EBI-10173304;
CC       Q96BZ8:LENG1; NbExp=5; IntAct=EBI-739624, EBI-726510;
CC       Q96PV6:LENG8; NbExp=3; IntAct=EBI-739624, EBI-739546;
CC       Q96GY3:LIN37; NbExp=3; IntAct=EBI-739624, EBI-748884;
CC       Q9H7H0:METTL17; NbExp=6; IntAct=EBI-739624, EBI-749353;
CC       Q9H7H0-2:METTL17; NbExp=3; IntAct=EBI-739624, EBI-11098807;
CC       P55081:MFAP1; NbExp=5; IntAct=EBI-739624, EBI-1048159;
CC       Q9BU76:MMTAG2; NbExp=4; IntAct=EBI-739624, EBI-742459;
CC       Q9UFN0:NIPSNAP3A; NbExp=3; IntAct=EBI-739624, EBI-716291;
CC       Q6ZUT1:NKAPD1; NbExp=5; IntAct=EBI-739624, EBI-3920396;
CC       Q6ZUT1-2:NKAPD1; NbExp=3; IntAct=EBI-739624, EBI-10180231;
CC       Q9UGY1:NOL12; NbExp=3; IntAct=EBI-739624, EBI-716098;
CC       P46087:NOP2; NbExp=3; IntAct=EBI-739624, EBI-356811;
CC       P48552:NRIP1; NbExp=3; IntAct=EBI-739624, EBI-746484;
CC       Q9BXS6:NUSAP1; NbExp=3; IntAct=EBI-739624, EBI-2555618;
CC       A0A087WUI6:PIBF1; NbExp=3; IntAct=EBI-739624, EBI-11749468;
CC       Q9BSJ6:PIMREG; NbExp=6; IntAct=EBI-739624, EBI-2568609;
CC       Q13427:PPIG; NbExp=3; IntAct=EBI-739624, EBI-396072;
CC       Q96T49:PPP1R16B; NbExp=3; IntAct=EBI-739624, EBI-10293968;
CC       Q9H875:PRKRIP1; NbExp=3; IntAct=EBI-739624, EBI-744488;
CC       Q99633:PRPF18; NbExp=4; IntAct=EBI-739624, EBI-2798416;
CC       O43395:PRPF3; NbExp=4; IntAct=EBI-739624, EBI-744322;
CC       Q8WWY3:PRPF31; NbExp=8; IntAct=EBI-739624, EBI-1567797;
CC       P25786:PSMA1; NbExp=5; IntAct=EBI-739624, EBI-359352;
CC       P98175:RBM10; NbExp=5; IntAct=EBI-739624, EBI-721525;
CC       A0A0S2Z4G9:RNF6; NbExp=3; IntAct=EBI-739624, EBI-16428950;
CC       P26373:RPL13; NbExp=3; IntAct=EBI-739624, EBI-356849;
CC       Q6NZ55:RPL13; NbExp=3; IntAct=EBI-739624, EBI-10252046;
CC       Q9C0A6-2:SETD5; NbExp=3; IntAct=EBI-739624, EBI-10303449;
CC       Q86XK3:SFR1; NbExp=3; IntAct=EBI-739624, EBI-1104535;
CC       Q9H788-2:SH2D4A; NbExp=3; IntAct=EBI-739624, EBI-10308083;
CC       O95391:SLU7; NbExp=3; IntAct=EBI-739624, EBI-750559;
CC       Q969G3:SMARCE1; NbExp=7; IntAct=EBI-739624, EBI-455078;
CC       P62316:SNRPD2; NbExp=3; IntAct=EBI-739624, EBI-297993;
CC       Q99909:SSX3; NbExp=3; IntAct=EBI-739624, EBI-10295431;
CC       O00506:STK25; NbExp=3; IntAct=EBI-739624, EBI-618295;
CC       O43463:SUV39H1; NbExp=3; IntAct=EBI-739624, EBI-349968;
CC       Q9BSW7:SYT17; NbExp=3; IntAct=EBI-739624, EBI-745392;
CC       Q96C24:SYTL4; NbExp=3; IntAct=EBI-739624, EBI-747142;
CC       Q8TDW5:SYTL5; NbExp=3; IntAct=EBI-739624, EBI-2939487;
CC       Q9H5J8:TAF1D; NbExp=4; IntAct=EBI-739624, EBI-716128;
CC       A0A0S2Z4E5:TEAD4; NbExp=3; IntAct=EBI-739624, EBI-16432288;
CC       A0A0S2Z4F2:TEAD4; NbExp=3; IntAct=EBI-739624, EBI-16429215;
CC       D3DUQ6:TEAD4; NbExp=3; IntAct=EBI-739624, EBI-10176734;
CC       Q14134:TRIM29; NbExp=4; IntAct=EBI-739624, EBI-702370;
CC       Q8IWZ5:TRIM42; NbExp=3; IntAct=EBI-739624, EBI-5235829;
CC       P43897:TSFM; NbExp=3; IntAct=EBI-739624, EBI-1049298;
CC       Q3SY00:TSGA10IP; NbExp=5; IntAct=EBI-739624, EBI-10241197;
CC       Q63HK5:TSHZ3; NbExp=3; IntAct=EBI-739624, EBI-9053916;
CC       Q96NG3:TTC25; NbExp=3; IntAct=EBI-739624, EBI-1046387;
CC       Q6ZVT0:TTLL10; NbExp=3; IntAct=EBI-739624, EBI-7844656;
CC       Q8N3L3:TXLNB; NbExp=5; IntAct=EBI-739624, EBI-6116822;
CC       Q9Y3A2:UTP11; NbExp=3; IntAct=EBI-739624, EBI-2876697;
CC       Q05516:ZBTB16; NbExp=3; IntAct=EBI-739624, EBI-711925;
CC       O43167:ZBTB24; NbExp=5; IntAct=EBI-739624, EBI-744471;
CC       Q6ZSB9:ZBTB49; NbExp=3; IntAct=EBI-739624, EBI-2859943;
CC       Q8TBK6:ZCCHC10; NbExp=3; IntAct=EBI-739624, EBI-597063;
CC       G3V1X1:ZFC3H1; NbExp=3; IntAct=EBI-739624, EBI-6448783;
CC       A0A0S2Z6H0:ZGPAT; NbExp=3; IntAct=EBI-739624, EBI-16428984;
CC       Q8N5A5:ZGPAT; NbExp=3; IntAct=EBI-739624, EBI-3439227;
CC       Q8N5A5-2:ZGPAT; NbExp=10; IntAct=EBI-739624, EBI-10183064;
CC       P52737:ZNF136; NbExp=5; IntAct=EBI-739624, EBI-749129;
CC       Q9UQR1:ZNF148; NbExp=3; IntAct=EBI-739624, EBI-2688184;
CC       Q14929:ZNF169; NbExp=3; IntAct=EBI-739624, EBI-10234472;
CC       Q86WZ6:ZNF227; NbExp=5; IntAct=EBI-739624, EBI-2799529;
CC       Q16600:ZNF239; NbExp=5; IntAct=EBI-739624, EBI-8787052;
CC       Q14584:ZNF266; NbExp=5; IntAct=EBI-739624, EBI-7115319;
CC       Q9NR11:ZNF302; NbExp=3; IntAct=EBI-739624, EBI-3916142;
CC       Q86UD4:ZNF329; NbExp=5; IntAct=EBI-739624, EBI-7233259;
CC       Q8N895:ZNF366; NbExp=5; IntAct=EBI-739624, EBI-2813661;
CC       Q9H9D4:ZNF408; NbExp=8; IntAct=EBI-739624, EBI-347633;
CC       Q86VK4:ZNF410; NbExp=3; IntAct=EBI-739624, EBI-720304;
CC       Q8TAU3:ZNF417; NbExp=5; IntAct=EBI-739624, EBI-740727;
CC       Q8NDP4:ZNF439; NbExp=3; IntAct=EBI-739624, EBI-747580;
CC       Q9ULM2:ZNF490; NbExp=5; IntAct=EBI-739624, EBI-1105370;
CC       Q8NEP9:ZNF555; NbExp=3; IntAct=EBI-739624, EBI-10270752;
CC       Q7Z3I7:ZNF572; NbExp=6; IntAct=EBI-739624, EBI-10172590;
CC       Q3MI94:ZNF578; NbExp=3; IntAct=EBI-739624, EBI-10241108;
CC       Q96SQ5:ZNF587; NbExp=5; IntAct=EBI-739624, EBI-6427977;
CC       Q96NL3:ZNF599; NbExp=4; IntAct=EBI-739624, EBI-8653994;
CC       A0A0S2Z5X4:ZNF688; NbExp=3; IntAct=EBI-739624, EBI-16429014;
CC       O43309:ZSCAN12; NbExp=3; IntAct=EBI-739624, EBI-1210440;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:14654843,
CC       ECO:0000269|PubMed:21795687}. Note=Localized at the center of the
CC       radial microtubule array in interphase and at the spindle poles
CC       during various stages of mitosis.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q8NHQ1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NHQ1-2; Sequence=VSP_012746, VSP_012747;
CC       Name=3;
CC         IsoId=Q8NHQ1-3; Sequence=VSP_012745;
CC       Name=4;
CC         IsoId=Q8NHQ1-4; Sequence=VSP_042140;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q8NHQ1-5; Sequence=VSP_042140, VSP_042141;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The coiled-coil domains may be important for tubulin-
CC       gamma-binding and hence for centrosomal localization.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF202146; AAG35616.1; -; mRNA.
DR   EMBL; AF289495; AAG35791.1; -; mRNA.
DR   EMBL; AK023098; BAB14403.1; -; mRNA.
DR   EMBL; AK299003; BAH12924.1; -; mRNA.
DR   EMBL; AK301913; BAH13584.1; -; mRNA.
DR   EMBL; AC020890; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC072045; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW79062.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79063.1; -; Genomic_DNA.
DR   EMBL; BC016050; AAH16050.1; -; mRNA.
DR   EMBL; BC030598; AAH30598.1; -; mRNA.
DR   CCDS; CCDS3102.1; -. [Q8NHQ1-1]
DR   CCDS; CCDS75022.1; -. [Q8NHQ1-4]
DR   CCDS; CCDS75023.1; -. [Q8NHQ1-2]
DR   CCDS; CCDS82842.1; -. [Q8NHQ1-3]
DR   RefSeq; NP_001275893.1; NM_001288964.1. [Q8NHQ1-4]
DR   RefSeq; NP_001275894.1; NM_001288965.1. [Q8NHQ1-5]
DR   RefSeq; NP_001275895.1; NM_001288966.1. [Q8NHQ1-2]
DR   RefSeq; NP_001275896.1; NM_001288967.1.
DR   RefSeq; NP_001307527.1; NM_001320598.1. [Q8NHQ1-1]
DR   RefSeq; NP_001307529.1; NM_001320600.1. [Q8NHQ1-3]
DR   RefSeq; NP_077817.2; NM_024491.3. [Q8NHQ1-1]
DR   RefSeq; XP_016862764.1; XM_017007275.1. [Q8NHQ1-1]
DR   UniGene; Hs.531962; -.
DR   ProteinModelPortal; Q8NHQ1; -.
DR   SMR; Q8NHQ1; -.
DR   BioGrid; 123234; 143.
DR   IntAct; Q8NHQ1; 246.
DR   MINT; Q8NHQ1; -.
DR   STRING; 9606.ENSP00000264982; -.
DR   iPTMnet; Q8NHQ1; -.
DR   PhosphoSitePlus; Q8NHQ1; -.
DR   BioMuta; CEP70; -.
DR   DMDM; 84028943; -.
DR   EPD; Q8NHQ1; -.
DR   PaxDb; Q8NHQ1; -.
DR   PeptideAtlas; Q8NHQ1; -.
DR   PRIDE; Q8NHQ1; -.
DR   DNASU; 80321; -.
DR   Ensembl; ENST00000264982; ENSP00000264982; ENSG00000114107. [Q8NHQ1-1]
DR   Ensembl; ENST00000464035; ENSP00000419743; ENSG00000114107. [Q8NHQ1-3]
DR   Ensembl; ENST00000474781; ENSP00000419833; ENSG00000114107. [Q8NHQ1-4]
DR   Ensembl; ENST00000481834; ENSP00000417465; ENSG00000114107. [Q8NHQ1-2]
DR   Ensembl; ENST00000484888; ENSP00000419231; ENSG00000114107. [Q8NHQ1-1]
DR   GeneID; 80321; -.
DR   KEGG; hsa:80321; -.
DR   UCSC; uc003esl.5; human. [Q8NHQ1-1]
DR   CTD; 80321; -.
DR   DisGeNET; 80321; -.
DR   EuPathDB; HostDB:ENSG00000114107.8; -.
DR   GeneCards; CEP70; -.
DR   H-InvDB; HIX0018484; -.
DR   HGNC; HGNC:29972; CEP70.
DR   HPA; HPA036941; -.
DR   HPA; HPA036942; -.
DR   MIM; 614310; gene.
DR   neXtProt; NX_Q8NHQ1; -.
DR   OpenTargets; ENSG00000114107; -.
DR   PharmGKB; PA128394729; -.
DR   eggNOG; ENOG410IFWI; Eukaryota.
DR   eggNOG; ENOG4111V7R; LUCA.
DR   GeneTree; ENSGT00390000009029; -.
DR   HOGENOM; HOG000290163; -.
DR   HOVERGEN; HBG050899; -.
DR   InParanoid; Q8NHQ1; -.
DR   KO; K16802; -.
DR   OMA; NVLLMMH; -.
DR   OrthoDB; EOG091G08G2; -.
DR   PhylomeDB; Q8NHQ1; -.
DR   TreeFam; TF330986; -.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   ChiTaRS; CEP70; human.
DR   GeneWiki; CEP70; -.
DR   GenomeRNAi; 80321; -.
DR   PRO; PR:Q8NHQ1; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000114107; -.
DR   CleanEx; HS_CEP70; -.
DR   ExpressionAtlas; Q8NHQ1; baseline and differential.
DR   Genevisible; Q8NHQ1; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0043015; F:gamma-tubulin binding; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0070507; P:regulation of microtubule cytoskeleton organization; IEA:InterPro.
DR   InterPro; IPR037692; CEP70.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR019734; TPR_repeat.
DR   PANTHER; PTHR14594; PTHR14594; 1.
DR   PROSITE; PS50005; TPR; 1.
DR   PROSITE; PS50293; TPR_REGION; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Polymorphism; Reference proteome; TPR repeat.
FT   CHAIN         1    597       Centrosomal protein of 70 kDa.
FT                                /FTId=PRO_0000089497.
FT   REPEAT      483    516       TPR.
FT   COILED       75    179       {ECO:0000255}.
FT   COILED      254    326       {ECO:0000255}.
FT   VAR_SEQ       1     18       Missing (in isoform 4 and isoform 5).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_042140.
FT   VAR_SEQ      22     23       Missing (in isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_042141.
FT   VAR_SEQ     213    597       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_012745.
FT   VAR_SEQ     551    554       SIIY -> RYLF (in isoform 2).
FT                                {ECO:0000303|Ref.1}.
FT                                /FTId=VSP_012746.
FT   VAR_SEQ     555    597       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.1}.
FT                                /FTId=VSP_012747.
FT   VARIANT     135    135       S -> N (in dbSNP:rs1673607).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_021177.
FT   VARIANT     537    537       N -> S (in dbSNP:rs35340237).
FT                                /FTId=VAR_061590.
FT   CONFLICT     52     52       Missing (in Ref. 2; BAB14403).
FT                                {ECO:0000305}.
FT   CONFLICT    293    293       Q -> L (in Ref. 2; BAH12924).
FT                                {ECO:0000305}.
FT   CONFLICT    371    371       Q -> R (in Ref. 2; BAB14403).
FT                                {ECO:0000305}.
FT   CONFLICT    385    385       Q -> R (in Ref. 2; BAH13584).
FT                                {ECO:0000305}.
FT   CONFLICT    393    393       V -> A (in Ref. 2; BAH13584).
FT                                {ECO:0000305}.
FT   CONFLICT    471    471       S -> P (in Ref. 1; AAG35616/AAG35791).
FT                                {ECO:0000305}.
FT   CONFLICT    478    478       D -> G (in Ref. 1; AAG35616/AAG35791).
FT                                {ECO:0000305}.
SQ   SEQUENCE   597 AA;  69752 MW;  345EEEB9B1F0D6C7 CRC64;
     MFPVAPKPQD SSQPSDRLMT EKQQEEAEWE SINVLLMMHG LKPLSLVKRT DLKDLIIFDK
     QSSQRMRQNL KLLVEETSCQ QNMIQELIET NQQLRNELQL EQSRAANQEQ RANDLEQIME
     SVKSKIGELE DESLSRACHQ QNKIKDLQKE QKTLQVKCQH YKKKRTEQEE TIASLQMEVC
     RLKKEEEDRI VTQNRVFAYL CKRVPHTVLD RQLLCLIDYY ESKIRKIHTQ RQYKEDESQS
     EEENDYRNLD ASPTYKGLLM SLQNQLKESK SKIDALSSEK LNLQKDLETR PTQHELRLYK
     QQVKKLEKAL KKNVKLQELI NHKKAEDTEK KDEPSKYNQQ QALIDQRYFQ VLCSINSIIH
     NPRAPVIIYK QTKGGVQNFN KDLVQDCGFE HLVPVIEMWA DQLTSLKDLY KSLKTLSAEL
     VPWLNLKKQD ENEGIKVEDL LFIVDTMLEE VENKEKDSNM PHFQTLQAIV SHFQKLFDVP
     SLNGVYPRMN EVYTRLGEMN NAVRNLQELL ELDSSSSLCV LVSTVGKLCR LINEDVNEQV
     MQVLGPEDLQ SIIYKLEEHE EFFPAFQAFT NDLLEILEID DLDAIVPAVK KLKVLSY
//
ID   NC2A_HUMAN              Reviewed;         205 AA.
AC   Q14919; Q13448;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   28-MAR-2018, entry version 149.
DE   RecName: Full=Dr1-associated corepressor;
DE   AltName: Full=Dr1-associated protein 1;
DE   AltName: Full=Negative cofactor 2-alpha;
DE            Short=NC2-alpha;
GN   Name=DRAP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 2-31,
RP   FUNCTION, PHOSPHORYLATION, INTERACTION WITH DR1, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=B-cell;
RX   PubMed=8670811;
RA   Goppelt A.R., Stelzer G., Lottspeich F., Meisterernst M.;
RT   "A mechanism for repression of class II gene transcription through
RT   specific binding of NC2 to TBP-promoter complexes via heterodimeric
RT   histone fold domains.";
RL   EMBO J. 15:3105-3116(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), PROTEIN SEQUENCE OF
RP   20-26; 30-39 AND 72-91, FUNCTION, INTERACTION WITH DR1,
RP   PHOSPHORYLATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=8608938; DOI=10.1101/gad.10.8.1033;
RA   Mermelstein F., Yeung K., Cao J., Inostroza J.A.,
RA   Erdjument-Bromage H., Eagelson K., Landsman D., Levitt P., Tempst P.,
RA   Reinberg D.;
RT   "Requirement of a corepressor for Dr1-mediated repression of
RT   transcription.";
RL   Genes Dev. 10:1033-1048(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH BTAF1.
RX   PubMed=15509807; DOI=10.1128/MCB.24.22.10072-10082.2004;
RA   Klejman M.P., Pereira L.A., van Zeeburg H.J.T., Gilfillan S.,
RA   Meisterernst M., Timmers H.T.M.;
RT   "NC2alpha interacts with BTAF1 and stimulates its ATP-dependent
RT   association with TATA-binding protein.";
RL   Mol. Cell. Biol. 24:10072-10082(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.62 ANGSTROMS) OF 1-77 IN COMPLEX WITH DR1;
RP   TBP AND DNA.
RX   PubMed=11461703; DOI=10.1016/S0092-8674(01)00417-2;
RA   Kamada K., Shu F., Chen H., Malik S., Stelzer G., Roeder R.G.,
RA   Meisterernst M., Burley S.K.;
RT   "Crystal structure of negative cofactor 2 recognizing the TBP-DNA
RT   transcription complex.";
RL   Cell 106:71-81(2001).
CC   -!- FUNCTION: The association of the DR1/DRAP1 heterodimer with TBP
CC       results in a functional repression of both activated and basal
CC       transcription of class II genes. This interaction precludes the
CC       formation of a transcription-competent complex by inhibiting the
CC       association of TFIIA and/or TFIIB with TBP. Can bind to DNA on its
CC       own. {ECO:0000269|PubMed:8608938, ECO:0000269|PubMed:8670811}.
CC   -!- SUBUNIT: Heterodimer with DR1. Binds BTAF1.
CC       {ECO:0000269|PubMed:11461703}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-712941, EBI-712941;
CC       Q00403:GTF2B; NbExp=5; IntAct=EBI-712941, EBI-389564;
CC       P25791:LMO2; NbExp=3; IntAct=EBI-712941, EBI-739696;
CC       Q9UBU8-2:MORF4L1; NbExp=4; IntAct=EBI-712941, EBI-10288852;
CC       O43639:NCK2; NbExp=3; IntAct=EBI-712941, EBI-713635;
CC       P25208:NFYB; NbExp=4; IntAct=EBI-712941, EBI-389728;
CC       Q9NRF9:POLE3; NbExp=6; IntAct=EBI-712941, EBI-744901;
CC       Q9BW04:SARG; NbExp=4; IntAct=EBI-712941, EBI-2320464;
CC       O00560:SDCBP; NbExp=4; IntAct=EBI-712941, EBI-727004;
CC       Q16594:TAF9; NbExp=8; IntAct=EBI-712941, EBI-712521;
CC       Q9HBM6:TAF9B; NbExp=6; IntAct=EBI-712941, EBI-751601;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q14919-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14919-2; Sequence=VSP_012215;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in adult testis,
CC       heart, skeletal muscle, pancreas and brain, and in fetal brain,
CC       liver and kidney. {ECO:0000269|PubMed:8608938,
CC       ECO:0000269|PubMed:8670811}.
CC   -!- PTM: Phosphorylation reduces DNA binding, but has no effect on
CC       heterodimerization and TBP binding. {ECO:0000269|PubMed:8608938,
CC       ECO:0000269|PubMed:8670811}.
CC   -!- SIMILARITY: Belongs to the NC2 alpha/DRAP1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X96506; CAA65358.1; -; mRNA.
DR   EMBL; U41843; AAB02192.1; -; mRNA.
DR   EMBL; BC010025; AAH10025.1; -; mRNA.
DR   CCDS; CCDS8123.1; -. [Q14919-1]
DR   PIR; S70618; S70618.
DR   RefSeq; NP_006433.2; NM_006442.3. [Q14919-1]
DR   UniGene; Hs.356742; -.
DR   PDB; 1JFI; X-ray; 2.62 A; A=1-77.
DR   PDBsum; 1JFI; -.
DR   ProteinModelPortal; Q14919; -.
DR   SMR; Q14919; -.
DR   BioGrid; 115838; 31.
DR   CORUM; Q14919; -.
DR   IntAct; Q14919; 31.
DR   MINT; Q14919; -.
DR   STRING; 9606.ENSP00000307850; -.
DR   iPTMnet; Q14919; -.
DR   PhosphoSitePlus; Q14919; -.
DR   BioMuta; DRAP1; -.
DR   DMDM; 56404465; -.
DR   EPD; Q14919; -.
DR   MaxQB; Q14919; -.
DR   PaxDb; Q14919; -.
DR   PeptideAtlas; Q14919; -.
DR   PRIDE; Q14919; -.
DR   DNASU; 10589; -.
DR   Ensembl; ENST00000312515; ENSP00000307850; ENSG00000175550. [Q14919-1]
DR   GeneID; 10589; -.
DR   KEGG; hsa:10589; -.
DR   UCSC; uc001ogj.3; human. [Q14919-1]
DR   CTD; 10589; -.
DR   DisGeNET; 10589; -.
DR   EuPathDB; HostDB:ENSG00000175550.7; -.
DR   GeneCards; DRAP1; -.
DR   HGNC; HGNC:3019; DRAP1.
DR   HPA; HPA006790; -.
DR   MIM; 602289; gene.
DR   neXtProt; NX_Q14919; -.
DR   OpenTargets; ENSG00000175550; -.
DR   PharmGKB; PA27476; -.
DR   eggNOG; KOG1659; Eukaryota.
DR   eggNOG; COG5247; LUCA.
DR   GeneTree; ENSGT00390000012424; -.
DR   HOGENOM; HOG000113741; -.
DR   HOVERGEN; HBG051403; -.
DR   InParanoid; Q14919; -.
DR   KO; K21752; -.
DR   PhylomeDB; Q14919; -.
DR   TreeFam; TF313964; -.
DR   Reactome; R-HSA-1181150; Signaling by NODAL.
DR   Reactome; R-HSA-1502540; Signaling by Activin.
DR   SIGNOR; Q14919; -.
DR   ChiTaRS; DRAP1; human.
DR   EvolutionaryTrace; Q14919; -.
DR   GeneWiki; DRAP1; -.
DR   GenomeRNAi; 10589; -.
DR   PRO; PR:Q14919; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000175550; -.
DR   CleanEx; HS_DRAP1; -.
DR   ExpressionAtlas; Q14919; baseline and differential.
DR   Genevisible; Q14919; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISM:NTNU_SB.
DR   GO; GO:0003714; F:transcription corepressor activity; TAS:ProtInc.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; TAS:ProtInc.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR003958; CBFA_NFYB_domain.
DR   InterPro; IPR009072; Histone-fold.
DR   Pfam; PF00808; CBFD_NFYB_HMF; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; DNA-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repressor; Transcription;
KW   Transcription regulation.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:8670811}.
FT   CHAIN         2    205       Dr1-associated corepressor.
FT                                /FTId=PRO_0000080001.
FT   DOMAIN       14     77       Histone-fold.
FT   COMPBIAS      4      7       Poly-Lys.
FT   COMPBIAS    158    195       Pro-rich.
FT   VAR_SEQ     111    111       G -> WTVPSQR (in isoform 2).
FT                                {ECO:0000303|PubMed:8608938}.
FT                                /FTId=VSP_012215.
FT   CONFLICT      2     15       PSKKKKYNARFPPA -> EF (in Ref. 2; AA
FT                                sequence). {ECO:0000305}.
FT   HELIX        14     21       {ECO:0000244|PDB:1JFI}.
FT   HELIX        34     58       {ECO:0000244|PDB:1JFI}.
FT   HELIX        67     71       {ECO:0000244|PDB:1JFI}.
SQ   SEQUENCE   205 AA;  22350 MW;  6154C43C6B8DC877 CRC64;
     MPSKKKKYNA RFPPARIKKI MQTDEEIGKV AAAVPVIISR ALELFLESLL KKACQVTQSR
     NAKTMTTSHL KQCIELEQQF DFLKDLVASV PDMQGDGEDN HMDGDKGARR GRKPGSGGRK
     NGGMGTKSKD KKLSGTDSEQ EDESEDTDTD GEEETSQPPP QASHPSAHFQ SPPTPFLPFA
     STLPLPPAPP GPSAPDEEDE EDYDS
//
ID   EIF3D_HUMAN             Reviewed;         548 AA.
AC   O15371; A8MWD3; B2R7D4; B4DTF8; B4DVY1; Q3MJD9; Q5M9Q6;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   23-MAY-2018, entry version 173.
DE   RecName: Full=Eukaryotic translation initiation factor 3 subunit D {ECO:0000255|HAMAP-Rule:MF_03003};
DE            Short=eIF3d {ECO:0000255|HAMAP-Rule:MF_03003};
DE   AltName: Full=Eukaryotic translation initiation factor 3 subunit 7 {ECO:0000255|HAMAP-Rule:MF_03003};
DE   AltName: Full=eIF-3-zeta {ECO:0000255|HAMAP-Rule:MF_03003};
DE   AltName: Full=eIF3 p66;
GN   Name=EIF3D {ECO:0000255|HAMAP-Rule:MF_03003};
GN   Synonyms=EIF3S7 {ECO:0000255|HAMAP-Rule:MF_03003};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=9341143; DOI=10.1074/jbc.272.43.27042;
RA   Asano K., Vornlocher H.-P., Richter-Cook N.J., Merrick W.C.,
RA   Hinnebusch A.G., Hershey J.W.B.;
RT   "Structure of cDNAs encoding human eukaryotic initiation factor 3
RT   subunits. Possible roles in RNA binding and macromolecular assembly.";
RL   J. Biol. Chem. 272:27042-27052(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Placenta, and Stomach;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, Lung, Muscle, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH NORWALK VIRUS VPG PROTEIN (MICROBIAL INFECTION).
RX   PubMed=12773399; DOI=10.1093/emboj/cdg251;
RA   Daughenbaugh K.F., Fraser C.S., Hershey J.W., Hardy M.E.;
RT   "The genome-linked protein VPg of the Norwalk virus binds eIF3,
RT   suggesting its role in translation initiation complex recruitment.";
RL   EMBO J. 22:2852-2859(2003).
RN   [9]
RP   CHARACTERIZATION OF THE EIF-3 COMPLEX.
RX   PubMed=15703437; DOI=10.1261/rna.7215305;
RA   Kolupaeva V.G., Unbehaun A., Lomakin I.B., Hellen C.U.T.,
RA   Pestova T.V.;
RT   "Binding of eukaryotic initiation factor 3 to ribosomal 40S subunits
RT   and its role in ribosomal dissociation and anti-association.";
RL   RNA 11:470-486(2005).
RN   [10]
RP   IDENTIFICATION IN THE EIF-3 COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=16766523; DOI=10.1074/jbc.M605418200;
RA   LeFebvre A.K., Korneeva N.L., Trutschl M., Cvek U., Duzan R.D.,
RA   Bradley C.A., Hershey J.W.B., Rhoads R.E.;
RT   "Translation initiation factor eIF4G-1 binds to eIF3 through the eIF3e
RT   subunit.";
RL   J. Biol. Chem. 281:22917-22932(2006).
RN   [11]
RP   CHARACTERIZATION OF THE EIF-3 COMPLEX.
RX   PubMed=17581632; DOI=10.1038/sj.emboj.7601765;
RA   Masutani M., Sonenberg N., Yokoyama S., Imataka H.;
RT   "Reconstitution reveals the functional core of mammalian eIF3.";
RL   EMBO J. 26:3373-3383(2007).
RN   [12]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=18056426; DOI=10.1101/gad.439507;
RA   Poyry T.A., Kaminski A., Connell E.J., Fraser C.S., Jackson R.J.;
RT   "The mechanism of an exceptional case of reinitiation after
RT   translation of a long ORF reveals why such events do not generally
RT   occur in mammalian mRNA translation.";
RL   Genes Dev. 21:3149-3162(2007).
RN   [13]
RP   IDENTIFICATION IN THE EIF-3 COMPLEX, CHARACTERIZATION OF THE EIF-3
RP   COMPLEX, AND MASS SPECTROMETRY.
RX   PubMed=17322308; DOI=10.1074/mcp.M600399-MCP200;
RA   Damoc E., Fraser C.S., Zhou M., Videler H., Mayeur G.L.,
RA   Hershey J.W.B., Doudna J.A., Robinson C.V., Leary J.A.;
RT   "Structural characterization of the human eukaryotic initiation factor
RT   3 protein complex by mass spectrometry.";
RL   Mol. Cell. Proteomics 6:1135-1146(2007).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-529, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   FUNCTION, IDENTIFICATION IN THE EIF-3 COMPLEX, CHARACTERIZATION OF THE
RP   EIF-3 COMPLEX, AND MASS SPECTROMETRY.
RX   PubMed=18599441; DOI=10.1073/pnas.0801313105;
RA   Zhou M., Sandercock A.M., Fraser C.S., Ridlova G., Stephens E.,
RA   Schenauer M.R., Yokoi-Fong T., Barsky D., Leary J.A., Hershey J.W.B.,
RA   Doudna J.A., Robinson C.V.;
RT   "Mass spectrometry reveals modularity and a complete subunit
RT   interaction map of the eukaryotic translation factor eIF3.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:18139-18144(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-528 AND SER-529, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-529, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-161, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   POSSIBLE INVOLVEMENT IN CANCER.
RX   PubMed=25370813; DOI=10.1042/BSR20140078;
RA   Yu X., Zheng B., Chai R.;
RT   "Lentivirus-mediated knockdown of eukaryotic translation initiation
RT   factor 3 subunit D inhibits proliferation of HCT116 colon cancer
RT   cells.";
RL   Biosci. Rep. 34:E00161-E00161(2014).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   POSSIBLE INVOLVEMENT IN CANCER.
RX   PubMed=25322666; DOI=10.1002/bab.1305;
RA   Li H., Zhou F., Wang H., Lin D., Chen G., Zuo X., Sun L., Zhang X.,
RA   Yang S.;
RT   "Knockdown of EIF3D suppresses proliferation of human melanoma cells
RT   through G2/M phase arrest.";
RL   Biotechnol. Appl. Biochem. 62:615-620(2015).
RN   [25]
RP   POSSIBLE INVOLVEMENT IN CANCER.
RX   PubMed=25682860; DOI=10.1111/cbdd.12542;
RA   Ren M., Zhou C., Liang H., Wang X., Xu L.;
RT   "RNAi-mediated silencing of eif3d alleviates proliferation and
RT   migration of glioma U251 and U87MG cells.";
RL   Chem. Biol. Drug Des. 86:715-722(2015).
RN   [26]
RP   POSSIBLE INVOLVEMENT IN CANCER.
RX   PubMed=26617750;
RA   Fan Y., Guo Y.;
RT   "Knockdown of eIF3D inhibits breast cancer cell proliferation and
RT   invasion through suppressing the Wnt/beta-catenin signaling pathway.";
RL   Int. J. Clin. Exp. Pathol. 8:10420-10427(2015).
RN   [27]
RP   POSSIBLE INVOLVEMENT IN CANCER.
RX   PubMed=26008152; DOI=10.1007/s12032-015-0625-8;
RA   Lin Z., Xiong L., Lin Q.;
RT   "Knockdown of eIF3d inhibits cell proliferation through G2/M phase
RT   arrest in non-small cell lung cancer.";
RL   Med. Oncol. 32:183-183(2015).
RN   [28]
RP   POSSIBLE INVOLVEMENT IN CANCER.
RX   PubMed=26036682; DOI=10.1007/s12032-015-0518-x;
RA   Gao Y., Teng J., Hong Y., Qu F., Ren J., Li L., Pan X., Chen L.,
RA   Yin L., Xu D., Cui X.;
RT   "The oncogenic role of EIF3D is associated with increased cell cycle
RT   progression and motility in prostate cancer.";
RL   Med. Oncol. 32:518-518(2015).
RN   [29]
RP   FUNCTION, AND IDENTIFICATION IN THE EIF-3 COMPLEX.
RX   PubMed=25849773; DOI=10.1038/nature14267;
RA   Lee A.S., Kranzusch P.J., Cate J.H.;
RT   "eIF3 targets cell-proliferation messenger RNAs for translational
RT   activation or repression.";
RL   Nature 522:111-114(2015).
RN   [30]
RP   POSSIBLE INVOLVEMENT IN CANCER.
RX   PubMed=27035563; DOI=10.3892/ijo.2016.3459;
RA   Pan X.W., Chen L., Hong Y., Xu D.F., Liu X., Li L., Huang Y.,
RA   Cui L.M., Gan S.S., Yang Q.W., Huang H., Qu F.J., Ye J.Q., Wang L.H.,
RA   Cui X.G.;
RT   "EIF3D silencing suppresses renal cell carcinoma tumorigenesis via
RT   inducing G2/M arrest through downregulation of Cyclin B1/CDK1
RT   signaling.";
RL   Int. J. Oncol. 48:2580-2590(2016).
RN   [31]
RP   FUNCTION, DOMAIN, RNA-BINDING, IDENTIFICATION BY MASS SPECTROMETRY,
RP   AND MUTAGENESIS OF ASP-249; 262-VAL-TYR-263 AND 317-THR--HIS-321.
RX   PubMed=27462815; DOI=10.1038/nature18954;
RA   Lee A.S., Kranzusch P.J., Doudna J.A., Cate J.H.;
RT   "eIF3d is an mRNA cap-binding protein that is required for specialized
RT   translation initiation.";
RL   Nature 536:96-99(2016).
RN   [32]
RP   3D-STRUCTURE MODELING, AND ELECTRON MICROSCOPY.
RX   PubMed=16322461; DOI=10.1126/science.1118977;
RA   Siridechadilok B., Fraser C.S., Hall R.J., Doudna J.A., Nogales E.;
RT   "Structural roles for human translation factor eIF3 in initiation of
RT   protein synthesis.";
RL   Science 310:1513-1515(2005).
RN   [33]
RP   VARIANT CYS-310.
RX   PubMed=25787250; DOI=10.1073/pnas.1503696112;
RA   Cromer M.K., Choi M., Nelson-Williams C., Fonseca A.L., Kunstman J.W.,
RA   Korah R.M., Overton J.D., Mane S., Kenney B., Malchoff C.D.,
RA   Stalberg P., Akerstroem G., Westin G., Hellman P., Carling T.,
RA   Bjoerklund P., Lifton R.P.;
RT   "Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in
RT   insulin-producing adenomas.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:4062-4067(2015).
CC   -!- FUNCTION: mRNA cap-binding component of the eukaryotic translation
CC       initiation factor 3 (eIF-3) complex, a complex required for
CC       several steps in the initiation of protein synthesis of a
CC       specialized repertoire of mRNAs (PubMed:27462815). The eIF-3
CC       complex associates with the 40S ribosome and facilitates the
CC       recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5
CC       to form the 43S pre-initiation complex (43S PIC). The eIF-3
CC       complex stimulates mRNA recruitment to the 43S PIC and scanning of
CC       the mRNA for AUG recognition. The eIF-3 complex is also required
CC       for disassembly and recycling of post-termination ribosomal
CC       complexes and subsequently prevents premature joining of the 40S
CC       and 60S ribosomal subunits prior to initiation (PubMed:18599441,
CC       PubMed:25849773). The eIF-3 complex specifically targets and
CC       initiates translation of a subset of mRNAs involved in cell
CC       proliferation, including cell cycling, differentiation and
CC       apoptosis, and uses different modes of RNA stem-loop binding to
CC       exert either translational activation or repression
CC       (PubMed:25849773). In the eIF-3 complex, EIF3D specifically
CC       recognizes and binds the 7-methylguanosine cap of a subset of
CC       mRNAs (PubMed:27462815). {ECO:0000269|PubMed:18599441,
CC       ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}.
CC   -!- FUNCTION: (Microbial infection) In case of FCV infection, plays a
CC       role in the ribosomal termination-reinitiation event leading to
CC       the translation of VP2 (PubMed:18056426).
CC       {ECO:0000269|PubMed:18056426}.
CC   -!- SUBUNIT: Component of the eukaryotic translation initiation factor
CC       3 (eIF-3) complex, which is composed of 13 subunits: EIF3A, EIF3B,
CC       EIF3C, EIF3D, EIF3E, EIF3F, EIF3G, EIF3H, EIF3I, EIF3J, EIF3K,
CC       EIF3L and EIF3M. The eIF-3 complex appears to include 3 stable
CC       modules: module A is composed of EIF3A, EIF3B, EIF3G and EIF3I;
CC       module B is composed of EIF3F, EIF3H, and EIF3M; and module C is
CC       composed of EIF3C, EIF3D, EIF3E, EIF3K and EIF3L. EIF3C of module
CC       C binds EIF3B of module A and EIF3H of module B, thereby linking
CC       the three modules. EIF3J is a labile subunit that binds to the
CC       eIF-3 complex via EIF3B. The eIF-3 complex interacts with RPS6KB1
CC       under conditions of nutrient depletion. Mitogenic stimulation
CC       leads to binding and activation of a complex composed of MTOR and
CC       RPTOR, leading to phosphorylation and release of RPS6KB1 and
CC       binding of EIF4B to eIF-3. {ECO:0000255|HAMAP-Rule:MF_03003,
CC       ECO:0000269|PubMed:12773399, ECO:0000269|PubMed:16766523,
CC       ECO:0000269|PubMed:17322308, ECO:0000269|PubMed:18599441,
CC       ECO:0000269|PubMed:25849773}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Norwalk virus VPg
CC       protein (PubMed:12773399). {ECO:0000269|PubMed:12773399}.
CC   -!- INTERACTION:
CC       Q7L4P6:BEND5; NbExp=3; IntAct=EBI-353818, EBI-724373;
CC       P60228:EIF3E; NbExp=5; IntAct=EBI-353818, EBI-347740;
CC       Q9NSC5:HOMER3; NbExp=5; IntAct=EBI-353818, EBI-748420;
CC       Q9BRK4:LZTS2; NbExp=3; IntAct=EBI-353818, EBI-741037;
CC       Q6PF18:MORN3; NbExp=4; IntAct=EBI-353818, EBI-9675802;
CC       Q9Q2G4:ORF (xeno); NbExp=5; IntAct=EBI-353818, EBI-6248094;
CC       Q8WV24:PHLDA1; NbExp=2; IntAct=EBI-353818, EBI-738731;
CC       Q04864:REL; NbExp=3; IntAct=EBI-353818, EBI-307352;
CC       P21673:SAT1; NbExp=3; IntAct=EBI-353818, EBI-711613;
CC       P14373:TRIM27; NbExp=5; IntAct=EBI-353818, EBI-719493;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03003}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O15371-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O15371-2; Sequence=VSP_055473;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=O15371-3; Sequence=VSP_055474;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The RNA gate region regulates mRNA cap recognition to
CC       prevent promiscuous mRNA-binding before assembly of EIF3D into the
CC       full eukaryotic translation initiation factor 3 (eIF-3) complex.
CC       {ECO:0000305|PubMed:27462815}.
CC   -!- MASS SPECTROMETRY: Mass=63972.9; Method=Unknown; Range=1-548;
CC       Evidence={ECO:0000269|PubMed:17322308};
CC   -!- MASS SPECTROMETRY: Mass=64046.7; Mass_error=1.4; Method=MALDI;
CC       Range=1-548; Evidence={ECO:0000269|PubMed:18599441};
CC   -!- DISEASE: Note=Defects in EIF3D are associated with some cancers,
CC       such as prostate, breast and colon cancers. Disease susceptibility
CC       may be associated with variations affecting the gene represented
CC       in this entry. Down-regulation inhibits proliferation of cancers
CC       (PubMed:25370813, PubMed:25322666, PubMed:25682860,
CC       PubMed:26617750, PubMed:26008152, PubMed:26036682,
CC       PubMed:27035563). {ECO:0000269|PubMed:25322666,
CC       ECO:0000269|PubMed:25370813, ECO:0000269|PubMed:25682860,
CC       ECO:0000269|PubMed:26008152, ECO:0000269|PubMed:26036682,
CC       ECO:0000269|PubMed:26617750, ECO:0000269|PubMed:27035563}.
CC   -!- SIMILARITY: Belongs to the eIF-3 subunit D family.
CC       {ECO:0000255|HAMAP-Rule:MF_03003}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U54558; AAD03466.1; -; mRNA.
DR   EMBL; BT007381; AAP36045.1; -; mRNA.
DR   EMBL; CR456489; CAG30375.1; -; mRNA.
DR   EMBL; AK300199; BAG61970.1; -; mRNA.
DR   EMBL; AK301284; BAG62843.1; -; mRNA.
DR   EMBL; AK312939; BAG35781.1; -; mRNA.
DR   EMBL; AL022313; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW60109.1; -; Genomic_DNA.
DR   EMBL; BC000328; AAH00328.1; -; mRNA.
DR   EMBL; BC000469; AAH00469.1; -; mRNA.
DR   EMBL; BC014912; AAH14912.1; -; mRNA.
DR   EMBL; BC080515; AAH80515.1; -; mRNA.
DR   EMBL; BC093100; AAH93100.1; -; mRNA.
DR   EMBL; BC093686; AAH93686.1; -; mRNA.
DR   EMBL; BC101477; AAI01478.1; -; mRNA.
DR   CCDS; CCDS13930.1; -. [O15371-1]
DR   RefSeq; NP_003744.1; NM_003753.3. [O15371-1]
DR   UniGene; Hs.55682; -.
DR   ProteinModelPortal; O15371; -.
DR   SMR; O15371; -.
DR   BioGrid; 114213; 88.
DR   CORUM; O15371; -.
DR   DIP; DIP-32870N; -.
DR   IntAct; O15371; 65.
DR   MINT; O15371; -.
DR   STRING; 9606.ENSP00000216190; -.
DR   MoonProt; O15371; -.
DR   iPTMnet; O15371; -.
DR   PhosphoSitePlus; O15371; -.
DR   SwissPalm; O15371; -.
DR   BioMuta; EIF3D; -.
DR   EPD; O15371; -.
DR   MaxQB; O15371; -.
DR   PaxDb; O15371; -.
DR   PeptideAtlas; O15371; -.
DR   PRIDE; O15371; -.
DR   DNASU; 8664; -.
DR   Ensembl; ENST00000216190; ENSP00000216190; ENSG00000100353. [O15371-1]
DR   Ensembl; ENST00000405442; ENSP00000385812; ENSG00000100353. [O15371-1]
DR   GeneID; 8664; -.
DR   KEGG; hsa:8664; -.
DR   UCSC; uc003apr.4; human. [O15371-1]
DR   CTD; 8664; -.
DR   DisGeNET; 8664; -.
DR   EuPathDB; HostDB:ENSG00000100353.17; -.
DR   GeneCards; EIF3D; -.
DR   HGNC; HGNC:3278; EIF3D.
DR   HPA; HPA045882; -.
DR   HPA; HPA063330; -.
DR   HPA; HPA066216; -.
DR   MIM; 603915; gene.
DR   neXtProt; NX_O15371; -.
DR   OpenTargets; ENSG00000100353; -.
DR   PharmGKB; PA162384740; -.
DR   eggNOG; KOG2479; Eukaryota.
DR   eggNOG; ENOG410XP1E; LUCA.
DR   GeneTree; ENSGT00390000002667; -.
DR   HOGENOM; HOG000241593; -.
DR   HOVERGEN; HBG000849; -.
DR   InParanoid; O15371; -.
DR   KO; K03251; -.
DR   OMA; DRIFHTV; -.
DR   OrthoDB; EOG091G07IK; -.
DR   PhylomeDB; O15371; -.
DR   TreeFam; TF101519; -.
DR   Reactome; R-HSA-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-HSA-72649; Translation initiation complex formation.
DR   Reactome; R-HSA-72689; Formation of a pool of free 40S subunits.
DR   Reactome; R-HSA-72695; Formation of the ternary complex, and subsequently, the 43S complex.
DR   Reactome; R-HSA-72702; Ribosomal scanning and start codon recognition.
DR   Reactome; R-HSA-72706; GTP hydrolysis and joining of the 60S ribosomal subunit.
DR   ChiTaRS; EIF3D; human.
DR   GeneWiki; EIF3D; -.
DR   GenomeRNAi; 8664; -.
DR   PRO; PR:O15371; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100353; -.
DR   CleanEx; HS_EIF3D; -.
DR   ExpressionAtlas; O15371; baseline and differential.
DR   Genevisible; O15371; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005852; C:eukaryotic translation initiation factor 3 complex; IDA:UniProtKB.
DR   GO; GO:0071541; C:eukaryotic translation initiation factor 3 complex, eIF3m; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0098808; F:mRNA cap binding; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0002191; P:cap-dependent translational initiation; IDA:UniProtKB.
DR   GO; GO:0001732; P:formation of cytoplasmic translation initiation complex; IEA:Ensembl.
DR   GO; GO:0075522; P:IRES-dependent viral translational initiation; IDA:UniProtKB.
DR   GO; GO:1902416; P:positive regulation of mRNA binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0045727; P:positive regulation of translation; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0006413; P:translational initiation; IDA:UniProtKB.
DR   GO; GO:0075525; P:viral translational termination-reinitiation; IDA:UniProtKB.
DR   HAMAP; MF_03003; eIF3d; 1.
DR   InterPro; IPR007783; eIF3d.
DR   PANTHER; PTHR12399; PTHR12399; 1.
DR   Pfam; PF05091; eIF-3_zeta; 1.
DR   PIRSF; PIRSF016281; EIF-3_zeta; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome; Cytoplasm;
KW   Initiation factor; Phosphoprotein; Polymorphism; Protein biosynthesis;
KW   Reference proteome; RNA-binding.
FT   CHAIN         1    548       Eukaryotic translation initiation factor
FT                                3 subunit D.
FT                                /FTId=PRO_0000123520.
FT   REGION      285    299       RNA gate. {ECO:0000250|UniProtKB:K7IM66}.
FT   COMPBIAS    530    547       Asp/Glu-rich (highly acidic).
FT   MOD_RES      53     53       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:O70194}.
FT   MOD_RES     161    161       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     528    528       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     529    529       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   VAR_SEQ      54    102       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055473.
FT   VAR_SEQ     137    151       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055474.
FT   VARIANT     310    310       R -> C (in dbSNP:rs745920273).
FT                                {ECO:0000269|PubMed:25787250}.
FT                                /FTId=VAR_074184.
FT   MUTAGEN     249    249       D->Q: Reduced binding to JUN mRNA; when
FT                                associated with 262-I-A-263.
FT                                {ECO:0000269|PubMed:27462815}.
FT   MUTAGEN     262    263       VY->IA: Reduced binding to JUN mRNA; when
FT                                associated with Q-249.
FT                                {ECO:0000269|PubMed:27462815}.
FT   MUTAGEN     317    321       TYINH->EYENA: Reduced binding to JUN
FT                                mRNA. {ECO:0000269|PubMed:27462815}.
SQ   SEQUENCE   548 AA;  63973 MW;  7FE0448EC3BE1711 CRC64;
     MAKFMTPVIQ DNPSGWGPCA VPEQFRDMPY QPFSKGDRLG KVADWTGATY QDKRYTNKYS
     SQFGGGSQYA YFHEEDESSF QLVDTARTQK TAYQRNRMRF AQRNLRRDKD RRNMLQFNLQ
     ILPKSAKQKE RERIRLQKKF QKQFGVRQKW DQKSQKPRDS SVEVRSDWEV KEEMDFPQLM
     KMRYLEVSEP QDIECCGALE YYDKAFDRIT TRSEKPLRSI KRIFHTVTTT DDPVIRKLAK
     TQGNVFATDA ILATLMSCTR SVYSWDIVVQ RVGSKLFFDK RDNSDFDLLT VSETANEPPQ
     DEGNSFNSPR NLAMEATYIN HNFSQQCLRM GKERYNFPNP NPFVEDDMDK NEIASVAYRY
     RRWKLGDDID LIVRCEHDGV MTGANGEVSF INIKTLNEWD SRHCNGVDWR QKLDSQRGAV
     IATELKNNSY KLARWTCCAL LAGSEYLKLG YVSRYHVKDS SRHVILGTQQ FKPNEFASQI
     NLSVENAWGI LRCVIDICMK LEEGKYLILK DPNKQVIRVY SLPDGTFSSD EDEEEEEEEE
     EEEEEEET
//
ID   A0A090N8E9_HUMAN        Unreviewed;       751 AA.
AC   A0A090N8E9;
DT   26-NOV-2014, integrated into UniProtKB/TrEMBL.
DT   26-NOV-2014, sequence version 1.
DT   23-MAY-2018, entry version 32.
DE   SubName: Full=Enhancer of zeste homolog 2 (Drosophila) {ECO:0000313|EMBL:EAL24424.1};
GN   Name=EZH2 {ECO:0000313|EMBL:EAL24424.1};
GN   ORFNames=tcag7.507 {ECO:0000313|EMBL:EAL24424.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAL24424.1};
RN   [1] {ECO:0000313|EMBL:EAL24424.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D., Zhang Q., Gu Z., Lu F.,
RA   Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J., Grzeschik K.H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Dohner H., Dohner K.,
RA   Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [2] {ECO:0000313|EMBL:EAL24424.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Nusskern D., Zhang Q., Gu Z., Lu F.,
RA   Zeesman S., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P., Lococo F., Belloni E.,
RA   Shaffer L.G., Morton C.C., Pober B., Gusella J., Bruns G., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M.,
RA   Gripp K.W., Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H.,
RA   Teebi A., Minassian B.A., Kere J., Armengol L., Pujana M.Angel.,
RA   Estivill X., Wilson M.D., Koop B.F., Tosi S., Moore G.E.,
RA   Boright A.P., Zlotorynski E., Kerem B., Kroisel P.M., Petek E.,
RA   Oscier D.G., Mould S.J., Doehner H., Doehner K., Rommens J.M.,
RA   Vincent J.B., Venter J.C., Li P.W., Mural R.J., Adams M.D.,
RA   Tsui L.-C.;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: The sequence shown here is derived from an
CC       EMBL/GenBank/DDBJ whole genome shotgun (WGS) entry which is
CC       preliminary data. {ECO:0000313|EMBL:EAL24424.1}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AACC02000041; EAL24424.1; -; Genomic_DNA.
DR   RefSeq; NP_004447.2; NM_004456.4.
DR   RefSeq; XP_011514186.1; XM_011515884.2.
DR   UniGene; Hs.444082; -.
DR   UniGene; Hs.732308; -.
DR   ProteinModelPortal; A0A090N8E9; -.
DR   SMR; A0A090N8E9; -.
DR   GeneID; 2146; -.
DR   CTD; 2146; -.
DR   EuPathDB; HostDB:ENSG00000106462.10; -.
DR   eggNOG; KOG1079; Eukaryota.
DR   eggNOG; COG2940; LUCA.
DR   OMA; IKEAWIK; -.
DR   OrthoDB; EOG091G09L0; -.
DR   PhylomeDB; A0A090N8E9; -.
DR   ChiTaRS; EZH2; human.
DR   GenomeRNAi; 2146; -.
DR   Bgee; ENSG00000106462; -.
DR   ExpressionAtlas; A0A090N8E9; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0035098; C:ESC/E(Z) complex; IEA:Ensembl.
DR   GO; GO:0000790; C:nuclear chromatin; IEA:Ensembl.
DR   GO; GO:0045120; C:pronucleus; IEA:Ensembl.
DR   GO; GO:0031490; F:chromatin DNA binding; IEA:Ensembl.
DR   GO; GO:0018024; F:histone-lysine N-methyltransferase activity; IEA:InterPro.
DR   GO; GO:0070878; F:primary miRNA binding; IEA:Ensembl.
DR   GO; GO:0043021; F:ribonucleoprotein complex binding; IEA:Ensembl.
DR   GO; GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0014898; P:cardiac muscle hypertrophy in response to stress; IEA:Ensembl.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0035984; P:cellular response to trichostatin A; IEA:Ensembl.
DR   GO; GO:0021695; P:cerebellar cortex development; IEA:Ensembl.
DR   GO; GO:0006306; P:DNA methylation; IEA:Ensembl.
DR   GO; GO:0070314; P:G1 to G0 transition; IEA:Ensembl.
DR   GO; GO:0036333; P:hepatocyte homeostasis; IEA:Ensembl.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0098532; P:histone H3-K27 trimethylation; IEA:Ensembl.
DR   GO; GO:0097421; P:liver regeneration; IEA:Ensembl.
DR   GO; GO:0043433; P:negative regulation of DNA binding transcription factor activity; IEA:Ensembl.
DR   GO; GO:0045605; P:negative regulation of epidermal cell differentiation; IEA:Ensembl.
DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0051154; P:negative regulation of striated muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0034244; P:negative regulation of transcription elongation from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:1900006; P:positive regulation of dendrite development; IEA:Ensembl.
DR   GO; GO:0071168; P:protein localization to chromatin; IEA:Ensembl.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0042752; P:regulation of circadian rhythm; IEA:Ensembl.
DR   GO; GO:0014013; P:regulation of gliogenesis; IEA:Ensembl.
DR   GO; GO:0001932; P:regulation of protein phosphorylation; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:1904772; P:response to tetrachloromethane; IEA:Ensembl.
DR   GO; GO:0014834; P:skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration; IEA:Ensembl.
DR   CDD; cd00167; SANT; 1.
DR   InterPro; IPR026489; CXC_dom.
DR   InterPro; IPR021654; EZH1/EZH2.
DR   InterPro; IPR001005; SANT/Myb.
DR   InterPro; IPR001214; SET_dom.
DR   InterPro; IPR033467; Tesmin/TSO1-like_CXC.
DR   Pfam; PF11616; EZH2_WD-Binding; 1.
DR   Pfam; PF00856; SET; 1.
DR   SMART; SM01114; CXC; 1.
DR   SMART; SM00717; SANT; 2.
DR   SMART; SM00317; SET; 1.
DR   PROSITE; PS51633; CXC; 1.
DR   PROSITE; PS50280; SET; 1.
PE   4: Predicted;
FT   DOMAIN      508    610       CXC. {ECO:0000259|PROSITE:PS51633}.
FT   DOMAIN      617    732       SET. {ECO:0000259|PROSITE:PS50280}.
SQ   SEQUENCE   751 AA;  86018 MW;  D885CF02E60EF836 CRC64;
     MGQTGKKSEK GPVCWRKRVK SEYMRLRQLK RFRRADEVKS MFSSNRQKIL ERTEILNQEW
     KQRRIQPVHI LTSVSSLRGT RECSVTSDLD FPTQVIPLKT LNAVASVPIM YSWSPLQQNF
     MVEDETVLHN IPYMGDEVLD QDGTFIEELI KNYDGKVHGD RECGFINDEI FVELVNALGQ
     YNDDDDDDDG DDPEEREEKQ KDLEDHRDDK ESRPPRKFPS DKIFEAISSM FPDKGTAEEL
     KEKYKELTEQ QLPGALPPEC TPNIDGPNAK SVQREQSLHS FHTLFCRRCF KYDCFLHRKC
     NYSFHATPNT YKRKNTETAL DNKPCGPQCY QHLEGAKEFA AALTAERIKT PPKRPGGRRR
     GRLPNNSSRP STPTINVLES KDTDSDREAG TETGGENNDK EEEEKKDETS SSSEANSRCQ
     TPIKMKPNIE PPENVEWSGA EASMFRVLIG TYYDNFCAIA RLIGTKTCRQ VYEFRVKESS
     IIAPAPAEDV DTPPRKKKRK HRLWAAHCRK IQLKKDGSSN HVYNYQPCDH PRQPCDSSCP
     CVIAQNFCEK FCQCSSECQN RFPGCRCKAQ CNTKQCPCYL AVRECDPDLC LTCGAADHWD
     SKNVSCKNCS IQRGSKKHLL LAPSDVAGWG IFIKDPVQKN EFISEYCGEI ISQDEADRRG
     KVYDKYMCSF LFNLNNDFVV DATRKGNKIR FANHSVNPNC YAKVMMVNGD HRIGIFAKRA
     IQTGEELFFD YRYSQADALK YVGIEREMEI P
//
ID   EZH2_HUMAN              Reviewed;         746 AA.
AC   Q15910; B2RAQ1; B3KS30; B7Z1D6; B7Z7L6; Q15755; Q75MG3; Q92857;
AC   Q96FI6;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   25-APR-2018, entry version 181.
DE   RecName: Full=Histone-lysine N-methyltransferase EZH2 {ECO:0000305};
DE            EC=2.1.1.43 {ECO:0000269|PubMed:22323599};
DE   AltName: Full=ENX-1;
DE   AltName: Full=Enhancer of zeste homolog 2 {ECO:0000303|PubMed:28229514};
DE   AltName: Full=Lysine N-methyltransferase 6;
GN   Name=EZH2 {ECO:0000312|HGNC:HGNC:3527}; Synonyms=KMT6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=8954776; DOI=10.1006/geno.1996.0588;
RA   Chen H., Rossier C., Antonarakis S.E.;
RT   "Cloning of a human homolog of the Drosophila enhancer of zeste gene
RT   (EZH2) that maps to chromosome 21q22.2.";
RL   Genomics 38:30-37(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9214638; DOI=10.1093/emboj/16.11.3219;
RA   Laible G., Wolf A., Dorn R., Reuter G., Nislow C., Lebersorger A.,
RA   Popkin D., Pillus L., Jenuwein T.;
RT   "Mammalian homologues of the Polycomb-group gene Enhancer of zeste
RT   mediate gene silencing in Drosophila heterochromatin and at S.
RT   cerevisiae telomeres.";
RL   EMBO J. 16:3219-3232(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3; 4 AND 5).
RC   TISSUE=Brain, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 134-746.
RX   PubMed=8649418; DOI=10.1128/MCB.16.6.3066;
RA   Hobert O., Jallal B., Ullrich A.;
RT   "Interaction of Vav with ENX-1, a putative transcriptional regulator
RT   of homeobox gene expression.";
RL   Mol. Cell. Biol. 16:3066-3073(1996).
RN   [8]
RP   INTERACTION WITH ATRX.
RX   PubMed=9499421; DOI=10.1093/hmg/7.4.679;
RA   Cardoso C., Timsit S., Villard L., Khrestchatisky M., Fontes M.,
RA   Colleaux L.;
RT   "Specific interaction between the XNP/ATR-X gene product and the SET
RT   domain of the human EZH2 protein.";
RL   Hum. Mol. Genet. 7:679-684(1998).
RN   [9]
RP   INTERACTION WITH EED, AND SUBCELLULAR LOCATION.
RX   PubMed=9584199; DOI=10.1128/MCB.18.6.3586;
RA   Sewalt R.G.A.B., van der Vlag J., Gunster M.J., Hamer K.M.,
RA   den Blaauwen J.L., Satijn D.P.E., Hendrix T., van Driel R., Otte A.P.;
RT   "Characterization of interactions between the mammalian polycomb-group
RT   proteins Enx1/EZH2 and EED suggests the existence of different
RT   mammalian polycomb-group protein complexes.";
RL   Mol. Cell. Biol. 18:3586-3595(1998).
RN   [10]
RP   INTERACTION WITH EED; HDAC1 AND HDAC2.
RX   PubMed=10581039; DOI=10.1038/70602;
RA   van der Vlag J., Otte A.P.;
RT   "Transcriptional repression mediated by the human polycomb-group
RT   protein EED involves histone deacetylation.";
RL   Nat. Genet. 23:474-478(1999).
RN   [11]
RP   INTERACTION WITH EED.
RX   PubMed=11158321; DOI=10.1128/MCB.21.4.1360-1369.2001;
RA   Satijn D.P.E., Hamer K.M., den Blaauwen J., Otte A.P.;
RT   "The polycomb group protein EED interacts with YY1, and both proteins
RT   induce neural tissue in Xenopus embryos.";
RL   Mol. Cell. Biol. 21:1360-1369(2001).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE PRC2
RP   COMPLEX WITH EED; RBBP4; RBBP7 AND SUZ12, METHYLTRANSFERASE ACTIVITY
RP   OF THE PRC2 COMPLEX, AND MUTAGENESIS OF CYS-588 AND HIS-689.
RX   PubMed=12435631; DOI=10.1101/gad.1035902;
RA   Kuzmichev A., Nishioka K., Erdjument-Bromage H., Tempst P.,
RA   Reinberg D.;
RT   "Histone methyltransferase activity associated with a human
RT   multiprotein complex containing the Enhancer of Zeste protein.";
RL   Genes Dev. 16:2893-2905(2002).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12101246; DOI=10.1128/MCB.22.15.5539-5553.2002;
RA   Sewalt R.G.A.B., Lachner M., Vargas M., Hamer K.M., den Blaauwen J.L.,
RA   Hendrix T., Melcher M., Schweizer D., Jenuwein T., Otte A.P.;
RT   "Selective interactions between vertebrate polycomb homologs and the
RT   SUV39H1 histone lysine methyltransferase suggest that histone H3-K9
RT   methylation contributes to chromosomal targeting of Polycomb group
RT   proteins.";
RL   Mol. Cell. Biol. 22:5539-5553(2002).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE PRC2
RP   COMPLEX WITH EED; RBBP4; RBBP7 AND SUZ12, AND METHYLTRANSFERASE
RP   ACTIVITY OF THE PRC2 COMPLEX.
RX   PubMed=12351676; DOI=10.1126/science.1076997;
RA   Cao R., Wang L., Wang H., Xia L., Erdjument-Bromage H., Tempst P.,
RA   Jones R.S., Zhang Y.;
RT   "Role of histone H3 lysine 27 methylation in Polycomb-group
RT   silencing.";
RL   Science 298:1039-1043(2002).
RN   [15]
RP   FUNCTION, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, INDUCTION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=14532106; DOI=10.1093/emboj/cdg542;
RA   Bracken A.P., Pasini D., Capra M., Prosperini E., Colli E., Helin K.;
RT   "EZH2 is downstream of the pRB-E2F pathway, essential for
RT   proliferation and amplified in cancer.";
RL   EMBO J. 22:5323-5335(2003).
RN   [16]
RP   FUNCTION, INTERACTION WITH EED AND SUZ12, AND METHYLTRANSFERASE
RP   ACTIVITY OF THE PRC2 COMPLEX.
RX   PubMed=15385962; DOI=10.1038/sj.emboj.7600402;
RA   Pasini D., Bracken A.P., Jensen M.R., Lazzerini Denchi E., Helin K.;
RT   "Suz12 is essential for mouse development and for EZH2 histone
RT   methyltransferase activity.";
RL   EMBO J. 23:4061-4071(2004).
RN   [17]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15231737; DOI=10.1101/gad.1200204;
RA   Kirmizis A., Bartley S.M., Kuzmichev A., Margueron R., Reinberg D.,
RA   Green R., Farnham P.J.;
RT   "Silencing of human polycomb target genes is associated with
RT   methylation of histone H3 Lys 27.";
RL   Genes Dev. 18:1592-1605(2004).
RN   [18]
RP   CHARACTERIZATION OF THE PRC2 AND PRC3 COMPLEXES INCLUDING EED; EZH2;
RP   RBBP4; RBBP7 AND SUZ12, AND METHYLTRANSFERASE ACTIVITY OF THE PRC2 AND
RP   PRC3 COMPLEXES.
RX   PubMed=15099518; DOI=10.1016/S1097-2765(04)00185-6;
RA   Kuzmichev A., Jenuwein T., Tempst P., Reinberg D.;
RT   "Different EZH2-containing complexes target methylation of histone H1
RT   or nucleosomal histone H3.";
RL   Mol. Cell 14:183-193(2004).
RN   [19]
RP   FUNCTION, CHARACTERIZATION OF THE PRC2 COMPLEX INCLUDING AEBP2; EED;
RP   EZH2; RBBP4 AND SUZ12, AND METHYLTRANSFERASE ACTIVITY OF THE PRC2
RP   COMPLEX.
RX   PubMed=15225548; DOI=10.1016/j.molcel.2004.06.020;
RA   Cao R., Zhang Y.;
RT   "SUZ12 is required for both the histone methyltransferase activity and
RT   the silencing function of the EED-EZH2 complex.";
RL   Mol. Cell 15:57-67(2004).
RN   [20]
RP   DEVELOPMENTAL STAGE, AND INDUCTION.
RX   PubMed=15208672; DOI=10.1038/sj.onc.1207706;
RA   Tang X., Milyavsky M., Shats I., Erez N., Goldfinger N., Rotter V.;
RT   "Activated p53 suppresses the histone methyltransferase EZH2 gene.";
RL   Oncogene 23:5759-5769(2004).
RN   [21]
RP   FUNCTION IN RETINOIC ACID SIGNALING, AND INTERACTION WITH PRAME.
RX   PubMed=16179254; DOI=10.1016/j.cell.2005.07.003;
RA   Epping M.T., Wang L., Edel M.J., Carlee L., Hernandez M., Bernards R.;
RT   "The human tumor antigen PRAME is a dominant repressor of retinoic
RT   acid receptor signaling.";
RL   Cell 122:835-847(2005).
RN   [22]
RP   CHARACTERIZATION OF THE PRC4 COMPLEX INCLUDING EED; EZH2; RBBP4;
RP   RBBP7; SUZ12 AND SIRT1, AND METHYLTRANSFERASE ACTIVITY OF THE PRC4
RP   COMPLEX.
RX   PubMed=15684044; DOI=10.1073/pnas.0409875102;
RA   Kuzmichev A., Margueron R., Vaquero A., Preissner T.S., Scher M.,
RA   Kirmizis A., Ouyang X., Brockdorff N., Abate-Shen C., Farnham P.J.,
RA   Reinberg D.;
RT   "Composition and histone substrates of polycomb repressive group
RT   complexes change during cellular differentiation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:1859-1864(2005).
RN   [23]
RP   INTERACTION WITH EED AND SUZ12, PHOSPHORYLATION AT SER-21 BY AKT1, AND
RP   MUTAGENESIS OF SER-21.
RX   PubMed=16224021; DOI=10.1126/science.1118947;
RA   Cha T.-L., Zhou B.P., Xia W., Wu Y., Yang C.-C., Chen C.-T., Ping B.,
RA   Otte A.P., Hung M.-C.;
RT   "Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine
RT   27 in histone H3.";
RL   Science 310:306-310(2005).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-487, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [25]
RP   FUNCTION.
RX   PubMed=16618801; DOI=10.1101/gad.381706;
RA   Bracken A.P., Dietrich N., Pasini D., Hansen K.H., Helin K.;
RT   "Genome-wide mapping of Polycomb target genes unravels their roles in
RT   cell fate transitions.";
RL   Genes Dev. 20:1123-1136(2006).
RN   [26]
RP   METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX.
RX   PubMed=16431907; DOI=10.1074/jbc.M513425200;
RA   Martin C., Cao R., Zhang Y.;
RT   "Substrate preferences of the EZH2 histone methyltransferase
RT   complex.";
RL   J. Biol. Chem. 281:8365-8370(2006).
RN   [27]
RP   FUNCTION.
RX   PubMed=16717091; DOI=10.1074/jbc.M603722200;
RA   Etchegaray J.P., Yang X., DeBruyne J.P., Peters A.H., Weaver D.R.,
RA   Jenuwein T., Reppert S.M.;
RT   "The polycomb group protein EZH2 is required for mammalian circadian
RT   clock function.";
RL   J. Biol. Chem. 281:21209-21215(2006).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-487, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [29]
RP   FUNCTION, AND INTERACTION OF THE PRC2 COMPLEX WITH DNMT1; DNMT3A AND
RP   DNMT3B.
RX   PubMed=16357870; DOI=10.1038/nature04431;
RA   Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C.,
RA   Morey L., Van Eynde A., Bernard D., Vanderwinden J.-M., Bollen M.,
RA   Esteller M., Di Croce L., de Launoit Y., Fuks F.;
RT   "The Polycomb group protein EZH2 directly controls DNA methylation.";
RL   Nature 439:871-874(2006).
RN   [30]
RP   ERRATUM.
RA   Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C.,
RA   Morey L., Van Eynde A., Bernard D., Vanderwinden J.-M., Bollen M.,
RA   Esteller M., Di Croce L., de Launoit Y., Fuks F.;
RL   Nature 446:824-824(2006).
RN   [31]
RP   FUNCTION.
RX   PubMed=16936726; DOI=10.1038/nsmb1142;
RA   Kim D.H., Villeneuve L.M., Morris K.V., Rossi J.J.;
RT   "Argonaute-1 directs siRNA-mediated transcriptional gene silencing in
RT   human cells.";
RL   Nat. Struct. Mol. Biol. 13:793-797(2006).
RN   [32]
RP   FUNCTION.
RX   PubMed=17210787; DOI=10.1101/gad.1499407;
RA   Kotake Y., Cao R., Viatour P., Sage J., Zhang Y., Xiong Y.;
RT   "pRB family proteins are required for H3K27 trimethylation and
RT   Polycomb repression complexes binding to and silencing p16INK4alpha
RT   tumor suppressor gene.";
RL   Genes Dev. 21:49-54(2007).
RN   [33]
RP   FUNCTION, DEVELOPMENTAL STAGE, AND INDUCTION.
RX   PubMed=17344414; DOI=10.1101/gad.415507;
RA   Bracken A.P., Kleine-Kohlbrecher D., Dietrich N., Pasini D.,
RA   Gargiulo G., Beekman C., Theilgaard-Moench K., Minucci S., Porse B.T.,
RA   Marine J.-C., Hansen K.H., Helin K.;
RT   "The Polycomb group proteins bind throughout the INK4A-ARF locus and
RT   are disassociated in senescent cells.";
RL   Genes Dev. 21:525-530(2007).
RN   [34]
RP   DE NOVO DNA METHYLATION OF PRC2 TARGET GENES.
RX   PubMed=17200670; DOI=10.1038/ng1950;
RA   Schlesinger Y., Straussman R., Keshet I., Farkash S., Hecht M.,
RA   Zimmerman J., Eden E., Yakhini Z., Ben-Shushan E., Reubinoff B.E.,
RA   Bergman Y., Simon I., Cedar H.;
RT   "Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes
RT   for de novo methylation in cancer.";
RL   Nat. Genet. 39:232-236(2007).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-487, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-487, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [37]
RP   FUNCTION, AND IDENTIFICATION IN THE PRC2/EED-EZH1 COMPLEX.
RX   PubMed=19026781; DOI=10.1016/j.molcel.2008.11.004;
RA   Margueron R., Li G., Sarma K., Blais A., Zavadil J., Woodcock C.L.,
RA   Dynlacht B.D., Reinberg D.;
RT   "Ezh1 and Ezh2 maintain repressive chromatin through different
RT   mechanisms.";
RL   Mol. Cell 32:503-518(2008).
RN   [38]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE PRC2
RP   COMPLEX, AND METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX.
RX   PubMed=18086877; DOI=10.1128/MCB.01589-07;
RA   Cao R., Wang H., He J., Erdjument-Bromage H., Tempst P., Zhang Y.;
RT   "Role of hPHF1 in H3K27 methylation and Hox gene silencing.";
RL   Mol. Cell. Biol. 28:1862-1872(2008).
RN   [39]
RP   FUNCTION, INTERACTION WITH EED; SUZ12 AND PHF1, METHYLTRANSFERASE
RP   ACTIVITY OF THE PRC2 COMPLEX, AND MUTAGENESIS OF HIS-689.
RX   PubMed=18285464; DOI=10.1128/MCB.02017-07;
RA   Sarma K., Margueron R., Ivanov A., Pirrotta V., Reinberg D.;
RT   "Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27
RT   trimethylation in vivo.";
RL   Mol. Cell. Biol. 28:2718-2731(2008).
RN   [40]
RP   SUMOYLATION.
RX   PubMed=18628979; DOI=10.1371/journal.pone.0002704;
RA   Riising E.M., Boggio R., Chiocca S., Helin K., Pasini D.;
RT   "The polycomb repressive complex 2 is a potential target of SUMO
RT   modifications.";
RL   PLoS ONE 3:E2704-E2704(2008).
RN   [41]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-366; THR-367 AND
RP   THR-487, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [42]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [43]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-487, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [44]
RP   FUNCTION, PHOSPHORYLATION AT THR-345 BY CDK1 AND CDK2, AND MUTAGENESIS
RP   OF THR-345.
RX   PubMed=20935635; DOI=10.1038/ncb2116;
RA   Chen S., Bohrer L.R., Rai A.N., Pan Y., Gan L., Zhou X., Bagchi A.,
RA   Simon J.A., Huang H.;
RT   "Cyclin-dependent kinases regulate epigenetic gene silencing through
RT   phosphorylation of EZH2.";
RL   Nat. Cell Biol. 12:1108-1114(2010).
RN   [45]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-487, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [46]
RP   INTERACTION WITH CDYL.
RX   PubMed=22009739; DOI=10.1074/jbc.M111.271064;
RA   Zhang Y., Yang X., Gui B., Xie G., Zhang D., Shang Y., Liang J.;
RT   "Corepressor protein CDYL functions as a molecular bridge between
RT   polycomb repressor complex 2 and repressive chromatin mark
RT   trimethylated histone lysine 27.";
RL   J. Biol. Chem. 286:42414-42425(2011).
RN   [47]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-487, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [48]
RP   FUNCTION.
RX   PubMed=23063525; DOI=10.1016/j.molcel.2012.09.004;
RA   Lee J.M., Lee J.S., Kim H., Kim K., Park H., Kim J.Y., Lee S.H.,
RA   Kim I.S., Kim J., Lee M., Chung C.H., Seo S.B., Yoon J.B., Ko E.,
RA   Noh D.Y., Kim K.I., Kim K.K., Baek S.H.;
RT   "EZH2 generates a methyl degron that is recognized by the
RT   DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex.";
RL   Mol. Cell 48:572-586(2012).
RN   [49]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76; THR-339; SER-363;
RP   THR-367 AND THR-487, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [50]
RP   GLYCOSYLATION AT SER-75, MUTAGENESIS OF SER-75, AND FUNCTION.
RX   PubMed=24474760; DOI=10.1073/pnas.1323226111;
RA   Chu C.S., Lo P.W., Yeh Y.H., Hsu P.H., Peng S.H., Teng Y.C.,
RA   Kang M.L., Wong C.H., Juan L.J.;
RT   "O-GlcNAcylation regulates EZH2 protein stability and function.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:1355-1360(2014).
RN   [51]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-634, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [52]
RP   VARIANTS PHE-641; SER-641; ASN-641; HIS-641 AND CYS-641.
RX   PubMed=20081860; DOI=10.1038/ng.518;
RA   Morin R.D., Johnson N.A., Severson T.M., Mungall A.J., An J., Goya R.,
RA   Paul J.E., Boyle M., Woolcock B.W., Kuchenbauer F., Yap D.,
RA   Humphries R.K., Griffith O.L., Shah S., Zhu H., Kimbara M.,
RA   Shashkin P., Charlot J.F., Tcherpakov M., Corbett R., Tam A.,
RA   Varhol R., Smailus D., Moksa M., Zhao Y., Delaney A., Qian H.,
RA   Birol I., Schein J., Moore R., Holt R., Horsman D.E., Connors J.M.,
RA   Jones S., Aparicio S., Hirst M., Gascoyne R.D., Marra M.A.;
RT   "Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse
RT   large B-cell lymphomas of germinal-center origin.";
RL   Nat. Genet. 42:181-185(2010).
RN   [53]
RP   VARIANTS TRP-571; CYS-641; CYS-685 AND ASP-726, AND CHARACTERIZATION
RP   OF VARIANTS TRP-571; CYS-641; CYS-685 AND ASP-726.
RX   PubMed=20601953; DOI=10.1038/ng.621;
RA   Ernst T., Chase A.J., Score J., Hidalgo-Curtis C.E., Bryant C.,
RA   Jones A.V., Waghorn K., Zoi K., Ross F.M., Reiter A., Hochhaus A.,
RA   Drexler H.G., Duncombe A., Cervantes F., Oscier D., Boultwood J.,
RA   Grand F.H., Cross N.C.;
RT   "Inactivating mutations of the histone methyltransferase gene EZH2 in
RT   myeloid disorders.";
RL   Nat. Genet. 42:722-726(2010).
RN   [54]
RP   CHARACTERIZATION OF VARIANTS PHE-641 AND ASN-641.
RX   PubMed=21190999; DOI=10.1182/blood-2010-11-321208;
RA   Yap D.B., Chu J., Berg T., Schapira M., Cheng S.W., Moradian A.,
RA   Morin R.D., Mungall A.J., Meissner B., Boyle M., Marquez V.E.,
RA   Marra M.A., Gascoyne R.D., Humphries R.K., Arrowsmith C.H.,
RA   Morin G.B., Aparicio S.A.;
RT   "Somatic mutations at EZH2 Y641 act dominantly through a mechanism of
RT   selectively altered PRC2 catalytic activity, to increase H3K27
RT   trimethylation.";
RL   Blood 117:2451-2459(2011).
RN   [55]
RP   VARIANT HIS-685.
RX   PubMed=21828135; DOI=10.1182/blood-2010-10-311019;
RA   Jankowska A.M., Makishima H., Tiu R.V., Szpurka H., Huang Y.,
RA   Traina F., Visconte V., Sugimoto Y., Prince C., O'Keefe C., Hsi E.D.,
RA   List A., Sekeres M.A., Rao A., McDevitt M.A., Maciejewski J.P.;
RT   "Mutational spectrum analysis of chronic myelomonocytic leukemia
RT   includes genes associated with epigenetic regulation: UTX, EZH2, and
RT   DNMT3A.";
RL   Blood 118:3932-3941(2011).
RN   [56]
RP   VARIANTS WVS THR-134; GLU-156; ARG-279; MET-621; ASN-658; THR-677;
RP   CYS-679; LEU-690; 728-TYR--PRO-746 DEL AND CYS-736.
RX   PubMed=22190405; DOI=10.18632/oncotarget.385;
RG   Childhood Overgrowth Collaboration;
RA   Tatton-Brown K., Hanks S., Ruark E., Zachariou A., Duarte S.V.,
RA   Ramsay E., Snape K., Murray A., Perdeaux E.R., Seal S., Loveday C.,
RA   Banka S., Clericuzio C., Flinter F., Magee A., McConnell V.,
RA   Patton M., Raith W., Rankin J., Splitt M., Strenger V., Taylor C.,
RA   Wheeler P., Temple K.I., Cole T., Douglas J., Rahman N.;
RT   "Germline mutations in the oncogene EZH2 cause Weaver syndrome and
RT   increased human height.";
RL   Oncotarget 2:1127-1133(2011).
RN   [57]
RP   VARIANTS WVS SER-132; TYR-153 DEL AND TYR-689.
RX   PubMed=22177091; DOI=10.1016/j.ajhg.2011.11.018;
RA   Gibson W.T., Hood R.L., Zhan S.H., Bulman D.E., Fejes A.P., Moore R.,
RA   Mungall A.J., Eydoux P., Babul-Hirji R., An J., Marra M.A.,
RA   Chitayat D., Boycott K.M., Weaver D.D., Jones S.J.;
RT   "Mutations in EZH2 cause Weaver syndrome.";
RL   Am. J. Hum. Genet. 90:110-118(2012).
RN   [58]
RP   VARIANT GLY-677, CHARACTERIZATION OF VARIANTS ASN-641; CYS-641;
RP   HIS-641; PHE-641 AND GLY-677, FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=22323599; DOI=10.1073/pnas.1116418109;
RA   McCabe M.T., Graves A.P., Ganji G., Diaz E., Halsey W.S., Jiang Y.,
RA   Smitheman K.N., Ott H.M., Pappalardi M.B., Allen K.E., Chen S.B.,
RA   Della Pietra A. III, Dul E., Hughes A.M., Gilbert S.A., Thrall S.H.,
RA   Tummino P.J., Kruger R.G., Brandt M., Schwartz B., Creasy C.L.;
RT   "Mutation of A677 in histone methyltransferase EZH2 in human B-cell
RT   lymphoma promotes hypertrimethylation of histone H3 on lysine 27
RT   (H3K27).";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:2989-2994(2012).
RN   [59]
RP   VARIANT WVS LYS-740.
RX   PubMed=23239504; DOI=10.1002/ajmg.a.35660;
RA   Al-Salem A., Alshammari M.J., Hassan H., Alazami A.M., Alkuraya F.S.;
RT   "Weaver syndrome and defective cortical development: a rare
RT   association.";
RL   Am. J. Med. Genet. A 161A:225-227(2013).
RN   [60]
RP   VARIANTS WVS CYS-133 AND CYS-679, CHARACTERIZATION OF VARIANTS WVS
RP   SER-132; CYS-133; TYR-153 DEL; CYS-679 AND TYR-689, VARIANT HIS-185,
RP   CHARACTERIZATION OF VARIANT HIS-185, AND MUTAGENESIS OF PHE-667.
RX   PubMed=26694085; DOI=10.1002/humu.22946;
RA   Cohen A.S., Yap D.B., Lewis M.E., Chijiwa C., Ramos-Arroyo M.A.,
RA   Tkachenko N., Milano V., Fradin M., McKinnon M.L., Townsend K.N.,
RA   Xu J., Van Allen M.I., Ross C.J., Dobyns W.B., Weaver D.D.,
RA   Gibson W.T.;
RT   "Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired
RT   Histone Methyltransferase Function In Vitro.";
RL   Hum. Mutat. 37:301-307(2016).
RN   [61]
RP   INVOLVEMENT IN WVS.
RX   PubMed=28229514; DOI=10.1002/humu.23200;
RA   Imagawa E., Higashimoto K., Sakai Y., Numakura C., Okamoto N.,
RA   Matsunaga S., Ryo A., Sato Y., Sanefuji M., Ihara K., Takada Y.,
RA   Nishimura G., Saitsu H., Mizuguchi T., Miyatake S., Nakashima M.,
RA   Miyake N., Soejima H., Matsumoto N.;
RT   "Mutations in genes encoding polycomb repressive complex 2 subunits
RT   cause Weaver syndrome.";
RL   Hum. Mutat. 38:637-648(2017).
CC   -!- FUNCTION: Polycomb group (PcG) protein. Catalytic subunit of the
CC       PRC2/EED-EZH2 complex, which methylates 'Lys-9' (H3K9me) and 'Lys-
CC       27' (H3K27me) of histone H3, leading to transcriptional repression
CC       of the affected target gene. Able to mono-, di- and trimethylate
CC       'Lys-27' of histone H3 to form H3K27me1, H3K27me2 and H3K27me3,
CC       respectively. Displays a preference for substrates with less
CC       methylation, loses activity when progressively more methyl groups
CC       are incorporated into H3K27, H3K27me0 > H3K27me1 > H3K27me2
CC       (PubMed:22323599). Compared to EZH1-containing complexes, it is
CC       more abundant in embryonic stem cells and plays a major role in
CC       forming H3K27me3, which is required for embryonic stem cell
CC       identity and proper differentiation. The PRC2/EED-EZH2 complex may
CC       also serve as a recruiting platform for DNA methyltransferases,
CC       thereby linking two epigenetic repression systems. Genes repressed
CC       by the PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1, CDKN2A
CC       and retinoic acid target genes. EZH2 can also methylate non-
CC       histone proteins such as the transcription factor GATA4 and the
CC       nuclear receptor RORA. Regulates the circadian clock via histone
CC       methylation at the promoter of the circadian genes. Essential for
CC       the CRY1/2-mediated repression of the transcriptional activation
CC       of PER1/2 by the CLOCK-ARNTL/BMAL1 heterodimer; involved in the di
CC       and trimethylation of 'Lys-27' of histone H3 on PER1/2 promoters
CC       which is necessary for the CRY1/2 proteins to inhibit
CC       transcription. {ECO:0000269|PubMed:14532106,
CC       ECO:0000269|PubMed:15225548, ECO:0000269|PubMed:15231737,
CC       ECO:0000269|PubMed:15385962, ECO:0000269|PubMed:16179254,
CC       ECO:0000269|PubMed:16357870, ECO:0000269|PubMed:16618801,
CC       ECO:0000269|PubMed:16717091, ECO:0000269|PubMed:16936726,
CC       ECO:0000269|PubMed:17210787, ECO:0000269|PubMed:17344414,
CC       ECO:0000269|PubMed:18285464, ECO:0000269|PubMed:19026781,
CC       ECO:0000269|PubMed:20935635, ECO:0000269|PubMed:22323599,
CC       ECO:0000269|PubMed:23063525, ECO:0000269|PubMed:24474760}.
CC   -!- CATALYTIC ACTIVITY: S-adenosyl-L-methionine + L-lysine-[histone] =
CC       S-adenosyl-L-homocysteine + N(6)-methyl-L-lysine-[histone].
CC       {ECO:0000269|PubMed:22323599}.
CC   -!- SUBUNIT: Binds ATRX via the SET domain (Probable). Component of
CC       the PRC2/EED-EZH2 complex, which includes EED, EZH2, SUZ12, RBBP4
CC       and RBBP7 and possibly AEBP2. The minimum components required for
CC       methyltransferase activity of the PRC2/EED-EZH2 complex are EED,
CC       EZH2 and SUZ12. The PRC2 complex may also interact with DNMT1,
CC       DNMT3A, DNMT3B and PHF1 via the EZH2 subunit and with SIRT1 via
CC       the SUZ12 subunit. Interacts with HDAC1 and HDAC2. Interacts with
CC       PRAME. Interacts with CDYL. Interacts with CLOCK, ARNTL/BMAL1 and
CC       CRY1 (By similarity). Interacts with DNMT3L; the interaction is
CC       direct (By similarity). {ECO:0000250|UniProtKB:Q61188,
CC       ECO:0000269|PubMed:10581039, ECO:0000269|PubMed:11158321,
CC       ECO:0000269|PubMed:12351676, ECO:0000269|PubMed:12435631,
CC       ECO:0000269|PubMed:15385962, ECO:0000269|PubMed:16179254,
CC       ECO:0000269|PubMed:16224021, ECO:0000269|PubMed:16357870,
CC       ECO:0000269|PubMed:18086877, ECO:0000269|PubMed:18285464,
CC       ECO:0000269|PubMed:19026781, ECO:0000269|PubMed:22009739,
CC       ECO:0000269|PubMed:9499421, ECO:0000269|PubMed:9584199,
CC       ECO:0000305}.
CC   -!- INTERACTION:
CC       Q8IXJ9:ASXL1; NbExp=6; IntAct=EBI-530054, EBI-1646500;
CC       P46100:ATRX; NbExp=2; IntAct=EBI-530054, EBI-396461;
CC       Q96MT8:CEP63; NbExp=3; IntAct=EBI-530054, EBI-741977;
CC       P26358:DNMT1; NbExp=8; IntAct=EBI-530054, EBI-719459;
CC       Q9Y6K1:DNMT3A; NbExp=6; IntAct=EBI-530054, EBI-923653;
CC       Q9UBC3:DNMT3B; NbExp=14; IntAct=EBI-530054, EBI-80125;
CC       Q9CWR8:Dnmt3l (xeno); NbExp=2; IntAct=EBI-530054, EBI-3043871;
CC       O75530:EED; NbExp=11; IntAct=EBI-530054, EBI-923794;
CC       Q92833-1:JARID2; NbExp=7; IntAct=EBI-530054, EBI-15825247;
CC       P60411:KRTAP10-9; NbExp=4; IntAct=EBI-10699473, EBI-10172052;
CC       O43189:PHF1; NbExp=5; IntAct=EBI-530054, EBI-530034;
CC       Q15156:PML-RAR; NbExp=8; IntAct=EBI-530054, EBI-867256;
CC       P10276:RARA; NbExp=2; IntAct=EBI-530054, EBI-413374;
CC       P40763:STAT3; NbExp=5; IntAct=EBI-530054, EBI-518675;
CC       O43463:SUV39H1; NbExp=2; IntAct=EBI-530054, EBI-349968;
CC       Q15022:SUZ12; NbExp=22; IntAct=EBI-530054, EBI-1264675;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12101246,
CC       ECO:0000269|PubMed:14532106, ECO:0000269|PubMed:15231737,
CC       ECO:0000269|PubMed:9584199}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q15910-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15910-2; Sequence=VSP_038815;
CC       Name=3;
CC         IsoId=Q15910-3; Sequence=VSP_038814;
CC       Name=4;
CC         IsoId=Q15910-4; Sequence=VSP_038813;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q15910-5; Sequence=VSP_038813, VSP_038816;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in many tissues. Overexpressed in
CC       numerous tumor types including carcinomas of the breast, colon,
CC       larynx, lymphoma and testis. {ECO:0000269|PubMed:14532106}.
CC   -!- DEVELOPMENTAL STAGE: Expression decreases during senescence of
CC       embryonic fibroblasts (HEFs). Expression peaks at the G1/S phase
CC       boundary. {ECO:0000269|PubMed:14532106,
CC       ECO:0000269|PubMed:15208672, ECO:0000269|PubMed:17344414}.
CC   -!- INDUCTION: Expression is induced by E2F1, E2F2 and E2F3.
CC       Expression is reduced in cells subject to numerous types of stress
CC       including UV-, IR- and bleomycin-induced DNA damage and by
CC       activation of p53/TP53. {ECO:0000269|PubMed:14532106,
CC       ECO:0000269|PubMed:15208672, ECO:0000269|PubMed:17344414}.
CC   -!- PTM: Phosphorylated by AKT1. Phosphorylation by AKT1 reduces
CC       methyltransferase activity. Phosphorylation at Thr-345 by CDK1 and
CC       CDK2 promotes maintenance of H3K27me3 levels at EZH2-target loci,
CC       thus leading to epigenetic gene silencing.
CC       {ECO:0000269|PubMed:16224021, ECO:0000269|PubMed:20935635}.
CC   -!- PTM: Sumoylated. {ECO:0000269|PubMed:18628979}.
CC   -!- PTM: Glycosylated: O-GlcNAcylation at Ser-75 by OGT increases
CC       stability of EZH2 and facilitates the formation of H3K27me3 by the
CC       PRC2/EED-EZH2 complex. {ECO:0000269|PubMed:24474760}.
CC   -!- DISEASE: Weaver syndrome (WVS) [MIM:277590]: A syndrome of
CC       accelerated growth and osseous maturation, unusual craniofacial
CC       appearance, hoarse and low-pitched cry, and hypertonia with
CC       camptodactyly. Distinguishing features of Weaver syndrome include
CC       broad forehead and face, ocular hypertelorism, prominent wide
CC       philtrum, micrognathia, deep horizontal chin groove, and deep-set
CC       nails. In addition, carpal bone development is advanced over the
CC       rest of the hand. {ECO:0000269|PubMed:22177091,
CC       ECO:0000269|PubMed:22190405, ECO:0000269|PubMed:23239504,
CC       ECO:0000269|PubMed:26694085, ECO:0000269|PubMed:28229514}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the class V-like SAM-binding
CC       methyltransferase superfamily. Histone-lysine methyltransferase
CC       family. EZ subfamily. {ECO:0000255|PROSITE-ProRule:PRU00190}.
CC   -!- CAUTION: Two variants of the PRC2 complex have been described,
CC       termed PRC3 and PRC4. Each of the three complexes may include a
CC       different complement of EED isoforms, although the precise
CC       sequences of the isoforms in each complex have not been
CC       determined. The PRC2 and PRC4 complexes may also methylate 'Lys-
CC       26' of histone H1 in addition to 'Lys-27' of histone H3
CC       (PubMed:15099518 and PubMed:15684044), although other studies have
CC       demonstrated no methylation of 'Lys-26' of histone H1 by PRC2
CC       (PubMed:16431907). {ECO:0000305|PubMed:16431907}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAS07448.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X95653; CAA64955.1; -; mRNA.
DR   EMBL; U61145; AAC51520.1; -; mRNA.
DR   EMBL; AK302216; BAH13652.1; -; mRNA.
DR   EMBL; AK092676; BAG52592.1; -; mRNA.
DR   EMBL; AK293239; BAH11472.1; -; mRNA.
DR   EMBL; AK314291; BAG36948.1; -; mRNA.
DR   EMBL; AC006323; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC073140; AAS07448.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471146; EAW80067.1; -; Genomic_DNA.
DR   EMBL; CH471146; EAW80070.1; -; Genomic_DNA.
DR   EMBL; BC010858; AAH10858.1; -; mRNA.
DR   EMBL; U52965; AAC50591.1; -; Genomic_DNA.
DR   CCDS; CCDS56516.1; -. [Q15910-1]
DR   CCDS; CCDS56517.1; -. [Q15910-5]
DR   CCDS; CCDS56518.1; -. [Q15910-4]
DR   CCDS; CCDS5891.1; -. [Q15910-2]
DR   CCDS; CCDS5892.1; -. [Q15910-3]
DR   PIR; G02838; G02838.
DR   RefSeq; NP_001190176.1; NM_001203247.1. [Q15910-1]
DR   RefSeq; NP_001190177.1; NM_001203248.1. [Q15910-4]
DR   RefSeq; NP_001190178.1; NM_001203249.1. [Q15910-5]
DR   RefSeq; NP_004447.2; NM_004456.4. [Q15910-2]
DR   RefSeq; NP_694543.1; NM_152998.2. [Q15910-3]
DR   RefSeq; XP_011514186.1; XM_011515884.2. [Q15910-2]
DR   UniGene; Hs.444082; -.
DR   UniGene; Hs.732308; -.
DR   PDB; 2C6V; Model; -; A=508-734.
DR   PDB; 4MI0; X-ray; 2.00 A; A=520-746.
DR   PDB; 4MI5; X-ray; 2.00 A; A=521-746.
DR   PDB; 5GSA; X-ray; 2.49 A; C/D=40-68.
DR   PDB; 5H14; X-ray; 1.90 A; C/D=40-68.
DR   PDB; 5H15; X-ray; 2.27 A; C/D=40-68.
DR   PDB; 5H17; X-ray; 2.30 A; B=40-68.
DR   PDB; 5H19; X-ray; 1.90 A; B=40-68.
DR   PDB; 5H24; X-ray; 2.50 A; C/D=40-68.
DR   PDB; 5H25; X-ray; 2.88 A; C/D=40-68.
DR   PDB; 5HYN; X-ray; 2.95 A; A/F/K/Q=1-746.
DR   PDB; 5IJ7; X-ray; 2.62 A; A/B=429-487, A/B=511-746.
DR   PDB; 5IJ8; X-ray; 2.99 A; A/B=429-487, A/B=511-531, A/B=533-746.
DR   PDB; 5LS6; X-ray; 3.47 A; A/D/G/J=1-385, A/D/G/J=421-746.
DR   PDB; 5U5T; X-ray; 1.60 A; C/D=39-68.
DR   PDB; 5U62; X-ray; 1.90 A; C/D=39-68.
DR   PDB; 5WUK; X-ray; 2.03 A; B=41-68.
DR   PDB; 6C23; EM; 3.90 A; C/K=1-746.
DR   PDB; 6C24; EM; 3.50 A; C/K=1-746.
DR   PDBsum; 2C6V; -.
DR   PDBsum; 4MI0; -.
DR   PDBsum; 4MI5; -.
DR   PDBsum; 5GSA; -.
DR   PDBsum; 5H14; -.
DR   PDBsum; 5H15; -.
DR   PDBsum; 5H17; -.
DR   PDBsum; 5H19; -.
DR   PDBsum; 5H24; -.
DR   PDBsum; 5H25; -.
DR   PDBsum; 5HYN; -.
DR   PDBsum; 5IJ7; -.
DR   PDBsum; 5IJ8; -.
DR   PDBsum; 5LS6; -.
DR   PDBsum; 5U5T; -.
DR   PDBsum; 5U62; -.
DR   PDBsum; 5WUK; -.
DR   PDBsum; 6C23; -.
DR   PDBsum; 6C24; -.
DR   ProteinModelPortal; Q15910; -.
DR   SMR; Q15910; -.
DR   BioGrid; 108446; 282.
DR   CORUM; Q15910; -.
DR   DIP; DIP-34002N; -.
DR   IntAct; Q15910; 113.
DR   MINT; Q15910; -.
DR   STRING; 9606.ENSP00000320147; -.
DR   BindingDB; Q15910; -.
DR   ChEMBL; CHEMBL2189110; -.
DR   GuidetoPHARMACOLOGY; 2654; -.
DR   iPTMnet; Q15910; -.
DR   PhosphoSitePlus; Q15910; -.
DR   BioMuta; EZH2; -.
DR   DMDM; 3334180; -.
DR   EPD; Q15910; -.
DR   MaxQB; Q15910; -.
DR   PaxDb; Q15910; -.
DR   PeptideAtlas; Q15910; -.
DR   PRIDE; Q15910; -.
DR   DNASU; 2146; -.
DR   Ensembl; ENST00000320356; ENSP00000320147; ENSG00000106462. [Q15910-2]
DR   Ensembl; ENST00000350995; ENSP00000223193; ENSG00000106462. [Q15910-3]
DR   Ensembl; ENST00000460911; ENSP00000419711; ENSG00000106462. [Q15910-1]
DR   Ensembl; ENST00000476773; ENSP00000419050; ENSG00000106462. [Q15910-5]
DR   Ensembl; ENST00000478654; ENSP00000417062; ENSG00000106462. [Q15910-5]
DR   Ensembl; ENST00000483967; ENSP00000419856; ENSG00000106462. [Q15910-4]
DR   GeneID; 2146; -.
DR   KEGG; hsa:2146; -.
DR   UCSC; uc003wfb.3; human. [Q15910-1]
DR   CTD; 2146; -.
DR   DisGeNET; 2146; -.
DR   EuPathDB; HostDB:ENSG00000106462.10; -.
DR   GeneCards; EZH2; -.
DR   GeneReviews; EZH2; -.
DR   HGNC; HGNC:3527; EZH2.
DR   HPA; CAB009589; -.
DR   HPA; HPA029131; -.
DR   MalaCards; EZH2; -.
DR   MIM; 277590; phenotype.
DR   MIM; 601573; gene.
DR   neXtProt; NX_Q15910; -.
DR   OpenTargets; ENSG00000106462; -.
DR   Orphanet; 3447; Weaver syndrome.
DR   PharmGKB; PA27939; -.
DR   eggNOG; KOG1079; Eukaryota.
DR   eggNOG; COG2940; LUCA.
DR   GeneTree; ENSGT00780000121845; -.
DR   HOVERGEN; HBG002453; -.
DR   InParanoid; Q15910; -.
DR   KO; K11430; -.
DR   OMA; IKEAWIK; -.
DR   PhylomeDB; Q15910; -.
DR   TreeFam; TF314509; -.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-3214841; PKMTs methylate histone lysines.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-8943724; Regulation of PTEN gene transcription.
DR   Reactome; R-HSA-8953750; Transcriptional Regulation by E2F6.
DR   SignaLink; Q15910; -.
DR   SIGNOR; Q15910; -.
DR   ChiTaRS; EZH2; human.
DR   GeneWiki; EZH2; -.
DR   GenomeRNAi; 2146; -.
DR   PRO; PR:Q15910; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000106462; -.
DR   CleanEx; HS_EZH2; -.
DR   ExpressionAtlas; Q15910; baseline and differential.
DR   Genevisible; Q15910; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0035098; C:ESC/E(Z) complex; IDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0045120; C:pronucleus; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0031490; F:chromatin DNA binding; IDA:UniProtKB.
DR   GO; GO:0001047; F:core promoter binding; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0042054; F:histone methyltransferase activity; IDA:MGI.
DR   GO; GO:0046976; F:histone methyltransferase activity (H3-K27 specific); IDA:UniProtKB.
DR   GO; GO:0018024; F:histone-lysine N-methyltransferase activity; IDA:MGI.
DR   GO; GO:0070878; F:primary miRNA binding; IEA:Ensembl.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; IDA:UniProtKB.
DR   GO; GO:0016279; F:protein-lysine N-methyltransferase activity; TAS:Reactome.
DR   GO; GO:0043021; F:ribonucleoprotein complex binding; IEA:Ensembl.
DR   GO; GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISM:NTNU_SB.
DR   GO; GO:0014898; P:cardiac muscle hypertrophy in response to stress; IEA:Ensembl.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0035984; P:cellular response to trichostatin A; IEA:Ensembl.
DR   GO; GO:0021695; P:cerebellar cortex development; IEA:Ensembl.
DR   GO; GO:0006325; P:chromatin organization; TAS:ProtInc.
DR   GO; GO:0006306; P:DNA methylation; IEA:Ensembl.
DR   GO; GO:0070314; P:G1 to G0 transition; IEA:Ensembl.
DR   GO; GO:0036333; P:hepatocyte homeostasis; IEA:Ensembl.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0070734; P:histone H3-K27 methylation; IDA:UniProtKB.
DR   GO; GO:0098532; P:histone H3-K27 trimethylation; IEA:Ensembl.
DR   GO; GO:0016571; P:histone methylation; IMP:UniProtKB.
DR   GO; GO:0097421; P:liver regeneration; IEA:Ensembl.
DR   GO; GO:0043433; P:negative regulation of DNA binding transcription factor activity; IEA:Ensembl.
DR   GO; GO:0045605; P:negative regulation of epidermal cell differentiation; IEA:Ensembl.
DR   GO; GO:0070317; P:negative regulation of G0 to G1 transition; TAS:Reactome.
DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0045814; P:negative regulation of gene expression, epigenetic; IDA:UniProtKB.
DR   GO; GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0051154; P:negative regulation of striated muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0034244; P:negative regulation of transcription elongation from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:1900006; P:positive regulation of dendrite development; IEA:Ensembl.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IDA:UniProtKB.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IDA:UniProtKB.
DR   GO; GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB.
DR   GO; GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0071168; P:protein localization to chromatin; IEA:Ensembl.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0042752; P:regulation of circadian rhythm; IMP:UniProtKB.
DR   GO; GO:0014013; P:regulation of gliogenesis; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:1904772; P:response to tetrachloromethane; IEA:Ensembl.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0014834; P:skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00167; SANT; 1.
DR   InterPro; IPR026489; CXC_dom.
DR   InterPro; IPR021654; EZH1/EZH2.
DR   InterPro; IPR001005; SANT/Myb.
DR   InterPro; IPR001214; SET_dom.
DR   InterPro; IPR033467; Tesmin/TSO1-like_CXC.
DR   Pfam; PF11616; EZH2_WD-Binding; 1.
DR   Pfam; PF00856; SET; 1.
DR   SMART; SM01114; CXC; 1.
DR   SMART; SM00717; SANT; 2.
DR   SMART; SM00317; SET; 1.
DR   PROSITE; PS51633; CXC; 1.
DR   PROSITE; PS50280; SET; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Biological rhythms;
KW   Chromatin regulator; Complete proteome; Disease mutation;
KW   Glycoprotein; Isopeptide bond; Methyltransferase; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repressor;
KW   S-adenosyl-L-methionine; Transcription; Transcription regulation;
KW   Transferase; Ubl conjugation.
FT   CHAIN         1    746       Histone-lysine N-methyltransferase EZH2.
FT                                /FTId=PRO_0000213992.
FT   DOMAIN      503    605       CXC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00970}.
FT   DOMAIN      612    727       SET. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00190}.
FT   REGION        1    340       Interaction with DNMT1, DNMT3A and
FT                                DNMT3B.
FT   REGION       39     68       Interaction with EED. {ECO:0000250}.
FT   REGION      329    522       Interaction with CDYL.
FT                                {ECO:0000269|PubMed:22009739}.
FT   COMPBIAS    523    605       Cys-rich.
FT   MOD_RES      21     21       Phosphoserine; by PKB/AKT1.
FT                                {ECO:0000269|PubMed:16224021}.
FT   MOD_RES      76     76       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     339    339       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     345    345       Phosphothreonine; by CDK1 and CDK2.
FT                                {ECO:0000269|PubMed:20935635}.
FT   MOD_RES     363    363       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     366    366       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     367    367       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     487    487       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   CARBOHYD     75     75       O-linked (GlcNAc) serine.
FT                                {ECO:0000269|PubMed:24474760}.
FT   CROSSLNK    634    634       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ      74     82       Missing (in isoform 4 and isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038813.
FT   VAR_SEQ      83    121       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038814.
FT   VAR_SEQ     297    298       HP -> HRKCNYS (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_038815.
FT   VAR_SEQ     511    553       DGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSS
FT                                EC -> G (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038816.
FT   VARIANT     132    132       P -> S (in WVS; decreased histone
FT                                methyltransferase activity;
FT                                dbSNP:rs193921148).
FT                                {ECO:0000269|PubMed:22177091,
FT                                ECO:0000269|PubMed:26694085}.
FT                                /FTId=VAR_067595.
FT   VARIANT     133    133       Y -> C (in WVS; decreased histone
FT                                methyltransferase activity).
FT                                {ECO:0000269|PubMed:26694085}.
FT                                /FTId=VAR_078320.
FT   VARIANT     134    134       M -> T (in WVS).
FT                                {ECO:0000269|PubMed:22190405}.
FT                                /FTId=VAR_078321.
FT   VARIANT     153    153       Missing (in WVS; decreased histone
FT                                methyltransferase activity).
FT                                {ECO:0000269|PubMed:22177091,
FT                                ECO:0000269|PubMed:26694085}.
FT                                /FTId=VAR_067596.
FT   VARIANT     156    156       K -> E (in WVS).
FT                                {ECO:0000269|PubMed:22190405}.
FT                                /FTId=VAR_078322.
FT   VARIANT     185    185       D -> H (polymorhism; decreased histone
FT                                methyltransferase activity;
FT                                dbSNP:rs2302427).
FT                                {ECO:0000269|PubMed:26694085}.
FT                                /FTId=VAR_055795.
FT   VARIANT     279    279       H -> R (in WVS).
FT                                {ECO:0000269|PubMed:22190405}.
FT                                /FTId=VAR_078323.
FT   VARIANT     571    571       C -> W (found in a patient with
FT                                myelodysplastic syndrome and
FT                                myelodysplastic-myeloproliferative
FT                                neoplasms; somatic mutation; loss of
FT                                histone methyltransferase activity).
FT                                {ECO:0000269|PubMed:20601953}.
FT                                /FTId=VAR_078324.
FT   VARIANT     621    621       V -> M (in WVS; unknown pathological
FT                                significance; dbSNP:rs587783625).
FT                                {ECO:0000269|PubMed:22190405}.
FT                                /FTId=VAR_078325.
FT   VARIANT     641    641       Y -> C (in a patient with diffuse large
FT                                B-cell lymphoma; somatic mutation;
FT                                changed substrate preferences; prefers
FT                                substrates with greater methylation
FT                                H3K27me0<me1<me2).
FT                                {ECO:0000269|PubMed:20081860,
FT                                ECO:0000269|PubMed:20601953,
FT                                ECO:0000269|PubMed:22323599}.
FT                                /FTId=VAR_067228.
FT   VARIANT     641    641       Y -> F (found in a patient with
FT                                follicular lymphoma; also in diffuse
FT                                large B-cell lymphoma; somatic mutation;
FT                                changed substrate preferences; prefers
FT                                substrates with greater methylation
FT                                H3K27me0<me1<me2; dbSNP:rs267601394).
FT                                {ECO:0000269|PubMed:20081860,
FT                                ECO:0000269|PubMed:22323599}.
FT                                /FTId=VAR_067229.
FT   VARIANT     641    641       Y -> H (found in patients with follicular
FT                                lymphoma; also in diffuse large B-cell
FT                                lymphoma; somatic mutation; changed
FT                                substrate preferences; prefers substrates
FT                                with greater methylation
FT                                H3K27me0<me1<me2; dbSNP:rs267601395).
FT                                {ECO:0000269|PubMed:20081860,
FT                                ECO:0000269|PubMed:22323599}.
FT                                /FTId=VAR_067230.
FT   VARIANT     641    641       Y -> N (found in patients with follicular
FT                                lymphoma; also in diffuse large B-cell
FT                                lymphoma; somatic mutation; changed
FT                                substrate preferences; prefers substrates
FT                                with greater methylation
FT                                H3K27me0<me1<me2).
FT                                {ECO:0000269|PubMed:20081860,
FT                                ECO:0000269|PubMed:22323599}.
FT                                /FTId=VAR_067231.
FT   VARIANT     641    641       Y -> S (found in patients with follicular
FT                                lymphoma; also in diffuse large B-cell
FT                                lymphoma; somatic mutation).
FT                                {ECO:0000269|PubMed:20081860}.
FT                                /FTId=VAR_067232.
FT   VARIANT     658    658       Y -> N (in WVS).
FT                                {ECO:0000269|PubMed:22190405}.
FT                                /FTId=VAR_078326.
FT   VARIANT     677    677       A -> G (found in a patient with B-cell
FT                                lymphoma; increased hypertrimethylation
FT                                of H3K27; changed substrate preferences;
FT                                confers biochemical activity independent
FT                                of H3K27 methylation state).
FT                                {ECO:0000269|PubMed:22323599}.
FT                                /FTId=VAR_078327.
FT   VARIANT     677    677       A -> T (in WVS; dbSNP:rs397515547).
FT                                {ECO:0000269|PubMed:22190405}.
FT                                /FTId=VAR_078328.
FT   VARIANT     679    679       R -> C (in WVS; decreased histone
FT                                methyltransferase activity;
FT                                dbSNP:rs587783626).
FT                                {ECO:0000269|PubMed:22190405,
FT                                ECO:0000269|PubMed:26694085}.
FT                                /FTId=VAR_078329.
FT   VARIANT     685    685       R -> C (found in a patient with myeloid
FT                                disorders; somatic mutation; loss of
FT                                histone methyltransferase activity).
FT                                {ECO:0000269|PubMed:20601953}.
FT                                /FTId=VAR_078330.
FT   VARIANT     685    685       R -> H (in a patient with chronic
FT                                myelomonocytic leukemia).
FT                                {ECO:0000269|PubMed:21828135}.
FT                                /FTId=VAR_067233.
FT   VARIANT     689    689       H -> Y (in WVS; decreased histone
FT                                methyltransferase activity;
FT                                dbSNP:rs193921147).
FT                                {ECO:0000269|PubMed:22177091,
FT                                ECO:0000269|PubMed:26694085}.
FT                                /FTId=VAR_067597.
FT   VARIANT     690    690       S -> L (in WVS).
FT                                {ECO:0000269|PubMed:22190405}.
FT                                /FTId=VAR_078331.
FT   VARIANT     726    726       Y -> D (found in a patient with chronic
FT                                myelomonocytic leukemia; somatic
FT                                mutation; loss of histone
FT                                methyltransferase activity).
FT                                {ECO:0000269|PubMed:20601953}.
FT                                /FTId=VAR_078332.
FT   VARIANT     728    746       Missing (in WVS).
FT                                {ECO:0000269|PubMed:22190405}.
FT                                /FTId=VAR_078333.
FT   VARIANT     736    736       Y -> C (in WVS).
FT                                {ECO:0000269|PubMed:22190405}.
FT                                /FTId=VAR_078334.
FT   VARIANT     740    740       E -> K (in WVS; unknown pathological
FT                                significance; dbSNP:rs397515548).
FT                                {ECO:0000269|PubMed:23239504}.
FT                                /FTId=VAR_078335.
FT   MUTAGEN      21     21       S->A: Enhances methyltransferase activity
FT                                towards 'Lys-27' of histone H3 and
FT                                abrogates phosphorylation by PKB/AKT1.
FT                                {ECO:0000269|PubMed:16224021}.
FT   MUTAGEN      21     21       S->D: Reduces methyltransferase activity
FT                                towards 'Lys-27' of histone H3 and
FT                                abrogates phosphorylation by PKB/AKT1.
FT                                {ECO:0000269|PubMed:16224021}.
FT   MUTAGEN      75     75       S->A: Reduced protein stability.
FT                                {ECO:0000269|PubMed:24474760}.
FT   MUTAGEN     345    345       T->A: Impaired CDK1- and CDK-2 mediated
FT                                phosphorylation and subsequent gene
FT                                silencing. Altered EZH2-mediated cell
FT                                proliferation and migration.
FT                                {ECO:0000269|PubMed:20935635}.
FT   MUTAGEN     588    588       C->Y: Strongly impairs methyltransferase
FT                                activity towards 'Lys-27' of histone H3.
FT                                {ECO:0000269|PubMed:12435631}.
FT   MUTAGEN     667    667       F->I: Strongly decreases histone
FT                                methyltransferase activity.
FT                                {ECO:0000269|PubMed:26694085}.
FT   MUTAGEN     689    689       H->A: Abrogates methyltransferase
FT                                activity. {ECO:0000269|PubMed:12435631,
FT                                ECO:0000269|PubMed:18285464}.
FT   CONFLICT     39     39       K -> N (in Ref. 3; BAG52592).
FT                                {ECO:0000305}.
FT   CONFLICT    224    224       F -> L (in Ref. 1; CAA64955).
FT                                {ECO:0000305}.
FT   CONFLICT    724    724       F -> V (in Ref. 1; CAA64955).
FT                                {ECO:0000305}.
FT   HELIX        44     62       {ECO:0000244|PDB:5U5T}.
FT   STRAND       82     87       {ECO:0000244|PDB:5HYN}.
FT   STRAND       94     97       {ECO:0000244|PDB:5HYN}.
FT   STRAND       99    101       {ECO:0000244|PDB:5HYN}.
FT   STRAND      126    129       {ECO:0000244|PDB:5HYN}.
FT   HELIX       135    138       {ECO:0000244|PDB:5HYN}.
FT   TURN        139    143       {ECO:0000244|PDB:5HYN}.
FT   HELIX       144    152       {ECO:0000244|PDB:5HYN}.
FT   TURN        153    155       {ECO:0000244|PDB:5HYN}.
FT   STRAND      161    163       {ECO:0000244|PDB:5LS6}.
FT   HELIX       168    181       {ECO:0000244|PDB:5HYN}.
FT   HELIX       221    230       {ECO:0000244|PDB:5HYN}.
FT   TURN        232    234       {ECO:0000244|PDB:5HYN}.
FT   HELIX       237    248       {ECO:0000244|PDB:5HYN}.
FT   STRAND      264    266       {ECO:0000244|PDB:5LS6}.
FT   HELIX       274    284       {ECO:0000244|PDB:5HYN}.
FT   TURN        287    289       {ECO:0000244|PDB:5HYN}.
FT   STRAND      291    293       {ECO:0000244|PDB:5HYN}.
FT   TURN        304    306       {ECO:0000244|PDB:5HYN}.
FT   HELIX       332    343       {ECO:0000244|PDB:5HYN}.
FT   HELIX       434    447       {ECO:0000244|PDB:5HYN}.
FT   HELIX       451    458       {ECO:0000244|PDB:5HYN}.
FT   HELIX       463    474       {ECO:0000244|PDB:5HYN}.
FT   STRAND      526    528       {ECO:0000244|PDB:5HYN}.
FT   HELIX       535    538       {ECO:0000244|PDB:4MI0}.
FT   STRAND      563    565       {ECO:0000244|PDB:4MI0}.
FT   STRAND      568    571       {ECO:0000244|PDB:6C24}.
FT   HELIX       572    575       {ECO:0000244|PDB:4MI0}.
FT   TURN        582    584       {ECO:0000244|PDB:4MI0}.
FT   STRAND      587    589       {ECO:0000244|PDB:4MI0}.
FT   STRAND      590    592       {ECO:0000244|PDB:5LS6}.
FT   STRAND      594    596       {ECO:0000244|PDB:5HYN}.
FT   STRAND      600    603       {ECO:0000244|PDB:4MI0}.
FT   HELIX       605    608       {ECO:0000244|PDB:4MI0}.
FT   STRAND      614    618       {ECO:0000244|PDB:4MI0}.
FT   STRAND      620    630       {ECO:0000244|PDB:4MI0}.
FT   STRAND      637    640       {ECO:0000244|PDB:4MI0}.
FT   STRAND      643    647       {ECO:0000244|PDB:4MI0}.
FT   HELIX       648    656       {ECO:0000244|PDB:4MI0}.
FT   STRAND      666    668       {ECO:0000244|PDB:4MI0}.
FT   STRAND      670    676       {ECO:0000244|PDB:4MI0}.
FT   TURN        678    680       {ECO:0000244|PDB:4MI0}.
FT   HELIX       683    686       {ECO:0000244|PDB:4MI0}.
FT   STRAND      687    689       {ECO:0000244|PDB:4MI0}.
FT   STRAND      694    702       {ECO:0000244|PDB:4MI0}.
FT   STRAND      705    714       {ECO:0000244|PDB:4MI0}.
FT   STRAND      721    723       {ECO:0000244|PDB:5LS6}.
SQ   SEQUENCE   746 AA;  85363 MW;  1B5029EB9D509BE5 CRC64;
     MGQTGKKSEK GPVCWRKRVK SEYMRLRQLK RFRRADEVKS MFSSNRQKIL ERTEILNQEW
     KQRRIQPVHI LTSVSSLRGT RECSVTSDLD FPTQVIPLKT LNAVASVPIM YSWSPLQQNF
     MVEDETVLHN IPYMGDEVLD QDGTFIEELI KNYDGKVHGD RECGFINDEI FVELVNALGQ
     YNDDDDDDDG DDPEEREEKQ KDLEDHRDDK ESRPPRKFPS DKIFEAISSM FPDKGTAEEL
     KEKYKELTEQ QLPGALPPEC TPNIDGPNAK SVQREQSLHS FHTLFCRRCF KYDCFLHPFH
     ATPNTYKRKN TETALDNKPC GPQCYQHLEG AKEFAAALTA ERIKTPPKRP GGRRRGRLPN
     NSSRPSTPTI NVLESKDTDS DREAGTETGG ENNDKEEEEK KDETSSSSEA NSRCQTPIKM
     KPNIEPPENV EWSGAEASMF RVLIGTYYDN FCAIARLIGT KTCRQVYEFR VKESSIIAPA
     PAEDVDTPPR KKKRKHRLWA AHCRKIQLKK DGSSNHVYNY QPCDHPRQPC DSSCPCVIAQ
     NFCEKFCQCS SECQNRFPGC RCKAQCNTKQ CPCYLAVREC DPDLCLTCGA ADHWDSKNVS
     CKNCSIQRGS KKHLLLAPSD VAGWGIFIKD PVQKNEFISE YCGEIISQDE ADRRGKVYDK
     YMCSFLFNLN NDFVVDATRK GNKIRFANHS VNPNCYAKVM MVNGDHRIGI FAKRAIQTGE
     ELFFDYRYSQ ADALKYVGIE REMEIP
//
ID   S4S3R8_HUMAN            Unreviewed;       707 AA.
AC   S4S3R8;
DT   16-OCT-2013, integrated into UniProtKB/TrEMBL.
DT   16-OCT-2013, sequence version 1.
DT   23-MAY-2018, entry version 42.
DE   SubName: Full=EZH2b {ECO:0000313|EMBL:AEN79481.1};
DE   SubName: Full=Enhancer of zeste homolog 2 (Drosophila) {ECO:0000313|EMBL:EAL24423.1};
GN   Name=EZH2 {ECO:0000313|EMBL:EAL24423.1};
GN   ORFNames=tcag7.507 {ECO:0000313|EMBL:EAL24423.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEN79481.1};
RN   [1] {ECO:0000313|EMBL:EAL24423.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D., Zhang Q., Gu Z., Lu F.,
RA   Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J., Grzeschik K.H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Dohner H., Dohner K.,
RA   Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [2] {ECO:0000313|EMBL:EAL24423.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Nusskern D., Zhang Q., Gu Z., Lu F.,
RA   Zeesman S., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P., Lococo F., Belloni E.,
RA   Shaffer L.G., Morton C.C., Pober B., Gusella J., Bruns G., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M.,
RA   Gripp K.W., Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H.,
RA   Teebi A., Minassian B.A., Kere J., Armengol L., Pujana M.Angel.,
RA   Estivill X., Wilson M.D., Koop B.F., Tosi S., Moore G.E.,
RA   Boright A.P., Zlotorynski E., Kerem B., Kroisel P.M., Petek E.,
RA   Oscier D.G., Mould S.J., Doehner H., Doehner K., Rommens J.M.,
RA   Vincent J.B., Venter J.C., Li P.W., Mural R.J., Adams M.D.,
RA   Tsui L.-C.;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:AEN79481.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Grzenda A.L., Urrutia R.A., Gwen L.A.;
RT   "Polycomb repressive complexes utilize distinct EZH2 isoforms to
RT   mediate gene silencing.";
RL   Submitted (MAY-2011) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; JF939048; AEN79481.1; -; Genomic_RNA.
DR   EMBL; AACC02000041; EAL24423.1; -; Genomic_DNA.
DR   RefSeq; NP_694543.1; NM_152998.2.
DR   UniGene; Hs.444082; -.
DR   UniGene; Hs.732308; -.
DR   SMR; S4S3R8; -.
DR   MaxQB; S4S3R8; -.
DR   GeneID; 2146; -.
DR   UCSC; uc003wfc.3; human.
DR   CTD; 2146; -.
DR   EuPathDB; HostDB:ENSG00000106462.10; -.
DR   ChiTaRS; EZH2; human.
DR   GenomeRNAi; 2146; -.
DR   Bgee; ENSG00000106462; -.
DR   ExpressionAtlas; S4S3R8; baseline and differential.
DR   GO; GO:0018024; F:histone-lysine N-methyltransferase activity; IEA:InterPro.
DR   CDD; cd00167; SANT; 1.
DR   InterPro; IPR026489; CXC_dom.
DR   InterPro; IPR021654; EZH1/EZH2.
DR   InterPro; IPR001005; SANT/Myb.
DR   InterPro; IPR001214; SET_dom.
DR   InterPro; IPR033467; Tesmin/TSO1-like_CXC.
DR   Pfam; PF11616; EZH2_WD-Binding; 1.
DR   Pfam; PF00856; SET; 1.
DR   SMART; SM01114; CXC; 1.
DR   SMART; SM00717; SANT; 2.
DR   SMART; SM00317; SET; 1.
DR   PROSITE; PS51633; CXC; 1.
DR   PROSITE; PS50280; SET; 1.
PE   4: Predicted;
FT   DOMAIN      464    566       CXC. {ECO:0000259|PROSITE:PS51633}.
FT   DOMAIN      573    688       SET. {ECO:0000259|PROSITE:PS50280}.
SQ   SEQUENCE   707 AA;  81038 MW;  48EAF1393A9EA4F2 CRC64;
     MGQTGKKSEK GPVCWRKRVK SEYMRLRQLK RFRRADEVKS MFSSNRQKIL ERTEILNQEW
     KQRRIQPVHI LTSVSSLRGT REVEDETVLH NIPYMGDEVL DQDGTFIEEL IKNYDGKVHG
     DRECGFINDE IFVELVNALG QYNDDDDDDD GDDPEEREEK QKDLEDHRDD KESRPPRKFP
     SDKIFEAISS MFPDKGTAEE LKEKYKELTE QQLPGALPPE CTPNIDGPNA KSVQREQSLH
     SFHTLFCRRC FKYDCFLHPF HATPNTYKRK NTETALDNKP CGPQCYQHLE GAKEFAAALT
     AERIKTPPKR PGGRRRGRLP NNSSRPSTPT INVLESKDTD SDREAGTETG GENNDKEEEE
     KKDETSSSSE ANSRCQTPIK MKPNIEPPEN VEWSGAEASM FRVLIGTYYD NFCAIARLIG
     TKTCRQVYEF RVKESSIIAP APAEDVDTPP RKKKRKHRLW AAHCRKIQLK KDGSSNHVYN
     YQPCDHPRQP CDSSCPCVIA QNFCEKFCQC SSECQNRFPG CRCKAQCNTK QCPCYLAVRE
     CDPDLCLTCG AADHWDSKNV SCKNCSIQRG SKKHLLLAPS DVAGWGIFIK DPVQKNEFIS
     EYCGEIISQD EADRRGKVYD KYMCSFLFNL NNDFVVDATR KGNKIRFANH SVNPNCYAKV
     MMVNGDHRIG IFAKRAIQTG EELFFDYRYS QADALKYVGI EREMEIP
//
ID   A0A024R464_HUMAN        Unreviewed;       726 AA.
AC   A0A024R464;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 38.
DE   SubName: Full=Ankyrin repeat and zinc finger domain containing 1, isoform CRA_b {ECO:0000313|EMBL:EAW70710.1};
GN   Name=ANKZF1 {ECO:0000313|EMBL:EAW70710.1};
GN   ORFNames=hCG_15582 {ECO:0000313|EMBL:EAW70710.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW70710.1};
RN   [1] {ECO:0000313|EMBL:EAW70710.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW70710.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471063; EAW70709.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70710.1; -; Genomic_DNA.
DR   RefSeq; NP_001035869.1; NM_001042410.1.
DR   RefSeq; NP_060559.2; NM_018089.2.
DR   UniGene; Hs.437647; -.
DR   SMR; A0A024R464; -.
DR   PRIDE; A0A024R464; -.
DR   GeneID; 55139; -.
DR   KEGG; hsa:55139; -.
DR   CTD; 55139; -.
DR   EuPathDB; HostDB:ENSG00000163516.13; -.
DR   eggNOG; KOG2505; Eukaryota.
DR   eggNOG; ENOG410XQAG; LUCA.
DR   OMA; SFCSTRC; -.
DR   OrthoDB; EOG091G06FM; -.
DR   ChiTaRS; ANKZF1; human.
DR   GenomeRNAi; 55139; -.
DR   Bgee; ENSG00000163516; -.
DR   ExpressionAtlas; A0A024R464; baseline and differential.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   SMART; SM00248; ANK; 2.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 1.
PE   4: Predicted;
KW   ANK repeat {ECO:0000256|PROSITE-ProRule:PRU00023};
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN      534    599       ANK_REP_REGION.
FT                                {ECO:0000259|PROSITE:PS50297}.
FT   REPEAT      534    566       ANK. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00023}.
FT   COILED      612    648       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   726 AA;  80927 MW;  44F7930A530F1355 CRC64;
     MSPAPDAAPA PASISLFDLS ADAPVFQGLS LVSHAPGEAL ARAPRTSCSG SGERESPERK
     LLQGPMDISE KLFCSTCDQT FQNHQEQREH YKLDWHRFNL KQRLKDKPLL SALDFEKQSS
     TGDLSSISGS EDSDSASEED LQTLDRERAT FEKLSRPPGF YPHRVLFQNA QGQFLYAYRC
     VLGPHQDPPE EAELLLQNLQ SRGPRDCVVL MAAAGHFAGA IFQGREVVTH KTFHRYTVRA
     KRGTAQGLRD ARGGPSHSAG ANLRRYNEAT LYKDVRDLLA GPSWAKALEE AGTILLRAPR
     SGRSLFFGGK GAPLQRGDPR LWDIPLATRR PTFQELQRVL HKLTTLHVYE EDPREAVRLH
     SPQTHWKTVR EERKKPTEEE IRKICRDEKE ALGQNEESPK QGSGSEGEDG FQVELELVEL
     TVGTLDLCES EVLPKRRRRK RNKKEKSRDQ EAGAHRTLLQ QTQEEEPSTQ SSQAVAAPLG
     PLLDEAKAPG QPELWNALLA ACRAGDVGVL KLQLAPSPAD PRVLSLLSAP LGSGGFTLLH
     AAAAAGRGSV VRLLLEAGAD PTVQDSRARP PYTVAADKST RNEFRRFMEK NPDAYDYNKA
     QVPGPLTPEM EARQATRKRE QKAARRQREE QQQRQQEQEE REREEQRRFA ALSDREKRAL
     AAERRLAAQL GAPTSPIPDS AIVNTRRCWS CGASLQGLTP FHYLDFSFCS TRCLQDHRRQ
     AGRPSS
//
ID   B8ZZS4_HUMAN            Unreviewed;       516 AA.
AC   B8ZZS4;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   25-APR-2018, entry version 75.
DE   SubName: Full=Ankyrin repeat and zinc finger domain-containing protein 1 {ECO:0000313|Ensembl:ENSP00000386815};
GN   Name=ANKZF1 {ECO:0000313|Ensembl:ENSP00000386815};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000386815, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000386815, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000213|PubMed:16964243}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [3] {ECO:0000213|PubMed:18220336}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.D., Yates J.R.;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [4] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [7] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [9] {ECO:0000313|Ensembl:ENSP00000386815}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [10] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC068946; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001269721.1; NM_001282792.1.
DR   UniGene; Hs.437647; -.
DR   ProteinModelPortal; B8ZZS4; -.
DR   EPD; B8ZZS4; -.
DR   MaxQB; B8ZZS4; -.
DR   PeptideAtlas; B8ZZS4; -.
DR   PRIDE; B8ZZS4; -.
DR   Ensembl; ENST00000409849; ENSP00000386815; ENSG00000163516.
DR   GeneID; 55139; -.
DR   UCSC; uc002vkh.4; human.
DR   CTD; 55139; -.
DR   EuPathDB; HostDB:ENSG00000163516.13; -.
DR   HGNC; HGNC:25527; ANKZF1.
DR   OpenTargets; ENSG00000163516; -.
DR   eggNOG; KOG2505; Eukaryota.
DR   eggNOG; ENOG410XQAG; LUCA.
DR   GeneTree; ENSGT00390000005911; -.
DR   HOGENOM; HOG000033947; -.
DR   HOVERGEN; HBG080842; -.
DR   ChiTaRS; ANKZF1; human.
DR   GenomeRNAi; 55139; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000163516; -.
DR   ExpressionAtlas; B8ZZS4; baseline and differential.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   SMART; SM00248; ANK; 2.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
PE   1: Evidence at protein level;
KW   ANK repeat {ECO:0000256|PROSITE-ProRule:PRU00023};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:B8ZZS4,
KW   ECO:0000213|MaxQB:B8ZZS4, ECO:0000213|PeptideAtlas:B8ZZS4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      324    389       ANK_REP_REGION.
FT                                {ECO:0000259|PROSITE:PS50297}.
FT   REPEAT      324    356       ANK. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00023}.
FT   COILED      402    438       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   516 AA;  57573 MW;  A5F3A89D3F89F382 CRC64;
     MAAAGHFAGA IFQGREVVTH KTFHRYTVRA KRGTAQGLRD ARGGPSHSAG ANLRRYNEAT
     LYKDVRDLLA GPSWAKALEE AGTILLRAPR SGRSLFFGGK GAPLQRGDPR LWDIPLATRR
     PTFQELQRVL HKLTTLHVYE EDPREAVRLH SPQTHWKTVR EERKKPTEEE IRKICRDEKE
     ALGQNEESPK QGSGSEGEDG FQVELELVEL TVGTLDLCES EVLPKRRRRK RNKKEKSRDQ
     EAGAHRTLLQ QTQEEEPSTQ SSQAVAAPLG PLLDEAKAPG QPELWNALLA ACRAGDVGVL
     KLQLAPSPAD PRVLSLLSAP LGSGGFTLLH AAAAAGRGSV VRLLLEAGAD PTVQDSRARP
     PYTVAADKST RNEFRRFMEK NPDAYDYNKA QVPGPLTPEM EARQATRKRE QKAARRQREE
     QQQRQQEQEE REREEQRRFA ALSDREKRAL AAERRLAAQL GAPTSPIPDS AIVNTRRCWS
     CGASLQGLTP FHYLDFSFCS TRCLQDHRRQ AGRPSS
//
ID   ANKZ1_HUMAN             Reviewed;         726 AA.
AC   Q9H8Y5; Q9NVZ4;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   25-APR-2018, entry version 151.
DE   RecName: Full=Ankyrin repeat and zinc finger domain-containing protein 1;
DE   AltName: Full=Zinc finger protein 744;
GN   Name=ANKZF1; Synonyms=ZNF744;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Zhao Y., Li Y., Yuan W., Wu X., Liu M.;
RL   Submitted (FEB-2006) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-675, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-258; SER-398; SER-533
RP   AND THR-607, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   INTERACTION WITH VCP, VIM MOTI, AND MUTAGENESIS OF 661-ARG-ARG-662.
RX   PubMed=21896481; DOI=10.1074/jbc.M111.274472;
RA   Stapf C., Cartwright E., Bycroft M., Hofmann K., Buchberger A.;
RT   "The general definition of the p97/valosin-containing protein (VCP)-
RT   interacting motif (VIM) delineates a new family of p97 cofactors.";
RL   J. Biol. Chem. 286:38670-38678(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-398, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-361; SER-533; THR-607;
RP   SER-675 AND SER-680, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH VPC, VARIANTS
RP   32-VAL--GLN-87 DEL; LYS-152; GLN-585 AND PRO-638, AND CHARACTERIZATION
RP   OF VARIANTS LYS-152 AND GLN-585.
RX   PubMed=28302725; DOI=10.1074/jbc.M116.772038;
RA   van Haaften-Visser D.Y., Harakalova M., Mocholi E.,
RA   van Montfrans J.M., Elkadri A., Rieter E., Fiedler K.,
RA   van Hasselt P.M., Triffaux E.M.M., van Haelst M.M., Nijman I.J.,
RA   Kloosterman W.P., Nieuwenhuis E.E.S., Muise A.M., Cuppen E.,
RA   Houwen R.H.J., Coffer P.J.;
RT   "Ankyrin repeat and zinc-finger domain-containing 1 mutations are
RT   associated with infantile-onset inflammatory bowel disease.";
RL   J. Biol. Chem. 292:7904-7920(2017).
CC   -!- FUNCTION: Plays a role in the cellular response to hydrogen
CC       peroxide and in the maintenance of mitochondrial integrity under
CC       conditions of cellular stress (PubMed:28302725). Involved in the
CC       endoplasmic reticulum (ER)-associated degradation (ERAD) pathway
CC       (By similarity). {ECO:0000250, ECO:0000269|PubMed:28302725}.
CC   -!- SUBUNIT: Interacts (via VIM motif) with VCP.
CC       {ECO:0000269|PubMed:21896481, ECO:0000269|PubMed:28302725}.
CC   -!- INTERACTION:
CC       Q9Q2G4:ORF (xeno); NbExp=2; IntAct=EBI-724848, EBI-6248094;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:28302725}.
CC       Note=Translocates to the mitochondria upon exposure to hydrogen
CC       peroxide. {ECO:0000269|PubMed:28302725}.
CC   -!- SIMILARITY: Belongs to the ANKZF1/VMS1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=ABD65410.1; Type=Frameshift; Positions=318; Evidence={ECO:0000305};
CC       Sequence=BAA91596.1; Type=Frameshift; Positions=318; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ412564; ABD65410.1; ALT_FRAME; mRNA.
DR   EMBL; AK001277; BAA91596.1; ALT_FRAME; mRNA.
DR   EMBL; AK023206; BAB14462.1; -; mRNA.
DR   EMBL; BC000238; AAH00238.1; -; mRNA.
DR   EMBL; BC008948; AAH08948.1; -; mRNA.
DR   CCDS; CCDS42821.1; -.
DR   RefSeq; NP_001035869.1; NM_001042410.1.
DR   RefSeq; NP_060559.2; NM_018089.2.
DR   UniGene; Hs.437647; -.
DR   ProteinModelPortal; Q9H8Y5; -.
DR   SMR; Q9H8Y5; -.
DR   BioGrid; 120443; 10.
DR   IntAct; Q9H8Y5; 10.
DR   MINT; Q9H8Y5; -.
DR   STRING; 9606.ENSP00000321617; -.
DR   iPTMnet; Q9H8Y5; -.
DR   PhosphoSitePlus; Q9H8Y5; -.
DR   SwissPalm; Q9H8Y5; -.
DR   BioMuta; ANKZF1; -.
DR   DMDM; 74761542; -.
DR   EPD; Q9H8Y5; -.
DR   MaxQB; Q9H8Y5; -.
DR   PaxDb; Q9H8Y5; -.
DR   PeptideAtlas; Q9H8Y5; -.
DR   PRIDE; Q9H8Y5; -.
DR   Ensembl; ENST00000323348; ENSP00000321617; ENSG00000163516.
DR   Ensembl; ENST00000410034; ENSP00000386337; ENSG00000163516.
DR   GeneID; 55139; -.
DR   KEGG; hsa:55139; -.
DR   UCSC; uc002vkg.3; human.
DR   CTD; 55139; -.
DR   EuPathDB; HostDB:ENSG00000163516.13; -.
DR   GeneCards; ANKZF1; -.
DR   HGNC; HGNC:25527; ANKZF1.
DR   HPA; HPA035208; -.
DR   MIM; 617541; gene.
DR   neXtProt; NX_Q9H8Y5; -.
DR   OpenTargets; ENSG00000163516; -.
DR   PharmGKB; PA143485305; -.
DR   eggNOG; KOG2505; Eukaryota.
DR   eggNOG; ENOG410XQAG; LUCA.
DR   GeneTree; ENSGT00390000005911; -.
DR   HOGENOM; HOG000033947; -.
DR   HOVERGEN; HBG080842; -.
DR   InParanoid; Q9H8Y5; -.
DR   OMA; SFCSTRC; -.
DR   OrthoDB; EOG091G06FM; -.
DR   PhylomeDB; Q9H8Y5; -.
DR   TreeFam; TF313431; -.
DR   ChiTaRS; ANKZF1; human.
DR   GeneWiki; ANKZF1; -.
DR   GenomeRNAi; 55139; -.
DR   PRO; PR:Q9H8Y5; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000163516; -.
DR   CleanEx; HS_ANKZF1; -.
DR   ExpressionAtlas; Q9H8Y5; baseline and differential.
DR   Genevisible; Q9H8Y5; HS.
DR   GO; GO:0036266; C:Cdc48p-Npl4p-Vms1p AAA ATPase complex; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IMP:UniProtKB.
DR   GO; GO:0072671; P:mitochondria-associated ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0071630; P:nuclear protein quality control by the ubiquitin-proteasome system; IBA:GO_Central.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IBA:GO_Central.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   SMART; SM00248; ANK; 2.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 1.
PE   1: Evidence at protein level;
KW   ANK repeat; Coiled coil; Complete proteome; Cytoplasm; Metal-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    726       Ankyrin repeat and zinc finger domain-
FT                                containing protein 1.
FT                                /FTId=PRO_0000247278.
FT   REPEAT      493    526       ANK 1.
FT   REPEAT      534    563       ANK 2.
FT   ZN_FING      72     96       C2H2-type.
FT   REGION      654    666       VCP/p97-interacting motif (VIM).
FT                                {ECO:0000269|PubMed:21896481}.
FT   COILED      609    659       {ECO:0000255}.
FT   MOD_RES     258    258       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     361    361       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     398    398       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     533    533       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     607    607       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     675    675       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     680    680       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT      32     87       Missing (found in a patient with
FT                                infantile-onset inflammatory bowel
FT                                disease; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:28302725}.
FT                                /FTId=VAR_079136.
FT   VARIANT     152    152       E -> K (found in a patient with
FT                                infantile-onset inflammatory bowel
FT                                disease; unknown pathological
FT                                significance; decreased function in
FT                                cellular response to hydrogen peroxide;
FT                                does not affect protein abundance; does
FT                                not affect interaction with VCP;
FT                                dbSNP:rs149382949).
FT                                {ECO:0000269|PubMed:28302725}.
FT                                /FTId=VAR_079137.
FT   VARIANT     569    569       R -> W (in dbSNP:rs2293076).
FT                                /FTId=VAR_048269.
FT   VARIANT     585    585       R -> Q (found in a patient with
FT                                infantile-onset inflammatory bowel
FT                                disease; unknown pathological
FT                                significance; decreased function in
FT                                cellular response to hydrogen peroxide;
FT                                decreased protein abundance; does not
FT                                affect interaction with VCP;
FT                                dbSNP:rs189875478).
FT                                {ECO:0000269|PubMed:28302725}.
FT                                /FTId=VAR_079138.
FT   VARIANT     638    638       Q -> P. {ECO:0000269|PubMed:28302725}.
FT                                /FTId=VAR_079139.
FT   VARIANT     676    676       P -> L (in dbSNP:rs2293079).
FT                                /FTId=VAR_048270.
FT   MUTAGEN     661    662       AA->LL: Abolishes interaction with VCP.
FT                                {ECO:0000269|PubMed:21896481}.
SQ   SEQUENCE   726 AA;  80927 MW;  44F7930A530F1355 CRC64;
     MSPAPDAAPA PASISLFDLS ADAPVFQGLS LVSHAPGEAL ARAPRTSCSG SGERESPERK
     LLQGPMDISE KLFCSTCDQT FQNHQEQREH YKLDWHRFNL KQRLKDKPLL SALDFEKQSS
     TGDLSSISGS EDSDSASEED LQTLDRERAT FEKLSRPPGF YPHRVLFQNA QGQFLYAYRC
     VLGPHQDPPE EAELLLQNLQ SRGPRDCVVL MAAAGHFAGA IFQGREVVTH KTFHRYTVRA
     KRGTAQGLRD ARGGPSHSAG ANLRRYNEAT LYKDVRDLLA GPSWAKALEE AGTILLRAPR
     SGRSLFFGGK GAPLQRGDPR LWDIPLATRR PTFQELQRVL HKLTTLHVYE EDPREAVRLH
     SPQTHWKTVR EERKKPTEEE IRKICRDEKE ALGQNEESPK QGSGSEGEDG FQVELELVEL
     TVGTLDLCES EVLPKRRRRK RNKKEKSRDQ EAGAHRTLLQ QTQEEEPSTQ SSQAVAAPLG
     PLLDEAKAPG QPELWNALLA ACRAGDVGVL KLQLAPSPAD PRVLSLLSAP LGSGGFTLLH
     AAAAAGRGSV VRLLLEAGAD PTVQDSRARP PYTVAADKST RNEFRRFMEK NPDAYDYNKA
     QVPGPLTPEM EARQATRKRE QKAARRQREE QQQRQQEQEE REREEQRRFA ALSDREKRAL
     AAERRLAAQL GAPTSPIPDS AIVNTRRCWS CGASLQGLTP FHYLDFSFCS TRCLQDHRRQ
     AGRPSS
//
ID   B3KN02_HUMAN            Unreviewed;       890 AA.
AC   B3KN02;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 42.
DE   SubName: Full=cDNA FLJ13106 fis, clone NT2RP3002455, highly similar to DnaJ homolog subfamily C member 13 {ECO:0000313|EMBL:BAG51164.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG51164.1};
RN   [1] {ECO:0000313|EMBL:BAG51164.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK023168; BAG51164.1; -; mRNA.
DR   RefSeq; NP_001316055.1; NM_001329126.1.
DR   UniGene; Hs.12707; -.
DR   PeptideAtlas; B3KN02; -.
DR   PRIDE; B3KN02; -.
DR   GeneID; 23317; -.
DR   CTD; 23317; -.
DR   eggNOG; KOG1789; Eukaryota.
DR   eggNOG; ENOG410XRI2; LUCA.
DR   HOVERGEN; HBG101510; -.
DR   GO; GO:0005765; C:lysosomal membrane; HDA:UniProtKB.
DR   Gene3D; 1.25.10.10; -; 2.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   SUPFAM; SSF48371; SSF48371; 2.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   890 AA;  99241 MW;  05E03B5A3A3A4534 CRC64;
     MYQISKNSGW ARSREYNFNL KTQSILFNRH KEDLQPYKYA GYPMLIRTIT METSDDLLFS
     KESPLLPAAT ELAFHTVNCS ALNAEELRRE NGLEVLQEAF SRCVAVLTRS SKPSDMSVQV
     CGYISKCYSV AAQFEECREK ITEMPSIIKD LCRVLYFGKS IPRVAALGVE CVSSFAVDFW
     LQTHLFQAGI LWHLLGFLFN YDYTLEESGI QKSEETNQQE VANSLAKLSV HALSRLGGYL
     AEEQATPENP TIRKSLAGML TPYVARKLAV ASVTEILKML NSNTESPYLI WNNSTRAELL
     EFLESQQENM IKKGDCDKTY GSEFVYSDHA KELIVGEIFV RVYNEVPTFQ LEVPKAFAAS
     LLDYIGSQAQ YLHTFMAITH AAKVESEQHG DRLPRVEMAL EALRNVIKYN PGSESECIGH
     FKLIFSLLRV HGAGQVQQLA LEVVNIVTSN QDCVNNIAES MVLSSLLALL HSLPSSRQLV
     LETLYALTSS TKIIKEAMAK GALIYLLDMF CNSTHPQVRA QTAELFAKMT ADKLIGPKVR
     ITLMKFLPSV FMDAMRDNPE AAVHIFEGTH ENPELIWNDN SRDKVSTTVR EMMLEHFKNQ
     QDNPEANWKL PEDFAVVFGE AEGELAVGGV FLRIFIAQPA WVLRKPREFL IALLEKLTEL
     LEKNNPHGET LETLTMATVC LFSAQPQLAD QVPPLGHLPK VIQAMNHRNN AIPKSAIRVI
     HALSENELCV RAMASLETIG PLMNGMKKRA DTVGLACEAI NRMFQKEQSE LVAQALKADL
     VPYLLKLLEG IGLENLDSPA ATKAQIVKAL KAMTRSLQYG EQVNEILCRS SVWSAFKDQK
     HDLFISESQT AGYLTGPGVA GYLTAGTSTS VMSNLPPPVD HEAGDLGYQT
//
ID   DJC13_HUMAN             Reviewed;        2243 AA.
AC   O75165; Q3L0T1; Q6PI82; Q6UJ77; Q6ZSW1; Q6ZUT5; Q86XG3; Q96DC1;
AC   Q9BWK9;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 5.
DT   23-MAY-2018, entry version 150.
DE   RecName: Full=DnaJ homolog subfamily C member 13;
DE   AltName: Full=Required for receptor-mediated endocytosis 8;
DE            Short=RME-8;
GN   Name=DNAJC13; Synonyms=KIAA0678, RME8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=16179350; DOI=10.1074/jbc.M505036200;
RA   Girard M., Poupon V., Blondeau F., McPherson P.S.;
RT   "The DnaJ-domain protein RME-8 functions in endosomal trafficking.";
RL   J. Biol. Chem. 280:40135-40143(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-1463.
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [3]
RP   SEQUENCE REVISION.
RC   TISSUE=Aortic endothelium;
RA   Ohara O., Nagase T., Kikuno R., Ishikawa K., Suyama M.;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-736 AND 1819-2243.
RC   TISSUE=Cervix, Placenta, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 617-2243, AND VARIANT
RP   SER-1463.
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 672-1098.
RA   Chang H.C., Hull M.J., Mellman I.;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18256511; DOI=10.1247/csf.07045;
RA   Fujibayashi A., Taguchi T., Misaki R., Ohtani M., Dohmae N., Takio K.,
RA   Yamada M., Gu J., Yamakami M., Fukuda M., Waguri S., Uchiyama Y.,
RA   Yoshimori T., Sekiguchi K.;
RT   "Human RME-8 is involved in membrane trafficking through early
RT   endosomes.";
RL   Cell Struct. Funct. 33:35-50(2008).
RN   [9]
RP   FUNCTION.
RX   PubMed=18307993; DOI=10.1016/j.febslet.2008.02.042;
RA   Girard M., McPherson P.S.;
RT   "RME-8 regulates trafficking of the epidermal growth factor
RT   receptor.";
RL   FEBS Lett. 582:961-966(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-84, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   POSSIBLE INVOLVEMENT IN PARK, VARIANT PARK SER-855, VARIANTS GLN-264;
RP   ILE-1082 AND LEU-2115, AND CHARACTERIZATION OF VARIANT PARK SER-855.
RX   PubMed=24218364; DOI=10.1093/hmg/ddt570;
RA   Vilarino-Guell C., Rajput A., Milnerwood A.J., Shah B., Szu-Tu C.,
RA   Trinh J., Yu I., Encarnacion M., Munsie L.N., Tapia L.,
RA   Gustavsson E.K., Chou P., Tatarnikov I., Evans D.M., Pishotta F.T.,
RA   Volta M., Beccano-Kelly D., Thompson C., Lin M.K., Sherman H.E.,
RA   Han H.J., Guenther B.L., Wasserman W.W., Bernard V., Ross C.J.,
RA   Appel-Cresswell S., Stoessl A.J., Robinson C.A., Dickson D.W.,
RA   Ross O.A., Wszolek Z.K., Aasly J.O., Wu R.M., Hentati F., Gibson R.A.,
RA   McPherson P.S., Girard M., Rajput M., Rajput A.H., Farrer M.J.;
RT   "DNAJC13 mutations in Parkinson disease.";
RL   Hum. Mol. Genet. 23:1794-1801(2014).
RN   [13]
RP   FUNCTION, INTERACTION WITH WASHC2C, AND SUBCELLULAR LOCATION.
RX   PubMed=24643499; DOI=10.1242/jcs.144659;
RA   Freeman C.L., Hesketh G., Seaman M.N.;
RT   "RME-8 coordinates the activity of the WASH complex with the function
RT   of the retromer SNX dimer to control endosomal tubulation.";
RL   J. Cell Sci. 127:2053-2070(2014).
RN   [14]
RP   POSSIBLE INVOLVEMENT IN PARK, VARIANTS SER-556; ALA-674; LYS-903;
RP   PHE-997; SER-1135; GLY-1291; HIS-1516; GLN-1740; SER-2057 AND
RP   TRP-2170, AND VARIANTS PARK LEU-722; SER-855; GLN-1266 AND MET-1895.
RX   PubMed=25393719; DOI=10.1002/mds.26064;
RA   Gustavsson E.K., Trinh J., Guella I., Vilarino-Gueell C.,
RA   Appel-Cresswell S., Stoessl A.J., Tsui J.K., McKeown M., Rajput A.,
RA   Rajput A.H., Aasly J.O., Farrer M.J.;
RT   "DNAJC13 genetic variants in parkinsonism.";
RL   Mov. Disord. 30:273-278(2015).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   DISCUSSION ON POSSIBLE INVOLVEMENT IN PARK.
RX   PubMed=27270108; DOI=10.1038/ng.3589;
RA   Deng H.X., Shi Y., Yang Y., Ahmeti K.B., Miller N., Huang C.,
RA   Cheng L., Zhai H., Deng S., Nuytemans K., Corbett N.J., Kim M.J.,
RA   Deng H., Tang B., Yang Z., Xu Y., Chan P., Huang B., Gao X.P.,
RA   Song Z., Liu Z., Fecto F., Siddique N., Foroud T., Jankovic J.,
RA   Ghetti B., Nicholson D.A., Krainc D., Melen O., Vance J.M.,
RA   Pericak-Vance M.A., Ma Y.C., Rajput A.H., Siddique T.;
RT   "Identification of TMEM230 mutations in familial Parkinson's
RT   disease.";
RL   Nat. Genet. 48:733-739(2016).
CC   -!- FUNCTION: Involved in membrane trafficking through early
CC       endosomes, such as the early endosome to recycling endosome
CC       transport implicated in the recycling of transferrin and the early
CC       endosome to late endosome transport implicated in degradation of
CC       EGF and EGFR (PubMed:18256511, PubMed:18307993). Involved in the
CC       regulation of endosomal membrane tubulation and regulates th
CC       dynamics of SNX1 on the endosomal membrane; via association with
CC       WASHC2 may link the WASH complex to the retromer SNX-BAR
CC       subcomplex (PubMed:24643499). {ECO:0000269|PubMed:18256511,
CC       ECO:0000269|PubMed:18307993, ECO:0000269|PubMed:24643499}.
CC   -!- SUBUNIT: Interacts with WASHC2C; mediates the association with the
CC       WASH complex (PubMed:24643499). {ECO:0000269|PubMed:24643499}.
CC   -!- SUBCELLULAR LOCATION: Early endosome
CC       {ECO:0000269|PubMed:18256511}. Early endosome membrane
CC       {ECO:0000305}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:18256511}. Endosome membrane
CC       {ECO:0000269|PubMed:24643499}.
CC   -!- DISEASE: Parkinson disease (PARK) [MIM:168600]: A complex
CC       neurodegenerative disorder characterized by bradykinesia, resting
CC       tremor, muscular rigidity and postural instability. Additional
CC       features are characteristic postural abnormalities, dysautonomia,
CC       dystonic cramps, and dementia. The pathology of Parkinson disease
CC       involves the loss of dopaminergic neurons in the substantia nigra
CC       and the presence of Lewy bodies (intraneuronal accumulations of
CC       aggregated proteins), in surviving neurons in various areas of the
CC       brain. The disease is progressive and usually manifests after the
CC       age of 50 years, although early-onset cases (before 50 years) are
CC       known. The majority of the cases are sporadic suggesting a
CC       multifactorial etiology based on environmental and genetic
CC       factors. However, some patients present with a positive family
CC       history for the disease. Familial forms of the disease usually
CC       begin at earlier ages and are associated with atypical clinical
CC       features. {ECO:0000269|PubMed:24218364,
CC       ECO:0000269|PubMed:25393719}. Note=The gene represented in this
CC       entry may be involved in disease pathogenesis. Genetic variants in
CC       DNAJC13 (PubMed:24218364, PubMed:25393719) and TMEM230
CC       (PubMed:27270108) have been found in the same large
CC       multigenerational family with adult-onset Parkinson disease. The
CC       pathological role of each gene and therefore the exact molecular
CC       basis of the disease is unclear. {ECO:0000305|PubMed:27270108}.
CC   -!- CAUTION: In human, WASHC2 has undergone evolutionary duplication
CC       giving rise to highly homologous family members. A WASHC2C
CC       construct with WASHC2A-specific sequence insertions (of 2 aa and
CC       21 aa length resulting in a construct length of 1341 aa similar to
CC       WASHC2A length) has been used to demonstrate the interaction with
CC       WASHC2 (PubMed:24643499). {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH43583.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=BAA31653.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAC86133.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAC86835.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAC86835.1; Type=Erroneous termination; Positions=1651; Note=Translated as Glu.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY779857; AAV41096.1; -; mRNA.
DR   EMBL; AB014578; BAA31653.2; ALT_INIT; mRNA.
DR   EMBL; AC020632; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020633; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026374; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000164; AAH00164.2; -; mRNA.
DR   EMBL; BC009630; AAH09630.1; -; mRNA.
DR   EMBL; BC040638; AAH40638.1; -; mRNA.
DR   EMBL; BC043583; AAH43583.1; ALT_SEQ; mRNA.
DR   EMBL; AK125330; BAC86133.1; ALT_INIT; mRNA.
DR   EMBL; AK127112; BAC86835.1; ALT_SEQ; mRNA.
DR   EMBL; AY369172; AAQ57271.1; -; mRNA.
DR   CCDS; CCDS33857.1; -.
DR   PIR; T00361; T00361.
DR   RefSeq; NP_056083.3; NM_015268.3.
DR   UniGene; Hs.12707; -.
DR   ProteinModelPortal; O75165; -.
DR   BioGrid; 116908; 61.
DR   IntAct; O75165; 23.
DR   MINT; O75165; -.
DR   STRING; 9606.ENSP00000260818; -.
DR   iPTMnet; O75165; -.
DR   PhosphoSitePlus; O75165; -.
DR   BioMuta; DNAJC13; -.
DR   EPD; O75165; -.
DR   MaxQB; O75165; -.
DR   PaxDb; O75165; -.
DR   PeptideAtlas; O75165; -.
DR   PRIDE; O75165; -.
DR   Ensembl; ENST00000260818; ENSP00000260818; ENSG00000138246.
DR   GeneID; 23317; -.
DR   KEGG; hsa:23317; -.
DR   UCSC; uc003eor.4; human.
DR   CTD; 23317; -.
DR   DisGeNET; 23317; -.
DR   EuPathDB; HostDB:ENSG00000138246.15; -.
DR   GeneCards; DNAJC13; -.
DR   H-InvDB; HIX0003688; -.
DR   HGNC; HGNC:30343; DNAJC13.
DR   HPA; HPA036923; -.
DR   HPA; HPA036924; -.
DR   MalaCards; DNAJC13; -.
DR   MIM; 168600; phenotype.
DR   MIM; 614334; gene.
DR   neXtProt; NX_O75165; -.
DR   OpenTargets; ENSG00000138246; -.
DR   Orphanet; 2828; Young adult-onset Parkinsonism.
DR   PharmGKB; PA134947358; -.
DR   eggNOG; KOG1789; Eukaryota.
DR   eggNOG; ENOG410XRI2; LUCA.
DR   GeneTree; ENSGT00390000017582; -.
DR   HOVERGEN; HBG081459; -.
DR   InParanoid; O75165; -.
DR   KO; K09533; -.
DR   OMA; GMLERCT; -.
DR   OrthoDB; EOG091G005A; -.
DR   PhylomeDB; O75165; -.
DR   TreeFam; TF105172; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   ChiTaRS; DNAJC13; human.
DR   GeneWiki; DNAJC13; -.
DR   GenomeRNAi; 23317; -.
DR   PRO; PR:O75165; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000138246; -.
DR   CleanEx; HS_DNAJC13; -.
DR   ExpressionAtlas; O75165; baseline and differential.
DR   Genevisible; O75165; HS.
DR   GO; GO:0035577; C:azurophil granule membrane; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0031901; C:early endosome membrane; IDA:UniProtKB.
DR   GO; GO:0010008; C:endosome membrane; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005765; C:lysosomal membrane; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030667; C:secretory granule membrane; TAS:Reactome.
DR   GO; GO:0007032; P:endosome organization; IMP:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0001649; P:osteoblast differentiation; HDA:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IBA:GO_Central.
DR   GO; GO:2000641; P:regulation of early endosome to late endosome transport; IMP:UniProtKB.
DR   GO; GO:1902954; P:regulation of early endosome to recycling endosome transport; IMP:UniProtKB.
DR   CDD; cd06257; DnaJ; 1.
DR   Gene3D; 1.10.287.110; -; 1.
DR   Gene3D; 1.25.10.10; -; 2.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR001623; DnaJ_domain.
DR   InterPro; IPR025640; DUF4339.
DR   InterPro; IPR035445; GYF-like_dom_sf.
DR   InterPro; IPR036869; J_dom_sf.
DR   Pfam; PF00226; DnaJ; 1.
DR   Pfam; PF14237; DUF4339; 1.
DR   SMART; SM00271; DnaJ; 1.
DR   SUPFAM; SSF46565; SSF46565; 1.
DR   SUPFAM; SSF48371; SSF48371; 7.
DR   SUPFAM; SSF55277; SSF55277; 1.
DR   PROSITE; PS50076; DNAJ_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chaperone; Complete proteome; Disease mutation; Endosome;
KW   Membrane; Neurodegeneration; Parkinson disease; Parkinsonism;
KW   Polymorphism; Protein transport; Reference proteome; Transport.
FT   CHAIN         1   2243       DnaJ homolog subfamily C member 13.
FT                                /FTId=PRO_0000071072.
FT   DOMAIN     1301   1366       J. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00286}.
FT   REGION        1    453       Involved in membrane association.
FT                                {ECO:0000269|PubMed:18256511}.
FT   MOD_RES      84     84       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT     264    264       E -> Q. {ECO:0000269|PubMed:24218364}.
FT                                /FTId=VAR_073784.
FT   VARIANT     556    556       L -> S (in dbSNP:rs749000301).
FT                                {ECO:0000269|PubMed:25393719}.
FT                                /FTId=VAR_076716.
FT   VARIANT     674    674       D -> A (in dbSNP:rs199541720).
FT                                {ECO:0000269|PubMed:25393719}.
FT                                /FTId=VAR_076717.
FT   VARIANT     722    722       V -> L (in PARK; unknown pathological
FT                                significance; dbSNP:rs146930051).
FT                                {ECO:0000269|PubMed:25393719}.
FT                                /FTId=VAR_076718.
FT   VARIANT     855    855       N -> S (in PARK; unknown pathological
FT                                significance; affects regulation of
FT                                endosomal membrane trafficking as
FT                                indicated by accumulation of transferrin
FT                                in endosomal compartments;
FT                                dbSNP:rs387907571).
FT                                {ECO:0000269|PubMed:24218364,
FT                                ECO:0000269|PubMed:25393719}.
FT                                /FTId=VAR_073785.
FT   VARIANT     903    903       R -> K (in dbSNP:rs141952333).
FT                                {ECO:0000269|PubMed:25393719}.
FT                                /FTId=VAR_076719.
FT   VARIANT     997    997       L -> F (in dbSNP:rs752189478).
FT                                {ECO:0000269|PubMed:25393719}.
FT                                /FTId=VAR_076720.
FT   VARIANT    1082   1082       T -> I (in dbSNP:rs202127368).
FT                                {ECO:0000269|PubMed:24218364}.
FT                                /FTId=VAR_073786.
FT   VARIANT    1135   1135       N -> S (in dbSNP:rs751747947).
FT                                {ECO:0000269|PubMed:25393719}.
FT                                /FTId=VAR_076721.
FT   VARIANT    1266   1266       R -> Q (in PARK; sporadic case; unknown
FT                                pathological significance;
FT                                dbSNP:rs766013346).
FT                                {ECO:0000269|PubMed:25393719}.
FT                                /FTId=VAR_076722.
FT   VARIANT    1291   1291       E -> G (in dbSNP:rs61748101).
FT                                {ECO:0000269|PubMed:25393719}.
FT                                /FTId=VAR_076723.
FT   VARIANT    1463   1463       A -> S (in dbSNP:rs3762672).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:9734811}.
FT                                /FTId=VAR_047458.
FT   VARIANT    1487   1487       F -> C (in dbSNP:rs4405917).
FT                                /FTId=VAR_047459.
FT   VARIANT    1515   1515       P -> S (in dbSNP:rs55825559).
FT                                /FTId=VAR_061144.
FT   VARIANT    1516   1516       R -> H (in dbSNP:rs139620588).
FT                                {ECO:0000269|PubMed:25393719}.
FT                                /FTId=VAR_076724.
FT   VARIANT    1740   1740       E -> Q (in dbSNP:rs142160751).
FT                                {ECO:0000269|PubMed:25393719}.
FT                                /FTId=VAR_076725.
FT   VARIANT    1895   1895       T -> M (in PARK; unknown pathological
FT                                significance; dbSNP:rs145242123).
FT                                {ECO:0000269|PubMed:25393719}.
FT                                /FTId=VAR_076726.
FT   VARIANT    1995   1995       V -> I (in dbSNP:rs10935014).
FT                                /FTId=VAR_047460.
FT   VARIANT    2057   2057       A -> S (in dbSNP:rs138693725).
FT                                {ECO:0000269|PubMed:25393719}.
FT                                /FTId=VAR_076727.
FT   VARIANT    2115   2115       R -> L (in dbSNP:rs770715465).
FT                                {ECO:0000269|PubMed:24218364}.
FT                                /FTId=VAR_073787.
FT   VARIANT    2170   2170       L -> W (in dbSNP:rs140537885).
FT                                {ECO:0000269|PubMed:25393719}.
FT                                /FTId=VAR_076728.
FT   CONFLICT    476    476       D -> E (in Ref. 2; BAA31653).
FT                                {ECO:0000305}.
FT   CONFLICT    562    562       N -> D (in Ref. 5; AAH43583).
FT                                {ECO:0000305}.
FT   CONFLICT   1097   1097       I -> T (in Ref. 6; BAC86133).
FT                                {ECO:0000305}.
FT   CONFLICT   1148   1148       T -> I (in Ref. 6; BAC86835).
FT                                {ECO:0000305}.
FT   CONFLICT   1227   1227       Q -> H (in Ref. 2; BAA31653).
FT                                {ECO:0000305}.
FT   CONFLICT   1230   1230       T -> A (in Ref. 6; BAC86835).
FT                                {ECO:0000305}.
FT   CONFLICT   1269   1269       D -> N (in Ref. 6; BAC86133).
FT                                {ECO:0000305}.
FT   CONFLICT   2041   2041       L -> P (in Ref. 6; BAC86835).
FT                                {ECO:0000305}.
FT   CONFLICT   2091   2091       T -> A (in Ref. 6; BAC86835).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2243 AA;  254415 MW;  C6D292837DE1F170 CRC64;
     MNIIRENKDL ACFYTTKHSW RGKYKRVFSV GTHAITTYNP NTLEVTNQWP YGDICSISPV
     GKGQGTEFNL TFRKGSGKKS ETLKFSTEHR TELLTEALRF RTDFSEGKIT GRRYNCYKHH
     WSDSRKPVIL EVTPGGFDQI NPATNRVLCS YDYRNIEGFV DLSDYQGGFC ILYGGFSRLH
     LFASEQREEI IKSAIDHAGN YIGISLRIRK EPLEFEQYLN LRFGKYSTDE SITSLAEFVV
     QKISPRHSEP VKRVLALTET CLVERDPATY NIATLKPLGE VFALVCDSEN PQLFTIEFIK
     GQVRKYSSTE RDSLLASLLD GVRASGNRDV CVKMTPTHKG QRWGLLSMPV DEEVESLHLR
     FLATPPNGNF ADAVFRFNAN ISYSGVLHAV TQDGLFSENK EKLINNAITA LLSQEGDVVA
     SNAELESQFQ AVRRLVASKA GFLAFTQLPK FRERLGVKVV KALKRSNNGI IHAAVDMLCA
     LMCPMHDDYD LRQEQLNKAS LLSSKKFLEN LLEKFNSHVD HGTGALVISS LLDFLTFALC
     APYSETTEGQ QFDMLLEMVA SNGRTLFKLF QHPSMAIIKG AGLVMKAIIE EGDKEIATKM
     QELALSEGAL PRHLHTAMFT ISSDQRMLTN RQLSRHLVGL WTADNATATN LLKRILPPGL
     LAYLESSDLV PEKDADRMHV RDNVKIAMDQ YGKFNKVPEW QRLAGKAAKE VEKFAKEKVD
     LVLMHWRDRM GIAQKENINQ KPVVLRKRRQ RIKIEANWDL FYYRFGQDHA RSNLIWNFKT
     REELKDTLES EMRAFNIDRE LGSANVISWN HHEFEVKYEC LAEEIKIGDY YLRLLLEEDE
     NEESGSIKRS YEFFNELYHR FLLTPKVNMK CLCLQALAIV YGRCHEEIGP FTDTRYIIGM
     LERCTDKLER DRLILFLNKL ILNKKNVKDL MDSNGIRILV DLLTLAHLHV SRATVPLQSN
     VIEAAPDMKR ESEKEWYFGN ADKERSGPYG FHEMQELWTK GMLNAKTRCW AQGMDGWRPL
     QSIPQLKWCL LASGQAVLNE TDLATLILNM LITMCGYFPS RDQDNAIIRP LPKVKRLLSD
     STCLPHIIQL LLTFDPILVE KVAILLYHIM QDNPQLPRLY LSGVFFFIMM YTGSNVLPVA
     RFLKYTHTKQ AFKSEETKGQ DIFQRSILGH ILPEAMVCYL ENYEPEKFSE IFLGEFDTPE
     AIWSSEMRRL MIEKIAAHLA DFTPRLQSNT RALYQYCPIP IINYPQLENE LFCNIYYLKQ
     LCDTLRFPDW PIKDPVKLLK DTLDAWKKEV EKKPPMMSID DAYEVLNLPQ GQGPHDESKI
     RKAYFRLAQK YHPDKNPEGR DMFEKVNKAY EFLCTKSAKI VDGPDPENII LILKTQSILF
     NRHKEDLQPY KYAGYPMLIR TITMETSDDL LFSKESPLLP AATELAFHTV NCSALNAEEL
     RRENGLEVLQ EAFSRCVAVL TRASKPSDMS VQVCGYISKC YSVAAQFEEC REKITEMPSI
     IKDLCRVLYF GKSIPRVAAL GVECVSSFAV DFWLQTHLFQ AGILWYLLGF LFNYDYTLEE
     SGIQKSEETN QQEVANSLAK LSVHALSRLG GYLAEEQATP ENPTIRKSLA GMLTPYVARK
     LAVASVTEIL KMLNSNTESP YLIWNNSTRA ELLEFLESQQ ENMIKKGDCD KTYGSEFVYS
     DHAKELIVGE IFVRVYNEVP TFQLEVPKAF AASLLDYIGS QAQYLHTFMA ITHAAKVESE
     QHGDRLPRVE MALEALRNVI KYNPGSESEC IGHFKLIFSL LRVHGAGQVQ QLALEVVNIV
     TSNQDCVNNI AESMVLSSLL ALLHSLPSSR QLVLETLYAL TSSTKIIKEA MAKGALIYLL
     DMFCNSTHPQ VRAQTAELFA KMTADKLIGP KVRITLMKFL PSVFMDAMRD NPEAAVHIFE
     GTHENPELIW NDNSRDKVST TVREMMLEHF KNQQDNPEAN WKLPEDFAVV FGEAEGELAV
     GGVFLRIFIA QPAWVLRKPR EFLIALLEKL TELLEKNNPH GETLETLTMA TVCLFSAQPQ
     LADQVPPLGH LPKVIQAMNH RNNAIPKSAI RVIHALSENE LCVRAMASLE TIGPLMNGMK
     KRADTVGLAC EAINRMFQKE QSELVAQALK ADLVPYLLKL LEGIGLENLD SPAATKAQIV
     KALKAMTRSL QYGEQVNEIL CRSSVWSAFK DQKHDLFISE SQTAGYLTGP GVAGYLTAGT
     STSVMSNLPP PVDHEAGDLG YQT
//
ID   DDAH2_HUMAN             Reviewed;         285 AA.
AC   O95865; A2BEZ7;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   28-MAR-2018, entry version 154.
DE   RecName: Full=N(G),N(G)-dimethylarginine dimethylaminohydrolase 2;
DE            Short=DDAH-2;
DE            Short=Dimethylarginine dimethylaminohydrolase 2;
DE            EC=3.5.3.18;
DE   AltName: Full=DDAHII;
DE   AltName: Full=Dimethylargininase-2;
DE   AltName: Full=Protein G6a;
DE   AltName: Full=S-phase protein;
GN   Name=DDAH2; Synonyms=DDAH, G6A, NG30;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10493931; DOI=10.1042/bj3430209;
RA   Leiper J.M., Santa Maria J., Chubb A., MacAllister R.J., Charles I.G.,
RA   Whitley G.S., Vallance P.;
RT   "Identification of two human dimethylarginine dimethylaminohydrolases
RT   with distinct tissue distributions and homology with microbial
RT   arginine deiminases.";
RL   Biochem. J. 343:209-214(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for
RT   300 previously undefined genes expressed in CD34+ hematopoietic
RT   stem/progenitor cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10384126;
RA   Ribas G., Neville M., Wixon J.L., Cheng J., Campbell R.D.;
RT   "Genes encoding three new members of the leukocyte antigen 6
RT   superfamily and a novel member of Ig superfamily, together with genes
RT   encoding the regulatory nuclear chloride ion channel protein (hRNCC)
RT   and an N omega-N omega-dimethylarginine dimethylaminohydrolase
RT   homologue, are found in a 30-kb segment of the MHC class III region.";
RL   J. Immunol. 163:278-287(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Yu L.;
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14656967; DOI=10.1101/gr.1736803;
RA   Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S.,
RA   Campbell R.D., Hood L.;
RT   "Analysis of the gene-dense major histocompatibility complex class III
RT   region and its comparison to mouse.";
RL   Genome Res. 13:2621-2636(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Shiina S., Tamiya G., Oka A., Inoko H.;
RT   "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 18-40; 113-134; 148-173 AND 268-285, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=21898353; DOI=10.1002/art.30652;
RA   Cillero-Pastor B., Mateos J., Fernandez-Lopez C., Oreiro N.,
RA   Ruiz-Romero C., Blanco F.J.;
RT   "Dimethylarginine dimethylaminohydrolase 2, a newly identified
RT   mitochondrial protein modulating nitric oxide synthesis in normal
RT   human chondrocytes.";
RL   Arthritis Rheum. 64:204-212(2012).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Hydrolyzes N(G),N(G)-dimethyl-L-arginine (ADMA) and
CC       N(G)-monomethyl-L-arginine (MMA) which act as inhibitors of NOS.
CC       Has therefore a role in the regulation of nitric oxide generation.
CC       {ECO:0000269|PubMed:10493931}.
CC   -!- CATALYTIC ACTIVITY: N(omega),N(omega)-dimethyl-L-arginine + H(2)O
CC       = dimethylamine + L-citrulline. {ECO:0000269|PubMed:10493931}.
CC   -!- INTERACTION:
CC       Q15645:TRIP13; NbExp=5; IntAct=EBI-749139, EBI-358993;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21898353}.
CC       Mitochondrion {ECO:0000269|PubMed:21898353}. Note=Translocates
CC       from cytosol to mitochondrion upon IL-1beta stimulation in
CC       chondrocytes.
CC   -!- TISSUE SPECIFICITY: Detected in heart, placenta, lung, liver,
CC       skeletal muscle, kidney and pancreas, and at very low levels in
CC       brain. {ECO:0000269|PubMed:10493931}.
CC   -!- SIMILARITY: Belongs to the DDAH family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF070667; AAD20973.1; -; mRNA.
DR   EMBL; AJ012008; CAB46079.1; -; Genomic_DNA.
DR   EMBL; AF087894; AAP97193.1; -; mRNA.
DR   EMBL; AF129756; AAD18074.1; -; Genomic_DNA.
DR   EMBL; BA000025; BAB63377.1; -; Genomic_DNA.
DR   EMBL; AL662899; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL670886; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL844216; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX248244; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR354443; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR759787; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR936239; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX03500.1; -; Genomic_DNA.
DR   EMBL; BC001435; AAH01435.1; -; mRNA.
DR   CCDS; CCDS4718.1; -.
DR   RefSeq; NP_001289936.1; NM_001303007.1.
DR   RefSeq; NP_001289937.1; NM_001303008.1.
DR   RefSeq; NP_039268.1; NM_013974.2.
DR   RefSeq; XP_011512750.1; XM_011514448.2.
DR   UniGene; Hs.247362; -.
DR   ProteinModelPortal; O95865; -.
DR   SMR; O95865; -.
DR   BioGrid; 117107; 37.
DR   IntAct; O95865; 26.
DR   MINT; O95865; -.
DR   STRING; 9606.ENSP00000364943; -.
DR   DrugBank; DB00155; L-Citrulline.
DR   iPTMnet; O95865; -.
DR   PhosphoSitePlus; O95865; -.
DR   BioMuta; DDAH2; -.
DR   REPRODUCTION-2DPAGE; IPI00000760; -.
DR   REPRODUCTION-2DPAGE; O95865; -.
DR   EPD; O95865; -.
DR   PaxDb; O95865; -.
DR   PeptideAtlas; O95865; -.
DR   PRIDE; O95865; -.
DR   DNASU; 23564; -.
DR   Ensembl; ENST00000375787; ENSP00000364943; ENSG00000213722.
DR   Ensembl; ENST00000375789; ENSP00000364945; ENSG00000213722.
DR   Ensembl; ENST00000375792; ENSP00000364949; ENSG00000213722.
DR   Ensembl; ENST00000383409; ENSP00000372901; ENSG00000206395.
DR   Ensembl; ENST00000400062; ENSP00000382935; ENSG00000206395.
DR   Ensembl; ENST00000400063; ENSP00000382936; ENSG00000206395.
DR   Ensembl; ENST00000411456; ENSP00000409396; ENSG00000226634.
DR   Ensembl; ENST00000413532; ENSP00000402594; ENSG00000226634.
DR   Ensembl; ENST00000413655; ENSP00000412800; ENSG00000233076.
DR   Ensembl; ENST00000414455; ENSP00000404342; ENSG00000225635.
DR   Ensembl; ENST00000424790; ENSP00000391632; ENSG00000233076.
DR   Ensembl; ENST00000426149; ENSP00000412327; ENSG00000228128.
DR   Ensembl; ENST00000427126; ENSP00000395372; ENSG00000228128.
DR   Ensembl; ENST00000430482; ENSP00000408148; ENSG00000227317.
DR   Ensembl; ENST00000434464; ENSP00000391833; ENSG00000228128.
DR   Ensembl; ENST00000437889; ENSP00000399023; ENSG00000227317.
DR   Ensembl; ENST00000443533; ENSP00000389552; ENSG00000226634.
DR   Ensembl; ENST00000444699; ENSP00000404851; ENSG00000225635.
DR   Ensembl; ENST00000447101; ENSP00000405515; ENSG00000233076.
DR   Ensembl; ENST00000451411; ENSP00000403154; ENSG00000227317.
DR   Ensembl; ENST00000454138; ENSP00000399357; ENSG00000225635.
DR   GeneID; 23564; -.
DR   KEGG; hsa:23564; -.
DR   CTD; 23564; -.
DR   DisGeNET; 23564; -.
DR   EuPathDB; HostDB:ENSG00000213722.8; -.
DR   GeneCards; DDAH2; -.
DR   HGNC; HGNC:2716; DDAH2.
DR   HPA; HPA012509; -.
DR   MIM; 604744; gene.
DR   neXtProt; NX_O95865; -.
DR   OpenTargets; ENSG00000213722; -.
DR   PharmGKB; PA27186; -.
DR   eggNOG; ENOG410ISNS; Eukaryota.
DR   eggNOG; ENOG4111YMV; LUCA.
DR   GeneTree; ENSGT00390000009331; -.
DR   HOGENOM; HOG000161035; -.
DR   HOVERGEN; HBG055937; -.
DR   InParanoid; O95865; -.
DR   KO; K01482; -.
DR   OMA; CPYGRFT; -.
DR   OrthoDB; EOG0937146R; -.
DR   PhylomeDB; O95865; -.
DR   TreeFam; TF314737; -.
DR   BRENDA; 3.5.3.18; 2681.
DR   Reactome; R-HSA-203615; eNOS activation.
DR   ChiTaRS; DDAH2; human.
DR   GenomeRNAi; 23564; -.
DR   PRO; PR:O95865; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000213722; -.
DR   CleanEx; HS_DDAH2; -.
DR   ExpressionAtlas; O95865; baseline and differential.
DR   Genevisible; O95865; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005815; C:microtubule organizing center; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0016597; F:amino acid binding; IEA:Ensembl.
DR   GO; GO:0003824; F:catalytic activity; TAS:ProtInc.
DR   GO; GO:0016403; F:dimethylargininase activity; IDA:UniProtKB.
DR   GO; GO:0006527; P:arginine catabolic process; TAS:ProtInc.
DR   GO; GO:0000052; P:citrulline metabolic process; IDA:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0006809; P:nitric oxide biosynthetic process; TAS:ProtInc.
DR   GO; GO:0007263; P:nitric oxide mediated signal transduction; TAS:ProtInc.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISS:BHF-UCL.
DR   GO; GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome.
DR   InterPro; IPR033199; DDAH/AD.
DR   InterPro; IPR033202; DDAH2.
DR   PANTHER; PTHR12737; PTHR12737; 1.
DR   PANTHER; PTHR12737:SF16; PTHR12737:SF16; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; Hydrolase;
KW   Mitochondrion; Reference proteome.
FT   CHAIN         1    285       N(G),N(G)-dimethylarginine
FT                                dimethylaminohydrolase 2.
FT                                /FTId=PRO_0000171121.
FT   ACT_SITE    171    171       Proton donor. {ECO:0000250}.
FT   ACT_SITE    276    276       Nucleophile. {ECO:0000255}.
SQ   SEQUENCE   285 AA;  29644 MW;  B3D9B00F29492548 CRC64;
     MGTPGEGLGR CSHALIRGVP ESLASGEGAG AGLPALDLAK AQREHGVLGG KLRQRLGLQL
     LELPPEESLP LGPLLGDTAV IQGDTALITR PWSPARRPEV DGVRKALQDL GLRIVEIGDE
     NATLDGTDVL FTGREFFVGL SKWTNHRGAE IVADTFRDFA VSTVPVSGPS HLRGLCGMGG
     PRTVVAGSSD AAQKAVRAMA VLTDHPYASL TLPDDAAADC LFLRPGLPGV PPFLLHRGGG
     DLPNSQEALQ KLSDVTLVPV SCSELEKAGA GLSSLCLVLS TRPHS
//
ID   V9HW53_HUMAN            Unreviewed;       285 AA.
AC   V9HW53;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   23-MAY-2018, entry version 45.
DE   SubName: Full=DDAH2 {ECO:0000313|EMBL:AQY76771.1};
DE   SubName: Full=Dimethylarginine dimethylaminohydrolase 2, isoform CRA_a {ECO:0000313|EMBL:EAX03501.1};
DE   SubName: Full=Epididymis secretory protein Li 277 {ECO:0000313|EMBL:ACI45982.1};
DE   SubName: Full=Testis tissue sperm-binding protein Li 54e {ECO:0000313|EMBL:AEE61274.1};
GN   Name=HEL-S-277 {ECO:0000313|EMBL:ACI45982.1};
GN   Synonyms=DDAH2 {ECO:0000313|EMBL:EAX03501.1};
GN   ORFNames=hCG_2039806 {ECO:0000313|EMBL:EAX03501.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACI45982.1};
RN   [1] {ECO:0000313|EMBL:EAX03501.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX03501.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ACI45982.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J., Wang H., Liu J., Liu F.;
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:AEE61274.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human testis protein.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:AQY76771.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Norman P.J., Norberg S.J., Nemat-Gorgani N., Ronaghi M., Parham P.;
RT   "CDS alleles of MHC region genes derived from homozygous
RT   individuals.";
RL   Submitted (APR-2017) to the EMBL/GenBank/DDBJ databases.
CC   -!- INTERACTION:
CC       Q08AM6:VAC14; NbExp=5; IntAct=EBI-10330115, EBI-2107455;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FJ224290; ACI45982.1; -; mRNA.
DR   EMBL; HM005677; AEE61274.1; -; mRNA.
DR   EMBL; KY500283; AQY76771.1; -; Genomic_DNA.
DR   EMBL; KY500284; AQY76772.1; -; Genomic_DNA.
DR   EMBL; KY500285; AQY76773.2; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03501.1; -; Genomic_DNA.
DR   RefSeq; NP_001289936.1; NM_001303007.1.
DR   RefSeq; NP_001289937.1; NM_001303008.1.
DR   RefSeq; NP_039268.1; NM_013974.2.
DR   RefSeq; XP_011512750.1; XM_011514448.2.
DR   UniGene; Hs.247362; -.
DR   SMR; V9HW53; -.
DR   IntAct; V9HW53; 1.
DR   MaxQB; V9HW53; -.
DR   PRIDE; V9HW53; -.
DR   GeneID; 23564; -.
DR   KEGG; hsa:23564; -.
DR   UCSC; uc003nwp.4; human.
DR   CTD; 23564; -.
DR   EuPathDB; HostDB:ENSG00000213722.8; -.
DR   eggNOG; ENOG410ISNS; Eukaryota.
DR   eggNOG; ENOG4111YMV; LUCA.
DR   KO; K01482; -.
DR   OMA; CPYGRFT; -.
DR   OrthoDB; EOG09370IBX; -.
DR   ChiTaRS; DDAH2; human.
DR   GenomeRNAi; 23564; -.
DR   Bgee; ENSG00000213722; -.
DR   ExpressionAtlas; V9HW53; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005815; C:microtubule organizing center; IDA:HPA.
DR   GO; GO:0016597; F:amino acid binding; IEA:Ensembl.
DR   GO; GO:0016403; F:dimethylargininase activity; IEA:Ensembl.
DR   GO; GO:0006527; P:arginine catabolic process; IEA:InterPro.
DR   GO; GO:0000052; P:citrulline metabolic process; IEA:InterPro.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IEA:InterPro.
DR   InterPro; IPR033199; DDAH/AD.
DR   InterPro; IPR033202; DDAH2.
DR   PANTHER; PTHR12737; PTHR12737; 1.
DR   PANTHER; PTHR12737:SF16; PTHR12737:SF16; 1.
PE   1: Evidence at protein level;
KW   Hydrolase {ECO:0000313|EMBL:EAX03501.1}.
SQ   SEQUENCE   285 AA;  29644 MW;  B3D9B00F29492548 CRC64;
     MGTPGEGLGR CSHALIRGVP ESLASGEGAG AGLPALDLAK AQREHGVLGG KLRQRLGLQL
     LELPPEESLP LGPLLGDTAV IQGDTALITR PWSPARRPEV DGVRKALQDL GLRIVEIGDE
     NATLDGTDVL FTGREFFVGL SKWTNHRGAE IVADTFRDFA VSTVPVSGPS HLRGLCGMGG
     PRTVVAGSSD AAQKAVRAMA VLTDHPYASL TLPDDAAADC LFLRPGLPGV PPFLLHRGGG
     DLPNSQEALQ KLSDVTLVPV SCSELEKAGA GLSSLCLVLS TRPHS
//
ID   CO6A1_HUMAN             Reviewed;        1028 AA.
AC   P12109; O00117; O00118; Q14040; Q14041; Q16258; Q7Z645; Q9BSA8;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 3.
DT   23-MAY-2018, entry version 193.
DE   RecName: Full=Collagen alpha-1(VI) chain;
DE   Flags: Precursor;
GN   Name=COL6A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Fibroblast;
RX   PubMed=2551668;
RA   Chu M.-L., Pan T.-C., Conway D., Kuo H.J., Glanville R.W., Timpl R.,
RA   Mann K., Deutzmann R.;
RT   "Sequence analysis of alpha 1(VI) and alpha 2(VI) chains of human type
RT   VI collagen reveals internal triplication of globular domains similar
RT   to the A domains of von Willebrand factor and two alpha 2(VI) chain
RT   variants that differ in the carboxy terminus.";
RL   EMBO J. 8:1939-1946(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-380 AND 383-1028.
RX   PubMed=8168508; DOI=10.1111/j.1432-1033.1994.tb18727.x;
RA   Tillet E., Wiedemann H., Golbik R., Pan T.-C., Zhang R.Z., Mann K.,
RA   Chu M.-L., Timpl R.;
RT   "Recombinant expression and structural and binding properties of alpha
RT   1(VI) and alpha 2(VI) chains of human collagen type VI.";
RL   Eur. J. Biochem. 221:177-185(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 144-268 AND 593-1028.
RX   PubMed=9107679; DOI=10.1007/s003359900436;
RA   Trikka D., Davis T., Lapenta V., Brahe C., Kessling A.M.;
RT   "Human COL6A1: genomic characterization of the globular domains,
RT   structural and evolutionary comparison with COL6A2.";
RL   Mamm. Genome 8:342-345(1997).
RN   [5]
RP   PROTEIN SEQUENCE OF 246-258.
RX   PubMed=6852033; DOI=10.1111/j.1432-1033.1983.tb07427.x;
RA   Jander R., Rauterberg J., Glanville R.W.;
RT   "Further characterization of the three polypeptide chains of bovine
RT   and human short-chain collagen (intima collagen).";
RL   Eur. J. Biochem. 133:39-46(1983).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 257-592.
RX   PubMed=3198591;
RA   Chu M.-L., Conway D., Pan T.-C., Baldwin C., Mann K., Deutzmann R.,
RA   Timpl R.;
RT   "Amino acid sequence of the triple-helical domain of human collagen
RT   type VI.";
RL   J. Biol. Chem. 263:18601-18606(1988).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 287-592.
RX   PubMed=1765372; DOI=10.1016/0888-7543(91)90111-Q;
RA   Saitta B., Wang Y.-M., Renkart L., Zhang R.-Z., Pan T.-C., Timpl R.,
RA   Chu M.-L.;
RT   "The exon organization of the triple-helical coding regions of the
RT   human alpha 1(VI) and alpha 2(VI) collagen genes is highly similar.";
RL   Genomics 11:145-153(1991).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 422-482.
RX   PubMed=3665927; DOI=10.1111/j.1432-1033.1987.tb13422.x;
RA   Chu M.-L., Mann K., Deutzmann R., Pribula-Conway D., Hsu-Chen C.-C.,
RA   Bernard M.P., Timpl R.;
RT   "Characterization of three constituent chains of collagen type VI by
RT   peptide sequences and cDNA clones.";
RL   Eur. J. Biochem. 168:309-317(1987).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 422-481.
RC   TISSUE=Placenta;
RX   PubMed=3348212;
RA   Weil D., Mattei M.-G., Passage E., N'Guyen V.C., Pribula-Conway D.,
RA   Mann K., Deutzmann R., Timpl R., Chu M.-L.;
RT   "Cloning and chromosomal localization of human genes encoding the
RT   three chains of type VI collagen.";
RL   Am. J. Hum. Genet. 42:435-445(1988).
RN   [10]
RP   PROTEIN SEQUENCE OF 693-711; 737-757; 939-957 AND 991-1005, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-212; ASN-516; ASN-804 AND
RP   ASN-896.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   VARIANT BTHLM1 VAL-305.
RX   PubMed=8782832; DOI=10.1038/ng0996-113;
RA   Joebsis G.J., Keizers H., Vreijling J.P., de Visser M., Speer M.C.,
RA   Wolterman R.A., Baas F., Bohlhuis P.A.;
RT   "Type VI collagen mutations in Bethlem myopathy, an autosomal dominant
RT   myopathy with contractures.";
RL   Nat. Genet. 14:113-115(1996).
RN   [16]
RP   VARIANTS BTHLM1 ARG-121 AND ASP-341.
RX   PubMed=11865138; DOI=10.1212/WNL.58.4.593;
RA   Scacheri P.C., Gillanders E.M., Subramony S.H., Vedanarayanan V.,
RA   Crowe C.A., Thakore N., Bingler M., Hoffman E.P.;
RT   "Novel mutations in collagen VI genes: expansion of the Bethlem
RT   myopathy phenotype.";
RL   Neurology 58:593-602(2002).
RN   [17]
RP   VARIANTS UCMD1 ARG-284 AND ARG-290, AND VARIANTS ASN-116 AND LEU-890.
RX   PubMed=16130093; DOI=10.1002/ana.20586;
RA   Giusti B., Lucarini L., Pietroni V., Lucioli S., Bandinelli B.,
RA   Sabatelli P., Squarzoni S., Petrini S., Gartioux C., Talim B.,
RA   Roelens F., Merlini L., Topaloglu H., Bertini E., Guicheney P.,
RA   Pepe G.;
RT   "Dominant and recessive COL6A1 mutations in Ullrich scleroatonic
RT   muscular dystrophy.";
RL   Ann. Neurol. 58:400-410(2005).
RN   [18]
RP   VARIANTS BTHLM1 ASN-116; LEU-274; ARG-290; VAL-341 AND THR-571,
RP   VARIANTS UCMD1 ARG-281 AND ARG-284, AND VARIANTS HIS-850; MET-881 AND
RP   LEU-890.
RX   PubMed=15689448; DOI=10.1136/jmg.2004.023754;
RA   Lampe A.K., Dunn D.M., von Niederhausern A.C., Hamil C., Aoyagi A.,
RA   Laval S.H., Marie S.K., Chu M.-L., Swoboda K., Muntoni F.,
RA   Bonnemann C.G., Flanigan K.M., Bushby K.M.D., Weiss R.B.;
RT   "Automated genomic sequence analysis of the three collagen VI genes:
RT   applications to Ullrich congenital muscular dystrophy and Bethlem
RT   myopathy.";
RL   J. Med. Genet. 42:108-120(2005).
RN   [19]
RP   VARIANTS BTHLM1 ASP-272; ARG-275; ARG-290 AND VAL-341.
RX   PubMed=15955946; DOI=10.1212/01.WNL.0000163990.00057.66;
RA   Lucioli S., Giusti B., Mercuri E., Vanegas O.C., Lucarini L.,
RA   Pietroni V., Urtizberea A., Ben Yaou R., de Visser M.,
RA   van der Kooi A.J., Boennemann C., Iannaccone S.T., Merlini L.,
RA   Bushby K., Muntoni F., Bertini E., Chu M.-L., Pepe G.;
RT   "Detection of common and private mutations in the COL6A1 gene of
RT   patients with Bethlem myopathy.";
RL   Neurology 64:1931-1937(2005).
RN   [20]
RP   CHARACTERIZATION OF VARIANT UCMD1 ARG-284.
RX   PubMed=17785674; DOI=10.1212/01.wnl.0000271386.89878.22;
RA   Kawahara G., Okada M., Morone N., Ibarra C.A., Nonaka I., Noguchi S.,
RA   Hayashi Y.K., Nishino I.;
RT   "Reduced cell anchorage may cause sarcolemma-specific collagen VI
RT   deficiency in Ullrich disease.";
RL   Neurology 69:1043-1049(2007).
CC   -!- FUNCTION: Collagen VI acts as a cell-binding protein.
CC   -!- SUBUNIT: Trimers composed of three different chains: alpha-1(VI),
CC       alpha-2(VI), and alpha-3(VI) or alpha-5(VI) or alpha-6(VI).
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000250}.
CC   -!- PTM: Prolines at the third position of the tripeptide repeating
CC       unit (G-X-Y) are hydroxylated in some or all of the chains.
CC   -!- DISEASE: Bethlem myopathy 1 (BTHLM1) [MIM:158810]: A benign
CC       proximal myopathy characterized by early childhood onset and joint
CC       contractures most frequently affecting the elbows and ankles.
CC       {ECO:0000269|PubMed:11865138, ECO:0000269|PubMed:15689448,
CC       ECO:0000269|PubMed:15955946, ECO:0000269|PubMed:8782832}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Ullrich congenital muscular dystrophy 1 (UCMD1)
CC       [MIM:254090]: A congenital myopathy characterized by muscle
CC       weakness and multiple joint contractures, generally noted at birth
CC       or early infancy. The clinical course is more severe than in
CC       Bethlem myopathy. {ECO:0000269|PubMed:15689448,
CC       ECO:0000269|PubMed:16130093, ECO:0000269|PubMed:17785674}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the type VI collagen family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X15879; CAA33888.1; -; mRNA.
DR   EMBL; X15880; CAA33889.1; -; mRNA.
DR   EMBL; BC005159; AAH05159.2; -; mRNA.
DR   EMBL; BC052575; AAH52575.1; -; mRNA.
DR   EMBL; X99109; CAA67559.1; -; Genomic_DNA.
DR   EMBL; X99135; CAA67576.1; -; Genomic_DNA.
DR   EMBL; X99136; CAA67576.1; JOINED; Genomic_DNA.
DR   EMBL; M20776; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; S75420; AAB20835.2; -; Genomic_DNA.
DR   EMBL; S75385; AAB20835.2; JOINED; Genomic_DNA.
DR   EMBL; S75388; AAB20835.2; JOINED; Genomic_DNA.
DR   EMBL; S75390; AAB20835.2; JOINED; Genomic_DNA.
DR   EMBL; S75392; AAB20835.2; JOINED; Genomic_DNA.
DR   EMBL; S75394; AAB20835.2; JOINED; Genomic_DNA.
DR   EMBL; S75396; AAB20835.2; JOINED; Genomic_DNA.
DR   EMBL; S75398; AAB20835.2; JOINED; Genomic_DNA.
DR   EMBL; S75400; AAB20835.2; JOINED; Genomic_DNA.
DR   EMBL; S75402; AAB20835.2; JOINED; Genomic_DNA.
DR   EMBL; S75404; AAB20835.2; JOINED; Genomic_DNA.
DR   EMBL; S75406; AAB20835.2; JOINED; Genomic_DNA.
DR   EMBL; S75408; AAB20835.2; JOINED; Genomic_DNA.
DR   EMBL; S75410; AAB20835.2; JOINED; Genomic_DNA.
DR   EMBL; S75412; AAB20835.2; JOINED; Genomic_DNA.
DR   EMBL; S75414; AAB20835.2; JOINED; Genomic_DNA.
DR   EMBL; S75416; AAB20835.2; JOINED; Genomic_DNA.
DR   EMBL; S75418; AAB20835.2; JOINED; Genomic_DNA.
DR   EMBL; X06194; CAA29555.1; -; mRNA.
DR   EMBL; M27447; AAA52055.1; -; mRNA.
DR   CCDS; CCDS13727.1; -.
DR   PIR; S05377; CGHU1A.
DR   RefSeq; NP_001839.2; NM_001848.2.
DR   UniGene; Hs.474053; -.
DR   ProteinModelPortal; P12109; -.
DR   BioGrid; 107688; 29.
DR   IntAct; P12109; 14.
DR   MINT; P12109; -.
DR   STRING; 9606.ENSP00000355180; -.
DR   ChEMBL; CHEMBL2364188; -.
DR   iPTMnet; P12109; -.
DR   PhosphoSitePlus; P12109; -.
DR   BioMuta; COL6A1; -.
DR   DMDM; 125987811; -.
DR   REPRODUCTION-2DPAGE; IPI00291136; -.
DR   REPRODUCTION-2DPAGE; P12109; -.
DR   EPD; P12109; -.
DR   MaxQB; P12109; -.
DR   PaxDb; P12109; -.
DR   PeptideAtlas; P12109; -.
DR   PRIDE; P12109; -.
DR   Ensembl; ENST00000361866; ENSP00000355180; ENSG00000142156.
DR   GeneID; 1291; -.
DR   KEGG; hsa:1291; -.
DR   UCSC; uc002zhu.2; human.
DR   CTD; 1291; -.
DR   DisGeNET; 1291; -.
DR   EuPathDB; HostDB:ENSG00000142156.14; -.
DR   GeneCards; COL6A1; -.
DR   GeneReviews; COL6A1; -.
DR   HGNC; HGNC:2211; COL6A1.
DR   HPA; HPA019142; -.
DR   HPA; HPA029401; -.
DR   MalaCards; COL6A1; -.
DR   MIM; 120220; gene.
DR   MIM; 158810; phenotype.
DR   MIM; 254090; phenotype.
DR   neXtProt; NX_P12109; -.
DR   OpenTargets; ENSG00000142156; -.
DR   Orphanet; 610; Bethlem myopathy.
DR   Orphanet; 75840; Congenital muscular dystrophy, Ullrich type.
DR   PharmGKB; PA26727; -.
DR   eggNOG; KOG3544; Eukaryota.
DR   eggNOG; ENOG410ZQTS; LUCA.
DR   GeneTree; ENSGT00820000126981; -.
DR   HOVERGEN; HBG095954; -.
DR   InParanoid; P12109; -.
DR   KO; K06238; -.
DR   OMA; VKENYAE; -.
DR   OrthoDB; EOG091G01WB; -.
DR   PhylomeDB; P12109; -.
DR   TreeFam; TF331207; -.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   Reactome; R-HSA-186797; Signaling by PDGF.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-419037; NCAM1 interactions.
DR   Reactome; R-HSA-8948216; Collagen chain trimerization.
DR   SIGNOR; P12109; -.
DR   ChiTaRS; COL6A1; human.
DR   GeneWiki; Collagen,_type_VI,_alpha_1; -.
DR   GenomeRNAi; 1291; -.
DR   PMAP-CutDB; P12109; -.
DR   PRO; PR:P12109; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; ENSG00000142156; -.
DR   CleanEx; HS_COL6A1; -.
DR   ExpressionAtlas; P12109; baseline and differential.
DR   Genevisible; P12109; HS.
DR   GO; GO:0005589; C:collagen type VI trimer; NAS:UniProtKB.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IDA:MGI.
DR   GO; GO:0005765; C:lysosomal membrane; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IPI:MGI.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0042383; C:sarcolemma; IEA:Ensembl.
DR   GO; GO:0048407; F:platelet-derived growth factor binding; IDA:MGI.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl.
DR   GO; GO:0035987; P:endodermal cell differentiation; IEP:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0001649; P:osteoblast differentiation; HDA:UniProtKB.
DR   GO; GO:0070208; P:protein heterotrimerization; IPI:MGI.
DR   Gene3D; 3.40.50.410; -; 3.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF01391; Collagen; 5.
DR   Pfam; PF00092; VWA; 3.
DR   SMART; SM00327; VWA; 3.
DR   SUPFAM; SSF53300; SSF53300; 3.
DR   PROSITE; PS50234; VWFA; 3.
PE   1: Evidence at protein level;
KW   Cell adhesion; Collagen; Complete proteome;
KW   Congenital muscular dystrophy; Direct protein sequencing;
KW   Disease mutation; Extracellular matrix; Glycoprotein; Hydroxylation;
KW   Polymorphism; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL        1     19
FT   CHAIN        20   1028       Collagen alpha-1(VI) chain.
FT                                /FTId=PRO_0000005758.
FT   DOMAIN       37    235       VWFA 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   DOMAIN      615    805       VWFA 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   DOMAIN      829   1021       VWFA 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   REGION       20    256       N-terminal globular domain.
FT   REGION      257    592       Triple-helical region.
FT   REGION      593   1028       C-terminal globular domain.
FT   MOTIF       262    264       Cell attachment site.
FT   MOTIF       442    444       Cell attachment site.
FT   MOTIF       478    480       Cell attachment site.
FT   CARBOHYD    212    212       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    516    516       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    537    537       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    804    804       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    896    896       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   VARIANT     116    116       S -> N (in BTHLM1; dbSNP:rs11553519).
FT                                {ECO:0000269|PubMed:15689448,
FT                                ECO:0000269|PubMed:16130093}.
FT                                /FTId=VAR_058213.
FT   VARIANT     121    121       K -> R (in BTHLM1; dbSNP:rs121912936).
FT                                {ECO:0000269|PubMed:11865138}.
FT                                /FTId=VAR_013580.
FT   VARIANT     272    272       G -> D (in BTHLM1).
FT                                {ECO:0000269|PubMed:15955946}.
FT                                /FTId=VAR_058214.
FT   VARIANT     274    274       P -> L (in BTHLM1; dbSNP:rs201093313).
FT                                {ECO:0000269|PubMed:15689448}.
FT                                /FTId=VAR_058215.
FT   VARIANT     275    275       G -> R (in BTHLM1).
FT                                {ECO:0000269|PubMed:15955946}.
FT                                /FTId=VAR_058216.
FT   VARIANT     281    281       G -> R (in UCMD1; dbSNP:rs267606746).
FT                                {ECO:0000269|PubMed:15689448}.
FT                                /FTId=VAR_058217.
FT   VARIANT     284    284       G -> R (in UCMD1; fibroblasts with the
FT                                mutation assembled and secreted normal
FT                                collagen VI microfibrils; cell adhesion
FT                                of heterozygous Arg-284 fibroblasts is
FT                                markedly decreased but can be rescued by
FT                                the addition of normal collagen VI;
FT                                dbSNP:rs121912938).
FT                                {ECO:0000269|PubMed:15689448,
FT                                ECO:0000269|PubMed:16130093,
FT                                ECO:0000269|PubMed:17785674}.
FT                                /FTId=VAR_058218.
FT   VARIANT     290    290       G -> R (in BTHLM1 and UCMD1;
FT                                dbSNP:rs121912939).
FT                                {ECO:0000269|PubMed:15689448,
FT                                ECO:0000269|PubMed:15955946,
FT                                ECO:0000269|PubMed:16130093}.
FT                                /FTId=VAR_058219.
FT   VARIANT     305    305       G -> V (in BTHLM1).
FT                                {ECO:0000269|PubMed:8782832}.
FT                                /FTId=VAR_013581.
FT   VARIANT     332    332       G -> S (in dbSNP:rs11701912).
FT                                /FTId=VAR_058220.
FT   VARIANT     341    341       G -> D (in BTHLM1; dbSNP:rs121912935).
FT                                {ECO:0000269|PubMed:11865138}.
FT                                /FTId=VAR_013582.
FT   VARIANT     341    341       G -> V (in BTHLM1; dbSNP:rs121912935).
FT                                {ECO:0000269|PubMed:15689448,
FT                                ECO:0000269|PubMed:15955946}.
FT                                /FTId=VAR_058221.
FT   VARIANT     439    439       R -> Q (in dbSNP:rs35059000).
FT                                /FTId=VAR_048763.
FT   VARIANT     571    571       K -> T (in BTHLM1; dbSNP:rs751040647).
FT                                {ECO:0000269|PubMed:15689448}.
FT                                /FTId=VAR_058222.
FT   VARIANT     850    850       R -> H (in dbSNP:rs1053312).
FT                                {ECO:0000269|PubMed:15689448}.
FT                                /FTId=VAR_048764.
FT   VARIANT     881    881       T -> M (in dbSNP:rs150432347).
FT                                {ECO:0000269|PubMed:15689448}.
FT                                /FTId=VAR_058223.
FT   VARIANT     890    890       S -> L (in dbSNP:rs13051496).
FT                                {ECO:0000269|PubMed:15689448,
FT                                ECO:0000269|PubMed:16130093}.
FT                                /FTId=VAR_058224.
FT   CONFLICT    387    388       SS -> AR (in Ref. 6; M20776 and 7;
FT                                AAB20835). {ECO:0000305}.
FT   CONFLICT    396    397       QP -> PA (in Ref. 6; M20776 and 7;
FT                                AAB20835). {ECO:0000305}.
FT   CONFLICT    438    438       T -> P (in Ref. 6; M20776).
FT                                {ECO:0000305}.
FT   CONFLICT    835    839       DGSAS -> EPPPD (in Ref. 1; CAA33889).
FT                                {ECO:0000305}.
FT   CONFLICT    997    997       A -> P (in Ref. 4; CAA67576).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1028 AA;  108529 MW;  04AFF538002A01CD CRC64;
     MRAARALLPL LLQACWTAAQ DEPETPRAVA FQDCPVDLFF VLDTSESVAL RLKPYGALVD
     KVKSFTKRFI DNLRDRYYRC DRNLVWNAGA LHYSDEVEII QGLTRMPGGR DALKSSVDAV
     KYFGKGTYTD CAIKKGLEQL LVGGSHLKEN KYLIVVTDGH PLEGYKEPCG GLEDAVNEAK
     HLGVKVFSVA ITPDHLEPRL SIIATDHTYR RNFTAADWGQ SRDAEEAISQ TIDTIVDMIK
     NNVEQVCCSF ECQPARGPPG LRGDPGFEGE RGKPGLPGEK GEAGDPGRPG DLGPVGYQGM
     KGEKGSRGEK GSRGPKGYKG EKGKRGIDGV DGVKGEMGYP GLPGCKGSPG FDGIQGPPGP
     KGDPGAFGLK GEKGEPGADG EAGRPGSSGP SGDEGQPGEP GPPGEKGEAG DEGNPGPDGA
     PGERGGPGER GPRGTPGTRG PRGDPGEAGP QGDQGREGPV GVPGDPGEAG PIGPKGYRGD
     EGPPGSEGAR GAPGPAGPPG DPGLMGERGE DGPAGNGTEG FPGFPGYPGN RGAPGINGTK
     GYPGLKGDEG EAGDPGDDNN DIAPRGVKGA KGYRGPEGPQ GPPGHQGPPG PDECEILDII
     MKMCSCCECK CGPIDLLFVL DSSESIGLQN FEIAKDFVVK VIDRLSRDEL VKFEPGQSYA
     GVVQYSHSQM QEHVSLRSPS IRNVQELKEA IKSLQWMAGG TFTGEALQYT RDQLLPPSPN
     NRIALVITDG RSDTQRDTTP LNVLCSPGIQ VVSVGIKDVF DFIPGSDQLN VISCQGLAPS
     QGRPGLSLVK ENYAELLEDA FLKNVTAQIC IDKKCPDYTC PITFSSPADI TILLDGSASV
     GSHNFDTTKR FAKRLAERFL TAGRTDPAHD VRVAVVQYSG TGQQRPERAS LQFLQNYTAL
     ASAVDAMDFI NDATDVNDAL GYVTRFYREA SSGAAKKRLL LFSDGNSQGA TPAAIEKAVQ
     EAQRAGIEIF VVVVGRQVNE PHIRVLVTGK TAEYDVAYGE SHLFRVPSYQ ALLRGVFHQT
     VSRKVALG
//
ID   B4DRM7_HUMAN            Unreviewed;       611 AA.
AC   B4DRM7;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 60.
DE   SubName: Full=cDNA FLJ56998 {ECO:0000313|EMBL:BAG61339.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG61339.1};
RN   [1] {ECO:0000313|EMBL:BAG61339.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK299336; BAG61339.1; -; mRNA.
DR   RefSeq; NP_001295124.1; NM_001308195.1.
DR   RefSeq; NP_001295125.1; NM_001308196.1.
DR   UniGene; Hs.719847; -.
DR   ProteinModelPortal; B4DRM7; -.
DR   MaxQB; B4DRM7; -.
DR   PeptideAtlas; B4DRM7; -.
DR   PRIDE; B4DRM7; -.
DR   GeneID; 375484; -.
DR   KEGG; hsa:375484; -.
DR   CTD; 375484; -.
DR   eggNOG; ENOG410IH7J; Eukaryota.
DR   eggNOG; ENOG410XQXC; LUCA.
DR   HOGENOM; HOG000070068; -.
DR   GenomeRNAi; 375484; -.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   611 AA;  66895 MW;  4CFB56A22570FCD5 CRC64;
     MEDFIVISDD SGSESSGGAR PGRSRRPRRA LSRTSGALPR RTVDFIDLTR ETRPRTKDRS
     GLYVIDLTRA EGENRPIATL DLTLEPVTPS QKEPTSLQTC ASLSGKAVME GHVDRSSQPT
     ARRIINSDPV DLDLVEENTF VGPPPATSIS GGSVYPTEPN CSSATFTGNL SFLASLQLSS
     DVSSLSPTSN NSRSSSSSSN QKAPLPCPQQ DVSRPPQALP CPLRPLPCPP RASPCPPRAS
     SCPPRALSCP SQTMQCQLPA LTHPPQEVPC PRQNIPGPPQ DSLGLPQDVP GLPQSILHPQ
     DVAYLQDMPR SPGDVPQSPS DVSPSPDAPQ SPGGMPHLPG DVLHSPGDMP HSSGDVTHSP
     RDIPHLPGDR PDFTQNDVQN RDMPMDISAL SSPSCSPSPQ SETPLEKVPW LSVMETPARK
     EISLSEPAKP GSAHVQSRTP QGGLYNRPCL HRLKYFLRPP VHHLFFQTLI PDKDTRENKG
     QKLEPIPHRR LRMVTNTIEE NFPLGTVQFL MDFVSPQHYP PREIVAHIIQ KILLSGSETV
     DVLKEAYMLL MKIQQLHPAN AKTVEWDWKL LTYVMEEEPA ECLRLQARAT TPDWFWWRRG
     FAVLAGPVSS P
//
ID   F6R0L0_HUMAN            Unreviewed;       891 AA.
AC   F6R0L0;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   23-MAY-2018, entry version 28.
DE   SubName: Full=SUMO-interacting motif-containing protein 1 {ECO:0000313|Ensembl:ENSP00000410552};
GN   Name=SIMC1 {ECO:0000313|Ensembl:ENSP00000410552};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000410552, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000213|PubMed:15144186}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000410552, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [3] {ECO:0000213|PubMed:17525332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y.,
RA   Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [4] {ECO:0000313|Ensembl:ENSP00000410552}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC138956; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC139493; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001295124.1; NM_001308195.1.
DR   UniGene; Hs.719847; -.
DR   ProteinModelPortal; F6R0L0; -.
DR   EPD; F6R0L0; -.
DR   PeptideAtlas; F6R0L0; -.
DR   Ensembl; ENST00000429602; ENSP00000410552; ENSG00000170085.
DR   GeneID; 375484; -.
DR   UCSC; uc032vui.2; human.
DR   CTD; 375484; -.
DR   EuPathDB; HostDB:ENSG00000170085.17; -.
DR   HGNC; HGNC:24779; SIMC1.
DR   OpenTargets; ENSG00000170085; -.
DR   eggNOG; ENOG410IH7J; Eukaryota.
DR   eggNOG; ENOG410XQXC; LUCA.
DR   GeneTree; ENSGT00390000013414; -.
DR   OMA; CPQQDVP; -.
DR   OrthoDB; EOG091G08T1; -.
DR   ChiTaRS; SIMC1; human.
DR   GenomeRNAi; 375484; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000170085; -.
DR   ExpressionAtlas; F6R0L0; baseline and differential.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:F6R0L0,
KW   ECO:0000213|MaxQB:F6R0L0, ECO:0000213|PeptideAtlas:F6R0L0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   891 AA;  98981 MW;  EAB9F2371F3570EC CRC64;
     MEDFIVISDD SGSESSGGAR PGRSRRPRRA LSRTSGALPR RTVDFIDLTR ETRPRTKDRS
     GLYVIDLTRA EGENRPIATL DLTLEPVTPS QKEPTSLQTC ASLSGKAVME GHVDRSSQPT
     ARRIINSDPV DLDLVEENTF VGPPPATSIS GGSVYPTEPN CSSATFTGNL SFLASLQLSS
     DVSSLSPTSN NSRSSSSSSN QKAPLPCPQQ DVSRPPQALP CPLRPLPCPP RASPCPPRAS
     SCPPRALSCP SQTMQCQLPA LTHPPQEVPC PRQNIPGPPQ DSLGLPQDVP GLPQSILHPQ
     DVAYLQDMPR SPGDVPQSPS DVSPSPDAPQ SPGGMPHLPG DVLHSPGDMP HSSGDVTHSP
     RDIPHLPGDR PDFTQNDVQN RDMPMDISAL SSPSCSPSPQ SETPLEKVPW LSVMETPARK
     EISLSEPAKP GSAHVQSRTP QGGLYNRPCL HRLKYFLRPP VHHLFFQTLI PDKDTRENKG
     QKLEPIPHRR LRMVTNTIEE NFPLGTVQFL MDFVSPQHYP PREIVAHIIQ KILLSGSETV
     DVLKEAYMLL MKIQQLHPAN AKTVEWDWKL LTYVMEEEGQ TLPGRVLFLR YVVQTLEDDF
     QQTLRRQRQH LQQSIANMVL SCDKQPHNVR DVIKWLVKAV TEDGLTQPPN GNQTSSGTGI
     LKASSSHPSS QPNLTKNTNQ LIVCQLQRML SIAVEVDRTP TCSSNKIAEM MFGFVLDIPE
     RSQREMFFTT MESHLLRCKV LEIIFLHSCE TPTRLPLSLA QALYFLNNST SLLKCQSDKS
     QWQTWDELVE HLQFLLSSYQ HVLREHLRSS VIDRKDLIIK RIKPKPQQGD DITVVDVEKQ
     IEAFRSRLIQ MLGEPLVPQL QDKVHLLKLL LFYAADLNPD AEPFQKGWSG S
//
ID   SIMC1_HUMAN             Reviewed;         872 AA.
AC   Q8NDZ2; J3KQQ8; Q6NXN8; Q6ZTU4; Q8IZ15;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2013, sequence version 3.
DT   28-FEB-2018, entry version 113.
DE   RecName: Full=SUMO-interacting motif-containing protein 1;
GN   Name=SIMC1; Synonyms=C5orf25;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4), AND
RP   VARIANTS ARG-463 AND ARG-772.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [6]
RP   IDENTIFICATION OF REPEAT SUMO-INTERACTING MOTIF, AND INTERACTION WITH
RP   SUMO1 AND SUMO2.
RX   PubMed=23086935; DOI=10.1074/jbc.M112.410985;
RA   Sun H., Hunter T.;
RT   "PolySUMO-binding proteins identified through a string search.";
RL   J. Biol. Chem. 287:42071-42083(2012).
CC   -!- SUBUNIT: Interacts (via SIM domains) with SUMO1 and SUMO2.
CC       {ECO:0000269|PubMed:23086935}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8NDZ2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NDZ2-2; Sequence=VSP_020673, VSP_020674, VSP_020675;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q8NDZ2-3; Sequence=VSP_020672, VSP_020676;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q8NDZ2-4; Sequence=VSP_020671, VSP_020677;
CC         Note=No experimental confirmation available.;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK126204; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC138956; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC139493; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC073880; AAH73880.1; -; mRNA.
DR   EMBL; BC037298; AAH37298.1; -; mRNA.
DR   EMBL; BC032390; AAH32390.1; -; mRNA.
DR   EMBL; BC066980; AAH66980.1; -; mRNA.
DR   CCDS; CCDS4398.2; -. [Q8NDZ2-3]
DR   CCDS; CCDS78089.1; -. [Q8NDZ2-1]
DR   CCDS; CCDS78090.1; -. [Q8NDZ2-4]
DR   RefSeq; NP_001295124.1; NM_001308195.1.
DR   RefSeq; NP_001295125.1; NM_001308196.1. [Q8NDZ2-1]
DR   RefSeq; NP_001295129.1; NM_001308200.1. [Q8NDZ2-4]
DR   RefSeq; NP_940969.3; NM_198567.5. [Q8NDZ2-3]
DR   RefSeq; XP_016864943.1; XM_017009454.1. [Q8NDZ2-1]
DR   UniGene; Hs.719847; -.
DR   ProteinModelPortal; Q8NDZ2; -.
DR   SMR; Q8NDZ2; -.
DR   BioGrid; 131981; 28.
DR   IntAct; Q8NDZ2; 8.
DR   MINT; Q8NDZ2; -.
DR   iPTMnet; Q8NDZ2; -.
DR   PhosphoSitePlus; Q8NDZ2; -.
DR   BioMuta; SIMC1; -.
DR   DMDM; 449081288; -.
DR   MaxQB; Q8NDZ2; -.
DR   PaxDb; Q8NDZ2; -.
DR   PeptideAtlas; Q8NDZ2; -.
DR   PRIDE; Q8NDZ2; -.
DR   Ensembl; ENST00000332772; ENSP00000331311; ENSG00000170085. [Q8NDZ2-4]
DR   Ensembl; ENST00000341199; ENSP00000342075; ENSG00000170085. [Q8NDZ2-3]
DR   Ensembl; ENST00000430704; ENSP00000409287; ENSG00000170085. [Q8NDZ2-3]
DR   Ensembl; ENST00000443967; ENSP00000406571; ENSG00000170085. [Q8NDZ2-1]
DR   GeneID; 375484; -.
DR   KEGG; hsa:375484; -.
DR   UCSC; uc003mdr.4; human. [Q8NDZ2-1]
DR   CTD; 375484; -.
DR   EuPathDB; HostDB:ENSG00000170085.17; -.
DR   GeneCards; SIMC1; -.
DR   H-InvDB; HIX0024821; -.
DR   HGNC; HGNC:24779; SIMC1.
DR   HPA; HPA037889; -.
DR   HPA; HPA037890; -.
DR   neXtProt; NX_Q8NDZ2; -.
DR   OpenTargets; ENSG00000170085; -.
DR   PharmGKB; PA144596506; -.
DR   eggNOG; ENOG410IH7J; Eukaryota.
DR   eggNOG; ENOG410XQXC; LUCA.
DR   GeneTree; ENSGT00390000013414; -.
DR   HOGENOM; HOG000070068; -.
DR   HOVERGEN; HBG062235; -.
DR   InParanoid; Q8NDZ2; -.
DR   PhylomeDB; Q8NDZ2; -.
DR   TreeFam; TF332523; -.
DR   ChiTaRS; SIMC1; human.
DR   GenomeRNAi; 375484; -.
DR   PRO; PR:Q8NDZ2; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000170085; -.
DR   CleanEx; HS_C5orf25; -.
DR   ExpressionAtlas; Q8NDZ2; baseline and differential.
DR   Genevisible; Q8NDZ2; HS.
DR   GO; GO:0032184; F:SUMO polymer binding; IDA:UniProtKB.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    872       SUMO-interacting motif-containing protein
FT                                1.
FT                                /FTId=PRO_0000250581.
FT   MOTIF        26     30       SUMO interaction motif 1 (SIM); mediates
FT                                the binding to polysumoylated substrates.
FT   MOTIF        45     49       SUMO interaction motif 2 (SIM); mediates
FT                                the binding to polysumoylated substrates.
FT   COMPBIAS    129    180       Ser-rich.
FT   COMPBIAS    185    352       Pro-rich.
FT   VAR_SEQ       1    539       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020671.
FT   VAR_SEQ       1    415       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020672.
FT   VAR_SEQ       1     89       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020673.
FT   VAR_SEQ     377    415       SPSPQSETPLEKVPWLSVMETPARKEISLSEPAKPGSAH
FT                                -> TPAWGTEQDSVSKKKKKKKRKEIPPNFLLFNLYRTRVK
FT                                N (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020674.
FT   VAR_SEQ     416    872       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020675.
FT   VAR_SEQ     416    458       VQSRTPQGGLYNRPCLHRLKYFLRPPVHHLFFQTLIPDKDT
FT                                RE -> MEDFIVISDDSGSESSGGARPGRSRRPRRALSRTS
FT                                GALPRRTV (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020676.
FT   VAR_SEQ     540    559       ANAKTVEWDWKLLTYVMEEE -> MPRSFEQVIILKKWFLK
FT                                PYK (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020677.
FT   VARIANT     221    221       S -> F (in dbSNP:rs2001605).
FT                                /FTId=VAR_027568.
FT   VARIANT     463    463       K -> R (in dbSNP:rs17857141).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027569.
FT   VARIANT     636    636       S -> F (in dbSNP:rs2001605).
FT                                /FTId=VAR_059603.
FT   VARIANT     772    772       H -> R (in dbSNP:rs17853733).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027570.
FT   CONFLICT    336    336       D -> G (in Ref. 1; AK126204).
FT                                {ECO:0000305}.
FT   CONFLICT    379    379       S -> R (in Ref. 3; AAH37298).
FT                                {ECO:0000305}.
FT   CONFLICT    693    693       F -> L (in Ref. 2; AAH66980).
FT                                {ECO:0000305}.
SQ   SEQUENCE   872 AA;  96838 MW;  D056ACDB8DD23805 CRC64;
     MAPASASGED LRKLPTMAEV NGEQDFIDLT RETRPRTKDR SGLYVIDLTR AEGENRPIAT
     LDLTLEPVTP SQKEPTSLQT CASLSGKAVM EGHVDRSSQP TARRIINSDP VDLDLVEENT
     FVGPPPATSI SGGSVYPTEP NCSSATFTGN LSFLASLQLS SDVSSLSPTS NNSRSSSSSS
     NQKAPLPCPQ QDVSRPPQAL PCPLRPLPCP PRASPCPPRA SSCPPRALSC PSQTMQCQLP
     ALTHPPQEVP CPRQNIPGPP QDSLGLPQDV PGLPQSILHP QDVAYLQDMP RSPGDVPQSP
     SDVSPSPDAP QSPGGMPHLP GDVLHSPGDM PHSSGDVTHS PRDIPHLPGD RPDFTQNDVQ
     NRDMPMDISA LSSPSCSPSP QSETPLEKVP WLSVMETPAR KEISLSEPAK PGSAHVQSRT
     PQGGLYNRPC LHRLKYFLRP PVHHLFFQTL IPDKDTRENK GQKLEPIPHR RLRMVTNTIE
     ENFPLGTVQF LMDFVSPQHY PPREIVAHII QKILLSGSET VDVLKEAYML LMKIQQLHPA
     NAKTVEWDWK LLTYVMEEEG QTLPGRVLFL RYVVQTLEDD FQQTLRRQRQ HLQQSIANMV
     LSCDKQPHNV RDVIKWLVKA VTEDGLTQPP NGNQTSSGTG ILKASSSHPS SQPNLTKNTN
     QLIVCQLQRM LSIAVEVDRT PTCSSNKIAE MMFGFVLDIP ERSQREMFFT TMESHLLRCK
     VLEIIFLHSC ETPTRLPLSL AQALYFLNNS TSLLKCQSDK SQWQTWDELV EHLQFLLSSY
     QHVLREHLRS SVIDRKDLII KRIKPKPQQG DDITVVDVEK QIEAFRSRLI QMLGEPLVPQ
     LQDKVHLLKL LLFYAADLNP DAEPFQKGWS GS
//
ID   R9TJD7_HUMAN            Unreviewed;       891 AA.
AC   R9TJD7;
DT   18-SEP-2013, integrated into UniProtKB/TrEMBL.
DT   18-SEP-2013, sequence version 1.
DT   28-FEB-2018, entry version 13.
DE   SubName: Full=SIMC1 {ECO:0000313|EMBL:AGN32860.1};
GN   Name=SIMC1 {ECO:0000313|EMBL:AGN32860.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AGN32860.1};
RN   [1] {ECO:0000313|EMBL:AGN32860.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Skeletal muscle {ECO:0000313|EMBL:AGN32860.1};
RX   PubMed=23707407;
RA   Ono Y., Iemura S.I., Novak S.M., Doi N., Kitamura F., Natsume T.,
RA   Gregorio C.C., Sorimachi H.;
RT   "PLEIAD/SIMC1/C5orf25, a Novel Autolysis Regulator for a Skeletal-
RT   Muscle-Specific Calpain, CAPN3, Scaffolds a CAPN3 Substrate, CTBP1.";
RL   J. Mol. Biol. 0:0-0(2013).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KF151170; AGN32860.1; -; mRNA.
DR   RefSeq; NP_001295124.1; NM_001308195.1.
DR   UniGene; Hs.719847; -.
DR   PeptideAtlas; R9TJD7; -.
DR   GeneID; 375484; -.
DR   CTD; 375484; -.
DR   eggNOG; ENOG410IH7J; Eukaryota.
DR   eggNOG; ENOG410XQXC; LUCA.
DR   ChiTaRS; SIMC1; human.
DR   GenomeRNAi; 375484; -.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   891 AA;  99097 MW;  82C86B0D0A99F920 CRC64;
     MEDFIVISDD SGSESSGGAR PGRSRRPRRA LSRTSGALPR RTVDFIDLTR ETRPRTKDRS
     GLYVIDLTRA EGENRPIATL DLTLEPVTPS QKEPTSLQTC ASLSGKAVME GHVDRSSQPT
     ARRIINSDPV DLDLVEENTF VGPPPATSIS GGSVYPTEPN CSSATFTGNL SFLASLQLSS
     DVSSLSPTSN NSRSSSSSSN QKAPLPCPQQ DVSRPPQALP CPLRPLPCPP RASPCPPRAS
     SCPPRALSCP SQTMQCQLPA LTHPPQEVPC PRQNIPGPPQ DSLGLPQDVP GLPQSILHPQ
     DVAYLQDMPR SPGDVPQSPS DVSPSPDAPQ SPGGMPHLPG DVLHSPGDMP HSSGDVTHSP
     RDIPHLPGDR PDFTQNDVQN RDMPMDISAL SSPSCSPRPQ SETPLEKVPW LSVMETPARK
     EISLSEPAKP GSAHVQSRTP QGGLYNRPCL HRLKYFLRPP VHHLFFQTLI PDKDTRENKG
     QRLEPIPHRR LRMVTNTIEE NFPLGTVQFL MDFVSPQHYP PREIVAHIIQ KILLSGSETV
     DVLKEAYMLL MKIQQLHPAN AKTVEWDWKL LTYVMEEEGQ TLPGRVLFLR YVVQTLEDDF
     QQTLRRQRQH LQQSIANMVL SCDKQPHNVR DVIKWLVKAV TEDGLTQPPN GNQTSSGTGI
     LKASSSHPSS QPNLTKNTNQ LIVCQLQRML SIAVEVDRTP TCSSNKIAEM MFGFVLDIPE
     RSQREMFFTT MESHLLRCKV LEIIFLHSCE TPTRLPLSLA QALYFLNNST SLLKCQSDKS
     QWQTWDELVE RLQFLLSSYQ HVLREHLRSS VIDRKDLIIK RIKPKPQQGD DITVVDVEKQ
     IEAFRSRLIQ MLGEPLVPQL QDKVHLLKLL LFYAADLNPD AEPFQKGWSG S
//
ID   B3KT07_HUMAN            Unreviewed;       509 AA.
AC   B3KT07;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   23-MAY-2018, entry version 70.
DE   SubName: Full=Collapsin response mediator protein 1, isoform CRA_d {ECO:0000313|EMBL:EAW82406.1};
DE   SubName: Full=cDNA FLJ37406 fis, clone BRAMY2028282, highly similar to Dihydropyrimidinase-related protein 1 {ECO:0000313|EMBL:BAG52919.1};
GN   Name=CRMP1 {ECO:0000313|EMBL:EAW82406.1};
GN   ORFNames=hCG_39896 {ECO:0000313|EMBL:EAW82406.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG52919.1};
RN   [1] {ECO:0000313|EMBL:EAW82406.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:BAG52919.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Amygdala {ECO:0000313|EMBL:BAG52919.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3] {ECO:0000313|EMBL:EAW82406.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK094725; BAG52919.1; -; mRNA.
DR   EMBL; CH471131; EAW82406.1; -; Genomic_DNA.
DR   RefSeq; NP_001014809.1; NM_001014809.2.
DR   UniGene; Hs.135270; -.
DR   PeptideAtlas; B3KT07; -.
DR   PRIDE; B3KT07; -.
DR   DNASU; 1400; -.
DR   GeneID; 1400; -.
DR   CTD; 1400; -.
DR   PharmGKB; PA26885; -.
DR   eggNOG; KOG2584; Eukaryota.
DR   eggNOG; COG0044; LUCA.
DR   HOVERGEN; HBG000806; -.
DR   ChiTaRS; CRMP1; human.
DR   GenomeRNAi; 1400; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:InterPro.
DR   GO; GO:0016810; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; IEA:InterPro.
DR   GO; GO:0007411; P:axon guidance; IEA:InterPro.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro.
DR   CDD; cd01314; D-HYD; 1.
DR   Gene3D; 2.30.40.10; -; 2.
DR   InterPro; IPR006680; Amidohydro-rel.
DR   InterPro; IPR030624; CRMP1.
DR   InterPro; IPR011778; Hydantoinase/dihydroPyrase.
DR   InterPro; IPR011059; Metal-dep_hydrolase_composite.
DR   InterPro; IPR032466; Metal_Hydrolase.
DR   PANTHER; PTHR11647:SF54; PTHR11647:SF54; 1.
DR   Pfam; PF01979; Amidohydro_1; 1.
DR   SUPFAM; SSF51338; SSF51338; 1.
DR   SUPFAM; SSF51556; SSF51556; 1.
DR   TIGRFAMs; TIGR02033; D-hydantoinase; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN        1    390       Amidohydro-rel.
FT                                {ECO:0000259|Pfam:PF01979}.
SQ   SEQUENCE   509 AA;  55289 MW;  EB188B7448833BDD CRC64;
     MVIPGGIDVN TYLQKPSQGM TAADDFFQGT RAALVGGTTM IIDHVVPEPG SSLLTSFEKW
     HEAADTKSCC DYSLHVDITS WYDGVREELE VLVQDKGVNS FQVYMAYKDV YQMSDSQLYE
     AFTFLKGLGA VILVHAENGD LIAQEQKRIL EMGITGPEGH ALSRPEELEA EAVFRAITIA
     GRINCPVYIT KVMSKSAADI IALARKKGPL VFGEPIAASL GTDGTHYWSK NWAKAAAFVT
     SPPLSPDPTT PDYLTSLLAC GDLQVTGSGH CPYSTAQKAV GKDNFTLIPE GVNGIEERMT
     VVWDKAVATG KMDENQFVAV TSTNAAKIFN LYPRKGRIAV GSDADVVIWD PDKLKTITAK
     SHKSAVEYNI FEGMECHGSP LVVISQGKIV FEDGNINVNK GMGRFIPRKA FPEHLYQRVK
     IRNKVFGLQG VSRGMYDGPV YEVPATPKYA TPAPSAKSSP SKHQPPPIRN LHQSNFSLSG
     AQIDDNNPRR TGHRIVAPPG GRSNITSLG
//
ID   B3KV96_HUMAN            Unreviewed;       566 AA.
AC   B3KV96;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 51.
DE   SubName: Full=cDNA FLJ16285 fis, clone OCBBF2004038, highly similar to Dihydropyrimidinase-related protein 1 {ECO:0000313|EMBL:BAG53708.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG53708.1};
RN   [1] {ECO:0000313|EMBL:BAG53708.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG53708.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK122754; BAG53708.1; -; mRNA.
DR   RefSeq; NP_001275591.1; NM_001288662.1.
DR   UniGene; Hs.135270; -.
DR   ProteinModelPortal; B3KV96; -.
DR   PeptideAtlas; B3KV96; -.
DR   PRIDE; B3KV96; -.
DR   GeneID; 1400; -.
DR   CTD; 1400; -.
DR   eggNOG; KOG2584; Eukaryota.
DR   eggNOG; COG0044; LUCA.
DR   HOGENOM; HOG000219145; -.
DR   HOVERGEN; HBG000806; -.
DR   GenomeRNAi; 1400; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:InterPro.
DR   GO; GO:0016810; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; IEA:InterPro.
DR   GO; GO:0007411; P:axon guidance; IEA:InterPro.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro.
DR   CDD; cd01314; D-HYD; 1.
DR   Gene3D; 2.30.40.10; -; 2.
DR   InterPro; IPR006680; Amidohydro-rel.
DR   InterPro; IPR030624; CRMP1.
DR   InterPro; IPR011778; Hydantoinase/dihydroPyrase.
DR   InterPro; IPR011059; Metal-dep_hydrolase_composite.
DR   InterPro; IPR032466; Metal_Hydrolase.
DR   PANTHER; PTHR11647:SF54; PTHR11647:SF54; 1.
DR   Pfam; PF01979; Amidohydro_1; 1.
DR   SUPFAM; SSF51338; SSF51338; 2.
DR   SUPFAM; SSF51556; SSF51556; 1.
DR   TIGRFAMs; TIGR02033; D-hydantoinase; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       58    447       Amidohydro-rel.
FT                                {ECO:0000259|Pfam:PF01979}.
SQ   SEQUENCE   566 AA;  61443 MW;  837D4F5E1D436CF6 CRC64;
     MRTTGALSDR LLIKGGRIIN DDQSLYADVY LEDGLIKQIG ENLIVPGGVK TIEANGRMVI
     PGGIDVNTYL QKPSQGMTAA DDFFQGTRAA LVGGTTMIID HVVPEPGSSL LTSFEKWHEA
     ADTKSCCDYS LHVDITSWYD GVREELEVLV QDKGVNSFQV YMAYKDVYQM SDSQLYEAFT
     FLKGLGAVIL VHAENGDLIA QEQKRILEMG ITGPEGHALS RPEELEAEAV FRAITIAGRI
     NCPVYITKVM SKSAADIIAL ARKKGPLVFG EPIAASLGTD GTHYWSKNWA KAAAFVTSPP
     LSPDPTTPDY LTSLLACGDL QVTGSGHCPY STAQKAVGKD NFTLIPEGVN GIEERMTVVW
     DKAVATGKMD ENQFVAVTST NAAKIFNLYP RKGRIAVGSD ADVVIWDPDK LKTITAKSHK
     SAVEYNIFEG MECHGSPLVV ISQGKIVFED GNINVNKGMG RFIPRKAFPE HLYQRVKIRN
     KVFGLQGVSR GMYDGPVYEV PATPKYATPA PSAKSSPSKH QPPPIRNLHQ SNFSLSGAQI
     DDNNPRRTGH RIVAPPGGRS NITSLG
//
ID   E9PD68_HUMAN            Unreviewed;       570 AA.
AC   E9PD68;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   28-MAR-2018, entry version 52.
DE   SubName: Full=Dihydropyrimidinase-related protein 1 {ECO:0000313|Ensembl:ENSP00000425742};
GN   Name=CRMP1 {ECO:0000313|Ensembl:ENSP00000425742};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000425742, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000425742, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Ensembl:ENSP00000425742}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC105915; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001275590.1; NM_001288661.1.
DR   UniGene; Hs.135270; -.
DR   ProteinModelPortal; E9PD68; -.
DR   EPD; E9PD68; -.
DR   MaxQB; E9PD68; -.
DR   PeptideAtlas; E9PD68; -.
DR   PRIDE; E9PD68; -.
DR   Ensembl; ENST00000512574; ENSP00000425742; ENSG00000072832.
DR   GeneID; 1400; -.
DR   UCSC; uc003gir.5; human.
DR   CTD; 1400; -.
DR   EuPathDB; HostDB:ENSG00000072832.14; -.
DR   HGNC; HGNC:2365; CRMP1.
DR   OpenTargets; ENSG00000072832; -.
DR   eggNOG; KOG2584; Eukaryota.
DR   eggNOG; COG0044; LUCA.
DR   GeneTree; ENSGT00760000119241; -.
DR   ChiTaRS; CRMP1; human.
DR   GenomeRNAi; 1400; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000072832; -.
DR   ExpressionAtlas; E9PD68; baseline and differential.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016810; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; IEA:InterPro.
DR   GO; GO:0007411; P:axon guidance; IEA:InterPro.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro.
DR   CDD; cd01314; D-HYD; 1.
DR   Gene3D; 2.30.40.10; -; 2.
DR   InterPro; IPR006680; Amidohydro-rel.
DR   InterPro; IPR030624; CRMP1.
DR   InterPro; IPR011778; Hydantoinase/dihydroPyrase.
DR   InterPro; IPR011059; Metal-dep_hydrolase_composite.
DR   InterPro; IPR032466; Metal_Hydrolase.
DR   PANTHER; PTHR11647:SF54; PTHR11647:SF54; 1.
DR   Pfam; PF01979; Amidohydro_1; 1.
DR   SUPFAM; SSF51338; SSF51338; 2.
DR   SUPFAM; SSF51556; SSF51556; 1.
DR   TIGRFAMs; TIGR02033; D-hydantoinase; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:E9PD68,
KW   ECO:0000213|MaxQB:E9PD68, ECO:0000213|PeptideAtlas:E9PD68};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       62    451       Amidohydro-rel.
FT                                {ECO:0000259|Pfam:PF01979}.
SQ   SEQUENCE   570 AA;  62030 MW;  67EA5570D6721353 CRC64;
     MQKMNNEVVD KSDRLLIKGG RIINDDQSLY ADVYLEDGLI KQIGENLIVP GGVKTIEANG
     RMVIPGGIDV NTYLQKPSQG MTAADDFFQG TRAALVGGTT MIIDHVVPEP GSSLLTSFEK
     WHEAADTKSC CDYSLHVDIT SWYDGVREEL EVLVQDKGVN SFQVYMAYKD VYQMSDSQLY
     EAFTFLKGLG AVILVHAENG DLIAQEQKRI LEMGITGPEG HALSRPEELE AEAVFRAITI
     AGRINCPVYI TKVMSKSAAD IIALARKKGP LVFGEPIAAS LGTDGTHYWS KNWAKAAAFV
     TSPPLSPDPT TPDYLTSLLA CGDLQVTGSG HCPYSTAQKA VGKDNFTLIP EGVNGIEERM
     TVVWDKAVAT GKMDENQFVA VTSTNAAKIF NLYPRKGRIA VGSDADVVIW DPDKLKTITA
     KSHKSAVEYN IFEGMECHGS PLVVISQGKI VFEDGNINVN KGMGRFIPRK AFPEHLYQRV
     KIRNKVFGLQ GVSRGMYDGP VYEVPATPKY ATPAPSAKSS PSKHQPPPIR NLHQSNFSLS
     GAQIDDNNPR RTGHRIVAPP GGRSNITSLG
//
ID   DPYL1_HUMAN             Reviewed;         572 AA.
AC   Q14194; A0EJG6; Q13024; Q4W5F1; Q96TC8;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   23-MAY-2018, entry version 178.
DE   RecName: Full=Dihydropyrimidinase-related protein 1;
DE            Short=DRP-1;
DE   AltName: Full=Collapsin response mediator protein 1;
DE            Short=CRMP-1;
DE   AltName: Full=Unc-33-like phosphoprotein 3;
DE            Short=ULIP-3;
GN   Name=CRMP1; Synonyms=DPYSL1, ULIP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=8973361; DOI=10.1016/S0378-1119(96)00445-3;
RA   Hamajima N., Matsuda K., Sakata S., Tamaki N., Sasaki M., Nonaka M.;
RT   "A novel gene family defined by human dihydropyrimidinase and three
RT   related proteins with differential tissue distribution.";
RL   Gene 180:157-163(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LCRMP-1), AND ALTERNATIVE
RP   SPLICING.
RC   TISSUE=Lung adenocarcinoma;
RX   PubMed=19362386; DOI=10.1016/j.lungcan.2009.03.006;
RA   Pan S.-H., Chao Y.-C., Chen H.Y., Hung P.F., Lin P.Y., Lin C.W.,
RA   Chang Y.L., Wu C.T., Lee Y.C., Yang S.-C., Hong T.-M., Yang P.-C.;
RT   "Long form collapsin response mediator protein-1 (LCRMP-1) expression
RT   is associated with clinical outcome and lymph node metastasis in non-
RT   small cell lung cancer patients.";
RL   Lung Cancer 67:93-100(2010).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 14-572 (ISOFORM 1).
RX   PubMed=10048489; DOI=10.1093/dnares/5.6.393;
RA   Torres R., Polymeropoulos M.H.;
RT   "Genomic organization and localization of the human CRMP-1 gene.";
RL   DNA Res. 5:393-395(1998).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 64-572 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=7637782; DOI=10.1038/376509a0;
RA   Goshima Y., Nakamura F., Strittmatter P., Strittmatter S.M.;
RT   "Collapsin-induced growth cone collapse mediated by an intracellular
RT   protein related to UNC-33.";
RL   Nature 376:509-514(1995).
RN   [9]
RP   PROTEIN SEQUENCE OF 44-56; 190-210; 246-254; 259-268; 346-361;
RP   391-397; 452-463; 472-481; 488-511 AND 533-552, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   SUBUNIT, AND INTERACTION WITH DPYSL2 AND DPYSL4.
RX   PubMed=9375656;
RA   Wang L.H., Strittmatter S.M.;
RT   "Brain CRMP forms heterotetramers similar to liver
RT   dihydropyrimidinase.";
RL   J. Neurochem. 69:2261-2269(1997).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11562390; DOI=10.1093/jnci/93.18.1392;
RA   Shih J.-Y., Yang S.-C., Hong T.-M., Yuan A., Chen J.J.W., Yu C.-J.,
RA   Chang Y.-L., Lee Y.-C., Peck K., Wu C.-W., Yang P.-C.;
RT   "Collapsin response mediator protein-1 and the invasion and metastasis
RT   of cancer cells.";
RL   J. Natl. Cancer Inst. 93:1392-1400(2001).
RN   [12]
RP   FUNCTION, PHOSPHORYLATION AT THR-101 AND THR-102, AND MUTAGENESIS OF
RP   101-THR-THR-102.
RX   PubMed=19799413; DOI=10.1021/pr900325f;
RA   Chen T.C., Lee S.A., Hong T.M., Shih J.Y., Lai J.M., Chiou H.Y.,
RA   Yang S.C., Chan C.H., Kao C.Y., Yang P.C., Huang C.Y.;
RT   "From midbody protein-protein interaction network construction to
RT   novel regulators in cytokinesis.";
RL   J. Proteome Res. 8:4943-4953(2009).
CC   -!- FUNCTION: Necessary for signaling by class 3 semaphorins and
CC       subsequent remodeling of the cytoskeleton. Plays a role in axon
CC       guidance, invasive growth and cell migration. May participate in
CC       cytokinesis. {ECO:0000269|PubMed:11562390,
CC       ECO:0000269|PubMed:19799413}.
CC   -!- SUBUNIT: Homotetramer, and heterotetramer with DPYSL2, DPYSL3,
CC       DPYSL4 or DPYSL5. Interacts with PLXNA1 (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9Y2T2:AP3M1; NbExp=5; IntAct=EBI-473101, EBI-2371151;
CC       O15169:AXIN1; NbExp=2; IntAct=EBI-473101, EBI-710484;
CC       Q16555:DPYSL2; NbExp=3; IntAct=EBI-473101, EBI-1104711;
CC       Q14195-2:DPYSL3; NbExp=5; IntAct=EBI-473101, EBI-10232496;
CC       P42858:HTT; NbExp=2; IntAct=EBI-473101, EBI-466029;
CC       P08670:VIM; NbExp=3; IntAct=EBI-473101, EBI-353844;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11562390}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:11562390}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000269|PubMed:11562390}. Note=Associated with centrosomes
CC       and the mitotic spindle during metaphase.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q14194-1; Sequence=Displayed;
CC       Name=LCRMP-1;
CC         IsoId=Q14194-2; Sequence=VSP_042545;
CC   -!- TISSUE SPECIFICITY: Brain.
CC   -!- SIMILARITY: Belongs to the metallo-dependent hydrolases
CC       superfamily. Hydantoinase/dihydropyrimidinase family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Lacks most of the conserved residues that are essential
CC       for binding the metal cofactor and hence for dihydropyrimidinase
CC       activity. Its enzyme activity is therefore unsure. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D78012; BAA11190.1; -; mRNA.
DR   EMBL; DQ206871; ABB22046.1; -; mRNA.
DR   EMBL; BT006806; AAP35452.1; -; mRNA.
DR   EMBL; AC105915; AAY40959.1; -; Genomic_DNA.
DR   EMBL; CH471131; EAW82405.1; -; Genomic_DNA.
DR   EMBL; CH471131; EAW82407.1; -; Genomic_DNA.
DR   EMBL; BC000252; AAH00252.1; -; mRNA.
DR   EMBL; BC007613; AAH07613.1; -; mRNA.
DR   EMBL; AH010780; AAK55500.1; -; Genomic_DNA.
DR   EMBL; U17278; AAA93201.1; -; mRNA.
DR   CCDS; CCDS33950.1; -. [Q14194-2]
DR   CCDS; CCDS43207.1; -. [Q14194-1]
DR   PIR; JC5316; JC5316.
DR   RefSeq; NP_001014809.1; NM_001014809.2. [Q14194-2]
DR   RefSeq; NP_001275590.1; NM_001288661.1.
DR   RefSeq; NP_001275591.1; NM_001288662.1.
DR   RefSeq; NP_001304.1; NM_001313.4. [Q14194-1]
DR   UniGene; Hs.135270; -.
DR   PDB; 4B3Z; X-ray; 3.05 A; A/B/C/D=1-572.
DR   PDBsum; 4B3Z; -.
DR   ProteinModelPortal; Q14194; -.
DR   SMR; Q14194; -.
DR   BioGrid; 107790; 108.
DR   CORUM; Q14194; -.
DR   IntAct; Q14194; 75.
DR   MINT; Q14194; -.
DR   STRING; 9606.ENSP00000321606; -.
DR   MEROPS; M38.974; -.
DR   iPTMnet; Q14194; -.
DR   PhosphoSitePlus; Q14194; -.
DR   BioMuta; CRMP1; -.
DR   DMDM; 3122031; -.
DR   EPD; Q14194; -.
DR   MaxQB; Q14194; -.
DR   PaxDb; Q14194; -.
DR   PeptideAtlas; Q14194; -.
DR   PRIDE; Q14194; -.
DR   DNASU; 1400; -.
DR   Ensembl; ENST00000324989; ENSP00000321606; ENSG00000072832. [Q14194-2]
DR   Ensembl; ENST00000397890; ENSP00000380987; ENSG00000072832. [Q14194-1]
DR   GeneID; 1400; -.
DR   KEGG; hsa:1400; -.
DR   UCSC; uc003giq.5; human. [Q14194-1]
DR   CTD; 1400; -.
DR   DisGeNET; 1400; -.
DR   EuPathDB; HostDB:ENSG00000072832.14; -.
DR   GeneCards; CRMP1; -.
DR   HGNC; HGNC:2365; CRMP1.
DR   HPA; CAB037313; -.
DR   HPA; HPA035640; -.
DR   MIM; 602462; gene.
DR   neXtProt; NX_Q14194; -.
DR   OpenTargets; ENSG00000072832; -.
DR   PharmGKB; PA26885; -.
DR   eggNOG; KOG2584; Eukaryota.
DR   eggNOG; COG0044; LUCA.
DR   GeneTree; ENSGT00760000119241; -.
DR   HOGENOM; HOG000219145; -.
DR   HOVERGEN; HBG000806; -.
DR   InParanoid; Q14194; -.
DR   OMA; PEYLYQR; -.
DR   PhylomeDB; Q14194; -.
DR   TreeFam; TF314706; -.
DR   Reactome; R-HSA-399956; CRMPs in Sema3A signaling.
DR   SIGNOR; Q14194; -.
DR   ChiTaRS; CRMP1; human.
DR   GeneWiki; CRMP1; -.
DR   GenomeRNAi; 1400; -.
DR   PRO; PR:Q14194; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000072832; -.
DR   CleanEx; HS_CRMP1; -.
DR   ExpressionAtlas; Q14194; baseline and differential.
DR   Genevisible; Q14194; HS.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0030496; C:midbody; IDA:HGNC.
DR   GO; GO:0005819; C:spindle; IEA:UniProtKB-SubCell.
DR   GO; GO:0031005; F:filamin binding; IPI:WormBase.
DR   GO; GO:0016810; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; IEA:InterPro.
DR   GO; GO:0007411; P:axon guidance; IEA:InterPro.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro.
DR   GO; GO:1904530; P:negative regulation of actin filament binding; IDA:WormBase.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; IGI:WormBase.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc.
DR   CDD; cd01314; D-HYD; 1.
DR   Gene3D; 2.30.40.10; -; 2.
DR   InterPro; IPR006680; Amidohydro-rel.
DR   InterPro; IPR030624; CRMP1.
DR   InterPro; IPR011778; Hydantoinase/dihydroPyrase.
DR   InterPro; IPR011059; Metal-dep_hydrolase_composite.
DR   InterPro; IPR032466; Metal_Hydrolase.
DR   PANTHER; PTHR11647:SF54; PTHR11647:SF54; 1.
DR   Pfam; PF01979; Amidohydro_1; 1.
DR   SUPFAM; SSF51338; SSF51338; 2.
DR   SUPFAM; SSF51556; SSF51556; 1.
DR   TIGRFAMs; TIGR02033; D-hydantoinase; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Direct protein sequencing; Methylation; Nitration;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    572       Dihydropyrimidinase-related protein 1.
FT                                /FTId=PRO_0000165909.
FT   MOD_RES       8      8       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62950}.
FT   MOD_RES      32     32       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q16555}.
FT   MOD_RES     101    101       Phosphothreonine; by AURKA.
FT                                {ECO:0000269|PubMed:19799413}.
FT   MOD_RES     102    102       Phosphothreonine; by AURKA.
FT                                {ECO:0000269|PubMed:19799413}.
FT   MOD_RES     258    258       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:O08553}.
FT   MOD_RES     259    259       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P47942}.
FT   MOD_RES     316    316       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:P97427}.
FT   MOD_RES     431    431       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:O08553}.
FT   MOD_RES     499    499       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:O08553}.
FT   MOD_RES     504    504       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P97427}.
FT   MOD_RES     509    509       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P97427}.
FT   MOD_RES     514    514       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q16555}.
FT   MOD_RES     518    518       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q16555}.
FT   MOD_RES     521    521       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62950}.
FT   MOD_RES     522    522       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q16555}.
FT   MOD_RES     537    537       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97427}.
FT   MOD_RES     540    540       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97427}.
FT   MOD_RES     542    542       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97427}.
FT   MOD_RES     565    565       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:O08553}.
FT   VAR_SEQ       1     13       MSYQGKKSIPHIT -> MADRRRAWNTEDDLPVYLARPGSA
FT                                AQTPRQKYGGMFAAVEGAYENKTIDFDAYSVGRRGSARTPR
FT                                SAGRPDAVGLPGPGGSEDTASDVSEPSGSAVSSPGERDERP
FT                                PTLRIRRPAPRDLPLGRDNGQ (in isoform LCRMP-
FT                                1). {ECO:0000303|PubMed:19362386}.
FT                                /FTId=VSP_042545.
FT   VARIANT     461    461       V -> I (in dbSNP:rs34611001).
FT                                /FTId=VAR_037745.
FT   MUTAGEN     101    102       TT->AA: 2.5-fold increase in cells with a
FT                                defect of cytokinesis.
FT                                {ECO:0000269|PubMed:19799413}.
FT   CONFLICT    351    370       Missing (in Ref. 7; AAK55500).
FT                                {ECO:0000305}.
FT   CONFLICT    504    504       Y -> H (in Ref. 8; AAA93201).
FT                                {ECO:0000305}.
FT   STRAND       16     25       {ECO:0000244|PDB:4B3Z}.
FT   STRAND       30     38       {ECO:0000244|PDB:4B3Z}.
FT   STRAND       41     48       {ECO:0000244|PDB:4B3Z}.
FT   STRAND       53     59       {ECO:0000244|PDB:4B3Z}.
FT   STRAND       64     67       {ECO:0000244|PDB:4B3Z}.
FT   STRAND       69     74       {ECO:0000244|PDB:4B3Z}.
FT   HELIX        89     99       {ECO:0000244|PDB:4B3Z}.
FT   STRAND      101    108       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       116    130       {ECO:0000244|PDB:4B3Z}.
FT   STRAND      132    140       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       148    157       {ECO:0000244|PDB:4B3Z}.
FT   STRAND      163    170       {ECO:0000244|PDB:4B3Z}.
FT   TURN        171    174       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       178    190       {ECO:0000244|PDB:4B3Z}.
FT   STRAND      194    198       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       202    213       {ECO:0000244|PDB:4B3Z}.
FT   TURN        214    216       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       221    225       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       229    246       {ECO:0000244|PDB:4B3Z}.
FT   STRAND      250    255       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       258    270       {ECO:0000244|PDB:4B3Z}.
FT   STRAND      274    279       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       280    284       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       288    291       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       295    300       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       313    322       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       338    341       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       342    344       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       348    350       {ECO:0000244|PDB:4B3Z}.
FT   TURN        358    360       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       361    369       {ECO:0000244|PDB:4B3Z}.
FT   TURN        370    373       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       377    384       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       386    391       {ECO:0000244|PDB:4B3Z}.
FT   TURN        395    397       {ECO:0000244|PDB:4B3Z}.
FT   STRAND      409    419       {ECO:0000244|PDB:4B3Z}.
FT   STRAND      426    430       {ECO:0000244|PDB:4B3Z}.
FT   TURN        433    436       {ECO:0000244|PDB:4B3Z}.
FT   STRAND      438    448       {ECO:0000244|PDB:4B3Z}.
FT   STRAND      451    455       {ECO:0000244|PDB:4B3Z}.
FT   HELIX       476    489       {ECO:0000244|PDB:4B3Z}.
SQ   SEQUENCE   572 AA;  62184 MW;  A5385FCC79328A30 CRC64;
     MSYQGKKSIP HITSDRLLIK GGRIINDDQS LYADVYLEDG LIKQIGENLI VPGGVKTIEA
     NGRMVIPGGI DVNTYLQKPS QGMTAADDFF QGTRAALVGG TTMIIDHVVP EPGSSLLTSF
     EKWHEAADTK SCCDYSLHVD ITSWYDGVRE ELEVLVQDKG VNSFQVYMAY KDVYQMSDSQ
     LYEAFTFLKG LGAVILVHAE NGDLIAQEQK RILEMGITGP EGHALSRPEE LEAEAVFRAI
     TIAGRINCPV YITKVMSKSA ADIIALARKK GPLVFGEPIA ASLGTDGTHY WSKNWAKAAA
     FVTSPPLSPD PTTPDYLTSL LACGDLQVTG SGHCPYSTAQ KAVGKDNFTL IPEGVNGIEE
     RMTVVWDKAV ATGKMDENQF VAVTSTNAAK IFNLYPRKGR IAVGSDADVV IWDPDKLKTI
     TAKSHKSAVE YNIFEGMECH GSPLVVISQG KIVFEDGNIN VNKGMGRFIP RKAFPEHLYQ
     RVKIRNKVFG LQGVSRGMYD GPVYEVPATP KYATPAPSAK SSPSKHQPPP IRNLHQSNFS
     LSGAQIDDNN PRRTGHRIVA PPGGRSNITS LG
//
ID   Q96I11_HUMAN            Unreviewed;       404 AA.
AC   Q96I11;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-MAR-2004, sequence version 2.
DT   23-MAY-2018, entry version 98.
DE   SubName: Full=CRMP1 protein {ECO:0000313|EMBL:AAH07898.2};
DE   Flags: Fragment;
GN   Name=CRMP1 {ECO:0000313|EMBL:AAH07898.2};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH07898.2};
RN   [1] {ECO:0000313|EMBL:AAH07898.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAH07898.2};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC007898; AAH07898.2; -; mRNA.
DR   RefSeq; NP_001014809.1; NM_001014809.2.
DR   RefSeq; NP_001275590.1; NM_001288661.1.
DR   RefSeq; NP_001275591.1; NM_001288662.1.
DR   RefSeq; NP_001304.1; NM_001313.4.
DR   UniGene; Hs.135270; -.
DR   ProteinModelPortal; Q96I11; -.
DR   IntAct; Q96I11; 1.
DR   PeptideAtlas; Q96I11; -.
DR   DNASU; 1400; -.
DR   GeneID; 1400; -.
DR   KEGG; hsa:1400; -.
DR   CTD; 1400; -.
DR   PharmGKB; PA26885; -.
DR   eggNOG; KOG2584; Eukaryota.
DR   eggNOG; COG0044; LUCA.
DR   HOVERGEN; HBG000806; -.
DR   ChiTaRS; CRMP1; human.
DR   GenomeRNAi; 1400; -.
DR   Genevisible; Q96I11; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:InterPro.
DR   GO; GO:0016810; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; IEA:InterPro.
DR   GO; GO:0007411; P:axon guidance; IEA:InterPro.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro.
DR   InterPro; IPR006680; Amidohydro-rel.
DR   InterPro; IPR030624; CRMP1.
DR   InterPro; IPR011778; Hydantoinase/dihydroPyrase.
DR   InterPro; IPR011059; Metal-dep_hydrolase_composite.
DR   InterPro; IPR032466; Metal_Hydrolase.
DR   PANTHER; PTHR11647:SF54; PTHR11647:SF54; 1.
DR   Pfam; PF01979; Amidohydro_1; 1.
DR   SUPFAM; SSF51338; SSF51338; 1.
DR   SUPFAM; SSF51556; SSF51556; 1.
DR   TIGRFAMs; TIGR02033; D-hydantoinase; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN        5    285       Amidohydro-rel.
FT                                {ECO:0000259|Pfam:PF01979}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAH07898.2}.
SQ   SEQUENCE   404 AA;  43746 MW;  5EC84A6ACBC7449D CRC64;
     AYKDVYQMSD SQLYEAFTFL KGLGAVILVH AENGDLIAQE QKRILEMGIT GPEGHALSRP
     EELEAEAVFR AITIAGRINC PVYITKVMSK SAADIIALAR KKGPLVFGEP IAASLGTDGT
     HYWSKNWAKA AAFVTSPPLS PDPTTPDYLT SLLACGDLQV TGSGHCPYST AQKAVGKDNF
     TLIPEGVNGI EERMTVVWDK AVATGKMDEN QFVAVTSTNA AKIFNLYPRK GRIAVGSDAD
     VVIWDPDKLK TITAKSHKSA VEYNIFEGME CHGSPLVVIS QGKIVFEDGN INVNKGMGRF
     IPRKAFPEHL YQRVKIRNKV FGLQGVSRGM YDGPVYEVPA TPKYATPAPS AKSSPSKHQP
     PPIRNLHQSN FSLSGAQIDD NNPRRTGHRI VAPPGGRSNI TSLG
//
ID   X5DNI1_HUMAN            Unreviewed;       686 AA.
AC   X5DNI1;
DT   11-JUN-2014, integrated into UniProtKB/TrEMBL.
DT   11-JUN-2014, sequence version 1.
DT   28-FEB-2018, entry version 32.
DE   SubName: Full=Collapsin response mediator protein 1 isoform A {ECO:0000313|EMBL:AHW56456.1};
DE   Flags: Fragment;
GN   Name=CRMP1 {ECO:0000313|EMBL:AHW56456.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AHW56456.1};
RN   [1] {ECO:0000313|EMBL:AHW56456.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Adult whole brain {ECO:0000313|EMBL:AHW56456.1};
RX   PubMed=24722188;
RA   Corominas R., Yang X., Lin G.N., Kang S., Shen Y., Ghamsari L.,
RA   Broly M., Rodriguez M., Tam S., Wanamaker S.A., Fan C., Yi S.,
RA   Tasan M., Lemmens I., Kuang X., Zhao N., Malhotra D., Michaelson J.J.,
RA   Vacic V., Calderwood M.A., Roth F.P., Tavernier J., Horvath S.,
RA   Salehi-Ashtiani K., Korkin D., Sebat J., Hill D.E., Hao T., Vidal M.,
RA   Iakoucheva L.M.;
RT   "Protein interaction network of alternatively spliced isoforms from
RT   brain links genetic risk factors for autism.";
RL   Nat. Commun. 5:3650-3650(2014).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KJ534816; AHW56456.1; -; mRNA.
DR   RefSeq; NP_001014809.1; NM_001014809.2.
DR   UniGene; Hs.135270; -.
DR   ProteinModelPortal; X5DNI1; -.
DR   SMR; X5DNI1; -.
DR   MaxQB; X5DNI1; -.
DR   GeneID; 1400; -.
DR   UCSC; uc003gis.5; human.
DR   CTD; 1400; -.
DR   EuPathDB; HostDB:ENSG00000072832.14; -.
DR   eggNOG; KOG2584; Eukaryota.
DR   eggNOG; COG0044; LUCA.
DR   OMA; PEYLYQR; -.
DR   OrthoDB; EOG091G05F3; -.
DR   PhylomeDB; X5DNI1; -.
DR   ChiTaRS; CRMP1; human.
DR   GenomeRNAi; 1400; -.
DR   Bgee; ENSG00000072832; -.
DR   ExpressionAtlas; X5DNI1; baseline and differential.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0031005; F:filamin binding; IEA:Ensembl.
DR   GO; GO:0016810; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; IEA:InterPro.
DR   GO; GO:0007411; P:axon guidance; IEA:InterPro.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro.
DR   CDD; cd01314; D-HYD; 1.
DR   Gene3D; 2.30.40.10; -; 2.
DR   InterPro; IPR006680; Amidohydro-rel.
DR   InterPro; IPR030624; CRMP1.
DR   InterPro; IPR011778; Hydantoinase/dihydroPyrase.
DR   InterPro; IPR011059; Metal-dep_hydrolase_composite.
DR   InterPro; IPR032466; Metal_Hydrolase.
DR   PANTHER; PTHR11647:SF54; PTHR11647:SF54; 1.
DR   Pfam; PF01979; Amidohydro_1; 1.
DR   SUPFAM; SSF51338; SSF51338; 2.
DR   SUPFAM; SSF51556; SSF51556; 1.
DR   TIGRFAMs; TIGR02033; D-hydantoinase; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN      178    567       Amidohydro-rel.
FT                                {ECO:0000259|Pfam:PF01979}.
FT   NON_TER     686    686       {ECO:0000313|EMBL:AHW56456.1}.
SQ   SEQUENCE   686 AA;  74262 MW;  2C897F656E5F34FA CRC64;
     MADRRRAWNT EDDLPVYLAR PGSAAQTPRQ KYGGMFAAVE GAYENKTIDF DAYSVGRRGS
     ARTPRSAGRP DAVGLPGPGG SEDTASDVSE PSGSAVSSPG ERDERPPTLR IRRPAPRDLP
     LGRDNGQSDR LLIKGGRIIN DDQSLYADVY LEDGLIKQIG ENLIVPGGVK TIEANGRMVI
     PGGIDVNTYL QKPSQGMTAA DDFFQGTRAA LVGGTTMIID HVVPEPGSSL LTSFEKWHEA
     ADTKSCCDYS LHVDITSWYD GVREELEVLV QDKGVNSFQV YMAYKDVYQM SDSQLYEAFT
     FLKGLGAVIL VHAENGDLIA QEQKRILEMG ITGPEGHALS RPEELEAEAV FRAITIAGRI
     NCPVYITKVM SKSAADIIAL ARKKGPLVFG EPIAASLGTD GTHYWSKNWA KAAAFVTSPP
     LSPDPTTPDY LTSLLACGDL QVTGSGHCPY STAQKAVGKD NFTLIPEGVN GIEERMTVVW
     DKAVATGKMD ENQFVAVTST NAAKIFNLYP RKGRIAVGSD ADVVIWDPDK LKTITAKSHK
     SAVEYNIFEG MECHGSPLVV ISQGKIVFED GNINVNKGMG RFIPRKAFPE HLYQRVKIRN
     KVFGLQGVSR GMYDGPVYEV PATPKYATPA PSAKSSPSKH QPPPIRNLHQ SNFSLSGAQI
     DDNNPRRTGH RIVAPPGGRS NITSLG
//
ID   Q6P5V6_HUMAN            Unreviewed;       412 AA.
AC   Q6P5V6;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   28-FEB-2018, entry version 79.
DE   SubName: Full=SNX5 protein {ECO:0000313|EMBL:AAH62638.1};
DE   Flags: Fragment;
GN   Name=SNX5 {ECO:0000313|EMBL:AAH62638.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH62638.1};
RN   [1] {ECO:0000313|EMBL:AAH62638.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph {ECO:0000313|EMBL:AAH62638.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC062638; AAH62638.1; -; mRNA.
DR   RefSeq; NP_001269383.1; NM_001282454.1.
DR   UniGene; Hs.316890; -.
DR   ProteinModelPortal; Q6P5V6; -.
DR   PeptideAtlas; Q6P5V6; -.
DR   PRIDE; Q6P5V6; -.
DR   GeneID; 27131; -.
DR   CTD; 27131; -.
DR   eggNOG; KOG1660; Eukaryota.
DR   eggNOG; ENOG410XPZY; LUCA.
DR   HOGENOM; HOG000231691; -.
DR   HOVERGEN; HBG000716; -.
DR   ChiTaRS; SNX5; human.
DR   GenomeRNAi; 27131; -.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IEA:InterPro.
DR   GO; GO:0006886; P:intracellular protein transport; IEA:InterPro.
DR   GO; GO:0006907; P:pinocytosis; IEA:InterPro.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   Gene3D; 3.30.1520.10; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR001683; Phox.
DR   InterPro; IPR036871; PX_dom_sf.
DR   InterPro; IPR028654; SNX5.
DR   InterPro; IPR014637; SNX5/SNX6/SNX32.
DR   InterPro; IPR015404; Vps5_C.
DR   PANTHER; PTHR10555:SF6; PTHR10555:SF6; 1.
DR   Pfam; PF00787; PX; 1.
DR   Pfam; PF09325; Vps5; 1.
DR   PIRSF; PIRSF036924; Snx5_Snx6; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF64268; SSF64268; 1.
DR   PROSITE; PS50195; PX; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN       33    180       PX. {ECO:0000259|PROSITE:PS50195}.
FT   COILED      270    290       {ECO:0000256|SAM:Coils}.
FT   COILED      355    375       {ECO:0000256|SAM:Coils}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAH62638.1}.
SQ   SEQUENCE   412 AA;  47438 MW;  80F6EF89031F8D0D CRC64;
     LGECPLLPVR VAALRLAASS WSGARLRSVS VDLNVDPSLQ IDIPDALSER DKVKFTVHTK
     TTLPTFQSPE FSVTRQHEDF VWLHDTLIET TDYAGLIIPP APTKPDFDGP REKMQKLGEG
     EGSMTKEEFA KMKQELEAEY LAVFKKTVSS HEVFLQRLSS HPVLSKDRNF HVFLEYDQDL
     SVRRKNTKEM FGGFFKSVVK SADEVLFTGV KEVDDFFEQE KNFLINYYNR IKDSCVKADK
     MTRSHKNVAD DYIHTAACLH SLALEEPTVI KKYLLKVAEL FEKLRKVEGR VSSDEDLKLT
     ELLRYYMLNI EAAKDLLYRR TKALIDYENS NKALDKARLK SKDVKLAEAH QQECCQKFEQ
     LSESAKEELI NFKRKRVAAF RKNLIEMSEL EIKHARNNVS LLQSCIDLFK NN
//
ID   SNX5_HUMAN              Reviewed;         404 AA.
AC   Q9Y5X3; B7ZKN3; D3DW26; Q52LC4; Q7KZN0; Q9BWP0;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   23-MAY-2018, entry version 159.
DE   RecName: Full=Sorting nexin-5;
GN   Name=SNX5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND SUBCELLULAR LOCATION.
RX   PubMed=11485546; DOI=10.1042/0264-6021:3580007;
RA   Teasdale R.D., Loci D., Houghton F., Karlsson L., Gleeson P.A.;
RT   "A large family of endosome-localized proteins related to sorting
RT   nexin 1.";
RL   Biochem. J. 358:7-16(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Ovarian carcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   SUBCELLULAR LOCATION, AND PHOSPHATIDYLINOSITOL 3,4-BISPHOSPHATE
RP   BINDING.
RX   PubMed=15561769; DOI=10.1242/jcs.01561;
RA   Merino-Trigo A., Kerr M.C., Houghton F., Lindberg A., Mitchell C.,
RA   Teasdale R.D., Gleeson P.A.;
RT   "Sorting nexin 5 is localized to a subdomain of the early endosomes
RT   and is recruited to the plasma membrane following EGF stimulation.";
RL   J. Cell Sci. 117:6413-6424(2004).
RN   [8]
RP   INTERACTION WITH MIB1.
RX   PubMed=16857196; DOI=10.1016/j.febslet.2006.07.009;
RA   Yoo K.W., Kim E.H., Jung S.H., Rhee M., Koo B.K., Yoon K.J.,
RA   Kong Y.Y., Kim C.H.;
RT   "Snx5, as a Mind bomb-binding protein, is expressed in hematopoietic
RT   and endothelial precursor cells in zebrafish.";
RL   FEBS Lett. 580:4409-4416(2006).
RN   [9]
RP   INTERACTION WITH SNX1, AND SUBCELLULAR LOCATION.
RX   PubMed=16968745; DOI=10.1242/jcs.03167;
RA   Kerr M.C., Lindsay M.R., Luetterforst R., Hamilton N., Simpson F.,
RA   Parton R.G., Gleeson P.A., Teasdale R.D.;
RT   "Visualisation of macropinosome maturation by the recruitment of
RT   sorting nexins.";
RL   J. Cell Sci. 119:3967-3980(2006).
RN   [10]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17148574; DOI=10.1242/jcs.03302;
RA   Wassmer T., Attar N., Bujny M.V., Oakley J., Traer C.J., Cullen P.J.;
RT   "A loss-of-function screen reveals SNX5 and SNX6 as potential
RT   components of the mammalian retromer.";
RL   J. Cell Sci. 120:45-54(2007).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18854019; DOI=10.1186/1471-2121-9-58;
RA   Lim J.P., Wang J.T., Kerr M.C., Teasdale R.D., Gleeson P.A.;
RT   "A role for SNX5 in the regulation of macropinocytosis.";
RL   BMC Cell Biol. 9:58-58(2008).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH DOCK1.
RX   PubMed=18596235; DOI=10.1091/mbc.E08-03-0314;
RA   Hara S., Kiyokawa E., Iemura S., Natsume T., Wassmer T., Cullen P.J.,
RA   Hiai H., Matsuda M.;
RT   "The DHR1 domain of DOCK180 binds to SNX5 and regulates cation-
RT   independent mannose 6-phosphate receptor transport.";
RL   Mol. Biol. Cell 19:3823-3835(2008).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   INTERACTION WITH SNX1; SNX2; VPS26A; VPS29; VPS35 AND DCTN1.
RX   PubMed=19619496; DOI=10.1016/j.devcel.2009.04.016;
RA   Wassmer T., Attar N., Harterink M., van Weering J.R., Traer C.J.,
RA   Oakley J., Goud B., Stephens D.J., Verkade P., Korswagen H.C.,
RA   Cullen P.J.;
RT   "The retromer coat complex coordinates endosomal sorting and dynein-
RT   mediated transport, with carrier recognition by the trans-Golgi
RT   network.";
RL   Dev. Cell 17:110-122(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-275, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [17]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=21048941; DOI=10.1371/journal.pone.0013763;
RA   Wang J.T., Kerr M.C., Karunaratne S., Jeanes A., Yap A.S.,
RA   Teasdale R.D.;
RT   "The SNX-PX-BAR family in macropinocytosis: the regulation of
RT   macropinosome formation by SNX-PX-BAR proteins.";
RL   PLoS ONE 5:E13763-E13763(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   FUNCTION, INTERACTION WITH SNX1 AND SNX2, DOMAIN, AND MUTAGENESIS OF
RP   186-PHE-PHE-187; GLU-280 AND GLU-383.
RX   PubMed=23085988; DOI=10.1038/emboj.2012.283;
RA   van Weering J.R., Sessions R.B., Traer C.J., Kloer D.P., Bhatia V.K.,
RA   Stamou D., Carlsson S.R., Hurley J.H., Cullen P.J.;
RT   "Molecular basis for SNX-BAR-mediated assembly of distinct endosomal
RT   sorting tubules.";
RL   EMBO J. 31:4466-4480(2012).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [22]
RP   FUNCTION, AND INTERACTION WITH PIP5K1C.
RX   PubMed=23602387; DOI=10.1016/j.devcel.2013.03.010;
RA   Sun Y., Hedman A.C., Tan X., Schill N.J., Anderson R.A.;
RT   "Endosomal type Igamma PIP 5-kinase controls EGF receptor lysosomal
RT   sorting.";
RL   Dev. Cell 25:144-155(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-193, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHOINOSITIDE BINDING, INTERACTION
RP   WITH PIP5K1C AND HGS, AND MUTAGENESIS OF LYS-224; ARG-235; LYS-324;
RP   LYS-328 AND ARG-330.
RX   PubMed=24610942; DOI=10.1242/jcs.132423;
RA   Schill N.J., Hedman A.C., Choi S., Anderson R.A.;
RT   "Isoform 5 of PIPKIgamma regulates the endosomal trafficking and
RT   degradation of E-cadherin.";
RL   J. Cell Sci. 127:2189-2203(2014).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 257-265 IN COMPLEX WITH HLA
RP   CLASS I HISTOCOMPATIBILITY COMPLEX.
RX   PubMed=15226359; DOI=10.1084/jem.20031680;
RA   Zernich D., Purcell A.W., Macdonald W.A., Kjer-Nielsen L., Ely L.K.,
RA   Laham N., Crockford T., Mifsud N.A., Bharadwaj M., Chang L.,
RA   Tait B.D., Holdsworth R., Brooks A.G., Bottomley S.P., Beddoe T.,
RA   Peh C.A., Rossjohn J., McCluskey J.;
RT   "Natural HLA class I polymorphism controls the pathway of antigen
RT   presentation and susceptibility to viral evasion.";
RL   J. Exp. Med. 200:13-24(2004).
CC   -!- FUNCTION: Involved in several stages of intracellular trafficking.
CC       Interacts with membranes containing phosphatidylinositol 3-
CC       phosphate (PtdIns(3P)) or phosphatidylinositol 3,4-bisphosphate
CC       (PtdIns(3,4)P2) (PubMed:15561769). Acts in part as component of
CC       the retromer membrane-deforming SNX-BAR subcomplex. The SNX-BAR
CC       retromer mediates retrograde transport of cargo proteins from
CC       endosomes to the trans-Golgi network (TGN) and is involved in
CC       endosome-to-plasma membrane transport for cargo protein recycling.
CC       The SNX-BAR subcomplex functions to deform the donor membrane into
CC       a tubular profile called endosome-to-TGN transport carrier (ETC)
CC       (Probable). Does not have in vitro vesicle-to-membrane remodeling
CC       activity (PubMed:23085988). Involved in retrograde transport of
CC       lysosomal enzyme receptor IGF2R (PubMed:17148574,
CC       PubMed:18596235). May function as link between endosomal transport
CC       vesicles and dynactin (Probable). Plays a role in the
CC       internalization of EGFR after EGF stimulation (Probable). Involved
CC       in EGFR endosomal sorting and degradation; the function involves
CC       PIP5K1C isoform 3 and is retromer-independent (PubMed:23602387).
CC       Together with PIP5K1C isoform 3 facilitates HGS interaction with
CC       ubiquitinated EGFR, which initiates EGFR sorting to intraluminal
CC       vesicles (ILVs) of the multivesicular body for subsequent
CC       lysosomal degradation (Probable). Involved in E-cadherin sorting
CC       and degradation; inhibits PIP5K1C isoform 3-mediated E-cadherin
CC       degradation (PubMed:24610942). Plays a role in macropinocytosis
CC       (PubMed:18854019, PubMed:21048941). {ECO:0000269|PubMed:18854019,
CC       ECO:0000269|PubMed:21048941, ECO:0000269|PubMed:24610942,
CC       ECO:0000303|PubMed:15561769, ECO:0000303|PubMed:19619496,
CC       ECO:0000303|PubMed:23085988}.
CC   -!- SUBUNIT: Forms heterodimers with BAR domain-containing sorting
CC       nexins SNX1 and SNX2; does not homodimerize (PubMed:23085988). The
CC       heterodimers are proposed to self-assemble into helical arrays on
CC       the membrane to stabilize and expand local membrane curvature
CC       underlying endosomal tubule formation. Thought to be a component
CC       of the originally described retromer complex (also called SNX-BAR
CC       retromer) which is a pentamer containing the heterotrimeric
CC       retromer cargo-selective complex (CSC), also described as vacuolar
CC       protein sorting subcomplex (VPS), and a heterodimeric membrane-
CC       deforming subcomplex formed between SNX1 or SNX2 and SNX5 or SNX6
CC       (also called SNX-BAR subcomplex); the respective CSC and SNX-BAR
CC       subcomplexes associate with low affinity (Probable). Interacts
CC       with SNX1, SNX2, VPS26A, VPS29, VPS35, DCTN1, DOCK1, MIB1, PIP5K1C
CC       isoform 3. Interacts with HGS; increased by PIP5K1C isoform 3
CC       kinase activity and by PtdIns(3P) and/or PtdIns(3,4)P2
CC       (PubMed:16857196, PubMed:16968745, PubMed:19619496,
CC       PubMed:23085988, PubMed:18596235, PubMed:23602387,
CC       PubMed:24610942). {ECO:0000269|PubMed:15226359,
CC       ECO:0000269|PubMed:16857196, ECO:0000269|PubMed:16968745,
CC       ECO:0000269|PubMed:18596235, ECO:0000269|PubMed:19619496,
CC       ECO:0000269|PubMed:23602387, ECO:0000269|PubMed:24610942,
CC       ECO:0000303|PubMed:19619496, ECO:0000303|PubMed:23085988}.
CC   -!- INTERACTION:
CC       Q92624:APPBP2; NbExp=3; IntAct=EBI-715760, EBI-743771;
CC   -!- SUBCELLULAR LOCATION: Endosome {ECO:0000269|PubMed:11485546}.
CC       Early endosome {ECO:0000269|PubMed:17148574,
CC       ECO:0000269|PubMed:24610942}. Early endosome membrane
CC       {ECO:0000269|PubMed:15561769}; Peripheral membrane protein;
CC       Cytoplasmic side. Cell membrane {ECO:0000269|PubMed:15561769};
CC       Peripheral membrane protein; Cytoplasmic side
CC       {ECO:0000269|PubMed:18854019}. Cytoplasmic vesicle membrane;
CC       Peripheral membrane protein; Cytoplasmic side. Cytoplasm. Cell
CC       projection, phagocytic cup. Cell projection, ruffle.
CC       Note=Recruited to the plasma membrane after EGF stimulation, which
CC       leads to increased levels of phosphatidylinositol 3,4-bisphosphate
CC       (PdtIns(3,4)P2) (PubMed:15561769). Detected on macropinosomes
CC       (PubMed:16968745, PubMed:21048941). Targeted to membrane ruffles
CC       in response to EGFR stimulation. {ECO:0000269|PubMed:15561769,
CC       ECO:0000269|PubMed:16968745, ECO:0000269|PubMed:21048941}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y5X3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y5X3-2; Sequence=VSP_056386, VSP_056387;
CC   -!- DOMAIN: The PX domain mediates interaction with membranes enriched
CC       in phosphatidylinositol 3,4-bisphosphate and/or
CC       phosphatidylinositol 4,5-bisphosphate. {ECO:0000250}.
CC   -!- DOMAIN: The BAR domain is able to sense membrane curvature upon
CC       dimerization. Membrane remodeling seems to implicate insertion of
CC       an amphipatric helix (AH) in the membrane (Probable).
CC       {ECO:0000303|PubMed:23085988}.
CC   -!- SIMILARITY: Belongs to the sorting nexin family. {ECO:0000305}.
CC   -!- CAUTION: The selectivity for particular phosphatidylinositol
CC       lipids is under debate. According to one report (PubMed:19553671),
CC       the rat protein binds exclusively to phosphatidylinositol 4,5-
CC       bisphosphate, while the human protein has been reported
CC       (PubMed:15561769) to bind to phosphatidylinositol 3,4-bisphosphate
CC       and also to phosphatidylinositol 3-phosphate.
CC       {ECO:0000305|PubMed:15561769}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF121855; AAD27828.1; -; mRNA.
DR   EMBL; BT007191; AAP35855.1; -; mRNA.
DR   EMBL; AK001793; BAA91914.1; -; mRNA.
DR   EMBL; AK123903; BAG53980.1; -; mRNA.
DR   EMBL; AL121585; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000100; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; CH471133; EAX10264.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10265.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10266.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10268.1; -; Genomic_DNA.
DR   EMBL; BC093623; AAH93623.1; -; mRNA.
DR   EMBL; BC093980; AAH93980.1; -; mRNA.
DR   EMBL; BC143274; AAI43275.1; -; mRNA.
DR   CCDS; CCDS13130.1; -. [Q9Y5X3-1]
DR   RefSeq; NP_055241.1; NM_014426.3. [Q9Y5X3-1]
DR   RefSeq; NP_689413.1; NM_152227.2. [Q9Y5X3-1]
DR   UniGene; Hs.316890; -.
DR   PDB; 1SYS; X-ray; 2.40 A; C=257-265.
DR   PDB; 5TGH; X-ray; 2.80 A; A/C/E/G=22-170.
DR   PDB; 5TGI; X-ray; 1.98 A; A/B=22-170.
DR   PDB; 5TGJ; X-ray; 2.60 A; A/C=22-170.
DR   PDB; 5WY2; X-ray; 1.90 A; A/C=20-180.
DR   PDBsum; 1SYS; -.
DR   PDBsum; 5TGH; -.
DR   PDBsum; 5TGI; -.
DR   PDBsum; 5TGJ; -.
DR   PDBsum; 5WY2; -.
DR   ProteinModelPortal; Q9Y5X3; -.
DR   SMR; Q9Y5X3; -.
DR   BioGrid; 118022; 56.
DR   IntAct; Q9Y5X3; 23.
DR   MINT; Q9Y5X3; -.
DR   STRING; 9606.ENSP00000366988; -.
DR   iPTMnet; Q9Y5X3; -.
DR   PhosphoSitePlus; Q9Y5X3; -.
DR   DMDM; 10720289; -.
DR   EPD; Q9Y5X3; -.
DR   PaxDb; Q9Y5X3; -.
DR   PeptideAtlas; Q9Y5X3; -.
DR   PRIDE; Q9Y5X3; -.
DR   DNASU; 27131; -.
DR   Ensembl; ENST00000377759; ENSP00000366988; ENSG00000089006. [Q9Y5X3-1]
DR   Ensembl; ENST00000377768; ENSP00000366998; ENSG00000089006. [Q9Y5X3-1]
DR   Ensembl; ENST00000606557; ENSP00000475510; ENSG00000089006. [Q9Y5X3-2]
DR   GeneID; 27131; -.
DR   KEGG; hsa:27131; -.
DR   UCSC; uc002wqc.5; human. [Q9Y5X3-1]
DR   CTD; 27131; -.
DR   DisGeNET; 27131; -.
DR   EuPathDB; HostDB:ENSG00000089006.16; -.
DR   GeneCards; SNX5; -.
DR   HGNC; HGNC:14969; SNX5.
DR   HPA; CAB020679; -.
DR   HPA; HPA051187; -.
DR   MIM; 605937; gene.
DR   neXtProt; NX_Q9Y5X3; -.
DR   OpenTargets; ENSG00000089006; -.
DR   PharmGKB; PA37945; -.
DR   eggNOG; KOG1660; Eukaryota.
DR   eggNOG; ENOG410XPZY; LUCA.
DR   GeneTree; ENSGT00910000144062; -.
DR   HOVERGEN; HBG000716; -.
DR   InParanoid; Q9Y5X3; -.
DR   KO; K17920; -.
DR   OMA; HEDFIWL; -.
DR   OrthoDB; EOG091G08NT; -.
DR   PhylomeDB; Q9Y5X3; -.
DR   TreeFam; TF313698; -.
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis.
DR   ChiTaRS; SNX5; human.
DR   EvolutionaryTrace; Q9Y5X3; -.
DR   GeneWiki; SNX5; -.
DR   GenomeRNAi; 27131; -.
DR   PRO; PR:Q9Y5X3; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000089006; -.
DR   CleanEx; HS_SNX5; -.
DR   ExpressionAtlas; Q9Y5X3; baseline and differential.
DR   Genevisible; Q9Y5X3; HS.
DR   GO; GO:0005903; C:brush border; IEA:Ensembl.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031313; C:extrinsic component of endosome membrane; IDA:UniProtKB.
DR   GO; GO:0070685; C:macropinocytic cup; IDA:UniProtKB.
DR   GO; GO:0001891; C:phagocytic cup; IEA:UniProtKB-SubCell.
DR   GO; GO:0030904; C:retromer complex; IDA:UniProtKB.
DR   GO; GO:0030905; C:retromer, tubulation complex; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0001726; C:ruffle; IEA:UniProtKB-SubCell.
DR   GO; GO:0097422; C:tubular endosome; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0031748; F:D1 dopamine receptor binding; IEA:Ensembl.
DR   GO; GO:0034452; F:dynactin binding; IDA:UniProtKB.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB.
DR   GO; GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; IEA:Ensembl.
DR   GO; GO:0070273; F:phosphatidylinositol-4-phosphate binding; IEA:Ensembl.
DR   GO; GO:0010314; F:phosphatidylinositol-5-phosphate binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0007174; P:epidermal growth factor catabolic process; IEA:Ensembl.
DR   GO; GO:0006886; P:intracellular protein transport; IEA:InterPro.
DR   GO; GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl.
DR   GO; GO:0006907; P:pinocytosis; IDA:UniProtKB.
DR   GO; GO:0035815; P:positive regulation of renal sodium excretion; IEA:Ensembl.
DR   GO; GO:0016241; P:regulation of macroautophagy; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB.
DR   GO; GO:0016050; P:vesicle organization; IBA:GO_Central.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   Gene3D; 3.30.1520.10; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR001683; Phox.
DR   InterPro; IPR036871; PX_dom_sf.
DR   InterPro; IPR028654; SNX5.
DR   InterPro; IPR014637; SNX5/SNX6/SNX32.
DR   InterPro; IPR015404; Vps5_C.
DR   PANTHER; PTHR10555:SF6; PTHR10555:SF6; 1.
DR   Pfam; PF00787; PX; 1.
DR   Pfam; PF09325; Vps5; 1.
DR   PIRSF; PIRSF036924; Snx5_Snx6; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF64268; SSF64268; 1.
DR   PROSITE; PS50195; PX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell membrane;
KW   Cell projection; Complete proteome; Cytoplasm; Cytoplasmic vesicle;
KW   Endocytosis; Endosome; Lipid-binding; Membrane; Phosphoprotein;
KW   Protein transport; Reference proteome; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    404       Sorting nexin-5.
FT                                /FTId=PRO_0000213844.
FT   DOMAIN       25    172       PX. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00147}.
FT   DOMAIN      202    404       BAR.
FT   REGION       40     46       Phosphatidylinositol bisphosphate
FT                                binding. {ECO:0000250|UniProtKB:B1H267}.
FT   REGION       99    105       Phosphatidylinositol bisphosphate
FT                                binding. {ECO:0000250|UniProtKB:B1H267}.
FT   REGION      113    116       Phosphatidylinositol bisphosphate
FT                                binding. {ECO:0000250|UniProtKB:B1H267}.
FT   REGION      169    261       Interaction with DOCK1.
FT                                {ECO:0000269|PubMed:18596235}.
FT   REGION      183    200       Membrane-binding amphipathic helix.
FT                                {ECO:0000303|PubMed:23085988}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES     193    193       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     275    275       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ      18    126       LRSVSVDLNVDPSLQIDIPDALSERDKVKFTVHTKTTLPTF
FT                                QSPEFSVTRQHEDFVWLHDTLIETTDYAGLIIPPAPTKPDF
FT                                DGPREKMQKLGEGEGSMTKEEFAKMKQ -> VRSSQPQTPG
FT                                RAALRAPGSLHSFPCASIGRGCSPPSPAREAPVRPGRPLSL
FT                                VFTEGCPGESLWMSRILLGQNQRRGTLAPAQAPVPSGLGEM
FT                                ISGDPGMFFLKLSSASW (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_056386.
FT   VAR_SEQ     127    404       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_056387.
FT   MUTAGEN     186    187       FF->EE: No effect on dimerization.
FT                                {ECO:0000269|PubMed:23085988}.
FT   MUTAGEN     224    224       K->E: Decreaes phosphoinositide binding,
FT                                including PtdIns(3,4)P2 and PtdIns(3P);
FT                                when associated with E-235, E-324, E-328
FT                                and E-330. {ECO:0000269|PubMed:23602387}.
FT   MUTAGEN     235    235       R->E: Decreaes phosphoinositide binding,
FT                                including PtdIns(3,4)P2 and PtdIns(3P);
FT                                when associated with E-224, E-324, E-328
FT                                and E-330. {ECO:0000269|PubMed:23602387}.
FT   MUTAGEN     280    280       E->A: Enables homodimerization; when
FT                                associated with A-383.
FT                                {ECO:0000269|PubMed:23085988}.
FT   MUTAGEN     324    324       K->E: Decreaes phosphoinositide binding,
FT                                including PtdIns(3,4)P2 and PtdIns(3P);
FT                                when associated with E-224, E-235, E-328
FT                                and E-330. {ECO:0000269|PubMed:23602387}.
FT   MUTAGEN     328    328       K->E: Decreaes phosphoinositide binding,
FT                                including PtdIns(3,4)P2 and PtdIns(3P);
FT                                when associated with E-224, E-235, E-324
FT                                and E-330. {ECO:0000269|PubMed:23602387}.
FT   MUTAGEN     330    330       R->E: Decreaes phosphoinositide binding,
FT                                including PtdIns(3,4)P2 and PtdIns(3P);
FT                                when associated with E-224, E-235, E-324
FT                                and E-328. {ECO:0000269|PubMed:23602387}.
FT   MUTAGEN     383    383       E->A: Enables homodimerization; when
FT                                associated with A-280.
FT   CONFLICT    279    279       V -> L (in Ref. 3). {ECO:0000305}.
FT   STRAND       31     34       {ECO:0000244|PDB:5WY2}.
FT   STRAND       37     41       {ECO:0000244|PDB:5WY2}.
FT   STRAND       44     53       {ECO:0000244|PDB:5WY2}.
FT   STRAND       56     59       {ECO:0000244|PDB:5TGH}.
FT   STRAND       61     68       {ECO:0000244|PDB:5WY2}.
FT   HELIX        69     80       {ECO:0000244|PDB:5WY2}.
FT   HELIX        83     85       {ECO:0000244|PDB:5WY2}.
FT   HELIX       100    108       {ECO:0000244|PDB:5WY2}.
FT   HELIX       112    114       {ECO:0000244|PDB:5WY2}.
FT   HELIX       122    152       {ECO:0000244|PDB:5WY2}.
FT   HELIX       156    158       {ECO:0000244|PDB:5WY2}.
FT   HELIX       160    167       {ECO:0000244|PDB:5WY2}.
FT   HELIX       172    175       {ECO:0000244|PDB:5WY2}.
SQ   SEQUENCE   404 AA;  46816 MW;  87A85620AF827EC6 CRC64;
     MAAVPELLQQ QEEDRSKLRS VSVDLNVDPS LQIDIPDALS ERDKVKFTVH TKTTLPTFQS
     PEFSVTRQHE DFVWLHDTLI ETTDYAGLII PPAPTKPDFD GPREKMQKLG EGEGSMTKEE
     FAKMKQELEA EYLAVFKKTV SSHEVFLQRL SSHPVLSKDR NFHVFLEYDQ DLSVRRKNTK
     EMFGGFFKSV VKSADEVLFT GVKEVDDFFE QEKNFLINYY NRIKDSCVKA DKMTRSHKNV
     ADDYIHTAAC LHSLALEEPT VIKKYLLKVA ELFEKLRKVE GRVSSDEDLK LTELLRYYML
     NIEAAKDLLY RRTKALIDYE NSNKALDKAR LKSKDVKLAE AHQQECCQKF EQLSESAKEE
     LINFKRKRVA AFRKNLIEMS ELEIKHARNN VSLLQSCIDL FKNN
//
ID   FAF1_HUMAN              Reviewed;         650 AA.
AC   Q9UNN5; Q549F0; Q9UF34; Q9UNT3; Q9Y2Z3;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2002, sequence version 2.
DT   23-MAY-2018, entry version 166.
DE   RecName: Full=FAS-associated factor 1;
DE            Short=hFAF1;
DE   AltName: Full=UBX domain-containing protein 12;
DE   AltName: Full=UBX domain-containing protein 3A;
GN   Name=FAF1; Synonyms=UBXD12, UBXN3A; ORFNames=CGI-03;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND SHORT), INTERACTION WITH
RP   FAS, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain, and Liver;
RX   PubMed=10462485; DOI=10.1006/bbrc.1999.1217;
RA   Ryu S.-W., Chae S.-K., Lee K.-J., Kim E.;
RT   "Identification and characterization of human Fas associated factor 1,
RT   hFAF1.";
RL   Biochem. Biophys. Res. Commun. 262:388-394(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
RA   Ding J.B., Yu L., Zhao S.Y.;
RT   "Cloning of a new human cDNA homologous to Mus musculus FAF1.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
RA   Boldyreff B.;
RT   "Full length cDNA sequence and chromosomal localization of the human
RT   Fas-associated factor 1 gene, hFaf1.";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Brain, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 97-650 (ISOFORM LONG).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   INTERACTION WITH NLRP12.
RX   PubMed=21978668; DOI=10.1016/j.jmb.2011.09.024;
RA   Pinheiro A.S., Eibl C., Ekman-Vural Z., Schwarzenbacher R., Peti W.;
RT   "The NLRP12 pyrin domain: structure, dynamics, and functional
RT   insights.";
RL   J. Mol. Biol. 413:790-803(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-580 AND SER-582, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   FUNCTION, INTERACTION WITH CDT1 AND VCP, AND SUBCELLULAR LOCATION.
RX   PubMed=26842564; DOI=10.1038/ncomms10612;
RA   Franz A., Pirson P.A., Pilger D., Halder S., Achuthankutty D.,
RA   Kashkar H., Ramadan K., Hoppe T.;
RT   "Chromatin-associated degradation is defined by UBXN-3/FAF1 to
RT   safeguard DNA replication fork progression.";
RL   Nat. Commun. 7:10612-10612(2016).
RN   [16]
RP   STRUCTURE BY NMR OF 569-650.
RX   PubMed=11243799; DOI=10.1006/jmbi.2000.4462;
RA   Buchberger A., Howard M.J., Proctor M., Bycroft M.M.;
RT   "The UBX domain: a widespread ubiquitin-like module.";
RL   J. Mol. Biol. 307:17-24(2001).
RN   [17]
RP   STRUCTURE BY NMR OF 99-191.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the ubiquitin-like domain in human FAS-
RT   associated factor 1 (hFAF1).";
RL   Submitted (OCT-2007) to the PDB data bank.
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.73 ANGSTROMS) OF 5-47, FUNCTION, AND DOMAIN
RP   UBA.
RX   PubMed=19722279; DOI=10.1002/pro.237;
RA   Song J., Park J.K., Lee J.J., Choi Y.S., Ryu K.S., Kim J.H., Kim E.,
RA   Lee K.J., Jeon Y.H., Kim E.E.;
RT   "Structure and interaction of ubiquitin-associated domain of human
RT   Fas-associated factor 1.";
RL   Protein Sci. 18:2265-2276(2009).
CC   -!- FUNCTION: Ubiquitin-binding protein (PubMed:19722279). Required
CC       for the progression of DNA replication forks by targeting DNA
CC       replication licensing factor CDT1 for degradation
CC       (PubMed:26842564). Potentiates but cannot initiate FAS-induced
CC       apoptosis (By similarity). {ECO:0000250|UniProtKB:P54731,
CC       ECO:0000269|PubMed:19722279, ECO:0000269|PubMed:26842564}.
CC   -!- SUBUNIT: Interacts with CDT1 and ATPase VCP/p97 (PubMed:26842564).
CC       Interacts (via UBA domain) with FAS (via death domain)
CC       (PubMed:10462485). Interacts (via UBA domain) with NLRP12 (via
CC       DAPIN/PYRIN domain) (PubMed:21978668).
CC       {ECO:0000269|PubMed:10462485, ECO:0000269|PubMed:21978668,
CC       ECO:0000269|PubMed:26842564}.
CC   -!- INTERACTION:
CC       P55072:VCP; NbExp=4; IntAct=EBI-15930546, EBI-355164;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:26842564}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=Q9UNN5-1; Sequence=Displayed;
CC       Name=Short; Synonyms=hFAF1(s);
CC         IsoId=Q9UNN5-2; Sequence=VSP_006704;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Most abundant in testis, slightly less
CC       abundant in skeletal muscle and heart, followed by prostate,
CC       thymus, ovary, small intestine, and colon. Not detected in the
CC       peripheral blood leukocytes. {ECO:0000269|PubMed:10462485}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD51876.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF106798; AAD51886.1; -; mRNA.
DR   EMBL; AF094700; AAD51876.1; ALT_INIT; mRNA.
DR   EMBL; AF136173; AAP97263.1; -; mRNA.
DR   EMBL; AJ271408; CAB67705.1; -; mRNA.
DR   EMBL; AF132938; AAD27713.1; -; mRNA.
DR   EMBL; AC091610; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC118557; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL049637; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359977; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL603746; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06837.1; -; Genomic_DNA.
DR   EMBL; BC004970; AAH04970.1; -; mRNA.
DR   EMBL; BC067100; AAH67100.1; -; mRNA.
DR   EMBL; AL133631; CAB63755.1; -; mRNA.
DR   CCDS; CCDS554.1; -. [Q9UNN5-1]
DR   PIR; JC7093; JC7093.
DR   PIR; T43466; T43466.
DR   RefSeq; NP_008982.1; NM_007051.2. [Q9UNN5-1]
DR   UniGene; Hs.530402; -.
DR   PDB; 1H8C; NMR; -; A=569-650.
DR   PDB; 2DZM; NMR; -; A=99-191.
DR   PDB; 2EC4; NMR; -; A=325-495.
DR   PDB; 3E21; X-ray; 1.73 A; A=5-47.
DR   PDB; 3QC8; X-ray; 2.20 A; B=571-650.
DR   PDB; 3QCA; X-ray; 2.90 A; A/B/C/D=571-650.
DR   PDB; 3QQ8; X-ray; 2.00 A; B=568-650.
DR   PDB; 3QWZ; X-ray; 2.00 A; B=571-650.
DR   PDB; 3QX1; X-ray; 1.60 A; A/B=571-650.
DR   PDB; 3R3M; X-ray; 3.00 A; A/B/C/D=568-650.
DR   PDBsum; 1H8C; -.
DR   PDBsum; 2DZM; -.
DR   PDBsum; 2EC4; -.
DR   PDBsum; 3E21; -.
DR   PDBsum; 3QC8; -.
DR   PDBsum; 3QCA; -.
DR   PDBsum; 3QQ8; -.
DR   PDBsum; 3QWZ; -.
DR   PDBsum; 3QX1; -.
DR   PDBsum; 3R3M; -.
DR   ProteinModelPortal; Q9UNN5; -.
DR   SMR; Q9UNN5; -.
DR   BioGrid; 116298; 132.
DR   DIP; DIP-38245N; -.
DR   IntAct; Q9UNN5; 50.
DR   MINT; Q9UNN5; -.
DR   STRING; 9606.ENSP00000360843; -.
DR   ChEMBL; CHEMBL3758063; -.
DR   iPTMnet; Q9UNN5; -.
DR   PhosphoSitePlus; Q9UNN5; -.
DR   BioMuta; FAF1; -.
DR   DMDM; 20454906; -.
DR   EPD; Q9UNN5; -.
DR   PaxDb; Q9UNN5; -.
DR   PeptideAtlas; Q9UNN5; -.
DR   PRIDE; Q9UNN5; -.
DR   DNASU; 11124; -.
DR   Ensembl; ENST00000396153; ENSP00000379457; ENSG00000185104. [Q9UNN5-1]
DR   GeneID; 11124; -.
DR   KEGG; hsa:11124; -.
DR   UCSC; uc001cse.2; human. [Q9UNN5-1]
DR   CTD; 11124; -.
DR   DisGeNET; 11124; -.
DR   EuPathDB; HostDB:ENSG00000185104.19; -.
DR   GeneCards; FAF1; -.
DR   HGNC; HGNC:3578; FAF1.
DR   HPA; CAB072814; -.
DR   HPA; HPA018253; -.
DR   MIM; 604460; gene.
DR   neXtProt; NX_Q9UNN5; -.
DR   OpenTargets; ENSG00000185104; -.
DR   PharmGKB; PA27976; -.
DR   eggNOG; ENOG410IPG5; Eukaryota.
DR   eggNOG; ENOG410Z9BT; LUCA.
DR   GeneTree; ENSGT00530000063422; -.
DR   HOGENOM; HOG000043073; -.
DR   HOVERGEN; HBG002876; -.
DR   InParanoid; Q9UNN5; -.
DR   KO; K20703; -.
DR   OMA; MEIFSAQ; -.
DR   OrthoDB; EOG091G04LQ; -.
DR   PhylomeDB; Q9UNN5; -.
DR   TreeFam; TF314172; -.
DR   SignaLink; Q9UNN5; -.
DR   SIGNOR; Q9UNN5; -.
DR   ChiTaRS; FAF1; human.
DR   EvolutionaryTrace; Q9UNN5; -.
DR   GeneWiki; FAF1; -.
DR   GenomeRNAi; 11124; -.
DR   PRO; PR:Q9UNN5; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000185104; -.
DR   CleanEx; HS_FAF1; -.
DR   ExpressionAtlas; Q9UNN5; baseline and differential.
DR   Genevisible; Q9UNN5; HS.
DR   GO; GO:0031265; C:CD95 death-inducing signaling complex; NAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0034098; C:VCP-NPL4-UFD1 AAA ATPase complex; IDA:BHF-UCL.
DR   GO; GO:0031072; F:heat shock protein binding; IDA:UniProtKB.
DR   GO; GO:0051059; F:NF-kappaB binding; IPI:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IDA:UniProtKB.
DR   GO; GO:0019887; F:protein kinase regulator activity; NAS:UniProtKB.
DR   GO; GO:0043130; F:ubiquitin binding; IDA:BHF-UCL.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IDA:BHF-UCL.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0008219; P:cell death; IMP:UniProtKB.
DR   GO; GO:0007253; P:cytoplasmic sequestering of NF-kappaB; IMP:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; NAS:UniProtKB.
DR   GO; GO:0010942; P:positive regulation of cell death; IDA:CACAO.
DR   GO; GO:1903364; P:positive regulation of cellular protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0045740; P:positive regulation of DNA replication; IMP:UniProtKB.
DR   GO; GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl.
DR   GO; GO:0031334; P:positive regulation of protein complex assembly; IMP:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; NAS:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; IEA:Ensembl.
DR   GO; GO:0042176; P:regulation of protein catabolic process; IMP:UniProtKB.
DR   CDD; cd01771; Faf1_UBX; 1.
DR   InterPro; IPR033043; FAF1_UBX.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   InterPro; IPR006577; UAS.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR001012; UBX_dom.
DR   Pfam; PF00789; UBX; 1.
DR   SMART; SM00594; UAS; 1.
DR   SMART; SM00166; UBX; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   SUPFAM; SSF54236; SSF54236; 3.
DR   PROSITE; PS50033; UBX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; Complete proteome;
KW   Nucleus; Phosphoprotein; Reference proteome.
FT   CHAIN         1    650       FAS-associated factor 1.
FT                                /FTId=PRO_0000211038.
FT   DOMAIN        1     57       UBA. {ECO:0000269|PubMed:19722279}.
FT   DOMAIN      569    646       UBX. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00215}.
FT   MOD_RES     320    320       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     580    580       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     582    582       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     188    339       Missing (in isoform Short).
FT                                {ECO:0000303|PubMed:10462485}.
FT                                /FTId=VSP_006704.
FT   CONFLICT    448    448       F -> K (in Ref. 1; AAD51886/AAD51876).
FT                                {ECO:0000305}.
FT   CONFLICT    498    498       E -> G (in Ref. 1; AAD51886/AAD51876).
FT                                {ECO:0000305}.
FT   CONFLICT    529    529       H -> R (in Ref. 1; AAD51886/AAD51876).
FT                                {ECO:0000305}.
FT   HELIX         7     18       {ECO:0000244|PDB:3E21}.
FT   HELIX        23     32       {ECO:0000244|PDB:3E21}.
FT   TURN         33     35       {ECO:0000244|PDB:3E21}.
FT   HELIX        37     41       {ECO:0000244|PDB:3E21}.
FT   STRAND      100    106       {ECO:0000244|PDB:2DZM}.
FT   STRAND      111    117       {ECO:0000244|PDB:2DZM}.
FT   HELIX       122    133       {ECO:0000244|PDB:2DZM}.
FT   TURN        137    139       {ECO:0000244|PDB:2DZM}.
FT   STRAND      146    148       {ECO:0000244|PDB:2DZM}.
FT   HELIX       156    159       {ECO:0000244|PDB:2DZM}.
FT   STRAND      163    169       {ECO:0000244|PDB:2DZM}.
FT   STRAND      172    174       {ECO:0000244|PDB:2DZM}.
FT   HELIX       330    345       {ECO:0000244|PDB:2EC4}.
FT   HELIX       357    362       {ECO:0000244|PDB:2EC4}.
FT   STRAND      365    367       {ECO:0000244|PDB:2EC4}.
FT   TURN        369    371       {ECO:0000244|PDB:2EC4}.
FT   STRAND      374    380       {ECO:0000244|PDB:2EC4}.
FT   HELIX       386    393       {ECO:0000244|PDB:2EC4}.
FT   TURN        394    396       {ECO:0000244|PDB:2EC4}.
FT   HELIX       398    406       {ECO:0000244|PDB:2EC4}.
FT   STRAND      408    414       {ECO:0000244|PDB:2EC4}.
FT   HELIX       418    431       {ECO:0000244|PDB:2EC4}.
FT   HELIX       434    442       {ECO:0000244|PDB:2EC4}.
FT   STRAND      449    454       {ECO:0000244|PDB:2EC4}.
FT   STRAND      463    467       {ECO:0000244|PDB:2EC4}.
FT   HELIX       473    490       {ECO:0000244|PDB:2EC4}.
FT   STRAND      573    579       {ECO:0000244|PDB:3QX1}.
FT   STRAND      585    591       {ECO:0000244|PDB:3QX1}.
FT   HELIX       596    605       {ECO:0000244|PDB:3QX1}.
FT   TURN        610    612       {ECO:0000244|PDB:3QX1}.
FT   STRAND      613    616       {ECO:0000244|PDB:3QX1}.
FT   STRAND      618    620       {ECO:0000244|PDB:3QX1}.
FT   HELIX       624    626       {ECO:0000244|PDB:3QX1}.
FT   TURN        633    637       {ECO:0000244|PDB:3QX1}.
FT   STRAND      640    648       {ECO:0000244|PDB:3QX1}.
SQ   SEQUENCE   650 AA;  73954 MW;  7FB9018B9A230488 CRC64;
     MASNMDREMI LADFQACTGI ENIDEAITLL EQNNWDLVAA INGVIPQENG ILQSEYGGET
     IPGPAFNPAS HPASAPTSSS SSAFRPVMPS RQIVERQPRM LDFRVEYRDR NVDVVLEDTC
     TVGEIKQILE NELQIPVSKM LLKGWKTGDV EDSTVLKSLH LPKNNSLYVL TPDLPPPSSS
     SHAGALQESL NQNFMLIITH REVQREYNLN FSGSSTIQEV KRNVYDLTSI PVRHQLWEGW
     PTSATDDSMC LAESGLSYPC HRLTVGRRSS PAQTREQSEE QITDVHMVSD SDGDDFEDAT
     EFGVDDGEVF GMASSALRKS PMMPENAENE GDALLQFTAE FSSRYGDCHP VFFIGSLEAA
     FQEAFYVKAR DRKLLAIYLH HDESVLTNVF CSQMLCAESI VSYLSQNFIT WAWDLTKDSN
     RARFLTMCNR HFGSVVAQTI RTQKTDQFPL FLIIMGKRSS NEVLNVIQGN TTVDELMMRL
     MAAMEIFTAQ QQEDIKDEDE REARENVKRE QDEAYRLSLE ADRAKREAHE REMAEQFRLE
     QIRKEQEEER EAIRLSLEQA LPPEPKEENA EPVSKLRIRT PSGEFLERRF LASNKLQIVF
     DFVASKGFPW DEYKLLSTFP RRDVTQLDPN KSLLEVKLFP QETLFLEAKE
//
ID   ELAV1_HUMAN             Reviewed;         326 AA.
AC   Q15717; B4DVB8; Q53XN6; Q9BTT1;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   15-MAY-2002, sequence version 2.
DT   23-MAY-2018, entry version 185.
DE   RecName: Full=ELAV-like protein 1;
DE   AltName: Full=Hu-antigen R;
DE            Short=HuR {ECO:0000303|PubMed:8626503};
GN   Name=ELAVL1; Synonyms=HUR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, RNA-BINDING, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=8626503; DOI=10.1074/jbc.271.14.7942;
RA   Ma W.-J., Cheng S., Campbell C., Wright A., Furneaux H.M.;
RT   "Cloning and characterization of HuR, a ubiquitously expressed Elav-
RT   like protein.";
RL   J. Biol. Chem. 271:8144-8151(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH ANP32A.
RX   PubMed=11729309; DOI=10.1126/science.1064693;
RA   Gallouzi I.-E., Steitz J.A.;
RT   "Delineation of mRNA export pathways by the use of cell-permeable
RT   peptides.";
RL   Science 294:1895-1901(2001).
RN   [8]
RP   METHYLATION AT ARG-217.
RX   PubMed=12237300; DOI=10.1074/jbc.M206187200;
RA   Li H., Park S., Kilburn B., Jelinek M.A., Henschen-Edman A.,
RA   Aswad D.W., Stallcup M.R., Laird-Offringa I.A.;
RT   "Lipopolysaccharide-induced methylation of HuR, an mRNA-stabilizing
RT   protein, by CARM1. Coactivator-associated arginine
RT   methyltransferase.";
RL   J. Biol. Chem. 277:44623-44630(2002).
RN   [9]
RP   FUNCTION, RNA-BINDING, SUBCELLULAR LOCATION, AND PHOSPHORYLATION BY
RP   MAPKAPK2.
RX   PubMed=14517288; DOI=10.1128/MCB.23.20.7177-7188.2003;
RA   Tran H., Maurer F., Nagamine Y.;
RT   "Stabilization of urokinase and urokinase receptor mRNAs by HuR is
RT   linked to its cytoplasmic accumulation induced by activated mitogen-
RT   activated protein kinase-activated protein kinase 2.";
RL   Mol. Cell. Biol. 23:7177-7188(2003).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   INTERACTION WITH AGO1 AND AGO2.
RX   PubMed=17932509; DOI=10.1038/sj.embor.7401088;
RA   Hoeck J., Weinmann L., Ender C., Ruedel S., Kremmer E., Raabe M.,
RA   Urlaub H., Meister G.;
RT   "Proteomic and functional analysis of Argonaute-containing mRNA-
RT   protein complexes in human cells.";
RL   EMBO Rep. 8:1052-1060(2007).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=17632515; DOI=10.1038/nchembio.2007.14;
RA   Meisner N.C., Hintersteiner M., Mueller K., Bauer R., Seifert J.M.,
RA   Naegeli H.U., Ottl J., Oberer L., Guenat C., Moss S., Harrer N.,
RA   Woisetschlaeger M., Buehler C., Uhl V., Auer M.;
RT   "Identification and mechanistic characterization of low-molecular-
RT   weight inhibitors for HuR.";
RL   Nat. Chem. Biol. 3:508-515(2007).
RN   [14]
RP   INTERACTION WITH HNRNPL.
RX   PubMed=18161049; DOI=10.1002/hep.22036;
RA   Matsui K., Nishizawa M., Ozaki T., Kimura T., Hashimoto I., Yamada M.,
RA   Kaibori M., Kamiyama Y., Ito S., Okumura T.;
RT   "Natural antisense transcript stabilizes inducible nitric oxide
RT   synthase messenger RNA in rat hepatocytes.";
RL   Hepatology 47:686-697(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [16]
RP   RNA-BINDING, FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT
RP   SER-158; SER-221 AND SER-318, AND MUTAGENESIS OF SER-158; SER-221 AND
RP   SER-318.
RX   PubMed=18285462; DOI=10.1128/MCB.01530-07;
RA   Doller A., Akool E.-S., Huwiler A., Mueller R., Radeke H.H.,
RA   Pfeilschifter J., Eberhardt W.;
RT   "Posttranslational modification of the AU-rich element binding protein
RT   HuR by protein kinase Cdelta elicits angiotensin II-induced
RT   stabilization and nuclear export of cyclooxygenase 2 mRNA.";
RL   Mol. Cell. Biol. 28:2608-2625(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-202, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [18]
RP   RNA-BINDING.
RX   PubMed=19561594; DOI=10.1038/nbt.1550;
RA   Ray D., Kazan H., Chan E.T., Pena Castillo L., Chaudhry S.,
RA   Talukder S., Blencowe B.J., Morris Q., Hughes T.R.;
RT   "Rapid and systematic analysis of the RNA recognition specificities of
RT   RNA-binding proteins.";
RL   Nat. Biotechnol. 27:667-670(2009).
RN   [19]
RP   FUNCTION, IDENTIFICATION IN A MRNP COMPLEX, SUBCELLULAR LOCATION, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=19029303; DOI=10.1261/rna.1175909;
RA   Weidensdorfer D., Stoehr N., Baude A., Lederer M., Koehn M.,
RA   Schierhorn A., Buchmeier S., Wahle E., Huettelmaiery S.;
RT   "Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic
RT   RNPs.";
RL   RNA 15:104-115(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-202, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-202, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-2 AND SER-202, CLEAVAGE OF INITIATOR METHIONINE
RP   [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [24]
RP   INTERACTION WITH IGF2BP1; IGF2BP2 AND IGF2BP3.
RX   PubMed=23640942; DOI=10.1515/hsz-2013-0111;
RA   Wachter K., Kohn M., Stohr N., Huttelmaier S.;
RT   "Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-
RT   binding proteins) is modulated by distinct RNA-binding domains.";
RL   Biol. Chem. 394:1077-1090(2013).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100; SER-197 AND
RP   SER-202, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-217, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [28]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-191, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 18-99, AND SUBUNIT.
RX   PubMed=20219472; DOI=10.1016/j.jmb.2010.02.043;
RA   Benoit R.M., Meisner N.C., Kallen J., Graff P., Hemmig R., Cebe R.,
RA   Ostermeier C., Widmer H., Auer M.;
RT   "The X-ray crystal structure of the first RNA recognition motif and
RT   site-directed mutagenesis suggest a possible HuR redox sensing
RT   mechanism.";
RL   J. Mol. Biol. 397:1231-1244(2010).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 18-186 OF APOPROTEIN AND IN
RP   COMPLEX WITH RNA, FUNCTION, RNA-BINDING, AND DOMAIN.
RX   PubMed=23519412; DOI=10.1107/S0907444912047828;
RA   Wang H., Zeng F., Liu Q., Liu H., Liu Z., Niu L., Teng M., Li X.;
RT   "The structure of the ARE-binding domains of Hu antigen R (HuR)
RT   undergoes conformational changes during RNA binding.";
RL   Acta Crystallogr. D 69:373-380(2013).
CC   -!- FUNCTION: RNA-binding protein that binds to the 3'-UTR region of
CC       mRNAs and increases their stability (PubMed:14517288,
CC       PubMed:18285462). Involved in embryonic stem cells (ESCs)
CC       differentiation: preferentially binds mRNAs that are not
CC       methylated by N6-methyladenosine (m6A), stabilizing them,
CC       promoting ESCs differentiation (By similarity). Binds to poly-U
CC       elements and AU-rich elements (AREs) in the 3'-UTR of target mRNAs
CC       (PubMed:8626503, PubMed:17632515, PubMed:18285462,
CC       PubMed:23519412). Binds avidly to the AU-rich element in FOS and
CC       IL3/interleukin-3 mRNAs. In the case of the FOS AU-rich element,
CC       binds to a core element of 27 nucleotides that contain AUUUA,
CC       AUUUUA, and AUUUUUA motifs. Binds preferentially to the 5'-
CC       UUUU[AG]UUU-3' motif in vitro (PubMed:8626503). With ZNF385A,
CC       binds the 3'-UTR of p53/TP53 mRNA to control their nuclear export
CC       induced by CDKN2A. Hence, may regulate p53/TP53 expression and
CC       mediate in part the CDKN2A anti-proliferative activity. May also
CC       bind with ZNF385A the CCNB1 mRNA (By similarity).
CC       {ECO:0000250|UniProtKB:P70372, ECO:0000269|PubMed:14517288,
CC       ECO:0000269|PubMed:17632515, ECO:0000269|PubMed:18285462,
CC       ECO:0000269|PubMed:19029303, ECO:0000269|PubMed:23519412,
CC       ECO:0000269|PubMed:8626503}.
CC   -!- SUBUNIT: Monomer and homodimer (in vitro) (PubMed:17632515,
CC       PubMed:20219472). Interacts with ANP32A (PubMed:11729309).
CC       Interacts with ZNF385A; the interaction is indirect and mRNA-
CC       dependent and may regulate p53/TP53 expression (By similarity).
CC       Identified in a mRNP complex, at least composed of DHX9, DDX3X,
CC       ELAVL1, HNRNPU, IGF2BP1, ILF3, PABPC1, PCBP2, PTBP2, STAU1, STAU2,
CC       SYNCRIP and YBX1 (PubMed:19029303). Interacts with AGO1 and AGO2
CC       (PubMed:17932509). Interacts with IGF2BP2 and IGF2BP3
CC       (PubMed:23640942). Interacts with HNRNPL (PubMed:18161049).
CC       {ECO:0000250|UniProtKB:P70372, ECO:0000269|PubMed:11729309,
CC       ECO:0000269|PubMed:17632515, ECO:0000269|PubMed:17932509,
CC       ECO:0000269|PubMed:18161049, ECO:0000269|PubMed:19029303,
CC       ECO:0000269|PubMed:20219472, ECO:0000269|PubMed:23640942}.
CC   -!- INTERACTION:
CC       O00560:SDCBP; NbExp=3; IntAct=EBI-374260, EBI-727004;
CC       P0CG48:UBC; NbExp=4; IntAct=EBI-374260, EBI-3390054;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:14517288,
CC       ECO:0000269|PubMed:17632515, ECO:0000269|PubMed:18285462,
CC       ECO:0000269|PubMed:19029303}. Nucleus
CC       {ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:17632515,
CC       ECO:0000269|PubMed:18285462}. Note=Translocates into the cytoplasm
CC       following phosphorylation by MAPKAPK2 (PubMed:14517288). Likewise,
CC       phosphorylation by PRKCD promotes translocation from the nucleus
CC       into the cytoplasm, where it is associated with free and
CC       cytoskeleton-bound polysomes (PubMed:18285462).
CC       {ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:18285462}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15717-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15717-2; Sequence=VSP_056148;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Detected in brain, liver, thymus
CC       and muscle. {ECO:0000269|PubMed:8626503}.
CC   -!- DOMAIN: The first RRM (RNA recognition motif) domain is essential
CC       for binding to AU-rich elements. {ECO:0000269|PubMed:23519412}.
CC   -!- PTM: Phosphorylated by MAPKAPK2 (PubMed:14517288). Phosphorylated
CC       by PRKCD (PubMed:18285462). {ECO:0000269|PubMed:14517288,
CC       ECO:0000269|PubMed:18285462}.
CC   -!- PTM: Methylated at Arg-217 by CARM1 in macrophages in response to
CC       LPS challenge. {ECO:0000269|PubMed:12237300}.
CC   -!- SIMILARITY: Belongs to the RRM elav family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ELAVL1ID44237ch19p13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U38175; AAB41913.1; -; mRNA.
DR   EMBL; BT009793; AAP88795.1; -; mRNA.
DR   EMBL; AK301013; BAG62630.1; -; mRNA.
DR   EMBL; AC008975; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010336; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471139; EAW68949.1; -; Genomic_DNA.
DR   EMBL; BC003376; AAH03376.1; -; mRNA.
DR   CCDS; CCDS12193.1; -. [Q15717-1]
DR   RefSeq; NP_001410.2; NM_001419.2. [Q15717-1]
DR   UniGene; Hs.184492; -.
DR   UniGene; Hs.713744; -.
DR   PDB; 3HI9; X-ray; 2.00 A; A/B/C/D=18-99.
DR   PDB; 4ED5; X-ray; 2.00 A; A/B=18-186.
DR   PDB; 4EGL; X-ray; 2.90 A; A=18-186.
DR   PDB; 4FXV; X-ray; 1.90 A; A/B/C/D=20-99.
DR   PDB; 5SZW; NMR; -; A=1-99.
DR   PDBsum; 3HI9; -.
DR   PDBsum; 4ED5; -.
DR   PDBsum; 4EGL; -.
DR   PDBsum; 4FXV; -.
DR   PDBsum; 5SZW; -.
DR   ProteinModelPortal; Q15717; -.
DR   SMR; Q15717; -.
DR   BioGrid; 108309; 1780.
DR   CORUM; Q15717; -.
DR   DIP; DIP-31291N; -.
DR   IntAct; Q15717; 51.
DR   MINT; Q15717; -.
DR   STRING; 9606.ENSP00000385269; -.
DR   BindingDB; Q15717; -.
DR   ChEMBL; CHEMBL1250379; -.
DR   iPTMnet; Q15717; -.
DR   PhosphoSitePlus; Q15717; -.
DR   SwissPalm; Q15717; -.
DR   BioMuta; ELAVL1; -.
DR   DMDM; 20981691; -.
DR   EPD; Q15717; -.
DR   MaxQB; Q15717; -.
DR   PaxDb; Q15717; -.
DR   PeptideAtlas; Q15717; -.
DR   PRIDE; Q15717; -.
DR   DNASU; 1994; -.
DR   Ensembl; ENST00000407627; ENSP00000385269; ENSG00000066044. [Q15717-1]
DR   Ensembl; ENST00000596459; ENSP00000472197; ENSG00000066044. [Q15717-1]
DR   GeneID; 1994; -.
DR   KEGG; hsa:1994; -.
DR   UCSC; uc002mjb.4; human. [Q15717-1]
DR   CTD; 1994; -.
DR   DisGeNET; 1994; -.
DR   EuPathDB; HostDB:ENSG00000066044.13; -.
DR   GeneCards; ELAVL1; -.
DR   HGNC; HGNC:3312; ELAVL1.
DR   HPA; CAB005256; -.
DR   HPA; HPA046298; -.
DR   MIM; 603466; gene.
DR   neXtProt; NX_Q15717; -.
DR   OpenTargets; ENSG00000066044; -.
DR   PharmGKB; PA27740; -.
DR   eggNOG; KOG0145; Eukaryota.
DR   eggNOG; ENOG410XP7S; LUCA.
DR   GeneTree; ENSGT00760000118913; -.
DR   HOGENOM; HOG000231162; -.
DR   HOVERGEN; HBG002295; -.
DR   InParanoid; Q15717; -.
DR   KO; K13088; -.
DR   OMA; ANPNQVK; -.
DR   OrthoDB; EOG091G0G9L; -.
DR   PhylomeDB; Q15717; -.
DR   TreeFam; TF313377; -.
DR   Reactome; R-HSA-450520; HuR (ELAVL1) binds and stabilizes mRNA.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   SIGNOR; Q15717; -.
DR   ChiTaRS; ELAVL1; human.
DR   EvolutionaryTrace; Q15717; -.
DR   GeneWiki; ELAVL1; -.
DR   GenomeRNAi; 1994; -.
DR   PRO; PR:Q15717; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000066044; -.
DR   CleanEx; HS_ELAVL1; -.
DR   ExpressionAtlas; Q15717; baseline and differential.
DR   Genevisible; Q15717; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0010494; C:cytoplasmic stress granule; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISS:UniProtKB.
DR   GO; GO:0017091; F:AU-rich element binding; IDA:UniProtKB.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:MGI.
DR   GO; GO:0035198; F:miRNA binding; IDA:UniProtKB.
DR   GO; GO:0035925; F:mRNA 3'-UTR AU-rich region binding; IDA:UniProtKB.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; TAS:ProtInc.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0070935; P:3'-UTR-mediated mRNA stabilization; IDA:UniProtKB.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0048255; P:mRNA stabilization; IDA:MGI.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0060965; P:negative regulation of gene silencing by miRNA; IMP:UniProtKB.
DR   GO; GO:0045727; P:positive regulation of translation; IDA:MGI.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:0043488; P:regulation of mRNA stability; TAS:Reactome.
DR   GO; GO:2000036; P:regulation of stem cell population maintenance; ISS:UniProtKB.
DR   CDD; cd12650; RRM1_Hu; 1.
DR   CDD; cd12773; RRM2_HuR; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR006548; ELAD_HU_SF.
DR   InterPro; IPR034775; ELAV/Hu_RRM1.
DR   InterPro; IPR002343; Hud_Sxl_RNA.
DR   InterPro; IPR034996; HuR_RRM2.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   Pfam; PF00076; RRM_1; 3.
DR   PRINTS; PR00961; HUDSXLRNA.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 3.
DR   TIGRFAMs; TIGR01661; ELAV_HUD_SF; 1.
DR   PROSITE; PS50102; RRM; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Isopeptide bond; Methylation; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; RNA-binding; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:21406692}.
FT   CHAIN         2    326       ELAV-like protein 1.
FT                                /FTId=PRO_0000081577.
FT   DOMAIN       20     98       RRM 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      106    186       RRM 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      244    322       RRM 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES       2      2       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     100    100       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     158    158       Phosphoserine.
FT                                {ECO:0000305|PubMed:18285462}.
FT   MOD_RES     197    197       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     202    202       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     206    206       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:P70372}.
FT   MOD_RES     217    217       Omega-N-methylarginine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     217    217       Omega-N-methylated arginine; by CARM1;
FT                                alternate. {ECO:0000269|PubMed:12237300}.
FT   MOD_RES     221    221       Phosphoserine.
FT                                {ECO:0000305|PubMed:18285462}.
FT   MOD_RES     318    318       Phosphoserine.
FT                                {ECO:0000305|PubMed:18285462}.
FT   CROSSLNK    191    191       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1      1       M -> MGSGGRSAQVSTGQRAWLLPCRFLKNTM (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056148.
FT   MUTAGEN     158    158       S->A: Decreases phosphorylation by PRKCD.
FT                                {ECO:0000269|PubMed:18285462}.
FT   MUTAGEN     221    221       S->A: Decreases phosphorylation by PRKCD.
FT                                Nearly abolishes phosphorylation by PRKCD
FT                                and translocation from the nucleus into
FT                                the cytoplasm; when associated with A-
FT                                318. {ECO:0000269|PubMed:18285462}.
FT   MUTAGEN     318    318       S->A: Decreases phosphorylation by PRKCD.
FT                                Nearly abolishes phosphorylation by PRKCD
FT                                and translocation from the nucleus into
FT                                the cytoplasm; when associated with A-
FT                                221. {ECO:0000269|PubMed:18285462}.
FT   CONFLICT    180    180       T -> A (in Ref. 1; AAB41913).
FT                                {ECO:0000305}.
FT   TURN          7     10       {ECO:0000244|PDB:5SZW}.
FT   STRAND       20     26       {ECO:0000244|PDB:4FXV}.
FT   HELIX        33     41       {ECO:0000244|PDB:4FXV}.
FT   STRAND       46     53       {ECO:0000244|PDB:4FXV}.
FT   STRAND       55     57       {ECO:0000244|PDB:4FXV}.
FT   STRAND       60     70       {ECO:0000244|PDB:4FXV}.
FT   HELIX        71     81       {ECO:0000244|PDB:4FXV}.
FT   STRAND       92     95       {ECO:0000244|PDB:4FXV}.
FT   HELIX       101    103       {ECO:0000244|PDB:4ED5}.
FT   STRAND      107    111       {ECO:0000244|PDB:4ED5}.
FT   HELIX       119    126       {ECO:0000244|PDB:4ED5}.
FT   HELIX       127    129       {ECO:0000244|PDB:4ED5}.
FT   STRAND      132    139       {ECO:0000244|PDB:4ED5}.
FT   TURN        141    143       {ECO:0000244|PDB:4ED5}.
FT   STRAND      146    156       {ECO:0000244|PDB:4ED5}.
FT   HELIX       157    167       {ECO:0000244|PDB:4ED5}.
FT   STRAND      180    183       {ECO:0000244|PDB:4ED5}.
SQ   SEQUENCE   326 AA;  36092 MW;  0B86143805264DEF CRC64;
     MSNGYEDHMA EDCRGDIGRT NLIVNYLPQN MTQDELRSLF SSIGEVESAK LIRDKVAGHS
     LGYGFVNYVT AKDAERAINT LNGLRLQSKT IKVSYARPSS EVIKDANLYI SGLPRTMTQK
     DVEDMFSRFG RIINSRVLVD QTTGLSRGVA FIRFDKRSEA EEAITSFNGH KPPGSSEPIT
     VKFAANPNQN KNVALLSQLY HSPARRFGGP VHHQAQRFRF SPMGVDHMSG LSGVNVPGNA
     SSGWCIFIYN LGQDADEGIL WQMFGPFGAV TNVKVIRDFN TNKCKGFGFV TMTNYEEAAM
     AIASLNGYRL GDKILQVSFK TNKSHK
//
ID   A0A024R475_HUMAN        Unreviewed;       768 AA.
AC   A0A024R475;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-MAR-2018, entry version 28.
DE   SubName: Full=Cullin 3, isoform CRA_a {ECO:0000313|EMBL:EAW70830.1};
GN   Name=CUL3 {ECO:0000313|EMBL:EAW70830.1};
GN   ORFNames=hCG_21435 {ECO:0000313|EMBL:EAW70830.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW70830.1};
RN   [1] {ECO:0000313|EMBL:EAW70830.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW70830.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the cullin family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00330, ECO:0000256|RuleBase:RU003829,
CC       ECO:0000256|SAAS:SAAS00585788}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471063; EAW70830.1; -; Genomic_DNA.
DR   RefSeq; NP_003581.1; NM_003590.4.
DR   UniGene; Hs.372286; -.
DR   ProteinModelPortal; A0A024R475; -.
DR   SMR; A0A024R475; -.
DR   PRIDE; A0A024R475; -.
DR   GeneID; 8452; -.
DR   KEGG; hsa:8452; -.
DR   CTD; 8452; -.
DR   EuPathDB; HostDB:ENSG00000036257.12; -.
DR   eggNOG; KOG2167; Eukaryota.
DR   eggNOG; COG5647; LUCA.
DR   KO; K03869; -.
DR   OMA; TSTFWPM; -.
DR   OrthoDB; EOG091G02DP; -.
DR   PhylomeDB; A0A024R475; -.
DR   ChiTaRS; CUL3; human.
DR   GenomeRNAi; 8452; -.
DR   Bgee; ENSG00000036257; -.
DR   ExpressionAtlas; A0A024R475; baseline and differential.
DR   GO; GO:0031461; C:cullin-RING ubiquitin ligase complex; IEA:InterPro.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0030332; F:cyclin binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:InterPro.
DR   GO; GO:0040016; P:embryonic cleavage; IEA:Ensembl.
DR   GO; GO:0044346; P:fibroblast apoptotic process; IEA:Ensembl.
DR   GO; GO:0007369; P:gastrulation; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0072576; P:liver morphogenesis; IEA:Ensembl.
DR   GO; GO:0000278; P:mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0017145; P:stem cell division; IEA:Ensembl.
DR   GO; GO:0001831; P:trophectodermal cellular morphogenesis; IEA:Ensembl.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:Ensembl.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR016157; Cullin_CS.
DR   InterPro; IPR016158; Cullin_homology.
DR   InterPro; IPR036317; Cullin_homology_sf.
DR   InterPro; IPR001373; Cullin_N.
DR   InterPro; IPR019559; Cullin_neddylation_domain.
DR   InterPro; IPR016159; Cullin_repeat-like_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00888; Cullin; 1.
DR   Pfam; PF10557; Cullin_Nedd8; 1.
DR   SMART; SM00182; CULLIN; 1.
DR   SMART; SM00884; Cullin_Nedd8; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF74788; SSF74788; 1.
DR   SUPFAM; SSF75632; SSF75632; 1.
DR   PROSITE; PS01256; CULLIN_1; 1.
DR   PROSITE; PS50069; CULLIN_2; 1.
PE   3: Inferred from homology;
FT   DOMAIN      383    635       CULLIN_2. {ECO:0000259|PROSITE:PS50069}.
SQ   SEQUENCE   768 AA;  88930 MW;  A1A02022480BF099 CRC64;
     MSNLSKGTGS RKDTKMRIRA FPMTMDEKYV NSIWDLLKNA IQEIQRKNNS GLSFEELYRN
     AYTMVLHKHG EKLYTGLREV VTEHLINKVR EDVLNSLNNN FLQTLNQAWN DHQTAMVMIR
     DILMYMDRVY VQQNNVENVY NLGLIIFRDQ VVRYGCIRDH LRQTLLDMIA RERKGEVVDR
     GAIRNACQML MILGLEGRSV YEEDFEAPFL EMSAEFFQME SQKFLAENSA SVYIKKVEAR
     INEEIERVMH CLDKSTEEPI VKVVERELIS KHMKTIVEME NSGLVHMLKN GKTEDLGCMY
     KLFSRVPNGL KTMCECMSSY LREQGKALVS EEGEGKNPVD YIQGLLDLKS RFDRFLLESF
     NNDRLFKQTI AGDFEYFLNL NSRSPEYLSL FIDDKLKKGV KGLTEQEVET ILDKAMVLFR
     FMQEKDVFER YYKQHLARRL LTNKSVSDDS EKNMISKLKT ECGCQFTSKL EGMFRDMSIS
     NTTMDEFRQH LQATGVSLGG VDLTVRVLTT GYWPTQSATP KCNIPPAPRH AFEIFRRFYL
     AKHSGRQLTL QHHMGSADLN ATFYGPVKKE DGSEVGVGGA QVTGSNTRKH ILQVSTFQMT
     ILMLFNNREK YTFEEIQQET DIPERELVRA LQSLACGKPT QRVLTKEPKS KEIENGHIFT
     VNDQFTSKLH RVKIQTVAAK QGESDPERKE TRQKVDDDRK HEIEAAIVRI MKSRKKMQHN
     VLVAEVTQQL KARFLPSPVV IKKRIEGLIE REYLARTPED RKVYTYVA
//
ID   B7Z600_HUMAN            Unreviewed;       550 AA.
AC   B7Z600;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   28-MAR-2018, entry version 47.
DE   SubName: Full=cDNA FLJ53180, highly similar to Cullin-3 {ECO:0000313|EMBL:BAH13086.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH13086.1};
RN   [1] {ECO:0000313|EMBL:BAH13086.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAH13086.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the cullin family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00330, ECO:0000256|RuleBase:RU003829,
CC       ECO:0000256|SAAS:SAAS00585788}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK299644; BAH13086.1; -; mRNA.
DR   RefSeq; NP_001244126.1; NM_001257197.1.
DR   UniGene; Hs.372286; -.
DR   PeptideAtlas; B7Z600; -.
DR   PRIDE; B7Z600; -.
DR   GeneID; 8452; -.
DR   CTD; 8452; -.
DR   eggNOG; KOG2167; Eukaryota.
DR   eggNOG; COG5647; LUCA.
DR   HOGENOM; HOG000176712; -.
DR   HOVERGEN; HBG003619; -.
DR   GenomeRNAi; 8452; -.
DR   GO; GO:0031461; C:cullin-RING ubiquitin ligase complex; IEA:InterPro.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:InterPro.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR016157; Cullin_CS.
DR   InterPro; IPR016158; Cullin_homology.
DR   InterPro; IPR036317; Cullin_homology_sf.
DR   InterPro; IPR001373; Cullin_N.
DR   InterPro; IPR019559; Cullin_neddylation_domain.
DR   InterPro; IPR016159; Cullin_repeat-like_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00888; Cullin; 1.
DR   Pfam; PF10557; Cullin_Nedd8; 1.
DR   SMART; SM00182; CULLIN; 1.
DR   SMART; SM00884; Cullin_Nedd8; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF74788; SSF74788; 1.
DR   SUPFAM; SSF75632; SSF75632; 1.
DR   PROSITE; PS01256; CULLIN_1; 1.
DR   PROSITE; PS50069; CULLIN_2; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN      165    417       CULLIN_2. {ECO:0000259|PROSITE:PS50069}.
SQ   SEQUENCE   550 AA;  63310 MW;  511659C88F9360D0 CRC64;
     MESQKFLAEN SASVYIKKVE ARINEEIERV MHCLDKSTEE PIVKVVEREL ISKHMKTIVE
     MENSGLVHML KNGKTEDLGC MYKLFSRVPN GLKTMCECMS SYLREQGKAL VSEEGEGKNP
     VDYIQGLLDL KSRFDRFLLE SFNNDRLFKQ TIAGDFEYFL NLNSRSPEYL SLFIDDKLKK
     GVKGLTEQEV ETILDKAMVL FRFMQEKDVF ERYYKQHLAR RLLTNKSVSD DSEKNMISKL
     KTECGCQFTS KLEGMFRDMS ISNTTMDEFR QHLQATGVSL GGVDLTVRVL TTGYWPTQSA
     TPKCNIPPAP RHAFEIFRRF YLAKHSGRQL TLQHHMGSAD LNATFYGPIK KEDGSEVGVG
     GAQVTGSNTR KHILQVSTFQ MTILMLFNNR EKYTFEEIQQ ETDIPERELV RALQSLACGK
     PTQRVLTKEP KSKEIENGHI FTVNDQFTSK LHRVKIQTVA AKQGESDPER KETRQKVDDD
     RKHEIEAAIV RIMKSRKKMQ HNVLVAEVTQ QLKARFLPSP VVIKKRIEGL IEREYLARTP
     EDRKVYTYVA
//
ID   CUL3_HUMAN              Reviewed;         768 AA.
AC   Q13618; A8K536; B8ZZC3; O75415; Q569L3; Q9UBI8; Q9UET7;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2001, sequence version 2.
DT   23-MAY-2018, entry version 186.
DE   RecName: Full=Cullin-3;
DE            Short=CUL-3;
GN   Name=CUL3; Synonyms=KIAA0617;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9733711; DOI=10.1074/jbc.273.38.24289;
RA   Du M., Sansores-Garcia L., Zu Z., Wu K.K.;
RT   "Cloning and expression analysis of a novel salicylate suppressible
RT   gene, Hs-CUL-3, a member of cullin/Cdc53 family.";
RL   J. Biol. Chem. 273:24289-24292(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Colon carcinoma;
RX   PubMed=9663463;
RA   Michel J.J., Xiong Y.;
RT   "Human CUL-1, but not other cullin family members, selectively
RT   interacts with SKP1 to form a complex with SKP2 and cyclin A.";
RL   Cell Growth Differ. 9:435-449(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RA   Xu M., Huang X.Y., Yin L.L., Xu Z.Y., Lu L., Zhou Z.M., Sha J.H.;
RT   "Cloning and characterization of a new isoform of CUL3 gene in
RT   testis.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Ovary, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 192-768.
RX   PubMed=8681378; DOI=10.1016/S0092-8674(00)81267-2;
RA   Kipreos E.T., Lander L.E., Wing J.P., He W.W., Hedgecock E.M.;
RT   "cul-1 is required for cell cycle exit in C. elegans and identifies a
RT   novel gene family.";
RL   Cell 85:829-839(1996).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 398-768.
RC   TISSUE=Brain;
RA   Yu W., Sarginson J., Gibbs R.A.;
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   ALTERNATIVE SPLICING (ISOFORMS 1 AND 3), FUNCTION, SUBCELLULAR
RP   LOCATION, INTERACTION WITH CYCE, AND NEDDYLATION.
RX   PubMed=10500095; DOI=10.1101/gad.13.18.2375;
RA   Singer J.D., Gurian-West M., Clurman B., Roberts J.M.;
RT   "Cullin-3 targets cyclin E for ubiquitination and controls S phase in
RT   mammalian cells.";
RL   Genes Dev. 13:2375-2387(1999).
RN   [12]
RP   FUNCTION.
RX   PubMed=11311237; DOI=10.1016/S0014-5793(01)02343-2;
RA   Maeda I., Ohta T., Koizumi H., Fukuda M.;
RT   "In vitro ubiquitination of cyclin D1 by ROC1-CUL1 and ROC1-CUL3.";
RL   FEBS Lett. 494:181-185(2001).
RN   [13]
RP   NEDDYLATION.
RX   PubMed=10597293; DOI=10.1038/sj.onc.1203093;
RA   Hori T., Osaka F., Chiba T., Miyamoto C., Okabayashi K., Shimbara N.,
RA   Kato S., Tanaka K.;
RT   "Covalent modification of all members of human cullin family proteins
RT   by NEDD8.";
RL   Oncogene 18:6829-6834(1999).
RN   [14]
RP   INTERACTION WITH RBX1 AND RNF7.
RX   PubMed=10230407; DOI=10.1016/S1097-2765(00)80482-7;
RA   Ohta T., Michel J.J., Schottelius A.J., Xiong Y.;
RT   "ROC1, a homolog of APC11, represents a family of cullin partners with
RT   an associated ubiquitin ligase activity.";
RL   Mol. Cell 3:535-541(1999).
RN   [15]
RP   INTERACTION WITH TIP120A.
RX   PubMed=12609982; DOI=10.1074/jbc.M213070200;
RA   Min K.-W., Hwang J.-W., Lee J.-S., Park Y., Tamura T.-A., Yoon J.-B.;
RT   "TIP120A associates with cullins and modulates ubiquitin ligase
RT   activity.";
RL   J. Biol. Chem. 278:15905-15910(2003).
RN   [16]
RP   INTERACTION WITH GAN; ZBTB16; KLHL9; KLHL13; KLHL21; KLHL3; KLHL15;
RP   KLHL20; KLHL36; GMCL2; BTBD1 AND SPOP.
RX   PubMed=14528312; DOI=10.1038/ncb1056;
RA   Furukawa M., He Y.J., Borchers C., Xiong Y.;
RT   "Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin
RT   ligases.";
RL   Nat. Cell Biol. 5:1001-1007(2003).
RN   [17]
RP   FUNCTION, IDENTIFICATION IN THE BCR(KLHL41) COMPLEX, IDENTIFICATION IN
RP   THE BCR(ENC1) COMPLEX, IDENTIFICATION IN THE BCR(KEAP1) COMPLEX, AND
RP   IDENTIFICATION IN THE BCR(GAN) COMPLEX.
RX   PubMed=15983046; DOI=10.1074/jbc.M501279200;
RA   Zhang D.D., Lo S.C., Sun Z., Habib G.M., Lieberman M.W., Hannink M.;
RT   "Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for
RT   Cul3, targets Keap1 for degradation by a proteasome-independent
RT   pathway.";
RL   J. Biol. Chem. 280:30091-30099(2005).
RN   [18]
RP   IDENTIFICATION IN A COMPLEX WITH SPOP AND BMI1, IDENTIFICATION IN A
RP   COMPLEX WITH SPOP AND H2AFY, AND FUNCTION.
RX   PubMed=15897469; DOI=10.1073/pnas.0408918102;
RA   Hernandez-Munoz I., Lund A.H., van der Stoop P., Boutsma E.,
RA   Muijrers I., Verhoeven E., Nusinow D.A., Panning B., Marahrens Y.,
RA   van Lohuizen M.;
RT   "Stable X chromosome inactivation involves the PRC1 Polycomb complex
RT   and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3
RT   ligase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:7635-7640(2005).
RN   [19]
RP   IDENTIFICATION IN THE BCR(SPOP) COMPLEX, INTERACTION WITH SPOP, AND
RP   FUNCTION IN UBIQUITINATION OF DAXX.
RX   PubMed=16524876; DOI=10.1074/jbc.M600204200;
RA   Kwon J.E., La M., Oh K.H., Oh Y.M., Kim G.R., Seol J.H., Baek S.H.,
RA   Chiba T., Tanaka K., Bang O.S., Joe C.O., Chung C.H.;
RT   "BTB domain-containing speckle-type POZ protein (SPOP) serves as an
RT   adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase.";
RL   J. Biol. Chem. 281:12664-12672(2006).
RN   [20]
RP   FUNCTION, AND INTERACTION WITH KLHL9 AND KLHL13.
RX   PubMed=17543862; DOI=10.1016/j.devcel.2007.03.019;
RA   Sumara I., Quadroni M., Frei C., Olma M.H., Sumara G., Ricci R.,
RA   Peter M.;
RT   "A Cul3-based E3 ligase removes Aurora B from mitotic chromosomes,
RT   regulating mitotic progression and completion of cytokinesis in human
RT   cells.";
RL   Dev. Cell 12:887-900(2007).
RN   [21]
RP   SELF-ASSOCIATION.
RX   PubMed=17254749; DOI=10.1016/j.cellsig.2006.12.002;
RA   Chew E.H., Poobalasingam T., Hawkey C.J., Hagen T.;
RT   "Characterization of cullin-based E3 ubiquitin ligases in intact
RT   mammalian cells -- evidence for cullin dimerization.";
RL   Cell. Signal. 19:1071-1080(2007).
RN   [22]
RP   BCR COMPLEX HOMODIMERIZATION.
RX   PubMed=17192413; DOI=10.1091/mbc.E06-06-0542;
RA   Wimuttisuk W., Singer J.D.;
RT   "The Cullin3 ubiquitin ligase functions as a Nedd8-bound
RT   heterodimer.";
RL   Mol. Biol. Cell 18:899-909(2007).
RN   [23]
RP   INTERACTION WITH KCTD5.
RX   PubMed=18573101; DOI=10.1111/j.1742-4658.2008.06537.x;
RA   Bayon Y., Trinidad A.G., de la Puerta M.L., Del Carmen Rodriguez M.,
RA   Bogetz J., Rojas A., De Pereda J.M., Rahmouni S., Williams S.,
RA   Matsuzawa S., Reed J.C., Crespo M.S., Mustelin T., Alonso A.;
RT   "KCTD5, a putative substrate adaptor for cullin3 ubiquitin ligases.";
RL   FEBS J. 275:3900-3910(2008).
RN   [24]
RP   FUNCTION, AND INTERACTION WITH ATF2 AND KAT5.
RX   PubMed=18397884; DOI=10.1074/jbc.M802030200;
RA   Bhoumik A., Singha N., O'Connell M.J., Ronai Z.A.;
RT   "Regulation of TIP60 by ATF2 modulates ATM activation.";
RL   J. Biol. Chem. 283:17605-17614(2008).
RN   [25]
RP   IDENTIFICATION IN THE BCR(KLHL42) COMPLEX, FUNCTION IN UBIQUITINATION
RP   OF KATNA1, AND INTERACTION WITH KATNA1 AND KLHL42.
RX   PubMed=19261606; DOI=10.1074/jbc.M809374200;
RA   Cummings C.M., Bentley C.A., Perdue S.A., Baas P.W., Singer J.D.;
RT   "The Cul3/Klhdc5 E3 ligase regulates p60/katanin and is required for
RT   normal mitosis in mammalian cells.";
RL   J. Biol. Chem. 284:11663-11675(2009).
RN   [26]
RP   IDENTIFICATION IN THE BCR(KLHL21) COMPLEX, AND FUNCTION.
RX   PubMed=19995937; DOI=10.1083/jcb.200906117;
RA   Maerki S., Olma M.H., Staubli T., Steigemann P., Gerlich D.W.,
RA   Quadroni M., Sumara I., Peter M.;
RT   "The Cul3-KLHL21 E3 ubiquitin ligase targets aurora B to midzone
RT   microtubules in anaphase and is required for cytokinesis.";
RL   J. Cell Biol. 187:791-800(2009).
RN   [27]
RP   FUNCTION, AND IDENTIFICATION IN A BCR (BTB-CUL3-RBX1) E3 UBIQUITIN
RP   LIGASE COMPLEX.
RX   PubMed=20389280; DOI=10.1038/emboj.2010.62;
RA   Lee Y.R., Yuan W.C., Ho H.C., Chen C.H., Shih H.M., Chen R.H.;
RT   "The Cullin 3 substrate adaptor KLHL20 mediates DAPK ubiquitination to
RT   control interferon responses.";
RL   EMBO J. 29:1748-1761(2010).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [29]
RP   FUNCTION, SUBCELLULAR LOCATION, AND IDENTIFICATION IN A COMPLEX WITH
RP   SPOP AND BRMS1.
RX   PubMed=22085717; DOI=10.1016/j.bbrc.2011.10.154;
RA   Kim B., Nam H.J., Pyo K.E., Jang M.J., Kim I.S., Kim D., Boo K.,
RA   Lee S.H., Yoon J.B., Baek S.H., Kim J.H.;
RT   "Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the
RT   Cul3-SPOP E3 ubiquitin ligase complex.";
RL   Biochem. Biophys. Res. Commun. 415:720-726(2011).
RN   [30]
RP   FUNCTION, AND IDENTIFICATION IN A BCR (BTB-CUL3-RBX1) E3 UBIQUITIN
RP   LIGASE COMPLEX.
RX   PubMed=21840486; DOI=10.1016/j.ccr.2011.07.008;
RA   Yuan W.C., Lee Y.R., Huang S.F., Lin Y.M., Chen T.Y., Chung H.C.,
RA   Tsai C.H., Chen H.Y., Chiang C.T., Lai C.K., Lu L.T., Chen C.H.,
RA   Gu D.L., Pu Y.S., Jou Y.S., Lu K.P., Hsiao P.W., Shih H.M., Chen R.H.;
RT   "A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to
RT   potentiate HIF-1 signaling and prostate cancer progression.";
RL   Cancer Cell 20:214-228(2011).
RN   [31]
RP   FUNCTION, AND IDENTIFICATION IN A BCR (BTB-CUL3-RBX1) E3 UBIQUITIN
RP   LIGASE COMPLEX.
RX   PubMed=21670212; DOI=10.1083/jcb.201103015;
RA   Lin M.Y., Lin Y.M., Kao T.C., Chuang H.H., Chen R.H.;
RT   "PDZ-RhoGEF ubiquitination by Cullin3-KLHL20 controls neurotrophin-
RT   induced neurite outgrowth.";
RL   J. Cell Biol. 193:985-994(2011).
RN   [32]
RP   INTERACTION WITH KCTD7.
RX   PubMed=22748208; DOI=10.1016/j.ajhg.2012.05.023;
RA   Staropoli J.F., Karaa A., Lim E.T., Kirby A., Elbalalesy N.,
RA   Romansky S.G., Leydiker K.B., Coppel S.H., Barone R., Xin W.,
RA   MacDonald M.E., Abdenur J.E., Daly M.J., Sims K.B., Cotman S.L.;
RT   "A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis
RT   to the ubiquitin-proteasome system.";
RL   Am. J. Hum. Genet. 91:202-208(2012).
RN   [33]
RP   INTERACTION WITH PPP2R5B.
RX   PubMed=23135275; DOI=10.1074/jbc.M112.420281;
RA   Oberg E.A., Nifoussi S.K., Gingras A.C., Strack S.;
RT   "Selective proteasomal degradation of the B'beta subunit of protein
RT   phosphatase 2A by the E3 ubiquitin ligase adaptor Kelch-like 15.";
RL   J. Biol. Chem. 287:43378-43389(2012).
RN   [34]
RP   IDENTIFICATION IN THE BCR(KLHL25) COMPLEX, AND FUNCTION.
RX   PubMed=22578813; DOI=10.1016/j.molcel.2012.04.004;
RA   Yanagiya A., Suyama E., Adachi H., Svitkin Y.V., Aza-Blanc P.,
RA   Imataka H., Mikami S., Martineau Y., Ronai Z.A., Sonenberg N.;
RT   "Translational homeostasis via the mRNA cap-binding protein, eIF4E.";
RL   Mol. Cell 46:847-858(2012).
RN   [35]
RP   IDENTIFICATION IN THE BCR(KLHL12) COMPLEX, AND FUNCTION.
RX   PubMed=22358839; DOI=10.1038/nature10822;
RA   Jin L., Pahuja K.B., Wickliffe K.E., Gorur A., Baumgartel C.,
RA   Schekman R., Rape M.;
RT   "Ubiquitin-dependent regulation of COPII coat size and function.";
RL   Nature 482:495-500(2012).
RN   [36]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [37]
RP   FUNCTION, AND INTERACTION WITH KLHL3.
RX   PubMed=23387299; DOI=10.1042/BJ20121903;
RA   Ohta A., Schumacher F.R., Mehellou Y., Johnson C., Knebel A.,
RA   Macartney T.J., Wood N.T., Alessi D.R., Kurz T.;
RT   "The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension
RT   syndrome interacts with and ubiquitylates WNK isoforms: disease-
RT   causing mutations in KLHL3 and WNK4 disrupt interaction.";
RL   Biochem. J. 451:111-122(2013).
RN   [38]
RP   FUNCTION, AND IDENTIFICATION IN THE BCR(KLHL3) COMPLEX.
RX   PubMed=23453970; DOI=10.1016/j.celrep.2013.02.024;
RA   Wakabayashi M., Mori T., Isobe K., Sohara E., Susa K., Araki Y.,
RA   Chiga M., Kikuchi E., Nomura N., Mori Y., Matsuo H., Murata T.,
RA   Nomura S., Asano T., Kawaguchi H., Nonoyama S., Rai T., Sasaki S.,
RA   Uchida S.;
RT   "Impaired KLHL3-mediated ubiquitination of WNK4 causes human
RT   hypertension.";
RL   Cell Rep. 3:858-868(2013).
RN   [39]
RP   INTERACTION WITH ARIH1, AND NEDDYLATION.
RX   PubMed=24076655; DOI=10.1038/emboj.2013.209;
RA   Kelsall I.R., Duda D.M., Olszewski J.L., Hofmann K., Knebel A.,
RA   Langevin F., Wood N., Wightman M., Schulman B.A., Alpi A.F.;
RT   "TRIAD1 and HHARI bind to and are activated by distinct neddylated
RT   Cullin-RING ligase complexes.";
RL   EMBO J. 32:2848-2860(2013).
RN   [40]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-585, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [41]
RP   IDENTIFICATION IN THE BCR(KLHL22) COMPLEX, AND FUNCTION.
RX   PubMed=23455478; DOI=10.1038/ncb2695;
RA   Beck J., Maerki S., Posch M., Metzger T., Persaud A., Scheel H.,
RA   Hofmann K., Rotin D., Pedrioli P., Swedlow J.R., Peter M., Sumara I.;
RT   "Ubiquitylation-dependent localization of PLK1 in mitosis.";
RL   Nat. Cell Biol. 15:430-439(2013).
RN   [42]
RP   INTERACTION WITH COPS9.
RX   PubMed=23776465; DOI=10.1371/journal.pone.0065285;
RA   Ebina M., Tsuruta F., Katoh M.C., Kigoshi Y., Someya A., Chiba T.;
RT   "Myeloma overexpressed 2 (Myeov2) regulates L11 subnuclear
RT   localization through Nedd8 modification.";
RL   PLoS ONE 8:E65285-E65285(2013).
RN   [43]
RP   FUNCTION, AND IDENTIFICATION IN THE BCR(KLHL3) COMPLEX.
RX   PubMed=23576762; DOI=10.1073/pnas.1304592110;
RA   Shibata S., Zhang J., Puthumana J., Stone K.L., Lifton R.P.;
RT   "Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via
RT   ubiquitination and degradation of WNK4.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:7838-7843(2013).
RN   [44]
RP   INTERACTION WITH DCUN1D3.
RX   PubMed=25349211; DOI=10.1074/jbc.M114.585505;
RA   Huang G., Stock C., Bommelje C.C., Weeda V.B., Shah K., Bains S.,
RA   Buss E., Shaha M., Rechler W., Ramanathan S.Y., Singh B.;
RT   "SCCRO3 (DCUN1D3) antagonizes the neddylation and oncogenic activity
RT   of SCCRO (DCUN1D1).";
RL   J. Biol. Chem. 289:34728-34742(2014).
RN   [45]
RP   FUNCTION, AND IDENTIFICATION IN A BCR (BTB-CUL3-RBX1) E3 UBIQUITIN
RP   LIGASE COMPLEX.
RX   PubMed=24768539; DOI=10.1016/j.molcel.2014.03.035;
RA   Yuan W.C., Lee Y.R., Lin S.Y., Chang L.Y., Tan Y.P., Hung C.C.,
RA   Kuo J.C., Liu C.H., Lin M.Y., Xu M., Chen Z.J., Chen R.H.;
RT   "K33-linked polyubiquitination of coronin 7 by Cul3-KLHL20 ubiquitin
RT   E3 ligase regulates protein trafficking.";
RL   Mol. Cell 54:586-600(2014).
RN   [46]
RP   INTERACTION WITH KCTD17, IDENTIFICATION IN THE BCR(KCTD17) E3
RP   UBIQUITIN LIGASE COMPLEX, AND FUNCTION.
RX   PubMed=25270598; DOI=10.1038/ncomms6081;
RA   Kasahara K., Kawakami Y., Kiyono T., Yonemura S., Kawamura Y., Era S.,
RA   Matsuzaki F., Goshima N., Inagaki M.;
RT   "Ubiquitin-proteasome system controls ciliogenesis at the initial step
RT   of axoneme extension.";
RL   Nat. Commun. 5:5081-5081(2014).
RN   [47]
RP   FUNCTION, AND INTERACTION WITH KBTBD8.
RX   PubMed=26399832; DOI=10.1038/nature14978;
RA   Werner A., Iwasaki S., McGourty C.A., Medina-Ruiz S., Teerikorpi N.,
RA   Fedrigo I., Ingolia N.T., Rape M.;
RT   "Cell-fate determination by ubiquitin-dependent regulation of
RT   translation.";
RL   Nature 525:523-527(2015).
RN   [48]
RP   FUNCTION.
RX   PubMed=27716508; DOI=10.1016/j.cell.2016.09.026;
RA   McGourty C.A., Akopian D., Walsh C., Gorur A., Werner A., Schekman R.,
RA   Bautista D., Rape M.;
RT   "Regulation of the CUL3 ubiquitin ligase by a calcium-dependent co-
RT   adaptor.";
RL   Cell 167:525-538(2016).
RN   [49]
RP   FUNCTION, INTERACTION WITH ARIH1, AND NEDDYLATION.
RX   PubMed=27565346; DOI=10.1016/j.cell.2016.07.027;
RA   Scott D.C., Rhee D.Y., Duda D.M., Kelsall I.R., Olszewski J.L.,
RA   Paulo J.A., de Jong A., Ovaa H., Alpi A.F., Harper J.W.,
RA   Schulman B.A.;
RT   "Two distinct types of E3 ligases work in unison to regulate substrate
RT   ubiquitylation.";
RL   Cell 166:1198-1214(2016).
RN   [50]
RP   INTERACTION WITH KLHL15 AND RBBP8, AND NEDDYLATION.
RX   PubMed=27561354; DOI=10.1038/ncomms12628;
RA   Ferretti L.P., Himmels S.F., Trenner A., Walker C., von Aesch C.,
RA   Eggenschwiler A., Murina O., Enchev R.I., Peter M., Freire R.,
RA   Porro A., Sartori A.A.;
RT   "Cullin3-KLHL15 ubiquitin ligase mediates CtIP protein turnover to
RT   fine-tune DNA-end resection.";
RL   Nat. Commun. 7:12628-12628(2016).
RN   [51]
RP   FUNCTION, IDENTIFICATION IN THE BCR(KLHL24) COMPLEX, AND INTERACTION
RP   WITH KLHL24.
RX   PubMed=27798626; DOI=10.1038/ng.3701;
RA   Lin Z., Li S., Feng C., Yang S., Wang H., Ma D., Zhang J., Gou M.,
RA   Bu D., Zhang T., Kong X., Wang X., Sarig O., Ren Y., Dai L., Liu H.,
RA   Zhang J., Li F., Hu Y., Padalon-Brauch G., Vodo D., Zhou F., Chen T.,
RA   Deng H., Sprecher E., Yang Y., Tan X.;
RT   "Stabilizing mutations of KLHL24 ubiquitin ligase cause loss of
RT   keratin 14 and human skin fragility.";
RL   Nat. Genet. 48:1508-1516(2016).
RN   [52]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=28395323; DOI=10.1095/biolreprod.116.143479;
RA   Jumeau F., Chalmel F., Fernandez-Gomez F.J., Carpentier C., Obriot H.,
RA   Tardivel M., Caillet-Boudin M.L., Rigot J.M., Rives N., Buee L.,
RA   Sergeant N., Mitchell V.;
RT   "Defining the human sperm microtubulome: an integrated genomics
RT   approach.";
RL   Biol. Reprod. 96:93-106(2017).
RN   [53]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 20-381 IN COMPLEX WITH SPOP,
RP   FUNCTION, IDENTIFICATION IN UBIQUITIN LIGASE COMPLEXES WITH SPOP AND
RP   SPOPL, AND SUBUNIT.
RX   PubMed=22632832; DOI=10.1016/j.str.2012.04.009;
RA   Errington W.J., Khan M.Q., Bueler S.A., Rubinstein J.L.,
RA   Chakrabartty A., Prive G.G.;
RT   "Adaptor protein self-assembly drives the control of a cullin-RING
RT   ubiquitin ligase.";
RL   Structure 20:1141-1153(2012).
RN   [54]
RP   X-RAY CRYSTALLOGRAPHY (3.51 ANGSTROMS) OF 20-381 IN COMPLEX WITH
RP   KLHL3.
RX   PubMed=23573258; DOI=10.1371/journal.pone.0060445;
RA   Ji A.X., Prive G.G.;
RT   "Crystal structure of KLHL3 in complex with Cullin3.";
RL   PLoS ONE 8:E60445-E60445(2013).
RN   [55]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-388 IN COMPLEX WITH KLHL11,
RP   AND INTERACTION WITH KLHL11.
RX   PubMed=23349464; DOI=10.1074/jbc.M112.437996;
RA   Canning P., Cooper C.D., Krojer T., Murray J.W., Pike A.C.,
RA   Chaikuad A., Keates T., Thangaratnarajah C., Hojzan V., Marsden B.D.,
RA   Gileadi O., Knapp S., von Delft F., Bullock A.N.;
RT   "Structural basis for Cul3 assembly with the BTB-Kelch family of E3
RT   ubiquitin ligases.";
RL   J. Biol. Chem. 288:7803-7814(2013).
RN   [56]
RP   VARIANTS PHA2E GLY-413 AND ARG-459.
RX   PubMed=22266938; DOI=10.1038/nature10814;
RA   Boyden L.M., Choi M., Choate K.A., Nelson-Williams C.J., Farhi A.,
RA   Toka H.R., Tikhonova I.R., Bjornson R., Mane S.M., Colussi G.,
RA   Lebel M., Gordon R.D., Semmekrot B.A., Poujol A., Valimaki M.J.,
RA   De Ferrari M.E., Sanjad S.A., Gutkin M., Karet F.E., Tucci J.R.,
RA   Stockigt J.R., Keppler-Noreuil K.M., Porter C.C., Anand S.K.,
RA   Whiteford M.L., Davis I.D., Dewar S.B., Bettinelli A., Fadrowski J.J.,
RA   Belsha C.W., Hunley T.E., Nelson R.D., Trachtman H., Cole T.R.,
RA   Pinsk M., Bockenhauer D., Shenoy M., Vaidyanathan P., Foreman J.W.,
RA   Rasoulpour M., Thameem F., Al-Shahrouri H.Z., Radhakrishnan J.,
RA   Gharavi A.G., Goilav B., Lifton R.P.;
RT   "Mutations in kelch-like 3 and cullin 3 cause hypertension and
RT   electrolyte abnormalities.";
RL   Nature 482:98-102(2012).
RN   [57]
RP   VARIANT ARG-719.
RX   PubMed=25969726; DOI=10.1186/s13229-015-0017-0;
RA   Codina-Sola M., Rodriguez-Santiago B., Homs A., Santoyo J., Rigau M.,
RA   Aznar-Lain G., Del Campo M., Gener B., Gabau E., Botella M.P.,
RA   Gutierrez-Arumi A., Antinolo G., Perez-Jurado L.A., Cusco I.;
RT   "Integrated analysis of whole-exome sequencing and transcriptome
RT   profiling in males with autism spectrum disorders.";
RL   Mol. Autism 6:21-21(2015).
CC   -!- FUNCTION: Core component of multiple cullin-RING-based BCR (BTB-
CC       CUL3-RBX1) E3 ubiquitin-protein ligase complexes which mediate the
CC       ubiquitination and subsequent proteasomal degradation of target
CC       proteins. BCR complexes and ARIH1 collaborate in tandem to mediate
CC       ubiquitination of target proteins (PubMed:27565346). As a scaffold
CC       protein may contribute to catalysis through positioning of the
CC       substrate and the ubiquitin-conjugating enzyme. The E3 ubiquitin-
CC       protein ligase activity of the complex is dependent on the
CC       neddylation of the cullin subunit and is inhibited by the
CC       association of the deneddylated cullin subunit with TIP120A/CAND1.
CC       The functional specificity of the BCR complex depends on the BTB
CC       domain-containing protein as the substrate recognition component.
CC       BCR(KLHL42) is involved in ubiquitination of KATNA1. BCR(SPOP) is
CC       involved in ubiquitination of BMI1/PCGF4, BRMS1, H2AFY and DAXX,
CC       GLI2 and GLI3. Can also form a cullin-RING-based BCR (BTB-CUL3-
CC       RBX1) E3 ubiquitin-protein ligase complex containing homodimeric
CC       SPOPL or the heterodimer formed by SPOP and SPOPL; these complexes
CC       have lower ubiquitin ligase activity. BCR(KLHL9-KLHL13) controls
CC       the dynamic behavior of AURKB on mitotic chromosomes and thereby
CC       coordinates faithful mitotic progression and completion of
CC       cytokinesis. BCR(KLHL12) is involved in ER-Golgi transport by
CC       regulating the size of COPII coats, thereby playing a key role in
CC       collagen export, which is required for embryonic stem (ES) cells
CC       division: BCR(KLHL12) acts by mediating monoubiquitination of
CC       SEC31 (SEC31A or SEC31B) (PubMed:22358839, PubMed:27716508).
CC       BCR(KLHL3) acts as a regulator of ion transport in the distal
CC       nephron; by mediating ubiquitination of WNK4 (PubMed:23387299,
CC       PubMed:23453970, PubMed:23576762). The BCR(KLHL20) E3 ubiquitin
CC       ligase complex is involved in interferon response and anterograde
CC       Golgi to endosome transport: it mediates both ubiquitination
CC       leading to degradation and 'Lys-33'-linked ubiquitination
CC       (PubMed:20389280, PubMed:21840486, PubMed:21670212,
CC       PubMed:24768539). The BCR(KLHL21) E3 ubiquitin ligase complex
CC       regulates localization of the chromosomal passenger complex (CPC)
CC       from chromosomes to the spindle midzone in anaphase and mediates
CC       the ubiquitination of AURKB (PubMed:19995937). The BCR(KLHL22)
CC       ubiquitin ligase complex mediates monoubiquitination of PLK1,
CC       leading to PLK1 dissociation from phosphoreceptor proteins and
CC       subsequent removal from kinetochores, allowing silencing of the
CC       spindle assembly checkpoint (SAC) and chromosome segregation
CC       (PubMed:23455478). The BCR(KLHL25) ubiquitin ligase complex is
CC       involved in translational homeostasis by mediating ubiquitination
CC       and subsequent degradation of hypophosphorylated EIF4EBP1 (4E-BP1)
CC       (PubMed:22578813). The BCR(KBTBD8) complex acts by mediating
CC       monoubiquitination of NOLC1 and TCOF1, leading to remodel the
CC       translational program of differentiating cells in favor of neural
CC       crest specification (PubMed:26399832). Involved in ubiquitination
CC       of cyclin E and of cyclin D1 (in vitro) thus involved in
CC       regulation of G1/S transition. Involved in the ubiquitination of
CC       KEAP1, ENC1 and KLHL41. In concert with ATF2 and RBX1, promotes
CC       degradation of KAT5 thereby attenuating its ability to acetylate
CC       and activate ATM. The BCR(KCTD17) E3 ubiquitin ligase complex
CC       mediates ubiquitination and degradation of TCHP, a down-regulator
CC       of cilium assembly, thereby inducing ciliogenesis
CC       (PubMed:25270598). The BCR(KLHL24) E3 ubiquitin ligase complex
CC       mediates ubiquitination of KRT14, controls KRT14 levels during
CC       keratinocytes differentiation, and is essential for skin integrity
CC       (PubMed:27798626). {ECO:0000269|PubMed:10500095,
CC       ECO:0000269|PubMed:11311237, ECO:0000269|PubMed:15897469,
CC       ECO:0000269|PubMed:15983046, ECO:0000269|PubMed:16524876,
CC       ECO:0000269|PubMed:17543862, ECO:0000269|PubMed:18397884,
CC       ECO:0000269|PubMed:19261606, ECO:0000269|PubMed:19995937,
CC       ECO:0000269|PubMed:20389280, ECO:0000269|PubMed:21670212,
CC       ECO:0000269|PubMed:21840486, ECO:0000269|PubMed:22085717,
CC       ECO:0000269|PubMed:22358839, ECO:0000269|PubMed:22578813,
CC       ECO:0000269|PubMed:22632832, ECO:0000269|PubMed:23387299,
CC       ECO:0000269|PubMed:23453970, ECO:0000269|PubMed:23455478,
CC       ECO:0000269|PubMed:23576762, ECO:0000269|PubMed:24768539,
CC       ECO:0000269|PubMed:25270598, ECO:0000269|PubMed:26399832,
CC       ECO:0000269|PubMed:27565346, ECO:0000269|PubMed:27716508,
CC       ECO:0000269|PubMed:27798626}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Forms neddylation-dependent homodimers. Component of
CC       multiple BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complexes
CC       formed of CUL3, RBX1 and a variable BTB domain-containing protein
CC       acting as both, adapter to cullin and substrate recognition
CC       subunit. The BCR complex may be active as a heterodimeric complex,
CC       in which NEDD8, covalently attached to one CUL3 molecule, binds to
CC       the C-terminus of a second CUL3 molecule. Interacts with RBX1,
CC       RNF7, CYCE and TIP120A/CAND1. Part of the BCR(SPOP) containing
CC       SPOP, and of BCR containing homodimeric SPOPL or the heterodimer
CC       formed by SPOP and SPOPL. Part of the probable BCR(KLHL9-KLHL13)
CC       complex with BTB domain proteins KLHL9 and KLHL13. Part of the
CC       BCR(KLHL41) complex containing KLHL41. Component of the
CC       BCR(KLHL12) E3 ubiquitin ligase complex, at least composed of CUL3
CC       and KLHL12 and RBX1. Component of the BCR(KLHL3) E3 ubiquitin
CC       ligase complex, at least composed of CUL3 and KLHL3 and RBX1
CC       (Probable). Part of the BCR(ENC1) complex containing ENC1. Part of
CC       a complex consisting of BMI1/PCGF4, CUL3 and SPOP. Part of a
CC       complex consisting of BRMS1, CUL3 and SPOP. Component of the
CC       BCR(KLHL21) E3 ubiquitin ligase complex, at least composed of
CC       CUL3, KLHL21 and RBX1. Component of the BCR(KLHL22) E3 ubiquitin
CC       ligase complex, at least composed of CUL3, KLHL22 and RBX1.
CC       Component of the BCR(KLHL25) E3 ubiquitin ligase complex, at least
CC       composed of CUL3, KLHL25 and RBX1. Part of a complex consisting of
CC       H2AFY, CUL3 and SPOP. Component of the BCR(KLHL42) E3 ubiquitin
CC       ligase complex, at least composed of CUL3 and KLHL42. Interacts
CC       with KLHL42 (via the BTB domain). Interacts with KATNA1; the
CC       interaction is enhanced by KLHL42. Component of the BCR(KBTBD8) E3
CC       ubiquitin ligase complex, at least composed of CUL3, KBTBD8 and
CC       RBX1 (PubMed:26399832). Interacts with KCTD5, KLHL9, KLHL11,
CC       KLHL13, GAN, ZBTB16, KLHL3, KLHL15, KLHL20, KLHL36, GMCL2, BTBD1.
CC       Part of a complex that contains CUL3, RBX1 and GAN. Interacts (via
CC       BTB domain) with KLHL17; the interaction regulates surface GRIK2
CC       expression. Interacts with KCTD7. Part of the BCR(GAN) complex
CC       containing GAN. Part of the BCR(KEAP1) complex containing KEAP1.
CC       Interacts with KLHL10 (By similarity). Interacts with KAT5 and
CC       ATF2. Interacts with DCUN1D3. Interacts with KCTD17 in the
CC       BCR(KCTD17) E3 ubiquitin ligase complex, at least composed of
CC       CUL3, KCTD17 and RBX1 (PubMed:25270598). Interacts (when
CC       neddylated) with ARIH1; leading to activate the E3 ligase activity
CC       of ARIH1 (PubMed:24076655, PubMed:27565346). Interacts with COPS9
CC       isoform 2 (PubMed:23776465). Interacts with PPP2R5B; this
CC       interaction is indirect and mediated through KLHL15-binding and
CC       leads to PPP2R5B proteasomal degradation (PubMed:23135275).
CC       Interacts with RBBP8/CtIP; this interaction is indirect and
CC       mediated through KLHL15-binding and leads to RBBP8 proteasomal
CC       degradation (PubMed:27561354). Interacts with KLHL24 in the
CC       BCR(KLHL24) E3 ubiquitin ligase complex, composed of CUL3, RBX1
CC       and KLHL24 (PubMed:27798626). {ECO:0000250,
CC       ECO:0000269|PubMed:10230407, ECO:0000269|PubMed:10500095,
CC       ECO:0000269|PubMed:12609982, ECO:0000269|PubMed:14528312,
CC       ECO:0000269|PubMed:15897469, ECO:0000269|PubMed:15983046,
CC       ECO:0000269|PubMed:16524876, ECO:0000269|PubMed:17543862,
CC       ECO:0000269|PubMed:18397884, ECO:0000269|PubMed:18573101,
CC       ECO:0000269|PubMed:19261606, ECO:0000269|PubMed:19995937,
CC       ECO:0000269|PubMed:20389280, ECO:0000269|PubMed:21670212,
CC       ECO:0000269|PubMed:21840486, ECO:0000269|PubMed:22085717,
CC       ECO:0000269|PubMed:22358839, ECO:0000269|PubMed:22578813,
CC       ECO:0000269|PubMed:22632832, ECO:0000269|PubMed:22748208,
CC       ECO:0000269|PubMed:23135275, ECO:0000269|PubMed:23349464,
CC       ECO:0000269|PubMed:23387299, ECO:0000269|PubMed:23453970,
CC       ECO:0000269|PubMed:23455478, ECO:0000269|PubMed:23573258,
CC       ECO:0000269|PubMed:23576762, ECO:0000269|PubMed:23776465,
CC       ECO:0000269|PubMed:24076655, ECO:0000269|PubMed:24768539,
CC       ECO:0000269|PubMed:25270598, ECO:0000269|PubMed:25349211,
CC       ECO:0000269|PubMed:26399832, ECO:0000269|PubMed:27561354,
CC       ECO:0000269|PubMed:27565346, ECO:0000269|PubMed:27798626,
CC       ECO:0000305}.
CC   -!- INTERACTION:
CC       Q969K4:ABTB1; NbExp=3; IntAct=EBI-456129, EBI-7223971;
CC       Q86VP6:CAND1; NbExp=2; IntAct=EBI-456129, EBI-456077;
CC       Q14790:CASP8; NbExp=6; IntAct=EBI-456129, EBI-78060;
CC       O60826:CCDC22; NbExp=2; IntAct=EBI-456129, EBI-3943153;
CC       Q8IWE4:DCUN1D3; NbExp=3; IntAct=EBI-15794202, EBI-15794102;
CC       Q53SE7:FLJ13057; NbExp=3; IntAct=EBI-456129, EBI-10172181;
CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-456129, EBI-352572;
CC       Q8WZ19:KCTD13; NbExp=5; IntAct=EBI-456129, EBI-742916;
CC       Q8NC69:KCTD6; NbExp=6; IntAct=EBI-456129, EBI-2511344;
CC       Q7L273:KCTD9; NbExp=5; IntAct=EBI-456129, EBI-4397613;
CC       Q53G59:KLHL12; NbExp=5; IntAct=EBI-456129, EBI-740929;
CC       O95198:KLHL2; NbExp=3; IntAct=EBI-456129, EBI-746999;
CC       Q9Y2M5:KLHL20; NbExp=2; IntAct=EBI-456129, EBI-714379;
CC       Q8N4I8:KLHL3; NbExp=3; IntAct=EBI-456129, EBI-10230467;
CC       Q9UH77:KLHL3; NbExp=3; IntAct=EBI-456129, EBI-8524663;
CC       Q8IXQ5:KLHL7; NbExp=7; IntAct=EBI-456129, EBI-6153160;
CC       Q8TBC3:SHKBP1; NbExp=5; IntAct=EBI-456129, EBI-724292;
CC       O43791:SPOP; NbExp=2; IntAct=EBI-456129, EBI-743549;
CC       Q13829:TNFAIP1; NbExp=3; IntAct=EBI-456129, EBI-2505861;
CC       P50591:TNFSF10; NbExp=2; IntAct=EBI-456129, EBI-495373;
CC       O94888:UBXN7; NbExp=6; IntAct=EBI-456129, EBI-1993627;
CC       Q9H898:ZMAT4; NbExp=3; IntAct=EBI-456129, EBI-2548542;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10500095,
CC       ECO:0000269|PubMed:22085717}. Golgi apparatus
CC       {ECO:0000269|PubMed:10500095}. Cell projection, cilium, flagellum
CC       {ECO:0000269|PubMed:28395323}. Cytoplasm. Note=Detected along the
CC       length of the sperm flagellum and in the cytoplasm of the germ
CC       cells. {ECO:0000269|PubMed:28395323}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Cul-3 Long;
CC         IsoId=Q13618-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13618-2; Sequence=VSP_008824;
CC       Name=3; Synonyms=Cul-3 Short;
CC         IsoId=Q13618-3; Sequence=VSP_008825;
CC   -!- TISSUE SPECIFICITY: Brain, spermatozoa, and testis (at protein
CC       level). Widely expressed. {ECO:0000269|PubMed:28395323}.
CC   -!- PTM: Neddylated. Attachment of NEDD8 is required for the E3
CC       ubiquitin-protein ligase activity of the BCR complex. Deneddylated
CC       via its interaction with the COP9 signalosome (CSN) complex.
CC       {ECO:0000269|PubMed:10500095, ECO:0000269|PubMed:10597293,
CC       ECO:0000269|PubMed:24076655, ECO:0000269|PubMed:27565346}.
CC   -!- DISEASE: Pseudohypoaldosteronism 2E (PHA2E) [MIM:614496]: An
CC       autosomal dominant disorder characterized by severe hypertension,
CC       hyperkalemia, hyperchloremia, hyperchloremic metabolic acidosis,
CC       and correction of physiologic abnormalities by thiazide diuretics.
CC       {ECO:0000269|PubMed:22266938}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cullin family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00330}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC28621.1; Type=Frameshift; Positions=452; Evidence={ECO:0000305};
CC       Sequence=AAC36682.1; Type=Frameshift; Positions=159, 179; Evidence={ECO:0000305};
CC       Sequence=BAA31592.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF064087; AAC36304.1; -; mRNA.
DR   EMBL; AB014517; BAA31592.2; ALT_INIT; mRNA.
DR   EMBL; AF062537; AAC36682.1; ALT_FRAME; mRNA.
DR   EMBL; AY337761; AAQ01660.1; -; mRNA.
DR   EMBL; AK291151; BAF83840.1; -; mRNA.
DR   EMBL; AC073052; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092679; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471063; EAW70828.1; -; Genomic_DNA.
DR   EMBL; BC031844; AAH31844.1; -; mRNA.
DR   EMBL; BC039598; AAH39598.1; -; mRNA.
DR   EMBL; BC092409; AAH92409.1; -; mRNA.
DR   EMBL; U58089; AAC50546.1; -; mRNA.
DR   EMBL; AF052147; AAC28621.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS2462.1; -. [Q13618-1]
DR   CCDS; CCDS58751.1; -. [Q13618-3]
DR   RefSeq; NP_001244126.1; NM_001257197.1. [Q13618-3]
DR   RefSeq; NP_001244127.1; NM_001257198.1.
DR   RefSeq; NP_003581.1; NM_003590.4. [Q13618-1]
DR   UniGene; Hs.372286; -.
DR   PDB; 2MYL; NMR; -; A=49-68.
DR   PDB; 2MYM; NMR; -; A=49-68.
DR   PDB; 4AP2; X-ray; 2.80 A; B=1-388.
DR   PDB; 4APF; X-ray; 3.10 A; B=23-388.
DR   PDB; 4EOZ; X-ray; 2.40 A; B/D=20-381.
DR   PDB; 4HXI; X-ray; 3.51 A; B=20-381.
DR   PDB; 5NLB; X-ray; 3.45 A; B=26-381.
DR   PDBsum; 2MYL; -.
DR   PDBsum; 2MYM; -.
DR   PDBsum; 4AP2; -.
DR   PDBsum; 4APF; -.
DR   PDBsum; 4EOZ; -.
DR   PDBsum; 4HXI; -.
DR   PDBsum; 5NLB; -.
DR   ProteinModelPortal; Q13618; -.
DR   SMR; Q13618; -.
DR   BioGrid; 114030; 1218.
DR   CORUM; Q13618; -.
DR   DIP; DIP-31611N; -.
DR   IntAct; Q13618; 71.
DR   MINT; Q13618; -.
DR   STRING; 9606.ENSP00000264414; -.
DR   iPTMnet; Q13618; -.
DR   PhosphoSitePlus; Q13618; -.
DR   BioMuta; CUL3; -.
DR   DMDM; 12643396; -.
DR   EPD; Q13618; -.
DR   MaxQB; Q13618; -.
DR   PaxDb; Q13618; -.
DR   PeptideAtlas; Q13618; -.
DR   PRIDE; Q13618; -.
DR   Ensembl; ENST00000264414; ENSP00000264414; ENSG00000036257. [Q13618-1]
DR   Ensembl; ENST00000344951; ENSP00000343601; ENSG00000036257. [Q13618-3]
DR   Ensembl; ENST00000409096; ENSP00000387200; ENSG00000036257. [Q13618-2]
DR   Ensembl; ENST00000409777; ENSP00000386525; ENSG00000036257. [Q13618-2]
DR   GeneID; 8452; -.
DR   KEGG; hsa:8452; -.
DR   UCSC; uc002vny.4; human. [Q13618-1]
DR   CTD; 8452; -.
DR   DisGeNET; 8452; -.
DR   EuPathDB; HostDB:ENSG00000036257.12; -.
DR   GeneCards; CUL3; -.
DR   HGNC; HGNC:2553; CUL3.
DR   HPA; CAB002678; -.
DR   MalaCards; CUL3; -.
DR   MIM; 603136; gene.
DR   MIM; 614496; phenotype.
DR   neXtProt; NX_Q13618; -.
DR   OpenTargets; ENSG00000036257; -.
DR   Orphanet; 300530; Pseudohypoaldosteronism type 2E.
DR   PharmGKB; PA27049; -.
DR   eggNOG; KOG2167; Eukaryota.
DR   eggNOG; COG5647; LUCA.
DR   GeneTree; ENSGT00760000119212; -.
DR   HOVERGEN; HBG003619; -.
DR   InParanoid; Q13618; -.
DR   KO; K03869; -.
DR   OMA; TSTFWPM; -.
DR   OrthoDB; EOG091G02DP; -.
DR   PhylomeDB; Q13618; -.
DR   TreeFam; TF105858; -.
DR   BRENDA; 6.3.2.19; 2681.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q13618; -.
DR   SIGNOR; Q13618; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; CUL3; human.
DR   GeneWiki; CUL3; -.
DR   GenomeRNAi; 8452; -.
DR   PRO; PR:Q13618; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000036257; -.
DR   CleanEx; HS_CUL3; -.
DR   ExpressionAtlas; Q13618; baseline and differential.
DR   Genevisible; Q13618; HS.
DR   GO; GO:0031463; C:Cul3-RING ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:GOC.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005827; C:polar microtubule; IDA:UniProtKB.
DR   GO; GO:0036126; C:sperm flagellum; IDA:UniProtKB.
DR   GO; GO:0030332; F:cyclin binding; IEA:Ensembl.
DR   GO; GO:0005112; F:Notch binding; IPI:MGI.
DR   GO; GO:0031208; F:POZ domain binding; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IBA:GO_Central.
DR   GO; GO:0031145; P:anaphase-promoting complex-dependent catabolic process; IDA:MGI.
DR   GO; GO:0007050; P:cell cycle arrest; TAS:ProtInc.
DR   GO; GO:0016477; P:cell migration; IMP:UniProtKB.
DR   GO; GO:0030030; P:cell projection organization; IEA:UniProtKB-KW.
DR   GO; GO:0048208; P:COPII vesicle coating; IMP:UniProtKB.
DR   GO; GO:0040016; P:embryonic cleavage; ISS:UniProtKB.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; IDA:UniProtKB.
DR   GO; GO:0044346; P:fibroblast apoptotic process; IEA:Ensembl.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:ProtInc.
DR   GO; GO:0007369; P:gastrulation; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:ProtInc.
DR   GO; GO:0072576; P:liver morphogenesis; IEA:Ensembl.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0007080; P:mitotic metaphase plate congression; IMP:UniProtKB.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; TAS:Reactome.
DR   GO; GO:0035024; P:negative regulation of Rho protein signal transduction; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0071630; P:nuclear protein quality control by the ubiquitin-proteasome system; IDA:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB.
DR   GO; GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; IMP:UniProtKB.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; IGI:BHF-UCL.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0031648; P:protein destabilization; IGI:BHF-UCL.
DR   GO; GO:0006513; P:protein monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0017145; P:stem cell division; ISS:UniProtKB.
DR   GO; GO:0043149; P:stress fiber assembly; IMP:UniProtKB.
DR   GO; GO:0001831; P:trophectodermal cellular morphogenesis; IEA:Ensembl.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:Ensembl.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR016157; Cullin_CS.
DR   InterPro; IPR016158; Cullin_homology.
DR   InterPro; IPR036317; Cullin_homology_sf.
DR   InterPro; IPR001373; Cullin_N.
DR   InterPro; IPR019559; Cullin_neddylation_domain.
DR   InterPro; IPR016159; Cullin_repeat-like_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00888; Cullin; 1.
DR   Pfam; PF10557; Cullin_Nedd8; 1.
DR   SMART; SM00182; CULLIN; 1.
DR   SMART; SM00884; Cullin_Nedd8; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF74788; SSF74788; 1.
DR   SUPFAM; SSF75632; SSF75632; 1.
DR   PROSITE; PS01256; CULLIN_1; 1.
DR   PROSITE; PS50069; CULLIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell projection;
KW   Cilium; Cilium biogenesis/degradation; Complete proteome; Cytoplasm;
KW   Disease mutation; ER-Golgi transport; Flagellum; Golgi apparatus;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transport; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    768       Cullin-3.
FT                                /FTId=PRO_0000119793.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     585    585       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    712    712       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in NEDD8).
FT                                {ECO:0000250|UniProtKB:Q13616}.
FT   VAR_SEQ       1     24       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_008824.
FT   VAR_SEQ      23     88       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_008825.
FT   VARIANT      13     13       D -> H (in dbSNP:rs2969802).
FT                                /FTId=VAR_017194.
FT   VARIANT     184    184       R -> S (in dbSNP:rs17480168).
FT                                /FTId=VAR_048839.
FT   VARIANT     413    413       D -> G (in PHA2E; dbSNP:rs199469656).
FT                                {ECO:0000269|PubMed:22266938}.
FT                                /FTId=VAR_067532.
FT   VARIANT     459    459       K -> R (in PHA2E; dbSNP:rs199469658).
FT                                {ECO:0000269|PubMed:22266938}.
FT                                /FTId=VAR_067533.
FT   VARIANT     567    567       V -> I (in dbSNP:rs3738952).
FT                                /FTId=VAR_017195.
FT   VARIANT     719    719       H -> R (found in a patient with autism
FT                                spectrum disorder; unknown pathological
FT                                significance; dbSNP:rs763087632).
FT                                {ECO:0000269|PubMed:25969726}.
FT                                /FTId=VAR_078688.
FT   CONFLICT     13     13       D -> G (in Ref. 3; AAC36682).
FT                                {ECO:0000305}.
FT   CONFLICT    397    397       K -> T (in Ref. 4; AAQ01660).
FT                                {ECO:0000305}.
FT   CONFLICT    481    481       N -> T (in Ref. 4; AAQ01660).
FT                                {ECO:0000305}.
FT   CONFLICT    609    609       E -> G (in Ref. 8; AAH31844).
FT                                {ECO:0000305}.
FT   CONFLICT    666    666       T -> I (in Ref. 4; AAQ01660).
FT                                {ECO:0000305}.
FT   HELIX        26     45       {ECO:0000244|PDB:4EOZ}.
FT   HELIX        49     51       {ECO:0000244|PDB:4EOZ}.
FT   HELIX        54     66       {ECO:0000244|PDB:4EOZ}.
FT   HELIX        70     87       {ECO:0000244|PDB:4EOZ}.
FT   HELIX        89     94       {ECO:0000244|PDB:4EOZ}.
FT   TURN         95     98       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       101    122       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       124    129       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       132    134       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       139    150       {ECO:0000244|PDB:4EOZ}.
FT   TURN        151    153       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       155    173       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       180    192       {ECO:0000244|PDB:4EOZ}.
FT   STRAND      195    198       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       199    204       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       206    227       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       230    251       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       254    256       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       257    268       {ECO:0000244|PDB:4EOZ}.
FT   TURN        269    272       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       273    277       {ECO:0000244|PDB:4EOZ}.
FT   TURN        280    282       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       284    287       {ECO:0000244|PDB:4EOZ}.
FT   TURN        288    291       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       293    303       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       309    323       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       339    358       {ECO:0000244|PDB:4AP2}.
FT   HELIX       364    380       {ECO:0000244|PDB:4AP2}.
SQ   SEQUENCE   768 AA;  88930 MW;  A1A02022480BF099 CRC64;
     MSNLSKGTGS RKDTKMRIRA FPMTMDEKYV NSIWDLLKNA IQEIQRKNNS GLSFEELYRN
     AYTMVLHKHG EKLYTGLREV VTEHLINKVR EDVLNSLNNN FLQTLNQAWN DHQTAMVMIR
     DILMYMDRVY VQQNNVENVY NLGLIIFRDQ VVRYGCIRDH LRQTLLDMIA RERKGEVVDR
     GAIRNACQML MILGLEGRSV YEEDFEAPFL EMSAEFFQME SQKFLAENSA SVYIKKVEAR
     INEEIERVMH CLDKSTEEPI VKVVERELIS KHMKTIVEME NSGLVHMLKN GKTEDLGCMY
     KLFSRVPNGL KTMCECMSSY LREQGKALVS EEGEGKNPVD YIQGLLDLKS RFDRFLLESF
     NNDRLFKQTI AGDFEYFLNL NSRSPEYLSL FIDDKLKKGV KGLTEQEVET ILDKAMVLFR
     FMQEKDVFER YYKQHLARRL LTNKSVSDDS EKNMISKLKT ECGCQFTSKL EGMFRDMSIS
     NTTMDEFRQH LQATGVSLGG VDLTVRVLTT GYWPTQSATP KCNIPPAPRH AFEIFRRFYL
     AKHSGRQLTL QHHMGSADLN ATFYGPVKKE DGSEVGVGGA QVTGSNTRKH ILQVSTFQMT
     ILMLFNNREK YTFEEIQQET DIPERELVRA LQSLACGKPT QRVLTKEPKS KEIENGHIFT
     VNDQFTSKLH RVKIQTVAAK QGESDPERKE TRQKVDDDRK HEIEAAIVRI MKSRKKMQHN
     VLVAEVTQQL KARFLPSPVV IKKRIEGLIE REYLARTPED RKVYTYVA
//
ID   A8K6A7_HUMAN            Unreviewed;      1011 AA.
AC   A8K6A7;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   28-FEB-2018, entry version 61.
DE   RecName: Full=Alpha-mannosidase {ECO:0000256|RuleBase:RU361199};
DE            EC=3.2.1.- {ECO:0000256|RuleBase:RU361199};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF84261.1};
RN   [1] {ECO:0000313|EMBL:BAF84261.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAF84261.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000256|RuleBase:RU361199};
CC       Note=Binds 1 zinc ion per subunit.
CC       {ECO:0000256|RuleBase:RU361199};
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 38 family.
CC       {ECO:0000256|RuleBase:RU361199}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK291572; BAF84261.1; -; mRNA.
DR   RefSeq; NP_001166969.1; NM_001173498.1.
DR   UniGene; Hs.356769; -.
DR   UniGene; Hs.657204; -.
DR   PeptideAtlas; A8K6A7; -.
DR   PRIDE; A8K6A7; -.
DR   DNASU; 4125; -.
DR   GeneID; 4125; -.
DR   CTD; 4125; -.
DR   PharmGKB; PA30575; -.
DR   eggNOG; KOG1959; Eukaryota.
DR   eggNOG; ENOG410XQMZ; LUCA.
DR   HOVERGEN; HBG052391; -.
DR   GenomeRNAi; 4125; -.
DR   Genevisible; A8K6A7; HS.
DR   GO; GO:0004559; F:alpha-mannosidase activity; IEA:InterPro.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006013; P:mannose metabolic process; IEA:InterPro.
DR   Gene3D; 1.20.1270.50; -; 2.
DR   Gene3D; 2.60.40.1180; -; 1.
DR   Gene3D; 3.20.110.10; -; 1.
DR   InterPro; IPR011013; Gal_mutarotase_sf_dom.
DR   InterPro; IPR011330; Glyco_hydro/deAcase_b/a-brl.
DR   InterPro; IPR011682; Glyco_hydro_38_C.
DR   InterPro; IPR015341; Glyco_hydro_38_cen.
DR   InterPro; IPR037094; Glyco_hydro_38_cen_sf.
DR   InterPro; IPR000602; Glyco_hydro_38_N.
DR   InterPro; IPR027291; Glyco_hydro_38_N_sf.
DR   InterPro; IPR028995; Glyco_hydro_57/38_cen_sf.
DR   InterPro; IPR013780; Glyco_hydro_b.
DR   Pfam; PF09261; Alpha-mann_mid; 1.
DR   Pfam; PF01074; Glyco_hydro_38; 1.
DR   Pfam; PF07748; Glyco_hydro_38C; 1.
DR   SMART; SM00872; Alpha-mann_mid; 1.
DR   SUPFAM; SSF74650; SSF74650; 1.
DR   SUPFAM; SSF88688; SSF88688; 1.
DR   SUPFAM; SSF88713; SSF88713; 1.
PE   2: Evidence at transcript level;
KW   Glycosidase {ECO:0000256|RuleBase:RU361199};
KW   Hydrolase {ECO:0000256|RuleBase:RU361199};
KW   Metal-binding {ECO:0000256|RuleBase:RU361199};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Zinc {ECO:0000256|RuleBase:RU361199}.
FT   SIGNAL        1     49       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        50   1011       Alpha-mannosidase.
FT                                {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002724659.
FT   DOMAIN      386    465       Alpha-mann_mid.
FT                                {ECO:0000259|SMART:SM00872}.
SQ   SEQUENCE   1011 AA;  113792 MW;  1B4C73D4DCDBD33C CRC64;
     MGAYARASGV CARGCLDSAG PWTMSRALRP PLPPLCFFLL LLAAAGARAG GYETCPTVQP
     NMLNVHLLPH THDDVGWLKT VDQYFYGIKN DIQHAGVQYI LDSVISALLA DPTRRFIYVE
     IAFFSRWWHQ QTNATQEVVR DLVRQGRLEF ANGGWVMNDE AATHYGAIVD QMTLGLRFLE
     DTFGNDGRPR VAWHIDPFGH SREQASLFAQ MGFDGFFFGR LDYQDKWVRM QKLEMEQVWR
     ASTSLKPPTA DLFTGVLPNG YNPPRNLCWD VLCVDQPLVE DPRSPEYNAK ELVDYFLNVA
     TAQGRYYRTN HTVMTMGSDF QYENANMWFK NLDKLIRLVN AQQAKGSSVH VLYSTPACYL
     WELNKANLTW SVKHDDFFPY ADGPHQFWTG YFSSRPALKR YERLSYNFLQ VCNQLEALVG
     LAANVGPYGS GDSAPLNEAM AVLQHHDAVS GTSRQHVAND YARQLAAGWG PCEVLLSNAL
     ARLRGFKDHF TFCQQLNISI CPLSQTAARF QVIVYNPLGR KVNWMVRLPV SEGVFVVKDP
     NGRTVPSDVV IFPSSDSQAH PPELLFSASL PALGFSTYSV AQVPRWKPQA RAPQPIPRRS
     WSPALTIENE HIRATFDPDT GLLMEIMNMN QQLLLPVRQT FFWYNASIGD NESDQASGAY
     IFRPNQQKPL PVSRWAQIHL VKTPLVQEVH QNFSAWCSQV VRLYPGQRHL ELEWSVGPIP
     VGDTWGKEFI SRFDTPLETK GRFYTDSNGR EILERRRDYR PTWKLNQTEP VAGNYYPVNT
     RIYITDGNMQ LTVLTDRSQG GSSLRDGSLE LMVHRRLLKD DGRGVSEPLM ENGSGAWVRG
     RHLVLLDTAQ AAAAGHRLLA EQEVLAPQVV LAPGGGAAYN LGAPPRTQFS GLRRDLPPSV
     HLLTLASWGP EMVLLRLEHQ FAVGEDSGRN LSAPVTLNLR DLFSTFTITR LQETTLVANQ
     LREAASRLKW TTNTGPTPHQ TPYQLDPANI TLEPMEIRTF LASVQWKEVD G
//
ID   MA2B1_HUMAN             Reviewed;        1011 AA.
AC   O00754; G5E928; O15330; Q16680; Q93094; Q9BW13;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   31-OCT-2006, sequence version 3.
DT   23-MAY-2018, entry version 189.
DE   RecName: Full=Lysosomal alpha-mannosidase;
DE            Short=Laman;
DE            EC=3.2.1.24;
DE   AltName: Full=Lysosomal acid alpha-mannosidase;
DE   AltName: Full=Mannosidase alpha class 2B member 1;
DE   AltName: Full=Mannosidase alpha-B;
DE   Contains:
DE     RecName: Full=Lysosomal alpha-mannosidase A peptide;
DE   Contains:
DE     RecName: Full=Lysosomal alpha-mannosidase B peptide;
DE   Contains:
DE     RecName: Full=Lysosomal alpha-mannosidase C peptide;
DE   Contains:
DE     RecName: Full=Lysosomal alpha-mannosidase D peptide;
DE   Contains:
DE     RecName: Full=Lysosomal alpha-mannosidase E peptide;
DE   Flags: Precursor;
GN   Name=MAN2B1; Synonyms=LAMAN, MANB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8166692; DOI=10.1006/bbrc.1994.1440;
RA   Nebes V.L., Schmidt M.C.;
RT   "Human lysosomal alpha-mannosidase: isolation and nucleotide sequence
RT   of the full-length cDNA.";
RL   Biochem. Biophys. Res. Commun. 200:239-245(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE, AND
RP   VARIANT MANSA LEU-72.
RC   TISSUE=Lung, and Skin;
RX   PubMed=9158146; DOI=10.1093/hmg/6.5.717;
RA   Nilssen O., Berg T., Riise H.M.F., Ramachandran U., Evjen G.,
RA   Hansen G.M., Malm D., Tranebjaerg L., Tollersrud O.-K.;
RT   "Alpha-mannosidosis: functional cloning of the lysosomal alpha-
RT   mannosidase cDNA and identification of a mutation in two affected
RT   siblings.";
RL   Hum. Mol. Genet. 6:717-726(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=9192839; DOI=10.1006/geno.1997.4668;
RA   Riise H.M.F., Berg T., Nilssen O., Romeo G., Tollersrud O.-K.,
RA   Ceccherini I.;
RT   "Genomic structure of the human lysosomal alpha-mannosidase gene
RT   (MANB).";
RL   Genomics 42:200-207(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-1010 (ISOFORM 1).
RC   TISSUE=Spleen;
RX   PubMed=8910458; DOI=10.1074/jbc.271.45.28348;
RA   Liao Y.-F., Lal A., Moremen K.W.;
RT   "Cloning, expression, purification, and characterization of the human
RT   broad specificity lysosomal acid alpha-mannosidase.";
RL   J. Biol. Chem. 271:28348-28358(1996).
RN   [8]
RP   PARTIAL PROTEIN SEQUENCE.
RX   PubMed=7832746; DOI=10.1042/bj3050363;
RA   Emiliani C., Martino S., Stirling J.L., Maras B., Orlacchio A.;
RT   "Partial sequence of the purified protein confirms the identity of
RT   cDNA coding for human lysosomal alpha-mannosidase B.";
RL   Biochem. J. 305:363-366(1995).
RN   [9]
RP   GLYCOSYLATION AT ASN-930.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-367 AND ASN-766.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   VARIANTS MANSA LEU-72; ARG-356 AND TRP-750.
RX   PubMed=9758606; DOI=10.1086/302048;
RA   Gotoda Y., Wakamatsu N., Kawai H., Nishida Y., Matsumoto T.;
RT   "Missense and nonsense mutations in the lysosomal alpha-mannosidase
RT   gene (MANB) in severe and mild forms of alpha-mannosidosis.";
RL   Am. J. Hum. Genet. 63:1015-1024(1998).
RN   [15]
RP   VARIANTS MANSA PRO-355; LYS-402; ARG-714 AND PRO-809, AND VARIANTS
RP   VAL-278; ILE-312; GLN-337 AND SER-413.
RX   PubMed=9915946; DOI=10.1086/302183;
RA   Berg T., Riise H.M.F., Hansen G.M., Malm D., Tranebjaerg L.,
RA   Tollersrud O.-K., Nilssen O.;
RT   "Spectrum of mutations in alpha-mannosidosis.";
RL   Am. J. Hum. Genet. 64:77-88(1999).
RN   [16]
RP   VARIANT MANSA TYR-453.
RX   PubMed=12718372;
RA   Oelmez A., Nilssen O., Coskun T., Klenow H.;
RT   "Alpha-mannosidosis and mutational analysis in a Turkish patient.";
RL   Turk. J. Pediatr. 45:46-50(2003).
RN   [17]
RP   VARIANTS MANSA LEU-200 AND ASP-801, AND CHARACTERIZATION OF VARIANTS
RP   MANSA LEU-200 AND ASP-801.
RX   PubMed=15712269; DOI=10.1002/humu.9310;
RA   Sbaragli M., Bibi L., Pittis M.G., Balducci C., Heikinheimo P.,
RA   Ricci R., Antuzzi D., Parini R., Spaccini L., Bembi B., Beccari T.;
RT   "Identification and characterization of five novel MAN2B1 mutations in
RT   Italian patients with alpha-mannosidosis.";
RL   Hum. Mutat. 25:320-320(2005).
RN   [18]
RP   VARIANTS MANSA PHE-55; GLU-74; PRO-95; HIS-99; ASN-159; ARG-197;
RP   ASN-200; LEU-200; PRO-202; TRP-229; LEU-263; LEU-318; 339-VAL--GLN-342
RP   DEL; PRO-352; LEU-379; CYS-390; LYS-402; VAL-420; TYR-445; CYS-451;
RP   TYR-453; PHE-453; GLU-457; SER-501; PRO-565; ARG-745; ARG-800;
RP   TRP-800; HIS-ARG-815 INS; ARG-891; PRO-892; CYS-916; HIS-916; PRO-950;
RP   ARG-956 AND SER-1000, VARIANTS LEU-248; VAL-278; SER-282; ILE-312;
RP   GLN-337; SER-413; SER-481 AND LEU-669, AND CHARACTERIZATION OF
RP   VARIANTS MANSA PHE-55; GLU-74; PRO-95; HIS-99; ASN-159; ARG-197;
RP   ASN-200; LEU-200; PRO-202; TRP-229; LEU-263; LEU-318; PRO-352;
RP   LEU-379; CYS-390; LYS-402; VAL-420; TYR-445; CYS-451; TYR-453;
RP   PHE-453; GLU-457; SER-501; PRO-565; ARG-745; ARG-800; TRP-800;
RP   HIS-ARG-815 INS; ARG-891; PRO-892; CYS-916; HIS-916; PRO-950; ARG-956
RP   AND SER-1000.
RX   PubMed=22161967; DOI=10.1002/humu.22005;
RA   Riise Stensland H.M., Klenow H.B., Van Nguyen L., Hansen G.M.,
RA   Malm D., Nilssen O.;
RT   "Identification of 83 novel alpha-mannosidosis-associated sequence
RT   variants: functional analysis of MAN2B1 missense mutations.";
RL   Hum. Mutat. 33:511-520(2012).
CC   -!- FUNCTION: Necessary for the catabolism of N-linked carbohydrates
CC       released during glycoprotein turnover. Cleaves all known types of
CC       alpha-mannosidic linkages.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of terminal, non-reducing alpha-D-
CC       mannose residues in alpha-D-mannosides.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O00754-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00754-2; Sequence=VSP_047391;
CC         Note=Gene prediction based on EST data.;
CC   -!- PTM: First processed into 3 peptides of 70 kDa, 42 kDa (D) and
CC       13/15 kDa (E). The 70 kDa peptide is further processed into three
CC       peptides (A, B and C). The A, B and C peptides are disulfide-
CC       linked.
CC   -!- PTM: Heavily glycosylated. {ECO:0000269|PubMed:12754519,
CC       ECO:0000269|PubMed:19159218}.
CC   -!- DISEASE: Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]: A
CC       lysosomal storage disease characterized by accumulation of
CC       unbranched oligosaccharide chains. This accumulation is expressed
CC       histologically as cytoplasmic vacuolation predominantly in the CNS
CC       and parenchymatous organs. Depending on the clinical findings at
CC       the age of onset, a severe infantile (type I) and a mild juvenile
CC       (type II) form of alpha-mannosidosis are recognized. There is
CC       considerable variation in the clinical expression with mental
CC       retardation, recurrent infections, impaired hearing and Hurler-
CC       like skeletal changes being the most consistent abnormalities.
CC       {ECO:0000269|PubMed:12718372, ECO:0000269|PubMed:15712269,
CC       ECO:0000269|PubMed:22161967, ECO:0000269|PubMed:9158146,
CC       ECO:0000269|PubMed:9758606, ECO:0000269|PubMed:9915946}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 38 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB03816.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAC50812.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Mendelian genes mannosidase, alpha, class 2B,
CC       member 1 (MAN2B1); Note=Leiden Open Variation Database (LOVD);
CC       URL="http://www.lovd.nl/MAN2B1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U05572; AAB03816.1; ALT_INIT; mRNA.
DR   EMBL; U60266; AAC34130.1; -; mRNA.
DR   EMBL; U60899; AAC51362.1; -; Genomic_DNA.
DR   EMBL; U60885; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60886; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60887; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60888; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60889; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60890; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60891; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60892; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60893; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60894; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60895; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60896; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60897; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60898; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; AC010422; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471106; EAW84279.1; -; Genomic_DNA.
DR   EMBL; BC000736; AAH00736.1; -; mRNA.
DR   EMBL; U68567; AAC50812.1; ALT_INIT; mRNA.
DR   CCDS; CCDS32919.1; -. [O00754-1]
DR   CCDS; CCDS54224.1; -. [O00754-2]
DR   RefSeq; NP_000519.2; NM_000528.3. [O00754-1]
DR   RefSeq; NP_001166969.1; NM_001173498.1. [O00754-2]
DR   UniGene; Hs.356769; -.
DR   UniGene; Hs.657204; -.
DR   ProteinModelPortal; O00754; -.
DR   BioGrid; 110298; 17.
DR   IntAct; O00754; 2.
DR   MINT; O00754; -.
DR   STRING; 9606.ENSP00000395473; -.
DR   BindingDB; O00754; -.
DR   ChEMBL; CHEMBL4059; -.
DR   CAZy; GH38; Glycoside Hydrolase Family 38.
DR   GlyConnect; 775; -.
DR   iPTMnet; O00754; -.
DR   PhosphoSitePlus; O00754; -.
DR   UniCarbKB; O00754; -.
DR   BioMuta; MAN2B1; -.
DR   EPD; O00754; -.
DR   MaxQB; O00754; -.
DR   PaxDb; O00754; -.
DR   PeptideAtlas; O00754; -.
DR   PRIDE; O00754; -.
DR   DNASU; 4125; -.
DR   Ensembl; ENST00000221363; ENSP00000221363; ENSG00000104774. [O00754-2]
DR   Ensembl; ENST00000456935; ENSP00000395473; ENSG00000104774. [O00754-1]
DR   GeneID; 4125; -.
DR   KEGG; hsa:4125; -.
DR   UCSC; uc002mub.3; human. [O00754-1]
DR   CTD; 4125; -.
DR   DisGeNET; 4125; -.
DR   EuPathDB; HostDB:ENSG00000104774.12; -.
DR   GeneCards; MAN2B1; -.
DR   GeneReviews; MAN2B1; -.
DR   HGNC; HGNC:6826; MAN2B1.
DR   HPA; HPA041530; -.
DR   HPA; HPA053404; -.
DR   MalaCards; MAN2B1; -.
DR   MIM; 248500; phenotype.
DR   MIM; 609458; gene.
DR   neXtProt; NX_O00754; -.
DR   OpenTargets; ENSG00000104774; -.
DR   Orphanet; 309288; Alpha-mannosidosis, adult form.
DR   Orphanet; 309282; Alpha-mannosidosis, infantile form.
DR   PharmGKB; PA30575; -.
DR   eggNOG; KOG1959; Eukaryota.
DR   eggNOG; ENOG410XQMZ; LUCA.
DR   GeneTree; ENSGT00510000046304; -.
DR   HOGENOM; HOG000007676; -.
DR   HOVERGEN; HBG052391; -.
DR   InParanoid; O00754; -.
DR   KO; K12311; -.
DR   OMA; MWYKNLD; -.
DR   OrthoDB; EOG091G02IS; -.
DR   PhylomeDB; O00754; -.
DR   TreeFam; TF313840; -.
DR   BRENDA; 3.2.1.24; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-8853383; Lysosomal oligosaccharide catabolism.
DR   ChiTaRS; MAN2B1; human.
DR   GenomeRNAi; 4125; -.
DR   PRO; PR:O00754; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000104774; -.
DR   CleanEx; HS_MAN2B1; -.
DR   ExpressionAtlas; O00754; baseline and differential.
DR   Genevisible; O00754; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0004559; F:alpha-mannosidase activity; IBA:GO_Central.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006464; P:cellular protein modification process; IDA:UniProtKB.
DR   GO; GO:0006013; P:mannose metabolic process; IBA:GO_Central.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0009313; P:oligosaccharide catabolic process; TAS:Reactome.
DR   GO; GO:0006517; P:protein deglycosylation; TAS:ProtInc.
DR   Gene3D; 1.20.1270.50; -; 2.
DR   Gene3D; 2.60.40.1180; -; 1.
DR   Gene3D; 3.20.110.10; -; 1.
DR   InterPro; IPR011013; Gal_mutarotase_sf_dom.
DR   InterPro; IPR011330; Glyco_hydro/deAcase_b/a-brl.
DR   InterPro; IPR011682; Glyco_hydro_38_C.
DR   InterPro; IPR015341; Glyco_hydro_38_cen.
DR   InterPro; IPR037094; Glyco_hydro_38_cen_sf.
DR   InterPro; IPR000602; Glyco_hydro_38_N.
DR   InterPro; IPR027291; Glyco_hydro_38_N_sf.
DR   InterPro; IPR028995; Glyco_hydro_57/38_cen_sf.
DR   InterPro; IPR013780; Glyco_hydro_b.
DR   Pfam; PF09261; Alpha-mann_mid; 1.
DR   Pfam; PF01074; Glyco_hydro_38; 1.
DR   Pfam; PF07748; Glyco_hydro_38C; 1.
DR   SMART; SM00872; Alpha-mann_mid; 1.
DR   SUPFAM; SSF74650; SSF74650; 1.
DR   SUPFAM; SSF88688; SSF88688; 1.
DR   SUPFAM; SSF88713; SSF88713; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Direct protein sequencing;
KW   Disease mutation; Disulfide bond; Glycoprotein; Glycosidase;
KW   Hydrolase; Lysosome; Metal-binding; Polymorphism; Reference proteome;
KW   Signal; Zinc; Zymogen.
FT   SIGNAL        1     49
FT   CHAIN        50   1011       Lysosomal alpha-mannosidase.
FT                                /FTId=PRO_0000012069.
FT   CHAIN        50    345       Lysosomal alpha-mannosidase A peptide.
FT                                /FTId=PRO_0000012070.
FT   CHAIN       346    429       Lysosomal alpha-mannosidase B peptide.
FT                                /FTId=PRO_0000012071.
FT   CHAIN       430    601       Lysosomal alpha-mannosidase C peptide.
FT                                /FTId=PRO_0000012072.
FT   CHAIN       602    882       Lysosomal alpha-mannosidase D peptide.
FT                                /FTId=PRO_0000012073.
FT   CHAIN       883   1011       Lysosomal alpha-mannosidase E peptide.
FT                                /FTId=PRO_0000012074.
FT   ACT_SITE    196    196       Nucleophile. {ECO:0000250}.
FT   METAL        72     72       Zinc. {ECO:0000250}.
FT   METAL        74     74       Zinc. {ECO:0000250}.
FT   METAL       196    196       Zinc. {ECO:0000250}.
FT   METAL       446    446       Zinc. {ECO:0000250}.
FT   CARBOHYD    133    133       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    310    310       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    367    367       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    497    497       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    645    645       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    651    651       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    692    692       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    766    766       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    832    832       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    930    930       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519}.
FT   CARBOHYD    989    989       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     55    358       {ECO:0000250}.
FT   DISULFID    268    273       {ECO:0000250}.
FT   DISULFID    412    472       {ECO:0000250}.
FT   DISULFID    493    501       {ECO:0000250}.
FT   VAR_SEQ     343    343       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_047391.
FT   VARIANT      55     55       C -> F (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621975).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068034.
FT   VARIANT      72     72       H -> L (in MANSA; type II;
FT                                dbSNP:rs387906261).
FT                                {ECO:0000269|PubMed:9158146,
FT                                ECO:0000269|PubMed:9758606}.
FT                                /FTId=VAR_003338.
FT   VARIANT      74     74       D -> E (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs746702002).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068035.
FT   VARIANT      95     95       A -> P (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs754036398).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068036.
FT   VARIANT      99     99       Y -> H (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs794727484).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068037.
FT   VARIANT     159    159       D -> N (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621976).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068038.
FT   VARIANT     197    197       P -> R (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621977).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068039.
FT   VARIANT     200    200       H -> L (in MANSA; no residual enzyme
FT                                activity; dbSNP:rs864621978).
FT                                {ECO:0000269|PubMed:15712269,
FT                                ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_026412.
FT   VARIANT     200    200       H -> N (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs772108001).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068040.
FT   VARIANT     202    202       R -> P (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs864621979).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068041.
FT   VARIANT     229    229       R -> W (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs763257568).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068042.
FT   VARIANT     248    248       P -> L (in dbSNP:rs117843968).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068043.
FT   VARIANT     250    250       A -> S (in dbSNP:rs3745650).
FT                                /FTId=VAR_049209.
FT   VARIANT     263    263       P -> L (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs746808159).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068044.
FT   VARIANT     278    278       L -> V (in dbSNP:rs1054486).
FT                                {ECO:0000269|PubMed:22161967,
FT                                ECO:0000269|PubMed:9915946}.
FT                                /FTId=VAR_003339.
FT   VARIANT     282    282       P -> S (in dbSNP:rs45576136).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068045.
FT   VARIANT     312    312       T -> I (in dbSNP:rs1054487).
FT                                {ECO:0000269|PubMed:22161967,
FT                                ECO:0000269|PubMed:9915946}.
FT                                /FTId=VAR_003340.
FT   VARIANT     318    318       S -> L (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs774034389).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068046.
FT   VARIANT     337    337       R -> Q (in dbSNP:rs1133330).
FT                                {ECO:0000269|PubMed:22161967,
FT                                ECO:0000269|PubMed:9915946}.
FT                                /FTId=VAR_003341.
FT   VARIANT     339    342       Missing (in MANSA).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068047.
FT   VARIANT     352    352       L -> P (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621980).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068048.
FT   VARIANT     355    355       T -> P (in MANSA; dbSNP:rs864621992).
FT                                {ECO:0000269|PubMed:9915946}.
FT                                /FTId=VAR_003342.
FT   VARIANT     356    356       P -> R (in MANSA; type I;
FT                                dbSNP:rs121434333).
FT                                {ECO:0000269|PubMed:9758606}.
FT                                /FTId=VAR_003343.
FT   VARIANT     379    379       P -> L (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs864621981).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068049.
FT   VARIANT     390    390       G -> C (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621982).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068050.
FT   VARIANT     402    402       E -> K (in MANSA; unknown pathological
FT                                significance; dbSNP:rs370760999).
FT                                {ECO:0000269|PubMed:22161967,
FT                                ECO:0000269|PubMed:9915946}.
FT                                /FTId=VAR_003344.
FT   VARIANT     413    413       N -> S (in dbSNP:rs35836657).
FT                                {ECO:0000269|PubMed:22161967,
FT                                ECO:0000269|PubMed:9915946}.
FT                                /FTId=VAR_003345.
FT   VARIANT     420    420       G -> V (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs772853856).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068051.
FT   VARIANT     445    445       H -> Y (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621983).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068052.
FT   VARIANT     451    451       G -> C (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs368899357).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068053.
FT   VARIANT     453    453       S -> F (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs864621984).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068054.
FT   VARIANT     453    453       S -> Y (in MANSA; dbSNP:rs864621984).
FT                                {ECO:0000269|PubMed:12718372,
FT                                ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_026413.
FT   VARIANT     457    457       V -> E (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs864621985).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068055.
FT   VARIANT     481    481       A -> S (in dbSNP:rs34544747).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_049210.
FT   VARIANT     501    501       C -> S (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs747721968).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068056.
FT   VARIANT     565    565       L -> P (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621986).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068057.
FT   VARIANT     669    669       P -> L (in dbSNP:rs75029862).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068058.
FT   VARIANT     714    714       W -> R (in MANSA; dbSNP:rs864621993).
FT                                {ECO:0000269|PubMed:9915946}.
FT                                /FTId=VAR_003346.
FT   VARIANT     745    745       T -> R (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621987).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068059.
FT   VARIANT     750    750       R -> W (in MANSA; type II;
FT                                dbSNP:rs80338680).
FT                                {ECO:0000269|PubMed:9758606}.
FT                                /FTId=VAR_003347.
FT   VARIANT     800    800       G -> R (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs398123456).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068060.
FT   VARIANT     800    800       G -> W (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs398123456).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068061.
FT   VARIANT     801    801       G -> D (in MANSA; no residual enzyme
FT                                activity; dbSNP:rs864621994).
FT                                {ECO:0000269|PubMed:15712269}.
FT                                /FTId=VAR_026414.
FT   VARIANT     809    809       L -> P (in MANSA; dbSNP:rs80338681).
FT                                {ECO:0000269|PubMed:9915946}.
FT                                /FTId=VAR_003348.
FT   VARIANT     815    815       R -> RHR (in MANSA; results in less than
FT                                20% of wild-type enzyme activity).
FT                                /FTId=VAR_068062.
FT   VARIANT     891    891       G -> R (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621988).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068063.
FT   VARIANT     892    892       L -> P (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621989).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068064.
FT   VARIANT     916    916       R -> C (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621990).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068065.
FT   VARIANT     916    916       R -> H (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs758765126).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068066.
FT   VARIANT     950    950       R -> P (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs139041112).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068067.
FT   VARIANT     956    956       L -> R (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs768233248).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068068.
FT   VARIANT    1000   1000       F -> S (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621991).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068069.
FT   CONFLICT      3      3       Missing (in Ref. 3; AAC51362).
FT                                {ECO:0000305}.
FT   CONFLICT    186    186       D -> V (in Ref. 2; AAC34130).
FT                                {ECO:0000305}.
FT   CONFLICT    384    384       P -> H (in Ref. 7; AAC50812).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1011 AA;  113744 MW;  E11C77C19D8BD88C CRC64;
     MGAYARASGV CARGCLDSAG PWTMSRALRP PLPPLCFFLL LLAAAGARAG GYETCPTVQP
     NMLNVHLLPH THDDVGWLKT VDQYFYGIKN DIQHAGVQYI LDSVISALLA DPTRRFIYVE
     IAFFSRWWHQ QTNATQEVVR DLVRQGRLEF ANGGWVMNDE AATHYGAIVD QMTLGLRFLE
     DTFGNDGRPR VAWHIDPFGH SREQASLFAQ MGFDGFFFGR LDYQDKWVRM QKLEMEQVWR
     ASTSLKPPTA DLFTGVLPNG YNPPRNLCWD VLCVDQPLVE DPRSPEYNAK ELVDYFLNVA
     TAQGRYYRTN HTVMTMGSDF QYENANMWFK NLDKLIRLVN AQQAKGSSVH VLYSTPACYL
     WELNKANLTW SVKHDDFFPY ADGPHQFWTG YFSSRPALKR YERLSYNFLQ VCNQLEALVG
     LAANVGPYGS GDSAPLNEAM AVLQHHDAVS GTSRQHVAND YARQLAAGWG PCEVLLSNAL
     ARLRGFKDHF TFCQQLNISI CPLSQTAARF QVIVYNPLGR KVNWMVRLPV SEGVFVVKDP
     NGRTVPSDVV IFPSSDSQAH PPELLFSASL PALGFSTYSV AQVPRWKPQA RAPQPIPRRS
     WSPALTIENE HIRATFDPDT GLLMEIMNMN QQLLLPVRQT FFWYNASIGD NESDQASGAY
     IFRPNQQKPL PVSRWAQIHL VKTPLVQEVH QNFSAWCSQV VRLYPGQRHL ELEWSVGPIP
     VGDTWGKEVI SRFDTPLETK GRFYTDSNGR EILERRRDYR PTWKLNQTEP VAGNYYPVNT
     RIYITDGNMQ LTVLTDRSQG GSSLRDGSLE LMVHRRLLKD DGRGVSEPLM ENGSGAWVRG
     RHLVLLDTAQ AAAAGHRLLA EQEVLAPQVV LAPGGGAAYN LGAPPRTQFS GLRRDLPPSV
     HLLTLASWGP EMVLLRLEHQ FAVGEDSGRN LSAPVTLNLR DLFSTFTITR LQETTLVANQ
     LREAASRLKW TTNTGPTPHQ TPYQLDPANI TLEPMEIRTF LASVQWKEVD G
//
ID   ECH1_HUMAN              Reviewed;         328 AA.
AC   Q13011; A8K745; Q8WVX0; Q96EZ9;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   22-NOV-2005, sequence version 2.
DT   23-MAY-2018, entry version 177.
DE   RecName: Full=Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial;
DE            EC=5.3.3.-;
DE   Flags: Precursor;
GN   Name=ECH1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RX   PubMed=7558027; DOI=10.1006/geno.1995.1077;
RA   Fitzpatrick D.R., Germain-Lee E., Valle D.;
RT   "Isolation and characterization of rat and human cDNAs encoding a
RT   novel putative peroxisomal enoyl-CoA hydratase.";
RL   Genomics 27:457-466(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Fitzpatrick D.R., Valle D.;
RT   "Genomic structure of human ECH1.";
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-41.
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ALA-41.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-41.
RC   TISSUE=Melanoma, and Pancreatic carcinoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 149-158 AND 215-230, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RA   Bienvenut W.V., Claeys D.;
RL   Submitted (NOV-2005) to UniProtKB.
RN   [7]
RP   PROTEIN SEQUENCE OF 66-77; 113-131; 149-211; 215-230 AND 232-245, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-327, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268, VARIANT [LARGE
RP   SCALE ANALYSIS] ALA-41, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 50-322.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human peroxisomal delta3,5,delta2,4-dienoyl CoA
RT   isomerase (ECH1).";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Isomerization of 3-trans,5-cis-dienoyl-CoA to 2-trans,4-
CC       trans-dienoyl-CoA. {ECO:0000250}.
CC   -!- PATHWAY: Lipid metabolism; fatty acid beta-oxidation.
CC   -!- SUBUNIT: Homohexamer. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q8IZU0:FAM9B; NbExp=3; IntAct=EBI-711968, EBI-10175124;
CC       P42858:HTT; NbExp=2; IntAct=EBI-711968, EBI-466029;
CC       P40763:STAT3; NbExp=2; IntAct=EBI-711968, EBI-518675;
CC       Q13077:TRAF1; NbExp=3; IntAct=EBI-711968, EBI-359224;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250}. Peroxisome
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the enoyl-CoA hydratase/isomerase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U16660; AAC50222.1; -; mRNA.
DR   EMBL; AF030249; AAB86485.1; -; Genomic_DNA.
DR   EMBL; AF030246; AAB86485.1; JOINED; Genomic_DNA.
DR   EMBL; AF030247; AAB86485.1; JOINED; Genomic_DNA.
DR   EMBL; AF030248; AAB86485.1; JOINED; Genomic_DNA.
DR   EMBL; AK291860; BAF84549.1; -; mRNA.
DR   EMBL; CH471126; EAW56824.1; -; Genomic_DNA.
DR   EMBL; BC011792; AAH11792.1; -; mRNA.
DR   EMBL; BC017408; AAH17408.1; -; mRNA.
DR   CCDS; CCDS33014.1; -.
DR   PIR; I38882; I38882.
DR   RefSeq; NP_001389.2; NM_001398.2.
DR   UniGene; Hs.196176; -.
DR   PDB; 2VRE; X-ray; 1.95 A; A/B/C=50-322.
DR   PDBsum; 2VRE; -.
DR   ProteinModelPortal; Q13011; -.
DR   SMR; Q13011; -.
DR   BioGrid; 108220; 109.
DR   IntAct; Q13011; 131.
DR   MINT; Q13011; -.
DR   STRING; 9606.ENSP00000221418; -.
DR   iPTMnet; Q13011; -.
DR   PhosphoSitePlus; Q13011; -.
DR   SwissPalm; Q13011; -.
DR   BioMuta; ECH1; -.
DR   DMDM; 82654933; -.
DR   REPRODUCTION-2DPAGE; IPI00011416; -.
DR   UCD-2DPAGE; Q13011; -.
DR   EPD; Q13011; -.
DR   MaxQB; Q13011; -.
DR   PaxDb; Q13011; -.
DR   PeptideAtlas; Q13011; -.
DR   PRIDE; Q13011; -.
DR   TopDownProteomics; Q13011; -.
DR   DNASU; 1891; -.
DR   Ensembl; ENST00000221418; ENSP00000221418; ENSG00000104823.
DR   Ensembl; ENST00000634245; ENSP00000489530; ENSG00000282853.
DR   GeneID; 1891; -.
DR   KEGG; hsa:1891; -.
DR   UCSC; uc002oji.4; human.
DR   CTD; 1891; -.
DR   DisGeNET; 1891; -.
DR   EuPathDB; HostDB:ENSG00000104823.8; -.
DR   GeneCards; ECH1; -.
DR   H-InvDB; HIX0080117; -.
DR   HGNC; HGNC:3149; ECH1.
DR   HPA; HPA002907; -.
DR   HPA; HPA005835; -.
DR   MIM; 600696; gene.
DR   neXtProt; NX_Q13011; -.
DR   OpenTargets; ENSG00000104823; -.
DR   PharmGKB; PA27596; -.
DR   eggNOG; KOG1681; Eukaryota.
DR   eggNOG; ENOG410XTHX; LUCA.
DR   GeneTree; ENSGT00890000139344; -.
DR   HOGENOM; HOG000027939; -.
DR   HOVERGEN; HBG005556; -.
DR   InParanoid; Q13011; -.
DR   KO; K12663; -.
DR   OMA; SWVKDVC; -.
DR   OrthoDB; EOG091G0H26; -.
DR   PhylomeDB; Q13011; -.
DR   TreeFam; TF314317; -.
DR   Reactome; R-HSA-9033241; Peroxisomal protein import.
DR   UniPathway; UPA00659; -.
DR   ChiTaRS; ECH1; human.
DR   EvolutionaryTrace; Q13011; -.
DR   GeneWiki; ECH1; -.
DR   GenomeRNAi; 1891; -.
DR   PRO; PR:Q13011; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000104823; -.
DR   CleanEx; HS_ECH1; -.
DR   ExpressionAtlas; Q13011; baseline and differential.
DR   Genevisible; Q13011; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005782; C:peroxisomal matrix; TAS:Reactome.
DR   GO; GO:0005777; C:peroxisome; NAS:UniProtKB.
DR   GO; GO:0016853; F:isomerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:UniProtKB.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006625; P:protein targeting to peroxisome; TAS:Reactome.
DR   Gene3D; 1.10.12.10; -; 1.
DR   InterPro; IPR029045; ClpP/crotonase-like_dom_sf.
DR   InterPro; IPR018376; Enoyl-CoA_hyd/isom_CS.
DR   InterPro; IPR001753; Enoyl-CoA_hydra/iso.
DR   InterPro; IPR014748; enoyl-CoA_hydra_C.
DR   Pfam; PF00378; ECH_1; 1.
DR   SUPFAM; SSF52096; SSF52096; 1.
DR   PROSITE; PS00166; ENOYL_COA_HYDRATASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Fatty acid metabolism; Isomerase;
KW   Lipid metabolism; Mitochondrion; Peroxisome; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transit peptide.
FT   TRANSIT       1     33       Mitochondrion. {ECO:0000255}.
FT   CHAIN        34    328       Delta(3,5)-Delta(2,4)-dienoyl-CoA
FT                                isomerase, mitochondrial.
FT                                /FTId=PRO_0000007417.
FT   REGION      116    120       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P42126}.
FT   MOTIF       326    328       Microbody targeting signal.
FT                                {ECO:0000255}.
FT   BINDING     174    174       Substrate; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P42126}.
FT   SITE        197    197       Important for catalytic activity.
FT                                {ECO:0000250|UniProtKB:P42126}.
FT   SITE        205    205       Important for catalytic activity.
FT                                {ECO:0000250|UniProtKB:Q62651}.
FT   MOD_RES     231    231       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:O35459}.
FT   MOD_RES     268    268       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     327    327       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT      41     41       E -> A (in dbSNP:rs9419).
FT                                {ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014927.
FT   VARIANT     217    217       G -> R (in dbSNP:rs2229259).
FT                                /FTId=VAR_033913.
FT   CONFLICT    210    210       Q -> E (in Ref. 1; AAC50222 and 2;
FT                                AAB86485). {ECO:0000305}.
FT   CONFLICT    230    230       R -> H (in Ref. 1; AAC50222 and 2;
FT                                AAB86485). {ECO:0000305}.
FT   CONFLICT    239    239       G -> D (in Ref. 1; AAC50222 and 2;
FT                                AAB86485). {ECO:0000305}.
FT   CONFLICT    259    259       A -> P (in Ref. 1; AAC50222 and 2;
FT                                AAB86485). {ECO:0000305}.
FT   CONFLICT    262    262       A -> P (in Ref. 1; AAC50222 and 2;
FT                                AAB86485). {ECO:0000305}.
FT   CONFLICT    268    271       SPVA -> TTVL (in Ref. 1; AAC50222 and 2;
FT                                AAB86485). {ECO:0000305}.
FT   CONFLICT    313    313       A -> P (in Ref. 1; AAC50222 and 2;
FT                                AAB86485). {ECO:0000305}.
FT   STRAND       56     62       {ECO:0000244|PDB:2VRE}.
FT   STRAND       64     72       {ECO:0000244|PDB:2VRE}.
FT   HELIX        75     77       {ECO:0000244|PDB:2VRE}.
FT   HELIX        83     97       {ECO:0000244|PDB:2VRE}.
FT   STRAND      104    110       {ECO:0000244|PDB:2VRE}.
FT   HELIX       120    128       {ECO:0000244|PDB:2VRE}.
FT   STRAND      132    134       {ECO:0000244|PDB:2VRE}.
FT   HELIX       135    158       {ECO:0000244|PDB:2VRE}.
FT   STRAND      159    161       {ECO:0000244|PDB:2VRE}.
FT   STRAND      163    167       {ECO:0000244|PDB:2VRE}.
FT   STRAND      169    172       {ECO:0000244|PDB:2VRE}.
FT   HELIX       174    179       {ECO:0000244|PDB:2VRE}.
FT   STRAND      182    188       {ECO:0000244|PDB:2VRE}.
FT   STRAND      192    194       {ECO:0000244|PDB:2VRE}.
FT   HELIX       197    199       {ECO:0000244|PDB:2VRE}.
FT   HELIX       208    215       {ECO:0000244|PDB:2VRE}.
FT   HELIX       219    228       {ECO:0000244|PDB:2VRE}.
FT   STRAND      231    233       {ECO:0000244|PDB:2VRE}.
FT   HELIX       234    239       {ECO:0000244|PDB:2VRE}.
FT   STRAND      242    249       {ECO:0000244|PDB:2VRE}.
FT   HELIX       250    265       {ECO:0000244|PDB:2VRE}.
FT   HELIX       269    284       {ECO:0000244|PDB:2VRE}.
FT   HELIX       287    301       {ECO:0000244|PDB:2VRE}.
FT   HELIX       305    313       {ECO:0000244|PDB:2VRE}.
SQ   SEQUENCE   328 AA;  35816 MW;  211E0FF40379E6DA CRC64;
     MAAGIVASRR LRDLLTRRLT GSNYPGLSIS LRLTGSSAQE EASGVALGEA PDHSYESLRV
     TSAQKHVLHV QLNRPNKRNA MNKVFWREMV ECFNKISRDA DCRAVVISGA GKMFTAGIDL
     MDMASDILQP KGDDVARISW YLRDIITRYQ ETFNVIERCP KPVIAAVHGG CIGGGVDLVT
     ACDIRYCAQD AFFQVKEVDV GLAADVGTLQ RLPKVIGNQS LVNELAFTAR KMMADEALGS
     GLVSRVFPDK EVMLDAALAL AAEISSKSPV AVQSTKVNLL YSRDHSVAES LNYVASWNMS
     MLQTQDLVKS VQATTENKEL KTVTFSKL
//
ID   HYEP_HUMAN              Reviewed;         455 AA.
AC   P07099; B2R8N0; Q5VTJ6; Q9NP75; Q9NPE7; Q9NQU6; Q9NQU7; Q9NQU8;
AC   Q9NQU9; Q9NQV0; Q9NQV1; Q9NQV2;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1988, sequence version 1.
DT   28-MAR-2018, entry version 185.
DE   RecName: Full=Epoxide hydrolase 1;
DE            EC=3.3.2.9 {ECO:0000250|UniProtKB:P07687};
DE   AltName: Full=Epoxide hydratase;
DE   AltName: Full=Microsomal epoxide hydrolase;
DE            Short=mEH {ECO:0000305};
GN   Name=EPHX1; Synonyms=EPHX, EPOX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 1-19.
RX   PubMed=2891713;
RA   Skoda R.C., Demierre A., McBride O.W., Gonzalez F.J., Meyer U.A.;
RT   "Human microsomal xenobiotic epoxide hydrolase. Complementary DNA
RT   sequence, complementary DNA-directed expression in COS-1 cells, and
RT   chromosomal localization.";
RL   J. Biol. Chem. 263:1549-1554(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal liver;
RA   Wilson N.M., Omiecinski C.J.;
RT   "Nucleotide sequence of a human microsomal epoxide hydrolase cDNA
RT   clone.";
RL   Submitted (JUL-1988) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=3502697; DOI=10.1093/nar/15.17.7188;
RA   Jackson M.R., Craft J.A., Burchell B.;
RT   "Nucleotide and deduced amino acid sequence of human liver microsomal
RT   epoxide hydrolase.";
RL   Nucleic Acids Res. 15:7188-7188(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS HIS-113; ARG-139 AND ILE-396.
RC   TISSUE=Liver;
RX   PubMed=7516776; DOI=10.1093/hmg/3.3.421;
RA   Hassett C., Aicher L., Sidhu J.S., Omiecinski C.J.;
RT   "Human microsomal epoxide hydrolase: genetic polymorphism and
RT   functional expression in vitro of amino acid variants.";
RL   Hum. Mol. Genet. 3:421-428(1994).
RN   [5]
RP   ERRATUM.
RA   Hassett C., Aicher L., Sidhu J.S., Omiecinski C.J.;
RL   Hum. Mol. Genet. 3:1214-1214(1994).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7835893; DOI=10.1006/geno.1994.1520;
RA   Hassett C., Robinson K.B., Beck N.B., Omiecinski C.J.;
RT   "The human microsomal epoxide hydrolase gene (EPHX1): complete
RT   nucleotide sequence and structural characterization.";
RL   Genomics 23:433-442(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain cortex;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS THR-43; HIS-113;
RP   ARG-139; LEU-285; MET-408 AND GLN-452.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin, Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-327.
RC   TISSUE=Liver;
RA   Craft J.A., Jackson M.R., Burchell B.;
RT   "Partial nucleotide sequence of a cloned cDNA for human liver
RT   microsomal epoxide hydrolase.";
RL   Biochem. Soc. Trans. 15:708-709(1987).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-197; 242-310 AND 348-455, AND
RP   VARIANTS CYS-49; HIS-113; ARG-139; PRO-260 AND GLN-454.
RX   PubMed=11058921;
RX   DOI=10.1002/1098-1004(200011)16:5<450::AID-HUMU28>3.0.CO;2-1;
RA   Belmahdi F., Chevalier D., Lo-Guidice J.-M., Allorge D., Cauffiez C.,
RA   Lafitte J.-J., Broly F.;
RT   "Identification of 6 new polymorphisms, g.11177G>A, g.14622C>T (R49C),
RT   g.17540T>C, g.17639T>C, g.30929T>C, g.31074G>A (R454Q), in the human
RT   microsomal epoxide hydrolase gene (EPHX1) in a French population.";
RL   Hum. Mutat. 16:450-450(2000).
RN   [13]
RP   INVOLVEMENT IN HYPERCHOLANEMIA, AND TISSUE SPECIFICITY.
RX   PubMed=12878321; DOI=10.1016/S0925-4439(03)00085-1;
RA   Zhu Q.S., Xing W., Qian B., von Dippe P., Shneider B.L., Fox V.L.,
RA   Levy D.;
RT   "Inhibition of human m-epoxide hydrolase gene expression in a case of
RT   hypercholanemia.";
RL   Biochim. Biophys. Acta 1638:208-216(2003).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=22798687; DOI=10.1194/jlr.M024448;
RA   Decker M., Adamska M., Cronin A., Di Giallonardo F., Burgener J.,
RA   Marowsky A., Falck J.R., Morisseau C., Hammock B.D., Gruzdev A.,
RA   Zeldin D.C., Arand M.;
RT   "EH3 (ABHD9): the first member of a new epoxide hydrolase family with
RT   high activity for fatty acid epoxides.";
RL   J. Lipid Res. 53:2038-2045(2012).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [18]
RP   VARIANTS HIS-113 AND ARG-139, AND DISEASE.
RX   PubMed=12173035; DOI=10.1038/sj.ejhg.5200849;
RA   Laasanen J., Romppanen E.-L., Hiltunen M., Helisalmi S., Mannermaa A.,
RA   Punnonen K., Heinonen S.;
RT   "Two exonic single nucleotide polymorphisms in the microsomal epoxide
RT   hydrolase gene are jointly associated with preeclampsia.";
RL   Eur. J. Hum. Genet. 10:569-573(2002).
RN   [19]
RP   VARIANT GLN-44.
RX   PubMed=15618730; DOI=10.2133/dmpk.18.150;
RA   Shiseki K., Itoda M., Saito Y., Nakajima Y., Maekawa K., Kimura H.,
RA   Goto Y., Saitoh O., Katoh M., Ohnuma T., Kawai M., Sugai K.,
RA   Ohtsuki T., Suzuki C., Minami N., Ozawa S., Sawada J.;
RT   "Five novel single nucleotide polymorphisms in the EPHX1 gene encoding
RT   microsomal epoxide hydrolase.";
RL   Drug Metab. Pharmacokinet. 18:150-153(2003).
RN   [20]
RP   CHARACTERIZATION OF VARIANTS HIS-113 AND ARG-139.
RX   PubMed=15535985; DOI=10.1016/j.cbi.2004.07.004;
RA   Hosagrahara V.P., Rettie A.E., Hassett C., Omiecinski C.J.;
RT   "Functional analysis of human microsomal epoxide hydrolase genetic
RT   variants.";
RL   Chem. Biol. Interact. 150:149-159(2004).
CC   -!- FUNCTION: Biotransformation enzyme that catalyzes the hydrolysis
CC       of arene and aliphatic epoxides to less reactive and more water
CC       soluble dihydrodiols by the trans addition of water (By
CC       similarity). May play a role in the metabolism of endogenous
CC       lipids such as epoxide-containing fatty acids (PubMed:22798687).
CC       {ECO:0000250|UniProtKB:P07687, ECO:0000269|PubMed:22798687}.
CC   -!- CATALYTIC ACTIVITY: Cis-stilbene oxide + H(2)O = (1R,2R)-1,2-
CC       diphenylethane-1,2-diol. {ECO:0000250|UniProtKB:P07687}.
CC   -!- CATALYTIC ACTIVITY: 1-(4-methoxyphenyl)-N-methyl-N-((3-
CC       methyloxetan-3-yl)methyl)methanamine + H(2)O = 2-((((4-
CC       methoxyphenyl)methyl)(methyl)amino)methyl)-2-methylpropane-1,3-
CC       diol. {ECO:0000250|UniProtKB:P07687}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.8 uM for 8,9-EET {ECO:0000269|PubMed:22798687};
CC         KM=0.4 uM for 11,12-EET {ECO:0000269|PubMed:22798687};
CC         KM=0.9 uM for 14,15-EET {ECO:0000269|PubMed:22798687};
CC         KM=5.8 uM for leukotoxin {ECO:0000269|PubMed:22798687};
CC         Vmax=0.12 umol/min/mg enzyme with 8,9-EET as substrate
CC         {ECO:0000269|PubMed:22798687};
CC         Vmax=0.6 umol/min/mg enzyme with 11,12-EET as substrate
CC         {ECO:0000269|PubMed:22798687};
CC         Vmax=0.04 umol/min/mg enzyme with 14,15-EET as substrate
CC         {ECO:0000269|PubMed:22798687};
CC         Vmax=0.008 umol/min/mg enzyme with leukotoxin as substrate
CC         {ECO:0000269|PubMed:22798687};
CC   -!- SUBCELLULAR LOCATION: Microsome membrane
CC       {ECO:0000250|UniProtKB:P07687}; Single-pass type III membrane
CC       protein {ECO:0000250|UniProtKB:P07687}. Endoplasmic reticulum
CC       membrane {ECO:0000250|UniProtKB:P07687}; Single-pass type III
CC       membrane protein {ECO:0000250|UniProtKB:P07687}.
CC   -!- TISSUE SPECIFICITY: Found in liver. {ECO:0000269|PubMed:12878321}.
CC   -!- DISEASE: Note=In some populations, the high activity haplotype
CC       tyr113/his139 is overrepresented among women suffering from
CC       pregnancy-induced hypertension (pre-eclampsia) when compared with
CC       healthy controls. {ECO:0000269|PubMed:12173035}.
CC   -!- DISEASE: Familial hypercholanemia (FHCA) [MIM:607748]: A disorder
CC       characterized by elevated serum bile acid concentrations, itching,
CC       and fat malabsorption. {ECO:0000269|PubMed:12878321}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the peptidase S33 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/ephx1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J03518; AAA61305.1; -; mRNA.
DR   EMBL; X07936; CAA30759.1; -; mRNA.
DR   EMBL; Y00424; CAA68486.1; -; mRNA.
DR   EMBL; L25878; AAA52389.1; -; mRNA.
DR   EMBL; L25879; AAA52390.1; -; mRNA.
DR   EMBL; U06661; AAB60649.1; -; Genomic_DNA.
DR   EMBL; U06656; AAB60649.1; JOINED; Genomic_DNA.
DR   EMBL; U06657; AAB60649.1; JOINED; Genomic_DNA.
DR   EMBL; U06658; AAB60649.1; JOINED; Genomic_DNA.
DR   EMBL; U06659; AAB60649.1; JOINED; Genomic_DNA.
DR   EMBL; U06660; AAB60649.1; JOINED; Genomic_DNA.
DR   EMBL; AK313436; BAG36227.1; -; mRNA.
DR   EMBL; AY948961; AAX81410.1; -; Genomic_DNA.
DR   EMBL; AL591895; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC003567; AAH03567.1; -; mRNA.
DR   EMBL; BC008291; AAH08291.1; -; mRNA.
DR   EMBL; BC095430; AAH95430.1; -; mRNA.
DR   EMBL; M36374; AAA59580.1; -; mRNA.
DR   EMBL; AF253417; AAC41694.1; -; Genomic_DNA.
DR   EMBL; AF276626; AAF87726.1; -; Genomic_DNA.
DR   EMBL; AF276627; AAF87727.1; -; Genomic_DNA.
DR   EMBL; AF276628; AAF87728.1; -; Genomic_DNA.
DR   EMBL; AF276629; AAF87729.1; -; Genomic_DNA.
DR   EMBL; AF276630; AAF87730.1; -; Genomic_DNA.
DR   EMBL; AF276631; AAF87731.1; -; Genomic_DNA.
DR   EMBL; AF276632; AAF87732.1; -; Genomic_DNA.
DR   EMBL; AF276633; AAF87733.1; -; Genomic_DNA.
DR   EMBL; AF276634; AAF87734.1; -; Genomic_DNA.
DR   EMBL; AF276635; AAF87735.1; -; Genomic_DNA.
DR   EMBL; AF276636; AAF87736.1; -; Genomic_DNA.
DR   EMBL; AF276637; AAF87737.1; -; Genomic_DNA.
DR   EMBL; AF276638; AAF87738.1; -; Genomic_DNA.
DR   CCDS; CCDS1547.1; -.
DR   PIR; A29939; A29939.
DR   RefSeq; NP_000111.1; NM_000120.3.
DR   RefSeq; NP_001129490.1; NM_001136018.3.
DR   RefSeq; NP_001278092.1; NM_001291163.1.
DR   UniGene; Hs.89649; -.
DR   ProteinModelPortal; P07099; -.
DR   SMR; P07099; -.
DR   BioGrid; 108366; 33.
DR   IntAct; P07099; 2.
DR   STRING; 9606.ENSP00000272167; -.
DR   BindingDB; P07099; -.
DR   ChEMBL; CHEMBL1968; -.
DR   SwissLipids; SLP:000001117; -.
DR   ESTHER; human-EPHX1; Epoxide_hydrolase.
DR   MEROPS; S33.971; -.
DR   iPTMnet; P07099; -.
DR   PhosphoSitePlus; P07099; -.
DR   SwissPalm; P07099; -.
DR   BioMuta; EPHX1; -.
DR   DMDM; 123926; -.
DR   EPD; P07099; -.
DR   PaxDb; P07099; -.
DR   PeptideAtlas; P07099; -.
DR   PRIDE; P07099; -.
DR   DNASU; 2052; -.
DR   Ensembl; ENST00000272167; ENSP00000272167; ENSG00000143819.
DR   Ensembl; ENST00000366837; ENSP00000355802; ENSG00000143819.
DR   Ensembl; ENST00000614058; ENSP00000480004; ENSG00000143819.
DR   GeneID; 2052; -.
DR   KEGG; hsa:2052; -.
DR   CTD; 2052; -.
DR   DisGeNET; 2052; -.
DR   EuPathDB; HostDB:ENSG00000143819.12; -.
DR   GeneCards; EPHX1; -.
DR   HGNC; HGNC:3401; EPHX1.
DR   HPA; HPA020593; -.
DR   HPA; HPA048847; -.
DR   MalaCards; EPHX1; -.
DR   MIM; 132810; gene+phenotype.
DR   MIM; 607748; phenotype.
DR   neXtProt; NX_P07099; -.
DR   OpenTargets; ENSG00000143819; -.
DR   Orphanet; 238475; Familial hypercholanemia.
DR   Orphanet; 1912; Fetal hydantoin syndrome.
DR   PharmGKB; PA27829; -.
DR   eggNOG; KOG2565; Eukaryota.
DR   eggNOG; COG0596; LUCA.
DR   GeneTree; ENSGT00390000002210; -.
DR   HOVERGEN; HBG002366; -.
DR   InParanoid; P07099; -.
DR   KO; K01253; -.
DR   OMA; YSLMRES; -.
DR   OrthoDB; EOG091G0B5A; -.
DR   PhylomeDB; P07099; -.
DR   TreeFam; TF313813; -.
DR   BioCyc; MetaCyc:HS07112-MONOMER; -.
DR   BRENDA; 3.3.2.9; 2681.
DR   Reactome; R-HSA-211945; Phase I - Functionalization of compounds.
DR   SABIO-RK; P07099; -.
DR   ChiTaRS; EPHX1; human.
DR   GeneWiki; EPHX1; -.
DR   GenomeRNAi; 2052; -.
DR   PRO; PR:P07099; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143819; -.
DR   ExpressionAtlas; P07099; baseline and differential.
DR   Genevisible; P07099; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0033961; F:cis-stilbene-oxide hydrolase activity; TAS:Reactome.
DR   GO; GO:0004301; F:epoxide hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0019439; P:aromatic compound catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0097176; P:epoxide metabolic process; IDA:UniProtKB.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0009636; P:response to toxic substance; IEA:UniProtKB-KW.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR000639; Epox_hydrolase-like.
DR   InterPro; IPR010497; Epoxide_hydro_N.
DR   InterPro; IPR016292; Epoxide_hydrolase.
DR   Pfam; PF06441; EHN; 1.
DR   PIRSF; PIRSF001112; Epoxide_hydrolase; 1.
DR   PRINTS; PR00412; EPOXHYDRLASE.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   1: Evidence at protein level;
KW   Aromatic hydrocarbons catabolism; Complete proteome; Detoxification;
KW   Direct protein sequencing; Endoplasmic reticulum; Hydrolase; Membrane;
KW   Methylation; Microsome; Polymorphism; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    455       Epoxide hydrolase 1.
FT                                /FTId=PRO_0000080855.
FT   TRANSMEM      1     21       Helical; Signal-anchor for type III
FT                                membrane protein.
FT                                {ECO:0000250|UniProtKB:P07687}.
FT   TOPO_DOM     22    455       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P07687}.
FT   ACT_SITE    226    226       Nucleophile.
FT                                {ECO:0000250|UniProtKB:P07687}.
FT   ACT_SITE    374    374       Proton donor.
FT                                {ECO:0000250|UniProtKB:P34913}.
FT   ACT_SITE    431    431       Proton acceptor.
FT                                {ECO:0000250|UniProtKB:P07687}.
FT   MOD_RES     295    295       Dimethylated arginine; alternate.
FT                                {ECO:0000250|UniProtKB:P07687}.
FT   MOD_RES     295    295       Omega-N-methylated arginine; alternate.
FT                                {ECO:0000250}.
FT   VARIANT      43     43       R -> T (in dbSNP:rs3738046).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_023303.
FT   VARIANT      44     44       E -> Q (in dbSNP:rs745306359).
FT                                {ECO:0000269|PubMed:15618730}.
FT                                /FTId=VAR_018347.
FT   VARIANT      49     49       R -> C (in allele EPHX1*2;
FT                                dbSNP:rs2234697).
FT                                {ECO:0000269|PubMed:11058921}.
FT                                /FTId=VAR_013298.
FT   VARIANT     113    113       Y -> H (in allele EPHX1*3; 55% of wild
FT                                type enzyme activity; dbSNP:rs1051740).
FT                                {ECO:0000269|PubMed:11058921,
FT                                ECO:0000269|PubMed:12173035,
FT                                ECO:0000269|PubMed:15535985,
FT                                ECO:0000269|PubMed:7516776,
FT                                ECO:0000269|Ref.8}.
FT                                /FTId=VAR_005295.
FT   VARIANT     139    139       H -> R (in allele EPHX1*4; 62% of wild
FT                                type enzyme activity; dbSNP:rs2234922).
FT                                {ECO:0000269|PubMed:11058921,
FT                                ECO:0000269|PubMed:12173035,
FT                                ECO:0000269|PubMed:15535985,
FT                                ECO:0000269|PubMed:7516776,
FT                                ECO:0000269|Ref.8}.
FT                                /FTId=VAR_005296.
FT   VARIANT     260    260       L -> P (in allele EPHX1*1G).
FT                                {ECO:0000269|PubMed:11058921}.
FT                                /FTId=VAR_013299.
FT   VARIANT     275    275       T -> A (in dbSNP:rs35073925).
FT                                /FTId=VAR_051828.
FT   VARIANT     285    285       V -> L (in dbSNP:rs45449793).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_023304.
FT   VARIANT     396    396       T -> I (either a rare polymorphism or a
FT                                sequencing error).
FT                                {ECO:0000269|PubMed:7516776}.
FT                                /FTId=VAR_005297.
FT   VARIANT     408    408       T -> M (in dbSNP:rs45495897).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_023305.
FT   VARIANT     452    452       L -> Q (in dbSNP:rs45563137).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_023306.
FT   VARIANT     454    454       R -> Q (in allele EPHX1*5;
FT                                dbSNP:rs2234701).
FT                                {ECO:0000269|PubMed:11058921}.
FT                                /FTId=VAR_013300.
FT   CONFLICT     15     15       I -> V (in Ref. 7; BAG36227).
FT                                {ECO:0000305}.
FT   CONFLICT    112    112       R -> K (in Ref. 11). {ECO:0000305}.
FT   CONFLICT    148    148       H -> N (in Ref. 3 and 11). {ECO:0000305}.
FT   CONFLICT    243    243       V -> L (in Ref. 11). {ECO:0000305}.
FT   CONFLICT    348    348       K -> S (in Ref. 3; CAA68486).
FT                                {ECO:0000305}.
FT   CONFLICT    406    406       L -> F (in Ref. 3; CAA68486).
FT                                {ECO:0000305}.
FT   CONFLICT    420    420       L -> V (in Ref. 3; CAA68486).
FT                                {ECO:0000305}.
SQ   SEQUENCE   455 AA;  52949 MW;  88E333838C841390 CRC64;
     MWLEILLTSV LGFAIYWFIS RDKEETLPLE DGWWGPGTRS AAREDDSIRP FKVETSDEEI
     HDLHQRIDKF RFTPPLEDSC FHYGFNSNYL KKVISYWRNE FDWKKQVEIL NRYPHFKTKI
     EGLDIHFIHV KPPQLPAGHT PKPLLMVHGW PGSFYEFYKI IPLLTDPKNH GLSDEHVFEV
     ICPSIPGYGF SEASSKKGFN SVATARIFYK LMLRLGFQEF YIQGGDWGSL ICTNMAQLVP
     SHVKGLHLNM ALVLSNFSTL TLLLGQRFGR FLGLTERDVE LLYPVKEKVF YSLMRESGYM
     HIQCTKPDTV GSALNDSPVG LAAYILEKFS TWTNTEFRYL EDGGLERKFS LDDLLTNVML
     YWTTGTIISS QRFYKENLGQ GWMTQKHERM KVYVPTGFSA FPFELLHTPE KWVRFKYPKL
     ISYSYMVRGG HFAAFEEPEL LAQDIRKFLS VLERQ
//
ID   R4SBI6_HUMAN            Unreviewed;       455 AA.
AC   R4SBI6;
DT   24-JUL-2013, integrated into UniProtKB/TrEMBL.
DT   24-JUL-2013, sequence version 1.
DT   23-MAY-2018, entry version 47.
DE   RecName: Full=Epoxide hydrolase {ECO:0000256|PIRNR:PIRNR001112};
DE            EC=3.3.2.9 {ECO:0000256|PIRNR:PIRNR001112};
GN   Name=EPHX1 {ECO:0000313|EMBL:AGL94507.1};
GN   ORFNames=hCG_2039431 {ECO:0000313|EMBL:EAW69754.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AGL94507.1};
RN   [1] {ECO:0000313|EMBL:EAW69754.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW69754.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:AGL94507.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver {ECO:0000313|EMBL:AGL94507.1};
RX   PubMed=23564882; DOI=10.1261/rna.037036.112;
RA   Nguyen H.L., Yang X., Omiecinski C.J.;
RT   "Expression of a novel mRNA transcript for human microsomal epoxide
RT   hydrolase (EPHX1) is regulated by short open reading frames within its
RT   5'-untranslated region.";
RL   RNA 19:752-766(2013).
RN   [4] {ECO:0000313|EMBL:AGL94507.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver {ECO:0000313|EMBL:AGL94507.1};
RA   Nguyen H.L.T., Yang X., Omiecinski C.J.;
RL   Submitted (MAY-2013) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:ALQ33500.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- FUNCTION: Biotransformation enzyme that catalyzes the hydrolysis
CC       of arene and aliphatic epoxides to less reactive and more water
CC       soluble dihydrodiols by the trans addition of water.
CC       {ECO:0000256|PIRNR:PIRNR001112}.
CC   -!- CATALYTIC ACTIVITY: 1-(4-methoxyphenyl)-N-methyl-N-((3-
CC       methyloxetan-3-yl)methyl)methanamine + H(2)O = 2-((((4-
CC       methoxyphenyl)methyl)(methyl)amino)methyl)-2-methylpropane-1,3-
CC       diol. {ECO:0000256|PIRNR:PIRNR001112}.
CC   -!- CATALYTIC ACTIVITY: Cis-stilbene oxide + H(2)O = (1R,2R)-1,2-
CC       diphenylethane-1,2-diol. {ECO:0000256|PIRNR:PIRNR001112}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000256|PIRNR:PIRNR001112}.
CC   -!- SIMILARITY: Belongs to the peptidase S33 family.
CC       {ECO:0000256|PIRNR:PIRNR001112}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KF032815; AGL94507.1; -; mRNA.
DR   EMBL; KU178042; ALQ33500.1; -; mRNA.
DR   EMBL; CH471098; EAW69754.1; -; Genomic_DNA.
DR   EMBL; CH471098; EAW69755.1; -; Genomic_DNA.
DR   EMBL; CH471098; EAW69756.1; -; Genomic_DNA.
DR   EMBL; CH471098; EAW69757.1; -; Genomic_DNA.
DR   RefSeq; NP_000111.1; NM_000120.3.
DR   RefSeq; NP_001129490.1; NM_001136018.3.
DR   RefSeq; NP_001278092.1; NM_001291163.1.
DR   UniGene; Hs.89649; -.
DR   SMR; R4SBI6; -.
DR   ESTHER; human-EPHX1; Epoxide_hydrolase.
DR   MaxQB; R4SBI6; -.
DR   PRIDE; R4SBI6; -.
DR   GeneID; 2052; -.
DR   KEGG; hsa:2052; -.
DR   UCSC; uc001hpk.4; human.
DR   CTD; 2052; -.
DR   EuPathDB; HostDB:ENSG00000143819.12; -.
DR   eggNOG; KOG2565; Eukaryota.
DR   eggNOG; COG0596; LUCA.
DR   KO; K01253; -.
DR   OMA; YSLMRES; -.
DR   OrthoDB; EOG091G0B5A; -.
DR   ChiTaRS; EPHX1; human.
DR   GenomeRNAi; 2052; -.
DR   Bgee; ENSG00000143819; -.
DR   ExpressionAtlas; R4SBI6; baseline and differential.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0033961; F:cis-stilbene-oxide hydrolase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0019439; P:aromatic compound catabolic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR000639; Epox_hydrolase-like.
DR   InterPro; IPR010497; Epoxide_hydro_N.
DR   InterPro; IPR016292; Epoxide_hydrolase.
DR   Pfam; PF06441; EHN; 1.
DR   PIRSF; PIRSF001112; Epoxide_hydrolase; 1.
DR   PRINTS; PR00412; EPOXHYDRLASE.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   2: Evidence at transcript level;
KW   Aromatic hydrocarbons catabolism {ECO:0000256|PIRNR:PIRNR001112};
KW   Endoplasmic reticulum {ECO:0000256|PIRNR:PIRNR001112};
KW   Hydrolase {ECO:0000256|PIRNR:PIRNR001112,
KW   ECO:0000313|EMBL:ALQ33500.1};
KW   Membrane {ECO:0000256|PIRNR:PIRNR001112}.
FT   DOMAIN       48    157       EHN. {ECO:0000259|Pfam:PF06441}.
FT   ACT_SITE    226    226       Nucleophile.
FT                                {ECO:0000256|PIRSR:PIRSR001112-1}.
FT   ACT_SITE    374    374       Proton donor.
FT                                {ECO:0000256|PIRSR:PIRSR001112-1}.
FT   ACT_SITE    431    431       Proton acceptor.
FT                                {ECO:0000256|PIRSR:PIRSR001112-1}.
FT   NON_TER     455    455       {ECO:0000313|EMBL:ALQ33500.1}.
SQ   SEQUENCE   455 AA;  52949 MW;  88E333838C841390 CRC64;
     MWLEILLTSV LGFAIYWFIS RDKEETLPLE DGWWGPGTRS AAREDDSIRP FKVETSDEEI
     HDLHQRIDKF RFTPPLEDSC FHYGFNSNYL KKVISYWRNE FDWKKQVEIL NRYPHFKTKI
     EGLDIHFIHV KPPQLPAGHT PKPLLMVHGW PGSFYEFYKI IPLLTDPKNH GLSDEHVFEV
     ICPSIPGYGF SEASSKKGFN SVATARIFYK LMLRLGFQEF YIQGGDWGSL ICTNMAQLVP
     SHVKGLHLNM ALVLSNFSTL TLLLGQRFGR FLGLTERDVE LLYPVKEKVF YSLMRESGYM
     HIQCTKPDTV GSALNDSPVG LAAYILEKFS TWTNTEFRYL EDGGLERKFS LDDLLTNVML
     YWTTGTIISS QRFYKENLGQ GWMTQKHERM KVYVPTGFSA FPFELLHTPE KWVRFKYPKL
     ISYSYMVRGG HFAAFEEPEL LAQDIRKFLS VLERQ
//
ID   PNPH_HUMAN              Reviewed;         289 AA.
AC   P00491; B2R8S5; D3DS00; Q15160; Q5PZ03;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2006, sequence version 2.
DT   23-MAY-2018, entry version 198.
DE   RecName: Full=Purine nucleoside phosphorylase;
DE            Short=PNP;
DE            EC=2.4.2.1;
DE   AltName: Full=Inosine phosphorylase;
DE   AltName: Full=Inosine-guanosine phosphorylase;
GN   Name=PNP; Synonyms=NP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-51.
RX   PubMed=6087295; DOI=10.1093/nar/12.14.5779;
RA   Williams S.R., Goddard J.M., Martin D.W. Jr.;
RT   "Human purine nucleoside phosphorylase cDNA sequence and genomic clone
RT   characterization.";
RL   Nucleic Acids Res. 12:5779-5787(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT PNPD LYS-89, AND VARIANT
RP   SER-51.
RX   PubMed=3029074;
RA   Williams S.R., Gekeler V., McIvor R.S., Martin D.W. Jr.;
RT   "A human purine nucleoside phosphorylase deficiency caused by a single
RT   base change.";
RL   J. Biol. Chem. 262:2332-2338(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-51.
RX   PubMed=12928150; DOI=10.1289/ehp.6420;
RA   Yu L., Kalla K., Guthrie E., Vidrine A., Klimecki W.T.;
RT   "Genetic variation in genes associated with arsenic metabolism:
RT   glutathione S-transferase omega 1-1 and purine nucleoside
RT   phosphorylase polymorphisms in European and indigenous Americans.";
RL   Environ. Health Perspect. 111:1421-1427(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-51.
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 1-22; 42-58; 68-76; 96-148; 212-229; 235-265 AND
RP   271-287, ACETYLATION AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RA   Bienvenut W.V., Claeys D.;
RL   Submitted (FEB-2006) to UniProtKB.
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [12]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=22509282; DOI=10.1371/journal.pone.0034237;
RA   von Lohneysen K., Scott T.M., Soldau K., Xu X., Friedman J.S.;
RT   "Assessment of the red cell proteome of young patients with
RT   unexplained hemolytic anemia by two-dimensional differential in-gel
RT   electrophoresis (DIGE).";
RL   PLoS ONE 7:E34237-E34237(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-251, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS), AND FUNCTION.
RX   PubMed=2104852;
RA   Ealick S.E., Rule S.A., Carter D.C., Greenhough T.J., Babu Y.S.,
RA   Cook W.J., Habash J., Helliwell J.R., Stoeckler J.D., Parks R.E. Jr.,
RA   Chen S.-F., Bugg C.E.;
RT   "Three-dimensional structure of human erythrocytic purine nucleoside
RT   phosphorylase at 3.2-A resolution.";
RL   J. Biol. Chem. 265:1812-1820(1990).
RN   [17]
RP   VARIANT SER-51, AND VARIANTS PNPD GLY-128 AND PRO-234.
RX   PubMed=1384322;
RA   Aust M.R., Andrews L.G., Barrett M.J., Norby-Slycord C.J.,
RA   Markert M.L.;
RT   "Molecular analysis of mutations in a patient with purine nucleoside
RT   phosphorylase deficiency.";
RL   Am. J. Hum. Genet. 51:763-772(1992).
RN   [18]
RP   VARIANT PNPD CYS-192.
RX   PubMed=8931706; DOI=10.1007/s004390050290;
RA   Pannicke U., Tuchschmid P., Friedrich W., Bartram C.R., Schwarz K.;
RT   "Two novel missense and frameshift mutations in exons 5 and 6 of the
RT   purine nucleoside phosphorylase (PNP) gene in a severe combined
RT   immunodeficiency (SCID) patient.";
RL   Hum. Genet. 98:706-709(1996).
CC   -!- FUNCTION: The purine nucleoside phosphorylases catalyze the
CC       phosphorolytic breakdown of the N-glycosidic bond in the beta-
CC       (deoxy)ribonucleoside molecules, with the formation of the
CC       corresponding free purine bases and pentose-1-phosphate.
CC       {ECO:0000269|PubMed:2104852}.
CC   -!- CATALYTIC ACTIVITY: Purine nucleoside + phosphate = purine +
CC       alpha-D-ribose 1-phosphate.
CC   -!- PATHWAY: Purine metabolism; purine nucleoside salvage.
CC   -!- SUBUNIT: Homotrimer.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}.
CC       Cytoplasm {ECO:0000269|PubMed:22509282}.
CC   -!- TISSUE SPECIFICITY: Expressed in red blood cells; overexpressed in
CC       red blood cells (cytoplasm) of patients with hereditary non-
CC       spherocytic hemolytic anemia of unknown etiology.
CC       {ECO:0000269|PubMed:22509282}.
CC   -!- DISEASE: Purine nucleoside phosphorylase deficiency (PNPD)
CC       [MIM:613179]: A disorder that interrupts both the catabolism of
CC       inosine into hypoxanthine and guanosine into guanine, and leads to
CC       the accumulation of guanosine, inosine, and their deoxified by-
CC       products. The main clinical presentation is recurrent infections
CC       due to severe T-cell immunodeficiency. Some patients also have
CC       neurologic impairment. {ECO:0000269|PubMed:1384322,
CC       ECO:0000269|PubMed:3029074, ECO:0000269|PubMed:8931706}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the PNP/MTAP phosphorylase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NPbase; Note=NP mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/NPbase/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X00737; CAA25320.1; -; mRNA.
DR   EMBL; M13953; AAA36460.1; -; Genomic_DNA.
DR   EMBL; J02672; AAA36460.1; JOINED; Genomic_DNA.
DR   EMBL; M13951; AAA36460.1; JOINED; Genomic_DNA.
DR   EMBL; M13952; AAA36460.1; JOINED; Genomic_DNA.
DR   EMBL; AY817667; AAV68044.1; -; Genomic_DNA.
DR   EMBL; AK313490; BAG36272.1; -; mRNA.
DR   EMBL; CR407607; CAG28535.1; -; mRNA.
DR   EMBL; CH471078; EAW66458.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW66459.1; -; Genomic_DNA.
DR   EMBL; BC104206; AAI04207.1; -; mRNA.
DR   EMBL; BC104207; AAI04208.1; -; mRNA.
DR   EMBL; BC106074; AAI06075.1; -; mRNA.
DR   CCDS; CCDS9552.1; -.
DR   PIR; A00578; PHHUPN.
DR   RefSeq; NP_000261.2; NM_000270.3.
DR   UniGene; Hs.75514; -.
DR   PDB; 1M73; X-ray; 2.30 A; E=2-289.
DR   PDB; 1PF7; X-ray; 2.60 A; E=1-289.
DR   PDB; 1PWY; X-ray; 2.80 A; E=2-289.
DR   PDB; 1RCT; X-ray; 2.80 A; E=2-289.
DR   PDB; 1RFG; X-ray; 2.90 A; E=2-289.
DR   PDB; 1RR6; X-ray; 2.50 A; A=1-289.
DR   PDB; 1RSZ; X-ray; 2.20 A; A=1-289.
DR   PDB; 1RT9; X-ray; 2.30 A; A=1-289.
DR   PDB; 1ULA; X-ray; 2.75 A; A=1-289.
DR   PDB; 1ULB; X-ray; 2.75 A; A=1-289.
DR   PDB; 1V2H; X-ray; 2.70 A; E=2-289.
DR   PDB; 1V3Q; X-ray; 2.80 A; E=2-289.
DR   PDB; 1V41; X-ray; 2.85 A; E=2-289.
DR   PDB; 1V45; X-ray; 2.86 A; E=2-289.
DR   PDB; 1YRY; X-ray; 2.80 A; E=1-289.
DR   PDB; 2A0W; X-ray; 2.28 A; A=1-289.
DR   PDB; 2A0X; X-ray; 2.28 A; A=1-289.
DR   PDB; 2A0Y; X-ray; 2.28 A; A=1-289.
DR   PDB; 2OC4; X-ray; 2.59 A; A=1-289.
DR   PDB; 2OC9; X-ray; 2.59 A; A=1-289.
DR   PDB; 2ON6; X-ray; 2.50 A; A=1-289.
DR   PDB; 2Q7O; X-ray; 2.90 A; E=1-289.
DR   PDB; 3BGS; X-ray; 2.10 A; A=1-289.
DR   PDB; 3D1V; X-ray; 2.70 A; A=1-289.
DR   PDB; 3GB9; X-ray; 2.30 A; A/B/C=1-289.
DR   PDB; 3GGS; X-ray; 2.52 A; A/B/C=1-289.
DR   PDB; 3INY; X-ray; 2.75 A; A=1-289.
DR   PDB; 3K8O; X-ray; 2.40 A; E/Q/S/T/U/Y=1-289.
DR   PDB; 3K8Q; X-ray; 2.50 A; A=1-289.
DR   PDB; 3PHB; X-ray; 2.30 A; E/Q/S/T/U/Y=1-289.
DR   PDB; 4EAR; X-ray; 1.70 A; A/B/C=1-289.
DR   PDB; 4EB8; X-ray; 2.30 A; A/B/C=1-289.
DR   PDB; 4ECE; X-ray; 2.60 A; A/B/C/D/E/F=1-289.
DR   PDB; 4GKA; X-ray; 2.20 A; A/B/C/D/E/F=1-289.
DR   PDB; 5ETJ; X-ray; 2.30 A; A/B/C/D/E/F=1-289.
DR   PDB; 5UGF; X-ray; 2.20 A; A/B/C/D/E/F=1-289.
DR   PDBsum; 1M73; -.
DR   PDBsum; 1PF7; -.
DR   PDBsum; 1PWY; -.
DR   PDBsum; 1RCT; -.
DR   PDBsum; 1RFG; -.
DR   PDBsum; 1RR6; -.
DR   PDBsum; 1RSZ; -.
DR   PDBsum; 1RT9; -.
DR   PDBsum; 1ULA; -.
DR   PDBsum; 1ULB; -.
DR   PDBsum; 1V2H; -.
DR   PDBsum; 1V3Q; -.
DR   PDBsum; 1V41; -.
DR   PDBsum; 1V45; -.
DR   PDBsum; 1YRY; -.
DR   PDBsum; 2A0W; -.
DR   PDBsum; 2A0X; -.
DR   PDBsum; 2A0Y; -.
DR   PDBsum; 2OC4; -.
DR   PDBsum; 2OC9; -.
DR   PDBsum; 2ON6; -.
DR   PDBsum; 2Q7O; -.
DR   PDBsum; 3BGS; -.
DR   PDBsum; 3D1V; -.
DR   PDBsum; 3GB9; -.
DR   PDBsum; 3GGS; -.
DR   PDBsum; 3INY; -.
DR   PDBsum; 3K8O; -.
DR   PDBsum; 3K8Q; -.
DR   PDBsum; 3PHB; -.
DR   PDBsum; 4EAR; -.
DR   PDBsum; 4EB8; -.
DR   PDBsum; 4ECE; -.
DR   PDBsum; 4GKA; -.
DR   PDBsum; 5ETJ; -.
DR   PDBsum; 5UGF; -.
DR   ProteinModelPortal; P00491; -.
DR   SMR; P00491; -.
DR   BioGrid; 110921; 39.
DR   CORUM; P00491; -.
DR   DIP; DIP-50406N; -.
DR   IntAct; P00491; 14.
DR   STRING; 9606.ENSP00000354532; -.
DR   BindingDB; P00491; -.
DR   ChEMBL; CHEMBL4338; -.
DR   DrugBank; DB03609; 3-Deoxyguanosine.
DR   DrugBank; DB01667; 8-azaguanine.
DR   DrugBank; DB02796; 9-Deazainosine.
DR   DrugBank; DB00242; Cladribine.
DR   DrugBank; DB00900; Didanosine.
DR   DrugBank; DB02377; Guanine.
DR   DrugBank; DB02857; Guanosine.
DR   DrugBank; DB04076; Hypoxanthine.
DR   DrugBank; DB02230; Immucillin-G.
DR   DrugBank; DB04335; Inosine.
DR   DrugBank; DB03881; MT-Immucillin-H.
DR   DrugBank; DB02568; Peldesine.
DR   DrugBank; DB03101; Ribose-1-Phosphate.
DR   GuidetoPHARMACOLOGY; 2841; -.
DR   iPTMnet; P00491; -.
DR   PhosphoSitePlus; P00491; -.
DR   SwissPalm; P00491; -.
DR   BioMuta; PNP; -.
DR   DMDM; 108935929; -.
DR   OGP; P00491; -.
DR   EPD; P00491; -.
DR   PaxDb; P00491; -.
DR   PeptideAtlas; P00491; -.
DR   PRIDE; P00491; -.
DR   TopDownProteomics; P00491; -.
DR   Ensembl; ENST00000361505; ENSP00000354532; ENSG00000198805.
DR   GeneID; 4860; -.
DR   KEGG; hsa:4860; -.
DR   CTD; 4860; -.
DR   DisGeNET; 4860; -.
DR   EuPathDB; HostDB:ENSG00000198805.11; -.
DR   GeneCards; PNP; -.
DR   HGNC; HGNC:7892; PNP.
DR   HPA; HPA001625; -.
DR   MalaCards; PNP; -.
DR   MIM; 164050; gene.
DR   MIM; 613179; phenotype.
DR   neXtProt; NX_P00491; -.
DR   OpenTargets; ENSG00000198805; -.
DR   Orphanet; 760; Purine nucleoside phosphorylase deficiency.
DR   PharmGKB; PA31694; -.
DR   eggNOG; KOG3984; Eukaryota.
DR   eggNOG; COG0005; LUCA.
DR   GeneTree; ENSGT00550000074740; -.
DR   HOVERGEN; HBG002460; -.
DR   InParanoid; P00491; -.
DR   KO; K03783; -.
DR   OMA; VLISDHI; -.
DR   OrthoDB; EOG091G0GEE; -.
DR   PhylomeDB; P00491; -.
DR   TreeFam; TF300049; -.
DR   BioCyc; MetaCyc:HS02151-MONOMER; -.
DR   BRENDA; 2.4.2.1; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-74217; Purine salvage.
DR   Reactome; R-HSA-74259; Purine catabolism.
DR   SABIO-RK; P00491; -.
DR   SignaLink; P00491; -.
DR   UniPathway; UPA00606; -.
DR   ChiTaRS; PNP; human.
DR   EvolutionaryTrace; P00491; -.
DR   GeneWiki; Purine_nucleoside_phosphorylase; -.
DR   GenomeRNAi; 4860; -.
DR   PRO; PR:P00491; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000198805; -.
DR   CleanEx; HS_NP; -.
DR   ExpressionAtlas; P00491; baseline and differential.
DR   Genevisible; P00491; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005622; C:intracellular; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0008144; F:drug binding; IDA:UniProtKB.
DR   GO; GO:0001882; F:nucleoside binding; IDA:UniProtKB.
DR   GO; GO:0042301; F:phosphate ion binding; IDA:UniProtKB.
DR   GO; GO:0002060; F:purine nucleobase binding; IDA:UniProtKB.
DR   GO; GO:0004731; F:purine-nucleoside phosphorylase activity; IDA:UniProtKB.
DR   GO; GO:0006955; P:immune response; IMP:UniProtKB.
DR   GO; GO:0006148; P:inosine catabolic process; IDA:MGI.
DR   GO; GO:0070970; P:interleukin-2 secretion; IMP:UniProtKB.
DR   GO; GO:0034356; P:NAD biosynthesis via nicotinamide riboside salvage pathway; IGI:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006738; P:nicotinamide riboside catabolic process; IDA:UniProtKB.
DR   GO; GO:0006139; P:nucleobase-containing compound metabolic process; IDA:UniProtKB.
DR   GO; GO:0046638; P:positive regulation of alpha-beta T cell differentiation; IDA:MGI.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; IDA:MGI.
DR   GO; GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome.
DR   GO; GO:0043101; P:purine-containing compound salvage; TAS:Reactome.
DR   GO; GO:0042493; P:response to drug; IDA:UniProtKB.
DR   GO; GO:0034418; P:urate biosynthetic process; IDA:MGI.
DR   InterPro; IPR000845; Nucleoside_phosphorylase_d.
DR   InterPro; IPR035994; Nucleoside_phosphorylase_sf.
DR   InterPro; IPR011270; Pur_Nuc_Pase_Ino/Guo-sp.
DR   InterPro; IPR011268; Purine_phosphorylase.
DR   InterPro; IPR018099; Purine_phosphorylase-2_CS.
DR   PANTHER; PTHR11904; PTHR11904; 1.
DR   Pfam; PF01048; PNP_UDP_1; 1.
DR   PIRSF; PIRSF000477; PurNPase; 1.
DR   SUPFAM; SSF53167; SSF53167; 1.
DR   TIGRFAMs; TIGR01700; PNPH; 1.
DR   TIGRFAMs; TIGR01697; PNPH-PUNA-XAPA; 1.
DR   PROSITE; PS01240; PNP_MTAP_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Disease mutation; Glycosyltransferase;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transferase.
FT   CHAIN         1    289       Purine nucleoside phosphorylase.
FT                                /FTId=PRO_0000184536.
FT   REGION       84     86       Phosphate binding.
FT                                {ECO:0000250|UniProtKB:P55859}.
FT   BINDING      33     33       Phosphate.
FT                                {ECO:0000250|UniProtKB:P55859}.
FT   BINDING      64     64       Phosphate.
FT                                {ECO:0000250|UniProtKB:P55859}.
FT   BINDING     116    116       Phosphate; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P55859}.
FT   BINDING     201    201       Purine nucleoside.
FT                                {ECO:0000250|UniProtKB:P55859}.
FT   BINDING     220    220       Phosphate.
FT                                {ECO:0000250|UniProtKB:P55859}.
FT   BINDING     243    243       Purine nucleoside.
FT                                {ECO:0000250|UniProtKB:P55859}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|Ref.8}.
FT   MOD_RES     251    251       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT      51     51       G -> S (in dbSNP:rs1049564).
FT                                {ECO:0000269|PubMed:12928150,
FT                                ECO:0000269|PubMed:1384322,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:3029074,
FT                                ECO:0000269|PubMed:6087295}.
FT                                /FTId=VAR_002243.
FT   VARIANT      89     89       E -> K (in PNPD; dbSNP:rs104894453).
FT                                {ECO:0000269|PubMed:3029074}.
FT                                /FTId=VAR_002244.
FT   VARIANT     128    128       D -> G (in PNPD; dbSNP:rs104894450).
FT                                {ECO:0000269|PubMed:1384322}.
FT                                /FTId=VAR_002245.
FT   VARIANT     174    174       A -> P (in PNPD; dbSNP:rs104894454).
FT                                /FTId=VAR_002246.
FT   VARIANT     192    192       Y -> C (in PNPD; dbSNP:rs104894452).
FT                                {ECO:0000269|PubMed:8931706}.
FT                                /FTId=VAR_010653.
FT   VARIANT     234    234       R -> P (in PNPD; dbSNP:rs104894451).
FT                                {ECO:0000269|PubMed:1384322}.
FT                                /FTId=VAR_002247.
FT   HELIX         7     20       {ECO:0000244|PDB:4EAR}.
FT   STRAND       26     31       {ECO:0000244|PDB:4EAR}.
FT   HELIX        36     41       {ECO:0000244|PDB:4EAR}.
FT   STRAND       43     49       {ECO:0000244|PDB:4EAR}.
FT   HELIX        50     52       {ECO:0000244|PDB:4EAR}.
FT   STRAND       53     55       {ECO:0000244|PDB:1PWY}.
FT   HELIX        62     65       {ECO:0000244|PDB:3BGS}.
FT   STRAND       67     73       {ECO:0000244|PDB:4EAR}.
FT   STRAND       76     83       {ECO:0000244|PDB:4EAR}.
FT   HELIX        87     89       {ECO:0000244|PDB:4EAR}.
FT   HELIX        93     96       {ECO:0000244|PDB:4EAR}.
FT   HELIX        98    106       {ECO:0000244|PDB:4EAR}.
FT   STRAND      110    119       {ECO:0000244|PDB:4EAR}.
FT   STRAND      121    123       {ECO:0000244|PDB:1V2H}.
FT   STRAND      129    137       {ECO:0000244|PDB:4EAR}.
FT   HELIX       138    141       {ECO:0000244|PDB:4EAR}.
FT   TURN        153    155       {ECO:0000244|PDB:4EAR}.
FT   TURN        163    166       {ECO:0000244|PDB:1V41}.
FT   HELIX       168    179       {ECO:0000244|PDB:4EAR}.
FT   TURN        180    182       {ECO:0000244|PDB:1RSZ}.
FT   STRAND      188    194       {ECO:0000244|PDB:4EAR}.
FT   STRAND      197    199       {ECO:0000244|PDB:1M73}.
FT   HELIX       203    211       {ECO:0000244|PDB:4EAR}.
FT   STRAND      215    221       {ECO:0000244|PDB:4EAR}.
FT   HELIX       222    230       {ECO:0000244|PDB:4EAR}.
FT   STRAND      234    244       {ECO:0000244|PDB:4EAR}.
FT   STRAND      248    250       {ECO:0000244|PDB:4EAR}.
FT   HELIX       257    266       {ECO:0000244|PDB:4EAR}.
FT   HELIX       268    280       {ECO:0000244|PDB:4EAR}.
FT   TURN        285    287       {ECO:0000244|PDB:1M73}.
SQ   SEQUENCE   289 AA;  32118 MW;  91622FB1D26479D3 CRC64;
     MENGYTYEDY KNTAEWLLSH TKHRPQVAII CGSGLGGLTD KLTQAQIFDY GEIPNFPRST
     VPGHAGRLVF GFLNGRACVM MQGRFHMYEG YPLWKVTFPV RVFHLLGVDT LVVTNAAGGL
     NPKFEVGDIM LIRDHINLPG FSGQNPLRGP NDERFGDRFP AMSDAYDRTM RQRALSTWKQ
     MGEQRELQEG TYVMVAGPSF ETVAECRVLQ KLGADAVGMS TVPEVIVARH CGLRVFGFSL
     ITNKVIMDYE SLEKANHEEV LAAGKQAAQK LEQFVSILMA SIPLPDKAS
//
ID   V9HWH6_HUMAN            Unreviewed;       289 AA.
AC   V9HWH6;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   23-MAY-2018, entry version 31.
DE   RecName: Full=Purine nucleoside phosphorylase {ECO:0000256|PIRNR:PIRNR000477};
DE            EC=2.4.2.1 {ECO:0000256|PIRNR:PIRNR000477};
DE   AltName: Full=Inosine-guanosine phosphorylase {ECO:0000256|PIRNR:PIRNR000477};
GN   Name=HEL-S-156an {ECO:0000313|EMBL:ACJ13703.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACJ13703.1};
RN   [1] {ECO:0000313|EMBL:ACJ13703.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu F.J., Liu J.;
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: The purine nucleoside phosphorylases catalyze the
CC       phosphorolytic breakdown of the N-glycosidic bond in the beta-
CC       (deoxy)ribonucleoside molecules, with the formation of the
CC       corresponding free purine bases and pentose-1-phosphate.
CC       {ECO:0000256|PIRNR:PIRNR000477}.
CC   -!- CATALYTIC ACTIVITY: Purine nucleoside + phosphate = purine +
CC       alpha-D-ribose 1-phosphate. {ECO:0000256|PIRNR:PIRNR000477}.
CC   -!- PATHWAY: Purine metabolism; purine nucleoside salvage.
CC       {ECO:0000256|PIRNR:PIRNR000477}.
CC   -!- SIMILARITY: Belongs to the PNP/MTAP phosphorylase family.
CC       {ECO:0000256|PIRNR:PIRNR000477}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU794649; ACJ13703.1; -; mRNA.
DR   RefSeq; NP_000261.2; NM_000270.3.
DR   UniGene; Hs.75514; -.
DR   ProteinModelPortal; V9HWH6; -.
DR   SMR; V9HWH6; -.
DR   MaxQB; V9HWH6; -.
DR   PRIDE; V9HWH6; -.
DR   GeneID; 4860; -.
DR   KEGG; hsa:4860; -.
DR   UCSC; uc001vxo.5; human.
DR   CTD; 4860; -.
DR   EuPathDB; HostDB:ENSG00000198805.11; -.
DR   eggNOG; KOG3984; Eukaryota.
DR   eggNOG; COG0005; LUCA.
DR   KO; K03783; -.
DR   OMA; VLISDHI; -.
DR   OrthoDB; EOG091G0GEE; -.
DR   PhylomeDB; V9HWH6; -.
DR   UniPathway; UPA00606; -.
DR   GenomeRNAi; 4860; -.
DR   Bgee; ENSG00000198805; -.
DR   ExpressionAtlas; V9HWH6; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005576; C:extracellular region; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0004731; F:purine-nucleoside phosphorylase activity; IEA:UniProtKB-EC.
DR   GO; GO:0042278; P:purine nucleoside metabolic process; IEA:Ensembl.
DR   InterPro; IPR000845; Nucleoside_phosphorylase_d.
DR   InterPro; IPR035994; Nucleoside_phosphorylase_sf.
DR   InterPro; IPR011270; Pur_Nuc_Pase_Ino/Guo-sp.
DR   InterPro; IPR011268; Purine_phosphorylase.
DR   InterPro; IPR018099; Purine_phosphorylase-2_CS.
DR   PANTHER; PTHR11904; PTHR11904; 1.
DR   Pfam; PF01048; PNP_UDP_1; 1.
DR   PIRSF; PIRSF000477; PurNPase; 1.
DR   SUPFAM; SSF53167; SSF53167; 1.
DR   TIGRFAMs; TIGR01700; PNPH; 1.
DR   TIGRFAMs; TIGR01697; PNPH-PUNA-XAPA; 1.
DR   PROSITE; PS01240; PNP_MTAP_2; 1.
PE   2: Evidence at transcript level;
KW   Glycosyltransferase {ECO:0000256|PIRNR:PIRNR000477};
KW   Transferase {ECO:0000256|PIRNR:PIRNR000477}.
FT   DOMAIN       27    275       PNP_UDP_1. {ECO:0000259|Pfam:PF01048}.
FT   REGION       84     86       Phosphate binding.
FT                                {ECO:0000256|PIRSR:PIRSR000477-2}.
FT   BINDING      33     33       Phosphate.
FT                                {ECO:0000256|PIRSR:PIRSR000477-2}.
FT   BINDING      64     64       Phosphate.
FT                                {ECO:0000256|PIRSR:PIRSR000477-2}.
FT   BINDING     116    116       Phosphate; via amide nitrogen.
FT                                {ECO:0000256|PIRSR:PIRSR000477-2}.
FT   BINDING     201    201       Purine nucleoside.
FT                                {ECO:0000256|PIRSR:PIRSR000477-2}.
FT   BINDING     220    220       Phosphate.
FT                                {ECO:0000256|PIRSR:PIRSR000477-2}.
FT   BINDING     243    243       Purine nucleoside.
FT                                {ECO:0000256|PIRSR:PIRSR000477-2}.
SQ   SEQUENCE   289 AA;  32118 MW;  91622FB1D26479D3 CRC64;
     MENGYTYEDY KNTAEWLLSH TKHRPQVAII CGSGLGGLTD KLTQAQIFDY GEIPNFPRST
     VPGHAGRLVF GFLNGRACVM MQGRFHMYEG YPLWKVTFPV RVFHLLGVDT LVVTNAAGGL
     NPKFEVGDIM LIRDHINLPG FSGQNPLRGP NDERFGDRFP AMSDAYDRTM RQRALSTWKQ
     MGEQRELQEG TYVMVAGPSF ETVAECRVLQ KLGADAVGMS TVPEVIVARH CGLRVFGFSL
     ITNKVIMDYE SLEKANHEEV LAAGKQAAQK LEQFVSILMA SIPLPDKAS
//
ID   B4DXD1_HUMAN            Unreviewed;       454 AA.
AC   B4DXD1;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 39.
DE   SubName: Full=cDNA FLJ51135, highly similar to Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) {ECO:0000313|EMBL:BAG63343.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG63343.1};
RN   [1] {ECO:0000313|EMBL:BAG63343.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:BAG63343.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK301922; BAG63343.1; -; mRNA.
DR   RefSeq; NP_001304994.1; NM_001318065.1.
DR   UniGene; Hs.445705; -.
DR   PeptideAtlas; B4DXD1; -.
DR   PRIDE; B4DXD1; -.
DR   GeneID; 6240; -.
DR   CTD; 6240; -.
DR   eggNOG; KOG1112; Eukaryota.
DR   eggNOG; COG0209; LUCA.
DR   HOVERGEN; HBG003447; -.
DR   GO; GO:0006260; P:DNA replication; IEA:InterPro.
DR   GO; GO:0055114; P:oxidation-reduction process; IEA:InterPro.
DR   InterPro; IPR013346; NrdE_NrdA.
DR   InterPro; IPR000788; RNR_lg_C.
DR   Pfam; PF02867; Ribonuc_red_lgC; 1.
DR   PRINTS; PR01183; RIBORDTASEM1.
DR   TIGRFAMs; TIGR02506; NrdE_NrdA; 1.
DR   PROSITE; PS00089; RIBORED_LARGE; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN      243    265       RIBORED_LARGE.
FT                                {ECO:0000259|PROSITE:PS00089}.
SQ   SEQUENCE   454 AA;  52033 MW;  E7A13E8D971EDEE7 CRC64;
     MKRVETNQDW SLMCPNECPG LDEVWGEEFE KLYASYEKQG RVRKVVKAQQ LWYAIIESQT
     ETGTPYMLYK DSCNRKSNQQ NLGTIKCSNL CTEIVEYTSK DEVAVCNLAS LALNMYVTSE
     HTYDFKKLAE VTKVVVRNLN KIIDINYYPV PEACLSNKRH RPIGIGVQGL ADAFILMRYP
     FESAEAQLLN KQIFETIYYG ALEASCDLAK EQGPYETYEG SPVSKGILQY DMWNVTPTDL
     WDWKVLKEKI AKYGIRNSLL IAPMPTASTA QILGNNESIE PYTSNIYTRR VLSGEFQIVN
     PHLLKDLTER GLWHEEMKNQ IIACNGSIQS IPEIPDDLKQ LYKTVWEISQ KTVLKMAAER
     GAFIDQSQSL NIHIAEPNYG KLTSMHFYGW KQGLKTGMYY LRTRPAANPI QFTLNKERLK
     DKEKVSKEEE EKERNTAAMV CSLENRDECL MCGS
//
ID   B4E0I8_HUMAN            Unreviewed;       695 AA.
AC   B4E0I8;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   23-MAY-2018, entry version 49.
DE   RecName: Full=Ribonucleoside-diphosphate reductase {ECO:0000256|RuleBase:RU003410};
DE            EC=1.17.4.1 {ECO:0000256|RuleBase:RU003410};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG64450.1};
RN   [1] {ECO:0000313|EMBL:BAG64450.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Thymus {ECO:0000313|EMBL:BAG64450.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Provides the precursors necessary for DNA synthesis.
CC       Catalyzes the biosynthesis of deoxyribonucleotides from the
CC       corresponding ribonucleotides. {ECO:0000256|RuleBase:RU003410}.
CC   -!- CATALYTIC ACTIVITY: 2'-deoxyribonucleoside diphosphate +
CC       thioredoxin disulfide + H(2)O = ribonucleoside diphosphate +
CC       thioredoxin. {ECO:0000256|RuleBase:RU003410}.
CC   -!- PATHWAY: Genetic information processing; DNA replication.
CC       {ECO:0000256|RuleBase:RU003410}.
CC   -!- SIMILARITY: Belongs to the ribonucleoside diphosphate reductase
CC       large chain family. {ECO:0000256|RuleBase:RU003410}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK303394; BAG64450.1; -; mRNA.
DR   RefSeq; NP_001304993.1; NM_001318064.1.
DR   UniGene; Hs.445705; -.
DR   PeptideAtlas; B4E0I8; -.
DR   PRIDE; B4E0I8; -.
DR   GeneID; 6240; -.
DR   CTD; 6240; -.
DR   eggNOG; KOG1112; Eukaryota.
DR   eggNOG; COG0209; LUCA.
DR   HOVERGEN; HBG003447; -.
DR   UniPathway; UPA00326; -.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0004748; F:ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; IEA:UniProtKB-EC.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR013346; NrdE_NrdA.
DR   InterPro; IPR000788; RNR_lg_C.
DR   InterPro; IPR013509; RNR_lsu_N.
DR   InterPro; IPR008926; RNR_R1-su_N.
DR   Pfam; PF02867; Ribonuc_red_lgC; 1.
DR   Pfam; PF00317; Ribonuc_red_lgN; 1.
DR   PRINTS; PR01183; RIBORDTASEM1.
DR   SUPFAM; SSF48168; SSF48168; 1.
DR   TIGRFAMs; TIGR02506; NrdE_NrdA; 1.
DR   PROSITE; PS00089; RIBORED_LARGE; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   DNA replication {ECO:0000256|RuleBase:RU003410};
KW   Oxidoreductase {ECO:0000256|RuleBase:RU003410}.
FT   DOMAIN      484    506       RIBORED_LARGE.
FT                                {ECO:0000259|PROSITE:PS00089}.
FT   COILED      656    676       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   695 AA;  79230 MW;  120C6624B61228BA CRC64;
     MEDLYNYINP HNGKHSPMVA KSTLDIVLAN KDRLNSAIIY DRDFSYNYFG FKTLERSYLL
     KINGKVAERP QHMLMRVSVG IHKEDIDAAI ETYNLLSERW FTHASPTLFN AGTNRPQLSS
     CFLLSMKDDS IEGIYDTLKQ CALISKSAGG IGVAVSCIRA TGSYIAGTNG NPNGLVPMLR
     VYNNTARYVD QGGNKRPGAF AIYLEPWHLD IFEFLDLKKN TGKEEQRARD LFFALWIPDL
     FMKRVETNQD WSLMCPNECP GLDEVWGEEF EKLYASYEKQ GRVRKVVKAQ QLWYAIIESQ
     TETGTPYMLY KDSCNRKSNQ QNLGTIKCSN LCTEIVEYTS KDEVAVCNLA SLALNMYVTS
     EHTYDFKKLA EVTKVVVRNL NKIIDINYYP VPEACLSNKR HRPIGIGVQG LADAFILMRY
     PFESAEAQLL NKQIFETIYY GALEASCDLA KEQGPYETYE GSPVSKGILQ YDMWNVTPTD
     LWDWKVLKEK IAKYGIRNSL LIAPMPTAST AQILGNNESI EPYTSNIYTR RVLSGEFQIV
     NPHLLKDLTE RGLWHEEMKN QIIACNGSIQ SIPEIPDDLK QLYKTVWEIS QKTVLKMAAE
     RGAFIDQSQS LNIHIAEPNY GKLTSMHFYG WKQGLKTGMY YLRTRPAANP IQFTLNKEKL
     KDKEKVSKEE EEKERNTAAM VCSLENRDEC LMCGS
//
ID   E9PL69_HUMAN            Unreviewed;       570 AA.
AC   E9PL69;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   28-MAR-2018, entry version 58.
DE   SubName: Full=Ribonucleoside-diphosphate reductase large subunit {ECO:0000313|Ensembl:ENSP00000431464};
GN   Name=RRM1 {ECO:0000313|Ensembl:ENSP00000431464};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000431464, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000431464, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000313|Ensembl:ENSP00000431464}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC015689; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001317122.1; NM_001330193.1.
DR   UniGene; Hs.445705; -.
DR   ProteinModelPortal; E9PL69; -.
DR   EPD; E9PL69; -.
DR   MaxQB; E9PL69; -.
DR   PeptideAtlas; E9PL69; -.
DR   PRIDE; E9PL69; -.
DR   Ensembl; ENST00000534285; ENSP00000431464; ENSG00000167325.
DR   GeneID; 6240; -.
DR   UCSC; uc057yfo.1; human.
DR   CTD; 6240; -.
DR   EuPathDB; HostDB:ENSG00000167325.14; -.
DR   HGNC; HGNC:10451; RRM1.
DR   OpenTargets; ENSG00000167325; -.
DR   eggNOG; KOG1112; Eukaryota.
DR   eggNOG; COG0209; LUCA.
DR   GeneTree; ENSGT00910000144246; -.
DR   ChiTaRS; RRM1; human.
DR   GenomeRNAi; 6240; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000167325; -.
DR   ExpressionAtlas; E9PL69; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0006260; P:DNA replication; IEA:InterPro.
DR   GO; GO:0055114; P:oxidation-reduction process; IEA:InterPro.
DR   InterPro; IPR013346; NrdE_NrdA.
DR   InterPro; IPR000788; RNR_lg_C.
DR   Pfam; PF02867; Ribonuc_red_lgC; 1.
DR   PRINTS; PR01183; RIBORDTASEM1.
DR   TIGRFAMs; TIGR02506; NrdE_NrdA; 1.
DR   PROSITE; PS00089; RIBORED_LARGE; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:E9PL69,
KW   ECO:0000213|MaxQB:E9PL69, ECO:0000213|PeptideAtlas:E9PL69};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      359    381       RIBORED_LARGE.
FT                                {ECO:0000259|PROSITE:PS00089}.
FT   COILED      531    551       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   570 AA;  64837 MW;  96219E93C3749A56 CRC64;
     MKDDSIEGIY DTLKQCALIS KSAGGIGVAV SCIRATGSYI AGTNGNSNGL VPMLRVYNNT
     ARYVDQGGNK RPGAFAIYLE PWHLDIFEFL DLKKNTGKEE QRARDLFFAL WIPDLFMKRV
     ETNQDWSLMC PNECPGLDEV WGEEFEKLYA SYEKQGRVRK VVKAQQLWYA IIESQTETGT
     PYMLYKDSCN RKSNQQNLGT IKCSNLCTEI VEYTSKDEVA VCNLASLALN MYVTSEHTYD
     FKKLAEVTKV VVRNLNKIID INYYPVPEAC LSNKRHRPIG IGVQGLADAF ILMRYPFESA
     EAQLLNKQIF ETIYYGALEA SCDLAKEQGP YETYEGSPVS KGILQYDMWN VTPTDLWDWK
     VLKEKIAKYG IRNSLLIAPM PTASTAQILG NNESIEPYTS NIYTRRVLSG EFQIVNPHLL
     KDLTERGLWH EEMKNQIIAC NGSIQSIPEI PDDLKQLYKT VWEISQKTVL KMAAERGAFI
     DQSQSLNIHI AEPNYGKLTS MHFYGWKQGL KTGMYYLRTR PAANPIQFTL NKEKLKDKEK
     VSKEEEEKER NTAAMVCSLE NRDECLMCGS
//
ID   RIR1_HUMAN              Reviewed;         792 AA.
AC   P23921; Q9UNN2;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-1992, sequence version 1.
DT   23-MAY-2018, entry version 187.
DE   RecName: Full=Ribonucleoside-diphosphate reductase large subunit;
DE            EC=1.17.4.1;
DE   AltName: Full=Ribonucleoside-diphosphate reductase subunit M1;
DE   AltName: Full=Ribonucleotide reductase large subunit;
GN   Name=RRM1; Synonyms=RR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Bone marrow;
RX   PubMed=1840662; DOI=10.1093/nar/19.13.3741;
RA   Parker N.J., Begley C.G., Fox R.M.;
RT   "Human M1 subunit of ribonucleotide reductase: cDNA sequence and
RT   expression in stimulated lymphocytes.";
RL   Nucleic Acids Res. 19:3741-3741(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Mammary carcinoma;
RX   PubMed=1627826; DOI=10.3109/10425179209020807;
RA   Pavloff N., Rivard D., Masson S., Shen S.-H., Mes-Masson A.-M.;
RT   "Sequence analysis of the large and small subunits of human
RT   ribonucleotide reductase.";
RL   DNA Seq. 2:227-234(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9933563; DOI=10.1006/geno.1998.5659;
RA   Bepler G., O'Briant K.C., Kim Y.-C., Schreiber G., Pitterle D.M.;
RT   "A 1.4-Mb high-resolution physical map and contig of chromosome
RT   segment 11p15.5 and genes in the LOH11A metastasis suppressor
RT   region.";
RL   Genomics 55:164-175(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-6.
RC   TISSUE=Placenta;
RX   PubMed=8188248; DOI=10.1006/geno.1994.1017;
RA   Parker N.J., Begley C.G., Fox R.M.;
RT   "Human R1 subunit of ribonucleotide reductase (RRM1): 5' flanking
RT   region of the gene.";
RL   Genomics 19:91-96(1994).
RN   [6]
RP   ENZYME REGULATION.
RX   PubMed=1867633; DOI=10.1016/0006-2952(91)90033-2;
RA   Harrington J.A., Spector T.;
RT   "Human ribonucleotide reductase. Activation and inhibition by analogs
RT   of ATP.";
RL   Biochem. Pharmacol. 42:759-763(1991).
RN   [7]
RP   INTERACTION WITH RRM2B.
RX   PubMed=12615712;
RA   Xue L., Zhou B., Liu X., Qiu W., Jin Z., Yen Y.;
RT   "Wild-type p53 regulates human ribonucleotide reductase by protein-
RT   protein interaction with p53R2 as well as hRRM2 subunits.";
RL   Cancer Res. 63:980-986(2003).
RN   [8]
RP   CATALYTIC ACTIVITY, SUBUNIT, AND ENZYME REGULATION.
RX   PubMed=16376858; DOI=10.1016/j.bbrc.2005.12.019;
RA   Qiu W., Zhou B., Darwish D., Shao J., Yen Y.;
RT   "Characterization of enzymatic properties of human ribonucleotide
RT   reductase holoenzyme reconstituted in vitro from hRRM1, hRRM2, and
RT   p53R2 subunits.";
RL   Biochem. Biophys. Res. Commun. 340:428-434(2006).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-17 AND LYS-376, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-751, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   ENZYME REGULATION, MUTAGENESIS OF ASP-57, AND INTERACTION WITH AHCYL1.
RX   PubMed=25237103; DOI=10.1126/science.1251550;
RA   Arnaoutov A., Dasso M.;
RT   "Enzyme regulation. IRBIT is a novel regulator of ribonucleotide
RT   reductase in higher eukaryotes.";
RL   Science 345:1512-1515(2014).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 75-742 IN COMPLEX WITH
RP   ALLOSTERIC EFFECTOR ATP AND MAGNESIUM IONS.
RX   PubMed=21336276; DOI=10.1038/nsmb.2007;
RA   Fairman J.W., Wijerathna S.R., Ahmad M.F., Xu H., Nakano R., Jha S.,
RA   Prendergast J., Welin R.M., Flodin S., Roos A., Nordlund P., Li Z.,
RA   Walz T., Dealwis C.G.;
RT   "Structural basis for allosteric regulation of human ribonucleotide
RT   reductase by nucleotide-induced oligomerization.";
RL   Nat. Struct. Mol. Biol. 18:316-322(2011).
CC   -!- FUNCTION: Provides the precursors necessary for DNA synthesis.
CC       Catalyzes the biosynthesis of deoxyribonucleotides from the
CC       corresponding ribonucleotides.
CC   -!- CATALYTIC ACTIVITY: 2'-deoxyribonucleoside diphosphate +
CC       thioredoxin disulfide + H(2)O = ribonucleoside diphosphate +
CC       thioredoxin. {ECO:0000269|PubMed:16376858}.
CC   -!- ENZYME REGULATION: Under complex allosteric control mediated by
CC       deoxynucleoside triphosphates and ATP binding to separate
CC       specificity and activation sites on the M1 subunit. The type of
CC       nucleotide bound at the specificity site determines substrate
CC       preference. It seems probable that ATP makes the enzyme reduce CDP
CC       and UDP, dGTP favors ADP reduction and dTTP favors GDP reduction.
CC       Stimulated by ATP and inhibited by dATP binding to the activity
CC       site, the dATP inhibition is mediated by AHCYL1 which stabilizes
CC       dATP in the site. {ECO:0000269|PubMed:16376858,
CC       ECO:0000269|PubMed:1867633, ECO:0000269|PubMed:25237103}.
CC   -!- PATHWAY: Genetic information processing; DNA replication.
CC   -!- SUBUNIT: Heterodimer of a large and a small subunit. Heterodimer
CC       with small subunit RRM2 or RRM2B. The heterodimer with RRM2 has
CC       higher catalytic activity than the heterodimer with RRM2B.
CC       Interacts with AHCYL1 which inhibits its activity.
CC       {ECO:0000269|PubMed:16376858, ECO:0000269|PubMed:21336276,
CC       ECO:0000269|PubMed:25237103}.
CC   -!- INTERACTION:
CC       Self; NbExp=5; IntAct=EBI-717006, EBI-717006;
CC       P31350:RRM2; NbExp=5; IntAct=EBI-717006, EBI-2339245;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- MISCELLANEOUS: Two distinct regulatory sites have been defined:
CC       the specificity site, which controls substrate specificity, and
CC       the activity site which regulates overall catalytic activity. A
CC       substrate-binding catalytic site, located on M1, is formed only in
CC       the presence of the second subunit M2.
CC   -!- MISCELLANEOUS: The level of the enzyme activity is closely
CC       correlated with the growth rate of a cell and appears to vary with
CC       the cell cycle.
CC   -!- SIMILARITY: Belongs to the ribonucleoside diphosphate reductase
CC       large chain family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Ribonucleotide reductase entry;
CC       URL="https://en.wikipedia.org/wiki/Ribonucleotide_reductase";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/RRM1ID42174ch11p15.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X59543; CAA42118.1; -; mRNA.
DR   EMBL; X59617; CAA42180.1; -; mRNA.
DR   EMBL; AF107045; AAD37491.1; -; Genomic_DNA.
DR   EMBL; BC006498; AAH06498.1; -; mRNA.
DR   EMBL; L10342; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS7750.1; -.
DR   PIR; S16680; S16680.
DR   RefSeq; NP_001024.1; NM_001033.4.
DR   RefSeq; NP_001304993.1; NM_001318064.1.
DR   RefSeq; NP_001304994.1; NM_001318065.1.
DR   UniGene; Hs.445705; -.
DR   PDB; 2WGH; X-ray; 2.30 A; A/B=75-742.
DR   PDB; 3HNC; X-ray; 2.41 A; A/B=1-792.
DR   PDB; 3HND; X-ray; 3.21 A; A/B=1-792.
DR   PDB; 3HNE; X-ray; 3.11 A; A/B=1-792.
DR   PDB; 3HNF; X-ray; 3.16 A; A/B=1-792.
DR   PDB; 4X3V; X-ray; 3.70 A; A/B=1-792.
DR   PDB; 5D1Y; X-ray; 9.01 A; A/B=1-792.
DR   PDB; 5TUS; X-ray; 2.66 A; A/B=1-792.
DR   PDBsum; 2WGH; -.
DR   PDBsum; 3HNC; -.
DR   PDBsum; 3HND; -.
DR   PDBsum; 3HNE; -.
DR   PDBsum; 3HNF; -.
DR   PDBsum; 4X3V; -.
DR   PDBsum; 5D1Y; -.
DR   PDBsum; 5TUS; -.
DR   ProteinModelPortal; P23921; -.
DR   SMR; P23921; -.
DR   BioGrid; 112154; 38.
DR   DIP; DIP-24233N; -.
DR   IntAct; P23921; 14.
DR   STRING; 9606.ENSP00000300738; -.
DR   BindingDB; P23921; -.
DR   ChEMBL; CHEMBL1830; -.
DR   DrugBank; DB00242; Cladribine.
DR   DrugBank; DB00631; Clofarabine.
DR   DrugBank; DB01073; Fludarabine.
DR   DrugBank; DB05420; gallium maltolate.
DR   DrugBank; DB00441; Gemcitabine.
DR   DrugBank; DB01005; Hydroxyurea.
DR   DrugBank; DB05003; Imexon.
DR   GuidetoPHARMACOLOGY; 2630; -.
DR   iPTMnet; P23921; -.
DR   PhosphoSitePlus; P23921; -.
DR   SwissPalm; P23921; -.
DR   BioMuta; RRM1; -.
DR   DMDM; 132608; -.
DR   EPD; P23921; -.
DR   MaxQB; P23921; -.
DR   PaxDb; P23921; -.
DR   PeptideAtlas; P23921; -.
DR   PRIDE; P23921; -.
DR   DNASU; 6240; -.
DR   Ensembl; ENST00000300738; ENSP00000300738; ENSG00000167325.
DR   GeneID; 6240; -.
DR   KEGG; hsa:6240; -.
DR   UCSC; uc001lyw.5; human.
DR   CTD; 6240; -.
DR   DisGeNET; 6240; -.
DR   EuPathDB; HostDB:ENSG00000167325.14; -.
DR   GeneCards; RRM1; -.
DR   HGNC; HGNC:10451; RRM1.
DR   HPA; CAB022093; -.
DR   HPA; HPA057265; -.
DR   HPA; HPA064297; -.
DR   MIM; 180410; gene.
DR   neXtProt; NX_P23921; -.
DR   OpenTargets; ENSG00000167325; -.
DR   PharmGKB; PA298; -.
DR   eggNOG; KOG1112; Eukaryota.
DR   eggNOG; COG0209; LUCA.
DR   GeneTree; ENSGT00910000144246; -.
DR   HOGENOM; HOG000057035; -.
DR   HOVERGEN; HBG003447; -.
DR   InParanoid; P23921; -.
DR   KO; K10807; -.
DR   OMA; DRYFLHI; -.
DR   OrthoDB; EOG091G01XV; -.
DR   PhylomeDB; P23921; -.
DR   TreeFam; TF300578; -.
DR   BioCyc; MetaCyc:HS09541-MONOMER; -.
DR   BRENDA; 1.17.4.1; 2681.
DR   Reactome; R-HSA-499943; Interconversion of nucleotide di- and triphosphates.
DR   SIGNOR; P23921; -.
DR   UniPathway; UPA00326; -.
DR   ChiTaRS; RRM1; human.
DR   EvolutionaryTrace; P23921; -.
DR   GeneWiki; RRM1; -.
DR   GenomeRNAi; 6240; -.
DR   PRO; PR:P23921; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000167325; -.
DR   CleanEx; HS_RRM1; -.
DR   ExpressionAtlas; P23921; baseline and differential.
DR   Genevisible; P23921; HS.
DR   GO; GO:0042995; C:cell projection; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005635; C:nuclear envelope; IEA:Ensembl.
DR   GO; GO:0005971; C:ribonucleoside-diphosphate reductase complex; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0097718; F:disordered domain specific binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004748; F:ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ISS:UniProtKB.
DR   GO; GO:0021846; P:cell proliferation in forebrain; IEA:Ensembl.
DR   GO; GO:0009263; P:deoxyribonucleotide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-UniPathway.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0000278; P:mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0051290; P:protein heterotetramerization; IEA:Ensembl.
DR   GO; GO:0006206; P:pyrimidine nucleobase metabolic process; IEA:Ensembl.
DR   GO; GO:0010212; P:response to ionizing radiation; IEA:Ensembl.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEA:Ensembl.
DR   InterPro; IPR005144; ATP-cone_dom.
DR   InterPro; IPR013346; NrdE_NrdA.
DR   InterPro; IPR000788; RNR_lg_C.
DR   InterPro; IPR013509; RNR_lsu_N.
DR   InterPro; IPR008926; RNR_R1-su_N.
DR   Pfam; PF03477; ATP-cone; 1.
DR   Pfam; PF02867; Ribonuc_red_lgC; 1.
DR   Pfam; PF00317; Ribonuc_red_lgN; 1.
DR   PRINTS; PR01183; RIBORDTASEM1.
DR   SUPFAM; SSF48168; SSF48168; 1.
DR   TIGRFAMs; TIGR02506; NrdE_NrdA; 1.
DR   PROSITE; PS51161; ATP_CONE; 1.
DR   PROSITE; PS00089; RIBORED_LARGE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Allosteric enzyme; ATP-binding;
KW   Complete proteome; Cytoplasm; Disulfide bond; DNA replication;
KW   Nucleotide-binding; Oxidoreductase; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    792       Ribonucleoside-diphosphate reductase
FT                                large subunit.
FT                                /FTId=PRO_0000187190.
FT   DOMAIN        1     92       ATP-cone. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00492}.
FT   REGION       11     17       Allosteric activator binding.
FT                                {ECO:0000250}.
FT   REGION      217    218       Substrate binding. {ECO:0000250}.
FT   REGION      285    288       Allosteric effector binding, determines
FT                                substrate specificity.
FT   REGION      427    431       Substrate binding. {ECO:0000250}.
FT   REGION      603    607       Substrate binding. {ECO:0000250}.
FT   ACT_SITE    427    427       Proton acceptor. {ECO:0000250}.
FT   ACT_SITE    429    429       Cysteine radical intermediate.
FT                                {ECO:0000250}.
FT   ACT_SITE    431    431       Proton acceptor. {ECO:0000250}.
FT   BINDING       5      5       Allosteric activator. {ECO:0000250}.
FT   BINDING      53     53       Allosteric activator. {ECO:0000250}.
FT   BINDING      88     88       Allosteric activator. {ECO:0000250}.
FT   BINDING     202    202       Substrate. {ECO:0000250}.
FT   BINDING     247    247       Substrate; via amide nitrogen.
FT                                {ECO:0000250}.
FT   SITE        218    218       Important for hydrogen atom transfer.
FT                                {ECO:0000250}.
FT   SITE        226    226       Allosteric effector binding, determines
FT                                substrate specificity.
FT   SITE        256    256       Allosteric effector binding, determines
FT                                substrate specificity.
FT   SITE        444    444       Important for hydrogen atom transfer.
FT                                {ECO:0000250}.
FT   SITE        737    737       Important for electron transfer.
FT                                {ECO:0000250}.
FT   SITE        738    738       Important for electron transfer.
FT                                {ECO:0000250}.
FT   SITE        787    787       Interacts with thioredoxin/glutaredoxin.
FT                                {ECO:0000250}.
FT   SITE        790    790       Interacts with thioredoxin/glutaredoxin.
FT                                {ECO:0000250}.
FT   MOD_RES      17     17       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     376    376       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     751    751       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   DISULFID    218    444       Redox-active. {ECO:0000250}.
FT   VARIANT     590    590       K -> Q (in dbSNP:rs2228123).
FT                                /FTId=VAR_052052.
FT   VARIANT     778    778       V -> A (in dbSNP:rs2229196).
FT                                /FTId=VAR_052053.
FT   MUTAGEN      57     57       D->N: Severely decreases interaction with
FT                                AHCYL1 in the presence of dATP.
FT                                {ECO:0000269|PubMed:25237103}.
FT   CONFLICT      6      6       R -> Q (in Ref. 3; AAD37491).
FT                                {ECO:0000305}.
FT   STRAND        2      4       {ECO:0000244|PDB:3HNC}.
FT   STRAND       10     12       {ECO:0000244|PDB:3HNC}.
FT   HELIX        15     23       {ECO:0000244|PDB:3HNC}.
FT   TURN         31     33       {ECO:0000244|PDB:3HNC}.
FT   HELIX        36     44       {ECO:0000244|PDB:3HNC}.
FT   STRAND       48     50       {ECO:0000244|PDB:3HND}.
FT   HELIX        53     66       {ECO:0000244|PDB:3HNC}.
FT   HELIX        67     69       {ECO:0000244|PDB:3HNC}.
FT   HELIX        78     88       {ECO:0000244|PDB:2WGH}.
FT   HELIX        94    103       {ECO:0000244|PDB:2WGH}.
FT   TURN        107    109       {ECO:0000244|PDB:2WGH}.
FT   HELIX       118    126       {ECO:0000244|PDB:2WGH}.
FT   HELIX       128    133       {ECO:0000244|PDB:2WGH}.
FT   HELIX       137    142       {ECO:0000244|PDB:2WGH}.
FT   HELIX       145    154       {ECO:0000244|PDB:2WGH}.
FT   STRAND      158    163       {ECO:0000244|PDB:3HNF}.
FT   HELIX       167    179       {ECO:0000244|PDB:2WGH}.
FT   HELIX       183    195       {ECO:0000244|PDB:2WGH}.
FT   STRAND      197    200       {ECO:0000244|PDB:2WGH}.
FT   HELIX       202    207       {ECO:0000244|PDB:2WGH}.
FT   STRAND      210    212       {ECO:0000244|PDB:2WGH}.
FT   STRAND      218    222       {ECO:0000244|PDB:2WGH}.
FT   HELIX       228    243       {ECO:0000244|PDB:2WGH}.
FT   STRAND      247    251       {ECO:0000244|PDB:2WGH}.
FT   STRAND      258    261       {ECO:0000244|PDB:3HNE}.
FT   HELIX       263    265       {ECO:0000244|PDB:2WGH}.
FT   STRAND      268    270       {ECO:0000244|PDB:3HNE}.
FT   HELIX       272    285       {ECO:0000244|PDB:2WGH}.
FT   STRAND      287    293       {ECO:0000244|PDB:3HND}.
FT   STRAND      297    301       {ECO:0000244|PDB:2WGH}.
FT   HELIX       308    311       {ECO:0000244|PDB:2WGH}.
FT   TURN        312    315       {ECO:0000244|PDB:2WGH}.
FT   STRAND      317    319       {ECO:0000244|PDB:2WGH}.
FT   HELIX       321    323       {ECO:0000244|PDB:2WGH}.
FT   STRAND      328    334       {ECO:0000244|PDB:2WGH}.
FT   HELIX       336    343       {ECO:0000244|PDB:2WGH}.
FT   STRAND      347    351       {ECO:0000244|PDB:2WGH}.
FT   TURN        353    355       {ECO:0000244|PDB:2WGH}.
FT   HELIX       359    361       {ECO:0000244|PDB:2WGH}.
FT   HELIX       365    376       {ECO:0000244|PDB:2WGH}.
FT   STRAND      381    385       {ECO:0000244|PDB:2WGH}.
FT   HELIX       386    400       {ECO:0000244|PDB:2WGH}.
FT   STRAND      404    407       {ECO:0000244|PDB:2WGH}.
FT   HELIX       408    413       {ECO:0000244|PDB:2WGH}.
FT   HELIX       418    420       {ECO:0000244|PDB:2WGH}.
FT   STRAND      428    430       {ECO:0000244|PDB:3HNC}.
FT   STRAND      442    444       {ECO:0000244|PDB:2WGH}.
FT   STRAND      446    450       {ECO:0000244|PDB:2WGH}.
FT   HELIX       451    454       {ECO:0000244|PDB:2WGH}.
FT   STRAND      459    461       {ECO:0000244|PDB:3HND}.
FT   HELIX       463    483       {ECO:0000244|PDB:2WGH}.
FT   HELIX       489    498       {ECO:0000244|PDB:2WGH}.
FT   STRAND      502    506       {ECO:0000244|PDB:2WGH}.
FT   HELIX       508    514       {ECO:0000244|PDB:2WGH}.
FT   STRAND      519    521       {ECO:0000244|PDB:3HND}.
FT   HELIX       522    550       {ECO:0000244|PDB:2WGH}.
FT   HELIX       554    556       {ECO:0000244|PDB:3HNE}.
FT   HELIX       561    563       {ECO:0000244|PDB:2WGH}.
FT   HELIX       567    570       {ECO:0000244|PDB:2WGH}.
FT   STRAND      577    579       {ECO:0000244|PDB:2WGH}.
FT   HELIX       581    591       {ECO:0000244|PDB:2WGH}.
FT   HELIX       607    611       {ECO:0000244|PDB:2WGH}.
FT   STRAND      623    629       {ECO:0000244|PDB:3HNC}.
FT   STRAND      632    637       {ECO:0000244|PDB:3HNC}.
FT   HELIX       639    648       {ECO:0000244|PDB:2WGH}.
FT   HELIX       655    661       {ECO:0000244|PDB:2WGH}.
FT   TURN        662    664       {ECO:0000244|PDB:3HNC}.
FT   STRAND      670    672       {ECO:0000244|PDB:2WGH}.
FT   HELIX       674    679       {ECO:0000244|PDB:2WGH}.
FT   TURN        683    685       {ECO:0000244|PDB:3HNC}.
FT   HELIX       688    699       {ECO:0000244|PDB:2WGH}.
FT   HELIX       717    729       {ECO:0000244|PDB:2WGH}.
FT   STRAND      733    737       {ECO:0000244|PDB:2WGH}.
SQ   SEQUENCE   792 AA;  90070 MW;  4470A76C61E8F86A CRC64;
     MHVIKRDGRQ ERVMFDKITS RIQKLCYGLN MDFVDPAQIT MKVIQGLYSG VTTVELDTLA
     AETAATLTTK HPDYAILAAR IAVSNLHKET KKVFSDVMED LYNYINPHNG KHSPMVAKST
     LDIVLANKDR LNSAIIYDRD FSYNYFGFKT LERSYLLKIN GKVAERPQHM LMRVSVGIHK
     EDIDAAIETY NLLSERWFTH ASPTLFNAGT NRPQLSSCFL LSMKDDSIEG IYDTLKQCAL
     ISKSAGGIGV AVSCIRATGS YIAGTNGNSN GLVPMLRVYN NTARYVDQGG NKRPGAFAIY
     LEPWHLDIFE FLDLKKNTGK EEQRARDLFF ALWIPDLFMK RVETNQDWSL MCPNECPGLD
     EVWGEEFEKL YASYEKQGRV RKVVKAQQLW YAIIESQTET GTPYMLYKDS CNRKSNQQNL
     GTIKCSNLCT EIVEYTSKDE VAVCNLASLA LNMYVTSEHT YDFKKLAEVT KVVVRNLNKI
     IDINYYPVPE ACLSNKRHRP IGIGVQGLAD AFILMRYPFE SAEAQLLNKQ IFETIYYGAL
     EASCDLAKEQ GPYETYEGSP VSKGILQYDM WNVTPTDLWD WKVLKEKIAK YGIRNSLLIA
     PMPTASTAQI LGNNESIEPY TSNIYTRRVL SGEFQIVNPH LLKDLTERGL WHEEMKNQII
     ACNGSIQSIP EIPDDLKQLY KTVWEISQKT VLKMAAERGA FIDQSQSLNI HIAEPNYGKL
     TSMHFYGWKQ GLKTGMYYLR TRPAANPIQF TLNKEKLKDK EKVSKEEEEK ERNTAAMVCS
     LENRDECLMC GS
//
ID   A0A024R048_HUMAN        Unreviewed;       279 AA.
AC   A0A024R048;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 32.
DE   RecName: Full=NAD kinase 2, mitochondrial {ECO:0000256|PIRNR:PIRNR017565};
DE            EC=2.7.1.23 {ECO:0000256|PIRNR:PIRNR017565};
DE   AltName: Full=NAD kinase domain-containing protein 1, mitochondrial {ECO:0000256|PIRNR:PIRNR017565};
GN   Name=FLJ30596 {ECO:0000313|EMBL:EAW55941.1};
GN   ORFNames=hCG_37582 {ECO:0000313|EMBL:EAW55941.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW55941.1};
RN   [1] {ECO:0000313|EMBL:EAW55941.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW55941.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Mitochondrial NAD(+) kinase that phosphorylates NAD(+)
CC       to yield NADP(+). Can use both ATP or inorganic polyphosphate as
CC       the phosphoryl donor. {ECO:0000256|PIRNR:PIRNR017565}.
CC   -!- CATALYTIC ACTIVITY: ATP + NAD(+) = ADP + NADP(+).
CC       {ECO:0000256|PIRNR:PIRNR017565}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000256|PIRNR:PIRNR017565}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion
CC       {ECO:0000256|PIRNR:PIRNR017565}.
CC   -!- SIMILARITY: Belongs to the NAD kinase family.
CC       {ECO:0000256|PIRNR:PIRNR017565}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471119; EAW55939.1; -; Genomic_DNA.
DR   EMBL; CH471119; EAW55940.1; -; Genomic_DNA.
DR   EMBL; CH471119; EAW55941.1; -; Genomic_DNA.
DR   RefSeq; NP_001274269.1; NM_001287340.1.
DR   RefSeq; NP_694558.1; NM_153013.4.
DR   UniGene; Hs.81907; -.
DR   GeneID; 133686; -.
DR   CTD; 133686; -.
DR   EuPathDB; HostDB:ENSG00000152620.12; -.
DR   eggNOG; KOG4180; Eukaryota.
DR   eggNOG; ENOG410XQA4; LUCA.
DR   GenomeRNAi; 133686; -.
DR   Bgee; ENSG00000152620; -.
DR   ExpressionAtlas; A0A024R048; baseline and differential.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003951; F:NAD+ kinase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0019674; P:NAD metabolic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0006741; P:NADP biosynthetic process; IEA:UniProtKB-UniRule.
DR   Gene3D; 2.60.200.30; -; 1.
DR   InterPro; IPR017437; ATP-NAD_kinase_PpnK-typ_C.
DR   InterPro; IPR016064; NAD/diacylglycerol_kinase_sf.
DR   InterPro; IPR012355; NADK_euk.
DR   PIRSF; PIRSF017565; Kin_ATP-NAD_euk; 1.
DR   SUPFAM; SSF111331; SSF111331; 2.
PE   3: Inferred from homology;
KW   ATP-binding {ECO:0000256|PIRNR:PIRNR017565};
KW   Kinase {ECO:0000256|PIRNR:PIRNR017565};
KW   Mitochondrion {ECO:0000256|PIRNR:PIRNR017565};
KW   NAD {ECO:0000256|PIRNR:PIRNR017565};
KW   NADP {ECO:0000256|PIRNR:PIRNR017565};
KW   Nucleotide-binding {ECO:0000256|PIRNR:PIRNR017565};
KW   Transferase {ECO:0000256|PIRNR:PIRNR017565}.
SQ   SEQUENCE   279 AA;  31716 MW;  8A6977E19682F747 CRC64;
     MLLAASKVLD RLKPVIGVNT DPERSEGHLC LPVRYTHSFP EALQKFYRGE FRWLWRQRIR
     LYLEGTGINP VPVDLHEQQL SLNQHNRALN IERAHDERSE ASGPQLLPVR ALNEVFIGES
     LSSRASYYEI SVDDGPWEKQ KSSGLNLCTG TGSKAWSFNI NRVATQAVED VLNIAKRQGN
     LSLPLNRELV EKVTNEYNES LLYSPEEPKI LFSIREPIAN RVFSSSRQRC FSSKVCVRSR
     CWDACMVVDG GTSFEFNDGA IASMMINKED ELRTVLLEQ
//
ID   B7Z8V7_HUMAN            Unreviewed;       301 AA.
AC   B7Z8V7;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   23-MAY-2018, entry version 76.
DE   RecName: Full=NAD kinase 2, mitochondrial {ECO:0000256|PIRNR:PIRNR017565};
DE            EC=2.7.1.23 {ECO:0000256|PIRNR:PIRNR017565};
DE   AltName: Full=NAD kinase domain-containing protein 1, mitochondrial {ECO:0000256|PIRNR:PIRNR017565};
GN   Name=NADK2 {ECO:0000313|Ensembl:ENSP00000422250};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH14093.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000422250, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [2] {ECO:0000313|EMBL:BAH14093.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAH14093.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000313|Ensembl:ENSP00000422250}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [5] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Mitochondrial NAD(+) kinase that phosphorylates NAD(+)
CC       to yield NADP(+). Can use both ATP or inorganic polyphosphate as
CC       the phosphoryl donor. {ECO:0000256|PIRNR:PIRNR017565}.
CC   -!- CATALYTIC ACTIVITY: ATP + NAD(+) = ADP + NADP(+).
CC       {ECO:0000256|PIRNR:PIRNR017565}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000256|PIRNR:PIRNR017565}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion
CC       {ECO:0000256|PIRNR:PIRNR017565}.
CC   -!- SIMILARITY: Belongs to the NAD kinase family.
CC       {ECO:0000256|PIRNR:PIRNR017565}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC008807; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008942; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK304009; BAH14093.1; -; mRNA.
DR   RefSeq; NP_001274270.1; NM_001287341.1.
DR   RefSeq; NP_694558.1; NM_153013.4.
DR   UniGene; Hs.81907; -.
DR   Ensembl; ENST00000506945; ENSP00000422250; ENSG00000152620.
DR   GeneID; 133686; -.
DR   UCSC; uc011cov.4; human.
DR   CTD; 133686; -.
DR   EuPathDB; HostDB:ENSG00000152620.12; -.
DR   HGNC; HGNC:26404; NADK2.
DR   OpenTargets; ENSG00000152620; -.
DR   GeneTree; ENSGT00390000006320; -.
DR   HOGENOM; HOG000020135; -.
DR   HOVERGEN; HBG106388; -.
DR   ChiTaRS; NADK2; human.
DR   GenomeRNAi; 133686; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000152620; -.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003951; F:NAD+ kinase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0019674; P:NAD metabolic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0006741; P:NADP biosynthetic process; IEA:UniProtKB-UniRule.
DR   InterPro; IPR016064; NAD/diacylglycerol_kinase_sf.
DR   InterPro; IPR012355; NADK_euk.
DR   PIRSF; PIRSF017565; Kin_ATP-NAD_euk; 1.
DR   SUPFAM; SSF111331; SSF111331; 2.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|PIRNR:PIRNR017565};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Kinase {ECO:0000256|PIRNR:PIRNR017565};
KW   Mitochondrion {ECO:0000256|PIRNR:PIRNR017565};
KW   NAD {ECO:0000256|PIRNR:PIRNR017565};
KW   NADP {ECO:0000256|PIRNR:PIRNR017565};
KW   Nucleotide-binding {ECO:0000256|PIRNR:PIRNR017565};
KW   Proteomics identification {ECO:0000213|EPD:B7Z8V7,
KW   ECO:0000213|MaxQB:B7Z8V7, ECO:0000213|PeptideAtlas:B7Z8V7};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transferase {ECO:0000256|PIRNR:PIRNR017565}.
SQ   SEQUENCE   301 AA;  34176 MW;  C3991E5C319A746E CRC64;
     MLLAASKVLD RLKPVIGVNT DPERSEGHLC LPVRYTHSFP EALQKFYRGE FRWLWRQRIR
     LYLEGTGINP VPVDLHEQQL SLNQHNRALN IERAHDERSE ASGPQLLPVR ALNEVFIGES
     LSSRMSYSWA VAVDNLRRSI PTLKGLASYY EISVDDGPWE KQKSSGLNLC TGTGSKAWSF
     NINRVATQAV EDVLNIAKRQ GNLSLPLNRE LVEKVTNEYN ESLLYSPEEP KILFSIREPI
     ANRVFSSSRQ RCFSSKVCVR SRCWDACMVV DGGTSFEFND GAIASMMINK EDELRTVLLE
     Q
//
ID   NAKD2_HUMAN             Reviewed;         442 AA.
AC   Q4G0N4; B5MC93; Q6UTX5; Q96NM0;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 2.
DT   23-MAY-2018, entry version 105.
DE   RecName: Full=NAD kinase 2, mitochondrial;
DE            EC=2.7.1.23;
DE   AltName: Full=Mitochondrial NAD kinase;
DE   AltName: Full=NAD kinase domain-containing protein 1, mitochondrial;
DE   Flags: Precursor;
GN   Name=NADK2; Synonyms=C5orf33, MNADK, NADKD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 39-442 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 164-442 (ISOFORM 2).
RA   Li H., Yu R., Zhou G., Shen C., Xiao W., Li M., Ke R., Zhong G.,
RA   Lin L., Yang S.;
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES,
RP   SUBCELLULAR LOCATION, ENZYME REGULATION, AND TISSUE SPECIFICITY.
RX   PubMed=23212377; DOI=10.1038/ncomms2262;
RA   Ohashi K., Kawai S., Murata K.;
RT   "Identification and characterization of a human mitochondrial NAD
RT   kinase.";
RL   Nat. Commun. 3:1248-1248(2012).
RN   [7]
RP   INVOLVEMENT IN DECRD.
RX   PubMed=24847004; DOI=10.1093/hmg/ddu218;
RA   Houten S.M., Denis S., Te Brinke H., Jongejan A., van Kampen A.H.,
RA   Bradley E.J., Baas F., Hennekam R.C., Millington D.S., Young S.P.,
RA   Frazier D.M., Gucsavas-Calikoglu M., Wanders R.J.;
RT   "Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes
RT   dienoyl-CoA reductase deficiency with hyperlysinemia.";
RL   Hum. Mol. Genet. 23:5009-5016(2014).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-188 AND SER-367, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Mitochondrial NAD(+) kinase that phosphorylates NAD(+)
CC       to yield NADP(+). Can use both ATP or inorganic polyphosphate as
CC       the phosphoryl donor. Also has weak NADH kinase activity in vitro;
CC       however NADH kinase activity is much weaker than the NAD(+) kinase
CC       activity and may not be relevant in vivo.
CC       {ECO:0000269|PubMed:23212377}.
CC   -!- CATALYTIC ACTIVITY: ATP + NAD(+) = ADP + NADP(+).
CC       {ECO:0000269|PubMed:23212377}.
CC   -!- ENZYME REGULATION: Inhibited by NADH, NADPH and NADP(+).
CC       {ECO:0000269|PubMed:23212377}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.022 mM for NAD(+) {ECO:0000269|PubMed:23212377};
CC         KM=1.7 mM for ATP {ECO:0000269|PubMed:23212377};
CC         KM=1.2 mM for tetrapolyphosphate {ECO:0000269|PubMed:23212377};
CC         Vmax=0.091 umol/min/mg enzyme {ECO:0000269|PubMed:23212377};
CC   -!- SUBUNIT: Homodimer. {ECO:0000305|PubMed:23212377}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:23212377}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q4G0N4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q4G0N4-2; Sequence=VSP_027193;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q4G0N4-3; Sequence=VSP_027192;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:23212377}.
CC   -!- DISEASE: 2,4-dienoyl-CoA reductase deficiency (DECRD)
CC       [MIM:616034]: A rare, autosomal recessive, inborn error of
CC       polyunsaturated fatty acids and lysine metabolism, resulting in
CC       mitochondrial dysfunction. Affected individuals have a severe
CC       encephalopathy with neurologic and metabolic abnormalities
CC       beginning in early infancy. Laboratory studies show increased
CC       C10:2 carnitine levels and hyperlysinemia.
CC       {ECO:0000269|PubMed:24847004}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the NAD kinase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK055158; BAB70864.1; -; mRNA.
DR   EMBL; AC008807; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008942; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC045565; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC062567; AAH62567.1; -; mRNA.
DR   EMBL; AY360463; AAQ62967.1; -; mRNA.
DR   CCDS; CCDS3917.1; -. [Q4G0N4-3]
DR   CCDS; CCDS47197.1; -. [Q4G0N4-1]
DR   RefSeq; NP_001078880.1; NM_001085411.2. [Q4G0N4-1]
DR   RefSeq; NP_001274269.1; NM_001287340.1. [Q4G0N4-3]
DR   RefSeq; NP_001274270.1; NM_001287341.1.
DR   RefSeq; NP_694558.1; NM_153013.4. [Q4G0N4-3]
DR   UniGene; Hs.81907; -.
DR   ProteinModelPortal; Q4G0N4; -.
DR   BioGrid; 126369; 18.
DR   IntAct; Q4G0N4; 3.
DR   STRING; 9606.ENSP00000371362; -.
DR   iPTMnet; Q4G0N4; -.
DR   PhosphoSitePlus; Q4G0N4; -.
DR   BioMuta; NADK2; -.
DR   DMDM; 156630863; -.
DR   EPD; Q4G0N4; -.
DR   MaxQB; Q4G0N4; -.
DR   PaxDb; Q4G0N4; -.
DR   PeptideAtlas; Q4G0N4; -.
DR   PRIDE; Q4G0N4; -.
DR   DNASU; 133686; -.
DR   Ensembl; ENST00000282512; ENSP00000282512; ENSG00000152620. [Q4G0N4-3]
DR   Ensembl; ENST00000381937; ENSP00000371362; ENSG00000152620. [Q4G0N4-1]
DR   Ensembl; ENST00000397338; ENSP00000380499; ENSG00000152620. [Q4G0N4-3]
DR   Ensembl; ENST00000514504; ENSP00000421029; ENSG00000152620. [Q4G0N4-2]
DR   GeneID; 133686; -.
DR   KEGG; hsa:133686; -.
DR   UCSC; uc003jkf.6; human. [Q4G0N4-1]
DR   CTD; 133686; -.
DR   DisGeNET; 133686; -.
DR   EuPathDB; HostDB:ENSG00000152620.12; -.
DR   GeneCards; NADK2; -.
DR   H-InvDB; HIX0004812; -.
DR   HGNC; HGNC:26404; NADK2.
DR   HPA; HPA038366; -.
DR   HPA; HPA038367; -.
DR   HPA; HPA061492; -.
DR   MalaCards; NADK2; -.
DR   MIM; 615787; gene.
DR   MIM; 616034; phenotype.
DR   neXtProt; NX_Q4G0N4; -.
DR   OpenTargets; ENSG00000152620; -.
DR   PharmGKB; PA162380039; -.
DR   eggNOG; KOG4180; Eukaryota.
DR   eggNOG; ENOG410XQA4; LUCA.
DR   GeneTree; ENSGT00390000006320; -.
DR   HOVERGEN; HBG106388; -.
DR   InParanoid; Q4G0N4; -.
DR   KO; K00858; -.
DR   OMA; YSWAVAV; -.
DR   OrthoDB; EOG091G0AX1; -.
DR   PhylomeDB; Q4G0N4; -.
DR   TreeFam; TF314077; -.
DR   Reactome; R-HSA-196807; Nicotinate metabolism.
DR   ChiTaRS; NADK2; human.
DR   GenomeRNAi; 133686; -.
DR   PRO; PR:Q4G0N4; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000152620; -.
DR   CleanEx; HS_C5orf33; -.
DR   ExpressionAtlas; Q4G0N4; baseline and differential.
DR   Genevisible; Q4G0N4; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003951; F:NAD+ kinase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0019674; P:NAD metabolic process; IDA:UniProtKB.
DR   GO; GO:0006741; P:NADP biosynthetic process; IEA:InterPro.
DR   Gene3D; 2.60.200.30; -; 1.
DR   Gene3D; 3.40.50.10330; -; 1.
DR   InterPro; IPR017438; ATP-NAD_kinase_N.
DR   InterPro; IPR017437; ATP-NAD_kinase_PpnK-typ_C.
DR   InterPro; IPR016064; NAD/diacylglycerol_kinase_sf.
DR   InterPro; IPR002504; NADK.
DR   InterPro; IPR012355; NADK_euk.
DR   Pfam; PF01513; NAD_kinase; 1.
DR   PIRSF; PIRSF017565; Kin_ATP-NAD_euk; 1.
DR   SUPFAM; SSF111331; SSF111331; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Mitochondrion; NAD; NADP; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Transferase; Transit peptide.
FT   TRANSIT       1     62       Mitochondrion. {ECO:0000255}.
FT   CHAIN        63    442       NAD kinase 2, mitochondrial.
FT                                /FTId=PRO_0000296292.
FT   MOD_RES      76     76       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8C5H8}.
FT   MOD_RES      76     76       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8C5H8}.
FT   MOD_RES     188    188       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     302    302       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8C5H8}.
FT   MOD_RES     317    317       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8C5H8}.
FT   MOD_RES     317    317       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8C5H8}.
FT   MOD_RES     367    367       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     397    397       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8C5H8}.
FT   VAR_SEQ       1    163       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_027192.
FT   VAR_SEQ     288    319       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_027193.
SQ   SEQUENCE   442 AA;  49433 MW;  289EA16979AF14D8 CRC64;
     MTCYRGFLLG SCCRVAGGRA AALRGPGAGG PAARPRLGGD GGGRRHLGQG QPRELAGCGS
     RADGGFRPSR VVVVAKTTRY EFEQQRYRYA ELSEEDLKQL LALKGSSYSG LLERHHIHTK
     NVEHIIDSLR NEGIEVRLVK RREYDEETVR WADAVIAAGG DGTMLLAASK VLDRLKPVIG
     VNTDPERSEG HLCLPVRYTH SFPEALQKFY RGEFRWLWRQ RIRLYLEGTG INPVPVDLHE
     QQLSLNQHNR ALNIERAHDE RSEASGPQLL PVRALNEVFI GESLSSRASY YEISVDDGPW
     EKQKSSGLNL CTGTGSKAWS FNINRVATQA VEDVLNIAKR QGNLSLPLNR ELVEKVTNEY
     NESLLYSPEE PKILFSIREP IANRVFSSSR QRCFSSKVCV RSRCWDACMV VDGGTSFEFN
     DGAIASMMIN KEDELRTVLL EQ
//
ID   ANXA4_HUMAN             Reviewed;         319 AA.
AC   P09525; B4DDF9; Q96F33; Q9BWK1;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   28-MAR-2018, entry version 190.
DE   RecName: Full=Annexin A4;
DE   AltName: Full=35-beta calcimedin;
DE   AltName: Full=Annexin IV;
DE   AltName: Full=Annexin-4;
DE   AltName: Full=Carbohydrate-binding protein p33/p41;
DE   AltName: Full=Chromobindin-4;
DE   AltName: Full=Endonexin I;
DE   AltName: Full=Lipocortin IV;
DE   AltName: Full=P32.5;
DE   AltName: Full=PP4-X;
DE   AltName: Full=Placental anticoagulant protein II;
DE            Short=PAP-II;
DE   AltName: Full=Protein II;
GN   Name=ANXA4; Synonyms=ANX4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2970257;
RA   Grundmann U., Amann E., Abel K.-J., Kuepper H.A.;
RT   "Isolation and expression of cDNA coding for a new member of the
RT   phospholipase A2 inhibitor family.";
RL   Behring Inst. Mitt. 82:59-67(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1346776; DOI=10.1016/0888-7543(92)90379-7;
RA   Tait J.F., Smith C., Frankenberry D.A., Miao C.H., Adler D.A.,
RA   Disteche C.M.;
RT   "Chromosomal mapping of the human annexin IV (ANX4) gene.";
RL   Genomics 12:313-318(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9084877; DOI=10.1248/bpb.20.224;
RA   Satoh A., Takayama E., Kojima K., Ogawa H., Katsura Y., Kina T.,
RA   Matsumoto I.;
RT   "Characterization of human p33/41 (annexin IV), a Ca2+ dependent
RT   carbohydrate-binding protein with monoclonal anti-annexin IV
RT   antibodies, AS11 and AS17.";
RL   Biol. Pharm. Bull. 20:224-229(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Adrenal gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-15; 28-72; 100-144 AND 281-319.
RX   PubMed=2975506; DOI=10.1021/bi00417a011;
RA   Tait J.F., Sakata M., McMullen B.A., Miao C.H., Funakoshi T.,
RA   Hendrickson L.E., Fujikawa K.;
RT   "Placental anticoagulant proteins: isolation and comparative
RT   characterization four members of the lipocortin family.";
RL   Biochemistry 27:6268-6276(1988).
RN   [8]
RP   PROTEIN SEQUENCE OF 27-56; 99-124 AND 280-308.
RC   TISSUE=Placenta;
RX   PubMed=2974032;
RA   Ahn N.G., Teller D.C., Bienkowski M.J., McMullen B.A., Lipkin E.W.,
RA   de Haen C.;
RT   "Sedimentation equilibrium analysis of five lipocortin-related
RT   phospholipase A2 inhibitors from human placenta. Evidence against a
RT   mechanistically relevant association between enzyme and inhibitor.";
RL   J. Biol. Chem. 263:18657-18663(1988).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-213; LYS-293 AND LYS-300,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=2254922; DOI=10.1016/S0022-2836(05)80310-9;
RA   Freemont P.S., Driessen H.P.C., Verbi W., Crumpton M.J.;
RT   "Crystallization and preliminary X-ray crystallographic studies of
RT   human placental annexin IV.";
RL   J. Mol. Biol. 216:219-221(1990).
CC   -!- FUNCTION: Calcium/phospholipid-binding protein which promotes
CC       membrane fusion and is involved in exocytosis. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9BSI4:TINF2; NbExp=2; IntAct=EBI-2556852, EBI-717399;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P09525-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P09525-2; Sequence=VSP_056396;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: A pair of annexin repeats may form one binding site for
CC       calcium and phospholipid.
CC   -!- MISCELLANEOUS: Seems to bind one calcium ion with high affinity.
CC   -!- SIMILARITY: Belongs to the annexin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC41689.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH00182.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH11659.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA11227.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M19383; AAC41689.1; ALT_INIT; mRNA.
DR   EMBL; M82809; AAA51740.1; -; mRNA.
DR   EMBL; D78152; BAA11227.1; ALT_INIT; mRNA.
DR   EMBL; AK293177; BAG56720.1; -; mRNA.
DR   EMBL; AC019206; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092431; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC112787; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000182; AAH00182.1; ALT_INIT; mRNA.
DR   EMBL; BC011659; AAH11659.1; ALT_INIT; mRNA.
DR   PIR; A42077; A42077.
DR   RefSeq; NP_001144.1; NM_001153.4.
DR   RefSeq; NP_001307627.1; NM_001320698.1.
DR   RefSeq; NP_001307629.1; NM_001320700.1.
DR   RefSeq; NP_001307631.1; NM_001320702.1. [P09525-2]
DR   RefSeq; XP_016859432.1; XM_017003943.1.
DR   RefSeq; XP_016859433.1; XM_017003944.1. [P09525-2]
DR   UniGene; Hs.422986; -.
DR   PDB; 2ZOC; X-ray; 2.00 A; A/B=1-319.
DR   PDBsum; 2ZOC; -.
DR   ProteinModelPortal; P09525; -.
DR   SMR; P09525; -.
DR   BioGrid; 106804; 21.
DR   IntAct; P09525; 6.
DR   MINT; P09525; -.
DR   STRING; 9606.ENSP00000377833; -.
DR   iPTMnet; P09525; -.
DR   PhosphoSitePlus; P09525; -.
DR   SwissPalm; P09525; -.
DR   BioMuta; ANXA4; -.
DR   DMDM; 1703319; -.
DR   DOSAC-COBS-2DPAGE; P09525; -.
DR   OGP; P09525; -.
DR   REPRODUCTION-2DPAGE; IPI00793199; -.
DR   REPRODUCTION-2DPAGE; P09525; -.
DR   SWISS-2DPAGE; P09525; -.
DR   EPD; P09525; -.
DR   MaxQB; P09525; -.
DR   PaxDb; P09525; -.
DR   PeptideAtlas; P09525; -.
DR   PRIDE; P09525; -.
DR   DNASU; 307; -.
DR   Ensembl; ENST00000394295; ENSP00000377833; ENSG00000196975.
DR   Ensembl; ENST00000536030; ENSP00000441931; ENSG00000196975.
DR   GeneID; 307; -.
DR   KEGG; hsa:307; -.
DR   CTD; 307; -.
DR   DisGeNET; 307; -.
DR   EuPathDB; HostDB:ENSG00000196975.15; -.
DR   GeneCards; ANXA4; -.
DR   HGNC; HGNC:542; ANXA4.
DR   HPA; CAB005076; -.
DR   HPA; CAB017560; -.
DR   HPA; HPA007393; -.
DR   MIM; 106491; gene.
DR   neXtProt; NX_P09525; -.
DR   PharmGKB; PA24832; -.
DR   eggNOG; KOG0819; Eukaryota.
DR   eggNOG; ENOG410XPUN; LUCA.
DR   HOVERGEN; HBG061815; -.
DR   InParanoid; P09525; -.
DR   KO; K17093; -.
DR   OrthoDB; EOG091G0H6H; -.
DR   PhylomeDB; P09525; -.
DR   TreeFam; TF105452; -.
DR   ChiTaRS; ANXA4; human.
DR   EvolutionaryTrace; P09525; -.
DR   GeneWiki; ANXA4; -.
DR   GenomeRNAi; 307; -.
DR   PRO; PR:P09525; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000196975; -.
DR   CleanEx; HS_ANXA4; -.
DR   ExpressionAtlas; P09525; baseline and differential.
DR   Genevisible; P09525; HS.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0012506; C:vesicle membrane; IDA:BHF-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IDA:BHF-UCL.
DR   GO; GO:0005544; F:calcium-dependent phospholipid binding; IDA:UniProtKB.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IPI:AgBase.
DR   GO; GO:0042802; F:identical protein binding; IPI:BHF-UCL.
DR   GO; GO:0051059; F:NF-kappaB binding; IPI:BHF-UCL.
DR   GO; GO:0004859; F:phospholipase inhibitor activity; NAS:UniProtKB.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEP:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:2000483; P:negative regulation of interleukin-8 secretion; IMP:BHF-UCL.
DR   GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; TAS:UniProtKB.
DR   Gene3D; 1.10.220.10; -; 4.
DR   InterPro; IPR001464; Annexin.
DR   InterPro; IPR018502; Annexin_repeat.
DR   InterPro; IPR018252; Annexin_repeat_CS.
DR   InterPro; IPR037104; Annexin_sf.
DR   InterPro; IPR002391; ANX4.
DR   PANTHER; PTHR10502:SF28; PTHR10502:SF28; 1.
DR   Pfam; PF00191; Annexin; 4.
DR   PRINTS; PR00196; ANNEXIN.
DR   SMART; SM00335; ANX; 4.
DR   PROSITE; PS00223; ANNEXIN; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Annexin; Calcium;
KW   Calcium/phospholipid-binding; Complete proteome;
KW   Direct protein sequencing; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:2975506}.
FT   CHAIN         2    319       Annexin A4.
FT                                /FTId=PRO_0000067482.
FT   REPEAT       23     83       Annexin 1.
FT   REPEAT       95    155       Annexin 2.
FT   REPEAT      179    239       Annexin 3.
FT   REPEAT      254    314       Annexin 4.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES       7      7       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P08132}.
FT   MOD_RES      12     12       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     213    213       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     293    293       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     300    300       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       1     82       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056396.
FT   VARIANT      85     85       T -> M (in dbSNP:rs2228203).
FT                                /FTId=VAR_055500.
FT   CONFLICT     96     96       R -> Q (in Ref. 1; AAC41689).
FT                                {ECO:0000305}.
FT   HELIX        16     26       {ECO:0000244|PDB:2ZOC}.
FT   STRAND       28     31       {ECO:0000244|PDB:2ZOC}.
FT   HELIX        34     41       {ECO:0000244|PDB:2ZOC}.
FT   HELIX        46     59       {ECO:0000244|PDB:2ZOC}.
FT   HELIX        64     71       {ECO:0000244|PDB:2ZOC}.
FT   HELIX        74     84       {ECO:0000244|PDB:2ZOC}.
FT   HELIX        87     99       {ECO:0000244|PDB:2ZOC}.
FT   STRAND      100    103       {ECO:0000244|PDB:2ZOC}.
FT   HELIX       106    115       {ECO:0000244|PDB:2ZOC}.
FT   HELIX       118    132       {ECO:0000244|PDB:2ZOC}.
FT   HELIX       136    143       {ECO:0000244|PDB:2ZOC}.
FT   HELIX       146    155       {ECO:0000244|PDB:2ZOC}.
FT   TURN        156    158       {ECO:0000244|PDB:2ZOC}.
FT   HELIX       168    181       {ECO:0000244|PDB:2ZOC}.
FT   TURN        182    184       {ECO:0000244|PDB:2ZOC}.
FT   STRAND      185    187       {ECO:0000244|PDB:2ZOC}.
FT   HELIX       190    199       {ECO:0000244|PDB:2ZOC}.
FT   HELIX       202    216       {ECO:0000244|PDB:2ZOC}.
FT   HELIX       220    227       {ECO:0000244|PDB:2ZOC}.
FT   HELIX       230    244       {ECO:0000244|PDB:2ZOC}.
FT   HELIX       246    258       {ECO:0000244|PDB:2ZOC}.
FT   STRAND      259    262       {ECO:0000244|PDB:2ZOC}.
FT   HELIX       265    275       {ECO:0000244|PDB:2ZOC}.
FT   TURN        276    279       {ECO:0000244|PDB:2ZOC}.
FT   HELIX       280    291       {ECO:0000244|PDB:2ZOC}.
FT   HELIX       295    302       {ECO:0000244|PDB:2ZOC}.
FT   HELIX       305    315       {ECO:0000244|PDB:2ZOC}.
SQ   SEQUENCE   319 AA;  35883 MW;  3799FE80A93AB215 CRC64;
     MATKGGTVKA ASGFNAMEDA QTLRKAMKGL GTDEDAIISV LAYRNTAQRQ EIRTAYKSTI
     GRDLIDDLKS ELSGNFEQVI VGMMTPTVLY DVQELRRAMK GAGTDEGCLI EILASRTPEE
     IRRISQTYQQ QYGRSLEDDI RSDTSFMFQR VLVSLSAGGR DEGNYLDDAL VRQDAQDLYE
     AGEKKWGTDE VKFLTVLCSR NRNHLLHVFD EYKRISQKDI EQSIKSETSG SFEDALLAIV
     KCMRNKSAYF AEKLYKSMKG LGTDDNTLIR VMVSRAEIDM LDIRAHFKRL YGKSLYSFIK
     GDTSGDYRKV LLVLCGGDD
//
ID   Q6LES2_HUMAN            Unreviewed;       321 AA.
AC   Q6LES2;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   23-MAY-2018, entry version 133.
DE   RecName: Full=Annexin {ECO:0000256|RuleBase:RU003540};
DE   Flags: Fragment;
GN   Name=ANXA4 {ECO:0000313|EMBL:CAG28609.1};
GN   Synonyms=PIG28 {ECO:0000313|EMBL:AAS47515.1};
GN   ORFNames=hCG_39482 {ECO:0000313|EMBL:EAW99844.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG28609.1};
RN   [1] {ECO:0000313|EMBL:AAY14864.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Waterston R.H.;
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:AAY14864.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Maupin R., Lamar B., Burkett M.;
RT   "The sequence of Homo sapiens BAC clone RP11-401N16.";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:EAW99844.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [4] {ECO:0000313|EMBL:AAY14864.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Waterston R.;
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:AAS47515.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kim J.W.;
RT   "Identification of a proliferation inducing gene.";
RL   Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000313|EMBL:CAG28609.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000313|EMBL:AAY14864.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wilson R.K.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8] {ECO:0000313|EMBL:EAW99844.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9] {ECO:0000313|EMBL:BAG37892.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Tongue {ECO:0000313|EMBL:BAG37892.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- INTERACTION:
CC       Q9UM07:PADI4; NbExp=5; IntAct=EBI-10250835, EBI-1042511;
CC   -!- DOMAIN: A pair of annexin repeats may form one binding site for
CC       calcium and phospholipid. {ECO:0000256|RuleBase:RU003540}.
CC   -!- SIMILARITY: Belongs to the annexin family.
CC       {ECO:0000256|RuleBase:RU003540}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY453398; AAS47515.1; -; mRNA.
DR   EMBL; AC019206; AAY14864.1; -; Genomic_DNA.
DR   EMBL; AK315511; BAG37892.1; -; mRNA.
DR   EMBL; CR407681; CAG28609.1; -; mRNA.
DR   EMBL; CH471053; EAW99844.1; -; Genomic_DNA.
DR   RefSeq; NP_001144.1; NM_001153.4.
DR   RefSeq; NP_001307627.1; NM_001320698.1.
DR   RefSeq; XP_016859432.1; XM_017003943.1.
DR   UniGene; Hs.422986; -.
DR   SMR; Q6LES2; -.
DR   IntAct; Q6LES2; 1.
DR   MaxQB; Q6LES2; -.
DR   PRIDE; Q6LES2; -.
DR   DNASU; 307; -.
DR   GeneID; 307; -.
DR   KEGG; hsa:307; -.
DR   UCSC; uc002sfr.5; human.
DR   CTD; 307; -.
DR   EuPathDB; HostDB:ENSG00000196975.15; -.
DR   PharmGKB; PA24832; -.
DR   eggNOG; KOG0819; Eukaryota.
DR   eggNOG; ENOG410XPUN; LUCA.
DR   HOGENOM; HOG000158803; -.
DR   HOVERGEN; HBG061815; -.
DR   KO; K17093; -.
DR   OMA; RANFKRL; -.
DR   OrthoDB; EOG091G0H6H; -.
DR   ChiTaRS; ANXA4; human.
DR   GenomeRNAi; 307; -.
DR   Bgee; ENSG00000196975; -.
DR   ExpressionAtlas; Q6LES2; baseline and differential.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005544; F:calcium-dependent phospholipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:Ensembl.
DR   Gene3D; 1.10.220.10; -; 4.
DR   InterPro; IPR001464; Annexin.
DR   InterPro; IPR018502; Annexin_repeat.
DR   InterPro; IPR018252; Annexin_repeat_CS.
DR   InterPro; IPR037104; Annexin_sf.
DR   InterPro; IPR002391; ANX4.
DR   PANTHER; PTHR10502:SF28; PTHR10502:SF28; 1.
DR   Pfam; PF00191; Annexin; 4.
DR   PRINTS; PR00196; ANNEXIN.
DR   SMART; SM00335; ANX; 4.
DR   PROSITE; PS00223; ANNEXIN; 3.
PE   1: Evidence at protein level;
KW   Annexin {ECO:0000256|RuleBase:RU003540,
KW   ECO:0000256|SAAS:SAAS00869627};
KW   Calcium {ECO:0000256|RuleBase:RU003540};
KW   Calcium/phospholipid-binding {ECO:0000256|RuleBase:RU003540};
KW   Repeat {ECO:0000256|RuleBase:RU003540, ECO:0000256|SAAS:SAAS00477337}.
FT   NON_TER     321    321       {ECO:0000313|EMBL:CAG28609.1}.
SQ   SEQUENCE   321 AA;  36085 MW;  59CFD538867E76B5 CRC64;
     MAMATKGGTV KAASGFNAME DAQTLRKAMK GLGTDEDAII SVLAYRNTAQ RQEIRTAYKS
     TIGRDLIDDL KSELSGNFEQ VIVGMMTPTV LYDVQELRRA MKGAGTDEGC LIEILASRTP
     EEIRRISQTY QQQYGRSLED DIRSDTSFMF QRVLVSLSAG GRDEGNYLDD ALVRQDAQDL
     YEAGEKKWGT DEVKFLTVLC SRNRNHLLHV FDEYKRISQK DIEQSIKSET SGSFEDALLA
     IVKCMRNKSA YFAEKLYKSM KGLGTDDNTL IRVMVSRAEI DMLDIRAHFK RLYGKSLYSF
     IKGDTSGDYR KVLLVLCGGD D
//
ID   Q6P452_HUMAN            Unreviewed;       299 AA.
AC   Q6P452;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   23-MAY-2018, entry version 127.
DE   RecName: Full=Annexin {ECO:0000256|RuleBase:RU003540};
GN   Name=ANXA4 {ECO:0000313|EMBL:AAH63672.1,
GN   ECO:0000313|Ensembl:ENSP00000386756};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH63672.1};
RN   [1] {ECO:0000313|EMBL:AAH63672.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus {ECO:0000313|EMBL:AAH63672.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000386756, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000386756}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [6] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [7] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- DOMAIN: A pair of annexin repeats may form one binding site for
CC       calcium and phospholipid. {ECO:0000256|RuleBase:RU003540}.
CC   -!- SIMILARITY: Belongs to the annexin family.
CC       {ECO:0000256|RuleBase:RU003540}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC019206; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092431; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC112787; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC063672; AAH63672.1; -; mRNA.
DR   RefSeq; NP_001144.1; NM_001153.4.
DR   RefSeq; NP_001307629.1; NM_001320700.1.
DR   RefSeq; NP_001307631.1; NM_001320702.1.
DR   UniGene; Hs.422986; -.
DR   IntAct; Q6P452; 1.
DR   MaxQB; Q6P452; -.
DR   PRIDE; Q6P452; -.
DR   Ensembl; ENST00000409920; ENSP00000386756; ENSG00000196975.
DR   GeneID; 307; -.
DR   KEGG; hsa:307; -.
DR   UCSC; uc002sfs.5; human.
DR   CTD; 307; -.
DR   EuPathDB; HostDB:ENSG00000196975.15; -.
DR   HGNC; HGNC:542; ANXA4.
DR   OpenTargets; ENSG00000196975; -.
DR   GeneTree; ENSGT00760000118972; -.
DR   HOVERGEN; HBG061815; -.
DR   KO; K17093; -.
DR   ChiTaRS; ANXA4; human.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000196975; -.
DR   ExpressionAtlas; Q6P452; baseline and differential.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005544; F:calcium-dependent phospholipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0050819; P:negative regulation of coagulation; IEA:InterPro.
DR   Gene3D; 1.10.220.10; -; 4.
DR   InterPro; IPR001464; Annexin.
DR   InterPro; IPR018502; Annexin_repeat.
DR   InterPro; IPR018252; Annexin_repeat_CS.
DR   InterPro; IPR037104; Annexin_sf.
DR   InterPro; IPR002391; ANX4.
DR   InterPro; IPR002392; ANX5.
DR   PANTHER; PTHR10502:SF28; PTHR10502:SF28; 2.
DR   Pfam; PF00191; Annexin; 4.
DR   PRINTS; PR00196; ANNEXIN.
DR   PRINTS; PR00201; ANNEXINV.
DR   SMART; SM00335; ANX; 4.
DR   PROSITE; PS00223; ANNEXIN; 2.
PE   1: Evidence at protein level;
KW   Annexin {ECO:0000256|RuleBase:RU003540,
KW   ECO:0000256|SAAS:SAAS00869627};
KW   Calcium {ECO:0000256|RuleBase:RU003540};
KW   Calcium/phospholipid-binding {ECO:0000256|RuleBase:RU003540};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:Q6P452,
KW   ECO:0000213|MaxQB:Q6P452, ECO:0000213|PeptideAtlas:Q6P452};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|RuleBase:RU003540, ECO:0000256|SAAS:SAAS00429366}.
SQ   SEQUENCE   299 AA;  33552 MW;  CB81FAA4E951DA56 CRC64;
     MAMATKGGTV KAASGFNAME DAQTLRKAMK GLGTDEDAII SVLAYRNTAQ RQEIRTAYKS
     TIGRDLIDDL KSELSGNFEQ GAGTDEGCLI EILASRTPEE IRRISQTYQQ QYGRSLEDDI
     RSDTSFMFQR VLVSLSAGGR DEGNYLDDAL VRQDAQDLYE AGEKKWGTDE VKFLTVLCSR
     NRNHLLHVFD EYKRISQKDI EQSIKSETSG SFEDALLAIV KCMRNKSAYF AEKLYKSMKG
     LGTDDNTLIR VMVSRAEIDM LDIRAHFKRL YGKSLYSFIK GDTSGDYRKV LLVLCGGDD
//
ID   E5KNH5_HUMAN            Unreviewed;       464 AA.
AC   E5KNH5;
DT   08-FEB-2011, integrated into UniProtKB/TrEMBL.
DT   08-FEB-2011, sequence version 1.
DT   23-MAY-2018, entry version 64.
DE   RecName: Full=NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial {ECO:0000256|RuleBase:RU364066};
DE            EC=1.6.5.3 {ECO:0000256|RuleBase:RU364066};
DE            EC=1.6.99.3 {ECO:0000256|RuleBase:RU364066};
GN   Name=NDUFV1 {ECO:0000313|EMBL:EAW74656.1};
GN   ORFNames=hCG_21057 {ECO:0000313|EMBL:EAW74656.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADP90734.1};
RN   [1] {ECO:0000313|EMBL:EAW74656.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW74656.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADP90734.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=20843780; DOI=10.1093/nar/gkq750;
RA   Wang W., Shen P., Thiyagarajan S., Lin S., Palm C., Horvath R.,
RA   Klopstock T., Cutler D., Pique L., Schrijver I., Davis R.W.,
RA   Mindrinos M., Speed T.P., Scharfe C.;
RT   "Identification of rare DNA variants in mitochondrial disorders with
RT   improved array-based sequencing.";
RL   Nucleic Acids Res. 39:44-58(2011).
CC   -!- FUNCTION: Core subunit of the mitochondrial membrane respiratory
CC       chain NADH dehydrogenase (Complex I) that is believed to belong to
CC       the minimal assembly required for catalysis. Complex I functions
CC       in the transfer of electrons from NADH to the respiratory chain.
CC       {ECO:0000256|RuleBase:RU364066}.
CC   -!- CATALYTIC ACTIVITY: NADH + acceptor = NAD(+) + reduced acceptor.
CC       {ECO:0000256|RuleBase:RU364066}.
CC   -!- CATALYTIC ACTIVITY: NADH + ubiquinone + 5 H(+)(In) = NAD(+) +
CC       ubiquinol + 4 H(+)(Out). {ECO:0000256|RuleBase:RU364066}.
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000256|RuleBase:RU364066};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000256|RuleBase:RU364066};
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000256|RuleBase:RU364066}; Peripheral membrane protein
CC       {ECO:0000256|RuleBase:RU364066}; Matrix side
CC       {ECO:0000256|RuleBase:RU364066}.
CC   -!- SIMILARITY: Belongs to the complex I 51 kDa subunit family.
CC       {ECO:0000256|RuleBase:RU364066}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HQ205266; ADP90734.1; -; Genomic_DNA.
DR   EMBL; HQ205267; ADP90735.1; -; Genomic_DNA.
DR   EMBL; HQ205268; ADP90736.1; -; Genomic_DNA.
DR   EMBL; HQ205269; ADP90737.1; -; Genomic_DNA.
DR   EMBL; HQ205270; ADP90738.1; -; Genomic_DNA.
DR   EMBL; HQ205271; ADP90739.1; -; Genomic_DNA.
DR   EMBL; HQ205272; ADP90740.1; -; Genomic_DNA.
DR   EMBL; HQ205273; ADP90741.1; -; Genomic_DNA.
DR   EMBL; HQ205274; ADP90742.1; -; Genomic_DNA.
DR   EMBL; HQ205275; ADP90743.1; -; Genomic_DNA.
DR   EMBL; HQ205276; ADP90744.1; -; Genomic_DNA.
DR   EMBL; HQ205277; ADP90745.1; -; Genomic_DNA.
DR   EMBL; HQ205278; ADP90746.1; -; Genomic_DNA.
DR   EMBL; HQ205279; ADP90747.1; -; Genomic_DNA.
DR   EMBL; HQ205280; ADP90748.1; -; Genomic_DNA.
DR   EMBL; HQ205281; ADP90749.1; -; Genomic_DNA.
DR   EMBL; HQ205282; ADP90750.1; -; Genomic_DNA.
DR   EMBL; HQ205283; ADP90751.1; -; Genomic_DNA.
DR   EMBL; HQ205284; ADP90752.1; -; Genomic_DNA.
DR   EMBL; HQ205285; ADP90753.1; -; Genomic_DNA.
DR   EMBL; HQ205286; ADP90754.1; -; Genomic_DNA.
DR   EMBL; HQ205287; ADP90755.1; -; Genomic_DNA.
DR   EMBL; HQ205288; ADP90756.1; -; Genomic_DNA.
DR   EMBL; HQ205289; ADP90757.1; -; Genomic_DNA.
DR   EMBL; HQ205290; ADP90758.1; -; Genomic_DNA.
DR   EMBL; HQ205291; ADP90759.1; -; Genomic_DNA.
DR   EMBL; HQ205292; ADP90760.1; -; Genomic_DNA.
DR   EMBL; HQ205293; ADP90761.1; -; Genomic_DNA.
DR   EMBL; HQ205294; ADP90762.1; -; Genomic_DNA.
DR   EMBL; HQ205295; ADP90763.1; -; Genomic_DNA.
DR   EMBL; HQ205296; ADP90764.1; -; Genomic_DNA.
DR   EMBL; HQ205297; ADP90765.1; -; Genomic_DNA.
DR   EMBL; HQ205298; ADP90766.1; -; Genomic_DNA.
DR   EMBL; HQ205299; ADP90767.1; -; Genomic_DNA.
DR   EMBL; HQ205300; ADP90768.1; -; Genomic_DNA.
DR   EMBL; HQ205301; ADP90769.1; -; Genomic_DNA.
DR   EMBL; HQ205302; ADP90770.1; -; Genomic_DNA.
DR   EMBL; HQ205303; ADP90771.1; -; Genomic_DNA.
DR   EMBL; HQ205304; ADP90772.1; -; Genomic_DNA.
DR   EMBL; HQ205305; ADP90773.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW74656.1; -; Genomic_DNA.
DR   RefSeq; NP_009034.2; NM_007103.3.
DR   UniGene; Hs.7744; -.
DR   SMR; E5KNH5; -.
DR   SwissPalm; E5KNH5; -.
DR   PRIDE; E5KNH5; -.
DR   DNASU; 4723; -.
DR   GeneID; 4723; -.
DR   KEGG; hsa:4723; -.
DR   CTD; 4723; -.
DR   EuPathDB; HostDB:ENSG00000167792.11; -.
DR   eggNOG; KOG2658; Eukaryota.
DR   eggNOG; COG1894; LUCA.
DR   KO; K03942; -.
DR   OMA; SGMKWSF; -.
DR   OrthoDB; EOG091G05AF; -.
DR   ChiTaRS; NDUFV1; human.
DR   GenomeRNAi; 4723; -.
DR   Bgee; ENSG00000167792; -.
DR   ExpressionAtlas; E5KNH5; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0070469; C:respiratory chain; IEA:UniProtKB-KW.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0010181; F:FMN binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0051287; F:NAD binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; IEA:UniProtKB-EC.
DR   Gene3D; 1.20.1440.230; -; 1.
DR   Gene3D; 3.40.50.11540; -; 1.
DR   InterPro; IPR001949; NADH-UbQ_OxRdtase_51kDa_CS.
DR   InterPro; IPR011537; NADH-UbQ_OxRdtase_suF.
DR   InterPro; IPR011538; Nuo51_FMN-bd.
DR   InterPro; IPR037225; Nuo51_FMN-bd_sf.
DR   InterPro; IPR019575; Nuop51_4Fe4S-bd.
DR   InterPro; IPR037207; Nuop51_4Fe4S-bd_sf.
DR   InterPro; IPR019554; Soluble_ligand-bd.
DR   Pfam; PF01512; Complex1_51K; 1.
DR   Pfam; PF10589; NADH_4Fe-4S; 1.
DR   Pfam; PF10531; SLBB; 1.
DR   SMART; SM00928; NADH_4Fe-4S; 1.
DR   SUPFAM; SSF140490; SSF140490; 1.
DR   SUPFAM; SSF142019; SSF142019; 1.
DR   TIGRFAMs; TIGR01959; nuoF_fam; 1.
DR   PROSITE; PS00644; COMPLEX1_51K_1; 1.
DR   PROSITE; PS00645; COMPLEX1_51K_2; 1.
PE   3: Inferred from homology;
KW   4Fe-4S {ECO:0000256|RuleBase:RU364066};
KW   Electron transport {ECO:0000256|RuleBase:RU364066};
KW   Flavoprotein {ECO:0000256|RuleBase:RU364066};
KW   FMN {ECO:0000256|RuleBase:RU364066};
KW   Iron {ECO:0000256|RuleBase:RU364066};
KW   Iron-sulfur {ECO:0000256|RuleBase:RU364066};
KW   Membrane {ECO:0000256|RuleBase:RU364066};
KW   Metal-binding {ECO:0000256|RuleBase:RU364066};
KW   Mitochondrion {ECO:0000256|RuleBase:RU364066};
KW   Mitochondrion inner membrane {ECO:0000256|RuleBase:RU364066};
KW   NAD {ECO:0000256|RuleBase:RU364066};
KW   Oxidoreductase {ECO:0000256|RuleBase:RU364066};
KW   Respiratory chain {ECO:0000256|RuleBase:RU364066};
KW   Transit peptide {ECO:0000256|RuleBase:RU364066};
KW   Transport {ECO:0000256|RuleBase:RU364066};
KW   Ubiquinone {ECO:0000313|EMBL:ADP90734.1}.
FT   DOMAIN      364    409       NADH_4Fe-4S. {ECO:0000259|SMART:SM00928}.
SQ   SEQUENCE   464 AA;  50817 MW;  8C261EA3B0267256 CRC64;
     MLATRRLLGW SLPARVSVRF SGDTTAPKKT SFGSLKDEDR IFTNLYGRHD WRLKGSLSRG
     DWYKTKEILL KGPDWILGEI KTSGLRGRGG AGFPTGLKWS FMNKPSDGRP KYLVVNADEG
     EPGTCKDREI LRHDPHKLLE GCLVGGRAMG ARAAYIYIRG EFYNEASNLQ VAIREAYEAG
     LIGKNACGSG YDFDVFVVRG AGAYICGEET ALIESIEGKQ GKPRLKPPFP ADVGVFGCPT
     TVANVETVAV SPTICRRGGT WFAGFGRERN SGTKLFNISG HVNHPCTVEE EMSVPLKELI
     EKHAGGVTGG WDNLLAVIPG GSSTPLIPKS VCETVLMDFD ALVQAQTGLG TAAVIVMDRS
     TDIVKAIARL IEFYKHESCG QCTPCREGVD WMNKVMARFV RGDARPAEID SLWEISKQIE
     GHTICALGDG AAWPVQGLIR HFRPELEERM QRFAQQHQAR QAAS
//
ID   NDUV1_HUMAN             Reviewed;         464 AA.
AC   P49821; O60924; O60940; Q16104; Q6IBR3; Q96BF8; Q96HS7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2002, sequence version 4.
DT   23-MAY-2018, entry version 187.
DE   RecName: Full=NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial;
DE            EC=1.6.5.3;
DE            EC=1.6.99.3;
DE   AltName: Full=Complex I-51kD;
DE            Short=CI-51kD;
DE   AltName: Full=NADH dehydrogenase flavoprotein 1;
DE   AltName: Full=NADH-ubiquinone oxidoreductase 51 kDa subunit;
DE   Flags: Precursor;
GN   Name=NDUFV1; Synonyms=UQOR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9892733; DOI=10.1007/s003359900941;
RA   de Coo R.F.M., Buddiger P.A., Smeets H.J.M., van Oost B.A.;
RT   "The structure of the human NDUFV1 gene encoding the 51-kDa subunit of
RT   mitochondrial complex I.";
RL   Mamm. Genome 10:49-53(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=9571201; DOI=10.1006/bbrc.1998.8486;
RA   Schuelke M., Loeffen J., Mariman E., Smeitink J., van den Heuvel L.;
RT   "Cloning of the human mitochondrial 51 kDa subunit (NDUFV1) reveals a
RT   100% antisense homology of its 3'UTR with the 5'UTR of the gamma-
RT   interferon inducible protein (IP-30) precursor: is this a link between
RT   mitochondrial myopathy and inflammation?";
RL   Biochem. Biophys. Res. Commun. 245:599-606(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pituitary;
RX   PubMed=10931946; DOI=10.1073/pnas.160270997;
RA   Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X.,
RA   Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H.,
RA   Gu B.-W., Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M., Zhou J.,
RA   Xu S.-H., Gu J., Shi J.-X., Jin W.-R., Zhang C.-K., Wu T.-M.,
RA   Huang G.-Y., Chen Z., Chen M.-D., Chen J.-L.;
RT   "Gene expression profiling in the human hypothalamus-pituitary-adrenal
RT   axis and full-length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-130.
RX   PubMed=1478657; DOI=10.1016/S0888-7543(05)80144-2;
RA   Spencer S.R., Taylor J.B., Cowell I.G., Xia C.L., Pemble S.E.,
RA   Ketterer B.;
RT   "The human mitochondrial NADH: ubiquinone oxidoreductase 51-kDa
RT   subunit maps adjacent to the glutathione S-transferase P1-1 gene on
RT   chromosome 11q13.";
RL   Genomics 14:1116-1118(1992).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 87-305.
RC   TISSUE=Kidney;
RX   PubMed=8288251; DOI=10.1006/geno.1993.1493;
RA   Ali S.T., Duncan A.M.V., Schappert K.T., Heng H.H.Q., Tsui L.-C.,
RA   Chow W., Robinson B.H.;
RT   "Chromosomal localization of the human gene encoding the 51-kDa
RT   subunit of mitochondrial complex I (NDUFV1) to 11q13.";
RL   Genomics 18:435-439(1993).
RN   [9]
RP   IDENTIFICATION IN THE NADH-UBIQUINONE OXIDOREDUCTASE COMPLEX, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=12611891; DOI=10.1074/jbc.C300064200;
RA   Murray J., Zhang B., Taylor S.W., Oglesbee D., Fahy E., Marusich M.F.,
RA   Ghosh S.S., Capaldi R.A.;
RT   "The subunit composition of the human NADH dehydrogenase obtained by
RT   rapid one-step immunopurification.";
RL   J. Biol. Chem. 278:13619-13622(2003).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   VARIANT MT-C1D VAL-341, AND VARIANT LS MET-423.
RX   PubMed=10080174; DOI=10.1038/6772;
RA   Schuelke M., Smeitink J., Mariman E., Loeffen J., Plecko B.,
RA   Trijbels F., Stockler-Ipsiroglu S., van den Heuvel L.;
RT   "Mutant NDUFV1 subunit of mitochondrial complex I causes
RT   leukodystrophy and myoclonic epilepsy.";
RL   Nat. Genet. 21:260-261(1999).
RN   [14]
RP   VARIANT MT-C1D LYS-214.
RX   PubMed=11349233; DOI=10.1086/320603;
RA   Benit P., Chretien D., Kadhom N., de Lonlay-Debeney P.,
RA   Cormier-Daire V., Cabral A., Peudenier S., Rustin P., Munnich A.,
RA   Roetig A.;
RT   "Large-scale deletion and point mutations of the nuclear NDUFV1 and
RT   NDUFS1 genes in mitochondrial complex I deficiency.";
RL   Am. J. Hum. Genet. 68:1344-1352(2001).
CC   -!- FUNCTION: Core subunit of the mitochondrial membrane respiratory
CC       chain NADH dehydrogenase (Complex I) that is believed to belong to
CC       the minimal assembly required for catalysis. Complex I functions
CC       in the transfer of electrons from NADH to the respiratory chain.
CC       The immediate electron acceptor for the enzyme is believed to be
CC       ubiquinone (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: NADH + ubiquinone + 5 H(+)(In) = NAD(+) +
CC       ubiquinol + 4 H(+)(Out).
CC   -!- CATALYTIC ACTIVITY: NADH + acceptor = NAD(+) + reduced acceptor.
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210; Evidence={ECO:0000305};
CC       Note=Binds 1 FMN. {ECO:0000305};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000305};
CC       Note=Binds 1 [4Fe-4S] cluster. {ECO:0000305};
CC   -!- SUBUNIT: Complex I is composed of 45 different subunits. This is a
CC       component of the flavoprotein-sulfur (FP) fragment of the enzyme.
CC       {ECO:0000269|PubMed:12611891}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane; Peripheral
CC       membrane protein; Matrix side.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P49821-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49821-2; Sequence=VSP_003730;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset
CC       progressive neurodegenerative disorder characterized by the
CC       presence of focal, bilateral lesions in one or more areas of the
CC       central nervous system including the brainstem, thalamus, basal
CC       ganglia, cerebellum and spinal cord. Clinical features depend on
CC       which areas of the central nervous system are involved and include
CC       subacute onset of psychomotor retardation, hypotonia, ataxia,
CC       weakness, vision loss, eye movement abnormalities, seizures, and
CC       dysphagia. {ECO:0000269|PubMed:10080174}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Mitochondrial complex I deficiency (MT-C1D) [MIM:252010]:
CC       A disorder of the mitochondrial respiratory chain that causes a
CC       wide range of clinical manifestations from lethal neonatal disease
CC       to adult-onset neurodegenerative disorders. Phenotypes include
CC       macrocephaly with progressive leukodystrophy, non-specific
CC       encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh
CC       syndrome, Leber hereditary optic neuropathy, and some forms of
CC       Parkinson disease. {ECO:0000269|PubMed:10080174,
CC       ECO:0000269|PubMed:11349233}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the complex I 51 kDa subunit family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y17379; CAA76757.1; -; Genomic_DNA.
DR   EMBL; Y17380; CAA76757.1; JOINED; Genomic_DNA.
DR   EMBL; Y17381; CAA76757.1; JOINED; Genomic_DNA.
DR   EMBL; Y17382; CAA76757.1; JOINED; Genomic_DNA.
DR   EMBL; Y17383; CAA76757.1; JOINED; Genomic_DNA.
DR   EMBL; AF053069; AAC39750.1; -; Genomic_DNA.
DR   EMBL; AF053070; AAC39722.1; -; mRNA.
DR   EMBL; AF092131; AAD40373.1; -; mRNA.
DR   EMBL; CR456739; CAG33020.1; -; mRNA.
DR   EMBL; CH471076; EAW74655.1; -; Genomic_DNA.
DR   EMBL; BC008146; AAH08146.1; -; mRNA.
DR   EMBL; BC015645; AAH15645.1; -; mRNA.
DR   EMBL; AH004147; AAB24883.1; -; Genomic_DNA.
DR   EMBL; S67973; AAB29698.2; ALT_SEQ; mRNA.
DR   CCDS; CCDS53669.1; -. [P49821-2]
DR   CCDS; CCDS8173.1; -. [P49821-1]
DR   PIR; JE0092; JE0092.
DR   RefSeq; NP_001159574.1; NM_001166102.1. [P49821-2]
DR   RefSeq; NP_009034.2; NM_007103.3. [P49821-1]
DR   UniGene; Hs.7744; -.
DR   PDB; 5XTB; EM; 3.40 A; A=27-457.
DR   PDB; 5XTD; EM; 3.70 A; A=27-457.
DR   PDB; 5XTH; EM; 3.90 A; A=27-457.
DR   PDB; 5XTI; EM; 17.40 A; A/BA=27-457.
DR   PDBsum; 5XTB; -.
DR   PDBsum; 5XTD; -.
DR   PDBsum; 5XTH; -.
DR   PDBsum; 5XTI; -.
DR   ProteinModelPortal; P49821; -.
DR   SMR; P49821; -.
DR   BioGrid; 110802; 93.
DR   CORUM; P49821; -.
DR   IntAct; P49821; 41.
DR   MINT; P49821; -.
DR   STRING; 9606.ENSP00000322450; -.
DR   ChEMBL; CHEMBL2363065; -.
DR   DrugBank; DB00157; NADH.
DR   CarbonylDB; P49821; -.
DR   iPTMnet; P49821; -.
DR   PhosphoSitePlus; P49821; -.
DR   SwissPalm; P49821; -.
DR   BioMuta; NDUFV1; -.
DR   DMDM; 20455501; -.
DR   REPRODUCTION-2DPAGE; IPI00028520; -.
DR   REPRODUCTION-2DPAGE; IPI00221298; -.
DR   EPD; P49821; -.
DR   MaxQB; P49821; -.
DR   PaxDb; P49821; -.
DR   PeptideAtlas; P49821; -.
DR   PRIDE; P49821; -.
DR   DNASU; 4723; -.
DR   Ensembl; ENST00000322776; ENSP00000322450; ENSG00000167792. [P49821-1]
DR   Ensembl; ENST00000529927; ENSP00000436766; ENSG00000167792. [P49821-2]
DR   GeneID; 4723; -.
DR   KEGG; hsa:4723; -.
DR   UCSC; uc001omj.3; human. [P49821-1]
DR   CTD; 4723; -.
DR   DisGeNET; 4723; -.
DR   EuPathDB; HostDB:ENSG00000167792.11; -.
DR   GeneCards; NDUFV1; -.
DR   HGNC; HGNC:7716; NDUFV1.
DR   HPA; HPA045211; -.
DR   HPA; HPA075051; -.
DR   MalaCards; NDUFV1; -.
DR   MIM; 161015; gene.
DR   MIM; 252010; phenotype.
DR   MIM; 256000; phenotype.
DR   neXtProt; NX_P49821; -.
DR   OpenTargets; ENSG00000167792; -.
DR   Orphanet; 2609; Isolated NADH-CoQ reductase deficiency.
DR   Orphanet; 255241; Leigh syndrome with leukodystrophy.
DR   PharmGKB; PA31526; -.
DR   eggNOG; KOG2658; Eukaryota.
DR   eggNOG; COG1894; LUCA.
DR   GeneTree; ENSGT00390000010641; -.
DR   HOVERGEN; HBG006542; -.
DR   InParanoid; P49821; -.
DR   KO; K03942; -.
DR   OMA; SGMKWSF; -.
DR   OrthoDB; EOG091G05AF; -.
DR   PhylomeDB; P49821; -.
DR   TreeFam; TF300381; -.
DR   Reactome; R-HSA-611105; Respiratory electron transport.
DR   Reactome; R-HSA-6799198; Complex I biogenesis.
DR   SIGNOR; P49821; -.
DR   ChiTaRS; NDUFV1; human.
DR   GeneWiki; NDUFV1; -.
DR   GenomeRNAi; 4723; -.
DR   PRO; PR:P49821; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000167792; -.
DR   CleanEx; HS_NDUFV1; -.
DR   ExpressionAtlas; P49821; baseline and differential.
DR   Genevisible; P49821; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:Reactome.
DR   GO; GO:0005747; C:mitochondrial respiratory chain complex I; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0010181; F:FMN binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB.
DR   GO; GO:0042775; P:mitochondrial ATP synthesis coupled electron transport; IMP:CAFA.
DR   GO; GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB.
DR   GO; GO:0032981; P:mitochondrial respiratory chain complex I assembly; TAS:Reactome.
DR   Gene3D; 1.20.1440.230; -; 1.
DR   Gene3D; 3.40.50.11540; -; 1.
DR   InterPro; IPR001949; NADH-UbQ_OxRdtase_51kDa_CS.
DR   InterPro; IPR011537; NADH-UbQ_OxRdtase_suF.
DR   InterPro; IPR011538; Nuo51_FMN-bd.
DR   InterPro; IPR037225; Nuo51_FMN-bd_sf.
DR   InterPro; IPR019575; Nuop51_4Fe4S-bd.
DR   InterPro; IPR037207; Nuop51_4Fe4S-bd_sf.
DR   InterPro; IPR019554; Soluble_ligand-bd.
DR   Pfam; PF01512; Complex1_51K; 1.
DR   Pfam; PF10589; NADH_4Fe-4S; 1.
DR   Pfam; PF10531; SLBB; 1.
DR   SMART; SM00928; NADH_4Fe-4S; 1.
DR   SUPFAM; SSF140490; SSF140490; 1.
DR   SUPFAM; SSF142019; SSF142019; 1.
DR   TIGRFAMs; TIGR01959; nuoF_fam; 1.
DR   PROSITE; PS00644; COMPLEX1_51K_1; 1.
DR   PROSITE; PS00645; COMPLEX1_51K_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; 4Fe-4S; Acetylation; Alternative splicing;
KW   Complete proteome; Disease mutation; Electron transport; Flavoprotein;
KW   FMN; Iron; Iron-sulfur; Leigh syndrome; Membrane; Metal-binding;
KW   Methylation; Mitochondrion; Mitochondrion inner membrane; NAD;
KW   Oxidoreductase; Polymorphism; Primary mitochondrial disease;
KW   Reference proteome; Respiratory chain; Transit peptide; Transport;
KW   Ubiquinone.
FT   TRANSIT       1     20       Mitochondrion. {ECO:0000250}.
FT   CHAIN        21    464       NADH dehydrogenase [ubiquinone]
FT                                flavoprotein 1, mitochondrial.
FT                                /FTId=PRO_0000019976.
FT   NP_BIND      87     96       NAD(H). {ECO:0000250}.
FT   NP_BIND     199    247       FMN. {ECO:0000250}.
FT   METAL       379    379       Iron-sulfur (4Fe-4S). {ECO:0000255}.
FT   METAL       382    382       Iron-sulfur (4Fe-4S). {ECO:0000255}.
FT   METAL       385    385       Iron-sulfur (4Fe-4S). {ECO:0000255}.
FT   METAL       425    425       Iron-sulfur (4Fe-4S). {ECO:0000255}.
FT   MOD_RES      81     81       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q91YT0}.
FT   MOD_RES      81     81       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q91YT0}.
FT   MOD_RES     104    104       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q91YT0}.
FT   MOD_RES     257    257       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q91YT0}.
FT   MOD_RES     375    375       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q91YT0}.
FT   VAR_SEQ      16     24       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_003730.
FT   VARIANT      76     76       I -> V (in dbSNP:rs1800670).
FT                                /FTId=VAR_014480.
FT   VARIANT     214    214       E -> K (in MT-C1D; dbSNP:rs121913661).
FT                                {ECO:0000269|PubMed:11349233}.
FT                                /FTId=VAR_019534.
FT   VARIANT     277    277       N -> Y (in dbSNP:rs1043770).
FT                                /FTId=VAR_014481.
FT   VARIANT     341    341       A -> V (in MT-C1D; dbSNP:rs121913660).
FT                                {ECO:0000269|PubMed:10080174}.
FT                                /FTId=VAR_008846.
FT   VARIANT     423    423       T -> M (in LS; dbSNP:rs121913659).
FT                                {ECO:0000269|PubMed:10080174}.
FT                                /FTId=VAR_008847.
FT   CONFLICT     80     80       I -> V (in Ref. 7; AAB24883).
FT                                {ECO:0000305}.
FT   CONFLICT    150    150       G -> A (in Ref. 8; AAB29698).
FT                                {ECO:0000305}.
FT   CONFLICT    306    306       G -> F (in Ref. 1; CAA76757).
FT                                {ECO:0000305}.
FT   CONFLICT    313    313       N -> Y (in Ref. 1; CAA76757).
FT                                {ECO:0000305}.
FT   TURN         37     39       {ECO:0000244|PDB:5XTB}.
FT   HELIX        53     58       {ECO:0000244|PDB:5XTB}.
FT   TURN         59     68       {ECO:0000244|PDB:5XTB}.
FT   HELIX        75     81       {ECO:0000244|PDB:5XTB}.
FT   TURN         82     84       {ECO:0000244|PDB:5XTB}.
FT   STRAND       88     91       {ECO:0000244|PDB:5XTB}.
FT   HELIX        95    100       {ECO:0000244|PDB:5XTB}.
FT   HELIX       101    103       {ECO:0000244|PDB:5XTB}.
FT   STRAND      114    116       {ECO:0000244|PDB:5XTB}.
FT   HELIX       126    133       {ECO:0000244|PDB:5XTB}.
FT   HELIX       135    149       {ECO:0000244|PDB:5XTB}.
FT   STRAND      152    158       {ECO:0000244|PDB:5XTB}.
FT   HELIX       164    178       {ECO:0000244|PDB:5XTB}.
FT   STRAND      181    183       {ECO:0000244|PDB:5XTB}.
FT   STRAND      186    188       {ECO:0000244|PDB:5XTB}.
FT   STRAND      193    199       {ECO:0000244|PDB:5XTB}.
FT   HELIX       204    207       {ECO:0000244|PDB:5XTB}.
FT   HELIX       209    216       {ECO:0000244|PDB:5XTB}.
FT   TURN        230    232       {ECO:0000244|PDB:5XTB}.
FT   HELIX       235    237       {ECO:0000244|PDB:5XTB}.
FT   STRAND      242    244       {ECO:0000244|PDB:5XTB}.
FT   HELIX       245    256       {ECO:0000244|PDB:5XTB}.
FT   HELIX       259    263       {ECO:0000244|PDB:5XTB}.
FT   STRAND      265    268       {ECO:0000244|PDB:5XTB}.
FT   STRAND      272    284       {ECO:0000244|PDB:5XTB}.
FT   STRAND      286    291       {ECO:0000244|PDB:5XTB}.
FT   HELIX       296    301       {ECO:0000244|PDB:5XTB}.
FT   TURN        302    304       {ECO:0000244|PDB:5XTB}.
FT   HELIX       311    313       {ECO:0000244|PDB:5XTB}.
FT   STRAND      314    322       {ECO:0000244|PDB:5XTB}.
FT   HELIX       329    332       {ECO:0000244|PDB:5XTB}.
FT   STRAND      336    338       {ECO:0000244|PDB:5XTB}.
FT   HELIX       339    344       {ECO:0000244|PDB:5XTB}.
FT   HELIX       350    352       {ECO:0000244|PDB:5XTB}.
FT   STRAND      353    358       {ECO:0000244|PDB:5XTB}.
FT   HELIX       364    376       {ECO:0000244|PDB:5XTB}.
FT   HELIX       383    401       {ECO:0000244|PDB:5XTB}.
FT   HELIX       408    419       {ECO:0000244|PDB:5XTB}.
FT   TURN        420    422       {ECO:0000244|PDB:5XTB}.
FT   STRAND      423    425       {ECO:0000244|PDB:5XTB}.
FT   HELIX       427    454       {ECO:0000244|PDB:5XTB}.
SQ   SEQUENCE   464 AA;  50817 MW;  8C261EA3B0267256 CRC64;
     MLATRRLLGW SLPARVSVRF SGDTTAPKKT SFGSLKDEDR IFTNLYGRHD WRLKGSLSRG
     DWYKTKEILL KGPDWILGEI KTSGLRGRGG AGFPTGLKWS FMNKPSDGRP KYLVVNADEG
     EPGTCKDREI LRHDPHKLLE GCLVGGRAMG ARAAYIYIRG EFYNEASNLQ VAIREAYEAG
     LIGKNACGSG YDFDVFVVRG AGAYICGEET ALIESIEGKQ GKPRLKPPFP ADVGVFGCPT
     TVANVETVAV SPTICRRGGT WFAGFGRERN SGTKLFNISG HVNHPCTVEE EMSVPLKELI
     EKHAGGVTGG WDNLLAVIPG GSSTPLIPKS VCETVLMDFD ALVQAQTGLG TAAVIVMDRS
     TDIVKAIARL IEFYKHESCG QCTPCREGVD WMNKVMARFV RGDARPAEID SLWEISKQIE
     GHTICALGDG AAWPVQGLIR HFRPELEERM QRFAQQHQAR QAAS
//
ID   A0A024R539_HUMAN        Unreviewed;       312 AA.
AC   A0A024R539;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 35.
DE   SubName: Full=Uncharacterized protein {ECO:0000313|EMBL:EAW74067.1};
GN   Name=LOC51035 {ECO:0000313|EMBL:EAW74067.1};
GN   ORFNames=hCG_1818009 {ECO:0000313|EMBL:EAW74067.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW74067.1};
RN   [1] {ECO:0000313|EMBL:EAW74067.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW74067.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471076; EAW74063.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW74067.1; -; Genomic_DNA.
DR   RefSeq; NP_056937.2; NM_015853.4.
DR   RefSeq; XP_005274090.1; XM_005274033.4.
DR   UniGene; Hs.351296; -.
DR   UniGene; Hs.731509; -.
DR   SMR; A0A024R539; -.
DR   PRIDE; A0A024R539; -.
DR   GeneID; 51035; -.
DR   CTD; 51035; -.
DR   EuPathDB; HostDB:ENSG00000162191.13; -.
DR   eggNOG; KOG2689; Eukaryota.
DR   eggNOG; ENOG4111HH6; LUCA.
DR   OMA; PSAVITM; -.
DR   OrthoDB; EOG091G0N23; -.
DR   GenomeRNAi; 51035; -.
DR   Bgee; ENSG00000162191; -.
DR   ExpressionAtlas; A0A024R539; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   InterPro; IPR015940; UBA.
DR   InterPro; IPR009060; UBA-like_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR001012; UBX_dom.
DR   Pfam; PF00627; UBA; 1.
DR   Pfam; PF00789; UBX; 1.
DR   SMART; SM00165; UBA; 1.
DR   SMART; SM00166; UBX; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50030; UBA; 1.
DR   PROSITE; PS50033; UBX; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN        1     42       UBA. {ECO:0000259|PROSITE:PS50030}.
FT   DOMAIN      209    291       UBX. {ECO:0000259|PROSITE:PS50033}.
FT   COILED       91    123       {ECO:0000256|SAM:Coils}.
FT   COILED      131    165       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   312 AA;  35107 MW;  75C94CB67C03EB78 CRC64;
     MAELTALESL IEMGFPRGRA EKALALTGNQ GIEAAMDWLM EHEDDPDVDE PLETPLGHIL
     GREPTSSEQG GLEGSGSAAG EGKPALSEEE RQEQTKRMLE LVAQKQRERE EREEREALER
     ERQRRRQGQE LSAARQRLQE DEMRRAAEER RREKAEELAA RQRVREKIER DKAERAKKYG
     GSVGSQPPPV APEPGPVPSS PSQEPPTKRE YDQCRIQVRL PDGTSLTQTF RAREQLAAVR
     LYVELHRGEE LGGGQDPVQL LSGFPRRAFS EADMERPLQE LGMAARLETR TRNWGSREAC
     LGKGGMQREG AL
//
ID   A0A024R598_HUMAN        Unreviewed;       297 AA.
AC   A0A024R598;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 35.
DE   SubName: Full=Uncharacterized protein {ECO:0000313|EMBL:EAW74064.1};
GN   Name=LOC51035 {ECO:0000313|EMBL:EAW74064.1};
GN   ORFNames=hCG_1818009 {ECO:0000313|EMBL:EAW74064.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW74064.1};
RN   [1] {ECO:0000313|EMBL:EAW74064.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW74064.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471076; EAW74061.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW74064.1; -; Genomic_DNA.
DR   RefSeq; NP_001273006.1; NM_001286077.1.
DR   RefSeq; XP_016873363.1; XM_017017874.1.
DR   UniGene; Hs.351296; -.
DR   UniGene; Hs.731509; -.
DR   SMR; A0A024R598; -.
DR   GeneID; 51035; -.
DR   KEGG; hsa:51035; -.
DR   CTD; 51035; -.
DR   EuPathDB; HostDB:ENSG00000162191.13; -.
DR   eggNOG; KOG2689; Eukaryota.
DR   eggNOG; ENOG4111HH6; LUCA.
DR   GenomeRNAi; 51035; -.
DR   Bgee; ENSG00000162191; -.
DR   ExpressionAtlas; A0A024R598; baseline and differential.
DR   InterPro; IPR015940; UBA.
DR   InterPro; IPR009060; UBA-like_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR001012; UBX_dom.
DR   Pfam; PF00627; UBA; 1.
DR   Pfam; PF00789; UBX; 1.
DR   SMART; SM00165; UBA; 1.
DR   SMART; SM00166; UBX; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50030; UBA; 1.
DR   PROSITE; PS50033; UBX; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN        1     42       UBA. {ECO:0000259|PROSITE:PS50030}.
FT   DOMAIN      209    291       UBX. {ECO:0000259|PROSITE:PS50033}.
FT   COILED       91    123       {ECO:0000256|SAM:Coils}.
FT   COILED      131    165       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   297 AA;  33325 MW;  E4E0C8BBAC93F2BB CRC64;
     MAELTALESL IEMGFPRGRA EKALALTGNQ GIEAAMDWLM EHEDDPDVDE PLETPLGHIL
     GREPTSSEQG GLEGSGSAAG EGKPALSEEE RQEQTKRMLE LVAQKQRERE EREEREALER
     ERQRRRQGQE LSAARQRLQE DEMRRAAEER RREKAEELAA RQRVREKIER DKAERAKKYG
     GSVGSQPPPV APEPGPVPSS PSQEPPTKRE YDQCRIQVRL PDGTSLTQTF RAREQLAAVR
     LYVELHRGEE LGGGQDPVQL LSGFPRRAFS EADMERPLQE LGLVPSAVLI VAKKCPS
//
ID   A0A087WTZ5_HUMAN        Unreviewed;       238 AA.
AC   A0A087WTZ5;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   23-MAY-2018, entry version 36.
DE   SubName: Full=UBX domain-containing protein 1 {ECO:0000313|Ensembl:ENSP00000478250};
GN   Name=UBXN1 {ECO:0000313|Ensembl:ENSP00000478250};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000478250, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000478250, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [4] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [5] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [6] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9] {ECO:0000313|Ensembl:ENSP00000478250}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
RN   [10] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP001458; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001273007.1; NM_001286078.1.
DR   UniGene; Hs.351296; -.
DR   UniGene; Hs.731509; -.
DR   ProteinModelPortal; A0A087WTZ5; -.
DR   SMR; A0A087WTZ5; -.
DR   PeptideAtlas; A0A087WTZ5; -.
DR   Ensembl; ENST00000616865; ENSP00000478250; ENSG00000162191.
DR   GeneID; 51035; -.
DR   UCSC; uc031xqw.2; human.
DR   CTD; 51035; -.
DR   EuPathDB; HostDB:ENSG00000162191.13; -.
DR   HGNC; HGNC:18402; UBXN1.
DR   OpenTargets; ENSG00000162191; -.
DR   eggNOG; KOG2689; Eukaryota.
DR   eggNOG; ENOG4111HH6; LUCA.
DR   GeneTree; ENSGT00530000063500; -.
DR   ChiTaRS; UBXN1; human.
DR   GenomeRNAi; 51035; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000162191; -.
DR   ExpressionAtlas; A0A087WTZ5; baseline and differential.
DR   InterPro; IPR015940; UBA.
DR   InterPro; IPR009060; UBA-like_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR001012; UBX_dom.
DR   Pfam; PF00627; UBA; 1.
DR   Pfam; PF00789; UBX; 1.
DR   SMART; SM00165; UBA; 1.
DR   SMART; SM00166; UBX; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50030; UBA; 1.
DR   PROSITE; PS50033; UBX; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A0A087WTZ5,
KW   ECO:0000213|MaxQB:A0A087WTZ5, ECO:0000213|PeptideAtlas:A0A087WTZ5};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN        1     42       UBA. {ECO:0000259|PROSITE:PS50030}.
FT   DOMAIN      150    232       UBX. {ECO:0000259|PROSITE:PS50033}.
FT   COILED       42     64       {ECO:0000256|SAM:Coils}.
FT   COILED       72    106       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   238 AA;  27016 MW;  11C6FC2E14E4F85A CRC64;
     MAELTALESL IEMGFPRGRA EKALALTGNQ GIEAAMDWML ELVAQKQRER EEREEREALE
     RERQRRRQGQ ELSAARQRLQ EDEMRRAAEE RRREKAEELA ARQRVREKIE RDKAERAKKY
     GGSVGSQPPP VAPEPGPVPS SPSQEPPTKR EYDQCRIQVR LPDGTSLTQT FRAREQLAAV
     RLYVELHRGE ELGGGQDPVQ LLSGFPRRAF SEADMERPLQ ELGLVPSAVL IVAKKCPS
//
ID   UBXN1_HUMAN             Reviewed;         297 AA.
AC   Q04323; Q9BV93; Q9BVV5;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2003, sequence version 2.
DT   23-MAY-2018, entry version 150.
DE   RecName: Full=UBX domain-containing protein 1;
DE   AltName: Full=SAPK substrate protein 1;
DE   AltName: Full=UBA/UBX 33.3 kDa protein;
GN   Name=UBXN1; Synonyms=SAKS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Pollard K.M.;
RL   Submitted (JUN-1991) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Colon, Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 220-231 AND 276-285, PHOSPHORYLATION AT SER-200,
RP   AND INTERACTION WITH VCP.
RX   PubMed=15362974; DOI=10.1042/BJ20041498;
RA   McNeill H., Knebel A., Arthur J.S., Cuenda A., Cohen P.;
RT   "A novel UBA and UBX domain protein that binds polyubiquitin and VCP
RT   and is a substrate for SAPKs.";
RL   Biochem. J. 384:391-400(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 220-231, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [5]
RP   UBIQUITIN-BINDING, AND INTERACTION WITH VCP.
RX   PubMed=18775313; DOI=10.1016/j.cell.2008.06.048;
RA   Alexandru G., Graumann J., Smith G.T., Kolawa N.J., Fang R.,
RA   Deshaies R.J.;
RT   "UBXD7 binds multiple ubiquitin ligases and implicates p97 in
RT   HIF1alpha turnover.";
RL   Cell 134:804-816(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-199, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-270, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   UBIQUITIN-BINDING, DOMAIN UBA, INTERACTION WITH BRCA1 AND BARD1,
RP   MUTAGENESIS OF MET-13 AND ARG-219, AND FUNCTION.
RX   PubMed=20351172; DOI=10.1128/MCB.01056-09;
RA   Wu-Baer F., Ludwig T., Baer R.;
RT   "The UBXN1 protein associates with autoubiquitinated forms of the
RT   BRCA1 tumor suppressor and inhibits its enzymatic function.";
RL   Mol. Cell. Biol. 30:2787-2798(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH MAVS.
RX   PubMed=23545497; DOI=10.1016/j.celrep.2013.02.027;
RA   Wang P., Yang L., Cheng G., Yang G., Xu Z., You F., Sun Q., Lin R.,
RA   Fikrig E., Sutton R.E.;
RT   "UBXN1 interferes with Rig-I-like receptor-mediated antiviral immune
RT   response by targeting MAVS.";
RL   Cell Rep. 3:1057-1070(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-229, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-207 AND SER-270, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   FUNCTION, AND INTERACTION WITH BIRC2.
RX   PubMed=25681446; DOI=10.1074/jbc.M114.631689;
RA   Wang Y.B., Tan B., Mu R., Chang Y., Wu M., Tu H.Q., Zhang Y.C.,
RA   Guo S.S., Qin X.H., Li T., Li W.H., Li A.L., Zhang X.M., Li H.Y.;
RT   "Ubiquitin-associated domain-containing ubiquitin regulatory X (UBX)
RT   protein UBXN1 is a negative regulator of nuclear factor kappaB (NF-
RT   kappaB) signaling.";
RL   J. Biol. Chem. 290:10395-10405(2015).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   FUNCTION, AND INTERACTION WITH CUL1.
RX   PubMed=28152074; DOI=10.1371/journal.ppat.1006187;
RA   Hu Y., O'Boyle K., Auer J., Raju S., You F., Wang P., Fikrig E.,
RA   Sutton R.E.;
RT   "Multiple UBXN family members inhibit retrovirus and lentivirus
RT   production and canonical NFkappaBeta signaling by stabilizing
RT   IkappaBalpha.";
RL   PLoS Pathog. 13:E1006187-E1006187(2017).
CC   -!- FUNCTION: Ubiquitin-binding protein that plays a role in the
CC       modulation of innate immune response. Blocks both the RIG-I-like
CC       receptors (RLR) and NF-kappa-B pathways. Following viral
CC       infection, UBXN1 is induced and recruited to the RLR component
CC       MAVS. In turn, interferes with MAVS oligomerization, and disrupts
CC       the MAVS/TRAF3/TRAF6 signalosome. This function probably serves as
CC       a brake to prevent excessive RLR signaling (PubMed:23545497).
CC       Interferes with the TNFalpha-triggered NF-kappa-B pathway by
CC       interacting with cellular inhibitors of apoptosis proteins (cIAPs)
CC       and thereby inhibiting their recruitment to TNFR1
CC       (PubMed:25681446). Prevents also the activation of NF-kappa-B by
CC       associating with CUL1 and thus inhibiting NF-kappa-B inhibitor
CC       alpha/NFKBIA degradation that remains bound to NF-kappa-B
CC       (PubMed:28152074). Interacts with the BRCA1-BARD1 heterodimer and
CC       regulates its activity. Specifically binds 'Lys-6'-linked
CC       polyubiquitin chains. Interaction with autoubiquitinated BRCA1
CC       leads to the inhibition of the E3 ubiquitin-protein ligase
CC       activity of the BRCA1-BARD1 heterodimer (PubMed:20351172).
CC       Component of a complex required to couple deglycosylation and
CC       proteasome-mediated degradation of misfolded proteins in the
CC       endoplasmic reticulum that are retrotranslocated in the cytosol.
CC       {ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:23545497,
CC       ECO:0000269|PubMed:25681446, ECO:0000269|PubMed:28152074}.
CC   -!- SUBUNIT: Interacts with MAVS; this interaction prevents MAVS
CC       oligomerization and thus disrupts the RLR signaling pathway
CC       (PubMed:23545497). Interacts with CUL1; this interaction inhibits
CC       CUL1-mediated degradation of NF-kappa-B inhibitors
CC       (PubMed:28152074). Interacts with BIRC2/c-IAP1; this interaction
CC       prevents TNFalpha-stimulated RIP1 ubiquitination and subsequent
CC       NF-kappa-B activation (PubMed:25681446). Component of a complex
CC       required to couple retrotranslocation, ubiquitination and
CC       deglycosylation composed of NGLY1, SAKS1, AMFR, VCP and RAD23B.
CC       Interacts with HOMER2 (By similarity). Interacts directly with
CC       VCP. Interacts with BRCA1 and BARD1; interaction takes place when
CC       BRCA1 is not autoubiquitinated but is strongly enhanced in the
CC       presence of autoubiquitinated BRCA1.
CC       {ECO:0000250|UniProtKB:Q922Y1, ECO:0000269|PubMed:15362974,
CC       ECO:0000269|PubMed:18775313, ECO:0000269|PubMed:20351172,
CC       ECO:0000269|PubMed:23545497, ECO:0000269|PubMed:25681446,
CC       ECO:0000269|PubMed:28152074}.
CC   -!- INTERACTION:
CC       Q8WU02:-; NbExp=3; IntAct=EBI-1058647, EBI-747182;
CC       V9HW80:HEL-S-70; NbExp=3; IntAct=EBI-1058647, EBI-10175326;
CC       Q9Y263:PLAA; NbExp=5; IntAct=EBI-1058647, EBI-1994037;
CC       Q9HCM9:TRIM39; NbExp=3; IntAct=EBI-1058647, EBI-739510;
CC       Q7KZS0:UBE2I; NbExp=3; IntAct=EBI-1058647, EBI-10180829;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-1058647, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-1058647, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23545497}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q04323-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q04323-2; Sequence=VSP_020367;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The UBA domain specifically recognizes and binds 'Lys-6'-
CC       linked polyubiquitin chains. {ECO:0000269|PubMed:20351172}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M68864; AAA36396.1; -; mRNA.
DR   EMBL; BC000902; AAH00902.1; -; mRNA.
DR   EMBL; BC001372; AAH01372.1; -; mRNA.
DR   EMBL; BC040129; AAH40129.1; -; mRNA.
DR   CCDS; CCDS66105.1; -. [Q04323-1]
DR   CCDS; CCDS8029.1; -. [Q04323-2]
DR   PIR; S27965; S27965.
DR   RefSeq; NP_001273006.1; NM_001286077.1. [Q04323-1]
DR   RefSeq; NP_001273007.1; NM_001286078.1.
DR   RefSeq; NP_056937.2; NM_015853.4. [Q04323-2]
DR   RefSeq; XP_005274090.1; XM_005274033.4. [Q04323-2]
DR   RefSeq; XP_016873363.1; XM_017017874.1. [Q04323-1]
DR   UniGene; Hs.351296; -.
DR   UniGene; Hs.731509; -.
DR   ProteinModelPortal; Q04323; -.
DR   SMR; Q04323; -.
DR   BioGrid; 119239; 146.
DR   DIP; DIP-29467N; -.
DR   IntAct; Q04323; 41.
DR   STRING; 9606.ENSP00000294119; -.
DR   iPTMnet; Q04323; -.
DR   PhosphoSitePlus; Q04323; -.
DR   BioMuta; UBXN1; -.
DR   DMDM; 30923268; -.
DR   EPD; Q04323; -.
DR   MaxQB; Q04323; -.
DR   PaxDb; Q04323; -.
DR   PeptideAtlas; Q04323; -.
DR   PRIDE; Q04323; -.
DR   DNASU; 51035; -.
DR   Ensembl; ENST00000294119; ENSP00000294119; ENSG00000162191. [Q04323-2]
DR   Ensembl; ENST00000301935; ENSP00000303991; ENSG00000162191. [Q04323-1]
DR   GeneID; 51035; -.
DR   KEGG; hsa:51035; -.
DR   UCSC; uc001nuj.5; human. [Q04323-1]
DR   CTD; 51035; -.
DR   DisGeNET; 51035; -.
DR   EuPathDB; HostDB:ENSG00000162191.13; -.
DR   GeneCards; UBXN1; -.
DR   H-InvDB; HIX0009719; -.
DR   HGNC; HGNC:18402; UBXN1.
DR   HPA; HPA012669; -.
DR   MIM; 616378; gene.
DR   neXtProt; NX_Q04323; -.
DR   OpenTargets; ENSG00000162191; -.
DR   PharmGKB; PA162408336; -.
DR   eggNOG; KOG2689; Eukaryota.
DR   eggNOG; ENOG4111HH6; LUCA.
DR   GeneTree; ENSGT00530000063500; -.
DR   HOGENOM; HOG000188321; -.
DR   HOVERGEN; HBG082310; -.
DR   InParanoid; Q04323; -.
DR   OMA; PSAVITM; -.
DR   PhylomeDB; Q04323; -.
DR   TreeFam; TF313944; -.
DR   Reactome; R-HSA-532668; N-glycan trimming in the ER and Calnexin/Calreticulin cycle.
DR   ChiTaRS; UBXN1; human.
DR   GenomeRNAi; 51035; -.
DR   PRO; PR:Q04323; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000162191; -.
DR   CleanEx; HS_UBXN1; -.
DR   ExpressionAtlas; Q04323; baseline and differential.
DR   Genevisible; Q04323; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0034098; C:VCP-NPL4-UFD1 AAA ATPase complex; IDA:BHF-UCL.
DR   GO; GO:0051117; F:ATPase binding; IPI:UniProtKB.
DR   GO; GO:0036435; F:K48-linked polyubiquitin modification-dependent protein binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0071796; F:K6-linked polyubiquitin modification-dependent protein binding; IDA:UniProtKB.
DR   GO; GO:0031593; F:polyubiquitin modification-dependent protein binding; IDA:UniProtKB.
DR   GO; GO:0043130; F:ubiquitin binding; IDA:BHF-UCL.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IDA:BHF-UCL.
DR   GO; GO:1904293; P:negative regulation of ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:1903094; P:negative regulation of protein K48-linked deubiquitination; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:2000157; P:negative regulation of ubiquitin-specific protease activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; NAS:UniProtKB.
DR   GO; GO:0006457; P:protein folding; TAS:Reactome.
DR   InterPro; IPR015940; UBA.
DR   InterPro; IPR009060; UBA-like_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR001012; UBX_dom.
DR   Pfam; PF00627; UBA; 1.
DR   Pfam; PF00789; UBX; 1.
DR   SMART; SM00165; UBA; 1.
DR   SMART; SM00166; UBX; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50030; UBA; 1.
DR   PROSITE; PS50033; UBX; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Coiled coil; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:25944712}.
FT   CHAIN         2    297       UBX domain-containing protein 1.
FT                                /FTId=PRO_0000211023.
FT   DOMAIN        2     42       UBA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00212}.
FT   DOMAIN      211    293       UBX. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00215}.
FT   REGION       43    297       Interaction with BRCA1.
FT                                {ECO:0000269|PubMed:20351172}.
FT   COILED       87    172       {ECO:0000255}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:25944712}.
FT   MOD_RES     199    199       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     200    200       Phosphoserine; by MAPK12.
FT                                {ECO:0000269|PubMed:15362974}.
FT   MOD_RES     207    207       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     229    229       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     270    270       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ     283    297       LVPSAVLIVAKKCPS -> MAARLETRTRNWGSREACLGKG
FT                                GMQREGAL (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020367.
FT   VARIANT      56     56       L -> F (in dbSNP:rs11543359).
FT                                /FTId=VAR_057370.
FT   MUTAGEN      13     13       M->T: Abolishes binding to 'Lys-6'-linked
FT                                polyubiquitin chains and ability to
FT                                inhibit E3 ubiquitin-protein ligase
FT                                activity of the BRCA1-BARD1 heterodimer.
FT                                {ECO:0000269|PubMed:20351172}.
FT   MUTAGEN     219    219       R->A: Does not affect binding to 'Lys-6'-
FT                                linked polyubiquitin chains and ability
FT                                to inhibit E3 ubiquitin-protein ligase
FT                                activity of the BRCA1-BARD1 heterodimer.
FT                                {ECO:0000269|PubMed:20351172}.
FT   CONFLICT     76     76       G -> A (in Ref. 1; AAA36396).
FT                                {ECO:0000305}.
FT   CONFLICT    148    148       E -> AE (in Ref. 1; AAA36396).
FT                                {ECO:0000305}.
FT   CONFLICT    154    154       K -> N (in Ref. 1; AAA36396).
FT                                {ECO:0000305}.
SQ   SEQUENCE   297 AA;  33325 MW;  E4E0C8BBAC93F2BB CRC64;
     MAELTALESL IEMGFPRGRA EKALALTGNQ GIEAAMDWLM EHEDDPDVDE PLETPLGHIL
     GREPTSSEQG GLEGSGSAAG EGKPALSEEE RQEQTKRMLE LVAQKQRERE EREEREALER
     ERQRRRQGQE LSAARQRLQE DEMRRAAEER RREKAEELAA RQRVREKIER DKAERAKKYG
     GSVGSQPPPV APEPGPVPSS PSQEPPTKRE YDQCRIQVRL PDGTSLTQTF RAREQLAAVR
     LYVELHRGEE LGGGQDPVQL LSGFPRRAFS EADMERPLQE LGLVPSAVLI VAKKCPS
//
ID   B7Z4Z2_HUMAN            Unreviewed;       360 AA.
AC   B7Z4Z2;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   23-MAY-2018, entry version 35.
DE   SubName: Full=cDNA FLJ52440, highly similar to Lysosomal acid phosphatase (EC 3.1.3.2) {ECO:0000313|EMBL:BAH12728.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH12728.1};
RN   [1] {ECO:0000313|EMBL:BAH12728.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Lung {ECO:0000313|EMBL:BAH12728.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the histidine acid phosphatase family.
CC       {ECO:0000256|SAAS:SAAS00793915}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK298122; BAH12728.1; -; mRNA.
DR   RefSeq; NP_001289420.1; NM_001302491.1.
DR   UniGene; Hs.532492; -.
DR   ProteinModelPortal; B7Z4Z2; -.
DR   PeptideAtlas; B7Z4Z2; -.
DR   GeneID; 53; -.
DR   CTD; 53; -.
DR   eggNOG; KOG3720; Eukaryota.
DR   eggNOG; ENOG410ZVBQ; LUCA.
DR   HOVERGEN; HBG002203; -.
DR   GenomeRNAi; 53; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   CDD; cd07061; HP_HAP_like; 1.
DR   Gene3D; 3.40.50.1240; -; 2.
DR   InterPro; IPR033379; Acid_Pase_AS.
DR   InterPro; IPR000560; His_Pase_clade-2.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   Pfam; PF00328; His_Phos_2; 2.
DR   SUPFAM; SSF53254; SSF53254; 1.
DR   PROSITE; PS00616; HIS_ACID_PHOSPHAT_1; 1.
DR   PROSITE; PS00778; HIS_ACID_PHOSPHAT_2; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     30       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        31    360       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002863963.
FT   TRANSMEM    318    341       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   360 AA;  40930 MW;  6848BFFAF674359F CRC64;
     MAGKRSGWSR AALLQLLLGV NLVVMPPTRA RSLRFVTLLY RHGDRSPVKT CPKDPYQEEE
     WPQGFGQLTK EGMLQHWELG QALRQRYHGF LNTSYHRQEV YVRSTDFDRT LMSAEANLAG
     LFPPNGMQRF NPNISWQPIP VHTVPITEDR QTHGLRLPPW ASPQTMQRLS RLKDFSFRFL
     FGIYQQAEKA RLQGGVLLAQ IRKNLTLMAT TSQLPKLLVY SAHDTTLVAL QMALDVYNGE
     QAPYASCHIF ELYQEDSGNF SVEMYFRNES DKAPWPLSLP GCPHRCPLQD FLRLTEPVVP
     KDWQQECQLA SGPADTEVIV ALAVCGSILF LLIVLLLTVL FRMQAQPPGY RHVADGEDHA
//
ID   B7Z552_HUMAN            Unreviewed;       395 AA.
AC   B7Z552;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   23-MAY-2018, entry version 44.
DE   SubName: Full=cDNA FLJ51033, highly similar to Lysosomal acid phosphatase (EC 3.1.3.2) {ECO:0000313|EMBL:BAH12788.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH12788.1};
RN   [1] {ECO:0000313|EMBL:BAH12788.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver {ECO:0000313|EMBL:BAH12788.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the histidine acid phosphatase family.
CC       {ECO:0000256|SAAS:SAAS00793915}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK298439; BAH12788.1; -; mRNA.
DR   RefSeq; NP_001289418.1; NM_001302489.1.
DR   UniGene; Hs.532492; -.
DR   ProteinModelPortal; B7Z552; -.
DR   PeptideAtlas; B7Z552; -.
DR   GeneID; 53; -.
DR   CTD; 53; -.
DR   eggNOG; KOG3720; Eukaryota.
DR   eggNOG; ENOG410ZVBQ; LUCA.
DR   HOVERGEN; HBG002203; -.
DR   GenomeRNAi; 53; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   CDD; cd07061; HP_HAP_like; 1.
DR   Gene3D; 3.40.50.1240; -; 1.
DR   InterPro; IPR033379; Acid_Pase_AS.
DR   InterPro; IPR000560; His_Pase_clade-2.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   Pfam; PF00328; His_Phos_2; 1.
DR   SUPFAM; SSF53254; SSF53254; 1.
DR   PROSITE; PS00778; HIS_ACID_PHOSPHAT_2; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    353    376       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   395 AA;  45323 MW;  DC406C343F450ADA CRC64;
     MGVRMTEYVG LYRHGDRSPV KTYPKDPYQE EEWPQGFGQL TKEGMLQHWE LGQALRQRYH
     GFLNTSYHRQ EVYVRSTDFD RTLMSAEANL AGLFPPNGMQ RFNPNISWQP IPVHTVPITE
     DRLLKFPLGP CPRYEQLQNE TRQTPEYQNE SSRNAQFLDM VANETGLTDL TLETVWNVYD
     TLFCEQTHGL RLPLWASPQT MQRLSRLKDF SFRFLFGIYQ QAEKARLQGG VLLAQIRKNL
     TLMATTSQLP KLLVYSAHDT TLVALQMALD VYNGEQAPYA SCHIFELYQE DSGNFSVEMY
     FRNESDKAPW PLSLPGCPHR CPLQDFLRLT EPVVPKDWQQ ECQLASGPAD TEVIVALAVC
     GSILFLLIVL LLTVLFRMQA QPPGYRHVAD GEDHA
//
ID   B7Z6L8_HUMAN            Unreviewed;       413 AA.
AC   B7Z6L8;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   23-MAY-2018, entry version 43.
DE   SubName: Full=cDNA FLJ53923, highly similar to Lysosomal acid phosphatase (EC 3.1.3.2) {ECO:0000313|EMBL:BAH13304.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH13304.1};
RN   [1] {ECO:0000313|EMBL:BAH13304.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Prostate {ECO:0000313|EMBL:BAH13304.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the histidine acid phosphatase family.
CC       {ECO:0000256|SAAS:SAAS00793915}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK300569; BAH13304.1; -; mRNA.
DR   RefSeq; NP_001289421.1; NM_001302492.1.
DR   UniGene; Hs.532492; -.
DR   ProteinModelPortal; B7Z6L8; -.
DR   PeptideAtlas; B7Z6L8; -.
DR   GeneID; 53; -.
DR   CTD; 53; -.
DR   eggNOG; KOG3720; Eukaryota.
DR   eggNOG; ENOG410ZVBQ; LUCA.
DR   HOVERGEN; HBG002203; -.
DR   GenomeRNAi; 53; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   CDD; cd07061; HP_HAP_like; 1.
DR   Gene3D; 3.40.50.1240; -; 1.
DR   InterPro; IPR033379; Acid_Pase_AS.
DR   InterPro; IPR000560; His_Pase_clade-2.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   Pfam; PF00328; His_Phos_2; 1.
DR   SUPFAM; SSF53254; SSF53254; 1.
DR   PROSITE; PS00616; HIS_ACID_PHOSPHAT_1; 1.
DR   PROSITE; PS00778; HIS_ACID_PHOSPHAT_2; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     30       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        31    413       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002863976.
FT   TRANSMEM    371    394       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   413 AA;  47097 MW;  32AF222C5B52997F CRC64;
     MAGKRSGWSR AALLQLLLGV NLVVMPPTQA RSLRFVTLLY RHGDRSPVKT YPKDPYQEEE
     WPQGFGQLTK EGMLQRYHGF LNTSYHRQEV YVRSTDFDRT LMSAEANLAG LFPPNGMQRF
     NPNISWQPIP VHTVPITEDR LLKFPLGPCP RYEQLQNETR QTPEYQNESS RNAQFLDMVA
     NETGLTDLTL ETVWNVYDTL FCEQTHGLRL PPWASPQTMQ RLSRLKDFSF RFLFGIYQQA
     EKARLQGGVL LAQIRKNLTL MATTSQLPKL LVYSAHDTTL VALQMALDVY NGEQAPYASC
     HIFELYQEDS GNFSVEMYFR NESDKAPWPL SLPGCPHRCP LQDFLRLTEP VVPKDWQQEC
     QLASGPADTE VIVALAVCGS ILFLLIVLLL TVLFRMQAQP PGYRHVADGE DHA
//
ID   B7Z6T8_HUMAN            Unreviewed;       160 AA.
AC   B7Z6T8;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   23-MAY-2018, entry version 48.
DE   SubName: Full=cDNA FLJ51106, highly similar to Lysosomal acid phosphatase (EC 3.1.3.2) {ECO:0000313|EMBL:BAH13374.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH13374.1};
RN   [1] {ECO:0000313|EMBL:BAH13374.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Small intestine {ECO:0000313|EMBL:BAH13374.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the histidine acid phosphatase family.
CC       {ECO:0000256|SAAS:SAAS00793915}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK300911; BAH13374.1; -; mRNA.
DR   RefSeq; NP_001289420.1; NM_001302491.1.
DR   UniGene; Hs.532492; -.
DR   ProteinModelPortal; B7Z6T8; -.
DR   PeptideAtlas; B7Z6T8; -.
DR   GeneID; 53; -.
DR   CTD; 53; -.
DR   eggNOG; KOG3720; Eukaryota.
DR   eggNOG; ENOG410ZVBQ; LUCA.
DR   HOVERGEN; HBG106194; -.
DR   GenomeRNAi; 53; -.
DR   CDD; cd07061; HP_HAP_like; 1.
DR   Gene3D; 3.40.50.1240; -; 1.
DR   InterPro; IPR033379; Acid_Pase_AS.
DR   InterPro; IPR000560; His_Pase_clade-2.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   Pfam; PF00328; His_Phos_2; 1.
DR   SUPFAM; SSF53254; SSF53254; 1.
DR   PROSITE; PS00616; HIS_ACID_PHOSPHAT_1; 1.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     30       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        31    160       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002866771.
SQ   SEQUENCE   160 AA;  18508 MW;  442C47EBDE6141D7 CRC64;
     MAGKRSGWSR AALLQLLLGV NLVVMPPTQA RSLRFVTLLY RHGDRSPVKT YPKDPYQEEE
     WPQGFGQLTK EGMLQHWELG QALRQRYHGF LNTSYHRQEV YVRSTDFDRT LMSAEANLAG
     LFPPNGMQRF NPNISWQPIP VHTVPITEDR SRTETLIHFS
//
ID   B7Z7D2_HUMAN            Unreviewed;       391 AA.
AC   B7Z7D2;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   23-MAY-2018, entry version 73.
DE   SubName: Full=Lysosomal acid phosphatase {ECO:0000313|Ensembl:ENSP00000432205};
DE   SubName: Full=cDNA FLJ51131, highly similar to Lysosomal acid phosphatase (EC 3.1.3.2) {ECO:0000313|EMBL:BAH13568.1};
GN   Name=ACP2 {ECO:0000313|Ensembl:ENSP00000432205};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH13568.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000432205, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000313|EMBL:BAH13568.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:BAH13568.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000432205}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- SIMILARITY: Belongs to the histidine acid phosphatase family.
CC       {ECO:0000256|SAAS:SAAS00793915}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC018410; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK301860; BAH13568.1; -; mRNA.
DR   RefSeq; NP_001289419.1; NM_001302490.1.
DR   UniGene; Hs.532492; -.
DR   MaxQB; B7Z7D2; -.
DR   PeptideAtlas; B7Z7D2; -.
DR   PRIDE; B7Z7D2; -.
DR   Ensembl; ENST00000527256; ENSP00000432205; ENSG00000134575.
DR   GeneID; 53; -.
DR   UCSC; uc010rhf.3; human.
DR   CTD; 53; -.
DR   EuPathDB; HostDB:ENSG00000134575.9; -.
DR   HGNC; HGNC:123; ACP2.
DR   OpenTargets; ENSG00000134575; -.
DR   GeneTree; ENSGT00530000062956; -.
DR   HOVERGEN; HBG002203; -.
DR   ChiTaRS; ACP2; human.
DR   GenomeRNAi; 53; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000134575; -.
DR   ExpressionAtlas; B7Z7D2; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   CDD; cd07061; HP_HAP_like; 1.
DR   Gene3D; 3.40.50.1240; -; 1.
DR   InterPro; IPR033379; Acid_Pase_AS.
DR   InterPro; IPR000560; His_Pase_clade-2.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   Pfam; PF00328; His_Phos_2; 1.
DR   SUPFAM; SSF53254; SSF53254; 1.
DR   PROSITE; PS00778; HIS_ACID_PHOSPHAT_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:B7Z7D2,
KW   ECO:0000213|MaxQB:B7Z7D2, ECO:0000213|PeptideAtlas:B7Z7D2};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     30       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        31    391       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014085666.
FT   TRANSMEM    349    372       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   391 AA;  44511 MW;  AAC4A82797E28E70 CRC64;
     MAGKRSGWSR AALLQLLLGV NLVVMPPTRA RSLRFVTLEG MLQHWELGQA LRQRYHGFLN
     TSYHRQEVYV RSTDFDRTLM SAEANLAGLF PPNGMQRFNP NISWQPIPVH TVPITEDRLL
     KFPLGPCPRY EQLQNETRQT PEYQNESSRN AQFLDMVANE TGLTDLTLET VWNVYDTLFC
     EQTHGLRLPP WASPQTMQRL SRLKDFSFRF LFGIYQQAEK ARLQGGVLLA QIRKNLTLMA
     TTSQLPKLLV YSAHDTTLVA LQMALDVYNG EQAPYASCHI FELYQEDSGN FSVEMYFRNE
     SDKAPWPLSL PGCPHRCPLQ DFLRLTEPVV PKDWQQECQL ASGPADTEVI VALAVCGSIL
     FLLIVLLLTV LFRMQAQPPG YRHVADGEDH A
//
ID   B7Z8T9_HUMAN            Unreviewed;       236 AA.
AC   B7Z8T9;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   23-MAY-2018, entry version 45.
DE   SubName: Full=cDNA FLJ52526, highly similar to Lysosomal acid phosphatase (EC 3.1.3.2) {ECO:0000313|EMBL:BAH14075.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH14075.1};
RN   [1] {ECO:0000313|EMBL:BAH14075.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAH14075.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the histidine acid phosphatase family.
CC       {ECO:0000256|SAAS:SAAS00793915}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK303894; BAH14075.1; -; mRNA.
DR   RefSeq; NP_001289421.1; NM_001302492.1.
DR   UniGene; Hs.532492; -.
DR   ProteinModelPortal; B7Z8T9; -.
DR   SMR; B7Z8T9; -.
DR   PeptideAtlas; B7Z8T9; -.
DR   GeneID; 53; -.
DR   CTD; 53; -.
DR   eggNOG; KOG3720; Eukaryota.
DR   eggNOG; ENOG410ZVBQ; LUCA.
DR   HOVERGEN; HBG106381; -.
DR   GenomeRNAi; 53; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   CDD; cd07061; HP_HAP_like; 1.
DR   Gene3D; 3.40.50.1240; -; 1.
DR   InterPro; IPR033379; Acid_Pase_AS.
DR   InterPro; IPR000560; His_Pase_clade-2.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   Pfam; PF00328; His_Phos_2; 1.
DR   SUPFAM; SSF53254; SSF53254; 1.
DR   PROSITE; PS00778; HIS_ACID_PHOSPHAT_2; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    194    217       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   236 AA;  26575 MW;  D99D9FC79954530F CRC64;
     MVANETGLTD LTLETVWNVY DTLFCEQTHG LRLPPWASPQ TMQRLSRLKD FSFRFLFGIY
     QQAEKARLQG GVLLAQIRKN LTLMATTSQL PKLLVYSAHD TTLVALQTAL DVYNGEQAPY
     ASCHIFELYQ EDSGNFSVEM YFRNESDKAP WPLSLPGCPH RCPLQDFLRL TEPVVPKDWQ
     QECQLASGPA DTEVIVALAV CGSILFLLIV LLLTVLFRMQ AQPPGYRHVA DGEDHA
//
ID   E9PHY0_HUMAN            Unreviewed;       360 AA.
AC   E9PHY0;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   28-MAR-2018, entry version 52.
DE   SubName: Full=Lysosomal acid phosphatase {ECO:0000313|Ensembl:ENSP00000436658};
GN   Name=ACP2 {ECO:0000313|Ensembl:ENSP00000436658};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000436658, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000436658, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000436658}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- SIMILARITY: Belongs to the histidine acid phosphatase family.
CC       {ECO:0000256|SAAS:SAAS00793915}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC018410; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001289420.1; NM_001302491.1.
DR   UniGene; Hs.532492; -.
DR   ProteinModelPortal; E9PHY0; -.
DR   MaxQB; E9PHY0; -.
DR   PeptideAtlas; E9PHY0; -.
DR   PRIDE; E9PHY0; -.
DR   Ensembl; ENST00000529444; ENSP00000436658; ENSG00000134575.
DR   GeneID; 53; -.
DR   UCSC; uc010rhg.3; human.
DR   CTD; 53; -.
DR   EuPathDB; HostDB:ENSG00000134575.9; -.
DR   HGNC; HGNC:123; ACP2.
DR   OpenTargets; ENSG00000134575; -.
DR   eggNOG; KOG3720; Eukaryota.
DR   eggNOG; ENOG410ZVBQ; LUCA.
DR   GeneTree; ENSGT00530000062956; -.
DR   ChiTaRS; ACP2; human.
DR   GenomeRNAi; 53; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000134575; -.
DR   ExpressionAtlas; E9PHY0; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   CDD; cd07061; HP_HAP_like; 1.
DR   Gene3D; 3.40.50.1240; -; 2.
DR   InterPro; IPR033379; Acid_Pase_AS.
DR   InterPro; IPR000560; His_Pase_clade-2.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   Pfam; PF00328; His_Phos_2; 2.
DR   SUPFAM; SSF53254; SSF53254; 1.
DR   PROSITE; PS00616; HIS_ACID_PHOSPHAT_1; 1.
DR   PROSITE; PS00778; HIS_ACID_PHOSPHAT_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:E9PHY0,
KW   ECO:0000213|MaxQB:E9PHY0, ECO:0000213|PeptideAtlas:E9PHY0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     30       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        31    360       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5003242846.
FT   TRANSMEM    318    341       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   360 AA;  40990 MW;  3EB3A21AF99FF6A4 CRC64;
     MAGKRSGWSR AALLQLLLGV NLVVMPPTRA RSLRFVTLLY RHGDRSPVKT YPKDPYQEEE
     WPQGFGQLTK EGMLQHWELG QALRQRYHGF LNTSYHRQEV YVRSTDFDRT LMSAEANLAG
     LFPPNGMQRF NPNISWQPIP VHTVPITEDR QTHGLRLPPW ASPQTMQRLS RLKDFSFRFL
     FGIYQQAEKA RLQGGVLLAQ IRKNLTLMAT TSQLPKLLVY SAHDTTLVAL QMALDVYNGE
     QAPYASCHIF ELYQEDSGNF SVEMYFRNES DKAPWPLSLP GCPHRCPLQD FLRLTEPVVP
     KDWQQECQLA SGPADTEVIV ALAVCGSILF LLIVLLLTVL FRMQAQPPGY RHVADGEDHA
//
ID   E9PQY3_HUMAN            Unreviewed;       395 AA.
AC   E9PQY3;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   28-MAR-2018, entry version 55.
DE   SubName: Full=Lysosomal acid phosphatase {ECO:0000313|Ensembl:ENSP00000432439};
GN   Name=ACP2 {ECO:0000313|Ensembl:ENSP00000432439};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000432439, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000432439, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000432439}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [3] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- SIMILARITY: Belongs to the histidine acid phosphatase family.
CC       {ECO:0000256|SAAS:SAAS00793915}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC018410; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001289418.1; NM_001302489.1.
DR   UniGene; Hs.532492; -.
DR   ProteinModelPortal; E9PQY3; -.
DR   EPD; E9PQY3; -.
DR   MaxQB; E9PQY3; -.
DR   PeptideAtlas; E9PQY3; -.
DR   PRIDE; E9PQY3; -.
DR   Ensembl; ENST00000533929; ENSP00000432439; ENSG00000134575.
DR   GeneID; 53; -.
DR   UCSC; uc010rhe.3; human.
DR   CTD; 53; -.
DR   EuPathDB; HostDB:ENSG00000134575.9; -.
DR   HGNC; HGNC:123; ACP2.
DR   OpenTargets; ENSG00000134575; -.
DR   eggNOG; KOG3720; Eukaryota.
DR   eggNOG; ENOG410ZVBQ; LUCA.
DR   GeneTree; ENSGT00530000062956; -.
DR   ChiTaRS; ACP2; human.
DR   GenomeRNAi; 53; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000134575; -.
DR   ExpressionAtlas; E9PQY3; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   CDD; cd07061; HP_HAP_like; 1.
DR   Gene3D; 3.40.50.1240; -; 1.
DR   InterPro; IPR033379; Acid_Pase_AS.
DR   InterPro; IPR000560; His_Pase_clade-2.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   Pfam; PF00328; His_Phos_2; 1.
DR   SUPFAM; SSF53254; SSF53254; 1.
DR   PROSITE; PS00778; HIS_ACID_PHOSPHAT_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:E9PQY3,
KW   ECO:0000213|MaxQB:E9PQY3, ECO:0000213|PeptideAtlas:E9PQY3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    353    376       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   395 AA;  45307 MW;  C84E5A17460B3CF6 CRC64;
     MGVRMTEYVG LYRHGDRSPV KTYPKDPYQE EEWPQGFGQL TKEGMLQHWE LGQALRQRYH
     GFLNTSYHRQ EVYVRSTDFD RTLMSAEANL AGLFPPNGMQ RFNPNISWQP IPVHTVPITE
     DRLLKFPLGP CPRYEQLQNE TRQTPEYQNE SSRNAQFLDM VANETGLTDL TLETVWNVYD
     TLFCEQTHGL RLPPWASPQT MQRLSRLKDF SFRFLFGIYQ QAEKARLQGG VLLAQIRKNL
     TLMATTSQLP KLLVYSAHDT TLVALQMALD VYNGEQAPYA SCHIFELYQE DSGNFSVEMY
     FRNESDKAPW PLSLPGCPHR CPLQDFLRLT EPVVPKDWQQ ECQLASGPAD TEVIVALAVC
     GSILFLLIVL LLTVLFRMQA QPPGYRHVAD GEDHA
//
ID   PPAL_HUMAN              Reviewed;         423 AA.
AC   P11117; E9PCI1; Q561W5; Q9BTU7;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2006, sequence version 3.
DT   28-FEB-2018, entry version 169.
DE   RecName: Full=Lysosomal acid phosphatase;
DE            Short=LAP;
DE            EC=3.1.3.2;
DE   Flags: Precursor;
GN   Name=ACP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Placenta;
RX   PubMed=3191910;
RA   Pohlmann R., Krentler C., Schmidt B., Schroeder W., Lorkowski G.,
RA   Culley J., Mersmann G., Geier C., Waheed A., Gottschalk S.,
RA   Grzeschik K.H., Hasikik A., von Figura K.;
RT   "Human lysosomal acid phosphatase: cloning, expression and chromosomal
RT   assignment.";
RL   EMBO J. 7:2343-2350(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Leukocyte;
RX   PubMed=2776754; DOI=10.1111/j.1432-1033.1989.tb21090.x;
RA   Geier C., von Figura K., Pohlmann R.;
RT   "Structure of the human lysosomal acid phosphatase gene.";
RL   Eur. J. Biochem. 183:611-616(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   GLN-29.
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLN-29.
RC   TISSUE=Kidney, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PARTIAL PROTEIN SEQUENCE, PROTEOLYTIC PROCESSING, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=2684640;
RA   Gottschalk S., Waheed A., Schmidt B., Laidler P., von Figura K.;
RT   "Sequential processing of lysosomal acid phosphatase by a cytoplasmic
RT   thiol proteinase and a lysosomal aspartyl proteinase.";
RL   EMBO J. 8:3215-3219(1989).
RN   [7]
RP   DISEASE.
RX   PubMed=5410815; DOI=10.1056/NEJM197002052820604;
RA   Nadler H.L., Egan T.J.;
RT   "Deficiency of lysosomal acid phosphatase. A new familial metabolic
RT   disorder.";
RL   N. Engl. J. Med. 282:302-307(1970).
RN   [8]
RP   SUBCELLULAR LOCATION, GLYCOSYLATION, MEMBRANE TOPOLOGY, AND
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=3056714;
RA   Waheed A., Gottschalk S., Hille A., Krentler C., Pohlmann R.,
RA   Braulke T., Hauser H., Geuze H., von Figura K.;
RT   "Human lysosomal acid phosphatase is transported as a transmembrane
RT   protein to lysosomes in transfected baby hamster kidney cells.";
RL   EMBO J. 7:2351-2358(1988).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-92; ASN-133; ASN-167;
RP   ASN-177; ASN-267 AND ASN-331.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CATALYTIC ACTIVITY: A phosphate monoester + H(2)O = an alcohol +
CC       phosphate.
CC   -!- SUBCELLULAR LOCATION: Lysosome membrane
CC       {ECO:0000269|PubMed:2684640, ECO:0000269|PubMed:3056714}; Single-
CC       pass membrane protein {ECO:0000255}; Lumenal side
CC       {ECO:0000305|PubMed:2684640, ECO:0000305|PubMed:3056714}. Lysosome
CC       lumen. Note=The soluble form arises by proteolytic processing of
CC       the membrane-bound form. {ECO:0000269|PubMed:2684640,
CC       ECO:0000269|PubMed:3056714}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P11117-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P11117-2; Sequence=VSP_045629, VSP_045630;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: The membrane-bound form is converted to the soluble form by
CC       sequential proteolytic processing. First, the C-terminal
CC       cytoplasmic tail is removed. Cleavage by a lysosomal protease
CC       releases the soluble form in the lysosome lumen.
CC       {ECO:0000269|PubMed:2684640, ECO:0000269|PubMed:3056714}.
CC   -!- PTM: N-glycosylated. The intermediates formed during enzymatic
CC       deglycosylation suggest that all eight predicted N-glycosylation
CC       sites are used. {ECO:0000269|PubMed:19159218,
CC       ECO:0000269|PubMed:3056714}.
CC   -!- DISEASE: Note=Lysosomal acid phosphatase has been shown to be
CC       deficient in cultured fibroblasts from patients manifesting
CC       intermittent vomiting, hypotonia, lethargy, opisthotonos, terminal
CC       bleeding and death in early infancy. {ECO:0000269|PubMed:5410815}.
CC   -!- SIMILARITY: Belongs to the histidine acid phosphatase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X12548; CAA31064.1; -; mRNA.
DR   EMBL; X15525; CAA33542.1; -; Genomic_DNA.
DR   EMBL; X15526; CAA33542.1; JOINED; Genomic_DNA.
DR   EMBL; X15527; CAA33542.1; JOINED; Genomic_DNA.
DR   EMBL; X15528; CAA33542.1; JOINED; Genomic_DNA.
DR   EMBL; X15529; CAA33542.1; JOINED; Genomic_DNA.
DR   EMBL; X15530; CAA33542.1; JOINED; Genomic_DNA.
DR   EMBL; X15531; CAA33542.1; JOINED; Genomic_DNA.
DR   EMBL; X15532; CAA33542.1; JOINED; Genomic_DNA.
DR   EMBL; X15533; CAA33542.1; JOINED; Genomic_DNA.
DR   EMBL; X15534; CAA33542.1; JOINED; Genomic_DNA.
DR   EMBL; X15535; CAA33542.1; JOINED; Genomic_DNA.
DR   EMBL; DA382854; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC018410; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC003160; AAH03160.1; -; mRNA.
DR   EMBL; BC093010; AAH93010.1; -; mRNA.
DR   CCDS; CCDS7928.1; -. [P11117-1]
DR   PIR; S06167; S06167.
DR   RefSeq; NP_001289418.1; NM_001302489.1.
DR   RefSeq; NP_001289419.1; NM_001302490.1.
DR   RefSeq; NP_001289420.1; NM_001302491.1.
DR   RefSeq; NP_001289421.1; NM_001302492.1.
DR   RefSeq; NP_001601.1; NM_001610.3. [P11117-1]
DR   UniGene; Hs.532492; -.
DR   ProteinModelPortal; P11117; -.
DR   SMR; P11117; -.
DR   BioGrid; 106569; 38.
DR   ELM; P11117; -.
DR   IntAct; P11117; 2.
DR   STRING; 9606.ENSP00000256997; -.
DR   DEPOD; P11117; -.
DR   iPTMnet; P11117; -.
DR   PhosphoSitePlus; P11117; -.
DR   BioMuta; ACP2; -.
DR   DMDM; 115502439; -.
DR   EPD; P11117; -.
DR   MaxQB; P11117; -.
DR   PaxDb; P11117; -.
DR   PeptideAtlas; P11117; -.
DR   PRIDE; P11117; -.
DR   TopDownProteomics; P11117-1; -. [P11117-1]
DR   DNASU; 53; -.
DR   Ensembl; ENST00000256997; ENSP00000256997; ENSG00000134575. [P11117-1]
DR   GeneID; 53; -.
DR   KEGG; hsa:53; -.
DR   UCSC; uc001nei.3; human. [P11117-1]
DR   CTD; 53; -.
DR   DisGeNET; 53; -.
DR   EuPathDB; HostDB:ENSG00000134575.9; -.
DR   GeneCards; ACP2; -.
DR   HGNC; HGNC:123; ACP2.
DR   MalaCards; ACP2; -.
DR   MIM; 171650; gene.
DR   neXtProt; NX_P11117; -.
DR   OpenTargets; ENSG00000134575; -.
DR   Orphanet; 35121; Acid phosphatase deficiency.
DR   PharmGKB; PA24447; -.
DR   eggNOG; KOG3720; Eukaryota.
DR   eggNOG; ENOG410ZVBQ; LUCA.
DR   GeneTree; ENSGT00530000062956; -.
DR   HOGENOM; HOG000231439; -.
DR   HOVERGEN; HBG002203; -.
DR   InParanoid; P11117; -.
DR   KO; K14410; -.
DR   OMA; FLHLTEP; -.
DR   OrthoDB; EOG091G09FA; -.
DR   PhylomeDB; P11117; -.
DR   TreeFam; TF312893; -.
DR   ChiTaRS; ACP2; human.
DR   GeneWiki; ACP2; -.
DR   GenomeRNAi; 53; -.
DR   PRO; PR:P11117; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000134575; -.
DR   CleanEx; HS_ACP2; -.
DR   ExpressionAtlas; P11117; baseline and differential.
DR   Genevisible; P11117; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0043202; C:lysosomal lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005764; C:lysosome; IDA:MGI.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0003993; F:acid phosphatase activity; TAS:ProtInc.
DR   GO; GO:0007040; P:lysosome organization; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; IEA:Ensembl.
DR   CDD; cd07061; HP_HAP_like; 1.
DR   Gene3D; 3.40.50.1240; -; 1.
DR   InterPro; IPR033379; Acid_Pase_AS.
DR   InterPro; IPR000560; His_Pase_clade-2.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   Pfam; PF00328; His_Phos_2; 1.
DR   SUPFAM; SSF53254; SSF53254; 1.
DR   PROSITE; PS00616; HIS_ACID_PHOSPHAT_1; 1.
DR   PROSITE; PS00778; HIS_ACID_PHOSPHAT_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Hydrolase; Lysosome; Membrane;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     30
FT   CHAIN        31    423       Lysosomal acid phosphatase.
FT                                /FTId=PRO_0000023960.
FT   TOPO_DOM     31    380       Lumenal. {ECO:0000255}.
FT   TRANSMEM    381    401       Helical. {ECO:0000255}.
FT   TOPO_DOM    402    423       Cytoplasmic. {ECO:0000255}.
FT   ACT_SITE     42     42       Nucleophile. {ECO:0000250}.
FT   ACT_SITE    287    287       Proton donor. {ECO:0000250}.
FT   CARBOHYD     92     92       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    133    133       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    167    167       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    177    177       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    191    191       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305|PubMed:3056714}.
FT   CARBOHYD    267    267       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    322    322       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305|PubMed:3056714}.
FT   CARBOHYD    331    331       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   DISULFID    159    370       {ECO:0000250}.
FT   DISULFID    212    310       {ECO:0000250}.
FT   DISULFID    345    349       {ECO:0000250}.
FT   VAR_SEQ     151    160       LLKFPLGPCP -> VRVASPSLGW (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045629.
FT   VAR_SEQ     161    423       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045630.
FT   VARIANT      29     29       R -> Q (in dbSNP:rs2167079).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027801.
FT   VARIANT     320    320       S -> F (in dbSNP:rs34425282).
FT                                /FTId=VAR_034394.
FT   VARIANT     402    402       V -> I (in dbSNP:rs4647764).
FT                                /FTId=VAR_050519.
SQ   SEQUENCE   423 AA;  48344 MW;  3431A30B83A1E2B4 CRC64;
     MAGKRSGWSR AALLQLLLGV NLVVMPPTRA RSLRFVTLLY RHGDRSPVKT YPKDPYQEEE
     WPQGFGQLTK EGMLQHWELG QALRQRYHGF LNTSYHRQEV YVRSTDFDRT LMSAEANLAG
     LFPPNGMQRF NPNISWQPIP VHTVPITEDR LLKFPLGPCP RYEQLQNETR QTPEYQNESS
     RNAQFLDMVA NETGLTDLTL ETVWNVYDTL FCEQTHGLRL PPWASPQTMQ RLSRLKDFSF
     RFLFGIYQQA EKARLQGGVL LAQIRKNLTL MATTSQLPKL LVYSAHDTTL VALQMALDVY
     NGEQAPYASC HIFELYQEDS GNFSVEMYFR NESDKAPWPL SLPGCPHRCP LQDFLRLTEP
     VVPKDWQQEC QLASGPADTE VIVALAVCGS ILFLLIVLLL TVLFRMQAQP PGYRHVADGE
     DHA
//
ID   A0A024R7F4_HUMAN        Unreviewed;       360 AA.
AC   A0A024R7F4;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 25.
DE   SubName: Full=Deoxyribonuclease II, lysosomal, isoform CRA_a {ECO:0000313|EMBL:EAW84322.1};
GN   Name=DNASE2 {ECO:0000313|EMBL:EAW84322.1};
GN   ORFNames=hCG_172486 {ECO:0000313|EMBL:EAW84322.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW84322.1};
RN   [1] {ECO:0000313|EMBL:EAW84322.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW84322.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471106; EAW84322.1; -; Genomic_DNA.
DR   RefSeq; NP_001366.1; NM_001375.2.
DR   UniGene; Hs.118243; -.
DR   ProteinModelPortal; A0A024R7F4; -.
DR   SMR; A0A024R7F4; -.
DR   PRIDE; A0A024R7F4; -.
DR   GeneID; 1777; -.
DR   KEGG; hsa:1777; -.
DR   CTD; 1777; -.
DR   EuPathDB; HostDB:ENSG00000105612.8; -.
DR   eggNOG; KOG3825; Eukaryota.
DR   eggNOG; ENOG4111G8U; LUCA.
DR   KO; K01158; -.
DR   OMA; LQVQFWQ; -.
DR   OrthoDB; EOG091G08N7; -.
DR   PhylomeDB; A0A024R7F4; -.
DR   ChiTaRS; DNASE2; human.
DR   GenomeRNAi; 1777; -.
DR   Bgee; ENSG00000105612; -.
DR   ExpressionAtlas; A0A024R7F4; baseline and differential.
DR   GO; GO:0004531; F:deoxyribonuclease II activity; IEA:Ensembl.
DR   GO; GO:0000737; P:DNA catabolic process, endonucleolytic; IEA:Ensembl.
DR   GO; GO:0030218; P:erythrocyte differentiation; IEA:Ensembl.
DR   InterPro; IPR004947; DNase_II.
DR   PANTHER; PTHR10858; PTHR10858; 1.
DR   Pfam; PF03265; DNase_II; 1.
PE   4: Predicted;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     18       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        19    360       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001533227.
SQ   SEQUENCE   360 AA;  39581 MW;  DF1BBFBA8A9676EA CRC64;
     MIPLLLAALL CVPAGALTCY GDSGQPVDWF VVYKLPALRG SGEAAQRGLQ YKYLDESSGG
     WRDGRALINS PEGAVGRSLQ PLYRSNTSQL AFLLYNDQPP QPSKAQDSSM RGHTKGVLLL
     DHDGGFWLVH SVPNFPPPAS SAAYSWPHSA CTYGQTLLCV SFPFAQFSKM GKQLTYTYPW
     VYNYQLEGIF AQEFPDLENV VKGHHVSQEP WNSSITLTSQ AGAVFQSFAK FSKFGDDLYS
     GWLAAALGTN LQVQFWHKTV GILPSNCSDI WQVLNVNQIA FPGPAGPSFN STEDHSKWCV
     SPKGPWTCVG DMNRNQGEEQ RGGGTLCAQL PALWKAFQPL VKNYQPCNGM ARKPSRAYKI
//
ID   DNS2A_HUMAN             Reviewed;         360 AA.
AC   O00115; B2RD06; B7Z4K6; O43910;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   23-MAY-2018, entry version 160.
DE   RecName: Full=Deoxyribonuclease-2-alpha;
DE            EC=3.1.22.1;
DE   AltName: Full=Acid DNase;
DE   AltName: Full=Deoxyribonuclease II alpha;
DE            Short=DNase II alpha;
DE   AltName: Full=Lysosomal DNase II;
DE   AltName: Full=R31240_2;
DE   Flags: Precursor;
GN   Name=DNASE2; Synonyms=DNASE2A, DNL2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9924608; DOI=10.1046/j.1469-1809.1998.6240299.x;
RA   Yasuda T., Takeshita H., Iida R., Tsutsumi S., Nakajima T., Hosomi O.,
RA   Nakashima Y., Mori S., Kishi K.;
RT   "Structure and organization of the human deoxyribonuclease II (DNase
RT   II) gene.";
RL   Ann. Hum. Genet. 62:299-305(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9647784; DOI=10.1006/bbrc.1998.8839;
RA   Shiokawa D., Tanuma S.;
RT   "Cloning of cDNAs encoding porcine and human DNase II.";
RL   Biochem. Biophys. Res. Commun. 247:864-869(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9714827; DOI=10.1016/S0378-1119(98)00280-7;
RA   Baker K.P., Baron W.F., Henzel W.J., Spencer S.A.;
RT   "Molecular cloning and characterization of human and murine DNase
RT   II.";
RL   Gene 215:281-289(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9812984; DOI=10.1074/jbc.273.47.30909;
RA   Krieser R.J., Eastman A.;
RT   "The cloning and expression of human deoxyribonuclease II. A possible
RT   role in apoptosis.";
RL   J. Biol. Chem. 273:30909-30914(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9446563; DOI=10.1074/jbc.273.5.2610;
RA   Yasuda T., Takeshita H., Iida R., Nakajima T., Hosomi O.,
RA   Nakashima Y., Kishi K.;
RT   "Molecular cloning of the cDNA encoding human deoxyribonuclease II.";
RL   J. Biol. Chem. 273:2610-2616(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   LACK OF PROTEOLYTIC PROCESSING, AND GLYCOSYLATION.
RX   PubMed=11906178; DOI=10.1006/bbrc.2002.6687;
RA   MacLea K.S., Krieser R.J., Eastman A.;
RT   "Revised structure of the active form of human deoxyribonuclease
RT   IIalpha.";
RL   Biochem. Biophys. Res. Commun. 292:415-421(2002).
RN   [12]
RP   MUTAGENESIS OF CYS-19; ASN-86; CYS-151; CYS-159; ASN-212; ASN-266;
RP   CYS-267; ASN-290; CYS-299; CYS-308; CYS-327 AND CYS-347,
RP   GLYCOSYLATION, AND DISULFIDE BONDS.
RX   PubMed=12558498; DOI=10.1042/BJ20021875;
RA   MacLea K.S., Krieser R.J., Eastman A.;
RT   "Structural requirements of human DNase II alpha for formation of the
RT   active enzyme: the role of the signal peptide, N-glycosylation, and
RT   disulphide bridging.";
RL   Biochem. J. 371:867-876(2003).
RN   [13]
RP   MUTAGENESIS OF HIS-295.
RX   PubMed=12594037; DOI=10.1016/S0378-1119(02)01233-7;
RA   MacLea K.S., Krieser R.J., Eastman A.;
RT   "A family history of deoxyribonuclease II: surprises from Trichinella
RT   spiralis and Burkholderia pseudomallei.";
RL   Gene 305:1-12(2003).
RN   [14]
RP   GLYCOSYLATION AT ASN-212.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-212.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Hydrolyzes DNA under acidic conditions with a preference
CC       for double-stranded DNA. Plays a major role in the degradation of
CC       nuclear DNA in cellular apoptosis during development. Necessary
CC       for proper fetal development and for definitive erythropoiesis in
CC       fetal liver, where it degrades nuclear DNA expelled from erythroid
CC       precursor cells.
CC   -!- CATALYTIC ACTIVITY: Endonucleolytic cleavage to nucleoside 3'-
CC       phosphates and 3'-phosphooligonucleotide end-products.
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O00115-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00115-2; Sequence=VSP_056921;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Glycosylated. Mutations that eliminate N-glycosylation sites
CC       reduce activity, but enzymatic deglycosylation has no effect.
CC       {ECO:0000269|PubMed:11906178, ECO:0000269|PubMed:12558498,
CC       ECO:0000269|PubMed:12754519, ECO:0000269|PubMed:19159218}.
CC   -!- MISCELLANEOUS: Not required for the generation of the
CC       characteristic DNA fragmentation observed in apoptotic cells, but
CC       for the degradation of DNA from dying cells. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the DNase II family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB008564; BAB55598.1; -; Genomic_DNA.
DR   EMBL; AF060222; AAC39852.1; -; mRNA.
DR   EMBL; AF045937; AAC35751.1; -; mRNA.
DR   EMBL; AF047016; AAC77366.1; -; mRNA.
DR   EMBL; AB004574; BAA28623.1; -; mRNA.
DR   EMBL; BT007047; AAP35696.1; -; mRNA.
DR   EMBL; AK297493; BAH12592.1; -; mRNA.
DR   EMBL; AK315358; BAG37753.1; -; mRNA.
DR   EMBL; AC020934; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AD000092; AAB51172.1; -; Genomic_DNA.
DR   EMBL; CH471106; EAW84320.1; -; Genomic_DNA.
DR   EMBL; BC010419; AAH10419.3; -; mRNA.
DR   EMBL; BC065209; AAH65209.1; -; mRNA.
DR   CCDS; CCDS12284.1; -. [O00115-1]
DR   PIR; JE0206; JE0206.
DR   PIR; T45071; T45071.
DR   RefSeq; NP_001366.1; NM_001375.2. [O00115-1]
DR   UniGene; Hs.118243; -.
DR   ProteinModelPortal; O00115; -.
DR   SMR; O00115; -.
DR   BioGrid; 108116; 10.
DR   IntAct; O00115; 1.
DR   STRING; 9606.ENSP00000222219; -.
DR   BindingDB; O00115; -.
DR   ChEMBL; CHEMBL1250342; -.
DR   iPTMnet; O00115; -.
DR   PhosphoSitePlus; O00115; -.
DR   BioMuta; DNASE2; -.
DR   EPD; O00115; -.
DR   MaxQB; O00115; -.
DR   PaxDb; O00115; -.
DR   PeptideAtlas; O00115; -.
DR   PRIDE; O00115; -.
DR   DNASU; 1777; -.
DR   Ensembl; ENST00000222219; ENSP00000222219; ENSG00000105612. [O00115-1]
DR   GeneID; 1777; -.
DR   KEGG; hsa:1777; -.
DR   UCSC; uc002mvn.2; human. [O00115-1]
DR   CTD; 1777; -.
DR   DisGeNET; 1777; -.
DR   EuPathDB; HostDB:ENSG00000105612.8; -.
DR   GeneCards; DNASE2; -.
DR   HGNC; HGNC:2960; DNASE2.
DR   HPA; HPA066185; -.
DR   MIM; 126350; gene.
DR   neXtProt; NX_O00115; -.
DR   OpenTargets; ENSG00000105612; -.
DR   PharmGKB; PA27431; -.
DR   eggNOG; KOG3825; Eukaryota.
DR   eggNOG; ENOG4111G8U; LUCA.
DR   GeneTree; ENSGT00390000002634; -.
DR   HOGENOM; HOG000261682; -.
DR   HOVERGEN; HBG051387; -.
DR   InParanoid; O00115; -.
DR   KO; K01158; -.
DR   OMA; LQVQFWQ; -.
DR   OrthoDB; EOG091G08N7; -.
DR   PhylomeDB; O00115; -.
DR   TreeFam; TF314536; -.
DR   BRENDA; 3.1.22.1; 2681.
DR   Reactome; R-HSA-432720; Lysosome Vesicle Biogenesis.
DR   ChiTaRS; DNASE2; human.
DR   GenomeRNAi; 1777; -.
DR   PRO; PR:O00115; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105612; -.
DR   CleanEx; HS_DNASE2; -.
DR   ExpressionAtlas; O00115; baseline and differential.
DR   Genevisible; O00115; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IBA:GO_Central.
DR   GO; GO:0005764; C:lysosome; TAS:ProtInc.
DR   GO; GO:0004531; F:deoxyribonuclease II activity; IBA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0006309; P:apoptotic DNA fragmentation; IBA:GO_Central.
DR   GO; GO:0006259; P:DNA metabolic process; TAS:ProtInc.
DR   GO; GO:0030218; P:erythrocyte differentiation; IEA:Ensembl.
DR   InterPro; IPR004947; DNase_II.
DR   PANTHER; PTHR10858; PTHR10858; 1.
DR   Pfam; PF03265; DNase_II; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Complete proteome;
KW   Developmental protein; Disulfide bond; Endonuclease; Glycoprotein;
KW   Hydrolase; Lysosome; Nuclease; Polymorphism; Reference proteome;
KW   Signal.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    360       Deoxyribonuclease-2-alpha.
FT                                /FTId=PRO_0000007291.
FT   ACT_SITE    295    295       {ECO:0000305}.
FT   CARBOHYD     86     86       N-linked (GlcNAc...) asparagine.
FT   CARBOHYD    212    212       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    266    266       N-linked (GlcNAc...) asparagine.
FT   CARBOHYD    290    290       N-linked (GlcNAc...) asparagine.
FT   DISULFID     19    159       {ECO:0000255}.
FT   DISULFID    267    347       {ECO:0000255}.
FT   DISULFID    308    327       {ECO:0000255}.
FT   VAR_SEQ     116    170       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056921.
FT   VARIANT      39     39       R -> I (in dbSNP:rs36075196).
FT                                /FTId=VAR_048870.
FT   VARIANT     204    204       H -> R (in dbSNP:rs16978744).
FT                                /FTId=VAR_048871.
FT   VARIANT     314    314       R -> L (in dbSNP:rs1061192).
FT                                /FTId=VAR_012044.
FT   MUTAGEN      19     19       C->A: Loss of activity.
FT                                {ECO:0000269|PubMed:12558498}.
FT   MUTAGEN      86     86       N->Q: Reduced N-glycosylation, complete
FT                                loss of N-glycosylation; when associated
FT                                with Q-212; Q-266 and Q-290.
FT                                {ECO:0000269|PubMed:12558498}.
FT   MUTAGEN     151    151       C->A: Loss of activity.
FT                                {ECO:0000269|PubMed:12558498}.
FT   MUTAGEN     159    159       C->A: Loss of activity.
FT                                {ECO:0000269|PubMed:12558498}.
FT   MUTAGEN     212    212       N->Q: Reduced N-glycosylation, complete
FT                                loss of N-glycosylation; when associated
FT                                with Q-86; Q-266 and Q-290.
FT                                {ECO:0000269|PubMed:12558498}.
FT   MUTAGEN     266    266       N->Q: Reduced N-glycosylation, complete
FT                                loss of N-glycosylation; when associated
FT                                with Q-86; Q-212 and Q-290.
FT                                {ECO:0000269|PubMed:12558498}.
FT   MUTAGEN     267    267       C->A: Loss of activity.
FT                                {ECO:0000269|PubMed:12558498}.
FT   MUTAGEN     290    290       N->Q: Reduced N-glycosylation, complete
FT                                loss of N-glycosylation; when associated
FT                                with Q-86; Q-212 and Q-266.
FT                                {ECO:0000269|PubMed:12558498}.
FT   MUTAGEN     295    295       H->A,K,N,R,S: Loss of activity, but not
FT                                of DNA-binding.
FT                                {ECO:0000269|PubMed:12594037}.
FT   MUTAGEN     299    299       C->A: No effect.
FT                                {ECO:0000269|PubMed:12558498}.
FT   MUTAGEN     308    308       C->A: Loss of activity.
FT                                {ECO:0000269|PubMed:12558498}.
FT   MUTAGEN     327    327       C->A: Loss of activity.
FT                                {ECO:0000269|PubMed:12558498}.
FT   MUTAGEN     347    347       C->A: Loss of activity.
FT                                {ECO:0000269|PubMed:12558498}.
FT   CONFLICT    160    171       Missing (in Ref. 8; AAB51172).
FT                                {ECO:0000305}.
SQ   SEQUENCE   360 AA;  39581 MW;  DF1BBFBA8A9676EA CRC64;
     MIPLLLAALL CVPAGALTCY GDSGQPVDWF VVYKLPALRG SGEAAQRGLQ YKYLDESSGG
     WRDGRALINS PEGAVGRSLQ PLYRSNTSQL AFLLYNDQPP QPSKAQDSSM RGHTKGVLLL
     DHDGGFWLVH SVPNFPPPAS SAAYSWPHSA CTYGQTLLCV SFPFAQFSKM GKQLTYTYPW
     VYNYQLEGIF AQEFPDLENV VKGHHVSQEP WNSSITLTSQ AGAVFQSFAK FSKFGDDLYS
     GWLAAALGTN LQVQFWHKTV GILPSNCSDI WQVLNVNQIA FPGPAGPSFN STEDHSKWCV
     SPKGPWTCVG DMNRNQGEEQ RGGGTLCAQL PALWKAFQPL VKNYQPCNGM ARKPSRAYKI
//
ID   A0A125SXW3_HUMAN        Unreviewed;       483 AA.
AC   A0A125SXW3;
DT   13-APR-2016, integrated into UniProtKB/TrEMBL.
DT   13-APR-2016, sequence version 1.
DT   23-MAY-2018, entry version 19.
DE   SubName: Full=Estrogen receptor alpha splice variant, ERalphai67 {ECO:0000313|EMBL:BAU46553.1};
GN   Name=ESR1 {ECO:0000313|EMBL:BAU46553.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAU46553.1};
RN   [1] {ECO:0000313|EMBL:BAU46553.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Uterus {ECO:0000313|EMBL:BAU46553.1};
RX   PubMed=26835991; DOI=10.1016/j.mce.2016.01.026;
RA   Hattori Y., Ishii H., Munetomo A., Watanabe H., Morita A., Sakuma Y.,
RA   Ozawa H.;
RT   "Human C-terminally truncated ER? variants resulting from the use of
RT   alternative exons in the ligand-binding domain.";
RL   Mol. Cell. Endocrinol. 425:111-122(2016).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PIRNR:PIRNR002527,
CC       ECO:0000256|PROSITE-ProRule:PRU00407,
CC       ECO:0000256|SAAS:SAAS01037405}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR3
CC       subfamily. {ECO:0000256|PIRNR:PIRNR002527}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; LC120330; BAU46553.1; -; mRNA.
DR   RefSeq; XP_011533849.1; XM_011535547.2.
DR   UniGene; Hs.208124; -.
DR   UniGene; Hs.744830; -.
DR   PeptideAtlas; A0A125SXW3; -.
DR   GeneID; 2099; -.
DR   CTD; 2099; -.
DR   ChiTaRS; ESR1; human.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0030284; F:estrogen receptor activity; IEA:InterPro.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0005496; F:steroid binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR035500; NHR_like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR024178; Oest_rcpt/oest-rel_rcp.
DR   InterPro; IPR001292; Oestr_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF02159; Oest_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PIRSF; PIRSF002527; ER-like_NR; 1.
DR   PRINTS; PR00543; OESTROGENR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 2.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   2: Evidence at transcript level;
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517091};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125};
KW   Nucleus {ECO:0000256|PIRNR:PIRNR002527, ECO:0000256|PROSITE-
KW   ProRule:PRU00407, ECO:0000256|SAAS:SAAS01037386};
KW   Receptor {ECO:0000256|PIRNR:PIRNR002527,
KW   ECO:0000256|SAAS:SAAS01037471, ECO:0000313|EMBL:BAU46553.1};
KW   Transcription {ECO:0000256|PIRNR:PIRNR002527, ECO:0000256|PROSITE-
KW   ProRule:PRU00407, ECO:0000256|SAAS:SAAS01037387};
KW   Transcription regulation {ECO:0000256|PIRNR:PIRNR002527,
KW   ECO:0000256|PROSITE-ProRule:PRU00407, ECO:0000256|SAAS:SAAS01037387};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125}.
FT   DOMAIN      182    257       Nuclear receptor.
FT                                {ECO:0000259|PROSITE:PS51030}.
FT   DOMAIN      311    483       NR LBD. {ECO:0000259|PROSITE:PS51843}.
FT   DNA_BIND    182    257       Nuclear receptor. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00407}.
SQ   SEQUENCE   483 AA;  53748 MW;  2BD7CE2C94A8D1B9 CRC64;
     MTMTLHTKAS GMALLHQIQG NELEPLNRPQ LKIPLERPLG EVYLDSSKPA VYNYPEGAAY
     EFNAAAAANA QVYGQTGLPY GPGSEAAAFG SNGLGGFPPL NSVSPSPLML LHPPPQLSPF
     LQPHGQQVPY YLENEPSGYT VREAGPPAFY RPNSDNRRQG GRERLASTND KGSMAMESAK
     ETRYCAVCND YASGYHYGVW SCEGCKAFFK RSIQGHNDYM CPATNQCTID KNRRKSCQAC
     RLRKCYEVGM MKGGIRKDRR GGRMLKHKRQ RDDGEGRGEV GSAGDMRAAN LWPSPLMIKR
     SKKNSLALSL TADQMVSALL DAEPPILYSE YDPTRPFSEA SMMGLLTNLA DRELVHMINW
     AKRVPGFVDL TLHDQVHLLE CAWLEILMIG LVWRSMEHPG KLLFAPNLLL DRNQGKCVEG
     MVEIFDMLLA TSSRFRMMNL QGEEFVCLKS IILLNSVLTT GRPGDTLPCL AQWVTRPWRL
     AHC
//
ID   A8KAF4_HUMAN            Unreviewed;       594 AA.
AC   A8KAF4;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   23-MAY-2018, entry version 79.
DE   RecName: Full=Estrogen receptor {ECO:0000256|PIRNR:PIRNR002527};
DE            Short=ER {ECO:0000256|PIRNR:PIRNR002527};
DE   AltName: Full=ER-alpha {ECO:0000256|PIRNR:PIRNR002527};
DE   AltName: Full=Estradiol receptor {ECO:0000256|PIRNR:PIRNR002527};
DE   AltName: Full=Nuclear receptor subfamily 3 group A member 1 {ECO:0000256|PIRNR:PIRNR002527};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF85708.1};
RN   [1] {ECO:0000313|EMBL:BAF85708.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Uterus {ECO:0000313|EMBL:BAF85708.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: The steroid hormones and their receptors are involved in
CC       the regulation of eukaryotic gene expression and affect cellular
CC       proliferation and differentiation in target tissues.
CC       {ECO:0000256|PIRNR:PIRNR002527}.
CC   -!- SUBUNIT: Binds DNA as a homodimer.
CC       {ECO:0000256|PIRNR:PIRNR002527}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PIRNR:PIRNR002527,
CC       ECO:0000256|PROSITE-ProRule:PRU00407,
CC       ECO:0000256|SAAS:SAAS01037405}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR3
CC       subfamily. {ECO:0000256|PIRNR:PIRNR002527}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK293019; BAF85708.1; -; mRNA.
DR   RefSeq; NP_001278170.1; NM_001291241.1.
DR   UniGene; Hs.208124; -.
DR   UniGene; Hs.744830; -.
DR   PeptideAtlas; A8KAF4; -.
DR   PRIDE; A8KAF4; -.
DR   GeneID; 2099; -.
DR   CTD; 2099; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   HOVERGEN; HBG108344; -.
DR   GenomeRNAi; 2099; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0030284; F:estrogen receptor activity; IEA:InterPro.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0005496; F:steroid binding; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR035500; NHR_like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR024178; Oest_rcpt/oest-rel_rcp.
DR   InterPro; IPR001292; Oestr_rcpt.
DR   InterPro; IPR024736; Oestrogen-typ_rcpt_final_C_dom.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF12743; ESR1_C; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF02159; Oest_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PIRSF; PIRSF500101; ER-a; 1.
DR   PIRSF; PIRSF002527; ER-like_NR; 1.
DR   PRINTS; PR00543; OESTROGENR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   2: Evidence at transcript level;
KW   DNA-binding {ECO:0000256|PIRNR:PIRNR002527, ECO:0000256|PROSITE-
KW   ProRule:PRU00407, ECO:0000256|SAAS:SAAS00517091};
KW   Lipid-binding {ECO:0000256|PIRNR:PIRNR002527};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125};
KW   Nucleus {ECO:0000256|PIRNR:PIRNR002527, ECO:0000256|PROSITE-
KW   ProRule:PRU00407, ECO:0000256|SAAS:SAAS01037386};
KW   Receptor {ECO:0000256|PIRNR:PIRNR002527,
KW   ECO:0000256|SAAS:SAAS01037471, ECO:0000313|EMBL:BAF85708.1};
KW   Steroid-binding {ECO:0000256|PIRNR:PIRNR002527};
KW   Transcription {ECO:0000256|PIRNR:PIRNR002527, ECO:0000256|PROSITE-
KW   ProRule:PRU00407, ECO:0000256|SAAS:SAAS01037387};
KW   Transcription regulation {ECO:0000256|PIRNR:PIRNR002527,
KW   ECO:0000256|PROSITE-ProRule:PRU00407, ECO:0000256|SAAS:SAAS01037387};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125}.
FT   DOMAIN      182    257       Nuclear receptor.
FT                                {ECO:0000259|PROSITE:PS51030}.
FT   DOMAIN      310    546       NR LBD. {ECO:0000259|PROSITE:PS51843}.
FT   DNA_BIND    182    257       Nuclear receptor. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00407}.
SQ   SEQUENCE   594 AA;  66169 MW;  48F6B6D48709786B CRC64;
     MTMTLHTKAS GMALLHQIQG NELEPLNRPQ LKIPLERPLG EVYLDSSKPA VYNYPEGAAY
     EFNAAAAANA QVYGQTGLPY GPGSEAAAFG SNGLGGFPPL NSVSPSPLML LHPPPQLSPF
     LQPHGQQVPY YLENEPSGYT VREAGPPAFY RPNSDNRRQG GRERLASTND KGSMAMESAK
     ETRYCAVCND YASGYHYGVW SCEGCKAFFK RSIQGHNDYM CPATNQCTID KNRRKSCQAC
     RLRKCYEVGM MKGIRKDRRG GRMLKHKRQR DDGEGRGEVG SAGDMRAANL WPSPLMIKRS
     KKNSLALSLT ADQMVSALLD AEPPILYPEY DPTRPFSEAS MMGLLTNLAD RELVHMINWA
     KRVPGFVDLT LHDQVHLLEC AWLEILMIGL VWRSMEHPGK LLFAPNLLLD RNQGKCVEGM
     VEIFDMLLAT SSRFRMMNLQ GEEFVCLKSI ILLNSGVYTF LSSTLKSLEE KDHIHRVLDK
     ITDTLIHLMA KAGLTLQQQH QRLAQLLLIL SHIRHMSNKG MEHLYSMKCK NVVPLYDLLL
     EMLDAHRLHA PTSRGGASVE ETDQSHLATA GSTSSHSLQK YYITGEAEGF PATV
//
ID   G4XH65_HUMAN            Unreviewed;       595 AA.
AC   G4XH65;
DT   14-DEC-2011, integrated into UniProtKB/TrEMBL.
DT   14-DEC-2011, sequence version 1.
DT   23-MAY-2018, entry version 61.
DE   RecName: Full=Estrogen receptor {ECO:0000256|PIRNR:PIRNR002527};
DE            Short=ER {ECO:0000256|PIRNR:PIRNR002527};
DE   AltName: Full=ER-alpha {ECO:0000256|PIRNR:PIRNR002527};
DE   AltName: Full=Estradiol receptor {ECO:0000256|PIRNR:PIRNR002527};
DE   AltName: Full=Nuclear receptor subfamily 3 group A member 1 {ECO:0000256|PIRNR:PIRNR002527};
GN   Name=ESR1 {ECO:0000313|EMBL:AEP43755.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEP43755.1};
RN   [1] {ECO:0000313|EMBL:AEP43755.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Kidney {ECO:0000313|EMBL:AEP43755.1};
RA   Kaighin V.A., Martin A.L., Aronstam R.S.;
RL   Submitted (APR-2011) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: The steroid hormones and their receptors are involved in
CC       the regulation of eukaryotic gene expression and affect cellular
CC       proliferation and differentiation in target tissues.
CC       {ECO:0000256|PIRNR:PIRNR002527}.
CC   -!- SUBUNIT: Binds DNA as a homodimer.
CC       {ECO:0000256|PIRNR:PIRNR002527}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PIRNR:PIRNR002527,
CC       ECO:0000256|PROSITE-ProRule:PRU00407,
CC       ECO:0000256|SAAS:SAAS01037405}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR3
CC       subfamily. {ECO:0000256|PIRNR:PIRNR002527}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; JF810888; AEP43755.1; -; mRNA.
DR   RefSeq; NP_000116.2; NM_000125.3.
DR   RefSeq; NP_001116212.1; NM_001122740.1.
DR   RefSeq; NP_001116213.1; NM_001122741.1.
DR   RefSeq; NP_001116214.1; NM_001122742.1.
DR   RefSeq; XP_011533845.1; XM_011535543.2.
DR   RefSeq; XP_011533846.1; XM_011535544.2.
DR   RefSeq; XP_011533847.1; XM_011535545.2.
DR   RefSeq; XP_016865865.1; XM_017010376.1.
DR   RefSeq; XP_016865866.1; XM_017010377.1.
DR   RefSeq; XP_016865867.1; XM_017010378.1.
DR   RefSeq; XP_016865868.1; XM_017010379.1.
DR   RefSeq; XP_016865869.1; XM_017010380.1.
DR   RefSeq; XP_016865870.1; XM_017010381.1.
DR   UniGene; Hs.208124; -.
DR   UniGene; Hs.744830; -.
DR   ProteinModelPortal; G4XH65; -.
DR   SMR; G4XH65; -.
DR   GeneID; 2099; -.
DR   KEGG; hsa:2099; -.
DR   CTD; 2099; -.
DR   EuPathDB; HostDB:ENSG00000091831.21; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   KO; K08550; -.
DR   OMA; EAGPPAF; -.
DR   OrthoDB; EOG091G03V4; -.
DR   PhylomeDB; G4XH65; -.
DR   ChiTaRS; ESR1; human.
DR   GenomeRNAi; 2099; -.
DR   Bgee; ENSG00000091831; -.
DR   ExpressionAtlas; G4XH65; baseline and differential.
DR   Genevisible; G4XH65; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0030284; F:estrogen receptor activity; IEA:InterPro.
DR   GO; GO:0004879; F:nuclear receptor activity; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0005496; F:steroid binding; IEA:UniProtKB-KW.
DR   GO; GO:0008134; F:transcription factor binding; IEA:Ensembl.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0008209; P:androgen metabolic process; IEA:Ensembl.
DR   GO; GO:0001547; P:antral ovarian follicle growth; IEA:Ensembl.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEA:Ensembl.
DR   GO; GO:0071391; P:cellular response to estrogen stimulus; IEA:Ensembl.
DR   GO; GO:0002064; P:epithelial cell development; IEA:Ensembl.
DR   GO; GO:0060750; P:epithelial cell proliferation involved in mammary gland duct elongation; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0060749; P:mammary gland alveolus development; IEA:Ensembl.
DR   GO; GO:0060745; P:mammary gland branching involved in pregnancy; IEA:Ensembl.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0060527; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; IEA:Ensembl.
DR   GO; GO:0060523; P:prostate epithelial cord elongation; IEA:Ensembl.
DR   GO; GO:0042981; P:regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0060687; P:regulation of branching involved in prostate gland morphogenesis; IEA:Ensembl.
DR   GO; GO:0050727; P:regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0034121; P:regulation of toll-like receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0048863; P:stem cell differentiation; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   GO; GO:0060065; P:uterus development; IEA:Ensembl.
DR   GO; GO:0060068; P:vagina development; IEA:Ensembl.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR035500; NHR_like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR024178; Oest_rcpt/oest-rel_rcp.
DR   InterPro; IPR001292; Oestr_rcpt.
DR   InterPro; IPR024736; Oestrogen-typ_rcpt_final_C_dom.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF12743; ESR1_C; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF02159; Oest_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PIRSF; PIRSF500101; ER-a; 1.
DR   PIRSF; PIRSF002527; ER-like_NR; 1.
DR   PRINTS; PR00543; OESTROGENR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   2: Evidence at transcript level;
KW   DNA-binding {ECO:0000256|PIRNR:PIRNR002527, ECO:0000256|PROSITE-
KW   ProRule:PRU00407, ECO:0000256|SAAS:SAAS00517091};
KW   Lipid-binding {ECO:0000256|PIRNR:PIRNR002527};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125};
KW   Nucleus {ECO:0000256|PIRNR:PIRNR002527, ECO:0000256|PROSITE-
KW   ProRule:PRU00407, ECO:0000256|SAAS:SAAS01037386};
KW   Receptor {ECO:0000256|PIRNR:PIRNR002527,
KW   ECO:0000256|SAAS:SAAS01037471, ECO:0000313|EMBL:AEP43755.1};
KW   Steroid-binding {ECO:0000256|PIRNR:PIRNR002527};
KW   Transcription {ECO:0000256|PIRNR:PIRNR002527, ECO:0000256|PROSITE-
KW   ProRule:PRU00407, ECO:0000256|SAAS:SAAS01037387};
KW   Transcription regulation {ECO:0000256|PIRNR:PIRNR002527,
KW   ECO:0000256|PROSITE-ProRule:PRU00407, ECO:0000256|SAAS:SAAS01037387};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125}.
FT   DOMAIN      182    257       Nuclear receptor.
FT                                {ECO:0000259|PROSITE:PS51030}.
FT   DOMAIN      311    547       NR LBD. {ECO:0000259|PROSITE:PS51843}.
FT   DNA_BIND    182    257       Nuclear receptor. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00407}.
SQ   SEQUENCE   595 AA;  66216 MW;  5455C57AB0CCCAA7 CRC64;
     MTMTLHTKAS GMALLHQIQG NELEPLNRPQ LKIPLERPLG EVYLDSSKPA VYNYPEGAAY
     EFNAAAAANA QVYGQTGLPY GPGSEAAAFG SNGLGGFPPL NSVSPSPLML LHPPPQLSPF
     LQPHGQQVPY YLENEPSGYT VREAGPPAFY RPNSDNRRQG GRERLASTND KGSMAMESAK
     ETRYCAVCND YASGYHYGVW SCEGCKAFFK RSIQGHNDYM CPATNQCTID KNRRKSCQAC
     RLRKCYEVGM MKGGIRKDRR GGRMLKHKRQ RDDGEGRGEV GSAGDMRAAN LWPSPLMIKR
     SKKNSLALSL TADQMVSALL DAEPPILYSE YDPTRPFSEA SMMGLLTNLA DRELVHMINW
     AKRVPGFVDL TLHDQVHLLE CAWLEILMIG LVWRSMEHPG KLLFAPNLLL DRNQGKCVEG
     MVEIFDMLLA TSSRFRMMNL QGEEFVCLKS IILLNSGVYT FLSSTLKSLE EKDHIHRVLD
     KITDTLIHLM AKAGLTLQQQ HQRLAQLLLI LSHIRHMSNK GMEHLYSMKC KNVVPLYDLL
     LEMLDAHRLH APTSRGGASV EETDQSHLAT AGSTSSHSLQ KYYITGEAEG FPATV
//
ID   H0Y4W6_HUMAN            Unreviewed;       310 AA.
AC   H0Y4W6;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   19-FEB-2014, sequence version 2.
DT   23-MAY-2018, entry version 54.
DE   SubName: Full=Estrogen receptor {ECO:0000313|Ensembl:ENSP00000394721};
GN   Name=ESR1 {ECO:0000313|Ensembl:ENSP00000394721};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000394721, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000394721, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000394721}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00407, ECO:0000256|SAAS:SAAS01037405}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family.
CC       {ECO:0000256|SAAS:SAAS01037406}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL035695; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL049821; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356311; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590993; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF454881; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458326; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458327; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001315029.1; NM_001328100.1.
DR   UniGene; Hs.208124; -.
DR   UniGene; Hs.744830; -.
DR   ProteinModelPortal; H0Y4W6; -.
DR   SMR; H0Y4W6; -.
DR   PeptideAtlas; H0Y4W6; -.
DR   PRIDE; H0Y4W6; -.
DR   Ensembl; ENST00000427531; ENSP00000394721; ENSG00000091831.
DR   GeneID; 2099; -.
DR   UCSC; uc063shm.1; human.
DR   CTD; 2099; -.
DR   EuPathDB; HostDB:ENSG00000091831.21; -.
DR   HGNC; HGNC:3467; ESR1.
DR   OpenTargets; ENSG00000091831; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   GeneTree; ENSGT00760000118887; -.
DR   ChiTaRS; ESR1; human.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000091831; -.
DR   ExpressionAtlas; H0Y4W6; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0005496; F:steroid binding; IEA:InterPro.
DR   GO; GO:0003707; F:steroid hormone receptor activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR035500; NHR_like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR024178; Oest_rcpt/oest-rel_rcp.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PIRSF; PIRSF002527; ER-like_NR; 1.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 2.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517091};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS01037386};
KW   Proteomics identification {ECO:0000213|EPD:H0Y4W6,
KW   ECO:0000213|MaxQB:H0Y4W6, ECO:0000213|PeptideAtlas:H0Y4W6};
KW   Receptor {ECO:0000256|SAAS:SAAS01037471};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS01037387};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS01037387};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125}.
FT   DOMAIN        9     84       Nuclear receptor.
FT                                {ECO:0000259|PROSITE:PS51030}.
FT   DOMAIN      138    310       NR LBD. {ECO:0000259|PROSITE:PS51843}.
FT   DNA_BIND      9     84       Nuclear receptor. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00407}.
SQ   SEQUENCE   310 AA;  35298 MW;  051CA0996E56C356 CRC64;
     MAMESAKETR YCAVCNDYAS GYHYGVWSCE GCKAFFKRSI QGHNDYMCPA TNQCTIDKNR
     RKSCQACRLR KCYEVGMMKG GIRKDRRGGR MLKHKRQRDD GEGRGEVGSA GDMRAANLWP
     SPLMIKRSKK NSLALSLTAD QMVSALLDAE PPILYSEYDP TRPFSEASMM GLLTNLADRE
     LVHMINWAKR VPGFVDLTLH DQVHLLECAW LEILMIGLVW RSMEHPGKLL FAPNLLLDRN
     QGKCVEGMVE IFDMLLATSS RFRMMNLQGE EFVCLKSIIL LNSGISHVEA KKRILNLHPK
     IFGNKWFPRV
//
ID   ESR1_HUMAN              Reviewed;         595 AA.
AC   P03372; Q13511; Q14276; Q5T5H7; Q6MZQ9; Q9NU51; Q9UDZ7; Q9UIS7;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 2.
DT   23-MAY-2018, entry version 252.
DE   RecName: Full=Estrogen receptor;
DE            Short=ER;
DE   AltName: Full=ER-alpha;
DE   AltName: Full=Estradiol receptor;
DE   AltName: Full=Nuclear receptor subfamily 3 group A member 1;
GN   Name=ESR1; Synonyms=ESR, NR3A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT VAL-400.
RX   PubMed=3754034; DOI=10.1038/320134a0;
RA   Green S., Walter P., Kumar V., Krust A., Bornert J.-M., Argos P.,
RA   Chambon P.;
RT   "Human oestrogen receptor cDNA: sequence, expression and homology to
RT   v-erb-A.";
RL   Nature 320:134-139(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT VAL-400.
RX   PubMed=3753802; DOI=10.1126/science.3753802;
RA   Greene G.L., Gilna P., Waterfield M., Baker A., Hort Y., Shine J.;
RT   "Sequence and expression of human estrogen receptor complementary
RT   DNA.";
RL   Science 231:1150-1154(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Mammary gland;
RX   PubMed=8600466; DOI=10.1093/nar/24.5.962;
RA   Pink J.J., Wu S.Q., Wolf D.M., Bilimoria M.M., Jordan V.C.;
RT   "A novel 80 kDa human estrogen receptor containing a duplication of
RT   exons 6 and 7.";
RL   Nucleic Acids Res. 24:962-969(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), ALTERNATIVE PROMOTER USAGE,
RP   AND SUBCELLULAR LOCATION.
RC   TISSUE=Placenta;
RX   PubMed=16165085; DOI=10.1016/j.bbrc.2005.08.226;
RA   Wang Z., Zhang X., Shen P., Loggie B.W., Chang Y., Deuel T.F.;
RT   "Identification, cloning, and expression of human estrogen receptor-
RT   alpha36, a novel variant of human estrogen receptor-alpha66.";
RL   Biochem. Biophys. Res. Commun. 336:1023-1027(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 110-117, PHOSPHORYLATION, AND MUTAGENESIS.
RX   PubMed=7476978; DOI=10.1210/mend.9.8.7476978;
RA   Joel P.B., Traish A.M., Lannigan D.A.;
RT   "Estradiol and phorbol ester cause phosphorylation of serine 118 in
RT   the human estrogen receptor.";
RL   Mol. Endocrinol. 9:1041-1052(1995).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 152-595 (ISOFORM 1).
RX   PubMed=10619354; DOI=10.1016/S0960-0760(99)00126-0;
RA   Schubert E.L., Lee M.K., Newman B., King M.C.;
RT   "Single nucleotide polymorphisms (SNPs) in the estrogen receptor gene
RT   and breast cancer susceptibility.";
RL   J. Steroid Biochem. Mol. Biol. 71:21-27(1999).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 216-434 (ISOFORM 2).
RC   TISSUE=Mammary carcinoma;
RX   PubMed=7916651;
RA   Pfeffer U., Fecarotta E., Castagnetta L., Vidali G.;
RT   "Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-
RT   responsive human breast cancer cell lines.";
RL   Cancer Res. 53:741-743(1993).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 354-548.
RC   TISSUE=Mammary carcinoma;
RA   Naundorf H., Becker M., Fiebig C., Buettner B., Fichtner I.;
RT   "Mechanisms of acquired tamoxifen resistance in a xenotransplanted
RT   human breast carcinoma.";
RL   Submitted (AUG-1996) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   PROTEIN SEQUENCE OF 532-542, AND PHOSPHORYLATION AT TYR-537.
RX   PubMed=7539106; DOI=10.1210/mend.9.1.7539106;
RA   Arnold S.F., Obourn J.D., Jaffe H., Notides A.C.;
RT   "Phosphorylation of the human estrogen receptor on tyrosine 537 in
RT   vivo and by src family tyrosine kinases in vitro.";
RL   Mol. Endocrinol. 9:24-33(1995).
RN   [15]
RP   MUTAGENESIS OF CYS-447.
RX   PubMed=1577818;
RA   Reese J.C., Katzenellenbogen B.S.;
RT   "Characterization of a temperature-sensitive mutation in the hormone
RT   binding domain of the human estrogen receptor. Studies in cell
RT   extracts and intact cells and their implications for hormone-dependent
RT   transcriptional activation.";
RL   J. Biol. Chem. 267:9868-9873(1992).
RN   [16]
RP   PHOSPHORYLATION AT SER-167 BY CK2.
RX   PubMed=7838153; DOI=10.1210/mend.8.9.7838153;
RA   Arnold S.F., Obourn J.D., Jaffe H., Notides A.C.;
RT   "Serine 167 is the major estradiol-induced phosphorylation site on the
RT   human estrogen receptor.";
RL   Mol. Endocrinol. 8:1208-1214(1994).
RN   [17]
RP   FUNCTION IN TRANSREPRESSION OF NF-KAPPA-B.
RX   PubMed=7651415; DOI=10.1128/MCB.15.9.4971;
RA   Stein B., Yang M.X.;
RT   "Repression of the interleukin-6 promoter by estrogen receptor is
RT   mediated by NF-kappa B and C/EBP beta.";
RL   Mol. Cell. Biol. 15:4971-4979(1995).
RN   [18]
RP   MUTAGENESIS OF VAL-364.
RX   PubMed=8961262; DOI=10.1210/mend.10.12.8961262;
RA   McInerney E.M., Ince B.A., Shapiro D.J., Katzenellenbogen B.S.;
RT   "A transcriptionally active estrogen receptor mutant is a novel type
RT   of dominant negative inhibitor of estrogen action.";
RL   Mol. Endocrinol. 10:1519-1526(1996).
RN   [19]
RP   INTERACTION WITH DDX5, AND MUTAGENESIS OF SER-118.
RX   PubMed=10409727; DOI=10.1128/MCB.19.8.5363;
RA   Endoh H., Maruyama K., Masuhiro Y., Kobayashi Y., Goto M., Tai H.,
RA   Yanagisawa J., Metzger D., Hashimoto S., Kato S.;
RT   "Purification and identification of p68 RNA helicase acting as a
RT   transcriptional coactivator specific for the activation function 1 of
RT   human estrogen receptor alpha.";
RL   Mol. Cell. Biol. 19:5363-5372(1999).
RN   [20]
RP   FUNCTION (ISOFORM 3), TISSUE SPECIFICITY, ALTERNATIVE PROMOTER USAGE
RP   (ISOFORM 3), AND SUBUNIT.
RX   PubMed=10970861; DOI=10.1093/emboj/19.17.4688;
RA   Flouriot G., Brand H., Denger S., Metivier R., Kos M., Reid G.,
RA   Sonntag-Buck V., Gannon F.;
RT   "Identification of a new isoform of the human estrogen receptor-alpha
RT   (hER-alpha) that is encoded by distinct transcripts and that is able
RT   to repress hER-alpha activation function 1.";
RL   EMBO J. 19:4688-4700(2000).
RN   [21]
RP   MUTAGENESIS OF LEU-39 AND TYR-43.
RX   PubMed=11075817; DOI=10.1210/mend.14.11.0546;
RA   Metivier R., Petit F.G., Valotaire Y., Pakdel F.;
RT   "Function of N-terminal transactivation domain of the estrogen
RT   receptor requires a potential alpha-helical structure and is
RT   negatively regulated by the A domain.";
RL   Mol. Endocrinol. 14:1849-1871(2000).
RN   [22]
RP   INTERACTION WITH NCOA1; NCOA2 AND NCOA3, SUBUNIT, AND MUTAGENESIS OF
RP   LEU-539.
RX   PubMed=12554772; DOI=10.1210/me.2002-0351;
RA   Bai Y., Giguere V.;
RT   "Isoform-selective interactions between estrogen receptors and steroid
RT   receptor coactivators promoted by estradiol and ErbB-2 signaling in
RT   living cells.";
RL   Mol. Endocrinol. 17:589-599(2003).
RN   [23]
RP   SUBCELLULAR LOCATION (ISOFORMS 1 AND 3), AND PALMITOYLATION (ISOFORM
RP   3).
RX   PubMed=12682286; DOI=10.1073/pnas.0831079100;
RA   Li L., Haynes M.P., Bender J.R.;
RT   "Plasma membrane localization and function of the estrogen receptor
RT   alpha variant (ER46) in human endothelial cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:4807-4812(2003).
RN   [24]
RP   GLYCOSYLATION.
RX   PubMed=8999954;
RA   Jiang M.S., Hart G.W.;
RT   "A subpopulation of estrogen receptors are modified by O-linked N-
RT   acetylglucosamine.";
RL   J. Biol. Chem. 272:2421-2428(1997).
RN   [25]
RP   FUNCTION, AND INTERACTION WITH SP1.
RX   PubMed=9328340; DOI=10.1210/mend.11.11.9916;
RA   Porter W., Saville B., Hoivik D., Safe S.;
RT   "Functional synergy between the transcription factor Sp1 and the
RT   estrogen receptor.";
RL   Mol. Endocrinol. 11:1569-1580(1997).
RN   [26]
RP   INTERACTION WITH AKAP13.
RX   PubMed=9627117; DOI=10.1038/sj.onc.1201783;
RA   Rubino D., Driggers P., Arbit D., Kemp L., Miller B., Coso O.,
RA   Pagliai K., Gray K., Gutkind S., Segars J.;
RT   "Characterization of Brx, a novel Dbl family member that modulates
RT   estrogen receptor action.";
RL   Oncogene 16:2513-2526(1998).
RN   [27]
RP   PHOSPHORYLATION AT SER-104 AND SER-106, AND MUTAGENESIS.
RX   PubMed=10428798; DOI=10.1074/jbc.274.32.22296;
RA   Rogatsky I., Trowbridge J.M., Garabedian M.J.;
RT   "Potentiation of human estrogen receptor alpha transcriptional
RT   activation through phosphorylation of serines 104 and 106 by the
RT   cyclin A-CDK2 complex.";
RL   J. Biol. Chem. 274:22296-22302(1999).
RN   [28]
RP   INTERACTION WITH NCOA6.
RX   PubMed=10567404; DOI=10.1074/jbc.274.48.34283;
RA   Lee S.-K., Anzick S.L., Choi J.-E., Bubendorf L., Guan X.-Y.,
RA   Jung Y.-K., Kallioniemi O.-P., Kononen J., Trent J.M., Azorsa D.,
RA   Jhun B.-H., Cheong J.H., Lee Y.C., Meltzer P.S., Lee J.W.;
RT   "A nuclear factor ASC-2, as a cancer-amplified transcriptional
RT   coactivator essential for ligand-dependent transactivation by nuclear
RT   receptors in vivo.";
RL   J. Biol. Chem. 274:34283-34293(1999).
RN   [29]
RP   INTERACTION WITH PHB2.
RX   PubMed=10359819; DOI=10.1073/pnas.96.12.6947;
RA   Montano M.M., Ekena K., Delage-Mourroux R., Chang W., Martini P.,
RA   Katzenellenbogen B.S.;
RT   "An estrogen receptor-selective coregulator that potentiates the
RT   effectiveness of antiestrogens and represses the activity of
RT   estrogens.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:6947-6952(1999).
RN   [30]
RP   INTERACTION WITH NCOA2.
RX   PubMed=11265755; DOI=10.1093/embo-reports/kvd028;
RA   Benecke A., Chambon P., Gronemeyer H.;
RT   "Synergy between estrogen receptor alpha activation functions AF1 and
RT   AF2 mediated by transcription intermediary factor TIF2.";
RL   EMBO Rep. 1:151-157(2000).
RN   [31]
RP   FUNCTION, AND INTERACTION WITH SP1.
RX   PubMed=10681512; DOI=10.1074/jbc.275.8.5379;
RA   Saville B., Wormke M., Wang F., Nguyen T., Enmark E., Kuiper G.,
RA   Gustafsson J.A., Safe S.;
RT   "Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent
RT   activation at GC-rich (Sp1) promoter elements.";
RL   J. Biol. Chem. 275:5379-5387(2000).
RN   [32]
RP   FUNCTION, AND INTERACTION WITH SP3.
RX   PubMed=10816575; DOI=10.1074/jbc.M002188200;
RA   Stoner M., Wang F., Wormke M., Nguyen T., Samudio I., Vyhlidal C.,
RA   Marme D., Finkenzeller G., Safe S.;
RT   "Inhibition of vascular endothelial growth factor expression in HEC1A
RT   endometrial cancer cells through interactions of estrogen receptor
RT   alpha and Sp3 proteins.";
RL   J. Biol. Chem. 275:22769-22779(2000).
RN   [33]
RP   INTERACTION WITH CITED1 AND EP300.
RX   PubMed=11581164; DOI=10.1101/gad.906301;
RA   Yahata T., Shao W., Endoh H., Hur J., Coser K.R., Sun H., Ueda Y.,
RA   Kato S., Isselbacher K.J., Brown M., Shioda T.;
RT   "Selective coactivation of estrogen-dependent transcription by CITED1
RT   CBP/p300-binding protein.";
RL   Genes Dev. 15:2598-2612(2001).
RN   [34]
RP   FUNCTION, AND INTERACTION WITH JUN; JUNB AND JUND.
RX   PubMed=11477071; DOI=10.1074/jbc.M101806200;
RA   Teyssier C., Belguise K., Galtier F., Chalbos D.;
RT   "Characterization of the physical interaction between estrogen
RT   receptor alpha and JUN proteins.";
RL   J. Biol. Chem. 276:36361-36369(2001).
RN   [35]
RP   INTERACTION WITH KDM5A.
RX   PubMed=11358960; DOI=10.1074/jbc.M100313200;
RA   Chan S.W., Hong W.;
RT   "Retinoblastoma-binding protein 2 (Rbp2) potentiates nuclear hormone
RT   receptor-mediated transcription.";
RL   J. Biol. Chem. 276:28402-28412(2001).
RN   [36]
RP   INTERACTION WITH NCOA5.
RX   PubMed=11113208; DOI=10.1128/MCB.21.1.343-353.2001;
RA   Sauve F., McBroom L.D.B., Gallant J., Moraitis A.N., Labrie F.,
RA   Giguere V.;
RT   "CIA, a novel estrogen receptor coactivator with a bifunctional
RT   nuclear receptor interacting determinant.";
RL   Mol. Cell. Biol. 21:343-353(2001).
RN   [37]
RP   FUNCTION, AND INTERACTION WITH NCOA1 AND DDX5.
RX   PubMed=11682626; DOI=10.1210/mend.15.11.0727;
RA   Metivier R., Penot G., Flouriot G., Pakdel F.;
RT   "Synergism between ERalpha transactivation function 1 (AF-1) and AF-2
RT   mediated by steroid receptor coactivator protein-1: requirement for
RT   the AF-1 alpha-helical core and for a direct interaction between the
RT   N- and C-terminal domains.";
RL   Mol. Endocrinol. 15:1953-1970(2001).
RN   [38]
RP   INTERACTION WITH PRMT2.
RX   PubMed=12039952; DOI=10.1074/jbc.M201053200;
RA   Qi C., Chang J., Zhu Y., Yeldandi A.V., Rao S.M., Zhu Y.-J.;
RT   "Identification of protein arginine methyltransferase 2 as a
RT   coactivator for estrogen receptor alpha.";
RL   J. Biol. Chem. 277:28624-28630(2002).
RN   [39]
RP   INTERACTION WITH NR2C1.
RX   PubMed=12093804; DOI=10.1074/jbc.M203531200;
RA   Hu Y.C., Shyr C.R., Che W., Mu X.M., Kim E., Chang C.;
RT   "Suppression of estrogen receptor-mediated transcription and cell
RT   growth by interaction with TR2 orphan receptor.";
RL   J. Biol. Chem. 277:33571-33579(2002).
RN   [40]
RP   INTERACTION WITH NCOA7.
RX   PubMed=11971969; DOI=10.1128/MCB.22.10.3358-3372.2002;
RA   Shao W., Halachmi S., Brown M.;
RT   "ERAP140, a conserved tissue-specific nuclear receptor coactivator.";
RL   Mol. Cell. Biol. 22:3358-3372(2002).
RN   [41]
RP   INTERACTION WITH RBFOX2.
RX   PubMed=11875103; DOI=10.1210/mend.16.3.0787;
RA   Norris J.D., Fan D., Sherk A., McDonnell D.P.;
RT   "A negative coregulator for the human ER.";
RL   Mol. Endocrinol. 16:459-468(2002).
RN   [42]
RP   INTERACTION WITH PELP1.
RX   PubMed=12415108; DOI=10.1073/pnas.192569699;
RA   Wong C.-W., McNally C., Nickbarg E., Komm B.S., Cheskis B.J.;
RT   "Estrogen receptor-interacting protein that modulates its nongenomic
RT   activity-crosstalk with Src/Erk phosphorylation cascade.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:14783-14788(2002).
RN   [43]
RP   INTERACTION WITH SMARD1.
RX   PubMed=12917342; DOI=10.1128/MCB.23.17.6210-6220.2003;
RA   Hsiao P.W., Fryer C.J., Trotter K.W., Wang W., Archer T.K.;
RT   "BAF60a mediates critical interactions between nuclear receptors and
RT   the BRG1 chromatin-remodeling complex for transactivation.";
RL   Mol. Cell. Biol. 23:6210-6220(2003).
RN   [44]
RP   INTERACTION WITH DNTTIP2.
RX   PubMed=15047147; DOI=10.1016/j.bbrc.2004.02.179;
RA   Bu H., Kashireddy P., Chang J., Zhu Y.T., Zhang Z., Zheng W.,
RA   Rao S.M., Zhu Y.-J.;
RT   "ERBP, a novel estrogen receptor binding protein enhancing the
RT   activity of estrogen receptor.";
RL   Biochem. Biophys. Res. Commun. 317:54-59(2004).
RN   [45]
RP   FUNCTION.
RX   PubMed=15078875; DOI=10.1074/jbc.M402148200;
RA   Merot Y., Metivier R., Penot G., Manu D., Saligaut C., Gannon F.,
RA   Pakdel F., Kah O., Flouriot G.;
RT   "The relative contribution exerted by AF-1 and AF-2 transactivation
RT   functions in estrogen receptor alpha transcriptional activity depends
RT   upon the differentiation stage of the cell.";
RL   J. Biol. Chem. 279:26184-26191(2004).
RN   [46]
RP   INTERACTION WITH TXNRD1.
RX   PubMed=15199063; DOI=10.1074/jbc.M402753200;
RA   Damdimopoulos A.E., Miranda-Vizuete A., Treuter E., Gustafsson J.-A.,
RA   Spyrou G.;
RT   "An alternative splicing variant of the selenoprotein thioredoxin
RT   reductase is a modulator of estrogen signaling.";
RL   J. Biol. Chem. 279:38721-38729(2004).
RN   [47]
RP   FUNCTION, PHOSPHORYLATION AT SER-118, DEPHOSPHORYLATION AT SER-118 BY
RP   PPP5C, AND MUTAGENESIS OF SER-118.
RX   PubMed=14764652; DOI=10.1210/me.2003-0308;
RA   Ikeda K., Ogawa S., Tsukui T., Horie-Inoue K., Ouchi Y., Kato S.,
RA   Muramatsu M., Inoue S.;
RT   "Protein phosphatase 5 is a negative regulator of estrogen receptor-
RT   mediated transcription.";
RL   Mol. Endocrinol. 18:1131-1143(2004).
RN   [48]
RP   FUNCTION IN NF-KAPPA-B TRANSREPRESSION.
RX   PubMed=16043358; DOI=10.1016/j.cyto.2004.12.008;
RA   Liu H., Liu K., Bodenner D.L.;
RT   "Estrogen receptor inhibits interleukin-6 gene expression by
RT   disruption of nuclear factor kappaB transactivation.";
RL   Cytokine 31:251-257(2005).
RN   [49]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH DYNLL1.
RX   PubMed=15891768; DOI=10.1038/sj.embor.7400417;
RA   Rayala S.K., den Hollander P., Balasenthil S., Yang Z., Broaddus R.R.,
RA   Kumar R.;
RT   "Functional regulation of oestrogen receptor pathway by the dynein
RT   light chain 1.";
RL   EMBO Rep. 6:538-544(2005).
RN   [50]
RP   ERRATUM.
RA   Rayala S.K., den Hollander P., Balasenthil S., Yang Z., Broaddus R.R.,
RA   Kumar R.;
RL   EMBO Rep. 6:1101-1101(2005).
RN   [51]
RP   INTERACTION WITH HEXIM1.
RX   PubMed=15940264; DOI=10.1038/sj.onc.1208728;
RA   Wittmann B.M., Fujinaga K., Deng H., Ogba N., Montano M.M.;
RT   "The breast cell growth inhibitor, estrogen down regulated gene 1,
RT   modulates a novel functional interaction between estrogen receptor
RT   alpha and transcriptional elongation factor cyclin T1.";
RL   Oncogene 24:5576-5588(2005).
RN   [52]
RP   INTERACTION WITH KMT2D.
RX   PubMed=16603732; DOI=10.1074/jbc.M513245200;
RA   Mo R., Rao S.M., Zhu Y.-J.;
RT   "Identification of the MLL2 complex as a coactivator for estrogen
RT   receptor alpha.";
RL   J. Biol. Chem. 281:15714-15720(2006).
RN   [53]
RP   FUNCTION.
RX   PubMed=16684779; DOI=10.1074/jbc.M600021200;
RA   Rayala S.K., den Hollander P., Manavathi B., Talukder A.H., Song C.,
RA   Peng S., Barnekow A., Kremerskothen J., Kumar R.;
RT   "Essential role of KIBRA in co-activator function of dynein light
RT   chain 1 in mammalian cells.";
RL   J. Biol. Chem. 281:19092-19099(2006).
RN   [54]
RP   INTERACTION WITH MUC1.
RX   PubMed=16427018; DOI=10.1016/j.molcel.2005.11.030;
RA   Wei X., Xu H., Kufe D.;
RT   "MUC1 oncoprotein stabilizes and activates estrogen receptor alpha.";
RL   Mol. Cell 21:295-305(2006).
RN   [55]
RP   INTERACTION WITH UBE3A AND WBP2.
RX   PubMed=16772533; DOI=10.1210/me.2005-0533;
RA   Dhananjayan S.C., Ramamoorthy S., Khan O.Y., Ismail A., Sun J.,
RA   Slingerland J., O'Malley B.W., Nawaz Z.;
RT   "WW domain binding protein-2, an E6-associated protein interacting
RT   protein, acts as a coactivator of estrogen and progesterone
RT   receptors.";
RL   Mol. Endocrinol. 20:2343-2354(2006).
RN   [56]
RP   INTERACTION WITH ZNF366.
RX   PubMed=17085477; DOI=10.1093/nar/gkl875;
RA   Lopez-Garcia J., Periyasamy M., Thomas R.S., Christian M., Leao M.,
RA   Jat P., Kindle K.B., Heery D.M., Parker M.G., Buluwela L.,
RA   Kamalati T., Ali S.;
RT   "ZNF366 is an estrogen receptor corepressor that acts through CtBP and
RT   histone deacetylases.";
RL   Nucleic Acids Res. 34:6126-6136(2006).
RN   [57]
RP   FUNCTION.
RX   PubMed=16617102; DOI=10.1073/pnas.0601989103;
RA   Gururaj A.E., Singh R.R., Rayala S.K., Holm C., den Hollander P.,
RA   Zhang H., Balasenthil S., Talukder A.H., Landberg G., Kumar R.;
RT   "MTA1, a transcriptional activator of breast cancer amplified sequence
RT   3.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:6670-6675(2006).
RN   [58]
RP   ERRATUM.
RA   Gururaj A.E., Singh R.R., Rayala S.K., Holm C., den Hollander P.,
RA   Zhang H., Balasenthil S., Talukder A.H., Landberg G., Kumar R.;
RL   Proc. Natl. Acad. Sci. U.S.A. 110:4147-4148(2013).
RN   [59]
RP   INTERACTION WITH PBXIP1.
RX   PubMed=17043237; DOI=10.1073/pnas.0607445103;
RA   Manavathi B., Acconcia F., Rayala S.K., Kumar R.;
RT   "An inherent role of microtubule network in the action of nuclear
RT   receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:15981-15986(2006).
RN   [60]
RP   INTERACTION WITH MAP1S.
RX   PubMed=17658481; DOI=10.1016/j.bbrc.2007.06.179;
RA   Eriksson M., Samuelsson H., Samuelsson E.-B., Liu L., McKeehan W.L.,
RA   Benedikz E., Sundstroem E.;
RT   "The NMDAR subunit NR3A interacts with microtubule-associated protein
RT   1S in the brain.";
RL   Biochem. Biophys. Res. Commun. 361:127-132(2007).
RN   [61]
RP   INTERACTION WITH CUEDC2.
RX   PubMed=17347654; DOI=10.1038/sj.emboj.7601602;
RA   Zhang P.-J., Zhao J., Li H.-Y., Man J.-H., He K., Zhou T., Pan X.,
RA   Li A.-L., Gong W.-L., Jin B.-F., Xia Q., Yu M., Shen B.-F.,
RA   Zhang X.-M.;
RT   "CUE domain containing 2 regulates degradation of progesterone
RT   receptor by ubiquitin-proteasome.";
RL   EMBO J. 26:1831-1842(2007).
RN   [62]
RP   INTERACTION WITH MACROD1.
RX   PubMed=17914104; DOI=10.1677/ERC-06-0082;
RA   Han W.-D., Zhao Y.-L., Meng Y.G., Zang L., Wu Z.-Q., Li Q., Si Y.-L.,
RA   Huang K., Ba J.-M., Morinaga H., Nomura M., Mu Y.-M.;
RT   "Estrogenically regulated LRP16 interacts with estrogen receptor alpha
RT   and enhances the receptor's transcriptional activity.";
RL   Endocr. Relat. Cancer 14:741-753(2007).
RN   [63]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH KIF18A.
RX   PubMed=17006958; DOI=10.1002/jcb.21000;
RA   Luboshits G., Benayahu D.;
RT   "MS-KIF18A, a kinesin, is associated with estrogen receptor.";
RL   J. Cell. Biochem. 100:693-702(2007).
RN   [64]
RP   INTERACTION WITH PRMT2.
RX   PubMed=17587566; DOI=10.1016/j.jsbmb.2007.05.006;
RA   Meyer R., Wolf S.S., Obendorf M.;
RT   "PRMT2, a member of the protein arginine methyltransferase family, is
RT   a coactivator of the androgen receptor.";
RL   J. Steroid Biochem. Mol. Biol. 107:1-14(2007).
RN   [65]
RP   INTERACTION WITH BCAS3.
RX   PubMed=17505058; DOI=10.1210/me.2006-0514;
RA   Gururaj A.E., Peng S., Vadlamudi R.K., Kumar R.;
RT   "Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha
RT   coactivator, through proline-, glutamic acid-, and leucine-rich
RT   protein-1 (PELP1).";
RL   Mol. Endocrinol. 21:1847-1860(2007).
RN   [66]
RP   INTERACTION WITH UIMC1.
RX   PubMed=17311814; DOI=10.1093/nar/gkl1112;
RA   Yan J., Kim Y.S., Yang X.-P., Albers M., Koegl M., Jetten A.M.;
RT   "Ubiquitin-interaction motifs of RAP80 are critical in its regulation
RT   of estrogen receptor alpha.";
RL   Nucleic Acids Res. 35:1673-1686(2007).
RN   [67]
RP   INTERACTION WITH ATAD2.
RX   PubMed=17998543; DOI=10.1073/pnas.0705814104;
RA   Zou J.X., Revenko A.S., Li L.B., Gemo A.T., Chen H.-W.;
RT   "ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is
RT   required for coregulator occupancy and chromatin modification.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:18067-18072(2007).
RN   [68]
RP   FUNCTION IN ASSOCIATION WITH AP-1.
RX   PubMed=18247370; DOI=10.1002/jcp.21379;
RA   Lambertini E., Tavanti E., Torreggiani E., Penolazzi L., Gambari R.,
RA   Piva R.;
RT   "ERalpha and AP-1 interact in vivo with a specific sequence of the F
RT   promoter of the human ERalpha gene in osteoblasts.";
RL   J. Cell. Physiol. 216:101-110(2008).
RN   [69]
RP   METHYLATION AT ARG-260 BY PRMT1, MUTAGENESIS OF ARG-260, SUBCELLULAR
RP   LOCATION, AND INTERACTION WITH PI3KR1/2; SRC AND PTK2/FAK1.
RX   PubMed=18657504; DOI=10.1016/j.molcel.2008.05.025;
RA   Le Romancer M., Treilleux I., Leconte N., Robin-Lespinasse Y.,
RA   Sentis S., Bouchekioua-Bouzaghou K., Goddard S., Gobert-Gosse S.,
RA   Corbo L.;
RT   "Regulation of estrogen rapid signaling through arginine methylation
RT   by PRMT1.";
RL   Mol. Cell 31:212-221(2008).
RN   [70]
RP   FUNCTION IN NF-KAPPA-B TRANSREPRESSION, AND INTERACTION WITH RELA.
RX   PubMed=17932106; DOI=10.1210/me.2007-0324;
RA   Nettles K.W., Gil G., Nowak J., Metivier R., Sharma V.B., Greene G.L.;
RT   "CBP Is a dosage-dependent regulator of nuclear factor-kappaB
RT   suppression by the estrogen receptor.";
RL   Mol. Endocrinol. 22:263-272(2008).
RN   [71]
RP   FUNCTION.
RX   PubMed=17922032; DOI=10.1038/sj.onc.1210839;
RA   Molli P.R., Singh R.R., Lee S.W., Kumar R.;
RT   "MTA1-mediated transcriptional repression of BRCA1 tumor suppressor
RT   gene.";
RL   Oncogene 27:1971-1980(2008).
RN   [72]
RP   INTERACTION WITH CCDC62.
RX   PubMed=18563714; DOI=10.1002/pros.20774;
RA   Chen M., Ni J., Zhang Y., Muyan M., Yeh S.;
RT   "ERAP75 functions as a coactivator to enhance estrogen receptor alpha
RT   transactivation in prostate stromal cells.";
RL   Prostate 68:1273-1282(2008).
RN   [73]
RP   INTERACTION WITH SH2D4A AND PLCG.
RX   PubMed=19712589; DOI=10.5483/BMBRep.2009.42.8.516;
RA   Li T., Li W., Lu J., Liu H., Li Y., Zhao Y.;
RT   "SH2D4A regulates cell proliferation via the ERalpha/PLC-gamma/PKC
RT   pathway.";
RL   BMB Rep. 42:516-522(2009).
RN   [74]
RP   INTERACTION WITH LDB1 AND RLIM.
RX   PubMed=19117995; DOI=10.1158/0008-5472.CAN-08-1630;
RA   Johnsen S.A., Guengoer C., Prenzel T., Riethdorf S., Riethdorf L.,
RA   Taniguchi-Ishigaki N., Rau T., Tursun B., Furlow J.D., Sauter G.,
RA   Scheffner M., Pantel K., Gannon F., Bach I.;
RT   "Regulation of estrogen-dependent transcription by the LIM cofactors
RT   CLIM and RLIM in breast cancer.";
RL   Cancer Res. 69:128-136(2009).
RN   [75]
RP   INTERACTION WITH DNAAF4.
RX   PubMed=19423554; DOI=10.1093/hmg/ddp215;
RA   Massinen S., Tammimies K., Tapia-Paez I., Matsson H., Hokkanen M.E.,
RA   Soederberg O., Landegren U., Castren E., Gustafsson J.A., Treuter E.,
RA   Kere J.;
RT   "Functional interaction of DYX1C1 with estrogen receptors suggests
RT   involvement of hormonal pathways in dyslexia.";
RL   Hum. Mol. Genet. 18:2802-2812(2009).
RN   [76]
RP   FUNCTION IN MUTUAL TRANSREPRESSION WITH NF-KAPPA-B, AND INTERACTION
RP   WITH NFKB1 AND RELA.
RX   PubMed=19350539; DOI=10.1002/jcb.22141;
RA   Gionet N., Jansson D., Mader S., Pratt M.A.;
RT   "NF-kappaB and estrogen receptor alpha interactions: Differential
RT   function in estrogen receptor-negative and -positive hormone-
RT   independent breast cancer cells.";
RL   J. Cell. Biochem. 107:448-459(2009).
RN   [77]
RP   UBIQUITINATION, AND INTERACTION WITH OTUB1.
RX   PubMed=19383985; DOI=10.1074/jbc.M109.007484;
RA   Stanisic V., Malovannaya A., Qin J., Lonard D.M., O'Malley B.W.;
RT   "OTU Domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1)
RT   deubiquitinates estrogen receptor (ER) alpha and affects ERalpha
RT   transcriptional activity.";
RL   J. Biol. Chem. 284:16135-16145(2009).
RN   [78]
RP   PHOSPHORYLATION BY CSNK1D/CK1, AND INTERACTION WITH CSNK1D.
RX   PubMed=19339517; DOI=10.1093/nar/gkp136;
RA   Giamas G., Castellano L., Feng Q., Knippschild U., Jacob J.,
RA   Thomas R.S., Coombes R.C., Smith C.L., Jiao L.R., Stebbing J.;
RT   "CK1delta modulates the transcriptional activity of ERalpha via AIB1
RT   in an estrogen-dependent manner and regulates ERalpha-AIB1
RT   interactions.";
RL   Nucleic Acids Res. 37:3110-3123(2009).
RN   [79]
RP   INTERACTION WITH DDX17.
RX   PubMed=19718048; DOI=10.1038/onc.2009.261;
RA   Wortham N.C., Ahamed E., Nicol S.M., Thomas R.S., Periyasamy M.,
RA   Jiang J., Ochocka A.M., Shousha S., Huson L., Bray S.E., Coombes R.C.,
RA   Ali S., Fuller-Pace F.V.;
RT   "The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent
RT   transcription and cell growth, and is associated with improved
RT   survival in ERalpha-positive breast cancer.";
RL   Oncogene 28:4053-4064(2009).
RN   [80]
RP   INTERACTION WITH KIF18A.
RX   PubMed=19636373; DOI=10.1371/journal.pone.0006407;
RA   Zusev M., Benayahu D.;
RT   "The regulation of MS-KIF18A expression and cross talk with estrogen
RT   receptor.";
RL   PLoS ONE 4:E6407-E6407(2009).
RN   [81]
RP   FUNCTION, INTERACTION WITH CCAR2, AND SUBCELLULAR LOCATION.
RX   PubMed=20074560; DOI=10.1016/j.bbrc.2010.01.025;
RA   Koyama S., Wada-Hiraike O., Nakagawa S., Tanikawa M., Hiraike H.,
RA   Miyamoto Y., Sone K., Oda K., Fukuhara H., Nakagawa K., Kato S.,
RA   Yano T., Taketani Y.;
RT   "Repression of estrogen receptor beta function by putative tumor
RT   suppressor DBC1.";
RL   Biochem. Biophys. Res. Commun. 392:357-362(2010).
RN   [82]
RP   FUNCTION IN SYNERGISM WITH NF-KAPPA-B.
RX   PubMed=20705611; DOI=10.1074/jbc.M110.155309;
RA   Pradhan M., Bembinster L.A., Baumgarten S.C., Frasor J.;
RT   "Proinflammatory cytokines enhance estrogen-dependent expression of
RT   the multidrug transporter gene ABCG2 through estrogen receptor and
RT   NF{kappa}B cooperativity at adjacent response elements.";
RL   J. Biol. Chem. 285:31100-31106(2010).
RN   [83]
RP   INTERACTION WITH ZFHX3.
RX   PubMed=20720010; DOI=10.1074/jbc.M110.128330;
RA   Dong X.Y., Sun X., Guo P., Li Q., Sasahara M., Ishii Y., Dong J.T.;
RT   "ATBF1 inhibits estrogen receptor (ER) function by selectively
RT   competing with AIB1 for binding to the ER in ER-positive breast cancer
RT   cells.";
RL   J. Biol. Chem. 285:32801-32809(2010).
RN   [84]
RP   INTERACTION WITH ESRRB.
RX   PubMed=19755138; DOI=10.1016/j.mce.2009.09.007;
RA   Bombail V., Collins F., Brown P., Saunders P.T.;
RT   "Modulation of ER alpha transcriptional activity by the orphan nuclear
RT   receptor ERR beta and evidence for differential effects of long- and
RT   short-form splice variants.";
RL   Mol. Cell. Endocrinol. 314:53-61(2010).
RN   [85]
RP   INTERACTION WITH SAV1 AND STK3/MST2.
RX   PubMed=21104395; DOI=10.1007/s00109-010-0698-y;
RA   Park Y., Park J., Lee Y., Lim W., Oh B.C., Shin C., Kim W., Lee Y.;
RT   "Mammalian MST2 kinase and human Salvador activate and reduce estrogen
RT   receptor alpha in the absence of ligand.";
RL   J. Mol. Med. 89:181-191(2011).
RN   [86]
RP   FUNCTION (ISOFORM 3), SUBCELLULAR LOCATION (ISOFORM 3), TOPOLOGY
RP   (ISOFORM 3), AND MUTAGENESIS OF ILE-386.
RX   PubMed=21937726; DOI=10.1091/mbc.E11-05-0416;
RA   Kim K.H., Toomre D., Bender J.R.;
RT   "Splice isoform estrogen receptors as integral transmembrane
RT   proteins.";
RL   Mol. Biol. Cell 22:4415-4423(2011).
RN   [87]
RP   FUNCTION IN ERE-INDEPENDENT SIGNALING.
RX   PubMed=21330404; DOI=10.1210/me.2010-0425;
RA   Heldring N., Isaacs G.D., Diehl A.G., Sun M., Cheung E., Ranish J.A.,
RA   Kraus W.L.;
RT   "Multiple sequence-specific DNA-binding proteins mediate estrogen
RT   receptor signaling through a tethering pathway.";
RL   Mol. Endocrinol. 25:564-574(2011).
RN   [88]
RP   INTERACTION WITH LMTK3, PHOSPHORYLATION, AND UBIQUITINATION.
RX   PubMed=21602804; DOI=10.1038/nm.2351;
RA   Giamas G., Filipovic A., Jacob J., Messier W., Zhang H., Yang D.,
RA   Zhang W., Shifa B.A., Photiou A., Tralau-Stewart C., Castellano L.,
RA   Green A.R., Coombes R.C., Ellis I.O., Ali S., Lenz H.J., Stebbing J.;
RT   "Kinome screening for regulators of the estrogen receptor identifies
RT   LMTK3 as a new therapeutic target in breast cancer.";
RL   Nat. Med. 17:715-719(2011).
RN   [89]
RP   SUBCELLULAR LOCATION, AND PALMITOYLATION.
RX   PubMed=22031296; DOI=10.1091/mbc.E11-07-0638;
RA   Pedram A., Razandi M., Deschenes R.J., Levin E.R.;
RT   "DHHC-7 and -21 are palmitoylacyltransferases for sex steroid
RT   receptors.";
RL   Mol. Biol. Cell 23:188-199(2012).
RN   [90]
RP   FUNCTION IN SYNERGISM WITH NF-KAPPA-B.
RX   PubMed=22083956; DOI=10.1128/MCB.05869-11;
RA   Pradhan M., Baumgarten S.C., Bembinster L.A., Frasor J.;
RT   "CBP mediates NF-kappaB-dependent histone acetylation and estrogen
RT   receptor recruitment to an estrogen response element in the BIRC3
RT   promoter.";
RL   Mol. Cell. Biol. 32:569-575(2012).
RN   [91]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH CLOCK.
RX   PubMed=23160374; DOI=10.1038/onc.2012.518;
RA   Li S., Wang M., Ao X., Chang A.K., Yang C., Zhao F., Bi H., Liu Y.,
RA   Xiao L., Wu H.;
RT   "CLOCK is a substrate of SUMO and sumoylation of CLOCK upregulates the
RT   transcriptional activity of estrogen receptor-alpha.";
RL   Oncogene 32:4883-4891(2013).
RN   [92]
RP   INTERACTION WITH SFR1.
RX   PubMed=23874500; DOI=10.1371/journal.pone.0068075;
RA   Feng Y., Singleton D., Guo C., Gardner A., Pakala S., Kumar R.,
RA   Jensen E., Zhang J., Khan S.;
RT   "DNA homologous recombination factor SFR1 physically and functionally
RT   interacts with estrogen receptor alpha.";
RL   PLoS ONE 8:E68075-E68075(2013).
RN   [93]
RP   INTERACTION WITH TRIP4.
RX   PubMed=25219498; DOI=10.1016/j.molcel.2014.08.007;
RA   Yoo H.M., Kang S.H., Kim J.Y., Lee J.E., Seong M.W., Lee S.W.,
RA   Ka S.H., Sou Y.S., Komatsu M., Tanaka K., Lee S.T., Noh D.Y.,
RA   Baek S.H., Jeon Y.J., Chung C.H.;
RT   "Modification of ASC1 by UFM1 is crucial for ERalpha transactivation
RT   and breast cancer development.";
RL   Mol. Cell 56:261-274(2014).
RN   [94]
RP   INTERACTION WITH DCAF13; LATS1 AND DCAF1, AND UBIQUITINATION.
RX   PubMed=28068668; DOI=10.1038/nature20829;
RA   Britschgi A., Duss S., Kim S., Couto J.P., Brinkhaus H., Koren S.,
RA   De Silva D., Mertz K.D., Kaup D., Varga Z., Voshol H., Vissieres A.,
RA   Leroy C., Roloff T., Stadler M.B., Scheel C.H., Miraglia L.J.,
RA   Orth A.P., Bonamy G.M., Reddy V.A., Bentires-Alj M.;
RT   "The Hippo kinases LATS1 and 2 control human breast cell fate via
RT   crosstalk with ERalpha.";
RL   Nature 541:541-545(2017).
RN   [95]
RP   STRUCTURE BY NMR OF 180-262.
RX   PubMed=2247153; DOI=10.1038/348458a0;
RA   Schwabe J.W.E., Neuhaus D., Rhodes D.;
RT   "Solution structure of the DNA-binding domain of the oestrogen
RT   receptor.";
RL   Nature 348:458-461(1990).
RN   [96]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 180-262.
RX   PubMed=8221895; DOI=10.1016/0092-8674(93)90390-C;
RA   Schwabe J.W.E., Chapman L., Finch J.T., Rhodes D.;
RT   "The crystal structure of the estrogen receptor DNA-binding domain
RT   bound to DNA: how receptors discriminate between their response
RT   elements.";
RL   Cell 75:567-578(1993).
RN   [97]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 305-548.
RX   PubMed=9338790; DOI=10.1038/39645;
RA   Brzozowski A.M., Pike A.C.W., Dauter Z., Hubbard R.E., Bonn T.,
RA   Engstroem O., Oehman L., Greene G.L., Gustafsson J.-A., Carlquist M.;
RT   "Molecular basis of agonism and antagonism in the oestrogen
RT   receptor.";
RL   Nature 389:753-758(1997).
RN   [98]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 306-544.
RX   PubMed=9600906; DOI=10.1073/pnas.95.11.5998;
RA   Tanenbaum D.M., Wang Y., Williams S.P., Sigler P.B.;
RT   "Crystallographic comparison of the estrogen and progesterone
RT   receptor's ligand binding domains.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:5998-6003(1998).
RN   [99]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 294-554.
RX   PubMed=9875847; DOI=10.1016/S0092-8674(00)81717-1;
RA   Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J.,
RA   Agard D.A., Greene G.L.;
RT   "The structural basis of estrogen receptor/coactivator recognition and
RT   the antagonism of this interaction by tamoxifen.";
RL   Cell 95:927-937(1998).
RN   [100]
RP   3D-STRUCTURE MODELING OF 311-547.
RX   PubMed=9619507; DOI=10.1080/07391102.1998.10508206;
RA   Maalouf G.J., Xu W., Smith T., Mohr S.C.;
RT   "Homology model for the ligand-binding domain of the human estrogen
RT   receptor.";
RL   J. Biomol. Struct. Dyn. 15:841-850(1998).
RN   [101]
RP   VARIANT VAL-400.
RX   PubMed=2792078;
RA   Tora L., Mullick A., Metzger D., Ponglikitmongkol M., Park I.,
RA   Chambon P.;
RT   "The cloned human oestrogen receptor contains a mutation which alters
RT   its hormone binding properties.";
RL   EMBO J. 8:1981-1986(1989).
RN   [102]
RP   VARIANT CYS-160.
RX   PubMed=9195227;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:6<531::AID-HUMU6>3.3.CO;2-J;
RA   Anderson T.I., Wooster R., Laake K., Collins N., Warren W., Skrede M.,
RA   Eeles R., Tveit K.M., Johnston S.R.D., Dowsett M., Olsen A.O.,
RA   Moeller P., Stratton M.R., Boerresen-Dale A.-L.;
RT   "Screening for ESR mutations in breast and ovarian cancer patients.";
RL   Hum. Mutat. 9:531-536(1997).
RN   [103]
RP   INVOLVEMENT IN BMD.
RX   PubMed=10942433; DOI=10.1093/hmg/9.13.2043;
RA   Becherini L., Gennari L., Masi L., Mansani R., Massart F., Morelli A.,
RA   Falchetti A., Gonnelli S., Fiorelli G., Tanini A., Brandi M.L.;
RT   "Evidence of a linkage disequilibrium between polymorphisms in the
RT   human estrogen receptor alpha gene and their relationship to bone mass
RT   variation in postmenopausal Italian women.";
RL   Hum. Mol. Genet. 9:2043-2050(2000).
RN   [104]
RP   INTERACTION WITH GPER1.
RX   PubMed=19749156; DOI=10.1210/me.2009-0120;
RA   Vivacqua A., Lappano R., De Marco P., Sisci D., Aquila S.,
RA   De Amicis F., Fuqua S.A., Ando S., Maggiolini M.;
RT   "G protein-coupled receptor 30 expression is up-regulated by EGF and
RT   TGF alpha in estrogen receptor alpha-positive cancer cells.";
RL   Mol. Endocrinol. 23:1815-1826(2009).
RN   [105]
RP   VARIANTS TYR-6 AND ILE-264.
RX   PubMed=17224074; DOI=10.1186/bcr1637;
RA   Chanock S.J., Burdett L., Yeager M., Llaca V., Langeroed A.,
RA   Presswalla S., Kaaresen R., Strausberg R.L., Gerhard D.S.,
RA   Kristensen V., Perou C.M., Boerresen-Dale A.-L.;
RT   "Somatic sequence alterations in twenty-one genes selected by
RT   expression profile analysis of breast carcinomas.";
RL   Breast Cancer Res. 9:R5-R5(2007).
RN   [106]
RP   VARIANT ESTRR HIS-375, AND CHARACTERIZATION OF VARIANT ESTRR HIS-375.
RX   PubMed=23841731; DOI=10.1056/NEJMoa1303611;
RA   Quaynor S.D., Stradtman E.W. Jr., Kim H.G., Shen Y., Chorich L.P.,
RA   Schreihofer D.A., Layman L.C.;
RT   "Delayed puberty and estrogen resistance in a woman with estrogen
RT   receptor alpha variant.";
RL   N. Engl. J. Med. 369:164-171(2013).
RN   [107]
RP   VARIANT ESTRR HIS-394, AND CHARACTERIZATION OF VARIANT ESTRR HIS-394.
RX   PubMed=27754803; DOI=10.1210/jc.2016-2749;
RA   Bernard V., Kherra S., Francou B., Fagart J., Viengchareun S.,
RA   Guechot J., Ladjouze A., Guiochon-Mantel A., Korach K.S., Binart N.,
RA   Lombes M., Christin-Maitre S.;
RT   "Familial multiplicity of estrogen insensitivity associated with a
RT   loss-of-function ESR1 mutation.";
RL   J. Clin. Endocrinol. Metab. 102:93-99(2017).
CC   -!- FUNCTION: Nuclear hormone receptor. The steroid hormones and their
CC       receptors are involved in the regulation of eukaryotic gene
CC       expression and affect cellular proliferation and differentiation
CC       in target tissues. Ligand-dependent nuclear transactivation
CC       involves either direct homodimer binding to a palindromic estrogen
CC       response element (ERE) sequence or association with other DNA-
CC       binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2,
CC       Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding
CC       induces a conformational change allowing subsequent or
CC       combinatorial association with multiprotein coactivator complexes
CC       through LXXLL motifs of their respective components. Mutual
CC       transrepression occurs between the estrogen receptor (ER) and NF-
CC       kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-
CC       binding activity and inhibits NF-kappa-B-mediated transcription
CC       from the IL6 promoter and displace RELA/p65 and associated
CC       coregulators from the promoter. Recruited to the NF-kappa-B
CC       response element of the CCL2 and IL8 promoters and can displace
CC       CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50
CC       on ERE sequences. Can also act synergistically with NF-kappa-B to
CC       activate transcription involving respective recruitment adjacent
CC       response elements; the function involves CREBBP. Can activate the
CC       transcriptional activity of TFF1. Also mediates membrane-initiated
CC       estrogen signaling involving various kinase cascades. Isoform 3 is
CC       involved in activation of NOS3 and endothelial nitric oxide
CC       production. Isoforms lacking one or several functional domains are
CC       thought to modulate transcriptional activity by competitive ligand
CC       or DNA binding and/or heterodimerization with the full-length
CC       receptor. Essential for MTA1-mediated transcriptional regulation
CC       of BRCA1 and BCAS3. Isoform 3 can bind to ERE and inhibit isoform
CC       1. {ECO:0000269|PubMed:10681512, ECO:0000269|PubMed:10816575,
CC       ECO:0000269|PubMed:11477071, ECO:0000269|PubMed:11682626,
CC       ECO:0000269|PubMed:14764652, ECO:0000269|PubMed:15078875,
CC       ECO:0000269|PubMed:15891768, ECO:0000269|PubMed:16043358,
CC       ECO:0000269|PubMed:16617102, ECO:0000269|PubMed:16684779,
CC       ECO:0000269|PubMed:17922032, ECO:0000269|PubMed:17932106,
CC       ECO:0000269|PubMed:18247370, ECO:0000269|PubMed:19350539,
CC       ECO:0000269|PubMed:20074560, ECO:0000269|PubMed:20705611,
CC       ECO:0000269|PubMed:21330404, ECO:0000269|PubMed:22083956,
CC       ECO:0000269|PubMed:7651415, ECO:0000269|PubMed:9328340}.
CC   -!- SUBUNIT: Binds DNA as a homodimer. Can form a heterodimer with
CC       ESR2. Isoform 3 can probably homodimerize or heterodimerize with
CC       isoform 1 and ESR2. Interacts with FOXC2, MAP1S, SLC30A9, UBE1C
CC       and NCOA3 coactivator (By similarity). Interacts with EP300; the
CC       interaction is estrogen-dependent and enhanced by CITED1.
CC       Interacts with CITED1; the interaction is estrogen-dependent.
CC       Interacts with NCOA5 and NCOA6 coactivators. Interacts with NCOA7;
CC       the interaction is a ligand-inducible. Interacts with PHB2, PELP1
CC       and UBE1C. Interacts with AKAP13. Interacts with CUEDC2. Interacts
CC       with KDM5A. Interacts with SMARD1. Interacts with HEXIM1.
CC       Interacts with PBXIP1. Interaction with MUC1 is stimulated by 7
CC       beta-estradiol (E2) and enhances ERS1-mediated transcription.
CC       Interacts with DNTTIP2, FAM120B and UIMC1. Interacts with isoform
CC       4 of TXNRD1. Interacts with KMT2D/MLL2. Interacts with ATAD2 and
CC       this interaction is enhanced by estradiol. Interacts with KIF18A
CC       and LDB1. Interacts with RLIM (via C-terminus). Interacts with
CC       MACROD1. Interacts with SH2D4A and PLCG. Interaction with SH2D4A
CC       blocks binding to PLCG and inhibits estrogen-induced cell
CC       proliferation. Interacts with DYNLL1. Interacts with CCDC62 in the
CC       presence of estradiol/E2; this interaction seems to enhance the
CC       transcription of target genes. Interacts with NR2C1; the
CC       interaction prevents homodimerization of ESR1 and suppresses its
CC       transcriptional activity and cell growth. Interacts with DNAAF4.
CC       Interacts with PRMT2. Interacts with PI3KR1 or PI3KR2, SRC and
CC       PTK2/FAK1. Interacts with RBFOX2. Interacts with STK3/MST2 only in
CC       the presence of SAV1 and vice-versa. Binds to CSNK1D. Interacts
CC       with NCOA2; NCOA2 can interact with ESR1 AF-1 and AF-2 domains
CC       simultaneously and mediate their transcriptional synergy.
CC       Interacts with DDX5. Interacts with NCOA1; the interaction seems
CC       to require a self-association of N-terminal and C-terminal
CC       regions. Interacts with ZNF366, DDX17, NFKB1, RELA, SP1 and SP3.
CC       Interacts with NRIP1 (By similarity). Interacts with GPER1; the
CC       interaction occurs in an estrogen-dependent manner. Interacts with
CC       CLOCK and the interaction is stimulated by estrogen. Interacts
CC       with BCAS3. Interacts with TRIP4 (ufmylated); estrogen dependent.
CC       Interacts with LMTK3; the interaction phosphorylates ESR1 (in
CC       vitro) and protects it against proteasomal degradation. Interacts
CC       with CCAR2 (via N-terminus) in a ligand-independent manner.
CC       Interacts with ZFHX3. Interacts with SFR1 in a ligand-dependent
CC       and -independent manner (PubMed:23874500). Interacts with DCAF13,
CC       LATS1 and DCAF1; regulates ESR1 ubiquitination and ubiquitin-
CC       mediated proteasomal degradation (PubMed:28068668). Interacts (via
CC       DNA-binding domain) with POU4F2 (C-terminus); this interaction
CC       increases the estrogen receptor ESR1 transcriptional activity in a
CC       DNA- and ligand 17-beta-estradiol-independent manner (By
CC       similarity). Interacts with ESRRB isoform 1 (PubMed:19755138).
CC       Interacts with UBE3A nad WBP2 (PubMed:16772533). {ECO:0000250,
CC       ECO:0000250|UniProtKB:P19785, ECO:0000269|PubMed:10359819,
CC       ECO:0000269|PubMed:10409727, ECO:0000269|PubMed:10567404,
CC       ECO:0000269|PubMed:10681512, ECO:0000269|PubMed:10816575,
CC       ECO:0000269|PubMed:10970861, ECO:0000269|PubMed:11113208,
CC       ECO:0000269|PubMed:11265755, ECO:0000269|PubMed:11358960,
CC       ECO:0000269|PubMed:11477071, ECO:0000269|PubMed:11581164,
CC       ECO:0000269|PubMed:11682626, ECO:0000269|PubMed:11875103,
CC       ECO:0000269|PubMed:11971969, ECO:0000269|PubMed:12039952,
CC       ECO:0000269|PubMed:12093804, ECO:0000269|PubMed:12415108,
CC       ECO:0000269|PubMed:12554772, ECO:0000269|PubMed:12917342,
CC       ECO:0000269|PubMed:15047147, ECO:0000269|PubMed:15199063,
CC       ECO:0000269|PubMed:15891768, ECO:0000269|PubMed:15940264,
CC       ECO:0000269|PubMed:16427018, ECO:0000269|PubMed:16603732,
CC       ECO:0000269|PubMed:16772533, ECO:0000269|PubMed:17006958,
CC       ECO:0000269|PubMed:17043237, ECO:0000269|PubMed:17085477,
CC       ECO:0000269|PubMed:17311814, ECO:0000269|PubMed:17347654,
CC       ECO:0000269|PubMed:17505058, ECO:0000269|PubMed:17587566,
CC       ECO:0000269|PubMed:17658481, ECO:0000269|PubMed:17914104,
CC       ECO:0000269|PubMed:17932106, ECO:0000269|PubMed:17998543,
CC       ECO:0000269|PubMed:18563714, ECO:0000269|PubMed:18657504,
CC       ECO:0000269|PubMed:19117995, ECO:0000269|PubMed:19339517,
CC       ECO:0000269|PubMed:19350539, ECO:0000269|PubMed:19383985,
CC       ECO:0000269|PubMed:19423554, ECO:0000269|PubMed:19636373,
CC       ECO:0000269|PubMed:19712589, ECO:0000269|PubMed:19718048,
CC       ECO:0000269|PubMed:19749156, ECO:0000269|PubMed:19755138,
CC       ECO:0000269|PubMed:20074560, ECO:0000269|PubMed:20720010,
CC       ECO:0000269|PubMed:21104395, ECO:0000269|PubMed:21602804,
CC       ECO:0000269|PubMed:23160374, ECO:0000269|PubMed:23874500,
CC       ECO:0000269|PubMed:25219498, ECO:0000269|PubMed:28068668,
CC       ECO:0000269|PubMed:9328340, ECO:0000269|PubMed:9627117}.
CC   -!- INTERACTION:
CC       Self; NbExp=9; IntAct=EBI-78473, EBI-78473;
CC       Q12802:AKAP13; NbExp=3; IntAct=EBI-78473, EBI-1373806;
CC       Q03989:ARID5A; NbExp=9; IntAct=EBI-78473, EBI-948603;
CC       Q9Y294:ASF1A; NbExp=2; IntAct=EBI-78473, EBI-749553;
CC       Q8IXJ9:ASXL1; NbExp=2; IntAct=EBI-78473, EBI-1646500;
CC       P59598:Asxl1 (xeno); NbExp=2; IntAct=EBI-78473, EBI-5743705;
CC       Q6PL18:ATAD2; NbExp=3; IntAct=EBI-78473, EBI-6598454;
CC       P62952:BLCAP; NbExp=2; IntAct=EBI-78473, EBI-3895726;
CC       P38398:BRCA1; NbExp=12; IntAct=EBI-78473, EBI-349905;
CC       P20290-2:BTF3; NbExp=5; IntAct=EBI-78473, EBI-1054703;
CC       Q86Y37:CACUL1; NbExp=5; IntAct=EBI-78473, EBI-8168227;
CC       Q99966:CITED1; NbExp=3; IntAct=EBI-78473, EBI-2624951;
CC       Q9H467:CUEDC2; NbExp=2; IntAct=EBI-78473, EBI-1248228;
CC       O00429:DNM1L; NbExp=2; IntAct=EBI-78473, EBI-724571;
CC       P00533:EGFR; NbExp=4; IntAct=EBI-4309277, EBI-297353;
CC       Q09472:EP300; NbExp=2; IntAct=EBI-78473, EBI-447295;
CC       Q92731:ESR2; NbExp=5; IntAct=EBI-15606245, EBI-78505;
CC       Q12778:FOXO1; NbExp=2; IntAct=EBI-78473, EBI-1108782;
CC       Q9Y3R0:GRIP1; NbExp=2; IntAct=EBI-78473, EBI-5349621;
CC       O00165:HAX1; NbExp=2; IntAct=EBI-78473, EBI-357001;
CC       Q6NYC1:JMJD6; NbExp=8; IntAct=EBI-78473, EBI-8464037;
CC       P05627:Jun (xeno); NbExp=6; IntAct=EBI-78473, EBI-764369;
CC       Q92993:KAT5; NbExp=3; IntAct=EBI-15606245, EBI-399080;
CC       O15054:KDM6B; NbExp=2; IntAct=EBI-78473, EBI-2831260;
CC       O14686:KMT2D; NbExp=3; IntAct=EBI-78473, EBI-996065;
CC       Q9BQ69:MACROD1; NbExp=4; IntAct=EBI-78473, EBI-5324932;
CC       Q00987:MDM2; NbExp=2; IntAct=EBI-78473, EBI-389668;
CC       P60660:MYL6; NbExp=3; IntAct=EBI-78473, EBI-300817;
CC       Q15788:NCOA1; NbExp=7; IntAct=EBI-78473, EBI-455189;
CC       Q15596:NCOA2; NbExp=5; IntAct=EBI-78473, EBI-81236;
CC       Q9Y6Q9:NCOA3; NbExp=4; IntAct=EBI-78473, EBI-81196;
CC       Q9JLI4:Ncoa6 (xeno); NbExp=2; IntAct=EBI-78473, EBI-286271;
CC       Q9UN36:NDRG2; NbExp=2; IntAct=EBI-78473, EBI-3895741;
CC       P19838:NFKB1; NbExp=3; IntAct=EBI-78473, EBI-697771;
CC       Q96RI1-3:NR1H4; NbExp=2; IntAct=EBI-78473, EBI-10921781;
CC       Q9BTK6:PAGR1; NbExp=5; IntAct=EBI-78473, EBI-2372223;
CC       Q96AQ6-1:PBXIP1; NbExp=5; IntAct=EBI-15606245, EBI-15606280;
CC       P62962:Pfn1 (xeno); NbExp=3; IntAct=EBI-78473, EBI-647096;
CC       P06401:PGR; NbExp=20; IntAct=EBI-78473, EBI-78539;
CC       P06401-1:PGR; NbExp=4; IntAct=EBI-78473, EBI-12590474;
CC       Q99623:PHB2; NbExp=4; IntAct=EBI-78473, EBI-358348;
CC       P27986:PIK3R1; NbExp=7; IntAct=EBI-78473, EBI-79464;
CC       P53041:PPP5C; NbExp=4; IntAct=EBI-78473, EBI-716663;
CC       P55345:PRMT2; NbExp=9; IntAct=EBI-78473, EBI-78458;
CC       P60763:RAC3; NbExp=5; IntAct=EBI-78473, EBI-767084;
CC       O43251:RBFOX2; NbExp=4; IntAct=EBI-78473, EBI-746056;
CC       Q04206:RELA; NbExp=7; IntAct=EBI-78473, EBI-73886;
CC       Q14151:SAFB2; NbExp=2; IntAct=EBI-78473, EBI-352869;
CC       Q96HI0:SENP5; NbExp=2; IntAct=EBI-78473, EBI-3895753;
CC       P29353:SHC1; NbExp=2; IntAct=EBI-4309277, EBI-78835;
CC       P08047:SP1; NbExp=2; IntAct=EBI-78473, EBI-298336;
CC       Q02447:SP3; NbExp=2; IntAct=EBI-78473, EBI-348158;
CC       P00523:SRC (xeno); NbExp=2; IntAct=EBI-78473, EBI-848039;
CC       P12931:SRC; NbExp=12; IntAct=EBI-78473, EBI-621482;
CC       O15164:TRIM24; NbExp=3; IntAct=EBI-78473, EBI-2130378;
CC       Q16881-4:TXNRD1; NbExp=4; IntAct=EBI-78473, EBI-9080335;
CC       Q9UBK9:UXT; NbExp=2; IntAct=EBI-78473, EBI-357355;
CC       Q8N895:ZNF366; NbExp=6; IntAct=EBI-78473, EBI-2813661;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00407, ECO:0000269|PubMed:12682286,
CC       ECO:0000269|PubMed:20074560}. Cytoplasm
CC       {ECO:0000269|PubMed:12682286}. Cell membrane
CC       {ECO:0000269|PubMed:12682286}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:12682286}; Cytoplasmic side
CC       {ECO:0000269|PubMed:12682286}. Note=A minor fraction is associated
CC       with the inner membrane.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Nucleus. Cytoplasm. Cell
CC       membrane; Peripheral membrane protein; Cytoplasmic side. Cell
CC       membrane; Single-pass type I membrane protein. Note=Associated
CC       with the inner membrane via palmitoylation (Probable). At least a
CC       subset exists as a transmembrane protein with a N-terminal
CC       extracellular domain. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Golgi apparatus. Cell membrane.
CC       Note=Colocalizes with ZDHHC7 and ZDHHC21 in the Golgi apparatus
CC       where most probably palmitoylation occurs. Associated with the
CC       plasma membrane when palmitoylated.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Long, hER-alpha66, ER66;
CC         IsoId=P03372-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=P03372-2; Sequence=VSP_003680;
CC         Note=No experimental confirmation available.;
CC       Name=3; Synonyms=hER-alpha46, ER46;
CC         IsoId=P03372-3; Sequence=VSP_042460;
CC         Note=Produced by alternative promoter usage.;
CC       Name=4; Synonyms=hER-alpha36, ER36;
CC         IsoId=P03372-4; Sequence=VSP_042460, VSP_042461;
CC         Note=Produced by alternative splicing of isoform 3.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Isoform 3 is not expressed
CC       in the pituitary gland. {ECO:0000269|PubMed:10970861}.
CC   -!- DOMAIN: Composed of three domains: a modulating N-terminal domain,
CC       a DNA-binding domain and a C-terminal ligand-binding domain. The
CC       modulating domain, also known as A/B or AF-1 domain has a ligand-
CC       independent transactivation function. The C-terminus contains a
CC       ligand-dependent transactivation domain, also known as E/F or AF-2
CC       domain which overlaps with the ligand binding domain. AF-1 and AF-
CC       2 activate transcription independently and synergistically and act
CC       in a promoter- and cell-specific manner. AF-1 seems to provide the
CC       major transactivation function in differentiated cells.
CC   -!- PTM: Phosphorylated by cyclin A/CDK2 and CK1. Phosphorylation
CC       probably enhances transcriptional activity. Self-association
CC       induces phosphorylation. Dephosphorylation at Ser-118 by PPP5C
CC       inhibits its transactivation activity. Phosphorylated by LMTK3 in
CC       vitro. {ECO:0000269|PubMed:10428798, ECO:0000269|PubMed:14764652,
CC       ECO:0000269|PubMed:19339517, ECO:0000269|PubMed:21602804,
CC       ECO:0000269|PubMed:7476978, ECO:0000269|PubMed:7539106,
CC       ECO:0000269|PubMed:7838153}.
CC   -!- PTM: Glycosylated; contains N-acetylglucosamine, probably O-
CC       linked. {ECO:0000269|PubMed:8999954}.
CC   -!- PTM: Ubiquitinated; regulated by LATS1 via DCAF1 it leads to ESR1
CC       proteasomal degradation (PubMed:21602804, PubMed:28068668).
CC       Deubiquitinated by OTUB1 (PubMed:19383985).
CC       {ECO:0000269|PubMed:19383985, ECO:0000269|PubMed:21602804,
CC       ECO:0000269|PubMed:28068668}.
CC   -!- PTM: Dimethylated by PRMT1 at Arg-260. The methylation may favor
CC       cytoplasmic localization. {ECO:0000269|PubMed:18657504}.
CC   -!- PTM: Palmitoylated (isoform 3). Not biotinylated (isoform 3).
CC       {ECO:0000269|PubMed:22031296}.
CC   -!- PTM: Palmitoylated by ZDHHC7 and ZDHHC21. Palmitoylation is
CC       required for plasma membrane targeting and for rapid intracellular
CC       signaling via ERK and AKT kinases and cAMP generation, but not for
CC       signaling mediated by the nuclear hormone receptor.
CC       {ECO:0000269|PubMed:22031296}.
CC   -!- POLYMORPHISM: Genetic variations in ESR1 are correlated with bone
CC       mineral density (BMD). Low BMD is a risk factor for osteoporotic
CC       fracture. Osteoporosis is characterized by reduced bone mineral
CC       density, disruption of bone microarchitecture, and the alteration
CC       of the amount and variety of non-collagenous proteins in bone.
CC       Osteoporotic bones are more at risk of fracture.
CC       {ECO:0000269|PubMed:10942433}.
CC   -!- DISEASE: Estrogen resistance (ESTRR) [MIM:615363]: A disorder
CC       characterized by partial or complete resistance to estrogens, in
CC       the presence of elevated estrogen serum levels. Clinical features
CC       include absence of the pubertal growth spurt, delayed bone
CC       maturation, unfused epiphyses, reduced bone mineral density,
CC       osteoporosis, continued growth into adulthood and very tall adult
CC       stature. Glucose intolerance, hyperinsulinemia and lipid
CC       abnormalities may also be present. {ECO:0000269|PubMed:23841731,
CC       ECO:0000269|PubMed:27754803}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Selective estrogen receptor modulators (SERMs),
CC       such as tamoxifen, raloxifene, toremifene, lasofoxifene,
CC       clomifene, femarelle and ormeloxifene, have tissue selective
CC       agonistic and antagonistic effects on the estrogen receptor (ER).
CC       They interfere with the ER association with coactivators or
CC       corepressors, mainly involving the AF-2 domain.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR3
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB00115.1; Type=Miscellaneous discrepancy; Note=contains an in-frame duplication of exons 6 and 7.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/esr1/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Estrogen receptor entry;
CC       URL="https://en.wikipedia.org/wiki/Estrogen_receptor";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X03635; CAA27284.1; -; mRNA.
DR   EMBL; M12674; AAA52399.1; -; mRNA.
DR   EMBL; U47678; AAB00115.1; ALT_SEQ; mRNA.
DR   EMBL; AY425004; AAQ91815.1; -; Genomic_DNA.
DR   EMBL; BX640939; CAE45969.1; -; mRNA.
DR   EMBL; AL049821; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL078582; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356311; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590993; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW47740.1; -; Genomic_DNA.
DR   EMBL; BC128573; AAI28574.1; -; mRNA.
DR   EMBL; BC128574; AAI28575.1; -; mRNA.
DR   EMBL; AH008151; AAD52984.1; -; Genomic_DNA.
DR   EMBL; X73067; CAA51528.1; -; mRNA.
DR   EMBL; Z75126; CAA99436.1; -; mRNA.
DR   CCDS; CCDS5234.1; -. [P03372-1]
DR   PIR; S64737; S64737.
DR   RefSeq; NP_000116.2; NM_000125.3. [P03372-1]
DR   RefSeq; NP_001116212.1; NM_001122740.1. [P03372-1]
DR   RefSeq; NP_001116213.1; NM_001122741.1. [P03372-1]
DR   RefSeq; NP_001116214.1; NM_001122742.1. [P03372-1]
DR   RefSeq; NP_001278159.1; NM_001291230.1.
DR   RefSeq; NP_001278170.1; NM_001291241.1.
DR   RefSeq; NP_001315029.1; NM_001328100.1.
DR   RefSeq; XP_006715438.1; XM_006715375.3. [P03372-3]
DR   RefSeq; XP_011533845.1; XM_011535543.2. [P03372-1]
DR   RefSeq; XP_011533846.1; XM_011535544.2. [P03372-1]
DR   RefSeq; XP_011533847.1; XM_011535545.2. [P03372-1]
DR   RefSeq; XP_016865865.1; XM_017010376.1. [P03372-1]
DR   RefSeq; XP_016865866.1; XM_017010377.1. [P03372-1]
DR   RefSeq; XP_016865867.1; XM_017010378.1. [P03372-1]
DR   RefSeq; XP_016865868.1; XM_017010379.1. [P03372-1]
DR   RefSeq; XP_016865869.1; XM_017010380.1. [P03372-1]
DR   RefSeq; XP_016865870.1; XM_017010381.1. [P03372-1]
DR   UniGene; Hs.208124; -.
DR   UniGene; Hs.744830; -.
DR   PDB; 1A52; X-ray; 2.80 A; A/B=297-554.
DR   PDB; 1AKF; Model; -; A=309-547.
DR   PDB; 1ERE; X-ray; 3.10 A; A/B/C/D/E/F=301-553.
DR   PDB; 1ERR; X-ray; 2.60 A; A/B=301-553.
DR   PDB; 1G50; X-ray; 2.90 A; A/B/C=304-550.
DR   PDB; 1GWQ; X-ray; 2.45 A; A/B=301-548.
DR   PDB; 1GWR; X-ray; 2.40 A; A/B=305-549.
DR   PDB; 1HCP; NMR; -; A=180-254.
DR   PDB; 1HCQ; X-ray; 2.40 A; A/B/E/F=180-262.
DR   PDB; 1L2I; X-ray; 1.95 A; A/B=297-554.
DR   PDB; 1PCG; X-ray; 2.70 A; A/B=304-547.
DR   PDB; 1QKT; X-ray; 2.20 A; A=304-551.
DR   PDB; 1QKU; X-ray; 3.20 A; A/B/C=301-550.
DR   PDB; 1R5K; X-ray; 2.70 A; A/B/C=297-554.
DR   PDB; 1SJ0; X-ray; 1.90 A; A=307-554.
DR   PDB; 1UOM; X-ray; 2.28 A; A=301-553.
DR   PDB; 1X7E; X-ray; 2.80 A; A/B=305-549.
DR   PDB; 1X7R; X-ray; 2.00 A; A=305-549.
DR   PDB; 1XP1; X-ray; 1.80 A; A=307-554.
DR   PDB; 1XP6; X-ray; 1.70 A; A=307-554.
DR   PDB; 1XP9; X-ray; 1.80 A; A=307-554.
DR   PDB; 1XPC; X-ray; 1.60 A; A=307-554.
DR   PDB; 1XQC; X-ray; 2.05 A; A/B/C/D=301-553.
DR   PDB; 1YIM; X-ray; 1.90 A; A=307-554.
DR   PDB; 1YIN; X-ray; 2.20 A; A=307-554.
DR   PDB; 1ZKY; X-ray; 2.25 A; A/B=298-554.
DR   PDB; 2AYR; X-ray; 1.90 A; A=304-551.
DR   PDB; 2B1V; X-ray; 1.80 A; A/B=298-554.
DR   PDB; 2B1Z; X-ray; 1.78 A; A/B=298-554.
DR   PDB; 2B23; X-ray; 2.10 A; A/B=298-554.
DR   PDB; 2BJ4; X-ray; 2.00 A; A/B=305-533.
DR   PDB; 2FAI; X-ray; 2.10 A; A/B=298-554.
DR   PDB; 2G44; X-ray; 2.65 A; A/B=298-554.
DR   PDB; 2G5O; X-ray; 2.30 A; A/B=298-554.
DR   PDB; 2I0J; X-ray; 2.90 A; A/B/C/D=304-547.
DR   PDB; 2IOG; X-ray; 1.60 A; A=309-554.
DR   PDB; 2IOK; X-ray; 2.40 A; A/B=301-554.
DR   PDB; 2JF9; X-ray; 2.10 A; A/B/C=304-533.
DR   PDB; 2JFA; X-ray; 2.55 A; A/B=304-533.
DR   PDB; 2LLO; NMR; -; B=287-305.
DR   PDB; 2LLQ; NMR; -; B=287-305.
DR   PDB; 2OCF; X-ray; 2.95 A; A=298-595.
DR   PDB; 2OUZ; X-ray; 2.00 A; A=301-553.
DR   PDB; 2P15; X-ray; 1.94 A; A/B=298-554.
DR   PDB; 2POG; X-ray; 1.84 A; A/B=304-551.
DR   PDB; 2Q6J; X-ray; 2.70 A; A/B=298-554.
DR   PDB; 2Q70; X-ray; 1.95 A; A/B=304-551.
DR   PDB; 2QA6; X-ray; 2.60 A; A/B=298-554.
DR   PDB; 2QA8; X-ray; 1.85 A; A/B=298-554.
DR   PDB; 2QAB; X-ray; 1.89 A; A/B=298-554.
DR   PDB; 2QE4; X-ray; 2.40 A; A/B=304-551.
DR   PDB; 2QGT; X-ray; 2.15 A; A/B=298-554.
DR   PDB; 2QGW; X-ray; 2.39 A; A/B=298-554.
DR   PDB; 2QH6; X-ray; 2.70 A; A/B=298-554.
DR   PDB; 2QR9; X-ray; 2.00 A; A/B=298-554.
DR   PDB; 2QSE; X-ray; 1.85 A; A/B=298-554.
DR   PDB; 2QXM; X-ray; 2.30 A; A/B=298-554.
DR   PDB; 2QXS; X-ray; 1.70 A; A/B=298-554.
DR   PDB; 2QZO; X-ray; 1.72 A; A/B=298-554.
DR   PDB; 2R6W; X-ray; 2.00 A; A/B=304-551.
DR   PDB; 2R6Y; X-ray; 2.00 A; A/B=304-551.
DR   PDB; 2YAT; X-ray; 2.60 A; A=301-551.
DR   PDB; 2YJA; X-ray; 1.82 A; B=299-551.
DR   PDB; 3CBM; X-ray; 1.69 A; B=298-307.
DR   PDB; 3CBO; X-ray; 1.65 A; B=298-307.
DR   PDB; 3CBP; X-ray; 1.42 A; B=298-307.
DR   PDB; 3DT3; X-ray; 2.40 A; A/B=299-551.
DR   PDB; 3ERD; X-ray; 2.03 A; A/B=297-554.
DR   PDB; 3ERT; X-ray; 1.90 A; A=297-554.
DR   PDB; 3HLV; X-ray; 3.00 A; A/B=298-550.
DR   PDB; 3HM1; X-ray; 2.33 A; A/B=298-550.
DR   PDB; 3L03; X-ray; 1.90 A; A/B=298-550.
DR   PDB; 3OS8; X-ray; 2.03 A; A/B/C/D=299-553.
DR   PDB; 3OS9; X-ray; 2.30 A; A/B/C/D=299-553.
DR   PDB; 3OSA; X-ray; 2.30 A; A/B/C/D=299-553.
DR   PDB; 3Q95; X-ray; 2.05 A; A/B=298-554.
DR   PDB; 3UU7; X-ray; 2.20 A; A/B=302-552.
DR   PDB; 3UUA; X-ray; 2.05 A; A/B=302-552.
DR   PDB; 3UUC; X-ray; 2.10 A; A/B/C/D=302-552.
DR   PDB; 3UUD; X-ray; 1.60 A; A/B=302-552.
DR   PDB; 4AA6; X-ray; 2.60 A; A/B/E/F=182-252.
DR   PDB; 4DMA; X-ray; 2.30 A; A/B=303-549.
DR   PDB; 4IU7; X-ray; 2.29 A; A/B=303-549.
DR   PDB; 4IUI; X-ray; 2.30 A; A/B=303-549.
DR   PDB; 4IV2; X-ray; 2.14 A; A/B=303-549.
DR   PDB; 4IV4; X-ray; 2.30 A; A/B=303-549.
DR   PDB; 4IVW; X-ray; 2.06 A; A/B=303-549.
DR   PDB; 4IVY; X-ray; 1.95 A; A/B=303-549.
DR   PDB; 4IW6; X-ray; 1.98 A; A/B=303-549.
DR   PDB; 4IW8; X-ray; 2.04 A; A/B=303-549.
DR   PDB; 4IWC; X-ray; 2.24 A; A/B=303-549.
DR   PDB; 4IWF; X-ray; 1.93 A; A/B=303-549.
DR   PDB; 4JC3; X-ray; 2.05 A; B=585-595.
DR   PDB; 4JDD; X-ray; 2.10 A; B=585-595.
DR   PDB; 4MG5; X-ray; 2.05 A; A/B=302-552.
DR   PDB; 4MG6; X-ray; 2.10 A; A/B=302-552.
DR   PDB; 4MG7; X-ray; 2.15 A; A/B=302-552.
DR   PDB; 4MG8; X-ray; 1.85 A; A/B=302-552.
DR   PDB; 4MG9; X-ray; 2.00 A; A/B=302-552.
DR   PDB; 4MGA; X-ray; 1.80 A; A/B=302-552.
DR   PDB; 4MGB; X-ray; 1.85 A; A/B=302-552.
DR   PDB; 4MGC; X-ray; 2.15 A; A/B=302-552.
DR   PDB; 4MGD; X-ray; 1.90 A; A/B=302-552.
DR   PDB; 4O6F; X-ray; 2.82 A; B=261-271.
DR   PDB; 4PP6; X-ray; 2.20 A; A/B=305-548.
DR   PDB; 4PPP; X-ray; 2.69 A; A/B=305-548.
DR   PDB; 4PPS; X-ray; 1.93 A; A/B=305-548.
DR   PDB; 4PXM; X-ray; 1.90 A; A/B=299-554.
DR   PDB; 4Q13; X-ray; 2.24 A; A/B=299-554.
DR   PDB; 4Q50; X-ray; 3.07 A; A/B/C/D/E/F/G/H=299-554.
DR   PDB; 4TUZ; X-ray; 1.90 A; A/B=302-552.
DR   PDB; 4TV1; X-ray; 1.85 A; A/B=302-552.
DR   PDB; 4XI3; X-ray; 2.49 A; A/B/C/D=306-548.
DR   PDB; 4ZN7; X-ray; 1.93 A; A/B=301-559.
DR   PDB; 4ZN9; X-ray; 2.21 A; A/B=301-559.
DR   PDB; 4ZNH; X-ray; 1.93 A; A/B=301-559.
DR   PDB; 4ZNS; X-ray; 1.86 A; A/B=301-559.
DR   PDB; 4ZNT; X-ray; 1.90 A; A/B=301-559.
DR   PDB; 4ZNU; X-ray; 2.40 A; A/B=301-559.
DR   PDB; 4ZNV; X-ray; 1.77 A; A/B=301-559.
DR   PDB; 4ZNW; X-ray; 2.31 A; A/B=301-559.
DR   PDB; 5AAU; X-ray; 1.90 A; A/B=307-554.
DR   PDB; 5AAV; X-ray; 1.95 A; A=307-554, B=306-554.
DR   PDB; 5ACC; X-ray; 1.88 A; A=307-554.
DR   PDB; 5AK2; X-ray; 2.19 A; A/B=307-554.
DR   PDB; 5DI7; X-ray; 2.24 A; A/B=298-554.
DR   PDB; 5DID; X-ray; 2.24 A; A/B=298-554.
DR   PDB; 5DIE; X-ray; 2.24 A; A/B=298-554.
DR   PDB; 5DIG; X-ray; 2.24 A; A/B=298-554.
DR   PDB; 5DK9; X-ray; 2.28 A; A/B=298-554.
DR   PDB; 5DKB; X-ray; 2.40 A; A/B=298-554.
DR   PDB; 5DKE; X-ray; 2.60 A; A/B=298-554.
DR   PDB; 5DKG; X-ray; 2.15 A; A/B=298-554.
DR   PDB; 5DKS; X-ray; 2.60 A; A/B=298-554.
DR   PDB; 5DL4; X-ray; 2.10 A; A/B=298-554.
DR   PDB; 5DLR; X-ray; 2.26 A; A/B=298-554.
DR   PDB; 5DMC; X-ray; 2.40 A; A/B=298-554.
DR   PDB; 5DMF; X-ray; 2.40 A; A/B=298-554.
DR   PDB; 5DP0; X-ray; 2.38 A; A/B=298-554.
DR   PDB; 5DRJ; X-ray; 2.07 A; A/B=298-554.
DR   PDB; 5DRM; X-ray; 2.24 A; A/B=298-554.
DR   PDB; 5DTV; X-ray; 2.29 A; A/B=298-554.
DR   PDB; 5DU5; X-ray; 2.19 A; A/B=298-554.
DR   PDB; 5DUE; X-ray; 2.09 A; A/B=298-554.
DR   PDB; 5DUG; X-ray; 2.25 A; A/B=298-554.
DR   PDB; 5DUH; X-ray; 2.24 A; A/B=298-554.
DR   PDB; 5DVS; X-ray; 2.28 A; A/B=298-554.
DR   PDB; 5DVV; X-ray; 2.50 A; A/B=298-554.
DR   PDB; 5DWE; X-ray; 1.92 A; A/B=298-554.
DR   PDB; 5DWG; X-ray; 2.30 A; A/B=298-554.
DR   PDB; 5DWI; X-ray; 2.43 A; A/B=298-554.
DR   PDB; 5DWJ; X-ray; 2.00 A; A/B=298-554.
DR   PDB; 5DX3; X-ray; 2.09 A; A/B=297-554.
DR   PDB; 5DXB; X-ray; 2.08 A; A/B=297-554.
DR   PDB; 5DXE; X-ray; 1.50 A; A/B=297-554.
DR   PDB; 5DXG; X-ray; 1.86 A; A/B=297-554.
DR   PDB; 5DXK; X-ray; 2.23 A; A/B=298-554.
DR   PDB; 5DXM; X-ray; 2.37 A; A/B=298-554.
DR   PDB; 5DXP; X-ray; 2.20 A; A/B=298-554.
DR   PDB; 5DXQ; X-ray; 2.40 A; A/B=298-554.
DR   PDB; 5DXR; X-ray; 2.28 A; A/B=298-554.
DR   PDB; 5DY8; X-ray; 2.03 A; A/B=298-554.
DR   PDB; 5DYB; X-ray; 2.27 A; A/B=298-554.
DR   PDB; 5DYD; X-ray; 2.48 A; A/B=298-554.
DR   PDB; 5DZ0; X-ray; 2.24 A; A/B=298-554.
DR   PDB; 5DZ1; X-ray; 2.20 A; A/B=298-554.
DR   PDB; 5DZ3; X-ray; 2.15 A; A/B=298-554.
DR   PDB; 5DZH; X-ray; 2.11 A; A/B=298-554.
DR   PDB; 5DZI; X-ray; 1.90 A; A/B=298-554.
DR   PDB; 5E0W; X-ray; 2.00 A; A/B=298-554.
DR   PDB; 5E0X; X-ray; 2.01 A; A/B=298-554.
DR   PDB; 5E14; X-ray; 2.22 A; A/B=298-554.
DR   PDB; 5E15; X-ray; 2.10 A; A/B=298-554.
DR   PDB; 5E19; X-ray; 2.24 A; A/B=298-554.
DR   PDB; 5E1C; X-ray; 1.98 A; A/B=298-554.
DR   PDB; 5EGV; X-ray; 2.86 A; A/B=298-554.
DR   PDB; 5EHJ; X-ray; 2.50 A; A/B=298-554.
DR   PDB; 5EI1; X-ray; 2.40 A; A/B=298-554.
DR   PDB; 5EIT; X-ray; 2.68 A; A/B=298-554.
DR   PDB; 5FQP; X-ray; 1.88 A; A=307-554.
DR   PDB; 5FQR; X-ray; 1.88 A; A=307-554.
DR   PDB; 5FQS; X-ray; 1.94 A; A=307-554.
DR   PDB; 5FQT; X-ray; 1.99 A; A=307-554.
DR   PDB; 5FQV; X-ray; 1.74 A; A=307-554.
DR   PDB; 5GS4; X-ray; 2.40 A; A=305-547.
DR   PDB; 5GTR; X-ray; 2.80 A; A=305-547.
DR   PDB; 5HYR; X-ray; 2.27 A; A/B=302-559.
DR   PDB; 5JMM; X-ray; 2.10 A; A/B=302-552.
DR   PDB; 5KCC; X-ray; 2.39 A; A/B=298-554, A/B=304-549.
DR   PDB; 5KCD; X-ray; 1.82 A; A/B=298-554, A/B=305-549.
DR   PDB; 5KCE; X-ray; 1.85 A; A/B=298-554, A/B=303-549.
DR   PDB; 5KCF; X-ray; 2.07 A; A/B=298-554, A/B=303-549.
DR   PDB; 5KCT; X-ray; 1.60 A; A/B=298-554, A/B=303-548.
DR   PDB; 5KCU; X-ray; 2.03 A; A/B=298-554, A/B=303-548.
DR   PDB; 5KCW; X-ray; 1.91 A; A/B=303-549, A/B=298-554.
DR   PDB; 5KD9; X-ray; 1.78 A; A/B=298-554, A/B=303-549.
DR   PDB; 5KR9; X-ray; 2.25 A; A/B=298-554.
DR   PDB; 5KRA; X-ray; 2.40 A; A/B/E/F=298-554.
DR   PDB; 5KRC; X-ray; 2.40 A; A/B=298-554.
DR   PDB; 5KRF; X-ray; 2.19 A; A/B=298-554.
DR   PDB; 5KRH; X-ray; 2.24 A; A/B=298-554.
DR   PDB; 5KRI; X-ray; 2.25 A; A/B=298-554.
DR   PDB; 5KRJ; X-ray; 2.70 A; A/B=298-554.
DR   PDB; 5KRK; X-ray; 2.39 A; A/B=298-554.
DR   PDB; 5KRL; X-ray; 2.40 A; A/B=298-554.
DR   PDB; 5KRM; X-ray; 2.24 A; A/B=298-554.
DR   PDB; 5KRO; X-ray; 2.10 A; A/B=298-554.
DR   PDB; 5N10; X-ray; 1.60 A; C/D/F=584-595.
DR   PDB; 5T0X; NMR; -; B/C=287-305.
DR   PDB; 5T1Z; X-ray; 2.10 A; A/B=298-554.
DR   PDB; 5T92; X-ray; 2.22 A; A/B=301-553.
DR   PDB; 5T97; X-ray; 3.00 A; A/B=301-553.
DR   PDB; 5TLD; X-ray; 2.38 A; A/B=298-554.
DR   PDB; 5TLF; X-ray; 2.20 A; A/B=298-554.
DR   PDB; 5TLG; X-ray; 2.23 A; A/B=298-554.
DR   PDB; 5TLL; X-ray; 2.42 A; A/B=298-554.
DR   PDB; 5TLM; X-ray; 2.50 A; A/B=298-554.
DR   PDB; 5TLO; X-ray; 2.28 A; A/B=298-554.
DR   PDB; 5TLP; X-ray; 2.08 A; A/B=298-554.
DR   PDB; 5TLT; X-ray; 1.90 A; A/B=298-554.
DR   PDB; 5TLU; X-ray; 2.22 A; A/B=298-554.
DR   PDB; 5TLV; X-ray; 2.32 A; A/B=298-554.
DR   PDB; 5TLX; X-ray; 2.10 A; A/B=298-554.
DR   PDB; 5TLY; X-ray; 2.14 A; A/B=298-554.
DR   PDB; 5TM1; X-ray; 2.23 A; A/B=298-554.
DR   PDB; 5TM2; X-ray; 2.60 A; A/B=298-554.
DR   PDB; 5TM3; X-ray; 2.19 A; A/B=298-554.
DR   PDB; 5TM4; X-ray; 2.25 A; A/B=298-554.
DR   PDB; 5TM5; X-ray; 2.24 A; A/B=298-554.
DR   PDB; 5TM6; X-ray; 2.54 A; A/B=298-554.
DR   PDB; 5TM7; X-ray; 2.40 A; A/B=298-554.
DR   PDB; 5TM8; X-ray; 1.99 A; A/B=298-554.
DR   PDB; 5TM9; X-ray; 2.50 A; A/B=298-554.
DR   PDB; 5TML; X-ray; 2.25 A; A/B=298-554.
DR   PDB; 5TMM; X-ray; 2.20 A; A/B=298-554.
DR   PDB; 5TMO; X-ray; 2.17 A; A/B=298-554.
DR   PDB; 5TMQ; X-ray; 2.24 A; A/B=298-554.
DR   PDB; 5TMR; X-ray; 2.30 A; A/B=298-554.
DR   PDB; 5TMS; X-ray; 2.24 A; A/B=298-554.
DR   PDB; 5TMT; X-ray; 2.05 A; A/B=298-554.
DR   PDB; 5TMU; X-ray; 2.43 A; A/B=298-554.
DR   PDB; 5TMV; X-ray; 2.38 A; A/B=298-554.
DR   PDB; 5TMW; X-ray; 2.29 A; A/B=298-554.
DR   PDB; 5TMZ; X-ray; 2.21 A; A/B=298-554.
DR   PDB; 5TN1; X-ray; 2.06 A; A/B=298-554.
DR   PDB; 5TN3; X-ray; 2.54 A; A/B=298-554.
DR   PDB; 5TN4; X-ray; 1.86 A; A/B=298-554.
DR   PDB; 5TN5; X-ray; 1.89 A; A/B=298-554.
DR   PDB; 5TN6; X-ray; 2.09 A; A/B=298-554.
DR   PDB; 5TN7; X-ray; 2.24 A; A/B=298-554.
DR   PDB; 5TN8; X-ray; 2.65 A; A/B=298-554.
DR   PDB; 5TN9; X-ray; 2.25 A; A/B/C/D=298-554.
DR   PDB; 5TNB; X-ray; 2.08 A; A/B/C/D=298-554.
DR   PDB; 5U2B; X-ray; 2.22 A; A/B/C/D/E/F=298-554.
DR   PDB; 5U2D; X-ray; 1.86 A; A/B=298-554.
DR   PDB; 5UFW; X-ray; 1.58 A; A/B=306-554.
DR   PDB; 5UFX; X-ray; 1.55 A; A/B=306-554.
DR   PDB; 5W9D; X-ray; 1.65 A; A/B=306-554.
DR   PDB; 6B0F; X-ray; 2.86 A; A/B=301-553.
DR   PDB; 6C42; X-ray; 2.00 A; A/B=307-554.
DR   PDB; 6CBZ; X-ray; 1.65 A; A/B=305-554.
DR   PDB; 6CHW; X-ray; 1.89 A; A=306-551.
DR   PDB; 6CHZ; X-ray; 1.68 A; A=307-554.
DR   PDBsum; 1A52; -.
DR   PDBsum; 1AKF; -.
DR   PDBsum; 1ERE; -.
DR   PDBsum; 1ERR; -.
DR   PDBsum; 1G50; -.
DR   PDBsum; 1GWQ; -.
DR   PDBsum; 1GWR; -.
DR   PDBsum; 1HCP; -.
DR   PDBsum; 1HCQ; -.
DR   PDBsum; 1L2I; -.
DR   PDBsum; 1PCG; -.
DR   PDBsum; 1QKT; -.
DR   PDBsum; 1QKU; -.
DR   PDBsum; 1R5K; -.
DR   PDBsum; 1SJ0; -.
DR   PDBsum; 1UOM; -.
DR   PDBsum; 1X7E; -.
DR   PDBsum; 1X7R; -.
DR   PDBsum; 1XP1; -.
DR   PDBsum; 1XP6; -.
DR   PDBsum; 1XP9; -.
DR   PDBsum; 1XPC; -.
DR   PDBsum; 1XQC; -.
DR   PDBsum; 1YIM; -.
DR   PDBsum; 1YIN; -.
DR   PDBsum; 1ZKY; -.
DR   PDBsum; 2AYR; -.
DR   PDBsum; 2B1V; -.
DR   PDBsum; 2B1Z; -.
DR   PDBsum; 2B23; -.
DR   PDBsum; 2BJ4; -.
DR   PDBsum; 2FAI; -.
DR   PDBsum; 2G44; -.
DR   PDBsum; 2G5O; -.
DR   PDBsum; 2I0J; -.
DR   PDBsum; 2IOG; -.
DR   PDBsum; 2IOK; -.
DR   PDBsum; 2JF9; -.
DR   PDBsum; 2JFA; -.
DR   PDBsum; 2LLO; -.
DR   PDBsum; 2LLQ; -.
DR   PDBsum; 2OCF; -.
DR   PDBsum; 2OUZ; -.
DR   PDBsum; 2P15; -.
DR   PDBsum; 2POG; -.
DR   PDBsum; 2Q6J; -.
DR   PDBsum; 2Q70; -.
DR   PDBsum; 2QA6; -.
DR   PDBsum; 2QA8; -.
DR   PDBsum; 2QAB; -.
DR   PDBsum; 2QE4; -.
DR   PDBsum; 2QGT; -.
DR   PDBsum; 2QGW; -.
DR   PDBsum; 2QH6; -.
DR   PDBsum; 2QR9; -.
DR   PDBsum; 2QSE; -.
DR   PDBsum; 2QXM; -.
DR   PDBsum; 2QXS; -.
DR   PDBsum; 2QZO; -.
DR   PDBsum; 2R6W; -.
DR   PDBsum; 2R6Y; -.
DR   PDBsum; 2YAT; -.
DR   PDBsum; 2YJA; -.
DR   PDBsum; 3CBM; -.
DR   PDBsum; 3CBO; -.
DR   PDBsum; 3CBP; -.
DR   PDBsum; 3DT3; -.
DR   PDBsum; 3ERD; -.
DR   PDBsum; 3ERT; -.
DR   PDBsum; 3HLV; -.
DR   PDBsum; 3HM1; -.
DR   PDBsum; 3L03; -.
DR   PDBsum; 3OS8; -.
DR   PDBsum; 3OS9; -.
DR   PDBsum; 3OSA; -.
DR   PDBsum; 3Q95; -.
DR   PDBsum; 3UU7; -.
DR   PDBsum; 3UUA; -.
DR   PDBsum; 3UUC; -.
DR   PDBsum; 3UUD; -.
DR   PDBsum; 4AA6; -.
DR   PDBsum; 4DMA; -.
DR   PDBsum; 4IU7; -.
DR   PDBsum; 4IUI; -.
DR   PDBsum; 4IV2; -.
DR   PDBsum; 4IV4; -.
DR   PDBsum; 4IVW; -.
DR   PDBsum; 4IVY; -.
DR   PDBsum; 4IW6; -.
DR   PDBsum; 4IW8; -.
DR   PDBsum; 4IWC; -.
DR   PDBsum; 4IWF; -.
DR   PDBsum; 4JC3; -.
DR   PDBsum; 4JDD; -.
DR   PDBsum; 4MG5; -.
DR   PDBsum; 4MG6; -.
DR   PDBsum; 4MG7; -.
DR   PDBsum; 4MG8; -.
DR   PDBsum; 4MG9; -.
DR   PDBsum; 4MGA; -.
DR   PDBsum; 4MGB; -.
DR   PDBsum; 4MGC; -.
DR   PDBsum; 4MGD; -.
DR   PDBsum; 4O6F; -.
DR   PDBsum; 4PP6; -.
DR   PDBsum; 4PPP; -.
DR   PDBsum; 4PPS; -.
DR   PDBsum; 4PXM; -.
DR   PDBsum; 4Q13; -.
DR   PDBsum; 4Q50; -.
DR   PDBsum; 4TUZ; -.
DR   PDBsum; 4TV1; -.
DR   PDBsum; 4XI3; -.
DR   PDBsum; 4ZN7; -.
DR   PDBsum; 4ZN9; -.
DR   PDBsum; 4ZNH; -.
DR   PDBsum; 4ZNS; -.
DR   PDBsum; 4ZNT; -.
DR   PDBsum; 4ZNU; -.
DR   PDBsum; 4ZNV; -.
DR   PDBsum; 4ZNW; -.
DR   PDBsum; 5AAU; -.
DR   PDBsum; 5AAV; -.
DR   PDBsum; 5ACC; -.
DR   PDBsum; 5AK2; -.
DR   PDBsum; 5DI7; -.
DR   PDBsum; 5DID; -.
DR   PDBsum; 5DIE; -.
DR   PDBsum; 5DIG; -.
DR   PDBsum; 5DK9; -.
DR   PDBsum; 5DKB; -.
DR   PDBsum; 5DKE; -.
DR   PDBsum; 5DKG; -.
DR   PDBsum; 5DKS; -.
DR   PDBsum; 5DL4; -.
DR   PDBsum; 5DLR; -.
DR   PDBsum; 5DMC; -.
DR   PDBsum; 5DMF; -.
DR   PDBsum; 5DP0; -.
DR   PDBsum; 5DRJ; -.
DR   PDBsum; 5DRM; -.
DR   PDBsum; 5DTV; -.
DR   PDBsum; 5DU5; -.
DR   PDBsum; 5DUE; -.
DR   PDBsum; 5DUG; -.
DR   PDBsum; 5DUH; -.
DR   PDBsum; 5DVS; -.
DR   PDBsum; 5DVV; -.
DR   PDBsum; 5DWE; -.
DR   PDBsum; 5DWG; -.
DR   PDBsum; 5DWI; -.
DR   PDBsum; 5DWJ; -.
DR   PDBsum; 5DX3; -.
DR   PDBsum; 5DXB; -.
DR   PDBsum; 5DXE; -.
DR   PDBsum; 5DXG; -.
DR   PDBsum; 5DXK; -.
DR   PDBsum; 5DXM; -.
DR   PDBsum; 5DXP; -.
DR   PDBsum; 5DXQ; -.
DR   PDBsum; 5DXR; -.
DR   PDBsum; 5DY8; -.
DR   PDBsum; 5DYB; -.
DR   PDBsum; 5DYD; -.
DR   PDBsum; 5DZ0; -.
DR   PDBsum; 5DZ1; -.
DR   PDBsum; 5DZ3; -.
DR   PDBsum; 5DZH; -.
DR   PDBsum; 5DZI; -.
DR   PDBsum; 5E0W; -.
DR   PDBsum; 5E0X; -.
DR   PDBsum; 5E14; -.
DR   PDBsum; 5E15; -.
DR   PDBsum; 5E19; -.
DR   PDBsum; 5E1C; -.
DR   PDBsum; 5EGV; -.
DR   PDBsum; 5EHJ; -.
DR   PDBsum; 5EI1; -.
DR   PDBsum; 5EIT; -.
DR   PDBsum; 5FQP; -.
DR   PDBsum; 5FQR; -.
DR   PDBsum; 5FQS; -.
DR   PDBsum; 5FQT; -.
DR   PDBsum; 5FQV; -.
DR   PDBsum; 5GS4; -.
DR   PDBsum; 5GTR; -.
DR   PDBsum; 5HYR; -.
DR   PDBsum; 5JMM; -.
DR   PDBsum; 5KCC; -.
DR   PDBsum; 5KCD; -.
DR   PDBsum; 5KCE; -.
DR   PDBsum; 5KCF; -.
DR   PDBsum; 5KCT; -.
DR   PDBsum; 5KCU; -.
DR   PDBsum; 5KCW; -.
DR   PDBsum; 5KD9; -.
DR   PDBsum; 5KR9; -.
DR   PDBsum; 5KRA; -.
DR   PDBsum; 5KRC; -.
DR   PDBsum; 5KRF; -.
DR   PDBsum; 5KRH; -.
DR   PDBsum; 5KRI; -.
DR   PDBsum; 5KRJ; -.
DR   PDBsum; 5KRK; -.
DR   PDBsum; 5KRL; -.
DR   PDBsum; 5KRM; -.
DR   PDBsum; 5KRO; -.
DR   PDBsum; 5N10; -.
DR   PDBsum; 5T0X; -.
DR   PDBsum; 5T1Z; -.
DR   PDBsum; 5T92; -.
DR   PDBsum; 5T97; -.
DR   PDBsum; 5TLD; -.
DR   PDBsum; 5TLF; -.
DR   PDBsum; 5TLG; -.
DR   PDBsum; 5TLL; -.
DR   PDBsum; 5TLM; -.
DR   PDBsum; 5TLO; -.
DR   PDBsum; 5TLP; -.
DR   PDBsum; 5TLT; -.
DR   PDBsum; 5TLU; -.
DR   PDBsum; 5TLV; -.
DR   PDBsum; 5TLX; -.
DR   PDBsum; 5TLY; -.
DR   PDBsum; 5TM1; -.
DR   PDBsum; 5TM2; -.
DR   PDBsum; 5TM3; -.
DR   PDBsum; 5TM4; -.
DR   PDBsum; 5TM5; -.
DR   PDBsum; 5TM6; -.
DR   PDBsum; 5TM7; -.
DR   PDBsum; 5TM8; -.
DR   PDBsum; 5TM9; -.
DR   PDBsum; 5TML; -.
DR   PDBsum; 5TMM; -.
DR   PDBsum; 5TMO; -.
DR   PDBsum; 5TMQ; -.
DR   PDBsum; 5TMR; -.
DR   PDBsum; 5TMS; -.
DR   PDBsum; 5TMT; -.
DR   PDBsum; 5TMU; -.
DR   PDBsum; 5TMV; -.
DR   PDBsum; 5TMW; -.
DR   PDBsum; 5TMZ; -.
DR   PDBsum; 5TN1; -.
DR   PDBsum; 5TN3; -.
DR   PDBsum; 5TN4; -.
DR   PDBsum; 5TN5; -.
DR   PDBsum; 5TN6; -.
DR   PDBsum; 5TN7; -.
DR   PDBsum; 5TN8; -.
DR   PDBsum; 5TN9; -.
DR   PDBsum; 5TNB; -.
DR   PDBsum; 5U2B; -.
DR   PDBsum; 5U2D; -.
DR   PDBsum; 5UFW; -.
DR   PDBsum; 5UFX; -.
DR   PDBsum; 5W9D; -.
DR   PDBsum; 6B0F; -.
DR   PDBsum; 6C42; -.
DR   PDBsum; 6CBZ; -.
DR   PDBsum; 6CHW; -.
DR   PDBsum; 6CHZ; -.
DR   DisProt; DP00074; -.
DR   ProteinModelPortal; P03372; -.
DR   SMR; P03372; -.
DR   BioGrid; 108403; 731.
DR   CORUM; P03372; -.
DR   DIP; DIP-5965N; -.
DR   ELM; P03372; -.
DR   IntAct; P03372; 473.
DR   MINT; P03372; -.
DR   STRING; 9606.ENSP00000206249; -.
DR   BindingDB; P03372; -.
DR   ChEMBL; CHEMBL206; -.
DR   DrugBank; DB06871; 17-METHYL-17-ALPHA-DIHYDROEQUILENIN.
DR   DrugBank; DB07708; 3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL.
DR   DrugBank; DB07712; 3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL.
DR   DrugBank; DB06927; [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE.
DR   DrugBank; DB04468; Afimoxifene.
DR   DrugBank; DB01431; Allylestrenol.
DR   DrugBank; DB05233; AP1081.
DR   DrugBank; DB05338; atamestane-plus-toremifene.
DR   DrugBank; DB06401; Bazedoxifene.
DR   DrugBank; DB05487; CC-8490.
DR   DrugBank; DB05882; CHF 4227.
DR   DrugBank; DB00269; Chlorotrianisene.
DR   DrugBank; DB00882; Clomifene.
DR   DrugBank; DB02715; Compound 18.
DR   DrugBank; DB02615; Compound 19.
DR   DrugBank; DB03742; Compound 4-D.
DR   DrugBank; DB00286; Conjugated Equine Estrogens.
DR   DrugBank; DB01406; Danazol.
DR   DrugBank; DB00304; Desogestrel.
DR   DrugBank; DB00890; Dienestrol.
DR   DrugBank; DB00255; Diethylstilbestrol.
DR   DrugBank; DB00783; Estradiol.
DR   DrugBank; DB01196; Estramustine.
DR   DrugBank; DB04573; Estriol.
DR   DrugBank; DB00655; Estrone.
DR   DrugBank; DB04574; Estrone sulfate.
DR   DrugBank; DB00977; Ethinyl Estradiol.
DR   DrugBank; DB00823; Ethynodiol diacetate.
DR   DrugBank; DB00294; Etonogestrel.
DR   DrugBank; DB01185; Fluoxymesterone.
DR   DrugBank; DB00947; Fulvestrant.
DR   DrugBank; DB01645; Genistein.
DR   DrugBank; DB06202; Lasofoxifene.
DR   DrugBank; DB00367; Levonorgestrel.
DR   DrugBank; DB00603; Medroxyprogesterone acetate.
DR   DrugBank; DB01065; Melatonin.
DR   DrugBank; DB01357; Mestranol.
DR   DrugBank; DB07991; N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE.
DR   DrugBank; DB01183; Naloxone.
DR   DrugBank; DB00957; Norgestimate.
DR   DrugBank; DB05662; NP-50301.
DR   DrugBank; DB04938; Ospemifene.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB00396; Progesterone.
DR   DrugBank; DB04575; Quinestrol.
DR   DrugBank; DB00481; Raloxifene.
DR   DrugBank; DB08773; RALOXIFENE CORE.
DR   DrugBank; DB00675; Tamoxifen.
DR   DrugBank; DB09070; Tibolone.
DR   DrugBank; DB00539; Toremifene.
DR   DrugBank; DB01108; Trilostane.
DR   GuidetoPHARMACOLOGY; 620; -.
DR   SwissLipids; SLP:000001568; -.
DR   GlyConnect; 144; -.
DR   iPTMnet; P03372; -.
DR   PhosphoSitePlus; P03372; -.
DR   SwissPalm; P03372; -.
DR   UniCarbKB; P03372; -.
DR   BioMuta; ESR1; -.
DR   DMDM; 544257; -.
DR   EPD; P03372; -.
DR   PaxDb; P03372; -.
DR   PeptideAtlas; P03372; -.
DR   PRIDE; P03372; -.
DR   DNASU; 2099; -.
DR   Ensembl; ENST00000206249; ENSP00000206249; ENSG00000091831. [P03372-1]
DR   Ensembl; ENST00000338799; ENSP00000342630; ENSG00000091831. [P03372-1]
DR   Ensembl; ENST00000440973; ENSP00000405330; ENSG00000091831. [P03372-1]
DR   Ensembl; ENST00000443427; ENSP00000387500; ENSG00000091831. [P03372-1]
DR   GeneID; 2099; -.
DR   KEGG; hsa:2099; -.
DR   UCSC; uc003qom.5; human. [P03372-1]
DR   CTD; 2099; -.
DR   DisGeNET; 2099; -.
DR   EuPathDB; HostDB:ENSG00000091831.21; -.
DR   GeneCards; ESR1; -.
DR   HGNC; HGNC:3467; ESR1.
DR   HPA; CAB000037; -.
DR   HPA; CAB055099; -.
DR   HPA; CAB072858; -.
DR   HPA; HPA000449; -.
DR   HPA; HPA000450; -.
DR   MalaCards; ESR1; -.
DR   MIM; 133430; gene.
DR   MIM; 615363; phenotype.
DR   neXtProt; NX_P03372; -.
DR   OpenTargets; ENSG00000091831; -.
DR   Orphanet; 785; Estrogen resistance syndrome.
DR   PharmGKB; PA156; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   GeneTree; ENSGT00760000118887; -.
DR   HOVERGEN; HBG108344; -.
DR   InParanoid; P03372; -.
DR   KO; K08550; -.
DR   OMA; EAGPPAF; -.
DR   OrthoDB; EOG091G03V4; -.
DR   PhylomeDB; P03372; -.
DR   TreeFam; TF323751; -.
DR   Reactome; R-HSA-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-2219530; Constitutive Signaling by Aberrant PI3K in Cancer.
DR   Reactome; R-HSA-383280; Nuclear Receptor transcription pathway.
DR   Reactome; R-HSA-5689896; Ovarian tumor domain proteases.
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-HSA-8866910; TFAP2 (AP-2) family regulates transcription of growth factors and their receptors.
DR   Reactome; R-HSA-8931987; RUNX1 regulates estrogen receptor mediated transcription.
DR   Reactome; R-HSA-8939211; ESR-mediated signaling.
DR   Reactome; R-HSA-8939256; RUNX1 regulates transcription of genes involved in WNT signaling.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   SignaLink; P03372; -.
DR   SIGNOR; P03372; -.
DR   ChiTaRS; ESR1; human.
DR   EvolutionaryTrace; P03372; -.
DR   GeneWiki; Estrogen_receptor_alpha; -.
DR   GenomeRNAi; 2099; -.
DR   PRO; PR:P03372; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000091831; -.
DR   CleanEx; HS_ESR1; -.
DR   ExpressionAtlas; P03372; baseline and differential.
DR   Genevisible; P03372; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IMP:CAFA.
DR   GO; GO:0097550; C:transcriptional preinitiation complex; IDA:CAFA.
DR   GO; GO:0035327; C:transcriptionally active chromatin; IDA:UniProtKB.
DR   GO; GO:0051117; F:ATPase binding; IDA:MGI.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:BHF-UCL.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0001046; F:core promoter sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; NAS:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0030284; F:estrogen receptor activity; IDA:CAFA.
DR   GO; GO:0030331; F:estrogen receptor binding; IPI:CAFA.
DR   GO; GO:0034056; F:estrogen response element binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0030235; F:nitric-oxide synthase regulator activity; NAS:UniProtKB.
DR   GO; GO:0046934; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; TAS:Reactome.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0038052; F:RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISA:NTNU_SB.
DR   GO; GO:0005496; F:steroid binding; ISS:UniProtKB.
DR   GO; GO:0003707; F:steroid hormone receptor activity; TAS:ProtInc.
DR   GO; GO:0017025; F:TBP-class protein binding; IPI:CAFA.
DR   GO; GO:0001093; F:TFIIB-class transcription factor binding; IPI:CAFA.
DR   GO; GO:0001223; F:transcription coactivator binding; IPI:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0008209; P:androgen metabolic process; IEA:Ensembl.
DR   GO; GO:0001547; P:antral ovarian follicle growth; IEA:Ensembl.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IDA:BHF-UCL.
DR   GO; GO:0071391; P:cellular response to estrogen stimulus; IEA:Ensembl.
DR   GO; GO:0006338; P:chromatin remodeling; NAS:UniProtKB.
DR   GO; GO:0002064; P:epithelial cell development; IEA:Ensembl.
DR   GO; GO:0060750; P:epithelial cell proliferation involved in mammary gland duct elongation; IEA:Ensembl.
DR   GO; GO:0030520; P:intracellular estrogen receptor signaling pathway; IDA:CAFA.
DR   GO; GO:0030518; P:intracellular steroid hormone receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0060749; P:mammary gland alveolus development; IEA:Ensembl.
DR   GO; GO:0060745; P:mammary gland branching involved in pregnancy; IEA:Ensembl.
DR   GO; GO:0043433; P:negative regulation of DNA binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB.
DR   GO; GO:1903799; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; IMP:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:BHF-UCL.
DR   GO; GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISS:UniProtKB.
DR   GO; GO:0051091; P:positive regulation of DNA binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0051000; P:positive regulation of nitric-oxide synthase activity; IDA:UniProtKB.
DR   GO; GO:0010863; P:positive regulation of phospholipase C activity; ISS:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; TAS:Reactome.
DR   GO; GO:0045899; P:positive regulation of RNA polymerase II transcriptional preinitiation complex assembly; IDA:CAFA.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0060527; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; IEA:Ensembl.
DR   GO; GO:0060523; P:prostate epithelial cord elongation; IEA:Ensembl.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0071168; P:protein localization to chromatin; IMP:BHF-UCL.
DR   GO; GO:0042981; P:regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0060687; P:regulation of branching involved in prostate gland morphogenesis; IEA:Ensembl.
DR   GO; GO:0050727; P:regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0033146; P:regulation of intracellular estrogen receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0034121; P:regulation of toll-like receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; TAS:Reactome.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0030111; P:regulation of Wnt signaling pathway; TAS:Reactome.
DR   GO; GO:0032355; P:response to estradiol; IDA:BHF-UCL.
DR   GO; GO:0043627; P:response to estrogen; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0048863; P:stem cell differentiation; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0006351; P:transcription, DNA-templated; TAS:ProtInc.
DR   GO; GO:0060065; P:uterus development; IEA:Ensembl.
DR   GO; GO:0060068; P:vagina development; IEA:Ensembl.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR035500; NHR_like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR024178; Oest_rcpt/oest-rel_rcp.
DR   InterPro; IPR001292; Oestr_rcpt.
DR   InterPro; IPR024736; Oestrogen-typ_rcpt_final_C_dom.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF12743; ESR1_C; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF02159; Oest_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PIRSF; PIRSF500101; ER-a; 1.
DR   PIRSF; PIRSF002527; ER-like_NR; 1.
DR   PRINTS; PR00543; OESTROGENR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative promoter usage;
KW   Alternative splicing; Cell membrane; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; DNA-binding;
KW   Glycoprotein; Golgi apparatus; Lipid-binding; Lipoprotein; Membrane;
KW   Metal-binding; Methylation; Nucleus; Palmitate; Phosphoprotein;
KW   Polymorphism; Receptor; Reference proteome; Steroid-binding;
KW   Transcription; Transcription regulation; Transmembrane;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1    595       Estrogen receptor.
FT                                /FTId=PRO_0000053618.
FT   DOMAIN      311    547       NR LBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01189}.
FT   DNA_BIND    185    250       Nuclear receptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00407}.
FT   ZN_FING     185    205       NR C4-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00407}.
FT   ZN_FING     221    245       NR C4-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00407}.
FT   REGION        1    184       Modulating (transactivation AF-1);
FT                                mediates interaction with MACROD1.
FT                                {ECO:0000269|PubMed:17914104}.
FT   REGION       35    174       Interaction with DDX5; self-association.
FT   REGION       35     47       Required for interaction with NCOA1.
FT   REGION      185    310       Mediates interaction with DNTTIP2.
FT                                {ECO:0000269|PubMed:15047147}.
FT   REGION      251    310       Hinge.
FT   REGION      262    595       Interaction with AKAP13.
FT                                {ECO:0000269|PubMed:9627117}.
FT   REGION      264    595       Self-association.
FT   REGION      311    595       Transactivation AF-2.
FT   MOD_RES     104    104       Phosphoserine; by CDK2.
FT                                {ECO:0000269|PubMed:10428798}.
FT   MOD_RES     106    106       Phosphoserine; by CDK2.
FT                                {ECO:0000269|PubMed:10428798}.
FT   MOD_RES     118    118       Phosphoserine.
FT                                {ECO:0000269|PubMed:14764652}.
FT   MOD_RES     167    167       Phosphoserine; by CK2.
FT                                {ECO:0000269|PubMed:7838153}.
FT   MOD_RES     260    260       Asymmetric dimethylarginine; by PRMT1.
FT                                {ECO:0000269|PubMed:18657504}.
FT   MOD_RES     537    537       Phosphotyrosine; by Tyr-kinases.
FT                                {ECO:0000269|PubMed:7539106}.
FT   LIPID       447    447       S-palmitoyl cysteine. {ECO:0000250}.
FT   CARBOHYD     10     10       O-linked (GlcNAc) serine. {ECO:0000250}.
FT   VAR_SEQ       1    173       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:16165085,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_042460.
FT   VAR_SEQ     255    366       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:3753802}.
FT                                /FTId=VSP_003680.
FT   VAR_SEQ     458    595       VYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQ
FT                                QQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLYDL
FT                                LLEMLDAHRLHAPTSRGGASVEETDQSHLATAGSTSSHSLQ
FT                                KYYITGEAEGFPATV -> FTISHVEAKKRILNLHPKIFGN
FT                                KWFPRV (in isoform 4).
FT                                {ECO:0000303|PubMed:16165085,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_042461.
FT   VARIANT       6      6       H -> Y (in a breast cancer sample;
FT                                somatic mutation; dbSNP:rs139960913).
FT                                {ECO:0000269|PubMed:17224074}.
FT                                /FTId=VAR_033028.
FT   VARIANT      77     77       G -> S (in dbSNP:rs9340773).
FT                                /FTId=VAR_018905.
FT   VARIANT     160    160       G -> C (in dbSNP:rs149308960).
FT                                {ECO:0000269|PubMed:9195227}.
FT                                /FTId=VAR_004671.
FT   VARIANT     264    264       M -> I (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17224074}.
FT                                /FTId=VAR_033029.
FT   VARIANT     375    375       Q -> H (in ESTRR; results in highly
FT                                reduced activity; dbSNP:rs397509428).
FT                                {ECO:0000269|PubMed:23841731}.
FT                                /FTId=VAR_070072.
FT   VARIANT     394    394       R -> H (in ESTRR; highly decreased
FT                                estrogen receptor activity).
FT                                {ECO:0000269|PubMed:27754803}.
FT                                /FTId=VAR_078516.
FT   VARIANT     400    400       G -> V (destabilizes the receptor and
FT                                decreases its affinity for estradiol at
FT                                25 degrees Celsius, but not at 4 degrees
FT                                Celsius). {ECO:0000269|PubMed:2792078,
FT                                ECO:0000269|PubMed:3753802,
FT                                ECO:0000269|PubMed:3754034}.
FT                                /FTId=VAR_004673.
FT   VARIANT     411    411       D -> RNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVC
FT                                LKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIH
FT                                LMAKAGLTLQQQHQRLAQLLLILSHIRHM (in a 80
FT                                kDa form found in a breast cancer line;
FT                                contains an in-frame duplication of exons
FT                                6 and 7).
FT                                /FTId=VAR_010143.
FT   MUTAGEN      39     39       L->P: Impairs AF-1 transactivation.
FT                                {ECO:0000269|PubMed:11075817}.
FT   MUTAGEN      43     43       Y->P: Impairs AF-1 transactivation.
FT                                {ECO:0000269|PubMed:11075817}.
FT   MUTAGEN     104    104       S->A: Loss of cyclin A-dependent
FT                                induction of transcriptional activation.
FT   MUTAGEN     106    106       S->A: Loss of cyclin A-dependent
FT                                induction of transcriptional activation.
FT   MUTAGEN     118    118       S->A: Decreases phosphorylation and
FT                                transactivation activity. Abolishes AF-1
FT                                transactivation. Insensitive to PPP5C
FT                                inhibition of transactivation activity.
FT                                {ECO:0000269|PubMed:10409727,
FT                                ECO:0000269|PubMed:14764652}.
FT   MUTAGEN     118    118       S->E: Enhances transactivation activity.
FT                                Enhances interaction with DDX5.
FT                                Insensitive to PPP5C inhibition of
FT                                transactivation activity.
FT                                {ECO:0000269|PubMed:10409727,
FT                                ECO:0000269|PubMed:14764652}.
FT   MUTAGEN     260    260       R->A,K: Loss of methylation.
FT                                {ECO:0000269|PubMed:18657504}.
FT   MUTAGEN     364    364       V->E: Has higher transcriptional activity
FT                                in the absence of wild type ER. Inhibits
FT                                transcriptional activity when coexpressed
FT                                with the wild type receptor.
FT                                {ECO:0000269|PubMed:8961262}.
FT   MUTAGEN     386    386       I->C: Loss of transmembrane localization,
FT                                no effect on peripheral membrane
FT                                localization. Impairs activation of
FT                                estrogen-induced activation of NOS3 and
FT                                production of nitric oxide. No effect on
FT                                binding to ERES.
FT                                {ECO:0000269|PubMed:21937726}.
FT   MUTAGEN     447    447       C->A: Loss of hormone binding capacity
FT                                and temperature-sensitive loss in DNA-
FT                                binding. {ECO:0000269|PubMed:1577818}.
FT   MUTAGEN     539    539       L->A: Abolishes interaction with NCOA1,
FT                                NCOA2 and NCOA3.
FT                                {ECO:0000269|PubMed:12554772}.
FT   CONFLICT    452    452       I -> L (in Ref. 5; CAE45969).
FT                                {ECO:0000305}.
FT   TURN        186    188       {ECO:0000244|PDB:1HCQ}.
FT   STRAND      189    191       {ECO:0000244|PDB:1HCP}.
FT   STRAND      194    196       {ECO:0000244|PDB:1HCQ}.
FT   STRAND      199    201       {ECO:0000244|PDB:1HCQ}.
FT   HELIX       203    213       {ECO:0000244|PDB:1HCQ}.
FT   STRAND      222    225       {ECO:0000244|PDB:1HCQ}.
FT   TURN        231    236       {ECO:0000244|PDB:1HCQ}.
FT   HELIX       238    248       {ECO:0000244|PDB:1HCQ}.
FT   HELIX       288    291       {ECO:0000244|PDB:2LLO}.
FT   HELIX       302    304       {ECO:0000244|PDB:3Q95}.
FT   HELIX       307    309       {ECO:0000244|PDB:3UUD}.
FT   HELIX       312    322       {ECO:0000244|PDB:5DXE}.
FT   STRAND      330    332       {ECO:0000244|PDB:2YJA}.
FT   STRAND      334    336       {ECO:0000244|PDB:2QZO}.
FT   HELIX       339    361       {ECO:0000244|PDB:5DXE}.
FT   HELIX       367    369       {ECO:0000244|PDB:5DXE}.
FT   HELIX       372    394       {ECO:0000244|PDB:5DXE}.
FT   TURN        395    397       {ECO:0000244|PDB:5DXE}.
FT   STRAND      402    405       {ECO:0000244|PDB:5DXE}.
FT   STRAND      408    410       {ECO:0000244|PDB:5DXE}.
FT   HELIX       412    415       {ECO:0000244|PDB:5DXE}.
FT   STRAND      418    420       {ECO:0000244|PDB:5KCW}.
FT   HELIX       421    438       {ECO:0000244|PDB:5DXE}.
FT   HELIX       442    455       {ECO:0000244|PDB:5DXE}.
FT   HELIX       458    460       {ECO:0000244|PDB:5DXE}.
FT   TURN        464    466       {ECO:0000244|PDB:2B1V}.
FT   HELIX       467    469       {ECO:0000244|PDB:3UUD}.
FT   HELIX       473    492       {ECO:0000244|PDB:5DXE}.
FT   HELIX       497    530       {ECO:0000244|PDB:5DXE}.
FT   STRAND      531    533       {ECO:0000244|PDB:2OUZ}.
FT   HELIX       538    545       {ECO:0000244|PDB:5DXE}.
FT   HELIX       547    549       {ECO:0000244|PDB:5AAU}.
FT   HELIX       588    590       {ECO:0000244|PDB:5N10}.
SQ   SEQUENCE   595 AA;  66216 MW;  5455C57AB0CCCAA7 CRC64;
     MTMTLHTKAS GMALLHQIQG NELEPLNRPQ LKIPLERPLG EVYLDSSKPA VYNYPEGAAY
     EFNAAAAANA QVYGQTGLPY GPGSEAAAFG SNGLGGFPPL NSVSPSPLML LHPPPQLSPF
     LQPHGQQVPY YLENEPSGYT VREAGPPAFY RPNSDNRRQG GRERLASTND KGSMAMESAK
     ETRYCAVCND YASGYHYGVW SCEGCKAFFK RSIQGHNDYM CPATNQCTID KNRRKSCQAC
     RLRKCYEVGM MKGGIRKDRR GGRMLKHKRQ RDDGEGRGEV GSAGDMRAAN LWPSPLMIKR
     SKKNSLALSL TADQMVSALL DAEPPILYSE YDPTRPFSEA SMMGLLTNLA DRELVHMINW
     AKRVPGFVDL TLHDQVHLLE CAWLEILMIG LVWRSMEHPG KLLFAPNLLL DRNQGKCVEG
     MVEIFDMLLA TSSRFRMMNL QGEEFVCLKS IILLNSGVYT FLSSTLKSLE EKDHIHRVLD
     KITDTLIHLM AKAGLTLQQQ HQRLAQLLLI LSHIRHMSNK GMEHLYSMKC KNVVPLYDLL
     LEMLDAHRLH APTSRGGASV EETDQSHLAT AGSTSSHSLQ KYYITGEAEG FPATV
//
ID   Q9UBT1_HUMAN            Unreviewed;        23 AA.
AC   Q9UBT1;
DT   01-MAY-2000, integrated into UniProtKB/TrEMBL.
DT   01-MAY-2000, sequence version 1.
DT   30-AUG-2017, entry version 89.
DE   SubName: Full=Estrogen receptor {ECO:0000313|EMBL:AAC51875.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAC51875.1};
RN   [1] {ECO:0000313|EMBL:AAC51875.1}
RP   NUCLEOTIDE SEQUENCE OF 1-17.
RC   TISSUE=Breast adenocarcinoma {ECO:0000313|EMBL:AAC51875.1};
RX   PubMed=3754034; DOI=10.1038/320134a0;
RA   Green S., Walter P., Kumar V., Krust A., Bornert J.M., Argos P.,
RA   Chambon P.;
RT   "Human oestrogen receptor cDNA: sequence, expression and homology to
RT   v-erb-A.";
RL   Nature 320:134-139(1986).
RN   [2] {ECO:0000313|EMBL:AAC51875.1}
RP   NUCLEOTIDE SEQUENCE OF 1-17.
RC   TISSUE=Breast adenocarcinoma {ECO:0000313|EMBL:AAC51875.1};
RX   PubMed=3753802; DOI=10.1126/science.3753802;
RA   Greene G.L., Gilna P., Waterfield M., Baker A., Hort Y., Shine J.;
RT   "Sequence and expression of human estrogen receptor complementary
RT   DNA.";
RL   Science 231:1150-1154(1986).
RN   [3] {ECO:0000313|EMBL:AAC51875.1}
RP   NUCLEOTIDE SEQUENCE OF 1-17.
RC   TISSUE=Breast adenocarcinoma {ECO:0000313|EMBL:AAC51875.1};
RX   PubMed=2015052;
RA   Keaveney M., Klug J., Dawson M.T., Nestor P.V., Neilan J.G.,
RA   Forde R.C., Gannon F.;
RT   "Evidence for a previously unidentified upstream exon in the human
RT   oestrogen receptor gene.";
RL   J. Mol. Endocrinol. 6:111-115(1991).
RN   [4] {ECO:0000313|EMBL:AAC51875.1}
RP   NUCLEOTIDE SEQUENCE OF 1-17.
RC   TISSUE=Breast adenocarcinoma {ECO:0000313|EMBL:AAC51875.1};
RX   PubMed=1567414; DOI=10.1016/S0006-291X(05)80289-X;
RA   Piva R., Gambari R., Zorzato F., Kumar L., del Senno L.;
RT   "Analysis of upstream sequences of the human estrogen receptor gene.";
RL   Biochem. Biophys. Res. Commun. 183:996-1002(1992).
RN   [5] {ECO:0000313|EMBL:AAC51875.1}
RP   NUCLEOTIDE SEQUENCE OF 1-17.
RC   TISSUE=Breast adenocarcinoma {ECO:0000313|EMBL:AAC51875.1};
RX   PubMed=1476547;
RA   Keaveney M., Klug J., Gannon F.;
RT   "Sequence analysis of the 5' flanking region of the human estrogen
RT   receptor gene.";
RL   DNA Seq. 2:347-358(1992).
RN   [6] {ECO:0000313|EMBL:AAC51875.1}
RP   NUCLEOTIDE SEQUENCE OF 1-17.
RC   TISSUE=Breast adenocarcinoma {ECO:0000313|EMBL:AAC51875.1};
RX   PubMed=8240974; DOI=10.1016/0960-0760(93)90179-Z;
RA   Piva R., Bianchi N., Aguiari G.L., Gambari R., del Senno L.;
RT   "Sequencing of an RNA transcript of the human estrogen receptor gene:
RT   evidence for a new transcriptional event.";
RL   J. Steroid Biochem. Mol. Biol. 46:531-538(1993).
RN   [7] {ECO:0000313|EMBL:AAC51875.1}
RP   NUCLEOTIDE SEQUENCE OF 1-17.
RC   TISSUE=Breast adenocarcinoma {ECO:0000313|EMBL:AAC51875.1};
RX   PubMed=8647321; DOI=10.1016/0303-7207(95)03716-0;
RA   Grandien K.;
RT   "Determination of transcription start sites in the human estrogen
RT   receptor gene and identification of a novel, tissue-specific, estrogen
RT   receptor-mRNA isoform.";
RL   Mol. Cell. Endocrinol. 116:207-212(1996).
RN   [8] {ECO:0000313|EMBL:AAC51875.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Breast adenocarcinoma {ECO:0000313|EMBL:AAC51875.1};
RX   PubMed=9393949; DOI=10.1016/S0960-0760(97)00029-0;
RA   Thompson D.A., McPherson L.A., Carmeci C., deConinck E.C.,
RA   Weigel R.J.;
RT   "Identification of two estrogen receptor transcripts with novel 5'
RT   exons isolated from a MCF7 cDNA library.";
RL   J. Steroid Biochem. Mol. Biol. 62:143-153(1997).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U68067; AAC51874.1; -; mRNA.
DR   EMBL; U68068; AAC51875.1; -; mRNA.
DR   RefSeq; NP_001116212.1; NM_001122740.1.
DR   UniGene; Hs.208124; -.
DR   UniGene; Hs.744830; -.
DR   DNASU; 2099; -.
DR   GeneID; 2099; -.
DR   CTD; 2099; -.
DR   PharmGKB; PA156; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   GenomeRNAi; 2099; -.
PE   2: Evidence at transcript level;
KW   Receptor {ECO:0000313|EMBL:AAC51875.1}.
FT   NON_TER      23     23       {ECO:0000313|EMBL:AAC51875.1}.
SQ   SEQUENCE   23 AA;  2526 MW;  4A678094301081FD CRC64;
     MTMTLHTKAS GMALLHQIQG NEL
//
ID   PAXI1_HUMAN             Reviewed;        1069 AA.
AC   Q6ZW49; O15404; Q6N099; Q6ZWH9; Q7Z315; Q86UN0; Q8N4P9; Q96HP2;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   23-MAY-2018, entry version 122.
DE   RecName: Full=PAX-interacting protein 1;
DE   AltName: Full=PAX transactivation activation domain-interacting protein;
GN   Name=PAXIP1; Synonyms=PAXIP1L, PTIP; ORFNames=CAGF28;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-680 (ISOFORM 1).
RC   TISSUE=Adrenal gland, Prostate, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   VAL-1013.
RC   TISSUE=Rectum tumor, and Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 202-1069.
RC   TISSUE=Fetal brain;
RX   PubMed=9225980; DOI=10.1007/s004390050476;
RA   Margolis R.L., Abraham M.R., Gatchell S.B., Li S.-H., Kidwai A.S.,
RA   Breschel T.S., Stine O.C., Callahan C., McInnis M.G., Ross C.A.;
RT   "cDNAs with long CAG trinucleotide repeats from human brain.";
RL   Hum. Genet. 100:114-122(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 244-1069.
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=14576432; DOI=10.1126/science.1088877;
RA   Manke I.A., Lowery D.M., Nguyen A., Yaffe M.B.;
RT   "BRCT repeats as phosphopeptide-binding modules involved in protein
RT   targeting.";
RL   Science 302:636-639(2003).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH TP53BP1.
RX   PubMed=15456759; DOI=10.1074/jbc.M411021200;
RA   Jowsey P.A., Doherty A.J., Rouse J.;
RT   "Human PTIP facilitates ATM-mediated activation of p53 and promotes
RT   cellular resistance to ionizing radiation.";
RL   J. Biol. Chem. 279:55562-55569(2004).
RN   [8]
RP   FUNCTION IN MLL2 COMPLEX ASSEMBLY, AND IDENTIFICATION IN THE MLL2/3
RP   COMPLEX.
RX   PubMed=17925232; DOI=10.1016/j.devcel.2007.09.004;
RA   Patel S.R., Kim D., Levitan I., Dressler G.R.;
RT   "The BRCT-domain containing protein PTIP links PAX2 to a histone H3,
RT   lysine 4 methyltransferase complex.";
RL   Dev. Cell 13:580-592(2007).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE MLL2/3
RP   COMPLEX.
RX   PubMed=17500065; DOI=10.1074/jbc.M701574200;
RA   Cho Y.-W., Hong T., Hong S., Guo H., Yu H., Kim D., Guszczynski T.,
RA   Dressler G.R., Copeland T.D., Kalkum M., Ge K.;
RT   "PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4
RT   methyltransferase complex.";
RL   J. Biol. Chem. 282:20395-20406(2007).
RN   [10]
RP   IDENTIFICATION IN THE MLL2 COMPLEX, AND ASSOCIATION WITH
RP   KMT2D-REGULATED GENE PROMOTERS.
RX   PubMed=17178841; DOI=10.1128/MCB.01506-06;
RA   Issaeva I., Zonis Y., Rozovskaia T., Orlovsky K., Croce C.M.,
RA   Nakamura T., Mazo A., Eisenbach L., Canaani E.;
RT   "Knockdown of ALR (MLL2) reveals ALR target genes and leads to
RT   alterations in cell adhesion and growth.";
RL   Mol. Cell. Biol. 27:1889-1903(2007).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH TP53BP1, AND
RP   MUTAGENESIS OF TRP-676; ARG-910 AND TRP-929.
RX   PubMed=17690115; DOI=10.1093/nar/gkm493;
RA   Munoz I.M., Jowsey P.A., Toth R., Rouse J.;
RT   "Phospho-epitope binding by the BRCT domains of hPTIP controls
RT   multiple aspects of the cellular response to DNA damage.";
RL   Nucleic Acids Res. 35:5312-5322(2007).
RN   [12]
RP   IDENTIFICATION IN THE MLL2/3 COMPLEX.
RX   PubMed=17761849; DOI=10.1126/science.1149042;
RA   Lee M.G., Villa R., Trojer P., Norman J., Yan K.P., Reinberg D.,
RA   Di Croce L., Shiekhattar R.;
RT   "Demethylation of H3K27 regulates polycomb recruitment and H2A
RT   ubiquitination.";
RL   Science 318:447-450(2007).
RN   [13]
RP   FUNCTION.
RX   PubMed=18353733; DOI=10.1016/j.dnarep.2008.02.001;
RA   Gohler T., Munoz I.M., Rouse J., Blow J.J.;
RT   "PTIP/Swift is required for efficient PCNA ubiquitination in response
RT   to DNA damage.";
RL   DNA Repair 7:775-787(2008).
RN   [14]
RP   INTERACTION WITH HLTF.
RX   PubMed=19723507; DOI=10.1016/j.bbrc.2009.08.151;
RA   MacKay C., Toth R., Rouse J.;
RT   "Biochemical characterisation of the SWI/SNF family member HLTF.";
RL   Biochem. Biophys. Res. Commun. 390:187-191(2009).
RN   [15]
RP   FUNCTION.
RX   PubMed=20088963; DOI=10.1111/j.1365-2443.2009.01379.x;
RA   Wang X., Takenaka K., Takeda S.;
RT   "PTIP promotes DNA double-strand break repair through homologous
RT   recombination.";
RL   Genes Cells 15:243-254(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   FUNCTION, AND INTERACTION WITH TP53BP1.
RX   PubMed=23727112; DOI=10.1016/j.cell.2013.05.023;
RA   Callen E., Di Virgilio M., Kruhlak M.J., Nieto-Soler M., Wong N.,
RA   Chen H.T., Faryabi R.B., Polato F., Santos M., Starnes L.M.,
RA   Wesemann D.R., Lee J.E., Tubbs A., Sleckman B.P., Daniel J.A., Ge K.,
RA   Alt F.W., Fernandez-Capetillo O., Nussenzweig M.C., Nussenzweig A.;
RT   "53BP1 mediates productive and mutagenic DNA repair through distinct
RT   phosphoprotein interactions.";
RL   Cell 153:1266-1280(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-235, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Involved in DNA damage response and in transcriptional
CC       regulation through histone methyltransferase (HMT) complexes.
CC       Plays a role in early development. In DNA damage response is
CC       required for cell survival after ionizing radiation. In vitro
CC       shown to be involved in the homologous recombination mechanism for
CC       the repair of double-strand breaks (DSBs). Its localization to DNA
CC       damage foci requires RNF8 and UBE2N. Recruits TP53BP1 to DNA
CC       damage foci and, at least in particular repair processes,
CC       effective DNA damage response appears to require the association
CC       with TP53BP1 phosphorylated by ATM at 'Ser-25'. Together with
CC       TP53BP1 regulates ATM association. Proposed to recruit PAGR1 to
CC       sites of DNA damage and the PAGR1:PAXIP1 complex is required for
CC       cell survival in response to DNA damage; the function is probably
CC       independent of MLL-containing histone methyltransferase (HMT)
CC       complexes. However, this function has been questioned (By
CC       similarity). Promotes ubiquitination of PCNA following UV
CC       irradiation and may regulate recruitment of polymerase eta and
CC       RAD51 to chromatin after DNA damage. Proposed to be involved in
CC       transcriptional regulation by linking MLL-containing histone
CC       methyltransferase (HMT) complexes to gene promoters by interacting
CC       with promoter-bound transcription factors such as PAX2. Associates
CC       with gene promoters that are known to be regulated by KMT2D/MLL2.
CC       During immunoglobulin class switching in activated B-cells is
CC       involved in trimethylation of histone H3 at 'Lys-4' and in
CC       transcription initiation of downstream switch regions at the
CC       immunoglobulin heavy-chain (Igh) locus; this function appears to
CC       involve the recruitment of MLL-containing HMT complexes.
CC       Conflictingly, its function in transcriptional regulation during
CC       immunoglobulin class switching is reported to be independent of
CC       the MLL2/MLL3 complex (By similarity).
CC       {ECO:0000250|UniProtKB:Q6NZQ4, ECO:0000269|PubMed:14576432,
CC       ECO:0000269|PubMed:15456759, ECO:0000269|PubMed:17690115,
CC       ECO:0000269|PubMed:17925232, ECO:0000269|PubMed:18353733,
CC       ECO:0000269|PubMed:20088963, ECO:0000269|PubMed:23727112}.
CC   -!- SUBUNIT: Interacts with the C-terminal transactivation domain of
CC       PAX2 (By similarity). Forms a constitutive complex with PAGR1
CC       independently of the MLL2/MLL3 complex (By similarity). Interacts
CC       with TP53BP1 (when phosphorylated at the N-terminus by ATM)
CC       (PubMed:15456759, PubMed:17690115, PubMed:23727112). Interacts
CC       with HLTF (PubMed:19723507). Component of the KMT2 family
CC       MLL2/MLL3 complex (also named ASCOM complex), at least composed of
CC       the HMTs KMT2D and/or KMT2C, the common subunits ASH2L, RBBP5,
CC       WDR5 and DPY30, and the complex type-specific subunits
CC       PAXIP1/PTIP, PAGR1, NCOA6 and KDM6A; required for the association
CC       of PAGR1 with the MLL2/MLL3 complex (PubMed:17178841,
CC       PubMed:17500065, PubMed:17761849, PubMed:17925232).
CC       {ECO:0000250|UniProtKB:Q6NZQ4, ECO:0000269|PubMed:15456759,
CC       ECO:0000269|PubMed:17178841, ECO:0000269|PubMed:17500065,
CC       ECO:0000269|PubMed:17690115, ECO:0000269|PubMed:17761849,
CC       ECO:0000269|PubMed:17925232, ECO:0000269|PubMed:19723507,
CC       ECO:0000269|PubMed:23727112}.
CC   -!- INTERACTION:
CC       Q9UBL3:ASH2L; NbExp=11; IntAct=EBI-743225, EBI-540797;
CC       P16104:H2AFX; NbExp=7; IntAct=EBI-7521368, EBI-494830;
CC       Q15555:MAPRE2; NbExp=3; IntAct=EBI-10236271, EBI-739717;
CC       Q9UKK6:NXT1; NbExp=3; IntAct=EBI-10236271, EBI-301889;
CC       Q9BTK6:PAGR1; NbExp=8; IntAct=EBI-743225, EBI-2372223;
CC       Q96HA1:POM121; NbExp=3; IntAct=EBI-10236271, EBI-739990;
CC       Q15291:RBBP5; NbExp=11; IntAct=EBI-743225, EBI-592823;
CC       Q12888:TP53BP1; NbExp=4; IntAct=EBI-743225, EBI-396540;
CC       P61964:WDR5; NbExp=8; IntAct=EBI-743225, EBI-540834;
CC   -!- SUBCELLULAR LOCATION: Nucleus matrix
CC       {ECO:0000250|UniProtKB:Q6NZQ4}. Chromosome
CC       {ECO:0000269|PubMed:15456759, ECO:0000269|PubMed:17690115}.
CC       Note=Localizes to DNA damage foci upon ionizing radiation.
CC       {ECO:0000269|PubMed:15456759, ECO:0000269|PubMed:17690115}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6ZW49-6; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6ZW49-1; Sequence=VSP_040300;
CC       Name=3;
CC         IsoId=Q6ZW49-2; Sequence=VSP_040303;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The BRCT 1 and 2 domains mediate the interaction with
CC       PAGR1A. {ECO:0000250|UniProtKB:Q6NZQ4}.
CC   -!- DOMAIN: The BRCT 5 and 6 domains mediate the association with the
CC       MLL2/MLL3 complex (By similarity). The BRCT 5 and 6 domains
CC       function as a single module and are necessary and sufficient for
CC       in vitro phospho-specific binding (substrates phosphorylated by
CC       the kinases ataxia telangiectasia-mutated (ATM), ataxia
CC       telangiectasia and RAD3-related (ATR) in response to gamma
CC       irradiation). In contrast, in vivo two pairs of BRCT domains (3-6)
CC       bind to phosphorylated TP53BP1 much more efficiently.
CC       {ECO:0000250|UniProtKB:Q6NZQ4}.
CC   -!- CAUTION: The terminology of MLL proteins in mammalia is not
CC       consistent also concerning the terminology of MLL protein-
CC       containing complexes. The decribed MLL2/MLL3 complex is commonly
CC       described as MLL3/MLL4 complex in literature. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB91434.1; Type=Frameshift; Positions=643, 662; Evidence={ECO:0000305};
CC       Sequence=AAH33781.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH33781.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence.; Evidence={ECO:0000305};
CC       Sequence=AAP21865.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=BAC85523.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK123044; BAC85523.1; ALT_SEQ; mRNA.
DR   EMBL; AK123600; BAC85657.1; -; mRNA.
DR   EMBL; AK307417; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BX538201; CAD98066.1; -; mRNA.
DR   EMBL; BX640616; CAE45762.1; -; mRNA.
DR   EMBL; AC093726; AAP21865.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; U80735; AAB91434.1; ALT_FRAME; mRNA.
DR   EMBL; BC008328; AAH08328.1; -; mRNA.
DR   EMBL; BC033781; AAH33781.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS47753.1; -. [Q6ZW49-6]
DR   RefSeq; NP_031375.3; NM_007349.3. [Q6ZW49-6]
DR   RefSeq; XP_005249596.1; XM_005249539.1. [Q6ZW49-1]
DR   RefSeq; XP_016867370.1; XM_017011881.1. [Q6ZW49-1]
DR   UniGene; Hs.443881; -.
DR   PDB; 3SQD; X-ray; 2.15 A; A/B=860-1069.
DR   PDBsum; 3SQD; -.
DR   ProteinModelPortal; Q6ZW49; -.
DR   SMR; Q6ZW49; -.
DR   BioGrid; 116625; 264.
DR   CORUM; Q6ZW49; -.
DR   DIP; DIP-41786N; -.
DR   IntAct; Q6ZW49; 32.
DR   MINT; Q6ZW49; -.
DR   STRING; 9606.ENSP00000384048; -.
DR   iPTMnet; Q6ZW49; -.
DR   PhosphoSitePlus; Q6ZW49; -.
DR   BioMuta; PAXIP1; -.
DR   DMDM; 317373316; -.
DR   EPD; Q6ZW49; -.
DR   MaxQB; Q6ZW49; -.
DR   PaxDb; Q6ZW49; -.
DR   PeptideAtlas; Q6ZW49; -.
DR   PRIDE; Q6ZW49; -.
DR   Ensembl; ENST00000397192; ENSP00000380376; ENSG00000157212. [Q6ZW49-6]
DR   Ensembl; ENST00000404141; ENSP00000384048; ENSG00000157212. [Q6ZW49-6]
DR   GeneID; 22976; -.
DR   KEGG; hsa:22976; -.
DR   UCSC; uc033aqm.2; human. [Q6ZW49-6]
DR   CTD; 22976; -.
DR   DisGeNET; 22976; -.
DR   EuPathDB; HostDB:ENSG00000157212.18; -.
DR   GeneCards; PAXIP1; -.
DR   H-InvDB; HIX0007243; -.
DR   HGNC; HGNC:8624; PAXIP1.
DR   HPA; HPA006694; -.
DR   HPA; HPA016950; -.
DR   MalaCards; PAXIP1; -.
DR   MIM; 608254; gene.
DR   neXtProt; NX_Q6ZW49; -.
DR   OpenTargets; ENSG00000157212; -.
DR   PharmGKB; PA32964; -.
DR   eggNOG; KOG2043; Eukaryota.
DR   eggNOG; ENOG410XSGS; LUCA.
DR   GeneTree; ENSGT00600000084454; -.
DR   HOVERGEN; HBG061191; -.
DR   InParanoid; Q6ZW49; -.
DR   KO; K14972; -.
DR   OMA; QINRPSN; -.
DR   OrthoDB; EOG091G0YK0; -.
DR   PhylomeDB; Q6ZW49; -.
DR   TreeFam; TF329580; -.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   SignaLink; Q6ZW49; -.
DR   SIGNOR; Q6ZW49; -.
DR   ChiTaRS; PAXIP1; human.
DR   GeneWiki; PAXIP1; -.
DR   GenomeRNAi; 22976; -.
DR   PRO; PR:Q6ZW49; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000157212; -.
DR   CleanEx; HS_PAXIP1; -.
DR   ExpressionAtlas; Q6ZW49; baseline and differential.
DR   Genevisible; Q6ZW49; HS.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0035097; C:histone methyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0044666; C:MLL3/4 complex; IDA:UniProtKB.
DR   GO; GO:0016363; C:nuclear matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0060612; P:adipose tissue development; IEA:Ensembl.
DR   GO; GO:0060717; P:chorion development; IEA:Ensembl.
DR   GO; GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; IMP:UniProtKB.
DR   GO; GO:0006310; P:DNA recombination; IEA:UniProtKB-KW.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; TAS:Reactome.
DR   GO; GO:0043542; P:endothelial cell migration; IEA:Ensembl.
DR   GO; GO:0051568; P:histone H3-K4 methylation; IDA:UniProtKB.
DR   GO; GO:0035066; P:positive regulation of histone acetylation; ISS:UniProtKB.
DR   GO; GO:0000416; P:positive regulation of histone H3-K36 methylation; ISS:UniProtKB.
DR   GO; GO:0051571; P:positive regulation of histone H3-K4 methylation; ISS:UniProtKB.
DR   GO; GO:0045830; P:positive regulation of isotype switching; ISS:UniProtKB.
DR   GO; GO:0048304; P:positive regulation of isotype switching to IgG isotypes; IEA:Ensembl.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; ISS:UniProtKB.
DR   GO; GO:2001022; P:positive regulation of response to DNA damage stimulus; IEA:Ensembl.
DR   GO; GO:0060261; P:positive regulation of transcription initiation from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:1902749; P:regulation of cell cycle G2/M phase transition; IEA:Ensembl.
DR   GO; GO:0010212; P:response to ionizing radiation; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0001570; P:vasculogenesis; IEA:Ensembl.
DR   CDD; cd00027; BRCT; 4.
DR   Gene3D; 3.40.50.10190; -; 5.
DR   InterPro; IPR001357; BRCT_dom.
DR   InterPro; IPR036420; BRCT_dom_sf.
DR   Pfam; PF00533; BRCT; 1.
DR   Pfam; PF12738; PTCB-BRCT; 2.
DR   Pfam; PF16770; RTT107_BRCT_5; 1.
DR   SMART; SM00292; BRCT; 5.
DR   SUPFAM; SSF52113; SSF52113; 5.
DR   PROSITE; PS50172; BRCT; 5.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosome; Complete proteome;
KW   DNA damage; DNA recombination; DNA repair; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Transcription;
KW   Transcription regulation.
FT   CHAIN         1   1069       PAX-interacting protein 1.
FT                                /FTId=PRO_0000296262.
FT   DOMAIN        8     93       BRCT 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00033}.
FT   DOMAIN       94    183       BRCT 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00033}.
FT   DOMAIN      601    694       BRCT 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00033}.
FT   DOMAIN      703    779       BRCT 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00033}.
FT   DOMAIN      866    947       BRCT 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00033}.
FT   DOMAIN      970   1059       BRCT 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00033}.
FT   REGION       94    183       Interaction with PAGR1. {ECO:0000250}.
FT   REGION      590   1069       Interaction with TP53BP1.
FT   MOTIF       702    719       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   COMPBIAS    223    250       Glu-rich.
FT   COMPBIAS    406    624       Gln-rich.
FT   MOD_RES     227    227       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6NZQ4}.
FT   MOD_RES     235    235       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    247       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_040303.
FT   VAR_SEQ       1    108       MSDQAPKVPEEMFREVKYYAVGDIDPQVIQLLKAGKAKEVS
FT                                YNALASHIISEDGDNPEVGEAREVFDLPVVKPSWVILSVQC
FT                                GTLLPVNGFSPESCQIFFGITACLSQ -> MVFLQNHVRFF
FT                                LESLPAFLRVLIQAGALCWSLPELSQGEVGKGACPAEVGKH
FT                                RDHLPSSDPVLMQAEASVVMCW (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_040300.
FT   VARIANT    1013   1013       M -> V (in dbSNP:rs3501).
FT                                {ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_034627.
FT   MUTAGEN     676    676       W->A: Abolishes interaction with TP53BP1;
FT                                prevents recruitment to DNA damage foci.
FT                                {ECO:0000269|PubMed:17690115}.
FT   MUTAGEN     910    910       R->Q: Abolishes interaction with TP53BP1;
FT                                impairs intact cellular response to DNA
FT                                damage. {ECO:0000269|PubMed:17690115}.
FT   MUTAGEN     929    929       W->A: Abolishes interaction with TP53BP1;
FT                                prevents recruitment to DNA damage foci.
FT                                {ECO:0000269|PubMed:17690115}.
FT   CONFLICT    121    121       V -> D (in Ref. 1; AK307417).
FT                                {ECO:0000305}.
FT   CONFLICT    154    154       K -> R (in Ref. 2; CAE45762).
FT                                {ECO:0000305}.
FT   CONFLICT    260    260       Q -> H (in Ref. 2; CAE45762).
FT                                {ECO:0000305}.
FT   CONFLICT    406    406       Missing (in Ref. 1; AK307417).
FT                                {ECO:0000305}.
FT   CONFLICT    458    581       Missing (in Ref. 4; AAB91434).
FT                                {ECO:0000305}.
FT   CONFLICT    847    847       K -> Q (in Ref. 4; AAB91434).
FT                                {ECO:0000305}.
FT   CONFLICT    912    912       V -> L (in Ref. 4; AAB91434).
FT                                {ECO:0000305}.
FT   CONFLICT    916    916       T -> A (in Ref. 4; AAB91434).
FT                                {ECO:0000305}.
FT   HELIX       863    865       {ECO:0000244|PDB:3SQD}.
FT   STRAND      868    871       {ECO:0000244|PDB:3SQD}.
FT   HELIX       876    888       {ECO:0000244|PDB:3SQD}.
FT   HELIX       897    899       {ECO:0000244|PDB:3SQD}.
FT   STRAND      901    904       {ECO:0000244|PDB:3SQD}.
FT   HELIX       912    917       {ECO:0000244|PDB:3SQD}.
FT   TURN        918    920       {ECO:0000244|PDB:3SQD}.
FT   STRAND      922    925       {ECO:0000244|PDB:3SQD}.
FT   HELIX       927    936       {ECO:0000244|PDB:3SQD}.
FT   HELIX       943    945       {ECO:0000244|PDB:3SQD}.
FT   HELIX       950    955       {ECO:0000244|PDB:3SQD}.
FT   HELIX       960    969       {ECO:0000244|PDB:3SQD}.
FT   TURN        972    975       {ECO:0000244|PDB:3SQD}.
FT   STRAND      976    980       {ECO:0000244|PDB:3SQD}.
FT   HELIX       988    997       {ECO:0000244|PDB:3SQD}.
FT   STRAND     1001   1005       {ECO:0000244|PDB:3SQD}.
FT   HELIX      1009   1017       {ECO:0000244|PDB:3SQD}.
FT   STRAND     1023   1028       {ECO:0000244|PDB:3SQD}.
FT   HELIX      1030   1036       {ECO:0000244|PDB:3SQD}.
FT   HELIX      1037   1041       {ECO:0000244|PDB:3SQD}.
FT   HELIX      1050   1058       {ECO:0000244|PDB:3SQD}.
FT   TURN       1063   1065       {ECO:0000244|PDB:3SQD}.
SQ   SEQUENCE   1069 AA;  121341 MW;  78CD535A150E1FC1 CRC64;
     MSDQAPKVPE EMFREVKYYA VGDIDPQVIQ LLKAGKAKEV SYNALASHII SEDGDNPEVG
     EAREVFDLPV VKPSWVILSV QCGTLLPVNG FSPESCQIFF GITACLSQVS SEDRSALWAL
     VTFYGGDCQL TLNKKCTHLI VPEPKGEKYE CALKRASIKI VTPDWVLDCV SEKTKKDEAF
     YHPRLIIYEE EEEEEEEEEE VENEEQDSQN EGSTDEKSSP ASSQEGSPSG DQQFSPKSNT
     EKSKGELMFD DSSDSSPEKQ ERNLNWTPAE VPQLAAAKRR LPQGKEPGLI NLCANVPPVP
     GNILPPEVRG NLMAAGQNLQ SSERSEMIAT WSPAVRTLRN ITNNADIQQM NRPSNVAHIL
     QTLSAPTKNL EQQVNHSQQG HTNANAVLFS QVKVTPETHM LQQQQQAQQQ QQQHPVLHLQ
     PQQIMQLQQQ QQQQISQQPY PQQPPHPFSQ QQQQQQQAHP HQFSQQQLQF PQQQLHPPQQ
     LHRPQQQLQP FQQQHALQQQ FHQLQQHQLQ QQQLAQLQQQ HSLLQQQQQQ QIQQQQLQRM
     HQQQQQQQMQ SQTAPHLSQT SQALQHQVPP QQPPQQQQQQ QPPPSPQQHQ LFGHDPAVEI
     PEEGFLLGCV FAIADYPEQM SDKQLLATWK RIIQAHGGTV DPTFTSRCTH LLCESQVSSA
     YAQAIRERKR CVTAHWLNTV LKKKKMVPPH RALHFPVAFP PGGKPCSQHI ISVTGFVDSD
     RDDLKLMAYL AGAKYTGYLC RSNTVLICKE PTGLKYEKAK EWRIPCVNAQ WLGDILLGNF
     EALRQIQYSR YTAFSLQDPF APTQHLVLNL LDAWRVPLKV SAELLMSIRL PPKLKQNEVA
     NVQPSSKRAR IEDVPPPTKK LTPELTPFVL FTGFEPVQVQ QYIKKLYILG GEVAESAQKC
     THLIASKVTR TVKFLTAISV VKHIVTPEWL EECFRCQKFI DEQNYILRDA EAEVLFSFSL
     EESLKRAHVS PLFKAKYFYI TPGICPSLST MKAIVECAGG KVLSKQPSFR KLMEHKQNSS
     LSEIILISCE NDLHLCREYF ARGIDVHNAE FVLTGVLTQT LDYESYKFN
//
ID   B3KNB2_HUMAN            Unreviewed;       537 AA.
AC   B3KNB2;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   23-MAY-2018, entry version 48.
DE   SubName: Full=cDNA FLJ14161 fis, clone NT2RM2001803, highly similar to IkappaB kinase complex-associated protein {ECO:0000313|EMBL:BAG51274.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG51274.1};
RN   [1] {ECO:0000313|EMBL:BAG51274.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK024223; BAG51274.1; -; mRNA.
DR   RefSeq; NP_001317678.1; NM_001330749.1.
DR   UniGene; Hs.494738; -.
DR   PeptideAtlas; B3KNB2; -.
DR   PRIDE; B3KNB2; -.
DR   GeneID; 8518; -.
DR   CTD; 8518; -.
DR   eggNOG; KOG1920; Eukaryota.
DR   eggNOG; COG5290; LUCA.
DR   HOVERGEN; HBG101919; -.
DR   GO; GO:0033588; C:Elongator holoenzyme complex; IEA:InterPro.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0002098; P:tRNA wobble uridine modification; IEA:InterPro.
DR   InterPro; IPR006849; Elp1.
DR   PANTHER; PTHR12747; PTHR12747; 1.
DR   Pfam; PF04762; IKI3; 1.
PE   2: Evidence at transcript level;
KW   Kinase {ECO:0000313|EMBL:BAG51274.1};
KW   Transferase {ECO:0000313|EMBL:BAG51274.1}.
SQ   SEQUENCE   537 AA;  61088 MW;  3F3D6D50C25EDE5F CRC64;
     MYPAPVTSSV YLSRDPDGNK IDLVCDAMRA VMESINPHKY CLSILTSHVK KTTPELEIVL
     QKVHELQGNA PSDPDAVSAE EALKYLLHLV DVNELYDHSL GTYDFDLVLM VAEKSQKDPK
     EYLPFLNTLK KMETNYQRFT IDKYLKRYEK AIGHLSKCGP EYFPECLNLI KDKNLYNEAL
     KLYSPSSQQY QDISIAYGEH LMQEHMYEPA GLMFARCGAH EKALSAFLTC GNWKQALCVA
     AQLNFTKDQL VGLGRTLAGK LVEQRKHIDA AMVLEECAQD YEEAVLLLLE GAAWEEALRL
     VYKYNRLDII ETNVKPSILE AQKNYMAFLD SQTATFSRHK KRLLVVRELK EQAQQAGLDD
     EVPHGQESDL FSETSSVVSG SEMSGKYSHS NSRISARSSK NRRKAERKKH SLKEGSPLED
     LALLEALSEV VQNTENLKDE VYHILKVLFL FEFDEQGREL QKAFEDTLQL MERSLPEIWT
     LTYQQNSATP VLGPNSTANS IMASYQQQKT SVPVLDAELF IPPKINRRTQ WKLSLLD
//
ID   B4E3I9_HUMAN            Unreviewed;      1218 AA.
AC   B4E3I9;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   23-MAY-2018, entry version 37.
DE   RecName: Full=Elongator complex protein 1 {ECO:0000256|PIRNR:PIRNR017233};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG65501.1};
RN   [1] {ECO:0000313|EMBL:BAG65501.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Uterus {ECO:0000313|EMBL:BAG65501.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Acts as subunit of the RNA polymerase II elongator
CC       complex, which is a histone acetyltransferase component of the RNA
CC       polymerase II (Pol II) holoenzyme and is involved in
CC       transcriptional elongation. {ECO:0000256|PIRNR:PIRNR017233}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|PIRNR:PIRNR017233}.
CC       Nucleus {ECO:0000256|PIRNR:PIRNR017233}.
CC   -!- SIMILARITY: Belongs to the ELP1/IKA1 family.
CC       {ECO:0000256|PIRNR:PIRNR017233}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK304742; BAG65501.1; -; mRNA.
DR   RefSeq; NP_001305289.1; NM_001318360.1.
DR   UniGene; Hs.494738; -.
DR   PeptideAtlas; B4E3I9; -.
DR   PRIDE; B4E3I9; -.
DR   GeneID; 8518; -.
DR   CTD; 8518; -.
DR   eggNOG; KOG1920; Eukaryota.
DR   eggNOG; COG5290; LUCA.
DR   HOVERGEN; HBG019038; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0033588; C:Elongator holoenzyme complex; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0002098; P:tRNA wobble uridine modification; IEA:InterPro.
DR   InterPro; IPR006849; Elp1.
DR   PANTHER; PTHR12747; PTHR12747; 1.
DR   Pfam; PF04762; IKI3; 1.
DR   PIRSF; PIRSF017233; IKAP; 1.
PE   2: Evidence at transcript level;
KW   Cytoplasm {ECO:0000256|PIRNR:PIRNR017233};
KW   Kinase {ECO:0000313|EMBL:BAG65501.1};
KW   Nucleus {ECO:0000256|PIRNR:PIRNR017233};
KW   Transcription {ECO:0000256|PIRNR:PIRNR017233};
KW   Transcription regulation {ECO:0000256|PIRNR:PIRNR017233};
KW   Transferase {ECO:0000313|EMBL:BAG65501.1}.
SQ   SEQUENCE   1218 AA;  138109 MW;  AA47B51C2BB5359E CRC64;
     MSWSPDQELV LLATGQQTLI MMTKDFEPIL EQQIHQDDFG ESKFITVGWG RKETQFHGSE
     GRQAAFQMQM HESALPWDDH RPQVTWRGDG QFFAVSVVCP ETGARKVRVW NREFALQSTS
     EPVAGLGPAL AWKPSGSLIA STQDKPNQQD IVFFEKNGLL HGHFTLPFLK DEVKVNDLLW
     NADSSVLAVW PEDLQREESS IPKTCVQLWT VGNYHWYLKQ SLSFSTCGKS KIVSLMWDPV
     TPYRLHVLCQ GWHYLAYDWH WTTDRSVGDN SSDLSNVAVI DGNRVLVTVF RQTVVPPPMC
     TYQLLFPHPV NQVTFLAHPQ KSNDLAVLDA SNQISVYKCG DCPSADPTVK LGAVGGSGFK
     VCLRTPHLEK RYKIQFENNE DQDVNPLKLG LLTWIEEDVF LAVSHSEFSP RSVIHHLTAA
     SSEMDEEHGQ LNVSSSAAVD GVIISLCCNS KTKSVVLQLA DGQIFKYLWE SPSLAIKPWK
     NSGGFPVRFP YPCTQTELAM IGEEECVLGL TDRCRFFIND IEVASNITSF AVYDEFLLLT
     THSHTCQCFC LRDASFKTLQ AGLSSNHVSH GEVLRKVERG SRIVTVVPQD TKLVLQMPRG
     NLEVVHHRAL VLAQIRKWLD KLMFKEAFEC MRKLRINLNL IYDHNPKVFL GNVETFIKQI
     DSVNHINLFF TELKEEDVTK TMYPAPVTSS VYLSRDPDGN KIDLVCDAMR AVMESINPHK
     YCLSILTSHV KKTTPELEIV LQKVHELQGN APSDPDAVSA EEALKYLLHL VDVNELYDHS
     LGTYDFDLVL MVAEKSQKDP KEYLPFLNTL KKMETNYQRF TIDKYLKRYE KAIGHLSKCG
     PEYFPECLNL IKDKNLYNEA LKLYSPSSQQ YQDISIAYGE HLMQEHMYEP AGLMFARCGA
     HEKALSAFLT CGNWKQALCV AAQLNFTKDQ LVGLGRTLAG KLVEQRKHID AAMVLEECAQ
     DYEEAVLLLL EGAAWEEALR LVYKYNRLDI IETNVKPSIL EAQKNYMAFL DSQTATFSRH
     KKRLLVVREL KEQAQQAGLD DEVPHGQESD LFSETSSVVS GSEMSGKYSH SNSRISARSS
     KNRRKAERKK HSLKEGSPLE DLALLEALSE VVQNTENLKD EVYHILKVLF LFEFDEQGRE
     LQKAFEDTLQ LMERSLPEIW TLTYQQNSAT PVLGPNSTAN SIMASYQQQK TSVPVLDAEL
     FIPPKINRRT QWKLSLLD
//
ID   F5H2T0_HUMAN            Unreviewed;       983 AA.
AC   F5H2T0;
DT   28-JUN-2011, integrated into UniProtKB/TrEMBL.
DT   28-JUN-2011, sequence version 1.
DT   23-MAY-2018, entry version 59.
DE   SubName: Full=Elongator complex protein 1 {ECO:0000313|Ensembl:ENSP00000439367};
GN   Name=ELP1 {ECO:0000313|Ensembl:ENSP00000439367};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000439367, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000439367, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000439367}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [6] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL354797; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359692; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001317678.1; NM_001330749.1.
DR   UniGene; Hs.494738; -.
DR   ProteinModelPortal; F5H2T0; -.
DR   MaxQB; F5H2T0; -.
DR   PeptideAtlas; F5H2T0; -.
DR   PRIDE; F5H2T0; -.
DR   Ensembl; ENST00000537196; ENSP00000439367; ENSG00000070061.
DR   GeneID; 8518; -.
DR   UCSC; uc010mtq.4; human.
DR   CTD; 8518; -.
DR   EuPathDB; HostDB:ENSG00000070061.14; -.
DR   HGNC; HGNC:5959; ELP1.
DR   OpenTargets; ENSG00000070061; -.
DR   eggNOG; KOG1920; Eukaryota.
DR   eggNOG; COG5290; LUCA.
DR   GeneTree; ENSGT00390000013344; -.
DR   ChiTaRS; IKBKAP; human.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000070061; -.
DR   ExpressionAtlas; F5H2T0; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0033588; C:Elongator holoenzyme complex; IEA:InterPro.
DR   GO; GO:0002098; P:tRNA wobble uridine modification; IEA:InterPro.
DR   InterPro; IPR006849; Elp1.
DR   PANTHER; PTHR12747; PTHR12747; 1.
DR   Pfam; PF04762; IKI3; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:F5H2T0,
KW   ECO:0000213|MaxQB:F5H2T0, ECO:0000213|PeptideAtlas:F5H2T0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   983 AA;  111475 MW;  98D35E248D5C2336 CRC64;
     MWDPVTPYRL HVLCQGWHYL AYDWHWTTDR SVGDNSSDLS NVAVIDGNRV LVTVFRQTVV
     PPPMCTYQLL FPHPVNQVTF LAHPQKSNDL AVLDASNQIS VYKCGDCPSA DPTVKLGAVG
     GSGFKVCLRT PHLEKRYKIQ FENNEDQDVN PLKLGLLTWI EEDVFLAVSH SEFSPRSVIH
     HLTAASSEMD EEHGQLNVSS SAAVDGVIIS LCCNSKTKSV VLQLADGQIF KYLWESPSLA
     IKPWKNSGGF PVRFPYPCTQ TELAMIGEEE CVLGLTDRCR FFINDIEVAS NITSFAVYDE
     FLLLTTHSHT CQCFCLRDAS FKTLQAGLSS NHVSHGEVLR KVERGSRIVT VVPQDTKLVL
     QMPRGNLEVV HHRALVLAQI RKWLDKLMFK EAFECMRKLR INLNLIYDHN PKVFLGNVET
     FIKQIDSVNH INLFFTELKE EDVTKTMYPA PVTSSVYLSR DPDGNKIDLV CDAMRAVMES
     INPHKYCLSI LTSHVKKTTP ELEIVLQKVH ELQGNAPSDP DAVSAEEALK YLLHLVDVNE
     LYDHSLGTYD FDLVLMVAEK SQKDPKEYLP FLNTLKKMET NYQRFTIDKY LKRYEKAIGH
     LSKCGPEYFP ECLNLIKDKN LYNEALKLYS PSSQQYQDIS IAYGEHLMQE HMYEPAGLMF
     ARCGAHEKAL SAFLTCGNWK QALCVAAQLN FTKDQLVGLG RTLAGKLVEQ RKHIDAAMVL
     EECAQDYEEA VLLLLEGAAW EEALRLVYKY NRLDIIETNV KPSILEAQKN YMAFLDSQTA
     TFSRHKKRLL VVRELKEQAQ QAGLDDEVPH GQESDLFSET SSVVSGSEMS GKYSHSNSRI
     SARSSKNRRK AERKKHSLKE GSPLEDLALL EALSEVVQNT ENLKDEVYHI LKVLFLFEFD
     EQGRELQKAF EDTLQLMERS LPEIWTLTYQ QNSATPVLGP NSTANSIMAS YQQQKTSVPV
     LDAELFIPPK INRRTQWKLS LLD
//
ID   ELP1_HUMAN              Reviewed;        1332 AA.
AC   O95163; Q5JSV2; Q9H327; Q9UG87;
DT   20-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 3.
DT   23-MAY-2018, entry version 168.
DE   RecName: Full=Elongator complex protein 1;
DE            Short=ELP1;
DE   AltName: Full=IkappaB kinase complex-associated protein;
DE            Short=IKK complex-associated protein;
DE   AltName: Full=p150;
GN   Name=ELP1 {ECO:0000312|HGNC:HGNC:5959}; Synonyms=IKAP, IKBKAP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND VARIANT
RP   LYS-312.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=9751059; DOI=10.1038/26254;
RA   Cohen L., Henzel W.J., Baeuerle P.A.;
RT   "IKAP is a scaffold protein of the IkappaB kinase complex.";
RL   Nature 395:292-296(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT HSAN3 PRO-696, AND VARIANT
RP   SER-1072.
RX   PubMed=11179008; DOI=10.1086/318810;
RA   Slaugenhaupt S.A., Blumenfeld A., Gill S.P., Leyne M., Mull J.,
RA   Cuajungco M.P., Liebert C.B., Chadwick B.P., Idelson M., Reznik L.,
RA   Robbins C.M., Makalowska I., Brownstein M.J., Krappmann D.,
RA   Scheidereit C., Maayan C., Axelrod F.B., Gusella J.F.;
RT   "Tissue-specific expression of a splicing mutation in the IKBKAP gene
RT   causes familial dysautonomia.";
RL   Am. J. Hum. Genet. 68:598-605(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 961-1332, AND VARIANTS
RP   SER-1072 AND LEU-1158.
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   IDENTIFICATION IN THE RNA POLYMERASE II ELONGATOR COMPLEX, SUBCELLULAR
RP   LOCATION, FUNCTION OF THE RNA POLYMERASE II ELONGATOR COMPLEX, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=11714725; DOI=10.1074/jbc.M110445200;
RA   Hawkes N.A., Otero G., Winkler G.S., Marshall N., Dahmus M.E.,
RA   Krappmann D., Scheidereit C., Thomas C.L., Schiavo G.,
RA   Erdjument-Bromage H., Tempst P., Svejstrup J.Q.;
RT   "Purification and characterization of the human elongator complex.";
RL   J. Biol. Chem. 277:3047-3052(2002).
RN   [8]
RP   IDENTIFICATION IN THE RNA POLYMERASE II ELONGATOR CORE COMPLEX,
RP   INTERACTION WITH ELP3, SUBCELLULAR LOCATION, FUNCTION OF THE RNA
RP   POLYMERASE II ELONGATOR COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=11818576; DOI=10.1073/pnas.251672198;
RA   Kim J.H., Lane W.S., Reinberg D.;
RT   "Human Elongator facilitates RNA polymerase II transcription through
RT   chromatin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:1241-1246(2002).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-867; SER-1171 AND
RP   SER-1174, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-867, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION IN THE RNA POLYMERASE II ELONGATOR COMPLEX, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=22854966; DOI=10.1074/jbc.M112.402727;
RA   Close P., Gillard M., Ladang A., Jiang Z., Papuga J., Hawkes N.,
RA   Nguyen L., Chapelle J.P., Bouillenne F., Svejstrup J., Fillet M.,
RA   Chariot A.;
RT   "DERP6 (ELP5) and C3ORF75 (ELP6) regulate tumorigenicity and migration
RT   of melanoma cells as subunits of Elongator.";
RL   J. Biol. Chem. 287:32535-32545(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-471; SER-804 AND
RP   SER-867, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   VARIANT HSAN3 PRO-696, AND EFFECT ON PHOSPHORYLATION.
RX   PubMed=11179021; DOI=10.1086/318808;
RA   Anderson S.L., Coli R., Daly I.W., Kichula E.A., Rork M.J.,
RA   Volpi S.A., Ekstein J., Rubin B.Y.;
RT   "Familial dysautonomia is caused by mutations of the IKAP gene.";
RL   Am. J. Hum. Genet. 68:753-758(2001).
CC   -!- FUNCTION: May act as a scaffold protein that may assemble active
CC       IKK-MAP3K14 complexes (IKKA, IKKB and MAP3K14/NIK).
CC   -!- FUNCTION: Acts as subunit of the RNA polymerase II elongator
CC       complex, which is a histone acetyltransferase component of the RNA
CC       polymerase II (Pol II) holoenzyme and is involved in
CC       transcriptional elongation. Elongator may play a role in chromatin
CC       remodeling and is involved in acetylation of histones H3 and
CC       probably H4. Involved in cell migration. Involved in neurogenesis
CC       (By similarity). Regulates the migration and branching of
CC       projection neurons in the developing cerebral cortex, through a
CC       process depending on alpha-tubulin acetylation (By similarity).
CC       {ECO:0000250|UniProtKB:Q7TT37, ECO:0000269|PubMed:11714725,
CC       ECO:0000269|PubMed:11818576}.
CC   -!- SUBUNIT: Interacts preferentially with MAP3K14/NIK followed by
CC       IKK-alpha and IKK-beta. Component of the RNA polymerase II
CC       elongator complex (Elongator), which consists of ELP1, STIP1/ELP2,
CC       ELP3, ELP4, ELP5 and ELP6. Elongator associates with the C-
CC       terminal domain (CTD) of Pol II largest subunit. Interacts with
CC       ELP3. {ECO:0000269|PubMed:11714725, ECO:0000269|PubMed:11818576,
CC       ECO:0000269|PubMed:22854966}.
CC   -!- INTERACTION:
CC       Q9H9T3:ELP3; NbExp=8; IntAct=EBI-347559, EBI-355217;
CC       P42858:HTT; NbExp=4; IntAct=EBI-347559, EBI-466029;
CC       Q15306:IRF4; NbExp=2; IntAct=EBI-347559, EBI-751345;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11714725,
CC       ECO:0000269|PubMed:11818576, ECO:0000269|PubMed:22854966}. Nucleus
CC       {ECO:0000269|PubMed:11714725, ECO:0000269|PubMed:11818576}.
CC   -!- DISEASE: Neuropathy, hereditary sensory and autonomic, 3 (HSAN3)
CC       [MIM:223900]: A form of hereditary sensory and autonomic
CC       neuropathy, a genetically and clinically heterogeneous group of
CC       disorders characterized by degeneration of dorsal root and
CC       autonomic ganglion cells, and by sensory and/or autonomic
CC       abnormalities. HSAN3 patients manifest a variety of symptoms such
CC       as alacrima, decreased taste, decreased sensitivity to pain and
CC       temperature, vasomotor instability, hypoactive or absent deep
CC       tendon reflexes, vomiting crises, and gastrointestinal
CC       dysfunction. {ECO:0000269|PubMed:11179008,
CC       ECO:0000269|PubMed:11179021}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ELP1/IKA1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB43219.1; Type=Frameshift; Positions=1286; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF044195; AAC64258.1; -; mRNA.
DR   EMBL; AF153419; AAG43369.1; -; mRNA.
DR   EMBL; AK001641; BAG50955.1; -; mRNA.
DR   EMBL; AK289962; BAF82651.1; -; mRNA.
DR   EMBL; AL354797; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359692; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471105; EAW59027.1; -; Genomic_DNA.
DR   EMBL; AL049945; CAB43219.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS6773.1; -.
DR   RefSeq; NP_001305289.1; NM_001318360.1.
DR   RefSeq; NP_003631.2; NM_003640.4.
DR   UniGene; Hs.494738; -.
DR   PDB; 5CQR; X-ray; 3.02 A; A=715-1332.
DR   PDBsum; 5CQR; -.
DR   ProteinModelPortal; O95163; -.
DR   SMR; O95163; -.
DR   BioGrid; 114090; 74.
DR   CORUM; O95163; -.
DR   DIP; DIP-27579N; -.
DR   IntAct; O95163; 42.
DR   MINT; O95163; -.
DR   STRING; 9606.ENSP00000363779; -.
DR   iPTMnet; O95163; -.
DR   PhosphoSitePlus; O95163; -.
DR   BioMuta; IKBKAP; -.
DR   EPD; O95163; -.
DR   MaxQB; O95163; -.
DR   PaxDb; O95163; -.
DR   PeptideAtlas; O95163; -.
DR   PRIDE; O95163; -.
DR   Ensembl; ENST00000374647; ENSP00000363779; ENSG00000070061.
DR   GeneID; 8518; -.
DR   KEGG; hsa:8518; -.
DR   UCSC; uc004bdm.5; human.
DR   CTD; 8518; -.
DR   DisGeNET; 8518; -.
DR   EuPathDB; HostDB:ENSG00000070061.14; -.
DR   GeneCards; ELP1; -.
DR   GeneReviews; IKBKAP; -.
DR   HGNC; HGNC:5959; ELP1.
DR   HPA; CAB021340; -.
DR   HPA; HPA049677; -.
DR   HPA; HPA050686; -.
DR   MalaCards; ELP1; -.
DR   MIM; 223900; phenotype.
DR   MIM; 603722; gene.
DR   neXtProt; NX_O95163; -.
DR   OpenTargets; ENSG00000070061; -.
DR   Orphanet; 1764; Familial dysautonomia.
DR   PharmGKB; PA29775; -.
DR   eggNOG; KOG1920; Eukaryota.
DR   eggNOG; COG5290; LUCA.
DR   GeneTree; ENSGT00390000013344; -.
DR   HOVERGEN; HBG019038; -.
DR   InParanoid; O95163; -.
DR   KO; K11373; -.
DR   OMA; KVRVWNR; -.
DR   OrthoDB; EOG091G01A5; -.
DR   PhylomeDB; O95163; -.
DR   TreeFam; TF300402; -.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   SignaLink; O95163; -.
DR   SIGNOR; O95163; -.
DR   ChiTaRS; IKBKAP; human.
DR   GenomeRNAi; 8518; -.
DR   PRO; PR:O95163; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000070061; -.
DR   CleanEx; HS_IKBKAP; -.
DR   ExpressionAtlas; O95163; baseline and differential.
DR   Genevisible; O95163; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0033588; C:Elongator holoenzyme complex; IDA:UniProtKB.
DR   GO; GO:0000123; C:histone acetyltransferase complex; IDA:BHF-UCL.
DR   GO; GO:0005730; C:nucleolus; IDA:HGNC.
DR   GO; GO:0008023; C:transcription elongation factor complex; IDA:UniProtKB.
DR   GO; GO:0008607; F:phosphorylase kinase regulator activity; IDA:UniProtKB.
DR   GO; GO:0004871; F:signal transducer activity; TAS:ProtInc.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0065003; P:protein-containing complex assembly; TAS:ProtInc.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:BHF-UCL.
DR   GO; GO:0002098; P:tRNA wobble uridine modification; IEA:InterPro.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR006849; Elp1.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   PANTHER; PTHR12747; PTHR12747; 1.
DR   Pfam; PF04762; IKI3; 1.
DR   PIRSF; PIRSF017233; IKAP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Disease mutation; Neurodegeneration; Neuropathy; Nucleus;
KW   Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1   1332       Elongator complex protein 1.
FT                                /FTId=PRO_0000084177.
FT   MOD_RES     471    471       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     804    804       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     867    867       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1171   1171       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1174   1174       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VARIANT      70     70       R -> C (in dbSNP:rs3737311).
FT                                /FTId=VAR_047476.
FT   VARIANT     182    182       M -> K (in dbSNP:rs10521092).
FT                                /FTId=VAR_047477.
FT   VARIANT     312    312       E -> K (in dbSNP:rs1140064).
FT                                {ECO:0000269|PubMed:9751059}.
FT                                /FTId=VAR_047478.
FT   VARIANT     525    525       R -> Q (in dbSNP:rs838827).
FT                                /FTId=VAR_047479.
FT   VARIANT     696    696       R -> P (in HSAN3; mild phenotype;
FT                                phosphorylation is reduced;
FT                                dbSNP:rs137853022).
FT                                {ECO:0000269|PubMed:11179008,
FT                                ECO:0000269|PubMed:11179021}.
FT                                /FTId=VAR_011327.
FT   VARIANT     765    765       G -> E (in dbSNP:rs2230792).
FT                                /FTId=VAR_047480.
FT   VARIANT     816    816       I -> L (in dbSNP:rs2230793).
FT                                /FTId=VAR_047481.
FT   VARIANT     830    830       I -> M (in dbSNP:rs2230794).
FT                                /FTId=VAR_047482.
FT   VARIANT     848    848       T -> N (in dbSNP:rs10979599).
FT                                /FTId=VAR_047483.
FT   VARIANT     952    952       K -> I (in dbSNP:rs2230798).
FT                                /FTId=VAR_047484.
FT   VARIANT    1013   1013       G -> S (in dbSNP:rs2230795).
FT                                /FTId=VAR_047485.
FT   VARIANT    1072   1072       C -> S (in dbSNP:rs3204145).
FT                                {ECO:0000269|PubMed:11179008,
FT                                ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_047486.
FT   VARIANT    1158   1158       P -> L (in dbSNP:rs1538660).
FT                                {ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_047487.
FT   CONFLICT    304    304       W -> R (in Ref. 1; AAC64258).
FT                                {ECO:0000305}.
FT   CONFLICT    754    754       L -> P (in Ref. 1; AAC64258).
FT                                {ECO:0000305}.
FT   CONFLICT    961    961       C -> G (in Ref. 6; CAB43219).
FT                                {ECO:0000305}.
FT   CONFLICT   1320   1320       I -> V (in Ref. 6; CAB43219).
FT                                {ECO:0000305}.
FT   HELIX       723    734       {ECO:0000244|PDB:5CQR}.
FT   HELIX       738    747       {ECO:0000244|PDB:5CQR}.
FT   HELIX       754    757       {ECO:0000244|PDB:5CQR}.
FT   HELIX       760    763       {ECO:0000244|PDB:5CQR}.
FT   HELIX       767    773       {ECO:0000244|PDB:5CQR}.
FT   HELIX       777    786       {ECO:0000244|PDB:5CQR}.
FT   TURN        792    796       {ECO:0000244|PDB:5CQR}.
FT   HELIX       815    830       {ECO:0000244|PDB:5CQR}.
FT   TURN        832    835       {ECO:0000244|PDB:5CQR}.
FT   HELIX       836    844       {ECO:0000244|PDB:5CQR}.
FT   STRAND      846    848       {ECO:0000244|PDB:5CQR}.
FT   HELIX       851    860       {ECO:0000244|PDB:5CQR}.
FT   HELIX       868    870       {ECO:0000244|PDB:5CQR}.
FT   HELIX       874    882       {ECO:0000244|PDB:5CQR}.
FT   HELIX       887    894       {ECO:0000244|PDB:5CQR}.
FT   TURN        895    897       {ECO:0000244|PDB:5CQR}.
FT   HELIX       900    908       {ECO:0000244|PDB:5CQR}.
FT   HELIX       918    924       {ECO:0000244|PDB:5CQR}.
FT   HELIX       929    939       {ECO:0000244|PDB:5CQR}.
FT   HELIX       943    950       {ECO:0000244|PDB:5CQR}.
FT   STRAND      955    957       {ECO:0000244|PDB:5CQR}.
FT   HELIX       958    967       {ECO:0000244|PDB:5CQR}.
FT   HELIX       971    975       {ECO:0000244|PDB:5CQR}.
FT   HELIX       983    997       {ECO:0000244|PDB:5CQR}.
FT   TURN        998   1000       {ECO:0000244|PDB:5CQR}.
FT   HELIX      1002   1011       {ECO:0000244|PDB:5CQR}.
FT   HELIX      1015   1024       {ECO:0000244|PDB:5CQR}.
FT   HELIX      1028   1036       {ECO:0000244|PDB:5CQR}.
FT   TURN       1037   1039       {ECO:0000244|PDB:5CQR}.
FT   HELIX      1042   1057       {ECO:0000244|PDB:5CQR}.
FT   TURN       1058   1060       {ECO:0000244|PDB:5CQR}.
FT   HELIX      1062   1072       {ECO:0000244|PDB:5CQR}.
FT   HELIX      1076   1085       {ECO:0000244|PDB:5CQR}.
FT   HELIX      1089   1097       {ECO:0000244|PDB:5CQR}.
FT   TURN       1098   1100       {ECO:0000244|PDB:5CQR}.
FT   HELIX      1103   1107       {ECO:0000244|PDB:5CQR}.
FT   HELIX      1109   1126       {ECO:0000244|PDB:5CQR}.
FT   TURN       1127   1130       {ECO:0000244|PDB:5CQR}.
FT   HELIX      1233   1245       {ECO:0000244|PDB:5CQR}.
FT   HELIX      1249   1264       {ECO:0000244|PDB:5CQR}.
SQ   SEQUENCE   1332 AA;  150254 MW;  5BAC580433CC8641 CRC64;
     MRNLKLFRTL EFRDIQGPGN PQCFSLRTEQ GTVLIGSEHG LIEVDPVSRE VKNEVSLVAE
     GFLPEDGSGR IVGVQDLLDQ ESVCVATASG DVILCSLSTQ QLECVGSVAS GISVMSWSPD
     QELVLLATGQ QTLIMMTKDF EPILEQQIHQ DDFGESKFIT VGWGRKETQF HGSEGRQAAF
     QMQMHESALP WDDHRPQVTW RGDGQFFAVS VVCPETGARK VRVWNREFAL QSTSEPVAGL
     GPALAWKPSG SLIASTQDKP NQQDIVFFEK NGLLHGHFTL PFLKDEVKVN DLLWNADSSV
     LAVWLEDLQR EESSIPKTCV QLWTVGNYHW YLKQSLSFST CGKSKIVSLM WDPVTPYRLH
     VLCQGWHYLA YDWHWTTDRS VGDNSSDLSN VAVIDGNRVL VTVFRQTVVP PPMCTYQLLF
     PHPVNQVTFL AHPQKSNDLA VLDASNQISV YKCGDCPSAD PTVKLGAVGG SGFKVCLRTP
     HLEKRYKIQF ENNEDQDVNP LKLGLLTWIE EDVFLAVSHS EFSPRSVIHH LTAASSEMDE
     EHGQLNVSSS AAVDGVIISL CCNSKTKSVV LQLADGQIFK YLWESPSLAI KPWKNSGGFP
     VRFPYPCTQT ELAMIGEEEC VLGLTDRCRF FINDIEVASN ITSFAVYDEF LLLTTHSHTC
     QCFCLRDASF KTLQAGLSSN HVSHGEVLRK VERGSRIVTV VPQDTKLVLQ MPRGNLEVVH
     HRALVLAQIR KWLDKLMFKE AFECMRKLRI NLNLIYDHNP KVFLGNVETF IKQIDSVNHI
     NLFFTELKEE DVTKTMYPAP VTSSVYLSRD PDGNKIDLVC DAMRAVMESI NPHKYCLSIL
     TSHVKKTTPE LEIVLQKVHE LQGNAPSDPD AVSAEEALKY LLHLVDVNEL YDHSLGTYDF
     DLVLMVAEKS QKDPKEYLPF LNTLKKMETN YQRFTIDKYL KRYEKAIGHL SKCGPEYFPE
     CLNLIKDKNL YNEALKLYSP SSQQYQDISI AYGEHLMQEH MYEPAGLMFA RCGAHEKALS
     AFLTCGNWKQ ALCVAAQLNF TKDQLVGLGR TLAGKLVEQR KHIDAAMVLE ECAQDYEEAV
     LLLLEGAAWE EALRLVYKYN RLDIIETNVK PSILEAQKNY MAFLDSQTAT FSRHKKRLLV
     VRELKEQAQQ AGLDDEVPHG QESDLFSETS SVVSGSEMSG KYSHSNSRIS ARSSKNRRKA
     ERKKHSLKEG SPLEDLALLE ALSEVVQNTE NLKDEVYHIL KVLFLFEFDE QGRELQKAFE
     DTLQLMERSL PEIWTLTYQQ NSATPVLGPN STANSIMASY QQQKTSVPVL DAELFIPPKI
     NRRTQWKLSL LD
//
ID   Q4LE38_HUMAN            Unreviewed;      1342 AA.
AC   Q4LE38;
DT   02-AUG-2005, integrated into UniProtKB/TrEMBL.
DT   02-AUG-2005, sequence version 1.
DT   28-FEB-2018, entry version 60.
DE   SubName: Full=IKBKAP variant protein {ECO:0000313|EMBL:BAE06115.1};
DE   Flags: Fragment;
GN   Name=IKBKAP variant protein {ECO:0000313|EMBL:BAE06115.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAE06115.1};
RN   [1] {ECO:0000313|EMBL:BAE06115.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAE06115.1};
RA   Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M.,
RA   Ohara R., Okazaki N., Koga H., Nagase T., Ohara O.;
RT   "Preparation of a set of expression-ready clones of mammalian long
RT   cDNAs encoding large proteins by the ORF trap cloning method.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB210033; BAE06115.1; -; mRNA.
DR   RefSeq; NP_003631.2; NM_003640.4.
DR   UniGene; Hs.494738; -.
DR   PRIDE; Q4LE38; -.
DR   GeneID; 8518; -.
DR   KEGG; hsa:8518; -.
DR   CTD; 8518; -.
DR   eggNOG; KOG1920; Eukaryota.
DR   eggNOG; COG5290; LUCA.
DR   HOGENOM; HOG000007712; -.
DR   HOVERGEN; HBG019038; -.
DR   KO; K11373; -.
DR   ChiTaRS; IKBKAP; human.
DR   GenomeRNAi; 8518; -.
DR   GO; GO:0033588; C:Elongator holoenzyme complex; IEA:InterPro.
DR   GO; GO:0002098; P:tRNA wobble uridine modification; IEA:InterPro.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR006849; Elp1.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   PANTHER; PTHR12747; PTHR12747; 1.
DR   Pfam; PF04762; IKI3; 1.
DR   PIRSF; PIRSF017233; IKAP; 1.
PE   2: Evidence at transcript level;
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAE06115.1}.
SQ   SEQUENCE   1342 AA;  151456 MW;  58D6B7FB9A77110E CRC64;
     LYLSRGNHFI MRNLKLFRTL EFRDIQGPGN PQCFSLRTEQ GTVLIGSEHG LIEVDPVSRE
     VKNEVSLVAE GFLPEDGSGR IVGVQDLLDQ ESVCVATASG DVILCSLSTQ QLECVGSVAS
     GISVMSWSPD QELVLLATGQ QTLIMMTKDF EPILEQQIHQ DDFGESKFIT VGWGRKETQF
     HGSEGRQAAF QMQMHESALP WDDHRPQVTW RGDGQFFAVS VVCPETGARK VRVWNREFAL
     QSTSEPVAGL GPALAWKPSG SLIASTQDKP NQQDIVFFEK NGLLHGHFTL PFLKDEVKVN
     DLLWNADSSV LAVWLEDLQR EESSIPKTCV QLWTVGNYHW YLKQSLSFST CGKSKIVSLM
     WDPVTPYRLH VLCQGWHYLA YDWHWTTDRS VGDNSSDLSN VAVIDGNRVL VTVFRQTVVP
     PPMCTYQLLF PHPVNQVTFL AHPQKSNDLA VLDASNQISV YKCGDCPSAD PTVKLGAVGG
     SGFKVCLRTP HLEKRYKIQF ENNEDQDVNP LKLGLLTWIE EDVFLAVSHS EFSPRSVIHH
     LTAASSEMDE EHGQLNVSSS AAVDGVIISL CCNSKTKSVV LQLADGQIFK YLWESPSLAI
     KPWKNSGGFP VRFPYPCTQT ELAMIGEEEC VLGLTDRCRF FINDIEVASN ITSFAVYDEF
     LLLTTHSHTC QCFCLRDASF KTLQAGLSSN HVSHGEVLRK VERGSRIVTV VPQDTKLVLQ
     MPRGNLEVVH HRALVLAQIR KWLDKLMFKE AFECMRKLRI NLNLIYDHNP KVFLGNVETF
     IKQIDSVNHI NLFFTELKEE DVTKTMYPAP VTSSVYLSRD PDGNKIDLVC DAMRAVMESI
     NPHKYCLSIL TSHVKKTTPE LEIVLQKVHE LQGNAPSDPD AVSAEEALKY LLHLVDVNEL
     YDHSLGTYDF DLVLMVAEKS QKDPKEYLPF LNTLKKMETN YQRFTIDKYL KRYEKAIGHL
     SKCGPEYFPE CLNLIKDKNL YNEALKLYSP SSQQYQDISI AYGEHLMQEH MYEPAGLMFA
     RCGAHEKALS AFLTCGNWKQ ALCVAAQLNF TKDQLVGLGR TLAGKLVEQR KHIDAAMVLE
     ECAQDYEEAV LLLLEGAAWE EALRLVYKYN RLDIIETNVK PSILEAQKNY MAFLDSQTAT
     FSRHKKRLLV VRELKEQAQQ AGLDDEVPHG QESDLFSETS SVVSGSEMSG KYSHSNSRIS
     ARSSKNRRKA ERKKHSLKEG SPLEDLALLE ALSEVVQNTE NLKDEVYHIL KVLFLFEFDE
     QGRELQKAFE DTLQLMERSL PEIWTLTYQQ NSATPVLGPN STANSIMASY QQQKTSVPVL
     DAELFIPPKI NRRTQWKLSL LD
//
ID   Q8N516_HUMAN            Unreviewed;      1332 AA.
AC   Q8N516;
DT   01-OCT-2002, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2002, sequence version 1.
DT   28-FEB-2018, entry version 73.
DE   RecName: Full=Elongator complex protein 1 {ECO:0000256|PIRNR:PIRNR017233};
GN   Name=IKBKAP {ECO:0000313|EMBL:AAH33094.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH33094.1};
RN   [1] {ECO:0000313|EMBL:AAH33094.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney {ECO:0000313|EMBL:AAH33094.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Acts as subunit of the RNA polymerase II elongator
CC       complex, which is a histone acetyltransferase component of the RNA
CC       polymerase II (Pol II) holoenzyme and is involved in
CC       transcriptional elongation. {ECO:0000256|PIRNR:PIRNR017233}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|PIRNR:PIRNR017233}.
CC       Nucleus {ECO:0000256|PIRNR:PIRNR017233}.
CC   -!- SIMILARITY: Belongs to the ELP1/IKA1 family.
CC       {ECO:0000256|PIRNR:PIRNR017233}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC033094; AAH33094.1; -; mRNA.
DR   RefSeq; NP_003631.2; NM_003640.4.
DR   UniGene; Hs.494738; -.
DR   ProteinModelPortal; Q8N516; -.
DR   PeptideAtlas; Q8N516; -.
DR   PRIDE; Q8N516; -.
DR   GeneID; 8518; -.
DR   KEGG; hsa:8518; -.
DR   CTD; 8518; -.
DR   PharmGKB; PA29775; -.
DR   eggNOG; KOG1920; Eukaryota.
DR   eggNOG; COG5290; LUCA.
DR   HOVERGEN; HBG019038; -.
DR   KO; K11373; -.
DR   ChiTaRS; IKBKAP; human.
DR   GenomeRNAi; 8518; -.
DR   Genevisible; Q8N516; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0033588; C:Elongator holoenzyme complex; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0002098; P:tRNA wobble uridine modification; IEA:InterPro.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR006849; Elp1.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   PANTHER; PTHR12747; PTHR12747; 1.
DR   Pfam; PF04762; IKI3; 1.
DR   PIRSF; PIRSF017233; IKAP; 1.
PE   2: Evidence at transcript level;
KW   Cytoplasm {ECO:0000256|PIRNR:PIRNR017233};
KW   Kinase {ECO:0000313|EMBL:AAH33094.1};
KW   Nucleus {ECO:0000256|PIRNR:PIRNR017233};
KW   Transcription {ECO:0000256|PIRNR:PIRNR017233};
KW   Transcription regulation {ECO:0000256|PIRNR:PIRNR017233};
KW   Transferase {ECO:0000313|EMBL:AAH33094.1}.
SQ   SEQUENCE   1332 AA;  150223 MW;  55509840671D60CC CRC64;
     MRNLKLFRTL EFRDIQGPGN PQCFSLRTEQ GTVLIGSEHG LIEVDPVSRE VKNEVSLVAE
     GFLPEDGSGR IVGVQDLLDQ ESVCVATASG DVILCSLSTQ QLECVGSVAS GISVMSWSPD
     QELVLLATGQ QTLIMMTKDF EPILEQQIHQ DDFGESKFIT VGWGRKETQF HGSEGRQAAF
     QMQMHESALP WDDHRPQVTW RGDGQFFAVS VVCPETGARK VRVWNREFAL QSTSEPVAGL
     GPALAWKPSG GLIASTQDKP NQQDIVFFEK NGLLHGHFTL PFLKDEVKVN DLLWNADSSV
     LAVWLEDLQR EKSSIPKTCV QLWTVGNYHW YLKQSLSFST CGKSKIVSLM WDPVTPYRLH
     VLCQGWHYLA YDWHWTTDRS VGDNSSDLSN VAVIDGNRVL VTVFRQTVVP PPMCTYQLLF
     PHPVNQVTFL AHPQKSNDLA VLDASNQISV YKCGDCPSAD PTVKLGAVGG SGFKVCLRTP
     HLEKRYKIQF ENNEDQDVNP LKLGLLTWIE EDVFLAVSHS EFSPRSVIHH LTAASSEMDE
     EHGQLNVSSS AAVDGVIISL CCNSKTKSVV LQLADGQIFK YLWESPSLAI KPWKNSGGFP
     VRFPYPCTQT ELAMIGEEEC VLGLTDRCRF FINDIEVASN ITSFAVYDEF LLLTTHSHTC
     QCFCLRDASF KTLQAGLSSN HVSHGEVLRK VERGSRIVTV VPQDTKLVLQ MPRGNLEVVH
     HRALVLAQIR KWLDKLMFKE AFECMRKLRI NLNLIYDHNP KVFLGNVETF IKQIDSVNHI
     NLFFTELKEE DVTKTMYPAP VTSSVYLSRD PDGNKIDLVC DAMRAVMESI NPHKYCLSIL
     TSHVKKTTPE LEIVLQKVHE LQGNAPSDPD AVSAEEALKY LLHLVDVNEL YDHSLGTYDF
     DLVLMVAEKS QKDPKEYLPF LNTLKKMETN YQRFTIDKYL KRYEKAIGHL SKCGPEYFPE
     CLNLIKDKNL YNEALKLYSP SSQQYQDISI AYGEHLMQEH MYEPAGLMFA RCGAHEKALS
     AFLTCGNWKQ ALCVAAQLNF TKDQLVGLGR TLAGKLVEQR KHIDAAMVLE ECAQDYEEAV
     LLLLEGAAWE EALRLVYKYN RLDIIETNVK PSILEAQKNY MAFLDSQTAT FSRHKKRLLV
     VRELKEQAQQ AGLDDEVPHG QESDLFSETS SVVSGSEMSG KYSHSNSRIS ARSSKNRRKA
     ERKKHSLKEG SPLEDLALLE ALSEVVQNTE NLKDEVYHIL KVLFLFEFDE QGRELQKAFE
     DTLQLMERSL PEIWTLTYQQ NSATPVLGPN STANSIMASY QQQKTSVPVL DAELFIPPKI
     NRRTQWKLSL LD
//
ID   OS9_HUMAN               Reviewed;         667 AA.
AC   Q13438; A6NDD1; A6NFR7; A6NLB2; A8K5Q9; B4DE28; B4DPX1; B4E1I6;
AC   E7ENT8; E7EW91; F8VUH2; G3XA88; O00579; Q6IBL2; Q8IZ58; Q9BW99;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   23-MAY-2018, entry version 160.
DE   RecName: Full=Protein OS-9;
DE   AltName: Full=Amplified in osteosarcoma 9;
DE   Flags: Precursor;
GN   Name=OS9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8634085;
RX   DOI=10.1002/(SICI)1098-2744(199604)15:4<270::AID-MC4>3.0.CO;2-K;
RA   Su Y.A., Hutter C.M., Trent J.M., Meltzer P.S.;
RT   "Complete sequence analysis of a gene (OS-9) ubiquitously expressed in
RT   human tissues and amplified in sarcomas.";
RL   Mol. Carcinog. 15:270-275(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=9498564; DOI=10.1093/oxfordjournals.jbchem.a021880;
RA   Kimura Y., Nakazawa M., Tsuchiya N., Asakawa S., Shimizu N.,
RA   Yamada M.;
RT   "Genomic organization of the OS-9 gene amplified in human sarcomas.";
RL   J. Biochem. 122:1190-1195(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1),
RP   CHARACTERIZATION, AND ALTERNATIVE SPLICING (ISOFORMS 2 AND 3).
RC   TISSUE=Promyelocytic leukemia;
RX   PubMed=9562620; DOI=10.1093/oxfordjournals.jbchem.a022019;
RA   Kimura Y., Nakazawa M., Yamada M.;
RT   "Cloning and characterization of three isoforms of OS-9 cDNA and
RT   expression of the OS-9 gene in various human tumor cell lines.";
RL   J. Biochem. 123:876-882(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 4; 5; 6 AND 8),
RP   AND VARIANT ASN-305.
RC   TISSUE=Brain, Tongue, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 194-667.
RX   PubMed=9192850; DOI=10.1006/geno.1997.4727;
RA   Elkahloun A.G., Krizman D.B., Wang Z., Hofmann T.A., Roe B.A.,
RA   Meltzer P.S.;
RT   "Transcript mapping in a 46-kb sequenced region at the core of 12q13.3
RT   amplification in human cancers.";
RL   Genomics 42:295-301(1997).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=10403379; DOI=10.1016/S0014-5793(99)00700-0;
RA   Nakayama T., Yaoi T., Kuwajima G., Yoshie O., Sakata T.;
RT   "Ca2(+)-dependent interaction of N-copine, a member of the two C2
RT   domain protein family, with OS-9, the product of a gene frequently
RT   amplified in osteosarcoma.";
RL   FEBS Lett. 453:77-80(1999).
RN   [11]
RP   FUNCTION IN TRPV4 MATURATION.
RX   PubMed=17932042; DOI=10.1074/jbc.M703903200;
RA   Wang Y., Fu X., Gaiser S., Koettgen M., Kramer-Zucker A., Walz G.,
RA   Wegierski T.;
RT   "OS-9 regulates the transit and polyubiquitination of TRPV4 in the
RT   endoplasmic reticulum.";
RL   J. Biol. Chem. 282:36561-36570(2007).
RN   [12]
RP   FUNCTION, ALTERNATIVE SPLICING (ISOFORMS 1 AND 2), SUBCELLULAR
RP   LOCATION, DISULFIDE BONDS, GLYCOSYLATION, INDUCTION, AND MUTAGENESIS
RP   OF ARG-188.
RX   PubMed=18417469; DOI=10.1074/jbc.M802272200;
RA   Bernasconi R., Pertel T., Luban J., Molinari M.;
RT   "A dual task for the Xbp1-responsive OS-9 variants in the mammalian
RT   endoplasmic reticulum: inhibiting secretion of misfolded protein
RT   conformers and enhancing their disposal.";
RL   J. Biol. Chem. 283:16446-16454(2008).
RN   [13]
RP   INTERACTION WITH ERLEC1; HSPA5; SEL1L AND SYVN1.
RX   PubMed=18502753; DOI=10.1074/jbc.M709336200;
RA   Hosokawa N., Wada I., Nagasawa K., Moriyama T., Okawa K., Nagata K.;
RT   "Human XTP3-B forms an endoplasmic reticulum quality control scaffold
RT   with the HRD1-SEL1L ubiquitin ligase complex and BiP.";
RL   J. Biol. Chem. 283:20914-20924(2008).
RN   [14]
RP   FUNCTION, INTERACTION WITH HSP90B1; SEL1L AND SYVN1, SUBCELLULAR
RP   LOCATION, GLYCOSYLATION, AND MUTAGENESIS OF ARG-188.
RX   PubMed=18264092; DOI=10.1038/ncb1689;
RA   Christianson J.C., Shaler T.A., Tyler R.E., Kopito R.R.;
RT   "OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L
RT   ubiquitin ligase complex for ERAD.";
RL   Nat. Cell Biol. 10:272-282(2008).
RN   [15]
RP   FUNCTION AS A LECTIN, AND MUTAGENESIS OF ARG-188.
RX   PubMed=19346256; DOI=10.1074/jbc.M809725200;
RA   Hosokawa N., Kamiya Y., Kamiya D., Kato K., Nagata K.;
RT   "Human OS-9, a lectin required for glycoprotein endoplasmic reticulum-
RT   associated degradation, recognizes mannose-trimmed N-glycans.";
RL   J. Biol. Chem. 284:17061-17068(2009).
RN   [16]
RP   FUNCTION IN MISFOLDED GLYCOPROTEIN UBIQUITINATION, SUBCELLULAR
RP   LOCATION, GLYCOSYLATION, INTERACTION WITH DERL2; HRD1 AND SEL1L, AND
RP   INDUCTION BY ER STRESS.
RX   PubMed=19084021; DOI=10.1016/j.jmb.2008.11.045;
RA   Alcock F., Swanton E.;
RT   "Mammalian OS-9 is upregulated in response to endoplasmic reticulum
RT   stress and facilitates ubiquitination of misfolded glycoproteins.";
RL   J. Mol. Biol. 385:1032-1042(2009).
RN   [17]
RP   INTERACTION WITH CREB3.
RX   PubMed=20546900; DOI=10.1016/j.molimm.2010.04.019;
RA   Eleveld-Trancikova D., Sanecka A., van Hout-Kuijer M.A., Looman M.W.,
RA   Hendriks I.A., Jansen B.J., Adema G.J.;
RT   "DC-STAMP interacts with ER-resident transcription factor LUMAN which
RT   becomes activated during DC maturation.";
RL   Mol. Immunol. 47:1963-1973(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 108-229 IN COMPLEX WITH
RP   MANNOPENTAOSE, FUNCTION, AND DISULFIDE BONDS.
RX   PubMed=21172656; DOI=10.1016/j.molcel.2010.11.017;
RA   Satoh T., Chen Y., Hu D., Hanashima S., Yamamoto K., Yamaguchi Y.;
RT   "Structural basis for oligosaccharide recognition of misfolded
RT   glycoproteins by OS-9 in ER-associated degradation.";
RL   Mol. Cell 40:905-916(2010).
CC   -!- FUNCTION: Lectin which functions in endoplasmic reticulum (ER)
CC       quality control and ER-associated degradation (ERAD). May bind
CC       terminally misfolded non-glycosylated proteins as well as
CC       improperly folded glycoproteins, retain them in the ER, and
CC       possibly transfer them to the ubiquitination machinery and promote
CC       their degradation. Possible targets include TRPV4.
CC       {ECO:0000269|PubMed:17932042, ECO:0000269|PubMed:18264092,
CC       ECO:0000269|PubMed:18417469, ECO:0000269|PubMed:19084021,
CC       ECO:0000269|PubMed:19346256, ECO:0000269|PubMed:21172656}.
CC   -!- SUBUNIT: Interacts (via C-terminus) with CPNE6 (via second C2
CC       domain); this interaction occurs in a calcium-dependent manner in
CC       vitro (By similarity). Probably part of the HRD1 ubiquitin ligase
CC       complex composed at least of SYVN1/HRD1 and SEL1L with which it
CC       interacts directly (PubMed:18502753, PubMed:18264092,
CC       PubMed:19084021). Through this complex it may interact with ERLEC1
CC       and HSPA5 (PubMed:18502753). Interacts with DERL2
CC       (PubMed:19084021). Interacts with HSP90B1 (PubMed:18264092).
CC       Interacts with CREB3 (PubMed:20546900). Interacts with SYVN1
CC       (PubMed:18264092). {ECO:0000250|UniProtKB:Q8K2C7,
CC       ECO:0000269|PubMed:18264092, ECO:0000269|PubMed:18502753,
CC       ECO:0000269|PubMed:19084021, ECO:0000269|PubMed:20546900}.
CC   -!- INTERACTION:
CC       Q9GZT9:EGLN1; NbExp=4; IntAct=EBI-725454, EBI-1174818;
CC       Q9H6Z9:EGLN3; NbExp=2; IntAct=EBI-725454, EBI-1175354;
CC       O75460-1:ERN1; NbExp=2; IntAct=EBI-725454, EBI-15600828;
CC       Q16665:HIF1A; NbExp=9; IntAct=EBI-725454, EBI-447269;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000269|PubMed:18264092, ECO:0000269|PubMed:18417469,
CC       ECO:0000269|PubMed:19084021}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=1; Synonyms=OS-9-1;
CC         IsoId=Q13438-1; Sequence=Displayed;
CC         Note=Major isoform.;
CC       Name=2; Synonyms=OS-9-2;
CC         IsoId=Q13438-2; Sequence=VSP_004353;
CC         Note=Major isoform.;
CC       Name=3; Synonyms=OS-9-3;
CC         IsoId=Q13438-3; Sequence=VSP_004352, VSP_004353;
CC       Name=4;
CC         IsoId=Q13438-4; Sequence=VSP_004352;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q13438-5; Sequence=VSP_044701, VSP_044702, VSP_004353;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=Q13438-6; Sequence=VSP_046001, VSP_004353;
CC         Note=No experimental confirmation available.;
CC       Name=7;
CC         IsoId=Q13438-7; Sequence=VSP_044702, VSP_004353;
CC         Note=Gene prediction based on EST data.;
CC       Name=8;
CC         IsoId=Q13438-8; Sequence=VSP_046770, VSP_004352, VSP_004353;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Found as well in all
CC       tumor cell lines analyzed, amplified in sarcomas. Highly expressed
CC       in osteosarcoma SJSA-1 and rhabdomyosarcoma Rh30 cell lines.
CC       Isoform 2 is the major isoform detected in all cell types
CC       examined.
CC   -!- INDUCTION: Up-regulated in response to endoplasmic reticulum
CC       stress (at protein level). {ECO:0000269|PubMed:18417469,
CC       ECO:0000269|PubMed:19084021}.
CC   -!- PTM: Intramolecular disulfide bonds.
CC   -!- PTM: Isoform 1 and isoform 2 are N-glycosylated.
CC       {ECO:0000269|PubMed:18264092, ECO:0000269|PubMed:18417469,
CC       ECO:0000269|PubMed:19084021}.
CC   -!- SIMILARITY: Belongs to the OS-9 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U41635; AAB06495.1; -; mRNA.
DR   EMBL; AB002805; BAA24362.1; -; Genomic_DNA.
DR   EMBL; AB002806; BAA24363.1; -; mRNA.
DR   EMBL; AK291374; BAF84063.1; -; mRNA.
DR   EMBL; AK293435; BAG56939.1; -; mRNA.
DR   EMBL; AK296770; BAG59349.1; -; mRNA.
DR   EMBL; AK298532; BAG60733.1; -; mRNA.
DR   EMBL; AK303858; BAG64798.1; -; mRNA.
DR   EMBL; CR456791; CAG33072.1; -; mRNA.
DR   EMBL; AC025165; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW97045.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW97046.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW97047.1; -; Genomic_DNA.
DR   EMBL; BC000532; AAH00532.1; -; mRNA.
DR   EMBL; BC007254; AAH07254.1; -; mRNA.
DR   EMBL; BC023513; AAH23513.2; -; mRNA.
DR   EMBL; U81031; AAC39523.2; -; Genomic_DNA.
DR   CCDS; CCDS31843.1; -. [Q13438-1]
DR   CCDS; CCDS31844.1; -. [Q13438-2]
DR   CCDS; CCDS31845.1; -. [Q13438-4]
DR   CCDS; CCDS31846.1; -. [Q13438-3]
DR   CCDS; CCDS58246.1; -. [Q13438-6]
DR   CCDS; CCDS58247.1; -. [Q13438-7]
DR   CCDS; CCDS58248.1; -. [Q13438-5]
DR   CCDS; CCDS58249.1; -. [Q13438-8]
DR   PIR; JC5889; JC5889.
DR   RefSeq; NP_001017956.1; NM_001017956.2. [Q13438-2]
DR   RefSeq; NP_001017957.1; NM_001017957.2. [Q13438-3]
DR   RefSeq; NP_001017958.1; NM_001017958.2. [Q13438-4]
DR   RefSeq; NP_001248349.1; NM_001261420.1. [Q13438-7]
DR   RefSeq; NP_001248350.1; NM_001261421.1. [Q13438-5]
DR   RefSeq; NP_001248351.1; NM_001261422.1. [Q13438-6]
DR   RefSeq; NP_001248352.1; NM_001261423.1. [Q13438-8]
DR   RefSeq; NP_006803.1; NM_006812.3. [Q13438-1]
DR   UniGene; Hs.527861; -.
DR   PDB; 3AIH; X-ray; 2.10 A; A/B=108-229.
DR   PDBsum; 3AIH; -.
DR   ProteinModelPortal; Q13438; -.
DR   SMR; Q13438; -.
DR   BioGrid; 116156; 136.
DR   CORUM; Q13438; -.
DR   DIP; DIP-37493N; -.
DR   IntAct; Q13438; 36.
DR   MINT; Q13438; -.
DR   STRING; 9606.ENSP00000318165; -.
DR   TCDB; 8.A.67.1.1; the os-9 quality control (erad) protein (os-9) family.
DR   iPTMnet; Q13438; -.
DR   PhosphoSitePlus; Q13438; -.
DR   BioMuta; OS9; -.
DR   DMDM; 3024310; -.
DR   EPD; Q13438; -.
DR   MaxQB; Q13438; -.
DR   PaxDb; Q13438; -.
DR   PeptideAtlas; Q13438; -.
DR   PRIDE; Q13438; -.
DR   DNASU; 10956; -.
DR   Ensembl; ENST00000257966; ENSP00000257966; ENSG00000135506. [Q13438-7]
DR   Ensembl; ENST00000315970; ENSP00000318165; ENSG00000135506. [Q13438-1]
DR   Ensembl; ENST00000389142; ENSP00000373794; ENSG00000135506. [Q13438-3]
DR   Ensembl; ENST00000389146; ENSP00000373798; ENSG00000135506. [Q13438-4]
DR   Ensembl; ENST00000435406; ENSP00000389632; ENSG00000135506. [Q13438-6]
DR   Ensembl; ENST00000439210; ENSP00000407360; ENSG00000135506. [Q13438-8]
DR   Ensembl; ENST00000551035; ENSP00000447866; ENSG00000135506. [Q13438-5]
DR   Ensembl; ENST00000552285; ENSP00000450010; ENSG00000135506. [Q13438-2]
DR   GeneID; 10956; -.
DR   KEGG; hsa:10956; -.
DR   UCSC; uc001spj.4; human. [Q13438-1]
DR   CTD; 10956; -.
DR   DisGeNET; 10956; -.
DR   EuPathDB; HostDB:ENSG00000135506.15; -.
DR   GeneCards; OS9; -.
DR   HGNC; HGNC:16994; OS9.
DR   HPA; CAB011518; -.
DR   HPA; HPA013694; -.
DR   MIM; 609677; gene.
DR   neXtProt; NX_Q13438; -.
DR   OpenTargets; ENSG00000135506; -.
DR   PharmGKB; PA164724245; -.
DR   eggNOG; KOG3394; Eukaryota.
DR   eggNOG; ENOG410XR8A; LUCA.
DR   GeneTree; ENSGT00530000063603; -.
DR   HOGENOM; HOG000293348; -.
DR   HOVERGEN; HBG000974; -.
DR   InParanoid; Q13438; -.
DR   KO; K10088; -.
DR   OMA; FQNNVQV; -.
DR   OrthoDB; EOG091G02WQ; -.
DR   PhylomeDB; Q13438; -.
DR   TreeFam; TF314309; -.
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-901032; ER Quality Control Compartment (ERQC).
DR   ChiTaRS; OS9; human.
DR   EvolutionaryTrace; Q13438; -.
DR   GeneWiki; OS9_(gene); -.
DR   GenomeRNAi; 10956; -.
DR   PRO; PR:Q13438; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000135506; -.
DR   ExpressionAtlas; Q13438; baseline and differential.
DR   Genevisible; Q13438; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0044322; C:endoplasmic reticulum quality control compartment; IEA:GOC.
DR   GO; GO:0000836; C:Hrd1p ubiquitin ligase complex; NAS:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:1904380; P:endoplasmic reticulum mannose trimming; TAS:Reactome.
DR   GO; GO:1904153; P:negative regulation of retrograde protein transport, ER to cytosol; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0006621; P:protein retention in ER lumen; IDA:UniProtKB.
DR   GO; GO:0006605; P:protein targeting; IEA:Ensembl.
DR   GO; GO:0016567; P:protein ubiquitination; IMP:UniProtKB.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   Gene3D; 2.70.130.10; -; 1.
DR   InterPro; IPR009011; Man6P_isomerase_rcpt-bd_dom_sf.
DR   InterPro; IPR012913; OS9-like.
DR   Pfam; PF07915; PRKCSH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Disulfide bond;
KW   Endoplasmic reticulum; Glycoprotein; Lectin; Polymorphism;
KW   Reference proteome; Signal.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    667       Protein OS-9.
FT                                /FTId=PRO_0000021951.
FT   DOMAIN      108    178       PRKCSH.
FT   COMPBIAS    414    429       Asp/Glu-rich (acidic).
FT   BINDING     130    130       Carbohydrate.
FT   BINDING     182    182       Carbohydrate.
FT   BINDING     188    188       Carbohydrate.
FT   BINDING     212    212       Carbohydrate.
FT   BINDING     218    218       Carbohydrate.
FT   CARBOHYD    177    177       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    110    123
FT   DISULFID    181    216
FT   DISULFID    196    228
FT   VAR_SEQ      55    113       Missing (in isoform 8).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046770.
FT   VAR_SEQ     142    193       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046001.
FT   VAR_SEQ     161    193       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044701.
FT   VAR_SEQ     263    263       A -> AV (in isoform 5 and isoform 7).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044702.
FT   VAR_SEQ     456    470       Missing (in isoform 3, isoform 4 and
FT                                isoform 8).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_004352.
FT   VAR_SEQ     534    588       Missing (in isoform 2, isoform 3, isoform
FT                                5, isoform 6, isoform 7 and isoform 8).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_004353.
FT   VARIANT     305    305       D -> N (in dbSNP:rs141986192).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_069062.
FT   VARIANT     398    398       R -> W (in dbSNP:rs1804598).
FT                                /FTId=VAR_011897.
FT   VARIANT     454    454       S -> L (in dbSNP:rs34764811).
FT                                /FTId=VAR_034364.
FT   MUTAGEN     188    188       R->A: Loss of glycan-binding activity and
FT                                partial inhibition of ERAD of the
FT                                misfolded glycoprotein NHK
FT                                (PubMed:19346256). Reduced interaction
FT                                with SEL1L (PubMed:18264092) not
FT                                confirmed in (PubMed:19346256).
FT                                {ECO:0000269|PubMed:18264092,
FT                                ECO:0000269|PubMed:18417469,
FT                                ECO:0000269|PubMed:19346256}.
FT   CONFLICT      7      7       L -> V (in Ref. 5; CAG33072).
FT                                {ECO:0000305}.
FT   CONFLICT    194    194       F -> V (in Ref. 4; BAG64798).
FT                                {ECO:0000305}.
FT   CONFLICT    371    371       E -> G (in Ref. 4; BAG56939).
FT                                {ECO:0000305}.
FT   CONFLICT    497    497       L -> F (in Ref. 4; BAG64798).
FT                                {ECO:0000305}.
FT   CONFLICT    522    522       V -> I (in Ref. 4; BAG60733).
FT                                {ECO:0000305}.
FT   CONFLICT    653    653       S -> P (in Ref. 4; BAG56939).
FT                                {ECO:0000305}.
FT   STRAND      111    115       {ECO:0000244|PDB:3AIH}.
FT   STRAND      118    123       {ECO:0000244|PDB:3AIH}.
FT   TURN        124    126       {ECO:0000244|PDB:3AIH}.
FT   STRAND      127    131       {ECO:0000244|PDB:3AIH}.
FT   STRAND      143    155       {ECO:0000244|PDB:3AIH}.
FT   STRAND      169    176       {ECO:0000244|PDB:3AIH}.
FT   TURN        182    184       {ECO:0000244|PDB:3AIH}.
FT   STRAND      189    196       {ECO:0000244|PDB:3AIH}.
FT   STRAND      206    214       {ECO:0000244|PDB:3AIH}.
FT   STRAND      217    224       {ECO:0000244|PDB:3AIH}.
FT   HELIX       225    227       {ECO:0000244|PDB:3AIH}.
SQ   SEQUENCE   667 AA;  75562 MW;  65BA3F66CEC58756 CRC64;
     MAAETLLSSL LGLLLLGLLL PASLTGGVGS LNLEELSEMR YGIEILPLPV MGGQSQSSDV
     VIVSSKYKQR YECRLPAGAI HFQREREEET PAYQGPGIPE LLSPMRDAPC LLKTKDWWTY
     EFCYGRHIQQ YHMEDSEIKG EVLYLGYYQS AFDWDDETAK ASKQHRLKRY HSQTYGNGSK
     CDLNGRPREA EVRFLCDEGA GISGDYIDRV DEPLSCSYVL TIRTPRLCPH PLLRPPPSAA
     PQAILCHPSL QPEEYMAYVQ RQADSKQYGD KIIEELQDLG PQVWSETKSG VAPQKMAGAS
     PTKDDSKDSD FWKMLNEPED QAPGGEEVPA EEQDPSPEAA DSASGAPNDF QNNVQVKVIR
     SPADLIRFIE ELKGGTKKGK PNIGQEQPVD DAAEVPQREP EKERGDPERQ REMEEEEDED
     EDEDEDEDER QLLGEFEKEL EGILLPSDRD RLRSEVKAGM ERELENIIQE TEKELDPDGL
     KKESERDRAM LALTSTLNKL IKRLEEKQSP ELVKKHKKKR VVPKKPPPSP QPTEEDPEHR
     VRVRVTKLRL GGPNQDLTVL EMKRENPQLK QIEGLVKELL EREGLTAAGK IEIKIVRPWA
     EGTEEGARWL TDEDTRNLKE IFFNILVPGA EEAQKERQRQ KELESNYRRV WGSPGGEGTG
     DLDEFDF
//
ID   A0A087WVR4_HUMAN        Unreviewed;       454 AA.
AC   A0A087WVR4;
DT   07-JUN-2017, integrated into UniProtKB/TrEMBL.
DT   07-JUN-2017, sequence version 1.
DT   25-APR-2018, entry version 10.
DE   SubName: Full=Myc proto-oncogene protein {ECO:0000313|Ensembl:ENSP00000479618};
GN   Name=MYC {ECO:0000313|Ensembl:ENSP00000479618};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000479618, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000479618}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [3] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Glockner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [4] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [7] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [8] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [9] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10] {ECO:0000313|Ensembl:ENSP00000479618}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
RN   [11] {ECO:0000213|PubMed:28112733}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC103819; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_002458.2; NM_002467.4.
DR   UniGene; Hs.202453; -.
DR   SMR; A0A087WVR4; -.
DR   Ensembl; ENST00000613283; ENSP00000479618; ENSG00000136997.
DR   GeneID; 4609; -.
DR   KEGG; hsa:4609; -.
DR   CTD; 4609; -.
DR   HGNC; HGNC:7553; MYC.
DR   OpenTargets; ENSG00000136997; -.
DR   eggNOG; ENOG410IFSM; Eukaryota.
DR   eggNOG; ENOG41124Q3; LUCA.
DR   KO; K04377; -.
DR   ChiTaRS; MYC; human.
DR   Proteomes; UP000005640; Chromosome 8.
DR   ExpressionAtlas; A0A087WVR4; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   CDD; cd00083; HLH; 1.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR003327; Myc-LZ.
DR   InterPro; IPR002418; Tscrpt_reg_Myc.
DR   InterPro; IPR012682; Tscrpt_reg_Myc_N.
DR   Pfam; PF00010; HLH; 1.
DR   Pfam; PF02344; Myc-LZ; 1.
DR   Pfam; PF01056; Myc_N; 1.
DR   PIRSF; PIRSF001705; Myc_protein; 1.
DR   PRINTS; PR00044; LEUZIPPRMYC.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A0A087WVR4,
KW   ECO:0000213|MaxQB:A0A087WVR4, ECO:0000213|PeptideAtlas:A0A087WVR4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      369    421       BHLH. {ECO:0000259|PROSITE:PS50888}.
FT   COILED      382    402       {ECO:0000256|SAM:Coils}.
FT   COILED      432    452       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   454 AA;  50565 MW;  8B4107BB740689E5 CRC64;
     MDFFRVVENQ QPPATMPLNV SFTNRNYDLD YDSVQPYFYC DEEENFYQQQ QQSELQPPAP
     SEDIWKKFEL LPTPPLSPSR RSGLCSPSYV AVTPFSLRGD NDGGGGSFST ADQLEMVTEL
     LGGDMVNQSF ICDPDDETFI KNIIIQDCMW SGFSAAAKLV SEKLASYQAA RKDSGSPNPA
     RGHSVCSTSS LYLQDLSAAA SECIDPSVVF PYPLNDSSSP KSCASQDSSA FSPSSDSLLS
     STESSPQGSP EPLVLHEETP PTTSSDSEEE QEDEEEIDVV SVEKRQAPGK RSESGSPSAG
     GHSKPPHSPL VLKRCHVSTH QHNYAAPPST RKDYPAAKRV KLDSVRVLRQ ISNNRKCTSP
     RSSDTEENVK RRTHNVLERQ RRNELKRSFF ALRDQIPELE NNEKAPKVVI LKKATAYILS
     VQAEEQKLIS EEDLLRKRRE QLKHKLEQLR NSCA
//
ID   MYC_HUMAN               Reviewed;         439 AA.
AC   P01106; A8WFE7; P01107; Q14026;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   23-MAY-2018, entry version 233.
DE   RecName: Full=Myc proto-oncogene protein;
DE   AltName: Full=Class E basic helix-loop-helix protein 39;
DE            Short=bHLHe39;
DE   AltName: Full=Proto-oncogene c-Myc;
DE   AltName: Full=Transcription factor p64;
GN   Name=MYC; Synonyms=BHLHE39;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING (ISOFORM
RP   1).
RX   PubMed=6414718; DOI=10.1016/0092-8674(83)90534-2;
RA   Battey J., Moulding C., Taub R., Murphy W., Stewart T., Potter H.,
RA   Lenoir G., Leder P.;
RT   "The human c-myc oncogene: structural consequences of translocation
RT   into the IgH locus in Burkitt lymphoma.";
RL   Cell 34:779-787(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING (ISOFORM
RP   1).
RX   PubMed=6321164;
RA   Bernard O., Cory S., Gerondakis S., Webb E., Adams J.M.;
RT   "Sequence of the murine and human cellular myc oncogenes and two modes
RT   of myc transcription resulting from chromosome translocation in B
RT   lymphoid tumours.";
RL   EMBO J. 2:2375-2383(1983).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING (ISOFORM
RP   1).
RX   PubMed=6298632; DOI=10.1038/301722a0;
RA   Colby W.W., Chen E.Y., Smith D.H., Levinson A.D.;
RT   "Identification and nucleotide sequence of a human locus homologous to
RT   the v-myc oncogene of avian myelocytomatosis virus MC29.";
RL   Nature 301:722-725(1983).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=6304538; DOI=10.1038/303725a0;
RA   Watt R., Stanton L.W., Marcu K.B., Gallo R.C., Croce C.M., Rovera G.;
RT   "Nucleotide sequence of cloned cDNA of human c-myc oncogene.";
RL   Nature 303:725-728(1983).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ASP-39.
RX   PubMed=6419122; DOI=10.1038/306760a0;
RA   Rabbitts T.H., Hamlyn P.H., Baer R.;
RT   "Altered nucleotide sequences of a translocated c-myc gene in Burkitt
RT   lymphoma.";
RL   Nature 306:760-765(1983).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING (ISOFORM
RP   1).
RX   PubMed=6304729; DOI=10.1073/pnas.80.12.3642;
RA   Watson D.K., Psallidopoulos M.C., Samuel K.P., Dalla-Favera R.,
RA   Papas T.S.;
RT   "Nucleotide sequence analysis of human c-myc locus, chicken homologue,
RT   and myelocytomatosis virus MC29 transforming gene reveals a highly
RT   conserved gene product.";
RL   Proc. Natl. Acad. Sci. U.S.A. 80:3642-3645(1983).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND NUCLEOTIDE SEQUENCE
RP   [GENOMIC DNA] OF 1-252.
RX   PubMed=6547209; DOI=10.1038/309592a0;
RA   Rabbitts T.H., Forster A., Hamlyn P., Baer R.;
RT   "Effect of somatic mutation within translocated c-myc genes in
RT   Burkitt's lymphoma.";
RL   Nature 309:592-597(1984).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING (ISOFORM
RP   1).
RX   PubMed=6714223;
RA   Gazin C., Dupont S., de Dinechin D., Hampe A., Masson J.-M.,
RA   Martin P., Stehelin D., Galibert F.;
RT   "Nucleotide sequence of the human c-myc locus: provocative open
RT   reading frame within the first exon.";
RL   EMBO J. 3:383-387(1984).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING (ISOFORMS
RP   1 AND 2).
RX   PubMed=8444346; DOI=10.1016/0378-1119(93)90398-M;
RA   Tachibana K., Takayama N., Matsuo K., Kato S., Yamamoto K., Ohyama K.,
RA   Umezawa A., Takano T.;
RT   "Allele-specific activation of the c-myc gene in an atypical Burkitt's
RT   lymphoma carrying the t(2;8) chromosomal translocation 250 kb
RT   downstream from c-myc.";
RL   Gene 124:231-237(1993).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-11; CYS-160;
RP   ILE-170 AND VAL-322.
RG   NIEHS SNPs program;
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cervix, Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-170 (ISOFORM 1).
RC   TISSUE=Promyelocytic leukemia;
RX   PubMed=3540591; DOI=10.1128/MCB.6.10.3481;
RA   Bentley D.L., Groudine M.;
RT   "Novel promoter upstream of the human c-myc gene and regulation of c-
RT   myc expression in B-cell lymphomas.";
RL   Mol. Cell. Biol. 6:3481-3489(1986).
RN   [17]
RP   INVOLVEMENT IN BURKITT LYMPHOMA.
RX   PubMed=2166998;
RA   Magrath I.;
RT   "The pathogenesis of Burkitt's lymphoma.";
RL   Adv. Cancer Res. 55:133-270(1990).
RN   [18]
RP   PHOSPHORYLATION.
RX   PubMed=1597196; DOI=10.1111/j.1432-1033.1992.tb16964.x;
RA   Iijima S., Teraoka H., Date T., Tsukada K.;
RT   "DNA-activated protein kinase in Raji Burkitt's lymphoma cells.
RT   Phosphorylation of c-Myc oncoprotein.";
RL   Eur. J. Biochem. 206:595-603(1992).
RN   [19]
RP   INVOLVEMENT IN BURKITT LYMPHOMA, AND VARIANTS ASP-39; SER-57; ALA-59
RP   AND THR-86.
RX   PubMed=8220424; DOI=10.1038/ng0993-56;
RA   Bhatia K., Huppi K., Spangler G., Siwarski D., Iyer R., Magrath I.;
RT   "Point mutations in the c-Myc transactivation domain are common in
RT   Burkitt's lymphoma and mouse plasmacytomas.";
RL   Nat. Genet. 5:56-61(1993).
RN   [20]
RP   PHOSPHORYLATION AT THR-58 AND SER-62.
RX   PubMed=8386367; DOI=10.1073/pnas.90.8.3216;
RA   Gupta S., Seth A., Davis R.J.;
RT   "Transactivation of gene expression by Myc is inhibited by mutation at
RT   the phosphorylation sites Thr-58 and Ser-62.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:3216-3220(1993).
RN   [21]
RP   GLYCOSYLATION AT THR-58.
RX   PubMed=7642555; DOI=10.1074/jbc.270.32.18961;
RA   Chou T.-Y., Hart G.W., Dang C.V.;
RT   "c-Myc is glycosylated at threonine 58, a known phosphorylation site
RT   and a mutational hot spot in lymphomas.";
RL   J. Biol. Chem. 270:18961-18965(1995).
RN   [22]
RP   PHOSPHORYLATION AT THR-8.
RX   PubMed=9315742; DOI=10.1016/S0014-5793(97)00992-7;
RA   Alexandrov I., Shlyakhova L., Vartanian A., Zajac-Kaye M.,
RA   Alexandrova N.;
RT   "c-Raf kinase binds to N-terminal domain of c-Myc.";
RL   FEBS Lett. 414:465-470(1997).
RN   [23]
RP   UBIQUITINATION, INTERACTION WITH FBXW7, PHOSPHORYLATION AT THR-58 AND
RP   SER-62, AND MUTAGENESIS OF THR-58 AND SER-62.
RX   PubMed=15103331; DOI=10.1038/sj.emboj.7600217;
RA   Yada M., Hatakeyama S., Kamura T., Nishiyama M., Tsunematsu R.,
RA   Imaki H., Ishida N., Okumura F., Nakayama K., Nakayama K.I.;
RT   "Phosphorylation-dependent degradation of c-Myc is mediated by the F-
RT   box protein Fbw7.";
RL   EMBO J. 23:2116-2125(2004).
RN   [24]
RP   ACETYLATION AT LYS-143; LYS-157; LYS-275; LYS-317; LYS-323 AND
RP   LYS-371, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16126174; DOI=10.1016/j.bbrc.2005.08.075;
RA   Zhang K., Faiola F., Martinez E.;
RT   "Six lysine residues on c-Myc are direct substrates for acetylation by
RT   p300.";
RL   Biochem. Biophys. Res. Commun. 336:274-280(2005).
RN   [25]
RP   INTERACTION WITH TAF1C.
RX   PubMed=15723054; DOI=10.1038/ncb1224;
RA   Grandori C., Gomez-Roman N., Felton-Edkins Z.A., Ngouenet C.,
RA   Galloway D.A., Eisenman R.N., White R.J.;
RT   "c-Myc binds to human ribosomal DNA and stimulates transcription of
RT   rRNA genes by RNA polymerase I.";
RL   Nat. Cell Biol. 7:311-318(2005).
RN   [26]
RP   INTERACTION WITH PARP10.
RX   PubMed=15674325; DOI=10.1038/sj.onc.1208410;
RA   Yu M., Schreek S., Cerni C., Schamberger C., Lesniewicz K., Poreba E.,
RA   Vervoorts J., Walsemann G., Groetzinger J., Kremmer E., Mehraein Y.,
RA   Mertsching J., Kraft R., Austen M., Luescher-Firzlaff J., Luescher B.;
RT   "PARP-10, a novel Myc-interacting protein with poly(ADP-ribose)
RT   polymerase activity, inhibits transformation.";
RL   Oncogene 24:1982-1993(2005).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-58, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [28]
RP   INTERACTION WITH CIP2A.
RX   PubMed=17632056; DOI=10.1016/j.cell.2007.04.044;
RA   Junttila M.R., Puustinen P., Niemelae M., Ahola R., Arnold H.,
RA   Boettzauw T., Ala-Aho R., Nielsen C., Ivaska J., Taya Y., Lu S.-L.,
RA   Lin S., Chan E.K.L., Wang X.-J., Grenman R., Kast J., Kallunki T.,
RA   Sears R., Kaehaeri V.-M., Westermarck J.;
RT   "CIP2A inhibits PP2A in human malignancies.";
RL   Cell 130:51-62(2007).
RN   [29]
RP   BIOTECHNOLOGY.
RX   PubMed=18035408; DOI=10.1016/j.cell.2007.11.019;
RA   Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K.,
RA   Yamanaka S.;
RT   "Induction of pluripotent stem cells from adult human fibroblasts by
RT   defined factors.";
RL   Cell 131:861-872(2007).
RN   [30]
RP   UBIQUITINATION, DEUBIQUITINATION BY USP28, AND INTERACTION WITH FBXW7.
RX   PubMed=17873522; DOI=10.4161/cc.6.19.4804;
RA   Popov N., Herold S., Llamazares M., Schulein C., Eilers M.;
RT   "Fbw7 and Usp28 regulate myc protein stability in response to DNA
RT   damage.";
RL   Cell Cycle 6:2327-2331(2007).
RN   [31]
RP   INTERACTION WITH KDM5A AND KDM5B.
RX   PubMed=17311883; DOI=10.1101/gad.1523007;
RA   Secombe J., Li L., Carlos L., Eisenman R.N.;
RT   "The Trithorax group protein Lid is a trimethyl histone H3K4
RT   demethylase required for dMyc-induced cell growth.";
RL   Genes Dev. 21:537-551(2007).
RN   [32]
RP   INTERACTION WITH RIOX1.
RX   PubMed=17308053; DOI=10.1158/1535-7163.MCT-06-0659;
RA   Suzuki C., Takahashi K., Hayama S., Ishikawa N., Kato T., Ito T.,
RA   Tsuchiya E., Nakamura Y., Daigo Y.;
RT   "Identification of Myc-associated protein with JmjC domain as a novel
RT   therapeutic target oncogene for lung cancer.";
RL   Mol. Cancer Ther. 6:542-551(2007).
RN   [33]
RP   UBIQUITINATION, DEUBIQUITINATION BY USP28, INTERACTION WITH FBXW7,
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-58 AND SER-62, AND
RP   MUTAGENESIS OF THR-58 AND SER-62.
RX   PubMed=17558397; DOI=10.1038/ncb1601;
RA   Popov N., Wanzel M., Madiredjo M., Zhang D., Beijersbergen R.,
RA   Bernards R., Moll R., Elledge S.J., Eilers M.;
RT   "The ubiquitin-specific protease USP28 is required for MYC
RT   stability.";
RL   Nat. Cell Biol. 9:765-774(2007).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-58; SER-62 AND SER-71,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [36]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-148, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [37]
RP   REVIEW ON SENESCENCE, PHOSPHORYLATION AT SER-62 BY CDK2, AND
RP   MUTAGENESIS OF THR-58 AND SER-62.
RX   PubMed=20713526; DOI=10.1158/0008-5472.CAN-10-1383;
RA   Hydbring P., Larsson L.-G.;
RT   "Tipping the balance: Cdk2 enables Myc to suppress senescence.";
RL   Cancer Res. 70:6687-6691(2010).
RN   [38]
RP   PHOSPHORYLATION AT SER-62 BY CDK2, AND MUTAGENESIS OF THR-58 AND
RP   SER-62.
RX   PubMed=19966300; DOI=10.1073/pnas.0900121106;
RA   Hydbring P., Bahram F., Su Y., Tronnersjoe S., Hoegstrand K.,
RA   von der Lehr N., Sharifi H.R., Lilischkis R., Hein N., Wu S.,
RA   Vervoorts J., Henriksson M., Grandien A., Luescher B., Larsson L.-G.;
RT   "Phosphorylation by Cdk2 is required for Myc to repress Ras-induced
RT   senescence in cotransformation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:58-63(2010).
RN   [39]
RP   UBIQUITINATION.
RX   PubMed=20551172; DOI=10.1101/gad.1920310;
RA   Choi S.H., Wright J.B., Gerber S.A., Cole M.D.;
RT   "Myc protein is stabilized by suppression of a novel E3 ligase complex
RT   in cancer cells.";
RL   Genes Dev. 24:1236-1241(2010).
RN   [40]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6 AND SER-161, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [41]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-58 AND SER-62, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [42]
RP   PHOSPHORYLATION AT SER-62, AND MUTAGENESIS OF SER-62.
RX   PubMed=22307329; DOI=10.1172/JCI60818;
RA   Taira N., Mimoto R., Kurata M., Yamaguchi T., Kitagawa M., Miki Y.,
RA   Yoshida K.;
RT   "DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle
RT   progression in human cancer cells.";
RL   J. Clin. Invest. 122:859-872(2012).
RN   [43]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6; THR-58; SER-62;
RP   SER-71 AND SER-293, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [44]
RP   FUNCTION.
RX   PubMed=24940000;
RA   Shi Y., Xu X., Zhang Q., Fu G., Mo Z., Wang G.S., Kishi S., Yang X.L.;
RT   "tRNA synthetase counteracts c-Myc to develop functional
RT   vasculature.";
RL   Elife 3:E02349-E02349(2014).
RN   [45]
RP   FUNCTION, AND INTERACTION WITH NPM1.
RX   PubMed=25956029; DOI=10.1016/j.ajpath.2015.03.016;
RA   Kim J.Y., Cho Y.E., Park J.H.;
RT   "The nucleolar protein GLTSCR2 is an upstream negative regulator of
RT   the oncogenic Nucleophosmin-MYC axis.";
RL   Am. J. Pathol. 185:2061-2068(2015).
RN   [46]
RP   UBIQUITINATION, DEUBIQUITINATION BY USP36, INTERACTION WITH FBXW7, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=25775507; DOI=10.1073/pnas.1411713112;
RA   Sun X.X., He X., Yin L., Komada M., Sears R.C., Dai M.S.;
RT   "The nucleolar ubiquitin-specific protease USP36 deubiquitinates and
RT   stabilizes c-Myc.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:3734-3739(2015).
RN   [47]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-52; LYS-143; LYS-148 AND
RP   LYS-298, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [48]
RP   STRUCTURE BY NMR OF 402-434 IN COMPLEX WITH MAX.
RX   PubMed=9680483; DOI=10.1006/jmbi.1998.1914;
RA   Lavigne P., Crump M.P., Gagne S.M., Hodges R.S., Kay C.M., Sykes B.D.;
RT   "Insights into the mechanism of heterodimerization from the 1H-NMR
RT   solution structure of the c-Myc-Max heterodimeric leucine zipper.";
RL   J. Mol. Biol. 281:165-181(1998).
RN   [49]
RP   CHROMOSOMAL TRANSLOCATION WITH BTG1.
RX   PubMed=2069907; DOI=10.1002/gcc.2870030106;
RA   Rimokh R., Rouault J.P., Wahbi K., Gadoux M., Lafage M.,
RA   Archimbaud E., Charrin C., Gentilhomme O., Germain D., Samarut J.;
RT   "A chromosome 12 coding region is juxtaposed to the MYC protooncogene
RT   locus in a t(8;12)(q24;q22) translocation in a case of B-cell chronic
RT   lymphocytic leukemia.";
RL   Genes Chromosomes Cancer 3:24-36(1991).
CC   -!- FUNCTION: Transcription factor that binds DNA in a non-specific
CC       manner, yet also specifically recognizes the core sequence 5'-
CC       CAC[GA]TG-3'. Activates the transcription of growth-related genes.
CC       Binds to the VEGFA promoter, promoting VEGFA production and
CC       subsequent sprouting angiogenesis (PubMed:24940000).
CC       {ECO:0000269|PubMed:24940000, ECO:0000269|PubMed:25956029}.
CC   -!- SUBUNIT: Efficient DNA binding requires dimerization with another
CC       bHLH protein. Binds DNA as a heterodimer with MAX
CC       (PubMed:9680483). Interacts with TAF1C and SPAG9. Interacts with
CC       PARP10. Interacts with KDM5A and KDM5B. Interacts (when
CC       phosphorylated at Thr-58 and Ser-62) with FBXW7(PubMed:25775507,
CC       PubMed:17558397). Interacts with PIM2. Interacts with RIOX1. The
CC       heterodimer MYC:MAX interacts with ABI1; the interaction may
CC       enhance MYC:MAX transcriptional activity. Interacts with TRIM6 (By
CC       similarity). Interacts with NPM1; the binary complex is recruited
CC       to the promoter of MYC target genes and enhances their
CC       transcription (PubMed:25956029). Interacts with CIP2A; leading to
CC       the stabilization of MYC (PubMed:17632056).
CC       {ECO:0000250|UniProtKB:P01108, ECO:0000269|PubMed:15103331,
CC       ECO:0000269|PubMed:15674325, ECO:0000269|PubMed:15723054,
CC       ECO:0000269|PubMed:17308053, ECO:0000269|PubMed:17311883,
CC       ECO:0000269|PubMed:17558397, ECO:0000269|PubMed:17632056,
CC       ECO:0000269|PubMed:17873522, ECO:0000269|PubMed:25775507,
CC       ECO:0000269|PubMed:25956029, ECO:0000269|PubMed:9680483}.
CC   -!- INTERACTION:
CC       P03070:- (xeno); NbExp=2; IntAct=EBI-447544, EBI-617698;
CC       O15169:AXIN1; NbExp=10; IntAct=EBI-447544, EBI-710484;
CC       O00499-10:BIN1; NbExp=3; IntAct=EBI-447544, EBI-7689134;
CC       O00499-11:BIN1; NbExp=2; IntAct=EBI-447544, EBI-7689211;
CC       Q15059:BRD3; NbExp=3; IntAct=EBI-447544, EBI-1383460;
CC       Q8N163:CCAR2; NbExp=8; IntAct=EBI-447544, EBI-355410;
CC       P11802:CDK4; NbExp=2; IntAct=EBI-447544, EBI-295644;
CC       Q86XR8:CEP57; NbExp=3; IntAct=EBI-447544, EBI-308614;
CC       Q14839:CHD4; NbExp=2; IntAct=EBI-447544, EBI-372916;
CC       O15111:CHUK; NbExp=3; IntAct=EBI-447544, EBI-81249;
CC       Q8TCG1:CIP2A; NbExp=2; IntAct=EBI-447544, EBI-1379376;
CC       P03129:E7 (xeno); NbExp=2; IntAct=EBI-447544, EBI-866453;
CC       P04020:E7 (xeno); NbExp=2; IntAct=EBI-447544, EBI-7005254;
CC       P06788:E7 (xeno); NbExp=5; IntAct=EBI-447544, EBI-1776887;
CC       P03204:EBNA6 (xeno); NbExp=11; IntAct=EBI-447544, EBI-9255985;
CC       Q15029:EFTUD2; NbExp=5; IntAct=EBI-447544, EBI-357897;
CC       Q96L91:EP400; NbExp=4; IntAct=EBI-447544, EBI-399163;
CC       Q96L91-2:EP400; NbExp=2; IntAct=EBI-447544, EBI-15698003;
CC       Q969H0:FBXW7; NbExp=4; IntAct=EBI-447544, EBI-359574;
CC       Q8N3Y1:FBXW8; NbExp=3; IntAct=EBI-447544, EBI-914770;
CC       O43524:FOXO3; NbExp=3; IntAct=EBI-447544, EBI-1644164;
CC       P49841-2:GSK3B; NbExp=3; IntAct=EBI-447544, EBI-15870655;
CC       Q92769:HDAC2; NbExp=2; IntAct=EBI-447544, EBI-301821;
CC       O15379:HDAC3; NbExp=6; IntAct=EBI-447544, EBI-607682;
CC       Q9Y6K9:IKBKG; NbExp=3; IntAct=EBI-447544, EBI-81279;
CC       P61244:MAX; NbExp=33; IntAct=EBI-447544, EBI-751711;
CC       P52164:Max (xeno); NbExp=4; IntAct=EBI-447544, EBI-1184963;
CC       O95983:MBD3; NbExp=3; IntAct=EBI-447544, EBI-1783068;
CC       P33993:MCM7; NbExp=6; IntAct=EBI-447544, EBI-355924;
CC       O75928:PIAS2; NbExp=4; IntAct=EBI-447544, EBI-348555;
CC       Q13526:PIN1; NbExp=5; IntAct=EBI-447544, EBI-714158;
CC       P62913:RPL11; NbExp=3; IntAct=EBI-447544, EBI-354380;
CC       O75182:SIN3B; NbExp=7; IntAct=EBI-447544, EBI-540462;
CC       Q62141:Sin3b (xeno); NbExp=8; IntAct=EBI-447544, EBI-591450;
CC       Q96EB6:SIRT1; NbExp=4; IntAct=EBI-447544, EBI-1802965;
CC       Q8N6T7:SIRT6; NbExp=3; IntAct=EBI-447544, EBI-712415;
CC       Q13309:SKP2; NbExp=2; IntAct=EBI-447544, EBI-456291;
CC       Q8TAD8:SNIP1; NbExp=9; IntAct=EBI-447544, EBI-749336;
CC       P08047:SP1; NbExp=4; IntAct=EBI-447544, EBI-298336;
CC       P11387:TOP1; NbExp=2; IntAct=EBI-447544, EBI-876302;
CC       Q14669:TRIP12; NbExp=7; IntAct=EBI-447544, EBI-308443;
CC       Q9Y4A5:TRRAP; NbExp=4; IntAct=EBI-447544, EBI-399128;
CC       P0CG48:UBC; NbExp=5; IntAct=EBI-447544, EBI-3390054;
CC       P17480:UBTF; NbExp=2; IntAct=EBI-447544, EBI-396235;
CC       Q13105:ZBTB17; NbExp=9; IntAct=EBI-447544, EBI-372156;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:17558397}. Nucleus, nucleolus
CC       {ECO:0000269|PubMed:17558397, ECO:0000269|PubMed:25775507}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P01106-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P01106-2; Sequence=VSP_037813;
CC         Note=Initiates from CTG codon. Ref.7 (BAA01374) sequence is in
CC         conflict in position: 2:D->N. Ref.7 (BAA01374) sequence is in
CC         conflict in position: 6:V->E. {ECO:0000305};
CC   -!- PTM: Phosphorylated by PRKDC. Phosphorylation at Ser-329 by PIM2
CC       leads to the stabilization of MYC (By similarity). Phosphorylation
CC       at Ser-62 by CDK2 prevents Ras-induced senescence. Phosphorylated
CC       at Ser-62 by DYRK2; this primes the protein for subsequent
CC       phosphorylation by GSK3B at Thr-58. Phosphorylation at Thr-58 and
CC       Ser-62 by GSK3 is required for ubiquitination and degradation by
CC       the proteasome. {ECO:0000250, ECO:0000269|PubMed:15103331,
CC       ECO:0000269|PubMed:17558397, ECO:0000269|PubMed:19966300,
CC       ECO:0000269|PubMed:20713526, ECO:0000269|PubMed:22307329,
CC       ECO:0000269|PubMed:8386367}.
CC   -!- PTM: Ubiquitinated by the SCF(FBXW7) complex when phosphorylated
CC       at Thr-58 and Ser-62, leading to its degradation by the
CC       proteasome. In the nucleoplasm, ubiquitination is counteracted by
CC       USP28, which interacts with isoform 1 of FBXW7 (FBW7alpha),
CC       leading to its deubiquitination and preventing degradation. In the
CC       nucleolus, however, ubiquitination is not counteracted by USP28
CC       but by USP36, due to the lack of interaction between isoform 3 of
CC       FBXW7 (FBW7gamma) and USP28, explaining the selective MYC
CC       degradation in the nucleolus (PubMed:25775507,PubMed:17558397).
CC       Also polyubiquitinated by the DCX(TRUSS) complex. Ubiquitinated by
CC       TRIM6 in a phosphorylation-independent manner (By similarity).
CC       {ECO:0000250|UniProtKB:P01108, ECO:0000269|PubMed:15103331,
CC       ECO:0000269|PubMed:17558397, ECO:0000269|PubMed:19966300,
CC       ECO:0000269|PubMed:20713526, ECO:0000269|PubMed:22307329,
CC       ECO:0000269|PubMed:25775507, ECO:0000269|PubMed:8386367}.
CC   -!- DISEASE: Note=A chromosomal aberration involving MYC may be a
CC       cause of a form of B-cell chronic lymphocytic leukemia.
CC       Translocation t(8;12)(q24;q22) with BTG1.
CC       {ECO:0000269|PubMed:2069907}.
CC   -!- DISEASE: Burkitt lymphoma (BL) [MIM:113970]: A form of
CC       undifferentiated malignant lymphoma commonly manifested as a large
CC       osteolytic lesion in the jaw or as an abdominal mass.
CC       {ECO:0000269|PubMed:2166998, ECO:0000269|PubMed:8220424}. Note=The
CC       gene represented in this entry is involved in disease
CC       pathogenesis. Chromosomal aberrations involving MYC are usually
CC       found in Burkitt lymphoma. Translocations t(8;14), t(8;22) or
CC       t(2;8) which juxtapose MYC to one of the heavy or light chain
CC       immunoglobulin gene loci.
CC   -!- BIOTECHNOLOGY: POU5F1/OCT4, SOX2, MYC/c-Myc and KLF4 are the four
CC       Yamanaka factors. When combined, these factors are sufficient to
CC       reprogram differentiated cells to an embryonic-like state
CC       designated iPS (induced pluripotent stem) cells. iPS cells exhibit
CC       the morphology and growth properties of ES cells and express ES
CC       cell marker genes. {ECO:0000269|PubMed:18035408}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MYCID27.html";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/myc/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Myc entry;
CC       URL="https://en.wikipedia.org/wiki/Myc";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L00058; AAA59882.1; -; Genomic_DNA.
DR   EMBL; L00057; AAA59882.1; JOINED; Genomic_DNA.
DR   EMBL; K00535; AAA59880.1; -; Genomic_DNA.
DR   EMBL; K00534; AAA59880.1; JOINED; Genomic_DNA.
DR   EMBL; K00535; ABW69847.1; -; Genomic_DNA.
DR   EMBL; K00534; ABW69847.1; JOINED; Genomic_DNA.
DR   EMBL; X00196; CAA25015.2; -; Genomic_DNA.
DR   EMBL; X00198; CAA25015.2; JOINED; Genomic_DNA.
DR   EMBL; X00364; CAA25106.1; -; Genomic_DNA.
DR   EMBL; V00568; CAA23831.1; -; mRNA.
DR   EMBL; K01906; AAA59881.1; -; Genomic_DNA.
DR   EMBL; K01905; AAA59881.1; JOINED; Genomic_DNA.
DR   EMBL; K02276; AAA36340.1; -; mRNA.
DR   EMBL; X00676; CAA25288.1; -; Genomic_DNA.
DR   EMBL; D10493; BAA01374.2; -; Genomic_DNA.
DR   EMBL; D10493; BAA01375.1; -; Genomic_DNA.
DR   EMBL; BT019768; AAV38573.1; -; mRNA.
DR   EMBL; AY214166; AAO21131.1; -; Genomic_DNA.
DR   EMBL; AK312883; BAG35731.1; -; mRNA.
DR   EMBL; AC103819; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471060; EAW92098.1; -; Genomic_DNA.
DR   EMBL; BC000141; AAH00141.2; -; mRNA.
DR   EMBL; BC000917; AAH00917.2; -; mRNA.
DR   EMBL; BC058901; AAH58901.2; -; mRNA.
DR   EMBL; M13929; AAA88092.1; -; mRNA.
DR   CCDS; CCDS6359.2; -. [P01106-2]
DR   PIR; A01349; TVHUM.
DR   PIR; A01350; TVHUT.
DR   RefSeq; NP_002458.2; NM_002467.4. [P01106-2]
DR   UniGene; Hs.202453; -.
DR   PDB; 1A93; NMR; -; A=406-434.
DR   PDB; 1EE4; X-ray; 2.10 A; C/D/E/F=320-328.
DR   PDB; 1MV0; NMR; -; A=55-68.
DR   PDB; 1NKP; X-ray; 1.80 A; A/D=353-434.
DR   PDB; 2A93; NMR; -; A=406-434.
DR   PDB; 2OR9; X-ray; 2.70 A; P=410-419.
DR   PDB; 4Y7R; X-ray; 1.90 A; B=260-267.
DR   PDB; 5I4Z; X-ray; 1.95 A; A/B=350-439.
DR   PDB; 5I50; X-ray; 2.70 A; A/B=350-439.
DR   PDBsum; 1A93; -.
DR   PDBsum; 1EE4; -.
DR   PDBsum; 1MV0; -.
DR   PDBsum; 1NKP; -.
DR   PDBsum; 2A93; -.
DR   PDBsum; 2OR9; -.
DR   PDBsum; 4Y7R; -.
DR   PDBsum; 5I4Z; -.
DR   PDBsum; 5I50; -.
DR   DisProt; DP00260; -.
DR   ProteinModelPortal; P01106; -.
DR   SMR; P01106; -.
DR   BioGrid; 110694; 618.
DR   CORUM; P01106; -.
DR   DIP; DIP-28143N; -.
DR   IntAct; P01106; 717.
DR   MINT; P01106; -.
DR   STRING; 9606.ENSP00000367207; -.
DR   BindingDB; P01106; -.
DR   ChEMBL; CHEMBL1250348; -.
DR   DrugBank; DB08813; Nadroparin.
DR   GlyConnect; 426; -.
DR   iPTMnet; P01106; -.
DR   PhosphoSitePlus; P01106; -.
DR   UniCarbKB; P01106; -.
DR   BioMuta; MYC; -.
DR   DMDM; 127619; -.
DR   SWISS-2DPAGE; P01106; -.
DR   EPD; P01106; -.
DR   MaxQB; P01106; -.
DR   PaxDb; P01106; -.
DR   PeptideAtlas; P01106; -.
DR   PRIDE; P01106; -.
DR   DNASU; 4609; -.
DR   Ensembl; ENST00000377970; ENSP00000367207; ENSG00000136997. [P01106-1]
DR   Ensembl; ENST00000613283; ENSP00000479618; ENSG00000136997. [P01106-2]
DR   GeneID; 4609; -.
DR   KEGG; hsa:4609; -.
DR   UCSC; uc064qdj.1; human. [P01106-1]
DR   CTD; 4609; -.
DR   DisGeNET; 4609; -.
DR   EuPathDB; HostDB:ENSG00000136997.15; -.
DR   GeneCards; MYC; -.
DR   H-InvDB; HIX0007784; -.
DR   HGNC; HGNC:7553; MYC.
DR   HPA; CAB000084; -.
DR   HPA; CAB010307; -.
DR   HPA; HPA055893; -.
DR   HPA; HPA066556; -.
DR   MalaCards; MYC; -.
DR   MIM; 113970; phenotype.
DR   MIM; 190080; gene.
DR   neXtProt; NX_P01106; -.
DR   OpenTargets; ENSG00000136997; -.
DR   Orphanet; 543; Burkitt lymphoma.
DR   Orphanet; 99861; Precursor T-cell acute lymphoblastic leukemia.
DR   PharmGKB; PA31353; -.
DR   eggNOG; ENOG410IFSM; Eukaryota.
DR   eggNOG; ENOG41124Q3; LUCA.
DR   GeneTree; ENSGT00510000046414; -.
DR   HOGENOM; HOG000043075; -.
DR   HOVERGEN; HBG000472; -.
DR   InParanoid; P01106; -.
DR   KO; K04377; -.
DR   PhylomeDB; P01106; -.
DR   TreeFam; TF106001; -.
DR   BioCyc; MetaCyc:ENSG00000136997-MONOMER; -.
DR   Reactome; R-HSA-1362277; Transcription of E2F targets under negative control by DREAM complex.
DR   Reactome; R-HSA-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-4411364; Binding of TCF/LEF:CTNNB1 to target gene promoters.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   Reactome; R-HSA-69202; Cyclin E associated events during G1/S transition.
DR   Reactome; R-HSA-69656; Cyclin A:Cdk2-associated events at S phase entry.
DR   Reactome; R-HSA-8866911; TFAP2 (AP-2) family regulates transcription of cell cycle factors.
DR   Reactome; R-HSA-8951430; RUNX3 regulates WNT signaling.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   SignaLink; P01106; -.
DR   SIGNOR; P01106; -.
DR   ChiTaRS; MYC; human.
DR   EvolutionaryTrace; P01106; -.
DR   GeneWiki; Myc; -.
DR   GenomeRNAi; 4609; -.
DR   PRO; PR:P01106; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000136997; -.
DR   CleanEx; HS_MYC; -.
DR   ExpressionAtlas; P01106; baseline and differential.
DR   Genevisible; P01106; HS.
DR   GO; GO:0000790; C:nuclear chromatin; IMP:BHF-UCL.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0033613; F:activating transcription factor binding; IPI:CAFA.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0070888; F:E-box binding; IDA:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:UniProtKB.
DR   GO; GO:0070491; F:repressing transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; IMP:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:1904837; P:beta-catenin-TCF complex assembly; TAS:Reactome.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; ISS:UniProtKB.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IDA:UniProtKB.
DR   GO; GO:0007050; P:cell cycle arrest; IDA:UniProtKB.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IDA:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0035690; P:cellular response to drug; IDA:UniProtKB.
DR   GO; GO:0071456; P:cellular response to hypoxia; IDA:CAFA.
DR   GO; GO:0034644; P:cellular response to UV; IEP:UniProtKB.
DR   GO; GO:0006338; P:chromatin remodeling; IDA:UniProtKB.
DR   GO; GO:0051276; P:chromosome organization; IDA:UniProtKB.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0006112; P:energy reserve metabolic process; NAS:UniProtKB.
DR   GO; GO:0070371; P:ERK1 and ERK2 cascade; IDA:CAFA.
DR   GO; GO:0044346; P:fibroblast apoptotic process; TAS:UniProtKB.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0000165; P:MAPK cascade; IMP:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0051782; P:negative regulation of cell division; IDA:UniProtKB.
DR   GO; GO:0048147; P:negative regulation of fibroblast proliferation; IDA:UniProtKB.
DR   GO; GO:0045656; P:negative regulation of monocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0032873; P:negative regulation of stress-activated MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0015671; P:oxygen transport; NAS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:CAFA.
DR   GO; GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB.
DR   GO; GO:2000573; P:positive regulation of DNA biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:UniProtKB.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IDA:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:CAFA.
DR   GO; GO:0002053; P:positive regulation of mesenchymal cell proliferation; ISS:UniProtKB.
DR   GO; GO:0090096; P:positive regulation of metanephric cap mesenchymal cell proliferation; ISS:UniProtKB.
DR   GO; GO:2001022; P:positive regulation of response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0051973; P:positive regulation of telomerase activity; ISS:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0032986; P:protein-DNA complex disassembly; IDA:CAFA.
DR   GO; GO:0010468; P:regulation of gene expression; IDA:MGI.
DR   GO; GO:0032204; P:regulation of telomere maintenance; IMP:BHF-UCL.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; TAS:Reactome.
DR   GO; GO:0042493; P:response to drug; IEP:UniProtKB.
DR   GO; GO:0010332; P:response to gamma radiation; IDA:UniProtKB.
DR   GO; GO:0070848; P:response to growth factor; TAS:UniProtKB.
DR   CDD; cd00083; HLH; 1.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR003327; Myc-LZ.
DR   InterPro; IPR002418; Tscrpt_reg_Myc.
DR   InterPro; IPR012682; Tscrpt_reg_Myc_N.
DR   Pfam; PF00010; HLH; 1.
DR   Pfam; PF02344; Myc-LZ; 1.
DR   Pfam; PF01056; Myc_N; 1.
DR   PIRSF; PIRSF001705; Myc_protein; 1.
DR   PRINTS; PR00044; LEUZIPPRMYC.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing;
KW   Chromosomal rearrangement; Complete proteome; DNA-binding;
KW   Glycoprotein; Isopeptide bond; Nucleus; Phosphoprotein; Polymorphism;
KW   Proto-oncogene; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN         1    439       Myc proto-oncogene protein.
FT                                /FTId=PRO_0000127293.
FT   DOMAIN      354    406       bHLH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00981}.
FT   REGION      413    434       Leucine-zipper.
FT   COMPBIAS     33     37       Poly-Gln.
FT   COMPBIAS     88     91       Poly-Gly.
FT   MOD_RES       6      6       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES       8      8       Phosphothreonine; by RAF; in vitro.
FT                                {ECO:0000269|PubMed:9315742}.
FT   MOD_RES      58     58       Phosphothreonine; by GSK3; alternate.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:15103331,
FT                                ECO:0000269|PubMed:17558397,
FT                                ECO:0000269|PubMed:8386367}.
FT   MOD_RES      62     62       Phosphoserine; by DYRK2, GSK3 and CDK2.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:15103331,
FT                                ECO:0000269|PubMed:17558397,
FT                                ECO:0000269|PubMed:19966300,
FT                                ECO:0000269|PubMed:20713526,
FT                                ECO:0000269|PubMed:22307329,
FT                                ECO:0000269|PubMed:8386367}.
FT   MOD_RES      71     71       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     143    143       N6-acetyllysine; by PCAF; alternate.
FT                                {ECO:0000269|PubMed:16126174}.
FT   MOD_RES     148    148       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     157    157       N6-acetyllysine; by PCAF.
FT                                {ECO:0000269|PubMed:16126174}.
FT   MOD_RES     161    161       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     275    275       N6-acetyllysine; by PCAF.
FT                                {ECO:0000269|PubMed:16126174}.
FT   MOD_RES     293    293       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     317    317       N6-acetyllysine; by PCAF.
FT                                {ECO:0000269|PubMed:16126174}.
FT   MOD_RES     323    323       N6-acetyllysine; by PCAF.
FT                                {ECO:0000269|PubMed:16126174}.
FT   MOD_RES     329    329       Phosphoserine; by PIM2; in vitro.
FT                                {ECO:0000250|UniProtKB:P01108}.
FT   MOD_RES     371    371       N6-acetyllysine; by PCAF.
FT                                {ECO:0000269|PubMed:16126174}.
FT   CARBOHYD     58     58       O-linked (GlcNAc) threonine; alternate.
FT                                {ECO:0000269|PubMed:7642555}.
FT                                /FTId=CAR_000033.
FT   CROSSLNK     52     52       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    143    143       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    148    148       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    298    298       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1      1       M -> MDFFRVVENQQPPATM (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_037813.
FT   VARIANT      11     11       N -> S (in dbSNP:rs4645959).
FT                                {ECO:0000269|Ref.11}.
FT                                /FTId=VAR_016327.
FT   VARIANT      39     39       E -> D (in a Burkitt lymphoma symple;
FT                                dbSNP:rs121918684).
FT                                {ECO:0000269|PubMed:6419122,
FT                                ECO:0000269|PubMed:8220424}.
FT                                /FTId=VAR_063384.
FT   VARIANT      57     57       P -> S (in a Burkitt lymphoma sample;
FT                                dbSNP:rs28933407).
FT                                {ECO:0000269|PubMed:8220424}.
FT                                /FTId=VAR_063385.
FT   VARIANT      59     59       P -> A (in a Burkitt lymphoma sample;
FT                                dbSNP:rs121918685).
FT                                {ECO:0000269|PubMed:8220424}.
FT                                /FTId=VAR_063386.
FT   VARIANT      86     86       N -> T (in a Burkitt lymphoma sample;
FT                                dbSNP:rs121918683).
FT                                {ECO:0000269|PubMed:8220424}.
FT                                /FTId=VAR_063387.
FT   VARIANT     160    160       G -> C (in dbSNP:rs4645960).
FT                                {ECO:0000269|Ref.11}.
FT                                /FTId=VAR_016328.
FT   VARIANT     170    170       V -> I (in dbSNP:rs4645961).
FT                                {ECO:0000269|Ref.11}.
FT                                /FTId=VAR_016329.
FT   VARIANT     322    322       A -> V (in dbSNP:rs4645968).
FT                                {ECO:0000269|Ref.11}.
FT                                /FTId=VAR_016330.
FT   MUTAGEN      58     58       T->A: Impairs interaction with FBXW7 and
FT                                subsequent degradation by the proteasome.
FT                                Normal inhibition of Ras-induced
FT                                senescence. {ECO:0000269|PubMed:15103331,
FT                                ECO:0000269|PubMed:17558397,
FT                                ECO:0000269|PubMed:19966300,
FT                                ECO:0000269|PubMed:20713526}.
FT   MUTAGEN      62     62       S->A: Impairs interaction with FBXW7 and
FT                                subsequent degradation by the proteasome.
FT                                Impaired inhibition of Ras-induced
FT                                senescence. Abolishes phosphorylation by
FT                                DYRK2, and subsequent phosphorylation by
FT                                GSK3B at Thr-58.
FT                                {ECO:0000269|PubMed:15103331,
FT                                ECO:0000269|PubMed:17558397,
FT                                ECO:0000269|PubMed:19966300,
FT                                ECO:0000269|PubMed:20713526,
FT                                ECO:0000269|PubMed:22307329}.
FT   CONFLICT      6      7       SF -> TI (in Ref. 5; no nucleotide
FT                                entry). {ECO:0000305}.
FT   CONFLICT     10     10       R -> K (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT     56     56       L -> LL (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT     62     62       S -> P (in Ref. 7; CAA25288).
FT                                {ECO:0000305}.
FT   CONFLICT     88     88       G -> D (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT     92     92       S -> N (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    114    114       S -> N (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    120    120       D -> G (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    171    171       C -> S (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    203    203       S -> R (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    230    230       S -> A (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    240    240       L -> F (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    245    245       P -> S (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   HELIX       353    378       {ECO:0000244|PDB:1NKP}.
FT   HELIX       382    384       {ECO:0000244|PDB:1NKP}.
FT   HELIX       392    434       {ECO:0000244|PDB:1NKP}.
SQ   SEQUENCE   439 AA;  48804 MW;  ED5C028029A4C5D1 CRC64;
     MPLNVSFTNR NYDLDYDSVQ PYFYCDEEEN FYQQQQQSEL QPPAPSEDIW KKFELLPTPP
     LSPSRRSGLC SPSYVAVTPF SLRGDNDGGG GSFSTADQLE MVTELLGGDM VNQSFICDPD
     DETFIKNIII QDCMWSGFSA AAKLVSEKLA SYQAARKDSG SPNPARGHSV CSTSSLYLQD
     LSAAASECID PSVVFPYPLN DSSSPKSCAS QDSSAFSPSS DSLLSSTESS PQGSPEPLVL
     HEETPPTTSS DSEEEQEDEE EIDVVSVEKR QAPGKRSESG SPSAGGHSKP PHSPLVLKRC
     HVSTHQHNYA APPSTRKDYP AAKRVKLDSV RVLRQISNNR KCTSPRSSDT EENVKRRTHN
     VLERQRRNEL KRSFFALRDQ IPELENNEKA PKVVILKKAT AYILSVQAEE QKLISEEDLL
     RKRREQLKHK LEQLRNSCA
//
ID   A0A024R8M5_HUMAN        Unreviewed;       190 AA.
AC   A0A024R8M5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   25-APR-2018, entry version 23.
DE   SubName: Full=HCG1818127, isoform CRA_a {ECO:0000313|EMBL:EAW89438.1};
GN   ORFNames=hCG_1818127 {ECO:0000313|EMBL:EAW89438.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW89438.1};
RN   [1] {ECO:0000313|EMBL:EAW89438.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW89438.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471099; EAW89438.1; -; Genomic_DNA.
DR   RefSeq; NP_001073979.3; NM_001080510.4.
DR   RefSeq; NP_001193912.1; NM_001206983.2.
DR   RefSeq; NP_001193913.1; NM_001206984.2.
DR   RefSeq; NP_001289632.1; NM_001302703.1.
DR   RefSeq; XP_006721737.1; XM_006721674.3.
DR   UniGene; Hs.74655; -.
DR   ProteinModelPortal; A0A024R8M5; -.
DR   SMR; A0A024R8M5; -.
DR   GeneID; 124512; -.
DR   KEGG; hsa:124512; -.
DR   CTD; 124512; -.
DR   EuPathDB; HostDB:ENSG00000181038.13; -.
DR   eggNOG; ENOG410ISZF; Eukaryota.
DR   eggNOG; ENOG4111GNX; LUCA.
DR   OMA; TWPCAPV; -.
DR   OrthoDB; EOG091G0NXJ; -.
DR   PhylomeDB; A0A024R8M5; -.
DR   GenomeRNAi; 124512; -.
DR   Bgee; ENSG00000181038; -.
DR   ExpressionAtlas; A0A024R8M5; baseline and differential.
DR   InterPro; IPR019410; Methyltransf_16.
DR   InterPro; IPR029063; SAM-dependent_MTases.
DR   Pfam; PF10294; Methyltransf_16; 1.
DR   SUPFAM; SSF53335; SSF53335; 1.
PE   4: Predicted;
SQ   SEQUENCE   190 AA;  21469 MW;  7820BDC5E7631700 CRC64;
     MYVWPCAVVL AQYLWFHRRS LPGKAILEIG AGVSLPGILA AKCGAEVILS DSSELPHCLE
     VCRQSCQMNN LPHLQVVGLT WGHISWDLLA LPPQDIILAS DVFFEPEDFE DILATIYFLM
     HKNPKVQLWS TYQVRSADWS LEALLYKWDM KCVHIPLESF DADKEDIAES TLPGRHTVEM
     LVISFAKDSL
//
ID   MET23_HUMAN             Reviewed;         190 AA.
AC   Q86XA0; H9ZYJ0; K7EK32;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   24-NOV-2009, sequence version 3.
DT   25-APR-2018, entry version 103.
DE   RecName: Full=Methyltransferase-like protein 23;
DE            EC=2.1.1.-;
GN   Name=METTL23; Synonyms=C17orf95;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Baron B.M.;
RT   "Isolation of a novel GABPalpha-interacting co-factor, E4TF-1 Binding
RT   Methyltransferase (EBM), which encodes a putative methyltransferase.";
RL   Submitted (DEC-2011) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH HSPA5; HSP90B1; TUBULIN; UGGT1 AND UGGT2, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=23349634; DOI=10.1371/journal.pgen.1003210;
RA   Cloutier P., Lavallee-Adam M., Faubert D., Blanchette M., Coulombe B.;
RT   "A newly uncovered group of distantly related lysine
RT   methyltransferases preferentially interact with molecular chaperones
RT   to regulate their activity.";
RL   PLoS Genet. 9:E1003210-E1003210(2013).
RN   [6]
RP   INVOLVEMENT IN MRT44.
RX   PubMed=24501276; DOI=10.1093/hmg/ddu054;
RA   Reiff R.E., Ali B.R., Baron B., Yu T.W., Ben-Salem S., Coulter M.E.,
RA   Schubert C.R., Hill R.S., Akawi N.A., Al-Younes B., Kaya N.,
RA   Evrony G.D., Al-Saffar M., Felie J.M., Partlow J.N., Sunu C.M.,
RA   Schembri-Wismayer P., Alkuraya F.S., Meyer B.F., Walsh C.A.,
RA   Al-Gazali L., Mochida G.H.;
RT   "METTL23, a transcriptional partner of GABPA, is essential for human
RT   cognition.";
RL   Hum. Mol. Genet. 23:3456-3466(2014).
RN   [7]
RP   INVOLVEMENT IN MRT44.
RX   PubMed=24626631; DOI=10.1093/hmg/ddu115;
RA   Bernkopf M., Webersinke G., Tongsook C., Koyani C.N., Rafiq M.A.,
RA   Ayaz M., Mueller D., Enzinger C., Aslam M., Naeem F., Schmidt K.,
RA   Gruber K., Speicher M.R., Malle E., Macheroux P., Ayub M.,
RA   Vincent J.B., Windpassinger C., Duba H.C.;
RT   "Disruption of the methyltransferase-like 23 gene METTL23 causes mild
RT   autosomal recessive intellectual disability.";
RL   Hum. Mol. Genet. 23:4015-4023(2014).
CC   -!- FUNCTION: Probable methyltransferase. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with HSPA5, HSP90B1, TUBULIN, UGGT1 and UGGT2.
CC       {ECO:0000269|PubMed:23349634}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23349634}.
CC       Membrane {ECO:0000305}; Single-pass membrane protein
CC       {ECO:0000305}. Note=When overexpressed, detected in cytoplasmic
CC       membrane-like structures.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q86XA0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86XA0-2; Sequence=VSP_055637;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC   -!- DISEASE: Mental retardation, autosomal recessive 44 (MRT44)
CC       [MIM:615942]: A disorder characterized by significantly below
CC       average general intellectual functioning associated with
CC       impairments in adaptive behavior and manifested during the
CC       developmental period. MRT44 manifestations include mild to severe
CC       cognitive impairment, delayed psychomotor development, seizures in
CC       some patients, and dysmorphic features.
CC       {ECO:0000269|PubMed:24501276, ECO:0000269|PubMed:24626631}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the methyltransferase superfamily. METTL23
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH45819.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; JQ313903; AFH41797.1; -; mRNA.
DR   EMBL; AC005837; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471099; EAW89435.1; -; Genomic_DNA.
DR   EMBL; CH471099; EAW89437.1; -; Genomic_DNA.
DR   EMBL; BC045819; AAH45819.1; ALT_INIT; mRNA.
DR   CCDS; CCDS45787.1; -. [Q86XA0-1]
DR   CCDS; CCDS59298.1; -. [Q86XA0-2]
DR   RefSeq; NP_001073979.3; NM_001080510.4. [Q86XA0-1]
DR   RefSeq; NP_001193912.1; NM_001206983.2. [Q86XA0-1]
DR   RefSeq; NP_001193913.1; NM_001206984.2. [Q86XA0-1]
DR   RefSeq; NP_001193914.1; NM_001206985.2. [Q86XA0-2]
DR   RefSeq; NP_001193915.1; NM_001206986.2. [Q86XA0-2]
DR   RefSeq; NP_001193916.1; NM_001206987.2. [Q86XA0-2]
DR   RefSeq; NP_001289632.1; NM_001302703.1. [Q86XA0-1]
DR   RefSeq; NP_001289633.1; NM_001302704.1. [Q86XA0-2]
DR   RefSeq; NP_001289634.1; NM_001302705.1.
DR   RefSeq; XP_006721737.1; XM_006721674.3. [Q86XA0-1]
DR   RefSeq; XP_006721743.1; XM_006721680.2. [Q86XA0-2]
DR   UniGene; Hs.74655; -.
DR   ProteinModelPortal; Q86XA0; -.
DR   SMR; Q86XA0; -.
DR   BioGrid; 125870; 28.
DR   IntAct; Q86XA0; 2.
DR   MINT; Q86XA0; -.
DR   STRING; 9606.ENSP00000341543; -.
DR   iPTMnet; Q86XA0; -.
DR   PhosphoSitePlus; Q86XA0; -.
DR   BioMuta; METTL23; -.
DR   DMDM; 269849695; -.
DR   PaxDb; Q86XA0; -.
DR   PeptideAtlas; Q86XA0; -.
DR   PRIDE; Q86XA0; -.
DR   Ensembl; ENST00000341249; ENSP00000341543; ENSG00000181038. [Q86XA0-1]
DR   Ensembl; ENST00000586752; ENSP00000466203; ENSG00000181038. [Q86XA0-2]
DR   Ensembl; ENST00000588822; ENSP00000465430; ENSG00000181038. [Q86XA0-2]
DR   Ensembl; ENST00000590964; ENSP00000465890; ENSG00000181038. [Q86XA0-2]
DR   Ensembl; ENST00000615984; ENSP00000482599; ENSG00000181038. [Q86XA0-1]
DR   GeneID; 124512; -.
DR   KEGG; hsa:124512; -.
DR   UCSC; uc002jsr.4; human. [Q86XA0-1]
DR   CTD; 124512; -.
DR   DisGeNET; 124512; -.
DR   EuPathDB; HostDB:ENSG00000181038.13; -.
DR   GeneCards; METTL23; -.
DR   HGNC; HGNC:26988; METTL23.
DR   MalaCards; METTL23; -.
DR   MIM; 615262; gene.
DR   MIM; 615942; phenotype.
DR   neXtProt; NX_Q86XA0; -.
DR   OpenTargets; ENSG00000181038; -.
DR   Orphanet; 88616; Autosomal recessive non-syndromic intellectual disability.
DR   PharmGKB; PA162378566; -.
DR   eggNOG; ENOG410ISZF; Eukaryota.
DR   eggNOG; ENOG4111GNX; LUCA.
DR   GeneTree; ENSGT00510000048008; -.
DR   HOVERGEN; HBG107758; -.
DR   InParanoid; Q86XA0; -.
DR   OMA; TWPCAPV; -.
DR   OrthoDB; EOG091G0NXJ; -.
DR   PhylomeDB; Q86XA0; -.
DR   TreeFam; TF352729; -.
DR   ChiTaRS; METTL23; human.
DR   GenomeRNAi; 124512; -.
DR   PRO; PR:Q86XA0; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000181038; -.
DR   CleanEx; HS_C17orf95; -.
DR   ExpressionAtlas; Q86XA0; baseline and differential.
DR   Genevisible; Q86XA0; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:UniProtKB.
DR   GO; GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0050890; P:cognition; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   InterPro; IPR019410; Methyltransf_16.
DR   InterPro; IPR029063; SAM-dependent_MTases.
DR   Pfam; PF10294; Methyltransf_16; 1.
DR   SUPFAM; SSF53335; SSF53335; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm; Membrane;
KW   Mental retardation; Methyltransferase; Polymorphism;
KW   Reference proteome; S-adenosyl-L-methionine; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    190       Methyltransferase-like protein 23.
FT                                /FTId=PRO_0000321520.
FT   TRANSMEM     29     45       Helical. {ECO:0000255}.
FT   VAR_SEQ       1     67       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_055637.
FT   VARIANT     141    141       L -> V (in dbSNP:rs12602772).
FT                                /FTId=VAR_039343.
FT   CONFLICT    138    138       D -> G (in Ref. 4; AAH45819).
FT                                {ECO:0000305}.
SQ   SEQUENCE   190 AA;  21469 MW;  7820BDC5E7631700 CRC64;
     MYVWPCAVVL AQYLWFHRRS LPGKAILEIG AGVSLPGILA AKCGAEVILS DSSELPHCLE
     VCRQSCQMNN LPHLQVVGLT WGHISWDLLA LPPQDIILAS DVFFEPEDFE DILATIYFLM
     HKNPKVQLWS TYQVRSADWS LEALLYKWDM KCVHIPLESF DADKEDIAES TLPGRHTVEM
     LVISFAKDSL
//
ID   Q8N712_HUMAN            Unreviewed;       270 AA.
AC   Q8N712;
DT   01-OCT-2002, integrated into UniProtKB/TrEMBL.
DT   01-MAR-2004, sequence version 2.
DT   28-FEB-2018, entry version 73.
DE   SubName: Full=C17orf95 protein {ECO:0000313|EMBL:AAH33998.2};
DE   Flags: Fragment;
GN   Name=C17orf95 {ECO:0000313|EMBL:AAH33998.2};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH33998.2};
RN   [1] {ECO:0000313|EMBL:AAH33998.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis {ECO:0000313|EMBL:AAH33998.2};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC033998; AAH33998.2; -; mRNA.
DR   RefSeq; NP_001193914.1; NM_001206985.2.
DR   UniGene; Hs.74655; -.
DR   ProteinModelPortal; Q8N712; -.
DR   IntAct; Q8N712; 2.
DR   iPTMnet; Q8N712; -.
DR   PeptideAtlas; Q8N712; -.
DR   GeneID; 124512; -.
DR   CTD; 124512; -.
DR   eggNOG; KOG2793; Eukaryota.
DR   eggNOG; COG0500; LUCA.
DR   HOGENOM; HOG000006463; -.
DR   HOVERGEN; HBG107758; -.
DR   ChiTaRS; METTL23; human.
DR   GenomeRNAi; 124512; -.
DR   Genevisible; Q8N712; HS.
DR   InterPro; IPR019410; Methyltransf_16.
DR   InterPro; IPR029063; SAM-dependent_MTases.
DR   Pfam; PF10294; Methyltransf_16; 1.
DR   SUPFAM; SSF53335; SSF53335; 1.
PE   2: Evidence at transcript level;
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAH33998.2}.
SQ   SEQUENCE   270 AA;  29582 MW;  79F0713F3E9A1D1A CRC64;
     GARCQFCACE SLSPCSGLSS LAARQGYHQI WAFPFLPSGA TATWPAASRS RSLAARSLPR
     SPARPGPNDA LLGEHDFRGQ GVRAQRFRFS EEPGPGADGA VLEVHVPQIG AGVSLPGILA
     AKCGAEVILS DSSELPHCLE VCRQSCQMNN LPHLQVVGLT WGHISWDLLA LPPQDIILAS
     DVFFEPEDFE DILATIYFLM HKNPKVQLWS TYQVRSADWS LEALLYKWDM KCVHIPLESF
     DADKEDIAES TLPGRHTVEM LVISFAKDSL
//
ID   ENV_HV1H2               Reviewed;         856 AA.
AC   P04578; O09779;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   23-MAY-2018, entry version 168.
DE   RecName: Full=Envelope glycoprotein gp160 {ECO:0000255|HAMAP-Rule:MF_04083};
DE   AltName: Full=Env polyprotein {ECO:0000255|HAMAP-Rule:MF_04083};
DE   Contains:
DE     RecName: Full=Surface protein gp120 {ECO:0000255|HAMAP-Rule:MF_04083};
DE              Short=SU {ECO:0000255|HAMAP-Rule:MF_04083};
DE     AltName: Full=Glycoprotein 120 {ECO:0000255|HAMAP-Rule:MF_04083};
DE              Short=gp120 {ECO:0000255|HAMAP-Rule:MF_04083};
DE   Contains:
DE     RecName: Full=Transmembrane protein gp41 {ECO:0000255|HAMAP-Rule:MF_04083};
DE              Short=TM {ECO:0000255|HAMAP-Rule:MF_04083};
DE     AltName: Full=Glycoprotein 41 {ECO:0000255|HAMAP-Rule:MF_04083};
DE              Short=gp41 {ECO:0000255|HAMAP-Rule:MF_04083};
DE   Flags: Precursor;
GN   Name=env {ECO:0000255|HAMAP-Rule:MF_04083};
OS   Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)
OS   (HIV-1).
OC   Viruses; Retro-transcribing viruses; Retroviridae; Orthoretrovirinae;
OC   Lentivirus; Primate lentivirus group.
OX   NCBI_TaxID=11706;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=3040055; DOI=10.1089/aid.1987.3.57;
RA   Ratner L., Fisher A., Jagodzinski L.L., Mitsuya H., Liou R.-S.,
RA   Gallo R.C., Wong-Staal F.;
RT   "Complete nucleotide sequences of functional clones of the AIDS
RT   virus.";
RL   AIDS Res. Hum. Retroviruses 3:57-69(1987).
RN   [2]
RP   SEQUENCE REVISION.
RA   Ratner L., Fisher A., Jagodzinski L.L., Mitsuya H., Liou R.-S.,
RA   Gallo R.C., Wong-Staal F.;
RL   Submitted (APR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION (ENVELOPE GLYCOPROTEIN GP160).
RX   PubMed=2450679; DOI=10.1016/0092-8674(88)90487-4;
RA   McCune J.M., Rabin L.B., Feinberg M.B., Lieberman M., Kosek J.C.,
RA   Reyes G.R., Weissman I.L.;
RT   "Endoproteolytic cleavage of gp160 is required for the activation of
RT   human immunodeficiency virus.";
RL   Cell 53:55-67(1988).
RN   [4]
RP   FUNCTION (TRANSMEMBRANE PROTEIN GP41).
RX   PubMed=2243396;
RA   Helseth E., Olshevsky U., Gabuzda D., Ardman B., Haseltine W.,
RA   Sodroski J.;
RT   "Changes in the transmembrane region of the human immunodeficiency
RT   virus type 1 gp41 envelope glycoprotein affect membrane fusion.";
RL   J. Virol. 64:6314-6318(1990).
RN   [5]
RP   FUNCTION (ENVELOPE GLYCOPROTEIN GP160).
RX   PubMed=1360148; DOI=10.1038/360358a0;
RA   Hallenberger S., Bosch V., Angliker H., Shaw E., Klenk H.D.,
RA   Garten W.;
RT   "Inhibition of furin-mediated cleavage activation of HIV-1
RT   glycoprotein gp160.";
RL   Nature 360:358-361(1992).
RN   [6]
RP   IMMUNOSUPPRESSIVE REGION.
RX   PubMed=7986401;
RA   Denner J., Norley S., Kurth R.;
RT   "The immunosuppressive peptide of HIV-1: functional domains and immune
RT   response in AIDS patients.";
RL   AIDS 8:1063-1072(1994).
RN   [7]
RP   PALMITOYLATION AT CYS-764 AND CYS-837, AND MUTAGENESIS OF CYS-764 AND
RP   CYS-837.
RX   PubMed=7568235; DOI=10.1073/pnas.92.21.9871;
RA   Yang C., Spies C.P., Compans R.W.;
RT   "The human and simian immunodeficiency virus envelope glycoprotein
RT   transmembrane subunits are palmitoylated.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:9871-9875(1995).
RN   [8]
RP   INTERACTION OF SURFACE PROTEIN GP120 WITH GALACTOSYL CERAMIDE AND
RP   SULFO-GALACTOSYL CERAMIDE.
RX   PubMed=7494242;
RA   Harouse J.M., Collman R.G., Gonzalez-Scarano F.;
RT   "Human immunodeficiency virus type 1 infection of SK-N-MC cells:
RT   domains of gp120 involved in entry into a CD4-negative, galactosyl
RT   ceramide/3' sulfo-galactosyl ceramide-positive cell line.";
RL   J. Virol. 69:7383-7390(1995).
RN   [9]
RP   DOMAIN YXXL MOTIF.
RX   PubMed=10233963;
RA   Deschambeault J., Lalonde J.P., Cervantes-Acosta G., Lodge R.,
RA   Cohen E.A., Lemay G.;
RT   "Polarized human immunodeficiency virus budding in lymphocytes
RT   involves a tyrosine-based signal and favors cell-to-cell viral
RT   transmission.";
RL   J. Virol. 73:5010-5017(1999).
RN   [10]
RP   FUNCTION (SURFACE PROTEIN GP120).
RX   PubMed=11257134; DOI=10.1084/jem.193.6.671;
RA   Bashirova A.A., Geijtenbeek T.B.H., van Duijnhoven G.C.F.,
RA   van Vliet S.J., Eilering J.B.G., Martin M.P., Wu L., Martin T.D.,
RA   Viebig N., Knolle P.A., Kewalramani V.N., van Kooyk Y., Carrington M.;
RT   "A dendritic cell-specific intercellular adhesion molecule 3-grabbing
RT   nonintegrin (DC-SIGN)-related protein is highly expressed on human
RT   liver sinusoidal endothelial cells and promotes HIV-1 infection.";
RL   J. Exp. Med. 193:671-678(2001).
RN   [11]
RP   REVIEW.
RX   PubMed=12974773; DOI=10.1034/j.1600-0463.2003.11107803.x;
RA   Geijtenbeek T.B., van Kooyk Y.;
RT   "Pathogens target DC-SIGN to influence their fate DC-SIGN functions as
RT   a pathogen receptor with broad specificity.";
RL   APMIS 111:698-714(2003).
RN   [12]
RP   DISULFIDE BOND.
RX   PubMed=12218052; DOI=10.1074/jbc.M205467200;
RA   Barbouche R., Miquelis R., Jones I.M., Fenouillet E.;
RT   "Protein-disulfide isomerase-mediated reduction of two disulfide bonds
RT   of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is
RT   required for fusion.";
RL   J. Biol. Chem. 278:3131-3136(2003).
RN   [13]
RP   INTERACTION OF SURFACE PROTEIN GP120 WITH HOST CD209/DC-SIGN AND
RP   CLEC4M/DC-SIGNR.
RX   PubMed=12502850; DOI=10.1128/JVI.77.2.1337-1346.2003;
RA   Lin G., Simmons G., Poehlmann S., Baribaud F., Ni H., Leslie G.J.,
RA   Haggarty B.S., Bates P., Weissman D., Hoxie J.A., Doms R.W.;
RT   "Differential N-linked glycosylation of human immunodeficiency virus
RT   and Ebola virus envelope glycoproteins modulates interactions with DC-
RT   SIGN and DC-SIGNR.";
RL   J. Virol. 77:1337-1346(2003).
RN   [14]
RP   STOICHIOMETRY (ENVELOPE GLYCOPROTEIN GP160).
RX   PubMed=16160141; DOI=10.1128/JVI.79.19.12132-12147.2005;
RA   Yang X., Kurteva S., Ren X., Lee S., Sodroski J.;
RT   "Stoichiometry of envelope glycoprotein trimers in the entry of human
RT   immunodeficiency virus type 1.";
RL   J. Virol. 79:12132-12147(2005).
RN   [15]
RP   REVIEW.
RX   PubMed=12873764; DOI=10.1016/S0005-2736(03)00161-5;
RA   Gallo S.A., Finnegan C.M., Viard M., Raviv Y., Dimitrov A.,
RA   Rawat S.S., Puri A., Durell S., Blumenthal R.;
RT   "The HIV Env-mediated fusion reaction.";
RL   Biochim. Biophys. Acta 1614:36-50(2003).
RN   [16]
RP   REVIEW.
RX   PubMed=15719026; DOI=10.1038/sj.cdd.4401584;
RA   Perfettini J.-L., Castedo M., Roumier T., Andreau K., Nardacci R.,
RA   Piacentini M., Kroemer G.;
RT   "Mechanisms of apoptosis induction by the HIV-1 envelope.";
RL   Cell Death Differ. 12:916-923(2005).
RN   [17]
RP   REVIEW.
RX   PubMed=15725757; DOI=10.1089/aid.2005.21.171;
RA   Hartley O., Klasse P.J., Sattentau Q.J., Moore J.P.;
RT   "V3: HIV's switch-hitter.";
RL   AIDS Res. Hum. Retroviruses 21:171-189(2005).
RN   [18]
RP   REVIEW.
RX   PubMed=16114975; DOI=10.2165/00003495-200565130-00002;
RA   Reeves J.D., Piefer A.J.;
RT   "Emerging drug targets for antiretroviral therapy.";
RL   Drugs 65:1747-1766(2005).
RN   [19]
RP   REVIEW.
RX   PubMed=16437164; DOI=10.1038/sj.emboj.7600947;
RA   Lusso P.;
RT   "HIV and the chemokine system: 10 years later.";
RL   EMBO J. 25:447-456(2006).
RN   [20]
RP   DI-LEUCINE INTERNALIZATION MOTIF.
RX   PubMed=17108326; DOI=10.1091/mbc.E06-06-0535;
RA   Byland R., Vance P.J., Hoxie J.A., Marsh M.;
RT   "A conserved dileucine motif mediates clathrin and AP-2-dependent
RT   endocytosis of the HIV-1 envelope protein.";
RL   Mol. Biol. Cell 18:414-425(2007).
RN   [21]
RP   MEMBRANE-PROXIMAL EXTERNAL REGION.
RX   PubMed=18322034; DOI=10.1128/MMBR.00020-07;
RA   Montero M., van Houten N.E., Wang X., Scott J.K.;
RT   "The membrane-proximal external region of the human immunodeficiency
RT   virus type 1 envelope: dominant site of antibody neutralization and
RT   target for vaccine design.";
RL   Microbiol. Mol. Biol. Rev. 72:54-84(2008).
RN   [22]
RP   INTERACTION OF SURFACE PROTEIN GP120 WITH HEPARAN SULFATE.
RC   STRAIN=HXBC2;
RX   PubMed=18378683; DOI=10.1074/jbc.M800066200;
RA   Crublet E., Andrieu J.P., Vives R.R., Lortat-Jacob H.;
RT   "The HIV-1 envelope glycoprotein gp120 features four heparan sulfate
RT   binding domains, including the co-receptor binding site.";
RL   J. Biol. Chem. 283:15193-15200(2008).
RN   [23]
RP   FUNCTION.
RX   PubMed=19410541; DOI=10.1016/j.cell.2009.02.046;
RA   Miyauchi K., Kim Y., Latinovic O., Morozov V., Melikyan G.B.;
RT   "HIV enters cells via endocytosis and dynamin-dependent fusion with
RT   endosomes.";
RL   Cell 137:433-444(2009).
RN   [24]
RP   IMMUNOSUPPRESSIVE REGION.
RX   PubMed=23383108; DOI=10.1371/journal.pone.0055199;
RA   Denner J., Eschricht M., Lauck M., Semaan M., Schlaermann P., Ryu H.,
RA   Akyuez L.;
RT   "Modulation of cytokine release and gene expression by the
RT   immunosuppressive domain of gp41 of HIV-1.";
RL   PLoS ONE 8:E55199-E55199(2013).
RN   [25]
RP   GLYCOSYLATION AT ASN-88; ASN-156; ASN-160; ASN-197; ASN-234; ASN-262;
RP   ASN-276; ASN-295; ASN-332; ASN-339; ASN-386; ASN-392; ASN-448; ASN-611
RP   AND ASN-637.
RC   STRAIN=BG505;
RX   PubMed=26972002; DOI=10.1016/j.celrep.2016.02.058;
RA   Behrens A.J., Vasiljevic S., Pritchard L.K., Harvey D.J., Andev R.S.,
RA   Krumm S.A., Struwe W.B., Cupo A., Kumar A., Zitzmann N.,
RA   Seabright G.E., Kramer H.B., Spencer D.I., Royle L., Lee J.H.,
RA   Klasse P.J., Burton D.R., Wilson I.A., Ward A.B., Sanders R.W.,
RA   Moore J.P., Doores K.J., Crispin M.;
RT   "Composition and antigenic effects of individual glycan sites of a
RT   trimeric HIV-1 envelope glycoprotein.";
RL   Cell Rep. 14:2695-2706(2016).
RN   [26]
RP   GLYCOSYLATION.
RX   PubMed=28667249; DOI=10.1038/s41598-017-04532-9;
RA   Yang M., Huang J., Simon R., Wang L.X., MacKerell A.D. Jr.;
RT   "Conformational heterogeneity of the HIV envelope glycan shield.";
RL   Sci. Rep. 7:4435-4435(2017).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 628-661 AND 546-581.
RX   PubMed=9108481; DOI=10.1016/S0092-8674(00)80205-6;
RA   Chan D.C., Fass D., Berger J.M., Kim P.S.;
RT   "Core structure of gp41 from the HIV envelope glycoprotein.";
RL   Cell 89:263-273(1997).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 83-127; 195-297; 330-396 AND
RP   410-492, AND GLYCOSYLATION AT ASN-197; ASN-262; ASN-276; ASN-289;
RP   ASN-295; ASN-332; ASN-339; ASN-386; ASN-392 AND ASN-448.
RX   PubMed=9641677; DOI=10.1038/31405;
RA   Kwong P.D., Wyatt R., Robinson J., Sweet R.W., Sodroski J.,
RA   Hendrickson W.A.;
RT   "Structure of an HIV gp120 envelope glycoprotein in complex with the
RT   CD4 receptor and a neutralizing human antibody.";
RL   Nature 393:648-659(1998).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 546-579 AND 628-655.
RX   PubMed=10677212; DOI=10.1021/bi9921687;
RA   Shu W., Liu J., Ji H., Radigen L., Jiang S., Lu M.;
RT   "Helical interactions in the HIV-1 gp41 core reveal structural basis
RT   for the inhibitory activity of gp41 peptides.";
RL   Biochemistry 39:1634-1642(2000).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 546-579 AND 628-655.
RX   PubMed=10636883; DOI=10.1074/jbc.275.3.1839;
RA   Shu W., Ji H., Lu M.;
RT   "Interactions between HIV-1 gp41 core and detergents and their
RT   implications for membrane fusion.";
RL   J. Biol. Chem. 275:1839-1845(2000).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 83-127; 195-297 AND 330-492,
RP   AND GLYCOSYLATION AT ASN-197; ASN-234; ASN-262; ASN-276; ASN-289;
RP   ASN-295; ASN-339; ASN-386; ASN-392; ASN-448 AND ASN-463.
RX   PubMed=11188697; DOI=10.1016/S0969-2126(00)00547-5;
RA   Kwong P.D., Wyatt R., Majeed S., Robinson J., Sweet R.W., Sodroski J.,
RA   Hendrickson W.A.;
RT   "Structures of HIV-1 gp120 envelope glycoproteins from laboratory-
RT   adapted and primary isolates.";
RL   Structure 8:1329-1339(2000).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 546-579 AND 628-655.
RX   PubMed=12044159; DOI=10.1021/bi025648y;
RA   Wang S., York J., Shu W., Stoller M.O., Nunberg J.H., Lu M.;
RT   "Interhelical interactions in the gp41 core: implications for
RT   activation of HIV-1 membrane fusion.";
RL   Biochemistry 41:7283-7292(2002).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 565-581.
RX   PubMed=12417739; DOI=10.1073/pnas.232566599;
RA   Sia S.K., Carr P.A., Cochran A.G., Malashkevich V.N., Kim P.S.;
RT   "Short constrained peptides that inhibit HIV-1 entry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:14664-14669(2002).
RN   [34]
RP   STRUCTURE BY NMR OF 659-671.
RX   PubMed=12860131; DOI=10.1016/S0022-2836(03)00611-9;
RA   Barbato G., Bianchi E., Ingallinella P., Hurni W.H., Miller M.D.,
RA   Ciliberto G., Cortese R., Bazzo R., Shiver J.W., Pessi A.;
RT   "Structural analysis of the epitope of the anti-HIV antibody 2F5 sheds
RT   light into its mechanism of neutralization and HIV fusion.";
RL   J. Mol. Biol. 330:1101-1115(2003).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 195-492, AND GLYCOSYLATION
RP   AT ASN-197; ASN-234; ASN-262; ASN-276; ASN-289; ASN-295; ASN-392;
RP   ASN-448 AND ASN-463.
RX   PubMed=14981267; DOI=10.1073/pnas.0308527100;
RA   Huang C.C., Venturi M., Majeed S., Moore M.J., Phogat S., Zhang M.Y.,
RA   Dimitrov D.S., Hendrickson W.A., Robinson J., Sodroski J., Wyatt R.,
RA   Choe H., Farzan M., Kwong P.D.;
RT   "Structural basis of tyrosine sulfation and VH-gene usage in
RT   antibodies that recognize the HIV type 1 coreceptor-binding site on
RT   gp120.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:2706-2711(2004).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 83-492, AND GLYCOSYLATION AT
RP   ASN-356.
RX   PubMed=17301785; DOI=10.1038/nature05580;
RA   Zhou T., Xu L., Dey B., Hessell A.J., Van Ryk D., Xiang S.H., Yang X.,
RA   Zhang M.Y., Zwick M.B., Arthos J., Burton D.R., Dimitrov D.S.,
RA   Sodroski J., Wyatt R., Nabel G.J., Kwong P.D.;
RT   "Structural definition of a conserved neutralization epitope on HIV-1
RT   gp120.";
RL   Nature 445:732-737(2007).
RN   [37]
RP   STRUCTURE BY NMR OF 662-683.
RX   PubMed=18191596; DOI=10.1016/j.immuni.2007.11.018;
RA   Sun Z.Y., Oh K.J., Kim M., Yu J., Brusic V., Song L., Qiao Z.,
RA   Wang J.H., Wagner G., Reinherz E.L.;
RT   "HIV-1 broadly neutralizing antibody extracts its epitope from a
RT   kinked gp41 ectodomain region on the viral membrane.";
RL   Immunity 28:52-63(2008).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 660-670.
RX   PubMed=18824005; DOI=10.1016/j.jmb.2008.09.024;
RA   Julien J.P., Bryson S., Nieva J.L., Pai E.F.;
RT   "Structural details of HIV-1 recognition by the broadly neutralizing
RT   monoclonal antibody 2F5: epitope conformation, antigen-recognition
RT   loop mobility, and anion-binding site.";
RL   J. Mol. Biol. 384:377-392(2008).
RN   [39]
RP   STRUCTURE BY ELECTRON MICROSCOPY (20.00 ANGSTROMS) OF 90-124; 198-297;
RP   330-396 AND 410-492.
RX   PubMed=18668044; DOI=10.1038/nature07159;
RA   Liu J., Bartesaghi A., Borgnia M.J., Sapiro G., Subramaniam S.;
RT   "Molecular architecture of native HIV-1 gp120 trimers.";
RL   Nature 455:109-113(2008).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 83-492, AND GLYCOSYLATION AT
RP   ASN-88 AND ASN-356.
RX   PubMed=19965434; DOI=10.1126/science.1175868;
RA   Chen L., Kwon Y.D., Zhou T., Wu X., O'Dell S., Cavacini L.,
RA   Hessell A.J., Pancera M., Tang M., Xu L., Yang Z.Y., Zhang M.Y.,
RA   Arthos J., Burton D.R., Dimitrov D.S., Nabel G.J., Posner M.R.,
RA   Sodroski J., Wyatt R., Mascola J.R., Kwong P.D.;
RT   "Structural basis of immune evasion at the site of CD4 attachment on
RT   HIV-1 gp120.";
RL   Science 326:1123-1127(2009).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 543-582; 590-639; 625-662
RP   AND 654-688.
RX   PubMed=21124990; DOI=10.1371/journal.ppat.1001195;
RA   Sabin C., Corti D., Buzon V., Seaman M.S., Lutje Hulsik D., Hinz A.,
RA   Vanzetta F., Agatic G., Silacci C., Mainetti L., Scarlatti G.,
RA   Sallusto F., Weiss R., Lanzavecchia A., Weissenhorn W.;
RT   "Crystal structure and size-dependent neutralization properties of
RT   HK20, a human monoclonal antibody binding to the highly conserved
RT   heptad repeat 1 of gp41.";
RL   PLoS Pathog. 6:E1001195-E1001195(2010).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (3.25 ANGSTROMS) OF 254-297; 330-401; 412-419
RP   AND 445-477, AND GLYCOSYLATION AT ASN-332.
RX   PubMed=21998254; DOI=10.1126/science.1213256;
RA   Pejchal R., Doores K.J., Walker L.M., Khayat R., Huang P.S.,
RA   Wang S.K., Stanfield R.L., Julien J.P., Ramos A., Crispin M.,
RA   Depetris R., Katpally U., Marozsan A., Cupo A., Maloveste S., Liu Y.,
RA   McBride R., Ito Y., Sanders R.W., Ogohara C., Paulson J.C., Feizi T.,
RA   Scanlan C.N., Wong C.H., Moore J.P., Olson W.C., Ward A.B.,
RA   Poignard P., Schief W.R., Burton D.R., Wilson I.A.;
RT   "A potent and broad neutralizing antibody recognizes and penetrates
RT   the HIV glycan shield.";
RL   Science 334:1097-1103(2011).
RN   [43]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 546-581.
RX   PubMed=22228771; DOI=10.1074/jbc.M111.317883;
RA   Yao X., Chong H., Zhang C., Waltersperger S., Wang M., Cui S., He Y.;
RT   "Broad antiviral activity and crystal structure of HIV-1 fusion
RT   inhibitor sifuvirtide.";
RL   J. Biol. Chem. 287:6788-6796(2012).
RN   [44]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 254-399, AND GLYCOSYLATION
RP   AT ASN-262.
RX   PubMed=23539181; DOI=10.1126/science.1234150;
RA   Jardine J., Julien J.P., Menis S., Ota T., Kalyuzhniy O., McGuire A.,
RA   Sok D., Huang P.S., MacPherson S., Jones M., Nieusma T., Mathison J.,
RA   Baker D., Ward A.B., Burton D.R., Stamatatos L., Nemazee D.,
RA   Wilson I.A., Schief W.R.;
RT   "Rational HIV immunogen design to target specific germline B cell
RT   receptors.";
RL   Science 340:711-716(2013).
RN   [45]
RP   STRUCTURE BY NMR OF 657-683.
RX   PubMed=24075869; DOI=10.1016/j.jmb.2013.09.030;
RA   Sun Z.Y., Cheng Y., Kim M., Song L., Choi J., Kudahl U.J., Brusic V.,
RA   Chowdhury B., Yu L., Seaman M.S., Bellot G., Shih W.M., Wagner G.,
RA   Reinherz E.L.;
RT   "Disruption of helix-capping residues 671 and 674 reveals a role in
RT   HIV-1 entry for a specialized hinge segment of the membrane proximal
RT   external region of gp41.";
RL   J. Mol. Biol. 426:1095-1108(2014).
CC   -!- FUNCTION: Envelope glycoprotein gp160: Oligomerizes in the host
CC       endoplasmic reticulum into predominantly trimers. In a second
CC       time, gp160 transits in the host Golgi, where glycosylation is
CC       completed. The precursor is then proteolytically cleaved in the
CC       trans-Golgi and thereby activated by cellular furin or furin-like
CC       proteases to produce gp120 and gp41. {ECO:0000255|HAMAP-
CC       Rule:MF_04083, ECO:0000269|PubMed:1360148,
CC       ECO:0000269|PubMed:2450679}.
CC   -!- FUNCTION: Surface protein gp120: Attaches the virus to the host
CC       lymphoid cell by binding to the primary receptor CD4. This
CC       interaction induces a structural rearrangement creating a high
CC       affinity binding site for a chemokine coreceptor like CXCR4 and/or
CC       CCR5. Acts as a ligand for CD209/DC-SIGN and CLEC4M/DC-SIGNR,
CC       which are respectively found on dendritic cells (DCs), and on
CC       endothelial cells of liver sinusoids and lymph node sinuses. These
CC       interactions allow capture of viral particles at mucosal surfaces
CC       by these cells and subsequent transmission to permissive cells.
CC       HIV subverts the migration properties of dendritic cells to gain
CC       access to CD4+ T-cells in lymph nodes. Virus transmission to
CC       permissive T-cells occurs either in trans (without DCs infection,
CC       through viral capture and transmission), or in cis (following DCs
CC       productive infection, through the usual CD4-gp120 interaction),
CC       thereby inducing a robust infection. In trans infection, bound
CC       virions remain infectious over days and it is proposed that they
CC       are not degraded, but protected in non-lysosomal acidic organelles
CC       within the DCs close to the cell membrane thus contributing to the
CC       viral infectious potential during DCs' migration from the
CC       periphery to the lymphoid tissues. On arrival at lymphoid tissues,
CC       intact virions recycle back to DCs' cell surface allowing virus
CC       transmission to CD4+ T-cells. {ECO:0000255|HAMAP-Rule:MF_04083,
CC       ECO:0000269|PubMed:11257134, ECO:0000269|PubMed:19410541}.
CC   -!- FUNCTION: Transmembrane protein gp41: Acts as a class I viral
CC       fusion protein. Under the current model, the protein has at least
CC       3 conformational states: pre-fusion native state, pre-hairpin
CC       intermediate state, and post-fusion hairpin state. During fusion
CC       of viral and target intracellular membranes, the coiled coil
CC       regions (heptad repeats) assume a trimer-of-hairpins structure,
CC       positioning the fusion peptide in close proximity to the C-
CC       terminal region of the ectodomain. The formation of this structure
CC       appears to drive apposition and subsequent fusion of viral and
CC       target cell membranes. Complete fusion occurs in host cell
CC       endosomes and is dynamin-dependent, however some lipid transfer
CC       might occur at the plasma membrane. The virus undergoes clathrin-
CC       dependent internalization long before endosomal fusion, thus
CC       minimizing the surface exposure of conserved viral epitopes during
CC       fusion and reducing the efficacy of inhibitors targeting these
CC       epitopes. Membranes fusion leads to delivery of the nucleocapsid
CC       into the cytoplasm. {ECO:0000255|HAMAP-Rule:MF_04083,
CC       ECO:0000269|PubMed:19410541, ECO:0000269|PubMed:2243396}.
CC   -!- SUBUNIT: The mature envelope protein (Env) consists of a
CC       homotrimer of non-covalently associated gp120-gp41 heterodimers.
CC       The resulting complex protrudes from the virus surface as a spike.
CC       There seems to be as few as 10 spikes on the average virion.
CC       Surface protein gp120 interacts with host CD4, CCR5 and CXCR4.
CC       Gp120 also interacts with the C-type lectins CD209/DC-SIGN and
CC       CLEC4M/DC-SIGNR (collectively referred to as DC-SIGN(R)). Gp120
CC       and gp41 interact with GalCer. Gp120 interacts with host
CC       ITGA4/ITGB7 complex; on CD4+ T-cells, this interaction results in
CC       rapid activation of integrin ITGAL/LFA-1, which facilitates
CC       efficient cell-to-cell spreading of HIV-1. Gp120 interacts with
CC       cell-associated heparan sulfate; this interaction increases virus
CC       infectivity on permissive cells and may be involved in infection
CC       of CD4- cells. {ECO:0000255|HAMAP-Rule:MF_04083,
CC       ECO:0000269|PubMed:12502850, ECO:0000269|PubMed:18378683,
CC       ECO:0000269|PubMed:7494242}.
CC   -!- INTERACTION:
CC       P27824:CANX (xeno); NbExp=3; IntAct=EBI-6163496, EBI-355947;
CC       P01730:CD4 (xeno); NbExp=2; IntAct=EBI-6163496, EBI-353826;
CC       P08962:CD63 (xeno); NbExp=4; IntAct=EBI-6179711, EBI-762053;
CC       Q9ULD8:KCNH3 (xeno); NbExp=3; IntAct=EBI-6163496, EBI-8079227;
CC       P04608:tat; NbExp=4; IntAct=EBI-6163496, EBI-6164389;
CC   -!- SUBCELLULAR LOCATION: Surface protein gp120: Virion membrane
CC       {ECO:0000255|HAMAP-Rule:MF_04083}; Peripheral membrane protein
CC       {ECO:0000255|HAMAP-Rule:MF_04083}. Host cell membrane
CC       {ECO:0000255|HAMAP-Rule:MF_04083}; Peripheral membrane protein
CC       {ECO:0000255|HAMAP-Rule:MF_04083}. Host endosome membrane
CC       {ECO:0000255|HAMAP-Rule:MF_04083}; Single-pass type I membrane
CC       protein {ECO:0000255|HAMAP-Rule:MF_04083}. Note=The surface
CC       protein is not anchored to the viral envelope, but associates with
CC       the extravirion surface through its binding to TM. It is probably
CC       concentrated at the site of budding and incorporated into the
CC       virions possibly by contacts between the cytoplasmic tail of Env
CC       and the N-terminus of Gag. {ECO:0000255|HAMAP-Rule:MF_04083}.
CC   -!- SUBCELLULAR LOCATION: Transmembrane protein gp41: Virion membrane
CC       {ECO:0000255|HAMAP-Rule:MF_04083}; Single-pass type I membrane
CC       protein {ECO:0000255|HAMAP-Rule:MF_04083}. Host cell membrane
CC       {ECO:0000255|HAMAP-Rule:MF_04083}; Single-pass type I membrane
CC       protein {ECO:0000255|HAMAP-Rule:MF_04083}. Host endosome membrane
CC       {ECO:0000255|HAMAP-Rule:MF_04083}; Single-pass type I membrane
CC       protein {ECO:0000255|HAMAP-Rule:MF_04083}. Note=It is probably
CC       concentrated at the site of budding and incorporated into the
CC       virions possibly by contacts between the cytoplasmic tail of Env
CC       and the N-terminus of Gag. {ECO:0000255|HAMAP-Rule:MF_04083}.
CC   -!- DOMAIN: Some of the most genetically diverse regions of the viral
CC       genome are present in Env. They are called variable regions 1
CC       through 5 (V1 through V5). Coreceptor usage of gp120 is determined
CC       mainly by the primary structure of the third variable region (V3)
CC       in the outer domain of gp120. The sequence of V3 determines which
CC       coreceptor, CCR5 and/or CXCR4 (corresponding to R5/macrophage,
CC       X4/T cell and R5X4/T cell and macrophage tropism), is used to
CC       trigger the fusion potential of the Env complex, and hence which
CC       cells the virus can infect. Binding to CCR5 involves a region
CC       adjacent in addition to V3. {ECO:0000255|HAMAP-Rule:MF_04083,
CC       ECO:0000269|PubMed:10233963}.
CC   -!- DOMAIN: The membrane proximal external region (MPER) present in
CC       gp41 is a tryptophan-rich region recognized by the antibodies 2F5,
CC       Z13, and 4E10. MPER seems to play a role in fusion.
CC       {ECO:0000255|HAMAP-Rule:MF_04083, ECO:0000269|PubMed:10233963}.
CC   -!- DOMAIN: The 17 amino acids long immunosuppressive region is
CC       present in many retroviral envelope proteins. Synthetic peptides
CC       derived from this relatively conserved sequence inhibit immune
CC       function in vitro and in vivo. {ECO:0000255|HAMAP-Rule:MF_04083,
CC       ECO:0000269|PubMed:23383108}.
CC   -!- DOMAIN: The YXXL motif is involved in determining the exact site
CC       of viral release at the surface of infected mononuclear cells and
CC       promotes endocytosis. YXXL and di-leucine endocytosis motifs
CC       interact directly or indirectly with the clathrin adapter
CC       complexes, opperate independently, and their activities are not
CC       additive. {ECO:0000255|HAMAP-Rule:MF_04083,
CC       ECO:0000269|PubMed:10233963}.
CC   -!- DOMAIN: The CD4-binding region is targeted by the antibody b12.
CC       {ECO:0000255|HAMAP-Rule:MF_04083, ECO:0000269|PubMed:10233963}.
CC   -!- PTM: Palmitoylation of the transmembrane protein and of Env
CC       polyprotein (prior to its proteolytic cleavage) is essential for
CC       their association with host cell membrane lipid rafts.
CC       Palmitoylation is therefore required for envelope trafficking to
CC       classical lipid rafts, but not for viral replication.
CC       {ECO:0000255|HAMAP-Rule:MF_04083, ECO:0000269|PubMed:7568235}.
CC   -!- PTM: Highly glycosylated by host. The high number of glycan on the
CC       protein is reffered to as 'glycan shield' because it contributes
CC       to hide protein sequence from adaptive immune system.
CC       {ECO:0000255|HAMAP-Rule:MF_04083, ECO:0000269|PubMed:26972002,
CC       ECO:0000269|PubMed:28667249}.
CC   -!- PTM: Specific enzymatic cleavages in vivo yield mature proteins.
CC       Envelope glycoproteins are synthesized as a inactive precursor
CC       that is heavily N-glycosylated and processed likely by host cell
CC       furin in the Golgi to yield the mature SU and TM proteins. The
CC       cleavage site between SU and TM requires the minimal sequence
CC       [KR]-X-[KR]-R. About 2 of the 9 disulfide bonds of gp41 are
CC       reduced by P4HB/PDI, following binding to CD4 receptor.
CC       {ECO:0000255|HAMAP-Rule:MF_04083, ECO:0000269|PubMed:12218052,
CC       ECO:0000269|PubMed:2450679}.
CC   -!- MISCELLANEOUS: Inhibitors targeting HIV-1 viral envelope proteins
CC       are used as antiretroviral drugs. Attachment of virions to the
CC       cell surface via non-specific interactions and CD4 binding can be
CC       blocked by inhibitors that include cyanovirin-N,
CC       cyclotriazadisulfonamide analogs, PRO 2000, TNX 355 and PRO 542.
CC       In addition, BMS 806 can block CD4-induced conformational changes.
CC       Env interactions with the coreceptor molecules can be targeted by
CC       CCR5 antagonists including SCH-D, maraviroc (UK 427857) and
CC       aplaviroc (GW 873140), and the CXCR4 antagonist AMD 070. Fusion of
CC       viral and cellular membranes can be inhibited by peptides such as
CC       enfuvirtide and tifuvirtide (T 1249). Resistance to inhibitors
CC       associated with mutations in Env are observed. Most of the time,
CC       single mutations confer only a modest reduction in drug
CC       susceptibility. Combination of several mutations is usually
CC       required to develop a high-level drug resistance.
CC       {ECO:0000255|HAMAP-Rule:MF_04083}.
CC   -!- MISCELLANEOUS: HIV-1 lineages are divided in three main groups, M
CC       (for Major), O (for Outlier), and N (for New, or Non-M, Non-O).
CC       The vast majority of strains found worldwide belong to the group
CC       M. Group O seems to be endemic to and largely confined to Cameroon
CC       and neighboring countries in West Central Africa, where these
CC       viruses represent a small minority of HIV-1 strains. The group N
CC       is represented by a limited number of isolates from Cameroonian
CC       persons. The group M is further subdivided in 9 clades or subtypes
CC       (A to D, F to H, J and K). {ECO:0000255|HAMAP-Rule:MF_04083}.
CC   -!- SIMILARITY: Belongs to the HIV-1 env protein family.
CC       {ECO:0000255|HAMAP-Rule:MF_04083}.
CC   -!- WEB RESOURCE: Name=BioAfrica HIV proteomics resource; Note=Env
CC       entry;
CC       URL="http://www.bioafrica.net/proteomics/ENVprot.html";
CC   -!- WEB RESOURCE: Name=BioAfrica HIV proteomics resource; Note=gp120
CC       entry;
CC       URL="http://www.bioafrica.net/proteomics/ENV-GP120prot.html";
CC   -!- WEB RESOURCE: Name=BioAfrica HIV proteomics resource; Note=gp41
CC       entry;
CC       URL="http://www.bioafrica.net/proteomics/ENV-GP41prot.html";
CC   -!- WEB RESOURCE: Name=hivdb; Note=HIV drug resistance database;
CC       URL="http://hivdb.stanford.edu";
CC   -!- WEB RESOURCE: Name=BioAfrica: HIV bioinformatics in Africa;
CC       URL="http://www.bioafrica.net/index.html";
CC   -!- WEB RESOURCE: Name=HIV drug resistance mutations;
CC       URL="https://www.iasusa.org/content/hiv-drug-resistance-mutations";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; K03455; AAB50262.1; -; Genomic_RNA.
DR   EMBL; AF038399; AAB99976.1; -; Genomic_DNA.
DR   EMBL; AF033819; AAC82596.1; -; Genomic_RNA.
DR   RefSeq; NP_057856.1; NC_001802.1.
DR   PDB; 1AIK; X-ray; 2.00 A; C=628-661, N=546-581.
DR   PDB; 1DF4; X-ray; 1.45 A; A=546-579, A=628-655.
DR   PDB; 1DF5; X-ray; 2.70 A; A=546-579, A=628-655.
DR   PDB; 1DLB; X-ray; 2.00 A; A=546-579, A=628-655.
DR   PDB; 1FAV; X-ray; 3.00 A; C=636-665.
DR   PDB; 1G9M; X-ray; 2.20 A; G=83-127, G=195-297, G=330-492.
DR   PDB; 1GC1; X-ray; 2.50 A; G=83-127, G=195-297, G=330-396, G=410-492.
DR   PDB; 1GZL; X-ray; 1.80 A; A/B=565-581, C/D=628-639.
DR   PDB; 1K33; X-ray; 1.75 A; A=546-579, A=628-655.
DR   PDB; 1K34; X-ray; 1.88 A; A=546-579, A=628-655.
DR   PDB; 1MZI; NMR; -; A=659-671.
DR   PDB; 1OPN; Model; -; G=156-492.
DR   PDB; 1OPT; Model; -; G=156-492.
DR   PDB; 1OPW; Model; -; G=156-492.
DR   PDB; 1RZJ; X-ray; 2.20 A; G=195-492.
DR   PDB; 2CMR; X-ray; 2.00 A; A=543-662.
DR   PDB; 2ME1; NMR; -; A=657-683.
DR   PDB; 2MG1; NMR; -; A=683-704.
DR   PDB; 2MG2; NMR; -; A=675-693.
DR   PDB; 2MG3; NMR; -; A=675-693.
DR   PDB; 2NY7; X-ray; 2.30 A; G=83-492.
DR   PDB; 2PV6; NMR; -; A=662-683.
DR   PDB; 2XRA; X-ray; 2.30 A; A=543-662.
DR   PDB; 3D0V; X-ray; 2.05 A; C=660-670.
DR   PDB; 3DNL; EM; 20.00 A; A/D/G=90-124, B/E/H=198-297, B/E/H=330-396, C/F/I=410-492.
DR   PDB; 3DNN; EM; 20.00 A; A/D/G=90-124, B/E/H=198-297, B/E/H=330-396, C/F/I=410-492.
DR   PDB; 3DNO; EM; 20.00 A; A/D/G=90-124, B/E/H=198-297, B/E/H=330-396, C/F/I=410-492.
DR   PDB; 3DRO; X-ray; 3.90 A; P=659-671.
DR   PDB; 3IDX; X-ray; 2.50 A; G=83-492.
DR   PDB; 3IDY; X-ray; 3.20 A; A/G=83-492.
DR   PDB; 3J70; EM; -; D/P/U=31-500.
DR   PDB; 3MNZ; X-ray; 1.80 A; P=653-671.
DR   PDB; 3TYG; X-ray; 3.25 A; A=254-297, A=330-401.
DR   PDB; 3VIE; X-ray; 1.80 A; A/C/E=546-581.
DR   PDB; 4JPJ; X-ray; 2.50 A; A/B/C/D=254-399.
DR   PDB; 4JPK; X-ray; 2.40 A; A=254-399.
DR   PDB; 4YDV; X-ray; 2.70 A; P/Q=596-606.
DR   PDB; 4ZTO; X-ray; 2.30 A; P/Q=430-444.
DR   PDB; 5BN0; X-ray; 2.80 A; A/C/D=627-661, B/E/N=546-581.
DR   PDB; 5C0R; X-ray; 3.19 A; A=546-577, A=628-654.
DR   PDB; 5C0S; X-ray; 4.30 A; A=546-577, A=630-654.
DR   PDB; 5CIL; X-ray; 1.81 A; P=671-683.
DR   PDB; 5CIN; X-ray; 1.70 A; P=671-683.
DR   PDB; 5CMU; X-ray; 2.11 A; A/B/C=546-635.
DR   PDB; 5CMZ; X-ray; 2.57 A; A/C=546-590.
DR   PDB; 5CN0; X-ray; 1.90 A; A=546-581.
DR   PDB; 5DD0; X-ray; 2.49 A; P=660-670.
DR   PDB; 5GHW; X-ray; 2.40 A; P=664-690.
DR   PDB; 5H0N; X-ray; 2.80 A; A/C/E/G/I/K=536-581.
DR   PDB; 5HFL; X-ray; 2.29 A; A/B/C/D/E/F=546-581.
DR   PDB; 5HM1; X-ray; 2.96 A; D/E/F=582-596.
DR   PDB; 5IVX; X-ray; 2.10 A; P=311-320.
DR   PDB; 5KA5; X-ray; 1.80 A; A=543-582, A=625-661.
DR   PDB; 5KA6; X-ray; 1.85 A; A/B/C=543-582, A/B/C=625-661.
DR   PDB; 5NWU; NMR; -; A=514-528, A=655-671.
DR   PDB; 5X08; X-ray; 1.49 A; P=671-683.
DR   PDB; 5YB4; X-ray; 2.50 A; D/E/F=546-581.
DR   PDB; 5Z0W; X-ray; 1.90 A; E=546-581.
DR   PDB; 6BXQ; X-ray; 1.58 A; A=2-11.
DR   PDBsum; 1AIK; -.
DR   PDBsum; 1DF4; -.
DR   PDBsum; 1DF5; -.
DR   PDBsum; 1DLB; -.
DR   PDBsum; 1FAV; -.
DR   PDBsum; 1G9M; -.
DR   PDBsum; 1GC1; -.
DR   PDBsum; 1GZL; -.
DR   PDBsum; 1K33; -.
DR   PDBsum; 1K34; -.
DR   PDBsum; 1MZI; -.
DR   PDBsum; 1OPN; -.
DR   PDBsum; 1OPT; -.
DR   PDBsum; 1OPW; -.
DR   PDBsum; 1RZJ; -.
DR   PDBsum; 2CMR; -.
DR   PDBsum; 2ME1; -.
DR   PDBsum; 2MG1; -.
DR   PDBsum; 2MG2; -.
DR   PDBsum; 2MG3; -.
DR   PDBsum; 2NY7; -.
DR   PDBsum; 2PV6; -.
DR   PDBsum; 2XRA; -.
DR   PDBsum; 3D0V; -.
DR   PDBsum; 3DNL; -.
DR   PDBsum; 3DNN; -.
DR   PDBsum; 3DNO; -.
DR   PDBsum; 3DRO; -.
DR   PDBsum; 3IDX; -.
DR   PDBsum; 3IDY; -.
DR   PDBsum; 3J70; -.
DR   PDBsum; 3MNZ; -.
DR   PDBsum; 3TYG; -.
DR   PDBsum; 3VIE; -.
DR   PDBsum; 4JPJ; -.
DR   PDBsum; 4JPK; -.
DR   PDBsum; 4YDV; -.
DR   PDBsum; 4ZTO; -.
DR   PDBsum; 5BN0; -.
DR   PDBsum; 5C0R; -.
DR   PDBsum; 5C0S; -.
DR   PDBsum; 5CIL; -.
DR   PDBsum; 5CIN; -.
DR   PDBsum; 5CMU; -.
DR   PDBsum; 5CMZ; -.
DR   PDBsum; 5CN0; -.
DR   PDBsum; 5DD0; -.
DR   PDBsum; 5GHW; -.
DR   PDBsum; 5H0N; -.
DR   PDBsum; 5HFL; -.
DR   PDBsum; 5HM1; -.
DR   PDBsum; 5IVX; -.
DR   PDBsum; 5KA5; -.
DR   PDBsum; 5KA6; -.
DR   PDBsum; 5NWU; -.
DR   PDBsum; 5X08; -.
DR   PDBsum; 5YB4; -.
DR   PDBsum; 5Z0W; -.
DR   PDBsum; 6BXQ; -.
DR   DisProt; DP00976; -.
DR   ProteinModelPortal; P04578; -.
DR   SMR; P04578; -.
DR   BioGrid; 1205544; 156.
DR   DIP; DIP-58525N; -.
DR   IntAct; P04578; 154.
DR   MINT; P04578; -.
DR   BindingDB; P04578; -.
DR   ChEMBL; CHEMBL3520; -.
DR   TCDB; 1.G.16.1.3; the human immunodeficiency virus type 1 (hiv-1) fusion peptide (hiv-fp) family.
DR   iPTMnet; P04578; -.
DR   SwissPalm; P04578; -.
DR   PRIDE; P04578; -.
DR   GeneID; 155971; -.
DR   KEGG; vg:155971; -.
DR   KO; K19287; -.
DR   OrthoDB; VOG09000036; -.
DR   Reactome; R-HSA-1462054; Alpha-defensins.
DR   Reactome; R-HSA-162588; Budding and maturation of HIV virion.
DR   Reactome; R-HSA-171286; Synthesis and processing of ENV and VPU.
DR   Reactome; R-HSA-173107; Binding and entry of HIV virion.
DR   Reactome; R-HSA-175474; Assembly Of The HIV Virion.
DR   Reactome; R-HSA-5621480; Dectin-2 family.
DR   EvolutionaryTrace; P04578; -.
DR   PRO; PR:P04578; -.
DR   Proteomes; UP000002241; Genome.
DR   Proteomes; UP000105453; Genome.
DR   GO; GO:0044175; C:host cell endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0020002; C:host cell plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0019031; C:viral envelope; IEA:UniProtKB-KW.
DR   GO; GO:0019012; C:virion; IDA:UniProtKB.
DR   GO; GO:0055036; C:virion membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0090527; P:actin filament reorganization; IDA:UniProtKB.
DR   GO; GO:0075512; P:clathrin-dependent endocytosis of virus by host cell; IDA:UniProtKB.
DR   GO; GO:0030260; P:entry into host cell; TAS:Reactome.
DR   GO; GO:0030683; P:evasion or tolerance by virus of host immune response; IEA:UniProtKB-KW.
DR   GO; GO:0039654; P:fusion of virus membrane with host endosome membrane; IEA:UniProtKB-KW.
DR   GO; GO:0019064; P:fusion of virus membrane with host plasma membrane; IDA:UniProtKB.
DR   GO; GO:1903905; P:positive regulation of establishment of T cell polarity; IDA:UniProtKB.
DR   GO; GO:1903908; P:positive regulation of plasma membrane raft polarization; IDA:UniProtKB.
DR   GO; GO:1903911; P:positive regulation of receptor clustering; IDA:UniProtKB.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0019058; P:viral life cycle; TAS:Reactome.
DR   GO; GO:0019082; P:viral protein processing; IDA:UniProtKB.
DR   GO; GO:0019068; P:virion assembly; TAS:Reactome.
DR   GO; GO:0019062; P:virion attachment to host cell; IDA:UniProtKB.
DR   CDD; cd09909; HIV-1-like_HR1-HR2; 1.
DR   Gene3D; 2.170.40.20; -; 2.
DR   HAMAP; MF_04083; HIV_ENV; 1.
DR   InterPro; IPR036377; Gp120_core_sf.
DR   InterPro; IPR037527; Gp160.
DR   InterPro; IPR000328; GP41-like.
DR   InterPro; IPR000777; HIV1_Gp120.
DR   Pfam; PF00516; GP120; 1.
DR   Pfam; PF00517; GP41; 1.
DR   SUPFAM; SSF56502; SSF56502; 3.
PE   1: Evidence at protein level;
KW   3D-structure; AIDS; Apoptosis;
KW   Clathrin-mediated endocytosis of virus by host;
KW   Cleavage on pair of basic residues; Coiled coil; Complete proteome;
KW   Disulfide bond; Fusion of virus membrane with host endosomal membrane;
KW   Fusion of virus membrane with host membrane; Glycoprotein;
KW   Host cell membrane; Host endosome; Host membrane;
KW   Host-virus interaction; Lipoprotein; Membrane; Palmitate;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Viral attachment to host cell; Viral envelope protein;
KW   Viral immunoevasion; Viral penetration into host cytoplasm; Virion;
KW   Virus endocytosis by host; Virus entry into host cell.
FT   SIGNAL        1     32       {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   CHAIN        33    856       Envelope glycoprotein gp160.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT                                /FTId=PRO_0000239240.
FT   CHAIN        33    511       Surface protein gp120.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT                                /FTId=PRO_0000038427.
FT   CHAIN       512    856       Transmembrane protein gp41.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT                                /FTId=PRO_0000038428.
FT   TOPO_DOM     33    684       Extracellular. {ECO:0000255|HAMAP-
FT                                Rule:MF_04083}.
FT   TRANSMEM    685    705       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_04083}.
FT   TOPO_DOM    706    856       Cytoplasmic. {ECO:0000255|HAMAP-
FT                                Rule:MF_04083}.
FT   REGION      131    156       V1. {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   REGION      157    196       V2. {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   REGION      296    330       V3. {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   REGION      364    374       CD4-binding loop. {ECO:0000255|HAMAP-
FT                                Rule:MF_04083}.
FT   REGION      385    418       V4. {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   REGION      461    471       V5.
FT   REGION      463    471       V5. {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   REGION      512    532       Fusion peptide. {ECO:0000255|HAMAP-
FT                                Rule:MF_04083}.
FT   REGION      574    592       Immunosuppression. {ECO:0000255|HAMAP-
FT                                Rule:MF_04083,
FT                                ECO:0000269|PubMed:23383108}.
FT   REGION      662    683       MPER; binding to GalCer.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   COILED      633    667       {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   MOTIF       712    715       YXXL motif; contains endocytosis signal.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   MOTIF       855    856       Di-leucine internalization motif.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   SITE        511    512       Cleavage; by host furin.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   LIPID       764    764       S-palmitoyl cysteine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:7568235}.
FT   LIPID       837    837       S-palmitoyl cysteine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:7568235}.
FT   CARBOHYD     88     88       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:19965434,
FT                                ECO:0000269|PubMed:26972002}.
FT   CARBOHYD    136    136       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   CARBOHYD    141    141       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   CARBOHYD    156    156       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:26972002}.
FT   CARBOHYD    160    160       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:26972002}.
FT   CARBOHYD    186    186       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   CARBOHYD    197    197       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:11188697,
FT                                ECO:0000269|PubMed:14981267,
FT                                ECO:0000269|PubMed:26972002,
FT                                ECO:0000269|PubMed:9641677}.
FT   CARBOHYD    230    230       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   CARBOHYD    234    234       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:11188697,
FT                                ECO:0000269|PubMed:14981267,
FT                                ECO:0000269|PubMed:26972002}.
FT   CARBOHYD    241    241       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   CARBOHYD    262    262       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:11188697,
FT                                ECO:0000269|PubMed:14981267,
FT                                ECO:0000269|PubMed:23539181,
FT                                ECO:0000269|PubMed:26972002,
FT                                ECO:0000269|PubMed:9641677}.
FT   CARBOHYD    276    276       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:11188697,
FT                                ECO:0000269|PubMed:14981267,
FT                                ECO:0000269|PubMed:26972002,
FT                                ECO:0000269|PubMed:9641677}.
FT   CARBOHYD    289    289       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:11188697,
FT                                ECO:0000269|PubMed:14981267,
FT                                ECO:0000269|PubMed:9641677}.
FT   CARBOHYD    295    295       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:11188697,
FT                                ECO:0000269|PubMed:14981267,
FT                                ECO:0000269|PubMed:26972002,
FT                                ECO:0000269|PubMed:9641677}.
FT   CARBOHYD    301    301       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   CARBOHYD    332    332       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:21998254,
FT                                ECO:0000269|PubMed:26972002,
FT                                ECO:0000269|PubMed:9641677}.
FT   CARBOHYD    339    339       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:11188697,
FT                                ECO:0000269|PubMed:26972002,
FT                                ECO:0000269|PubMed:9641677}.
FT   CARBOHYD    356    356       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000244|PDB:2NY7,
FT                                ECO:0000244|PDB:3IDX,
FT                                ECO:0000244|PDB:3IDY, ECO:0000255|HAMAP-
FT                                Rule:MF_04083,
FT                                ECO:0000269|PubMed:17301785,
FT                                ECO:0000269|PubMed:19965434}.
FT   CARBOHYD    386    386       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:11188697,
FT                                ECO:0000269|PubMed:26972002,
FT                                ECO:0000269|PubMed:9641677}.
FT   CARBOHYD    392    392       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:11188697,
FT                                ECO:0000269|PubMed:14981267,
FT                                ECO:0000269|PubMed:26972002,
FT                                ECO:0000269|PubMed:9641677}.
FT   CARBOHYD    397    397       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   CARBOHYD    406    406       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   CARBOHYD    448    448       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:11188697,
FT                                ECO:0000269|PubMed:14981267,
FT                                ECO:0000269|PubMed:26972002,
FT                                ECO:0000269|PubMed:9641677}.
FT   CARBOHYD    463    463       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:11188697,
FT                                ECO:0000269|PubMed:14981267}.
FT   CARBOHYD    611    611       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:26972002}.
FT   CARBOHYD    616    616       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   CARBOHYD    624    624       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   CARBOHYD    637    637       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083,
FT                                ECO:0000269|PubMed:26972002}.
FT   CARBOHYD    674    674       N-linked (GlcNAc...) asparagine; by host.
FT                                {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   DISULFID     54     74       {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   DISULFID    119    205       {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   DISULFID    126    196       {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   DISULFID    131    157       {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   DISULFID    218    247       {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   DISULFID    228    239       {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   DISULFID    296    331       {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   DISULFID    378    445       {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   DISULFID    385    418       {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   DISULFID    598    604       {ECO:0000255|HAMAP-Rule:MF_04083}.
FT   MUTAGEN     764    764       C->S: Complete loss of palmitoylation,
FT                                decreased association with host cell
FT                                membrane lipid rafts, decreased
FT                                incorporation onto virions and severe
FT                                reduction of infectivity; when associated
FT                                with S-837. {ECO:0000269|PubMed:7568235}.
FT   MUTAGEN     837    837       C->S: Complete loss of palmitoylation,
FT                                decreased association with host cell
FT                                membrane lipid rafts, decreased
FT                                incorporation onto virions and severe
FT                                reduction of infectivity; when associated
FT                                with S-764. {ECO:0000269|PubMed:7568235}.
FT   STRAND       84     93       {ECO:0000244|PDB:1G9M}.
FT   TURN         95     98       {ECO:0000244|PDB:2NY7}.
FT   HELIX        99    113       {ECO:0000244|PDB:1G9M}.
FT   STRAND      119    123       {ECO:0000244|PDB:1G9M}.
FT   STRAND      199    201       {ECO:0000244|PDB:1G9M}.
FT   STRAND      210    212       {ECO:0000244|PDB:2NY7}.
FT   STRAND      223    228       {ECO:0000244|PDB:1G9M}.
FT   STRAND      235    247       {ECO:0000244|PDB:1G9M}.
FT   STRAND      251    254       {ECO:0000244|PDB:2NY7}.
FT   STRAND      256    258       {ECO:0000244|PDB:1G9M}.
FT   STRAND      260    262       {ECO:0000244|PDB:1G9M}.
FT   STRAND      267    269       {ECO:0000244|PDB:1G9M}.
FT   STRAND      271    273       {ECO:0000244|PDB:1G9M}.
FT   STRAND      277    279       {ECO:0000244|PDB:1GC1}.
FT   STRAND      284    297       {ECO:0000244|PDB:1G9M}.
FT   STRAND      302    304       {ECO:0000244|PDB:3TYG}.
FT   STRAND      306    310       {ECO:0000244|PDB:3TYG}.
FT   TURN        312    314       {ECO:0000244|PDB:1G9M}.
FT   STRAND      315    317       {ECO:0000244|PDB:3TYG}.
FT   STRAND      330    334       {ECO:0000244|PDB:1G9M}.
FT   HELIX       335    352       {ECO:0000244|PDB:1G9M}.
FT   STRAND      359    361       {ECO:0000244|PDB:1G9M}.
FT   TURN        365    367       {ECO:0000244|PDB:3TYG}.
FT   HELIX       369    372       {ECO:0000244|PDB:1G9M}.
FT   STRAND      374    378       {ECO:0000244|PDB:1G9M}.
FT   STRAND      381    385       {ECO:0000244|PDB:1G9M}.
FT   HELIX       388    390       {ECO:0000244|PDB:1G9M}.
FT   STRAND      393    395       {ECO:0000244|PDB:1G9M}.
FT   STRAND      413    417       {ECO:0000244|PDB:1G9M}.
FT   STRAND      420    425       {ECO:0000244|PDB:1G9M}.
FT   STRAND      427    430       {ECO:0000244|PDB:1G9M}.
FT   STRAND      432    434       {ECO:0000244|PDB:1G9M}.
FT   TURN        440    442       {ECO:0000244|PDB:3IDX}.
FT   STRAND      444    456       {ECO:0000244|PDB:1G9M}.
FT   STRAND      466    470       {ECO:0000244|PDB:1G9M}.
FT   HELIX       475    483       {ECO:0000244|PDB:1G9M}.
FT   STRAND      486    490       {ECO:0000244|PDB:1G9M}.
FT   HELIX       549    577       {ECO:0000244|PDB:1DF4}.
FT   HELIX       583    593       {ECO:0000244|PDB:2XRA}.
FT   HELIX       595    601       {ECO:0000244|PDB:2XRA}.
FT   TURN        602    605       {ECO:0000244|PDB:4YDV}.
FT   HELIX       626    628       {ECO:0000244|PDB:1K33}.
FT   HELIX       629    650       {ECO:0000244|PDB:1DF4}.
FT   HELIX       657    667       {ECO:0000244|PDB:3MNZ}.
FT   HELIX       672    674       {ECO:0000244|PDB:5X08}.
FT   HELIX       675    683       {ECO:0000244|PDB:5X08}.
FT   HELIX       690    693       {ECO:0000244|PDB:2MG3}.
SQ   SEQUENCE   856 AA;  97213 MW;  6FAB16AF85107FE0 CRC64;
     MRVKEKYQHL WRWGWRWGTM LLGMLMICSA TEKLWVTVYY GVPVWKEATT TLFCASDAKA
     YDTEVHNVWA THACVPTDPN PQEVVLVNVT ENFNMWKNDM VEQMHEDIIS LWDQSLKPCV
     KLTPLCVSLK CTDLKNDTNT NSSSGRMIME KGEIKNCSFN ISTSIRGKVQ KEYAFFYKLD
     IIPIDNDTTS YKLTSCNTSV ITQACPKVSF EPIPIHYCAP AGFAILKCNN KTFNGTGPCT
     NVSTVQCTHG IRPVVSTQLL LNGSLAEEEV VIRSVNFTDN AKTIIVQLNT SVEINCTRPN
     NNTRKRIRIQ RGPGRAFVTI GKIGNMRQAH CNISRAKWNN TLKQIASKLR EQFGNNKTII
     FKQSSGGDPE IVTHSFNCGG EFFYCNSTQL FNSTWFNSTW STEGSNNTEG SDTITLPCRI
     KQIINMWQKV GKAMYAPPIS GQIRCSSNIT GLLLTRDGGN SNNESEIFRP GGGDMRDNWR
     SELYKYKVVK IEPLGVAPTK AKRRVVQREK RAVGIGALFL GFLGAAGSTM GAASMTLTVQ
     ARQLLSGIVQ QQNNLLRAIE AQQHLLQLTV WGIKQLQARI LAVERYLKDQ QLLGIWGCSG
     KLICTTAVPW NASWSNKSLE QIWNHTTWME WDREINNYTS LIHSLIEESQ NQQEKNEQEL
     LELDKWASLW NWFNITNWLW YIKLFIMIVG GLVGLRIVFA VLSIVNRVRQ GYSPLSFQTH
     LPTPRGPDRP EGIEEEGGER DRDRSIRLVN GSLALIWDDL RSLCLFSYHR LRDLLLIVTR
     IVELLGRRGW EALKYWWNLL QYWSQELKNS AVSLLNATAI AVAEGTDRVI EVVQGACRAI
     RHIPRRIRQG LERILL
//
ID   MMS19_HUMAN             Reviewed;        1030 AA.
AC   Q96T76; B0QZ75; B3KPE5; B4DQX2; B4E2I3; D3DR55; F8W9Y2; Q17RZ8;
AC   Q5T455; Q66K82; Q7L4W8; Q969Z1; Q96DF1; Q96MR1; Q96RK5; Q96SK1;
AC   Q9BUE2; Q9BYS9;
DT   13-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   26-JUN-2007, sequence version 2.
DT   23-MAY-2018, entry version 153.
DE   RecName: Full=MMS19 nucleotide excision repair protein homolog;
DE            Short=hMMS19;
DE   AltName: Full=MET18 homolog;
DE   AltName: Full=MMS19-like protein;
GN   Name=MMS19 {ECO:0000312|HGNC:HGNC:13824}; Synonyms=MMS19L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT GLY-68, TISSUE
RP   SPECIFICITY, SUBCELLULAR LOCATION, AND INTERACTION WITH ERCC2 AND
RP   ERCC3.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=11071939; DOI=10.1093/nar/28.22.4506;
RA   Seroz T., Winkler G.S., Auriol J., Verhage R.A., Vermeulen W.,
RA   Smit B., Brouwer J., Eker A.P.M., Weeda G., Egly J.-M.,
RA   Hoeijmakers J.H.J.;
RT   "Cloning of a human homolog of the yeast nucleotide excision repair
RT   gene MMS19 and interaction with transcription repair factor TFIIH via
RT   the XPB and XPD helicases.";
RL   Nucleic Acids Res. 28:4506-4513(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT GLY-68, INTERACTION
RP   WITH NCOA3, AND SUBCELLULAR LOCATION.
RX   PubMed=11279242; DOI=10.1074/jbc.M101041200;
RA   Wu X., Li H., Chen J.D.;
RT   "The human homologue of the yeast DNA repair and TFIIH regulator MMS19
RT   is an AF-1-specific coactivator of estrogen receptor.";
RL   J. Biol. Chem. 276:23962-23968(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND VARIANT GLY-68.
RX   PubMed=11328871; DOI=10.1093/nar/29.9.1884;
RA   Queimado L., Rao M., Schultz R.A., Koonin E.V., Aravind L., Nardo T.,
RA   Stefanini M., Friedberg E.C.;
RT   "Cloning the human and mouse MMS19 genes and functional
RT   complementation of a yeast mms19 deletion mutant.";
RL   Nucleic Acids Res. 29:1884-1891(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 5 AND 6), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 48-1030 (ISOFORM 4), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 127-1030 (ISOFORM 2), AND VARIANTS
RP   GLY-68 AND ASP-790.
RC   TISSUE=Teratocarcinoma, Tongue, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLY-68; TRP-98;
RP   ILE-197; HIS-306; VAL-365; PRO-409; GLU-434; ILE-526; VAL-558; ASP-790
RP   AND HIS-983.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLY-68.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND
RP   VARIANTS GLY-68 AND ASP-790.
RC   TISSUE=Brain, Lymph, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-496, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   FUNCTION, IDENTIFICATION IN MMXD COMPLEX, INTERACTION WITH FAM96B, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=20797633; DOI=10.1016/j.molcel.2010.07.029;
RA   Ito S., Tan L.J., Andoh D., Narita T., Seki M., Hirano Y., Narita K.,
RA   Kuraoka I., Hiraoka Y., Tanaka K.;
RT   "MMXD, a TFIIH-independent XPD-MMS19 protein complex involved in
RT   chromosome segregation.";
RL   Mol. Cell 39:632-640(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1027, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   FUNCTION, AND IDENTIFICATION IN THE CIA COMPLEX.
RX   PubMed=22678362; DOI=10.1126/science.1219723;
RA   Stehling O., Vashisht A.A., Mascarenhas J., Jonsson Z.O., Sharma T.,
RA   Netz D.J., Pierik A.J., Wohlschlegel J.A., Lill R.;
RT   "MMS19 assembles iron-sulfur proteins required for DNA metabolism and
RT   genomic integrity.";
RL   Science 337:195-199(2012).
RN   [15]
RP   FUNCTION, IDENTIFICATION IN THE CIA COMPLEX, SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH RTEL1.
RX   PubMed=22678361; DOI=10.1126/science.1219664;
RA   Gari K., Leon Ortiz A.M., Borel V., Flynn H., Skehel J.M.,
RA   Boulton S.J.;
RT   "MMS19 links cytoplasmic iron-sulfur cluster assembly to DNA
RT   metabolism.";
RL   Science 337:243-245(2012).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   FUNCTION, UBIQUITINATION, AND MUTAGENESIS OF LYS-993; LYS-1002;
RP   1007-LYS-LYS-1008 AND LYS-1013.
RX   PubMed=29225034; DOI=10.1016/j.molcel.2017.11.010;
RA   Weon J.L., Yang S.W., Potts P.R.;
RT   "Cytosolic Iron-Sulfur Assembly Is Evolutionarily Tuned by a Cancer-
RT   Amplified Ubiquitin Ligase.";
RL   Mol. Cell 69:113-125(2018).
CC   -!- FUNCTION: Key component of the cytosolic iron-sulfur protein
CC       assembly (CIA) complex, a multiprotein complex that mediates the
CC       incorporation of iron-sulfur cluster into apoproteins specifically
CC       involved in DNA metabolism and genomic integrity. In the CIA
CC       complex, MMS19 acts as an adapter between early-acting CIA
CC       components and a subset of cellular target iron-sulfur proteins
CC       such as ERCC2/XPD, FANCJ and RTEL1, thereby playing a key role in
CC       nucleotide excision repair (NER), homologous recombination-
CC       mediated double-strand break DNA repair, DNA replication and RNA
CC       polymerase II (POL II) transcription (PubMed:22678362,
CC       PubMed:22678361, PubMed:29225034). As part of the mitotic spindle-
CC       associated MMXD complex, plays a role in chromosome segregation,
CC       probably by facilitating iron-sulfur cluster assembly into
CC       ERCC2/XPD (PubMed:20797633). Indirectly acts as a transcriptional
CC       coactivator of estrogen receptor (ER), via its role in iron-sulfur
CC       insertion into some component of the TFIIH-machinery
CC       (PubMed:11279242). {ECO:0000269|PubMed:11279242,
CC       ECO:0000269|PubMed:20797633, ECO:0000269|PubMed:22678361,
CC       ECO:0000269|PubMed:22678362, ECO:0000269|PubMed:29225034}.
CC   -!- SUBUNIT: Component of the CIA complex. Component of the MMXD
CC       complex, composed of CIAO1, ERCC2, FAM96B, MMS19 and SLC25A5.
CC       Interacts with FAM96B; the interaction is direct. Interacts with
CC       ERCC2/XPD; the interaction is direct. Interacts with ERCC3/XPB and
CC       NCOA3/RAC3. Interacts with RTEL1; the interaction mediates the
CC       association of RTEL1 with the CIA complex.
CC       {ECO:0000269|PubMed:11071939, ECO:0000269|PubMed:11279242,
CC       ECO:0000269|PubMed:20797633, ECO:0000269|PubMed:22678361,
CC       ECO:0000269|PubMed:22678362}.
CC   -!- INTERACTION:
CC       O76071:CIAO1; NbExp=9; IntAct=EBI-1044169, EBI-725145;
CC       P18074:ERCC2; NbExp=7; IntAct=EBI-1044169, EBI-6380590;
CC       Q9Y3D0:FAM96B; NbExp=11; IntAct=EBI-1044169, EBI-744045;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20797633}.
CC       Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:20797633}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q96T76-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96T76-7; Sequence=VSP_040312, VSP_040313;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=3;
CC         IsoId=Q96T76-6; Sequence=VSP_040310, VSP_040311;
CC         Note=No experimental confirmation available. May be produced at
CC         very low levels due to a premature stop codon in the mRNA,
CC         leading to nonsense-mediated mRNA decay.;
CC       Name=4;
CC         IsoId=Q96T76-5; Sequence=VSP_015565;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q96T76-8; Sequence=VSP_044182;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=Q96T76-9; Sequence=VSP_044183;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed with higher expression
CC       in testis. {ECO:0000269|PubMed:11071939,
CC       ECO:0000269|PubMed:11328871}.
CC   -!- PTM: Ubiquitinated; undergoes 'Lys-48'-linked polyubiquitination
CC       by MAGEF1-NSMCE1 ubiquitin ligase complex leading to proteasomal
CC       degradation. {ECO:0000269|PubMed:29225034}.
CC   -!- SIMILARITY: Belongs to the MET18/MMS19 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH80532.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305};
CC       Sequence=BAB55315.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB71223.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305};
CC       Sequence=BAG51657.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAC29239.1; Type=Frameshift; Positions=373, 412; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/mms19l/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ306408; CAC29239.1; ALT_FRAME; mRNA.
DR   EMBL; AF357881; AAK70402.1; -; mRNA.
DR   EMBL; AF319947; AAK52668.1; -; mRNA.
DR   EMBL; AK027710; BAB55315.1; ALT_INIT; mRNA.
DR   EMBL; AK056244; BAG51657.1; ALT_INIT; mRNA.
DR   EMBL; AK056581; BAB71223.1; ALT_SEQ; mRNA.
DR   EMBL; AK298995; BAG61084.1; -; mRNA.
DR   EMBL; AK304287; BAG65145.1; -; mRNA.
DR   EMBL; AY974244; AAX59033.1; -; Genomic_DNA.
DR   EMBL; AL355490; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359388; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49924.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49927.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49928.1; -; Genomic_DNA.
DR   EMBL; BC002692; AAH02692.1; -; mRNA.
DR   EMBL; BC006575; AAH06575.2; -; mRNA.
DR   EMBL; BC009396; AAH09396.2; -; mRNA.
DR   EMBL; BC080532; AAH80532.1; ALT_SEQ; mRNA.
DR   EMBL; BC117129; AAI17130.1; -; mRNA.
DR   CCDS; CCDS73177.1; -. [Q96T76-9]
DR   CCDS; CCDS7464.1; -. [Q96T76-1]
DR   CCDS; CCDS81493.1; -. [Q96T76-5]
DR   RefSeq; NP_001276332.1; NM_001289403.1. [Q96T76-9]
DR   RefSeq; NP_001276333.1; NM_001289404.1.
DR   RefSeq; NP_001276334.1; NM_001289405.1. [Q96T76-1]
DR   RefSeq; NP_001317057.1; NM_001330128.1. [Q96T76-5]
DR   RefSeq; NP_071757.4; NM_022362.4. [Q96T76-1]
DR   RefSeq; XP_016872013.1; XM_017016524.1.
DR   UniGene; Hs.500721; -.
DR   ProteinModelPortal; Q96T76; -.
DR   BioGrid; 122103; 192.
DR   IntAct; Q96T76; 28.
DR   MINT; Q96T76; -.
DR   STRING; 9606.ENSP00000359818; -.
DR   iPTMnet; Q96T76; -.
DR   PhosphoSitePlus; Q96T76; -.
DR   BioMuta; MMS19; -.
DR   DMDM; 150421597; -.
DR   EPD; Q96T76; -.
DR   MaxQB; Q96T76; -.
DR   PaxDb; Q96T76; -.
DR   PeptideAtlas; Q96T76; -.
DR   PRIDE; Q96T76; -.
DR   TopDownProteomics; Q96T76-6; -. [Q96T76-6]
DR   Ensembl; ENST00000327238; ENSP00000320059; ENSG00000155229. [Q96T76-5]
DR   Ensembl; ENST00000355839; ENSP00000348097; ENSG00000155229. [Q96T76-9]
DR   Ensembl; ENST00000370782; ENSP00000359818; ENSG00000155229. [Q96T76-1]
DR   Ensembl; ENST00000415383; ENSP00000395045; ENSG00000155229. [Q96T76-6]
DR   Ensembl; ENST00000438925; ENSP00000412698; ENSG00000155229. [Q96T76-1]
DR   Ensembl; ENST00000441194; ENSP00000413801; ENSG00000155229. [Q96T76-6]
DR   GeneID; 64210; -.
DR   KEGG; hsa:64210; -.
DR   UCSC; uc001kns.5; human. [Q96T76-1]
DR   CTD; 64210; -.
DR   DisGeNET; 64210; -.
DR   EuPathDB; HostDB:ENSG00000155229.20; -.
DR   GeneCards; MMS19; -.
DR   H-InvDB; HIX0009091; -.
DR   HGNC; HGNC:13824; MMS19.
DR   HPA; HPA051936; -.
DR   HPA; HPA056299; -.
DR   MIM; 614777; gene.
DR   neXtProt; NX_Q96T76; -.
DR   OpenTargets; ENSG00000155229; -.
DR   PharmGKB; PA162395974; -.
DR   eggNOG; KOG1967; Eukaryota.
DR   eggNOG; ENOG410XNMZ; LUCA.
DR   GeneTree; ENSGT00390000015583; -.
DR   HOGENOM; HOG000038024; -.
DR   HOVERGEN; HBG057358; -.
DR   InParanoid; Q96T76; -.
DR   KO; K15075; -.
DR   OMA; PESCWYF; -.
DR   OrthoDB; EOG091G00K8; -.
DR   PhylomeDB; Q96T76; -.
DR   TreeFam; TF314469; -.
DR   Reactome; R-HSA-2564830; Cytosolic iron-sulfur cluster assembly.
DR   ChiTaRS; MMS19; human.
DR   GeneWiki; MMS19; -.
DR   GenomeRNAi; 64210; -.
DR   PRO; PR:Q96T76; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000155229; -.
DR   CleanEx; HS_MMS19; -.
DR   ExpressionAtlas; Q96T76; baseline and differential.
DR   Genevisible; Q96T76; HS.
DR   GO; GO:0097361; C:CIA complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005675; C:holo TFIIH complex; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0071817; C:MMXD complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IEA:Ensembl.
DR   GO; GO:0030331; F:estrogen receptor binding; IPI:UniProtKB.
DR   GO; GO:0030674; F:protein binding, bridging; NAS:UniProtKB.
DR   GO; GO:0030159; F:receptor signaling complex scaffold activity; NAS:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; IMP:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB.
DR   GO; GO:0007059; P:chromosome segregation; IMP:UniProtKB.
DR   GO; GO:0006259; P:DNA metabolic process; IMP:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IMP:UniProtKB.
DR   GO; GO:0016226; P:iron-sulfur cluster assembly; IMP:UniProtKB.
DR   GO; GO:0006289; P:nucleotide-excision repair; TAS:UniProtKB.
DR   GO; GO:0000160; P:phosphorelay signal transduction system; NAS:UniProtKB.
DR   GO; GO:1905168; P:positive regulation of double-strand break repair via homologous recombination; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0097428; P:protein maturation by iron-sulfur cluster transfer; IDA:UniProtKB.
DR   GO; GO:0009725; P:response to hormone; NAS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; NAS:UniProtKB.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR024687; MMS19_C.
DR   Pfam; PF12460; MMS19_C; 1.
DR   SUPFAM; SSF48371; SSF48371; 5.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Alternative splicing; Chromosome partition;
KW   Complete proteome; Cytoplasm; Cytoskeleton; DNA damage; DNA repair;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:25944712}.
FT   CHAIN         2   1030       MMS19 nucleotide excision repair protein
FT                                homolog.
FT                                /FTId=PRO_0000096514.
FT   REPEAT      866    904       HEAT 1.
FT   REPEAT      908    946       HEAT 2.
FT   REPEAT      949    987       HEAT 3.
FT   REPEAT      990   1028       HEAT 4.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:25944712}.
FT   MOD_RES     496    496       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1027   1027       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   VAR_SEQ       1      1       M -> MRGEPVSSHRPYPLPRSLVRVM (in isoform
FT                                5). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044182.
FT   VAR_SEQ      38     40       DVK -> GPL (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_040310.
FT   VAR_SEQ      41   1030       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_040311.
FT   VAR_SEQ     165    207       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044183.
FT   VAR_SEQ     309    406       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_015565.
FT   VAR_SEQ     309    318       VFQTASERVE -> TAGTTCVNRT (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_040312.
FT   VAR_SEQ     319   1030       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_040313.
FT   VARIANT      68     68       A -> G (in dbSNP:rs2275586).
FT                                {ECO:0000269|PubMed:11071939,
FT                                ECO:0000269|PubMed:11279242,
FT                                ECO:0000269|PubMed:11328871,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.7}.
FT                                /FTId=VAR_023448.
FT   VARIANT      98     98       R -> W (in dbSNP:rs29001280).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_023449.
FT   VARIANT     197    197       V -> I (in dbSNP:rs29001285).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_023450.
FT   VARIANT     306    306       R -> H (in dbSNP:rs29001306).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_023451.
FT   VARIANT     365    365       M -> V (in dbSNP:rs29001309).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_023452.
FT   VARIANT     409    409       Q -> P (in dbSNP:rs29001311).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_023453.
FT   VARIANT     434    434       Q -> E (in dbSNP:rs29001314).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_023454.
FT   VARIANT     526    526       V -> I (in dbSNP:rs17112809).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_023455.
FT   VARIANT     558    558       A -> V (in dbSNP:rs12360068).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_023456.
FT   VARIANT     790    790       G -> D (in dbSNP:rs3740526).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_023457.
FT   VARIANT     983    983       R -> H (in dbSNP:rs29001332).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_023458.
FT   MUTAGEN     993    993       K->R: Impairs MAGEF1-NSMCE1-mediated
FT                                polyubiquitination when associated with
FT                                R-1002, 1007-R-R-1008 and R-1013.
FT                                {ECO:0000269|PubMed:29225034}.
FT   MUTAGEN    1002   1002       K->R: Impairs MAGEF1-NSMCE1-mediated
FT                                polyubiquitination when associated with
FT                                R-993, 1007-R-R-1008 and R-1013.
FT                                {ECO:0000269|PubMed:29225034}.
FT   MUTAGEN    1007   1008       KK->RR: Impairs MAGEF1-NSMCE1-mediated
FT                                polyubiquitination when associated with
FT                                R-993, R-1002 and R-1013.
FT                                {ECO:0000269|PubMed:29225034}.
FT   MUTAGEN    1013   1013       K->R: Impairs MAGEF1-NSMCE1-mediated
FT                                polyubiquitination when associated with
FT                                R-993, R-1002 and 1007-R-R-1008.
FT                                {ECO:0000269|PubMed:29225034}.
FT   CONFLICT    179    179       Q -> H (in Ref. 2; AAK70402).
FT                                {ECO:0000305}.
FT   CONFLICT    389    389       V -> D (in Ref. 2; AAK70402).
FT                                {ECO:0000305}.
FT   CONFLICT    394    394       L -> P (in Ref. 2; AAK70402).
FT                                {ECO:0000305}.
FT   CONFLICT    473    473       Q -> R (in Ref. 4; BAG51657).
FT                                {ECO:0000305}.
FT   CONFLICT    502    503       CR -> W (in Ref. 4; BAG51657).
FT                                {ECO:0000305}.
FT   CONFLICT    607    607       E -> K (in Ref. 4; BAG65145).
FT                                {ECO:0000305}.
FT   CONFLICT    640    640       E -> G (in Ref. 4; BAB55315).
FT                                {ECO:0000305}.
FT   CONFLICT    661    661       I -> V (in Ref. 4; BAG65145).
FT                                {ECO:0000305}.
FT   CONFLICT    741    741       L -> F (in Ref. 2; AAK70402).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1030 AA;  113290 MW;  7EC22CF0E38EFE1D CRC64;
     MAAAAAVEAA APMGALWGLV HDFVVGQQEG PADQVAADVK SGNYTVLQVV EALGSSLENP
     EPRTRARAIQ LLSQVLLHCH TLLLEKEVVH LILFYENRLK DHHLVIPSVL QGLKALSLCV
     ALPPGLAVSV LKAIFQEVHV QSLPQVDRHT VYNIITNFMR TREEELKSLG ADFTFGFIQV
     MDGEKDPRNL LVAFRIVHDL ISRDYSLGPF VEELFEVTSC YFPIDFTPPP NDPHGIQRED
     LILSLRAVLA STPRFAEFLL PLLIEKVDSE VLSAKLDSLQ TLNACCAVYG QKELKDFLPS
     LWASIRREVF QTASERVEAE GLAALHSLTA CLSRSVLRAD AEDLLDSFLS NILQDCRHHL
     CEPDMKLVWP SAKLLQAAAG ASARACDSVT SNVLPLLLEQ FHKHSQSSQR RTILEMLLGF
     LKLQQKWSYE DKDQRPLNGF KDQLCSLVFM ALTDPSTQLQ LVGIRTLTVL GAQPDLLSYE
     DLELAVGHLY RLSFLKEDSQ SCRVAALEAS GTLAALYPVA FSSHLVPKLA EELRVGESNL
     TNGDEPTQCS RHLCCLQALS AVSTHPSIVK ETLPLLLQHL WQVNRGNMVA QSSDVIAVCQ
     SLRQMAEKCQ QDPESCWYFH QTAIPCLLAL AVQASMPEKE PSVLRKVLLE DEVLAAMVSV
     IGTATTHLSP ELAAQSVTHI VPLFLDGNVS FLPENSFPSR FQPFQDGSSG QRRLIALLMA
     FVCSLPRNVE IPQLNQLMRE LLELSCCHSC PFSSTAAAKC FAGLLNKHPA GQQLDEFLQL
     AVDKVEAGLG SGPCRSQAFT LLLWVTKALV LRYHPLSSCL TARLMGLLSD PELGPAAADG
     FSLLMSDCTD VLTRAGHAEV RIMFRQRFFT DNVPALVQGF HAAPQDVKPN YLKGLSHVLN
     RLPKPVLLPE LPTLLSLLLE ALSCPDCVVQ LSTLSCLQPL LLEAPQVMSL HVDTLVTKFL
     NLSSSPSMAV RIAALQCMHA LTRLPTPVLL PYKPQVIRAL AKPLDDKKRL VRKEAVSARG
     EWFLLGSPGS
//
ID   A0A024R2I1_HUMAN        Unreviewed;       347 AA.
AC   A0A024R2I1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 33.
DE   SubName: Full=Histone deacetylase 11, isoform CRA_i {ECO:0000313|EMBL:EAW64168.1};
GN   Name=HDAC11 {ECO:0000313|EMBL:EAW64168.1};
GN   ORFNames=hCG_28391 {ECO:0000313|EMBL:EAW64168.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW64168.1};
RN   [1] {ECO:0000313|EMBL:EAW64168.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW64168.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471055; EAW64165.1; -; Genomic_DNA.
DR   EMBL; CH471055; EAW64168.1; -; Genomic_DNA.
DR   RefSeq; NP_079103.2; NM_024827.3.
DR   UniGene; Hs.744132; -.
DR   GeneID; 79885; -.
DR   KEGG; hsa:79885; -.
DR   CTD; 79885; -.
DR   EuPathDB; HostDB:ENSG00000163517.14; -.
DR   eggNOG; KOG1344; Eukaryota.
DR   eggNOG; COG0123; LUCA.
DR   KO; K11418; -.
DR   OMA; RVFTFSM; -.
DR   OrthoDB; EOG091G0EQP; -.
DR   ChiTaRS; HDAC11; human.
DR   GenomeRNAi; 79885; -.
DR   Bgee; ENSG00000163517; -.
DR   ExpressionAtlas; A0A024R2I1; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   GO; GO:0014003; P:oligodendrocyte development; IEA:Ensembl.
DR   Gene3D; 3.40.800.20; -; 1.
DR   InterPro; IPR000286; His_deacetylse.
DR   InterPro; IPR023801; His_deacetylse_dom.
DR   InterPro; IPR037138; His_deacetylse_dom_sf.
DR   InterPro; IPR023696; Ureohydrolase_dom_sf.
DR   Pfam; PF00850; Hist_deacetyl; 1.
DR   PRINTS; PR01270; HDASUPER.
DR   SUPFAM; SSF52768; SSF52768; 1.
PE   4: Predicted;
KW   Hydrolase {ECO:0000256|SAAS:SAAS00870288}.
FT   DOMAIN       35    316       Hist_deacetyl.
FT                                {ECO:0000259|Pfam:PF00850}.
SQ   SEQUENCE   347 AA;  39183 MW;  0D976CAF6EAC7A15 CRC64;
     MLHTTQLYQH VPETRWPIVY SPRYNITFMG LEKLHPFDAG KWGKVINFLK EEKLLSDSML
     VEAREASEED LLVVHTRRYL NELKWSFAVA TITEIPPVIF LPNFLVQRKV LRPLRTQTGG
     TIMAGKLAVE RGWAINVGGG FHHCSSDRGG GFCAYADITL AIKFLFERVE GISRATIIDL
     DAHQGNGHER DFMDDKRVYI MDVYNRHIYP GDRFAKQAIR RKVELEWGTE DDEYLDKVER
     NIKKSLQEHL PDVVVYNAGT DILEGDRLGG LSISPAGIVK RDELVFRMVR GRRVPILMVT
     SGGYQKRTAR IIADSILNLF GLGLIGPESP SVSAQNSDTP LLPPAVP
//
ID   B5MCQ6_HUMAN            Unreviewed;       268 AA.
AC   B5MCQ6;
DT   14-OCT-2008, integrated into UniProtKB/TrEMBL.
DT   14-OCT-2008, sequence version 1.
DT   23-MAY-2018, entry version 69.
DE   SubName: Full=Histone deacetylase 11 {ECO:0000313|Ensembl:ENSP00000384123};
GN   Name=HDAC11 {ECO:0000313|Ensembl:ENSP00000384123};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000384123, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000384123, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000384123}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC027124; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001317565.1; NM_001330636.1.
DR   UniGene; Hs.744132; -.
DR   ProteinModelPortal; B5MCQ6; -.
DR   PeptideAtlas; B5MCQ6; -.
DR   PRIDE; B5MCQ6; -.
DR   Ensembl; ENST00000402271; ENSP00000384123; ENSG00000163517.
DR   GeneID; 79885; -.
DR   UCSC; uc062gxc.1; human.
DR   CTD; 79885; -.
DR   EuPathDB; HostDB:ENSG00000163517.14; -.
DR   HGNC; HGNC:19086; HDAC11.
DR   OpenTargets; ENSG00000163517; -.
DR   eggNOG; KOG1344; Eukaryota.
DR   eggNOG; COG0123; LUCA.
DR   GeneTree; ENSGT00910000144047; -.
DR   HOGENOM; HOG000280018; -.
DR   HOVERGEN; HBG051893; -.
DR   ChiTaRS; HDAC11; human.
DR   GenomeRNAi; 79885; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000163517; -.
DR   ExpressionAtlas; B5MCQ6; baseline and differential.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.800.20; -; 2.
DR   InterPro; IPR023801; His_deacetylse_dom.
DR   InterPro; IPR037138; His_deacetylse_dom_sf.
DR   InterPro; IPR023696; Ureohydrolase_dom_sf.
DR   Pfam; PF00850; Hist_deacetyl; 1.
DR   SUPFAM; SSF52768; SSF52768; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Hydrolase {ECO:0000256|SAAS:SAAS00870288};
KW   Proteomics identification {ECO:0000213|MaxQB:B5MCQ6,
KW   ECO:0000213|PeptideAtlas:B5MCQ6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       90    237       Hist_deacetyl.
FT                                {ECO:0000259|Pfam:PF00850}.
SQ   SEQUENCE   268 AA;  30700 MW;  1166BB1CEC0FF015 CRC64;
     MLHTTQLYQH VPETRWPIVY SPRYNITFMG LEKLHPFDAG KWGKVINFLK EEKLLSDSML
     VEAREASEED LLVVHTRRYL NELKFLFERV EGISRATIID LDAHQGNGHE RDFMDDKRVY
     IMDVYNRHIY PGDRFAKQAI RRKVELEWGT EDDEYLDKVE RNIKKSLQEH LPDVVVYNAG
     TDILEGDRLG GLSISPAGIV KRDELVFRMV RGRRVPILMV TSGGYQKRTA RIIADSILNL
     FGLGLIGPES PSVSAQNSDT PLLPPAVP
//
ID   E7ETT9_HUMAN            Unreviewed;       319 AA.
AC   E7ETT9;
DT   08-MAR-2011, integrated into UniProtKB/TrEMBL.
DT   08-MAR-2011, sequence version 1.
DT   23-MAY-2018, entry version 54.
DE   SubName: Full=Histone deacetylase 11 {ECO:0000313|Ensembl:ENSP00000395188};
GN   Name=HDAC11 {ECO:0000313|Ensembl:ENSP00000395188};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000395188, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000395188, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000395188}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC027124; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_005265548.1; XM_005265491.1.
DR   RefSeq; XP_011532433.1; XM_011534131.1.
DR   UniGene; Hs.744132; -.
DR   ProteinModelPortal; E7ETT9; -.
DR   PeptideAtlas; E7ETT9; -.
DR   PRIDE; E7ETT9; -.
DR   Ensembl; ENST00000437379; ENSP00000395188; ENSG00000163517.
DR   GeneID; 79885; -.
DR   UCSC; uc062gxo.1; human.
DR   CTD; 79885; -.
DR   EuPathDB; HostDB:ENSG00000163517.14; -.
DR   HGNC; HGNC:19086; HDAC11.
DR   OpenTargets; ENSG00000163517; -.
DR   eggNOG; KOG1344; Eukaryota.
DR   eggNOG; COG0123; LUCA.
DR   GeneTree; ENSGT00910000144047; -.
DR   ChiTaRS; HDAC11; human.
DR   GenomeRNAi; 79885; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000163517; -.
DR   ExpressionAtlas; E7ETT9; baseline and differential.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.800.20; -; 1.
DR   InterPro; IPR000286; His_deacetylse.
DR   InterPro; IPR023801; His_deacetylse_dom.
DR   InterPro; IPR037138; His_deacetylse_dom_sf.
DR   InterPro; IPR023696; Ureohydrolase_dom_sf.
DR   Pfam; PF00850; Hist_deacetyl; 1.
DR   PRINTS; PR01270; HDASUPER.
DR   SUPFAM; SSF52768; SSF52768; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Hydrolase {ECO:0000256|SAAS:SAAS00870288};
KW   Proteomics identification {ECO:0000213|MaxQB:E7ETT9,
KW   ECO:0000213|PeptideAtlas:E7ETT9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN        7    288       Hist_deacetyl.
FT                                {ECO:0000259|Pfam:PF00850}.
SQ   SEQUENCE   319 AA;  35709 MW;  74F22907DB3626F0 CRC64;
     MGLEKLHPFD AGKWGKVINF LKEEKLLSDS MLVEAREASE EDLLVVHTRR YLNELKWSFA
     VATITEIPPV IFLPNFLVQR KVLRPLRTQT GGTIMAGKLA VERGWAINVG GGFHHCSSDR
     GGGFCAYADI TLAIKFLFER VEGISRATII DLDAHQGNGH ERDFMDDKRV YIMDVYNRHI
     YPGDRFAKQA IRRKVELEWG TEDDEYLDKV ERNIKKSLQE HLPDVVVYNA GTDILEGDRL
     GGLSISPAGI VKRDELVFRM VRGRRVPILM VTSGGYQKRT ARIIADSILN LFGLGLIGPE
     SPSVSAQNSD TPLLPPAVP
//
ID   Q6IA14_HUMAN            Unreviewed;       225 AA.
AC   Q6IA14;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   31-JAN-2018, entry version 84.
DE   SubName: Full=HDAC11 protein {ECO:0000313|EMBL:CAG33622.1};
GN   Name=HDAC11 {ECO:0000313|EMBL:CAG33622.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG33622.1};
RN   [1] {ECO:0000313|EMBL:CAG33622.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CR457341; CAG33622.1; -; mRNA.
DR   RefSeq; XP_011532437.1; XM_011534135.1.
DR   UniGene; Hs.744132; -.
DR   ProteinModelPortal; Q6IA14; -.
DR   SMR; Q6IA14; -.
DR   PeptideAtlas; Q6IA14; -.
DR   GeneID; 79885; -.
DR   CTD; 79885; -.
DR   eggNOG; KOG1344; Eukaryota.
DR   eggNOG; COG0123; LUCA.
DR   HOGENOM; HOG000280018; -.
DR   HOVERGEN; HBG051893; -.
DR   ChiTaRS; HDAC11; human.
DR   GenomeRNAi; 79885; -.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.800.20; -; 1.
DR   InterPro; IPR000286; His_deacetylse.
DR   InterPro; IPR023801; His_deacetylse_dom.
DR   InterPro; IPR037138; His_deacetylse_dom_sf.
DR   InterPro; IPR023696; Ureohydrolase_dom_sf.
DR   Pfam; PF00850; Hist_deacetyl; 1.
DR   PRINTS; PR01270; HDASUPER.
DR   SUPFAM; SSF52768; SSF52768; 1.
PE   2: Evidence at transcript level;
KW   Hydrolase {ECO:0000256|SAAS:SAAS00870288}.
FT   DOMAIN        7    194       Hist_deacetyl.
FT                                {ECO:0000259|Pfam:PF00850}.
SQ   SEQUENCE   225 AA;  24936 MW;  0B7340B09E9A942F CRC64;
     MAGKLAVERG WAINVGGGFH HCSSDRGGGF CAYADITLAI KFLFERVEGI SRATIIDLDA
     HQGNGHERDF MDDKRVYIMD VYNRHIYPGD RFAKQAIRRK VELEWGTEDD EYLDKVERNI
     KKSLQEHLPD VVVYNAGTDI LEGDRLGGLS ISPAGIVKRD ELVFRMVRGR RVPILMVTSG
     GYQKRTARII ADSILNLFGL GLIGPESPSV SAQNSDTPLL PPAVP
//
ID   HDA11_HUMAN             Reviewed;         347 AA.
AC   Q96DB2; B4DDK1; Q9H6I7; Q9H6X3; Q9NTC9;
DT   06-DEC-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   23-MAY-2018, entry version 151.
DE   RecName: Full=Histone deacetylase 11;
DE            Short=HD11;
DE            EC=3.5.1.98;
GN   Name=HDAC11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Colon mucosa;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 113-347 (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   CHARACTERIZATION, FUNCTION, AND INTERACTION WITH HDAC6.
RX   PubMed=11948178; DOI=10.1074/jbc.M111871200;
RA   Gao L., Cueto M.A., Asselbergs F., Atadja P.;
RT   "Cloning and functional characterization of HDAC11, a novel member of
RT   the human histone deacetylase family.";
RL   J. Biol. Chem. 277:25748-25755(2002).
CC   -!- FUNCTION: Responsible for the deacetylation of lysine residues on
CC       the N-terminal part of the core histones (H2A, H2B, H3 and H4).
CC       Histone deacetylation gives a tag for epigenetic repression and
CC       plays an important role in transcriptional regulation, cell cycle
CC       progression and developmental events. Histone deacetylases act via
CC       the formation of large multiprotein complexes.
CC       {ECO:0000269|PubMed:11948178}.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of an N(6)-acetyl-lysine residue of
CC       a histone to yield a deacetylated histone.
CC   -!- SUBUNIT: Interacts with HDAC6. {ECO:0000269|PubMed:11948178}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Note=Predominantly nuclear.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96DB2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96DB2-2; Sequence=VSP_043082, VSP_043083;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Weakly expressed in most tissues. Strongly
CC       expressed in brain, heart, skeletal muscle, kidney and testis.
CC   -!- MISCELLANEOUS: Its activity is inhibited by trapoxin, a known
CC       histone deacetylase inhibitor.
CC   -!- SIMILARITY: Belongs to the histone deacetylase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15127.1; Type=Erroneous termination; Positions=107; Note=Translated as Gln.; Evidence={ECO:0000305};
CC       Sequence=CAB70712.1; Type=Frameshift; Positions=177, 198, 200; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK025426; BAB15127.1; ALT_SEQ; mRNA.
DR   EMBL; AK025890; BAB15272.1; -; mRNA.
DR   EMBL; AK293223; BAG56762.1; -; mRNA.
DR   EMBL; AC027124; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC009676; AAH09676.1; -; mRNA.
DR   EMBL; AL137362; CAB70712.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS2615.1; -. [Q96DB2-1]
DR   CCDS; CCDS46760.1; -. [Q96DB2-2]
DR   RefSeq; NP_001129513.1; NM_001136041.2. [Q96DB2-2]
DR   RefSeq; NP_079103.2; NM_024827.3. [Q96DB2-1]
DR   RefSeq; XP_011532437.1; XM_011534135.1.
DR   UniGene; Hs.744132; -.
DR   ProteinModelPortal; Q96DB2; -.
DR   BioGrid; 122970; 147.
DR   IntAct; Q96DB2; 130.
DR   MINT; Q96DB2; -.
DR   STRING; 9606.ENSP00000295757; -.
DR   BindingDB; Q96DB2; -.
DR   ChEMBL; CHEMBL3310; -.
DR   DrugBank; DB05015; Belinostat.
DR   DrugBank; DB06603; Panobinostat.
DR   GuidetoPHARMACOLOGY; 2615; -.
DR   iPTMnet; Q96DB2; -.
DR   PhosphoSitePlus; Q96DB2; -.
DR   BioMuta; HDAC11; -.
DR   DMDM; 26394832; -.
DR   PaxDb; Q96DB2; -.
DR   PeptideAtlas; Q96DB2; -.
DR   PRIDE; Q96DB2; -.
DR   DNASU; 79885; -.
DR   Ensembl; ENST00000295757; ENSP00000295757; ENSG00000163517. [Q96DB2-1]
DR   Ensembl; ENST00000522202; ENSP00000429794; ENSG00000163517. [Q96DB2-2]
DR   GeneID; 79885; -.
DR   KEGG; hsa:79885; -.
DR   UCSC; uc003bxy.4; human. [Q96DB2-1]
DR   CTD; 79885; -.
DR   DisGeNET; 79885; -.
DR   EuPathDB; HostDB:ENSG00000163517.14; -.
DR   GeneCards; HDAC11; -.
DR   HGNC; HGNC:19086; HDAC11.
DR   MIM; 607226; gene.
DR   neXtProt; NX_Q96DB2; -.
DR   OpenTargets; ENSG00000163517; -.
DR   PharmGKB; PA38793; -.
DR   eggNOG; KOG1344; Eukaryota.
DR   eggNOG; COG0123; LUCA.
DR   GeneTree; ENSGT00910000144047; -.
DR   HOGENOM; HOG000280018; -.
DR   HOVERGEN; HBG051893; -.
DR   InParanoid; Q96DB2; -.
DR   KO; K11418; -.
DR   OMA; RVFTFSM; -.
DR   OrthoDB; EOG091G0EQP; -.
DR   PhylomeDB; Q96DB2; -.
DR   TreeFam; TF106176; -.
DR   BRENDA; 3.5.1.98; 2681.
DR   Reactome; R-HSA-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   ChiTaRS; HDAC11; human.
DR   GeneWiki; HDAC11; -.
DR   GenomeRNAi; 79885; -.
DR   PRO; PR:Q96DB2; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000163517; -.
DR   CleanEx; HS_HDAC11; -.
DR   ExpressionAtlas; Q96DB2; baseline and differential.
DR   Genevisible; Q96DB2; HS.
DR   GO; GO:0000118; C:histone deacetylase complex; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:LIFEdb.
DR   GO; GO:0004407; F:histone deacetylase activity; IDA:UniProtKB.
DR   GO; GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC.
DR   GO; GO:0008134; F:transcription factor binding; TAS:UniProtKB.
DR   GO; GO:0006325; P:chromatin organization; TAS:UniProtKB.
DR   GO; GO:0016575; P:histone deacetylation; IDA:UniProtKB.
DR   GO; GO:0014003; P:oligodendrocyte development; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.800.20; -; 1.
DR   InterPro; IPR000286; His_deacetylse.
DR   InterPro; IPR023801; His_deacetylse_dom.
DR   InterPro; IPR037138; His_deacetylse_dom_sf.
DR   InterPro; IPR023696; Ureohydrolase_dom_sf.
DR   Pfam; PF00850; Hist_deacetyl; 1.
DR   PRINTS; PR01270; HDASUPER.
DR   SUPFAM; SSF52768; SSF52768; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromatin regulator; Complete proteome;
KW   Hydrolase; Nucleus; Reference proteome; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    347       Histone deacetylase 11.
FT                                /FTId=PRO_0000114715.
FT   REGION       14    326       Histone deacetylase.
FT   ACT_SITE    143    143       {ECO:0000250}.
FT   VAR_SEQ       1     28       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043082.
FT   VAR_SEQ      85    107       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043083.
FT   CONFLICT     15     15       R -> P (in Ref. 1; BAB15272).
FT                                {ECO:0000305}.
FT   CONFLICT    113    113       P -> A (in Ref. 4; CAB70712).
FT                                {ECO:0000305}.
FT   CONFLICT    212    212       D -> Y (in Ref. 4; CAB70712).
FT                                {ECO:0000305}.
SQ   SEQUENCE   347 AA;  39183 MW;  0D976CAF6EAC7A15 CRC64;
     MLHTTQLYQH VPETRWPIVY SPRYNITFMG LEKLHPFDAG KWGKVINFLK EEKLLSDSML
     VEAREASEED LLVVHTRRYL NELKWSFAVA TITEIPPVIF LPNFLVQRKV LRPLRTQTGG
     TIMAGKLAVE RGWAINVGGG FHHCSSDRGG GFCAYADITL AIKFLFERVE GISRATIIDL
     DAHQGNGHER DFMDDKRVYI MDVYNRHIYP GDRFAKQAIR RKVELEWGTE DDEYLDKVER
     NIKKSLQEHL PDVVVYNAGT DILEGDRLGG LSISPAGIVK RDELVFRMVR GRRVPILMVT
     SGGYQKRTAR IIADSILNLF GLGLIGPESP SVSAQNSDTP LLPPAVP
//
ID   ADRB2_HUMAN             Reviewed;         413 AA.
AC   P07550; B0LPE4; B2R7X2; O14823; O14824; O14825; O14826; Q4JG18;
AC   Q53GA6; Q6GMT4; Q6P4D8; Q8NEQ9; Q96EC3; Q9UCZ0; Q9UCZ1; Q9UCZ2;
AC   Q9UCZ3; Q9UH95; Q9UHA1; Q9UMZ5;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   23-MAY-2018, entry version 213.
DE   RecName: Full=Beta-2 adrenergic receptor;
DE   AltName: Full=Beta-2 adrenoreceptor;
DE            Short=Beta-2 adrenoceptor;
GN   Name=ADRB2; Synonyms=ADRB2R, B2AR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-27.
RC   TISSUE=Brain;
RX   PubMed=3026848; DOI=10.1016/0014-5793(87)81436-9;
RA   Chung F.-Z., Lentes K.-U., Gocayne J.D., Fitzgerald M.G.,
RA   Robinson D.A., Kerlavage A.R., Fraser C.M., Venter J.C.;
RT   "Cloning and sequence analysis of the human brain beta-adrenergic
RT   receptor. Evolutionary relationship to rodent and avian beta-receptors
RT   and porcine muscarinic receptors.";
RL   FEBS Lett. 211:200-206(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ARG-16 AND GLN-27.
RX   PubMed=3034889;
RA   Kobilka B.K., Frielle T., Dohlman H.G., Bolanowski M.A., Dixon R.A.F.,
RA   Keller P., Caron M.G., Lefkowitz R.J.;
RT   "Delineation of the intronless nature of the genes for the human and
RT   hamster beta 2-adrenergic receptor and their putative promoter
RT   regions.";
RL   J. Biol. Chem. 262:7321-7327(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ARG-16 AND GLN-27.
RX   PubMed=3033609; DOI=10.1093/nar/15.8.3636;
RA   Schofield P.R., Rhee L.M., Peralta E.G.;
RT   "Primary structure of the human beta-adrenergic receptor gene.";
RL   Nucleic Acids Res. 15:3636-3636(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ARG-16 AND GLN-27.
RX   PubMed=3025863; DOI=10.1073/pnas.84.1.46;
RA   Kobilka B.K., Dixon R.A.F., Frielle T., Dohlman H.G., Bolanowski M.A.,
RA   Sigal I.S., Yang-Feng T.L., Francke U., Caron M.G., Lefkowitz R.J.;
RT   "cDNA for the human beta 2-adrenergic receptor: a protein with
RT   multiple membrane-spanning domains and encoded by a gene whose
RT   chromosomal location is shared with that of the receptor for platelet-
RT   derived growth factor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:46-50(1987).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLN-27.
RX   PubMed=2823249; DOI=10.1073/pnas.84.20.6995;
RA   Emorine L.J., Marullo S., Delavier-Klutchko C., Kaveri S.V.,
RA   Durieu-Trautmann O., Strosberg A.D.;
RT   "Structure of the gene for human beta 2-adrenergic receptor:
RT   expression and promoter characterization.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:6995-6999(1987).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ARG-16; GLN-27; MET-34
RP   AND ILE-164.
RX   PubMed=8383511; DOI=10.1165/ajrcmb/8.3.334;
RA   Reihsaus E., Innis M., Macintyre N., Liggett S.B.;
RT   "Mutations in the gene encoding for the beta 2-adrenergic receptor in
RT   normal and asthmatic subjects.";
RL   Am. J. Respir. Cell Mol. Biol. 8:334-339(1993).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLN-27; LEU-159;
RP   PHE-159 AND ARG-375.
RC   TISSUE=Blood;
RX   PubMed=11246467; DOI=10.1046/j.1469-1809.2000.6420135.x;
RA   Rupert J.L., Monsalve M.V., Devine D.V., Hochachka P.W.;
RT   "Beta2-adrenergic receptor allele frequencies in the Quechua, a high
RT   altitude native population.";
RL   Ann. Hum. Genet. 64:135-143(2000).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ARG-16 AND
RP   GLN-27.
RC   TISSUE=Heart;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-27.
RC   TISSUE=Thyroid;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLN-27 AND CYS-220.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLN-27.
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ARG-16 AND
RP   GLN-27.
RC   TISSUE=Fetal brain, Leukocyte, and Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   MUTAGENESIS OF ASP-79, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=2831218;
RA   Chung F.-Z., Wang C.-D., Potter P.C., Venter J.C., Fraser C.M.;
RT   "Site-directed mutagenesis and continuous expression of human beta-
RT   adrenergic receptors. Identification of a conserved aspartate residue
RT   involved in agonist binding and receptor activation.";
RL   J. Biol. Chem. 263:4052-4055(1988).
RN   [16]
RP   PALMITOYLATION AT CYS-341, AND MUTAGENESIS OF CYS-341.
RX   PubMed=2540197;
RA   O'Dowd B.F., Hnatowich M., Caron M.G., Lefkowitz R.J., Bouvier M.;
RT   "Palmitoylation of the human beta 2-adrenergic receptor. Mutation of
RT   Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated
RT   form of the receptor.";
RL   J. Biol. Chem. 264:7564-7569(1989).
RN   [17]
RP   MUTAGENESIS OF TYR-141; TYR-350; TYR-354 AND TYR-366, AND
RP   PHOSPHORYLATION AT TYR-141.
RX   PubMed=8521811;
RA   Valiquette M., Parent S., Loisel T.P., Bouvier M.;
RT   "Mutation of tyrosine-141 inhibits insulin-promoted tyrosine
RT   phosphorylation and increased responsiveness of the human beta 2-
RT   adrenergic receptor.";
RL   EMBO J. 14:5542-5549(1995).
RN   [18]
RP   INTERACTION WITH ARRB1 AND ARRB2.
RX   PubMed=7822302; DOI=10.1074/jbc.270.2.720;
RA   Gurevich V.V., Dion S.B., Onorato J.J., Ptasienski J., Kim C.M.,
RA   Sterne-Marr R., Hosey M.M., Benovic J.L.;
RT   "Arrestin interactions with G protein-coupled receptors. Direct
RT   binding studies of wild type and mutant arrestins with rhodopsin, beta
RT   2-adrenergic, and m2 muscarinic cholinergic receptors.";
RL   J. Biol. Chem. 270:720-731(1995).
RN   [19]
RP   INTERACTION WITH ARRB1.
RX   PubMed=9388255; DOI=10.1074/jbc.272.49.31051;
RA   Lin F.-T., Krueger K.M., Kendall H.E., Daaka Y., Fredericks Z.L.,
RA   Pitcher J.A., Lefkowitz R.J.;
RT   "Clathrin-mediated endocytosis of the beta-adrenergic receptor is
RT   regulated by phosphorylation/dephosphorylation of beta-arrestin1.";
RL   J. Biol. Chem. 272:31051-31057(1997).
RN   [20]
RP   INTERACTION WITH SLC9A3R1.
RX   PubMed=10499588; DOI=10.1038/45816;
RA   Cao T.T., Deacon H.W., Reczek D., Bretscher A., von Zastrow M.;
RT   "A kinase-regulated PDZ-domain interaction controls endocytic sorting
RT   of the beta2-adrenergic receptor.";
RL   Nature 401:286-290(1999).
RN   [21]
RP   INTERACTION WITH SRC AND ARRB1.
RX   PubMed=9924018; DOI=10.1126/science.283.5402.655;
RA   Luttrell L.M., Ferguson S.S.G., Daaka Y., Miller W.E., Maudsley S.,
RA   Della Rocca G.J., Lin F.-T., Kawakatsu H., Owada K., Luttrell D.K.,
RA   Caron M.G., Lefkowitz R.J.;
RT   "Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src
RT   protein kinase complexes.";
RL   Science 283:655-661(1999).
RN   [22]
RP   EFFECT OF PALMITOYLATION, PHOSPHORYLATION AT SER-345 AND SER-346, AND
RP   MUTAGENESIS OF 345-SER-SER-346.
RX   PubMed=11146000; DOI=10.1046/j.1471-4159.2001.00005.x;
RA   Moffett S., Rousseau G., Lagace M., Bouvier M.;
RT   "The palmitoylation state of the beta(2)-adrenergic receptor regulates
RT   the synergistic action of cyclic AMP-dependent protein kinase and
RT   beta-adrenergic receptor kinase involved in its phosphorylation and
RT   desensitization.";
RL   J. Neurochem. 76:269-279(2001).
RN   [23]
RP   INTERACTION WITH GPRASP1.
RX   PubMed=12142540; DOI=10.1126/science.1073308;
RA   Whistler J.L., Enquist J., Marley A., Fong J., Gladher F., Tsuruda P.,
RA   Murray S.R., Von Zastrow M.;
RT   "Modulation of postendocytic sorting of G protein-coupled receptors.";
RL   Science 297:615-620(2002).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-246, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [25]
RP   UBIQUITINATION, DEUBIQUITINATION BY USP20 AND USP33, AND INTERACTION
RP   WITH USP20 AND USP33.
RX   PubMed=19424180; DOI=10.1038/emboj.2009.128;
RA   Berthouze M., Venkataramanan V., Li Y., Shenoy S.K.;
RT   "The deubiquitinases USP33 and USP20 coordinate beta2 adrenergic
RT   receptor recycling and resensitization.";
RL   EMBO J. 28:1684-1696(2009).
RN   [26]
RP   INTERACTION WITH EGLN3 AND VHL, SUBCELLULAR LOCATION, INDUCTION,
RP   UBIQUITINATION, HYDROXYLATION AT PRO-382 AND PRO-395, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=19584355; DOI=10.1126/scisignal.2000444;
RA   Xie L., Xiao K., Whalen E.J., Forrester M.T., Freeman R.S., Fong G.,
RA   Gygi S.P., Lefkowitz R.J., Stamler J.S.;
RT   "Oxygen-regulated beta(2)-adrenergic receptor hydroxylation by EGLN3
RT   and ubiquitylation by pVHL.";
RL   Sci. Signal. 2:RA33-RA33(2009).
RN   [27]
RP   UBIQUITINATION, SUBCELLULAR LOCATION, AND INTERACTION WITH ARRDC3.
RX   PubMed=20559325; DOI=10.1038/embor.2010.80;
RA   Nabhan J.F., Pan H., Lu Q.;
RT   "Arrestin domain-containing protein 3 recruits the NEDD4 E3 ligase to
RT   mediate ubiquitination of the beta2-adrenergic receptor.";
RL   EMBO Rep. 11:605-611(2010).
RN   [28]
RP   INTERACTION WITH SNX27.
RX   PubMed=20733053; DOI=10.1083/jcb.201004060;
RA   Lauffer B.E., Melero C., Temkin P., Lei C., Hong W., Kortemme T.,
RA   von Zastrow M.;
RT   "SNX27 mediates PDZ-directed sorting from endosomes to the plasma
RT   membrane.";
RL   J. Cell Biol. 190:565-574(2010).
RN   [29]
RP   INTERACTION WITH SNX27.
RX   PubMed=21602791; DOI=10.1038/ncb2252;
RA   Temkin P., Lauffer B., Jager S., Cimermancic P., Krogan N.J.,
RA   von Zastrow M.;
RT   "SNX27 mediates retromer tubule entry and endosome-to-plasma membrane
RT   trafficking of signalling receptors.";
RL   Nat. Cell Biol. 13:715-721(2011).
RN   [30]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH ARRDC3.
RX   PubMed=25220262; DOI=10.1002/pro.2549;
RA   Qi S., O'Hayre M., Gutkind J.S., Hurley J.H.;
RT   "Insights into beta2-adrenergic receptor binding from structures of
RT   the N-terminal lobe of ARRDC3.";
RL   Protein Sci. 23:1708-1716(2014).
RN   [31]
RP   INTERACTION WITH CNIH4.
RX   PubMed=24405750; DOI=10.1111/tra.12148;
RA   Sauvageau E., Rochdi M.D., Oueslati M., Hamdan F.F., Percherancier Y.,
RA   Simpson J.C., Pepperkok R., Bouvier M.;
RT   "CNIH4 interacts with newly synthesized GPCR and controls their export
RT   from the endoplasmic reticulum.";
RL   Traffic 15:383-400(2014).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (3.4 ANGSTROMS) OF 1-365 IN COMPLEX WITH
RP   CARAZOLOL, AND TOPOLOGY.
RX   PubMed=17952055; DOI=10.1038/nature06325;
RA   Rasmussen S.G.F., Choi H.-J., Rosenbaum D.M., Kobilka T.S.,
RA   Thian F.S., Edwards P.C., Burghammer M., Ratnala V.R.P.,
RA   Sanishvili R., Fischetti R.F., Schertler G.F.X., Weis W.I.,
RA   Kobilka B.K.;
RT   "Crystal structure of the human beta2 adrenergic G-protein-coupled
RT   receptor.";
RL   Nature 450:383-387(2007).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 1-365 IN COMPLEX WITH
RP   CARAZOLOL AND CHOLESTEROL, DISULFIDE BONDS, TOPOLOGY, AND
RP   PALMITOYLATION AT CYS-341.
RX   PubMed=17962520; DOI=10.1126/science.1150577;
RA   Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G.F.,
RA   Thian F.S., Kobilka T.S., Choi H.-J., Kuhn P., Weis W.I.,
RA   Kobilka B.K., Stevens R.C.;
RT   "High-resolution crystal structure of an engineered human beta2-
RT   adrenergic G protein-coupled receptor.";
RL   Science 318:1258-1265(2007).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-365 IN COMPLEX WITH TIMOLOL
RP   AND CHOLESTEROL, DISULFIDE BONDS, TOPOLOGY, AND PALMITOYLATION AT
RP   CYS-341.
RX   PubMed=18547522; DOI=10.1016/j.str.2008.05.001;
RA   Hanson M.A., Cherezov V., Griffith M.T., Roth C.B., Jaakola V.P.,
RA   Chien E.Y., Velasquez J., Kuhn P., Stevens R.C.;
RT   "A specific cholesterol binding site is established by the 2.8 A
RT   structure of the human beta2-adrenergic receptor.";
RL   Structure 16:897-905(2008).
RN   [35]
RP   VARIANTS ARG-16 AND GLN-27, CHARACTERIZATION, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=7915137; DOI=10.1021/bi00198a006;
RA   Green S.A., Turki J., Innis M., Ligget S.B.;
RT   "Amino-terminal polymorphisms of the human beta 2-adrenergic receptor
RT   impart distinct agonist-promoted regulatory properties.";
RL   Biochemistry 33:9414-9419(1994).
RN   [36]
RP   VARIANT ARG-16, AND POLYMORPHISM.
RX   PubMed=7706471; DOI=10.1172/JCI117838;
RA   Turki J., Pak J., Green S.A., Martin R.J., Liggett S.B.;
RT   "Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal
RT   and nonnocturnal asthma. Evidence that Gly16 correlates with the
RT   nocturnal phenotype.";
RL   J. Clin. Invest. 95:1635-1641(1995).
CC   -!- FUNCTION: Beta-adrenergic receptors mediate the catecholamine-
CC       induced activation of adenylate cyclase through the action of G
CC       proteins. The beta-2-adrenergic receptor binds epinephrine with an
CC       approximately 30-fold greater affinity than it does
CC       norepinephrine. {ECO:0000269|PubMed:2831218,
CC       ECO:0000269|PubMed:7915137}.
CC   -!- SUBUNIT: Binds SLC9A3R1 and GPRASP1. Interacts with ARRB1 and
CC       ARRB2. Interacts with SRC, USP20 and USP33. Interacts with VHL;
CC       the interaction, which is increased on hydroxylation of ADRB2,
CC       ubiquitinates ADRB2 leading to its degradation. Interacts with
CC       EGLN3; the interaction hydroxylates ADRB2 facilitating VHL-E3
CC       ligase-mediated ubiquitination. Interacts (via PDZ-binding motif)
CC       with SNX27 (via PDZ domain); the interaction is required when
CC       endocytosed to prevent degradation in lysosomes and promote
CC       recycling to the plasma membrane. Interacts with CNIH4
CC       (PubMed:24405750). Interacts with ARRDC3 (PubMed:20559325,
CC       PubMed:25220262). {ECO:0000269|PubMed:10499588,
CC       ECO:0000269|PubMed:12142540, ECO:0000269|PubMed:17952055,
CC       ECO:0000269|PubMed:17962520, ECO:0000269|PubMed:18547522,
CC       ECO:0000269|PubMed:19424180, ECO:0000269|PubMed:19584355,
CC       ECO:0000269|PubMed:20559325, ECO:0000269|PubMed:20733053,
CC       ECO:0000269|PubMed:21602791, ECO:0000269|PubMed:24405750,
CC       ECO:0000269|PubMed:25220262, ECO:0000269|PubMed:7822302,
CC       ECO:0000269|PubMed:9388255, ECO:0000269|PubMed:9924018}.
CC   -!- INTERACTION:
CC       P32121:ARRB2; NbExp=3; IntAct=EBI-491169, EBI-714559;
CC       Q96B67:ARRDC3; NbExp=6; IntAct=EBI-491169, EBI-2875665;
CC       Q5TCQ9:MAGI3; NbExp=9; IntAct=EBI-491169, EBI-310506;
CC       O14745:SLC9A3R1; NbExp=6; IntAct=EBI-491169, EBI-349787;
CC       P12931:SRC; NbExp=3; IntAct=EBI-491169, EBI-621482;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19584355,
CC       ECO:0000269|PubMed:20559325, ECO:0000269|PubMed:25220262,
CC       ECO:0000269|PubMed:2831218, ECO:0000269|PubMed:7915137}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:19584355}. Early
CC       endosome {ECO:0000269|PubMed:20559325}. Note=Colocalizes with VHL
CC       at the cell membrane (PubMed:19584355). Activated receptors are
CC       internalized into endosomes prior to their degradation in
CC       lysosomes (PubMed:20559325). {ECO:0000269|PubMed:19584355,
CC       ECO:0000269|PubMed:20559325}.
CC   -!- PTM: Palmitoylated; may reduce accessibility of Ser-345 and Ser-
CC       346 by anchoring Cys-341 to the plasma membrane. Agonist
CC       stimulation promotes depalmitoylation and further allows Ser-345
CC       and Ser-346 phosphorylation. {ECO:0000269|PubMed:11146000,
CC       ECO:0000269|PubMed:17962520, ECO:0000269|PubMed:18547522,
CC       ECO:0000269|PubMed:2540197}.
CC   -!- PTM: Phosphorylated by PKA and BARK upon agonist stimulation,
CC       which mediates homologous desensitization of the receptor. PKA-
CC       mediated phosphorylation seems to facilitate phosphorylation by
CC       BARK.
CC   -!- PTM: Phosphorylation of Tyr-141 is induced by insulin and leads to
CC       supersensitization of the receptor. {ECO:0000269|PubMed:8521811}.
CC   -!- PTM: Polyubiquitinated. Agonist-induced ubiquitination leads to
CC       sort internalized receptors to the lysosomes for degradation
CC       (PubMed:19424180, PubMed:20559325). Deubiquitination by USP20 and
CC       USP33, leads to ADRB2 recycling and resensitization after
CC       prolonged agonist stimulation. USP20 and USP33 are constitutively
CC       associated and are dissociated immediately after agonist
CC       stimulation. Ubiquitination by the VHL-E3 ligase complex is
CC       oxygen-dependent. {ECO:0000269|PubMed:19424180,
CC       ECO:0000269|PubMed:20559325}.
CC   -!- PTM: Hydroxylation by EGLN3 occurs only under normoxia and
CC       increases the interaction with VHL and the subsequent
CC       ubiquitination and degradation of ADRB2.
CC       {ECO:0000269|PubMed:19424180, ECO:0000269|PubMed:19584355}.
CC   -!- POLYMORPHISM: The Gly-16 allele is overrepresented in individuals
CC       affected by nocturnal asthma as compared to controls, and appears
CC       to be an important genetic factor in the expression of this
CC       asthmatic phenotype.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       Adrenergic receptor subfamily. ADRB2 sub-subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD96745.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/adrb2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X04827; CAA28511.1; -; mRNA.
DR   EMBL; Y00106; CAA68289.1; -; Genomic_DNA.
DR   EMBL; M15169; AAA88015.1; -; mRNA.
DR   EMBL; J02960; AAA88017.1; -; Genomic_DNA.
DR   EMBL; AF022953; AAB82148.1; -; Genomic_DNA.
DR   EMBL; AF022954; AAB82149.1; -; Genomic_DNA.
DR   EMBL; AF022955; AAB82150.1; -; Genomic_DNA.
DR   EMBL; AF022956; AAB82151.1; -; Genomic_DNA.
DR   EMBL; AF169225; AAD48036.1; -; Genomic_DNA.
DR   EMBL; AF202305; AAF17569.1; -; Genomic_DNA.
DR   EMBL; AF203386; AAF20199.1; -; Genomic_DNA.
DR   EMBL; AY136741; AAN01267.1; -; mRNA.
DR   EMBL; AK313151; BAG35969.1; -; mRNA.
DR   EMBL; AK223025; BAD96745.1; ALT_INIT; mRNA.
DR   EMBL; DQ094845; AAY88739.1; -; Genomic_DNA.
DR   EMBL; EU332834; ABY87523.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61798.1; -; Genomic_DNA.
DR   EMBL; BC012481; AAH12481.3; -; mRNA.
DR   EMBL; BC063486; AAH63486.2; -; mRNA.
DR   EMBL; BC073856; AAH73856.1; -; mRNA.
DR   CCDS; CCDS4292.1; -.
DR   PIR; A27525; QRHUB2.
DR   RefSeq; NP_000015.1; NM_000024.5.
DR   UniGene; Hs.2551; -.
DR   PDB; 1GQ4; X-ray; 1.90 A; A=409-413.
DR   PDB; 2R4R; X-ray; 3.40 A; A=1-365.
DR   PDB; 2R4S; X-ray; 3.40 A; A=24-365.
DR   PDB; 2RH1; X-ray; 2.40 A; A=1-230, A=263-365.
DR   PDB; 3D4S; X-ray; 2.80 A; A=1-230, A=263-348.
DR   PDB; 3KJ6; X-ray; 3.40 A; A=2-365.
DR   PDB; 3NY8; X-ray; 2.84 A; A=1-230, A=263-348.
DR   PDB; 3NY9; X-ray; 2.84 A; A=1-230, A=263-348.
DR   PDB; 3NYA; X-ray; 3.16 A; A=1-230, A=263-348.
DR   PDB; 3P0G; X-ray; 3.50 A; A=1-230, A=263-365.
DR   PDB; 3PDS; X-ray; 3.50 A; A=25-230, A=264-348.
DR   PDB; 3SN6; X-ray; 3.20 A; R=29-365.
DR   PDB; 4GBR; X-ray; 3.99 A; A=29-365.
DR   PDB; 4LDE; X-ray; 2.79 A; A=29-348.
DR   PDB; 4LDL; X-ray; 3.10 A; A=29-348.
DR   PDB; 4LDO; X-ray; 3.20 A; A=29-348.
DR   PDB; 4QKX; X-ray; 3.30 A; A=29-348.
DR   PDB; 5D5A; X-ray; 2.48 A; A=1-230, A=263-365.
DR   PDB; 5D5B; X-ray; 3.80 A; A=1-230, A=263-365.
DR   PDB; 5D6L; X-ray; 3.20 A; A=1-223, A=264-365.
DR   PDB; 5JQH; X-ray; 3.20 A; A/B=30-348.
DR   PDB; 5X7D; X-ray; 2.70 A; A=1-230, A=264-365.
DR   PDBsum; 1GQ4; -.
DR   PDBsum; 2R4R; -.
DR   PDBsum; 2R4S; -.
DR   PDBsum; 2RH1; -.
DR   PDBsum; 3D4S; -.
DR   PDBsum; 3KJ6; -.
DR   PDBsum; 3NY8; -.
DR   PDBsum; 3NY9; -.
DR   PDBsum; 3NYA; -.
DR   PDBsum; 3P0G; -.
DR   PDBsum; 3PDS; -.
DR   PDBsum; 3SN6; -.
DR   PDBsum; 4GBR; -.
DR   PDBsum; 4LDE; -.
DR   PDBsum; 4LDL; -.
DR   PDBsum; 4LDO; -.
DR   PDBsum; 4QKX; -.
DR   PDBsum; 5D5A; -.
DR   PDBsum; 5D5B; -.
DR   PDBsum; 5D6L; -.
DR   PDBsum; 5JQH; -.
DR   PDBsum; 5X7D; -.
DR   ProteinModelPortal; P07550; -.
DR   SMR; P07550; -.
DR   BioGrid; 106663; 246.
DR   CORUM; P07550; -.
DR   DIP; DIP-33948N; -.
DR   ELM; P07550; -.
DR   IntAct; P07550; 15.
DR   MINT; P07550; -.
DR   STRING; 9606.ENSP00000305372; -.
DR   BindingDB; P07550; -.
DR   ChEMBL; CHEMBL210; -.
DR   DrugBank; DB07543; (2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol.
DR   DrugBank; DB01193; Acebutolol.
DR   DrugBank; DB00866; Alprenolol.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB00182; Amphetamine.
DR   DrugBank; DB01102; Arbutamine.
DR   DrugBank; DB01274; Arformoterol.
DR   DrugBank; DB06216; Asenapine.
DR   DrugBank; DB00335; Atenolol.
DR   DrugBank; DB01408; Bambuterol.
DR   DrugBank; DB00195; Betaxolol.
DR   DrugBank; DB00217; Bethanidine.
DR   DrugBank; DB01295; Bevantolol.
DR   DrugBank; DB00612; Bisoprolol.
DR   DrugBank; DB00901; Bitolterol.
DR   DrugBank; DB08807; Bopindolol.
DR   DrugBank; DB06726; Bufuralol.
DR   DrugBank; DB08808; Bupranolol.
DR   DrugBank; DB00248; Cabergoline.
DR   DrugBank; DB00521; Carteolol.
DR   DrugBank; DB01136; Carvedilol.
DR   DrugBank; DB04846; Celiprolol.
DR   DrugBank; DB01407; Clenbuterol.
DR   DrugBank; DB01151; Desipramine.
DR   DrugBank; DB00449; Dipivefrin.
DR   DrugBank; DB00841; Dobutamine.
DR   DrugBank; DB06262; Droxidopa.
DR   DrugBank; DB01363; Ephedra.
DR   DrugBank; DB00668; Epinephrine.
DR   DrugBank; DB01288; Fenoterol.
DR   DrugBank; DB00983; Formoterol.
DR   DrugBank; DB05039; Indacaterol.
DR   DrugBank; DB00221; Isoetarine.
DR   DrugBank; DB01064; Isoprenaline.
DR   DrugBank; DB00598; Labetalol.
DR   DrugBank; DB01210; Levobunolol.
DR   DrugBank; DB13139; Levosalbutamol.
DR   DrugBank; DB01365; Mephentermine.
DR   DrugBank; DB01214; Metipranolol.
DR   DrugBank; DB00264; Metoprolol.
DR   DrugBank; DB00370; Mirtazapine.
DR   DrugBank; DB01203; Nadolol.
DR   DrugBank; DB05849; NCX 950.
DR   DrugBank; DB04861; Nebivolol.
DR   DrugBank; DB00368; Norepinephrine.
DR   DrugBank; DB00540; Nortriptyline.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB09080; Olodaterol.
DR   DrugBank; DB00816; Orciprenaline.
DR   DrugBank; DB01580; Oxprenolol.
DR   DrugBank; DB01359; Penbutolol.
DR   DrugBank; DB00925; Phenoxybenzamine.
DR   DrugBank; DB00397; Phenylpropanolamine.
DR   DrugBank; DB00960; Pindolol.
DR   DrugBank; DB01291; Pirbuterol.
DR   DrugBank; DB01366; Procaterol.
DR   DrugBank; DB00571; Propranolol.
DR   DrugBank; DB00852; Pseudoephedrine.
DR   DrugBank; DB00867; Ritodrine.
DR   DrugBank; DB01001; Salbutamol.
DR   DrugBank; DB00938; Salmeterol.
DR   DrugBank; DB00489; Sotalol.
DR   DrugBank; DB00871; Terbutaline.
DR   DrugBank; DB00373; Timolol.
DR   DrugBank; DB00726; Trimipramine.
DR   DrugBank; DB09082; Vilanterol.
DR   GuidetoPHARMACOLOGY; 29; -.
DR   TCDB; 9.A.14.3.5; the g-protein-coupled receptor (gpcr) family.
DR   iPTMnet; P07550; -.
DR   PhosphoSitePlus; P07550; -.
DR   SwissPalm; P07550; -.
DR   BioMuta; ADRB2; -.
DR   DMDM; 296439450; -.
DR   PaxDb; P07550; -.
DR   PeptideAtlas; P07550; -.
DR   PRIDE; P07550; -.
DR   DNASU; 154; -.
DR   Ensembl; ENST00000305988; ENSP00000305372; ENSG00000169252.
DR   GeneID; 154; -.
DR   KEGG; hsa:154; -.
DR   CTD; 154; -.
DR   DisGeNET; 154; -.
DR   EuPathDB; HostDB:ENSG00000169252.5; -.
DR   GeneCards; ADRB2; -.
DR   HGNC; HGNC:286; ADRB2.
DR   HPA; HPA003431; -.
DR   HPA; HPA075322; -.
DR   MalaCards; ADRB2; -.
DR   MIM; 109690; gene+phenotype.
DR   neXtProt; NX_P07550; -.
DR   OpenTargets; ENSG00000169252; -.
DR   PharmGKB; PA39; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   eggNOG; ENOG410XRW9; LUCA.
DR   GeneTree; ENSGT00890000139331; -.
DR   HOVERGEN; HBG106962; -.
DR   InParanoid; P07550; -.
DR   KO; K04142; -.
DR   OMA; GRFHAQN; -.
DR   OrthoDB; EOG091G06VI; -.
DR   PhylomeDB; P07550; -.
DR   TreeFam; TF316350; -.
DR   Reactome; R-HSA-390696; Adrenoceptors.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   SignaLink; P07550; -.
DR   SIGNOR; P07550; -.
DR   ChiTaRS; ADRB2; human.
DR   EvolutionaryTrace; P07550; -.
DR   GeneWiki; Beta-2_adrenergic_receptor; -.
DR   GenomeRNAi; 154; -.
DR   PRO; PR:P07550; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000169252; -.
DR   ExpressionAtlas; P07550; baseline and differential.
DR   Genevisible; P07550; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0030665; C:clathrin-coated vesicle membrane; TAS:Reactome.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; TAS:ProtInc.
DR   GO; GO:0010008; C:endosome membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0005764; C:lysosome; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; NAS:ARUK-UCL.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0043235; C:receptor complex; IDA:HGNC.
DR   GO; GO:0008179; F:adenylate cyclase binding; IEA:Ensembl.
DR   GO; GO:0001540; F:amyloid-beta binding; IDA:ARUK-UCL.
DR   GO; GO:0004941; F:beta2-adrenergic receptor activity; IDA:HGNC.
DR   GO; GO:0051379; F:epinephrine binding; IBA:GO_Central.
DR   GO; GO:0051380; F:norepinephrine binding; IDA:HGNC.
DR   GO; GO:0015459; F:potassium channel regulator activity; IDA:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:HGNC.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:ARUK-UCL.
DR   GO; GO:0007190; P:activation of adenylate cyclase activity; IDA:HGNC.
DR   GO; GO:0007171; P:activation of transmembrane receptor protein tyrosine kinase activity; TAS:ProtInc.
DR   GO; GO:0071880; P:adenylate cyclase-activating adrenergic receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0071875; P:adrenergic receptor signaling pathway; IDA:CAFA.
DR   GO; GO:0045453; P:bone resorption; IEA:Ensembl.
DR   GO; GO:0050873; P:brown fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0007267; P:cell-cell signaling; IBA:GO_Central.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; IGI:ARUK-UCL.
DR   GO; GO:0002032; P:desensitization of G-protein coupled receptor protein signaling pathway by arrestin; IDA:HGNC.
DR   GO; GO:0002024; P:diet induced thermogenesis; IEA:Ensembl.
DR   GO; GO:0008333; P:endosome to lysosome transport; TAS:ProtInc.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0031649; P:heat generation; IEA:Ensembl.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0040015; P:negative regulation of multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0045986; P:negative regulation of smooth muscle contraction; IBA:GO_Central.
DR   GO; GO:0002025; P:norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure; IBA:GO_Central.
DR   GO; GO:2000969; P:positive regulation of AMPA receptor activity; IGI:ARUK-UCL.
DR   GO; GO:1901098; P:positive regulation of autophagosome maturation; IDA:GO_Central.
DR   GO; GO:0030501; P:positive regulation of bone mineralization; IEA:Ensembl.
DR   GO; GO:2000481; P:positive regulation of cAMP-dependent protein kinase activity; TAS:ARUK-UCL.
DR   GO; GO:1904504; P:positive regulation of lipophagy; IDA:GO_Central.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IDA:HGNC.
DR   GO; GO:0061885; P:positive regulation of mini excitatory postsynaptic potential; IEA:Ensembl.
DR   GO; GO:0010739; P:positive regulation of protein kinase A signaling; IGI:ARUK-UCL.
DR   GO; GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IGI:ARUK-UCL.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; IMP:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IDA:HGNC.
DR   GO; GO:0002028; P:regulation of sodium ion transport; IEA:Ensembl.
DR   GO; GO:0009409; P:response to cold; IEA:Ensembl.
DR   GO; GO:1990911; P:response to psychosocial stress; TAS:ARUK-UCL.
DR   CDD; cd15957; 7tmA_Beta2_AR; 1.
DR   InterPro; IPR002233; ADR_fam.
DR   InterPro; IPR000332; ADRB2_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR24248:SF21; PTHR24248:SF21; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR01103; ADRENERGICR.
DR   PRINTS; PR00562; ADRENRGCB2AR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Disulfide bond;
KW   Endosome; G-protein coupled receptor; Glycoprotein; Hydroxylation;
KW   Lipoprotein; Membrane; Palmitate; Phosphoprotein; Polymorphism;
KW   Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   CHAIN         1    413       Beta-2 adrenergic receptor.
FT                                /FTId=PRO_0000069130.
FT   TOPO_DOM      1     34       Extracellular.
FT   TRANSMEM     35     58       Helical; Name=1.
FT   TOPO_DOM     59     71       Cytoplasmic.
FT   TRANSMEM     72     95       Helical; Name=2.
FT   TOPO_DOM     96    106       Extracellular.
FT   TRANSMEM    107    129       Helical; Name=3.
FT   TOPO_DOM    130    150       Cytoplasmic.
FT   TRANSMEM    151    174       Helical; Name=4.
FT   TOPO_DOM    175    196       Extracellular.
FT   TRANSMEM    197    220       Helical; Name=5.
FT   TOPO_DOM    221    274       Cytoplasmic.
FT   TRANSMEM    275    298       Helical; Name=6.
FT   TOPO_DOM    299    305       Extracellular.
FT   TRANSMEM    306    329       Helical; Name=7.
FT   TOPO_DOM    330    413       Cytoplasmic.
FT   REGION      193    207       Agonist and antagonist binding.
FT   REGION      286    293       Agonist and antagonist binding.
FT   REGION      312    316       Agonist and antagonist binding.
FT   MOTIF       410    413       PDZ-binding.
FT   BINDING     113    113       Agonist or antagonist.
FT   BINDING     118    118       Agonist or antagonist.
FT   MOD_RES     141    141       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:8521811}.
FT   MOD_RES     246    246       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES     261    261       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES     262    262       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES     345    345       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:11146000}.
FT   MOD_RES     346    346       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:11146000}.
FT   MOD_RES     355    355       Phosphoserine; by BARK. {ECO:0000305}.
FT   MOD_RES     356    356       Phosphoserine; by BARK. {ECO:0000305}.
FT   MOD_RES     382    382       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:19584355}.
FT   MOD_RES     395    395       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:19584355}.
FT   LIPID       341    341       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:17962520,
FT                                ECO:0000269|PubMed:18547522,
FT                                ECO:0000269|PubMed:2540197}.
FT   CARBOHYD      6      6       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305}.
FT   CARBOHYD     15     15       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305}.
FT   DISULFID    106    191
FT   DISULFID    184    190
FT   VARIANT      15     15       N -> S (in dbSNP:rs33973603).
FT                                /FTId=VAR_049373.
FT   VARIANT      16     16       G -> R (common polymorphism;
FT                                dbSNP:rs1042713).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:3025863,
FT                                ECO:0000269|PubMed:3033609,
FT                                ECO:0000269|PubMed:3034889,
FT                                ECO:0000269|PubMed:7706471,
FT                                ECO:0000269|PubMed:7915137,
FT                                ECO:0000269|PubMed:8383511,
FT                                ECO:0000269|Ref.8}.
FT                                /FTId=VAR_003452.
FT   VARIANT      27     27       E -> Q (in dbSNP:rs1042714).
FT                                {ECO:0000269|PubMed:11246467,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2823249,
FT                                ECO:0000269|PubMed:3025863,
FT                                ECO:0000269|PubMed:3026848,
FT                                ECO:0000269|PubMed:3033609,
FT                                ECO:0000269|PubMed:3034889,
FT                                ECO:0000269|PubMed:7915137,
FT                                ECO:0000269|PubMed:8383511,
FT                                ECO:0000269|Ref.10, ECO:0000269|Ref.11,
FT                                ECO:0000269|Ref.12, ECO:0000269|Ref.8}.
FT                                /FTId=VAR_003453.
FT   VARIANT      34     34       V -> M (in dbSNP:rs990810566).
FT                                {ECO:0000269|PubMed:8383511}.
FT                                /FTId=VAR_003454.
FT   VARIANT     159    159       I -> F. {ECO:0000269|PubMed:11246467}.
FT                                /FTId=VAR_009125.
FT   VARIANT     159    159       I -> L. {ECO:0000269|PubMed:11246467}.
FT                                /FTId=VAR_009124.
FT   VARIANT     164    164       T -> I (in dbSNP:rs1800888).
FT                                {ECO:0000269|PubMed:8383511}.
FT                                /FTId=VAR_003455.
FT   VARIANT     220    220       S -> C (in dbSNP:rs3729943).
FT                                {ECO:0000269|Ref.11}.
FT                                /FTId=VAR_025101.
FT   VARIANT     375    375       K -> R (in dbSNP:rs771585355).
FT                                {ECO:0000269|PubMed:11246467}.
FT                                /FTId=VAR_009394.
FT   MUTAGEN      79     79       D->N: Affects binding of catecholamines,
FT                                and produces an uncoupling between the
FT                                receptor and stimulatory G proteins.
FT                                {ECO:0000269|PubMed:2831218}.
FT   MUTAGEN     141    141       Y->F: Abolishes insulin-induced tyrosine
FT                                phosphorylation and insulin-induced
FT                                receptor supersensitization.
FT                                {ECO:0000269|PubMed:8521811}.
FT   MUTAGEN     341    341       C->G: Uncoupled receptor.
FT                                {ECO:0000269|PubMed:2540197}.
FT   MUTAGEN     345    346       SS->AA: Delayed agonist-promoted
FT                                desensitization.
FT                                {ECO:0000269|PubMed:11146000}.
FT   MUTAGEN     350    350       Y->A: Does not affect insulin-induced
FT                                tyrosine phosphorylation or insulin-
FT                                induced receptor supersensitization.
FT                                {ECO:0000269|PubMed:8521811}.
FT   MUTAGEN     354    354       Y->A: Does not affect insulin-induced
FT                                tyrosine phosphorylation or insulin-
FT                                induced receptor supersensitization.
FT                                {ECO:0000269|PubMed:8521811}.
FT   MUTAGEN     366    366       Y->F: Does not affect insulin-induced
FT                                tyrosine phosphorylation or insulin-
FT                                induced receptor supersensitization.
FT                                {ECO:0000269|PubMed:8521811}.
FT   CONFLICT     71     71       F -> L (in Ref. 9; BAG35969).
FT                                {ECO:0000305}.
FT   CONFLICT    216    216       V -> A (in Ref. 8; AAN01267).
FT                                {ECO:0000305}.
FT   CONFLICT    261    261       S -> P (in Ref. 10; BAD96745).
FT                                {ECO:0000305}.
FT   CONFLICT    402    402       Q -> P (in Ref. 14; AAH12481).
FT                                {ECO:0000305}.
FT   STRAND       25     27       {ECO:0000244|PDB:3P0G}.
FT   HELIX        31     60       {ECO:0000244|PDB:2RH1}.
FT   HELIX        62     64       {ECO:0000244|PDB:2RH1}.
FT   HELIX        67     85       {ECO:0000244|PDB:2RH1}.
FT   HELIX        87     96       {ECO:0000244|PDB:2RH1}.
FT   HELIX       102    136       {ECO:0000244|PDB:2RH1}.
FT   STRAND      137    139       {ECO:0000244|PDB:2RH1}.
FT   HELIX       147    170       {ECO:0000244|PDB:2RH1}.
FT   TURN        171    174       {ECO:0000244|PDB:2RH1}.
FT   HELIX       179    186       {ECO:0000244|PDB:2RH1}.
FT   STRAND      187    189       {ECO:0000244|PDB:3SN6}.
FT   HELIX       197    207       {ECO:0000244|PDB:2RH1}.
FT   HELIX       209    229       {ECO:0000244|PDB:2RH1}.
FT   TURN        235    239       {ECO:0000244|PDB:2R4R}.
FT   HELIX       267    298       {ECO:0000244|PDB:2RH1}.
FT   STRAND      299    303       {ECO:0000244|PDB:4LDL}.
FT   HELIX       305    317       {ECO:0000244|PDB:2RH1}.
FT   HELIX       318    320       {ECO:0000244|PDB:2RH1}.
FT   HELIX       322    325       {ECO:0000244|PDB:2RH1}.
FT   HELIX       326    328       {ECO:0000244|PDB:2RH1}.
FT   HELIX       330    339       {ECO:0000244|PDB:2RH1}.
FT   TURN        340    342       {ECO:0000244|PDB:5JQH}.
FT   TURN        345    347       {ECO:0000244|PDB:2R4R}.
SQ   SEQUENCE   413 AA;  46459 MW;  408C22731C6EDFBE CRC64;
     MGQPGNGSAF LLAPNGSHAP DHDVTQERDE VWVVGMGIVM SLIVLAIVFG NVLVITAIAK
     FERLQTVTNY FITSLACADL VMGLAVVPFG AAHILMKMWT FGNFWCEFWT SIDVLCVTAS
     IETLCVIAVD RYFAITSPFK YQSLLTKNKA RVIILMVWIV SGLTSFLPIQ MHWYRATHQE
     AINCYANETC CDFFTNQAYA IASSIVSFYV PLVIMVFVYS RVFQEAKRQL QKIDKSEGRF
     HVQNLSQVEQ DGRTGHGLRR SSKFCLKEHK ALKTLGIIMG TFTLCWLPFF IVNIVHVIQD
     NLIRKEVYIL LNWIGYVNSG FNPLIYCRSP DFRIAFQELL CLRRSSLKAY GNGYSSNGNT
     GEQSGYHVEQ EKENKLLCED LPGTEDFVGH QGTVPSDNID SQGRNCSTND SLL
//
ID   FBX6_HUMAN              Reviewed;         293 AA.
AC   Q9NRD1; B1AK42; B2RC88; Q9UKT3;
DT   01-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-FEB-2018, entry version 151.
DE   RecName: Full=F-box only protein 6;
DE   AltName: Full=F-box protein that recognizes sugar chains 2;
DE   AltName: Full=F-box/G-domain protein 2;
GN   Name=FBXO6; Synonyms=FBG2, FBS2, FBX6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10531035; DOI=10.1016/S0960-9822(00)80020-2;
RA   Cenciarelli C., Chiaur D.S., Guardavaccaro D., Parks W., Vidal M.,
RA   Pagano M.;
RT   "Identification of a family of human F-box proteins.";
RL   Curr. Biol. 9:1177-1179(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10945468; DOI=10.1006/geno.2000.6211;
RA   Ilyin G.P., Rialland M., Pigeon C., Guguen-Guillouzo C.;
RT   "cDNA cloning and expression analysis of new members of the mammalian
RT   F-box protein family.";
RL   Genomics 67:40-47(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, SUGAR-BINDING, INTERACTION WITH CUL1, AND MUTAGENESIS OF
RP   241-TYR-TRP-242.
RX   PubMed=18203720; DOI=10.1074/jbc.M709508200;
RA   Glenn K.A., Nelson R.F., Wen H.M., Mallinger A.J., Paulson H.L.;
RT   "Diversity in tissue expression, substrate binding, and SCF complex
RT   formation for a lectin family of ubiquitin ligases.";
RL   J. Biol. Chem. 283:12717-12729(2008).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION IN A SCF PROTEIN LIGASE
RP   COMPLEX, AND INTERACTION WITH CHEK1.
RX   PubMed=19716789; DOI=10.1016/j.molcel.2009.06.030;
RA   Zhang Y.-W., Brognard J., Coughlin C., You Z., Dolled-Filhart M.,
RA   Aslanian A., Manning G., Abraham R.T., Hunter T.;
RT   "The F box protein Fbx6 regulates Chk1 stability and cellular
RT   sensitivity to replication stress.";
RL   Mol. Cell 35:442-453(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-258 AND SER-284, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Substrate-recognition component of some SCF (SKP1-CUL1-
CC       F-box protein)-type E3 ubiquitin ligase complexes. Involved in
CC       endoplasmic reticulum-associated degradation pathway (ERAD) for
CC       misfolded lumenal proteins by recognizing and binding sugar chains
CC       on unfolded glycoproteins that are retrotranslocated into the
CC       cytosol and promoting their ubiquitination and subsequent
CC       degradation. Able to recognize and bind denatured glycoproteins,
CC       which are modified with not only high-mannose but also complex-
CC       type oligosaccharides. Also recognizes sulfated glycans. Also
CC       involved in DNA damage response by specifically recognizing
CC       activated CHEK1 (phosphorylated on 'Ser-345'), promoting its
CC       ubiquitination and degradation. Ubiquitination of CHEK1 is
CC       required to insure that activated CHEK1 does not accumulate as
CC       cells progress through S phase, or when replication forks
CC       encounter transient impediments during normal DNA replication.
CC       {ECO:0000269|PubMed:18203720, ECO:0000269|PubMed:19716789}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with VCP (By similarity). Part of a SCF (SKP1-
CC       cullin-F-box) protein ligase complex. Interacts with CHEK1 and
CC       CUL1. {ECO:0000250, ECO:0000269|PubMed:18203720,
CC       ECO:0000269|PubMed:19716789}.
CC   -!- INTERACTION:
CC       P63208:SKP1; NbExp=3; IntAct=EBI-3938499, EBI-307486;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF04470.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAI20215.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=hFBG2;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_other_821";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF129536; AAF04470.1; ALT_INIT; mRNA.
DR   EMBL; AF233223; AAF67153.1; -; mRNA.
DR   EMBL; AK314989; BAG37485.1; -; mRNA.
DR   EMBL; AL031731; CAI20214.1; -; Genomic_DNA.
DR   EMBL; AL031731; CAI20215.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471130; EAW71696.1; -; Genomic_DNA.
DR   EMBL; BC020880; AAH20880.1; -; mRNA.
DR   CCDS; CCDS133.1; -.
DR   RefSeq; NP_060908.1; NM_018438.5.
DR   RefSeq; XP_005263505.1; XM_005263448.4.
DR   RefSeq; XP_005263506.1; XM_005263449.4.
DR   RefSeq; XP_005263508.1; XM_005263451.4.
DR   RefSeq; XP_006710634.1; XM_006710571.3.
DR   RefSeq; XP_011539534.1; XM_011541232.2.
DR   RefSeq; XP_016856496.1; XM_017001007.1.
DR   UniGene; Hs.464419; -.
DR   ProteinModelPortal; Q9NRD1; -.
DR   SMR; Q9NRD1; -.
DR   BioGrid; 117654; 622.
DR   IntAct; Q9NRD1; 5.
DR   MINT; Q9NRD1; -.
DR   STRING; 9606.ENSP00000365944; -.
DR   iPTMnet; Q9NRD1; -.
DR   PhosphoSitePlus; Q9NRD1; -.
DR   BioMuta; FBXO6; -.
DR   DMDM; 24636846; -.
DR   EPD; Q9NRD1; -.
DR   MaxQB; Q9NRD1; -.
DR   PaxDb; Q9NRD1; -.
DR   PeptideAtlas; Q9NRD1; -.
DR   PRIDE; Q9NRD1; -.
DR   DNASU; 26270; -.
DR   Ensembl; ENST00000376753; ENSP00000365944; ENSG00000116663.
DR   GeneID; 26270; -.
DR   KEGG; hsa:26270; -.
DR   UCSC; uc001aso.4; human.
DR   CTD; 26270; -.
DR   DisGeNET; 26270; -.
DR   EuPathDB; HostDB:ENSG00000116663.10; -.
DR   GeneCards; FBXO6; -.
DR   HGNC; HGNC:13585; FBXO6.
DR   HPA; HPA051175; -.
DR   MIM; 605647; gene.
DR   neXtProt; NX_Q9NRD1; -.
DR   OpenTargets; ENSG00000116663; -.
DR   PharmGKB; PA28046; -.
DR   eggNOG; ENOG410IK6V; Eukaryota.
DR   eggNOG; ENOG4111MF5; LUCA.
DR   GeneTree; ENSGT00390000003865; -.
DR   HOGENOM; HOG000231084; -.
DR   HOVERGEN; HBG003593; -.
DR   InParanoid; Q9NRD1; -.
DR   KO; K10100; -.
DR   OMA; EMCLKSQ; -.
DR   OrthoDB; EOG091G0G3L; -.
DR   PhylomeDB; Q9NRD1; -.
DR   TreeFam; TF320527; -.
DR   Reactome; R-HSA-390471; Association of TriC/CCT with target proteins during biosynthesis.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; FBXO6; human.
DR   GeneWiki; FBXO6; -.
DR   GenomeRNAi; 26270; -.
DR   PRO; PR:Q9NRD1; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116663; -.
DR   CleanEx; HS_FBXO6; -.
DR   ExpressionAtlas; Q9NRD1; baseline and differential.
DR   Genevisible; Q9NRD1; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0044322; C:endoplasmic reticulum quality control compartment; IEA:Ensembl.
DR   GO; GO:0019005; C:SCF ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:Ensembl.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IEA:Ensembl.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; EXP:Reactome.
DR   GO; GO:0000077; P:DNA damage checkpoint; TAS:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; TAS:UniProtKB.
DR   GO; GO:0006516; P:glycoprotein catabolic process; IEA:Ensembl.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0000209; P:protein polyubiquitination; TAS:Reactome.
DR   GO; GO:0006508; P:proteolysis; TAS:ProtInc.
DR   GO; GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW.
DR   GO; GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; ISS:UniProtKB.
DR   Gene3D; 2.60.120.260; -; 1.
DR   InterPro; IPR007397; F-box-assoc_dom.
DR   InterPro; IPR036047; F-box-like_dom_sf.
DR   InterPro; IPR001810; F-box_dom.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   Pfam; PF12937; F-box-like; 1.
DR   Pfam; PF04300; FBA; 1.
DR   SMART; SM01198; FBA; 1.
DR   SMART; SM00256; FBOX; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF81383; SSF81383; 1.
DR   PROSITE; PS51114; FBA; 1.
DR   PROSITE; PS50181; FBOX; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; DNA damage; DNA repair; Phosphoprotein;
KW   Polymorphism; Reference proteome; Ubl conjugation pathway;
KW   Unfolded protein response.
FT   CHAIN         1    293       F-box only protein 6.
FT                                /FTId=PRO_0000119882.
FT   DOMAIN       10     57       F-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00080}.
FT   DOMAIN       78    259       FBA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00482}.
FT   MOD_RES     258    258       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     284    284       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT      60     60       R -> Q (in dbSNP:rs3125818).
FT                                /FTId=VAR_049039.
FT   VARIANT     201    201       P -> T (in dbSNP:rs2294639).
FT                                /FTId=VAR_022158.
FT   MUTAGEN     241    242       YW->AA: Abolishes interaction with
FT                                glycosylated concanavalin-A in vitro.
FT                                {ECO:0000269|PubMed:18203720}.
FT   CONFLICT     18     18       E -> D (in Ref. 1; AAF04470).
FT                                {ECO:0000305}.
FT   CONFLICT     51     51       M -> L (in Ref. 1; AAF04470).
FT                                {ECO:0000305}.
FT   CONFLICT     61     61       E -> K (in Ref. 1; AAF04470).
FT                                {ECO:0000305}.
FT   CONFLICT     96     96       E -> N (in Ref. 1; AAF04470).
FT                                {ECO:0000305}.
FT   CONFLICT    114    114       E -> D (in Ref. 1; AAF04470).
FT                                {ECO:0000305}.
FT   CONFLICT    123    123       D -> E (in Ref. 1; AAF04470).
FT                                {ECO:0000305}.
FT   CONFLICT    132    132       Y -> S (in Ref. 1; AAF04470).
FT                                {ECO:0000305}.
FT   CONFLICT    139    139       M -> L (in Ref. 1; AAF04470).
FT                                {ECO:0000305}.
FT   CONFLICT    143    144       SQ -> WE (in Ref. 1; AAF04470).
FT                                {ECO:0000305}.
FT   CONFLICT    149    152       VAEG -> LADR (in Ref. 1; AAF04470).
FT                                {ECO:0000305}.
FT   CONFLICT    287    287       R -> G (in Ref. 1; AAF04470).
FT                                {ECO:0000305}.
SQ   SEQUENCE   293 AA;  33933 MW;  EA4235CD9CCD80FF CRC64;
     MDAPHSKAAL DSINELPENI LLELFTHVPA RQLLLNCRLV CSLWRDLIDL MTLWKRKCLR
     EGFITKDWDQ PVADWKIFYF LRSLHRNLLR NPCAEEDMFA WQIDFNGGDR WKVESLPGAH
     GTDFPDPKVK KYFVTSYEMC LKSQLVDLVA EGYWEELLDT FRPDIVVKDW FAARADCGCT
     YQLKVQLASA DYFVLASFEP PPVTIQQWNN ATWTEVSYTF SDYPRGVRYI LFQHGGRDTQ
     YWAGWYGPRV TNSSIVVSPK MTRNQASSEA QPGQKHGQEE AAQSPYRAVV QIF
//
ID   A0A024RBI5_HUMAN        Unreviewed;       474 AA.
AC   A0A024RBI5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 38.
DE   RecName: Full=Coronin {ECO:0000256|RuleBase:RU280818};
GN   Name=CORO1C {ECO:0000313|EMBL:EAW97827.1};
GN   ORFNames=hCG_15695 {ECO:0000313|EMBL:EAW97827.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW97827.1};
RN   [1] {ECO:0000313|EMBL:EAW97827.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW97827.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the WD repeat coronin family.
CC       {ECO:0000256|RuleBase:RU280818}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471054; EAW97827.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW97828.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW97829.1; -; Genomic_DNA.
DR   RefSeq; NP_001263400.1; NM_001276471.1.
DR   RefSeq; NP_055140.1; NM_014325.3.
DR   RefSeq; XP_016874611.1; XM_017019122.1.
DR   RefSeq; XP_016874612.1; XM_017019123.1.
DR   UniGene; Hs.330384; -.
DR   SMR; A0A024RBI5; -.
DR   PRIDE; A0A024RBI5; -.
DR   GeneID; 23603; -.
DR   KEGG; hsa:23603; -.
DR   CTD; 23603; -.
DR   EuPathDB; HostDB:ENSG00000110880.10; -.
DR   eggNOG; KOG0303; Eukaryota.
DR   eggNOG; ENOG410XQAD; LUCA.
DR   KO; K13886; -.
DR   ChiTaRS; CORO1C; human.
DR   GenomeRNAi; 23603; -.
DR   Bgee; ENSG00000110880; -.
DR   ExpressionAtlas; A0A024RBI5; baseline and differential.
DR   GO; GO:0015629; C:actin cytoskeleton; IEA:InterPro.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IEA:InterPro.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR027333; CORO1C.
DR   InterPro; IPR015505; Coronin.
DR   InterPro; IPR015048; DUF1899.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR10856; PTHR10856; 1.
DR   PANTHER; PTHR10856:SF10; PTHR10856:SF10; 1.
DR   Pfam; PF08953; DUF1899; 1.
DR   Pfam; PF00400; WD40; 3.
DR   SMART; SM01166; DUF1899; 1.
DR   SMART; SM00320; WD40; 3.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 3.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   3: Inferred from homology;
KW   Repeat {ECO:0000256|RuleBase:RU280818};
KW   WD repeat {ECO:0000256|PROSITE-ProRule:PRU00221,
KW   ECO:0000256|RuleBase:RU280818}.
FT   DOMAIN       76    211       WD_REPEATS_REGION.
FT                                {ECO:0000259|PROSITE:PS50294}.
FT   REPEAT       76    118       WD. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00221}.
FT   REPEAT      126    168       WD. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00221}.
FT   REPEAT      170    211       WD. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00221}.
SQ   SEQUENCE   474 AA;  53249 MW;  C7256797C514BB53 CRC64;
     MRRVVRQSKF RHVFGQAVKN DQCYDDIRVS RVTWDSSFCA VNPRFVAIII EASGGGAFLV
     LPLHKTGRID KSYPTVCGHT GPVLDIDWCP HNDQVIASGS EDCTVMVWQI PENGLTLSLT
     EPVVILEGHS KRVGIVAWHP TARNVLLSAG CDNAIIIWNV GTGEALINLD DMHSDMIYNV
     SWNRNGSLIC TASKDKKVRV IDPRKQEIVA EKEKAHEGAR PMRAIFLADG NVFTTGFSRM
     SERQLALWNP KNMQEPIALH EMDTSNGVLL PFYDPDTSII YLCGKGDSSI RYFEITDESP
     YVHYLNTFSS KEPQRGMGYM PKRGLDVNKC EIARFFKLHE RKCEPIIMTV PRKSDLFQDD
     LYPDTAGPEA ALEAEEWFEG KNADPILISL KHGYIPGKNR DLKVVKKNIL DSKPTANKKC
     DLISIPKKTT DTASVQNEAK LDEILKEIKS IKDTICNQDE RISKLEQQMA KIAA
//
ID   COR1C_HUMAN             Reviewed;         474 AA.
AC   Q9ULV4; A7MAP0; A7MAP1; B3KU12; Q9NSK5;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   23-MAY-2018, entry version 167.
DE   RecName: Full=Coronin-1C;
DE   AltName: Full=Coronin-3;
DE   AltName: Full=hCRNN4;
GN   Name=CORO1C; Synonyms=CRN2, CRNN4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10828594;
RA   Iizaka M., Han H.-J., Akashi H., Furukawa Y., Nakajima Y., Sugano S.,
RA   Ogawa M., Nakamura Y.;
RT   "Isolation and chromosomal assignment of a novel human gene, CORO1C,
RT   homologous to coronin-like actin-binding proteins.";
RL   Cytogenet. Cell Genet. 88:221-224(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), FUNCTION (ISOFORM 3),
RP   ALTERNATIVE SPLICING, AND SUBUNIT.
RX   PubMed=19651142; DOI=10.1016/j.jmb.2009.07.079;
RA   Xavier C.P., Rastetter R.H., Stumpf M., Rosentreter A., Muller R.,
RA   Reimann J., Cornfine S., Linder S., van Vliet V., Hofmann A.,
RA   Morgan R.O., Fernandez M.P., Schroder R., Noegel A.A., Clemen C.S.;
RT   "Structural and functional diversity of novel coronin 1C (CRN2)
RT   isoforms in muscle.";
RL   J. Mol. Biol. 393:287-299(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   SUBUNIT, COILED-COIL REGION, WD REPEATS, INTERACTION WITH F-ACTIN, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=12377779; DOI=10.1074/jbc.M205136200;
RA   Spoerl Z., Stumpf M., Noegel A.A., Hasse A.;
RT   "Oligomerization, F-actin interaction, and membrane association of the
RT   ubiquitous mammalian coronin 3 are mediated by its carboxyl
RT   terminus.";
RL   J. Biol. Chem. 277:48858-48867(2002).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-446, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: May be involved in cytokinesis, motility, and signal
CC       transduction. {ECO:0000250}.
CC   -!- FUNCTION: Isoform 3: Involved in myogenic differentiation.
CC   -!- SUBUNIT: Binds F-actin. Isoform 1 and isoform 2 appear as
CC       homotrimers, while isoform 3 seems to exist as monomers.
CC       {ECO:0000269|PubMed:12377779, ECO:0000269|PubMed:19651142}.
CC   -!- INTERACTION:
CC       Q9BR76:CORO1B; NbExp=2; IntAct=EBI-351384, EBI-351152;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12377779}.
CC       Cell projection, lamellipodium {ECO:0000269|PubMed:12377779}.
CC       Cytoplasm, cytoskeleton {ECO:0000269|PubMed:12377779}. Note=All
CC       isoforms localize in a diffuse and punctate pattern in the cytosol
CC       and are highly enriched in F-actin-rich areas. Isoform 3
CC       colocalizes with the thin filaments of the sarcomere and with the
CC       postsynaptic area and the junctional sarcoplasm of motor end
CC       plates.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9ULV4-1; Sequence=Displayed;
CC       Name=2; Synonyms=CRN2i2;
CC         IsoId=Q9ULV4-2; Sequence=VSP_047727;
CC       Name=3; Synonyms=CRN2i3;
CC         IsoId=Q9ULV4-3; Sequence=VSP_047728;
CC         Note=Exclusively expressed in well-differentiated myoblasts as
CC         well as in mature skeletal muscle.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DOMAIN: The C-terminal coiled-coil domain is essential for
CC       cortical membrane localization and oligomerization.
CC   -!- SIMILARITY: Belongs to the WD repeat coronin family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB82406.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB030656; BAA83077.1; -; mRNA.
DR   EMBL; AM849477; CAO94662.1; -; mRNA.
DR   EMBL; AM849478; CAO94663.1; -; mRNA.
DR   EMBL; AK096363; BAG53274.1; -; mRNA.
DR   EMBL; AL162070; CAB82406.1; ALT_INIT; mRNA.
DR   EMBL; AC007569; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW97826.1; -; Genomic_DNA.
DR   EMBL; BC002342; AAH02342.1; -; mRNA.
DR   CCDS; CCDS61236.1; -. [Q9ULV4-3]
DR   CCDS; CCDS9120.1; -. [Q9ULV4-1]
DR   RefSeq; NP_001098707.1; NM_001105237.2. [Q9ULV4-3]
DR   RefSeq; NP_001263400.1; NM_001276471.1. [Q9ULV4-1]
DR   RefSeq; NP_055140.1; NM_014325.3. [Q9ULV4-1]
DR   RefSeq; XP_016874610.1; XM_017019121.1. [Q9ULV4-3]
DR   RefSeq; XP_016874611.1; XM_017019122.1. [Q9ULV4-1]
DR   RefSeq; XP_016874612.1; XM_017019123.1. [Q9ULV4-1]
DR   UniGene; Hs.330384; -.
DR   ProteinModelPortal; Q9ULV4; -.
DR   SMR; Q9ULV4; -.
DR   BioGrid; 117136; 108.
DR   DIP; DIP-33138N; -.
DR   IntAct; Q9ULV4; 49.
DR   MINT; Q9ULV4; -.
DR   STRING; 9606.ENSP00000261401; -.
DR   iPTMnet; Q9ULV4; -.
DR   PhosphoSitePlus; Q9ULV4; -.
DR   SwissPalm; Q9ULV4; -.
DR   DMDM; 12643898; -.
DR   OGP; Q9ULV4; -.
DR   EPD; Q9ULV4; -.
DR   PaxDb; Q9ULV4; -.
DR   PeptideAtlas; Q9ULV4; -.
DR   PRIDE; Q9ULV4; -.
DR   DNASU; 23603; -.
DR   Ensembl; ENST00000261401; ENSP00000261401; ENSG00000110880. [Q9ULV4-1]
DR   Ensembl; ENST00000420959; ENSP00000394496; ENSG00000110880. [Q9ULV4-3]
DR   Ensembl; ENST00000541050; ENSP00000438341; ENSG00000110880. [Q9ULV4-1]
DR   Ensembl; ENST00000549772; ENSP00000447534; ENSG00000110880. [Q9ULV4-2]
DR   GeneID; 23603; -.
DR   KEGG; hsa:23603; -.
DR   UCSC; uc001tnj.6; human. [Q9ULV4-1]
DR   CTD; 23603; -.
DR   DisGeNET; 23603; -.
DR   EuPathDB; HostDB:ENSG00000110880.10; -.
DR   GeneCards; CORO1C; -.
DR   HGNC; HGNC:2254; CORO1C.
DR   HPA; HPA041737; -.
DR   MIM; 605269; gene.
DR   neXtProt; NX_Q9ULV4; -.
DR   OpenTargets; ENSG00000110880; -.
DR   PharmGKB; PA26770; -.
DR   eggNOG; KOG0303; Eukaryota.
DR   eggNOG; ENOG410XQAD; LUCA.
DR   GeneTree; ENSGT00760000119195; -.
DR   HOGENOM; HOG000166356; -.
DR   HOVERGEN; HBG059978; -.
DR   InParanoid; Q9ULV4; -.
DR   KO; K13886; -.
DR   OMA; ISRNAWD; -.
DR   OrthoDB; EOG091G03H5; -.
DR   PhylomeDB; Q9ULV4; -.
DR   TreeFam; TF314280; -.
DR   SignaLink; Q9ULV4; -.
DR   SIGNOR; Q9ULV4; -.
DR   ChiTaRS; CORO1C; human.
DR   GeneWiki; CORO1C; -.
DR   GenomeRNAi; 23603; -.
DR   PRO; PR:Q9ULV4; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000110880; -.
DR   CleanEx; HS_CORO1C; -.
DR   ExpressionAtlas; Q9ULV4; baseline and differential.
DR   Genevisible; Q9ULV4; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0016600; C:flotillin complex; ISS:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; IDA:UniProtKB.
DR   GO; GO:0016328; C:lateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; IMP:UniProtKB.
DR   GO; GO:0048365; F:Rac GTPase binding; IEA:Ensembl.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0090630; P:activation of GTPase activity; ISS:UniProtKB.
DR   GO; GO:0045184; P:establishment of protein localization; ISS:UniProtKB.
DR   GO; GO:0010633; P:negative regulation of epithelial cell migration; IMP:UniProtKB.
DR   GO; GO:0051895; P:negative regulation of focal adhesion assembly; IMP:UniProtKB.
DR   GO; GO:0044387; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:1900025; P:negative regulation of substrate adhesion-dependent cell spreading; IMP:UniProtKB.
DR   GO; GO:0001755; P:neural crest cell migration; IMP:UniProtKB.
DR   GO; GO:0006909; P:phagocytosis; TAS:ProtInc.
DR   GO; GO:2000394; P:positive regulation of lamellipodium morphogenesis; IMP:UniProtKB.
DR   GO; GO:0010632; P:regulation of epithelial cell migration; IGI:UniProtKB.
DR   GO; GO:0010762; P:regulation of fibroblast migration; ISS:UniProtKB.
DR   GO; GO:0051893; P:regulation of focal adhesion assembly; IGI:UniProtKB.
DR   GO; GO:0001932; P:regulation of protein phosphorylation; IGI:UniProtKB.
DR   GO; GO:1900027; P:regulation of ruffle assembly; IEA:Ensembl.
DR   GO; GO:1900024; P:regulation of substrate adhesion-dependent cell spreading; IGI:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR027333; CORO1C.
DR   InterPro; IPR015505; Coronin.
DR   InterPro; IPR015048; DUF1899.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR10856; PTHR10856; 1.
DR   PANTHER; PTHR10856:SF10; PTHR10856:SF10; 1.
DR   Pfam; PF08953; DUF1899; 1.
DR   Pfam; PF00400; WD40; 3.
DR   SMART; SM01166; DUF1899; 1.
DR   SMART; SM00320; WD40; 3.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 3.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Actin-binding; Alternative splicing; Cell membrane;
KW   Cell projection; Coiled coil; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Membrane; Reference proteome; Repeat; WD repeat.
FT   CHAIN         1    474       Coronin-1C.
FT                                /FTId=PRO_0000050926.
FT   REPEAT       25     70       WD 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00221}.
FT   REPEAT       78    118       WD 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00221,
FT                                ECO:0000269|PubMed:12377779}.
FT   REPEAT      128    168       WD 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00221,
FT                                ECO:0000269|PubMed:12377779}.
FT   REPEAT      172    202       WD 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00221,
FT                                ECO:0000269|PubMed:12377779}.
FT   REPEAT      215    249       WD 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00221,
FT                                ECO:0000269|PubMed:12377779}.
FT   REPEAT      263    303       WD 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00221,
FT                                ECO:0000269|PubMed:12377779}.
FT   COILED      436    474       {ECO:0000269|PubMed:12377779}.
FT   MOD_RES     446    446       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       1      1       M -> MRWKDTM (in isoform 2).
FT                                {ECO:0000303|PubMed:19651142}.
FT                                /FTId=VSP_047727.
FT   VAR_SEQ       1      1       M -> MYGPGSQLGKSGNNSWAKERGCSIACQGSLTSARLH
FT                                APSIGERPLSHMRWKDTM (in isoform 3).
FT                                {ECO:0000303|PubMed:19651142}.
FT                                /FTId=VSP_047728.
SQ   SEQUENCE   474 AA;  53249 MW;  C7256797C514BB53 CRC64;
     MRRVVRQSKF RHVFGQAVKN DQCYDDIRVS RVTWDSSFCA VNPRFVAIII EASGGGAFLV
     LPLHKTGRID KSYPTVCGHT GPVLDIDWCP HNDQVIASGS EDCTVMVWQI PENGLTLSLT
     EPVVILEGHS KRVGIVAWHP TARNVLLSAG CDNAIIIWNV GTGEALINLD DMHSDMIYNV
     SWNRNGSLIC TASKDKKVRV IDPRKQEIVA EKEKAHEGAR PMRAIFLADG NVFTTGFSRM
     SERQLALWNP KNMQEPIALH EMDTSNGVLL PFYDPDTSII YLCGKGDSSI RYFEITDESP
     YVHYLNTFSS KEPQRGMGYM PKRGLDVNKC EIARFFKLHE RKCEPIIMTV PRKSDLFQDD
     LYPDTAGPEA ALEAEEWFEG KNADPILISL KHGYIPGKNR DLKVVKKNIL DSKPTANKKC
     DLISIPKKTT DTASVQNEAK LDEILKEIKS IKDTICNQDE RISKLEQQMA KIAA
//
ID   A0A024R6E0_HUMAN        Unreviewed;       434 AA.
AC   A0A024R6E0;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 30.
DE   SubName: Full=SPARC related modular calcium binding 1, isoform CRA_b {ECO:0000313|EMBL:EAW81015.1};
GN   Name=SMOC1 {ECO:0000313|EMBL:EAW81015.1};
GN   ORFNames=hCG_21971 {ECO:0000313|EMBL:EAW81015.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW81015.1};
RN   [1] {ECO:0000313|EMBL:EAW81015.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW81015.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00500}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471061; EAW81015.1; -; Genomic_DNA.
DR   RefSeq; NP_071420.1; NM_022137.5.
DR   UniGene; Hs.497349; -.
DR   ProteinModelPortal; A0A024R6E0; -.
DR   SMR; A0A024R6E0; -.
DR   PRIDE; A0A024R6E0; -.
DR   GeneID; 64093; -.
DR   KEGG; hsa:64093; -.
DR   CTD; 64093; -.
DR   EuPathDB; HostDB:ENSG00000198732.10; -.
DR   eggNOG; KOG4578; Eukaryota.
DR   eggNOG; ENOG410YP7C; LUCA.
DR   PhylomeDB; A0A024R6E0; -.
DR   ChiTaRS; SMOC1; human.
DR   GenomeRNAi; 64093; -.
DR   Bgee; ENSG00000198732; -.
DR   ExpressionAtlas; A0A024R6E0; baseline and differential.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0050840; F:extracellular matrix binding; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   CDD; cd16240; EFh_SPARC_SMOC1; 1.
DR   CDD; cd00191; TY; 2.
DR   Gene3D; 4.10.800.10; -; 2.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002350; Kazal_dom.
DR   InterPro; IPR036058; Kazal_dom_sf.
DR   InterPro; IPR037639; SMOC1_EC.
DR   InterPro; IPR019577; SPARC/Testican_Ca-bd-dom.
DR   InterPro; IPR000716; Thyroglobulin_1.
DR   InterPro; IPR036857; Thyroglobulin_1_sf.
DR   Pfam; PF07648; Kazal_2; 1.
DR   Pfam; PF10591; SPARC_Ca_bdg; 1.
DR   Pfam; PF00086; Thyroglobulin_1; 2.
DR   SMART; SM00280; KAZAL; 1.
DR   SMART; SM00211; TY; 2.
DR   SUPFAM; SSF100895; SSF100895; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF57610; SSF57610; 2.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS51465; KAZAL_2; 1.
DR   PROSITE; PS00484; THYROGLOBULIN_1_1; 2.
DR   PROSITE; PS51162; THYROGLOBULIN_1_2; 2.
PE   4: Predicted;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00500,
KW   ECO:0000256|SAAS:SAAS00485231}; Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     26       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        27    434       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001533206.
FT   DOMAIN       37     89       Kazal-like.
FT                                {ECO:0000259|PROSITE:PS51465}.
FT   DOMAIN       92    158       Thyroglobulin type-1.
FT                                {ECO:0000259|PROSITE:PS51162}.
FT   DOMAIN      224    292       Thyroglobulin type-1.
FT                                {ECO:0000259|PROSITE:PS51162}.
FT   DISULFID    129    136       {ECO:0000256|PROSITE-ProRule:PRU00500}.
FT   DISULFID    138    158       {ECO:0000256|PROSITE-ProRule:PRU00500}.
FT   DISULFID    262    269       {ECO:0000256|PROSITE-ProRule:PRU00500}.
SQ   SEQUENCE   434 AA;  48163 MW;  2CB639212BA42478 CRC64;
     MLPARCARLL TPHLLLVLVQ LSPARGHRTT GPRFLISDRD PQCNLHCSRT QPKPICASDG
     RSYESMCEYQ RAKCRDPTLG VVHRGRCKDA GQSKCRLERA QALEQAKKPQ EAVFVPECGE
     DGSFTQVQCH TYTGYCWCVT PDGKPISGSS VQNKTPVCSG SVTDKPLSQG NSGRKDDGSK
     PTPTMETQPV FDGDEITAPT LWIKHLVIKD SKLNNTNIRN SEKVYSCDQE RQSALEEAQQ
     NPREGIVIPE CAPGGLYKPV QCHQSTGYCW CVLVDTGRPL PGTSTRYVMP SCESDARAKT
     TEADDPFKDR ELPGCPEGKK MEFITSLLDA LTTDMVQAIN SAAPTGGGRF SEPDPSHTLE
     ERVVHWYFSQ LDSNSSNDIN KREMKPFKRY VKKKAKPKKC ARRFTDYCDL NKDKVISLPE
     LKGCLGVSKE GRLV
//
ID   SMOC1_HUMAN             Reviewed;         434 AA.
AC   Q9H4F8; A8K1S3; B2R7P5; Q96F78;
DT   31-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   23-MAY-2018, entry version 155.
DE   RecName: Full=SPARC-related modular calcium-binding protein 1;
DE   AltName: Full=Secreted modular calcium-binding protein 1;
DE            Short=SMOC-1;
DE   Flags: Precursor;
GN   Name=SMOC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, AND GLYCOSYLATION.
RC   TISSUE=Fetal brain;
RX   PubMed=12130637; DOI=10.1074/jbc.M203830200;
RA   Vannahme C., Smyth N., Miosge N., Goesling S., Frie C., Paulsson M.,
RA   Maurer P., Hartmann U.;
RT   "Characterization of SMOC-1, a novel modular calcium-binding protein
RT   in basement membranes.";
RL   J. Biol. Chem. 277:37977-37986(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Caudate nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION AS REGULATOR OF OSTEOBLAST DIFFERENTIATION, SUBCELLULAR
RP   LOCATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=20359165; DOI=10.1021/pr901110q;
RA   Choi Y.A., Lim J., Kim K.M., Acharya B., Cho J.Y., Bae Y.C.,
RA   Shin H.I., Kim S.Y., Park E.K.;
RT   "Secretome analysis of human BMSCs and identification of SMOC1 as an
RT   important ECM protein in osteoblast differentiation.";
RL   J. Proteome Res. 9:2946-2956(2010).
RN   [7]
RP   FUNCTION, AND INVOLVEMENT IN OAS.
RX   PubMed=21194678; DOI=10.1016/j.ajhg.2010.11.012;
RA   Okada I., Hamanoue H., Terada K., Tohma T., Megarbane A., Chouery E.,
RA   Abou-Ghoch J., Jalkh N., Cogulu O., Ozkinay F., Horie K., Takeda J.,
RA   Furuichi T., Ikegawa S., Nishiyama K., Miyatake S., Nishimura A.,
RA   Mizuguchi T., Niikawa N., Hirahara F., Kaname T., Yoshiura K.,
RA   Tsurusaki Y., Doi H., Miyake N., Furukawa T., Matsumoto N., Saitsu H.;
RT   "SMOC1 is essential for ocular and limb development in humans and
RT   mice.";
RL   Am. J. Hum. Genet. 88:30-41(2011).
RN   [8]
RP   FUNCTION, AND INVOLVEMENT IN OAS.
RX   PubMed=21194680; DOI=10.1016/j.ajhg.2010.12.002;
RA   Abouzeid H., Boisset G., Favez T., Youssef M., Marzouk I.,
RA   Shakankiry N., Bayoumi N., Descombes P., Agosti C., Munier F.L.,
RA   Schorderet D.F.;
RT   "Mutations in the SPARC-related modular calcium-binding protein 1
RT   gene, SMOC1, cause waardenburg anophthalmia syndrome.";
RL   Am. J. Hum. Genet. 88:92-98(2011).
RN   [9]
RP   VARIANTS OAS CYS-278 AND ASN-283.
RX   PubMed=21750680; DOI=10.1371/journal.pgen.1002114;
RA   Rainger J., van Beusekom E., Ramsay J.K., McKie L., Al-Gazali L.,
RA   Pallotta R., Saponari A., Branney P., Fisher M., Morrison H.,
RA   Bicknell L., Gautier P., Perry P., Sokhi K., Sexton D.,
RA   Bardakjian T.M., Schneider A.S., Elcioglu N., Ozkinay F., Koenig R.,
RA   Megarbane A., Semerci C.N., Khan A., Zafar S., Hennekam R.,
RA   Sousa S.B., Ramos L., Garavelli L., Furga A.S., Wischmeijer A.,
RA   Jackson I.J., Gillessen-Kaesbach G., Brunner H.G., Wieczorek D.,
RA   van Bokhoven H., Fitzpatrick D.R.;
RT   "Loss of the BMP antagonist, SMOC-1, causes Ophthalmo-acromelic
RT   (Waardenburg Anophthalmia) syndrome in humans and mice.";
RL   PLoS Genet. 7:E1002114-E1002114(2011).
RN   [10]
RP   VARIANT OAS HIS-286.
RX   PubMed=23646827; DOI=10.1111/cge.12184;
RA   Aldahmesh M.A., Khan A.O., Hijazi H., Alkuraya F.S.;
RT   "Mutations in ALDH1A3 cause Microphthalmia.";
RL   Clin. Genet. 84:128-131(2013).
CC   -!- FUNCTION: Plays essential roles in both eye and limb development.
CC       Probable regulator of osteoblast differentiation.
CC       {ECO:0000269|PubMed:20359165, ECO:0000269|PubMed:21194678,
CC       ECO:0000269|PubMed:21194680}.
CC   -!- INTERACTION:
CC       P09022:Hoxa1 (xeno); NbExp=2; IntAct=EBI-2801103, EBI-3957603;
CC       P60410:KRTAP10-8; NbExp=3; IntAct=EBI-2801103, EBI-10171774;
CC       Q7Z3S9:NOTCH2NL; NbExp=3; IntAct=EBI-2801103, EBI-945833;
CC       P15884:TCF4; NbExp=3; IntAct=EBI-2801103, EBI-533224;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix, basement membrane {ECO:0000269|PubMed:12130637,
CC       ECO:0000269|PubMed:20359165}. Note=In or around the basement
CC       membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H4F8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H4F8-2; Sequence=VSP_008720;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed in many tissues with a
CC       strongest signal in ovary. No expression in spleen.
CC       {ECO:0000269|PubMed:12130637}.
CC   -!- PTM: Glycosylated. {ECO:0000269|PubMed:12130637}.
CC   -!- DISEASE: Ophthalmoacromelic syndrome (OAS) [MIM:206920]: A rare
CC       disorder presenting with ocular anomalies, ranging from mild
CC       microphthalmia to true anophthalmia, and limb anomalies. Limb
CC       malformations include fused 4th and 5th metacarpals and short 5th
CC       finger in hands, and oligodactyly in foot (four toes). Most
CC       patients have bilateral anophthalmia/ microphthalmia, but
CC       unilateral abnormality is also noted. Other malformations are
CC       rare, but venous or vertebral anomaly was recognized each in
CC       single cases. {ECO:0000269|PubMed:21194678,
CC       ECO:0000269|PubMed:21194680, ECO:0000269|PubMed:21750680,
CC       ECO:0000269|PubMed:23646827}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ249900; CAC10352.1; -; mRNA.
DR   EMBL; AK289988; BAF82677.1; -; mRNA.
DR   EMBL; AK313063; BAG35892.1; -; mRNA.
DR   EMBL; AL135747; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL157789; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW81013.1; -; Genomic_DNA.
DR   EMBL; CH471061; EAW81014.1; -; Genomic_DNA.
DR   EMBL; BC008608; AAH08608.1; -; mRNA.
DR   EMBL; BC011548; AAH11548.1; -; mRNA.
DR   CCDS; CCDS32110.1; -. [Q9H4F8-2]
DR   CCDS; CCDS9798.1; -. [Q9H4F8-1]
DR   RefSeq; NP_001030024.1; NM_001034852.2. [Q9H4F8-2]
DR   RefSeq; NP_071420.1; NM_022137.5. [Q9H4F8-1]
DR   UniGene; Hs.497349; -.
DR   ProteinModelPortal; Q9H4F8; -.
DR   SMR; Q9H4F8; -.
DR   BioGrid; 122055; 30.
DR   IntAct; Q9H4F8; 8.
DR   STRING; 9606.ENSP00000355110; -.
DR   iPTMnet; Q9H4F8; -.
DR   PhosphoSitePlus; Q9H4F8; -.
DR   BioMuta; SMOC1; -.
DR   DMDM; 38258649; -.
DR   MaxQB; Q9H4F8; -.
DR   PaxDb; Q9H4F8; -.
DR   PeptideAtlas; Q9H4F8; -.
DR   PRIDE; Q9H4F8; -.
DR   DNASU; 64093; -.
DR   Ensembl; ENST00000361956; ENSP00000355110; ENSG00000198732. [Q9H4F8-2]
DR   Ensembl; ENST00000381280; ENSP00000370680; ENSG00000198732. [Q9H4F8-1]
DR   GeneID; 64093; -.
DR   KEGG; hsa:64093; -.
DR   UCSC; uc001xls.3; human. [Q9H4F8-1]
DR   CTD; 64093; -.
DR   DisGeNET; 64093; -.
DR   EuPathDB; HostDB:ENSG00000198732.10; -.
DR   GeneCards; SMOC1; -.
DR   HGNC; HGNC:20318; SMOC1.
DR   HPA; CAB034427; -.
DR   HPA; HPA004153; -.
DR   MalaCards; SMOC1; -.
DR   MIM; 206920; phenotype.
DR   MIM; 608488; gene.
DR   neXtProt; NX_Q9H4F8; -.
DR   OpenTargets; ENSG00000198732; -.
DR   Orphanet; 1106; Microphthalmia with limb anomalies.
DR   PharmGKB; PA134942329; -.
DR   eggNOG; KOG4578; Eukaryota.
DR   eggNOG; ENOG410YP7C; LUCA.
DR   GeneTree; ENSGT00390000018436; -.
DR   HOGENOM; HOG000234328; -.
DR   HOVERGEN; HBG058558; -.
DR   InParanoid; Q9H4F8; -.
DR   OMA; RGHRTTG; -.
DR   OrthoDB; EOG091G083O; -.
DR   PhylomeDB; Q9H4F8; -.
DR   TreeFam; TF320666; -.
DR   ChiTaRS; SMOC1; human.
DR   GenomeRNAi; 64093; -.
DR   PRO; PR:Q9H4F8; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000198732; -.
DR   CleanEx; HS_SMOC1; -.
DR   ExpressionAtlas; Q9H4F8; baseline and differential.
DR   Genevisible; Q9H4F8; HS.
DR   GO; GO:0005604; C:basement membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0050840; F:extracellular matrix binding; IEA:InterPro.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0001654; P:eye development; IMP:UniProtKB.
DR   GO; GO:0060173; P:limb development; IMP:UniProtKB.
DR   GO; GO:0045667; P:regulation of osteoblast differentiation; IMP:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   CDD; cd16240; EFh_SPARC_SMOC1; 1.
DR   CDD; cd00191; TY; 2.
DR   Gene3D; 4.10.800.10; -; 2.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002350; Kazal_dom.
DR   InterPro; IPR036058; Kazal_dom_sf.
DR   InterPro; IPR037639; SMOC1_EC.
DR   InterPro; IPR019577; SPARC/Testican_Ca-bd-dom.
DR   InterPro; IPR000716; Thyroglobulin_1.
DR   InterPro; IPR036857; Thyroglobulin_1_sf.
DR   Pfam; PF07648; Kazal_2; 1.
DR   Pfam; PF10591; SPARC_Ca_bdg; 1.
DR   Pfam; PF00086; Thyroglobulin_1; 2.
DR   SMART; SM00280; KAZAL; 1.
DR   SMART; SM00211; TY; 2.
DR   SUPFAM; SSF100895; SSF100895; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF57610; SSF57610; 2.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS51465; KAZAL_2; 1.
DR   PROSITE; PS00484; THYROGLOBULIN_1_1; 2.
DR   PROSITE; PS51162; THYROGLOBULIN_1_2; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Basement membrane; Calcium; Complete proteome;
KW   Developmental protein; Differentiation; Disease mutation;
KW   Disulfide bond; Extracellular matrix; Glycoprotein; Metal-binding;
KW   Microphthalmia; Polymorphism; Reference proteome; Repeat; Secreted;
KW   Signal.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27    434       SPARC-related modular calcium-binding
FT                                protein 1.
FT                                /FTId=PRO_0000020316.
FT   DOMAIN       37     89       Kazal-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00798}.
FT   DOMAIN       92    158       Thyroglobulin type-1 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00500}.
FT   DOMAIN      224    292       Thyroglobulin type-1 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00500}.
FT   DOMAIN      359    394       EF-hand 1.
FT   DOMAIN      396    431       EF-hand 2.
FT   CA_BIND     372    383       1. {ECO:0000255}.
FT   CA_BIND     409    420       2. {ECO:0000255}.
FT   CARBOHYD    214    214       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    374    374       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     43     74       {ECO:0000255|PROSITE-ProRule:PRU00798}.
FT   DISULFID     47     67       {ECO:0000255|PROSITE-ProRule:PRU00798}.
FT   DISULFID     56     87       {ECO:0000255|PROSITE-ProRule:PRU00798}.
FT   DISULFID     95    118       {ECO:0000250}.
FT   DISULFID    129    136       {ECO:0000250}.
FT   DISULFID    138    158       {ECO:0000250}.
FT   DISULFID    227    251       {ECO:0000250}.
FT   DISULFID    262    269       {ECO:0000250}.
FT   DISULFID    271    292       {ECO:0000250}.
FT   VAR_SEQ     430    430       E -> EV (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008720.
FT   VARIANT      82     82       V -> M (in dbSNP:rs10150925).
FT                                /FTId=VAR_034498.
FT   VARIANT     278    278       R -> C (in OAS; dbSNP:rs776638586).
FT                                {ECO:0000269|PubMed:21750680}.
FT                                /FTId=VAR_069326.
FT   VARIANT     283    283       T -> N (in OAS).
FT                                {ECO:0000269|PubMed:21750680}.
FT                                /FTId=VAR_069327.
FT   VARIANT     286    286       R -> H (in OAS).
FT                                {ECO:0000269|PubMed:23646827}.
FT                                /FTId=VAR_069328.
SQ   SEQUENCE   434 AA;  48163 MW;  2CB639212BA42478 CRC64;
     MLPARCARLL TPHLLLVLVQ LSPARGHRTT GPRFLISDRD PQCNLHCSRT QPKPICASDG
     RSYESMCEYQ RAKCRDPTLG VVHRGRCKDA GQSKCRLERA QALEQAKKPQ EAVFVPECGE
     DGSFTQVQCH TYTGYCWCVT PDGKPISGSS VQNKTPVCSG SVTDKPLSQG NSGRKDDGSK
     PTPTMETQPV FDGDEITAPT LWIKHLVIKD SKLNNTNIRN SEKVYSCDQE RQSALEEAQQ
     NPREGIVIPE CAPGGLYKPV QCHQSTGYCW CVLVDTGRPL PGTSTRYVMP SCESDARAKT
     TEADDPFKDR ELPGCPEGKK MEFITSLLDA LTTDMVQAIN SAAPTGGGRF SEPDPSHTLE
     ERVVHWYFSQ LDSNSSNDIN KREMKPFKRY VKKKAKPKKC ARRFTDYCDL NKDKVISLPE
     LKGCLGVSKE GRLV
//
ID   BIP_HUMAN               Reviewed;         654 AA.
AC   P11021; B0QZ61; Q2EF78; Q9NPF1; Q9UK02;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2001, sequence version 2.
DT   23-MAY-2018, entry version 213.
DE   RecName: Full=Endoplasmic reticulum chaperone BiP {ECO:0000305};
DE            EC=3.6.4.10 {ECO:0000269|PubMed:26655470};
DE   AltName: Full=78 kDa glucose-regulated protein {ECO:0000303|PubMed:2840249};
DE            Short=GRP-78 {ECO:0000303|PubMed:2840249};
DE   AltName: Full=Binding-immunoglobulin protein {ECO:0000303|Ref.4};
DE            Short=BiP {ECO:0000303|Ref.4};
DE   AltName: Full=Heat shock protein 70 family protein 5 {ECO:0000305};
DE            Short=HSP70 family protein 5 {ECO:0000305};
DE   AltName: Full=Heat shock protein family A member 5 {ECO:0000312|HGNC:HGNC:5238};
DE   AltName: Full=Immunoglobulin heavy chain-binding protein {ECO:0000303|Ref.4};
DE   Flags: Precursor;
GN   Name=HSPA5 {ECO:0000312|HGNC:HGNC:5238};
GN   Synonyms=GRP78 {ECO:0000303|PubMed:2840249};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2840249; DOI=10.1089/dna.1988.7.275;
RA   Ting J., Lee A.S.;
RT   "Human gene encoding the 78,000-dalton glucose-regulated protein and
RT   its pseudogene: structure, conservation, and regulation.";
RL   DNA 7:275-286(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Cervix carcinoma;
RA   Chao C.C.K.;
RL   Submitted (DEC-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fibroblast;
RA   Hansen J.J., Nielsen M.N., Jorgensen M.M., Gregersen N., Bolund L.;
RT   "Grp78 is involved in the quality control of the LDL-receptor.";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Bermudez-Fajardo A., Llewellyn D.H., Campbell A.K., Errington R.R.;
RT   "Sequence differences between human grp78/BiP isolated from HeLa cells
RT   and previously reported human sequences.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT HIS-543.
RG   NIEHS SNPs program;
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-25.
RX   PubMed=1480470; DOI=10.1093/nar/20.24.6481;
RA   Chao C.C.K., Lin-Chao S.;
RT   "A direct-repeat sequence of the human BiP gene is required for
RT   A23187-mediated inducibility and an inducible nuclear factor
RT   binding.";
RL   Nucleic Acids Res. 20:6481-6485(1992).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 20-650, AND DISEASE.
RC   TISSUE=Articular cartilage;
RX   PubMed=11160188; DOI=10.4049/jimmunol.166.3.1492;
RA   Corrigall V.M., Bodman-Smith M.D., Fife M.S., Canas B., Myers L.K.,
RA   Wooley P., Soh C., Staines N.A., Pappin D.J.C., Berlo S.E.,
RA   van Eden W., van Der Zee R., Lanchbury J.S., Panayi G.S.;
RT   "The human endoplasmic reticulum molecular chaperone BiP is an
RT   autoantigen for rheumatoid arthritis and prevents the induction of
RT   experimental arthritis.";
RL   J. Immunol. 166:1492-1498(2001).
RN   [11]
RP   PROTEIN SEQUENCE OF 22-38.
RC   TISSUE=Mammary carcinoma;
RX   PubMed=9150946; DOI=10.1002/elps.1150180342;
RA   Rasmussen R.K., Ji H., Eddes J.S., Moritz R.L., Reid G.E.,
RA   Simpson R.J., Dorow D.S.;
RT   "Two-dimensional electrophoretic analysis of human breast carcinoma
RT   proteins: mapping of proteins that bind to the SH3 domain of mixed
RT   lineage kinase MLK2.";
RL   Electrophoresis 18:588-598(1997).
RN   [12]
RP   PROTEIN SEQUENCE OF 19-39, AND FUNCTION.
RX   PubMed=2294010; DOI=10.1210/endo-126-1-672;
RA   Dana R.C., Welch W.J., Deftos L.J.;
RT   "Heat shock proteins bind calcitonin.";
RL   Endocrinology 126:672-674(1990).
RN   [13]
RP   PROTEIN SEQUENCE OF 19-40.
RC   TISSUE=Colon carcinoma;
RX   PubMed=9150948; DOI=10.1002/elps.1150180344;
RA   Ji H., Reid G.E., Moritz R.L., Eddes J.S., Burgess A.W., Simpson R.J.;
RT   "A two-dimensional gel database of human colon carcinoma proteins.";
RL   Electrophoresis 18:605-613(1997).
RN   [14]
RP   PROTEIN SEQUENCE OF 61-74; 82-96; 102-113; 124-152; 164-181; 186-214;
RP   307-336; 353-367; 448-464; 475-492; 563-573; 602-617 AND 622-654, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [15]
RP   FUNCTION.
RX   PubMed=1550958;
RA   Ng D.T., Watowich S.S., Lamb R.A.;
RT   "Analysis in vivo of GRP78-BiP/substrate interactions and their role
RT   in induction of the GRP78-BiP gene.";
RL   Mol. Biol. Cell 3:143-155(1992).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-518, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   INTERACTION WITH CCDC88B, SUBCELLULAR LOCATION, AND INDUCTION BY ER
RP   STRESS.
RX   PubMed=21289099; DOI=10.1091/mbc.E10-08-0724;
RA   Matsushita E., Asai N., Enomoto A., Kawamoto Y., Kato T., Mii S.,
RA   Maeda K., Shibata R., Hattori S., Hagikura M., Takahashi K.,
RA   Sokabe M., Murakumo Y., Murohara T., Takahashi M.;
RT   "Protective role of Gipie, a Girdin family protein, in endoplasmic
RT   reticulum stress responses in endothelial cells.";
RL   Mol. Biol. Cell 22:736-747(2011).
RN   [19]
RP   PROTEIN SEQUENCE OF 582-596, INTERACTION WITH METTL23, METHYLATION AT
RP   LYS-585, MUTAGENESIS OF LYS-585, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=23349634; DOI=10.1371/journal.pgen.1003210;
RA   Cloutier P., Lavallee-Adam M., Faubert D., Blanchette M., Coulombe B.;
RT   "A newly uncovered group of distantly related lysine
RT   methyltransferases preferentially interact with molecular chaperones
RT   to regulate their activity.";
RL   PLoS Genet. 9:E1003210-E1003210(2013).
RN   [20]
RP   COMPONENT OF A CHAPERONE COMPLEX.
RX   PubMed=12475965; DOI=10.1091/mbc.E02-05-0311;
RA   Meunier L., Usherwood Y.-K., Chung K.T., Hendershot L.M.;
RT   "A subset of chaperones and folding enzymes form multiprotein
RT   complexes in endoplasmic reticulum to bind nascent proteins.";
RL   Mol. Biol. Cell 13:4456-4469(2002).
RN   [21]
RP   INTERACTION WITH TRIM21.
RX   PubMed=12699405; DOI=10.1046/j.1365-2249.2003.02153.x;
RA   Purcell A.W., Todd A., Kinoshita G., Lynch T.A., Keech C.L.,
RA   Gething M.J., Gordon T.P.;
RT   "Association of stress proteins with autoantigens: a possible
RT   mechanism for triggering autoimmunity?";
RL   Clin. Exp. Immunol. 132:193-200(2003).
RN   [22]
RP   INTERACTION WITH DNAJC10.
RX   PubMed=12411443; DOI=10.1074/jbc.M206995200;
RA   Cunnea P.M., Miranda-Vizuete A., Bertoli G., Simmen T.,
RA   Damdimopoulos A.E., Hermann S., Leinonen S., Huikko M.P.,
RA   Gustafsson J.-A., Sitia R., Spyrou G.;
RT   "ERdj5, an endoplasmic reticulum (ER)-resident protein containing DnaJ
RT   and thioredoxin domains, is expressed in secretory cells or following
RT   ER stress.";
RL   J. Biol. Chem. 278:1059-1066(2003).
RN   [23]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=12643545; DOI=10.1021/pr025562r;
RA   Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K.,
RA   Valencia J., Muller J., Vieira W.D., Watabe H., Shabanowitz J.,
RA   Hearing V.J., Hunt D.F., Appella E.;
RT   "Proteomic analysis of early melanosomes: identification of novel
RT   melanosomal proteins.";
RL   J. Proteome Res. 2:69-79(2003).
RN   [24]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [25]
RP   INTERACTION WITH ERLEC1; OS9; SEL1L AND SYVN1.
RX   PubMed=18502753; DOI=10.1074/jbc.M709336200;
RA   Hosokawa N., Wada I., Nagasawa K., Moriyama T., Okawa K., Nagata K.;
RT   "Human XTP3-B forms an endoplasmic reticulum quality control scaffold
RT   with the HRD1-SEL1L ubiquitin ligase complex and BiP.";
RL   J. Biol. Chem. 283:20914-20924(2008).
RN   [26]
RP   INTERACTION WITH ERLEC1; OS9; SEL1L AND SYVN1.
RX   PubMed=18264092; DOI=10.1038/ncb1689;
RA   Christianson J.C., Shaler T.A., Tyler R.E., Kopito R.R.;
RT   "OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L
RT   ubiquitin ligase complex for ERAD.";
RL   Nat. Cell Biol. 10:272-282(2008).
RN   [27]
RP   FUNCTION.
RX   PubMed=19538957; DOI=10.1016/j.yexcr.2009.06.009;
RA   Oikawa D., Kimata Y., Kohno K., Iwawaki T.;
RT   "Activation of mammalian IRE1alpha upon ER stress depends on
RT   dissociation of BiP rather than on direct interaction with unfolded
RT   proteins.";
RL   Exp. Cell Res. 315:2496-2504(2009).
RN   [28]
RP   INTERACTION WITH PCSK4, AND SUBCELLULAR LOCATION.
RX   PubMed=21080038; DOI=10.1007/s11010-010-0635-y;
RA   Gyamera-Acheampong C., Sirois F., Denis N.J., Mishra P., Figeys D.,
RA   Basak A., Mbikay M.;
RT   "The precursor to the germ cell-specific PCSK4 proteinase is
RT   inefficiently activated in transfected somatic cells: evidence of
RT   interaction with the BiP chaperone.";
RL   Mol. Cell. Biochem. 348:43-52(2011).
RN   [29]
RP   INTERACTION WITH MANF.
RX   PubMed=22637475; DOI=10.1074/jbc.M112.356345;
RA   Glembotski C.C., Thuerauf D.J., Huang C., Vekich J.A., Gottlieb R.A.,
RA   Doroudgar S.;
RT   "Mesencephalic astrocyte-derived neurotrophic factor protects the
RT   heart from ischemic damage and is selectively secreted upon
RT   sarco/endoplasmic reticulum calcium depletion.";
RL   J. Biol. Chem. 287:25893-25904(2012).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [31]
RP   METHYLATION AT LYS-585, AND MUTAGENESIS OF LYS-585.
RX   PubMed=23921388; DOI=10.1074/jbc.M113.483248;
RA   Jakobsson M.E., Moen A., Bousset L., Egge-Jacobsen W., Kernstock S.,
RA   Melki R., Falnes P.O.;
RT   "Identification and characterization of a novel human
RT   methyltransferase modulating Hsp70 function through lysine
RT   methylation.";
RL   J. Biol. Chem. 288:27752-27763(2013).
RN   [32]
RP   FUNCTION, INTERACTION WITH CEMIP, AND SUBCELLULAR LOCATION.
RX   PubMed=23990668; DOI=10.1093/jnci/djt224;
RA   Evensen N.A., Kuscu C., Nguyen H.L., Zarrabi K., Dufour A., Kadam P.,
RA   Hu Y.J., Pulkoski-Gross A., Bahou W.F., Zucker S., Cao J.;
RT   "Unraveling the role of KIAA1199, a novel endoplasmic reticulum
RT   protein, in cancer cell migration.";
RL   J. Natl. Cancer Inst. 105:1402-1416(2013).
RN   [33]
RP   FUNCTION, AND INTERACTION WITH DNAJC10.
RX   PubMed=23769672; DOI=10.1016/j.molcel.2013.05.014;
RA   Oka O.B., Pringle M.A., Schopp I.M., Braakman I., Bulleid N.J.;
RT   "ERdj5 is the ER reductase that catalyzes the removal of non-native
RT   disulfides and correct folding of the LDL receptor.";
RL   Mol. Cell 50:793-804(2013).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-518, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [35]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT LYS-585 AND LYS-591, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [36]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-352, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [37]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-352 AND LYS-353, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [38]
RP   AMPYLATION.
RX   PubMed=25601083; DOI=10.1074/jbc.M114.618348;
RA   Sanyal A., Chen A.J., Nakayasu E.S., Lazar C.S., Zbornik E.A.,
RA   Worby C.A., Koller A., Mattoo S.;
RT   "A novel link between Fic (filamentation induced by cAMP)-mediated
RT   adenylylation/AMPylation and the unfolded protein response.";
RL   J. Biol. Chem. 290:8482-8499(2015).
RN   [39]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-352, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [40]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [41]
RP   INTERACTION WITH CIPC.
RX   PubMed=26657846; DOI=10.1016/j.bbrc.2015.11.117;
RA   Matsunaga R., Nishino T., Yokoyama A., Nakashima A., Kikkawa U.,
RA   Konishi H.;
RT   "Versatile function of the circadian protein CIPC as a regulator of
RT   Erk activation.";
RL   Biochem. Biophys. Res. Commun. 469:377-383(2016).
RN   [42]
RP   INTERACTION WITH INPP5K.
RX   PubMed=26940976; DOI=10.1111/gtc.12353;
RA   Ijuin T., Hatano N., Takenawa T.;
RT   "Glucose-regulated protein 78 (GRP78) binds directly to PIP3
RT   phosphatase SKIP and determines its localization.";
RL   Genes Cells 21:457-465(2016).
RN   [43]
RP   REVIEW.
RX   PubMed=28286085; DOI=10.1016/j.gene.2017.03.005;
RA   Wang J., Lee J., Liem D., Ping P.;
RT   "HSPA5 Gene encoding Hsp70 chaperone BiP in the endoplasmic
RT   reticulum.";
RL   Gene 618:14-23(2017).
RN   [44]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-352, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [45]
RP   FUNCTION, INTERACTION WITH LOXL2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=28332555; DOI=10.1038/srep44988;
RA   Cuevas E.P., Eraso P., Mazon M.J., Santos V., Moreno-Bueno G.,
RA   Cano A., Portillo F.;
RT   "LOXL2 drives epithelial-mesenchymal transition via activation of
RT   IRE1-XBP1 signalling pathway.";
RL   Sci. Rep. 7:44988-44988(2017).
RN   [46]
RP   SUBCELLULAR LOCATION.
RX   PubMed=29497057; DOI=10.1038/s41467-018-03355-0;
RA   Bai M., Vozdek R., Hnizda A., Jiang C., Wang B., Kuchar L., Li T.,
RA   Zhang Y., Wood C., Feng L., Dang Y., Ma D.K.;
RT   "Conserved roles of C. elegans and human MANFs in sulfatide binding
RT   and cytoprotection.";
RL   Nat. Commun. 9:897-897(2018).
RN   [47]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 26-410.
RX   PubMed=20072699; DOI=10.1371/journal.pone.0008625;
RA   Wisniewska M., Karlberg T., Lehtio L., Johansson I., Kotenyova T.,
RA   Moche M., Schuler H.;
RT   "Crystal structures of the ATPase domains of four human Hsp70
RT   isoforms: HSPA1L/Hsp70-hom, HSPA2/Hsp70-2, HSPA6/Hsp70B', and
RT   HSPA5/BiP/GRP78.";
RL   PLoS ONE 5:E8625-E8625(2010).
RN   [48]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 26-407 IN COMPLEXES WITH ATP
RP   ANALOG.
RX   PubMed=21526763; DOI=10.1021/jm101625x;
RA   Macias A.T., Williamson D.S., Allen N., Borgognoni J., Clay A.,
RA   Daniels Z., Dokurno P., Drysdale M.J., Francis G.L., Graham C.J.,
RA   Howes R., Matassova N., Murray J.B., Parsons R., Shaw T.,
RA   Surgenor A.E., Terry L., Wang Y., Wood M., Massey A.J.;
RT   "Adenosine-derived inhibitors of 78 kDa glucose regulated protein
RT   (Grp78) ATPase: insights into isoform selectivity.";
RL   J. Med. Chem. 54:4034-4041(2011).
RN   [49] {ECO:0000244|PDB:5E84, ECO:0000244|PDB:5E85, ECO:0000244|PDB:5E86}
RP   X-RAY CRYSTALLOGRAPHY (2.57 ANGSTROMS) OF 418-637 IN COMPLEX WITH ATP,
RP   CATALYTIC ACTIVITY, ENZYME REGULATION, AND MUTAGENESIS OF THR-229.
RX   PubMed=26655470; DOI=10.1016/j.str.2015.10.012;
RA   Yang J., Nune M., Zong Y., Zhou L., Liu Q.;
RT   "Close and allosteric opening of the polypeptide-binding site in a
RT   human Hsp70 chaperone BiP.";
RL   Structure 23:2191-2203(2015).
CC   -!- FUNCTION: Endoplasmic reticulum chaperone that plays a key role in
CC       protein folding and quality control in the endoplasmic reticulum
CC       lumen (PubMed:2294010, PubMed:23769672, PubMed:23990668,
CC       PubMed:28332555). Involved in the correct folding of proteins and
CC       degradation of misfolded proteins via its interaction with
CC       DNAJC10/ERdj5, probably to facilitate the release of DNAJC10/ERdj5
CC       from its substrate (By similarity). Acts as a key repressor of the
CC       ERN1/IRE1-mediated unfolded protein response (UPR)
CC       (PubMed:1550958, PubMed:19538957). In the unstressed endoplasmic
CC       reticulum, recruited by DNAJB9/ERdj4 to the luminal region of
CC       ERN1/IRE1, leading to disrupt the dimerization of ERN1/IRE1,
CC       thereby inactivating ERN1/IRE1 (By similarity). Accumulation of
CC       misfolded protein in the endoplasmic reticulum causes release of
CC       HSPA5/BiP from ERN1/IRE1, allowing homodimerization and subsequent
CC       activation of ERN1/IRE1 (By similarity).
CC       {ECO:0000250|UniProtKB:G3I8R9, ECO:0000250|UniProtKB:P20029,
CC       ECO:0000269|PubMed:1550958, ECO:0000269|PubMed:19538957,
CC       ECO:0000269|PubMed:2294010, ECO:0000269|PubMed:23769672,
CC       ECO:0000269|PubMed:23990668, ECO:0000269|PubMed:28332555}.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate.
CC       {ECO:0000269|PubMed:26655470}.
CC   -!- ENZYME REGULATION: The chaperone activity is regulated by ATP-
CC       induced allosteric coupling of the nucleotide-binding (NBD) and
CC       substrate-binding (SBD) domains. In the ADP-bound and nucleotide-
CC       free (apo) states, the two domains have little interaction
CC       (PubMed:26655470). In contrast, in the ATP-bound state the two
CC       domains are tightly coupled, which results in drastically
CC       accelerated kinetics in both binding and release of polypeptide
CC       substrates (PubMed:26655470). J domain-containing co-chaperones
CC       (DNAJB9/ERdj4 or DNAJC10/ERdj5) stimulate the ATPase activity and
CC       are required for efficient substrate recognition by HSPA5/BiP (By
CC       similarity). Homooligomerization inactivates participating
CC       HSPA5/BiP protomers and probably act as reservoirs to store
CC       HSPA5/BiP molecules when they are not needed by the cell (By
CC       similarity). {ECO:0000250|UniProtKB:G3I8R9,
CC       ECO:0000269|PubMed:26655470, ECO:0000303|PubMed:28286085}.
CC   -!- SUBUNIT: Monomer and homooligomer; homooligomerization via the
CC       interdomain linker inactivates the chaperone activity and acts as
CC       a storage of HSPA5/BiP molecules (By similarity). Interacts with
CC       DNAJC1 (via J domain) (By similarity). Component of an EIF2
CC       complex at least composed of CELF1/CUGBP1, CALR, CALR3, EIF2S1,
CC       EIF2S2, HSP90B1 and HSPA5 (By similarity). Part of a large
CC       chaperone multiprotein complex comprising DNAJB11, HSP90B1, HSPA5,
CC       HYOU, PDIA2, PDIA4, PDIA6, PPIB, SDF2L1, UGT1A1 and very small
CC       amounts of ERP29, but not, or at very low levels, CALR nor CANX
CC       (By similarity). Interacts with TMEM132A and TRIM21
CC       (PubMed:12699405). May form a complex with ERLEC1, OS9, SEL1L and
CC       SYVN1 (PubMed:18264092,PubMed:18502753). Interacts with DNAJC10
CC       (PubMed:12411443, PubMed:23769672). Interacts with DNAJB9/ERdj4;
CC       leading to recruit HSPA5/BiP to ERN1/IRE1 (By similarity).
CC       Interacts with ERN1/IRE1; interaction takes place following
CC       interaction with DNAJB9/ERdj4 and leads to inactivate ERN1/IRE1
CC       (By similarity). Interacts with MX1 (By similarity). Interacts
CC       with METTL23 (PubMed:23349634). Interacts with CEMIP; the
CC       interaction induces calcium leakage from the endoplasmic reticulum
CC       and cell migration (PubMed:23990668). Interacts with PCSK4 form;
CC       the interaction takes place in the endoplasmic reticulum
CC       (PubMed:21080038). Interacts with CIPC (PubMed:26657846).
CC       Interacts with CCDC88B (via C-terminus); the interaction opposes
CC       ERN1-mediated JNK activation, protecting against apoptosis
CC       (PubMed:21289099). Interacts with INPP5K; necessary for INPP5K
CC       localization at the endoplasmic reticulum (PubMed:26940976).
CC       Interacts with MANF; the interaction is direct (PubMed:22637475).
CC       Interacts with LOXL2; leading to activate the ERN1/IRE1-XBP1
CC       pathway of the unfolded protein response (PubMed:28332555).
CC       {ECO:0000250|UniProtKB:G3I8R9, ECO:0000250|UniProtKB:P20029,
CC       ECO:0000269|PubMed:12411443, ECO:0000269|PubMed:12699405,
CC       ECO:0000269|PubMed:18264092, ECO:0000269|PubMed:18502753,
CC       ECO:0000269|PubMed:21080038, ECO:0000269|PubMed:21289099,
CC       ECO:0000269|PubMed:22637475, ECO:0000269|PubMed:23349634,
CC       ECO:0000269|PubMed:23769672, ECO:0000269|PubMed:23990668,
CC       ECO:0000269|PubMed:26657846, ECO:0000269|PubMed:26940976,
CC       ECO:0000269|PubMed:28332555}.
CC   -!- INTERACTION:
CC       Q6T424:-; NbExp=3; IntAct=EBI-354921, EBI-7888150;
CC       P31749:AKT1; NbExp=2; IntAct=EBI-354921, EBI-296087;
CC       P18850:ATF6; NbExp=2; IntAct=EBI-354921, EBI-852157;
CC       Q6E0U4:DMKN; NbExp=3; IntAct=EBI-354921, EBI-7943171;
CC       Q9UBS4:DNAJB11; NbExp=3; IntAct=EBI-354921, EBI-713113;
CC       Q91YW3:Dnajc3 (xeno); NbExp=2; IntAct=EBI-354921, EBI-8381770;
CC       Q9NZJ5:EIF2AK3; NbExp=4; IntAct=EBI-354921, EBI-766076;
CC       O75460:ERN1; NbExp=3; IntAct=EBI-354921, EBI-371750;
CC       O75460-1:ERN1; NbExp=4; IntAct=EBI-354921, EBI-15600828;
CC       Q96IZ0:PAWR; NbExp=8; IntAct=EBI-354921, EBI-595869;
CC       Q62627:Pawr (xeno); NbExp=4; IntAct=EBI-354921, EBI-1187240;
CC       P04049:RAF1; NbExp=5; IntAct=EBI-354921, EBI-365996;
CC       P61619:SEC61A1; NbExp=3; IntAct=EBI-354921, EBI-358919;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000269|PubMed:21080038, ECO:0000269|PubMed:21289099,
CC       ECO:0000269|PubMed:23990668, ECO:0000269|PubMed:29497057}.
CC       Melanosome {ECO:0000269|PubMed:12643545}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P20029}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV.
CC       {ECO:0000269|PubMed:12643545}.
CC   -!- INDUCTION: By endoplasmic reticulum stress.
CC       {ECO:0000269|PubMed:21289099}.
CC   -!- DOMAIN: The interdomain linker regulates the chaperone activity by
CC       mediating the formation of homooligomers. Homooligomers are formed
CC       by engagement of the interdomain linker of one HSPA5/BiP molecule
CC       as a typical substrate of an adjacent HSPA5/BiP molecule.
CC       HSPA5/BiP oligomerization inactivates participating HSPA5/BiP
CC       protomers. HSPA5/BiP oligomers probably act as reservoirs to store
CC       HSPA5/BiP molecules when they are not needed by the cell. When the
CC       levels of unfolded proteins rise, cells can rapidly break up these
CC       oligomers to make active monomers. {ECO:0000250|UniProtKB:G3I8R9}.
CC   -!- PTM: AMPylated by FICD (PubMed:25601083). In unstressed cells,
CC       AMPylation at Thr-518 by FICD inactivates the chaperome activity:
CC       AMPylated form is locked in a relatively inert state and only
CC       weakly stimulated by J domain-containing proteins (By similarity).
CC       In response to endoplasmic reticulum stress, de-AMPylation by the
CC       same protein, FICD, restores the chaperone activity (By
CC       similarity). {ECO:0000250|UniProtKB:G3I8R9,
CC       ECO:0000269|PubMed:25601083}.
CC   -!- DISEASE: Note=Autoantigen in rheumatoid arthritis.
CC       {ECO:0000269|PubMed:11160188}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000305}.
CC   -!- CAUTION: AMPylation was initially reported to take place at Ser-
CC       365 and Thr-366 in vitro, and promote activation of HSPA5/BiP
CC       (PubMed:25601083). However, it was later shown that AMPylation
CC       takes place at Thr-518 and leads to inactivation of HSPA5/BiP.
CC       {ECO:0000250|UniProtKB:G3I8R9, ECO:0000269|PubMed:25601083}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/hspa5/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/HSPA5ID40876ch9q33.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M19645; AAA52614.1; -; Genomic_DNA.
DR   EMBL; X87949; CAA61201.1; -; mRNA.
DR   EMBL; AJ271729; CAB71335.1; -; mRNA.
DR   EMBL; AF216292; AAF42836.1; -; mRNA.
DR   EMBL; DQ385847; ABD04090.1; -; Genomic_DNA.
DR   EMBL; AL354710; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471090; EAW87620.1; -; Genomic_DNA.
DR   EMBL; BC020235; AAH20235.1; -; mRNA.
DR   EMBL; X59969; CAA42595.1; -; Genomic_DNA.
DR   EMBL; AF188611; AAF13605.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS6863.1; -.
DR   PIR; A29821; A29821.
DR   RefSeq; NP_005338.1; NM_005347.4.
DR   UniGene; Hs.743241; -.
DR   PDB; 3IUC; X-ray; 2.40 A; A/C=26-410.
DR   PDB; 3LDL; X-ray; 2.30 A; A/B=26-407.
DR   PDB; 3LDN; X-ray; 2.20 A; A/B=26-407.
DR   PDB; 3LDO; X-ray; 1.95 A; A/B=26-407.
DR   PDB; 3LDP; X-ray; 2.20 A; A/B=26-407.
DR   PDB; 5E84; X-ray; 2.99 A; A/B/C/D/E/F=25-633.
DR   PDB; 5E85; X-ray; 2.57 A; A=418-637.
DR   PDB; 5E86; X-ray; 2.68 A; A=418-637.
DR   PDB; 5EVZ; X-ray; 1.85 A; A/B=26-407.
DR   PDB; 5EX5; X-ray; 1.90 A; A/B=26-407.
DR   PDB; 5EXW; X-ray; 1.90 A; A/B=26-407.
DR   PDB; 5EY4; X-ray; 1.86 A; A/B=26-407.
DR   PDB; 5F0X; X-ray; 1.60 A; A/B=26-407.
DR   PDB; 5F1X; X-ray; 1.90 A; A/B=26-407.
DR   PDB; 5F2R; X-ray; 2.15 A; A/B=26-407.
DR   PDB; 6ASY; X-ray; 1.85 A; A/B=25-633.
DR   PDBsum; 3IUC; -.
DR   PDBsum; 3LDL; -.
DR   PDBsum; 3LDN; -.
DR   PDBsum; 3LDO; -.
DR   PDBsum; 3LDP; -.
DR   PDBsum; 5E84; -.
DR   PDBsum; 5E85; -.
DR   PDBsum; 5E86; -.
DR   PDBsum; 5EVZ; -.
DR   PDBsum; 5EX5; -.
DR   PDBsum; 5EXW; -.
DR   PDBsum; 5EY4; -.
DR   PDBsum; 5F0X; -.
DR   PDBsum; 5F1X; -.
DR   PDBsum; 5F2R; -.
DR   PDBsum; 6ASY; -.
DR   ProteinModelPortal; P11021; -.
DR   SMR; P11021; -.
DR   BioGrid; 109541; 571.
DR   CORUM; P11021; -.
DR   DIP; DIP-33189N; -.
DR   ELM; P11021; -.
DR   IntAct; P11021; 194.
DR   MINT; P11021; -.
DR   STRING; 9606.ENSP00000324173; -.
DR   BindingDB; P11021; -.
DR   ChEMBL; CHEMBL1781865; -.
DR   DrugBank; DB00945; Acetylsalicylic acid.
DR   DrugBank; DB00025; Antihemophilic Factor (Recombinant).
DR   TCDB; 1.A.33.1.6; the cation channel-forming heat shock protein-70 (hsp70) family.
DR   iPTMnet; P11021; -.
DR   PhosphoSitePlus; P11021; -.
DR   SwissPalm; P11021; -.
DR   BioMuta; HSPA5; -.
DR   DMDM; 14916999; -.
DR   DOSAC-COBS-2DPAGE; P11021; -.
DR   OGP; P11021; -.
DR   REPRODUCTION-2DPAGE; P11021; -.
DR   SWISS-2DPAGE; P11021; -.
DR   UCD-2DPAGE; P11021; -.
DR   EPD; P11021; -.
DR   PaxDb; P11021; -.
DR   PeptideAtlas; P11021; -.
DR   PRIDE; P11021; -.
DR   TopDownProteomics; P11021; -.
DR   DNASU; 3309; -.
DR   Ensembl; ENST00000324460; ENSP00000324173; ENSG00000044574.
DR   GeneID; 3309; -.
DR   KEGG; hsa:3309; -.
DR   CTD; 3309; -.
DR   DisGeNET; 3309; -.
DR   EuPathDB; HostDB:ENSG00000044574.7; -.
DR   GeneCards; HSPA5; -.
DR   HGNC; HGNC:5238; HSPA5.
DR   HPA; CAB005221; -.
DR   HPA; HPA038845; -.
DR   HPA; HPA038846; -.
DR   MIM; 138120; gene.
DR   neXtProt; NX_P11021; -.
DR   OpenTargets; ENSG00000044574; -.
DR   PharmGKB; PA29504; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   GeneTree; ENSGT00910000144045; -.
DR   HOGENOM; HOG000228135; -.
DR   HOVERGEN; HBG051845; -.
DR   InParanoid; P11021; -.
DR   KO; K09490; -.
DR   OMA; CVGVMQK; -.
DR   OrthoDB; EOG091G0352; -.
DR   PhylomeDB; P11021; -.
DR   TreeFam; TF105044; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-381033; ATF6 (ATF6-alpha) activates chaperones.
DR   Reactome; R-HSA-381042; PERK regulates gene expression.
DR   Reactome; R-HSA-381070; IRE1alpha activates chaperones.
DR   Reactome; R-HSA-381183; ATF6 (ATF6-alpha) activates chaperone genes.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   SIGNOR; P11021; -.
DR   ChiTaRS; HSPA5; human.
DR   EvolutionaryTrace; P11021; -.
DR   GeneWiki; Binding_immunoglobulin_protein; -.
DR   GenomeRNAi; 3309; -.
DR   PRO; PR:P11021; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000044574; -.
DR   CleanEx; HS_HSPA5; -.
DR   ExpressionAtlas; P11021; baseline and differential.
DR   Genevisible; P11021; HS.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0034663; C:endoplasmic reticulum chaperone complex; IDA:UniProtKB.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IDA:BHF-UCL.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0030496; C:midbody; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IMP:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATPase activity; IDA:AgBase.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0005509; F:calcium ion binding; TAS:UniProtKB.
DR   GO; GO:0051087; F:chaperone binding; TAS:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0051787; F:misfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0043022; F:ribosome binding; IEA:Ensembl.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; TAS:UniProtKB.
DR   GO; GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; IEA:Ensembl.
DR   GO; GO:0036500; P:ATF6-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0071236; P:cellular response to antibiotic; IEA:Ensembl.
DR   GO; GO:0071277; P:cellular response to calcium ion; IEA:Ensembl.
DR   GO; GO:0071320; P:cellular response to cAMP; IEA:Ensembl.
DR   GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
DR   GO; GO:0071480; P:cellular response to gamma radiation; IEA:Ensembl.
DR   GO; GO:0042149; P:cellular response to glucose starvation; IDA:UniProtKB.
DR   GO; GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl.
DR   GO; GO:0071287; P:cellular response to manganese ion; IEA:Ensembl.
DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0021680; P:cerebellar Purkinje cell layer development; IEA:Ensembl.
DR   GO; GO:0021589; P:cerebellum structural organization; IEA:Ensembl.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:BHF-UCL.
DR   GO; GO:0006983; P:ER overload response; IEA:Ensembl.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0035437; P:maintenance of protein localization in endoplasmic reticulum; IMP:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:1903895; P:negative regulation of IRE1-mediated unfolded protein response; ISS:UniProtKB.
DR   GO; GO:0090074; P:negative regulation of protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0051402; P:neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0036499; P:PERK-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; IEA:Ensembl.
DR   GO; GO:1990440; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0034975; P:protein folding in endoplasmic reticulum; TAS:ParkinsonsUK-UCL.
DR   GO; GO:1903891; P:regulation of ATF6-mediated unfolded protein response; TAS:ParkinsonsUK-UCL.
DR   GO; GO:1903894; P:regulation of IRE1-mediated unfolded protein response; TAS:ParkinsonsUK-UCL.
DR   GO; GO:1903897; P:regulation of PERK-mediated unfolded protein response; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0060904; P:regulation of protein folding in endoplasmic reticulum; TAS:BHF-UCL.
DR   GO; GO:0042220; P:response to cocaine; IEA:Ensembl.
DR   GO; GO:1904313; P:response to methamphetamine hydrochloride; IEA:Ensembl.
DR   GO; GO:0097501; P:stress response to metal ion; IEA:Ensembl.
DR   GO; GO:0021762; P:substantia nigra development; HEP:UniProtKB.
DR   GO; GO:1901998; P:toxin transport; IEA:Ensembl.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; TAS:BHF-UCL.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   SUPFAM; SSF100934; SSF100934; 1.
DR   PROSITE; PS00014; ER_TARGET; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Endoplasmic reticulum; Hydrolase;
KW   Isopeptide bond; Methylation; Nitration; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Signal;
KW   Ubl conjugation.
FT   SIGNAL        1     18       {ECO:0000269|PubMed:2294010,
FT                                ECO:0000269|PubMed:9150948}.
FT   CHAIN        19    654       Endoplasmic reticulum chaperone BiP.
FT                                /FTId=PRO_0000013566.
FT   NP_BIND      36     39       ATP. {ECO:0000269|PubMed:21526763}.
FT   NP_BIND     227    229       ATP. {ECO:0000269|PubMed:21526763}.
FT   NP_BIND     293    300       ATP. {ECO:0000269|PubMed:21526763}.
FT   NP_BIND     364    367       ATP. {ECO:0000269|PubMed:21526763}.
FT   REGION      125    280       Nucleotide-binding (NBD).
FT                                {ECO:0000303|PubMed:28286085}.
FT   REGION      409    419       Interdomain linker.
FT                                {ECO:0000250|UniProtKB:G3I8R9}.
FT   REGION      420    500       Substrate-binding (SBD).
FT                                {ECO:0000303|PubMed:28286085}.
FT   MOTIF       651    654       Prevents secretion from ER.
FT                                {ECO:0000255}.
FT   BINDING      96     96       ATP. {ECO:0000269|PubMed:21526763}.
FT   MOD_RES      86     86       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P06761}.
FT   MOD_RES     125    125       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P20029}.
FT   MOD_RES     160    160       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:P20029}.
FT   MOD_RES     213    213       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P20029}.
FT   MOD_RES     271    271       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P0DMV8}.
FT   MOD_RES     326    326       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P20029}.
FT   MOD_RES     353    353       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P20029}.
FT   MOD_RES     447    447       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P20029}.
FT   MOD_RES     492    492       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:P0DMV8}.
FT   MOD_RES     518    518       O-AMP-threonine.
FT                                {ECO:0000250|UniProtKB:G3I8R9}.
FT   MOD_RES     518    518       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     585    585       N6,N6,N6-trimethyllysine; by METTL21A; in
FT                                vitro. {ECO:0000244|PubMed:24129315,
FT                                ECO:0000269|PubMed:23349634,
FT                                ECO:0000269|PubMed:23921388}.
FT   MOD_RES     585    585       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     585    585       N6-methyllysine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     591    591       N6-methyllysine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     643    643       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P20029}.
FT   MOD_RES     648    648       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P20029}.
FT   CROSSLNK    352    352       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    353    353       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   VARIANT     543    543       N -> H (in dbSNP:rs35356639).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_025815.
FT   MUTAGEN     229    229       T->A: Impaired ATPase activity.
FT                                {ECO:0000269|PubMed:26655470}.
FT   MUTAGEN     585    585       K->R: Complete loss of in vitro
FT                                methylation by METTL21A.
FT                                {ECO:0000269|PubMed:23349634,
FT                                ECO:0000269|PubMed:23921388}.
FT   CONFLICT    297    297       Missing (in Ref. 1; AAA52614 and 2;
FT                                CAA61201). {ECO:0000305}.
FT   CONFLICT    418    418       D -> H (in Ref. 1; AAA52614 and 2;
FT                                CAA61201). {ECO:0000305}.
FT   CONFLICT    439    439       R -> S (in Ref. 1; AAA52614 and 2;
FT                                CAA61201). {ECO:0000305}.
FT   CONFLICT    447    447       K -> N (in Ref. 1; AAA52614 and 2;
FT                                CAA61201). {ECO:0000305}.
FT   STRAND       31     34       {ECO:0000244|PDB:5F0X}.
FT   STRAND       37     45       {ECO:0000244|PDB:5F0X}.
FT   STRAND       47     52       {ECO:0000244|PDB:5F0X}.
FT   STRAND       60     63       {ECO:0000244|PDB:5F0X}.
FT   STRAND       66     68       {ECO:0000244|PDB:5F0X}.
FT   STRAND       74     76       {ECO:0000244|PDB:5F0X}.
FT   HELIX        78     82       {ECO:0000244|PDB:5F0X}.
FT   HELIX        84     86       {ECO:0000244|PDB:6ASY}.
FT   HELIX        88     90       {ECO:0000244|PDB:5F0X}.
FT   STRAND       91     93       {ECO:0000244|PDB:6ASY}.
FT   HELIX        95     97       {ECO:0000244|PDB:5F0X}.
FT   TURN         98    100       {ECO:0000244|PDB:5F0X}.
FT   HELIX       106    114       {ECO:0000244|PDB:5F0X}.
FT   STRAND      116    122       {ECO:0000244|PDB:5F0X}.
FT   STRAND      125    131       {ECO:0000244|PDB:5F0X}.
FT   STRAND      137    140       {ECO:0000244|PDB:5F0X}.
FT   HELIX       142    161       {ECO:0000244|PDB:5F0X}.
FT   STRAND      167    172       {ECO:0000244|PDB:5F0X}.
FT   HELIX       178    190       {ECO:0000244|PDB:5F0X}.
FT   STRAND      194    200       {ECO:0000244|PDB:5F0X}.
FT   HELIX       201    208       {ECO:0000244|PDB:5F0X}.
FT   TURN        209    212       {ECO:0000244|PDB:5F0X}.
FT   STRAND      215    225       {ECO:0000244|PDB:5F0X}.
FT   STRAND      230    238       {ECO:0000244|PDB:5F0X}.
FT   STRAND      241    250       {ECO:0000244|PDB:5F0X}.
FT   HELIX       255    274       {ECO:0000244|PDB:5F0X}.
FT   HELIX       278    280       {ECO:0000244|PDB:5F0X}.
FT   HELIX       282    298       {ECO:0000244|PDB:5F0X}.
FT   TURN        299    301       {ECO:0000244|PDB:5F0X}.
FT   STRAND      302    313       {ECO:0000244|PDB:5F0X}.
FT   STRAND      316    323       {ECO:0000244|PDB:5F0X}.
FT   HELIX       324    337       {ECO:0000244|PDB:5F0X}.
FT   HELIX       339    348       {ECO:0000244|PDB:5F0X}.
FT   HELIX       353    355       {ECO:0000244|PDB:5F0X}.
FT   STRAND      358    363       {ECO:0000244|PDB:5F0X}.
FT   HELIX       364    367       {ECO:0000244|PDB:5F0X}.
FT   HELIX       369    378       {ECO:0000244|PDB:5F0X}.
FT   TURN        379    381       {ECO:0000244|PDB:5F0X}.
FT   TURN        390    392       {ECO:0000244|PDB:5F0X}.
FT   HELIX       393    405       {ECO:0000244|PDB:5F0X}.
FT   STRAND      415    419       {ECO:0000244|PDB:6ASY}.
FT   STRAND      424    428       {ECO:0000244|PDB:6ASY}.
FT   TURN        429    431       {ECO:0000244|PDB:5E85}.
FT   STRAND      433    437       {ECO:0000244|PDB:6ASY}.
FT   STRAND      442    451       {ECO:0000244|PDB:6ASY}.
FT   STRAND      461    468       {ECO:0000244|PDB:6ASY}.
FT   HELIX       473    475       {ECO:0000244|PDB:6ASY}.
FT   STRAND      476    484       {ECO:0000244|PDB:6ASY}.
FT   STRAND      491    493       {ECO:0000244|PDB:6ASY}.
FT   STRAND      497    503       {ECO:0000244|PDB:6ASY}.
FT   STRAND      509    515       {ECO:0000244|PDB:6ASY}.
FT   TURN        516    518       {ECO:0000244|PDB:6ASY}.
FT   STRAND      521    526       {ECO:0000244|PDB:5E85}.
FT   TURN        528    531       {ECO:0000244|PDB:5E85}.
FT   HELIX       535    576       {ECO:0000244|PDB:6ASY}.
FT   TURN        579    581       {ECO:0000244|PDB:6ASY}.
FT   HELIX       582    585       {ECO:0000244|PDB:6ASY}.
FT   HELIX       588    607       {ECO:0000244|PDB:6ASY}.
FT   HELIX       613    631       {ECO:0000244|PDB:6ASY}.
SQ   SEQUENCE   654 AA;  72333 MW;  59B7D8D85BC32A00 CRC64;
     MKLSLVAAML LLLSAARAEE EDKKEDVGTV VGIDLGTTYS CVGVFKNGRV EIIANDQGNR
     ITPSYVAFTP EGERLIGDAA KNQLTSNPEN TVFDAKRLIG RTWNDPSVQQ DIKFLPFKVV
     EKKTKPYIQV DIGGGQTKTF APEEISAMVL TKMKETAEAY LGKKVTHAVV TVPAYFNDAQ
     RQATKDAGTI AGLNVMRIIN EPTAAAIAYG LDKREGEKNI LVFDLGGGTF DVSLLTIDNG
     VFEVVATNGD THLGGEDFDQ RVMEHFIKLY KKKTGKDVRK DNRAVQKLRR EVEKAKRALS
     SQHQARIEIE SFYEGEDFSE TLTRAKFEEL NMDLFRSTMK PVQKVLEDSD LKKSDIDEIV
     LVGGSTRIPK IQQLVKEFFN GKEPSRGINP DEAVAYGAAV QAGVLSGDQD TGDLVLLDVC
     PLTLGIETVG GVMTKLIPRN TVVPTKKSQI FSTASDNQPT VTIKVYEGER PLTKDNHLLG
     TFDLTGIPPA PRGVPQIEVT FEIDVNGILR VTAEDKGTGN KNKITITNDQ NRLTPEEIER
     MVNDAEKFAE EDKKLKERID TRNELESYAY SLKNQIGDKE KLGGKLSSED KETMEKAVEE
     KIEWLESHQD ADIEDFKAKK KELEEIVQPI ISKLYGSAGP PPTGEEDTAE KDEL
//
ID   V9HWB4_HUMAN            Unreviewed;       654 AA.
AC   V9HWB4;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   23-MAY-2018, entry version 34.
DE   SubName: Full=Epididymis secretory sperm binding protein Li 89n {ECO:0000313|EMBL:ACJ13671.1};
GN   Name=HEL-S-89n {ECO:0000313|EMBL:ACJ13671.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACJ13671.1};
RN   [1] {ECO:0000313|EMBL:ACJ13671.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu F.J., Liu J.;
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000256|RuleBase:RU003322}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU794617; ACJ13671.1; -; mRNA.
DR   RefSeq; NP_005338.1; NM_005347.4.
DR   UniGene; Hs.743241; -.
DR   ProteinModelPortal; V9HWB4; -.
DR   SMR; V9HWB4; -.
DR   BindingDB; V9HWB4; -.
DR   MaxQB; V9HWB4; -.
DR   PRIDE; V9HWB4; -.
DR   GeneID; 3309; -.
DR   KEGG; hsa:3309; -.
DR   UCSC; uc004bpn.4; human.
DR   CTD; 3309; -.
DR   EuPathDB; HostDB:ENSG00000044574.7; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   KO; K09490; -.
DR   OMA; CVGVMQK; -.
DR   OrthoDB; EOG091G0352; -.
DR   PhylomeDB; V9HWB4; -.
DR   ChiTaRS; HSPA5; human.
DR   GenomeRNAi; 3309; -.
DR   Bgee; ENSG00000044574; -.
DR   ExpressionAtlas; V9HWB4; baseline and differential.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0034663; C:endoplasmic reticulum chaperone complex; IEA:Ensembl.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IEA:Ensembl.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:Ensembl.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0051787; F:misfolded protein binding; IEA:Ensembl.
DR   GO; GO:0043022; F:ribosome binding; IEA:Ensembl.
DR   GO; GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; IEA:Ensembl.
DR   GO; GO:0071236; P:cellular response to antibiotic; IEA:Ensembl.
DR   GO; GO:0071277; P:cellular response to calcium ion; IEA:Ensembl.
DR   GO; GO:0071320; P:cellular response to cAMP; IEA:Ensembl.
DR   GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
DR   GO; GO:0071480; P:cellular response to gamma radiation; IEA:Ensembl.
DR   GO; GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl.
DR   GO; GO:0071287; P:cellular response to manganese ion; IEA:Ensembl.
DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0021680; P:cerebellar Purkinje cell layer development; IEA:Ensembl.
DR   GO; GO:0021589; P:cerebellum structural organization; IEA:Ensembl.
DR   GO; GO:0006983; P:ER overload response; IEA:Ensembl.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0051402; P:neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; IEA:Ensembl.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IEA:Ensembl.
DR   GO; GO:0042220; P:response to cocaine; IEA:Ensembl.
DR   GO; GO:1904313; P:response to methamphetamine hydrochloride; IEA:Ensembl.
DR   GO; GO:0097501; P:stress response to metal ion; IEA:Ensembl.
DR   GO; GO:1901998; P:toxin transport; IEA:Ensembl.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   SUPFAM; SSF100934; SSF100934; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|RuleBase:RU003322};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU003322};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     18       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        19    654       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004776903.
FT   COILED      278    305       {ECO:0000256|SAM:Coils}.
FT   COILED      538    558       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   654 AA;  72333 MW;  59B7D8D85BC32A00 CRC64;
     MKLSLVAAML LLLSAARAEE EDKKEDVGTV VGIDLGTTYS CVGVFKNGRV EIIANDQGNR
     ITPSYVAFTP EGERLIGDAA KNQLTSNPEN TVFDAKRLIG RTWNDPSVQQ DIKFLPFKVV
     EKKTKPYIQV DIGGGQTKTF APEEISAMVL TKMKETAEAY LGKKVTHAVV TVPAYFNDAQ
     RQATKDAGTI AGLNVMRIIN EPTAAAIAYG LDKREGEKNI LVFDLGGGTF DVSLLTIDNG
     VFEVVATNGD THLGGEDFDQ RVMEHFIKLY KKKTGKDVRK DNRAVQKLRR EVEKAKRALS
     SQHQARIEIE SFYEGEDFSE TLTRAKFEEL NMDLFRSTMK PVQKVLEDSD LKKSDIDEIV
     LVGGSTRIPK IQQLVKEFFN GKEPSRGINP DEAVAYGAAV QAGVLSGDQD TGDLVLLDVC
     PLTLGIETVG GVMTKLIPRN TVVPTKKSQI FSTASDNQPT VTIKVYEGER PLTKDNHLLG
     TFDLTGIPPA PRGVPQIEVT FEIDVNGILR VTAEDKGTGN KNKITITNDQ NRLTPEEIER
     MVNDAEKFAE EDKKLKERID TRNELESYAY SLKNQIGDKE KLGGKLSSED KETMEKAVEE
     KIEWLESHQD ADIEDFKAKK KELEEIVQPI ISKLYGSAGP PPTGEEDTAE KDEL
//
ID   B2RAD8_HUMAN            Unreviewed;       857 AA.
AC   B2RAD8;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   31-JAN-2018, entry version 57.
DE   SubName: Full=cDNA, FLJ94852, highly similar to Homo sapiens eukaryotic translation initiation factor 2C, 1 (EIF2C1), mRNA {ECO:0000313|EMBL:BAG36835.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG36835.1};
RN   [1] {ECO:0000313|EMBL:BAG36835.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the argonaute family.
CC       {ECO:0000256|RuleBase:RU361178, ECO:0000256|SAAS:SAAS00702966}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK314148; BAG36835.1; -; mRNA.
DR   RefSeq; NP_001304051.1; NM_001317122.1.
DR   RefSeq; NP_001304052.1; NM_001317123.1.
DR   RefSeq; NP_036331.1; NM_012199.4.
DR   UniGene; Hs.22867; -.
DR   UniGene; Hs.656677; -.
DR   IntAct; B2RAD8; 1.
DR   PeptideAtlas; B2RAD8; -.
DR   PRIDE; B2RAD8; -.
DR   GeneID; 26523; -.
DR   KEGG; hsa:26523; -.
DR   CTD; 26523; -.
DR   eggNOG; KOG1041; Eukaryota.
DR   eggNOG; ENOG410XP07; LUCA.
DR   HOVERGEN; HBG006101; -.
DR   KO; K11593; -.
DR   GO; GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.420.10; -; 1.
DR   InterPro; IPR014811; ArgoL1.
DR   InterPro; IPR032472; ArgoL2.
DR   InterPro; IPR032473; Argonaute_Mid_dom.
DR   InterPro; IPR032474; Argonaute_N.
DR   InterPro; IPR003100; PAZ_dom.
DR   InterPro; IPR036085; PAZ_dom_sf.
DR   InterPro; IPR003165; Piwi.
DR   InterPro; IPR012337; RNaseH-like_sf.
DR   InterPro; IPR036397; RNaseH_sf.
DR   Pfam; PF08699; ArgoL1; 1.
DR   Pfam; PF16488; ArgoL2; 1.
DR   Pfam; PF16487; ArgoMid; 1.
DR   Pfam; PF16486; ArgoN; 1.
DR   Pfam; PF02170; PAZ; 1.
DR   Pfam; PF02171; Piwi; 1.
DR   SMART; SM01163; DUF1785; 1.
DR   SMART; SM00949; PAZ; 1.
DR   SMART; SM00950; Piwi; 1.
DR   SUPFAM; SSF101690; SSF101690; 1.
DR   SUPFAM; SSF53098; SSF53098; 1.
DR   PROSITE; PS50821; PAZ; 1.
DR   PROSITE; PS50822; PIWI; 1.
PE   2: Evidence at transcript level;
KW   Initiation factor {ECO:0000313|EMBL:BAG36835.1};
KW   Protein biosynthesis {ECO:0000313|EMBL:BAG36835.1};
KW   RNA-mediated gene silencing {ECO:0000256|SAAS:SAAS00703041}.
FT   DOMAIN      226    346       PAZ. {ECO:0000259|PROSITE:PS50821}.
FT   DOMAIN      515    816       Piwi. {ECO:0000259|PROSITE:PS50822}.
SQ   SEQUENCE   857 AA;  97244 MW;  5F3903B410EB2399 CRC64;
     MEAGPSGAAA SAYLPPLQQV FQAPRRPGIG TVGKPIKLLA NYFEVDIPKI DVYHYEVDIK
     PDKCPRRVNR EVVEYMVQHF KPQIFGDRKP VYDGKKNIYT VTALPIGNER VDFEVTIPGE
     GKDRIFKVSI KWLAIVSWRM LHEALVSGQI PVPLESVQAL DVAMRHLASM RYTPVGRSFF
     SPPEGYYHPL GGGREVWFGF HQSVRPAMWK MMLNIDVSAT AFYKAQPVIE FMCEVLDIRN
     IDEQPKPLTD SQRVRFTKEI KGLKVEVTHC GQMKRKYRVC NVTRRPASHQ TFPLQLESGQ
     TVECTVAQYF KQKYNLQLKY PHLPCLQVGQ EQKHTYLPLE VCNIVAGQRC IKKLTDNQTS
     TMIKATARSA PDRQEEISRL MKNASYNLDP YIQEFGIKVK DDMTEVTGRV LPAPILQYGG
     RNRAIATPNQ GVWDMRGKQF YNGIEIKVWA IACFAPQKQC REEVLKNFTD QLRKISKDAG
     MPIQGQPCFC KYAQGADSVE PMFRHLKNTY SGLQLIIVIL PGKTPVYAEV KRVGDTLLGM
     ATQCVQVKNV VKTSPQTLSN LCLKINVKLG GINNILVPHQ RSAVFQQPVI FLGADVTHPP
     AGDGKKPSIT AVVGSMDAHP SRYCATVRVQ RPRQEIIEDL SYMVRELLIQ FYKSTRFKPT
     RIIFYRDGVP EGQLPQILHY ELLAIRDACI KLEKDYQPGI TYIVVQKRHH TRLFCADKNE
     RIGKSGNIPA GTTVDTNITH PFEFDFYLCS HAGIQGTSRP SHYYVLWDDN RFTADELQIL
     TYQLCHTYVR CTRSVSIPAP AYYARLVAFR ARYHLVDKEH DSGEGSHISG QSNGRDPQAL
     AKAVQVHQDT LRTMYFA
//
ID   B3KME0_HUMAN            Unreviewed;       782 AA.
AC   B3KME0;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 55.
DE   SubName: Full=cDNA FLJ10760 fis, clone NT2RP3004618, highly similar to Eukaryotic translation initiation factor 2C 1 {ECO:0000313|EMBL:BAG50952.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG50952.1};
RN   [1] {ECO:0000313|EMBL:BAG50952.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -!- SIMILARITY: Belongs to the argonaute family.
CC       {ECO:0000256|RuleBase:RU361178, ECO:0000256|SAAS:SAAS00702966}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK001622; BAG50952.1; -; mRNA.
DR   RefSeq; NP_001304052.1; NM_001317123.1.
DR   UniGene; Hs.22867; -.
DR   UniGene; Hs.656677; -.
DR   PeptideAtlas; B3KME0; -.
DR   GeneID; 26523; -.
DR   CTD; 26523; -.
DR   eggNOG; KOG1041; Eukaryota.
DR   eggNOG; ENOG410XP07; LUCA.
DR   HOGENOM; HOG000116043; -.
DR   HOVERGEN; HBG006101; -.
DR   GO; GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.420.10; -; 1.
DR   InterPro; IPR014811; ArgoL1.
DR   InterPro; IPR032472; ArgoL2.
DR   InterPro; IPR032473; Argonaute_Mid_dom.
DR   InterPro; IPR032474; Argonaute_N.
DR   InterPro; IPR003100; PAZ_dom.
DR   InterPro; IPR036085; PAZ_dom_sf.
DR   InterPro; IPR003165; Piwi.
DR   InterPro; IPR012337; RNaseH-like_sf.
DR   InterPro; IPR036397; RNaseH_sf.
DR   Pfam; PF08699; ArgoL1; 1.
DR   Pfam; PF16488; ArgoL2; 1.
DR   Pfam; PF16487; ArgoMid; 1.
DR   Pfam; PF16486; ArgoN; 1.
DR   Pfam; PF02170; PAZ; 1.
DR   Pfam; PF02171; Piwi; 1.
DR   SMART; SM01163; DUF1785; 1.
DR   SMART; SM00949; PAZ; 1.
DR   SMART; SM00950; Piwi; 1.
DR   SUPFAM; SSF101690; SSF101690; 1.
DR   SUPFAM; SSF53098; SSF53098; 1.
DR   PROSITE; PS50821; PAZ; 1.
DR   PROSITE; PS50822; PIWI; 1.
PE   2: Evidence at transcript level;
KW   Initiation factor {ECO:0000313|EMBL:BAG50952.1};
KW   Protein biosynthesis {ECO:0000313|EMBL:BAG50952.1};
KW   RNA-mediated gene silencing {ECO:0000256|SAAS:SAAS00703041}.
FT   DOMAIN      151    271       PAZ. {ECO:0000259|PROSITE:PS50821}.
FT   DOMAIN      440    741       Piwi. {ECO:0000259|PROSITE:PS50822}.
SQ   SEQUENCE   782 AA;  88720 MW;  E2EFBDF9CE573B0E CRC64;
     MVQHFKPQIF GDRKPVYDGK KNIYTVTALP IGNERVDFEV TIPGEGKDRI FKVSIKWLAI
     VSWRMLHEAL VSGQIPVPLE SVQALDVAMR HLASMRYTPV GRSFFSPPEG YYHPLGGGRE
     VWFGFHQSVR PAMWKMMLNI DVSATAFYKA QPVIEFMCEV LDIRNIDEQP KPLTDSQRVR
     FTKEIKGLKV EVTHCGQMKR KYRVCNVTRR PASHQTFPLQ LESGQTVECT VAQYFKQKYN
     LQLKYPHLPC LQVGQEQKHT YLPLEVCNIV AGQRCIKKLT DNQTSTMIKA TARSAPDRQE
     EISRLMKNAS YNLDPYIQEF GIKVKDDMTE VTGRVLPAPI LQYGGRNRAI ATPNQGVWDM
     RGKQFYNGIE IKVWAIACFA PQKQCREEVL KNFTDQLRKI SKDAGMPIQG QPCFCKYAQG
     ADSVEPMFRH LKNTYSGLQL IIVILPGKTP VYAEVKRVGD TLLGMATQCV QVKNVVKTSP
     QTLSNLCLKI NVKLGGINSI LVPHQRSAVF QQPVIFLGAD VTHPPAGDGK KPSITAVVGS
     MDAHPSRYCA TVRVQRPRQE IIEDLSYMVR ELLIQFYKST RFKPTRIIFC RDGVPEGQLP
     QILHYELLAI RDACIKLEKD YQPGITYIVV QKRHHTRLFC ADKNGRIGKS GNIPAGTTVD
     TNITHPFEFD FYLCSHAGIQ GTSRPSHYYV LWDDNRFTAD ELQILTYQLC HTYVRCTRSV
     SIPAPAYYAR LVAFRARYHL VDKEHDSGEG SHISGQSNGR DPQALAKAVQ VHQDTLRTMY
     FA
//
ID   Q5TA58_HUMAN            Unreviewed;       782 AA.
AC   Q5TA58;
DT   21-DEC-2004, integrated into UniProtKB/TrEMBL.
DT   21-DEC-2004, sequence version 1.
DT   23-MAY-2018, entry version 109.
DE   SubName: Full=Protein argonaute-1 {ECO:0000313|Ensembl:ENSP00000362302};
GN   Name=AGO1 {ECO:0000313|Ensembl:ENSP00000362302};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000362302, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000362302, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000313|Ensembl:ENSP00000362302}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (MAR-2013) to UniProtKB.
CC   -!- SIMILARITY: Belongs to the argonaute family.
CC       {ECO:0000256|RuleBase:RU361178, ECO:0000256|SAAS:SAAS00702966}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL139286; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001304052.1; NM_001317123.1.
DR   UniGene; Hs.22867; -.
DR   UniGene; Hs.656677; -.
DR   ProteinModelPortal; Q5TA58; -.
DR   MaxQB; Q5TA58; -.
DR   PeptideAtlas; Q5TA58; -.
DR   PRIDE; Q5TA58; -.
DR   Ensembl; ENST00000373206; ENSP00000362302; ENSG00000092847.
DR   GeneID; 26523; -.
DR   UCSC; uc001bzk.4; human.
DR   CTD; 26523; -.
DR   EuPathDB; HostDB:ENSG00000092847.11; -.
DR   HGNC; HGNC:3262; AGO1.
DR   OpenTargets; ENSG00000092847; -.
DR   eggNOG; KOG1041; Eukaryota.
DR   eggNOG; ENOG410XP07; LUCA.
DR   GeneTree; ENSGT00760000119148; -.
DR   HOVERGEN; HBG006101; -.
DR   ChiTaRS; AGO1; human.
DR   GenomeRNAi; 26523; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000092847; -.
DR   ExpressionAtlas; Q5TA58; baseline and differential.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.420.10; -; 1.
DR   InterPro; IPR014811; ArgoL1.
DR   InterPro; IPR032472; ArgoL2.
DR   InterPro; IPR032473; Argonaute_Mid_dom.
DR   InterPro; IPR032474; Argonaute_N.
DR   InterPro; IPR003100; PAZ_dom.
DR   InterPro; IPR036085; PAZ_dom_sf.
DR   InterPro; IPR003165; Piwi.
DR   InterPro; IPR012337; RNaseH-like_sf.
DR   InterPro; IPR036397; RNaseH_sf.
DR   Pfam; PF08699; ArgoL1; 1.
DR   Pfam; PF16488; ArgoL2; 1.
DR   Pfam; PF16487; ArgoMid; 1.
DR   Pfam; PF16486; ArgoN; 1.
DR   Pfam; PF02170; PAZ; 1.
DR   Pfam; PF02171; Piwi; 1.
DR   SMART; SM01163; DUF1785; 1.
DR   SMART; SM00949; PAZ; 1.
DR   SMART; SM00950; Piwi; 1.
DR   SUPFAM; SSF101690; SSF101690; 1.
DR   SUPFAM; SSF53098; SSF53098; 1.
DR   PROSITE; PS50821; PAZ; 1.
DR   PROSITE; PS50822; PIWI; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:Q5TA58,
KW   ECO:0000213|MaxQB:Q5TA58, ECO:0000213|PeptideAtlas:Q5TA58};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   RNA-mediated gene silencing {ECO:0000256|SAAS:SAAS00703041}.
FT   DOMAIN      151    271       PAZ. {ECO:0000259|PROSITE:PS50821}.
FT   DOMAIN      440    741       Piwi. {ECO:0000259|PROSITE:PS50822}.
SQ   SEQUENCE   782 AA;  88879 MW;  9B2F2112E4B56215 CRC64;
     MVQHFKPQIF GDRKPVYDGK KNIYTVTALP IGNERVDFEV TIPGEGKDRI FKVSIKWLAI
     VSWRMLHEAL VSGQIPVPLE SVQALDVAMR HLASMRYTPV GRSFFSPPEG YYHPLGGGRE
     VWFGFHQSVR PAMWKMMLNI DVSATAFYKA QPVIEFMCEV LDIRNIDEQP KPLTDSQRVR
     FTKEIKGLKV EVTHCGQMKR KYRVCNVTRR PASHQTFPLQ LESGQTVECT VAQYFKQKYN
     LQLKYPHLPC LQVGQEQKHT YLPLEVCNIV AGQRCIKKLT DNQTSTMIKA TARSAPDRQE
     EISRLMKNAS YNLDPYIQEF GIKVKDDMTE VTGRVLPAPI LQYGGRNRAI ATPNQGVWDM
     RGKQFYNGIE IKVWAIACFA PQKQCREEVL KNFTDQLRKI SKDAGMPIQG QPCFCKYAQG
     ADSVEPMFRH LKNTYSGLQL IIVILPGKTP VYAEVKRVGD TLLGMATQCV QVKNVVKTSP
     QTLSNLCLKI NVKLGGINNI LVPHQRSAVF QQPVIFLGAD VTHPPAGDGK KPSITAVVGS
     MDAHPSRYCA TVRVQRPRQE IIEDLSYMVR ELLIQFYKST RFKPTRIIFY RDGVPEGQLP
     QILHYELLAI RDACIKLEKD YQPGITYIVV QKRHHTRLFC ADKNERIGKS GNIPAGTTVD
     TNITHPFEFD FYLCSHAGIQ GTSRPSHYYV LWDDNRFTAD ELQILTYQLC HTYVRCTRSV
     SIPAPAYYAR LVAFRARYHL VDKEHDSGEG SHISGQSNGR DPQALAKAVQ VHQDTLRTMY
     FA
//
ID   AGO1_HUMAN              Reviewed;         857 AA.
AC   Q9UL18; Q5TA57; Q6P4S0;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2006, sequence version 3.
DT   23-MAY-2018, entry version 157.
DE   RecName: Full=Protein argonaute-1;
DE            Short=Argonaute1;
DE            Short=hAgo1;
DE   AltName: Full=Argonaute RISC catalytic component 1;
DE   AltName: Full=Eukaryotic translation initiation factor 2C 1;
DE            Short=eIF-2C 1;
DE            Short=eIF2C 1;
DE   AltName: Full=Putative RNA-binding protein Q99;
GN   Name=AGO1; Synonyms=EIF2C1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10534406; DOI=10.1006/geno.1999.5951;
RA   Koesters R., Adams V., Betts D., Moos R., Schmid M., Siermann A.,
RA   Hassam S., Weitz S., Lichter P., Heitz P.U., von Knebel Doeberitz M.,
RA   Briner J.;
RT   "Human eukaryotic initiation factor EIF2C1 gene: cDNA sequence,
RT   genomic organization, localization to chromosomal bands 1p34-p35, and
RT   expression.";
RL   Genomics 61:210-218(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   ASSOCIATION WITH MIRNA.
RX   PubMed=15260970; DOI=10.1016/j.molcel.2004.07.007;
RA   Meister G., Landthaler M., Patkaniowska A., Dorsett Y., Teng G.,
RA   Tuschl T.;
RT   "Human Argonaute2 mediates RNA cleavage targeted by miRNAs and
RT   siRNAs.";
RL   Mol. Cell 15:185-197(2004).
RN   [5]
RP   FUNCTION, INTERACTION WITH DICER1; MOV10; PRMT5 AND TNRC6B, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=16289642; DOI=10.1016/j.cub.2005.10.048;
RA   Meister G., Landthaler M., Peters L., Chen P.Y., Urlaub H.,
RA   Luehrmann R., Tuschl T.;
RT   "Identification of novel argonaute-associated proteins.";
RL   Curr. Biol. 15:2149-2155(2005).
RN   [6]
RP   FUNCTION.
RX   PubMed=16936728; DOI=10.1038/nsmb1140;
RA   Janowski B.A., Huffman K.E., Schwartz J.C., Ram R., Nordsell R.,
RA   Shames D.S., Minna J.D., Corey D.R.;
RT   "Involvement of AGO1 and AGO2 in mammalian transcriptional
RT   silencing.";
RL   Nat. Struct. Mol. Biol. 13:787-792(2006).
RN   [7]
RP   INTERACTION WITH DDX6 AND AGO2.
RX   PubMed=16756390; DOI=10.1371/journal.pbio.0040210;
RA   Chu C.-Y., Rana T.M.;
RT   "Translation repression in human cells by microRNA-induced gene
RT   silencing requires RCK/p54.";
RL   PLoS Biol. 4:E210-E210(2006).
RN   [8]
RP   ASSOCIATION WITH POLYSOMES AND MNRP, AND INTERACTION WITH DDB1; DDX5;
RP   DHX30; DHX36; DDX47; ELAVL1; HNRNPF; IGF2BP1; ILF3; MATR3; PABPC1;
RP   RBM4; SART3; UPF1 AND YBX1.
RX   PubMed=17932509; DOI=10.1038/sj.embor.7401088;
RA   Hoeck J., Weinmann L., Ender C., Ruedel S., Kremmer E., Raabe M.,
RA   Urlaub H., Meister G.;
RT   "Proteomic and functional analysis of Argonaute-containing mRNA-
RT   protein complexes in human cells.";
RL   EMBO Rep. 8:1052-1060(2007).
RN   [9]
RP   FUNCTION.
RX   PubMed=18771919; DOI=10.1016/j.cub.2008.07.072;
RA   Wu L., Fan J., Belasco J.G.;
RT   "Importance of translation and nonnucleolytic ago proteins for on-
RT   target RNA interference.";
RL   Curr. Biol. 18:1327-1332(2008).
RN   [10]
RP   INTERACTION WITH IMP8.
RX   PubMed=19167051; DOI=10.1016/j.cell.2008.12.023;
RA   Weinmann L., Hoeck J., Ivacevic T., Ohrt T., Muetze J., Schwille P.,
RA   Kremmer E., Benes V., Urlaub H., Meister G.;
RT   "Importin 8 is a gene silencing factor that targets argonaute proteins
RT   to distinct mRNAs.";
RL   Cell 136:496-507(2009).
RN   [11]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH LIMD1; WTIP AND AJUBA.
RX   PubMed=20616046; DOI=10.1073/pnas.0914987107;
RA   James V., Zhang Y., Foxler D.E., de Moor C.H., Kong Y.W., Webb T.M.,
RA   Self T.J., Feng Y., Lagos D., Chu C.Y., Rana T.M., Morley S.J.,
RA   Longmore G.D., Bushell M., Sharp T.V.;
RT   "LIM-domain proteins, LIMD1, Ajuba, and WTIP are required for
RT   microRNA-mediated gene silencing.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:12499-12504(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   INTERACTION WITH APOBEC3F; APOBEC3G AND APOBEC3H.
RX   PubMed=22915799; DOI=10.1128/JVI.00595-12;
RA   Phalora P.K., Sherer N.M., Wolinsky S.M., Swanson C.M., Malim M.H.;
RT   "HIV-1 replication and APOBEC3 antiviral activity are not regulated by
RT   P bodies.";
RL   J. Virol. 86:11712-11724(2012).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 225-369, AND RNA-BINDING.
RX   PubMed=15152257; DOI=10.1038/nature02519;
RA   Ma J.-B., Ye K., Patel D.J.;
RT   "Structural basis for overhang-specific small interfering RNA
RT   recognition by the PAZ domain.";
RL   Nature 429:318-322(2004).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.29 ANGSTROMS) IN COMPLEX WITH RNA,
RP   RNA-BINDING, MUTAGENESIS OF PRO-670; PRO-675 AND ARG-805, AND LACK OF
RP   CATALYTIC ACTIVITY.
RX   PubMed=23809764; DOI=10.1016/j.celrep.2013.06.010;
RA   Nakanishi K., Ascano M., Gogakos T., Ishibe-Murakami S.,
RA   Serganov A.A., Briskin D., Morozov P., Tuschl T., Patel D.J.;
RT   "Eukaryote-specific insertion elements control human ARGONAUTE slicer
RT   activity.";
RL   Cell Rep. 3:1893-1900(2013).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) IN COMPLEX WITH RNA, LACK OF
RP   CATALYTIC ACTIVITY, AND MUTAGENESIS OF LEU-674 AND ARG-805.
RX   PubMed=23746446; DOI=10.1016/j.celrep.2013.05.033;
RA   Faehnle C.R., Elkayam E., Haase A.D., Hannon G.J., Joshua-Tor L.;
RT   "The making of a slicer: activation of human Argonaute-1.";
RL   Cell Rep. 3:1901-1909(2013).
RN   [17]
RP   VARIANT SER-199.
RX   PubMed=25003005; DOI=10.4161/rdis.26144;
RA   Tuzovic L., Yu L., Zeng W., Li X., Lu H., Lu H.M., Gonzalez K.D.,
RA   Chung W.K.;
RT   "A human de novo mutation in MYH10 phenocopies the loss of function
RT   mutation in mice.";
RL   Rare Dis. 1:E26144-E26144(2013).
CC   -!- FUNCTION: Required for RNA-mediated gene silencing (RNAi). Binds
CC       to short RNAs such as microRNAs (miRNAs) or short interfering RNAs
CC       (siRNAs), and represses the translation of mRNAs which are
CC       complementary to them. Lacks endonuclease activity and does not
CC       appear to cleave target mRNAs. Also required for transcriptional
CC       gene silencing (TGS) of promoter regions which are complementary
CC       to bound short antigene RNAs (agRNAs).
CC       {ECO:0000269|PubMed:16289642, ECO:0000269|PubMed:16936728,
CC       ECO:0000269|PubMed:18771919}.
CC   -!- SUBUNIT: Interacts with DDB1, DDX5, DDX6, DHX30, DHX36, DDX47,
CC       DICER1, AGO2, ELAVL1, HNRNPF, IGF2BP1, ILF3, IMP8, MATR3, MOV10,
CC       PABPC1, PRMT5, RBM4, SART3, TNRC6B, UPF1 and YBX1. Associates with
CC       polysomes and messenger ribonucleoproteins (mNRPs). Interacts with
CC       LIMD1, WTIP and AJUBA. Interacts with APOBEC3F, APOBEC3G and
CC       APOBEC3H. {ECO:0000269|PubMed:16289642,
CC       ECO:0000269|PubMed:16756390, ECO:0000269|PubMed:17932509,
CC       ECO:0000269|PubMed:19167051, ECO:0000269|PubMed:20616046,
CC       ECO:0000269|PubMed:22915799, ECO:0000269|PubMed:23746446,
CC       ECO:0000269|PubMed:23809764}.
CC   -!- INTERACTION:
CC       Q9UKV8:AGO2; NbExp=3; IntAct=EBI-527363, EBI-528269;
CC       Q9UPY3:DICER1; NbExp=5; IntAct=EBI-527363, EBI-395506;
CC       P08238:HSP90AB1; NbExp=3; IntAct=EBI-527363, EBI-352572;
CC       O15397:IPO8; NbExp=2; IntAct=EBI-527363, EBI-358808;
CC       P53041:PPP5C; NbExp=2; IntAct=EBI-527363, EBI-716663;
CC       P04156:PRNP; NbExp=2; IntAct=EBI-527363, EBI-977302;
CC       Q8NDV7:TNRC6A; NbExp=5; IntAct=EBI-527363, EBI-2269715;
CC       Q9UPQ9-2:TNRC6B; NbExp=4; IntAct=EBI-527363, EBI-6514011;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, P-body
CC       {ECO:0000269|PubMed:16289642, ECO:0000269|PubMed:20616046}.
CC   -!- MISCELLANEOUS: Lacks RNA cleavage activity due to the absence of
CC       the conserved His at position 805, but also because it binds the
CC       RNA in a subtly different manner that precludes efficient
CC       cleavage.
CC   -!- SIMILARITY: Belongs to the argonaute family. Ago subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF093097; AAF00068.1; -; mRNA.
DR   EMBL; AL139286; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC063275; AAH63275.1; -; mRNA.
DR   CCDS; CCDS398.1; -.
DR   RefSeq; NP_001304051.1; NM_001317122.1.
DR   RefSeq; NP_001304052.1; NM_001317123.1.
DR   RefSeq; NP_036331.1; NM_012199.4.
DR   UniGene; Hs.22867; -.
DR   UniGene; Hs.656677; -.
DR   PDB; 1SI2; X-ray; 2.60 A; A=225-369.
DR   PDB; 1SI3; X-ray; 2.60 A; A=225-369.
DR   PDB; 4KRE; X-ray; 1.75 A; A=1-857.
DR   PDB; 4KRF; X-ray; 2.10 A; A=1-857.
DR   PDB; 4KXT; X-ray; 2.29 A; A=1-857.
DR   PDB; 5W6V; X-ray; 2.83 A; A=1-857.
DR   PDBsum; 1SI2; -.
DR   PDBsum; 1SI3; -.
DR   PDBsum; 4KRE; -.
DR   PDBsum; 4KRF; -.
DR   PDBsum; 4KXT; -.
DR   PDBsum; 5W6V; -.
DR   ProteinModelPortal; Q9UL18; -.
DR   SMR; Q9UL18; -.
DR   BioGrid; 117726; 56.
DR   DIP; DIP-29193N; -.
DR   IntAct; Q9UL18; 185.
DR   MINT; Q9UL18; -.
DR   STRING; 9606.ENSP00000362300; -.
DR   iPTMnet; Q9UL18; -.
DR   PhosphoSitePlus; Q9UL18; -.
DR   BioMuta; AGO1; -.
DR   DMDM; 88984241; -.
DR   EPD; Q9UL18; -.
DR   MaxQB; Q9UL18; -.
DR   PaxDb; Q9UL18; -.
DR   PeptideAtlas; Q9UL18; -.
DR   PRIDE; Q9UL18; -.
DR   Ensembl; ENST00000373204; ENSP00000362300; ENSG00000092847.
DR   GeneID; 26523; -.
DR   KEGG; hsa:26523; -.
DR   UCSC; uc001bzl.4; human.
DR   CTD; 26523; -.
DR   DisGeNET; 26523; -.
DR   EuPathDB; HostDB:ENSG00000092847.11; -.
DR   GeneCards; AGO1; -.
DR   HGNC; HGNC:3262; AGO1.
DR   MIM; 606228; gene.
DR   neXtProt; NX_Q9UL18; -.
DR   OpenTargets; ENSG00000092847; -.
DR   PharmGKB; PA27693; -.
DR   eggNOG; KOG1041; Eukaryota.
DR   eggNOG; ENOG410XP07; LUCA.
DR   GeneTree; ENSGT00760000119148; -.
DR   HOGENOM; HOG000116043; -.
DR   InParanoid; Q9UL18; -.
DR   KO; K11593; -.
DR   OMA; TNPNNIE; -.
DR   OrthoDB; EOG091G020J; -.
DR   PhylomeDB; Q9UL18; -.
DR   TreeFam; TF101510; -.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-203927; MicroRNA (miRNA) biogenesis.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559585; Oncogene Induced Senescence.
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   Reactome; R-HSA-426486; Small interfering RNA (siRNA) biogenesis.
DR   Reactome; R-HSA-426496; Post-transcriptional silencing by small RNAs.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-8934593; Regulation of RUNX1 Expression and Activity.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8943723; Regulation of PTEN mRNA translation.
DR   Reactome; R-HSA-8948700; Competing endogenous RNAs (ceRNAs) regulate PTEN translation.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   ChiTaRS; AGO1; human.
DR   EvolutionaryTrace; Q9UL18; -.
DR   GeneWiki; EIF2C1; -.
DR   GenomeRNAi; 26523; -.
DR   PRO; PR:Q9UL18; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000092847; -.
DR   CleanEx; HS_EIF2C1; -.
DR   ExpressionAtlas; Q9UL18; baseline and differential.
DR   Genevisible; Q9UL18; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0035068; C:micro-ribonucleoprotein complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IC:BHF-UCL.
DR   GO; GO:0000932; C:P-body; IEA:UniProtKB-SubCell.
DR   GO; GO:0005844; C:polysome; IDA:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:UniProtKB.
DR   GO; GO:0016442; C:RISC complex; IDA:BHF-UCL.
DR   GO; GO:0070578; C:RISC-loading complex; IDA:BHF-UCL.
DR   GO; GO:0001047; F:core promoter binding; IMP:BHF-UCL.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:BHF-UCL.
DR   GO; GO:0035198; F:miRNA binding; IDA:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0000993; F:RNA polymerase II core binding; IDA:BHF-UCL.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003727; F:single-stranded RNA binding; IDA:BHF-UCL.
DR   GO; GO:0035280; P:miRNA loading onto RISC involved in gene silencing by miRNA; IDA:BHF-UCL.
DR   GO; GO:0035278; P:miRNA mediated inhibition of translation; IDA:UniProtKB.
DR   GO; GO:0010586; P:miRNA metabolic process; IEA:Ensembl.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IMP:BHF-UCL.
DR   GO; GO:0000956; P:nuclear-transcribed mRNA catabolic process; IDA:UniProtKB.
DR   GO; GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:BHF-UCL.
DR   GO; GO:0035194; P:posttranscriptional gene silencing by RNA; TAS:Reactome.
DR   GO; GO:0031054; P:pre-miRNA processing; IDA:BHF-UCL.
DR   GO; GO:0035196; P:production of miRNAs involved in gene silencing by miRNA; IMP:BHF-UCL.
DR   GO; GO:0060964; P:regulation of gene silencing by miRNA; TAS:Reactome.
DR   GO; GO:0045652; P:regulation of megakaryocyte differentiation; TAS:Reactome.
DR   GO; GO:0010501; P:RNA secondary structure unwinding; IDA:BHF-UCL.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; TAS:Reactome.
DR   Gene3D; 3.30.420.10; -; 1.
DR   InterPro; IPR014811; ArgoL1.
DR   InterPro; IPR032472; ArgoL2.
DR   InterPro; IPR032473; Argonaute_Mid_dom.
DR   InterPro; IPR032474; Argonaute_N.
DR   InterPro; IPR003100; PAZ_dom.
DR   InterPro; IPR036085; PAZ_dom_sf.
DR   InterPro; IPR003165; Piwi.
DR   InterPro; IPR012337; RNaseH-like_sf.
DR   InterPro; IPR036397; RNaseH_sf.
DR   Pfam; PF08699; ArgoL1; 1.
DR   Pfam; PF16488; ArgoL2; 1.
DR   Pfam; PF16487; ArgoMid; 1.
DR   Pfam; PF16486; ArgoN; 1.
DR   Pfam; PF02170; PAZ; 1.
DR   Pfam; PF02171; Piwi; 1.
DR   SMART; SM01163; DUF1785; 1.
DR   SMART; SM00949; PAZ; 1.
DR   SMART; SM00950; Piwi; 1.
DR   SUPFAM; SSF101690; SSF101690; 1.
DR   SUPFAM; SSF53098; SSF53098; 1.
DR   PROSITE; PS50821; PAZ; 1.
DR   PROSITE; PS50822; PIWI; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Disease mutation;
KW   Reference proteome; Repressor; Ribonucleoprotein; RNA-binding;
KW   RNA-mediated gene silencing; Transcription; Transcription regulation;
KW   Translation regulation.
FT   CHAIN         1    857       Protein argonaute-1.
FT                                /FTId=PRO_0000194055.
FT   DOMAIN      226    346       PAZ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00142}.
FT   DOMAIN      515    816       Piwi. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00150}.
FT   REGION      309    314       Interaction with guide RNA.
FT   REGION      522    564       Interaction with guide RNA.
FT   REGION      670    675       Impairs access of bound RNA to the active
FT                                site.
FT   REGION      708    712       Interaction with guide RNA.
FT   REGION      751    759       Interaction with guide RNA.
FT   REGION      788    813       Interaction with guide RNA.
FT   VARIANT     199    199       G -> S (probable disease-associated
FT                                mutation found in a patient with moderate
FT                                intellectual disability and epilepsy).
FT                                {ECO:0000269|PubMed:25003005}.
FT                                /FTId=VAR_078651.
FT   MUTAGEN     670    670       P->S: Confers modest RNA cleavage
FT                                activity; when associated with Q-675 and
FT                                H-805. {ECO:0000269|PubMed:23809764}.
FT   MUTAGEN     674    674       L->F: Confers modest RNA cleavage
FT                                activity; when associated with H-805.
FT                                {ECO:0000269|PubMed:23746446}.
FT   MUTAGEN     675    675       P->Q: Does not confer enzyme activity by
FT                                itself. Confers low RNA cleavage
FT                                activity; when associated with H-805.
FT                                Confers modest RNA cleavage activity;
FT                                when associated with S-670 and H-805.
FT                                {ECO:0000269|PubMed:23809764}.
FT   MUTAGEN     805    805       R->H: Does not confer enzyme activity by
FT                                itself. Confers modest RNA cleavage
FT                                activity; when associated with F-674.
FT                                {ECO:0000269|PubMed:23746446,
FT                                ECO:0000269|PubMed:23809764}.
FT   CONFLICT    242    242       D -> N (in Ref. 3; AAH63275).
FT                                {ECO:0000305}.
FT   STRAND       33     46       {ECO:0000244|PDB:4KRE}.
FT   STRAND       51     62       {ECO:0000244|PDB:4KRE}.
FT   HELIX        66     79       {ECO:0000244|PDB:4KRE}.
FT   HELIX        81     85       {ECO:0000244|PDB:4KRF}.
FT   STRAND       94    102       {ECO:0000244|PDB:4KRE}.
FT   TURN        105    108       {ECO:0000244|PDB:4KXT}.
FT   STRAND      110    115       {ECO:0000244|PDB:4KRE}.
FT   STRAND      125    137       {ECO:0000244|PDB:4KRE}.
FT   HELIX       138    147       {ECO:0000244|PDB:4KRE}.
FT   HELIX       154    171       {ECO:0000244|PDB:4KRE}.
FT   STRAND      172    175       {ECO:0000244|PDB:4KRE}.
FT   STRAND      178    180       {ECO:0000244|PDB:4KRE}.
FT   STRAND      189    191       {ECO:0000244|PDB:4KRE}.
FT   STRAND      194    206       {ECO:0000244|PDB:4KRE}.
FT   STRAND      208    223       {ECO:0000244|PDB:4KRE}.
FT   HELIX       228    236       {ECO:0000244|PDB:4KRE}.
FT   TURN        241    243       {ECO:0000244|PDB:1SI2}.
FT   HELIX       250    260       {ECO:0000244|PDB:4KRE}.
FT   STRAND      264    268       {ECO:0000244|PDB:4KRE}.
FT   TURN        269    272       {ECO:0000244|PDB:1SI2}.
FT   STRAND      276    286       {ECO:0000244|PDB:4KRE}.
FT   TURN        287    289       {ECO:0000244|PDB:4KRE}.
FT   STRAND      291    295       {ECO:0000244|PDB:4KRE}.
FT   STRAND      301    305       {ECO:0000244|PDB:4KRE}.
FT   HELIX       306    314       {ECO:0000244|PDB:4KRE}.
FT   STRAND      323    328       {ECO:0000244|PDB:4KRE}.
FT   HELIX       331    333       {ECO:0000244|PDB:1SI2}.
FT   STRAND      335    338       {ECO:0000244|PDB:4KRE}.
FT   HELIX       339    341       {ECO:0000244|PDB:4KRE}.
FT   STRAND      342    344       {ECO:0000244|PDB:4KRE}.
FT   HELIX       356    366       {ECO:0000244|PDB:4KRE}.
FT   HELIX       370    384       {ECO:0000244|PDB:4KRE}.
FT   HELIX       386    388       {ECO:0000244|PDB:4KRE}.
FT   HELIX       390    394       {ECO:0000244|PDB:4KRE}.
FT   STRAND      404    410       {ECO:0000244|PDB:4KRE}.
FT   TURN        420    423       {ECO:0000244|PDB:4KRE}.
FT   STRAND      448    453       {ECO:0000244|PDB:4KRE}.
FT   TURN        457    459       {ECO:0000244|PDB:4KRE}.
FT   HELIX       462    478       {ECO:0000244|PDB:4KRE}.
FT   STRAND      488    492       {ECO:0000244|PDB:4KRE}.
FT   HELIX       496    498       {ECO:0000244|PDB:4KRE}.
FT   HELIX       499    509       {ECO:0000244|PDB:4KRE}.
FT   STRAND      515    520       {ECO:0000244|PDB:4KRE}.
FT   HELIX       526    535       {ECO:0000244|PDB:4KRE}.
FT   TURN        536    538       {ECO:0000244|PDB:4KRE}.
FT   STRAND      542    546       {ECO:0000244|PDB:4KRE}.
FT   HELIX       547    551       {ECO:0000244|PDB:4KRE}.
FT   HELIX       555    568       {ECO:0000244|PDB:4KRE}.
FT   HELIX       578    580       {ECO:0000244|PDB:4KRE}.
FT   HELIX       583    586       {ECO:0000244|PDB:4KRE}.
FT   STRAND      589    597       {ECO:0000244|PDB:4KRE}.
FT   STRAND      608    615       {ECO:0000244|PDB:4KRE}.
FT   STRAND      617    620       {ECO:0000244|PDB:4KRE}.
FT   STRAND      623    631       {ECO:0000244|PDB:4KRE}.
FT   HELIX       640    655       {ECO:0000244|PDB:4KRE}.
FT   STRAND      660    666       {ECO:0000244|PDB:4KRE}.
FT   HELIX       671    673       {ECO:0000244|PDB:4KRF}.
FT   HELIX       674    692       {ECO:0000244|PDB:4KRE}.
FT   STRAND      699    706       {ECO:0000244|PDB:4KRE}.
FT   STRAND      713    717       {ECO:0000244|PDB:4KRE}.
FT   HELIX       718    720       {ECO:0000244|PDB:4KRE}.
FT   TURN        723    726       {ECO:0000244|PDB:4KRE}.
FT   STRAND      732    734       {ECO:0000244|PDB:4KRE}.
FT   STRAND      736    739       {ECO:0000244|PDB:4KRE}.
FT   STRAND      741    743       {ECO:0000244|PDB:4KRE}.
FT   STRAND      745    749       {ECO:0000244|PDB:4KRE}.
FT   STRAND      755    757       {ECO:0000244|PDB:4KRE}.
FT   STRAND      761    768       {ECO:0000244|PDB:4KRE}.
FT   HELIX       774    784       {ECO:0000244|PDB:4KRE}.
FT   STRAND      791    793       {ECO:0000244|PDB:5W6V}.
FT   HELIX       799    814       {ECO:0000244|PDB:4KRE}.
FT   HELIX       837    843       {ECO:0000244|PDB:4KRE}.
FT   HELIX       848    851       {ECO:0000244|PDB:4KRE}.
SQ   SEQUENCE   857 AA;  97214 MW;  1DBB524AE7CBAF66 CRC64;
     MEAGPSGAAA GAYLPPLQQV FQAPRRPGIG TVGKPIKLLA NYFEVDIPKI DVYHYEVDIK
     PDKCPRRVNR EVVEYMVQHF KPQIFGDRKP VYDGKKNIYT VTALPIGNER VDFEVTIPGE
     GKDRIFKVSI KWLAIVSWRM LHEALVSGQI PVPLESVQAL DVAMRHLASM RYTPVGRSFF
     SPPEGYYHPL GGGREVWFGF HQSVRPAMWK MMLNIDVSAT AFYKAQPVIE FMCEVLDIRN
     IDEQPKPLTD SQRVRFTKEI KGLKVEVTHC GQMKRKYRVC NVTRRPASHQ TFPLQLESGQ
     TVECTVAQYF KQKYNLQLKY PHLPCLQVGQ EQKHTYLPLE VCNIVAGQRC IKKLTDNQTS
     TMIKATARSA PDRQEEISRL MKNASYNLDP YIQEFGIKVK DDMTEVTGRV LPAPILQYGG
     RNRAIATPNQ GVWDMRGKQF YNGIEIKVWA IACFAPQKQC REEVLKNFTD QLRKISKDAG
     MPIQGQPCFC KYAQGADSVE PMFRHLKNTY SGLQLIIVIL PGKTPVYAEV KRVGDTLLGM
     ATQCVQVKNV VKTSPQTLSN LCLKINVKLG GINNILVPHQ RSAVFQQPVI FLGADVTHPP
     AGDGKKPSIT AVVGSMDAHP SRYCATVRVQ RPRQEIIEDL SYMVRELLIQ FYKSTRFKPT
     RIIFYRDGVP EGQLPQILHY ELLAIRDACI KLEKDYQPGI TYIVVQKRHH TRLFCADKNE
     RIGKSGNIPA GTTVDTNITH PFEFDFYLCS HAGIQGTSRP SHYYVLWDDN RFTADELQIL
     TYQLCHTYVR CTRSVSIPAP AYYARLVAFR ARYHLVDKEH DSGEGSHISG QSNGRDPQAL
     AKAVQVHQDT LRTMYFA
//
ID   TERA_HUMAN              Reviewed;         806 AA.
AC   P55072; B2R5T8; Q0V924; Q2TAI5; Q969G7; Q9UCD5;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   23-MAY-2018, entry version 201.
DE   RecName: Full=Transitional endoplasmic reticulum ATPase;
DE            Short=TER ATPase;
DE            EC=3.6.4.6 {ECO:0000269|PubMed:26471729};
DE   AltName: Full=15S Mg(2+)-ATPase p97 subunit;
DE   AltName: Full=Valosin-containing protein;
DE            Short=VCP;
GN   Name=VCP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Lamerdin J.E., McCready P.M., Skowronski E., Adamson A.W.,
RA   Burkhart-Schultz K., Gordon L., Kyle A., Ramirez M., Stilwagen S.,
RA   Phan H., Velasco N., Garnes J., Danganan L., Poundstone P.,
RA   Christensen M., Georgescu A., Avila J., Liu S., Attix C., Andreise T.,
RA   Trankheim M., Amico-Keller G., Coefield J., Duarte S., Lucas S.,
RA   Bruce R., Thomas P., Quan G., Kronmiller B., Arellano A.,
RA   Montgomery M., Ow D., Nolan M., Trong S., Kobayashi A., Olsen A.O.,
RA   Carrano A.V.;
RT   "Sequence analysis of a human P1 clone containing the XRCC9 DNA repair
RT   gene.";
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pituitary;
RX   PubMed=10931946; DOI=10.1073/pnas.160270997;
RA   Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X.,
RA   Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H.,
RA   Gu B.-W., Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M., Zhou J.,
RA   Xu S.-H., Gu J., Shi J.-X., Jin W.-R., Zhang C.-K., Wu T.-M.,
RA   Huang G.-Y., Chen Z., Chen M.-D., Chen J.-L.;
RT   "Gene expression profiling in the human hypothalamus-pituitary-adrenal
RT   axis and full-length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-25.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-18; 148-155; 278-287; 296-312; 366-377; 466-487;
RP   587-599; 639-651 AND 669-677, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Platelet;
RA   Bienvenut W.V., Claeys D.;
RL   Submitted (NOV-2005) to UniProtKB.
RN   [9]
RP   PROTEIN SEQUENCE OF 27-41 AND 233-238, AND INTERACTION WITH CLATHRIN.
RC   TISSUE=Glial tumor;
RX   PubMed=8413590; DOI=10.1038/365459a0;
RA   Pleasure I.T., Black M.M., Keen J.H.;
RT   "Valosin-containing protein, VCP, is a ubiquitous clathrin-binding
RT   protein.";
RL   Nature 365:459-462(1993).
RN   [10]
RP   PROTEIN SEQUENCE OF 46-53; 66-81; 96-109; 148-155; 240-251; 323-336;
RP   454-502; 530-560; 600-614; 639-651; 678-693; 714-732 AND 754-766, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [11]
RP   PROTEIN SEQUENCE OF 314-322, IDENTIFICATION BY MASS SPECTROMETRY,
RP   METHYLATION AT LYS-315, MUTAGENESIS OF LYS-315, CHARACTERIZATION OF
RP   VARIANTS IBMPFD1 HIS-155 AND GLN-191, AND CHARACTERIZATION OF VARIANT
RP   ALS14 GLY-159.
RX   PubMed=23349634; DOI=10.1371/journal.pgen.1003210;
RA   Cloutier P., Lavallee-Adam M., Faubert D., Blanchette M., Coulombe B.;
RT   "A newly uncovered group of distantly related lysine
RT   methyltransferases preferentially interact with molecular chaperones
RT   to regulate their activity.";
RL   PLoS Genet. 9:E1003210-E1003210(2013).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 388-483.
RC   TISSUE=Fetal brain;
RA   Dmitrenko V.V., Garifulin O.M., Kavsan V.M.;
RT   "Characterization of different mRNA types expressed in human brain.";
RL   Submitted (APR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   INTERACTION WITH NGLY1.
RX   PubMed=15362974; DOI=10.1042/BJ20041498;
RA   McNeill H., Knebel A., Arthur J.S., Cuenda A., Cohen P.;
RT   "A novel UBA and UBX domain protein that binds polyubiquitin and VCP
RT   and is a substrate for SAPKs.";
RL   Biochem. J. 384:391-400(2004).
RN   [14]
RP   FUNCTION, INTERACTION WITH RNF19A, IDENTIFICATION BY MASS
RP   SPECTROMETRY, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-524.
RX   PubMed=15456787; DOI=10.1074/jbc.M406683200;
RA   Ishigaki S., Hishikawa N., Niwa J., Iemura S., Natsume T., Hori S.,
RA   Kakizuka A., Tanaka K., Sobue G.;
RT   "Physical and functional interaction between dorfin and valosin-
RT   containing protein that are colocalized in ubiquitylated inclusions in
RT   neurodegenerative disorders.";
RL   J. Biol. Chem. 279:51376-51385(2004).
RN   [15]
RP   INTERACTION WITH SELENOS, AND SUBCELLULAR LOCATION.
RX   PubMed=15215856; DOI=10.1038/nature02656;
RA   Ye Y., Shibata Y., Yun C., Ron D., Rapoport T.A.;
RT   "A membrane protein complex mediates retro-translocation from the ER
RT   lumen into the cytosol.";
RL   Nature 429:841-847(2004).
RN   [16]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [17]
RP   INTERACTION WITH SYVN1 AND DERL1.
RX   PubMed=16289116; DOI=10.1016/j.jmb.2005.10.020;
RA   Schulze A., Standera S., Buerger E., Kikkert M., van Voorden S.,
RA   Wiertz E., Koning F., Kloetzel P.-M., Seeger M.;
RT   "The ubiquitin-domain protein HERP forms a complex with components of
RT   the endoplasmic reticulum associated degradation pathway.";
RL   J. Mol. Biol. 354:1021-1027(2005).
RN   [18]
RP   INTERACTION WITH AMFR, FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS
RP   OF LYS-251 AND LYS-524.
RX   PubMed=16168377; DOI=10.1016/j.molcel.2005.08.009;
RA   Song B.L., Sever N., DeBose-Boyd R.A.;
RT   "Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1
RT   and couples sterol-regulated ubiquitination to degradation of HMG CoA
RT   reductase.";
RL   Mol. Cell 19:829-840(2005).
RN   [19]
RP   FUNCTION, AND INTERACTION WITH DERL1; AMFR; SYVN1 AND SELENOS.
RX   PubMed=16186510; DOI=10.1073/pnas.0505006102;
RA   Ye Y., Shibata Y., Kikkert M., van Voorden S., Wiertz E.,
RA   Rapoport T.A.;
RT   "Recruitment of the p97 ATPase and ubiquitin ligases to the site of
RT   retrotranslocation at the endoplasmic reticulum membrane.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:14132-14138(2005).
RN   [20]
RP   INTERACTION WITH DERL1 AND DERL2.
RX   PubMed=16186509; DOI=10.1073/pnas.0505014102;
RA   Lilley B.N., Ploegh H.L.;
RT   "Multiprotein complexes that link dislocation, ubiquitination, and
RT   extraction of misfolded proteins from the endoplasmic reticulum
RT   membrane.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:14296-14301(2005).
RN   [21]
RP   INTERACTION WITH CASR AND RNF19A.
RX   PubMed=16513638; DOI=10.1074/jbc.M513552200;
RA   Huang Y., Niwa J., Sobue G., Breitwieser G.E.;
RT   "Calcium-sensing receptor ubiquitination and degradation mediated by
RT   the E3 ubiquitin ligase dorfin.";
RL   J. Biol. Chem. 281:11610-11617(2006).
RN   [22]
RP   INTERACTION WITH DERL1; DERL2 AND DERL3.
RX   PubMed=16449189; DOI=10.1083/jcb.200507057;
RA   Oda Y., Okada T., Yoshida H., Kaufman R.J., Nagata K., Mori K.;
RT   "Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein
RT   response and are required for ER-associated degradation.";
RL   J. Cell Biol. 172:383-393(2006).
RN   [23]
RP   INTERACTION WITH UBXN4.
RX   PubMed=16968747; DOI=10.1242/jcs.03163;
RA   Liang J., Yin C., Doong H., Fang S., Peterhoff C., Nixon R.A.,
RA   Monteiro M.J.;
RT   "Characterization of erasin (UBXD2): a new ER protein that promotes
RT   ER-associated protein degradation.";
RL   J. Cell Sci. 119:4011-4024(2006).
RN   [24]
RP   INTERACTION WITH TRIM13.
RX   PubMed=17314412; DOI=10.1091/mbc.E06-03-0248;
RA   Lerner M., Corcoran M., Cepeda D., Nielsen M.L., Zubarev R.,
RA   Ponten F., Uhlen M., Hober S., Grander D., Sangfelt O.;
RT   "The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin
RT   ligase involved in ERAD.";
RL   Mol. Biol. Cell 18:1670-1682(2007).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [26]
RP   INTERACTION WITH RNF103.
RX   PubMed=18675248; DOI=10.1016/j.bbrc.2008.07.126;
RA   Maruyama Y., Yamada M., Takahashi K., Yamada M.;
RT   "Ubiquitin ligase Kf-1 is involved in the endoplasmic reticulum-
RT   associated degradation pathway.";
RL   Biochem. Biophys. Res. Commun. 374:737-741(2008).
RN   [27]
RP   INTERACTION WITH UBXN6.
RX   PubMed=18656546; DOI=10.1016/j.biocel.2008.06.008;
RA   Madsen L., Andersen K.M., Prag S., Moos T., Semple C.A., Seeger M.,
RA   Hartmann-Petersen R.;
RT   "Ubxd1 is a novel co-factor of the human p97 ATPase.";
RL   Int. J. Biochem. Cell Biol. 40:2927-2942(2008).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; THR-436 AND SER-787,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [29]
RP   INTERACTION WITH TRIM21.
RX   PubMed=18022694; DOI=10.1016/j.molimm.2007.10.023;
RA   Takahata M., Bohgaki M., Tsukiyama T., Kondo T., Asaka M.,
RA   Hatakeyama S.;
RT   "Ro52 functionally interacts with IgG1 and regulates its quality
RT   control via the ERAD system.";
RL   Mol. Immunol. 45:2045-2054(2008).
RN   [30]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [31]
RP   INTERACTION WITH UBXN6.
RX   PubMed=19174149; DOI=10.1016/j.bbrc.2009.01.076;
RA   Kern M., Fernandez-Saiz V., Schaefer Z., Buchberger A.;
RT   "UBXD1 binds p97 through two independent binding sites.";
RL   Biochem. Biophys. Res. Commun. 380:303-307(2009).
RN   [32]
RP   INTERACTION WITH UBXN6.
RX   PubMed=19275885; DOI=10.1016/j.bbrc.2009.03.012;
RA   Nagahama M., Ohnishi M., Kawate Y., Matsui T., Miyake H., Yuasa K.,
RA   Tani K., Tagaya M., Tsuji A.;
RT   "UBXD1 is a VCP-interacting protein that is involved in ER-associated
RT   degradation.";
RL   Biochem. Biophys. Res. Commun. 382:303-308(2009).
RN   [33]
RP   INTERACTION WITH UBXN4, AND IDENTIFICATION IN A COMPLEX WITH UBQLN1
RP   AND UBXN4.
RX   PubMed=19822669; DOI=10.1083/jcb.200903024;
RA   Lim P.J., Danner R., Liang J., Doong H., Harman C., Srinivasan D.,
RA   Rothenberg C., Wang H., Ye Y., Fang S., Monteiro M.J.;
RT   "Ubiquilin and p97/VCP bind erasin, forming a complex involved in
RT   ERAD.";
RL   J. Cell Biol. 187:201-217(2009).
RN   [34]
RP   INTERACTION WITH YOD1.
RX   PubMed=19818707; DOI=10.1016/j.molcel.2009.09.016;
RA   Ernst R., Mueller B., Ploegh H.L., Schlieker C.;
RT   "The otubain YOD1 is a deubiquitinating enzyme that associates with
RT   p97 to facilitate protein dislocation from the ER.";
RL   Mol. Cell 36:28-38(2009).
RN   [35]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-3 AND SER-37, CLEAVAGE OF INITIATOR METHIONINE
RP   [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-770 AND SER-775, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [37]
RP   INTERACTION WITH WASHC5.
RX   PubMed=20833645; DOI=10.1093/brain/awq222;
RA   Clemen C.S., Tangavelou K., Strucksberg K.H., Just S., Gaertner L.,
RA   Regus-Leidig H., Stumpf M., Reimann J., Coras R., Morgan R.O.,
RA   Fernandez M.P., Hofmann A., Muller S., Schoser B., Hanisch F.G.,
RA   Rottbauer W., Blumcke I., von Horsten S., Eichinger L., Schroder R.;
RT   "Strumpellin is a novel valosin-containing protein binding partner
RT   linking hereditary spastic paraplegia to protein aggregation
RT   diseases.";
RL   Brain 133:2920-2941(2010).
RN   [38]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [39]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [40]
RP   FUNCTION IN OMM PROTEIN TURNOVER.
RX   PubMed=21118995; DOI=10.1091/mbc.E10-09-0748;
RA   Xu S., Peng G., Wang Y., Fang S., Karbowski M.;
RT   "The AAA-ATPase p97 is essential for outer mitochondrial membrane
RT   protein turnover.";
RL   Mol. Biol. Cell 22:291-300(2011).
RN   [41]
RP   INTERACTION WITH BAG6.
RX   PubMed=21636303; DOI=10.1016/j.molcel.2011.05.010;
RA   Wang Q., Liu Y., Soetandyo N., Baek K., Hegde R., Ye Y.;
RT   "A ubiquitin ligase-associated chaperone holdase maintains
RT   polypeptides in soluble states for proteasome degradation.";
RL   Mol. Cell 42:758-770(2011).
RN   [42]
RP   FUNCTION, INTERACTION WITH CAV1 AND UBXN6, CHARACTERIZATION OF
RP   VARIANTS IBMPFD1 GLY-95; HIS-155 AND GLU-232, AND MUTAGENESIS OF
RP   GLU-578.
RX   PubMed=21822278; DOI=10.1038/ncb2301;
RA   Ritz D., Vuk M., Kirchner P., Bug M., Schuetz S., Hayer A., Bremer S.,
RA   Lusk C., Baloh R.H., Lee H., Glatter T., Gstaiger M., Aebersold R.,
RA   Weihl C.C., Meyer H.;
RT   "Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP
RT   and UBXD1 and impaired by VCP disease mutations.";
RL   Nat. Cell Biol. 13:1116-1123(2011).
RN   [43]
RP   FUNCTION.
RX   PubMed=22020440; DOI=10.1038/ncb2367;
RA   Meerang M., Ritz D., Paliwal S., Garajova Z., Bosshard M., Mailand N.,
RA   Janscak P., Hubscher U., Meyer H., Ramadan K.;
RT   "The ubiquitin-selective segregase VCP/p97 orchestrates the response
RT   to DNA double-strand breaks.";
RL   Nat. Cell Biol. 13:1376-1382(2011).
RN   [44]
RP   FUNCTION, INTERACTION WITH L3MBTL1, AND SUBCELLULAR LOCATION.
RX   PubMed=22120668; DOI=10.1038/nsmb.2188;
RA   Acs K., Luijsterburg M.S., Ackermann L., Salomons F.A., Hoppe T.,
RA   Dantuma N.P.;
RT   "The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1
RT   from DNA double-strand breaks.";
RL   Nat. Struct. Mol. Biol. 18:1345-1350(2011).
RN   [45]
RP   INTERACTION WITH UBXN8.
RX   PubMed=21949850; DOI=10.1371/journal.pone.0025061;
RA   Madsen L., Kriegenburg F., Vala A., Best D., Prag S., Hofmann K.,
RA   Seeger M., Adams I.R., Hartmann-Petersen R.;
RT   "The tissue-specific Rep8/UBXD6 tethers p97 to the endoplasmic
RT   reticulum membrane for degradation of misfolded proteins.";
RL   PLoS ONE 6:E25061-E25061(2011).
RN   [46]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-3, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [47]
RP   INTERACTION WITH UBXN7.
RX   PubMed=22537386; DOI=10.1186/1741-7007-10-36;
RA   Bandau S., Knebel A., Gage Z.O., Wood N.T., Alexandru G.;
RT   "UBXN7 docks on neddylated cullin complexes using its UIM motif and
RT   causes HIF1alpha accumulation.";
RL   BMC Biol. 10:36-36(2012).
RN   [48]
RP   INTERACTION WITH RHBDD1, MUTAGENESIS OF LYS-251; LYS-524 AND GLU-578,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=22795130; DOI=10.1016/j.molcel.2012.06.008;
RA   Fleig L., Bergbold N., Sahasrabudhe P., Geiger B., Kaltak L.,
RA   Lemberg M.K.;
RT   "Ubiquitin-dependent intramembrane rhomboid protease promotes ERAD of
RT   membrane proteins.";
RL   Mol. Cell 47:558-569(2012).
RN   [49]
RP   INTERACTION WITH SPRTN.
RX   PubMed=22902628; DOI=10.1074/jbc.M112.400135;
RA   Ghosal G., Leung J.W., Nair B.C., Fong K.W., Chen J.;
RT   "Proliferating cell nuclear antigen (PCNA)-binding protein C1orf124 is
RT   a regulator of translesion synthesis.";
RL   J. Biol. Chem. 287:34225-34233(2012).
RN   [50]
RP   FUNCTION IN ERAD PATHWAY.
RX   PubMed=22607976; DOI=10.1016/j.molcel.2012.04.015;
RA   Sato T., Sako Y., Sho M., Momohara M., Suico M.A., Shuto T.,
RA   Nishitoh H., Okiyoneda T., Kokame K., Kaneko M., Taura M., Miyata M.,
RA   Chosa K., Koga T., Morino-Koga S., Wada I., Kai H.;
RT   "STT3B-dependent posttranslational N-glycosylation as a surveillance
RT   system for secretory protein.";
RL   Mol. Cell 47:99-110(2012).
RN   [51]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [52]
RP   METHYLATION AT LYS-315, AND MUTAGENESIS OF LYS-312; ARG-313; GLU-314;
RP   LYS-315; THR-316; HIS-317 AND GLY-318.
RX   PubMed=22948820; DOI=10.1038/ncomms2041;
RA   Kernstock S., Davydova E., Jakobsson M., Moen A., Pettersen S.,
RA   Maelandsmo G.M., Egge-Jacobsen W., Falnes P.O.;
RT   "Lysine methylation of VCP by a member of a novel human protein
RT   methyltransferase family.";
RL   Nat. Commun. 3:1038-1038(2012).
RN   [53]
RP   FUNCTION, AND INTERACTION WITH SPRTN.
RX   PubMed=23042607; DOI=10.1038/nsmb.2394;
RA   Davis E.J., Lachaud C., Appleton P., Macartney T.J., Nathke I.,
RA   Rouse J.;
RT   "DVC1 (C1orf124) recruits the p97 protein segregase to sites of DNA
RT   damage.";
RL   Nat. Struct. Mol. Biol. 19:1093-1100(2012).
RN   [54]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH SPRTN.
RX   PubMed=23042605; DOI=10.1038/nsmb.2395;
RA   Mosbech A., Gibbs-Seymour I., Kagias K., Thorslund T., Beli P.,
RA   Povlsen L., Nielsen S.V., Smedegaard S., Sedgwick G., Lukas C.,
RA   Hartmann-Petersen R., Lukas J., Choudhary C., Pocock R.,
RA   Bekker-Jensen S., Mailand N.;
RT   "DVC1 (C1orf124) is a DNA damage-targeting p97 adaptor that promotes
RT   ubiquitin-dependent responses to replication blocks.";
RL   Nat. Struct. Mol. Biol. 19:1084-1092(2012).
RN   [55]
RP   FUNCTION.
RX   PubMed=23335559; DOI=10.1074/jbc.M112.429076;
RA   Kirchner P., Bug M., Meyer H.;
RT   "Ubiquitination of the N-terminal region of caveolin-1 regulates
RT   endosomal sorting by the VCP/p97 AAA-ATPase.";
RL   J. Biol. Chem. 288:7363-7372(2013).
RN   [56]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-7; SER-13;
RP   SER-462 AND SER-702, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [57]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [58]
RP   INTERACTION WITH RNF31.
RX   PubMed=24726327; DOI=10.1016/j.molcel.2014.03.016;
RA   Schaeffer V., Akutsu M., Olma M.H., Gomes L.C., Kawasaki M., Dikic I.;
RT   "Binding of OTULIN to the PUB domain of HOIP controls NF-kappaB
RT   signaling.";
RL   Mol. Cell 54:349-361(2014).
RN   [59]
RP   FUNCTION.
RX   PubMed=26565908; DOI=10.1016/j.celrep.2015.09.047;
RA   Kadowaki H., Nagai A., Maruyama T., Takami Y., Satrimafitrah P.,
RA   Kato H., Honda A., Hatta T., Natsume T., Sato T., Kai H., Ichijo H.,
RA   Nishitoh H.;
RT   "Pre-emptive quality control protects the ER from protein overload via
RT   the proximity of ERAD components and SRP.";
RL   Cell Rep. 13:944-956(2015).
RN   [60]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH DDX58 AND RNF125, AND
RP   MUTAGENESIS OF 52-PHE--ASP-55; TYR-110; GLU-305 AND GLU-578.
RX   PubMed=26471729; DOI=10.15252/embj.201591888;
RA   Hao Q., Jiao S., Shi Z., Li C., Meng X., Zhang Z., Wang Y., Song X.,
RA   Wang W., Zhang R., Zhao Y., Wong C.C., Zhou Z.;
RT   "A non-canonical role of the p97 complex in RIG-I antiviral
RT   signaling.";
RL   EMBO J. 34:2903-2920(2015).
RN   [61]
RP   INTERACTION WITH UBXN10.
RX   PubMed=26389662; DOI=10.1038/ncb3238;
RA   Raman M., Sergeev M., Garnaas M., Lydeard J.R., Huttlin E.L.,
RA   Goessling W., Shah J.V., Harper J.W.;
RT   "Systematic proteomics of the VCP-UBXD adaptor network identifies a
RT   role for UBXN10 in regulating ciliogenesis.";
RL   Nat. Cell Biol. 17:1356-1369(2015).
RN   [62]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [63]
RP   INTERACTION WITH FAF1, AND SUBCELLULAR LOCATION.
RX   PubMed=26842564; DOI=10.1038/ncomms10612;
RA   Franz A., Pirson P.A., Pilger D., Halder S., Achuthankutty D.,
RA   Kashkar H., Ramadan K., Hoppe T.;
RT   "Chromatin-associated degradation is defined by UBXN-3/FAF1 to
RT   safeguard DNA replication fork progression.";
RL   Nat. Commun. 7:10612-10612(2016).
RN   [64]
RP   INTERACTION WITH ANKZF1.
RX   PubMed=28302725; DOI=10.1074/jbc.M116.772038;
RA   van Haaften-Visser D.Y., Harakalova M., Mocholi E.,
RA   van Montfrans J.M., Elkadri A., Rieter E., Fiedler K.,
RA   van Hasselt P.M., Triffaux E.M.M., van Haelst M.M., Nijman I.J.,
RA   Kloosterman W.P., Nieuwenhuis E.E.S., Muise A.M., Cuppen E.,
RA   Houwen R.H.J., Coffer P.J.;
RT   "Ankyrin repeat and zinc-finger domain-containing 1 mutations are
RT   associated with infantile-onset inflammatory bowel disease.";
RL   J. Biol. Chem. 292:7904-7920(2017).
RN   [65]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-8 AND LYS-18, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [66]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-481 IN COMPLEX WITH ATP
RP   ANALOG, CHARACTERIZATION OF VARIANTS IBMPFD1 GLY-95 AND HIS-155,
RP   MUTAGENESIS OF ARG-53 AND ARG-86, AND SUBUNIT.
RX   PubMed=20512113; DOI=10.1038/emboj.2010.104;
RA   Tang W.K., Li D., Li C.C., Esser L., Dai R., Guo L., Xia D.;
RT   "A novel ATP-dependent conformation in p97 N-D1 fragment revealed by
RT   crystal structures of disease-related mutants.";
RL   EMBO J. 29:2217-2229(2010).
RN   [67]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 797-806 IN COMPLEX WITH PLAA.
RX   PubMed=19887378; DOI=10.1074/jbc.M109.044685;
RA   Qiu L., Pashkova N., Walker J.R., Winistorfer S., Allali-Hassani A.,
RA   Akutsu M., Piper R., Dhe-Paganon S.;
RT   "Structure and function of the PLAA/Ufd3-p97/Cdc48 complex.";
RL   J. Biol. Chem. 285:365-372(2010).
RN   [68]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-187 IN COMPLEX WITH AMFR.
RX   PubMed=21914798; DOI=10.1074/jbc.M111.274506;
RA   Hanzelmann P., Schindelin H.;
RT   "The structural and functional basis of the p97/valosin-containing
RT   protein (VCP)-interacting motif (VIM): mutually exclusive binding of
RT   cofactors to the N-terminal domain of p97.";
RL   J. Biol. Chem. 286:38679-38690(2011).
RN   [69]
RP   VARIANTS IBMPFD1 GLY-95; CYS-155; HIS-155; PRO-155; GLN-191 AND
RP   GLU-232.
RX   PubMed=15034582; DOI=10.1038/ng1332;
RA   Watts G.D.J., Wymer J., Kovach M.J., Mehta S.G., Mumm S., Darvish D.,
RA   Pestronk A., Whyte M.P., Kimonis V.E.;
RT   "Inclusion body myopathy associated with Paget disease of bone and
RT   frontotemporal dementia is caused by mutant valosin-containing
RT   protein.";
RL   Nat. Genet. 36:377-381(2004).
RN   [70]
RP   VARIANT IBMPFD1 CYS-155.
RX   PubMed=15732117; DOI=10.1002/ana.20407;
RA   Schroeder R., Watts G.D.J., Mehta S.G., Evert B.O., Broich P.,
RA   Fliessbach K., Pauls K., Hans V.H., Kimonis V., Thal D.R.;
RT   "Mutant valosin-containing protein causes a novel type of
RT   frontotemporal dementia.";
RL   Ann. Neurol. 57:457-461(2005).
RN   [71]
RP   VARIANT IBMPFD1 HIS-159.
RX   PubMed=16247064; DOI=10.1212/01.wnl.0000180407.15369.92;
RA   Haubenberger D., Bittner R.E., Rauch-Shorny S., Zimprich F.,
RA   Mannhalter C., Wagner L., Mineva I., Vass K., Auff E., Zimprich A.;
RT   "Inclusion body myopathy and Paget disease is linked to a novel
RT   mutation in the VCP gene.";
RL   Neurology 65:1304-1305(2005).
RN   [72]
RP   CHARACTERIZATION OF VARIANTS IBMPFD1 GLY-95 AND HIS-155.
RX   PubMed=16321991; DOI=10.1093/hmg/ddi426;
RA   Weihl C.C., Dalal S., Pestronk A., Hanson P.I.;
RT   "Inclusion body myopathy-associated mutations in p97/VCP impair
RT   endoplasmic reticulum-associated degradation.";
RL   Hum. Mol. Genet. 15:189-199(2006).
RN   [73]
RP   VARIANTS IBMPFD1 TRP-198 AND HIS-387.
RX   PubMed=17935506; DOI=10.1111/j.1399-0004.2007.00887.x;
RA   Watts G.D., Thomasova D., Ramdeen S.K., Fulchiero E.C., Mehta S.G.,
RA   Drachman D.A., Weihl C.C., Jamrozik Z., Kwiecinski H., Kaminska A.,
RA   Kimonis V.E.;
RT   "Novel VCP mutations in inclusion body myopathy associated with Paget
RT   disease of bone and frontotemporal dementia.";
RL   Clin. Genet. 72:420-426(2007).
RN   [74]
RP   CHARACTERIZATION OF VARIANTS IBMPFD1 HIS-155; SER-155 AND GLU-232,
RP   MUTAGENESIS OF GLU-305 AND GLU-578, AND FUNCTION.
RX   PubMed=20104022; DOI=10.4161/auto.6.2.11014;
RA   Tresse E., Salomons F.A., Vesa J., Bott L.C., Kimonis V., Yao T.P.,
RA   Dantuma N.P., Taylor J.P.;
RT   "VCP/p97 is essential for maturation of ubiquitin-containing
RT   autophagosomes and this function is impaired by mutations that cause
RT   IBMPFD.";
RL   Autophagy 6:217-227(2010).
RN   [75]
RP   VARIANTS IBMPFD1 LEU-155 AND TRP-198.
RX   PubMed=20335036; DOI=10.1016/j.nmd.2010.03.002;
RA   Kumar K.R., Needham M., Mina K., Davis M., Brewer J., Staples C.,
RA   Ng K., Sue C.M., Mastaglia F.L.;
RT   "Two Australian families with inclusion-body myopathy, Paget's disease
RT   of bone and frontotemporal dementia: novel clinical and genetic
RT   findings.";
RL   Neuromuscul. Disord. 20:330-334(2010).
RN   [76]
RP   VARIANTS ALS14 HIS-155; GLY-159; GLN-191 AND ASN-592.
RX   PubMed=21145000; DOI=10.1016/j.neuron.2010.11.036;
RA   Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M.,
RA   Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., Ding J.,
RA   McCluskey L., Martinez-Lage M., Falcone D., Hernandez D.G.,
RA   Arepalli S., Chong S., Schymick J.C., Rothstein J., Landi F.,
RA   Wang Y.D., Calvo A., Mora G., Sabatelli M., Monsurro M.R.,
RA   Battistini S., Salvi F., Spataro R., Sola P., Borghero G., Galassi G.,
RA   Scholz S.W., Taylor J.P., Restagno G., Chio A., Traynor B.J.;
RT   "Exome sequencing reveals VCP mutations as a cause of familial ALS.";
RL   Neuron 68:857-864(2010).
RN   [77]
RP   VARIANT CMT2Y LYS-185, CHARACTERIZATION OF VARIANT CMT2Y LYS-185, AND
RP   CHARACTERIZATION OF VARIANTS IBMPFD1 HIS-155 AND GLU-232.
RX   PubMed=25125609; DOI=10.1093/brain/awu224;
RA   Gonzalez M.A., Feely S.M., Speziani F., Strickland A.V., Danzi M.,
RA   Bacon C., Lee Y., Chou T.F., Blanton S.H., Weihl C.C., Zuchner S.,
RA   Shy M.E.;
RT   "A novel mutation in VCP causes Charcot-Marie-Tooth Type 2 disease.";
RL   Brain 137:2897-2902(2014).
RN   [78]
RP   VARIANT CMT2Y GLU-97, CHARACTERIZATION OF VARIANT CMT2Y GLU-97, AND
RP   CHARACTERIZATION OF VARIANTS IBMPFD1 HIS-155; TRP-198 AND GLU-232.
RX   PubMed=25878907; DOI=10.1155/2015/239167;
RA   Jerath N.U., Crockett C.D., Moore S.A., Shy M.E., Weihl C.C.,
RA   Chou T.F., Grider T., Gonzalez M.A., Zuchner S., Swenson A.;
RT   "Rare Manifestation of a c.290 C>T, p.Gly97Glu VCP Mutation.";
RL   Case. Rep. Genet. 2015:239167-239167(2015).
RN   [79]
RP   VARIANT IBMPFD1 PHE-126.
RX   PubMed=27209344; DOI=10.1016/j.nmd.2016.05.001;
RA   Matsubara S., Shimizu T., Komori T., Mori-Yoshimura M., Minami N.,
RA   Hayashi Y.K.;
RT   "Nuclear inclusions mimicking poly(A)-binding protein nuclear 1
RT   inclusions in a case of inclusion body myopathy associated with Paget
RT   disease of bone and frontotemporal dementia with a novel mutation in
RT   the valosin-containing protein gene.";
RL   Neuromuscul. Disord. 26:436-440(2016).
RN   [80]
RP   FUNCTION, INTERACTION WITH PLAA; UBXN6 AND YOD1, SUBCELLULAR LOCATION,
RP   CHARACTERIZATION OF VARIANTS IBMPFD1 HIS-155; TRP-198 AND GLU-232, AND
RP   MUTAGENESIS OF GLU-578.
RX   PubMed=27753622; DOI=10.15252/embj.201695148;
RA   Papadopoulos C., Kirchner P., Bug M., Grum D., Koerver L., Schulze N.,
RA   Poehler R., Dressler A., Fengler S., Arhzaouy K., Lux V., Ehrmann M.,
RA   Weihl C.C., Meyer H.;
RT   "VCP/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of
RT   ruptured lysosomes by autophagy.";
RL   EMBO J. 36:135-150(2017).
CC   -!- FUNCTION: Necessary for the fragmentation of Golgi stacks during
CC       mitosis and for their reassembly after mitosis. Involved in the
CC       formation of the transitional endoplasmic reticulum (tER). The
CC       transfer of membranes from the endoplasmic reticulum to the Golgi
CC       apparatus occurs via 50-70 nm transition vesicles which derive
CC       from part-rough, part-smooth transitional elements of the
CC       endoplasmic reticulum (tER). Vesicle budding from the tER is an
CC       ATP-dependent process. The ternary complex containing UFD1, VCP
CC       and NPLOC4 binds ubiquitinated proteins and is necessary for the
CC       export of misfolded proteins from the ER to the cytoplasm, where
CC       they are degraded by the proteasome. The NPLOC4-UFD1-VCP complex
CC       regulates spindle disassembly at the end of mitosis and is
CC       necessary for the formation of a closed nuclear envelope.
CC       Regulates E3 ubiquitin-protein ligase activity of RNF19A.
CC       Component of the VCP/p97-AMFR/gp78 complex that participates in
CC       the final step of the sterol-mediated ubiquitination and
CC       endoplasmic reticulum-associated degradation (ERAD) of HMGCR.
CC       Involved in endoplasmic reticulum stress-induced pre-emptive
CC       quality control, a mechanism that selectively attenuates the
CC       translocation of newly synthesized proteins into the endoplasmic
CC       reticulum and reroutes them to the cytosol for proteasomal
CC       degradation (PubMed:26565908). Also involved in DNA damage
CC       response: recruited to double-strand breaks (DSBs) sites in a
CC       RNF8- and RNF168-dependent manner and promotes the recruitment of
CC       TP53BP1 at DNA damage sites (PubMed:22020440, PubMed:22120668).
CC       Recruited to stalled replication forks by SPRTN: may act by
CC       mediating extraction of DNA polymerase eta (POLH) to prevent
CC       excessive translesion DNA synthesis and limit the incidence of
CC       mutations induced by DNA damage (PubMed:23042607,
CC       PubMed:23042605). Required for cytoplasmic retrotranslocation of
CC       stressed/damaged mitochondrial outer-membrane proteins and their
CC       subsequent proteasomal degradation (PubMed:16186510,
CC       PubMed:21118995). Essential for the maturation of ubiquitin-
CC       containing autophagosomes and the clearance of ubiquitinated
CC       protein by autophagy (PubMed:20104022, PubMed:27753622). Acts as a
CC       negative regulator of type I interferon production by interacting
CC       with DDX58/RIG-I: interaction takes place when DDX58/RIG-I is
CC       ubiquitinated via 'Lys-63'-linked ubiquitin on its CARD domains,
CC       leading to recruit RNF125 and promote ubiquitination and
CC       degradation of DDX58/RIG-I (PubMed:26471729). May play a role in
CC       the ubiquitin-dependent sorting of membrane proteins to lysosomes
CC       where they undergo degradation (PubMed:21822278). May more
CC       particularly play a role in caveolins sorting in cells
CC       (PubMed:21822278, PubMed:23335559). {ECO:0000269|PubMed:15456787,
CC       ECO:0000269|PubMed:16168377, ECO:0000269|PubMed:16186510,
CC       ECO:0000269|PubMed:20104022, ECO:0000269|PubMed:21118995,
CC       ECO:0000269|PubMed:21822278, ECO:0000269|PubMed:22020440,
CC       ECO:0000269|PubMed:22120668, ECO:0000269|PubMed:22607976,
CC       ECO:0000269|PubMed:23042605, ECO:0000269|PubMed:23042607,
CC       ECO:0000269|PubMed:23335559, ECO:0000269|PubMed:26471729,
CC       ECO:0000269|PubMed:26565908, ECO:0000269|PubMed:27753622}.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate.
CC       {ECO:0000269|PubMed:26471729}.
CC   -!- SUBUNIT: Homohexamer. Forms a ring-shaped particle of 12.5 nm
CC       diameter, that displays 6-fold radial symmetry. Part of a ternary
CC       complex containing STX5A, NSFL1C and VCP. NSFL1C forms a
CC       homotrimer that binds to one end of a VCP homohexamer. The complex
CC       binds to membranes enriched in phosphatidylethanolamine-containing
CC       lipids and promotes Golgi membrane fusion. Binds to a heterodimer
CC       of NPLOC4 and UFD1, binding to this heterodimer inhibits Golgi-
CC       membrane fusion (PubMed:26471729). Interaction with VCIP135 leads
CC       to dissociation of the complex via ATP hydrolysis by VCP. Part of
CC       a ternary complex containing NPLOC4, UFD1 and VCP. Interacts with
CC       NSFL1C-like protein p37; the complex has membrane fusion activity
CC       and is required for Golgi and endoplasmic reticulum biogenesis.
CC       Interacts with SELENOS and SYVN1, as well as with DERL1, DERL2 and
CC       DERL3; which probably transfer misfolded proteins from the ER to
CC       VCP. Interacts with SVIP. Component of a complex required to
CC       couple retrotranslocation, ubiquitination and deglycosylation
CC       composed of NGLY1, SAKS1, AMFR, VCP and RAD23B. Directly interacts
CC       with UBXN4 and RNF19A. Interacts with CASR. Interacts with UBE4B
CC       and YOD1. Interacts with clathrin. Interacts with RNF103.
CC       Interacts with TRIM13 and TRIM21. Component of a VCP/p97-AMFR/gp78
CC       complex that participates in the final step of the endoplasmic
CC       reticulum-associated degradation (ERAD) of HMGCR. Interacts
CC       directly with AMFR/gp78 (via its VIM). Interacts with RHBDD1 (via
CC       C-terminal domain). Interacts with SPRTN; leading to recruitment
CC       to stalled replication forks (PubMed:23042607, PubMed:23042605).
CC       Interacts with WASHC5. Interacts with UBOX5. Interacts (via N-
CC       terminus) with UBXN7, UBXN8, and probably several other UBX
CC       domain-containing proteins (via UBX domains); the interactions are
CC       mutually exclusive with VIM-dependent interactions such as those
CC       with AMFR and SELENOS. Forms a complex with UBQLN1 and UBXN4.
CC       Interacts (via the PIM motif) with RNF31 (via the PUB domain)
CC       (PubMed:24726327). Interacts with DDX58/RIG-I and RNF125;
CC       interaction takes place when DDX58/RIG-I is ubiquitinated via
CC       'Lys-63'-linked ubiquitin on its CARD domains, leading to recruit
CC       RNF125 and promote ubiquitination and degradation of DDX58/RIG-I
CC       (PubMed:26471729). Interacts with BAG6 (PubMed:21636303).
CC       Interacts with UBXN10 (PubMed:26389662). Interacts with UBXN6; the
CC       interaction with UBXN6 is direct and competitive with UFD1
CC       (PubMed:19174149, PubMed:19275885). Forms a ternary complex with
CC       CAV1 and UBXN6 (PubMed:21822278, PubMed:18656546,
CC       PubMed:19174149). Interacts with PLAA, UBXN6 and YOD1; may form a
CC       complex involved in macroautophagy (PubMed:27753622). Interacts
CC       with ANKZF1 (PubMed:28302725). Interacts with ubiquitin-binding
CC       protein FAF1 (PubMed:26842564). {ECO:0000250|UniProtKB:P46462,
CC       ECO:0000250|UniProtKB:Q01853, ECO:0000269|PubMed:15215856,
CC       ECO:0000269|PubMed:15362974, ECO:0000269|PubMed:15456787,
CC       ECO:0000269|PubMed:16168377, ECO:0000269|PubMed:16186509,
CC       ECO:0000269|PubMed:16186510, ECO:0000269|PubMed:16289116,
CC       ECO:0000269|PubMed:16449189, ECO:0000269|PubMed:16513638,
CC       ECO:0000269|PubMed:16968747, ECO:0000269|PubMed:17314412,
CC       ECO:0000269|PubMed:18022694, ECO:0000269|PubMed:18656546,
CC       ECO:0000269|PubMed:18675248, ECO:0000269|PubMed:19174149,
CC       ECO:0000269|PubMed:19275885, ECO:0000269|PubMed:19818707,
CC       ECO:0000269|PubMed:19822669, ECO:0000269|PubMed:19887378,
CC       ECO:0000269|PubMed:20512113, ECO:0000269|PubMed:20833645,
CC       ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:21822278,
CC       ECO:0000269|PubMed:21914798, ECO:0000269|PubMed:21949850,
CC       ECO:0000269|PubMed:22120668, ECO:0000269|PubMed:22537386,
CC       ECO:0000269|PubMed:22795130, ECO:0000269|PubMed:22902628,
CC       ECO:0000269|PubMed:23042605, ECO:0000269|PubMed:23042607,
CC       ECO:0000269|PubMed:24726327, ECO:0000269|PubMed:26389662,
CC       ECO:0000269|PubMed:26471729, ECO:0000269|PubMed:26842564,
CC       ECO:0000269|PubMed:27753622, ECO:0000269|PubMed:28302725,
CC       ECO:0000269|PubMed:8413590}.
CC   -!- INTERACTION:
CC       Self; NbExp=7; IntAct=EBI-355164, EBI-355164;
CC       Q9UKV5:AMFR; NbExp=10; IntAct=EBI-355164, EBI-1046367;
CC       Q9BZE9:ASPSCR1; NbExp=6; IntAct=EBI-355164, EBI-1993677;
CC       P54252-1:ATXN3; NbExp=16; IntAct=EBI-355164, EBI-946068;
CC       O96017:CHEK2; NbExp=2; IntAct=EBI-355164, EBI-1180783;
CC       Q9WTX6:Cul1 (xeno); NbExp=2; IntAct=EBI-355164, EBI-1551052;
CC       Q13619:CUL4A; NbExp=2; IntAct=EBI-355164, EBI-456106;
CC       Q9UNN5-1:FAF1; NbExp=4; IntAct=EBI-355164, EBI-15930546;
CC       Q96CS3:FAF2; NbExp=3; IntAct=EBI-355164, EBI-1055805;
CC       O94868:FCHSD2; NbExp=2; IntAct=EBI-355164, EBI-1215612;
CC       P62993:GRB2; NbExp=3; IntAct=EBI-355164, EBI-401755;
CC       Q9UNZ2:NSFL1C; NbExp=8; IntAct=EBI-355164, EBI-721577;
CC       P62136:PPP1CA; NbExp=2; IntAct=EBI-355164, EBI-357253;
CC       P07602-1:PSAP; NbExp=3; IntAct=EBI-355164, EBI-10635648;
CC       P26045:PTPN3; NbExp=2; IntAct=EBI-355164, EBI-1047946;
CC       P32969:RPL9P9; NbExp=4; IntAct=EBI-355164, EBI-358122;
CC       B1AQ61:UBE4B; NbExp=4; IntAct=EBI-355164, EBI-7931266;
CC       P68543:UBXN2A; NbExp=3; IntAct=EBI-355164, EBI-1993668;
CC       Q14CS0:UBXN2B; NbExp=4; IntAct=EBI-355164, EBI-1993619;
CC       Q92575:UBXN4; NbExp=2; IntAct=EBI-355164, EBI-723441;
CC       Q9BZV1:UBXN6; NbExp=7; IntAct=EBI-355164, EBI-1993899;
CC       O94888:UBXN7; NbExp=19; IntAct=EBI-355164, EBI-1993627;
CC       Q92890:UFD1; NbExp=5; IntAct=EBI-355164, EBI-1994090;
CC       P63104:YWHAZ; NbExp=2; IntAct=EBI-355164, EBI-347088;
CC       P24278:ZBTB25; NbExp=4; IntAct=EBI-355164, EBI-739899;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:15456787}. Endoplasmic reticulum
CC       {ECO:0000269|PubMed:15215856}. Nucleus
CC       {ECO:0000269|PubMed:23042605, ECO:0000269|PubMed:26842564}.
CC       Note=Present in the neuronal hyaline inclusion bodies specifically
CC       found in motor neurons from amyotrophic lateral sclerosis patients
CC       (PubMed:15456787). Present in the Lewy bodies specifically found
CC       in neurons from Parkinson disease patients (PubMed:15456787).
CC       Recruited to the cytoplasmic surface of the endoplasmic reticulum
CC       via interaction with AMFR/gp78 (PubMed:16168377). Following DNA
CC       double-strand breaks, recruited to the sites of damage
CC       (PubMed:22120668). Recruited to stalled replication forks via
CC       interaction with SPRTN (PubMed:23042605). Recruited to damaged
CC       lysosomes decorated with K48-linked ubiquitin chains
CC       (PubMed:27753622). {ECO:0000269|PubMed:15456787,
CC       ECO:0000269|PubMed:16168377, ECO:0000269|PubMed:22120668,
CC       ECO:0000269|PubMed:23042605, ECO:0000269|PubMed:27753622}.
CC   -!- DOMAIN: The PIM (PUB-interaction motif) motif mediates interaction
CC       with the PUB domain of RNF31. {ECO:0000269|PubMed:24726327}.
CC   -!- PTM: Phosphorylated by tyrosine kinases in response to T-cell
CC       antigen receptor activation. Phosphorylated in mitotic cells.
CC       {ECO:0000250|UniProtKB:P46462}.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798}.
CC   -!- PTM: Methylation at Lys-315 catalyzed by VCPKMT is increased in
CC       the presence of ASPSCR1. Lys-315 methylation may decrease ATPase
CC       activity. {ECO:0000269|PubMed:22948820,
CC       ECO:0000269|PubMed:23349634}.
CC   -!- DISEASE: Inclusion body myopathy with early-onset Paget disease
CC       with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320]:
CC       An autosomal dominant disease characterized by disabling muscle
CC       weakness clinically resembling to limb girdle muscular dystrophy,
CC       osteolytic bone lesions consistent with Paget disease, and
CC       premature frontotemporal dementia. Clinical features show
CC       incomplete penetrance. {ECO:0000269|PubMed:15034582,
CC       ECO:0000269|PubMed:15732117, ECO:0000269|PubMed:16247064,
CC       ECO:0000269|PubMed:16321991, ECO:0000269|PubMed:17935506,
CC       ECO:0000269|PubMed:20104022, ECO:0000269|PubMed:20335036,
CC       ECO:0000269|PubMed:20512113, ECO:0000269|PubMed:21822278,
CC       ECO:0000269|PubMed:23349634, ECO:0000269|PubMed:25125609,
CC       ECO:0000269|PubMed:25878907, ECO:0000269|PubMed:27209344,
CC       ECO:0000269|PubMed:27753622}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Amyotrophic lateral sclerosis 14, with or without
CC       frontotemporal dementia (ALS14) [MIM:613954]: A neurodegenerative
CC       disorder affecting upper motor neurons in the brain and lower
CC       motor neurons in the brain stem and spinal cord, resulting in
CC       fatal paralysis. Sensory abnormalities are absent. The pathologic
CC       hallmarks of the disease include pallor of the corticospinal tract
CC       due to loss of motor neurons, presence of ubiquitin-positive
CC       inclusions within surviving motor neurons, and deposition of
CC       pathologic aggregates. The etiology of amyotrophic lateral
CC       sclerosis is likely to be multifactorial, involving both genetic
CC       and environmental factors. The disease is inherited in 5-10% of
CC       the cases. Patients with ALS14 may develop frontotemporal
CC       dementia. {ECO:0000269|PubMed:21145000,
CC       ECO:0000269|PubMed:23349634}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Charcot-Marie-Tooth disease 2Y (CMT2Y) [MIM:616687]: An
CC       autosomal dominant, axonal form of Charcot-Marie-Tooth disease, a
CC       disorder of the peripheral nervous system, characterized by
CC       progressive weakness and atrophy, initially of the peroneal
CC       muscles and later of the distal muscles of the arms. Charcot-
CC       Marie-Tooth disease is classified in two main groups on the basis
CC       of electrophysiologic properties and histopathology: primary
CC       peripheral demyelinating neuropathies (designated CMT1 when they
CC       are dominantly inherited) and primary peripheral axonal
CC       neuropathies (CMT2). Neuropathies of the CMT2 group are
CC       characterized by signs of axonal degeneration in the absence of
CC       obvious myelin alterations, normal or slightly reduced nerve
CC       conduction velocities, and progressive distal muscle weakness and
CC       atrophy. {ECO:0000269|PubMed:25125609,
CC       ECO:0000269|PubMed:25878907}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the AAA ATPase family. {ECO:0000305}.
CC   -!- CAUTION: It is unclear how it participates in the recruitment of
CC       TP53BP1 at DNA damage sites. According to a first report,
CC       participates in the recruitment of TP53BP1 by promoting
CC       ubiquitination and removal of L3MBTL1 from DNA damage sites
CC       (PubMed:22120668). According to a second report, it acts by
CC       removing 'Lys-48'-linked ubiquitination from sites of DNA damage
CC       (PubMed:22020440). {ECO:0000305|PubMed:22020440,
CC       ECO:0000305|PubMed:22120668}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC004472; AAC07984.1; -; Genomic_DNA.
DR   EMBL; AF100752; AAD43016.1; -; mRNA.
DR   EMBL; AK312310; BAG35235.1; -; mRNA.
DR   EMBL; AL353795; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471071; EAW58404.1; -; Genomic_DNA.
DR   EMBL; BC110913; AAI10914.1; -; mRNA.
DR   EMBL; BC121794; AAI21795.1; -; mRNA.
DR   EMBL; Z70768; CAA94809.1; -; mRNA.
DR   CCDS; CCDS6573.1; -.
DR   PIR; T02243; T02243.
DR   RefSeq; NP_009057.1; NM_007126.3.
DR   UniGene; Hs.529782; -.
DR   PDB; 3EBB; X-ray; 1.90 A; E/F/G/H=797-806.
DR   PDB; 3HU1; X-ray; 2.81 A; A/B/C/D/E/F=1-481.
DR   PDB; 3HU2; X-ray; 2.85 A; A/B/C/D/E/F=1-481.
DR   PDB; 3HU3; X-ray; 2.20 A; A/B=1-481.
DR   PDB; 3QC8; X-ray; 2.20 A; A=21-196.
DR   PDB; 3QQ7; X-ray; 2.65 A; A=2-187.
DR   PDB; 3QQ8; X-ray; 2.00 A; A=2-187.
DR   PDB; 3QWZ; X-ray; 2.00 A; A=1-208.
DR   PDB; 3TIW; X-ray; 1.80 A; A/B=1-187.
DR   PDB; 4KDI; X-ray; 1.86 A; A/B=21-196.
DR   PDB; 4KDL; X-ray; 1.81 A; A=21-196.
DR   PDB; 4KLN; X-ray; 2.62 A; A/B/C/D/E/F=1-481.
DR   PDB; 4KO8; X-ray; 1.98 A; A/B=1-481.
DR   PDB; 4KOD; X-ray; 2.96 A; A/B/C/D/E/F/G/H/I/J/K/L=1-481.
DR   PDB; 4P0A; X-ray; 2.30 A; B/D=797-806.
DR   PDB; 5B6C; X-ray; 1.55 A; A=21-191.
DR   PDB; 5C18; X-ray; 3.30 A; A/B/C/D/E/F=2-806.
DR   PDB; 5C19; X-ray; 4.20 A; A/B/C/D/E/F=2-806.
DR   PDB; 5C1A; X-ray; 3.80 A; A/B/C/D/E/F/G/H/I/J/K/L=2-806.
DR   PDB; 5C1B; X-ray; 3.08 A; A/B/C/D/E/F=2-806.
DR   PDB; 5DYG; X-ray; 2.20 A; A=1-460.
DR   PDB; 5DYI; X-ray; 3.71 A; A/B/C/D/E/F/G/H/I/J/K/L=1-481.
DR   PDB; 5EPP; X-ray; 1.88 A; A=21-199.
DR   PDB; 5FTJ; EM; 2.30 A; A/B/C/D/E/F=1-806.
DR   PDB; 5FTK; EM; 2.40 A; A/B/C/D/E/F=1-806.
DR   PDB; 5FTL; EM; 3.30 A; A/B/C/D/E/F=1-806.
DR   PDB; 5FTM; EM; 3.20 A; A/B/C/D/E/F=1-806.
DR   PDB; 5FTN; EM; 3.30 A; A/B/C/D/E/F=1-806.
DR   PDB; 5GLF; X-ray; 2.25 A; A/C/E/G=21-199.
DR   PDB; 5IFS; X-ray; 2.46 A; B/D=1-481.
DR   PDB; 5IFW; X-ray; 3.40 A; B=2-806.
DR   PDB; 5KIW; X-ray; 3.41 A; A/B=1-460.
DR   PDB; 5KIY; X-ray; 2.79 A; A=1-460.
DR   PDB; 5X4L; X-ray; 2.40 A; A/B=23-196.
DR   PDBsum; 3EBB; -.
DR   PDBsum; 3HU1; -.
DR   PDBsum; 3HU2; -.
DR   PDBsum; 3HU3; -.
DR   PDBsum; 3QC8; -.
DR   PDBsum; 3QQ7; -.
DR   PDBsum; 3QQ8; -.
DR   PDBsum; 3QWZ; -.
DR   PDBsum; 3TIW; -.
DR   PDBsum; 4KDI; -.
DR   PDBsum; 4KDL; -.
DR   PDBsum; 4KLN; -.
DR   PDBsum; 4KO8; -.
DR   PDBsum; 4KOD; -.
DR   PDBsum; 4P0A; -.
DR   PDBsum; 5B6C; -.
DR   PDBsum; 5C18; -.
DR   PDBsum; 5C19; -.
DR   PDBsum; 5C1A; -.
DR   PDBsum; 5C1B; -.
DR   PDBsum; 5DYG; -.
DR   PDBsum; 5DYI; -.
DR   PDBsum; 5EPP; -.
DR   PDBsum; 5FTJ; -.
DR   PDBsum; 5FTK; -.
DR   PDBsum; 5FTL; -.
DR   PDBsum; 5FTM; -.
DR   PDBsum; 5FTN; -.
DR   PDBsum; 5GLF; -.
DR   PDBsum; 5IFS; -.
DR   PDBsum; 5IFW; -.
DR   PDBsum; 5KIW; -.
DR   PDBsum; 5KIY; -.
DR   PDBsum; 5X4L; -.
DR   ProteinModelPortal; P55072; -.
DR   SMR; P55072; -.
DR   BioGrid; 113258; 619.
DR   CORUM; P55072; -.
DR   DIP; DIP-33543N; -.
DR   IntAct; P55072; 105.
DR   MINT; P55072; -.
DR   STRING; 9606.ENSP00000351777; -.
DR   BindingDB; P55072; -.
DR   ChEMBL; CHEMBL1075145; -.
DR   DrugBank; DB04395; Phosphoaminophosphonic Acid-Adenylate Ester.
DR   TCDB; 3.A.16.1.1; the endoplasmic reticular retrotranslocon (er-rt) family.
DR   CarbonylDB; P55072; -.
DR   iPTMnet; P55072; -.
DR   PhosphoSitePlus; P55072; -.
DR   SwissPalm; P55072; -.
DR   BioMuta; VCP; -.
DR   DMDM; 6094447; -.
DR   DOSAC-COBS-2DPAGE; P55072; -.
DR   OGP; P55072; -.
DR   REPRODUCTION-2DPAGE; IPI00022774; -.
DR   REPRODUCTION-2DPAGE; P55072; -.
DR   EPD; P55072; -.
DR   PaxDb; P55072; -.
DR   PeptideAtlas; P55072; -.
DR   PRIDE; P55072; -.
DR   TopDownProteomics; P55072; -.
DR   Ensembl; ENST00000358901; ENSP00000351777; ENSG00000165280.
DR   GeneID; 7415; -.
DR   KEGG; hsa:7415; -.
DR   CTD; 7415; -.
DR   DisGeNET; 7415; -.
DR   EuPathDB; HostDB:ENSG00000165280.15; -.
DR   GeneCards; VCP; -.
DR   GeneReviews; VCP; -.
DR   HGNC; HGNC:12666; VCP.
DR   HPA; CAB005593; -.
DR   HPA; HPA012728; -.
DR   HPA; HPA012814; -.
DR   MalaCards; VCP; -.
DR   MIM; 167320; phenotype.
DR   MIM; 601023; gene.
DR   MIM; 613954; phenotype.
DR   MIM; 616687; phenotype.
DR   neXtProt; NX_P55072; -.
DR   OpenTargets; ENSG00000165280; -.
DR   Orphanet; 329478; Adult-onset distal myopathy due to VCP mutation.
DR   Orphanet; 803; Amyotrophic lateral sclerosis.
DR   Orphanet; 275864; Behavioral variant of frontotemporal dementia.
DR   Orphanet; 275872; Frontotemporal dementia with motor neuron disease.
DR   Orphanet; 52430; Inclusion body myopathy with Paget disease of bone and frontotemporal dementia.
DR   Orphanet; 100070; Progressive non-fluent aphasia.
DR   Orphanet; 100069; Semantic dementia.
DR   Orphanet; 329475; Spastic paraplegia - Paget disease of bone.
DR   PharmGKB; PA37289; -.
DR   eggNOG; KOG0730; Eukaryota.
DR   eggNOG; COG0464; LUCA.
DR   GeneTree; ENSGT00900000141071; -.
DR   HOGENOM; HOG000223224; -.
DR   HOVERGEN; HBG001226; -.
DR   InParanoid; P55072; -.
DR   KO; K13525; -.
DR   OMA; PIDDTTE; -.
DR   OrthoDB; EOG091G024K; -.
DR   PhylomeDB; P55072; -.
DR   TreeFam; TF300542; -.
DR   Reactome; R-HSA-110320; Translesion Synthesis by POLH.
DR   Reactome; R-HSA-3371511; HSF1 activation.
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-532668; N-glycan trimming in the ER and Calnexin/Calreticulin cycle.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-5689877; Josephin domain DUBs.
DR   Reactome; R-HSA-5689896; Ovarian tumor domain proteases.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-8876725; Protein methylation.
DR   SignaLink; P55072; -.
DR   SIGNOR; P55072; -.
DR   ChiTaRS; VCP; human.
DR   EvolutionaryTrace; P55072; -.
DR   GeneWiki; Valosin-containing_protein; -.
DR   GenomeRNAi; 7415; -.
DR   PRO; PR:P55072; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000165280; -.
DR   CleanEx; HS_VCP; -.
DR   ExpressionAtlas; P55072; baseline and differential.
DR   Genevisible; P55072; HS.
DR   GO; GO:1904949; C:ATPase complex; IEA:Ensembl.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0036513; C:Derlin-1 retrotranslocation complex; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISS:UniProtKB.
DR   GO; GO:0005811; C:lipid droplet; IDA:MGI.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0000502; C:proteasome complex; IDA:BHF-UCL.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0035861; C:site of double-strand break; IDA:UniProtKB.
DR   GO; GO:0034098; C:VCP-NPL4-UFD1 AAA ATPase complex; ISS:ParkinsonsUK-UCL.
DR   GO; GO:1990730; C:VCP-NSFL1C complex; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0043531; F:ADP binding; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATPase activity; IMP:UniProtKB.
DR   GO; GO:1904288; F:BAT3 complex binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0035800; F:deubiquitinase activator activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0036435; F:K48-linked polyubiquitin modification-dependent protein binding; IEA:Ensembl.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0042288; F:MHC class I protein binding; IEA:Ensembl.
DR   GO; GO:0031593; F:polyubiquitin modification-dependent protein binding; IDA:BHF-UCL.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0019903; F:protein phosphatase binding; IPI:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0044389; F:ubiquitin-like protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:1990381; F:ubiquitin-specific protease binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB.
DR   GO; GO:0070842; P:aggresome assembly; IEA:Ensembl.
DR   GO; GO:0046034; P:ATP metabolic process; IEA:Ensembl.
DR   GO; GO:0097352; P:autophagosome maturation; IMP:UniProtKB.
DR   GO; GO:0006914; P:autophagy; IMP:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; NAS:UniProtKB.
DR   GO; GO:0006302; P:double-strand break repair; IDA:UniProtKB.
DR   GO; GO:0061857; P:endoplasmic reticulum stress-induced pre-emptive quality control; IMP:UniProtKB.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:UniProtKB.
DR   GO; GO:0032510; P:endosome to lysosome transport via multivesicular body sorting pathway; IMP:UniProtKB.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; IEA:Ensembl.
DR   GO; GO:0071712; P:ER-associated misfolded protein catabolic process; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0036503; P:ERAD pathway; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0070987; P:error-free translesion synthesis; TAS:Reactome.
DR   GO; GO:0045184; P:establishment of protein localization; TAS:UniProtKB.
DR   GO; GO:0072389; P:flavin adenine dinucleotide catabolic process; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0016236; P:macroautophagy; IMP:UniProtKB.
DR   GO; GO:0006734; P:NADH metabolic process; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:2001171; P:positive regulation of ATP biosynthetic process; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:FlyBase.
DR   GO; GO:1903007; P:positive regulation of Lys63-specific deubiquitinase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0010918; P:positive regulation of mitochondrial membrane potential; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1903862; P:positive regulation of oxidative phosphorylation; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:BHF-UCL.
DR   GO; GO:0045732; P:positive regulation of protein catabolic process; IDA:BHF-UCL.
DR   GO; GO:0031334; P:positive regulation of protein complex assembly; IDA:BHF-UCL.
DR   GO; GO:1903006; P:positive regulation of protein K63-linked deubiquitination; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0010498; P:proteasomal protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0006457; P:protein folding; TAS:Reactome.
DR   GO; GO:0034214; P:protein hexamerization; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; IMP:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:1903715; P:regulation of aerobic respiration; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0030970; P:retrograde protein transport, ER to cytosol; IDA:UniProtKB.
DR   GO; GO:0019985; P:translesion synthesis; IMP:UniProtKB.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IDA:UniProtKB.
DR   GO; GO:0019079; P:viral genome replication; IMP:CACAO.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR005938; AAA_ATPase_CDC48.
DR   InterPro; IPR009010; Asp_de-COase-like_dom_sf.
DR   InterPro; IPR003959; ATPase_AAA_core.
DR   InterPro; IPR003960; ATPase_AAA_CS.
DR   InterPro; IPR004201; Cdc48_dom2.
DR   InterPro; IPR029067; CDC48_domain_2-like_sf.
DR   InterPro; IPR003338; CDC4_N-term_subdom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR015415; Vps4_C.
DR   Pfam; PF00004; AAA; 2.
DR   Pfam; PF02933; CDC48_2; 1.
DR   Pfam; PF02359; CDC48_N; 1.
DR   Pfam; PF09336; Vps4_C; 1.
DR   SMART; SM00382; AAA; 2.
DR   SMART; SM01072; CDC48_2; 1.
DR   SMART; SM01073; CDC48_N; 1.
DR   SUPFAM; SSF50692; SSF50692; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF54585; SSF54585; 1.
DR   TIGRFAMs; TIGR01243; CDC48; 1.
DR   PROSITE; PS00674; AAA; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Amyotrophic lateral sclerosis; ATP-binding;
KW   Autophagy; Charcot-Marie-Tooth disease; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; DNA damage; DNA repair;
KW   Endoplasmic reticulum; Hydrolase; Isopeptide bond; Lipid-binding;
KW   Methylation; Neurodegeneration; Neuropathy; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Transport;
KW   Ubl conjugation; Ubl conjugation pathway.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|Ref.8}.
FT   CHAIN         2    806       Transitional endoplasmic reticulum
FT                                ATPase.
FT                                /FTId=PRO_0000084572.
FT   NP_BIND     247    253       ATP. {ECO:0000269|PubMed:20512113}.
FT   NP_BIND     521    526       ATP. {ECO:0000250|UniProtKB:Q01853}.
FT   REGION      797    806       Interaction with UBXN6.
FT                                {ECO:0000269|PubMed:18656546}.
FT   MOTIF       802    806       PIM motif. {ECO:0000269|PubMed:24726327}.
FT   BINDING     348    348       ATP. {ECO:0000269|PubMed:20512113}.
FT   BINDING     384    384       ATP. {ECO:0000269|PubMed:20512113}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|Ref.8}.
FT   MOD_RES       3      3       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES       7      7       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      13     13       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      37     37       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     315    315       N6,N6,N6-trimethyllysine; by VCPKMT.
FT                                {ECO:0000269|PubMed:22948820,
FT                                ECO:0000269|PubMed:23349634}.
FT   MOD_RES     436    436       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     462    462       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     502    502       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q01853}.
FT   MOD_RES     505    505       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q01853}.
FT   MOD_RES     668    668       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q01853}.
FT   MOD_RES     668    668       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q01853}.
FT   MOD_RES     702    702       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     754    754       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q01853}.
FT   MOD_RES     770    770       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     775    775       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     787    787       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     805    805       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q01853}.
FT   CROSSLNK      8      8       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK     18     18       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VARIANT      95     95       R -> G (in IBMPFD1; cultured cells
FT                                expressing the mutant protein show a
FT                                marked general increase in the level of
FT                                ubiquitin-conjugated proteins and
FT                                impaired protein degradation through the
FT                                endoplasmic reticulum-associated
FT                                degradation (ERAD) pathway; shows
FT                                strongly reduced affinity for ADP and
FT                                increased affinity for ATP; abolishes
FT                                enhancement of K-315 methylation by
FT                                ASPSCR1; decreased interaction with CAV1
FT                                and UBXN6; dbSNP:rs121909332).
FT                                {ECO:0000269|PubMed:15034582,
FT                                ECO:0000269|PubMed:16321991,
FT                                ECO:0000269|PubMed:20512113,
FT                                ECO:0000269|PubMed:21822278}.
FT                                /FTId=VAR_033016.
FT   VARIANT      97     97       G -> E (in CMT2Y; increased ATPase
FT                                activity; dbSNP:rs864309502).
FT                                {ECO:0000269|PubMed:25878907}.
FT                                /FTId=VAR_076464.
FT   VARIANT     126    126       I -> F (in IBMPFD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27209344}.
FT                                /FTId=VAR_076465.
FT   VARIANT     155    155       R -> C (in IBMPFD1; also in one patient
FT                                without evidence of Paget disease of the
FT                                bone; dbSNP:rs121909330).
FT                                {ECO:0000269|PubMed:15034582,
FT                                ECO:0000269|PubMed:15732117}.
FT                                /FTId=VAR_033017.
FT   VARIANT     155    155       R -> H (in ALS14 and IBMPFD1; ALS14
FT                                patients do not manifest frontotemporal
FT                                dementia; properly assembles into a
FT                                hexameric structure; cultured cells
FT                                expressing the mutant protein show a
FT                                marked general increase in the level of
FT                                ubiquitin-conjugated proteins and
FT                                impaired protein degradation through the
FT                                endoplasmic reticulum-associated
FT                                degradation (ERAD) pathway; shows
FT                                strongly reduced affinity for ADP and
FT                                increased affinity for ATP; shows normal
FT                                ATPase activity according to
FT                                PubMed:16321991 while according to
FT                                PubMed:25878907 and PubMed:25125609 shows
FT                                increased ATPase activity; no defect in
FT                                ubiquitin-dependent protein degradation
FT                                by the proteasome; impaired autophagic
FT                                function; defective maturation of
FT                                ubiquitin-containing autophagosomes;
FT                                decreased interaction with CAV1 and
FT                                UBXN6; decreased endosome to lysosome
FT                                transport via multivesicular body sorting
FT                                pathway of CAV1; dbSNP:rs121909329).
FT                                {ECO:0000269|PubMed:15034582,
FT                                ECO:0000269|PubMed:16321991,
FT                                ECO:0000269|PubMed:20104022,
FT                                ECO:0000269|PubMed:20512113,
FT                                ECO:0000269|PubMed:21145000,
FT                                ECO:0000269|PubMed:21822278,
FT                                ECO:0000269|PubMed:23349634,
FT                                ECO:0000269|PubMed:25125609,
FT                                ECO:0000269|PubMed:25878907,
FT                                ECO:0000269|PubMed:27753622}.
FT                                /FTId=VAR_033018.
FT   VARIANT     155    155       R -> L (in IBMPFD1).
FT                                {ECO:0000269|PubMed:20335036}.
FT                                /FTId=VAR_078910.
FT   VARIANT     155    155       R -> P (in IBMPFD1; dbSNP:rs121909329).
FT                                {ECO:0000269|PubMed:15034582}.
FT                                /FTId=VAR_033019.
FT   VARIANT     155    155       R -> S (in IBMPFD1; impaired autophagic
FT                                function). {ECO:0000269|PubMed:20104022}.
FT                                /FTId=VAR_076466.
FT   VARIANT     159    159       R -> G (in ALS14; dbSNP:rs387906789).
FT                                {ECO:0000269|PubMed:21145000,
FT                                ECO:0000269|PubMed:23349634}.
FT                                /FTId=VAR_065910.
FT   VARIANT     159    159       R -> H (in IBMPFD1; without
FT                                frontotemporal dementia; abolishes
FT                                enhancement of K-315 methylation by
FT                                ASPSCR1; dbSNP:rs121909335).
FT                                {ECO:0000269|PubMed:16247064}.
FT                                /FTId=VAR_033020.
FT   VARIANT     185    185       E -> K (in CMT2Y; normal ATPase activity;
FT                                impaired autophagic function;
FT                                dbSNP:rs864309501).
FT                                {ECO:0000269|PubMed:25125609}.
FT                                /FTId=VAR_076467.
FT   VARIANT     191    191       R -> Q (in ALS14 and IBMPFD1; abolishes
FT                                enhancement of K-315 methylation by
FT                                ASPSCR1; dbSNP:rs121909334).
FT                                {ECO:0000269|PubMed:15034582,
FT                                ECO:0000269|PubMed:21145000,
FT                                ECO:0000269|PubMed:23349634}.
FT                                /FTId=VAR_033021.
FT   VARIANT     198    198       L -> W (in IBMPFD1; increased ATPase
FT                                activity; impaired autophagic function).
FT                                {ECO:0000269|PubMed:17935506,
FT                                ECO:0000269|PubMed:20335036,
FT                                ECO:0000269|PubMed:25878907,
FT                                ECO:0000269|PubMed:27753622}.
FT                                /FTId=VAR_076468.
FT   VARIANT     232    232       A -> E (in IBMPFD1; increased ATPase
FT                                activity; no defect in ubiquitin-
FT                                dependent protein degradation by the
FT                                proteasome; impaired autophagic function;
FT                                defect in maturation of ubiquitin-
FT                                containing autophagosomes; decreased
FT                                interaction with CAV1 and UBXN6;
FT                                dbSNP:rs121909331).
FT                                {ECO:0000269|PubMed:15034582,
FT                                ECO:0000269|PubMed:20104022,
FT                                ECO:0000269|PubMed:21822278,
FT                                ECO:0000269|PubMed:25125609,
FT                                ECO:0000269|PubMed:25878907,
FT                                ECO:0000269|PubMed:27753622}.
FT                                /FTId=VAR_033022.
FT   VARIANT     387    387       N -> H (in IBMPFD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:17935506}.
FT                                /FTId=VAR_078911.
FT   VARIANT     592    592       D -> N (in ALS14; ALS14 patients do not
FT                                show frontotemporal dementia;
FT                                dbSNP:rs387906790).
FT                                {ECO:0000269|PubMed:21145000}.
FT                                /FTId=VAR_065911.
FT   MUTAGEN      52     55       FRGD->ARGA: Abolishes interaction with
FT                                NPLOC4; when associated with A-110.
FT                                {ECO:0000269|PubMed:26471729}.
FT   MUTAGEN      53     53       R->A: Minor effect on affinity for ATP
FT                                and ADP. {ECO:0000269|PubMed:20512113}.
FT   MUTAGEN      86     86       R->A: Strongly increased affinity for
FT                                ATP. Strongly reduced affinity for ADP.
FT                                {ECO:0000269|PubMed:20512113}.
FT   MUTAGEN     110    110       Y->A: Abolishes interaction with NPLOC4;
FT                                when associated with 52-A--A-55.
FT                                {ECO:0000269|PubMed:26471729}.
FT   MUTAGEN     251    251       K->Q: Impairs ERAD degradation of HMGCR
FT                                and does not inhibit interaction with
FT                                RHBDD1; when associated with Q-524.
FT                                {ECO:0000269|PubMed:16168377,
FT                                ECO:0000269|PubMed:22795130}.
FT   MUTAGEN     305    305       E->Q: Defect in ubiquitin-dependent
FT                                protein degradation by the proteasome;
FT                                when associated with Q-578.
FT                                {ECO:0000269|PubMed:20104022,
FT                                ECO:0000269|PubMed:26471729}.
FT   MUTAGEN     312    312       K->A: Does not affect methylation by
FT                                VCPKMT. {ECO:0000269|PubMed:22948820}.
FT   MUTAGEN     313    313       R->A: Does not affect methylation by
FT                                VCPKMT. {ECO:0000269|PubMed:22948820}.
FT   MUTAGEN     314    314       E->A: Does not affect methylation by
FT                                VCPKMT. {ECO:0000269|PubMed:22948820}.
FT   MUTAGEN     314    314       Missing: Strongly impairs methylation by
FT                                VCPKMT. {ECO:0000269|PubMed:22948820}.
FT   MUTAGEN     315    315       K->L,Q,R: Abolishes methylation by
FT                                VCPKMT. {ECO:0000269|PubMed:22948820,
FT                                ECO:0000269|PubMed:23349634}.
FT   MUTAGEN     316    316       T->A: Does not affect methylation by
FT                                VCPKMT. {ECO:0000269|PubMed:22948820}.
FT   MUTAGEN     317    317       H->A: Does not affect methylation by
FT                                VCPKMT. {ECO:0000269|PubMed:22948820}.
FT   MUTAGEN     318    318       G->A: Does not affect methylation by
FT                                VCPKMT. {ECO:0000269|PubMed:22948820}.
FT   MUTAGEN     524    524       K->A: Impairs catalytic activity of
FT                                RNF19A toward SOD1 mutant. Does not
FT                                inhibit interaction with RHBDD1; when
FT                                associated with A-251.
FT                                {ECO:0000269|PubMed:15456787,
FT                                ECO:0000269|PubMed:16168377,
FT                                ECO:0000269|PubMed:22795130}.
FT   MUTAGEN     524    524       K->Q: Impairs ERAD degradation of HMGCR;
FT                                when associated with Q-251.
FT                                {ECO:0000269|PubMed:15456787,
FT                                ECO:0000269|PubMed:16168377,
FT                                ECO:0000269|PubMed:22795130}.
FT   MUTAGEN     578    578       E->Q: Does not inhibit interaction with
FT                                RHBDD1. Increased interaction with CAV1
FT                                and UBXN6. Impaired autophagic function.
FT                                Defect in ubiquitin-dependent protein
FT                                degradation by the proteasome; when
FT                                associated with Q-305.
FT                                {ECO:0000269|PubMed:20104022,
FT                                ECO:0000269|PubMed:21822278,
FT                                ECO:0000269|PubMed:22795130,
FT                                ECO:0000269|PubMed:26471729}.
FT   CONFLICT    169    169       D -> H (in Ref. 6; AAI21795).
FT                                {ECO:0000305}.
FT   CONFLICT    312    312       K -> I (in Ref. 3; BAG35235).
FT                                {ECO:0000305}.
FT   TURN         15     17       {ECO:0000244|PDB:4KLN}.
FT   HELIX        22     24       {ECO:0000244|PDB:5IFW}.
FT   STRAND       25     29       {ECO:0000244|PDB:5B6C}.
FT   STRAND       38     41       {ECO:0000244|PDB:5B6C}.
FT   HELIX        43     48       {ECO:0000244|PDB:5B6C}.
FT   STRAND       53     55       {ECO:0000244|PDB:5FTN}.
FT   STRAND       56     60       {ECO:0000244|PDB:5B6C}.
FT   HELIX        62     64       {ECO:0000244|PDB:3QQ8}.
FT   STRAND       66     73       {ECO:0000244|PDB:5B6C}.
FT   STRAND       75     77       {ECO:0000244|PDB:3HU1}.
FT   STRAND       81     83       {ECO:0000244|PDB:5B6C}.
FT   HELIX        86     92       {ECO:0000244|PDB:5B6C}.
FT   STRAND       93     95       {ECO:0000244|PDB:5FTN}.
FT   STRAND       99    104       {ECO:0000244|PDB:5B6C}.
FT   STRAND      112    119       {ECO:0000244|PDB:5B6C}.
FT   HELIX       120    123       {ECO:0000244|PDB:5B6C}.
FT   STRAND      126    128       {ECO:0000244|PDB:5IFS}.
FT   HELIX       130    133       {ECO:0000244|PDB:5B6C}.
FT   HELIX       135    139       {ECO:0000244|PDB:5B6C}.
FT   TURN        140    142       {ECO:0000244|PDB:5B6C}.
FT   STRAND      144    147       {ECO:0000244|PDB:5B6C}.
FT   STRAND      151    154       {ECO:0000244|PDB:5B6C}.
FT   STRAND      157    159       {ECO:0000244|PDB:4KDI}.
FT   STRAND      161    176       {ECO:0000244|PDB:5B6C}.
FT   STRAND      181    183       {ECO:0000244|PDB:5B6C}.
FT   HELIX       191    193       {ECO:0000244|PDB:4KDL}.
FT   STRAND      198    200       {ECO:0000244|PDB:5FTJ}.
FT   HELIX       203    205       {ECO:0000244|PDB:4KO8}.
FT   HELIX       210    219       {ECO:0000244|PDB:4KO8}.
FT   HELIX       221    225       {ECO:0000244|PDB:4KO8}.
FT   HELIX       227    233       {ECO:0000244|PDB:4KO8}.
FT   STRAND      240    244       {ECO:0000244|PDB:4KO8}.
FT   STRAND      246    250       {ECO:0000244|PDB:4KLN}.
FT   HELIX       251    261       {ECO:0000244|PDB:4KO8}.
FT   STRAND      263    270       {ECO:0000244|PDB:4KO8}.
FT   HELIX       271    275       {ECO:0000244|PDB:4KO8}.
FT   HELIX       281    295       {ECO:0000244|PDB:4KO8}.
FT   STRAND      298    305       {ECO:0000244|PDB:4KO8}.
FT   HELIX       306    308       {ECO:0000244|PDB:4KO8}.
FT   STRAND      313    315       {ECO:0000244|PDB:5FTK}.
FT   HELIX       319    333       {ECO:0000244|PDB:4KO8}.
FT   HELIX       335    337       {ECO:0000244|PDB:5DYG}.
FT   STRAND      341    348       {ECO:0000244|PDB:4KO8}.
FT   HELIX       350    352       {ECO:0000244|PDB:4KO8}.
FT   HELIX       355    358       {ECO:0000244|PDB:4KO8}.
FT   TURN        360    362       {ECO:0000244|PDB:5FTL}.
FT   STRAND      365    368       {ECO:0000244|PDB:4KO8}.
FT   HELIX       374    385       {ECO:0000244|PDB:4KO8}.
FT   STRAND      388    390       {ECO:0000244|PDB:5DYG}.
FT   HELIX       396    401       {ECO:0000244|PDB:4KO8}.
FT   TURN        403    405       {ECO:0000244|PDB:5FTJ}.
FT   HELIX       408    424       {ECO:0000244|PDB:4KO8}.
FT   TURN        425    429       {ECO:0000244|PDB:4KO8}.
FT   STRAND      432    436       {ECO:0000244|PDB:3HU1}.
FT   HELIX       439    444       {ECO:0000244|PDB:4KO8}.
FT   HELIX       449    457       {ECO:0000244|PDB:4KO8}.
FT   STRAND      458    461       {ECO:0000244|PDB:4KO8}.
FT   TURN        462    468       {ECO:0000244|PDB:4KO8}.
FT   HELIX       476    478       {ECO:0000244|PDB:5FTK}.
FT   HELIX       483    498       {ECO:0000244|PDB:5FTJ}.
FT   HELIX       500    505       {ECO:0000244|PDB:5FTJ}.
FT   STRAND      513    517       {ECO:0000244|PDB:5FTJ}.
FT   HELIX       524    534       {ECO:0000244|PDB:5FTJ}.
FT   STRAND      538    542       {ECO:0000244|PDB:5FTJ}.
FT   HELIX       544    552       {ECO:0000244|PDB:5FTJ}.
FT   HELIX       559    568       {ECO:0000244|PDB:5FTJ}.
FT   STRAND      571    578       {ECO:0000244|PDB:5FTJ}.
FT   HELIX       581    586       {ECO:0000244|PDB:5FTJ}.
FT   STRAND      588    590       {ECO:0000244|PDB:5FTJ}.
FT   HELIX       599    609       {ECO:0000244|PDB:5FTJ}.
FT   STRAND      613    624       {ECO:0000244|PDB:5FTJ}.
FT   STRAND      626    629       {ECO:0000244|PDB:5FTJ}.
FT   HELIX       631    634       {ECO:0000244|PDB:5FTJ}.
FT   STRAND      635    639       {ECO:0000244|PDB:5FTK}.
FT   STRAND      641    644       {ECO:0000244|PDB:5FTJ}.
FT   HELIX       650    661       {ECO:0000244|PDB:5FTJ}.
FT   STRAND      662    664       {ECO:0000244|PDB:5C1B}.
FT   HELIX       672    678       {ECO:0000244|PDB:5FTJ}.
FT   HELIX       684    706       {ECO:0000244|PDB:5FTJ}.
FT   STRAND      722    724       {ECO:0000244|PDB:5IFW}.
FT   HELIX       735    741       {ECO:0000244|PDB:5FTJ}.
FT   HELIX       749    762       {ECO:0000244|PDB:5FTJ}.
FT   HELIX       763    765       {ECO:0000244|PDB:5FTM}.
SQ   SEQUENCE   806 AA;  89322 MW;  501B721D3A77BA8A CRC64;
     MASGADSKGD DLSTAILKQK NRPNRLIVDE AINEDNSVVS LSQPKMDELQ LFRGDTVLLK
     GKKRREAVCI VLSDDTCSDE KIRMNRVVRN NLRVRLGDVI SIQPCPDVKY GKRIHVLPID
     DTVEGITGNL FEVYLKPYFL EAYRPIRKGD IFLVRGGMRA VEFKVVETDP SPYCIVAPDT
     VIHCEGEPIK REDEEESLNE VGYDDIGGCR KQLAQIKEMV ELPLRHPALF KAIGVKPPRG
     ILLYGPPGTG KTLIARAVAN ETGAFFFLIN GPEIMSKLAG ESESNLRKAF EEAEKNAPAI
     IFIDELDAIA PKREKTHGEV ERRIVSQLLT LMDGLKQRAH VIVMAATNRP NSIDPALRRF
     GRFDREVDIG IPDATGRLEI LQIHTKNMKL ADDVDLEQVA NETHGHVGAD LAALCSEAAL
     QAIRKKMDLI DLEDETIDAE VMNSLAVTMD DFRWALSQSN PSALRETVVE VPQVTWEDIG
     GLEDVKRELQ ELVQYPVEHP DKFLKFGMTP SKGVLFYGPP GCGKTLLAKA IANECQANFI
     SIKGPELLTM WFGESEANVR EIFDKARQAA PCVLFFDELD SIAKARGGNI GDGGGAADRV
     INQILTEMDG MSTKKNVFII GATNRPDIID PAILRPGRLD QLIYIPLPDE KSRVAILKAN
     LRKSPVAKDV DLEFLAKMTN GFSGADLTEI CQRACKLAIR ESIESEIRRE RERQTNPSAM
     EVEEDDPVPE IRRDHFEEAM RFARRSVSDN DIRKYEMFAQ TLQQSRGFGS FRFPSGNQGG
     AGPSQGSGGG TGGSVYTEDN DDDLYG
//
ID   V9HW80_HUMAN            Unreviewed;       806 AA.
AC   V9HW80;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   23-MAY-2018, entry version 45.
DE   SubName: Full=Epididymis luminal protein 220 {ECO:0000313|EMBL:ACI46036.1};
DE   SubName: Full=Epididymis secretory protein Li 70 {ECO:0000313|EMBL:ACI46044.1};
GN   Name=HEL-S-70 {ECO:0000313|EMBL:ACI46044.1};
GN   Synonyms=HEL-220 {ECO:0000313|EMBL:ACI46036.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACI46044.1};
RN   [1] {ECO:0000313|EMBL:ACI46044.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J., Wang H., Liu J., Liu F.;
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- INTERACTION:
CC       Q9BZE9:ASPSCR1; NbExp=3; IntAct=EBI-10175326, EBI-1993677;
CC       A9UGY9:ATG5; NbExp=3; IntAct=EBI-10175326, EBI-10175276;
CC       Q96LK0:CEP19; NbExp=3; IntAct=EBI-10175326, EBI-741885;
CC       O60941:DTNB; NbExp=3; IntAct=EBI-10175326, EBI-740402;
CC       Q969W3:FAM104A; NbExp=3; IntAct=EBI-10175326, EBI-10281506;
CC       Q8TBB1:LNX1; NbExp=3; IntAct=EBI-10175326, EBI-739832;
CC       Q9UNZ2:NSFL1C; NbExp=3; IntAct=EBI-10175326, EBI-721577;
CC       Q9Y263:PLAA; NbExp=3; IntAct=EBI-10175326, EBI-1994037;
CC       P25786:PSMA1; NbExp=3; IntAct=EBI-10175326, EBI-359352;
CC       O76064:RNF8; NbExp=3; IntAct=EBI-10175326, EBI-373337;
CC       P32969:RPL9P9; NbExp=3; IntAct=EBI-10175326, EBI-358122;
CC       O94941:UBOX5; NbExp=3; IntAct=EBI-10175326, EBI-751901;
CC       Q04323:UBXN1; NbExp=3; IntAct=EBI-10175326, EBI-1058647;
CC       Q14CS0:UBXN2B; NbExp=3; IntAct=EBI-10175326, EBI-1993619;
CC       Q96HA8:WDYHV1; NbExp=3; IntAct=EBI-10175326, EBI-741158;
CC   -!- SIMILARITY: Belongs to the AAA ATPase family.
CC       {ECO:0000256|SAAS:SAAS00552016}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FJ224344; ACI46036.1; -; mRNA.
DR   EMBL; FJ224352; ACI46044.1; -; mRNA.
DR   RefSeq; NP_009057.1; NM_007126.3.
DR   UniGene; Hs.529782; -.
DR   SMR; V9HW80; -.
DR   IntAct; V9HW80; 15.
DR   MaxQB; V9HW80; -.
DR   PRIDE; V9HW80; -.
DR   GeneID; 7415; -.
DR   KEGG; hsa:7415; -.
DR   UCSC; uc003zvy.3; human.
DR   CTD; 7415; -.
DR   EuPathDB; HostDB:ENSG00000165280.15; -.
DR   eggNOG; KOG0730; Eukaryota.
DR   eggNOG; COG0464; LUCA.
DR   KO; K13525; -.
DR   OMA; PIDDTTE; -.
DR   OrthoDB; EOG091G024K; -.
DR   ChiTaRS; VCP; human.
DR   GenomeRNAi; 7415; -.
DR   Bgee; ENSG00000165280; -.
DR   ExpressionAtlas; V9HW80; baseline and differential.
DR   GO; GO:1904949; C:ATPase complex; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0036513; C:Derlin-1 retrotranslocation complex; IEA:Ensembl.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0034098; C:VCP-NPL4-UFD1 AAA ATPase complex; IEA:Ensembl.
DR   GO; GO:1990730; C:VCP-NSFL1C complex; IEA:Ensembl.
DR   GO; GO:0043531; F:ADP binding; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATPase activity; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0036435; F:K48-linked polyubiquitin modification-dependent protein binding; IEA:Ensembl.
DR   GO; GO:0042288; F:MHC class I protein binding; IEA:Ensembl.
DR   GO; GO:1990381; F:ubiquitin-specific protease binding; IEA:Ensembl.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
DR   GO; GO:0070842; P:aggresome assembly; IEA:Ensembl.
DR   GO; GO:0046034; P:ATP metabolic process; IEA:Ensembl.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; IEA:Ensembl.
DR   GO; GO:0010918; P:positive regulation of mitochondrial membrane potential; IEA:Ensembl.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0034214; P:protein hexamerization; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
DR   GO; GO:0030970; P:retrograde protein transport, ER to cytosol; IEA:Ensembl.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR005938; AAA_ATPase_CDC48.
DR   InterPro; IPR009010; Asp_de-COase-like_dom_sf.
DR   InterPro; IPR003959; ATPase_AAA_core.
DR   InterPro; IPR003960; ATPase_AAA_CS.
DR   InterPro; IPR004201; Cdc48_dom2.
DR   InterPro; IPR029067; CDC48_domain_2-like_sf.
DR   InterPro; IPR003338; CDC4_N-term_subdom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR015415; Vps4_C.
DR   Pfam; PF00004; AAA; 2.
DR   Pfam; PF02933; CDC48_2; 1.
DR   Pfam; PF02359; CDC48_N; 1.
DR   Pfam; PF09336; Vps4_C; 1.
DR   SMART; SM00382; AAA; 2.
DR   SMART; SM01072; CDC48_2; 1.
DR   SMART; SM01073; CDC48_N; 1.
DR   SUPFAM; SSF50692; SSF50692; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF54585; SSF54585; 1.
DR   TIGRFAMs; TIGR01243; CDC48; 1.
DR   PROSITE; PS00674; AAA; 2.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|SAAS:SAAS00552105};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00552105}.
FT   DOMAIN       25    108       CDC48_N. {ECO:0000259|SMART:SM01073}.
FT   DOMAIN      125    191       CDC48_2. {ECO:0000259|SMART:SM01072}.
FT   DOMAIN      237    373       AAA. {ECO:0000259|SMART:SM00382}.
FT   DOMAIN      510    649       AAA. {ECO:0000259|SMART:SM00382}.
SQ   SEQUENCE   806 AA;  89322 MW;  501B721D3A77BA8A CRC64;
     MASGADSKGD DLSTAILKQK NRPNRLIVDE AINEDNSVVS LSQPKMDELQ LFRGDTVLLK
     GKKRREAVCI VLSDDTCSDE KIRMNRVVRN NLRVRLGDVI SIQPCPDVKY GKRIHVLPID
     DTVEGITGNL FEVYLKPYFL EAYRPIRKGD IFLVRGGMRA VEFKVVETDP SPYCIVAPDT
     VIHCEGEPIK REDEEESLNE VGYDDIGGCR KQLAQIKEMV ELPLRHPALF KAIGVKPPRG
     ILLYGPPGTG KTLIARAVAN ETGAFFFLIN GPEIMSKLAG ESESNLRKAF EEAEKNAPAI
     IFIDELDAIA PKREKTHGEV ERRIVSQLLT LMDGLKQRAH VIVMAATNRP NSIDPALRRF
     GRFDREVDIG IPDATGRLEI LQIHTKNMKL ADDVDLEQVA NETHGHVGAD LAALCSEAAL
     QAIRKKMDLI DLEDETIDAE VMNSLAVTMD DFRWALSQSN PSALRETVVE VPQVTWEDIG
     GLEDVKRELQ ELVQYPVEHP DKFLKFGMTP SKGVLFYGPP GCGKTLLAKA IANECQANFI
     SIKGPELLTM WFGESEANVR EIFDKARQAA PCVLFFDELD SIAKARGGNI GDGGGAADRV
     INQILTEMDG MSTKKNVFII GATNRPDIID PAILRPGRLD QLIYIPLPDE KSRVAILKAN
     LRKSPVAKDV DLEFLAKMTN GFSGADLTEI CQRACKLAIR ESIESEIRRE RERQTNPSAM
     EVEEDDPVPE IRRDHFEEAM RFARRSVSDN DIRKYEMFAQ TLQQSRGFGS FRFPSGNQGG
     AGPSQGSGGG TGGSVYTEDN DDDLYG
//
ID   GPX7_HUMAN              Reviewed;         187 AA.
AC   Q96SL4; O95337; Q5T501;
DT   04-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   28-FEB-2018, entry version 149.
DE   RecName: Full=Glutathione peroxidase 7;
DE            Short=GPx-7;
DE            Short=GSHPx-7;
DE            EC=1.11.1.9;
DE   AltName: Full=CL683;
DE   Flags: Precursor;
GN   Name=GPX7; Synonyms=GPX6; ORFNames=UNQ469/PRO828;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal brain;
RA   Gu S., Lin S., Ying K., Xie Y., Mao Y.;
RT   "Cloning and characterizing a novel human glutathione peroxidase-
RT   GPX6.";
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 75-187.
RA   Barrow I.K.-P., Boguski M.S., Touchman J.W., Spencer F.;
RT   "Full-insert sequence of mapped XREF EST.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   FUNCTION, TISSUE SPECIFICITY, AND INVOLVEMENT IN BE.
RX   PubMed=22157330; DOI=10.1136/gutjnl-2011-301078;
RA   Peng D., Belkhiri A., Hu T., Chaturvedi R., Asim M., Wilson K.T.,
RA   Zaika A., El-Rifai W.;
RT   "Glutathione peroxidase 7 protects against oxidative DNA damage in
RT   oesophageal cells.";
RL   Gut 61:1250-1260(2012).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 20-177.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human glutathione peroxidase 7.";
RL   Submitted (MAR-2007) to the PDB data bank.
CC   -!- FUNCTION: It protects esophageal epithelia from hydrogen peroxide-
CC       induced oxidative stress. It suppresses acidic bile acid-induced
CC       reactive oxigen species (ROS) and protects against oxidative DNA
CC       damage and double-strand breaks. {ECO:0000269|PubMed:22157330}.
CC   -!- CATALYTIC ACTIVITY: 2 glutathione + H(2)O(2) = glutathione
CC       disulfide + 2 H(2)O.
CC   -!- INTERACTION:
CC       O43681:ASNA1; NbExp=5; IntAct=EBI-749411, EBI-2515857;
CC       Q8NHQ1:CEP70; NbExp=3; IntAct=EBI-749411, EBI-739624;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-749411, EBI-347996;
CC       Q96EQ0:SGTB; NbExp=4; IntAct=EBI-749411, EBI-744081;
CC       Q9UHD9:UBQLN2; NbExp=4; IntAct=EBI-749411, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in esophageal epithelial cells;
CC       expression is up-regulated after exposure to acidic bile acids.
CC       {ECO:0000269|PubMed:22157330}.
CC   -!- DISEASE: Barrett esophagus (BE) [MIM:614266]: A condition
CC       characterized by a metaplastic change in which normal esophageal
CC       squamous epithelium is replaced by a columnar and intestinal-type
CC       epithelium. Patients with Barrett esophagus have an increased risk
CC       of esophageal adenocarcinoma. The main cause of Barrett esophagus
CC       is gastroesophageal reflux. The retrograde movement of acid and
CC       bile salts from the stomach into the esophagus causes prolonged
CC       injury to the esophageal epithelium and induces chronic
CC       esophagitis, which in turn is believed to trigger the pathologic
CC       changes. {ECO:0000269|PubMed:22157330}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry. The
CC       pathologic mechanisms leading to Barrett esophagus involve GPX7
CC       dysfunction that results in higher levels of hydrogen peroxide and
CC       ROS-induced oxidative stress and DNA damage in esophageal cells.
CC   -!- SIMILARITY: Belongs to the glutathione peroxidase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC72961.1; Type=Erroneous translation; Note=Wrong choice of frame.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/gpx7/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF320068; AAN76501.1; -; mRNA.
DR   EMBL; AY358402; AAQ88768.1; -; mRNA.
DR   EMBL; AK027683; BAB55294.1; -; mRNA.
DR   EMBL; DQ096732; AAY88741.1; -; Genomic_DNA.
DR   EMBL; AL356976; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032788; AAH32788.1; -; mRNA.
DR   EMBL; AF091092; AAC72961.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS569.1; -.
DR   RefSeq; NP_056511.2; NM_015696.4.
DR   UniGene; Hs.43728; -.
DR   PDB; 2P31; X-ray; 2.00 A; A/B=20-177.
DR   PDBsum; 2P31; -.
DR   ProteinModelPortal; Q96SL4; -.
DR   SMR; Q96SL4; -.
DR   BioGrid; 109139; 45.
DR   IntAct; Q96SL4; 11.
DR   STRING; 9606.ENSP00000354677; -.
DR   DrugBank; DB00143; Glutathione.
DR   PeroxiBase; 3606; HsGPx07.
DR   iPTMnet; Q96SL4; -.
DR   PhosphoSitePlus; Q96SL4; -.
DR   BioMuta; GPX7; -.
DR   DMDM; 33516901; -.
DR   EPD; Q96SL4; -.
DR   MaxQB; Q96SL4; -.
DR   PaxDb; Q96SL4; -.
DR   PeptideAtlas; Q96SL4; -.
DR   PRIDE; Q96SL4; -.
DR   DNASU; 2882; -.
DR   Ensembl; ENST00000361314; ENSP00000354677; ENSG00000116157.
DR   GeneID; 2882; -.
DR   KEGG; hsa:2882; -.
DR   UCSC; uc001cue.4; human.
DR   CTD; 2882; -.
DR   DisGeNET; 2882; -.
DR   EuPathDB; HostDB:ENSG00000116157.5; -.
DR   GeneCards; GPX7; -.
DR   HGNC; HGNC:4559; GPX7.
DR   HPA; HPA025829; -.
DR   MIM; 614266; phenotype.
DR   MIM; 615784; gene.
DR   neXtProt; NX_Q96SL4; -.
DR   OpenTargets; ENSG00000116157; -.
DR   PharmGKB; PA28955; -.
DR   eggNOG; KOG1651; Eukaryota.
DR   eggNOG; COG0386; LUCA.
DR   GeneTree; ENSGT00760000119230; -.
DR   HOGENOM; HOG000277054; -.
DR   HOVERGEN; HBG004333; -.
DR   InParanoid; Q96SL4; -.
DR   KO; K00432; -.
DR   OMA; IAQTCHI; -.
DR   OrthoDB; EOG091G0OJG; -.
DR   PhylomeDB; Q96SL4; -.
DR   TreeFam; TF331942; -.
DR   BRENDA; 1.11.1.9; 2681.
DR   Reactome; R-HSA-3299685; Detoxification of Reactive Oxygen Species.
DR   ChiTaRS; GPX7; human.
DR   EvolutionaryTrace; Q96SL4; -.
DR   GeneWiki; GPX7; -.
DR   GenomeRNAi; 2882; -.
DR   PRO; PR:Q96SL4; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116157; -.
DR   CleanEx; HS_GPX6; -.
DR   CleanEx; HS_GPX7; -.
DR   Genevisible; Q96SL4; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004096; F:catalase activity; IDA:CACAO.
DR   GO; GO:0004602; F:glutathione peroxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004601; F:peroxidase activity; EXP:Reactome.
DR   GO; GO:0034599; P:cellular response to oxidative stress; TAS:Reactome.
DR   CDD; cd00340; GSH_Peroxidase; 1.
DR   InterPro; IPR013376; Glut_perox_Gpx7.
DR   InterPro; IPR000889; Glutathione_peroxidase.
DR   InterPro; IPR029759; GPX_AS.
DR   InterPro; IPR029760; GPX_CS.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   PANTHER; PTHR11592; PTHR11592; 1.
DR   Pfam; PF00255; GSHPx; 1.
DR   PIRSF; PIRSF000303; Glutathion_perox; 1.
DR   PRINTS; PR01011; GLUTPROXDASE.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   TIGRFAMs; TIGR02540; gpx7; 1.
DR   PROSITE; PS00460; GLUTATHIONE_PEROXID_1; 1.
DR   PROSITE; PS00763; GLUTATHIONE_PEROXID_2; 1.
DR   PROSITE; PS51355; GLUTATHIONE_PEROXID_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Oxidoreductase; Peroxidase;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    187       Glutathione peroxidase 7.
FT                                /FTId=PRO_0000013084.
FT   ACT_SITE     57     57       {ECO:0000250}.
FT   CONFLICT     75     77       GPH -> HED (in Ref. 7). {ECO:0000305}.
FT   HELIX        25     27       {ECO:0000244|PDB:2P31}.
FT   STRAND       29     32       {ECO:0000244|PDB:2P31}.
FT   STRAND       37     39       {ECO:0000244|PDB:2P31}.
FT   HELIX        40     43       {ECO:0000244|PDB:2P31}.
FT   STRAND       46     53       {ECO:0000244|PDB:2P31}.
FT   STRAND       55     57       {ECO:0000244|PDB:2P31}.
FT   HELIX        60     74       {ECO:0000244|PDB:2P31}.
FT   HELIX        75     77       {ECO:0000244|PDB:2P31}.
FT   STRAND       79     85       {ECO:0000244|PDB:2P31}.
FT   HELIX        97    108       {ECO:0000244|PDB:2P31}.
FT   HELIX       127    136       {ECO:0000244|PDB:2P31}.
FT   STRAND      146    149       {ECO:0000244|PDB:2P31}.
FT   STRAND      155    159       {ECO:0000244|PDB:2P31}.
FT   HELIX       165    173       {ECO:0000244|PDB:2P31}.
SQ   SEQUENCE   187 AA;  20996 MW;  0ACB80AC2522EFCD CRC64;
     MVAATVAAAW LLLWAAACAQ QEQDFYDFKA VNIRGKLVSL EKYRGSVSLV VNVASECGFT
     DQHYRALQQL QRDLGPHHFN VLAFPCNQFG QQEPDSNKEI ESFARRTYSV SFPMFSKIAV
     TGTGAHPAFK YLAQTSGKEP TWNFWKYLVA PDGKVVGAWD PTVSVEEVRP QITALVRKLI
     LLKREDL
//
ID   PCSK9_HUMAN             Reviewed;         692 AA.
AC   Q8NBP7; A8T640; C0JYY9; Q5PSM5; Q5SZQ2;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   23-MAY-2018, entry version 171.
DE   RecName: Full=Proprotein convertase subtilisin/kexin type 9;
DE            EC=3.4.21.-;
DE   AltName: Full=Neural apoptosis-regulated convertase 1;
DE            Short=NARC-1;
DE   AltName: Full=Proprotein convertase 9;
DE            Short=PC9;
DE   AltName: Full=Subtilisin/kexin-like protease PC9;
DE   Flags: Precursor;
GN   Name=PCSK9; Synonyms=NARC1; ORFNames=PSEC0052;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ILE-474 AND
RP   GLU-670.
RA   Chiang L.W.;
RT   "Nucleic acid molecules derived from rat brain and programmed cell
RT   death models.";
RL   Patent number WO0131007, 03-MAY-2001.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ILE-474 AND
RP   GLU-670.
RX   PubMed=17971861; DOI=10.1371/journal.pone.0001098;
RA   Ding K., McDonough S.J., Kullo I.J.;
RT   "Evidence for positive selection in the C-terminal domain of the
RT   cholesterol metabolism gene PCSK9 based on phylogenetic analysis in 14
RT   primate species.";
RL   PLoS ONE 2:E1098-E1098(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   ILE-474.
RC   TISSUE=Cerebellum, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-23 INS; LEU-46;
RP   VAL-53; SER-425; THR-443; ILE-474; ARG-553; PRO-619 AND GLU-670.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-23 INS; ILE-474
RP   AND GLU-670.
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2008) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS ILE-474
RP   AND GLU-670.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   PROTEIN SEQUENCE OF N-TERMINUS, CHARACTERIZATION, AND MUTAGENESIS OF
RP   CYS-67; HIS-226 AND ASN-533.
RX   PubMed=12552133; DOI=10.1073/pnas.0335507100;
RA   Seidah N.G., Benjannet S., Wickham L., Marcinkiewicz J., Jasmin S.B.,
RA   Stifani S., Basak A., Prat A., Chretien M.;
RT   "The secretory proprotein convertase neural apoptosis-regulated
RT   convertase 1 (NARC-1): liver regeneration and neuronal
RT   differentiation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:928-933(2003).
RN   [9]
RP   AUTOCATALYTIC CLEAVAGE AT GLN-152.
RX   PubMed=14622975; DOI=10.1016/j.abb.2003.09.011;
RA   Naureckiene S., Ma L., Sreekumar K., Purandare U., Lo C.F., Huang Y.,
RA   Chiang L.W., Grenier J.M., Ozenberger B.A., Jacobsen J.S.,
RA   Kennedy J.D., DiStefano P.S., Wood A., Bingham B.;
RT   "Functional characterization of Narc 1, a novel proteinase related to
RT   proteinase K.";
RL   Arch. Biochem. Biophys. 420:55-67(2003).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-688, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   GLYCOSYLATION AT ASN-533, SULFATION AT TYR-38, AND PROTEOLYTIC
RP   CLEAVAGE AT ARG-218 BY FURIN AND PCSK5.
RX   PubMed=16912035; DOI=10.1074/jbc.M606495200;
RA   Benjannet S., Rhainds D., Hamelin J., Nassoury N., Seidah N.G.;
RT   "The proprotein convertase (PC) PCSK9 is inactivated by furin and/or
RT   PC5/6A: functional consequences of natural mutations and post-
RT   translational modifications.";
RL   J. Biol. Chem. 281:30561-30572(2006).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH LDLR.
RX   PubMed=17461796; DOI=10.1111/j.1600-0854.2007.00562.x;
RA   Nassoury N., Blasiole D.A., Tebon Oler A., Benjannet S., Hamelin J.,
RA   Poupon V., McPherson P.S., Attie A.D., Prat A., Seidah N.G.;
RT   "The cellular trafficking of the secretory proprotein convertase PCSK9
RT   and its dependence on the LDLR.";
RL   Traffic 8:718-732(2007).
RN   [13]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=18197702; DOI=10.1021/bi7016359;
RA   Fan D., Yancey P.G., Qiu S., Ding L., Weeber E.J., Linton M.F.,
RA   Fazio S.;
RT   "Self-association of human PCSK9 correlates with its LDLR-degrading
RT   activity.";
RL   Biochemistry 47:1631-1639(2008).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH BACE1.
RX   PubMed=18660751; DOI=10.1038/embor.2008.132;
RA   Jonas M.C., Costantini C., Puglielli L.;
RT   "PCSK9 is required for the disposal of non-acetylated intermediates of
RT   the nascent membrane protein BACE1.";
RL   EMBO Rep. 9:916-922(2008).
RN   [15]
RP   PHOSPHORYLATION AT SER-47 AND SER-688, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=18498363; DOI=10.1111/j.1742-4658.2008.06495.x;
RA   Dewpura T., Raymond A., Hamelin J., Seidah N.G., Mbikay M.,
RA   Chretien M., Mayne J.;
RT   "PCSK9 is phosphorylated by a Golgi casein kinase-like kinase ex vivo
RT   and circulates as a phosphoprotein in humans.";
RL   FEBS J. 275:3480-3493(2008).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH VLDLR AND
RP   LRP8/APOER2.
RX   PubMed=18039658; DOI=10.1074/jbc.M708098200;
RA   Poirier S., Mayer G., Benjannet S., Bergeron E., Marcinkiewicz J.,
RA   Nassoury N., Mayer H., Nimpf J., Prat A., Seidah N.G.;
RT   "The proprotein convertase PCSK9 induces the degradation of low
RT   density lipoprotein receptor (LDLR) and its closest family members
RT   VLDLR and ApoER2.";
RL   J. Biol. Chem. 283:2363-2372(2008).
RN   [17]
RP   FUNCTION, INTERACTION WITH ANXA2, VARIANT HCHOLA3 TYR-374,
RP   CHARACTERIZATION OF VARIANT HCHOLA3 TYR-374, VARIANT GLU-554, AND
RP   CHARACTERIZATION OF VARIANT GLU-554.
RX   PubMed=18799458; DOI=10.1074/jbc.M805971200;
RA   Mayer G., Poirier S., Seidah N.G.;
RT   "Annexin A2 is a C-terminal PCSK9-binding protein that regulates
RT   endogenous low density lipoprotein receptor levels.";
RL   J. Biol. Chem. 283:31791-31801(2008).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-688, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   FUNCTION.
RX   PubMed=22074827; DOI=10.1016/j.bbrc.2011.10.110;
RA   Chen Y., Wang H., Yu L., Yu X., Qian Y.W., Cao G., Wang J.;
RT   "Role of ubiquitination in PCSK9-mediated low-density lipoprotein
RT   receptor degradation.";
RL   Biochem. Biophys. Res. Commun. 415:515-518(2011).
RN   [21]
RP   INTERACTION WITH LDLR.
RX   PubMed=21149300; DOI=10.1074/jbc.M110.199042;
RA   Yamamoto T., Lu C., Ryan R.O.;
RT   "A two-step binding model of PCSK9 interaction with the low density
RT   lipoprotein receptor.";
RL   J. Biol. Chem. 286:5464-5470(2011).
RN   [22]
RP   DOMAIN C-TERMINAL.
RX   PubMed=22027821; DOI=10.1074/jbc.M111.273474;
RA   Du F., Hui Y., Zhang M., Linton M.F., Fazio S., Fan D.;
RT   "Novel domain interaction regulates secretion of proprotein convertase
RT   subtilisin/kexin type 9 (PCSK9) protein.";
RL   J. Biol. Chem. 286:43054-43061(2011).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-688, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [24]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH APOB.
RX   PubMed=22580899; DOI=10.1161/ATVBAHA.112.250043;
RA   Sun H., Samarghandi A., Zhang N., Yao Z., Xiong M., Teng B.B.;
RT   "Proprotein convertase subtilisin/kexin type 9 interacts with
RT   apolipoprotein B and prevents its intracellular degradation,
RT   irrespective of the low-density lipoprotein receptor.";
RL   Arterioscler. Thromb. Vasc. Biol. 32:1585-1595(2012).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-688, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   PHOSPHORYLATION AT SER-47 AND SER-688.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted
RT   phosphoproteome.";
RL   Cell 161:1619-1632(2015).
RN   [27]
RP   REVIEW.
RX   PubMed=18280815; DOI=10.1016/j.bbalip.2008.01.003;
RA   Lopez D.;
RT   "PCSK9: an enigmatic protease.";
RL   Biochim. Biophys. Acta 1781:184-191(2008).
RN   [28]
RP   REVIEW.
RX   PubMed=18649882; DOI=10.1016/j.atherosclerosis.2008.06.010;
RA   Lambert G., Charlton F., Rye K.A., Piper D.E.;
RT   "Molecular basis of PCSK9 function.";
RL   Atherosclerosis 203:1-7(2009).
RN   [29]
RP   REVIEW.
RX   PubMed=19930098; DOI=10.1111/j.1365-2796.2009.02167.x;
RA   Mousavi S.A., Berge K.E., Leren T.P.;
RT   "The unique role of proprotein convertase subtilisin/kexin 9 in
RT   cholesterol homeostasis.";
RL   J. Intern. Med. 266:507-519(2009).
RN   [30]
RP   REVIEW.
RX   PubMed=19020338; DOI=10.1194/jlr.R800091-JLR200;
RA   Horton J.D., Cohen J.C., Hobbs H.H.;
RT   "PCSK9: a convertase that coordinates LDL catabolism.";
RL   J. Lipid Res. 50:S172-S177(2009).
RN   [31]
RP   REVIEW.
RX   PubMed=21943799; DOI=10.1016/j.numecd.2011.06.002;
RA   Tibolla G., Norata G.D., Artali R., Meneghetti F., Catapano A.L.;
RT   "Proprotein convertase subtilisin/kexin type 9 (PCSK9): from
RT   structure-function relation to therapeutic inhibition.";
RL   Nutr. Metab. Cardiovasc. Dis. 21:835-843(2011).
RN   [32]
RP   REVIEW ON VARIANTS.
RX   PubMed=19191301; DOI=10.1002/humu.20882;
RA   Abifadel M., Rabes J.P., Devillers M., Munnich A., Erlich D.,
RA   Junien C., Varret M., Boileau C.;
RT   "Mutations and polymorphisms in the proprotein convertase subtilisin
RT   kexin 9 (PCSK9) gene in cholesterol metabolism and disease.";
RL   Hum. Mutat. 30:520-529(2009).
RN   [33]
RP   POLYMORPHISM, AND VARIANT SER-174.
RX   PubMed=22417841; DOI=10.1016/j.atherosclerosis.2012.02.018;
RA   Slimani A., Jelassi A., Jguirim I., Najah M., Rebhi L., Omezzine A.,
RA   Maatouk F., Hamda K.B., Kacem M., Rabes J.P., Abifadel M., Boileau C.,
RA   Rouis M., Slimane M.N., Varret M.;
RT   "Effect of mutations in LDLR and PCSK9 genes on phenotypic variability
RT   in Tunisian familial hypercholesterolemia patients.";
RL   Atherosclerosis 222:158-166(2012).
RN   [34]
RP   FUNCTION, AND INTERACTION WITH SCNN1A; SCNN1B AND SCNN1G.
RX   PubMed=22493497; DOI=10.1074/jbc.M112.363382;
RA   Sharotri V., Collier D.M., Olson D.R., Zhou R., Snyder P.M.;
RT   "Regulation of epithelial sodium channel trafficking by proprotein
RT   convertase subtilisin/kexin type 9 (PCSK9).";
RL   J. Biol. Chem. 287:19266-19274(2012).
RN   [35]
RP   FUNCTION, INTERACTION WITH ANXA2, VARIANT GLN-482, CHARACTERIZATION OF
RP   VARIANT GLN-482, VARIANTS HCHOLA3 SER-218 AND TYR-374,
RP   CHARACTERIZATION OF VARIANTS HCHOLA3 SER-218 AND TYR-374, SULFATION,
RP   PHOSPHORYLATION, GLYCOSYLATION, AND SUBUNIT.
RX   PubMed=24808179; DOI=10.1074/jbc.M113.541094;
RA   Ly K., Saavedra Y.G., Canuel M., Routhier S., Desjardins R.,
RA   Hamelin J., Mayne J., Lazure C., Seidah N.G., Day R.;
RT   "Annexin A2 reduces PCSK9 protein levels via a translational mechanism
RT   and interacts with the M1 and M2 domains of PCSK9.";
RL   J. Biol. Chem. 289:17732-17746(2014).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 31-692.
RX   PubMed=17502100; DOI=10.1016/j.str.2007.04.004;
RA   Piper D.E., Jackson S., Liu Q., Romanow W.G., Shetterly S.,
RA   Thibault S.T., Shan B., Walker N.P.;
RT   "The crystal structure of PCSK9: a regulator of plasma LDL-
RT   cholesterol.";
RL   Structure 15:545-552(2007).
RN   [37]
RP   VARIANTS HCHOLA3 ARG-127 AND LEU-216, AND VARIANTS LEU-46; VAL-53 AND
RP   GLU-670.
RX   PubMed=12730697; DOI=10.1038/ng1161;
RA   Abifadel M., Varret M., Rabes J.-P., Allard D., Ouguerram K.,
RA   Devillers M., Cruaud C., Benjannet S., Wickham L., Erlich D.,
RA   Derre A., Villeger L., Farnier M., Beucler I., Bruckert E.,
RA   Chambaz J., Chanu B., Lecerf J.-M., Luc G., Moulin P., Weissenbach J.,
RA   Prat A., Krempf M., Junien C., Seidah N.G., Boileau C.;
RT   "Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.";
RL   Nat. Genet. 34:154-156(2003).
RN   [38]
RP   VARIANTS LEU-46; VAL-53; LYS-57; TRP-237; PHE-253; ASN-391; GLN-417;
RP   SER-425; THR-443; TRP-469; ILE-474; GLY-482; LEU-515; ARG-553;
RP   GLU-554; PRO-619 AND GLU-670.
RX   PubMed=16465619; DOI=10.1086/500615;
RA   Kotowski I.K., Pertsemlidis A., Luke A., Cooper R.S., Vega G.L.,
RA   Cohen J.C., Hobbs H.H.;
RT   "A spectrum of PCSK9 alleles contributes to plasma levels of low-
RT   density lipoprotein cholesterol.";
RL   Am. J. Hum. Genet. 78:410-422(2006).
RN   [39]
RP   POLYMORPHISM, VARIANT LEU-23 INS, AND IMPACT ON FAMILIAL
RP   HYPERCHOLESTEROLEMIA.
RX   PubMed=19319977; DOI=10.1002/humu.21002;
RA   Abifadel M., Rabes J.-P., Jambart S., Halaby G., Gannage-Yared M.-H.,
RA   Sarkis A., Beaino G., Varret M., Salem N., Corbani S., Aydenian H.,
RA   Junien C., Munnich A., Boileau C.;
RT   "The molecular basis of familial hypercholesterolemia in Lebanon:
RT   spectrum of LDLR mutations and role of PCSK9 as a modifier gene.";
RL   Hum. Mutat. 30:E682-E691(2009).
RN   [40]
RP   POLYMORPHISM, AND VARIANTS LEU-23 INS; LEU-46; VAL-53; SER-394;
RP   ILE-474 AND GLU-670.
RX   PubMed=22095935; DOI=10.1002/humu.21660;
RA   Huijgen R., Sjouke B., Vis K., de Randamie J.S., Defesche J.C.,
RA   Kastelein J.J., Hovingh G.K., Fouchier S.W.;
RT   "Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of
RT   pathogenic autosomal dominant hypercholesterolemic mutations with
RT   unexpected low LDL-Cl Levels.";
RL   Hum. Mutat. 33:448-455(2012).
CC   -!- FUNCTION: Crucial player in the regulation of plasma cholesterol
CC       homeostasis. Binds to low-density lipid receptor family members:
CC       low density lipoprotein receptor (LDLR), very low density
CC       lipoprotein receptor (VLDLR), apolipoprotein E receptor
CC       (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and
CC       promotes their degradation in intracellular acidic compartments
CC       (PubMed:18039658). Acts via a non-proteolytic mechanism to enhance
CC       the degradation of the hepatic LDLR through a clathrin
CC       LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR
CC       from endosomes to the cell surface or direct it to lysosomes for
CC       degradation. Can induce ubiquitination of LDLR leading to its
CC       subsequent degradation (PubMed:18799458, PubMed:17461796,
CC       PubMed:18197702, PubMed:22074827). Inhibits intracellular
CC       degradation of APOB via the autophagosome/lysosome pathway in a
CC       LDLR-independent manner. Involved in the disposal of non-
CC       acetylated intermediates of BACE1 in the early secretory pathway
CC       (PubMed:18660751). Inhibits epithelial Na(+) channel (ENaC)-
CC       mediated Na(+) absorption by reducing ENaC surface expression
CC       primarily by increasing its proteasomal degradation. Regulates
CC       neuronal apoptosis via modulation of LRP8/APOER2 levels and
CC       related anti-apoptotic signaling pathways.
CC       {ECO:0000269|PubMed:17461796, ECO:0000269|PubMed:18039658,
CC       ECO:0000269|PubMed:18197702, ECO:0000269|PubMed:18660751,
CC       ECO:0000269|PubMed:18799458, ECO:0000269|PubMed:22074827,
CC       ECO:0000269|PubMed:22493497, ECO:0000269|PubMed:22580899}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000305};
CC   -!- ENZYME REGULATION: Its proteolytic activity is autoinhibited by
CC       the non-covalent binding of the propeptide to the catalytic
CC       domain. Inhibited by EGTA.
CC   -!- SUBUNIT: Monomer. Can self-associate to form dimers and higher
CC       multimers which may have increased LDLR degrading activity. The
CC       precursor protein but not the mature protein may form multimers.
CC       Interacts with APOB, VLDLR, LRP8/APOER2 and BACE1. The full-length
CC       immature form (pro-PCSK9) interacts with SCNN1A, SCNN1B and
CC       SCNN1G. The pro-PCSK9 form (via C-terminal domain) interacts with
CC       LDLR. Interacts (via the C-terminal domain) with ANXA2 (via repeat
CC       Annexin 1); the interaction inhibits the degradation of LDLR
CC       (PubMed:18799458). {ECO:0000269|PubMed:17461796,
CC       ECO:0000269|PubMed:18039658, ECO:0000269|PubMed:18197702,
CC       ECO:0000269|PubMed:18660751, ECO:0000269|PubMed:18799458,
CC       ECO:0000269|PubMed:21149300, ECO:0000269|PubMed:22493497,
CC       ECO:0000269|PubMed:22580899, ECO:0000269|PubMed:24808179}.
CC   -!- INTERACTION:
CC       P07355:ANXA2; NbExp=7; IntAct=EBI-7539251, EBI-352622;
CC       P01130:LDLR; NbExp=10; IntAct=EBI-7539251, EBI-988319;
CC       P08253:MMP2; NbExp=4; IntAct=EBI-7539251, EBI-1033518;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Secreted. Endosome. Lysosome.
CC       Cell surface. Endoplasmic reticulum. Golgi apparatus.
CC       Note=Autocatalytic cleavage is required to transport it from the
CC       endoplasmic reticulum to the Golgi apparatus and for the secretion
CC       of the mature protein. Localizes to the endoplasmic reticulum in
CC       the absence of LDLR and colocalizes to the cell surface and to the
CC       endosomes/lysosomes in the presence of LDLR. The sorting to the
CC       cell surface and endosomes is required in order to fully promote
CC       LDLR degradation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8NBP7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NBP7-2; Sequence=VSP_008844, VSP_008845, VSP_008846;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in neuro-epithelioma, colon
CC       carcinoma, hepatic and pancreatic cell lines, and in Schwann
CC       cells.
CC   -!- DOMAIN: The C-terminal domain (CRD) is essential for the LDLR-
CC       binding and degrading activities. {ECO:0000269|PubMed:22027821}.
CC   -!- DOMAIN: The catalytic domain is responsible for mediating its
CC       self-association. {ECO:0000269|PubMed:22027821}.
CC   -!- PTM: Cleavage by furin and PCSK5 generates a truncated inactive
CC       protein that is unable to induce LDLR degradation.
CC       {ECO:0000269|PubMed:16912035}.
CC   -!- PTM: Undergoes autocatalytic cleavage in the endoplasmic reticulum
CC       to release the propeptide from the N-terminus and the cleavage of
CC       the propeptide is strictly required for its maturation and
CC       activation. The cleaved propeptide however remains associated with
CC       the catalytic domain through non-covalent interactions, preventing
CC       potential substrates from accessing its active site. As a result,
CC       it is secreted from cells as a propeptide-containing,
CC       enzymatically inactive protein. {ECO:0000269|PubMed:14622975}.
CC   -!- PTM: Phosphorylation protects the propeptide against proteolysis.
CC       {ECO:0000269|PubMed:18498363}.
CC   -!- POLYMORPHISM: Variant Leu-23 ins polymorphism in PCSK9 might have
CC       a modifier effect on LDLR mutation and familial
CC       hypercholesterolemia.
CC   -!- POLYMORPHISM: Genetic variations in PCSK9 define the low density
CC       lipoprotein cholesterol level quantitative trait locus 1 (LDLCQ1)
CC       [MIM:603776]. {ECO:0000269|PubMed:19319977,
CC       ECO:0000269|PubMed:22095935, ECO:0000269|PubMed:22417841}.
CC   -!- DISEASE: Hypercholesterolemia, autosomal dominant, 3 (HCHOLA3)
CC       [MIM:603776]: A familial condition characterized by elevated
CC       circulating cholesterol contained in either low-density
CC       lipoproteins alone or also in very-low-density lipoproteins.
CC       {ECO:0000269|PubMed:12730697, ECO:0000269|PubMed:18799458,
CC       ECO:0000269|PubMed:24808179}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the peptidase S8 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11572.1; Type=Frameshift; Positions=494; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/pcsk9/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AX127530; CAC38896.1; -; mRNA.
DR   EMBL; EF692496; ABV59216.1; -; mRNA.
DR   EMBL; AK075365; BAC11572.1; ALT_FRAME; mRNA.
DR   EMBL; AK124635; BAC85910.1; -; mRNA.
DR   EMBL; AY829011; AAV67948.1; -; Genomic_DNA.
DR   EMBL; FJ525880; ACN81318.1; -; Genomic_DNA.
DR   EMBL; AC091609; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL589790; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06660.1; -; Genomic_DNA.
DR   CCDS; CCDS603.1; -. [Q8NBP7-1]
DR   RefSeq; NP_777596.2; NM_174936.3. [Q8NBP7-1]
DR   UniGene; Hs.18844; -.
DR   PDB; 2P4E; X-ray; 1.98 A; A/P=1-692.
DR   PDB; 2PMW; X-ray; 2.30 A; A=31-152, B=153-692.
DR   PDB; 2QTW; X-ray; 1.90 A; A=29-152, B=153-692.
DR   PDB; 2W2M; X-ray; 2.40 A; A=153-451, P=53-152.
DR   PDB; 2W2N; X-ray; 2.30 A; A=153-451, P=53-152.
DR   PDB; 2W2O; X-ray; 2.62 A; A=153-451, P=53-152.
DR   PDB; 2W2P; X-ray; 2.62 A; A=153-451, P=53-152.
DR   PDB; 2W2Q; X-ray; 2.33 A; A=153-451, P=53-152.
DR   PDB; 2XTJ; X-ray; 2.70 A; A=153-451, P=53-152.
DR   PDB; 3BPS; X-ray; 2.41 A; A=153-692, P=53-152.
DR   PDB; 3GCW; X-ray; 2.70 A; A=153-692, P=53-152.
DR   PDB; 3GCX; X-ray; 2.70 A; A=153-692, P=53-152.
DR   PDB; 3H42; X-ray; 2.30 A; A=31-152, B=153-692.
DR   PDB; 3M0C; X-ray; 7.01 A; A=29-152, B=153-692.
DR   PDB; 3P5B; X-ray; 3.30 A; A=153-692, P=61-152.
DR   PDB; 3P5C; X-ray; 4.20 A; A=153-692, P=61-152.
DR   PDB; 3SQO; X-ray; 2.70 A; A=153-692, P=31-152.
DR   PDB; 4K8R; X-ray; 3.22 A; A=61-152, B=153-692.
DR   PDB; 4NE9; X-ray; 2.60 A; A/B=153-692, C/P=1-152.
DR   PDB; 4NMX; X-ray; 1.85 A; A=31-152, B=153-452.
DR   PDB; 4OV6; X-ray; 2.69 A; A/D=60-152, B/E=153-446.
DR   PDB; 5OCA; X-ray; 2.30 A; A=31-152, B=153-692.
DR   PDB; 5VL7; X-ray; 3.50 A; A=31-152, B=153-692.
DR   PDB; 5VLA; X-ray; 2.40 A; A=1-452.
DR   PDB; 5VLH; X-ray; 2.86 A; A=1-452.
DR   PDB; 5VLK; X-ray; 2.20 A; A=1-452.
DR   PDB; 5VLL; X-ray; 2.37 A; A=1-452.
DR   PDB; 5VLP; X-ray; 2.90 A; A=1-692.
DR   PDBsum; 2P4E; -.
DR   PDBsum; 2PMW; -.
DR   PDBsum; 2QTW; -.
DR   PDBsum; 2W2M; -.
DR   PDBsum; 2W2N; -.
DR   PDBsum; 2W2O; -.
DR   PDBsum; 2W2P; -.
DR   PDBsum; 2W2Q; -.
DR   PDBsum; 2XTJ; -.
DR   PDBsum; 3BPS; -.
DR   PDBsum; 3GCW; -.
DR   PDBsum; 3GCX; -.
DR   PDBsum; 3H42; -.
DR   PDBsum; 3M0C; -.
DR   PDBsum; 3P5B; -.
DR   PDBsum; 3P5C; -.
DR   PDBsum; 3SQO; -.
DR   PDBsum; 4K8R; -.
DR   PDBsum; 4NE9; -.
DR   PDBsum; 4NMX; -.
DR   PDBsum; 4OV6; -.
DR   PDBsum; 5OCA; -.
DR   PDBsum; 5VL7; -.
DR   PDBsum; 5VLA; -.
DR   PDBsum; 5VLH; -.
DR   PDBsum; 5VLK; -.
DR   PDBsum; 5VLL; -.
DR   PDBsum; 5VLP; -.
DR   ProteinModelPortal; Q8NBP7; -.
DR   SMR; Q8NBP7; -.
DR   BioGrid; 129116; 27.
DR   DIP; DIP-29694N; -.
DR   IntAct; Q8NBP7; 5.
DR   MINT; Q8NBP7; -.
DR   STRING; 9606.ENSP00000303208; -.
DR   BindingDB; Q8NBP7; -.
DR   ChEMBL; CHEMBL2929; -.
DR   DrugBank; DB09302; Alirocumab.
DR   DrugBank; DB09303; Evolocumab.
DR   GuidetoPHARMACOLOGY; 2388; -.
DR   MEROPS; S08.039; -.
DR   iPTMnet; Q8NBP7; -.
DR   PhosphoSitePlus; Q8NBP7; -.
DR   BioMuta; PCSK9; -.
DR   DMDM; 317373487; -.
DR   EPD; Q8NBP7; -.
DR   MaxQB; Q8NBP7; -.
DR   PaxDb; Q8NBP7; -.
DR   PeptideAtlas; Q8NBP7; -.
DR   PRIDE; Q8NBP7; -.
DR   DNASU; 255738; -.
DR   Ensembl; ENST00000302118; ENSP00000303208; ENSG00000169174. [Q8NBP7-1]
DR   GeneID; 255738; -.
DR   KEGG; hsa:255738; -.
DR   UCSC; uc001cyf.3; human. [Q8NBP7-1]
DR   CTD; 255738; -.
DR   DisGeNET; 255738; -.
DR   EuPathDB; HostDB:ENSG00000169174.10; -.
DR   GeneCards; PCSK9; -.
DR   GeneReviews; PCSK9; -.
DR   H-InvDB; HIX0023558; -.
DR   HGNC; HGNC:20001; PCSK9.
DR   MalaCards; PCSK9; -.
DR   MIM; 603776; phenotype.
DR   MIM; 607786; gene.
DR   neXtProt; NX_Q8NBP7; -.
DR   OpenTargets; ENSG00000169174; -.
DR   Orphanet; 426; Familial hypobetalipoproteinemia.
DR   Orphanet; 406; Heterozygous familial hypercholesterolemia.
DR   Orphanet; 391665; Homozygous familial hypercholesterolemia.
DR   PharmGKB; PA38617; -.
DR   eggNOG; KOG1153; Eukaryota.
DR   eggNOG; COG1404; LUCA.
DR   GeneTree; ENSGT00490000043472; -.
DR   HOGENOM; HOG000049267; -.
DR   HOVERGEN; HBG053530; -.
DR   InParanoid; Q8NBP7; -.
DR   KO; K13050; -.
DR   OMA; HVLTGCS; -.
DR   OrthoDB; EOG091G067E; -.
DR   PhylomeDB; Q8NBP7; -.
DR   TreeFam; TF106271; -.
DR   BRENDA; 3.4.21.61; 2681.
DR   Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-HSA-8866427; VLDLR internalisation and degradation.
DR   Reactome; R-HSA-8957275; Post-translational protein phosphorylation.
DR   Reactome; R-HSA-8964038; LDL clearance.
DR   SignaLink; Q8NBP7; -.
DR   SIGNOR; Q8NBP7; -.
DR   EvolutionaryTrace; Q8NBP7; -.
DR   GeneWiki; PCSK9; -.
DR   GenomeRNAi; 255738; -.
DR   PRO; PR:Q8NBP7; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000169174; -.
DR   CleanEx; HS_PCSK9; -.
DR   Genevisible; Q8NBP7; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0030134; C:COPII-coated ER to Golgi transport vesicle; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005769; C:early endosome; IDA:UniProtKB.
DR   GO; GO:0036020; C:endolysosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:HGNC.
DR   GO; GO:0031232; C:extrinsic component of external side of plasma membrane; IC:BHF-UCL.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0005770; C:late endosome; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; TAS:Reactome.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:1990667; C:PCSK9-AnxA2 complex; IDA:BHF-UCL.
DR   GO; GO:1990666; C:PCSK9-LDLR complex; IDA:BHF-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0034185; F:apolipoprotein binding; ISS:UniProtKB.
DR   GO; GO:0034190; F:apolipoprotein receptor binding; IDA:BHF-UCL.
DR   GO; GO:0030169; F:low-density lipoprotein particle binding; ISS:UniProtKB.
DR   GO; GO:0050750; F:low-density lipoprotein particle receptor binding; IDA:HGNC.
DR   GO; GO:0043621; F:protein self-association; IDA:UniProtKB.
DR   GO; GO:0030547; F:receptor inhibitor activity; IDA:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IDA:HGNC.
DR   GO; GO:0019871; F:sodium channel inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0034189; F:very-low-density lipoprotein particle binding; ISS:UniProtKB.
DR   GO; GO:0070326; F:very-low-density lipoprotein particle receptor binding; IDA:BHF-UCL.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISS:HGNC.
DR   GO; GO:0009267; P:cellular response to starvation; ISS:HGNC.
DR   GO; GO:0042632; P:cholesterol homeostasis; IMP:HGNC.
DR   GO; GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0001822; P:kidney development; ISS:HGNC.
DR   GO; GO:0042157; P:lipoprotein metabolic process; IEA:Ensembl.
DR   GO; GO:0001889; P:liver development; ISS:HGNC.
DR   GO; GO:0034383; P:low-density lipoprotein particle clearance; TAS:Reactome.
DR   GO; GO:0032802; P:low-density lipoprotein particle receptor catabolic process; IDA:UniProtKB.
DR   GO; GO:0007041; P:lysosomal transport; IDA:BHF-UCL.
DR   GO; GO:0010989; P:negative regulation of low-density lipoprotein particle clearance; IDA:BHF-UCL.
DR   GO; GO:1905596; P:negative regulation of low-density lipoprotein particle receptor binding; IDA:BHF-UCL.
DR   GO; GO:1905598; P:negative regulation of low-density lipoprotein receptor activity; IDA:BHF-UCL.
DR   GO; GO:0001920; P:negative regulation of receptor recycling; IDA:BHF-UCL.
DR   GO; GO:1905601; P:negative regulation of receptor-mediated endocytosis involved in cholesterol transport; IDA:BHF-UCL.
DR   GO; GO:2000650; P:negative regulation of sodium ion transmembrane transporter activity; IDA:BHF-UCL.
DR   GO; GO:0022008; P:neurogenesis; ISS:HGNC.
DR   GO; GO:0030182; P:neuron differentiation; ISS:HGNC.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:Ensembl.
DR   GO; GO:0032805; P:positive regulation of low-density lipoprotein particle receptor catabolic process; IDA:BHF-UCL.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:HGNC.
DR   GO; GO:0002092; P:positive regulation of receptor internalization; IDA:BHF-UCL.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0016540; P:protein autoprocessing; IDA:HGNC.
DR   GO; GO:0043523; P:regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0010469; P:regulation of signaling receptor activity; IDA:BHF-UCL.
DR   GO; GO:0006641; P:triglyceride metabolic process; IEA:Ensembl.
DR   CDD; cd04077; Peptidases_S8_PCSK9_Proteinase; 1.
DR   Gene3D; 3.30.70.80; -; 1.
DR   Gene3D; 3.40.50.200; -; 1.
DR   InterPro; IPR034193; PCSK9_ProteinaseK-like.
DR   InterPro; IPR000209; Peptidase_S8/S53_dom.
DR   InterPro; IPR036852; Peptidase_S8/S53_dom_sf.
DR   InterPro; IPR015500; Peptidase_S8_subtilisin-rel.
DR   InterPro; IPR010259; S8pro/Inhibitor_I9.
DR   InterPro; IPR037045; S8pro/Inhibitor_I9_sf.
DR   Pfam; PF05922; Inhibitor_I9; 1.
DR   Pfam; PF00082; Peptidase_S8; 1.
DR   PRINTS; PR00723; SUBTILISIN.
DR   SUPFAM; SSF52743; SSF52743; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; Autocatalytic cleavage;
KW   Calcium; Cholesterol metabolism; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Golgi apparatus;
KW   Hydrolase; Lipid metabolism; Lysosome; Phosphoprotein; Polymorphism;
KW   Protease; Reference proteome; Secreted; Serine protease; Signal;
KW   Steroid metabolism; Sterol metabolism; Sulfation; Zymogen.
FT   SIGNAL        1     30       {ECO:0000269|PubMed:12552133}.
FT   PROPEP       31    152       {ECO:0000269|PubMed:12552133}.
FT                                /FTId=PRO_0000027120.
FT   CHAIN       153    692       Proprotein convertase subtilisin/kexin
FT                                type 9.
FT                                /FTId=PRO_0000027121.
FT   DOMAIN      182    424       Peptidase S8.
FT   REGION      450    692       C-terminal domain.
FT   ACT_SITE    186    186       Charge relay system. {ECO:0000250}.
FT   ACT_SITE    226    226       Charge relay system. {ECO:0000250}.
FT   ACT_SITE    386    386       Charge relay system. {ECO:0000250}.
FT   SITE        152    153       Cleavage; by autolysis.
FT                                {ECO:0000269|PubMed:14622975}.
FT   SITE        218    219       Cleavage; by furin and PCSK5.
FT                                {ECO:0000269|PubMed:16912035}.
FT   MOD_RES      38     38       Sulfotyrosine.
FT                                {ECO:0000269|PubMed:16912035}.
FT   MOD_RES      47     47       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:18498363,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     688    688       Phosphoserine; by FAM20C.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:18498363,
FT                                ECO:0000269|PubMed:26091039}.
FT   CARBOHYD    533    533       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16912035}.
FT   DISULFID    223    255       {ECO:0000255}.
FT   DISULFID    323    358       {ECO:0000255}.
FT   DISULFID    457    527       {ECO:0000255}.
FT   DISULFID    477    526       {ECO:0000255}.
FT   DISULFID    486    509       {ECO:0000255}.
FT   DISULFID    534    601       {ECO:0000255}.
FT   DISULFID    552    600       {ECO:0000255}.
FT   DISULFID    562    588       {ECO:0000255}.
FT   DISULFID    608    679       {ECO:0000255}.
FT   DISULFID    626    678       {ECO:0000255}.
FT   DISULFID    635    654       {ECO:0000255}.
FT   VAR_SEQ       1    174       MGTVSSRRSWWPLPLLLLLLLLLGPAGARAQEDEDGDYEEL
FT                                VLALRSEEDGLAEAPEHGTTATFHRCAKDPWRLPGTYVVVL
FT                                KEETHLSQSERTARRLQAQAARRGYLTKILHVFHGLLPGFL
FT                                VKMSGDLLELALKLPHVDYIEEDSSVFAQSIPWNLERITPP
FT                                RYRADEYQPP -> MSPWK (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_008844.
FT   VAR_SEQ     333    365       VITVGATNAQDQPVTLGTLGTNFGRCVDLFAPG -> GRTS
FT                                LVPPATAAPALCHRVGHHRLLPTWLALQP (in isoform
FT                                2). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_008845.
FT   VAR_SEQ     366    692       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_008846.
FT   VARIANT      23     23       L -> LL (this polymoprhism seems to have
FT                                a modifier effect on LDLR mutation and
FT                                familial hypercholesterolemia).
FT                                {ECO:0000269|PubMed:19319977,
FT                                ECO:0000269|PubMed:22095935,
FT                                ECO:0000269|Ref.4, ECO:0000269|Ref.5}.
FT                                /FTId=VAR_021336.
FT   VARIANT      46     46       R -> L (polymorphism; associated with
FT                                lower plasma levels of low-density
FT                                lipoprotein cholesterol; reduced
FT                                phosphorylation at Ser-47;
FT                                dbSNP:rs11591147).
FT                                {ECO:0000269|PubMed:12730697,
FT                                ECO:0000269|PubMed:16465619,
FT                                ECO:0000269|PubMed:22095935,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_017197.
FT   VARIANT      53     53       A -> V (polymorphism; associated with
FT                                reduced phosphorylation at Ser-47;
FT                                dbSNP:rs11583680).
FT                                {ECO:0000269|PubMed:12730697,
FT                                ECO:0000269|PubMed:16465619,
FT                                ECO:0000269|PubMed:22095935,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_017198.
FT   VARIANT      57     57       E -> K (in dbSNP:rs145886902).
FT                                {ECO:0000269|PubMed:16465619}.
FT                                /FTId=VAR_025451.
FT   VARIANT      77     77       T -> I (in dbSNP:rs756060557).
FT                                /FTId=VAR_058520.
FT   VARIANT      93     93       R -> C (in dbSNP:rs151193009).
FT                                /FTId=VAR_058521.
FT   VARIANT     106    106       G -> R.
FT                                /FTId=VAR_058522.
FT   VARIANT     114    114       V -> A (in dbSNP:rs775988212).
FT                                /FTId=VAR_058523.
FT   VARIANT     127    127       S -> R (in HCHOLA3; dbSNP:rs28942111).
FT                                {ECO:0000269|PubMed:12730697}.
FT                                /FTId=VAR_017199.
FT   VARIANT     129    129       D -> G (in HCHOLA3).
FT                                /FTId=VAR_058524.
FT   VARIANT     157    157       N -> K (in dbSNP:rs143117125).
FT                                /FTId=VAR_058525.
FT   VARIANT     174    174       P -> S (found in patients with familial
FT                                hypercholesterolemia carrying a
FT                                homozygous LDLR mutation; acts as a
FT                                disease modifier resulting in a mild
FT                                phenotype; dbSNP:rs533273863).
FT                                {ECO:0000269|PubMed:22417841}.
FT                                /FTId=VAR_067351.
FT   VARIANT     215    215       R -> H (in HCHOLA3; dbSNP:rs794728683).
FT                                /FTId=VAR_058526.
FT   VARIANT     216    216       F -> L (in HCHOLA3; partial loss of
FT                                cleavage by furin and PCSK5;
FT                                dbSNP:rs28942112).
FT                                {ECO:0000269|PubMed:12730697}.
FT                                /FTId=VAR_017200.
FT   VARIANT     218    218       R -> S (in HCHOLA3; complete loss of
FT                                cleavage by furin and PCSK5; reduces
FT                                glycosylation levels; no effect on
FT                                protein sulfation and phosphorylation; no
FT                                effect on protein sulfation but inhibits
FT                                phosphorylation when associated with Y-
FT                                374; highly reduces LDL uptake when
FT                                associated with Y-374;
FT                                dbSNP:rs970575319).
FT                                {ECO:0000269|PubMed:18799458,
FT                                ECO:0000269|PubMed:24808179}.
FT                                /FTId=VAR_058527.
FT   VARIANT     219    219       Q -> E (in dbSNP:rs778617372).
FT                                /FTId=VAR_058528.
FT   VARIANT     237    237       R -> W (in dbSNP:rs148195424).
FT                                {ECO:0000269|PubMed:16465619}.
FT                                /FTId=VAR_025452.
FT   VARIANT     239    239       A -> D.
FT                                /FTId=VAR_058529.
FT   VARIANT     253    253       L -> F (polymorphism; associated with
FT                                lower plasma levels of low-density
FT                                lipoprotein cholesterol;
FT                                dbSNP:rs28362270).
FT                                {ECO:0000269|PubMed:16465619}.
FT                                /FTId=VAR_025453.
FT   VARIANT     357    357       R -> H (in HCHOLA3; dbSNP:rs370507566).
FT                                /FTId=VAR_058530.
FT   VARIANT     374    374       D -> H (in HCHOLA3; dbSNP:rs137852912).
FT                                /FTId=VAR_058531.
FT   VARIANT     374    374       D -> Y (in HCHOLA3; partial loss of
FT                                cleavage by furin and PCSK5; no effect on
FT                                protein sulfation but inhibits
FT                                phosphorylation when associated with S-
FT                                218; highly increases LDL uptake when
FT                                associated with S-218;
FT                                dbSNP:rs137852912).
FT                                {ECO:0000269|PubMed:18799458,
FT                                ECO:0000269|PubMed:24808179}.
FT                                /FTId=VAR_058532.
FT   VARIANT     391    391       H -> N (in dbSNP:rs146471967).
FT                                {ECO:0000269|PubMed:16465619}.
FT                                /FTId=VAR_025454.
FT   VARIANT     394    394       G -> S (found in a patient associated
FT                                with autosomal dominant
FT                                hypercholesterolemia; unknown
FT                                pathological significance;
FT                                dbSNP:rs368257906).
FT                                {ECO:0000269|PubMed:22095935}.
FT                                /FTId=VAR_067282.
FT   VARIANT     417    417       H -> Q (in dbSNP:rs143275858).
FT                                {ECO:0000269|PubMed:16465619}.
FT                                /FTId=VAR_025455.
FT   VARIANT     425    425       N -> S (in dbSNP:rs28362261).
FT                                {ECO:0000269|PubMed:16465619,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_021337.
FT   VARIANT     443    443       A -> T (polymorphism; associated with
FT                                lower plasma levels of low-density
FT                                lipoprotein cholesterol; more extensive
FT                                cleavage by furin and PCSK5;
FT                                dbSNP:rs28362263).
FT                                {ECO:0000269|PubMed:16465619,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_021338.
FT   VARIANT     452    452       G -> D.
FT                                /FTId=VAR_058533.
FT   VARIANT     469    469       R -> W (in dbSNP:rs141502002).
FT                                {ECO:0000269|PubMed:16465619}.
FT                                /FTId=VAR_025456.
FT   VARIANT     474    474       V -> I (in dbSNP:rs562556).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:16465619,
FT                                ECO:0000269|PubMed:17971861,
FT                                ECO:0000269|PubMed:22095935,
FT                                ECO:0000269|Ref.1, ECO:0000269|Ref.4,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.7}.
FT                                /FTId=VAR_021339.
FT   VARIANT     482    482       E -> G (in dbSNP:rs141995194).
FT                                {ECO:0000269|PubMed:16465619}.
FT                                /FTId=VAR_025457.
FT   VARIANT     482    482       E -> Q (no effect on interaction with
FT                                ANXA2). {ECO:0000269|PubMed:24808179}.
FT                                /FTId=VAR_073657.
FT   VARIANT     496    496       R -> W (in HCHOLA3; dbSNP:rs374603772).
FT                                /FTId=VAR_058534.
FT   VARIANT     515    515       F -> L. {ECO:0000269|PubMed:16465619}.
FT                                /FTId=VAR_025458.
FT   VARIANT     522    522       A -> T (in dbSNP:rs777300852).
FT                                /FTId=VAR_058535.
FT   VARIANT     553    553       H -> R (in dbSNP:rs28362270).
FT                                {ECO:0000269|PubMed:16465619,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_021340.
FT   VARIANT     554    554       Q -> E (increases interaction with ANXA2;
FT                                dbSNP:rs149311926).
FT                                {ECO:0000269|PubMed:16465619,
FT                                ECO:0000269|PubMed:18799458}.
FT                                /FTId=VAR_025459.
FT   VARIANT     616    616       P -> L (in dbSNP:rs755750316).
FT                                /FTId=VAR_058536.
FT   VARIANT     619    619       Q -> P (in dbSNP:rs28362277).
FT                                {ECO:0000269|PubMed:16465619,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_021341.
FT   VARIANT     668    668       S -> R (in dbSNP:rs762298323).
FT                                /FTId=VAR_058537.
FT   VARIANT     670    670       G -> E (in dbSNP:rs505151).
FT                                {ECO:0000269|PubMed:12730697,
FT                                ECO:0000269|PubMed:16465619,
FT                                ECO:0000269|PubMed:17971861,
FT                                ECO:0000269|PubMed:22095935,
FT                                ECO:0000269|Ref.1, ECO:0000269|Ref.4,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.7}.
FT                                /FTId=VAR_017201.
FT   MUTAGEN      67     67       C->A: Does not affect multimerization or
FT                                zymogen processing.
FT                                {ECO:0000269|PubMed:12552133}.
FT   MUTAGEN     226    226       H->A: Remains in the endoplasmic
FT                                reticulum and is not secreted.
FT                                {ECO:0000269|PubMed:12552133}.
FT   MUTAGEN     533    533       N->A: 1.5 kDa decrease of the apparent
FT                                molecular mass of pro-PCSK9 and PCSK9 and
FT                                no effect on processing and secretion.
FT                                {ECO:0000269|PubMed:12552133}.
FT   CONFLICT    423    423       V -> A (in Ref. 3; BAC11572).
FT                                {ECO:0000305}.
FT   STRAND       63     65       {ECO:0000244|PDB:4NMX}.
FT   HELIX        70     72       {ECO:0000244|PDB:4NMX}.
FT   STRAND       73     82       {ECO:0000244|PDB:4NMX}.
FT   STRAND       84     86       {ECO:0000244|PDB:4OV6}.
FT   HELIX        88    104       {ECO:0000244|PDB:4NMX}.
FT   STRAND      110    115       {ECO:0000244|PDB:4NMX}.
FT   STRAND      117    119       {ECO:0000244|PDB:4NMX}.
FT   STRAND      121    125       {ECO:0000244|PDB:4NMX}.
FT   HELIX       128    130       {ECO:0000244|PDB:4NMX}.
FT   HELIX       131    135       {ECO:0000244|PDB:4NMX}.
FT   STRAND      140    151       {ECO:0000244|PDB:4NMX}.
FT   HELIX       156    160       {ECO:0000244|PDB:4NMX}.
FT   HELIX       168    170       {ECO:0000244|PDB:3BPS}.
FT   STRAND      181    187       {ECO:0000244|PDB:4NMX}.
FT   TURN        194    199       {ECO:0000244|PDB:4NMX}.
FT   STRAND      200    206       {ECO:0000244|PDB:4NMX}.
FT   STRAND      212    214       {ECO:0000244|PDB:4NMX}.
FT   TURN        218    220       {ECO:0000244|PDB:3H42}.
FT   TURN        221    224       {ECO:0000244|PDB:2QTW}.
FT   HELIX       225    235       {ECO:0000244|PDB:4NMX}.
FT   TURN        237    239       {ECO:0000244|PDB:4NMX}.
FT   STRAND      241    244       {ECO:0000244|PDB:2P4E}.
FT   STRAND      246    251       {ECO:0000244|PDB:4NMX}.
FT   STRAND      257    260       {ECO:0000244|PDB:4NMX}.
FT   HELIX       261    277       {ECO:0000244|PDB:4NMX}.
FT   STRAND      283    287       {ECO:0000244|PDB:4NMX}.
FT   STRAND      289    292       {ECO:0000244|PDB:4NMX}.
FT   HELIX       295    306       {ECO:0000244|PDB:4NMX}.
FT   STRAND      310    314       {ECO:0000244|PDB:4NMX}.
FT   STRAND      317    321       {ECO:0000244|PDB:4NMX}.
FT   HELIX       322    324       {ECO:0000244|PDB:4NMX}.
FT   TURN        327    329       {ECO:0000244|PDB:4NMX}.
FT   STRAND      333    339       {ECO:0000244|PDB:4NMX}.
FT   STRAND      343    345       {ECO:0000244|PDB:2PMW}.
FT   STRAND      349    352       {ECO:0000244|PDB:2W2Q}.
FT   STRAND      355    358       {ECO:0000244|PDB:3P5B}.
FT   STRAND      361    364       {ECO:0000244|PDB:4NMX}.
FT   STRAND      366    372       {ECO:0000244|PDB:4NMX}.
FT   STRAND      373    375       {ECO:0000244|PDB:5VLL}.
FT   STRAND      378    382       {ECO:0000244|PDB:4NMX}.
FT   HELIX       385    402       {ECO:0000244|PDB:4NMX}.
FT   HELIX       408    417       {ECO:0000244|PDB:4NMX}.
FT   STRAND      419    422       {ECO:0000244|PDB:4NMX}.
FT   HELIX       426    428       {ECO:0000244|PDB:4NMX}.
FT   HELIX       431    433       {ECO:0000244|PDB:4NMX}.
FT   TURN        434    436       {ECO:0000244|PDB:4NMX}.
FT   STRAND      440    442       {ECO:0000244|PDB:3P5B}.
FT   STRAND      456    461       {ECO:0000244|PDB:2QTW}.
FT   STRAND      467    470       {ECO:0000244|PDB:3SQO}.
FT   STRAND      472    475       {ECO:0000244|PDB:2QTW}.
FT   STRAND      482    489       {ECO:0000244|PDB:2QTW}.
FT   STRAND      491    493       {ECO:0000244|PDB:3GCX}.
FT   STRAND      495    503       {ECO:0000244|PDB:2QTW}.
FT   STRAND      506    513       {ECO:0000244|PDB:2QTW}.
FT   STRAND      515    517       {ECO:0000244|PDB:5OCA}.
FT   STRAND      521    528       {ECO:0000244|PDB:2QTW}.
FT   STRAND      533    539       {ECO:0000244|PDB:2QTW}.
FT   STRAND      544    546       {ECO:0000244|PDB:2QTW}.
FT   STRAND      548    551       {ECO:0000244|PDB:2QTW}.
FT   STRAND      554    556       {ECO:0000244|PDB:5VL7}.
FT   STRAND      558    565       {ECO:0000244|PDB:2QTW}.
FT   STRAND      568    570       {ECO:0000244|PDB:2P4E}.
FT   STRAND      587    590       {ECO:0000244|PDB:2QTW}.
FT   STRAND      594    602       {ECO:0000244|PDB:2QTW}.
FT   STRAND      606    615       {ECO:0000244|PDB:2QTW}.
FT   STRAND      621    625       {ECO:0000244|PDB:2QTW}.
FT   STRAND      631    637       {ECO:0000244|PDB:2QTW}.
FT   STRAND      644    650       {ECO:0000244|PDB:2QTW}.
FT   STRAND      653    658       {ECO:0000244|PDB:2QTW}.
FT   STRAND      672    681       {ECO:0000244|PDB:2QTW}.
SQ   SEQUENCE   692 AA;  74286 MW;  9BCB9418B90AEE23 CRC64;
     MGTVSSRRSW WPLPLLLLLL LLLGPAGARA QEDEDGDYEE LVLALRSEED GLAEAPEHGT
     TATFHRCAKD PWRLPGTYVV VLKEETHLSQ SERTARRLQA QAARRGYLTK ILHVFHGLLP
     GFLVKMSGDL LELALKLPHV DYIEEDSSVF AQSIPWNLER ITPPRYRADE YQPPDGGSLV
     EVYLLDTSIQ SDHREIEGRV MVTDFENVPE EDGTRFHRQA SKCDSHGTHL AGVVSGRDAG
     VAKGASMRSL RVLNCQGKGT VSGTLIGLEF IRKSQLVQPV GPLVVLLPLA GGYSRVLNAA
     CQRLARAGVV LVTAAGNFRD DACLYSPASA PEVITVGATN AQDQPVTLGT LGTNFGRCVD
     LFAPGEDIIG ASSDCSTCFV SQSGTSQAAA HVAGIAAMML SAEPELTLAE LRQRLIHFSA
     KDVINEAWFP EDQRVLTPNL VAALPPSTHG AGWQLFCRTV WSAHSGPTRM ATAVARCAPD
     EELLSCSSFS RSGKRRGERM EAQGGKLVCR AHNAFGGEGV YAIARCCLLP QANCSVHTAP
     PAEASMGTRV HCHQQGHVLT GCSSHWEVED LGTHKPPVLR PRGQPNQCVG HREASIHASC
     CHAPGLECKV KEHGIPAPQE QVTVACEEGW TLTGCSALPG TSHVLGAYAV DNTCVVRSRD
     VSTTGSTSEG AVTAVAICCR SRHLAQASQE LQ
//
ID   CUL7_HUMAN              Reviewed;        1698 AA.
AC   Q14999; B4DYZ0; F5H0L1; Q5T654;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 2.
DT   23-MAY-2018, entry version 179.
DE   RecName: Full=Cullin-7;
DE            Short=CUL-7;
GN   Name=CUL7; Synonyms=KIAA0076;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-813.
RC   TISSUE=Bone marrow;
RX   PubMed=7584044; DOI=10.1093/dnares/1.5.223;
RA   Nomura N., Nagase T., Miyajima N., Sazuka T., Tanaka A., Sato S.,
RA   Seki N., Kawarabayasi Y., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. II.
RT   The coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 1:223-229(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   ARG-813.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-813.
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION IN A COMPLEX WITH SKP1; FBXW8 AND RBX1.
RX   PubMed=12481031; DOI=10.1073/pnas.252646399;
RA   Dias D.C., Dolios G., Wang R., Pan Z.Q.;
RT   "CUL7: a DOC domain-containing cullin selectively binds Skp1.Fbx29 to
RT   form an SCF-like complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:16601-16606(2002).
RN   [6]
RP   INTERACTION WITH RBX1, AND IDENTIFICATION IN A COMPLEX WITH SKP1;
RP   FBXW8; RBX1 AND GLMN.
RX   PubMed=12904573; DOI=10.1073/pnas.1733908100;
RA   Arai T., Kasper J.S., Skaar J.R., Ali S.H., Takahashi C.,
RA   DeCaprio J.A.;
RT   "Targeted disruption of p185/Cul7 gene results in abnormal vascular
RT   morphogenesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:9855-9860(2003).
RN   [7]
RP   INTERACTION WITH SV40 LARGE ANTIGEN, AND IDENTIFICATION IN A
RP   SFC(CUL7)-LIKE COMPLEX.
RX   PubMed=16140746; DOI=10.1128/JVI.79.18.11685-11692.2005;
RA   Kasper J.S., Kuwabara H., Arai T., Ali S.H., DeCaprio J.A.;
RT   "Simian virus 40 large T antigen's association with the CUL7 SCF
RT   complex contributes to cellular transformation.";
RL   J. Virol. 79:11685-11692(2005).
RN   [8]
RP   INTERACTION WITH CUL9.
RX   PubMed=15964813; DOI=10.1128/MCB.25.13.5579-5589.2005;
RA   Skaar J.R., Arai T., DeCaprio J.A.;
RT   "Dimerization of CUL7 and PARC is not required for all CUL7 functions
RT   and mouse development.";
RL   Mol. Cell. Biol. 25:5579-5589(2005).
RN   [9]
RP   FUNCTION, INTERACTION WITH RBX1 AND TP53, AND SUBCELLULAR LOCATION.
RX   PubMed=16547496; DOI=10.1038/sj.onc.1209490;
RA   Andrews P., He Y.J., Xiong Y.;
RT   "Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and
RT   promotes cell growth by antagonizing p53 function.";
RL   Oncogene 25:4534-4548(2006).
RN   [10]
RP   FUNCTION, INTERACTION WITH CUL9; SKP1; FBXW8; RBX1 AND TP53, AND LACK
RP   OF NEDDYLATION.
RX   PubMed=17332328; DOI=10.1158/0008-5472.CAN-06-3241;
RA   Skaar J.R., Florens L., Tsutsumi T., Arai T., Tron A., Swanson S.K.,
RA   Washburn M.P., DeCaprio J.A.;
RT   "PARC and CUL7 form atypical cullin RING ligase complexes.";
RL   Cancer Res. 67:2006-2014(2007).
RN   [11]
RP   INVOLVEMENT IN 3M1.
RX   PubMed=17675530; DOI=10.1136/jmg.2007.051979;
RA   Maksimova N., Hara K., Miyashia A., Nikolaeva I., Shiga A.,
RA   Nogovicina A., Sukhomyasova A., Argunov V., Shvedova A., Ikeuchi T.,
RA   Nishizawa M., Kuwano R., Onodera O.;
RT   "Clinical, molecular and histopathological features of short stature
RT   syndrome with novel CUL7 mutation in Yakuts: new population isolate in
RT   Asia.";
RL   J. Med. Genet. 44:772-778(2007).
RN   [12]
RP   FUNCTION.
RX   PubMed=18498745; DOI=10.1016/j.molcel.2008.03.009;
RA   Xu X., Sarikas A., Dias-Santagata D.C., Dolios G., Lafontant P.J.,
RA   Tsai S.C., Zhu W., Nakajima H., Nakajima H.O., Field L.J., Wang R.,
RA   Pan Z.Q.;
RT   "The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for
RT   ubiquitin-dependent degradation.";
RL   Mol. Cell 30:403-414(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   INTERACTION WITH OBSL1.
RX   PubMed=21737058; DOI=10.1016/j.ajhg.2011.05.028;
RA   Hanson D., Murray P.G., O'Sullivan J., Urquhart J., Daly S.,
RA   Bhaskar S.S., Biesecker L.G., Skae M., Smith C., Cole T., Kirk J.,
RA   Chandler K., Kingston H., Donnai D., Clayton P.E., Black G.C.;
RT   "Exome sequencing identifies CCDC8 mutations in 3-M syndrome,
RT   Suggesting that CCDC8 Contributes in a Pathway with CUL7 and OBSL1 to
RT   Control Human Growth.";
RL   Am. J. Hum. Genet. 89:148-153(2011).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   FUNCTION, INTERACTION WITH FBXW8 AND OBSL1, AND SUBCELLULAR LOCATION.
RX   PubMed=21572988; DOI=10.1371/journal.pbio.1001060;
RA   Litterman N., Ikeuchi Y., Gallardo G., O'Connell B.C., Sowa M.E.,
RA   Gygi S.P., Harper J.W., Bonni A.;
RT   "An OBSL1-Cul7Fbxw8 ubiquitin ligase signaling mechanism regulates
RT   Golgi morphology and dendrite patterning.";
RL   PLoS Biol. 9:E1001060-E1001060(2011).
RN   [18]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=20139075; DOI=10.1074/jbc.M109.004200;
RA   Fu J., Lv X., Lin H., Wu L., Wang R., Zhou Z., Zhang B., Wang Y.L.,
RA   Tsang B.K., Zhu C., Wang H.;
RT   "Ubiquitin ligase cullin 7 induces epithelial-mesenchymal transition
RT   in human choriocarcinoma cells.";
RL   J. Biol. Chem. 285:10870-10879(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   FUNCTION, AND INTERACTION WITH FBXW8.
RX   PubMed=24362026; DOI=10.1074/jbc.M113.520106;
RA   Wang H., Chen Y., Lin P., Li L., Zhou G., Liu G., Logsdon C., Jin J.,
RA   Abbruzzese J.L., Tan T.H., Wang H.;
RT   "The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8)
RT   ubiquitin ligase promotes degradation of hematopoietic progenitor
RT   kinase 1.";
RL   J. Biol. Chem. 289:4009-4017(2014).
RN   [21]
RP   FUNCTION, IDENTIFICATION IN THE 3M COMPLEX, AND SUBCELLULAR LOCATION.
RX   PubMed=24793695; DOI=10.1016/j.molcel.2014.03.047;
RA   Yan J., Yan F., Li Z., Sinnott B., Cappell K.M., Yu Y., Mo J.,
RA   Duncan J.A., Chen X., Cormier-Daire V., Whitehurst A.W., Xiong Y.;
RT   "The 3M complex maintains microtubule and genome integrity.";
RL   Mol. Cell 54:791-804(2014).
RN   [22]
RP   FUNCTION, AND INTERACTION WITH CUL9.
RX   PubMed=24793696; DOI=10.1016/j.molcel.2014.03.046;
RA   Li Z., Pei X.H., Yan J., Yan F., Cappell K.M., Whitehurst A.W.,
RA   Xiong Y.;
RT   "CUL9 mediates the functions of the 3M complex and ubiquitylates
RT   survivin to maintain genome integrity.";
RL   Mol. Cell 54:805-819(2014).
RN   [23]
RP   INTERACTION WITH HDAC4 AND HDAC5.
RX   PubMed=25752541; DOI=10.1016/j.str.2015.02.001;
RA   Nie J., Xu C., Jin J., Aka J.A., Tempel W., Nguyen V., You L.,
RA   Weist R., Min J., Pawson T., Yang X.J.;
RT   "Ankyrin repeats of ANKRA2 recognize a PxLPxL motif on the 3M syndrome
RT   protein CCDC8.";
RL   Structure 23:700-712(2015).
RN   [24]
RP   STRUCTURE BY NMR OF 360-460, AND INTERACTION WITH TP53.
RX   PubMed=17298945; DOI=10.1074/jbc.M611297200;
RA   Kaustov L., Lukin J., Lemak A., Duan S., Ho M., Doherty R., Penn L.Z.,
RA   Arrowsmith C.H.;
RT   "The conserved CPH domains of Cul7 and PARC are protein-protein
RT   interaction modules that bind the tetramerization domain of p53.";
RL   J. Biol. Chem. 282:11300-11307(2007).
RN   [25]
RP   VARIANTS 3M1 ARG-1014; GLY-1246 AND PRO-1464, AND TISSUE SPECIFICITY.
RX   PubMed=16142236; DOI=10.1038/ng1628;
RA   Huber C., Dias-Santagata D., Glaser A., O'Sullivan J., Brauner R.,
RA   Wu K., Xu X., Pearce K., Wang R., Giovannucci Uzielli M.L.,
RA   Dagoneau N., Chemaitilly W., Superti-Furga A., Dos Santos H.,
RA   Megarbane A., Morin G., Gillessen-Kaesbach G., Hennekam R.C.M.,
RA   Van der Burgt I., Black G.C.M., Clayton P.E., Read A., Le Merrer M.,
RA   Scambler P.J., Munnich A., Pan Z.-Q., Winter R., Cormier-Daire V.;
RT   "Identification of mutations in CUL7 in 3-M syndrome.";
RL   Nat. Genet. 37:1119-1124(2005).
RN   [26]
RP   VARIANT 3M1 PRO-1588.
RX   PubMed=23018678; DOI=10.1530/JME-12-0034;
RA   Hanson D., Murray P.G., Coulson T., Sud A., Omokanye A., Stratta E.,
RA   Sakhinia F., Bonshek C., Wilson L.C., Wakeling E., Temtamy S.A.,
RA   Aglan M., Rosser E.M., Mansour S., Carcavilla A., Nampoothiri S.,
RA   Khan W.I., Banerjee I., Chandler K.E., Black G.C., Clayton P.E.;
RT   "Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered
RT   growth factor signalling.";
RL   J. Mol. Endocrinol. 49:267-275(2012).
CC   -!- FUNCTION: Core component of the 3M and Cul7-RING(FBXW8) complexes,
CC       which mediates the ubiquitination of target proteins. Core
CC       component of the 3M complex, a complex required to regulate
CC       microtubule dynamics and genome integrity. It is unclear how the
CC       3M complex regulates microtubules, it could act by controlling the
CC       level of a microtubule stabilizer (PubMed:24793695). Interaction
CC       with CUL9 is required to inhibit CUL9 activity and ubiquitination
CC       of BIRC5 (PubMed:24793696). Core component of a Cul7-RING
CC       ubiquitin-protein ligase with FBXW8, which mediates ubiquitination
CC       and consequent degradation of target proteins such as GORASP1,
CC       IRS1 and MAP4K1/HPK1 (PubMed:21572988, PubMed:24362026).
CC       Ubiquitination of GORASP1 regulates Golgi morphogenesis and
CC       dendrite patterning in brain (PubMed:21572988). Mediates
CC       ubiquitination and degradation of IRS1 in a mTOR-dependent manner:
CC       the Cul7-RING(FBXW8) complex recognizes and binds IRS1 previously
CC       phosphorylated by S6 kinase (RPS6KB1 or RPS6KB2)
CC       (PubMed:18498745). The Cul7-RING(FBXW8) complex also mediates
CC       ubiquitination of MAP4K1/HPK1: recognizes and binds
CC       autophosphorylated MAP4K1/HPK1, leading to its degradation,
CC       thereby affecting cell proliferation and differentiation
CC       (PubMed:24362026). Acts as a regulator in trophoblast cell
CC       epithelial-mesenchymal transition and placental development
CC       (PubMed:20139075). Does not promote polyubiquitination and
CC       proteasomal degradation of p53/TP53 (PubMed:16547496,
CC       PubMed:17332328). While the Cul7-RING(FBXW8) and the 3M complexes
CC       are associated and involved in common processes, CUL7 and the
CC       Cul7-RING(FBXW8) complex may be have additional functions.
CC       {ECO:0000269|PubMed:16547496, ECO:0000269|PubMed:17332328,
CC       ECO:0000269|PubMed:18498745, ECO:0000269|PubMed:20139075,
CC       ECO:0000269|PubMed:21572988, ECO:0000269|PubMed:24362026,
CC       ECO:0000269|PubMed:24793695, ECO:0000269|PubMed:24793696}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Component of the 3M complex, composed of core components
CC       CUL7, CCDC8 and OBSL1. Part of a Cul7-RING complex consisting of
CC       CUL7, RBX1, SKP1 and FBXW8. Interacts with a complex of SKP1 and
CC       FBXW8, but not with SKP1 alone. Interacts with CUL9; leading to
CC       inhibit CUL9 activity. Interacts with FBXW8; interaction is
CC       mutually exclusive of binding to CUL9 or p53/TP53. Interacts with
CC       p53/TP53; the interaction preferentially involves tetrameric and
CC       dimeric p53/TP53. The CUL7-CUL9 heterodimer seems to interact
CC       specifically with p53/TP53. Interacts with CUL1; the interactions
CC       seems to be mediated by FBXW8. Interacts with SV40 Large T
CC       antigen; this interaction seems to inhibit CUL7. Interacts with
CC       OBSL1. Interacts (as part of the 3M complex) with HDAC4 and HDAC5;
CC       it is negatively regulated by ANKRA2.
CC       {ECO:0000269|PubMed:12481031, ECO:0000269|PubMed:12904573,
CC       ECO:0000269|PubMed:15964813, ECO:0000269|PubMed:16140746,
CC       ECO:0000269|PubMed:16547496, ECO:0000269|PubMed:17298945,
CC       ECO:0000269|PubMed:17332328, ECO:0000269|PubMed:21572988,
CC       ECO:0000269|PubMed:21737058, ECO:0000269|PubMed:24362026,
CC       ECO:0000269|PubMed:24793695, ECO:0000269|PubMed:24793696,
CC       ECO:0000269|PubMed:25752541}.
CC   -!- INTERACTION:
CC       O75147-2:OBSL1; NbExp=4; IntAct=EBI-308606, EBI-15927144;
CC       P04637:TP53; NbExp=5; IntAct=EBI-308606, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome. Cytoplasm, perinuclear
CC       region. Golgi apparatus. Note=Colocalizes with FBXW8 at the Golgi
CC       apparatus in neurons; localization to Golgi is mediated by OBSL1.
CC       During mitosis, localizes to the mitotic apparatus
CC       (PubMed:24793695). CCDC8 is required for centrosomal location
CC       (PubMed:24793695). {ECO:0000269|PubMed:24793695}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q14999-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14999-2; Sequence=VSP_046105, VSP_046106;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in fetal kidney and adult
CC       skeletal muscle. Also abundant in fetal brain, as well as in adult
CC       pancreas, kidney, placenta and heart. Detected in trophoblasts,
CC       lymphoblasts, osteoblasts, chondrocytes and skin fibroblasts.
CC       {ECO:0000269|PubMed:16142236}.
CC   -!- DEVELOPMENTAL STAGE: Highly expressed in invasive placental villi
CC       during first trimester. {ECO:0000269|PubMed:20139075}.
CC   -!- PTM: According to a report, may not be neddylated despite the
CC       conserved consensus site for neddylation at Lys-1576.
CC       {ECO:0000269|PubMed:17332328}.
CC   -!- DISEASE: 3M syndrome 1 (3M1) [MIM:273750]: An autosomal recessive
CC       disorder characterized by severe pre- and postnatal growth
CC       retardation, facial dysmorphism, large head circumference, and
CC       normal intelligence and endocrine function. Skeletal changes
CC       include long slender tubular bones and tall vertebral bodies.
CC       {ECO:0000269|PubMed:16142236, ECO:0000269|PubMed:17675530,
CC       ECO:0000269|PubMed:23018678}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cullin family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00330}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA07551.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D38548; BAA07551.2; ALT_INIT; mRNA.
DR   EMBL; AK302668; BAG63902.1; -; mRNA.
DR   EMBL; AL355385; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136304; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC033647; AAH33647.1; -; mRNA.
DR   CCDS; CCDS4881.1; -. [Q14999-1]
DR   CCDS; CCDS55003.1; -. [Q14999-2]
DR   RefSeq; NP_001161842.1; NM_001168370.1. [Q14999-2]
DR   RefSeq; NP_055595.2; NM_014780.4. [Q14999-1]
DR   UniGene; Hs.520136; -.
DR   PDB; 2JNG; NMR; -; A=360-460.
DR   PDBsum; 2JNG; -.
DR   ProteinModelPortal; Q14999; -.
DR   SMR; Q14999; -.
DR   BioGrid; 115159; 661.
DR   CORUM; Q14999; -.
DR   DIP; DIP-31618N; -.
DR   DIP; DIP-60187N; -.
DR   IntAct; Q14999; 16.
DR   MINT; Q14999; -.
DR   STRING; 9606.ENSP00000438788; -.
DR   iPTMnet; Q14999; -.
DR   PhosphoSitePlus; Q14999; -.
DR   BioMuta; CUL7; -.
DR   DMDM; 160370003; -.
DR   EPD; Q14999; -.
DR   MaxQB; Q14999; -.
DR   PaxDb; Q14999; -.
DR   PeptideAtlas; Q14999; -.
DR   PRIDE; Q14999; -.
DR   Ensembl; ENST00000265348; ENSP00000265348; ENSG00000044090. [Q14999-1]
DR   Ensembl; ENST00000535468; ENSP00000438788; ENSG00000044090. [Q14999-2]
DR   GeneID; 9820; -.
DR   KEGG; hsa:9820; -.
DR   UCSC; uc003otq.4; human. [Q14999-1]
DR   CTD; 9820; -.
DR   DisGeNET; 9820; -.
DR   EuPathDB; HostDB:ENSG00000044090.8; -.
DR   GeneCards; CUL7; -.
DR   GeneReviews; CUL7; -.
DR   HGNC; HGNC:21024; CUL7.
DR   HPA; CAB015449; -.
DR   HPA; HPA030095; -.
DR   HPA; HPA030096; -.
DR   MalaCards; CUL7; -.
DR   MIM; 273750; phenotype.
DR   MIM; 609577; gene.
DR   neXtProt; NX_Q14999; -.
DR   OpenTargets; ENSG00000044090; -.
DR   Orphanet; 2616; 3M syndrome.
DR   PharmGKB; PA134897835; -.
DR   eggNOG; KOG1815; Eukaryota.
DR   eggNOG; ENOG410XP9Y; LUCA.
DR   GeneTree; ENSGT00890000139411; -.
DR   HOGENOM; HOG000024831; -.
DR   HOVERGEN; HBG103792; -.
DR   InParanoid; Q14999; -.
DR   KO; K10613; -.
DR   OMA; EHILLWM; -.
DR   OrthoDB; EOG091G0053; -.
DR   PhylomeDB; Q14999; -.
DR   TreeFam; TF101154; -.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SIGNOR; Q14999; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; CUL7; human.
DR   EvolutionaryTrace; Q14999; -.
DR   GeneWiki; CUL7; -.
DR   GenomeRNAi; 9820; -.
DR   PRO; PR:Q14999; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000044090; -.
DR   CleanEx; HS_CUL7; -.
DR   Genevisible; Q14999; HS.
DR   GO; GO:1990393; C:3M complex; IDA:UniProtKB.
DR   GO; GO:0005680; C:anaphase-promoting complex; NAS:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0031467; C:Cul7-RING ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:InterPro.
DR   GO; GO:0001837; P:epithelial to mesenchymal transition; IDA:UniProtKB.
DR   GO; GO:0007030; P:Golgi organization; ISS:UniProtKB.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0000281; P:mitotic cytokinesis; IMP:UniProtKB.
DR   GO; GO:0001890; P:placenta development; IDA:UniProtKB.
DR   GO; GO:0050775; P:positive regulation of dendrite morphogenesis; IGI:UniProtKB.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; NAS:UniProtKB.
DR   GO; GO:0007088; P:regulation of mitotic nuclear division; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   GO; GO:0001570; P:vasculogenesis; ISS:UniProtKB.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.30.30.30; -; 1.
DR   Gene3D; 2.60.120.260; -; 1.
DR   InterPro; IPR004939; APC_su10/DOC_dom.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR021097; CPH_domain.
DR   InterPro; IPR031223; CUL7.
DR   InterPro; IPR016158; Cullin_homology.
DR   InterPro; IPR036317; Cullin_homology_sf.
DR   InterPro; IPR001373; Cullin_N.
DR   InterPro; IPR019559; Cullin_neddylation_domain.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR014722; Rib_L2_dom2.
DR   PANTHER; PTHR22771:SF3; PTHR22771:SF3; 1.
DR   Pfam; PF03256; ANAPC10; 1.
DR   Pfam; PF11515; Cul7; 1.
DR   Pfam; PF00888; Cullin; 1.
DR   SMART; SM01337; APC10; 1.
DR   SMART; SM00884; Cullin_Nedd8; 1.
DR   SUPFAM; SSF48371; SSF48371; 3.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF75632; SSF75632; 2.
DR   PROSITE; PS50069; CULLIN_2; 1.
DR   PROSITE; PS51284; DOC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Disease mutation; Dwarfism; Golgi apparatus;
KW   Host-virus interaction; Isopeptide bond; Phosphoprotein; Polymorphism;
KW   Reference proteome; Ubl conjugation; Ubl conjugation pathway.
FT   CHAIN         1   1698       Cullin-7.
FT                                /FTId=PRO_0000119802.
FT   DOMAIN      814    993       DOC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00614}.
FT   REGION      360    460       Interaction with TP53.
FT   MOD_RES     339    339       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   CROSSLNK   1576   1576       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in NEDD8).
FT                                {ECO:0000255}.
FT   VAR_SEQ       1      1       M -> MSRGFWLAEPLAGTGPHPAPVAADSRGCSSVPRRHA
FT                                PSRLSVSTPSRGPGARM (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046105.
FT   VAR_SEQ     194    194       G -> GEGQCGEEGKAGEGLGRLRDSQDTVAGASDLIR
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046106.
FT   VARIANT     616    616       S -> G (in dbSNP:rs7774330).
FT                                /FTId=VAR_048841.
FT   VARIANT     813    813       Q -> R (in dbSNP:rs9381231).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7584044}.
FT                                /FTId=VAR_026121.
FT   VARIANT     852    852       R -> Q (in dbSNP:rs34574340).
FT                                /FTId=VAR_048842.
FT   VARIANT    1014   1014       L -> R (in 3M1; unknown pathological
FT                                significance; dbSNP:rs61752334).
FT                                {ECO:0000269|PubMed:16142236}.
FT                                /FTId=VAR_026122.
FT   VARIANT    1246   1246       Q -> G (in 3M1; requires 2 nucleotide
FT                                substitutions).
FT                                {ECO:0000269|PubMed:16142236}.
FT                                /FTId=VAR_026123.
FT   VARIANT    1246   1246       Q -> H (in dbSNP:rs36071170).
FT                                /FTId=VAR_048843.
FT   VARIANT    1464   1464       H -> P (in 3M1; impairs the ability to
FT                                interact with RBX1, thus hampers the
FT                                assembly of polyubiquitin chains;
FT                                dbSNP:rs121918229).
FT                                {ECO:0000269|PubMed:16142236}.
FT                                /FTId=VAR_026124.
FT   VARIANT    1588   1588       L -> P (in 3M1; dbSNP:rs759300846).
FT                                {ECO:0000269|PubMed:23018678}.
FT                                /FTId=VAR_071120.
FT   HELIX       360    362       {ECO:0000244|PDB:2JNG}.
FT   STRAND      363    366       {ECO:0000244|PDB:2JNG}.
FT   HELIX       367    376       {ECO:0000244|PDB:2JNG}.
FT   STRAND      382    385       {ECO:0000244|PDB:2JNG}.
FT   STRAND      397    403       {ECO:0000244|PDB:2JNG}.
FT   STRAND      407    414       {ECO:0000244|PDB:2JNG}.
FT   TURN        415    418       {ECO:0000244|PDB:2JNG}.
FT   STRAND      419    424       {ECO:0000244|PDB:2JNG}.
FT   HELIX       425    427       {ECO:0000244|PDB:2JNG}.
FT   STRAND      428    430       {ECO:0000244|PDB:2JNG}.
SQ   SEQUENCE   1698 AA;  191161 MW;  EC9EED17E98FC9A1 CRC64;
     MVGELRYREF RVPLGPGLHA YPDELIRQRV GHDGHPEYQI RWLILRRGDE GDGGSGQVDC
     KAEHILLWMS KDEIYANCHK MLGEDGQVIG PSQESAGEVG ALDKSVLEEM ETDVKSLIQR
     ALRQLEECVG TIPPAPLLHT VHVLSAYASI EPLTGVFKDP RVLDLLMHML SSPDYQIRWS
     AGRMIQALSS HDAGTRTQIL LSLSQQEAIE KHLDFDSRCA LLALFAQATL SEHPMSFEGI
     QLPQVPGRVL FSLVKRYLHV TSLLDQLNDS AAEPGAQNTS APEELSGERG QLELEFSMAM
     GTLISELVQA MRWDQASDRP RSSARSPGSI FQPQLADVSP GLPAAQAQPS FRRSRRFRPR
     SEFASGNTYA LYVRDTLQPG MRVRMLDDYE EISAGDEGEF RQSNNGVPPV QVFWESTGRT
     YWVHWHMLEI LGFEEDIEDM VEADEYQGAV ASRVLGRALP AWRWRPMTEL YAVPYVLPED
     EDTEECEHLT LAEWWELLFF IKKLDGPDHQ EVLQILQENL DGEILDDEIL AELAVPIELA
     QDLLLTLPQR LNDSALRDLI NCHVYKKYGP EALAGNQAYP SLLEAQEDVL LLDAQAQAKD
     SEDAAKVEAK EPPSQSPNTP LQRLVEGYGP AGKILLDLEQ ALSSEGTQEN KVKPLLLQLQ
     RQPQPFLALM QSLDTPETNR TLHLTVLRIL KQLVDFPEAL LLPWHEAVDA CMACLRSPNT
     DREVLQELIF FLHRLTSVSR DYAVVLNQLG ARDAISKALE KHLGKLELAQ ELRDMVFKCE
     KHAHLYRKLI TNILGGCIQM VLGQIEDHRR THQPINIPFF DVFLRYLCQG SSVEVKEDKC
     WEKVEVSSNP HRASKLTDHN PKTYWESNGS AGSHYITLHM RRGILIRQLT LLVASEDSSY
     MPARVVVCGG DSTSSLHTEL NSVNVMPSAS RVILLENLTR FWPIIQIRIK RCQQGGIDTR
     IRGLEILGPK PTFWPVFREQ LCRHTRLFYM VRAQAWSQDM AEDRRSLLHL SSRLNGALRQ
     EQNFADRFLP DDEAAQALGK TCWEALVSPV VQNITSPDED GISPLGWLLD QYLECQEAVF
     NPQSRGPAFF SRVRRLTHLL VHVEPCEAPP PVVATPRPKG RNRSHDWSSL ATRGLPSSIM
     RNLTRCWRAV VEKQVNNFLT SSWRDDDFVP RYCEHFNILQ NSSSELFGPR AAFLLALQNG
     CAGALLKLPF LKAAHVSEQF ARHIDQQIQG SRIGGAQEME RLAQLQQCLQ AVLIFSGLEI
     ATTFEHYYQH YMADRLLGVV SSWLEGAVLE QIGPCFPNRL PQQMLQSLST SKELQRQFHV
     YQLQQLDQEL LKLEDTEKKI QVGLGASGKE HKSEKEEEAG AAAVVDVAEG EEEEEENEDL
     YYEGAMPEVS VLVLSRHSWP VASICHTLNP RTCLPSYLRG TLNRYSNFYN KSQSHPALER
     GSQRRLQWTW LGWAELQFGN QTLHVSTVQM WLLLYLNDLK AVSVESLLAF SGLSADMLNQ
     AIGPLTSSRG PLDLHEQKDI PGGVLKIRDG SKEPRSRWDI VRLIPPQTYL QAEGEDGQNL
     EKRRNLLNCL IVRILKAHGD EGLHIDQLVC LVLEAWQKGP CPPRGLVSSL GKGSACSSTD
     VLSCILHLLG KGTLRRHDDR PQVLSYAVPV TVMEPHTESL NPGSSGPNPP LTFHTLQIRS
     RGVPYASCTA TQSFSTFR
//
ID   B7Z2I3_HUMAN            Unreviewed;      1157 AA.
AC   B7Z2I3;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   28-FEB-2018, entry version 67.
DE   RecName: Full=Receptor protein-tyrosine kinase {ECO:0000256|SAAS:SAAS00593197};
DE            EC=2.7.10.1 {ECO:0000256|SAAS:SAAS00593197};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH11869.1};
RN   [1] {ECO:0000313|EMBL:BAH11869.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAH11869.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000256|SAAS:SAAS00594546}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. {ECO:0000256|SAAS:SAAS00941529}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK294750; BAH11869.1; -; mRNA.
DR   RefSeq; NP_001333829.1; NM_001346900.1.
DR   UniGene; Hs.488293; -.
DR   UniGene; Hs.605083; -.
DR   UniGene; Hs.731652; -.
DR   ProteinModelPortal; B7Z2I3; -.
DR   PeptideAtlas; B7Z2I3; -.
DR   PRIDE; B7Z2I3; -.
DR   GeneID; 1956; -.
DR   CTD; 1956; -.
DR   eggNOG; KOG1025; Eukaryota.
DR   eggNOG; ENOG410XNSR; LUCA.
DR   HOVERGEN; HBG000490; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004716; F:signal transducer, downstream of receptor, with protein tyrosine kinase activity; IEA:InterPro.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:InterPro.
DR   Gene3D; 3.80.20.20; -; 2.
DR   InterPro; IPR006211; Furin-like_Cys-rich_dom.
DR   InterPro; IPR006212; Furin_repeat.
DR   InterPro; IPR032778; GF_recep_IV.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR000494; Rcpt_L-dom.
DR   InterPro; IPR036941; Rcpt_L-dom_sf.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016245; Tyr_kinase_EGF/ERB/XmrK_rcpt.
DR   Pfam; PF00757; Furin-like; 1.
DR   Pfam; PF14843; GF_recep_IV; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF01030; Recep_L_domain; 2.
DR   PIRSF; PIRSF000619; TyrPK_EGF-R; 2.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00261; FU; 3.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|PIRSR:PIRSR000619-2,
KW   ECO:0000256|SAAS:SAAS00461464};
KW   Kinase {ECO:0000256|SAAS:SAAS00594505};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Nucleotide-binding {ECO:0000256|PIRSR:PIRSR000619-2,
KW   ECO:0000256|SAAS:SAAS00461464};
KW   Receptor {ECO:0000313|EMBL:BAH11869.1};
KW   Transferase {ECO:0000256|SAAS:SAAS00594505};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius};
KW   Tyrosine-protein kinase {ECO:0000256|SAAS:SAAS00594505}.
FT   TRANSMEM    593    614       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      659    926       Protein kinase.
FT                                {ECO:0000259|PROSITE:PS50011}.
FT   NP_BIND     665    673       ATP. {ECO:0000256|PIRSR:PIRSR000619-2}.
FT   ACT_SITE    784    784       Proton acceptor.
FT                                {ECO:0000256|PIRSR:PIRSR000619-1}.
FT   BINDING     692    692       ATP. {ECO:0000256|PIRSR:PIRSR000619-2}.
SQ   SEQUENCE   1157 AA;  128653 MW;  F46F912139C1FEC1 CRC64;
     MFNNCEVVLG NLEITYVQRN YDLSFLKTIQ EVAGYVLIAL NTVERIPLEN LQIIRGNMYY
     ENSYALAVLS NYDANKTGLK ELPMRNLQEI LHGAVRFSNN PALCNVESIQ WRDIVSSDFL
     SNMSMDFQNH LGSCQKCDPS CPNGSCWGAG EENCQKLTKI ICAQQCSGRC RGKSPSDCCH
     NQCAAGCTGP RESDCLVCRK FRDEATCKDT CPPLMLYNPT TYQMDVNPEG KYSFGATCVK
     KCPRNYVVTD HGSCVRACGA DSYEMEEDGV RKCKKCEGPC RKVCNGIGIG EFKDSLSINA
     TNIKHFKNCT SISGDLHILP VAFRGDSFTH TPPLDPQELD ILKTVKEITG FLLIQAWPEN
     RTDLHAFENL EIIRGRTKQH GQFSLAVVSL NITSLGLRSL KEISDGDVII SGNKNLCYAN
     TINWKKLFGT SGQKTKIISN RGENSCKATG QVCHALCSPE GCWGPEPRDC VSCRNVSRGR
     ECVDKCNLLE GEPREFVENS ECIQCHPECL PQAMNITCTG RGPDNCIQCA HYIDGPHCVK
     TCPAGVMGEN NTLVWKYADA GHVCHLCHPN CTYGCTGPGL EGCPTNGPKI PSIATGMVGA
     LLLLLVVALG IGLFMRRRHI VRKRTLRRLL QERELVEPLT PSGEAPSQAL LRILKETEFK
     KIKVLGSGAF GTVYKGLWIP EGEKVKIPVA IKELREATSP KANKEILDEA YVMASVDNPH
     VCRLLGICLT STVQLITQLM PFGCLLDYVR EHKDNIGSQY LLNWCVQIAK GMNYLEDRRL
     VHRDLAARNV LVKTPQHVKI TDFGLAKLLG AEEKEYHAEG GKVPIKWMAL ESILHRIYTH
     QSDVWSYGVT VWELMTFGSK PYDGIPASEI SSILEKGERL PQPPICTIDV YMIMVKCWMI
     DADSRPKFRE LIIEFSKMAR DPQRYLVIQG DERMHLPSPT DSNFYRALMD EEDMDDVVDA
     DEYLIPQQGF FSSPSTSRTP LLSSLSATSN NSTVACIDRN GLQSCPIKED SFLQRYSSDP
     TGALTEDSID DTFLPVPEYI NQSVPKRPAG SVQNPVYHNQ PLNPAPSRDP HYQDPHSTAV
     GNPEYLNTVQ PTCVNSTFDS PAHWAQKGSH QISLDNPDYQ QDFFPKEAKP NGIFKGSTAE
     NAEYLRVAPQ SSEFIGA
//
ID   E7BSV0_HUMAN            Unreviewed;      1136 AA.
AC   E7BSV0;
DT   08-MAR-2011, integrated into UniProtKB/TrEMBL.
DT   08-MAR-2011, sequence version 1.
DT   28-FEB-2018, entry version 51.
DE   RecName: Full=Receptor protein-tyrosine kinase {ECO:0000256|SAAS:SAAS00593197};
DE            EC=2.7.10.1 {ECO:0000256|SAAS:SAAS00593197};
GN   Name=EGFR {ECO:0000313|EMBL:ADL28125.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADL28125.1};
RN   [1] {ECO:0000313|EMBL:ADL28125.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Zhou M., Wang H., Li Z.H.;
RT   "Identification of a more invasive isoform of EGFR.";
RL   Submitted (DEC-2009) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000256|SAAS:SAAS00594546}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. {ECO:0000256|SAAS:SAAS00941529}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; GU255993; ADL28125.1; -; mRNA.
DR   RefSeq; NP_001333827.1; NM_001346898.1.
DR   UniGene; Hs.488293; -.
DR   UniGene; Hs.605083; -.
DR   UniGene; Hs.731652; -.
DR   ProteinModelPortal; E7BSV0; -.
DR   PeptideAtlas; E7BSV0; -.
DR   PRIDE; E7BSV0; -.
DR   GeneID; 1956; -.
DR   CTD; 1956; -.
DR   eggNOG; KOG1025; Eukaryota.
DR   eggNOG; ENOG410XNSR; LUCA.
DR   ChiTaRS; EGFR; human.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004716; F:signal transducer, downstream of receptor, with protein tyrosine kinase activity; IEA:InterPro.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:InterPro.
DR   Gene3D; 3.80.20.20; -; 2.
DR   InterPro; IPR006211; Furin-like_Cys-rich_dom.
DR   InterPro; IPR006212; Furin_repeat.
DR   InterPro; IPR032778; GF_recep_IV.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR000494; Rcpt_L-dom.
DR   InterPro; IPR036941; Rcpt_L-dom_sf.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016245; Tyr_kinase_EGF/ERB/XmrK_rcpt.
DR   Pfam; PF00757; Furin-like; 1.
DR   Pfam; PF14843; GF_recep_IV; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF01030; Recep_L_domain; 2.
DR   PIRSF; PIRSF000619; TyrPK_EGF-R; 2.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00261; FU; 3.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|PIRSR:PIRSR000619-2,
KW   ECO:0000256|SAAS:SAAS00461464};
KW   Kinase {ECO:0000256|SAAS:SAAS00594505};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Nucleotide-binding {ECO:0000256|PIRSR:PIRSR000619-2,
KW   ECO:0000256|SAAS:SAAS00461464};
KW   Receptor {ECO:0000313|EMBL:ADL28125.1};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transferase {ECO:0000256|SAAS:SAAS00594505};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius};
KW   Tyrosine-protein kinase {ECO:0000256|SAAS:SAAS00594505}.
FT   SIGNAL        1     24       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        25   1136       Receptor protein-tyrosine kinase.
FT                                {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5003216067.
FT   TRANSMEM    646    667       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      712    979       Protein kinase.
FT                                {ECO:0000259|PROSITE:PS50011}.
FT   NP_BIND     718    726       ATP. {ECO:0000256|PIRSR:PIRSR000619-2}.
FT   ACT_SITE    837    837       Proton acceptor.
FT                                {ECO:0000256|PIRSR:PIRSR000619-1}.
FT   BINDING     745    745       ATP. {ECO:0000256|PIRSR:PIRSR000619-2}.
SQ   SEQUENCE   1136 AA;  125801 MW;  77E46C2B5E691E9F CRC64;
     MRPSGTAGAA LLALLAALCP ASRALEEKKV CQGTSNKLTQ LGTFEDHFLS LQRMFNNCEV
     VLGNLEITYV QRNYDLSFLK TIQEVAGYVL IALNTVERIP LENLQIIRGN MYYENSYALA
     VLSNYDANKT GLKELPMRNL QEILHGAVRF SNNPALCNVE SIQWRDIVSS DFLSNMSMDF
     QNHLGSCQKC DPSCPNGSCW GAGEENCQKL TKIICAQQCS GRCRGKSPSD CCHNQCAAGC
     TGPRESDCLV CRKFRDEATC KDTCPPLMLY NPTTYQMDVN PEGKYSFGAT CVKKCPRNYV
     VTDHGSCVRA CGADSYEMEE DGVRKCKKCE GPCRKVCNGI GIGEFKDSLS INATNIKHFK
     NCTSISGDLH ILPVAFRGDS FTHTPPLDPQ ELDILKTVKE ITGFLLIQAW PENRTDLHAF
     ENLEIIRGRT KQHGQFSLAV VSLNITSLGL RSLKEISDGD VIISGNKNLC YANTINWKKL
     FGTSGQKTKI ISNRGENSCK ATGQVCHALC SPEGCWGPEP RDCVSCRNVS RGRECVDKCN
     LLEGEPREFV ENSECIQCHP ECLPQAMNIT CTGRGPDNCI QCAHYIDGPH CVKTCPAGVM
     GENNTLVWKY ADAGHVCHLC HPNCTYGCTG PGLEGCPTNG PKIPSIATGM VGALLLLLVV
     ALGIGLFMRR RHIVRKRTLR RLLQERELVE PLTPSGEAPN QALLRILKET EFKKIKVLGS
     GAFGTVYKGL WIPEGEKVKI PVAIKELREA TSPKANKEIL DEAYVMASVD NPHVCRLLGI
     CLTSTVQLIT QLMPFGCLLD YVREHKDNIG SQYLLNWCVQ IAKGMNYLED RRLVHRDLAA
     RNVLVKTPQH VKITDFGLAK LLGAEEKEYH AEGGKVPIKW MALESILHRI YTHQSDVWSY
     GVTVWELMTF GSKPYDGIPA SEISSILEKG ERLPQPPICT IDVYMIMVKC WMIDADSRPK
     FRELIIEFSK MARDPQRYLV IQGDERMHLP SPTDSNFYRA LMDEEDMDDV VDADEYLIPQ
     QGFFSSPSTS RTPLLSSLSA TSNNSTVACI DRNGLQSCPI KEDSFLQRYS SDPTGALTED
     SIDDTFLPVP GEWLVWKQSC SSTSSTHSAA ASLQCPSQVL PPASPEGETV ADLQTQ
//
ID   E9PFD7_HUMAN            Unreviewed;      1165 AA.
AC   E9PFD7;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 3.
DT   23-MAY-2018, entry version 71.
DE   RecName: Full=Receptor protein-tyrosine kinase {ECO:0000256|SAAS:SAAS00593197};
DE            EC=2.7.10.1 {ECO:0000256|SAAS:SAAS00593197};
GN   Name=EGFR {ECO:0000313|Ensembl:ENSP00000395243};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000395243, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000395243, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [3] {ECO:0000213|PubMed:18220336}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.D., Yates J.R.;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [4] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7] {ECO:0000213|PubMed:19369195}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [8] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [9] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10] {ECO:0000313|Ensembl:ENSP00000395243}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [11] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000256|SAAS:SAAS00594546}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. {ECO:0000256|SAAS:SAAS00941529}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC006977; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC073324; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458469; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001333828.1; NM_001346899.1.
DR   UniGene; Hs.488293; -.
DR   UniGene; Hs.605083; -.
DR   UniGene; Hs.731652; -.
DR   ProteinModelPortal; E9PFD7; -.
DR   PeptideAtlas; E9PFD7; -.
DR   PRIDE; E9PFD7; -.
DR   Ensembl; ENST00000454757; ENSP00000395243; ENSG00000146648.
DR   GeneID; 1956; -.
DR   UCSC; uc022adn.2; human.
DR   CTD; 1956; -.
DR   EuPathDB; HostDB:ENSG00000146648.15; -.
DR   HGNC; HGNC:3236; EGFR.
DR   OpenTargets; ENSG00000146648; -.
DR   eggNOG; KOG1025; Eukaryota.
DR   eggNOG; ENOG410XNSR; LUCA.
DR   GeneTree; ENSGT00760000118799; -.
DR   ChiTaRS; EGFR; human.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000146648; -.
DR   ExpressionAtlas; E9PFD7; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004716; F:signal transducer, downstream of receptor, with protein tyrosine kinase activity; IEA:InterPro.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:InterPro.
DR   Gene3D; 3.80.20.20; -; 3.
DR   InterPro; IPR006211; Furin-like_Cys-rich_dom.
DR   InterPro; IPR006212; Furin_repeat.
DR   InterPro; IPR032778; GF_recep_IV.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR000494; Rcpt_L-dom.
DR   InterPro; IPR036941; Rcpt_L-dom_sf.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016245; Tyr_kinase_EGF/ERB/XmrK_rcpt.
DR   Pfam; PF00757; Furin-like; 1.
DR   Pfam; PF14843; GF_recep_IV; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF01030; Recep_L_domain; 2.
DR   PIRSF; PIRSF000619; TyrPK_EGF-R; 3.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00261; FU; 3.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|PIRSR:PIRSR000619-2,
KW   ECO:0000256|SAAS:SAAS00461464};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Kinase {ECO:0000256|SAAS:SAAS00594505};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Nucleotide-binding {ECO:0000256|PIRSR:PIRSR000619-2,
KW   ECO:0000256|SAAS:SAAS00461464};
KW   Proteomics identification {ECO:0000213|EPD:E9PFD7,
KW   ECO:0000213|MaxQB:E9PFD7, ECO:0000213|PeptideAtlas:E9PFD7};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transferase {ECO:0000256|SAAS:SAAS00594505};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius};
KW   Tyrosine-protein kinase {ECO:0000256|SAAS:SAAS00594505}.
FT   SIGNAL        1     24       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        25   1165       Receptor protein-tyrosine kinase.
FT                                {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5003244049.
FT   TRANSMEM    601    622       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      667    934       Protein kinase.
FT                                {ECO:0000259|PROSITE:PS50011}.
FT   NP_BIND     673    681       ATP. {ECO:0000256|PIRSR:PIRSR000619-2}.
FT   ACT_SITE    792    792       Proton acceptor.
FT                                {ECO:0000256|PIRSR:PIRSR000619-1}.
FT   BINDING     700    700       ATP. {ECO:0000256|PIRSR:PIRSR000619-2}.
SQ   SEQUENCE   1165 AA;  129169 MW;  9CEE26B795A041B2 CRC64;
     MRPSGTAGAA LLALLAALCP ASRALEEKKV CQGTSNKLTQ LGTFEDHFLS LQRMFNNCEV
     VLGNLEITYV QRNYDLSFLK TIQEVAGYVL IALNTVERIP LENLQIIRGN MYYENSYALA
     VLSNYDANKT GLKELPMRNL QGQKCDPSCP NGSCWGAGEE NCQKLTKIIC AQQCSGRCRG
     KSPSDCCHNQ CAAGCTGPRE SDCLVCRKFR DEATCKDTCP PLMLYNPTTY QMDVNPEGKY
     SFGATCVKKC PRNYVVTDHG SCVRACGADS YEMEEDGVRK CKKCEGPCRK VCNGIGIGEF
     KDSLSINATN IKHFKNCTSI SGDLHILPVA FRGDSFTHTP PLDPQELDIL KTVKEITGFL
     LIQAWPENRT DLHAFENLEI IRGRTKQHGQ FSLAVVSLNI TSLGLRSLKE ISDGDVIISG
     NKNLCYANTI NWKKLFGTSG QKTKIISNRG ENSCKATGQV CHALCSPEGC WGPEPRDCVS
     CRNVSRGREC VDKCNLLEGE PREFVENSEC IQCHPECLPQ AMNITCTGRG PDNCIQCAHY
     IDGPHCVKTC PAGVMGENNT LVWKYADAGH VCHLCHPNCT YGCTGPGLEG CPTNGPKIPS
     IATGMVGALL LLLVVALGIG LFMRRRHIVR KRTLRRLLQE RELVEPLTPS GEAPNQALLR
     ILKETEFKKI KVLGSGAFGT VYKGLWIPEG EKVKIPVAIK ELREATSPKA NKEILDEAYV
     MASVDNPHVC RLLGICLTST VQLITQLMPF GCLLDYVREH KDNIGSQYLL NWCVQIAKGM
     NYLEDRRLVH RDLAARNVLV KTPQHVKITD FGLAKLLGAE EKEYHAEGGK VPIKWMALES
     ILHRIYTHQS DVWSYGVTVW ELMTFGSKPY DGIPASEISS ILEKGERLPQ PPICTIDVYM
     IMVKCWMIDA DSRPKFRELI IEFSKMARDP QRYLVIQGDE RMHLPSPTDS NFYRALMDEE
     DMDDVVDADE YLIPQQGFFS SPSTSRTPLL SSLSATSNNS TVACIDRNGL QSCPIKEDSF
     LQRYSSDPTG ALTEDSIDDT FLPVPEYINQ SVPKRPAGSV QNPVYHNQPL NPAPSRDPHY
     QDPHSTAVGN PEYLNTVQPT CVNSTFDSPA HWAQKGSHQI SLDNPDYQQD FFPKEAKPNG
     IFKGSTAENA EYLRVAPQSS EFIGA
//
ID   F2YGG7_HUMAN            Unreviewed;      1167 AA.
AC   F2YGG7;
DT   31-MAY-2011, integrated into UniProtKB/TrEMBL.
DT   31-MAY-2011, sequence version 1.
DT   28-FEB-2018, entry version 50.
DE   RecName: Full=Receptor protein-tyrosine kinase {ECO:0000256|SAAS:SAAS00593197};
DE            EC=2.7.10.1 {ECO:0000256|SAAS:SAAS00593197};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADZ75461.1};
RN   [1] {ECO:0000313|EMBL:ADZ75461.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li Z., Wang H., Zhou M., Jiang H.;
RT   "Identification of an exon 4-deletion variant of epidermal growth
RT   factor receptor.";
RL   Submitted (JAN-2011) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000256|SAAS:SAAS00594546}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. {ECO:0000256|SAAS:SAAS00941529}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HQ912715; ADZ75461.1; -; mRNA.
DR   RefSeq; NP_001333827.1; NM_001346898.1.
DR   RefSeq; NP_001333828.1; NM_001346899.1.
DR   RefSeq; NP_001333829.1; NM_001346900.1.
DR   RefSeq; NP_005219.2; NM_005228.4.
DR   UniGene; Hs.488293; -.
DR   UniGene; Hs.605083; -.
DR   UniGene; Hs.731652; -.
DR   ProteinModelPortal; F2YGG7; -.
DR   SMR; F2YGG7; -.
DR   PeptideAtlas; F2YGG7; -.
DR   PRIDE; F2YGG7; -.
DR   GeneID; 1956; -.
DR   KEGG; hsa:1956; -.
DR   CTD; 1956; -.
DR   eggNOG; KOG1025; Eukaryota.
DR   eggNOG; ENOG410XNSR; LUCA.
DR   KO; K04361; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004716; F:signal transducer, downstream of receptor, with protein tyrosine kinase activity; IEA:InterPro.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:InterPro.
DR   Gene3D; 3.80.20.20; -; 3.
DR   InterPro; IPR006211; Furin-like_Cys-rich_dom.
DR   InterPro; IPR006212; Furin_repeat.
DR   InterPro; IPR032778; GF_recep_IV.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR000494; Rcpt_L-dom.
DR   InterPro; IPR036941; Rcpt_L-dom_sf.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016245; Tyr_kinase_EGF/ERB/XmrK_rcpt.
DR   Pfam; PF00757; Furin-like; 1.
DR   Pfam; PF14843; GF_recep_IV; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF01030; Recep_L_domain; 2.
DR   PIRSF; PIRSF000619; TyrPK_EGF-R; 3.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00261; FU; 3.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|PIRSR:PIRSR000619-2,
KW   ECO:0000256|SAAS:SAAS00461464};
KW   Kinase {ECO:0000256|SAAS:SAAS00594505};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Nucleotide-binding {ECO:0000256|PIRSR:PIRSR000619-2,
KW   ECO:0000256|SAAS:SAAS00461464};
KW   Receptor {ECO:0000313|EMBL:ADZ75461.1};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transferase {ECO:0000256|SAAS:SAAS00594505};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius};
KW   Tyrosine-protein kinase {ECO:0000256|SAAS:SAAS00594505}.
FT   SIGNAL        1     24       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        25   1167       Receptor protein-tyrosine kinase.
FT                                {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5003289839.
FT   TRANSMEM    601    622       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      667    934       Protein kinase.
FT                                {ECO:0000259|PROSITE:PS50011}.
FT   NP_BIND     673    681       ATP. {ECO:0000256|PIRSR:PIRSR000619-2}.
FT   ACT_SITE    792    792       Proton acceptor.
FT                                {ECO:0000256|PIRSR:PIRSR000619-1}.
FT   BINDING     700    700       ATP. {ECO:0000256|PIRSR:PIRSR000619-2}.
SQ   SEQUENCE   1167 AA;  129365 MW;  1A345CEE26B795A0 CRC64;
     MRPSGTAGAA LLALLAALCP ASRALEEKKV CQGTSNKLTQ LGTFEDHFLS LQRMFNNCEV
     VLGNLEITYV QRNYDLSFLK TIQEVAGYVL IALNTVERIP LENLQIIRGN MYYENSYALA
     VLSNYDANKT GLKELPMRNL QGQKCDPSCP NGSCWGAGEE NCQKLTKIIC AQQCSGRCRG
     KSPSDCCHNQ CAAGCTGPRE SDCLVCRKFR DEATCKDTCP PLMLYNPTTY QMDVNPEGKY
     SFGATCVKKC PRNYVVTDHG SCVRACGADS YEMEEDGVRK CKKCEGPCRK VCNGIGIGEF
     KDSLSINATN IKHFKNCTSI SGDLHILPVA FRGDSFTHTP PLDPQELDIL KTVKEITGFL
     LIQAWPENRT DLHAFENLEI IRGRTKQHGQ FSLAVVSLNI TSLGLRSLKE ISDGDVIISG
     NKNLCYANTI NWKKLFGTSG QKTKIISNRG ENSCKATGQV CHALCSPEGC WGPEPRDCVS
     CRNVSRGREC VDKCNLLEGE PREFVENSEC IQCHPECLPQ AMNITCTGRG PDNCIQCAHY
     IDGPHCVKTC PAGVMGENNT LVWKYADAGH VCHLCHPNCT YGCTGPGLEG CPTNGPKIPS
     IATGMVGALL LLLVVALGIG LFMRRRHIVR KRTLRRLLQE RELVEPLTPS GEAPNQALLR
     ILKETEFKKI KVLGSGAFGT VYKGLWIPEG EKVKIPVAIK ELREATSPKA NKEILDEAYV
     MASVDNPHVC RLLGICLTST VQLITQLMPF GCLLDYVREH KDNIGSQYLL NWCVQIAKGM
     NYLEDRRLVH RDLAARNVLV KTPQHVKITD FGLAKLLGAE EKEYHAEGGK VPIKWMALES
     ILHRIYTHQS DVWSYGVTVW ELMTFGSKPY DGIPASEISS ILEKGERLPQ PPICTIDVYM
     IMVKCWMIDA DSRPKFRELI IEFSKMARDP QRYLVIQGDE RMHLPSPTDS NFYRALMDEE
     DMDDVVDADE YLIPQQGFFS SPSTSRTPLL SSLSATSNNS TVACIDRNGL QSCPIKEDSF
     LQRYSSDPTG ALTEDSIDDT FLPVPEYINQ SVPKRPAGSV QNPVYHNQPL NPAPSRDPHY
     QDPHSTAVGN PEYLNTVQPT CVNSTFDSPA HWAQKGSHQI SLDNPDYQQD FFPKEAKPNG
     IFKGSTAENA EYLRVAPQSS EFIGAVP
//
ID   EGFR_HUMAN              Reviewed;        1210 AA.
AC   P00533; O00688; O00732; P06268; Q14225; Q68GS5; Q92795; Q9BZS2;
AC   Q9GZX1; Q9H2C9; Q9H3C9; Q9UMD7; Q9UMD8; Q9UMG5;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   23-MAY-2018, entry version 252.
DE   RecName: Full=Epidermal growth factor receptor;
DE            EC=2.7.10.1;
DE   AltName: Full=Proto-oncogene c-ErbB-1;
DE   AltName: Full=Receptor tyrosine-protein kinase erbB-1;
DE   Flags: Precursor;
GN   Name=EGFR; Synonyms=ERBB, ERBB1, HER1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PROTEIN SEQUENCE OF 25-32.
RX   PubMed=6328312; DOI=10.1038/309418a0;
RA   Ullrich A., Coussens L., Hayflick J.S., Dull T.J., Gray A., Tam A.W.,
RA   Lee J., Yarden Y., Libermann T.A., Schlessinger J., Downward J.,
RA   Mayes E.L.V., Whittle N., Waterfield M.D., Seeburg P.H.;
RT   "Human epidermal growth factor receptor cDNA sequence and aberrant
RT   expression of the amplified gene in A431 epidermoid carcinoma cells.";
RL   Nature 309:418-425(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=7654368; DOI=10.1002/mrd.1080410205;
RA   Ilekis J.V., Stark B.C., Scoccia B.;
RT   "Possible role of variant RNA transcripts in the regulation of
RT   epidermal growth factor receptor expression in human placenta.";
RL   Mol. Reprod. Dev. 41:149-156(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=8918811; DOI=10.1093/nar/24.20.4050;
RA   Reiter J.L., Maihle N.J.;
RT   "A 1.8 kb alternative transcript from the human epidermal growth
RT   factor receptor gene encodes a truncated form of the receptor.";
RL   Nucleic Acids Res. 24:4050-4056(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=9103388; DOI=10.1006/gyno.1996.4526;
RA   Ilekis J.V., Gariti J., Niederberger C., Scoccia B.;
RT   "Expression of a truncated epidermal growth factor receptor-like
RT   protein (TEGFR) in ovarian cancer.";
RL   Gynecol. Oncol. 65:36-41(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Placenta;
RX   PubMed=11161793; DOI=10.1006/geno.2000.6341;
RA   Reiter J.L., Threadgill D.W., Eley G.D., Strunk K.E., Danielsen A.J.,
RA   Schehl Sinclair C., Pearsall R.S., Green P.J., Yee D., Lampland A.L.,
RA   Balasubramaniam S., Crossley T.D., Magnuson T.R., James C.D.,
RA   Maihle N.J.;
RT   "Comparative genomic sequence analysis and isolation of human and
RT   mouse alternative EGFR transcripts encoding truncated receptor
RT   isoforms.";
RL   Genomics 71:1-20(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Xu L., Hong A., He X.;
RT   "Cloning of the cDNA for a short EGF receptor from human placenta.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLN-98; ARG-266;
RP   LYS-521; ILE-674; GLY-962 AND PRO-988.
RG   NIEHS SNPs program;
RL   Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 575-687.
RA   Reiter J.L., Threadgill D.W., Danielsen A.J., Schehl C.M.,
RA   Lampland A.L., Balasubramaniam S., Crossley T.O., Magnuson T.R.,
RA   Maihle N.J.;
RT   "Human and mouse alternative EGFR transcripts encoding only the
RT   extracellular domain of the receptor.";
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 713-924.
RX   PubMed=6326261; DOI=10.1126/science.6326261;
RA   Lin C.R., Chen W.S., Kruiger W., Stolarsky L.S., Weber W., Evans R.M.,
RA   Verma I.M., Gill G.N., Rosenfeld M.G.;
RT   "Expression cloning of human EGF receptor complementary DNA: gene
RT   amplification and three related messenger RNA products in A431
RT   cells.";
RL   Science 224:843-848(1984).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 150-962.
RX   PubMed=6330563; DOI=10.1038/309806a0;
RA   Xu Y.H., Ishii S., Clark A.J.L., Sullivan M., Wilson R.K., Ma D.P.,
RA   Roe B.A., Merlino G.T., Pastan I.;
RT   "Human epidermal growth factor receptor cDNA is homologous to a
RT   variety of RNAs overproduced in A431 carcinoma cells.";
RL   Nature 309:806-810(1984).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1028-1210.
RX   PubMed=6093780; DOI=10.1016/0006-291X(84)90926-4;
RA   Simmen F.A., Gope M.L., Schulz T.Z., Wright D.A., Carpenter G.,
RA   O'Malley B.W.;
RT   "Isolation of an evolutionarily conserved epidermal growth factor
RT   receptor cDNA from human A431 carcinoma cells.";
RL   Biochem. Biophys. Res. Commun. 124:125-132(1984).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29.
RX   PubMed=3329716;
RA   Haley J.D., Whittle N., Bennett P., Kinchington D., Ullrich A.,
RA   Waterfield M.D.;
RT   "The human EGF receptor gene: structure of the 110 kb locus and
RT   identification of sequences regulating its transcription.";
RL   Oncogene Res. 1:375-396(1987).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29.
RX   PubMed=1988448;
RA   Haley J.D., Waterfield M.D.;
RT   "Contributory effects of de novo transcription and premature
RT   transcript termination in the regulation of human epidermal growth
RT   factor receptor proto-oncogene RNA synthesis.";
RL   J. Biol. Chem. 266:1746-1753(1991).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29.
RX   PubMed=2991899; DOI=10.1073/pnas.82.15.4920;
RA   Ishii S., Xu Y.H., Stratton R.H., Roe B.A., Merlino G.T., Pastan I.;
RT   "Characterization and sequence of the promoter region of the human
RT   epidermal growth factor receptor gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:4920-4924(1985).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 25-49.
RX   PubMed=6324343; DOI=10.1126/science.6324343;
RA   Weber W., Gill G.N., Spiess J.;
RT   "Production of an epidermal growth factor receptor-related protein.";
RL   Science 224:294-297(1984).
RN   [16]
RP   PROTEIN SEQUENCE OF 540.
RA   Kohda D.;
RL   Submitted (SEP-1997) to UniProtKB.
RN   [17]
RP   PROTEIN SEQUENCE OF 687-705; 986-998; 1000-1023; 1026-1030 AND
RP   1068-1077, AND PHOSPHORYLATION AT THR-693; SER-695; SER-1070 AND
RP   SER-1071.
RX   PubMed=3138233;
RA   Heisermann G.J., Gill G.N.;
RT   "Epidermal growth factor receptor threonine and serine residues
RT   phosphorylated in vivo.";
RL   J. Biol. Chem. 263:13152-13158(1988).
RN   [18]
RP   PROTEIN SEQUENCE OF 25-39.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [19]
RP   PROTEIN SEQUENCE OF 740-744 AND 746-747.
RX   PubMed=2985580;
RA   Russo M.W., Lukas T.J., Cohen S., Staros J.V.;
RT   "Identification of residues in the nucleotide binding site of the
RT   epidermal growth factor receptor/kinase.";
RL   J. Biol. Chem. 260:5205-5208(1985).
RN   [20]
RP   PROTEIN SEQUENCE OF 861-875 AND 914-932, UBIQUITINATION AT LYS-716;
RP   LYS-737; LYS-754; LYS-867; LYS-929 AND LYS-970, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=16543144; DOI=10.1016/j.molcel.2006.02.018;
RA   Huang F., Kirkpatrick D., Jiang X., Gygi S.P., Sorkin A.;
RT   "Differential regulation of EGF receptor internalization and
RT   degradation by multiubiquitination within the kinase domain.";
RL   Mol. Cell 21:737-748(2006).
RN   [21]
RP   PARTIAL PROTEIN SEQUENCE, AND DISULFIDE BONDS.
RX   PubMed=9556602; DOI=10.1074/jbc.273.18.11150;
RA   Abe Y., Odaka M., Inagaki F., Lax I., Schlessinger J., Kohda D.;
RT   "Disulfide bond structure of human epidermal growth factor receptor.";
RL   J. Biol. Chem. 273:11150-11157(1998).
RN   [22]
RP   RECEPTOR ACTIVITY.
RX   PubMed=6325948; DOI=10.1038/309270a0;
RA   Mroczkowski B., Mosig G., Cohen S.;
RT   "ATP-stimulated interaction between epidermal growth factor receptor
RT   and supercoiled DNA.";
RL   Nature 309:270-273(1984).
RN   [23]
RP   REVIEW.
RX   PubMed=3039909; DOI=10.1146/annurev.bi.56.070187.004313;
RA   Carpenter G.;
RT   "Receptors for epidermal growth factor and other polypeptide
RT   mitogens.";
RL   Annu. Rev. Biochem. 56:881-914(1987).
RN   [24]
RP   FUNCTION, SUBCELLULAR LOCATION, AND LIGAND-BINDING.
RX   PubMed=2790960; DOI=10.1016/0092-8674(89)90867-2;
RA   Chen W.S., Lazar C.S., Lund K.A., Welsh J.B., Chang C.P., Walton G.M.,
RA   Der C.J., Wiley H.S., Gill G.N., Rosenfeld M.G.;
RT   "Functional independence of the epidermal growth factor receptor from
RT   a domain required for ligand-induced internalization and calcium
RT   regulation.";
RL   Cell 59:33-43(1989).
RN   [25]
RP   PHOSPHORYLATION AT TYR-1110.
RX   PubMed=2543678;
RA   Margolis B.L., Lax I., Kris R., Dombalagian M., Honegger A.M.,
RA   Howk R., Givol D., Ullrich A., Schlessinger J.;
RT   "All autophosphorylation sites of epidermal growth factor (EGF)
RT   receptor and HER2/neu are located in their carboxyl-terminal tails.
RT   Identification of a novel site in EGF receptor.";
RL   J. Biol. Chem. 264:10667-10671(1989).
RN   [26]
RP   IDENTIFICATION OF AREG AS LIGAND, AND FUNCTION.
RX   PubMed=7679104;
RA   Johnson G.R., Kannan B., Shoyab M., Stromberg K.;
RT   "Amphiregulin induces tyrosine phosphorylation of the epidermal growth
RT   factor receptor and p185erbB2. Evidence that amphiregulin acts
RT   exclusively through the epidermal growth factor receptor at the
RT   surface of human epithelial cells.";
RL   J. Biol. Chem. 268:2924-2931(1993).
RN   [27]
RP   INTERACTION WITH ZPR1.
RX   PubMed=8650580; DOI=10.1126/science.272.5269.1797;
RA   Galcheva-Gargova Z., Konstantinov K.N., Wu I.-H., Klier F.G.,
RA   Barrett T., Davis R.J.;
RT   "Binding of zinc finger protein ZPR1 to the epidermal growth factor
RT   receptor.";
RL   Science 272:1797-1802(1996).
RN   [28]
RP   INTERACTION WITH ZPR1.
RX   PubMed=9852145; DOI=10.1083/jcb.143.6.1471;
RA   Gangwani L., Mikrut M., Galcheva-Gargova Z., Davis R.J.;
RT   "Interaction of ZPR1 with translation elongation factor-1alpha in
RT   proliferating cells.";
RL   J. Cell Biol. 143:1471-1484(1998).
RN   [29]
RP   PHOSPHORYLATION AT THR-678 AND THR-693.
RX   PubMed=10523301; DOI=10.1093/emboj/18.20.5567;
RA   Bagowski C.P., Stein-Gerlach M., Choidas A., Ullrich A.;
RT   "Cell-type specific phosphorylation of threonines T654 and T669 by PKD
RT   defines the signal capacity of the EGF receptor.";
RL   EMBO J. 18:5567-5576(1999).
RN   [30]
RP   IDENTIFICATION OF BETACELLULIN/BTC AS LIGAND.
RX   PubMed=8144591;
RA   Watanabe T., Shintani A., Nakata M., Shing Y., Folkman J.,
RA   Igarashi K., Sasada R.;
RT   "Recombinant human betacellulin. Molecular structure, biological
RT   activities, and receptor interaction.";
RL   J. Biol. Chem. 269:9966-9973(1994).
RN   [31]
RP   FUNCTION IN PHOSPHORYLATION OF CBL, AND INTERACTION WITH CBL.
RX   PubMed=7657591; DOI=10.1074/jbc.270.35.20242;
RA   Galisteo M.L., Dikic I., Batzer A.G., Langdon W.Y., Schlessinger J.;
RT   "Tyrosine phosphorylation of the c-cbl proto-oncogene protein product
RT   and association with epidermal growth factor (EGF) receptor upon EGF
RT   stimulation.";
RL   J. Biol. Chem. 270:20242-20245(1995).
RN   [32]
RP   GLYCOSYLATION AT ASN-128; ASN-175; ASN-413; ASN-444 AND ASN-528.
RX   PubMed=8962717; DOI=10.3109/08977199609034572;
RA   Smith K.D., Davies M.J., Bailey D., Renouf D.V., Hounsell E.F.;
RT   "Analysis of the glycosylation patterns of the extracellular domain of
RT   the epidermal growth factor receptor expressed in Chinese hamster
RT   ovary fibroblasts.";
RL   Growth Factors 13:121-132(1996).
RN   [33]
RP   IDENTIFICATION OF EPIREGULIN/EREG AS LIGAND, AND FUNCTION.
RX   PubMed=9419975; DOI=10.1038/sj.onc.1201458;
RA   Komurasaki T., Toyoda H., Uchida D., Morimoto S.;
RT   "Epiregulin binds to epidermal growth factor receptor and ErbB-4 and
RT   induces tyrosine phosphorylation of epidermal growth factor receptor,
RT   ErbB-2, ErbB-3 and ErbB-4.";
RL   Oncogene 15:2841-2848(1997).
RN   [34]
RP   PHOSPHORYLATION, AND DEPHOSPHORYLATION BY PTPN1 AND PTPN2.
RX   PubMed=9488479; DOI=10.1128/MCB.18.3.1622;
RA   Tiganis T., Bennett A.M., Ravichandran K.S., Tonks N.K.;
RT   "Epidermal growth factor receptor and the adaptor protein p52Shc are
RT   specific substrates of T-cell protein tyrosine phosphatase.";
RL   Mol. Cell. Biol. 18:1622-1634(1998).
RN   [35]
RP   INTERACTION WITH AP2M1.
RX   PubMed=10228163; DOI=10.1093/emboj/18.9.2489;
RA   Nesterov A., Carter R.E., Sorkina T., Gill G.N., Sorkin A.;
RT   "Inhibition of the receptor-binding function of clathrin adaptor
RT   protein AP-2 by dominant-negative mutant mu2 subunit and its effects
RT   on endocytosis.";
RL   EMBO J. 18:2489-2499(1999).
RN   [36]
RP   INTERACTION WITH GRB2; NCK1 AND NCK2.
RX   PubMed=10026169; DOI=10.1074/jbc.274.9.5542;
RA   Braverman L.E., Quilliam L.A.;
RT   "Identification of Grb4/Nckbeta, a src homology 2 and 3 domain-
RT   containing adapter protein having similar binding and biological
RT   properties to Nck.";
RL   J. Biol. Chem. 274:5542-5549(1999).
RN   [37]
RP   GLYCOSYLATION AT ASN-56; ASN-352; ASN-361; ASN-568 AND ASN-603.
RX   PubMed=10731668; DOI=10.1093/oxfordjournals.jbchem.a022585;
RA   Sato C., Kim J.-H., Abe Y., Saito K., Yokoyama S., Kohda D.;
RT   "Characterization of the N-oligosaccharides attached to the atypical
RT   Asn-X-Cys sequence of recombinant human epidermal growth factor
RT   receptor.";
RL   J. Biochem. 127:65-72(2000).
RN   [38]
RP   FUNCTION IN PHOSPHORYLATION OF RGS16.
RX   PubMed=11602604; DOI=10.1074/jbc.M108862200;
RA   Derrien A., Druey K.M.;
RT   "RGS16 function is regulated by epidermal growth factor receptor-
RT   mediated tyrosine phosphorylation.";
RL   J. Biol. Chem. 276:48532-48538(2001).
RN   [39]
RP   GLYCOSYLATION AT ASN-56; ASN-128; ASN-175; ASN-196; ASN-352; ASN-361;
RP   ASN-413; ASN-444; ASN-528; ASN-568; ASN-603 AND ASN-623.
RX   PubMed=12731890; DOI=10.1021/bi027101p;
RA   Zhen Y., Caprioli R.M., Staros J.V.;
RT   "Characterization of glycosylation sites of the epidermal growth
RT   factor receptor.";
RL   Biochemistry 42:5478-5492(2003).
RN   [40]
RP   FUNCTION IN CELL PROLIFERATION, INTERACTION WITH STAT3, AND
RP   PHOSPHORYLATION AT TYR-1092 AND TYR-1110.
RX   PubMed=12873986;
RA   Shao H., Cheng H.Y., Cook R.G., Tweardy D.J.;
RT   "Identification and characterization of signal transducer and
RT   activator of transcription 3 recruitment sites within the epidermal
RT   growth factor receptor.";
RL   Cancer Res. 63:3923-3930(2003).
RN   [41]
RP   ENZYME REGULATION, AND INTERACTION WITH LRIG1.
RX   PubMed=15282549; DOI=10.1038/sj.emboj.7600342;
RA   Gur G., Rubin C., Katz M., Amit I., Citri A., Nilsson J.,
RA   Amariglio N., Henriksson R., Rechavi G., Hedman H., Wides R.,
RA   Yarden Y.;
RT   "LRIG1 restricts growth factor signaling by enhancing receptor
RT   ubiquitylation and degradation.";
RL   EMBO J. 23:3270-3281(2004).
RN   [42]
RP   FUNCTION IN EGFR SIGNALING, IDENTIFICATION IN A COMPLEX WITH PIK3C2A
RP   AND ERBB2, IDENTIFICATION IN A COMPLEX WITH PIK3C2B AND ERBB2,
RP   INTERACTION WITH PIK3C2B, AND MUTAGENESIS OF TYR-1016; TYR-1092;
RP   TYR-1110; TYR-1172 AND TYR-1197.
RX   PubMed=10805725; DOI=10.1128/MCB.20.11.3817-3830.2000;
RA   Arcaro A., Zvelebil M.J., Wallasch C., Ullrich A., Waterfield M.D.,
RA   Domin J.;
RT   "Class II phosphoinositide 3-kinases are downstream targets of
RT   activated polypeptide growth factor receptors.";
RL   Mol. Cell. Biol. 20:3817-3830(2000).
RN   [43]
RP   FUNCTION IN NF-KAPPA-B ACTIVATION, AND INTERACTION WITH RIPK1.
RX   PubMed=11116146; DOI=10.1074/jbc.M008458200;
RA   Habib A.A., Chatterjee S., Park S.-K., Ratan R.R., Lefebvre S.,
RA   Vartanian T.;
RT   "The epidermal growth factor receptor engages receptor interacting
RT   protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to
RT   activate NF-kappa B. Identification of a novel receptor-tyrosine
RT   kinase signalosome.";
RL   J. Biol. Chem. 276:8865-8874(2001).
RN   [44]
RP   FUNCTION IN PHOSPHORYLATION OF MUC1, AND INTERACTION WITH MUC1.
RX   PubMed=11483589; DOI=10.1074/jbc.C100359200;
RA   Li Y., Ren J., Yu W., Li Q., Kuwahara H., Yin L., Carraway K.L. III,
RA   Kufe D.;
RT   "The epidermal growth factor receptor regulates interaction of the
RT   human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin.";
RL   J. Biol. Chem. 276:35239-35242(2001).
RN   [45]
RP   FUNCTION, ENZYME REGULATION, AND INTERACTION WITH SOCS5.
RX   PubMed=15590694; DOI=10.1074/jbc.M408575200;
RA   Kario E., Marmor M.D., Adamsky K., Citri A., Amit I., Amariglio N.,
RA   Rechavi G., Yarden Y.;
RT   "Suppressors of cytokine signaling 4 and 5 regulate epidermal growth
RT   factor receptor signaling.";
RL   J. Biol. Chem. 280:7038-7048(2005).
RN   [46]
RP   IDENTIFICATION OF EPIGEN/EPGN AS A LIGAND, AND FUNCTION.
RX   PubMed=15611079; DOI=10.1074/jbc.M413919200;
RA   Kochupurakkal B.S., Harari D., Di-Segni A., Maik-Rachline G.,
RA   Lyass L., Gur G., Kerber G., Citri A., Lavi S., Eilam R.,
RA   Chalifa-Caspi V., Eshhar Z., Pikarsky E., Pinkas-Kramarski R.,
RA   Bacus S.S., Yarden Y.;
RT   "Epigen, the last ligand of ErbB receptors, reveals intricate
RT   relationships between affinity and mitogenicity.";
RL   J. Biol. Chem. 280:8503-8512(2005).
RN   [47]
RP   GLYCOSYLATION AT ASN-56; ASN-128; ASN-175; ASN-196; ASN-352; ASN-361;
RP   ASN-413; ASN-444; ASN-528; ASN-568 AND ASN-603, PHOSPHORYLATION AT
RP   THR-693; SER-991 AND SER-1026, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=16083266; DOI=10.1021/pr050113n;
RA   Wu S.L., Kim J., Hancock W.S., Karger B.;
RT   "Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS
RT   platform for high sequence coverage of complex proteins with extensive
RT   post-translational modifications-comprehensive analysis of beta-casein
RT   and epidermal growth factor receptor (EGFR).";
RL   J. Proteome Res. 4:1155-1170(2005).
RN   [48]
RP   INTERACTION WITH PELP1.
RX   PubMed=16140940; DOI=10.1158/0008-5472.CAN-05-0614;
RA   Vadlamudi R.K., Manavathi B., Balasenthil S., Nair S.S., Yang Z.,
RA   Sahin A.A., Kumar R.;
RT   "Functional implications of altered subcellular localization of PELP1
RT   in breast cancer cells.";
RL   Cancer Res. 65:7724-7732(2005).
RN   [49]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1172 AND TYR-1197, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [50]
RP   FUNCTION IN CELL PROLIFERATION, FUNCTION IN PCNA PHOSPHORYLATION,
RP   INTERACTION WITH PCNA, AND SUBCELLULAR LOCATION.
RX   PubMed=17115032; DOI=10.1038/ncb1501;
RA   Wang S.C., Nakajima Y., Yu Y.L., Xia W., Chen C.T., Yang C.C.,
RA   McIntush E.W., Li L.Y., Hawke D.H., Kobayashi R., Hung M.C.;
RT   "Tyrosine phosphorylation controls PCNA function through protein
RT   stability.";
RL   Nat. Cell Biol. 8:1359-1368(2006).
RN   [51]
RP   INTERACTION WITH STX19.
RX   PubMed=16420529; DOI=10.1111/j.1600-0854.2005.00378.x;
RA   Wang Y., Foo L.Y., Guo K., Gan B.Q., Zeng Q., Hong W., Tang B.L.;
RT   "Syntaxin 9 is enriched in skin hair follicle epithelium and interacts
RT   with the epidermal growth factor receptor.";
RL   Traffic 7:216-226(2006).
RN   [52]
RP   TISSUE SPECIFICITY.
RX   PubMed=17671655; DOI=10.1172/JCI31680;
RA   Groenestege W.M.T., Thebault S., van der Wijst J., van den Berg D.,
RA   Janssen R., Tejpar S., van den Heuvel L.P., van Cutsem E.,
RA   Hoenderop J.G., Knoers N.V., Bindels R.J.;
RT   "Impaired basolateral sorting of pro-EGF causes isolated recessive
RT   renal hypomagnesemia.";
RL   J. Clin. Invest. 117:2260-2267(2007).
RN   [53]
RP   INTERACTION WITH TNF2, AND SUBCELLULAR LOCATION.
RX   PubMed=17182860; DOI=10.1091/mbc.E06-02-0142;
RA   Shen F., Lin Q., Gu Y., Childress C., Yang W.;
RT   "Activated Cdc42-associated kinase 1 is a component of EGF receptor
RT   signaling complex and regulates EGF receptor degradation.";
RL   Mol. Biol. Cell 18:732-742(2007).
RN   [54]
RP   INTERACTION WITH ATX2.
RX   PubMed=18602463; DOI=10.1016/j.cellsig.2008.05.018;
RA   Nonis D., Schmidt M.H., van de Loo S., Eich F., Dikic I., Nowock J.,
RA   Auburger G.;
RT   "Ataxin-2 associates with the endocytosis complex and affects EGF
RT   receptor trafficking.";
RL   Cell. Signal. 20:1725-1739(2008).
RN   [55]
RP   INTERACTION WITH GAB2.
RX   PubMed=19172738; DOI=10.1038/emboj.2008.159;
RA   Brummer T., Larance M., Herrera Abreu M.T., Lyons R.J., Timpson P.,
RA   Emmerich C.H., Fleuren E.D.G., Lehrbach G.M., Schramek D.,
RA   Guilhaus M., James D.E., Daly R.J.;
RT   "Phosphorylation-dependent binding of 14-3-3 terminates signalling by
RT   the Gab2 docking protein.";
RL   EMBO J. 27:2305-2316(2008).
RN   [56]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [57]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693; SER-695; SER-1064;
RP   SER-1081; SER-1166 AND TYR-1197, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [58]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-991; SER-995; TYR-998;
RP   SER-1039; THR-1041; SER-1042; SER-1064 AND SER-1166, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [59]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [60]
RP   ENZYME REGULATION BY PTPRJ AND PTPRK, PHOSPHORYLATION AT TYR-1197,
RP   DEPHOSPHORYLATION BY PTPRJ, SUBCELLULAR LOCATION, AND INTERACTION WITH
RP   CBL AND GRB2.
RX   PubMed=19836242; DOI=10.1016/j.cub.2009.09.048;
RA   Tarcic G., Boguslavsky S.K., Wakim J., Kiuchi T., Liu A., Reinitz F.,
RA   Nathanson D., Takahashi T., Mischel P.S., Ng T., Yarden Y.;
RT   "An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase
RT   controlling EGFR endocytosis.";
RL   Curr. Biol. 19:1788-1798(2009).
RN   [61]
RP   INTERACTION WITH GAREM1.
RX   PubMed=19509291; DOI=10.1074/jbc.M109.021139;
RA   Tashiro K., Tsunematsu T., Okubo H., Ohta T., Sano E., Yamauchi E.,
RA   Taniguchi H., Konishi H.;
RT   "GAREM, a novel adaptor protein for growth factor receptor-bound
RT   protein 2, contributes to cellular transformation through the
RT   activation of extracellular signal-regulated kinase signaling.";
RL   J. Biol. Chem. 284:20206-20214(2009).
RN   [62]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-352; ASN-413 AND ASN-568.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [63]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [64]
RP   INTERACTION WITH GPER1.
RX   PubMed=19749156; DOI=10.1210/me.2009-0120;
RA   Vivacqua A., Lappano R., De Marco P., Sisci D., Aquila S.,
RA   De Amicis F., Fuqua S.A., Ando S., Maggiolini M.;
RT   "G protein-coupled receptor 30 expression is up-regulated by EGF and
RT   TGF alpha in estrogen receptor alpha-positive cancer cells.";
RL   Mol. Endocrinol. 23:1815-1826(2009).
RN   [65]
RP   INTERACTION WITH COPG1, SUBCELLULAR LOCATION, AND TOPOLOGY.
RX   PubMed=20674546; DOI=10.1016/j.bbrc.2010.07.096;
RA   Wang Y.N., Wang H., Yamaguchi H., Lee H.J., Lee H.H., Hung M.C.;
RT   "COPI-mediated retrograde trafficking from the Golgi to the ER
RT   regulates EGFR nuclear transport.";
RL   Biochem. Biophys. Res. Commun. 399:498-504(2010).
RN   [66]
RP   INTERACTION WITH GPER1, AND SUBCELLULAR LOCATION.
RX   PubMed=20551055; DOI=10.1158/0008-5472.CAN-10-0408;
RA   Madeo A., Maggiolini M.;
RT   "Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-
RT   induced gene expression and migration in breast cancer-associated
RT   fibroblasts.";
RL   Cancer Res. 70:6036-6046(2010).
RN   [67]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693; SER-991; SER-1064
RP   AND TYR-1197, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [68]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [69]
RP   PHOSPHORYLATION AT SER-229.
RX   PubMed=21487020; DOI=10.1074/jbc.M111.240796;
RA   Huang W.C., Chen Y.J., Li L.Y., Wei Y.L., Hsu S.C., Tsai S.L.,
RA   Chiu P.C., Huang W.P., Wang Y.N., Chen C.H., Chang W.C., Chang W.C.,
RA   Chen A.J., Tsai C.H., Hung M.C.;
RT   "Nuclear translocation of epidermal growth factor receptor by Akt-
RT   dependent phosphorylation enhances breast cancer-resistant protein
RT   expression in gefitinib-resistant cells.";
RL   J. Biol. Chem. 286:20558-20568(2011).
RN   [70]
RP   FUNCTION IN CELL PROLIFERATION AND CELL MIGRATION, METHYLATION AT
RP   ARG-1199 BY PRMT5, AND INTERACTION WITH PRMT5 AND PTPN6.
RX   PubMed=21258366; DOI=10.1038/ncb2158;
RA   Hsu J.M., Chen C.T., Chou C.K., Kuo H.P., Li L.Y., Lin C.Y., Lee H.J.,
RA   Wang Y.N., Liu M., Liao H.W., Shi B., Lai C.C., Bedford M.T.,
RA   Tsai C.H., Hung M.C.;
RT   "Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation
RT   negatively modulates EGFR-mediated ERK activation.";
RL   Nat. Cell Biol. 13:174-181(2011).
RN   [71]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=21516087; DOI=10.1038/nm.2341;
RA   Lupberger J., Zeisel M.B., Xiao F., Thumann C., Fofana I., Zona L.,
RA   Davis C., Mee C.J., Turek M., Gorke S., Royer C., Fischer B.,
RA   Zahid M.N., Lavillette D., Fresquet J., Cosset F.L., Rothenberg S.M.,
RA   Pietschmann T., Patel A.H., Pessaux P., Doffoel M., Raffelsberger W.,
RA   Poch O., McKeating J.A., Brino L., Baumert T.F.;
RT   "EGFR and EphA2 are host factors for hepatitis C virus entry and
RT   possible targets for antiviral therapy.";
RL   Nat. Med. 17:589-595(2011).
RN   [72]
RP   INTERACTION WITH FER, AND PHOSPHORYLATION.
RX   PubMed=21518868; DOI=10.1073/pnas.1105369108;
RA   Guo C., Stark G.R.;
RT   "FER tyrosine kinase (FER) overexpression mediates resistance to
RT   quinacrine through EGF-dependent activation of NF-kappaB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:7968-7973(2011).
RN   [73]
RP   INTERACTION WITH ANKRD13A; ANKRD13B AND ALKRD13D, UBIQUITINATION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=22298428; DOI=10.1091/mbc.E11-09-0817;
RA   Tanno H., Yamaguchi T., Goto E., Ishido S., Komada M.;
RT   "The Ankrd 13 family of UIM-bearing proteins regulates EGF receptor
RT   endocytosis from the plasma membrane.";
RL   Mol. Biol. Cell 23:1343-1353(2012).
RN   [74]
RP   UBIQUITINATION, AND DEUBIQUITINATION BY OTUD7B.
RX   PubMed=22179831; DOI=10.1038/onc.2011.587;
RA   Pareja F., Ferraro D.A., Rubin C., Cohen-Dvashi H., Zhang F.,
RA   Aulmann S., Ben-Chetrit N., Pines G., Navon R., Crosetto N.,
RA   Kostler W., Carvalho S., Lavi S., Schmitt F., Dikic I., Yakhini Z.,
RA   Sinn P., Mills G.B., Yarden Y.;
RT   "Deubiquitination of EGFR by Cezanne-1 contributes to cancer
RT   progression.";
RL   Oncogene 31:4599-4608(2012).
RN   [75]
RP   INTERACTION WITH RNF115 AND RNF126.
RX   PubMed=23418353; DOI=10.1242/jcs.116129;
RA   Smith C.J., Berry D.M., McGlade C.J.;
RT   "The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal
RT   sorting of the epidermal growth factor receptor.";
RL   J. Cell Sci. 126:1366-1380(2013).
RN   [76]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693 AND SER-1064, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [77]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693; SER-991; SER-1026
RP   AND SER-1166, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [78]
RP   INTERACTION WITH GPRC5A.
RX   PubMed=25311788; DOI=10.1186/1476-4598-13-233;
RA   Lin X., Zhong S., Ye X., Liao Y., Yao F., Yang X., Sun B., Zhang J.,
RA   Li Q., Gao Y., Wang Y., Liu J., Han B., Chin Y.E., Zhou B.P., Deng J.;
RT   "EGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung
RT   cancer.";
RL   Mol. Cancer 13:233-233(2014).
RN   [79]
RP   INTERACTION WITH FAM83B.
RX   PubMed=23912460; DOI=10.1038/onc.2013.293;
RA   Cipriano R., Bryson B.L., Miskimen K.L., Bartel C.A.,
RA   Hernandez-Sanchez W., Bruntz R.C., Scott S.A., Lindsley C.W.,
RA   Brown H.A., Jackson M.W.;
RT   "Hyperactivation of EGFR and downstream effector phospholipase D1 by
RT   oncogenic FAM83B.";
RL   Oncogene 33:3298-3306(2014).
RN   [80]
RP   FUNCTION, PALMITOYLATION AT CYS-1049 AND CYS-1146, IDENTIFICATION BY
RP   MASS SPECTROMETRY, UBIQUITINATION, PHOSPHORYLATION AT TYR-1092;
RP   TYR-1172 AND TYR-1197, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   1048-ALA--ALA-1210; CYS-1049 AND CYS-1146.
RX   PubMed=27153536; DOI=10.1016/j.molcel.2016.04.003;
RA   Runkle K.B., Kharbanda A., Stypulkowski E., Cao X.J., Wang W.,
RA   Garcia B.A., Witze E.S.;
RT   "Inhibition of DHHC20-Mediated EGFR Palmitoylation Creates a
RT   Dependence on EGFR Signaling.";
RL   Mol. Cell 62:385-396(2016).
RN   [81]
RP   INTERACTION WITH LAPTM4B.
RX   PubMed=28479384; DOI=10.1016/j.gene.2017.05.006;
RA   Tian M., Chen Y., Tian D., Qiao X., Ma Z., Li J.;
RT   "Beclin1 antagonizes LAPTM4B-mediated EGFR overactivation in gastric
RT   cancer cells.";
RL   Gene 626:48-53(2017).
RN   [82] {ECO:0000244|PDB:1MOX}
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 25-525 IN COMPLEX WITH TGFA,
RP   FUNCTION, GLYCOSYLATION AT ASN-56; ASN-196 AND ASN-352, AND DISULFIDE
RP   BONDS.
RX   PubMed=12297049; DOI=10.1016/S0092-8674(02)00940-6;
RA   Garrett T.P., McKern N.M., Lou M., Elleman T.C., Adams T.E.,
RA   Lovrecz G.O., Zhu H.J., Walker F., Frenkel M.J., Hoyne P.A.,
RA   Jorissen R.N., Nice E.C., Burgess A.W., Ward C.W.;
RT   "Crystal structure of a truncated epidermal growth factor receptor
RT   extracellular domain bound to transforming growth factor alpha.";
RL   Cell 110:763-773(2002).
RN   [83] {ECO:0000244|PDB:1IVO}
RP   X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 25-646 IN COMPLEX WITH EGF,
RP   FUNCTION IN MAPK1 AND/OR MAPK3 ACTIVATION, SUBUNIT, SUBCELLULAR
RP   LOCATION, MUTAGENESIS OF TYR-275; PHE-287; ARG-309 AND ARG-429,
RP   DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-56; ASN-175; ASN-196;
RP   ASN-352; ASN-361 AND ASN-444.
RX   PubMed=12297050; DOI=10.1016/S0092-8674(02)00963-7;
RA   Ogiso H., Ishitani R., Nureki O., Fukai S., Yamanaka M., Kim J.H.,
RA   Saito K., Sakamoto A., Inoue M., Shirouzu M., Yokoyama S.;
RT   "Crystal structure of the complex of human epidermal growth factor and
RT   receptor extracellular domains.";
RL   Cell 110:775-787(2002).
RN   [84] {ECO:0000244|PDB:1NQL}
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 25-642 IN COMPLEX WITH EGF,
RP   FUNCTION, SUBUNIT, MUTAGENESIS OF 587-ASP--HIS-590 AND LYS-609,
RP   DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-352; ASN-361; ASN-444;
RP   ASN-528; ASN-568 AND ASN-603.
RX   PubMed=12620237; DOI=10.1016/S1097-2765(03)00047-9;
RA   Ferguson K.M., Berger M.B., Mendrola J.M., Cho H.S., Leahy D.J.,
RA   Lemmon M.A.;
RT   "EGF activates its receptor by removing interactions that autoinhibit
RT   ectodomain dimerization.";
RL   Mol. Cell 11:507-517(2003).
RN   [85] {ECO:0000244|PDB:1XKK}
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 695-1022 IN COMPLEX WITH
RP   GW572016, CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=15374980; DOI=10.1158/0008-5472.CAN-04-1168;
RA   Wood E.R., Truesdale A.T., McDonald O.B., Yuan D., Hassell A.,
RA   Dickerson S.H., Ellis B., Pennisi C., Horne E., Lackey K.,
RA   Alligood K.J., Rusnak D.W., Gilmer T.M., Shewchuk L.;
RT   "A unique structure for epidermal growth factor receptor bound to
RT   GW572016 (Lapatinib): relationships among protein conformation,
RT   inhibitor off-rate, and receptor activity in tumor cells.";
RL   Cancer Res. 64:6652-6659(2004).
RN   [86] {ECO:0000244|PDB:1YY9}
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 25-642 IN COMPLEX WITH
RP   CETUXIMAB.
RX   PubMed=15837620; DOI=10.1016/j.ccr.2005.03.003;
RA   Li S., Schmitz K.R., Jeffrey P.D., Wiltzius J.J., Kussie P.,
RA   Ferguson K.M.;
RT   "Structural basis for inhibition of the epidermal growth factor
RT   receptor by cetuximab.";
RL   Cancer Cell 7:301-311(2005).
RN   [87]
RP   STRUCTURE BY NMR OF 669-721.
RX   PubMed=15840573; DOI=10.1074/jbc.M502698200;
RA   Choowongkomon K., Carlin C.R., Sonnichsen F.D.;
RT   "A structural model for the membrane-bound form of the juxtamembrane
RT   domain of the epidermal growth factor receptor.";
RL   J. Biol. Chem. 280:24043-24052(2005).
RN   [88] {ECO:0000244|PDB:2ITN, ECO:0000244|PDB:2ITO, ECO:0000244|PDB:2ITP, ECO:0000244|PDB:2ITQ, ECO:0000244|PDB:2ITT, ECO:0000244|PDB:2ITU, ECO:0000244|PDB:2ITV, ECO:0000244|PDB:2J6M}
RP   X-RAY CRYSTALLOGRAPHY (2.47 ANGSTROMS) OF 696-1022 OF WILD-TYPE AND
RP   VARIANTS SER-719 AND ARG-858 IN COMPLEXES WITH ATP ANALOGS AND
RP   SYNTHETIC INHIBITORS, CATALYTIC ACTIVITY, AUTOPHOSPHORYLATION, AND
RP   CHARACTERIZATION OF VARIANTS SER-719 AND ARG-858.
RX   PubMed=17349580; DOI=10.1016/j.ccr.2006.12.017;
RA   Yun C.H., Boggon T.J., Li Y., Woo M.S., Greulich H., Meyerson M.,
RA   Eck M.J.;
RT   "Structures of lung cancer-derived EGFR mutants and inhibitor
RT   complexes: mechanism of activation and insights into differential
RT   inhibitor sensitivity.";
RL   Cancer Cell 11:217-227(2007).
RN   [89]
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 702-1022 IN COMPLEX WITH
RP   ERRFI1, ENZYME REGULATION, CATALYTIC ACTIVITY, AUTOPHOSPHORYLATION,
RP   SUBUNIT, AND INTERACTION WITH ERRFI1.
RX   PubMed=18046415; DOI=10.1038/nature05998;
RA   Zhang X., Pickin K.A., Bose R., Jura N., Cole P.A., Kuriyan J.;
RT   "Inhibition of the EGF receptor by binding of MIG6 to an activating
RT   kinase domain interface.";
RL   Nature 450:741-744(2007).
RN   [90] {ECO:0000244|PDB:2JIT, ECO:0000244|PDB:2JIU, ECO:0000244|PDB:2JIV}
RP   X-RAY CRYSTALLOGRAPHY (3.05 ANGSTROMS) OF 695-1022 OF VARIANT MET-790,
RP   CATALYTIC ACTIVITY, AND CHARACTERIZATION OF VARIANT MET-790.
RX   PubMed=18227510; DOI=10.1073/pnas.0709662105;
RA   Yun C.H., Mengwasser K.E., Toms A.V., Woo M.S., Greulich H.,
RA   Wong K.K., Meyerson M., Eck M.J.;
RT   "The T790M mutation in EGFR kinase causes drug resistance by
RT   increasing the affinity for ATP.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:2070-2075(2008).
RN   [91] {ECO:0000244|PDB:3GT8}
RP   X-RAY CRYSTALLOGRAPHY (2.96 ANGSTROMS) OF 696-1022, CATALYTIC
RP   ACTIVITY, PHOSPHORYLATION AT TYR-998; TYR-1016 AND TYR-1197,
RP   MUTAGENESIS OF LEU-688; GLU-690; LEU-692; ARG-977 AND
RP   1005-GLU-ASP-1006, AND SUBUNIT.
RX   PubMed=19563760; DOI=10.1016/j.cell.2009.04.025;
RA   Jura N., Endres N.F., Engel K., Deindl S., Das R., Lamers M.H.,
RA   Wemmer D.E., Zhang X., Kuriyan J.;
RT   "Mechanism for activation of the EGF receptor catalytic domain by the
RT   juxtamembrane segment.";
RL   Cell 137:1293-1307(2009).
RN   [92]
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 669-1022 OF MUTANT MET-745,
RP   CATALYTIC ACTIVITY, FUNCTION, SUBUNIT, SUBCELLULAR LOCATION,
RP   AUTOPHOSPHORYLATION, AND MUTAGENESIS OF LEU-688; VAL-689; GLU-690;
RP   LEU-692; THR-693; PRO-694; PRO-699; ASN-700; LEU-704; ARG-705; ILE-706
RP   AND LYS-745.
RX   PubMed=19560417; DOI=10.1016/j.molcel.2009.04.034;
RA   Red Brewer M., Choi S.H., Alvarado D., Moravcevic K., Pozzi A.,
RA   Lemmon M.A., Carpenter G.;
RT   "The juxtamembrane region of the EGF receptor functions as an
RT   activation domain.";
RL   Mol. Cell 34:641-651(2009).
RN   [93]
RP   STRUCTURE BY NMR OF 634-677 IN COMPLEX WITH ERBB2, AND SUBUNIT.
RX   PubMed=20471394; DOI=10.1016/j.jmb.2010.05.016;
RA   Mineev K.S., Bocharov E.V., Pustovalova Y.E., Bocharova O.V.,
RA   Chupin V.V., Arseniev A.S.;
RT   "Spatial structure of the transmembrane domain heterodimer of ErbB1
RT   and ErbB2 receptor tyrosine kinases.";
RL   J. Mol. Biol. 400:231-243(2010).
RN   [94] {ECO:0000244|PDB:3NJP}
RP   X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 25-638 IN COMPLEX WITH EGF,
RP   FUNCTION, SUBUNIT, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-56;
RP   ASN-73; ASN-175; ASN-196; ASN-352; ASN-361; ASN-444 AND ASN-528.
RX   PubMed=20837704; DOI=10.1128/MCB.00742-10;
RA   Lu C., Mi L.Z., Grey M.J., Zhu J., Graef E., Yokoyama S.,
RA   Springer T.A.;
RT   "Structural evidence for loose linkage between ligand binding and
RT   kinase activation in the epidermal growth factor receptor.";
RL   Mol. Cell. Biol. 30:5432-5443(2010).
RN   [95]
RP   X-RAY CRYSTALLOGRAPHY (2.27 ANGSTROMS) OF 1066-1076 IN COMPLEX WITH
RP   CBLB, AND INTERACTION WITH CBLB.
RG   Structural genomics consortium;
RT   "Crystal structure of Cbl-b TKB domain in complex with EGFR pY1069
RT   peptide.";
RL   Submitted (OCT-2010) to the PDB data bank.
RN   [96]
RP   X-RAY CRYSTALLOGRAPHY (1.52 ANGSTROMS) OF 1062-1074 IN COMPLEX WITH
RP   CBLC, PHOSPHORYLATION AT TYR-1069, INTERACTION WITH CBLC, AND
RP   MUTAGENESIS OF GLN-1067; ARG-1068 AND TYR-1069.
RX   PubMed=22888118; DOI=10.1093/jb/mvs085;
RA   Takeshita K., Tezuka T., Isozaki Y., Yamashita E., Suzuki M., Kim M.,
RA   Yamanashi Y., Yamamoto T., Nakagawa A.;
RT   "Structural flexibility regulates phosphopeptide-binding activity of
RT   the tyrosine kinase binding domain of Cbl-c.";
RL   J. Biochem. 152:487-495(2012).
RN   [97]
RP   VARIANTS ALA-709; GLY-709; CYS-719; SER-719; 746-GLU--ALA-750 DEL;
RP   746-GLU--THR-751 DELINS ALA; 746-GLU--SER-752 DELINS ASP;
RP   747-LEU--THR-751 DEL; ILE-768; MET-769; VAL-833; LEU-835; VAL-838;
RP   ARG-858 AND GLN-861.
RX   PubMed=15623594; DOI=10.1158/1078-0432.CCR-04-1245;
RA   Huang S.F., Liu H.P., Li L.H., Ku Y.C., Fu Y.N., Tsai H.Y., Chen Y.T.,
RA   Lin Y.F., Chang W.C., Kuo H.P., Wu Y.C., Chen Y.R., Tsai S.F.;
RT   "High frequency of epidermal growth factor receptor mutations with
RT   complex patterns in non-small cell lung cancers related to gefitinib
RT   responsiveness in Taiwan.";
RL   Clin. Cancer Res. 10:8195-8203(2004).
RN   [98]
RP   VARIANTS SER-719 AND ARG-858, AND POSSIBLE INVOLVEMENT IN LUNG CANCER.
RX   PubMed=15118125; DOI=10.1126/science.1099314;
RA   Paez J.G., Janne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S.,
RA   Herman P., Kaye F.J., Lindeman N., Boggon T.J., Naoki K., Sasaki H.,
RA   Fujii Y., Eck M.J., Sellers W.R., Johnson B.E., Meyerson M.;
RT   "EGFR mutations in lung cancer: correlation with clinical response to
RT   gefitinib therapy.";
RL   Science 304:1497-1500(2004).
RN   [99]
RP   VARIANTS ALA-709; LYS-709; ALA-719; ASP-719; CYS-719; SER-719;
RP   SER-724; LYS-734; GLU-746 DEL; PHE-747; 747-LEU--GLU-749 DEL; PRO-748;
RP   752-SER--ILE-759 DEL; ARG-787; MET-790; VAL-833; LEU-834; MET-858;
RP   ARG-858; GLN-861 AND GLU-873, AND POSSIBLE INVOLVEMENT IN LUNG CANCER.
RX   PubMed=16533793; DOI=10.1158/1078-0432.CCR-05-1981;
RA   Tam I.Y.S., Chung L.P., Suen W.S., Wang E., Wong M.C.M., Ho K.K.,
RA   Lam W.K., Chiu S.W., Girard L., Minna J.D., Gazdar A.F., Wong M.P.;
RT   "Distinct epidermal growth factor receptor and KRAS mutation patterns
RT   in non-small cell lung cancer patients with different tobacco exposure
RT   and clinicopathologic features.";
RL   Clin. Cancer Res. 12:1647-1653(2006).
RN   [100]
RP   CHARACTERIZATION OF VARIANTS ALA-709; GLY-709; SER-719; ILE-768;
RP   VAL-833; LEU-835; VAL-838; ARG-858 AND GLN-861.
RX   PubMed=16205628; DOI=10.1038/sj.onc.1209159;
RA   Chen Y.R., Fu Y.N., Lin C.H., Yang S.T., Hu S.F., Chen Y.T.,
RA   Tsai S.F., Huang S.F.;
RT   "Distinctive activation patterns in constitutively active and
RT   gefitinib-sensitive EGFR mutants.";
RL   Oncogene 25:1205-1215(2006).
RN   [101]
RP   VARIANT 30-VAL--ARG-297 DEL, AND POSSIBLE INVOLVEMENT IN LUNG CANCER.
RX   PubMed=16672372; DOI=10.1073/pnas.0510284103;
RA   Ji H., Zhao X., Yuza Y., Shimamura T., Li D., Protopopov A.,
RA   Jung B.L., McNamara K., Xia H., Glatt K.A., Thomas R.K., Sasaki H.,
RA   Horner J.W., Eck M., Mitchell A., Sun Y., Al-Hashem R., Bronson R.T.,
RA   Rabindran S.K., Discafani C.M., Maher E., Shapiro G.I., Meyerson M.,
RA   Wong K.K.;
RT   "Epidermal growth factor receptor variant III mutations in lung
RT   tumorigenesis and sensitivity to tyrosine kinase inhibitors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7817-7822(2006).
RN   [102]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-521; ARG-1034 AND VAL-1210.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [103]
RP   VARIANT NISBD2 ASP-428, CHARACTERIZATION OF VARIANT NISBD2 ASP-428,
RP   AND INVOLVEMENT IN NISBD2.
RX   PubMed=24691054; DOI=10.1038/jid.2014.164;
RA   Campbell P., Morton P.E., Takeichi T., Salam A., Roberts N.,
RA   Proudfoot L.E., Mellerio J.E., Aminu K., Wellington C., Patil S.N.,
RA   Akiyama M., Liu L., McMillan J.R., Aristodemou S., Ishida-Yamamoto A.,
RA   Abdul-Wahab A., Petrof G., Fong K., Harnchoowong S., Stone K.L.,
RA   Harper J.I., McLean W.H., Simpson M.A., Parsons M., McGrath J.A.;
RT   "Epithelial inflammation resulting from an inherited loss-of-function
RT   mutation in EGFR.";
RL   J. Invest. Dermatol. 134:2570-2578(2014).
CC   -!- FUNCTION: Receptor tyrosine kinase binding ligands of the EGF
CC       family and activating several signaling cascades to convert
CC       extracellular cues into appropriate cellular responses
CC       (PubMed:2790960, PubMed:10805725, PubMed:27153536). Known ligands
CC       include EGF, TGFA/TGF-alpha, AREG, epigen/EPGN, BTC/betacellulin,
CC       epiregulin/EREG and HBEGF/heparin-binding EGF (PubMed:2790960,
CC       PubMed:7679104, PubMed:8144591, PubMed:9419975, PubMed:15611079,
CC       PubMed:12297049, PubMed:27153536, PubMed:20837704). Ligand binding
CC       triggers receptor homo- and/or heterodimerization and
CC       autophosphorylation on key cytoplasmic residues. The
CC       phosphorylated receptor recruits adapter proteins like GRB2 which
CC       in turn activates complex downstream signaling cascades. Activates
CC       at least 4 major downstream signaling cascades including the RAS-
CC       RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules
CC       (PubMed:27153536). May also activate the NF-kappa-B signaling
CC       cascade (PubMed:11116146). Also directly phosphorylates other
CC       proteins like RGS16, activating its GTPase activity and probably
CC       coupling the EGF receptor signaling to the G protein-coupled
CC       receptor signaling (PubMed:11602604). Also phosphorylates MUC1 and
CC       increases its interaction with SRC and CTNNB1/beta-catenin
CC       (PubMed:11483589). Plays a role in enhancing learning and memory
CC       performance (By similarity). {ECO:0000250|UniProtKB:Q01279,
CC       ECO:0000269|PubMed:10805725, ECO:0000269|PubMed:11116146,
CC       ECO:0000269|PubMed:11483589, ECO:0000269|PubMed:11602604,
CC       ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050,
CC       ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:12873986,
CC       ECO:0000269|PubMed:15374980, ECO:0000269|PubMed:15590694,
CC       ECO:0000269|PubMed:15611079, ECO:0000269|PubMed:17115032,
CC       ECO:0000269|PubMed:19560417, ECO:0000269|PubMed:20837704,
CC       ECO:0000269|PubMed:21258366, ECO:0000269|PubMed:27153536,
CC       ECO:0000269|PubMed:2790960, ECO:0000269|PubMed:7679104,
CC       ECO:0000269|PubMed:8144591, ECO:0000269|PubMed:9419975}.
CC   -!- FUNCTION: Isoform 2 may act as an antagonist of EGF action.
CC   -!- FUNCTION: (Microbial infection) Acts as a receptor for hepatitis C
CC       virus (HCV) in hepatocytes and facilitates its cell entry.
CC       Mediates HCV entry by promoting the formation of the CD81-CLDN1
CC       receptor complexes that are essential for HCV entry and by
CC       enhancing membrane fusion of cells expressing HCV envelope
CC       glycoproteins. {ECO:0000269|PubMed:21516087}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028, ECO:0000269|PubMed:15374980,
CC       ECO:0000269|PubMed:17349580, ECO:0000269|PubMed:18046415,
CC       ECO:0000269|PubMed:18227510, ECO:0000269|PubMed:19560417,
CC       ECO:0000269|PubMed:19563760}.
CC   -!- ENZYME REGULATION: Endocytosis and inhibition of the activated
CC       EGFR by phosphatases like PTPRJ and PTPRK constitute immediate
CC       regulatory mechanisms. Upon EGF-binding phosphorylates EPS15 that
CC       regulates EGFR endocytosis and activity. Moreover, inducible
CC       feedback inhibitors including LRIG1, SOCS4, SOCS5 and ERRFI1
CC       constitute alternative regulatory mechanisms for the EGFR
CC       signaling. {ECO:0000269|PubMed:15282549,
CC       ECO:0000269|PubMed:15590694, ECO:0000269|PubMed:18046415,
CC       ECO:0000269|PubMed:19836242}.
CC   -!- SUBUNIT: Binding of the ligand triggers homo- and/or
CC       heterodimerization of the receptor triggering its
CC       autophosphorylation. Heterodimer with ERBB2 (PubMed:10805725).
CC       Interacts with ERRFI1; inhibits dimerization of the kinase domain
CC       and autophosphorylation (PubMed:18046415). Part of a complex with
CC       ERBB2 and either PIK3C2A or PIK3C2B (PubMed:10805725). Interacts
CC       with GRB2; an adapter protein coupling the receptor to downstream
CC       signaling pathways. Interacts with GAB2; involved in signaling
CC       downstream of EGFR. Interacts with STAT3; mediates EGFR downstream
CC       signaling in cell proliferation. Interacts with RIPK1; involved in
CC       NF-kappa-B activation. Interacts (autophosphorylated) with CBL,
CC       CBLB and CBLC; involved in EGFR ubiquitination and regulation.
CC       Interacts with SOCS5; regulates EGFR degradation through ELOC- and
CC       ELOB-mediated ubiquitination and proteasomal degradation.
CC       Interacts with PRMT5; methylates EGFR and enhances interaction
CC       with PTPN6. Interacts (phosphorylated) with PTPN6; inhibits EGFR-
CC       dependent activation of MAPK/ERK. Interacts with COPG1; essential
CC       for regulation of EGF-dependent nuclear transport of EGFR by
CC       retrograde trafficking from the Golgi to the ER. Interacts with
CC       TNK2; this interaction is dependent on EGF stimulation and kinase
CC       activity of EGFR. Interacts with PCNA; positively regulates PCNA
CC       (PubMed:17115032). Interacts with PELP1. Interacts with MUC1.
CC       Interacts with AP2M1. Interacts with FER. May interact with EPS8;
CC       mediates EPS8 phosphorylation. Interacts (via SH2 domains) with
CC       GRB2, NCK1 and NCK2 (PubMed:10026169). Interacts with ATX2.
CC       Interacts with GAREM1. Interacts (ubiquitinated) with
CC       ANKRD13A/B/D; the interaction is direct and may regulate EGFR
CC       internalization after EGF stimulation. Interacts with GPER1; the
CC       interaction occurs in an estrogen-dependent manner. Interacts (via
CC       C-terminal cytoplasmic kinase domain) with ZPR1 (via zinc
CC       fingers). Interacts with RNF115 and RNF126 (PubMed:23418353).
CC       Interacts with GPRC5A (via its transmembrane domain)
CC       (PubMed:25311788). Interacts with FAM83B; positively regulates
CC       EGFR inducing its autophosphorylation in absence of stimulation by
CC       EGF (PubMed:23912460). Interacts with LAPTM4B; positively
CC       correlates with EGFR activation (PubMed:28479384). Interacts with
CC       STX19 (PubMed:16420529). {ECO:0000269|PubMed:10026169,
CC       ECO:0000269|PubMed:10228163, ECO:0000269|PubMed:10805725,
CC       ECO:0000269|PubMed:11116146, ECO:0000269|PubMed:11483589,
CC       ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237,
CC       ECO:0000269|PubMed:12873986, ECO:0000269|PubMed:15282549,
CC       ECO:0000269|PubMed:15374980, ECO:0000269|PubMed:15590694,
CC       ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:16140940,
CC       ECO:0000269|PubMed:16420529, ECO:0000269|PubMed:17115032,
CC       ECO:0000269|PubMed:17182860, ECO:0000269|PubMed:18046415,
CC       ECO:0000269|PubMed:18602463, ECO:0000269|PubMed:19172738,
CC       ECO:0000269|PubMed:19509291, ECO:0000269|PubMed:19560417,
CC       ECO:0000269|PubMed:19563760, ECO:0000269|PubMed:19749156,
CC       ECO:0000269|PubMed:19836242, ECO:0000269|PubMed:20471394,
CC       ECO:0000269|PubMed:20551055, ECO:0000269|PubMed:20674546,
CC       ECO:0000269|PubMed:20837704, ECO:0000269|PubMed:21258366,
CC       ECO:0000269|PubMed:21518868, ECO:0000269|PubMed:22298428,
CC       ECO:0000269|PubMed:22888118, ECO:0000269|PubMed:23418353,
CC       ECO:0000269|PubMed:23912460, ECO:0000269|PubMed:25311788,
CC       ECO:0000269|PubMed:28479384, ECO:0000269|PubMed:7657591,
CC       ECO:0000269|PubMed:8650580, ECO:0000269|PubMed:9852145,
CC       ECO:0000269|Ref.95}.
CC   -!- INTERACTION:
CC       Self; NbExp=26; IntAct=EBI-297353, EBI-297353;
CC       Q53FC7:-; NbExp=3; IntAct=EBI-297353, EBI-9356749;
CC       Q96BE0:-; NbExp=2; IntAct=EBI-297353, EBI-9356686;
CC       P00519:ABL1; NbExp=2; IntAct=EBI-297353, EBI-375543;
CC       P42684:ABL2; NbExp=8; IntAct=EBI-297353, EBI-1102694;
CC       Q15109:AGER; NbExp=2; IntAct=EBI-297353, EBI-1646426;
CC       Q9UKV8:AGO2; NbExp=11; IntAct=EBI-297353, EBI-528269;
CC       Q09666:AHNAK; NbExp=3; IntAct=EBI-297353, EBI-2555881;
CC       Q02952:AKAP12; NbExp=2; IntAct=EBI-297353, EBI-2562430;
CC       Q92625:ANKS1A; NbExp=5; IntAct=EBI-297353, EBI-1048612;
CC       Q96CW1:AP2M1; NbExp=4; IntAct=EBI-297353, EBI-297683;
CC       O00213:APBB1; NbExp=4; IntAct=EBI-297353, EBI-81694;
CC       Q92870:APBB2; NbExp=6; IntAct=EBI-297353, EBI-79277;
CC       O95704:APBB3; NbExp=2; IntAct=EBI-297353, EBI-286427;
CC       Q9UKG1:APPL1; NbExp=2; IntAct=EBI-297353, EBI-741243;
CC       O14965:AURKA; NbExp=4; IntAct=EBI-297353, EBI-448680;
CC       P30530:AXL; NbExp=4; IntAct=EBI-297353, EBI-2850927;
CC       Q14457:BECN1; NbExp=7; IntAct=EBI-297353, EBI-949378;
CC       P51451:BLK; NbExp=2; IntAct=EBI-297353, EBI-2105445;
CC       P0DP25:CALM3; NbExp=4; IntAct=EBI-297353, EBI-397435;
CC       P49069:CAMLG; NbExp=2; IntAct=EBI-297353, EBI-1748958;
CC       Q03135:CAV1; NbExp=6; IntAct=EBI-297353, EBI-603614;
CC       P22681:CBL; NbExp=22; IntAct=EBI-297353, EBI-518228;
CC       P22682:Cbl (xeno); NbExp=2; IntAct=EBI-297353, EBI-640919;
CC       Q16543:CDC37; NbExp=9; IntAct=EBI-297353, EBI-295634;
CC       P12830:CDH1; NbExp=3; IntAct=EBI-297353, EBI-727477;
CC       Q9NSE2:CISH; NbExp=3; IntAct=EBI-297353, EBI-617866;
CC       Q7Z7G1:CLNK; NbExp=2; IntAct=EBI-297353, EBI-7878194;
CC       P46108:CRK; NbExp=3; IntAct=EBI-297353, EBI-886;
CC       P46108-1:CRK; NbExp=3; IntAct=EBI-297353, EBI-287556;
CC       P46109:CRKL; NbExp=3; IntAct=EBI-297353, EBI-910;
CC       P35221:CTNNA1; NbExp=4; IntAct=EBI-297353, EBI-701918;
CC       O60716:CTNND1; NbExp=4; IntAct=EBI-297353, EBI-701927;
CC       Q14247:CTTN; NbExp=3; IntAct=EBI-297353, EBI-351886;
CC       Q6PKX4:DOK6; NbExp=2; IntAct=EBI-297353, EBI-2880244;
CC       P01133:EGF; NbExp=21; IntAct=EBI-297353, EBI-640857;
CC       Q12929:EPS8; NbExp=2; IntAct=EBI-297353, EBI-375576;
CC       P04626:ERBB2; NbExp=25; IntAct=EBI-297353, EBI-641062;
CC       P21860:ERBB3; NbExp=13; IntAct=EBI-297353, EBI-720706;
CC       Q15303:ERBB4; NbExp=2; IntAct=EBI-297353, EBI-80371;
CC       P07992:ERCC1; NbExp=21; IntAct=EBI-297353, EBI-750962;
CC       Q9UJM3:ERRFI1; NbExp=13; IntAct=EBI-297353, EBI-2941912;
CC       P03372:ESR1; NbExp=2; IntAct=EBI-297353, EBI-78473;
CC       P03372-4:ESR1; NbExp=4; IntAct=EBI-297353, EBI-4309277;
CC       Q96A65:EXOC4; NbExp=2; IntAct=EBI-297353, EBI-355383;
CC       P09769:FGR; NbExp=2; IntAct=EBI-297353, EBI-1383732;
CC       Q14318:FKBP8; NbExp=3; IntAct=EBI-297353, EBI-724839;
CC       Q13480:GAB1; NbExp=3; IntAct=EBI-297353, EBI-517684;
CC       P60520:GABARAPL2; NbExp=2; IntAct=EBI-297353, EBI-720116;
CC       P04406:GAPDH; NbExp=6; IntAct=EBI-297353, EBI-354056;
CC       Q8NBJ4:GOLM1; NbExp=13; IntAct=EBI-297353, EBI-712073;
CC       Q14956:GPNMB; NbExp=3; IntAct=EBI-297353, EBI-7250369;
CC       Q14956-1:GPNMB; NbExp=2; IntAct=EBI-297353, EBI-16191078;
CC       O75791:GRAP2; NbExp=2; IntAct=EBI-297353, EBI-740418;
CC       P62993:GRB2; NbExp=36; IntAct=EBI-297353, EBI-401755;
CC       P08631:HCK; NbExp=2; IntAct=EBI-297353, EBI-346340;
CC       Q9UBN7:HDAC6; NbExp=11; IntAct=EBI-297353, EBI-301697;
CC       Q8WUI4:HDAC7; NbExp=2; IntAct=EBI-297353, EBI-1048378;
CC       P07900:HSP90AA1; NbExp=5; IntAct=EBI-297353, EBI-296047;
CC       P08238:HSP90AB1; NbExp=8; IntAct=EBI-297353, EBI-352572;
CC       Q6PK50:HSP90AB1; NbExp=2; IntAct=EBI-297353, EBI-9356629;
CC       P08107:HSPA1B; NbExp=6; IntAct=EBI-297353, EBI-629985;
CC       P11142:HSPA8; NbExp=5; IntAct=EBI-297353, EBI-351896;
CC       P38646:HSPA9; NbExp=4; IntAct=EBI-297353, EBI-354932;
CC       P04792:HSPB1; NbExp=3; IntAct=EBI-297353, EBI-352682;
CC       P17936:IGFBP3; NbExp=3; IntAct=EBI-297353, EBI-715709;
CC       P46940:IQGAP1; NbExp=4; IntAct=EBI-297353, EBI-297509;
CC       O14654:IRS4; NbExp=2; IntAct=EBI-297353, EBI-356594;
CC       Q86VI4:LAPTM4B; NbExp=10; IntAct=EBI-297353, EBI-3267258;
CC       O43561:LAT; NbExp=2; IntAct=EBI-297353, EBI-1222766;
CC       Q13094:LCP2; NbExp=2; IntAct=EBI-297353, EBI-346946;
CC       Q96FE5:LINGO1; NbExp=2; IntAct=EBI-297353, EBI-719955;
CC       Q38SD2:LRRK1; NbExp=2; IntAct=EBI-297353, EBI-1050422;
CC       P07948:LYN; NbExp=6; IntAct=EBI-297353, EBI-79452;
CC       P07948-1:LYN; NbExp=2; IntAct=EBI-297353, EBI-6895930;
CC       Q9UQF2:MAPK8IP1; NbExp=3; IntAct=EBI-297353, EBI-78404;
CC       Q13387:MAPK8IP2; NbExp=4; IntAct=EBI-297353, EBI-722813;
CC       Q9Y2H9:MAST1; NbExp=2; IntAct=EBI-297353, EBI-3385920;
CC       P08581:MET; NbExp=8; IntAct=EBI-297353, EBI-1039152;
CC       P14174:MIF; NbExp=3; IntAct=EBI-297353, EBI-372712;
CC       P15941:MUC1; NbExp=3; IntAct=EBI-297353, EBI-2804728;
CC       P16333:NCK1; NbExp=3; IntAct=EBI-297353, EBI-389883;
CC       P04150:NR3C1; NbExp=2; IntAct=EBI-297353, EBI-493507;
CC       P16234:PDGFRA; NbExp=3; IntAct=EBI-297353, EBI-2861522;
CC       O00750:PIK3C2B; NbExp=9; IntAct=EBI-297353, EBI-641107;
CC       P27986:PIK3R1; NbExp=5; IntAct=EBI-297353, EBI-79464;
CC       O00459:PIK3R2; NbExp=3; IntAct=EBI-297353, EBI-346930;
CC       Q92569:PIK3R3; NbExp=6; IntAct=EBI-297353, EBI-79893;
CC       P19174:PLCG1; NbExp=6; IntAct=EBI-297353, EBI-79387;
CC       P16885:PLCG2; NbExp=5; IntAct=EBI-297353, EBI-617403;
CC       P17252:PRKCA; NbExp=2; IntAct=EBI-297353, EBI-1383528;
CC       P97313:Prkdc (xeno); NbExp=4; IntAct=EBI-297353, EBI-2272005;
CC       Q05397:PTK2; NbExp=3; IntAct=EBI-297353, EBI-702142;
CC       P18031:PTPN1; NbExp=7; IntAct=EBI-297353, EBI-968788;
CC       P20417:Ptpn1 (xeno); NbExp=11; IntAct=EBI-297353, EBI-916819;
CC       Q05209:PTPN12; NbExp=3; IntAct=EBI-297353, EBI-2266035;
CC       Q9Y2R2:PTPN22; NbExp=2; IntAct=EBI-297353, EBI-1211241;
CC       P23470:PTPRG; NbExp=2; IntAct=EBI-297353, EBI-2258115;
CC       Q9UJ41:RABGEF1; NbExp=4; IntAct=EBI-297353, EBI-913954;
CC       Q70E73:RAPH1; NbExp=2; IntAct=EBI-297353, EBI-3940924;
CC       P20936:RASA1; NbExp=7; IntAct=EBI-297353, EBI-1026476;
CC       Q13671:RIN1; NbExp=3; IntAct=EBI-297353, EBI-366017;
CC       Q01973:ROR1; NbExp=8; IntAct=EBI-297353, EBI-6082337;
CC       Q92622:RUBCN; NbExp=3; IntAct=EBI-297353, EBI-2952709;
CC       Q80U62:Rubcn (xeno); NbExp=2; IntAct=EBI-297353, EBI-3506572;
CC       P31947:SFN; NbExp=8; IntAct=EBI-297353, EBI-476295;
CC       Q9NRF2:SH2B1; NbExp=2; IntAct=EBI-297353, EBI-310491;
CC       Q9UQQ2:SH2B3; NbExp=2; IntAct=EBI-297353, EBI-7879749;
CC       Q9BRG2:SH2D3A; NbExp=2; IntAct=EBI-297353, EBI-2339271;
CC       P29353:SHC1; NbExp=28; IntAct=EBI-297353, EBI-78835;
CC       P29353-7:SHC1; NbExp=4; IntAct=EBI-297353, EBI-9691288;
CC       P98077:SHC2; NbExp=3; IntAct=EBI-297353, EBI-7256023;
CC       Q6S5L8:SHC4; NbExp=2; IntAct=EBI-297353, EBI-9453524;
CC       Q13239:SLA; NbExp=2; IntAct=EBI-297353, EBI-726214;
CC       P13866:SLC5A1; NbExp=3; IntAct=EBI-297353, EBI-1772443;
CC       P12931:SRC; NbExp=7; IntAct=EBI-297353, EBI-621482;
CC       P42224:STAT1; NbExp=6; IntAct=EBI-297353, EBI-1057697;
CC       P40763:STAT3; NbExp=14; IntAct=EBI-297353, EBI-518675;
CC       P42229:STAT5A; NbExp=3; IntAct=EBI-297353, EBI-749537;
CC       P31948:STIP1; NbExp=2; IntAct=EBI-297353, EBI-1054052;
CC       Q9UNE7:STUB1; NbExp=3; IntAct=EBI-297353, EBI-357085;
CC       P43405:SYK; NbExp=6; IntAct=EBI-297353, EBI-78302;
CC       P01135:TGFA; NbExp=2; IntAct=EBI-297353, EBI-1034374;
CC       Q9Y490:TLN1; NbExp=2; IntAct=EBI-297353, EBI-2462036;
CC       O60603:TLR2; NbExp=2; IntAct=EBI-297353, EBI-973722;
CC       Q68CZ2:TNS3; NbExp=4; IntAct=EBI-297353, EBI-1220488;
CC       O75674:TOM1L1; NbExp=6; IntAct=EBI-297353, EBI-712991;
CC       Q12933:TRAF2; NbExp=3; IntAct=EBI-297353, EBI-355744;
CC       Q8K424:Trpv3 (xeno); NbExp=2; IntAct=EBI-297353, EBI-2650739;
CC       Q71U36:TUBA1A; NbExp=3; IntAct=EBI-297353, EBI-302552;
CC       P10599:TXN; NbExp=4; IntAct=EBI-297353, EBI-594644;
CC       P09936:UCHL1; NbExp=2; IntAct=EBI-297353, EBI-714860;
CC       Q9P0L0:VAPA; NbExp=2; IntAct=EBI-297353, EBI-1059156;
CC       P07947:YES1; NbExp=3; IntAct=EBI-297353, EBI-515331;
CC       P27348:YWHAQ; NbExp=6; IntAct=EBI-297353, EBI-359854;
CC       P63104:YWHAZ; NbExp=5; IntAct=EBI-297353, EBI-347088;
CC       P43403:ZAP70; NbExp=2; IntAct=EBI-297353, EBI-1211276;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17182860,
CC       ECO:0000269|PubMed:27153536, ECO:0000269|PubMed:2790960}; Single-
CC       pass type I membrane protein {ECO:0000269|PubMed:27153536}.
CC       Endoplasmic reticulum membrane {ECO:0000269|PubMed:27153536};
CC       Single-pass type I membrane protein. Golgi apparatus membrane;
CC       Single-pass type I membrane protein. Nucleus membrane; Single-pass
CC       type I membrane protein. Endosome {ECO:0000269|PubMed:17182860,
CC       ECO:0000269|PubMed:27153536}. Endosome membrane. Nucleus
CC       {ECO:0000269|PubMed:17115032, ECO:0000269|PubMed:20551055,
CC       ECO:0000269|PubMed:20674546}. Note=In response to EGF,
CC       translocated from the cell membrane to the nucleus via Golgi and
CC       ER (PubMed:20674546). Endocytosed upon activation by ligand
CC       (PubMed:2790960, PubMed:17182860, PubMed:27153536). Colocalized
CC       with GPER1 in the nucleus of estrogen agonist-induced cancer-
CC       associated fibroblasts (CAF) (PubMed:20551055).
CC       {ECO:0000269|PubMed:17182860, ECO:0000269|PubMed:20674546,
CC       ECO:0000269|PubMed:27153536, ECO:0000269|PubMed:2790960}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=p170;
CC         IsoId=P00533-1; Sequence=Displayed;
CC       Name=2; Synonyms=p60, Truncated, TEGFR;
CC         IsoId=P00533-2; Sequence=VSP_002887, VSP_002888;
CC       Name=3; Synonyms=p110;
CC         IsoId=P00533-3; Sequence=VSP_002889, VSP_002890;
CC       Name=4;
CC         IsoId=P00533-4; Sequence=VSP_002891, VSP_002892;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Isoform 2 is also
CC       expressed in ovarian cancers. {ECO:0000269|PubMed:17671655}.
CC   -!- PTM: Phosphorylated on Tyr residues in response to EGF
CC       (PubMed:27153536). Phosphorylation at Ser-695 is partial and
CC       occurs only if Thr-693 is phosphorylated. Phosphorylation at Thr-
CC       678 and Thr-693 by PRKD1 inhibits EGF-induced MAPK8/JNK1
CC       activation. Dephosphorylation by PTPRJ prevents endocytosis and
CC       stabilizes the receptor at the plasma membrane.
CC       Autophosphorylation at Tyr-1197 is stimulated by methylation at
CC       Arg-1199 and enhances interaction with PTPN6. Autophosphorylation
CC       at Tyr-1092 and/or Tyr-1110 recruits STAT3. Dephosphorylated by
CC       PTPN1 and PTPN2. {ECO:0000269|PubMed:10523301,
CC       ECO:0000269|PubMed:12873986, ECO:0000269|PubMed:16083266,
CC       ECO:0000269|PubMed:19563760, ECO:0000269|PubMed:19836242,
CC       ECO:0000269|PubMed:21258366, ECO:0000269|PubMed:2543678,
CC       ECO:0000269|PubMed:27153536, ECO:0000269|PubMed:3138233}.
CC   -!- PTM: Monoubiquitinated and polyubiquitinated upon EGF stimulation;
CC       which does not affect tyrosine kinase activity or signaling
CC       capacity but may play a role in lysosomal targeting
CC       (PubMed:27153536). Polyubiquitin linkage is mainly through 'Lys-
CC       63', but linkage through 'Lys-48', 'Lys-11' and 'Lys-29' also
CC       occurs. Deubiquitination by OTUD7B prevents degradation.
CC       Ubiquitinated by RNF115 and RNF126 (By similarity).
CC       {ECO:0000250|UniProtKB:Q01279, ECO:0000269|PubMed:16543144,
CC       ECO:0000269|PubMed:22179831, ECO:0000269|PubMed:22298428,
CC       ECO:0000269|PubMed:27153536}.
CC   -!- PTM: Palmitoylated on Cys residues by ZDHHC20. Palmitoylation
CC       inhibits internalization after ligand binding, and increases the
CC       persistence of tyrosine-phosphorylated EGFR at the cell membrane.
CC       Palmitoylation increases the amplitude and duration of EGFR
CC       signaling. {ECO:0000269|PubMed:27153536}.
CC   -!- PTM: Methylated. Methylation at Arg-1199 by PRMT5 stimulates
CC       phosphorylation at Tyr-1197. {ECO:0000269|PubMed:19563760,
CC       ECO:0000269|PubMed:19836242, ECO:0000269|PubMed:21258366}.
CC   -!- DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy
CC       affecting tissues of the lung. The most common form of lung cancer
CC       is non-small cell lung cancer (NSCLC) that can be divided into 3
CC       major histologic subtypes: squamous cell carcinoma,
CC       adenocarcinoma, and large cell lung cancer. NSCLC is often
CC       diagnosed at an advanced stage and has a poor prognosis.
CC       {ECO:0000269|PubMed:15118125, ECO:0000269|PubMed:16533793,
CC       ECO:0000269|PubMed:16672372}. Note=The gene represented in this
CC       entry is involved in disease pathogenesis.
CC   -!- DISEASE: Inflammatory skin and bowel disease, neonatal, 2 (NISBD2)
CC       [MIM:616069]: A disorder characterized by inflammatory features
CC       with neonatal onset, involving the skin, hair, and gut. The skin
CC       lesions involve perioral and perianal erythema, psoriasiform
CC       erythroderma, with flares of erythema, scaling, and widespread
CC       pustules. Gastrointestinal symptoms include malabsorptive diarrhea
CC       that is exacerbated by intercurrent gastrointestinal infections.
CC       The hair is short or broken, and the eyelashes and eyebrows are
CC       wiry and disorganized. {ECO:0000269|PubMed:24691054}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. EGF receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/egfr/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=EGFR entry;
CC       URL="https://en.wikipedia.org/wiki/Epidermal_growth_factor_receptor";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X00588; CAA25240.1; -; mRNA.
DR   EMBL; U95089; AAB53063.1; -; mRNA.
DR   EMBL; U48722; AAC50802.1; -; mRNA.
DR   EMBL; U48723; AAC50804.1; -; Genomic_DNA.
DR   EMBL; U48724; AAC50796.1; -; Genomic_DNA.
DR   EMBL; U48725; AAC50797.1; -; Genomic_DNA.
DR   EMBL; U48726; AAC50798.1; -; Genomic_DNA.
DR   EMBL; U48727; AAC50799.1; -; Genomic_DNA.
DR   EMBL; U48728; AAC50800.1; -; Genomic_DNA.
DR   EMBL; U48729; AAC50801.1; -; Genomic_DNA.
DR   EMBL; AF288738; AAG35786.1; -; Genomic_DNA.
DR   EMBL; AF288738; AAG35787.1; -; Genomic_DNA.
DR   EMBL; AF288738; AAG35788.1; -; Genomic_DNA.
DR   EMBL; AF288738; AAG35789.1; -; Genomic_DNA.
DR   EMBL; AF288738; AAG35790.1; -; Genomic_DNA.
DR   EMBL; AY698024; AAT97979.1; -; mRNA.
DR   EMBL; AY588246; AAS83109.1; -; Genomic_DNA.
DR   EMBL; AF277897; AAK01080.1; -; mRNA.
DR   EMBL; AF125253; AAG43240.1; -; mRNA.
DR   EMBL; AF125539; AAG43243.1; -; Genomic_DNA.
DR   EMBL; AF125538; AAG43243.1; JOINED; Genomic_DNA.
DR   EMBL; X06370; CAA29668.1; -; Genomic_DNA.
DR   EMBL; X00663; CAA25282.1; -; mRNA.
DR   EMBL; M38425; AAA63171.1; -; Genomic_DNA.
DR   EMBL; M11234; AAA52370.1; -; Genomic_DNA.
DR   CCDS; CCDS47587.1; -. [P00533-2]
DR   CCDS; CCDS5514.1; -. [P00533-1]
DR   CCDS; CCDS5515.1; -. [P00533-3]
DR   CCDS; CCDS5516.1; -. [P00533-4]
DR   PIR; A00641; GQHUE.
DR   RefSeq; NP_005219.2; NM_005228.4. [P00533-1]
DR   RefSeq; NP_958439.1; NM_201282.1. [P00533-4]
DR   RefSeq; NP_958440.1; NM_201283.1. [P00533-2]
DR   RefSeq; NP_958441.1; NM_201284.1. [P00533-3]
DR   UniGene; Hs.488293; -.
DR   UniGene; Hs.605083; -.
DR   UniGene; Hs.731652; -.
DR   PDB; 1DNQ; Model; -; A=25-336.
DR   PDB; 1DNR; Model; -; A=337-645.
DR   PDB; 1IVO; X-ray; 3.30 A; A/B=25-646.
DR   PDB; 1M14; X-ray; 2.60 A; A=695-1022.
DR   PDB; 1M17; X-ray; 2.60 A; A=695-1022.
DR   PDB; 1MOX; X-ray; 2.50 A; A/B=25-525.
DR   PDB; 1NQL; X-ray; 2.80 A; A=25-642.
DR   PDB; 1XKK; X-ray; 2.40 A; A=695-1022.
DR   PDB; 1YY9; X-ray; 2.60 A; A=25-642.
DR   PDB; 1Z9I; NMR; -; A=669-721.
DR   PDB; 2EB2; X-ray; 2.50 A; A=695-1022.
DR   PDB; 2EB3; X-ray; 2.84 A; A=695-1022.
DR   PDB; 2EXP; Model; -; A=311-326.
DR   PDB; 2EXQ; Model; -; A=27-536.
DR   PDB; 2GS2; X-ray; 2.80 A; A=696-1022.
DR   PDB; 2GS6; X-ray; 2.60 A; A=696-1022.
DR   PDB; 2GS7; X-ray; 2.60 A; A/B=696-1022.
DR   PDB; 2ITN; X-ray; 2.47 A; A=696-1022.
DR   PDB; 2ITO; X-ray; 3.25 A; A=696-1022.
DR   PDB; 2ITP; X-ray; 2.74 A; A=696-1022.
DR   PDB; 2ITQ; X-ray; 2.68 A; A=696-1022.
DR   PDB; 2ITT; X-ray; 2.73 A; A=696-1022.
DR   PDB; 2ITU; X-ray; 2.80 A; A=696-1022.
DR   PDB; 2ITV; X-ray; 2.47 A; A=696-1022.
DR   PDB; 2ITW; X-ray; 2.88 A; A=696-1022.
DR   PDB; 2ITX; X-ray; 2.98 A; A=696-1022.
DR   PDB; 2ITY; X-ray; 3.42 A; A=696-1022.
DR   PDB; 2ITZ; X-ray; 2.72 A; A=696-1022.
DR   PDB; 2J5E; X-ray; 3.10 A; A=696-1022.
DR   PDB; 2J5F; X-ray; 3.00 A; A=696-1022.
DR   PDB; 2J6M; X-ray; 3.10 A; A=696-1022.
DR   PDB; 2JIT; X-ray; 3.10 A; A/B=696-1022.
DR   PDB; 2JIU; X-ray; 3.05 A; A/B=695-1022.
DR   PDB; 2JIV; X-ray; 3.50 A; A/B=695-1022.
DR   PDB; 2KS1; NMR; -; B=634-677.
DR   PDB; 2M0B; NMR; -; A/B=634-677.
DR   PDB; 2M20; NMR; -; A/B=642-697.
DR   PDB; 2N5S; NMR; -; A=642-690.
DR   PDB; 2RF9; X-ray; 3.50 A; A/B=696-1022.
DR   PDB; 2RFD; X-ray; 3.60 A; A/B=702-1022.
DR   PDB; 2RFE; X-ray; 2.90 A; A/B/C/D=702-1022.
DR   PDB; 2RGP; X-ray; 2.00 A; A=702-1016.
DR   PDB; 3B2U; X-ray; 2.58 A; A/B/E/I/M/P/S/V=335-538.
DR   PDB; 3B2V; X-ray; 3.30 A; A=25-642.
DR   PDB; 3BEL; X-ray; 2.30 A; A=702-1016.
DR   PDB; 3BUO; X-ray; 2.60 A; A/C=1063-1075.
DR   PDB; 3C09; X-ray; 3.20 A; A/D=336-538.
DR   PDB; 3G5V; X-ray; 2.00 A; C=311-326.
DR   PDB; 3G5Y; X-ray; 1.59 A; E=311-326.
DR   PDB; 3GOP; X-ray; 2.80 A; A=669-1022.
DR   PDB; 3GT8; X-ray; 2.96 A; A/B/C/D=696-1022.
DR   PDB; 3IKA; X-ray; 2.90 A; A/B=694-1022.
DR   PDB; 3LZB; X-ray; 2.70 A; A/B/C/D/E/F/G/H=696-983.
DR   PDB; 3NJP; X-ray; 3.30 A; A/B=25-638.
DR   PDB; 3OB2; X-ray; 2.10 A; A=1063-1074.
DR   PDB; 3OP0; X-ray; 2.52 A; C/D=1066-1076.
DR   PDB; 3P0Y; X-ray; 1.80 A; A=334-538.
DR   PDB; 3PFV; X-ray; 2.27 A; C/D=1066-1076.
DR   PDB; 3POZ; X-ray; 1.50 A; A=696-1022.
DR   PDB; 3QWQ; X-ray; 2.75 A; A=1-642.
DR   PDB; 3UG1; X-ray; 2.75 A; A=695-1022.
DR   PDB; 3UG2; X-ray; 2.50 A; A=695-1022.
DR   PDB; 3VJN; X-ray; 2.34 A; A=695-1022.
DR   PDB; 3VJO; X-ray; 2.64 A; A=695-1022.
DR   PDB; 3VRP; X-ray; 1.52 A; B=1062-1074.
DR   PDB; 3VRR; X-ray; 2.00 A; C=1062-1074.
DR   PDB; 3W2O; X-ray; 2.35 A; A=698-1022.
DR   PDB; 3W2P; X-ray; 2.05 A; A=698-1022.
DR   PDB; 3W2Q; X-ray; 2.20 A; A=698-1022.
DR   PDB; 3W2R; X-ray; 2.05 A; A=698-1022.
DR   PDB; 3W2S; X-ray; 1.90 A; A=696-1022.
DR   PDB; 3W32; X-ray; 1.80 A; A=696-1022.
DR   PDB; 3W33; X-ray; 1.70 A; A=696-1022.
DR   PDB; 4G5J; X-ray; 2.80 A; A=696-1022.
DR   PDB; 4G5P; X-ray; 3.17 A; A/B=696-1022.
DR   PDB; 4HJO; X-ray; 2.75 A; A=696-1022.
DR   PDB; 4I1Z; X-ray; 3.00 A; A=695-1022.
DR   PDB; 4I20; X-ray; 3.34 A; A=695-1022.
DR   PDB; 4I21; X-ray; 3.37 A; A/B=695-1022.
DR   PDB; 4I22; X-ray; 1.71 A; A=695-1022.
DR   PDB; 4I23; X-ray; 2.80 A; A=695-1022.
DR   PDB; 4I24; X-ray; 1.80 A; A/B=695-1022.
DR   PDB; 4JQ7; X-ray; 2.73 A; A=696-1021.
DR   PDB; 4JQ8; X-ray; 2.83 A; A=696-1021.
DR   PDB; 4JR3; X-ray; 2.70 A; A=696-1021.
DR   PDB; 4JRV; X-ray; 2.80 A; A=696-1021.
DR   PDB; 4KRL; X-ray; 2.85 A; A=335-538.
DR   PDB; 4KRM; X-ray; 2.66 A; A/C/E/G/I/K=335-538.
DR   PDB; 4KRO; X-ray; 3.05 A; A=25-642.
DR   PDB; 4KRP; X-ray; 2.82 A; A=25-642.
DR   PDB; 4LI5; X-ray; 2.64 A; A=696-1020.
DR   PDB; 4LL0; X-ray; 4.00 A; A/B=694-1022.
DR   PDB; 4LQM; X-ray; 2.50 A; A=694-1022.
DR   PDB; 4LRM; X-ray; 3.53 A; A/B/C/D/E=694-1022.
DR   PDB; 4R3P; X-ray; 2.90 A; A=696-1018.
DR   PDB; 4R3R; X-ray; 3.25 A; A=696-1018.
DR   PDB; 4R5S; X-ray; 3.00 A; A=696-1022.
DR   PDB; 4RIW; X-ray; 3.10 A; B/D=682-1022.
DR   PDB; 4RIX; X-ray; 3.10 A; B/D=682-1022.
DR   PDB; 4RIY; X-ray; 2.98 A; B/D=682-1022.
DR   PDB; 4RJ4; X-ray; 2.78 A; A=695-1022.
DR   PDB; 4RJ5; X-ray; 3.10 A; A=695-1022.
DR   PDB; 4RJ6; X-ray; 2.70 A; A=695-1022.
DR   PDB; 4RJ7; X-ray; 2.55 A; A=695-1022.
DR   PDB; 4RJ8; X-ray; 2.50 A; A=695-1022.
DR   PDB; 4TKS; X-ray; 3.20 A; A=695-1022.
DR   PDB; 4UIP; X-ray; 2.95 A; A=26-637.
DR   PDB; 4UV7; X-ray; 2.10 A; A=25-645.
DR   PDB; 4WD5; X-ray; 3.30 A; A/B=694-1022.
DR   PDB; 4WKQ; X-ray; 1.85 A; A=696-1022.
DR   PDB; 4WRG; X-ray; 1.90 A; A=696-1022.
DR   PDB; 4ZAU; X-ray; 2.80 A; A=696-1022.
DR   PDB; 4ZJV; X-ray; 2.70 A; A/B=695-1022.
DR   PDB; 4ZSE; X-ray; 1.97 A; A/B/C/D=695-1022.
DR   PDB; 5C8K; X-ray; 3.00 A; A=695-1022.
DR   PDB; 5C8M; X-ray; 2.90 A; A=695-1022.
DR   PDB; 5C8N; X-ray; 2.40 A; A=695-1022.
DR   PDB; 5CAL; X-ray; 2.70 A; A=695-1022.
DR   PDB; 5CAN; X-ray; 2.80 A; A=695-1022.
DR   PDB; 5CAO; X-ray; 2.60 A; A=695-1022.
DR   PDB; 5CAP; X-ray; 2.40 A; A=695-1022.
DR   PDB; 5CAQ; X-ray; 2.50 A; A=695-1022.
DR   PDB; 5CAS; X-ray; 2.10 A; A=695-1022.
DR   PDB; 5CAU; X-ray; 2.25 A; A=695-1022.
DR   PDB; 5CAV; X-ray; 2.73 A; A=695-1022.
DR   PDB; 5CNN; X-ray; 1.90 A; A/B=696-1042.
DR   PDB; 5CNO; X-ray; 1.55 A; A/B/X=696-1022.
DR   PDB; 5CZH; X-ray; 2.80 A; A=694-1022.
DR   PDB; 5CZI; X-ray; 2.60 A; A=694-1022.
DR   PDB; 5D41; X-ray; 2.31 A; A/B=695-1022.
DR   PDB; 5EDP; X-ray; 2.90 A; A=695-1022.
DR   PDB; 5EDQ; X-ray; 2.80 A; A=695-1022.
DR   PDB; 5EDR; X-ray; 2.60 A; A=695-1022.
DR   PDB; 5EM5; X-ray; 2.65 A; A=695-1022.
DR   PDB; 5EM6; X-ray; 2.78 A; A=695-1022.
DR   PDB; 5EM7; X-ray; 2.81 A; A=695-1022.
DR   PDB; 5EM8; X-ray; 2.80 A; A=695-1022.
DR   PDB; 5FED; X-ray; 2.65 A; A=696-1022.
DR   PDB; 5FEE; X-ray; 2.70 A; A=696-1022.
DR   PDB; 5FEQ; X-ray; 3.40 A; A=696-1022.
DR   PDB; 5GMP; X-ray; 2.80 A; A=696-1022.
DR   PDB; 5GNK; X-ray; 1.80 A; A=696-988.
DR   PDB; 5GTY; X-ray; 3.14 A; A/B/C/D/E/F/G/H=696-1022.
DR   PDB; 5GTZ; X-ray; 3.00 A; A=696-1022.
DR   PDB; 5HCX; X-ray; 2.60 A; A=696-1022.
DR   PDB; 5HCY; X-ray; 2.46 A; A=696-1022.
DR   PDB; 5HCZ; X-ray; 2.62 A; A=696-1022.
DR   PDB; 5HG5; X-ray; 1.52 A; A=695-1022.
DR   PDB; 5HG7; X-ray; 1.85 A; A=695-1022.
DR   PDB; 5HG8; X-ray; 1.42 A; A=695-1022.
DR   PDB; 5HG9; X-ray; 2.15 A; A=695-1022.
DR   PDB; 5HIB; X-ray; 2.85 A; A=695-1022.
DR   PDB; 5HIC; X-ray; 2.60 A; A=695-1022.
DR   PDB; 5J9Y; X-ray; 2.80 A; A=697-1019.
DR   PDB; 5J9Z; X-ray; 2.50 A; A=696-1020.
DR   PDB; 5JEB; X-ray; 3.30 A; A=696-1022.
DR   PDB; 5LV6; NMR; -; A/B=634-677.
DR   PDB; 5SX4; X-ray; 2.80 A; M/N=335-525.
DR   PDB; 5SX5; X-ray; 2.50 A; M/N=335-525.
DR   PDB; 5U8L; X-ray; 1.60 A; A=695-1022.
DR   PDB; 5UG8; X-ray; 1.46 A; A=695-1022.
DR   PDB; 5UG9; X-ray; 1.33 A; A=695-1022.
DR   PDB; 5UGA; X-ray; 1.82 A; A=695-1022.
DR   PDB; 5UGB; X-ray; 2.53 A; A=695-1022.
DR   PDB; 5UGC; X-ray; 1.58 A; A=695-1022.
DR   PDB; 5UWD; X-ray; 3.06 A; A=695-1022.
DR   PDB; 5WB7; X-ray; 2.94 A; A/B/C/D=25-525.
DR   PDB; 5WB8; X-ray; 3.00 A; A/D=25-525.
DR   PDB; 5X26; X-ray; 2.95 A; A=696-1022.
DR   PDB; 5X27; X-ray; 2.95 A; A=696-1022.
DR   PDB; 5X28; X-ray; 2.95 A; A=696-1022.
DR   PDB; 5X2A; X-ray; 1.85 A; A/B/C/D=696-1022.
DR   PDB; 5X2C; X-ray; 2.05 A; A/B=696-1022.
DR   PDB; 5X2F; X-ray; 2.20 A; A/B/C/D=696-1022.
DR   PDB; 5X2K; X-ray; 3.20 A; A=696-1022.
DR   PDB; 5XDK; X-ray; 2.35 A; A=696-1022.
DR   PDB; 5XDL; X-ray; 2.70 A; A=696-1022.
DR   PDB; 5XGM; X-ray; 2.95 A; A=696-1022.
DR   PDB; 5XGN; X-ray; 3.00 A; A/B=696-1022.
DR   PDB; 5XWD; X-ray; 2.89 A; A=1-643.
DR   PDB; 5YU9; X-ray; 1.95 A; A/B/C/D=696-1022.
DR   PDB; 6B3S; X-ray; 2.80 A; A/B/E/I=335-538.
DR   PDBsum; 1DNQ; -.
DR   PDBsum; 1DNR; -.
DR   PDBsum; 1IVO; -.
DR   PDBsum; 1M14; -.
DR   PDBsum; 1M17; -.
DR   PDBsum; 1MOX; -.
DR   PDBsum; 1NQL; -.
DR   PDBsum; 1XKK; -.
DR   PDBsum; 1YY9; -.
DR   PDBsum; 1Z9I; -.
DR   PDBsum; 2EB2; -.
DR   PDBsum; 2EB3; -.
DR   PDBsum; 2EXP; -.
DR   PDBsum; 2EXQ; -.
DR   PDBsum; 2GS2; -.
DR   PDBsum; 2GS6; -.
DR   PDBsum; 2GS7; -.
DR   PDBsum; 2ITN; -.
DR   PDBsum; 2ITO; -.
DR   PDBsum; 2ITP; -.
DR   PDBsum; 2ITQ; -.
DR   PDBsum; 2ITT; -.
DR   PDBsum; 2ITU; -.
DR   PDBsum; 2ITV; -.
DR   PDBsum; 2ITW; -.
DR   PDBsum; 2ITX; -.
DR   PDBsum; 2ITY; -.
DR   PDBsum; 2ITZ; -.
DR   PDBsum; 2J5E; -.
DR   PDBsum; 2J5F; -.
DR   PDBsum; 2J6M; -.
DR   PDBsum; 2JIT; -.
DR   PDBsum; 2JIU; -.
DR   PDBsum; 2JIV; -.
DR   PDBsum; 2KS1; -.
DR   PDBsum; 2M0B; -.
DR   PDBsum; 2M20; -.
DR   PDBsum; 2N5S; -.
DR   PDBsum; 2RF9; -.
DR   PDBsum; 2RFD; -.
DR   PDBsum; 2RFE; -.
DR   PDBsum; 2RGP; -.
DR   PDBsum; 3B2U; -.
DR   PDBsum; 3B2V; -.
DR   PDBsum; 3BEL; -.
DR   PDBsum; 3BUO; -.
DR   PDBsum; 3C09; -.
DR   PDBsum; 3G5V; -.
DR   PDBsum; 3G5Y; -.
DR   PDBsum; 3GOP; -.
DR   PDBsum; 3GT8; -.
DR   PDBsum; 3IKA; -.
DR   PDBsum; 3LZB; -.
DR   PDBsum; 3NJP; -.
DR   PDBsum; 3OB2; -.
DR   PDBsum; 3OP0; -.
DR   PDBsum; 3P0Y; -.
DR   PDBsum; 3PFV; -.
DR   PDBsum; 3POZ; -.
DR   PDBsum; 3QWQ; -.
DR   PDBsum; 3UG1; -.
DR   PDBsum; 3UG2; -.
DR   PDBsum; 3VJN; -.
DR   PDBsum; 3VJO; -.
DR   PDBsum; 3VRP; -.
DR   PDBsum; 3VRR; -.
DR   PDBsum; 3W2O; -.
DR   PDBsum; 3W2P; -.
DR   PDBsum; 3W2Q; -.
DR   PDBsum; 3W2R; -.
DR   PDBsum; 3W2S; -.
DR   PDBsum; 3W32; -.
DR   PDBsum; 3W33; -.
DR   PDBsum; 4G5J; -.
DR   PDBsum; 4G5P; -.
DR   PDBsum; 4HJO; -.
DR   PDBsum; 4I1Z; -.
DR   PDBsum; 4I20; -.
DR   PDBsum; 4I21; -.
DR   PDBsum; 4I22; -.
DR   PDBsum; 4I23; -.
DR   PDBsum; 4I24; -.
DR   PDBsum; 4JQ7; -.
DR   PDBsum; 4JQ8; -.
DR   PDBsum; 4JR3; -.
DR   PDBsum; 4JRV; -.
DR   PDBsum; 4KRL; -.
DR   PDBsum; 4KRM; -.
DR   PDBsum; 4KRO; -.
DR   PDBsum; 4KRP; -.
DR   PDBsum; 4LI5; -.
DR   PDBsum; 4LL0; -.
DR   PDBsum; 4LQM; -.
DR   PDBsum; 4LRM; -.
DR   PDBsum; 4R3P; -.
DR   PDBsum; 4R3R; -.
DR   PDBsum; 4R5S; -.
DR   PDBsum; 4RIW; -.
DR   PDBsum; 4RIX; -.
DR   PDBsum; 4RIY; -.
DR   PDBsum; 4RJ4; -.
DR   PDBsum; 4RJ5; -.
DR   PDBsum; 4RJ6; -.
DR   PDBsum; 4RJ7; -.
DR   PDBsum; 4RJ8; -.
DR   PDBsum; 4TKS; -.
DR   PDBsum; 4UIP; -.
DR   PDBsum; 4UV7; -.
DR   PDBsum; 4WD5; -.
DR   PDBsum; 4WKQ; -.
DR   PDBsum; 4WRG; -.
DR   PDBsum; 4ZAU; -.
DR   PDBsum; 4ZJV; -.
DR   PDBsum; 4ZSE; -.
DR   PDBsum; 5C8K; -.
DR   PDBsum; 5C8M; -.
DR   PDBsum; 5C8N; -.
DR   PDBsum; 5CAL; -.
DR   PDBsum; 5CAN; -.
DR   PDBsum; 5CAO; -.
DR   PDBsum; 5CAP; -.
DR   PDBsum; 5CAQ; -.
DR   PDBsum; 5CAS; -.
DR   PDBsum; 5CAU; -.
DR   PDBsum; 5CAV; -.
DR   PDBsum; 5CNN; -.
DR   PDBsum; 5CNO; -.
DR   PDBsum; 5CZH; -.
DR   PDBsum; 5CZI; -.
DR   PDBsum; 5D41; -.
DR   PDBsum; 5EDP; -.
DR   PDBsum; 5EDQ; -.
DR   PDBsum; 5EDR; -.
DR   PDBsum; 5EM5; -.
DR   PDBsum; 5EM6; -.
DR   PDBsum; 5EM7; -.
DR   PDBsum; 5EM8; -.
DR   PDBsum; 5FED; -.
DR   PDBsum; 5FEE; -.
DR   PDBsum; 5FEQ; -.
DR   PDBsum; 5GMP; -.
DR   PDBsum; 5GNK; -.
DR   PDBsum; 5GTY; -.
DR   PDBsum; 5GTZ; -.
DR   PDBsum; 5HCX; -.
DR   PDBsum; 5HCY; -.
DR   PDBsum; 5HCZ; -.
DR   PDBsum; 5HG5; -.
DR   PDBsum; 5HG7; -.
DR   PDBsum; 5HG8; -.
DR   PDBsum; 5HG9; -.
DR   PDBsum; 5HIB; -.
DR   PDBsum; 5HIC; -.
DR   PDBsum; 5J9Y; -.
DR   PDBsum; 5J9Z; -.
DR   PDBsum; 5JEB; -.
DR   PDBsum; 5LV6; -.
DR   PDBsum; 5SX4; -.
DR   PDBsum; 5SX5; -.
DR   PDBsum; 5U8L; -.
DR   PDBsum; 5UG8; -.
DR   PDBsum; 5UG9; -.
DR   PDBsum; 5UGA; -.
DR   PDBsum; 5UGB; -.
DR   PDBsum; 5UGC; -.
DR   PDBsum; 5UWD; -.
DR   PDBsum; 5WB7; -.
DR   PDBsum; 5WB8; -.
DR   PDBsum; 5X26; -.
DR   PDBsum; 5X27; -.
DR   PDBsum; 5X28; -.
DR   PDBsum; 5X2A; -.
DR   PDBsum; 5X2C; -.
DR   PDBsum; 5X2F; -.
DR   PDBsum; 5X2K; -.
DR   PDBsum; 5XDK; -.
DR   PDBsum; 5XDL; -.
DR   PDBsum; 5XGM; -.
DR   PDBsum; 5XGN; -.
DR   PDBsum; 5XWD; -.
DR   PDBsum; 5YU9; -.
DR   PDBsum; 6B3S; -.
DR   DisProt; DP00309; -.
DR   ProteinModelPortal; P00533; -.
DR   SMR; P00533; -.
DR   BioGrid; 108276; 1208.
DR   CORUM; P00533; -.
DR   DIP; DIP-405N; -.
DR   ELM; P00533; -.
DR   IntAct; P00533; 493.
DR   MINT; P00533; -.
DR   STRING; 9606.ENSP00000275493; -.
DR   BindingDB; P00533; -.
DR   ChEMBL; CHEMBL203; -.
DR   DrugBank; DB08916; Afatinib.
DR   DrugBank; DB00002; Cetuximab.
DR   DrugBank; DB05424; CI-1033.
DR   DrugBank; DB00530; Erlotinib.
DR   DrugBank; DB03496; Flavopiridol.
DR   DrugBank; DB00317; Gefitinib.
DR   DrugBank; DB05324; HuMax-EGFr.
DR   DrugBank; DB11737; Icotinib.
DR   DrugBank; DB04988; IGN311.
DR   DrugBank; DB05774; IMC-11F8.
DR   DrugBank; DB05900; INSM-18.
DR   DrugBank; DB01259; Lapatinib.
DR   DrugBank; DB00281; Lidocaine.
DR   DrugBank; DB05101; Matuzumab.
DR   DrugBank; DB07662; N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE.
DR   DrugBank; DB09559; Necitumumab.
DR   DrugBank; DB13164; Olmutinib.
DR   DrugBank; DB09330; Osimertinib.
DR   DrugBank; DB01269; Panitumumab.
DR   DrugBank; DB05374; Rindopepimut.
DR   DrugBank; DB07602; S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE.
DR   DrugBank; DB00072; Trastuzumab.
DR   DrugBank; DB05294; Vandetanib.
DR   GuidetoPHARMACOLOGY; 1797; -.
DR   GlyConnect; 137; -.
DR   iPTMnet; P00533; -.
DR   PhosphoSitePlus; P00533; -.
DR   SwissPalm; P00533; -.
DR   UniCarbKB; P00533; -.
DR   BioMuta; EGFR; -.
DR   DMDM; 2811086; -.
DR   SWISS-2DPAGE; P00533; -.
DR   EPD; P00533; -.
DR   MaxQB; P00533; -.
DR   PaxDb; P00533; -.
DR   PeptideAtlas; P00533; -.
DR   PRIDE; P00533; -.
DR   DNASU; 1956; -.
DR   Ensembl; ENST00000275493; ENSP00000275493; ENSG00000146648. [P00533-1]
DR   Ensembl; ENST00000342916; ENSP00000342376; ENSG00000146648. [P00533-4]
DR   Ensembl; ENST00000344576; ENSP00000345973; ENSG00000146648. [P00533-3]
DR   Ensembl; ENST00000420316; ENSP00000413843; ENSG00000146648. [P00533-2]
DR   GeneID; 1956; -.
DR   KEGG; hsa:1956; -.
DR   UCSC; uc003tqh.4; human. [P00533-1]
DR   CTD; 1956; -.
DR   DisGeNET; 1956; -.
DR   EuPathDB; HostDB:ENSG00000146648.15; -.
DR   GeneCards; EGFR; -.
DR   HGNC; HGNC:3236; EGFR.
DR   HPA; CAB000035; -.
DR   HPA; CAB068186; -.
DR   HPA; CAB073534; -.
DR   HPA; HPA001200; -.
DR   HPA; HPA018530; -.
DR   MalaCards; EGFR; -.
DR   MIM; 131550; gene.
DR   MIM; 211980; phenotype.
DR   MIM; 616069; phenotype.
DR   neXtProt; NX_P00533; -.
DR   OpenTargets; ENSG00000146648; -.
DR   Orphanet; 251579; Giant cell glioblastoma.
DR   Orphanet; 251576; Gliosarcoma.
DR   Orphanet; 294023; Neonatal inflammatory skin and bowel disease.
DR   Orphanet; 357191; Selection of therapeutic option in non-small cell lung carcinoma.
DR   PharmGKB; PA7360; -.
DR   eggNOG; KOG1025; Eukaryota.
DR   eggNOG; ENOG410XNSR; LUCA.
DR   GeneTree; ENSGT00760000118799; -.
DR   HOVERGEN; HBG000490; -.
DR   InParanoid; P00533; -.
DR   KO; K04361; -.
DR   OMA; MRRRHIV; -.
DR   OrthoDB; EOG091G00NO; -.
DR   PhylomeDB; P00533; -.
DR   TreeFam; TF106002; -.
DR   BRENDA; 2.7.10.1; 2681.
DR   Reactome; R-HSA-1227986; Signaling by ERBB2.
DR   Reactome; R-HSA-1236382; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants.
DR   Reactome; R-HSA-1236394; Signaling by ERBB4.
DR   Reactome; R-HSA-1250196; SHC1 events in ERBB2 signaling.
DR   Reactome; R-HSA-1251932; PLCG1 events in ERBB2 signaling.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-177929; Signaling by EGFR.
DR   Reactome; R-HSA-179812; GRB2 events in EGFR signaling.
DR   Reactome; R-HSA-180292; GAB1 signalosome.
DR   Reactome; R-HSA-180336; SHC1 events in EGFR signaling.
DR   Reactome; R-HSA-182971; EGFR downregulation.
DR   Reactome; R-HSA-1963640; GRB2 events in ERBB2 signaling.
DR   Reactome; R-HSA-1963642; PI3K events in ERBB2 signaling.
DR   Reactome; R-HSA-212718; EGFR interacts with phospholipase C-gamma.
DR   Reactome; R-HSA-2179392; EGFR Transactivation by Gastrin.
DR   Reactome; R-HSA-2219530; Constitutive Signaling by Aberrant PI3K in Cancer.
DR   Reactome; R-HSA-445144; Signal transduction by L1.
DR   Reactome; R-HSA-5637810; Constitutive Signaling by EGFRvIII.
DR   Reactome; R-HSA-5638303; Inhibition of Signaling by Overexpressed EGFR.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-HSA-6785631; ERBB2 Regulates Cell Motility.
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-HSA-8847993; ERBB2 Activates PTK6 Signaling.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8857538; PTK6 promotes HIF1A stabilization.
DR   Reactome; R-HSA-8863795; Downregulation of ERBB2 signaling.
DR   Reactome; R-HSA-8866910; TFAP2 (AP-2) family regulates transcription of growth factors and their receptors.
DR   Reactome; R-HSA-9013507; NOTCH3 Activation and Transmission of Signal to the Nucleus.
DR   SignaLink; P00533; -.
DR   SIGNOR; P00533; -.
DR   ChiTaRS; EGFR; human.
DR   EvolutionaryTrace; P00533; -.
DR   GeneWiki; Epidermal_growth_factor_receptor; -.
DR   GenomeRNAi; 1956; -.
DR   PMAP-CutDB; P00533; -.
DR   PRO; PR:P00533; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000146648; -.
DR   ExpressionAtlas; P00533; baseline and differential.
DR   Genevisible; P00533; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0030665; C:clathrin-coated vesicle membrane; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IDA:UniProtKB.
DR   GO; GO:0030139; C:endocytic vesicle; IEA:Ensembl.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0010008; C:endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; NAS:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0097489; C:multivesicular body, internal vesicle lumen; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HGNC.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0070435; C:Shc-EGFR complex; ISS:BHF-UCL.
DR   GO; GO:0045202; C:synapse; IEA:Ensembl.
DR   GO; GO:0051015; F:actin filament binding; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0005516; F:calmodulin binding; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; NAS:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0048408; F:epidermal growth factor binding; IEA:Ensembl.
DR   GO; GO:0005006; F:epidermal growth factor-activated receptor activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; NAS:UniProtKB.
DR   GO; GO:0046934; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; TAS:Reactome.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0019903; F:protein phosphatase binding; IPI:UniProtKB.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0004716; F:signal transducer, downstream of receptor, with protein tyrosine kinase activity; IEA:InterPro.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:Reactome.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IDA:MGI.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0043006; P:activation of phospholipase A2 activity by calcium-mediated signaling; TAS:UniProtKB.
DR   GO; GO:0007202; P:activation of phospholipase C activity; TAS:UniProtKB.
DR   GO; GO:0048143; P:astrocyte activation; IEA:Ensembl.
DR   GO; GO:0008283; P:cell proliferation; IDA:UniProtKB.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IDA:MGI.
DR   GO; GO:0098609; P:cell-cell adhesion; IMP:UniProtKB.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl.
DR   GO; GO:0071276; P:cellular response to cadmium ion; IMP:CAFA.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEA:Ensembl.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IDA:UniProtKB.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; IMP:CAFA.
DR   GO; GO:0021795; P:cerebral cortex cell migration; IEA:Ensembl.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0048546; P:digestive tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0016101; P:diterpenoid metabolic process; IEA:Ensembl.
DR   GO; GO:0001892; P:embryonic placenta development; IEA:Ensembl.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0038128; P:ERBB2 signaling pathway; TAS:Reactome.
DR   GO; GO:0061029; P:eyelid development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0001942; P:hair follicle development; IEA:Ensembl.
DR   GO; GO:0042743; P:hydrogen peroxide metabolic process; IEA:Ensembl.
DR   GO; GO:0007611; P:learning or memory; ISS:UniProtKB.
DR   GO; GO:0097421; P:liver regeneration; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0010960; P:magnesium ion homeostasis; IEA:Ensembl.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0007494; P:midgut development; IEA:Ensembl.
DR   GO; GO:0060571; P:morphogenesis of an epithelial fold; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:1905208; P:negative regulation of cardiocyte differentiation; IMP:BHF-UCL.
DR   GO; GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:1901185; P:negative regulation of ERBB signaling pathway; TAS:Reactome.
DR   GO; GO:0045930; P:negative regulation of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0045746; P:negative regulation of Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl.
DR   GO; GO:0001503; P:ossification; NAS:UniProtKB.
DR   GO; GO:0042698; P:ovulation cycle; IEA:Ensembl.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IMP:UniProtKB.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0097755; P:positive regulation of blood vessel diameter; IEA:Ensembl.
DR   GO; GO:0045780; P:positive regulation of bone resorption; IEA:Ensembl.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0030307; P:positive regulation of cell growth; IDA:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:MGI.
DR   GO; GO:0031659; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle; IDA:BHF-UCL.
DR   GO; GO:0045739; P:positive regulation of DNA repair; IDA:UniProtKB.
DR   GO; GO:0045740; P:positive regulation of DNA replication; IDA:UniProtKB.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB.
DR   GO; GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; IMP:CAFA.
DR   GO; GO:0010750; P:positive regulation of nitric oxide mediated signal transduction; IDA:UniProtKB.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IMP:UniProtKB.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; IDA:UniProtKB.
DR   GO; GO:1903800; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; IMP:BHF-UCL.
DR   GO; GO:1902722; P:positive regulation of prolactin secretion; IEA:Ensembl.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; IMP:BHF-UCL.
DR   GO; GO:1900020; P:positive regulation of protein kinase C activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; IEA:Ensembl.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:CAFA.
DR   GO; GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl.
DR   GO; GO:0046777; P:protein autophosphorylation; IMP:UniProtKB.
DR   GO; GO:0051205; P:protein insertion into membrane; TAS:UniProtKB.
DR   GO; GO:2000145; P:regulation of cell motility; TAS:Reactome.
DR   GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; IMP:CAFA.
DR   GO; GO:0046328; P:regulation of JNK cascade; IMP:CAFA.
DR   GO; GO:0050999; P:regulation of nitric-oxide synthase activity; IDA:UniProtKB.
DR   GO; GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IMP:UniProtKB.
DR   GO; GO:0014066; P:regulation of phosphatidylinositol 3-kinase signaling; IMP:CAFA.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; TAS:Reactome.
DR   GO; GO:0051592; P:response to calcium ion; IEA:Ensembl.
DR   GO; GO:0033590; P:response to cobalamin; IEA:Ensembl.
DR   GO; GO:0033594; P:response to hydroxyisoflavone; IEA:Ensembl.
DR   GO; GO:0006970; P:response to osmotic stress; IEA:Ensembl.
DR   GO; GO:0070141; P:response to UV-A; IDA:BHF-UCL.
DR   GO; GO:0007435; P:salivary gland morphogenesis; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; IDA:UniProtKB.
DR   GO; GO:0043586; P:tongue development; IEA:Ensembl.
DR   GO; GO:0006412; P:translation; IEA:Ensembl.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   Gene3D; 3.80.20.20; -; 2.
DR   InterPro; IPR006211; Furin-like_Cys-rich_dom.
DR   InterPro; IPR006212; Furin_repeat.
DR   InterPro; IPR032778; GF_recep_IV.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR000494; Rcpt_L-dom.
DR   InterPro; IPR036941; Rcpt_L-dom_sf.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016245; Tyr_kinase_EGF/ERB/XmrK_rcpt.
DR   Pfam; PF00757; Furin-like; 1.
DR   Pfam; PF14843; GF_recep_IV; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF01030; Recep_L_domain; 2.
DR   PIRSF; PIRSF000619; TyrPK_EGF-R; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00261; FU; 3.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane;
KW   Complete proteome; Developmental protein; Direct protein sequencing;
KW   Disease mutation; Disulfide bond; Endoplasmic reticulum; Endosome;
KW   Glycoprotein; Golgi apparatus; Host cell receptor for virus entry;
KW   Isopeptide bond; Kinase; Lipoprotein; Membrane; Methylation;
KW   Nucleotide-binding; Nucleus; Palmitate; Phosphoprotein; Polymorphism;
KW   Proto-oncogene; Receptor; Reference proteome; Repeat; Secreted;
KW   Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase; Ubl conjugation.
FT   SIGNAL        1     24       {ECO:0000269|PubMed:15340161,
FT                                ECO:0000269|PubMed:6328312,
FT                                ECO:0000269|Ref.16}.
FT   CHAIN        25   1210       Epidermal growth factor receptor.
FT                                /FTId=PRO_0000016665.
FT   TOPO_DOM     25    645       Extracellular. {ECO:0000255}.
FT   TRANSMEM    646    668       Helical. {ECO:0000255}.
FT   TOPO_DOM    669   1210       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       75    300       Approximate.
FT   REPEAT      390    600       Approximate.
FT   DOMAIN      712    979       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     718    726       ATP. {ECO:0000244|PDB:2GS7,
FT                                ECO:0000244|PDB:3GT8,
FT                                ECO:0000244|PDB:4ZSE,
FT                                ECO:0000244|PDB:5CNN,
FT                                ECO:0000244|PDB:5CNO,
FT                                ECO:0000244|PDB:5D41,
FT                                ECO:0000269|PubMed:19563760}.
FT   NP_BIND     790    791       ATP. {ECO:0000244|PDB:2EB3,
FT                                ECO:0000244|PDB:2GS7,
FT                                ECO:0000244|PDB:2ITN,
FT                                ECO:0000244|PDB:2ITV,
FT                                ECO:0000244|PDB:2ITX,
FT                                ECO:0000244|PDB:3GT8,
FT                                ECO:0000244|PDB:3VJN,
FT                                ECO:0000244|PDB:3VJO,
FT                                ECO:0000244|PDB:4RIW,
FT                                ECO:0000244|PDB:4RIX,
FT                                ECO:0000244|PDB:4RIY,
FT                                ECO:0000244|PDB:4ZSE,
FT                                ECO:0000244|PDB:5CNN,
FT                                ECO:0000244|PDB:5CNO,
FT                                ECO:0000244|PDB:5D41,
FT                                ECO:0000269|PubMed:17349580,
FT                                ECO:0000269|PubMed:19563760}.
FT   REGION      688    704       Important for dimerization,
FT                                phosphorylation and activation.
FT   ACT_SITE    837    837       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     745    745       ATP. {ECO:0000244|PDB:2EB3,
FT                                ECO:0000244|PDB:2GS7,
FT                                ECO:0000244|PDB:2ITN,
FT                                ECO:0000244|PDB:3GT8,
FT                                ECO:0000244|PDB:3VJN,
FT                                ECO:0000244|PDB:3VJO,
FT                                ECO:0000244|PDB:4RIW,
FT                                ECO:0000244|PDB:4RIY,
FT                                ECO:0000244|PDB:4ZSE,
FT                                ECO:0000244|PDB:5CNN,
FT                                ECO:0000244|PDB:5CNO,
FT                                ECO:0000244|PDB:5D41,
FT                                ECO:0000269|PubMed:17349580,
FT                                ECO:0000269|PubMed:19563760}.
FT   BINDING     855    855       ATP. {ECO:0000244|PDB:2EB3,
FT                                ECO:0000244|PDB:2GS7,
FT                                ECO:0000244|PDB:2ITN,
FT                                ECO:0000244|PDB:2ITV,
FT                                ECO:0000244|PDB:2ITX,
FT                                ECO:0000244|PDB:3GT8,
FT                                ECO:0000244|PDB:3VJN,
FT                                ECO:0000244|PDB:4RIW,
FT                                ECO:0000244|PDB:4RIX,
FT                                ECO:0000244|PDB:4RIY,
FT                                ECO:0000244|PDB:4ZSE,
FT                                ECO:0000244|PDB:5CNN,
FT                                ECO:0000244|PDB:5CNO,
FT                                ECO:0000244|PDB:5D41,
FT                                ECO:0000269|PubMed:17349580,
FT                                ECO:0000269|PubMed:19563760}.
FT   SITE       1016   1016       Important for interaction with PIK3C2B.
FT   MOD_RES     229    229       Phosphoserine.
FT                                {ECO:0000269|PubMed:21487020}.
FT   MOD_RES     678    678       Phosphothreonine; by PKC and PKD/PRKD1.
FT                                {ECO:0000269|PubMed:10523301}.
FT   MOD_RES     693    693       Phosphothreonine; by PKD/PRKD1.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:10523301,
FT                                ECO:0000269|PubMed:16083266,
FT                                ECO:0000269|PubMed:3138233}.
FT   MOD_RES     695    695       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000269|PubMed:3138233}.
FT   MOD_RES     991    991       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:16083266}.
FT   MOD_RES     995    995       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     998    998       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000269|PubMed:19563760}.
FT   MOD_RES    1016   1016       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:19563760}.
FT   MOD_RES    1026   1026       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:16083266}.
FT   MOD_RES    1039   1039       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1041   1041       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1042   1042       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1064   1064       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1069   1069       Phosphotyrosine.
FT                                {ECO:0000305|PubMed:22888118}.
FT   MOD_RES    1070   1070       Phosphoserine.
FT                                {ECO:0000269|PubMed:3138233}.
FT   MOD_RES    1071   1071       Phosphoserine.
FT                                {ECO:0000269|PubMed:3138233}.
FT   MOD_RES    1081   1081       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES    1092   1092       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:12873986,
FT                                ECO:0000269|PubMed:27153536}.
FT   MOD_RES    1110   1110       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:12873986,
FT                                ECO:0000269|PubMed:2543678}.
FT   MOD_RES    1166   1166       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1172   1172       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000269|PubMed:27153536}.
FT   MOD_RES    1197   1197       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000269|PubMed:19563760,
FT                                ECO:0000269|PubMed:19836242,
FT                                ECO:0000269|PubMed:27153536}.
FT   MOD_RES    1199   1199       Omega-N-methylarginine.
FT                                {ECO:0000269|PubMed:21258366}.
FT   LIPID      1049   1049       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:27153536}.
FT   LIPID      1146   1146       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:27153536}.
FT   CARBOHYD     56     56       N-linked (GlcNAc...) (complex)
FT                                asparagine; atypical; partial.
FT                                {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000269|PubMed:10731668,
FT                                ECO:0000269|PubMed:12297049,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12731890,
FT                                ECO:0000269|PubMed:16083266,
FT                                ECO:0000269|PubMed:20837704}.
FT                                /FTId=CAR_000227.
FT   CARBOHYD     73     73       N-linked (GlcNAc...) asparagine;
FT                                atypical. {ECO:0000244|PDB:3NJP,
FT                                ECO:0000269|PubMed:20837704}.
FT   CARBOHYD    128    128       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12731890,
FT                                ECO:0000269|PubMed:16083266,
FT                                ECO:0000269|PubMed:8962717}.
FT   CARBOHYD    175    175       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12731890,
FT                                ECO:0000269|PubMed:16083266,
FT                                ECO:0000269|PubMed:20837704,
FT                                ECO:0000269|PubMed:8962717}.
FT   CARBOHYD    196    196       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000269|PubMed:12297049,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12731890,
FT                                ECO:0000269|PubMed:16083266,
FT                                ECO:0000269|PubMed:20837704}.
FT   CARBOHYD    352    352       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2U,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3P0Y,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRL,
FT                                ECO:0000244|PDB:4KRM,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000269|PubMed:10731668,
FT                                ECO:0000269|PubMed:12297049,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:12731890,
FT                                ECO:0000269|PubMed:16083266,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:20837704}.
FT   CARBOHYD    361    361       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2U,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRL,
FT                                ECO:0000244|PDB:4KRM,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000269|PubMed:10731668,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:12731890,
FT                                ECO:0000269|PubMed:16083266,
FT                                ECO:0000269|PubMed:20837704}.
FT   CARBOHYD    413    413       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2U,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3P0Y,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000269|PubMed:12731890,
FT                                ECO:0000269|PubMed:16083266,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:8962717}.
FT   CARBOHYD    444    444       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2U,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3P0Y,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRL,
FT                                ECO:0000244|PDB:4KRM,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:12731890,
FT                                ECO:0000269|PubMed:16083266,
FT                                ECO:0000269|PubMed:20837704,
FT                                ECO:0000269|PubMed:8962717}.
FT   CARBOHYD    528    528       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:12731890,
FT                                ECO:0000269|PubMed:16083266,
FT                                ECO:0000269|PubMed:20837704,
FT                                ECO:0000269|PubMed:8962717}.
FT   CARBOHYD    568    568       N-linked (GlcNAc...) asparagine; partial.
FT                                {ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000269|PubMed:10731668,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:12731890,
FT                                ECO:0000269|PubMed:16083266,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    603    603       N-linked (GlcNAc...) asparagine; partial.
FT                                {ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000269|PubMed:10731668,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:12731890,
FT                                ECO:0000269|PubMed:16083266}.
FT   CARBOHYD    623    623       N-linked (GlcNAc...) (high mannose)
FT                                asparagine.
FT                                {ECO:0000305|PubMed:12731890}.
FT   DISULFID     31     58       {ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5WB7,
FT                                ECO:0000244|PDB:5WB8,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    157    187       {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:5WB7,
FT                                ECO:0000244|PDB:5WB8,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12297049,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    190    199       {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5WB7,
FT                                ECO:0000244|PDB:5WB8,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12297049,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    194    207       {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5WB7,
FT                                ECO:0000244|PDB:5WB8,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12297049,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    215    223       {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5WB7,
FT                                ECO:0000244|PDB:5WB8,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12297049,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    219    231       {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5WB7,
FT                                ECO:0000244|PDB:5WB8,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12297049,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    232    240       {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5WB7,
FT                                ECO:0000244|PDB:5WB8,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12297049,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    236    248       {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5WB7,
FT                                ECO:0000244|PDB:5WB8,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12297049,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    251    260       {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5WB7,
FT                                ECO:0000244|PDB:5WB8,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12297049,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    264    291       {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5WB7,
FT                                ECO:0000244|PDB:5WB8,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12297049,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    295    307       {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5WB7,
FT                                ECO:0000244|PDB:5WB8,
FT                                ECO:0000244|PDB:5XWD}.
FT   DISULFID    311    326       {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3G5V,
FT                                ECO:0000244|PDB:3G5Y,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5WB7,
FT                                ECO:0000244|PDB:5WB8,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12297049,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    329    333       {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5WB7,
FT                                ECO:0000244|PDB:5WB8,
FT                                ECO:0000244|PDB:5XWD}.
FT   DISULFID    337    362       {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2U,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3C09,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3P0Y,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRL,
FT                                ECO:0000244|PDB:4KRM,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5SX4,
FT                                ECO:0000244|PDB:5SX5,
FT                                ECO:0000244|PDB:5WB7,
FT                                ECO:0000244|PDB:5WB8,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000244|PDB:6B3S,
FT                                ECO:0000269|PubMed:12297049,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    470    499       {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2U,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3C09,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3P0Y,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRL,
FT                                ECO:0000244|PDB:4KRM,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5SX4,
FT                                ECO:0000244|PDB:5SX5,
FT                                ECO:0000244|PDB:5WB7,
FT                                ECO:0000244|PDB:5WB8,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000244|PDB:6B3S}.
FT   DISULFID    506    515       {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2U,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3P0Y,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRL,
FT                                ECO:0000244|PDB:4KRM,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5SX4,
FT                                ECO:0000244|PDB:5SX5,
FT                                ECO:0000244|PDB:5WB7,
FT                                ECO:0000244|PDB:5WB8,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000244|PDB:6B3S,
FT                                ECO:0000269|PubMed:12297049,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    510    523       {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1MOX,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2U,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3C09,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3P0Y,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRL,
FT                                ECO:0000244|PDB:4KRM,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5SX4,
FT                                ECO:0000244|PDB:5SX5,
FT                                ECO:0000244|PDB:5WB7,
FT                                ECO:0000244|PDB:5WB8,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000244|PDB:6B3S,
FT                                ECO:0000269|PubMed:12297049,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    526    535       {ECO:0000244|PDB:1IVO,
FT                                ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRL,
FT                                ECO:0000244|PDB:4KRM,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12297050,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    539    555       {ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    558    571       {ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    562    579       {ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    582    591       {ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    595    617       {ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    620    628       {ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRO,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UIP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   DISULFID    624    636       {ECO:0000244|PDB:1NQL,
FT                                ECO:0000244|PDB:1YY9,
FT                                ECO:0000244|PDB:3B2V,
FT                                ECO:0000244|PDB:3NJP,
FT                                ECO:0000244|PDB:3QWQ,
FT                                ECO:0000244|PDB:4KRP,
FT                                ECO:0000244|PDB:4UV7,
FT                                ECO:0000244|PDB:5XWD,
FT                                ECO:0000269|PubMed:12620237,
FT                                ECO:0000269|PubMed:15837620,
FT                                ECO:0000269|PubMed:20837704}.
FT   CROSSLNK    716    716       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16543144}.
FT   CROSSLNK    737    737       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16543144}.
FT   CROSSLNK    754    754       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16543144}.
FT   CROSSLNK    867    867       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16543144}.
FT   CROSSLNK    929    929       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16543144}.
FT   CROSSLNK    970    970       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16543144}.
FT   VAR_SEQ     404    405       FL -> LS (in isoform 2).
FT                                {ECO:0000303|PubMed:7654368,
FT                                ECO:0000303|PubMed:8918811,
FT                                ECO:0000303|PubMed:9103388,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_002887.
FT   VAR_SEQ     406   1210       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:7654368,
FT                                ECO:0000303|PubMed:8918811,
FT                                ECO:0000303|PubMed:9103388,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_002888.
FT   VAR_SEQ     628    705       CTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFM
FT                                RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLR ->
FT                                PGNESLKAMLFCLFKLSSCNQSNDGSVSHQSGSPAAQESCL
FT                                GWIPSLLPSEFQLGWGGCSHLHAWPSASVIITASSCH (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:11161793}.
FT                                /FTId=VSP_002889.
FT   VAR_SEQ     628    628       C -> S (in isoform 4).
FT                                {ECO:0000303|PubMed:11161793}.
FT                                /FTId=VSP_002891.
FT   VAR_SEQ     629   1210       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:11161793}.
FT                                /FTId=VSP_002892.
FT   VAR_SEQ     706   1210       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11161793}.
FT                                /FTId=VSP_002890.
FT   VARIANT      30    297       Missing (variant EGFR vIII; found in a
FT                                lung cancer sample; somatic mutation;
FT                                induces lung cancer when exogenously
FT                                expressed).
FT                                {ECO:0000269|PubMed:16672372}.
FT                                /FTId=VAR_066493.
FT   VARIANT      98     98       R -> Q (in dbSNP:rs17289589).
FT                                {ECO:0000269|Ref.7}.
FT                                /FTId=VAR_019293.
FT   VARIANT     266    266       P -> R (in dbSNP:rs17336639).
FT                                {ECO:0000269|Ref.7}.
FT                                /FTId=VAR_019294.
FT   VARIANT     428    428       G -> D (in NISBD2; loss of function; the
FT                                mutant does not localize to the cell
FT                                membrane; has diffuse cytoplasmic
FT                                localization; dbSNP:rs606231253).
FT                                {ECO:0000269|PubMed:24691054}.
FT                                /FTId=VAR_072435.
FT   VARIANT     521    521       R -> K (in dbSNP:rs2227983).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_019295.
FT   VARIANT     674    674       V -> I (in dbSNP:rs17337079).
FT                                {ECO:0000269|Ref.7}.
FT                                /FTId=VAR_019296.
FT   VARIANT     709    709       E -> A (found in a lung cancer sample;
FT                                more sensitive to gefitinib than wild-
FT                                type; dbSNP:rs397517085).
FT                                {ECO:0000269|PubMed:15623594,
FT                                ECO:0000269|PubMed:16205628,
FT                                ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026084.
FT   VARIANT     709    709       E -> G (found in a lung cancer sample;
FT                                constitutively activated kinase with
FT                                higher levels of basal
FT                                autophosphorylation; more sensitive to
FT                                gefitinib than wild-type;
FT                                dbSNP:rs397517085).
FT                                {ECO:0000269|PubMed:15623594,
FT                                ECO:0000269|PubMed:16205628}.
FT                                /FTId=VAR_069498.
FT   VARIANT     709    709       E -> K (found in a lung cancer sample;
FT                                dbSNP:rs727504256).
FT                                {ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026085.
FT   VARIANT     719    719       G -> A (found in a lung cancer sample;
FT                                dbSNP:rs121913428).
FT                                {ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026086.
FT   VARIANT     719    719       G -> C (found in a lung cancer sample;
FT                                dbSNP:rs28929495).
FT                                {ECO:0000269|PubMed:15623594,
FT                                ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026087.
FT   VARIANT     719    719       G -> D (found in a lung cancer sample;
FT                                dbSNP:rs121913428).
FT                                {ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026088.
FT   VARIANT     719    719       G -> S (found in a lung cancer sample;
FT                                somatic mutation; strongly increased
FT                                kinase activity; constitutively activated
FT                                kinase with higher levels of basal
FT                                autophosphorylation; more sensitive to
FT                                gefitinib than wild-type;
FT                                dbSNP:rs28929495).
FT                                {ECO:0000269|PubMed:15118125,
FT                                ECO:0000269|PubMed:15623594,
FT                                ECO:0000269|PubMed:16205628,
FT                                ECO:0000269|PubMed:16533793,
FT                                ECO:0000269|PubMed:17349580}.
FT                                /FTId=VAR_019297.
FT   VARIANT     724    724       G -> S (found in a lung cancer sample;
FT                                dbSNP:rs1051753269).
FT                                {ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026089.
FT   VARIANT     734    734       E -> K (found in a lung cancer sample;
FT                                dbSNP:rs121913420).
FT                                {ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026090.
FT   VARIANT     746    752       ELREATS -> D (found in a lung cancer
FT                                sample). {ECO:0000269|PubMed:15623594}.
FT                                /FTId=VAR_069499.
FT   VARIANT     746    751       ELREAT -> A (found in a lung cancer
FT                                sample). {ECO:0000269|PubMed:15623594}.
FT                                /FTId=VAR_069500.
FT   VARIANT     746    750       Missing (found in a lung cancer sample).
FT                                {ECO:0000269|PubMed:15623594}.
FT                                /FTId=VAR_026092.
FT   VARIANT     746    746       Missing (found in a lung cancer sample).
FT                                {ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026091.
FT   VARIANT     747    751       Missing (found in a lung cancer sample).
FT                                {ECO:0000269|PubMed:15623594}.
FT                                /FTId=VAR_069501.
FT   VARIANT     747    749       Missing (found in a lung cancer sample).
FT                                {ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026094.
FT   VARIANT     747    747       L -> F (found in a lung cancer sample).
FT                                {ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026093.
FT   VARIANT     748    748       R -> P (found in a lung cancer sample).
FT                                {ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026095.
FT   VARIANT     752    759       Missing (found in a lung cancer sample).
FT                                {ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026096.
FT   VARIANT     768    768       S -> I (found in a lung cancer sample;
FT                                constitutively activated kinase with
FT                                higher levels of basal
FT                                autophosphorylation; more sensitive to
FT                                gefitinib than wild-type;
FT                                dbSNP:rs121913465).
FT                                {ECO:0000269|PubMed:15623594,
FT                                ECO:0000269|PubMed:16205628}.
FT                                /FTId=VAR_069502.
FT   VARIANT     769    769       V -> M (found in a lung cancer sample;
FT                                dbSNP:rs147149347).
FT                                {ECO:0000269|PubMed:15623594}.
FT                                /FTId=VAR_069503.
FT   VARIANT     787    787       Q -> R (found in a lung cancer sample).
FT                                {ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026097.
FT   VARIANT     790    790       T -> M (found in a lung cancer sample;
FT                                increased kinase activity;
FT                                dbSNP:rs121434569).
FT                                {ECO:0000269|PubMed:16533793,
FT                                ECO:0000269|PubMed:18227510}.
FT                                /FTId=VAR_026098.
FT   VARIANT     833    833       L -> V (found in a lung cancer sample;
FT                                more sensitive to gefitinib than wild-
FT                                type; dbSNP:rs397517126).
FT                                {ECO:0000269|PubMed:15623594,
FT                                ECO:0000269|PubMed:16205628,
FT                                ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026099.
FT   VARIANT     834    834       V -> L (found in a lung cancer sample;
FT                                dbSNP:rs397517127).
FT                                {ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026100.
FT   VARIANT     835    835       H -> L (found in a lung cancer sample;
FT                                more sensitive to gefitinib than wild-
FT                                type; dbSNP:rs397517128).
FT                                {ECO:0000269|PubMed:15623594,
FT                                ECO:0000269|PubMed:16205628}.
FT                                /FTId=VAR_069504.
FT   VARIANT     838    838       L -> V (found in a lung cancer sample;
FT                                more sensitive to gefitinib than wild-
FT                                type; dbSNP:rs864621996).
FT                                {ECO:0000269|PubMed:15623594,
FT                                ECO:0000269|PubMed:16205628}.
FT                                /FTId=VAR_069505.
FT   VARIANT     858    858       L -> M (found in a lung cancer sample;
FT                                dbSNP:rs121913443).
FT                                {ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026101.
FT   VARIANT     858    858       L -> R (found in a lung cancer sample;
FT                                somatic mutation; constitutively
FT                                activated enzyme with strongly increased
FT                                kinase activity; more sensitive to
FT                                gefitinib than wild-type;
FT                                dbSNP:rs121434568).
FT                                {ECO:0000269|PubMed:15118125,
FT                                ECO:0000269|PubMed:15623594,
FT                                ECO:0000269|PubMed:16205628,
FT                                ECO:0000269|PubMed:16533793,
FT                                ECO:0000269|PubMed:17349580}.
FT                                /FTId=VAR_019298.
FT   VARIANT     861    861       L -> Q (found in a lung cancer sample;
FT                                constitutively activated kinase with
FT                                higher levels of basal
FT                                autophosphorylation; more sensitive to
FT                                gefitinib than wild-type;
FT                                dbSNP:rs121913444).
FT                                {ECO:0000269|PubMed:15623594,
FT                                ECO:0000269|PubMed:16205628,
FT                                ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026102.
FT   VARIANT     873    873       G -> E (found in a lung cancer sample).
FT                                {ECO:0000269|PubMed:16533793}.
FT                                /FTId=VAR_026103.
FT   VARIANT     962    962       R -> G (in dbSNP:rs17337451).
FT                                {ECO:0000269|Ref.7}.
FT                                /FTId=VAR_019299.
FT   VARIANT     988    988       H -> P (in dbSNP:rs17290699).
FT                                {ECO:0000269|Ref.7}.
FT                                /FTId=VAR_019300.
FT   VARIANT    1034   1034       L -> R (in dbSNP:rs34352568).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042095.
FT   VARIANT    1210   1210       A -> V (in dbSNP:rs35918369).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042096.
FT   MUTAGEN     275    275       Y->A: Strongly reduced
FT                                autophosphorylation and activation of
FT                                downstream kinases; when associated with
FT                                A-309. {ECO:0000269|PubMed:12297050}.
FT   MUTAGEN     287    287       F->A: Strongly reduced
FT                                autophosphorylation and activation of
FT                                downstream kinases; when associated with
FT                                A-309. {ECO:0000269|PubMed:12297050}.
FT   MUTAGEN     309    309       R->S: Strongly reduced
FT                                autophosphorylation and activation of
FT                                downstream kinases; when associated with
FT                                A-275. Strongly reduced
FT                                autophosphorylation and activation of
FT                                downstream kinases; when associated with
FT                                A-287. {ECO:0000269|PubMed:12297050}.
FT   MUTAGEN     429    429       R->E: Abolishes autophosphorylation and
FT                                activation of downstream kinases.
FT                                {ECO:0000269|PubMed:12297050}.
FT   MUTAGEN     587    590       DGPH->AGPA: Decreases intramolecular
FT                                interactions and facilitates EGF binding.
FT                                {ECO:0000269|PubMed:12620237}.
FT   MUTAGEN     609    609       K->A: Decreases intramolecular
FT                                interactions and facilitates EGF binding.
FT                                {ECO:0000269|PubMed:12620237}.
FT   MUTAGEN     688    688       L->A: Strongly reduced phosphorylation.
FT                                {ECO:0000269|PubMed:19560417,
FT                                ECO:0000269|PubMed:19563760}.
FT   MUTAGEN     689    689       V->A: Reduced autophosphorylation.
FT                                {ECO:0000269|PubMed:19560417}.
FT   MUTAGEN     689    689       V->M: Constitutively activated kinase.
FT                                {ECO:0000269|PubMed:19560417}.
FT   MUTAGEN     690    690       E->A: Reduced phosphorylation.
FT                                {ECO:0000269|PubMed:19560417,
FT                                ECO:0000269|PubMed:19563760}.
FT   MUTAGEN     692    692       L->A,P: Strongly reduced phosphorylation.
FT                                {ECO:0000269|PubMed:19560417,
FT                                ECO:0000269|PubMed:19563760}.
FT   MUTAGEN     693    693       T->A: Increased phosphorylation.
FT                                {ECO:0000269|PubMed:19560417}.
FT   MUTAGEN     693    693       T->D: Strongly reduced phosphorylation.
FT                                {ECO:0000269|PubMed:19560417}.
FT   MUTAGEN     694    694       P->A: Strongly reduced phosphorylation.
FT                                {ECO:0000269|PubMed:19560417}.
FT   MUTAGEN     699    699       P->A: Reduced phosphorylation.
FT                                {ECO:0000269|PubMed:19560417}.
FT   MUTAGEN     700    700       N->A: Abolishes phosphorylation.
FT                                {ECO:0000269|PubMed:19560417}.
FT   MUTAGEN     704    704       L->A: Abolishes phosphorylation.
FT                                {ECO:0000269|PubMed:19560417}.
FT   MUTAGEN     705    705       R->A: Abolishes phosphorylation.
FT                                {ECO:0000269|PubMed:19560417}.
FT   MUTAGEN     706    706       I->A: Abolishes phosphorylation.
FT                                {ECO:0000269|PubMed:19560417}.
FT   MUTAGEN     745    745       K->A,M: Abolishes kinase activity.
FT                                {ECO:0000269|PubMed:19560417}.
FT   MUTAGEN     974    974       D->A: Strongly reduced phosphorylation.
FT   MUTAGEN     977    977       R->A: Reduced phosphorylation.
FT                                {ECO:0000269|PubMed:19563760}.
FT   MUTAGEN    1005   1006       ED->RK: Constitutively activated kinase.
FT                                {ECO:0000269|PubMed:19563760}.
FT   MUTAGEN    1016   1016       Y->F: 50% decrease in interaction with
FT                                PIK3C2B. 65% decrease in interaction with
FT                                PIK3C2B; when associated with F-1197.
FT                                Abolishes interaction with PIK3C2B; when
FT                                associated with F-1197 and F-1092.
FT                                {ECO:0000269|PubMed:10805725}.
FT   MUTAGEN    1048   1210       Missing: Abolishes palmitoylation.
FT                                {ECO:0000269|PubMed:27153536}.
FT   MUTAGEN    1049   1049       C->A: Decreased palmitoylation.
FT                                {ECO:0000269|PubMed:27153536}.
FT   MUTAGEN    1067   1067       Q->G: No effect on interaction with CBLC.
FT                                {ECO:0000269|PubMed:22888118}.
FT   MUTAGEN    1068   1068       R->G: Strongly decreases interaction with
FT                                CBLC. {ECO:0000269|PubMed:22888118}.
FT   MUTAGEN    1069   1069       Y->F: Abolishes interaction with CBLC.
FT                                {ECO:0000269|PubMed:22888118}.
FT   MUTAGEN    1092   1092       Y->F: No change in interaction with
FT                                PIK3C2B. Abolishes interaction with
FT                                PIK3C2B; when associated with F-1197 and
FT                                F-1016. {ECO:0000269|PubMed:10805725}.
FT   MUTAGEN    1110   1110       Y->F: No change in interaction with
FT                                PIK3C2B. {ECO:0000269|PubMed:10805725}.
FT   MUTAGEN    1146   1146       C->A: Decreased palmitoylation.
FT                                {ECO:0000269|PubMed:27153536}.
FT   MUTAGEN    1172   1172       Y->F: No change in interaction with
FT                                PIK3C2B. {ECO:0000269|PubMed:10805725}.
FT   MUTAGEN    1197   1197       Y->F: No change in interaction with
FT                                PIK3C2B. 65% decrease in interaction with
FT                                PIK3C2B; when associated with F-1016.
FT                                Abolishes interaction with PIK3C2B; when
FT                                associated with F-1092 and F-1016.
FT                                {ECO:0000269|PubMed:10805725}.
FT   CONFLICT    540    540       N -> K (in Ref. 1; CAA25240).
FT                                {ECO:0000305}.
FT   STRAND       40     43       {ECO:0000244|PDB:3QWQ}.
FT   HELIX        44     55       {ECO:0000244|PDB:4UV7}.
FT   STRAND       60     69       {ECO:0000244|PDB:4UV7}.
FT   HELIX        77     81       {ECO:0000244|PDB:4UV7}.
FT   STRAND       84     87       {ECO:0000244|PDB:4UV7}.
FT   STRAND       89     93       {ECO:0000244|PDB:4UV7}.
FT   HELIX       101    103       {ECO:0000244|PDB:1IVO}.
FT   TURN        114    116       {ECO:0000244|PDB:4UV7}.
FT   STRAND      117    122       {ECO:0000244|PDB:4UV7}.
FT   STRAND      125    129       {ECO:0000244|PDB:1MOX}.
FT   STRAND      145    152       {ECO:0000244|PDB:4UV7}.
FT   HELIX       159    161       {ECO:0000244|PDB:4UV7}.
FT   HELIX       164    166       {ECO:0000244|PDB:4UV7}.
FT   HELIX       170    173       {ECO:0000244|PDB:1MOX}.
FT   HELIX       195    197       {ECO:0000244|PDB:4UV7}.
FT   STRAND      199    204       {ECO:0000244|PDB:4UV7}.
FT   STRAND      211    214       {ECO:0000244|PDB:1MOX}.
FT   STRAND      223    227       {ECO:0000244|PDB:4UV7}.
FT   HELIX       228    230       {ECO:0000244|PDB:4UV7}.
FT   STRAND      236    238       {ECO:0000244|PDB:4UV7}.
FT   STRAND      240    244       {ECO:0000244|PDB:4UV7}.
FT   TURN        245    247       {ECO:0000244|PDB:4UV7}.
FT   STRAND      248    256       {ECO:0000244|PDB:4UV7}.
FT   STRAND      259    263       {ECO:0000244|PDB:4UV7}.
FT   STRAND      267    271       {ECO:0000244|PDB:4UV7}.
FT   TURN        272    275       {ECO:0000244|PDB:4UV7}.
FT   STRAND      276    279       {ECO:0000244|PDB:4UV7}.
FT   STRAND      285    287       {ECO:0000244|PDB:4UV7}.
FT   STRAND      290    294       {ECO:0000244|PDB:4UV7}.
FT   TURN        296    298       {ECO:0000244|PDB:3B2V}.
FT   STRAND      299    301       {ECO:0000244|PDB:5WB7}.
FT   STRAND      303    305       {ECO:0000244|PDB:4KRP}.
FT   STRAND      306    310       {ECO:0000244|PDB:4UV7}.
FT   STRAND      313    315       {ECO:0000244|PDB:3B2V}.
FT   STRAND      318    320       {ECO:0000244|PDB:3G5Y}.
FT   STRAND      323    325       {ECO:0000244|PDB:3G5Y}.
FT   STRAND      330    332       {ECO:0000244|PDB:4UV7}.
FT   STRAND      336    338       {ECO:0000244|PDB:3P0Y}.
FT   TURN        340    342       {ECO:0000244|PDB:3QWQ}.
FT   HELIX       343    345       {ECO:0000244|PDB:3P0Y}.
FT   STRAND      349    351       {ECO:0000244|PDB:3P0Y}.
FT   TURN        353    355       {ECO:0000244|PDB:3P0Y}.
FT   HELIX       356    359       {ECO:0000244|PDB:3P0Y}.
FT   STRAND      363    367       {ECO:0000244|PDB:3P0Y}.
FT   STRAND      369    371       {ECO:0000244|PDB:3P0Y}.
FT   HELIX       373    377       {ECO:0000244|PDB:3P0Y}.
FT   TURN        380    383       {ECO:0000244|PDB:3P0Y}.
FT   HELIX       389    397       {ECO:0000244|PDB:3P0Y}.
FT   STRAND      400    403       {ECO:0000244|PDB:3P0Y}.
FT   STRAND      405    407       {ECO:0000244|PDB:3P0Y}.
FT   HELIX       418    420       {ECO:0000244|PDB:3P0Y}.
FT   TURN        433    435       {ECO:0000244|PDB:3P0Y}.
FT   STRAND      436    442       {ECO:0000244|PDB:3P0Y}.
FT   STRAND      458    464       {ECO:0000244|PDB:3P0Y}.
FT   HELIX       472    474       {ECO:0000244|PDB:3P0Y}.
FT   HELIX       477    480       {ECO:0000244|PDB:3P0Y}.
FT   STRAND      481    483       {ECO:0000244|PDB:1YY9}.
FT   STRAND      488    494       {ECO:0000244|PDB:3P0Y}.
FT   HELIX       496    501       {ECO:0000244|PDB:3P0Y}.
FT   STRAND      508    510       {ECO:0000244|PDB:5SX4}.
FT   STRAND      515    519       {ECO:0000244|PDB:3P0Y}.
FT   HELIX       520    522       {ECO:0000244|PDB:3P0Y}.
FT   STRAND      523    526       {ECO:0000244|PDB:3P0Y}.
FT   STRAND      531    533       {ECO:0000244|PDB:4KRL}.
FT   STRAND      535    537       {ECO:0000244|PDB:1YY9}.
FT   STRAND      540    546       {ECO:0000244|PDB:4UV7}.
FT   STRAND      548    551       {ECO:0000244|PDB:4UV7}.
FT   STRAND      554    557       {ECO:0000244|PDB:4UV7}.
FT   STRAND      560    562       {ECO:0000244|PDB:4KRO}.
FT   STRAND      566    568       {ECO:0000244|PDB:1YY9}.
FT   STRAND      570    575       {ECO:0000244|PDB:4UV7}.
FT   STRAND      578    587       {ECO:0000244|PDB:4UV7}.
FT   STRAND      590    594       {ECO:0000244|PDB:4UV7}.
FT   STRAND      597    602       {ECO:0000244|PDB:4UV7}.
FT   STRAND      606    611       {ECO:0000244|PDB:4UV7}.
FT   STRAND      615    619       {ECO:0000244|PDB:4UV7}.
FT   STRAND      629    632       {ECO:0000244|PDB:4UV7}.
FT   HELIX       633    635       {ECO:0000244|PDB:4UV7}.
FT   STRAND      643    646       {ECO:0000244|PDB:2KS1}.
FT   HELIX       648    669       {ECO:0000244|PDB:2KS1}.
FT   STRAND      671    673       {ECO:0000244|PDB:1Z9I}.
FT   HELIX       679    684       {ECO:0000244|PDB:3GOP}.
FT   HELIX       685    687       {ECO:0000244|PDB:3GOP}.
FT   STRAND      688    692       {ECO:0000244|PDB:1Z9I}.
FT   STRAND      694    697       {ECO:0000244|PDB:1Z9I}.
FT   STRAND      703    706       {ECO:0000244|PDB:3POZ}.
FT   HELIX       709    711       {ECO:0000244|PDB:5UG9}.
FT   STRAND      712    721       {ECO:0000244|PDB:5UG9}.
FT   STRAND      724    731       {ECO:0000244|PDB:5UG9}.
FT   TURN        734    736       {ECO:0000244|PDB:5UG9}.
FT   STRAND      740    747       {ECO:0000244|PDB:5UG9}.
FT   STRAND      748    750       {ECO:0000244|PDB:2ITU}.
FT   TURN        753    755       {ECO:0000244|PDB:3W2S}.
FT   HELIX       756    767       {ECO:0000244|PDB:5UG9}.
FT   STRAND      772    774       {ECO:0000244|PDB:4I21}.
FT   STRAND      777    791       {ECO:0000244|PDB:5UG9}.
FT   STRAND      794    797       {ECO:0000244|PDB:4G5P}.
FT   HELIX       798    804       {ECO:0000244|PDB:5UG9}.
FT   HELIX       806    808       {ECO:0000244|PDB:5UG9}.
FT   HELIX       811    830       {ECO:0000244|PDB:5UG9}.
FT   HELIX       840    842       {ECO:0000244|PDB:5UG9}.
FT   STRAND      843    847       {ECO:0000244|PDB:5UG9}.
FT   STRAND      850    853       {ECO:0000244|PDB:5UG9}.
FT   HELIX       858    862       {ECO:0000244|PDB:3POZ}.
FT   TURN        863    865       {ECO:0000244|PDB:3POZ}.
FT   STRAND      867    870       {ECO:0000244|PDB:5UG9}.
FT   STRAND      871    875       {ECO:0000244|PDB:5X2A}.
FT   HELIX       878    880       {ECO:0000244|PDB:5UG9}.
FT   HELIX       883    888       {ECO:0000244|PDB:5UG9}.
FT   HELIX       893    908       {ECO:0000244|PDB:5UG9}.
FT   TURN        909    911       {ECO:0000244|PDB:2GS7}.
FT   TURN        914    917       {ECO:0000244|PDB:5UG9}.
FT   HELIX       920    922       {ECO:0000244|PDB:5UG9}.
FT   HELIX       923    928       {ECO:0000244|PDB:5UG9}.
FT   STRAND      937    939       {ECO:0000244|PDB:5JEB}.
FT   HELIX       941    950       {ECO:0000244|PDB:5UG9}.
FT   STRAND      951    953       {ECO:0000244|PDB:5JEB}.
FT   HELIX       955    957       {ECO:0000244|PDB:5UG9}.
FT   HELIX       961    972       {ECO:0000244|PDB:5UG9}.
FT   HELIX       975    977       {ECO:0000244|PDB:5UG9}.
FT   HELIX       984    986       {ECO:0000244|PDB:5HG8}.
FT   TURN        992    998       {ECO:0000244|PDB:5HG8}.
FT   STRAND     1004   1010       {ECO:0000244|PDB:3W2S}.
FT   HELIX      1013   1016       {ECO:0000244|PDB:3POZ}.
FT   STRAND     1068   1070       {ECO:0000244|PDB:3PFV}.
SQ   SEQUENCE   1210 AA;  134277 MW;  D8A2A50B4EFB6ED2 CRC64;
     MRPSGTAGAA LLALLAALCP ASRALEEKKV CQGTSNKLTQ LGTFEDHFLS LQRMFNNCEV
     VLGNLEITYV QRNYDLSFLK TIQEVAGYVL IALNTVERIP LENLQIIRGN MYYENSYALA
     VLSNYDANKT GLKELPMRNL QEILHGAVRF SNNPALCNVE SIQWRDIVSS DFLSNMSMDF
     QNHLGSCQKC DPSCPNGSCW GAGEENCQKL TKIICAQQCS GRCRGKSPSD CCHNQCAAGC
     TGPRESDCLV CRKFRDEATC KDTCPPLMLY NPTTYQMDVN PEGKYSFGAT CVKKCPRNYV
     VTDHGSCVRA CGADSYEMEE DGVRKCKKCE GPCRKVCNGI GIGEFKDSLS INATNIKHFK
     NCTSISGDLH ILPVAFRGDS FTHTPPLDPQ ELDILKTVKE ITGFLLIQAW PENRTDLHAF
     ENLEIIRGRT KQHGQFSLAV VSLNITSLGL RSLKEISDGD VIISGNKNLC YANTINWKKL
     FGTSGQKTKI ISNRGENSCK ATGQVCHALC SPEGCWGPEP RDCVSCRNVS RGRECVDKCN
     LLEGEPREFV ENSECIQCHP ECLPQAMNIT CTGRGPDNCI QCAHYIDGPH CVKTCPAGVM
     GENNTLVWKY ADAGHVCHLC HPNCTYGCTG PGLEGCPTNG PKIPSIATGM VGALLLLLVV
     ALGIGLFMRR RHIVRKRTLR RLLQERELVE PLTPSGEAPN QALLRILKET EFKKIKVLGS
     GAFGTVYKGL WIPEGEKVKI PVAIKELREA TSPKANKEIL DEAYVMASVD NPHVCRLLGI
     CLTSTVQLIT QLMPFGCLLD YVREHKDNIG SQYLLNWCVQ IAKGMNYLED RRLVHRDLAA
     RNVLVKTPQH VKITDFGLAK LLGAEEKEYH AEGGKVPIKW MALESILHRI YTHQSDVWSY
     GVTVWELMTF GSKPYDGIPA SEISSILEKG ERLPQPPICT IDVYMIMVKC WMIDADSRPK
     FRELIIEFSK MARDPQRYLV IQGDERMHLP SPTDSNFYRA LMDEEDMDDV VDADEYLIPQ
     QGFFSSPSTS RTPLLSSLSA TSNNSTVACI DRNGLQSCPI KEDSFLQRYS SDPTGALTED
     SIDDTFLPVP EYINQSVPKR PAGSVQNPVY HNQPLNPAPS RDPHYQDPHS TAVGNPEYLN
     TVQPTCVNST FDSPAHWAQK GSHQISLDNP DYQQDFFPKE AKPNGIFKGS TAENAEYLRV
     APQSSEFIGA
//
ID   Q504U8_HUMAN            Unreviewed;      1091 AA.
AC   Q504U8;
DT   07-JUN-2005, integrated into UniProtKB/TrEMBL.
DT   07-JUN-2005, sequence version 1.
DT   23-MAY-2018, entry version 139.
DE   RecName: Full=Receptor protein-tyrosine kinase {ECO:0000256|SAAS:SAAS00593197};
DE            EC=2.7.10.1 {ECO:0000256|SAAS:SAAS00593197};
GN   Name=EGFR {ECO:0000313|EMBL:AAH94761.1,
GN   ECO:0000313|Ensembl:ENSP00000415559};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH94761.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000415559, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000313|EMBL:AAH94761.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta {ECO:0000313|EMBL:AAH94761.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [4] {ECO:0000213|PubMed:18220336}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.D., Yates J.R.;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [5] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [6] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8] {ECO:0000213|PubMed:19369195}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [9] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [10] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11] {ECO:0000313|Ensembl:ENSP00000415559}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [12] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000256|SAAS:SAAS00594546}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. {ECO:0000256|SAAS:SAAS00941529}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC006977; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC073324; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458469; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC094761; AAH94761.1; -; mRNA.
DR   RefSeq; NP_001333826.1; NM_001346897.1.
DR   RefSeq; NP_001333827.1; NM_001346898.1.
DR   RefSeq; NP_001333828.1; NM_001346899.1.
DR   RefSeq; NP_005219.2; NM_005228.4.
DR   UniGene; Hs.488293; -.
DR   UniGene; Hs.605083; -.
DR   UniGene; Hs.731652; -.
DR   Ensembl; ENST00000455089; ENSP00000415559; ENSG00000146648.
DR   GeneID; 1956; -.
DR   KEGG; hsa:1956; -.
DR   UCSC; uc010kzg.3; human.
DR   CTD; 1956; -.
DR   EuPathDB; HostDB:ENSG00000146648.15; -.
DR   HGNC; HGNC:3236; EGFR.
DR   OpenTargets; ENSG00000146648; -.
DR   eggNOG; KOG1025; Eukaryota.
DR   eggNOG; ENOG410XNSR; LUCA.
DR   GeneTree; ENSGT00760000118799; -.
DR   HOGENOM; HOG000230982; -.
DR   HOVERGEN; HBG000490; -.
DR   KO; K04361; -.
DR   ChiTaRS; EGFR; human.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000146648; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004716; F:signal transducer, downstream of receptor, with protein tyrosine kinase activity; IEA:InterPro.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IDA:CACAO.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:InterPro.
DR   Gene3D; 3.80.20.20; -; 3.
DR   InterPro; IPR006211; Furin-like_Cys-rich_dom.
DR   InterPro; IPR006212; Furin_repeat.
DR   InterPro; IPR032778; GF_recep_IV.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR000494; Rcpt_L-dom.
DR   InterPro; IPR036941; Rcpt_L-dom_sf.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016245; Tyr_kinase_EGF/ERB/XmrK_rcpt.
DR   Pfam; PF00757; Furin-like; 1.
DR   Pfam; PF14843; GF_recep_IV; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF01030; Recep_L_domain; 2.
DR   PIRSF; PIRSF000619; TyrPK_EGF-R; 3.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00261; FU; 3.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|PIRSR:PIRSR000619-2,
KW   ECO:0000256|SAAS:SAAS00461464};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Kinase {ECO:0000256|SAAS:SAAS00594505};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Nucleotide-binding {ECO:0000256|PIRSR:PIRSR000619-2,
KW   ECO:0000256|SAAS:SAAS00461464};
KW   Proteomics identification {ECO:0000213|EPD:Q504U8,
KW   ECO:0000213|MaxQB:Q504U8, ECO:0000213|PeptideAtlas:Q504U8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transferase {ECO:0000256|SAAS:SAAS00594505};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius};
KW   Tyrosine-protein kinase {ECO:0000256|SAAS:SAAS00594505}.
FT   SIGNAL        1     24       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        25   1091       Receptor protein-tyrosine kinase.
FT                                {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014586593.
FT   TRANSMEM    601    622       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      667    934       Protein kinase.
FT                                {ECO:0000259|PROSITE:PS50011}.
FT   NP_BIND     673    681       ATP. {ECO:0000256|PIRSR:PIRSR000619-2}.
FT   ACT_SITE    792    792       Proton acceptor.
FT                                {ECO:0000256|PIRSR:PIRSR000619-1}.
FT   BINDING     700    700       ATP. {ECO:0000256|PIRSR:PIRSR000619-2}.
SQ   SEQUENCE   1091 AA;  120692 MW;  25B062C735D62AD1 CRC64;
     MRPSGTAGAA LLALLAALCP ASRALEEKKV CQGTSNKLTQ LGTFEDHFLS LQRMFNNCEV
     VLGNLEITYV QRNYDLSFLK TIQEVAGYVL IALNTVERIP LENLQIIRGN MYYENSYALA
     VLSNYDANKT GLKELPMRNL QGQKCDPSCP NGSCWGAGEE NCQKLTKIIC AQQCSGRCRG
     KSPSDCCHNQ CAAGCTGPRE SDCLVCRKFR DEATCKDTCP PLMLYNPTTY QMDVNPEGKY
     SFGATCVKKC PRNYVVTDHG SCVRACGADS YEMEEDGVRK CKKCEGPCRK VCNGIGIGEF
     KDSLSINATN IKHFKNCTSI SGDLHILPVA FRGDSFTHTP PLDPQELDIL KTVKEITGFL
     LIQAWPENRT DLHAFENLEI IRGRTKQHGQ FSLAVVSLNI TSLGLRSLKE ISDGDVIISG
     NKNLCYANTI NWKKLFGTSG QKTKIISNRG ENSCKATGQV CHALCSPEGC WGPEPRDCVS
     CRNVSRGREC VDKCNLLEGE PREFVENSEC IQCHPECLPQ AMNITCTGRG PDNCIQCAHY
     IDGPHCVKTC PAGVMGENNT LVWKYADAGH VCHLCHPNCT YGCTGPGLEG CPTNGPKIPS
     IATGMVGALL LLLVVALGIG LFMRRRHIVR KRTLRRLLQE RELVEPLTPS GEAPNQALLR
     ILKETEFKKI KVLGSGAFGT VYKGLWIPEG EKVKIPVAIK ELREATSPKA NKEILDEAYV
     MASVDNPHVC RLLGICLTST VQLITQLMPF GCLLDYVREH KDNIGSQYLL NWCVQIAKGM
     NYLEDRRLVH RDLAARNVLV KTPQHVKITD FGLAKLLGAE EKEYHAEGGK VPIKWMALES
     ILHRIYTHQS DVWSYGVTVW ELMTFGSKPY DGIPASEISS ILEKGERLPQ PPICTIDVYM
     IMVKCWMIDA DSRPKFRELI IEFSKMARDP QRYLVIQGDE RMHLPSPTDS NFYRALMDEE
     DMDDVVDADE YLIPQQGFFS SPSTSRTPLL SSLSATSNNS TVACIDRNGL QSCPIKEDSF
     LQRYSSDPTG ALTEDSIDDT FLPVPGEWLV WKQSCSSTSS THSAAASLQC PSQVLPPASP
     EGETVADLQT Q
//
ID   ILK_HUMAN               Reviewed;         452 AA.
AC   Q13418; B7Z1I0; B7Z418; D3DQU0; P57043; Q68DZ3;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 2.
DT   23-MAY-2018, entry version 197.
DE   RecName: Full=Integrin-linked protein kinase;
DE            EC=2.7.11.1;
DE   AltName: Full=59 kDa serine/threonine-protein kinase;
DE   AltName: Full=ILK-1;
DE   AltName: Full=ILK-2;
DE   AltName: Full=p59ILK;
GN   Name=ILK; Synonyms=ILK1, ILK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Placenta;
RX   PubMed=8538749; DOI=10.1038/379091a0;
RA   Hannigan G.E., Leung-Hagesteijn C., Fitz-Gibbon L., Coppolino M.G.,
RA   Radeva G., Filmus J., Bell J.C., Dedhar S.;
RT   "Regulation of cell adhesion and anchorage-dependent growth by a new
RT   beta 1-integrin-linked protein kinase.";
RL   Nature 379:91-96(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10871859; DOI=10.1038/sj.onc.1203640;
RA   Janji B., Melchior C., Vallar L., Kieffer N.;
RT   "Cloning of an isoform of integrin-linked kinase (ILK) that is
RT   upregulated in HT-144 melanoma cells following TGF-beta1
RT   stimulation.";
RL   Oncogene 19:3069-3077(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Tadic B., Hannigan G.E.;
RT   "Integrin-linked kinase genomic sequence.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Melchior C., Janji B., Kreis S., Kieffer N.;
RT   "Structural organisation of the gene encoding integrin-linked kinase
RT   1.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Cerebellum, and Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Endometrium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   FUNCTION, AND MUTAGENESIS OF GLU-359.
RX   PubMed=9736715; DOI=10.1073/pnas.95.19.11211;
RA   Delcommenne M., Tan C., Gray V., Rue L., Woodgett J.R., Dedhar S.;
RT   "Phosphoinositide-3-OH kinase-dependent regulation of glycogen
RT   synthase kinase 3 and protein kinase B/AKT by the integrin-linked
RT   kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:11211-11216(1998).
RN   [12]
RP   REVIEW.
RX   PubMed=10712922; DOI=10.1016/S0955-0674(99)00083-6;
RA   Dedhar S.;
RT   "Cell-substrate interactions and signaling through ILK.";
RL   Curr. Opin. Cell Biol. 12:250-256(2000).
RN   [13]
RP   INTERACTION WITH PARVB, AND SUBCELLULAR LOCATION.
RX   PubMed=11402068; DOI=10.1083/jcb.153.6.1251;
RA   Yamaji S., Suzuki A., Sugiyama Y., Koide Y., Yoshida M., Kanamori H.,
RA   Mohri H., Ohno S., Ishigatsubo Y.;
RT   "A novel integrin-linked kinase-binding protein, affixin, is involved
RT   in the early stage of cell-substrate interaction.";
RL   J. Cell Biol. 153:1251-1264(2001).
RN   [14]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH LIMS1 AND LIMS2.
RX   PubMed=12167643; DOI=10.1074/jbc.M205576200;
RA   Zhang Y., Chen K., Guo L., Wu C.;
RT   "Characterization of PINCH-2, a new focal adhesion protein that
RT   regulates the PINCH-1-ILK interaction, cell spreading, and
RT   migration.";
RL   J. Biol. Chem. 277:38328-38338(2002).
RN   [15]
RP   INTERACTION WITH PARVA AND PARVB.
RX   PubMed=15284246; DOI=10.1074/jbc.M401563200;
RA   Zhang Y., Chen K., Tu Y., Wu C.;
RT   "Distinct roles of two structurally closely related focal adhesion
RT   proteins, alpha-parvins and beta-parvins, in regulation of cell
RT   morphology and survival.";
RL   J. Biol. Chem. 279:41695-41705(2004).
RN   [16]
RP   INTERACTION WITH EPHA1.
RX   PubMed=19118217; DOI=10.1242/jcs.036467;
RA   Yamazaki T., Masuda J., Omori T., Usui R., Akiyama H., Maru Y.;
RT   "EphA1 interacts with integrin-linked kinase and regulates cell
RT   morphology and motility.";
RL   J. Cell Sci. 122:243-255(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [21]
RP   INTERACTION WITH LIMD2, AND ENZYME REGULATION.
RX   PubMed=24590809; DOI=10.1158/0008-5472.CAN-13-1275;
RA   Peng H., Talebzadeh-Farrooji M., Osborne M.J., Prokop J.W.,
RA   McDonald P.C., Karar J., Hou Z., He M., Kebebew E., Orntoft T.,
RA   Herlyn M., Caton A.J., Fredericks W., Malkowicz B., Paterno C.S.,
RA   Carolin A.S., Speicher D.W., Skordalakes E., Huang Q., Dedhar S.,
RA   Borden K.L., Rauscher F.J. III;
RT   "LIMD2 is a small LIM-only protein overexpressed in metastatic lesions
RT   that regulates cell motility and tumor progression by directly binding
RT   to and activating the integrin-linked kinase.";
RL   Cancer Res. 74:1390-1403(2014).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 1-174 IN COMPLEX WITH LIMS1,
RP   DOMAIN ANK REPEATS, AND MUTAGENESIS OF HIS-99.
RX   PubMed=19074270; DOI=10.1073/pnas.0811415106;
RA   Chiswell B.P., Zhang R., Murphy J.W., Boggon T.J., Calderwood D.A.;
RT   "The structural basis of integrin-linked kinase-PINCH interactions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:20677-20682(2008).
RN   [24]
RP   STRUCTURE BY NMR OF 1-171 IN COMPLEX WITH LIMS1, AND DOMAIN ANK
RP   REPEATS.
RX   PubMed=19117955; DOI=10.1074/jbc.M805319200;
RA   Yang Y., Wang X., Hawkins C.A., Chen K., Vaynberg J., Mao X., Tu Y.,
RA   Zuo X., Wang J., Wang Y.-X., Wu C., Tjandra N., Qin J.;
RT   "Structural basis of focal adhesion localization of LIM-only adaptor
RT   PINCH by integrin-linked kinase.";
RL   J. Biol. Chem. 284:5836-5844(2009).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 183-452 IN COMPLEX WITH
RP   PARVA, AND INTERACTION WITH PARVA.
RX   PubMed=20005845; DOI=10.1016/j.molcel.2009.11.028;
RA   Fukuda K., Gupta S., Chen K., Wu C., Qin J.;
RT   "The pseudoactive site of ILK is essential for its binding to alpha-
RT   parvin and localization to focal adhesions.";
RL   Mol. Cell 36:819-830(2009).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 183-452 IN COMPLEX WITH
RP   PARVA, AND INTERACTION WITH PARVA.
RX   PubMed=20117114; DOI=10.1016/j.jmb.2010.01.048;
RA   Im Y.J., Kang G.B., Lee J.H., Park K.R., Song H.E., Kim E., Song W.K.,
RA   Park D., Eom S.H.;
RT   "Structural basis for asymmetric association of the betaPIX coiled
RT   coil and shank PDZ.";
RL   J. Mol. Biol. 397:457-466(2010).
RN   [27]
RP   VARIANT VAL-262.
RX   PubMed=17646580; DOI=10.1161/CIRCULATIONAHA.107.689984;
RA   Knoell R., Postel R., Wang J., Kraetzner R., Hennecke G., Vacaru A.M.,
RA   Vakeel P., Schubert C., Murthy K., Rana B.K., Kube D., Knoell G.,
RA   Schaefer K., Hayashi T., Holm T., Kimura A., Schork N., Toliat M.R.,
RA   Nuernberg P., Schultheiss H.P., Schaper W., Schaper J., Bos E.,
RA   Den Hertog J., van Eeden F.J., Peters P.J., Hasenfuss G., Chien K.R.,
RA   Bakkers J.;
RT   "Laminin-alpha4 and integrin-linked kinase mutations cause human
RT   cardiomyopathy via simultaneous defects in cardiomyocytes and
RT   endothelial cells.";
RL   Circulation 116:515-525(2007).
CC   -!- FUNCTION: Receptor-proximal protein kinase regulating integrin-
CC       mediated signal transduction (PubMed:8538749, PubMed:9736715). May
CC       act as a mediator of inside-out integrin signaling. Focal adhesion
CC       protein part of the complex ILK-PINCH. This complex is considered
CC       to be one of the convergence points of integrin- and growth
CC       factor-signaling pathway. Could be implicated in mediating cell
CC       architecture, adhesion to integrin substrates and anchorage-
CC       dependent growth in epithelial cells. Phosphorylates beta-1 and
CC       beta-3 integrin subunit on serine and threonine residues, but also
CC       AKT1 and GSK3B (PubMed:8538749, PubMed:9736715).
CC       {ECO:0000269|PubMed:8538749, ECO:0000269|PubMed:9736715,
CC       ECO:0000303|PubMed:10712922}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Stimulated rapidly but transiently by both cell
CC       fibronectin interactions, as well as by insulin, in a PI3-K-
CC       dependent manner, likely via the binding of PtdIns(3,4,5)P3 with a
CC       PH-like domain of ILK. The protein kinase activity is stimulated
CC       by LIMD2 (PubMed:24590809). {ECO:0000269|PubMed:24590809}.
CC   -!- SUBUNIT: Interacts with FERMT2 (By similarity). Interacts with the
CC       cytoplasmic domain of ITGB1. Could also interact with integrin
CC       ITGB2, ITGB3 and/or ITGB5. Interacts (via ANK repeats) with LIMS1
CC       and LIMS2. Interacts with PARVA and PARVB; these compete for the
CC       same binding site. Interacts probably also with TGFB1I1. Interacts
CC       (via ANK repeats) with EPHA1 (via SAM domain); stimulated by EFNA1
CC       but independent of the kinase activity of EPHA1. Interacts with
CC       LIMD2; leading to activate the protein kinase activity
CC       (PubMed:24590809). {ECO:0000250, ECO:0000269|PubMed:11402068,
CC       ECO:0000269|PubMed:12167643, ECO:0000269|PubMed:15284246,
CC       ECO:0000269|PubMed:19074270, ECO:0000269|PubMed:19117955,
CC       ECO:0000269|PubMed:19118217, ECO:0000269|PubMed:20005845,
CC       ECO:0000269|PubMed:20117114, ECO:0000269|PubMed:24590809}.
CC   -!- INTERACTION:
CC       Q14790:CASP8; NbExp=2; IntAct=EBI-747644, EBI-78060;
CC       P55211:CASP9; NbExp=2; IntAct=EBI-747644, EBI-516799;
CC       Q9NWT6:HIF1AN; NbExp=2; IntAct=EBI-747644, EBI-745632;
CC       Q9H0C8:ILKAP; NbExp=3; IntAct=EBI-747644, EBI-2620298;
CC       P48059:LIMS1; NbExp=10; IntAct=EBI-747644, EBI-306928;
CC       Q9NVD7:PARVA; NbExp=14; IntAct=EBI-747644, EBI-747655;
CC       Q9HBI0:PARVG; NbExp=9; IntAct=EBI-747644, EBI-3921217;
CC       Q6R327:RICTOR; NbExp=8; IntAct=EBI-747644, EBI-1387196;
CC       Q9BWU0:SLC4A1AP; NbExp=8; IntAct=EBI-747644, EBI-1999704;
CC       Q9UMS6:SYNPO2; NbExp=6; IntAct=EBI-747644, EBI-3453434;
CC       P14373:TRIM27; NbExp=3; IntAct=EBI-747644, EBI-719493;
CC   -!- SUBCELLULAR LOCATION: Cell junction, focal adhesion
CC       {ECO:0000269|PubMed:11402068, ECO:0000269|PubMed:12167643}. Cell
CC       membrane; Peripheral membrane protein; Cytoplasmic side
CC       {ECO:0000269|PubMed:11402068}. Cell projection, lamellipodium
CC       {ECO:0000250|UniProtKB:O55222}. Cytoplasm, myofibril, sarcomere
CC       {ECO:0000269|PubMed:11402068}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q13418-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13418-2; Sequence=VSP_054920;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q13418-3; Sequence=VSP_055925;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart followed by skeletal
CC       muscle, pancreas and kidney. Weakly expressed in placenta, lung
CC       and liver.
CC   -!- DOMAIN: A PH-like domain is involved in phosphatidylinositol
CC       phosphate binding. {ECO:0000269|PubMed:19074270,
CC       ECO:0000269|PubMed:19117955}.
CC   -!- PTM: Autophosphorylated on serine residues.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB94832.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact. Was originally thought to be distinct gene (ILK2) (PubMed:10871859).; Evidence={ECO:0000305|PubMed:10871859};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U40282; AAC16892.1; -; mRNA.
DR   EMBL; AJ277481; CAB94832.1; ALT_SEQ; mRNA.
DR   EMBL; AF244139; AAF74449.1; -; Genomic_DNA.
DR   EMBL; AJ404847; CAB99253.1; -; Genomic_DNA.
DR   EMBL; AK293474; BAH11516.1; -; mRNA.
DR   EMBL; AK296628; BAH12404.1; -; mRNA.
DR   EMBL; CR407673; CAG28601.1; -; mRNA.
DR   EMBL; CR749220; CAH18077.1; -; mRNA.
DR   EMBL; AC091564; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471064; EAW68688.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68689.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68690.1; -; Genomic_DNA.
DR   EMBL; BC001554; AAH01554.1; -; mRNA.
DR   CCDS; CCDS60712.1; -. [Q13418-2]
DR   CCDS; CCDS60713.1; -. [Q13418-3]
DR   CCDS; CCDS7768.1; -. [Q13418-1]
DR   PIR; S68455; S68455.
DR   RefSeq; NP_001014794.1; NM_001014794.2. [Q13418-1]
DR   RefSeq; NP_001014795.1; NM_001014795.2. [Q13418-1]
DR   RefSeq; NP_001265370.1; NM_001278441.1. [Q13418-2]
DR   RefSeq; NP_001265371.1; NM_001278442.1. [Q13418-3]
DR   RefSeq; NP_004508.1; NM_004517.3. [Q13418-1]
DR   RefSeq; XP_005252961.1; XM_005252904.4. [Q13418-1]
DR   RefSeq; XP_005252962.1; XM_005252905.2. [Q13418-3]
DR   RefSeq; XP_011518367.1; XM_011520065.1. [Q13418-1]
DR   UniGene; Hs.706355; -.
DR   PDB; 2KBX; NMR; -; A=1-171.
DR   PDB; 3F6Q; X-ray; 1.60 A; A=1-170.
DR   PDB; 3IXE; X-ray; 1.90 A; A=1-174.
DR   PDB; 3KMU; X-ray; 1.80 A; A=183-452.
DR   PDB; 3KMW; X-ray; 2.00 A; A=183-452.
DR   PDB; 3REP; X-ray; 1.80 A; A=183-452.
DR   PDB; 4HI8; X-ray; 1.20 A; A=1-174.
DR   PDB; 4HI9; X-ray; 1.20 A; A=1-174.
DR   PDBsum; 2KBX; -.
DR   PDBsum; 3F6Q; -.
DR   PDBsum; 3IXE; -.
DR   PDBsum; 3KMU; -.
DR   PDBsum; 3KMW; -.
DR   PDBsum; 3REP; -.
DR   PDBsum; 4HI8; -.
DR   PDBsum; 4HI9; -.
DR   ProteinModelPortal; Q13418; -.
DR   SMR; Q13418; -.
DR   BioGrid; 109824; 219.
DR   CORUM; Q13418; -.
DR   DIP; DIP-38657N; -.
DR   IntAct; Q13418; 179.
DR   MINT; Q13418; -.
DR   STRING; 9606.ENSP00000299421; -.
DR   BindingDB; Q13418; -.
DR   ChEMBL; CHEMBL5247; -.
DR   GuidetoPHARMACOLOGY; 2041; -.
DR   iPTMnet; Q13418; -.
DR   PhosphoSitePlus; Q13418; -.
DR   SwissPalm; Q13418; -.
DR   DMDM; 9973397; -.
DR   OGP; Q13418; -.
DR   EPD; Q13418; -.
DR   PaxDb; Q13418; -.
DR   PeptideAtlas; Q13418; -.
DR   PRIDE; Q13418; -.
DR   DNASU; 3611; -.
DR   Ensembl; ENST00000299421; ENSP00000299421; ENSG00000166333. [Q13418-1]
DR   Ensembl; ENST00000396751; ENSP00000379975; ENSG00000166333. [Q13418-1]
DR   Ensembl; ENST00000420936; ENSP00000403487; ENSG00000166333. [Q13418-1]
DR   Ensembl; ENST00000528995; ENSP00000435323; ENSG00000166333. [Q13418-2]
DR   Ensembl; ENST00000532063; ENSP00000434492; ENSG00000166333. [Q13418-3]
DR   GeneID; 3611; -.
DR   KEGG; hsa:3611; -.
DR   UCSC; uc010rap.3; human. [Q13418-1]
DR   CTD; 3611; -.
DR   DisGeNET; 3611; -.
DR   EuPathDB; HostDB:ENSG00000166333.13; -.
DR   GeneCards; ILK; -.
DR   HGNC; HGNC:6040; ILK.
DR   HPA; CAB004041; -.
DR   HPA; HPA048437; -.
DR   MIM; 602366; gene.
DR   neXtProt; NX_Q13418; -.
DR   OpenTargets; ENSG00000166333; -.
DR   PharmGKB; PA29855; -.
DR   eggNOG; KOG0195; Eukaryota.
DR   eggNOG; COG0666; LUCA.
DR   GeneTree; ENSGT00910000144123; -.
DR   HOGENOM; HOG000047828; -.
DR   HOVERGEN; HBG002437; -.
DR   InParanoid; Q13418; -.
DR   KO; K06272; -.
DR   PhylomeDB; Q13418; -.
DR   TreeFam; TF315194; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-446343; Localization of the PINCH-ILK-PARVIN complex to focal adhesions.
DR   Reactome; R-HSA-446353; Cell-extracellular matrix interactions.
DR   SignaLink; Q13418; -.
DR   SIGNOR; Q13418; -.
DR   ChiTaRS; ILK; human.
DR   EvolutionaryTrace; Q13418; -.
DR   GeneWiki; Integrin-linked_kinase; -.
DR   GenomeRNAi; 3611; -.
DR   PRO; PR:Q13418; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000166333; -.
DR   CleanEx; HS_ILK; -.
DR   ExpressionAtlas; Q13418; baseline and differential.
DR   Genevisible; Q13418; HS.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0043034; C:costamere; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043198; C:dendritic shaft; IEA:Ensembl.
DR   GO; GO:0005925; C:focal adhesion; IDA:HPA.
DR   GO; GO:0030027; C:lamellipodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032991; C:protein-containing complex; IEA:Ensembl.
DR   GO; GO:0030017; C:sarcomere; IEA:UniProtKB-SubCell.
DR   GO; GO:0001725; C:stress fiber; IEA:Ensembl.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:Ensembl.
DR   GO; GO:0004871; F:signal transducer activity; IBA:GO_Central.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl.
DR   GO; GO:0007569; P:cell aging; IEA:Ensembl.
DR   GO; GO:0007050; P:cell cycle arrest; IEA:Ensembl.
DR   GO; GO:0034329; P:cell junction assembly; TAS:Reactome.
DR   GO; GO:0008283; P:cell proliferation; NAS:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; TAS:ProtInc.
DR   GO; GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IEA:Ensembl.
DR   GO; GO:0010761; P:fibroblast migration; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IDA:MGI.
DR   GO; GO:0000165; P:MAPK cascade; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IBA:GO_Central.
DR   GO; GO:0032288; P:myelin assembly; IEA:Ensembl.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; IEA:Ensembl.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IEA:Ensembl.
DR   GO; GO:2000178; P:negative regulation of neural precursor cell proliferation; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl.
DR   GO; GO:0014912; P:negative regulation of smooth muscle cell migration; IEA:Ensembl.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0021675; P:nerve development; IEA:Ensembl.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl.
DR   GO; GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:0070527; P:platelet aggregation; HMP:UniProtKB.
DR   GO; GO:0045773; P:positive regulation of axon extension; IEA:Ensembl.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0001954; P:positive regulation of cell-matrix adhesion; IEA:Ensembl.
DR   GO; GO:0050775; P:positive regulation of dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0043406; P:positive regulation of MAP kinase activity; IEA:Ensembl.
DR   GO; GO:0045663; P:positive regulation of myoblast differentiation; IEA:Ensembl.
DR   GO; GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; IMP:CAFA.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; IMP:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:0009967; P:positive regulation of signal transduction; IMP:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0043491; P:protein kinase B signaling; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; IEA:Ensembl.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IMP:UniProtKB.
DR   GO; GO:0097435; P:supramolecular fiber organization; IEA:Ensembl.
DR   GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IMP:CAFA.
DR   CDD; cd00204; ANK; 1.
DR   CDD; cd14057; PK_ILK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR035692; PK_ILK.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ANK repeat;
KW   ATP-binding; Cell junction; Cell membrane; Cell projection;
KW   Complete proteome; Cytoplasm; Kinase; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    452       Integrin-linked protein kinase.
FT                                /FTId=PRO_0000086020.
FT   REPEAT        2     30       ANK 1.
FT   REPEAT       31     63       ANK 2.
FT   REPEAT       64     96       ANK 3.
FT   REPEAT       97    129       ANK 4.
FT   REPEAT      130    174       ANK 5.
FT   DOMAIN      193    446       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     199    207       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION       33    139       Interaction with LIMS1.
FT                                {ECO:0000269|PubMed:12167643}.
FT   REGION      180    212       PH-like; mediates interaction with
FT                                TGFB1I1.
FT   BINDING     220    220       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES     186    186       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     426    426       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:O55222}.
FT   VAR_SEQ       1    134       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055925.
FT   VAR_SEQ     118    206       DLVANGALVSICNKYGEMPVDKAKAPLRELLRERAEKMGQN
FT                                LNRIPYKDTFWKGTTRTRPRNGTLNKHSGIDFKQLNFLTKL
FT                                NENHSGE -> SGQRRWARISTVFHTRTHSGRGPPALGP
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054920.
FT   VARIANT     262    262       A -> V (found in a patient with severe
FT                                dilated cardiomyopathy; unknown
FT                                pathological significance;
FT                                dbSNP:rs387907366).
FT                                {ECO:0000269|PubMed:17646580}.
FT                                /FTId=VAR_069753.
FT   MUTAGEN      99     99       H->D: Alters interaction with LIMS1.
FT                                {ECO:0000269|PubMed:19074270}.
FT   MUTAGEN     359    359       E->K: Inactivation of ILK.
FT                                {ECO:0000269|PubMed:9736715}.
FT   HELIX         4     10       {ECO:0000244|PDB:4HI8}.
FT   HELIX        13     21       {ECO:0000244|PDB:4HI8}.
FT   HELIX        37     43       {ECO:0000244|PDB:4HI8}.
FT   HELIX        47     55       {ECO:0000244|PDB:4HI8}.
FT   HELIX        70     76       {ECO:0000244|PDB:4HI8}.
FT   HELIX        80     88       {ECO:0000244|PDB:4HI8}.
FT   HELIX        92     94       {ECO:0000244|PDB:2KBX}.
FT   HELIX       103    109       {ECO:0000244|PDB:4HI8}.
FT   HELIX       113    121       {ECO:0000244|PDB:4HI8}.
FT   STRAND      126    128       {ECO:0000244|PDB:4HI8}.
FT   STRAND      131    133       {ECO:0000244|PDB:2KBX}.
FT   HELIX       136    139       {ECO:0000244|PDB:4HI8}.
FT   HELIX       142    154       {ECO:0000244|PDB:4HI8}.
FT   TURN        167    169       {ECO:0000244|PDB:4HI9}.
FT   HELIX       190    192       {ECO:0000244|PDB:3KMU}.
FT   STRAND      194    202       {ECO:0000244|PDB:3KMU}.
FT   STRAND      205    212       {ECO:0000244|PDB:3KMU}.
FT   STRAND      215    222       {ECO:0000244|PDB:3KMU}.
FT   HELIX       229    238       {ECO:0000244|PDB:3KMU}.
FT   HELIX       239    242       {ECO:0000244|PDB:3KMU}.
FT   STRAND      255    257       {ECO:0000244|PDB:3KMU}.
FT   TURN        259    261       {ECO:0000244|PDB:3KMU}.
FT   STRAND      262    264       {ECO:0000244|PDB:3KMU}.
FT   STRAND      266    270       {ECO:0000244|PDB:3KMU}.
FT   HELIX       277    282       {ECO:0000244|PDB:3KMU}.
FT   HELIX       291    308       {ECO:0000244|PDB:3KMU}.
FT   STRAND      311    313       {ECO:0000244|PDB:3KMU}.
FT   STRAND      324    327       {ECO:0000244|PDB:3KMU}.
FT   STRAND      333    336       {ECO:0000244|PDB:3KMU}.
FT   HELIX       337    339       {ECO:0000244|PDB:3KMU}.
FT   HELIX       353    355       {ECO:0000244|PDB:3KMU}.
FT   HELIX       358    362       {ECO:0000244|PDB:3KMU}.
FT   HELIX       365    367       {ECO:0000244|PDB:3KMU}.
FT   HELIX       370    387       {ECO:0000244|PDB:3KMU}.
FT   TURN        391    394       {ECO:0000244|PDB:3KMU}.
FT   HELIX       397    406       {ECO:0000244|PDB:3KMU}.
FT   HELIX       419    428       {ECO:0000244|PDB:3KMU}.
FT   HELIX       433    435       {ECO:0000244|PDB:3KMU}.
FT   HELIX       439    449       {ECO:0000244|PDB:3KMU}.
SQ   SEQUENCE   452 AA;  51419 MW;  E37DC2AD5311A1C2 CRC64;
     MDDIFTQCRE GNAVAVRLWL DNTENDLNQG DDHGFSPLHW ACREGRSAVV EMLIMRGARI
     NVMNRGDDTP LHLAASHGHR DIVQKLLQYK ADINAVNEHG NVPLHYACFW GQDQVAEDLV
     ANGALVSICN KYGEMPVDKA KAPLRELLRE RAEKMGQNLN RIPYKDTFWK GTTRTRPRNG
     TLNKHSGIDF KQLNFLTKLN ENHSGELWKG RWQGNDIVVK VLKVRDWSTR KSRDFNEECP
     RLRIFSHPNV LPVLGACQSP PAPHPTLITH WMPYGSLYNV LHEGTNFVVD QSQAVKFALD
     MARGMAFLHT LEPLIPRHAL NSRSVMIDED MTARISMADV KFSFQCPGRM YAPAWVAPEA
     LQKKPEDTNR RSADMWSFAV LLWELVTREV PFADLSNMEI GMKVALEGLR PTIPPGISPH
     VCKLMKICMN EDPAKRPKFD MIVPILEKMQ DK
//
ID   V9HWF0_HUMAN            Unreviewed;       452 AA.
AC   V9HWF0;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   23-MAY-2018, entry version 41.
DE   SubName: Full=Epididymis secretory protein Li 28 {ECO:0000313|EMBL:ACJ13679.1};
GN   Name=HEL-S-28 {ECO:0000313|EMBL:ACJ13679.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACJ13679.1};
RN   [1] {ECO:0000313|EMBL:ACJ13679.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu F.J., Liu J.;
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU794625; ACJ13679.1; -; mRNA.
DR   RefSeq; NP_001014794.1; NM_001014794.2.
DR   RefSeq; NP_001014795.1; NM_001014795.2.
DR   RefSeq; NP_004508.1; NM_004517.3.
DR   RefSeq; XP_005252961.1; XM_005252904.4.
DR   RefSeq; XP_011518367.1; XM_011520065.1.
DR   UniGene; Hs.706355; -.
DR   ProteinModelPortal; V9HWF0; -.
DR   SMR; V9HWF0; -.
DR   MaxQB; V9HWF0; -.
DR   PRIDE; V9HWF0; -.
DR   GeneID; 3611; -.
DR   KEGG; hsa:3611; -.
DR   UCSC; uc001mee.5; human.
DR   CTD; 3611; -.
DR   EuPathDB; HostDB:ENSG00000166333.13; -.
DR   eggNOG; KOG0195; Eukaryota.
DR   eggNOG; COG0666; LUCA.
DR   KO; K06272; -.
DR   PhylomeDB; V9HWF0; -.
DR   ChiTaRS; ILK; human.
DR   GenomeRNAi; 3611; -.
DR   Bgee; ENSG00000166333; -.
DR   ExpressionAtlas; V9HWF0; baseline and differential.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0043034; C:costamere; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043198; C:dendritic shaft; IEA:Ensembl.
DR   GO; GO:0005925; C:focal adhesion; IDA:HPA.
DR   GO; GO:0030027; C:lamellipodium; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0032991; C:protein-containing complex; IEA:Ensembl.
DR   GO; GO:0001725; C:stress fiber; IEA:Ensembl.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:Ensembl.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:Ensembl.
DR   GO; GO:0004871; F:signal transducer activity; IEA:Ensembl.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl.
DR   GO; GO:0007569; P:cell aging; IEA:Ensembl.
DR   GO; GO:0007050; P:cell cycle arrest; IEA:Ensembl.
DR   GO; GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IEA:Ensembl.
DR   GO; GO:0010761; P:fibroblast migration; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0032288; P:myelin assembly; IEA:Ensembl.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; IEA:Ensembl.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IEA:Ensembl.
DR   GO; GO:2000178; P:negative regulation of neural precursor cell proliferation; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl.
DR   GO; GO:0014912; P:negative regulation of smooth muscle cell migration; IEA:Ensembl.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0021675; P:nerve development; IEA:Ensembl.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl.
DR   GO; GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:0045773; P:positive regulation of axon extension; IEA:Ensembl.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:0030335; P:positive regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0001954; P:positive regulation of cell-matrix adhesion; IEA:Ensembl.
DR   GO; GO:0050775; P:positive regulation of dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0043406; P:positive regulation of MAP kinase activity; IEA:Ensembl.
DR   GO; GO:0045663; P:positive regulation of myoblast differentiation; IEA:Ensembl.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0043491; P:protein kinase B signaling; IEA:Ensembl.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; IEA:Ensembl.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IEA:Ensembl.
DR   GO; GO:0097435; P:supramolecular fiber organization; IEA:Ensembl.
DR   CDD; cd00204; ANK; 1.
DR   CDD; cd14057; PK_ILK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR035692; PK_ILK.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   2: Evidence at transcript level;
KW   ANK repeat {ECO:0000256|PROSITE-ProRule:PRU00023}.
FT   DOMAIN       26    140       ANK_REP_REGION.
FT                                {ECO:0000259|PROSITE:PS50297}.
FT   REPEAT       33     65       ANK. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00023}.
FT   REPEAT       66     98       ANK. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00023}.
FT   REPEAT       99    131       ANK. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00023}.
FT   DOMAIN      193    446       Protein kinase.
FT                                {ECO:0000259|PROSITE:PS50011}.
SQ   SEQUENCE   452 AA;  51419 MW;  E37DC2AD5311A1C2 CRC64;
     MDDIFTQCRE GNAVAVRLWL DNTENDLNQG DDHGFSPLHW ACREGRSAVV EMLIMRGARI
     NVMNRGDDTP LHLAASHGHR DIVQKLLQYK ADINAVNEHG NVPLHYACFW GQDQVAEDLV
     ANGALVSICN KYGEMPVDKA KAPLRELLRE RAEKMGQNLN RIPYKDTFWK GTTRTRPRNG
     TLNKHSGIDF KQLNFLTKLN ENHSGELWKG RWQGNDIVVK VLKVRDWSTR KSRDFNEECP
     RLRIFSHPNV LPVLGACQSP PAPHPTLITH WMPYGSLYNV LHEGTNFVVD QSQAVKFALD
     MARGMAFLHT LEPLIPRHAL NSRSVMIDED MTARISMADV KFSFQCPGRM YAPAWVAPEA
     LQKKPEDTNR RSADMWSFAV LLWELVTREV PFADLSNMEI GMKVALEGLR PTIPPGISPH
     VCKLMKICMN EDPAKRPKFD MIVPILEKMQ DK
//
ID   SDF2L_HUMAN             Reviewed;         221 AA.
AC   Q9HCN8; A2RUD3; Q9BRI5;
DT   20-JUN-2002, integrated into UniProtKB/Swiss-Prot.
DT   13-APR-2004, sequence version 2.
DT   23-MAY-2018, entry version 146.
DE   RecName: Full=Stromal cell-derived factor 2-like protein 1;
DE            Short=SDF2-like protein 1;
DE   AltName: Full=PWP1-interacting protein 8;
DE   Flags: Precursor;
GN   Name=SDF2L1; ORFNames=UNQ1941/PRO4424;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=11162531; DOI=10.1006/bbrc.2000.4111;
RA   Fukuda S., Sumii M., Masuda Y., Takahashi M., Koike N., Teishima J.,
RA   Yasumoto H., Itamoto T., Asahara T., Dohi K., Kamiya K.;
RT   "Murine and human SDF2L1 is an endoplasmic reticulum stress-inducible
RT   gene and encodes a new member of the Pmt/rt protein family.";
RL   Biochem. Biophys. Res. Commun. 280:407-414(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Uterus;
RA   Honore B.;
RT   "hPWP1-interacting protein 8.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-215, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000255|PROSITE-ProRule:PRU10138}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed with high expression in
CC       testis, moderate expression in the pancreas, spleen, prostate,
CC       small intestine and colon. Very low expression is seen in brain
CC       and skeletal muscle. {ECO:0000269|PubMed:11162531}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB043007; BAB18277.1; -; mRNA.
DR   EMBL; AF277316; AAK69113.1; -; mRNA.
DR   EMBL; AY359118; AAQ89476.1; -; mRNA.
DR   EMBL; CR456570; CAG30456.1; -; mRNA.
DR   EMBL; BC006248; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; CH471095; EAW59467.1; -; Genomic_DNA.
DR   EMBL; BC132849; AAI32850.1; -; mRNA.
DR   EMBL; BC132851; AAI32852.1; -; mRNA.
DR   CCDS; CCDS13792.1; -.
DR   PIR; JC7587; JC7587.
DR   RefSeq; NP_071327.2; NM_022044.2.
DR   UniGene; Hs.303116; -.
DR   ProteinModelPortal; Q9HCN8; -.
DR   SMR; Q9HCN8; -.
DR   BioGrid; 117254; 42.
DR   IntAct; Q9HCN8; 18.
DR   MINT; Q9HCN8; -.
DR   STRING; 9606.ENSP00000248958; -.
DR   iPTMnet; Q9HCN8; -.
DR   PhosphoSitePlus; Q9HCN8; -.
DR   SwissPalm; Q9HCN8; -.
DR   BioMuta; SDF2L1; -.
DR   DMDM; 46397883; -.
DR   EPD; Q9HCN8; -.
DR   MaxQB; Q9HCN8; -.
DR   PaxDb; Q9HCN8; -.
DR   PeptideAtlas; Q9HCN8; -.
DR   PRIDE; Q9HCN8; -.
DR   TopDownProteomics; Q9HCN8; -.
DR   DNASU; 23753; -.
DR   Ensembl; ENST00000248958; ENSP00000248958; ENSG00000128228.
DR   GeneID; 23753; -.
DR   KEGG; hsa:23753; -.
DR   UCSC; uc002zvf.4; human.
DR   CTD; 23753; -.
DR   DisGeNET; 23753; -.
DR   EuPathDB; HostDB:ENSG00000128228.4; -.
DR   GeneCards; SDF2L1; -.
DR   HGNC; HGNC:10676; SDF2L1.
DR   HPA; HPA005638; -.
DR   MIM; 607551; gene.
DR   neXtProt; NX_Q9HCN8; -.
DR   OpenTargets; ENSG00000128228; -.
DR   PharmGKB; PA35604; -.
DR   eggNOG; KOG3358; Eukaryota.
DR   eggNOG; ENOG410ZBU3; LUCA.
DR   GeneTree; ENSGT00510000046663; -.
DR   HOGENOM; HOG000236354; -.
DR   HOVERGEN; HBG024385; -.
DR   InParanoid; Q9HCN8; -.
DR   OMA; RFQHVGT; -.
DR   OrthoDB; EOG091G0MFB; -.
DR   PhylomeDB; Q9HCN8; -.
DR   TreeFam; TF314557; -.
DR   SIGNOR; Q9HCN8; -.
DR   ChiTaRS; SDF2L1; human.
DR   GenomeRNAi; 23753; -.
DR   PRO; PR:Q9HCN8; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000128228; -.
DR   CleanEx; HS_SDF2L1; -.
DR   Genevisible; Q9HCN8; HS.
DR   GO; GO:0034663; C:endoplasmic reticulum chaperone complex; IEA:Ensembl.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0051117; F:ATPase binding; IEA:Ensembl.
DR   GO; GO:0051087; F:chaperone binding; IEA:Ensembl.
DR   GO; GO:0004169; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; IBA:GO_Central.
DR   GO; GO:0051787; F:misfolded protein binding; IEA:Ensembl.
DR   GO; GO:0071712; P:ER-associated misfolded protein catabolic process; IBA:GO_Central.
DR   GO; GO:0042981; P:regulation of apoptotic process; IEA:Ensembl.
DR   InterPro; IPR027005; GlyclTrfase_39-like.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   PANTHER; PTHR10050; PTHR10050; 1.
DR   Pfam; PF02815; MIR; 1.
DR   SMART; SM00472; MIR; 3.
DR   SUPFAM; SSF82109; SSF82109; 1.
DR   PROSITE; PS00014; ER_TARGET; 1.
DR   PROSITE; PS50919; MIR; 3.
PE   1: Evidence at protein level;
KW   Complete proteome; Endoplasmic reticulum; Phosphoprotein;
KW   Reference proteome; Repeat; Signal.
FT   SIGNAL        1     28       {ECO:0000255}.
FT   CHAIN        29    221       Stromal cell-derived factor 2-like
FT                                protein 1.
FT                                /FTId=PRO_0000031957.
FT   DOMAIN       33     87       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN       95    150       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      151    205       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   MOTIF       218    221       Prevents secretion from ER.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10138}.
FT   MOD_RES     215    215       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CONFLICT     94     94       R -> C (in Ref. 1; BAB18277).
FT                                {ECO:0000305}.
FT   CONFLICT    162    162       F -> L (in Ref. 1; BAB18277).
FT                                {ECO:0000305}.
SQ   SEQUENCE   221 AA;  23598 MW;  D6F15E1EB48428EE CRC64;
     MWSAGRGGAA WPVLLGLLLA LLVPGGGAAK TGAELVTCGS VLKLLNTHHR VRLHSHDIKY
     GSGSGQQSVT GVEASDDANS YWRIRGGSEG GCPRGSPVRC GQAVRLTHVL TGKNLHTHHF
     PSPLSNNQEV SAFGEDGEGD DLDLWTVRCS GQHWEREAAV RFQHVGTSVF LSVTGEQYGS
     PIRGQHEVHG MPSANTHNTW KAMEGIFIKP SVEPSAGHDE L
//
ID   ROCK2_HUMAN             Reviewed;        1388 AA.
AC   O75116; Q53QZ0; Q53SJ7; Q9UQN5;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   24-NOV-2009, sequence version 4.
DT   23-MAY-2018, entry version 186.
DE   RecName: Full=Rho-associated protein kinase 2;
DE            EC=2.7.11.1;
DE   AltName: Full=Rho kinase 2;
DE   AltName: Full=Rho-associated, coiled-coil-containing protein kinase 2;
DE   AltName: Full=Rho-associated, coiled-coil-containing protein kinase II;
DE            Short=ROCK-II;
DE   AltName: Full=p164 ROCK-2;
GN   Name=ROCK2; Synonyms=KIAA0619;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASN-431.
RC   TISSUE=Brain;
RX   PubMed=9933571; DOI=10.1006/geno.1998.5344;
RA   Takahashi N., Tuiki H., Saya H., Kaibuchi K.;
RT   "Localization of the gene coding for ROCK II/Rho kinase on human
RT   chromosome 2p24.";
RL   Genomics 55:235-237(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASN-431.
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   FUNCTION, AND INTERACTION WITH PPP1R12A.
RX   PubMed=10579722; DOI=10.1083/jcb.147.5.1023;
RA   Kawano Y., Fukata Y., Oshiro N., Amano M., Nakamura T., Ito M.,
RA   Matsumura F., Inagaki M., Kaibuchi K.;
RT   "Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase
RT   by Rho-kinase in vivo.";
RL   J. Cell Biol. 147:1023-1038(1999).
RN   [5]
RP   CLEAVAGE BY GRANZYME B, MUTAGENESIS OF ASP-1131, AND FUNCTION.
RX   PubMed=15699075; DOI=10.1084/jem.20031877;
RA   Sebbagh M., Hamelin J., Bertoglio J., Solary E., Breard J.;
RT   "Direct cleavage of ROCK II by granzyme B induces target cell membrane
RT   blebbing in a caspase-independent manner.";
RL   J. Exp. Med. 201:465-471(2005).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH EP300.
RX   PubMed=16574662; DOI=10.1074/jbc.M510954200;
RA   Tanaka T., Nishimura D., Wu R.C., Amano M., Iso T., Kedes L.,
RA   Nishida H., Kaibuchi K., Hamamori Y.;
RT   "Nuclear Rho kinase, ROCK2, targets p300 acetyltransferase.";
RL   J. Biol. Chem. 281:15320-15329(2006).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH NPM1.
RX   PubMed=17015463; DOI=10.1128/MCB.01383-06;
RA   Ma Z., Kanai M., Kawamura K., Kaibuchi K., Ye K., Fukasawa K.;
RT   "Interaction between ROCK II and nucleophosmin/B23 in the regulation
RT   of centrosome duplication.";
RL   Mol. Cell. Biol. 26:9016-9034(2006).
RN   [8]
RP   PHOSPHORYLATION AT TYR-722, AND DEPHOSPHORYLATION.
RX   PubMed=18559669; DOI=10.1083/jcb.200710187;
RA   Lee H.H., Chang Z.F.;
RT   "Regulation of RhoA-dependent ROCKII activation by Shp2.";
RL   J. Cell Biol. 181:999-1012(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1137, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1137, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH PPP1R12A.
RX   PubMed=19131646; DOI=10.1161/CIRCRESAHA.108.188524;
RA   Wang Y., Zheng X.R., Riddick N., Bryden M., Baur W., Zhang X.,
RA   Surks H.K.;
RT   "ROCK isoform regulation of myosin phosphatase and contractility in
RT   vascular smooth muscle cells.";
RL   Circ. Res. 104:531-540(2009).
RN   [12]
RP   FUNCTION.
RX   PubMed=19997641; DOI=10.1371/journal.pone.0008190;
RA   Lock F.E., Hotchin N.A.;
RT   "Distinct roles for ROCK1 and ROCK2 in the regulation of keratinocyte
RT   differentiation.";
RL   PLoS ONE 4:E8190-E8190(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1137, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   INTERACTION WITH CHORDC1.
RX   PubMed=20230755; DOI=10.1016/j.devcel.2009.12.020;
RA   Ferretti R., Palumbo V., Di Savino A., Velasco S., Sbroggio M.,
RA   Sportoletti P., Micale L., Turco E., Silengo L., Palumbo G.,
RA   Hirsch E., Teruya-Feldstein J., Bonaccorsi S., Pandolfi P.P.,
RA   Gatti M., Tarone G., Brancaccio M.;
RT   "Morgana/chp-1, a ROCK inhibitor involved in centrosome duplication
RT   and tumorigenesis.";
RL   Dev. Cell 18:486-495(2010).
RN   [15]
RP   PHOSPHORYLATION AT TYR-722.
RX   PubMed=20826462; DOI=10.1242/jcs.071555;
RA   Lee H.H., Tien S.C., Jou T.S., Chang Y.C., Jhong J.G., Chang Z.F.;
RT   "Src-dependent phosphorylation of ROCK participates in regulation of
RT   focal adhesion dynamics.";
RL   J. Cell Sci. 123:3368-3377(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1137, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   FUNCTION, AND INTERACTION WITH BRCA2.
RX   PubMed=21084279; DOI=10.1158/0008-5472.CAN-10-0030;
RA   Wang H.F., Takenaka K., Nakanishi A., Miki Y.;
RT   "BRCA2 and nucleophosmin coregulate centrosome amplification and form
RT   a complex with the Rho effector kinase ROCK2.";
RL   Cancer Res. 71:68-77(2011).
RN   [19]
RP   FUNCTION, AND INTERACTION WITH SORL1.
RX   PubMed=21147781; DOI=10.1074/jbc.M110.167239;
RA   Herskowitz J.H., Seyfried N.T., Gearing M., Kahn R.A., Peng J.,
RA   Levey A.I., Lah J.J.;
RT   "Rho kinase II phosphorylation of the lipoprotein receptor LR11/SORLA
RT   alters amyloid-beta production.";
RL   J. Biol. Chem. 286:6117-6127(2011).
RN   [20]
RP   REVIEW.
RX   PubMed=12778124; DOI=10.1038/nrm1128;
RA   Riento K., Ridley A.J.;
RT   "Rocks: multifunctional kinases in cell behaviour.";
RL   Nat. Rev. Mol. Cell Biol. 4:446-456(2003).
RN   [21]
RP   REVIEW.
RX   PubMed=20803696; DOI=10.1002/cm.20472;
RA   Amano M., Nakayama M., Kaibuchi K.;
RT   "Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell
RT   polarity.";
RL   Cytoskeleton 67:545-554(2010).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1137, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1212; SER-1362 AND
RP   SER-1374, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [26]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASN-431; VAL-601 AND PRO-1194.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Protein kinase which is a key regulator of actin
CC       cytoskeleton and cell polarity. Involved in regulation of smooth
CC       muscle contraction, actin cytoskeleton organization, stress fiber
CC       and focal adhesion formation, neurite retraction, cell adhesion
CC       and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR,
CC       DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM.
CC       Phosphorylates SORL1 and IRF4. Acts as a negative regulator of
CC       VEGF-induced angiogenic endothelial cell activation. Positively
CC       regulates the activation of p42/MAPK1-p44/MAPK3 and of
CC       p90RSK/RPS6KA1 during myogenic differentiation. Plays an important
CC       role in the timely initiation of centrosome duplication. Inhibits
CC       keratinocyte terminal differentiation. May regulate closure of the
CC       eyelids and ventral body wall through organization of actomyosin
CC       bundles. Plays a critical role in the regulation of spine and
CC       synaptic properties in the hippocampus. Plays an important role in
CC       generating the circadian rhythm of the aortic myofilament Ca(2+)
CC       sensitivity and vascular contractility by modulating the myosin
CC       light chain phosphorylation. {ECO:0000269|PubMed:10579722,
CC       ECO:0000269|PubMed:15699075, ECO:0000269|PubMed:16574662,
CC       ECO:0000269|PubMed:17015463, ECO:0000269|PubMed:19131646,
CC       ECO:0000269|PubMed:19997641, ECO:0000269|PubMed:21084279,
CC       ECO:0000269|PubMed:21147781}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ENZYME REGULATION: Activated by RHOA binding. Inhibited by Y-27632
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. Interacts with IRS1, RHOB and RHOC (By
CC       similarity). Interacts with RHOA (activated by GTP), PPP1R12A,
CC       CHORDC1, SORL1, EP300 and BRCA2. Interacts with NPM1 and this
CC       interaction enhances its activity. Interacts with RAF1 (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cell membrane {ECO:0000250};
CC       Peripheral membrane protein {ECO:0000250}. Nucleus. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome.
CC       Note=Cytoplasmic, and associated with actin microfilaments and the
CC       plasma membrane. {ECO:0000250}.
CC   -!- DOMAIN: An interaction between Thr-414 and Asp-48 is essential for
CC       kinase activity and dimerization. {ECO:0000250}.
CC   -!- PTM: Phosphorylation at Tyr-722 reduces its binding to RHOA and is
CC       crucial for focal adhesion dynamics. Dephosphorylation by PTPN11
CC       stimulates its RHOA binding activity.
CC       {ECO:0000269|PubMed:18559669, ECO:0000269|PubMed:20826462}.
CC   -!- PTM: Cleaved by granzyme B during apoptosis. This leads to
CC       constitutive activation of the kinase and membrane blebbing.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAX93049.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=BAA31594.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ROCK2ID43474ch2p25.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D87931; BAA75636.1; -; mRNA.
DR   EMBL; AB014519; BAA31594.2; ALT_INIT; mRNA.
DR   EMBL; AC018463; AAX93049.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC099344; AAY14825.1; -; Genomic_DNA.
DR   CCDS; CCDS42654.1; -.
DR   RefSeq; NP_001308572.1; NM_001321643.1.
DR   RefSeq; NP_004841.2; NM_004850.4.
DR   UniGene; Hs.681743; -.
DR   PDB; 4L6Q; X-ray; 2.79 A; A/B=19-417.
DR   PDB; 4WOT; X-ray; 2.93 A; A/B/C/D=22-417.
DR   PDB; 5U7Q; X-ray; 3.15 A; A/B/C/D=23-417.
DR   PDB; 5U7R; X-ray; 3.33 A; A/B/C/D=23-417.
DR   PDBsum; 4L6Q; -.
DR   PDBsum; 4WOT; -.
DR   PDBsum; 5U7Q; -.
DR   PDBsum; 5U7R; -.
DR   ProteinModelPortal; O75116; -.
DR   SMR; O75116; -.
DR   BioGrid; 114860; 28.
DR   CORUM; O75116; -.
DR   IntAct; O75116; 12.
DR   MINT; O75116; -.
DR   STRING; 9606.ENSP00000317985; -.
DR   BindingDB; O75116; -.
DR   ChEMBL; CHEMBL2973; -.
DR   DrugBank; DB08756; (R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE.
DR   GuidetoPHARMACOLOGY; 1504; -.
DR   iPTMnet; O75116; -.
DR   PhosphoSitePlus; O75116; -.
DR   SwissPalm; O75116; -.
DR   BioMuta; ROCK2; -.
DR   EPD; O75116; -.
DR   MaxQB; O75116; -.
DR   PaxDb; O75116; -.
DR   PeptideAtlas; O75116; -.
DR   PRIDE; O75116; -.
DR   Ensembl; ENST00000315872; ENSP00000317985; ENSG00000134318.
DR   GeneID; 9475; -.
DR   KEGG; hsa:9475; -.
DR   UCSC; uc002rbd.2; human.
DR   CTD; 9475; -.
DR   DisGeNET; 9475; -.
DR   EuPathDB; HostDB:ENSG00000134318.13; -.
DR   GeneCards; ROCK2; -.
DR   H-InvDB; HIX0001828; -.
DR   HGNC; HGNC:10252; ROCK2.
DR   HPA; CAB008666; -.
DR   HPA; HPA007459; -.
DR   HPA; HPA044109; -.
DR   MIM; 604002; gene.
DR   neXtProt; NX_O75116; -.
DR   OpenTargets; ENSG00000134318; -.
DR   PharmGKB; PA34624; -.
DR   eggNOG; KOG0612; Eukaryota.
DR   eggNOG; ENOG410XR1Q; LUCA.
DR   GeneTree; ENSGT00760000118994; -.
DR   HOGENOM; HOG000017259; -.
DR   HOVERGEN; HBG053111; -.
DR   InParanoid; O75116; -.
DR   KO; K17388; -.
DR   OMA; PNQSIRR; -.
DR   OrthoDB; EOG091G0BOR; -.
DR   PhylomeDB; O75116; -.
DR   TreeFam; TF313551; -.
DR   Reactome; R-HSA-3928662; EPHB-mediated forward signaling.
DR   Reactome; R-HSA-3928663; EPHA-mediated growth cone collapse.
DR   Reactome; R-HSA-416482; G alpha (12/13) signalling events.
DR   Reactome; R-HSA-416572; Sema4D induced cell migration and growth-cone collapse.
DR   Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-HSA-5627117; RHO GTPases Activate ROCKs.
DR   SignaLink; O75116; -.
DR   SIGNOR; O75116; -.
DR   ChiTaRS; ROCK2; human.
DR   GenomeRNAi; 9475; -.
DR   PRO; PR:O75116; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000134318; -.
DR   CleanEx; HS_ROCK2; -.
DR   ExpressionAtlas; O75116; baseline and differential.
DR   Genevisible; O75116; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0017048; F:Rho GTPase binding; IEA:InterPro.
DR   GO; GO:0072518; F:Rho-dependent protein serine/threonine kinase activity; IMP:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0005198; F:structural molecule activity; NAS:ProtInc.
DR   GO; GO:0071394; P:cellular response to testosterone stimulus; IMP:UniProtKB.
DR   GO; GO:0051298; P:centrosome duplication; IMP:UniProtKB.
DR   GO; GO:0030866; P:cortical actin cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IMP:UniProtKB.
DR   GO; GO:1903347; P:negative regulation of bicellular tight junction assembly; IGI:UniProtKB.
DR   GO; GO:0035509; P:negative regulation of myosin-light-chain-phosphatase activity; IMP:UniProtKB.
DR   GO; GO:0150033; P:negative regulation of protein localization to lysosome; IMP:ARUK-UCL.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IMP:ARUK-UCL.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IMP:ARUK-UCL.
DR   GO; GO:1902993; P:positive regulation of amyloid precursor protein catabolic process; IMP:ARUK-UCL.
DR   GO; GO:1902004; P:positive regulation of amyloid-beta formation; IMP:ARUK-UCL.
DR   GO; GO:1902961; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; IMP:ARUK-UCL.
DR   GO; GO:0010825; P:positive regulation of centrosome duplication; IEA:InterPro.
DR   GO; GO:0010595; P:positive regulation of endothelial cell migration; IMP:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:1902966; P:positive regulation of protein localization to early endosome; IMP:ARUK-UCL.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; TAS:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; TAS:UniProtKB.
DR   GO; GO:2000145; P:regulation of cell motility; TAS:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:2000114; P:regulation of establishment of cell polarity; TAS:UniProtKB.
DR   GO; GO:1903140; P:regulation of establishment of endothelial barrier; IMP:UniProtKB.
DR   GO; GO:0051893; P:regulation of focal adhesion assembly; TAS:UniProtKB.
DR   GO; GO:0045616; P:regulation of keratinocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0051246; P:regulation of protein metabolic process; ISS:ARUK-UCL.
DR   GO; GO:0051492; P:regulation of stress fiber assembly; TAS:UniProtKB.
DR   GO; GO:0007266; P:Rho protein signal transduction; IEA:InterPro.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0006939; P:smooth muscle contraction; TAS:UniProtKB.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0039694; P:viral RNA genome replication; IMP:ParkinsonsUK-UCL.
DR   CDD; cd00029; C1; 1.
DR   CDD; cd11638; HR1_ROCK2; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR015008; Rho-bd_dom.
DR   InterPro; IPR020684; ROCK1/ROCK2.
DR   InterPro; IPR029878; ROCK2.
DR   InterPro; IPR037311; ROCK2_HR1.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR22988:SF28; PTHR22988:SF28; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF08912; Rho_Binding; 1.
DR   PIRSF; PIRSF037568; Rho_kinase; 1.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS51860; REM_1; 1.
DR   PROSITE; PS51859; RHO_BD; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Biological rhythms; Cell membrane;
KW   Coiled coil; Complete proteome; Cytoplasm; Cytoskeleton; Kinase;
KW   Magnesium; Membrane; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Zinc; Zinc-finger.
FT   CHAIN         1   1388       Rho-associated protein kinase 2.
FT                                /FTId=PRO_0000086625.
FT   DOMAIN       92    354       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      357    425       AGC-kinase C-terminal.
FT   DOMAIN      497    573       REM-1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01207}.
FT   DOMAIN      979   1047       RhoBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01206}.
FT   DOMAIN     1150   1349       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   NP_BIND      98    106       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ZN_FING    1260   1315       Phorbol-ester/DAG-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   REGION      363    784       Interaction with PPP1R12A.
FT   REGION      373    420       Interaction with NPM1.
FT                                {ECO:0000269|PubMed:17015463}.
FT   REGION      979   1047       RHOA binding. {ECO:0000250}.
FT   COILED      429   1024       {ECO:0000255}.
FT   COILED     1053   1131       {ECO:0000255}.
FT   ACT_SITE    214    214       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     121    121       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   SITE       1131   1132       Cleavage; by granzyme B.
FT   MOD_RES     414    414       Phosphothreonine; by ROCK2.
FT                                {ECO:0000250|UniProtKB:Q62868}.
FT   MOD_RES     722    722       Phosphotyrosine; by SRC.
FT                                {ECO:0000269|PubMed:18559669,
FT                                ECO:0000269|PubMed:20826462}.
FT   MOD_RES    1137   1137       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES    1212   1212       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1362   1362       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1374   1374       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     431    431       T -> N (in dbSNP:rs2230774).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:9734811,
FT                                ECO:0000269|PubMed:9933571}.
FT                                /FTId=VAR_041062.
FT   VARIANT     601    601       D -> V (in dbSNP:rs35768389).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041063.
FT   VARIANT    1083   1083       K -> M (in dbSNP:rs34945852).
FT                                /FTId=VAR_057110.
FT   VARIANT    1194   1194       S -> P (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041064.
FT   MUTAGEN    1131   1131       D->A: Abolishes cleavage by granzyme B.
FT                                {ECO:0000269|PubMed:15699075}.
FT   CONFLICT     83     83       R -> K (in Ref. 1; BAA75636).
FT                                {ECO:0000305}.
FT   HELIX        29     35       {ECO:0000244|PDB:4L6Q}.
FT   HELIX        43     57       {ECO:0000244|PDB:4L6Q}.
FT   HELIX        60     63       {ECO:0000244|PDB:4L6Q}.
FT   HELIX        66     85       {ECO:0000244|PDB:4L6Q}.
FT   HELIX        89     91       {ECO:0000244|PDB:4L6Q}.
FT   STRAND       92    100       {ECO:0000244|PDB:4L6Q}.
FT   STRAND      102    111       {ECO:0000244|PDB:4L6Q}.
FT   TURN        112    114       {ECO:0000244|PDB:4L6Q}.
FT   STRAND      117    124       {ECO:0000244|PDB:4L6Q}.
FT   HELIX       125    130       {ECO:0000244|PDB:4L6Q}.
FT   HELIX       138    146       {ECO:0000244|PDB:4L6Q}.
FT   STRAND      155    160       {ECO:0000244|PDB:4L6Q}.
FT   STRAND      162    169       {ECO:0000244|PDB:4L6Q}.
FT   HELIX       177    183       {ECO:0000244|PDB:4L6Q}.
FT   HELIX       188    207       {ECO:0000244|PDB:4L6Q}.
FT   HELIX       217    219       {ECO:0000244|PDB:4L6Q}.
FT   STRAND      220    222       {ECO:0000244|PDB:4L6Q}.
FT   STRAND      228    230       {ECO:0000244|PDB:4L6Q}.
FT   STRAND      241    246       {ECO:0000244|PDB:4L6Q}.
FT   HELIX       254    256       {ECO:0000244|PDB:4L6Q}.
FT   HELIX       259    264       {ECO:0000244|PDB:4L6Q}.
FT   STRAND      270    272       {ECO:0000244|PDB:4L6Q}.
FT   HELIX       274    289       {ECO:0000244|PDB:4L6Q}.
FT   HELIX       299    307       {ECO:0000244|PDB:4L6Q}.
FT   HELIX       309    312       {ECO:0000244|PDB:4L6Q}.
FT   STRAND      317    319       {ECO:0000244|PDB:5U7Q}.
FT   HELIX       323    332       {ECO:0000244|PDB:4L6Q}.
FT   HELIX       336    338       {ECO:0000244|PDB:4L6Q}.
FT   TURN        340    343       {ECO:0000244|PDB:4L6Q}.
FT   HELIX       346    349       {ECO:0000244|PDB:4L6Q}.
FT   HELIX       352    354       {ECO:0000244|PDB:4L6Q}.
FT   TURN        361    363       {ECO:0000244|PDB:4L6Q}.
FT   HELIX       364    366       {ECO:0000244|PDB:4L6Q}.
FT   HELIX       408    410       {ECO:0000244|PDB:4L6Q}.
SQ   SEQUENCE   1388 AA;  160900 MW;  876240F410C2487E CRC64;
     MSRPPPTGKM PGAPETAPGD GAGASRQRKL EALIRDPRSP INVESLLDGL NSLVLDLDFP
     ALRKNKNIDN FLNRYEKIVK KIRGLQMKAE DYDVVKVIGR GAFGEVQLVR HKASQKVYAM
     KLLSKFEMIK RSDSAFFWEE RDIMAFANSP WVVQLFYAFQ DDRYLYMVME YMPGGDLVNL
     MSNYDVPEKW AKFYTAEVVL ALDAIHSMGL IHRDVKPDNM LLDKHGHLKL ADFGTCMKMD
     ETGMVHCDTA VGTPDYISPE VLKSQGGDGF YGRECDWWSV GVFLYEMLVG DTPFYADSLV
     GTYSKIMDHK NSLCFPEDAE ISKHAKNLIC AFLTDREVRL GRNGVEEIRQ HPFFKNDQWH
     WDNIRETAAP VVPELSSDID SSNFDDIEDD KGDVETFPIP KAFVGNQLPF IGFTYYRENL
     LLSDSPSCRE TDSIQSRKNE ESQEIQKKLY TLEEHLSNEM QAKEELEQKC KSVNTRLEKT
     AKELEEEITL RKSVESALRQ LEREKALLQH KNAEYQRKAD HEADKKRNLE NDVNSLKDQL
     EDLKKRNQNS QISTEKVNQL QRQLDETNAL LRTESDTAAR LRKTQAESSK QIQQLESNNR
     DLQDKNCLLE TAKLKLEKEF INLQSALESE RRDRTHGSEI INDLQGRICG LEEDLKNGKI
     LLAKVELEKR QLQERFTDLE KEKSNMEIDM TYQLKVIQQS LEQEEAEHKA TKARLADKNK
     IYESIEEAKS EAMKEMEKKL LEERTLKQKV ENLLLEAEKR CSLLDCDLKQ SQQKINELLK
     QKDVLNEDVR NLTLKIEQET QKRCLTQNDL KMQTQQVNTL KMSEKQLKQE NNHLMEMKMN
     LEKQNAELRK ERQDADGQMK ELQDQLEAEQ YFSTLYKTQV RELKEECEEK TKLGKELQQK
     KQELQDERDS LAAQLEITLT KADSEQLARS IAEEQYSDLE KEKIMKELEI KEMMARHKQE
     LTEKDATIAS LEETNRTLTS DVANLANEKE ELNNKLKDVQ EQLSRLKDEE ISAAAIKAQF
     EKQLLTERTL KTQAVNKLAE IMNRKEPVKR GNDTDVRRKE KENRKLHMEL KSEREKLTQQ
     MIKYQKELNE MQAQIAEESQ IRIELQMTLD SKDSDIEQLR SQLQALHIGL DSSSIGSGPG
     DAEADDGFPE SRLEGWLSLP VRNNTKKFGW VKKYVIVSSK KILFYDSEQD KEQSNPYMVL
     DIDKLFHVRP VTQTDVYRAD AKEIPRIFQI LYANEGESKK EQEFPVEPVG EKSNYICHKG
     HEFIPTLYHF PTNCEACMKP LWHMFKPPPA LECRRCHIKC HKDHMDKKEE IIAPCKVYYD
     ISTAKNLLLL ANSTEEQQKW VSRLVKKIPK KPPAPDPFAR SSPRTSMKIQ QNQSIRRPSR
     QLAPNKPS
//
ID   Q14DU5_HUMAN            Unreviewed;       703 AA.
AC   Q14DU5;
DT   22-AUG-2006, integrated into UniProtKB/TrEMBL.
DT   22-AUG-2006, sequence version 1.
DT   23-MAY-2018, entry version 104.
DE   SubName: Full=ROCK2 protein {ECO:0000313|EMBL:AAI11802.1};
DE   SubName: Full=Rho-associated protein kinase 2 {ECO:0000313|Ensembl:ENSP00000481789};
GN   Name=ROCK2 {ECO:0000313|EMBL:AAI11802.1,
GN   ECO:0000313|Ensembl:ENSP00000481789};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI11802.1};
RN   [1] {ECO:0000313|EMBL:AAI11802.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000481789, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [4] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [6] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [7] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [9] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11] {ECO:0000313|Ensembl:ENSP00000481789}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
RN   [12] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC018463; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC099344; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC111801; AAI11802.1; -; mRNA.
DR   RefSeq; NP_001308572.1; NM_001321643.1.
DR   RefSeq; NP_004841.2; NM_004850.4.
DR   UniGene; Hs.681743; -.
DR   PRIDE; Q14DU5; -.
DR   Ensembl; ENST00000616279; ENSP00000481789; ENSG00000134318.
DR   GeneID; 9475; -.
DR   KEGG; hsa:9475; -.
DR   UCSC; uc061grr.1; human.
DR   CTD; 9475; -.
DR   EuPathDB; HostDB:ENSG00000134318.13; -.
DR   HGNC; HGNC:10252; ROCK2.
DR   OpenTargets; ENSG00000134318; -.
DR   eggNOG; KOG0612; Eukaryota.
DR   eggNOG; ENOG410XR1Q; LUCA.
DR   GeneTree; ENSGT00760000118994; -.
DR   HOGENOM; HOG000017259; -.
DR   HOVERGEN; HBG083077; -.
DR   KO; K17388; -.
DR   ChiTaRS; ROCK2; human.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000134318; -.
DR   ExpressionAtlas; Q14DU5; baseline and differential.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:InterPro.
DR   GO; GO:0017048; F:Rho GTPase binding; IEA:InterPro.
DR   GO; GO:0010825; P:positive regulation of centrosome duplication; IEA:InterPro.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; IEA:InterPro.
DR   GO; GO:0007266; P:Rho protein signal transduction; IEA:InterPro.
DR   GO; GO:0006939; P:smooth muscle contraction; IEA:InterPro.
DR   CDD; cd00029; C1; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR015008; Rho-bd_dom.
DR   InterPro; IPR029878; ROCK2.
DR   PANTHER; PTHR22988:SF28; PTHR22988:SF28; 1.
DR   Pfam; PF08912; Rho_Binding; 1.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00233; PH; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Metal-binding {ECO:0000256|SAAS:SAAS00515414};
KW   Proteomics identification {ECO:0000213|EPD:Q14DU5,
KW   ECO:0000213|MaxQB:Q14DU5, ECO:0000213|PeptideAtlas:Q14DU5};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Zinc {ECO:0000256|SAAS:SAAS00515409}.
FT   DOMAIN      465    664       PH. {ECO:0000259|PROSITE:PS50003}.
FT   DOMAIN      575    630       Phorbol-ester/DAG-type.
FT                                {ECO:0000259|PROSITE:PS50081}.
FT   COILED        9    117       {ECO:0000256|SAM:Coils}.
FT   COILED      125    180       {ECO:0000256|SAM:Coils}.
FT   COILED      195    324       {ECO:0000256|SAM:Coils}.
FT   COILED      371    416       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   703 AA;  82149 MW;  23BDD34321929F96 CRC64;
     MEIDMTYQLK VIQQSLEQEE AEHKATKARL ADKNKIYESI EEAKSEAMKE MEKKLLEERT
     LKQKVENLLL EAEKRCSLLD CDLKQSQQKI NELLKQKDVL NEDVRNLTLK IEQETQKRCL
     TQNDLKMQTQ QVNTLKMSEK QLKQENNHLM EMKMNLEKQN AELRKERQDA DGQMKELQDQ
     LEAEQYFSTL YKTQVRELKE ECEEKTKLGK ELQQKKQELQ DERDSLAAQL EITLTKADSE
     QLARSIAEEQ YSDLEKEKIM KELEIKEMMA RHKQELTEKD ATIASLEETN RTLTSDVANL
     ANEKEELNNK LKDVQEQLSR LKDEEISAAA IKAQFEKQLL TERTLKTQAV NKLAEIMNRK
     EPVKRGNDTD VRRKEKENRK LHMELKSERE KLTQQMIKYQ KELNEMQAQI AEESQIRIEL
     QMTLDSKDSD IEQLRSQLQA LHIGLDSSSI GSGPGDAEAD DGFPESRLEG WLSLPVRNNT
     KKFGWVKKYV IVSSKKILFY DSEQDKEQSN PYMVLDIDKL FHVRPVTQTD VYRADAKEIP
     RIFQILYANE GESKKEQEFP VEPVGEKSNY ICHKGHEFIP TLYHFPTNCE ACMKPLWHMF
     KPPPALECRR CHIKCHKDHM DKKEEIIAPC KVYYDISTAK NLLLLANSTE EQQKWVSRLV
     KKIPKKPPAP DPFARSSPRT SMKIQQNQSI RRPSRQLAPN KPS
//
ID   B3KSK2_HUMAN            Unreviewed;       136 AA.
AC   B3KSK2; C9J751;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 53.
DE   SubName: Full=cDNA FLJ36470 fis, clone THYMU2015918, highly similar to Nucleotide-binding protein-like {ECO:0000313|EMBL:BAG52764.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG52764.1};
RN   [1] {ECO:0000313|EMBL:BAG52764.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Thymus {ECO:0000313|EMBL:BAG52764.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK093789; BAG52764.1; -; mRNA.
DR   RefSeq; NP_001188503.1; NM_001201574.1.
DR   RefSeq; XP_011535486.1; XM_011537184.2.
DR   UniGene; Hs.288981; -.
DR   ProteinModelPortal; B3KSK2; -.
DR   PeptideAtlas; B3KSK2; -.
DR   PRIDE; B3KSK2; -.
DR   DNASU; 80224; -.
DR   GeneID; 80224; -.
DR   CTD; 80224; -.
DR   eggNOG; KOG3022; Eukaryota.
DR   eggNOG; COG0489; LUCA.
DR   GenomeRNAi; 80224; -.
DR   Genevisible; B3KSK2; HS.
DR   CDD; cd02037; MRP-like; 1.
DR   InterPro; IPR019591; Mrp/NBP35_ATP-bd.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR033756; YlxH/NBP35.
DR   Pfam; PF10609; ParA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   136 AA;  14701 MW;  F4764B1701EFFE05 CRC64;
     MPPGTGDVQL SVSQNIPITG AVIVSTPQDI ALMDAHKGAE MFRRVHVPVL GLVQNMSVFQ
     CPKCKHKTHI FGADGARKLA QTLGLEVLGD IPLHLNIREA SDTGQPIVFS QPESDEAKAY
     LRIAVEVVRR LPSPSE
//
ID   B4DWB0_HUMAN            Unreviewed;       223 AA.
AC   B4DWB0;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 64.
DE   SubName: Full=cDNA FLJ59772, highly similar to Nucleotide-binding protein-like {ECO:0000313|EMBL:BAG62972.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG62972.1};
RN   [1] {ECO:0000313|EMBL:BAG62972.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Synovial membrane tissue {ECO:0000313|EMBL:BAG62972.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK301447; BAG62972.1; -; mRNA.
DR   RefSeq; NP_001188502.1; NM_001201573.1.
DR   UniGene; Hs.288981; -.
DR   ProteinModelPortal; B4DWB0; -.
DR   SMR; B4DWB0; -.
DR   iPTMnet; B4DWB0; -.
DR   MaxQB; B4DWB0; -.
DR   PeptideAtlas; B4DWB0; -.
DR   PRIDE; B4DWB0; -.
DR   DNASU; 80224; -.
DR   GeneID; 80224; -.
DR   CTD; 80224; -.
DR   eggNOG; KOG3022; Eukaryota.
DR   eggNOG; COG0489; LUCA.
DR   HOVERGEN; HBG051027; -.
DR   GenomeRNAi; 80224; -.
DR   Genevisible; B4DWB0; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   CDD; cd02037; MRP-like; 1.
DR   InterPro; IPR019591; Mrp/NBP35_ATP-bd.
DR   InterPro; IPR000808; Mrp_CS.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR033756; YlxH/NBP35.
DR   Pfam; PF10609; ParA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS01215; MRP; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   223 AA;  24416 MW;  A18A65E740B255F3 CRC64;
     MSKAIGLLDV DVYGPSVPKM MNLKGNPELS QSNLMRPLLN YGIACMSMGF LVEESEPVVW
     RGLMVMSAIE KLLRQVDWGQ LDYLVVDMPP GTGDVQLSVS QNIPITGAVI VSTPQDIALM
     DAHKGAEMFR RVHVPVLGLV QNMSVFQCPK CKHKTHIFGA DGARKLAQTL GLEVLGDIPL
     HLNIREASDT GQPIVFSQPE SDEAKAYLRI AVEVVRRLPS PSE
//
ID   NUBPL_HUMAN             Reviewed;         319 AA.
AC   Q8TB37; B4DHZ1; Q86TZ4; Q9H9M2;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   31-JAN-2018, entry version 134.
DE   RecName: Full=Iron-sulfur protein NUBPL;
DE   AltName: Full=IND1 homolog;
DE   AltName: Full=Nucleotide-binding protein-like;
DE   AltName: Full=huInd1;
DE   Flags: Precursor;
GN   Name=NUBPL; Synonyms=C14orf127;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Neuroblastoma;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Teratocarcinoma, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 8-319 (ISOFORM 1), AND
RP   VARIANT THR-198.
RC   TISSUE=Prostatic adenocarcinoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, IRON-SULFUR CLUSTER-BINDING, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF CYS-244 AND CYS-247.
RX   PubMed=19752196; DOI=10.1128/MCB.00817-09;
RA   Sheftel A.D., Stehling O., Pierik A.J., Netz D.J., Kerscher S.,
RA   Elsasser H.P., Wittig I., Balk J., Brandt U., Lill R.;
RT   "Human ind1, an iron-sulfur cluster assembly factor for respiratory
RT   complex I.";
RL   Mol. Cell. Biol. 29:6059-6073(2009).
RN   [6]
RP   INVOLVEMENT IN MT-C1D, AND VARIANT ARG-56.
RX   PubMed=20818383; DOI=10.1038/ng.659;
RA   Calvo S.E., Tucker E.J., Compton A.G., Kirby D.M., Crawford G.,
RA   Burtt N.P., Rivas M., Guiducci C., Bruno D.L., Goldberger O.A.,
RA   Redman M.C., Wiltshire E., Wilson C.J., Altshuler D., Gabriel S.B.,
RA   Daly M.J., Thorburn D.R., Mootha V.K.;
RT   "High-throughput, pooled sequencing identifies mutations in NUBPL and
RT   FOXRED1 in human complex I deficiency.";
RL   Nat. Genet. 42:851-858(2010).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   CHARACTERIZATION OF VARIANT ARG-56.
RX   PubMed=22072591; DOI=10.1002/humu.21654;
RA   Tucker E.J., Mimaki M., Compton A.G., McKenzie M., Ryan M.T.,
RA   Thorburn D.R.;
RT   "Next generation sequencing in molecular diagnosis: NUBPL mutations
RT   highlight the challenges of variant detection and interpretation.";
RL   Hum. Mutat. 33:411-418(2012).
RN   [9]
RP   VARIANTS MT-C1D TYR-105 AND PHE-193, AND VARIANT ARG-56.
RX   PubMed=23553477; DOI=10.1212/WNL.0b013e31828f1914;
RA   Kevelam S.H., Rodenburg R.J., Wolf N.I., Ferreira P., Lunsing R.J.,
RA   Nijtmans L.G., Mitchell A., Arroyo H.A., Rating D., Vanderver A.,
RA   van Berkel C.G., Abbink T.E., Heutink P., van der Knaap M.S.;
RT   "NUBPL mutations in patients with complex I deficiency and a distinct
RT   MRI pattern.";
RL   Neurology 80:1577-1583(2013).
CC   -!- FUNCTION: Required for the assembly of the mitochondrial membrane
CC       respiratory chain NADH dehydrogenase (Complex I). May deliver of
CC       one or more Fe-S clusters to complex I subunits.
CC       {ECO:0000269|PubMed:19752196}.
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC       Note=Binds 1 [4Fe-4S] cluster.;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:19752196}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TB37-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TB37-2; Sequence=VSP_020985, VSP_008797;
CC         Note=May be due to exon skipping.;
CC   -!- TISSUE SPECIFICITY: Highest expression in liver and kidney.
CC       expressed at significant levels in small intestine and brain (at
CC       protein level). {ECO:0000269|PubMed:19752196}.
CC   -!- DISEASE: Mitochondrial complex I deficiency (MT-C1D) [MIM:252010]:
CC       A disorder of the mitochondrial respiratory chain that causes a
CC       wide range of clinical manifestations from lethal neonatal disease
CC       to adult-onset neurodegenerative disorders. Phenotypes include
CC       macrocephaly with progressive leukodystrophy, non-specific
CC       encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh
CC       syndrome, Leber hereditary optic neuropathy, and some forms of
CC       Parkinson disease. {ECO:0000269|PubMed:20818383,
CC       ECO:0000269|PubMed:23553477}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the Mrp/NBP35 ATP-binding proteins family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH24919.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB14203.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAD62349.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX248028; CAD62349.1; ALT_INIT; mRNA.
DR   EMBL; AK022722; BAB14203.1; ALT_INIT; mRNA.
DR   EMBL; AK295326; BAG58303.1; -; mRNA.
DR   EMBL; AK316445; BAH14816.1; -; mRNA.
DR   EMBL; CH471078; EAW65942.1; -; Genomic_DNA.
DR   EMBL; BC024919; AAH24919.1; ALT_INIT; mRNA.
DR   CCDS; CCDS41940.1; -. [Q8TB37-1]
DR   RefSeq; NP_001188502.1; NM_001201573.1.
DR   RefSeq; NP_079428.2; NM_025152.2. [Q8TB37-1]
DR   UniGene; Hs.288981; -.
DR   ProteinModelPortal; Q8TB37; -.
DR   SMR; Q8TB37; -.
DR   BioGrid; 123190; 4.
DR   IntAct; Q8TB37; 3.
DR   STRING; 9606.ENSP00000281081; -.
DR   iPTMnet; Q8TB37; -.
DR   PhosphoSitePlus; Q8TB37; -.
DR   BioMuta; NUBPL; -.
DR   DMDM; 116242683; -.
DR   EPD; Q8TB37; -.
DR   PaxDb; Q8TB37; -.
DR   PeptideAtlas; Q8TB37; -.
DR   PRIDE; Q8TB37; -.
DR   DNASU; 80224; -.
DR   Ensembl; ENST00000281081; ENSP00000281081; ENSG00000151413. [Q8TB37-1]
DR   Ensembl; ENST00000547839; ENSP00000449918; ENSG00000151413. [Q8TB37-2]
DR   GeneID; 80224; -.
DR   KEGG; hsa:80224; -.
DR   UCSC; uc059apb.1; human. [Q8TB37-1]
DR   CTD; 80224; -.
DR   DisGeNET; 80224; -.
DR   EuPathDB; HostDB:ENSG00000151413.16; -.
DR   GeneCards; NUBPL; -.
DR   H-InvDB; HIX0011583; -.
DR   HGNC; HGNC:20278; NUBPL.
DR   HPA; HPA029203; -.
DR   MalaCards; NUBPL; -.
DR   MIM; 252010; phenotype.
DR   MIM; 613621; gene.
DR   neXtProt; NX_Q8TB37; -.
DR   OpenTargets; ENSG00000151413; -.
DR   Orphanet; 2609; Isolated NADH-CoQ reductase deficiency.
DR   PharmGKB; PA134907818; -.
DR   eggNOG; KOG3022; Eukaryota.
DR   eggNOG; COG0489; LUCA.
DR   GeneTree; ENSGT00390000009735; -.
DR   HOGENOM; HOG000079916; -.
DR   HOVERGEN; HBG051027; -.
DR   InParanoid; Q8TB37; -.
DR   KO; K03593; -.
DR   OMA; PMLNGII; -.
DR   OrthoDB; EOG091G0D7U; -.
DR   PhylomeDB; Q8TB37; -.
DR   TreeFam; TF323196; -.
DR   Reactome; R-HSA-6799198; Complex I biogenesis.
DR   ChiTaRS; NUBPL; human.
DR   GenomeRNAi; 80224; -.
DR   PRO; PR:Q8TB37; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000151413; -.
DR   CleanEx; HS_NUBPL; -.
DR   ExpressionAtlas; Q8TB37; baseline and differential.
DR   Genevisible; Q8TB37; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB.
DR   GO; GO:0070584; P:mitochondrion morphogenesis; IMP:UniProtKB.
DR   CDD; cd02037; MRP-like; 1.
DR   HAMAP; MF_02040; Mrp_NBP35; 1.
DR   InterPro; IPR019591; Mrp/NBP35_ATP-bd.
DR   InterPro; IPR000808; Mrp_CS.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR033756; YlxH/NBP35.
DR   Pfam; PF10609; ParA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS01215; MRP; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome;
KW   Disease mutation; Iron; Iron-sulfur; Metal-binding; Mitochondrion;
KW   Nucleotide-binding; Polymorphism; Primary mitochondrial disease;
KW   Reference proteome; Transit peptide.
FT   TRANSIT       1     38       Mitochondrion. {ECO:0000255}.
FT   CHAIN        39    319       Iron-sulfur protein NUBPL.
FT                                /FTId=PRO_0000184950.
FT   NP_BIND      75     82       ATP. {ECO:0000255}.
FT   VAR_SEQ     173    173       D -> L (in isoform 2).
FT                                {ECO:0000303|Ref.1}.
FT                                /FTId=VSP_020985.
FT   VAR_SEQ     174    319       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.1}.
FT                                /FTId=VSP_008797.
FT   VARIANT      56     56       G -> R (rare variant found in a patient
FT                                with MT-C1D; found in association with a
FT                                nucleotide transition causing exon
FT                                skipping; does not affect protein
FT                                stability, processing and import in the
FT                                mitochondrion; can restore complex I
FT                                activity when overexpressed in patient
FT                                fibroblasts; dbSNP:rs200401432).
FT                                {ECO:0000269|PubMed:20818383,
FT                                ECO:0000269|PubMed:22072591,
FT                                ECO:0000269|PubMed:23553477}.
FT                                /FTId=VAR_064570.
FT   VARIANT     105    105       D -> Y (in MT-C1D; dbSNP:rs397515440).
FT                                {ECO:0000269|PubMed:23553477}.
FT                                /FTId=VAR_069767.
FT   VARIANT     193    193       L -> F (in MT-C1D; dbSNP:rs552722349).
FT                                {ECO:0000269|PubMed:23553477}.
FT                                /FTId=VAR_069768.
FT   VARIANT     198    198       N -> T (in dbSNP:rs11558436).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027895.
FT   MUTAGEN     244    244       C->A: Defect in complex I assembly; when
FT                                associated with A-247.
FT                                {ECO:0000269|PubMed:19752196}.
FT   MUTAGEN     247    247       C->A: Defect in complex I assembly; when
FT                                associated with A-244.
FT                                {ECO:0000269|PubMed:19752196}.
SQ   SEQUENCE   319 AA;  34083 MW;  7A497482A4D449A4 CRC64;
     MGIWQRLLLF GGVSLRAGGG ATAPLGGSRA MVCGRQLSGA GSETLKQRRT QIMSRGLPKQ
     KPIEGVKQVI VVASGKGGVG KSTTAVNLAL ALAANDSSKA IGLLDVDVYG PSVPKMMNLK
     GNPELSQSNL MRPLLNYGIA CMSMGFLVEE SEPVVWRGLM VMSAIEKLLR QVDWGQLDYL
     VVDMPPGTGD VQLSVSQNIP ITGAVIVSTP QDIALMDAHK GAEMFRRVHV PVLGLVQNMS
     VFQCPKCKHK THIFGADGAR KLAQTLGLEV LGDIPLHLNI REASDTGQPI VFSQPESDEA
     KAYLRIAVEV VRRLPSPSE
//
ID   X5D2R5_HUMAN            Unreviewed;       319 AA.
AC   X5D2R5;
DT   11-JUN-2014, integrated into UniProtKB/TrEMBL.
DT   11-JUN-2014, sequence version 1.
DT   31-JAN-2018, entry version 30.
DE   SubName: Full=Nucleotide binding protein-like isoform A {ECO:0000313|EMBL:AHW56549.1};
DE   Flags: Fragment;
GN   Name=NUBPL {ECO:0000313|EMBL:AHW56549.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AHW56549.1};
RN   [1] {ECO:0000313|EMBL:AHW56549.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Fetal whole brain {ECO:0000313|EMBL:AHW56549.1};
RX   PubMed=24722188;
RA   Corominas R., Yang X., Lin G.N., Kang S., Shen Y., Ghamsari L.,
RA   Broly M., Rodriguez M., Tam S., Wanamaker S.A., Fan C., Yi S.,
RA   Tasan M., Lemmens I., Kuang X., Zhao N., Malhotra D., Michaelson J.J.,
RA   Vacic V., Calderwood M.A., Roth F.P., Tavernier J., Horvath S.,
RA   Salehi-Ashtiani K., Korkin D., Sebat J., Hill D.E., Hao T., Vidal M.,
RA   Iakoucheva L.M.;
RT   "Protein interaction network of alternatively spliced isoforms from
RT   brain links genetic risk factors for autism.";
RL   Nat. Commun. 5:3650-3650(2014).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KJ534909; AHW56549.1; -; mRNA.
DR   RefSeq; NP_079428.2; NM_025152.2.
DR   UniGene; Hs.288981; -.
DR   ProteinModelPortal; X5D2R5; -.
DR   SMR; X5D2R5; -.
DR   MaxQB; X5D2R5; -.
DR   GeneID; 80224; -.
DR   KEGG; hsa:80224; -.
DR   UCSC; uc001wrk.5; human.
DR   CTD; 80224; -.
DR   EuPathDB; HostDB:ENSG00000151413.16; -.
DR   eggNOG; KOG3022; Eukaryota.
DR   eggNOG; COG0489; LUCA.
DR   KO; K03593; -.
DR   OMA; PMLNGII; -.
DR   OrthoDB; EOG091G0D7U; -.
DR   PhylomeDB; X5D2R5; -.
DR   ChiTaRS; NUBPL; human.
DR   GenomeRNAi; 80224; -.
DR   Bgee; ENSG00000151413; -.
DR   ExpressionAtlas; X5D2R5; baseline and differential.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   CDD; cd02037; MRP-like; 1.
DR   HAMAP; MF_02040; Mrp_NBP35; 1.
DR   InterPro; IPR019591; Mrp/NBP35_ATP-bd.
DR   InterPro; IPR000808; Mrp_CS.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR033756; YlxH/NBP35.
DR   Pfam; PF10609; ParA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS01215; MRP; 1.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     22       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        23    319       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004954348.
FT   NON_TER     319    319       {ECO:0000313|EMBL:AHW56549.1}.
SQ   SEQUENCE   319 AA;  34083 MW;  7A497482A4D449A4 CRC64;
     MGIWQRLLLF GGVSLRAGGG ATAPLGGSRA MVCGRQLSGA GSETLKQRRT QIMSRGLPKQ
     KPIEGVKQVI VVASGKGGVG KSTTAVNLAL ALAANDSSKA IGLLDVDVYG PSVPKMMNLK
     GNPELSQSNL MRPLLNYGIA CMSMGFLVEE SEPVVWRGLM VMSAIEKLLR QVDWGQLDYL
     VVDMPPGTGD VQLSVSQNIP ITGAVIVSTP QDIALMDAHK GAEMFRRVHV PVLGLVQNMS
     VFQCPKCKHK THIFGADGAR KLAQTLGLEV LGDIPLHLNI REASDTGQPI VFSQPESDEA
     KAYLRIAVEV VRRLPSPSE
//
ID   B3KSR0_HUMAN            Unreviewed;       291 AA.
AC   B3KSR0;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   28-MAR-2018, entry version 57.
DE   SubName: Full=cDNA FLJ36814 fis, clone ASTRO2003316, highly similar to Homo sapiens solute carrier family 25, member 30 (SLC25A30), mRNA {ECO:0000313|EMBL:BAG52822.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG52822.1};
RN   [1] {ECO:0000313|EMBL:BAG52822.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -!- SIMILARITY: Belongs to the mitochondrial carrier (TC 2.A.29)
CC       family. {ECO:0000256|RuleBase:RU000488,
CC       ECO:0000256|SAAS:SAAS00548220}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK094133; BAG52822.1; -; mRNA.
DR   RefSeq; NP_001010875.1; NM_001010875.3.
DR   UniGene; Hs.591230; -.
DR   ProteinModelPortal; B3KSR0; -.
DR   PeptideAtlas; B3KSR0; -.
DR   GeneID; 253512; -.
DR   KEGG; hsa:253512; -.
DR   CTD; 253512; -.
DR   eggNOG; KOG0753; Eukaryota.
DR   eggNOG; ENOG410XRV1; LUCA.
DR   HOGENOM; HOG000165140; -.
DR   HOVERGEN; HBG009528; -.
DR   KO; K15106; -.
DR   GenomeRNAi; 253512; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-UniRule.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:InterPro.
DR   GO; GO:0006839; P:mitochondrial transport; IEA:InterPro.
DR   Gene3D; 1.50.40.10; -; 1.
DR   InterPro; IPR002030; Mit_uncoupling_UCP-like.
DR   InterPro; IPR018108; Mitochondrial_sb/sol_carrier.
DR   InterPro; IPR023395; Mt_carrier_dom_sf.
DR   Pfam; PF00153; Mito_carr; 3.
DR   PRINTS; PR00784; MTUNCOUPLING.
DR   SUPFAM; SSF103506; SSF103506; 1.
DR   PROSITE; PS50920; SOLCAR; 3.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAAS:SAAS00013441};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00013441};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00013441};
KW   Transport {ECO:0000256|RuleBase:RU000488}.
FT   REPEAT        7     96       Solcar. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00282}.
FT   REPEAT      104    189       Solcar. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00282}.
FT   REPEAT      198    289       Solcar. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00282}.
SQ   SEQUENCE   291 AA;  32415 MW;  76A8A6F0875EEAC5 CRC64;
     MSALNWKPFV YGGLASITAE CGTFPIDLTK TRLQIQGQTN DAKFKEIRYR GMLHALVRIG
     REEGLKALYS GIAPAMLRQA SYGTIKIGTY QSLKRLFIER PEDETLPINV ICGILSGVIS
     STIANPTDVL KIRMQAQSNT IQGGMIGNFM NIYQQEGTRG LWKGVSLTAQ RAAIVVGVEL
     PVYDITKKHL ILSGLMGDTV YTHFLSSFTC GLAGALASNP VDVVRTRMMN QRVLRDGRCS
     GYTGTLDCLL QTWKNEGFFA LCKGFWPNWL RLGPWNIIFF VTYEQLKKLD L
//
ID   B3KTE8_HUMAN            Unreviewed;       216 AA.
AC   B3KTE8;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   28-MAR-2018, entry version 74.
DE   SubName: Full=cDNA FLJ38146 fis, clone D9OST2003594, highly similar to Homo sapiens solute carrier family 25, member 30 (SLC25A30), mRNA {ECO:0000313|EMBL:BAG53060.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG53060.1};
RN   [1] {ECO:0000313|EMBL:BAG53060.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -!- SIMILARITY: Belongs to the mitochondrial carrier (TC 2.A.29)
CC       family. {ECO:0000256|RuleBase:RU000488,
CC       ECO:0000256|SAAS:SAAS00548220}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK095465; BAG53060.1; -; mRNA.
DR   RefSeq; NP_001010875.1; NM_001010875.3.
DR   RefSeq; NP_001273735.1; NM_001286806.1.
DR   RefSeq; NP_001273736.1; NM_001286807.1.
DR   RefSeq; XP_011533329.1; XM_011535027.2.
DR   UniGene; Hs.591230; -.
DR   ProteinModelPortal; B3KTE8; -.
DR   PeptideAtlas; B3KTE8; -.
DR   PRIDE; B3KTE8; -.
DR   GeneID; 253512; -.
DR   KEGG; hsa:253512; -.
DR   CTD; 253512; -.
DR   eggNOG; KOG0753; Eukaryota.
DR   eggNOG; ENOG410XRV1; LUCA.
DR   HOVERGEN; HBG009528; -.
DR   KO; K15106; -.
DR   GenomeRNAi; 253512; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-UniRule.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:InterPro.
DR   GO; GO:0006839; P:mitochondrial transport; IEA:InterPro.
DR   Gene3D; 1.50.40.10; -; 1.
DR   InterPro; IPR002030; Mit_uncoupling_UCP-like.
DR   InterPro; IPR018108; Mitochondrial_sb/sol_carrier.
DR   InterPro; IPR023395; Mt_carrier_dom_sf.
DR   Pfam; PF00153; Mito_carr; 2.
DR   PRINTS; PR00784; MTUNCOUPLING.
DR   SUPFAM; SSF103506; SSF103506; 1.
DR   PROSITE; PS50920; SOLCAR; 2.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAAS:SAAS00013441};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00013441};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00013441};
KW   Transport {ECO:0000256|RuleBase:RU000488}.
FT   REPEAT       29    114       Solcar. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00282}.
FT   REPEAT      123    214       Solcar. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00282}.
SQ   SEQUENCE   216 AA;  24208 MW;  EEC8D81172BFAED2 CRC64;
     MLRQASYGTI KIGTYQSLKR LFIERPEDET LPINVICGIL SGVISSTIAN PTDVLKIRMQ
     AQSNTIQGGM IGNFMNIYQQ EGTRGLWKGV SLTAQRAAIV VGVELPVYDI TKKHLILSGL
     MGDTVYTHFL SSFTCGLAGA LASNPVDVVR TRMMNQRVLR DGRCSGYTGT LDCLLQTWKN
     EGFFALYKGF WPNWLRLGPW NIIFFVTYEQ LKKLDL
//
ID   KMCP1_HUMAN             Reviewed;         291 AA.
AC   Q5SVS4; B2RN96; B4DZK3; F5H8H8;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   28-FEB-2018, entry version 109.
DE   RecName: Full=Kidney mitochondrial carrier protein 1;
DE   AltName: Full=Solute carrier family 25 member 30;
GN   Name=SLC25A30; Synonyms=KMCP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH VDAC1.
RX   PubMed=26387735; DOI=10.1016/j.molcel.2015.08.009;
RA   Shanmughapriya S., Rajan S., Hoffman N.E., Higgins A.M., Tomar D.,
RA   Nemani N., Hines K.J., Smith D.J., Eguchi A., Vallem S., Shaikh F.,
RA   Cheung M., Leonard N.J., Stolakis R.S., Wolfers M.P., Ibetti J.,
RA   Chuprun J.K., Jog N.R., Houser S.R., Koch W.J., Elrod J.W., Madesh M.;
RT   "SPG7 is an essential and conserved component of the mitochondrial
RT   permeability transition pore.";
RL   Mol. Cell 60:47-62(2015).
RN   [5]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Probable transporter. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with VDAC1. {ECO:0000269|PubMed:26387735}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000250};
CC       Multi-pass membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q5SVS4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5SVS4-2; Sequence=VSP_053984;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the mitochondrial carrier (TC 2.A.29)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK302967; BAG64115.1; -; mRNA.
DR   EMBL; AL627107; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC132739; AAI32740.1; -; mRNA.
DR   EMBL; BC136760; AAI36761.1; -; mRNA.
DR   CCDS; CCDS31967.1; -. [Q5SVS4-1]
DR   CCDS; CCDS66539.1; -. [Q5SVS4-2]
DR   RefSeq; NP_001010875.1; NM_001010875.3. [Q5SVS4-1]
DR   RefSeq; NP_001273735.1; NM_001286806.1. [Q5SVS4-2]
DR   RefSeq; XP_016876013.1; XM_017020524.1. [Q5SVS4-1]
DR   UniGene; Hs.591230; -.
DR   ProteinModelPortal; Q5SVS4; -.
DR   SMR; Q5SVS4; -.
DR   BioGrid; 128971; 19.
DR   STRING; 9606.ENSP00000429168; -.
DR   TCDB; 2.A.29.24.4; the mitochondrial carrier (mc) family.
DR   iPTMnet; Q5SVS4; -.
DR   PhosphoSitePlus; Q5SVS4; -.
DR   DMDM; 74743890; -.
DR   MaxQB; Q5SVS4; -.
DR   PaxDb; Q5SVS4; -.
DR   PeptideAtlas; Q5SVS4; -.
DR   PRIDE; Q5SVS4; -.
DR   Ensembl; ENST00000519676; ENSP00000429168; ENSG00000174032. [Q5SVS4-1]
DR   Ensembl; ENST00000539591; ENSP00000443542; ENSG00000174032. [Q5SVS4-2]
DR   GeneID; 253512; -.
DR   KEGG; hsa:253512; -.
DR   UCSC; uc001vag.5; human. [Q5SVS4-1]
DR   CTD; 253512; -.
DR   DisGeNET; 253512; -.
DR   EuPathDB; HostDB:ENSG00000174032.16; -.
DR   GeneCards; SLC25A30; -.
DR   HGNC; HGNC:27371; SLC25A30.
DR   HPA; HPA045260; -.
DR   MIM; 610793; gene.
DR   neXtProt; NX_Q5SVS4; -.
DR   OpenTargets; ENSG00000174032; -.
DR   PharmGKB; PA134931353; -.
DR   eggNOG; KOG0753; Eukaryota.
DR   eggNOG; ENOG410XRV1; LUCA.
DR   GeneTree; ENSGT00760000119170; -.
DR   HOVERGEN; HBG009528; -.
DR   InParanoid; Q5SVS4; -.
DR   KO; K15106; -.
DR   OMA; SITAECG; -.
DR   OrthoDB; EOG091G0BQ7; -.
DR   PhylomeDB; Q5SVS4; -.
DR   TreeFam; TF323211; -.
DR   ChiTaRS; SLC25A30; human.
DR   GenomeRNAi; 253512; -.
DR   PRO; PR:Q5SVS4; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000174032; -.
DR   CleanEx; HS_SLC25A30; -.
DR   ExpressionAtlas; Q5SVS4; baseline and differential.
DR   Genevisible; Q5SVS4; HS.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; ISS:BHF-UCL.
DR   GO; GO:0022857; F:transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0006839; P:mitochondrial transport; IBA:GO_Central.
DR   Gene3D; 1.50.40.10; -; 1.
DR   InterPro; IPR002030; Mit_uncoupling_UCP-like.
DR   InterPro; IPR018108; Mitochondrial_sb/sol_carrier.
DR   InterPro; IPR023395; Mt_carrier_dom_sf.
DR   Pfam; PF00153; Mito_carr; 3.
DR   PRINTS; PR00784; MTUNCOUPLING.
DR   SUPFAM; SSF103506; SSF103506; 1.
DR   PROSITE; PS50920; SOLCAR; 3.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome; Membrane;
KW   Mitochondrion; Mitochondrion inner membrane; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:25944712}.
FT   CHAIN         2    291       Kidney mitochondrial carrier protein 1.
FT                                /FTId=PRO_0000288916.
FT   TRANSMEM      9     26       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM     71     89       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM    105    124       Helical; Name=3. {ECO:0000255}.
FT   TRANSMEM    164    183       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    204    224       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    264    283       Helical; Name=6. {ECO:0000255}.
FT   REPEAT        7     96       Solcar 1.
FT   REPEAT      104    189       Solcar 2.
FT   REPEAT      198    289       Solcar 3.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:25944712}.
FT   VAR_SEQ       1     51       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053984.
FT   CONFLICT    204    204       F -> L (in Ref. 1; BAG64115).
FT                                {ECO:0000305}.
SQ   SEQUENCE   291 AA;  32475 MW;  76A8A6F087454B7F CRC64;
     MSALNWKPFV YGGLASITAE CGTFPIDLTK TRLQIQGQTN DAKFKEIRYR GMLHALVRIG
     REEGLKALYS GIAPAMLRQA SYGTIKIGTY QSLKRLFIER PEDETLPINV ICGILSGVIS
     STIANPTDVL KIRMQAQSNT IQGGMIGNFM NIYQQEGTRG LWKGVSLTAQ RAAIVVGVEL
     PVYDITKKHL ILSGLMGDTV YTHFLSSFTC GLAGALASNP VDVVRTRMMN QRVLRDGRCS
     GYTGTLDCLL QTWKNEGFFA LYKGFWPNWL RLGPWNIIFF VTYEQLKKLD L
//
ID   Q6IBU4_HUMAN            Unreviewed;       211 AA.
AC   Q6IBU4;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   23-MAY-2018, entry version 104.
DE   SubName: Full=SDF2 protein {ECO:0000313|EMBL:CAG32989.1};
DE   SubName: Full=Stromal cell-derived factor 2 {ECO:0000313|EMBL:AAP35355.1};
DE   SubName: Full=Stromal cell-derived factor 2, isoform CRA_c {ECO:0000313|EMBL:EAW51123.1};
GN   Name=SDF2 {ECO:0000313|EMBL:CAG32989.1};
GN   ORFNames=hCG_2039636 {ECO:0000313|EMBL:EAW51123.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG32989.1};
RN   [1] {ECO:0000313|EMBL:EAW51123.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAP35355.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) System Donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:CAG32989.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:EAW51123.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BT006709; AAP35355.1; -; mRNA.
DR   EMBL; CR456708; CAG32989.1; -; mRNA.
DR   EMBL; CH471159; EAW51123.1; -; Genomic_DNA.
DR   RefSeq; NP_008854.2; NM_006923.3.
DR   UniGene; Hs.514036; -.
DR   SMR; Q6IBU4; -.
DR   DNASU; 6388; -.
DR   GeneID; 6388; -.
DR   KEGG; hsa:6388; -.
DR   CTD; 6388; -.
DR   EuPathDB; HostDB:ENSG00000132581.9; -.
DR   PharmGKB; PA35603; -.
DR   eggNOG; KOG3358; Eukaryota.
DR   eggNOG; ENOG410ZBU3; LUCA.
DR   HOVERGEN; HBG024385; -.
DR   OMA; MAQPSQN; -.
DR   OrthoDB; EOG091G0MFB; -.
DR   GenomeRNAi; 6388; -.
DR   Bgee; ENSG00000132581; -.
DR   ExpressionAtlas; Q6IBU4; baseline and differential.
DR   GO; GO:0016020; C:membrane; IEA:InterPro.
DR   InterPro; IPR027005; GlyclTrfase_39-like.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   PANTHER; PTHR10050; PTHR10050; 1.
DR   Pfam; PF02815; MIR; 1.
DR   SMART; SM00472; MIR; 3.
DR   SUPFAM; SSF82109; SSF82109; 1.
DR   PROSITE; PS50919; MIR; 3.
PE   2: Evidence at transcript level;
KW   Repeat {ECO:0000256|SAAS:SAAS00903904};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     18       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        19    211       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014310485.
FT   DOMAIN       21     75       MIR. {ECO:0000259|PROSITE:PS50919}.
FT   DOMAIN       83    138       MIR. {ECO:0000259|PROSITE:PS50919}.
FT   DOMAIN      139    193       MIR. {ECO:0000259|PROSITE:PS50919}.
SQ   SEQUENCE   211 AA;  23026 MW;  5EFC91C62E7B61E9 CRC64;
     MAVVPLLLLG GLWSAVGASS LGVVTCGSVV KLLNTRHNVR LHSHDVRYGS GSGQQSVTGV
     TSVDDSNSYW RIRGKSATVC ERGTPIKCGQ PIRLTHVNTG RNLHSHHFTS PLSGNQEVSA
     FGEEGEGDYL DDWTVLCNGP YWVRDGEVRF KHSSTEVLLS VTGEQYGRPI SGQKEVHGMA
     QPSQNNYWKA MEGIFMKPSE LLKAEAHHAE L
//
ID   SDF2_HUMAN              Reviewed;         211 AA.
AC   Q99470; Q9BQ79;
DT   20-JUN-2002, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   25-APR-2018, entry version 143.
DE   RecName: Full=Stromal cell-derived factor 2;
DE            Short=SDF-2;
DE   Flags: Precursor;
GN   Name=SDF2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Glioblastoma;
RX   PubMed=8918255; DOI=10.1016/0378-1119(96)00251-X;
RA   Hamada T., Tashiro K., Tada H., Inazawa J., Shirozu M., Shibahara K.,
RA   Nakamura T., Martina N., Nakano T., Honjo T.;
RT   "Isolation and characterization of a novel secretory protein, stromal
RT   cell-derived factor-2 (SDF-2) using the signal sequence trap method.";
RL   Gene 176:211-214(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4]
RP   CLEAVAGE OF SIGNAL PEPTIDE [LARGE SCALE ANALYSIS] AFTER ALA-18, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D50645; BAA09312.1; -; mRNA.
DR   EMBL; BC000500; AAH00500.1; -; mRNA.
DR   EMBL; BC001406; AAH01406.1; -; mRNA.
DR   CCDS; CCDS11238.1; -.
DR   PIR; JC5106; JC5106.
DR   RefSeq; NP_008854.2; NM_006923.3.
DR   UniGene; Hs.514036; -.
DR   ProteinModelPortal; Q99470; -.
DR   SMR; Q99470; -.
DR   BioGrid; 112289; 16.
DR   IntAct; Q99470; 6.
DR   STRING; 9606.ENSP00000247020; -.
DR   DrugBank; DB02201; Malonate Ion.
DR   iPTMnet; Q99470; -.
DR   PhosphoSitePlus; Q99470; -.
DR   BioMuta; SDF2; -.
DR   DMDM; 116242785; -.
DR   EPD; Q99470; -.
DR   MaxQB; Q99470; -.
DR   PaxDb; Q99470; -.
DR   PeptideAtlas; Q99470; -.
DR   PRIDE; Q99470; -.
DR   TopDownProteomics; Q99470; -.
DR   DNASU; 6388; -.
DR   Ensembl; ENST00000247020; ENSP00000247020; ENSG00000132581.
DR   GeneID; 6388; -.
DR   KEGG; hsa:6388; -.
DR   UCSC; uc002hbw.4; human.
DR   CTD; 6388; -.
DR   DisGeNET; 6388; -.
DR   EuPathDB; HostDB:ENSG00000132581.9; -.
DR   GeneCards; SDF2; -.
DR   HGNC; HGNC:10675; SDF2.
DR   HPA; HPA042799; -.
DR   MIM; 602934; gene.
DR   neXtProt; NX_Q99470; -.
DR   OpenTargets; ENSG00000132581; -.
DR   PharmGKB; PA35603; -.
DR   eggNOG; KOG3358; Eukaryota.
DR   eggNOG; ENOG410ZBU3; LUCA.
DR   GeneTree; ENSGT00510000046663; -.
DR   HOGENOM; HOG000236354; -.
DR   HOVERGEN; HBG024385; -.
DR   InParanoid; Q99470; -.
DR   OMA; MAQPSQN; -.
DR   OrthoDB; EOG091G0MFB; -.
DR   PhylomeDB; Q99470; -.
DR   TreeFam; TF314557; -.
DR   SignaLink; Q99470; -.
DR   GenomeRNAi; 6388; -.
DR   PRO; PR:Q99470; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000132581; -.
DR   CleanEx; HS_SDF2; -.
DR   ExpressionAtlas; Q99470; baseline and differential.
DR   Genevisible; Q99470; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; TAS:ProtInc.
DR   GO; GO:0004169; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; TAS:ProtInc.
DR   GO; GO:0071712; P:ER-associated misfolded protein catabolic process; IBA:GO_Central.
DR   GO; GO:0006486; P:protein glycosylation; TAS:ProtInc.
DR   InterPro; IPR027005; GlyclTrfase_39-like.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   PANTHER; PTHR10050; PTHR10050; 1.
DR   Pfam; PF02815; MIR; 1.
DR   SMART; SM00472; MIR; 3.
DR   SUPFAM; SSF82109; SSF82109; 1.
DR   PROSITE; PS50919; MIR; 3.
PE   1: Evidence at protein level;
KW   Complete proteome; Polymorphism; Reference proteome; Repeat; Secreted;
KW   Signal.
FT   SIGNAL        1     18       {ECO:0000244|PubMed:25944712,
FT                                ECO:0000255}.
FT   CHAIN        19    211       Stromal cell-derived factor 2.
FT                                /FTId=PRO_0000031955.
FT   DOMAIN       21     75       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN       83    138       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      139    193       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   VARIANT      15     15       A -> T (in dbSNP:rs35404078).
FT                                /FTId=VAR_051913.
FT   CONFLICT     51     51       G -> S (in Ref. 1; BAA09312).
FT                                {ECO:0000305}.
FT   CONFLICT     74     74       G -> R (in Ref. 1; BAA09312).
FT                                {ECO:0000305}.
FT   CONFLICT    119    119       S -> T (in Ref. 1; BAA09312).
FT                                {ECO:0000305}.
SQ   SEQUENCE   211 AA;  23026 MW;  5EFC91C62E7B61E9 CRC64;
     MAVVPLLLLG GLWSAVGASS LGVVTCGSVV KLLNTRHNVR LHSHDVRYGS GSGQQSVTGV
     TSVDDSNSYW RIRGKSATVC ERGTPIKCGQ PIRLTHVNTG RNLHSHHFTS PLSGNQEVSA
     FGEEGEGDYL DDWTVLCNGP YWVRDGEVRF KHSSTEVLLS VTGEQYGRPI SGQKEVHGMA
     QPSQNNYWKA MEGIFMKPSE LLKAEAHHAE L
//
ID   TBA4A_HUMAN             Reviewed;         448 AA.
AC   P68366; A8MUB1; B3KNQ6; P05215;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   23-MAY-2018, entry version 151.
DE   RecName: Full=Tubulin alpha-4A chain;
DE   AltName: Full=Alpha-tubulin 1;
DE   AltName: Full=Testis-specific alpha-tubulin;
DE   AltName: Full=Tubulin H2-alpha;
DE   AltName: Full=Tubulin alpha-1 chain;
GN   Name=TUBA4A; Synonyms=TUBA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3029670; DOI=10.1093/nar/15.1.199;
RA   Dobner P.R., Kislauskis E., Wentworth B.M., Villa-Komaroff L.;
RT   "Alternative 5' exons either provide or deny an initiator methionine
RT   codon to the same alpha-tubulin coding region.";
RL   Nucleic Acids Res. 15:199-218(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 41-60; 65-79; 85-121; 157-164; 216-280; 327-336;
RP   340-370; 391-401 AND 403-430, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Platelet;
RA   Bienvenut W.V., Claeys D.;
RL   Submitted (NOV-2005) to UniProtKB.
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   GLYCYLATION.
RX   PubMed=19524510; DOI=10.1016/j.cell.2009.05.020;
RA   Rogowski K., Juge F., van Dijk J., Wloga D., Strub J.-M.,
RA   Levilliers N., Thomas D., Bre M.-H., Van Dorsselaer A., Gaertig J.,
RA   Janke C.;
RT   "Evolutionary divergence of enzymatic mechanisms for posttranslational
RT   polyglycylation.";
RL   Cell 137:1076-1087(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   ACETYLATION AT LYS-40.
RX   PubMed=24906155; DOI=10.1016/j.cell.2014.03.061;
RA   Szyk A., Deaconescu A.M., Spector J., Goodman B., Valenstein M.L.,
RA   Ziolkowska N.E., Kormendi V., Grigorieff N., Roll-Mecak A.;
RT   "Molecular basis for age-dependent microtubule acetylation by tubulin
RT   acetyltransferase.";
RL   Cell 157:1405-1415(2014).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   INVOLVEMENT IN ALS22, VARIANTS ALS22 PRO-145; CYS-215; CYS-320;
RP   HIS-320 AND THR-383, AND CHARACTERIZATION OF VARIANTS ALS22 CYS-215;
RP   CYS-320; HIS-320 AND THR-383.
RX   PubMed=25374358; DOI=10.1016/j.neuron.2014.09.027;
RG   SLAGEN Consortium;
RA   Smith B.N., Ticozzi N., Fallini C., Gkazi A.S., Topp S., Kenna K.P.,
RA   Scotter E.L., Kost J., Keagle P., Miller J.W., Calini D., Vance C.,
RA   Danielson E.W., Troakes C., Tiloca C., Al-Sarraj S., Lewis E.A.,
RA   King A., Colombrita C., Pensato V., Castellotti B., de Belleroche J.,
RA   Baas F., ten Asbroek A.L., Sapp P.C., McKenna-Yasek D.,
RA   McLaughlin R.L., Polak M., Asress S., Esteban-Perez J.,
RA   Munoz-Blanco J.L., Simpson M., van Rheenen W., Diekstra F.P.,
RA   Lauria G., Duga S., Corti S., Cereda C., Corrado L., Soraru G.,
RA   Morrison K.E., Williams K.L., Nicholson G.A., Blair I.P., Dion P.A.,
RA   Leblond C.S., Rouleau G.A., Hardiman O., Veldink J.H.,
RA   van den Berg L.H., Al-Chalabi A., Pall H., Shaw P.J., Turner M.R.,
RA   Talbot K., Taroni F., Garcia-Redondo A., Wu Z., Glass J.D.,
RA   Gellera C., Ratti A., Brown R.H. Jr., Silani V., Shaw C.E.,
RA   Landers J.E.;
RT   "Exome-wide rare variant analysis identifies TUBA4A mutations
RT   associated with familial ALS.";
RL   Neuron 84:324-331(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [19]
RP   GLUTAMYLATION.
RX   PubMed=26875866; DOI=10.1016/j.cell.2016.01.019;
RA   Valenstein M.L., Roll-Mecak A.;
RT   "Graded control of microtubule severing by tubulin glutamylation.";
RL   Cell 164:911-921(2016).
CC   -!- FUNCTION: Tubulin is the major constituent of microtubules. It
CC       binds two moles of GTP, one at an exchangeable site on the beta
CC       chain and one at a non-exchangeable site on the alpha chain.
CC   -!- SUBUNIT: Dimer of alpha and beta chains. A typical microtubule is
CC       a hollow water-filled tube with an outer diameter of 25 nm and an
CC       inner diameter of 15 nM. Alpha-beta heterodimers associate head-
CC       to-tail to form protofilaments running lengthwise along the
CC       microtubule wall with the beta-tubulin subunit facing the
CC       microtubule plus end conferring a structural polarity.
CC       Microtubules usually have 13 protofilaments but different
CC       protofilament numbers can be found in some organisms and
CC       specialized cells. Interacts with CFAP157 (By similarity).
CC       {ECO:0000250|UniProtKB:P68368}.
CC   -!- INTERACTION:
CC       P30622:CLIP1; NbExp=3; IntAct=EBI-351772, EBI-2683569;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P68366-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P68366-2; Sequence=VSP_055194;
CC   -!- PTM: Some glutamate residues at the C-terminus are
CC       polyglutamylated, resulting in polyglutamate chains on the gamma-
CC       carboxyl group (PubMed:26875866). Polyglutamylation plays a key
CC       role in microtubule severing by spastin (SPAST). SPAST
CC       preferentially recognizes and acts on microtubules decorated with
CC       short polyglutamate tails: severing activity by SPAST increases as
CC       the number of glutamates per tubulin rises from one to eight, but
CC       decreases beyond this glutamylation threshold (PubMed:26875866).
CC       {ECO:0000269|PubMed:26875866}.
CC   -!- PTM: Some glutamate residues at the C-terminus are monoglycylated
CC       but not polyglycylated due to the absence of functional TTLL10 in
CC       human. Monoglycylation is mainly limited to tubulin incorporated
CC       into axonemes (cilia and flagella). Both polyglutamylation and
CC       monoglycylation can coexist on the same protein on adjacent
CC       residues, and lowering glycylation levels increases
CC       polyglutamylation, and reciprocally. The precise function of
CC       monoglycylation is still unclear (Probable).
CC       {ECO:0000305|PubMed:19524510}.
CC   -!- PTM: Acetylation of alpha chains at Lys-40 is located inside the
CC       microtubule lumen. This modification has been correlated with
CC       increased microtubule stability, intracellular transport and
CC       ciliary assembly. {ECO:0000269|PubMed:24906155}.
CC   -!- PTM: Methylation of alpha chains at Lys-40 is found in mitotic
CC       microtubules and is required for normal mitosis and cytokinesis
CC       contributing to genomic stability. {ECO:0000250|UniProtKB:P68363}.
CC   -!- DISEASE: Amyotrophic lateral sclerosis 22, with or without
CC       frontotemporal dementia (ALS22) [MIM:616208]: A neurodegenerative
CC       disorder affecting upper motor neurons in the brain and lower
CC       motor neurons in the brain stem and spinal cord, resulting in
CC       fatal paralysis. Sensory abnormalities are absent. The pathologic
CC       hallmarks of the disease include pallor of the corticospinal tract
CC       due to loss of motor neurons, presence of ubiquitin-positive
CC       inclusions within surviving motor neurons, and deposition of
CC       pathologic aggregates. The etiology of amyotrophic lateral
CC       sclerosis is likely to be multifactorial, involving both genetic
CC       and environmental factors. The disease is inherited in 5-10% of
CC       the cases. Patients with ALS22 may develop frontotemporal
CC       dementia. {ECO:0000269|PubMed:25374358}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: This tubulin does not have a C-terminal tyrosine.
CC   -!- SIMILARITY: Belongs to the tubulin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/tuba1/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Tubulin entry;
CC       URL="https://en.wikipedia.org/wiki/Tubulin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X06956; CAA30026.1; -; Genomic_DNA.
DR   EMBL; BT006731; AAP35377.1; -; mRNA.
DR   EMBL; AK054731; BAG51418.1; -; mRNA.
DR   EMBL; AK299958; BAH13182.1; -; mRNA.
DR   EMBL; AY895018; AAW65371.1; -; Genomic_DNA.
DR   EMBL; AC068946; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC114803; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471063; EAW70718.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70719.1; -; Genomic_DNA.
DR   EMBL; BC009238; AAH09238.1; -; mRNA.
DR   CCDS; CCDS2438.1; -. [P68366-1]
DR   CCDS; CCDS63131.1; -. [P68366-2]
DR   PIR; A25873; A25873.
DR   RefSeq; NP_001265481.1; NM_001278552.1. [P68366-2]
DR   RefSeq; NP_005991.1; NM_006000.2. [P68366-1]
DR   UniGene; Hs.75318; -.
DR   ProteinModelPortal; P68366; -.
DR   SMR; P68366; -.
DR   BioGrid; 113128; 286.
DR   CORUM; P68366; -.
DR   IntAct; P68366; 59.
DR   MINT; P68366; -.
DR   STRING; 9606.ENSP00000248437; -.
DR   ChEMBL; CHEMBL2095182; -.
DR   DrugBank; DB06772; Cabazitaxel.
DR   DrugBank; DB05147; CYT997.
DR   DrugBank; DB03010; Epothilone B.
DR   DrugBank; DB01873; Epothilone D.
DR   DrugBank; DB01179; Podofilox.
DR   DrugBank; DB05281; S-8184.
DR   DrugBank; DB00541; Vincristine.
DR   iPTMnet; P68366; -.
DR   PhosphoSitePlus; P68366; -.
DR   SwissPalm; P68366; -.
DR   DMDM; 55977476; -.
DR   DOSAC-COBS-2DPAGE; P68366; -.
DR   OGP; P05215; -.
DR   EPD; P68366; -.
DR   MaxQB; P68366; -.
DR   PaxDb; P68366; -.
DR   PeptideAtlas; P68366; -.
DR   PRIDE; P68366; -.
DR   DNASU; 7277; -.
DR   Ensembl; ENST00000248437; ENSP00000248437; ENSG00000127824. [P68366-1]
DR   Ensembl; ENST00000392088; ENSP00000375938; ENSG00000127824. [P68366-2]
DR   GeneID; 7277; -.
DR   KEGG; hsa:7277; -.
DR   UCSC; uc002vkt.3; human. [P68366-1]
DR   CTD; 7277; -.
DR   DisGeNET; 7277; -.
DR   EuPathDB; HostDB:ENSG00000127824.13; -.
DR   GeneCards; TUBA4A; -.
DR   HGNC; HGNC:12407; TUBA4A.
DR   HPA; CAB004621; -.
DR   HPA; CAB005887; -.
DR   HPA; HPA039247; -.
DR   HPA; HPA043684; -.
DR   HPA; HPA063394; -.
DR   MalaCards; TUBA4A; -.
DR   MIM; 191110; gene.
DR   MIM; 616208; phenotype.
DR   neXtProt; NX_P68366; -.
DR   OpenTargets; ENSG00000127824; -.
DR   PharmGKB; PA162407391; -.
DR   eggNOG; KOG1376; Eukaryota.
DR   eggNOG; COG5023; LUCA.
DR   GeneTree; ENSGT00760000119060; -.
DR   HOGENOM; HOG000165711; -.
DR   HOVERGEN; HBG000089; -.
DR   InParanoid; P68366; -.
DR   KO; K07374; -.
DR   OMA; HLHIGQA; -.
DR   OrthoDB; EOG091G0736; -.
DR   PhylomeDB; P68366; -.
DR   TreeFam; TF300314; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   Reactome; R-HSA-1445148; Translocation of GLUT4 to the plasma membrane.
DR   Reactome; R-HSA-190840; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane.
DR   Reactome; R-HSA-190861; Gap junction assembly.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-389957; Prefoldin mediated transfer of substrate to CCT/TriC.
DR   Reactome; R-HSA-389960; Formation of tubulin folding intermediates by CCT/TriC.
DR   Reactome; R-HSA-389977; Post-chaperonin tubulin folding pathway.
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   Reactome; R-HSA-5610787; Hedgehog 'off' state.
DR   Reactome; R-HSA-5617833; Cilium Assembly.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-5620924; Intraflagellar transport.
DR   Reactome; R-HSA-5626467; RHO GTPases activate IQGAPs.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-6807878; COPI-mediated anterograde transport.
DR   Reactome; R-HSA-6811434; COPI-dependent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-6811436; COPI-independent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   Reactome; R-HSA-8955332; Carboxyterminal post-translational modifications of tubulin.
DR   Reactome; R-HSA-983189; Kinesins.
DR   SIGNOR; P68366; -.
DR   ChiTaRS; TUBA4A; human.
DR   GeneWiki; TUBA4A; -.
DR   GenomeRNAi; 7277; -.
DR   PMAP-CutDB; P68366; -.
DR   PRO; PR:P68366; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000127824; -.
DR   CleanEx; HS_TUBA4A; -.
DR   ExpressionAtlas; P68366; baseline and differential.
DR   Genevisible; P68366; HS.
DR   GO; GO:0005856; C:cytoskeleton; IDA:ARUK-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005874; C:microtubule; IDA:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR   GO; GO:0019901; F:protein kinase binding; IPI:ARUK-UCL.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0007017; P:microtubule-based process; IEA:InterPro.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   Gene3D; 1.10.287.600; -; 1.
DR   Gene3D; 3.30.1330.20; -; 1.
DR   Gene3D; 3.40.50.1440; -; 1.
DR   InterPro; IPR002452; Alpha_tubulin.
DR   InterPro; IPR008280; Tub_FtsZ_C.
DR   InterPro; IPR000217; Tubulin.
DR   InterPro; IPR018316; Tubulin/FtsZ_2-layer-sand-dom.
DR   InterPro; IPR037103; Tubulin/FtsZ_C_sf.
DR   InterPro; IPR036525; Tubulin/FtsZ_GTPase_sf.
DR   InterPro; IPR023123; Tubulin_C.
DR   InterPro; IPR017975; Tubulin_CS.
DR   InterPro; IPR003008; Tubulin_FtsZ_GTPase.
DR   PANTHER; PTHR11588; PTHR11588; 1.
DR   Pfam; PF00091; Tubulin; 1.
DR   Pfam; PF03953; Tubulin_C; 1.
DR   PRINTS; PR01162; ALPHATUBULIN.
DR   PRINTS; PR01161; TUBULIN.
DR   SMART; SM00864; Tubulin; 1.
DR   SMART; SM00865; Tubulin_C; 1.
DR   SUPFAM; SSF52490; SSF52490; 1.
DR   SUPFAM; SSF55307; SSF55307; 1.
DR   PROSITE; PS00227; TUBULIN; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Amyotrophic lateral sclerosis;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   GTP-binding; Methylation; Microtubule; Neurodegeneration; Nitration;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome.
FT   CHAIN         1    448       Tubulin alpha-4A chain.
FT                                /FTId=PRO_0000048106.
FT   NP_BIND     142    148       GTP. {ECO:0000255}.
FT   MOD_RES      40     40       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:24906155}.
FT   MOD_RES      48     48       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      83     83       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:P68368}.
FT   MOD_RES     432    432       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q9BQE3}.
FT   MOD_RES     439    439       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5XIF6}.
FT   VAR_SEQ       1     15       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055194.
FT   VARIANT     145    145       T -> P (in ALS22; dbSNP:rs730880029).
FT                                {ECO:0000269|PubMed:25374358}.
FT                                /FTId=VAR_072714.
FT   VARIANT     215    215       R -> C (in ALS22; displays significantly
FT                                different distribution in terms of
FT                                incorporation into microtubules;
FT                                dbSNP:rs730880028).
FT                                {ECO:0000269|PubMed:25374358}.
FT                                /FTId=VAR_072715.
FT   VARIANT     320    320       R -> C (in ALS22; displays significantly
FT                                lower levels of dimer assembly;
FT                                dbSNP:rs730880025).
FT                                {ECO:0000269|PubMed:25374358}.
FT                                /FTId=VAR_072716.
FT   VARIANT     320    320       R -> H (in ALS22; displays significantly
FT                                lower levels of dimer assembly;
FT                                dbSNP:rs730880026).
FT                                {ECO:0000269|PubMed:25374358}.
FT                                /FTId=VAR_072717.
FT   VARIANT     383    383       A -> T (in ALS22; displays significantly
FT                                different distribution in terms of
FT                                incorporation into microtubules;
FT                                destabilizes the microtubule network;
FT                                dbSNP:rs368743618).
FT                                {ECO:0000269|PubMed:25374358}.
FT                                /FTId=VAR_072718.
SQ   SEQUENCE   448 AA;  49924 MW;  C00ED90A183FE8F2 CRC64;
     MRECISVHVG QAGVQMGNAC WELYCLEHGI QPDGQMPSDK TIGGGDDSFT TFFCETGAGK
     HVPRAVFVDL EPTVIDEIRN GPYRQLFHPE QLITGKEDAA NNYARGHYTI GKEIIDPVLD
     RIRKLSDQCT GLQGFLVFHS FGGGTGSGFT SLLMERLSVD YGKKSKLEFS IYPAPQVSTA
     VVEPYNSILT THTTLEHSDC AFMVDNEAIY DICRRNLDIE RPTYTNLNRL ISQIVSSITA
     SLRFDGALNV DLTEFQTNLV PYPRIHFPLA TYAPVISAEK AYHEQLSVAE ITNACFEPAN
     QMVKCDPRHG KYMACCLLYR GDVVPKDVNA AIAAIKTKRS IQFVDWCPTG FKVGINYQPP
     TVVPGGDLAK VQRAVCMLSN TTAIAEAWAR LDHKFDLMYA KRAFVHWYVG EGMEEGEFSE
     AREDMAALEK DYEEVGIDSY EDEDEGEE
//
ID   TBA1A_HUMAN             Reviewed;         451 AA.
AC   Q71U36; A8K0B8; G3V1U9; P04687; P05209;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   23-MAY-2018, entry version 151.
DE   RecName: Full=Tubulin alpha-1A chain;
DE   AltName: Full=Alpha-tubulin 3;
DE   AltName: Full=Tubulin B-alpha-1;
DE   AltName: Full=Tubulin alpha-3 chain;
DE   Contains:
DE     RecName: Full=Detyrosinated tubulin alpha-1A chain;
GN   Name=TUBA1A; Synonyms=TUBA3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3839072; DOI=10.1093/nar/13.1.207;
RA   Hall J.L., Cowan N.J.;
RT   "Structural features and restricted expression of a human alpha-
RT   tubulin gene.";
RL   Nucleic Acids Res. 13:207-223(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Retina;
RX   PubMed=11504633; DOI=10.1016/S0968-0896(01)00103-1;
RA   Crabtree D.V., Ojima I., Geng X., Adler A.J.;
RT   "Tubulins in the primate retina: evidence that xanthophylls may be
RT   endogenous ligands for the paclitaxel-binding site.";
RL   Bioorg. Med. Chem. 9:1967-1976(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 41-60; 65-79; 85-105; 113-121; 157-163; 216-304;
RP   312-320; 327-336; 340-352; 374-390; 395-401 AND 403-430, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 110-451.
RC   TISSUE=Fetal brain;
RX   PubMed=6646120; DOI=10.1128/MCB.3.10.1738;
RA   Cowan N.J., Dobner P., Fuchs E.V., Cleveland D.W.;
RT   "Expression of human alpha-tubulin genes: interspecies conservation of
RT   3' untranslated regions.";
RL   Mol. Cell. Biol. 3:1738-1745(1983).
RN   [9]
RP   PROTEIN SEQUENCE OF 439-451, AND NITRATION AT TYR-451.
RX   PubMed=10339593; DOI=10.1073/pnas.96.11.6365;
RA   Eiserich J.P., Estevez A.G., Bamberg T.V., Ye Y.Z., Chumley P.H.,
RA   Beckman J.S., Freeman B.A.;
RT   "Microtubule dysfunction by posttranslational nitrotyrosination of
RT   alpha-tubulin: a nitric oxide-dependent mechanism of cellular
RT   injury.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:6365-6370(1999).
RN   [10]
RP   TISSUE SPECIFICITY, AND VARIANTS LIS3 LEU-188; THR-263; CYS-264;
RP   PHE-286; HIS-402; CYS-402 AND LEU-419.
RX   PubMed=17584854; DOI=10.1002/humu.20572;
RA   Poirier K., Keays D.A., Francis F., Saillour Y., Bahi N.,
RA   Manouvrier S., Fallet-Bianco C., Pasquier L., Toutain A., Tuy F.P.,
RA   Bienvenu T., Joriot S., Odent S., Ville D., Desguerre I.,
RA   Goldenberg A., Moutard M.L., Fryns J.-P., van Esch H., Harvey R.J.,
RA   Siebold C., Flint J., Beldjord C., Chelly J.;
RT   "Large spectrum of lissencephaly and pachygyria phenotypes resulting
RT   from de novo missense mutations in tubulin alpha 1A (TUBA1A).";
RL   Hum. Mutat. 28:1055-1064(2007).
RN   [11]
RP   GLYCYLATION.
RX   PubMed=19524510; DOI=10.1016/j.cell.2009.05.020;
RA   Rogowski K., Juge F., van Dijk J., Wloga D., Strub J.-M.,
RA   Levilliers N., Thomas D., Bre M.-H., Van Dorsselaer A., Gaertig J.,
RA   Janke C.;
RT   "Evolutionary divergence of enzymatic mechanisms for posttranslational
RT   polyglycylation.";
RL   Cell 137:1076-1087(2009).
RN   [12]
RP   ACETYLATION AT LYS-40.
RX   PubMed=24906155; DOI=10.1016/j.cell.2014.03.061;
RA   Szyk A., Deaconescu A.M., Spector J., Goodman B., Valenstein M.L.,
RA   Ziolkowska N.E., Kormendi V., Grigorieff N., Roll-Mecak A.;
RT   "Molecular basis for age-dependent microtubule acetylation by tubulin
RT   acetyltransferase.";
RL   Cell 157:1405-1415(2014).
RN   [13]
RP   DETYROSINATION.
RX   PubMed=25908662; DOI=10.1126/science.aaa5175;
RA   Barisic M., Silva e Sousa R., Tripathy S.K., Magiera M.M.,
RA   Zaytsev A.V., Pereira A.L., Janke C., Grishchuk E.L., Maiato H.;
RT   "Mitosis. Microtubule detyrosination guides chromosomes during
RT   mitosis.";
RL   Science 348:799-803(2015).
RN   [14]
RP   GLUTAMYLATION.
RX   PubMed=26875866; DOI=10.1016/j.cell.2016.01.019;
RA   Valenstein M.L., Roll-Mecak A.;
RT   "Graded control of microtubule severing by tubulin glutamylation.";
RL   Cell 164:911-921(2016).
RN   [15]
RP   INTERACTION WITH SETD2.
RX   PubMed=27518565; DOI=10.1016/j.cell.2016.07.005;
RA   Park I.Y., Powell R.T., Tripathi D.N., Dere R., Ho T.H., Blasius T.L.,
RA   Chiang Y.C., Davis I.J., Fahey C.C., Hacker K.E., Verhey K.J.,
RA   Bedford M.T., Jonasch E., Rathmell W.K., Walker C.L.;
RT   "Dual chromatin and cytoskeletal remodeling by SETD2.";
RL   Cell 166:950-962(2016).
RN   [16]
RP   TYROSINATION.
RX   PubMed=26972003; DOI=10.1016/j.celrep.2016.02.046;
RA   Nirschl J.J., Magiera M.M., Lazarus J.E., Janke C., Holzbaur E.L.;
RT   "Alpha-tubulin tyrosination and CLIP-170 phosphorylation regulate the
RT   initiation of dynein-driven transport in neurons.";
RL   Cell Rep. 14:2637-2652(2016).
RN   [17]
RP   TYROSINATION.
RX   PubMed=26968983; DOI=10.15252/embj.201593071;
RA   McKenney R.J., Huynh W., Vale R.D., Sirajuddin M.;
RT   "Tyrosination of alpha-tubulin controls the initiation of processive
RT   dynein-dynactin motility.";
RL   EMBO J. 35:1175-1185(2016).
RN   [18]
RP   VARIANT LIS3 LEU-402.
RX   PubMed=25818041; DOI=10.1111/epi.12954;
RA   Mercimek-Mahmutoglu S., Patel J., Cordeiro D., Hewson S., Callen D.,
RA   Donner E.J., Hahn C.D., Kannu P., Kobayashi J., Minassian B.A.,
RA   Moharir M., Siriwardena K., Weiss S.K., Weksberg R., Snead O.C. III;
RT   "Diagnostic yield of genetic testing in epileptic encephalopathy in
RT   childhood.";
RL   Epilepsia 56:707-716(2015).
CC   -!- FUNCTION: Tubulin is the major constituent of microtubules. It
CC       binds two moles of GTP, one at an exchangeable site on the beta
CC       chain and one at a non-exchangeable site on the alpha chain.
CC   -!- SUBUNIT: Dimer of alpha and beta chains. A typical microtubule is
CC       a hollow water-filled tube with an outer diameter of 25 nm and an
CC       inner diameter of 15 nM. Alpha-beta heterodimers associate head-
CC       to-tail to form protofilaments running lengthwise along the
CC       microtubule wall with the beta-tubulin subunit facing the
CC       microtubule plus end conferring a structural polarity.
CC       Microtubules usually have 13 protofilaments but different
CC       protofilament numbers can be found in some organisms and
CC       specialized cells. Interacts with SETD2; the interaction is
CC       independent on alpha-tubulin acetylation on Lys-40.
CC   -!- INTERACTION:
CC       P30622-2:CLIP1; NbExp=3; IntAct=EBI-302552, EBI-6479976;
CC       Q9NQC7:CYLD; NbExp=6; IntAct=EBI-302552, EBI-2117940;
CC       P00533:EGFR; NbExp=3; IntAct=EBI-302552, EBI-297353;
CC       P05412:JUN; NbExp=3; IntAct=EBI-302552, EBI-852823;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q71U36-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q71U36-2; Sequence=VSP_046782;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed at a high level in fetal brain.
CC       {ECO:0000269|PubMed:17584854}.
CC   -!- PTM: Some glutamate residues at the C-terminus are
CC       polyglutamylated, resulting in polyglutamate chains on the gamma-
CC       carboxyl group (PubMed:26875866). Polyglutamylation plays a key
CC       role in microtubule severing by spastin (SPAST). SPAST
CC       preferentially recognizes and acts on microtubules decorated with
CC       short polyglutamate tails: severing activity by SPAST increases as
CC       the number of glutamates per tubulin rises from one to eight, but
CC       decreases beyond this glutamylation threshold (PubMed:26875866).
CC       {ECO:0000269|PubMed:26875866}.
CC   -!- PTM: Some glutamate residues at the C-terminus are monoglycylated
CC       but not polyglycylated due to the absence of functional TTLL10 in
CC       human. Monoglycylation is mainly limited to tubulin incorporated
CC       into axonemes (cilia and flagella). Both polyglutamylation and
CC       monoglycylation can coexist on the same protein on adjacent
CC       residues, and lowering glycylation levels increases
CC       polyglutamylation, and reciprocally. The precise function of
CC       monoglycylation is still unclear (Probable).
CC       {ECO:0000305|PubMed:19524510}.
CC   -!- PTM: Acetylation of alpha chains at Lys-40 is located inside the
CC       microtubule lumen. This modification has been correlated with
CC       increased microtubule stability, intracellular transport and
CC       ciliary assembly. {ECO:0000269|PubMed:24906155}.
CC   -!- PTM: Methylation of alpha chains at Lys-40 is found in mitotic
CC       microtubules and is required for normal mitosis and cytokinesis
CC       contributing to genomic stability. {ECO:0000250|UniProtKB:P68363}.
CC   -!- PTM: Nitration of Tyr-451 is irreversible and interferes with
CC       normal dynein intracellular distribution.
CC       {ECO:0000269|PubMed:10339593}.
CC   -!- PTM: Undergoes a tyrosination/detyrosination cycle, the cyclic
CC       removal and re-addition of a C-terminal tyrosine residue by the
CC       enzymes tubulin tyrosine carboxypeptidase (TTCP) and tubulin
CC       tyrosine ligase (TTL), respectively. {ECO:0000269|PubMed:25908662,
CC       ECO:0000269|PubMed:26968983, ECO:0000269|PubMed:26972003}.
CC   -!- PTM: Tubulin alpha-1A chain: Tyrosination promotes microtubule
CC       interaction with CAP-Gly domain-containing proteins such as CLIP1,
CC       CLIP2 and DCTN1. Tyrosination regulates the initiation of dynein-
CC       dynactin motility via interaction with DCTN1, which brings the
CC       dynein-dynactin complex into contact with microtubules
CC       (PubMed:26972003, PubMed:26968983). In neurons, tyrosinated
CC       tubulins mediate the initiation of retrograde vesicle transport
CC       (PubMed:26968983). {ECO:0000269|PubMed:26968983,
CC       ECO:0000269|PubMed:26972003}.
CC   -!- PTM: Detyrosinated tubulin alpha-1A chain: Detyrosination is
CC       involved in metaphase plate congression by guiding chromosomes
CC       during mitosis: detyrosination promotes interaction with CENPE,
CC       promoting pole-proximal transport of chromosomes toward the
CC       equator (PubMed:25908662). Detyrosination increases microtubules-
CC       dependent mechanotransduction in dystrophic cardiac and skeletal
CC       muscle. In cardiomyocytes, detyrosinated microtubules are required
CC       to resist to contractile compression during contraction:
CC       detyrosination promotes association with desmin (DES) at force-
CC       generating sarcomeres, leading to buckled microtubules and
CC       mechanical resistance to contraction (By similarity).
CC       {ECO:0000250|UniProtKB:P68369, ECO:0000269|PubMed:25908662}.
CC   -!- DISEASE: Lissencephaly 3 (LIS3) [MIM:611603]: A classic type
CC       lissencephaly associated with psychomotor retardation and
CC       seizures. Features include agyria or pachygyria or laminar
CC       heterotopia, severe mental retardation, motor delay, variable
CC       presence of seizures, and abnormalities of corpus callosum,
CC       hippocampus, cerebellar vermis and brainstem.
CC       {ECO:0000269|PubMed:17584854, ECO:0000269|PubMed:25818041}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the tubulin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X01703; CAA25855.1; -; Genomic_DNA.
DR   EMBL; AF141347; AAD33871.1; -; mRNA.
DR   EMBL; AK289483; BAF82172.1; -; mRNA.
DR   EMBL; AC010173; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471111; EAW58052.1; -; Genomic_DNA.
DR   EMBL; CH471111; EAW58054.1; -; Genomic_DNA.
DR   EMBL; CH471111; EAW58055.1; -; Genomic_DNA.
DR   EMBL; BC006468; AAH06468.1; -; mRNA.
DR   EMBL; BC050637; AAH50637.1; -; mRNA.
DR   EMBL; K00557; AAA91575.1; -; mRNA.
DR   CCDS; CCDS58226.1; -. [Q71U36-2]
DR   CCDS; CCDS58227.1; -. [Q71U36-1]
DR   CCDS; CCDS8781.1; -. [Q71U36-1]
DR   RefSeq; NP_001257328.1; NM_001270399.1. [Q71U36-1]
DR   RefSeq; NP_001257329.1; NM_001270400.1. [Q71U36-2]
DR   RefSeq; NP_006000.2; NM_006009.3. [Q71U36-1]
DR   UniGene; Hs.654422; -.
DR   PDB; 5JCO; EM; 4.00 A; A/B/E/F/G/H=1-437.
DR   PDBsum; 5JCO; -.
DR   ProteinModelPortal; Q71U36; -.
DR   SMR; Q71U36; -.
DR   BioGrid; 113603; 282.
DR   CORUM; Q71U36; -.
DR   DIP; DIP-32773N; -.
DR   ELM; Q71U36; -.
DR   IntAct; Q71U36; 352.
DR   MINT; Q71U36; -.
DR   STRING; 9606.ENSP00000301071; -.
DR   ChEMBL; CHEMBL3661; -.
DR   DrugBank; DB00518; Albendazole.
DR   DrugBank; DB05147; CYT997.
DR   DrugBank; DB03010; Epothilone B.
DR   DrugBank; DB01873; Epothilone D.
DR   DrugBank; DB00643; Mebendazole.
DR   DrugBank; DB00570; Vinblastine.
DR   iPTMnet; Q71U36; -.
DR   PhosphoSitePlus; Q71U36; -.
DR   SwissPalm; Q71U36; -.
DR   BioMuta; TUBA1A; -.
DR   DMDM; 55977864; -.
DR   EPD; Q71U36; -.
DR   MaxQB; Q71U36; -.
DR   PaxDb; Q71U36; -.
DR   PeptideAtlas; Q71U36; -.
DR   PRIDE; Q71U36; -.
DR   TopDownProteomics; Q71U36-1; -. [Q71U36-1]
DR   DNASU; 7846; -.
DR   Ensembl; ENST00000295766; ENSP00000439020; ENSG00000167552. [Q71U36-1]
DR   Ensembl; ENST00000301071; ENSP00000301071; ENSG00000167552. [Q71U36-1]
DR   Ensembl; ENST00000550767; ENSP00000446637; ENSG00000167552. [Q71U36-2]
DR   GeneID; 7846; -.
DR   KEGG; hsa:7846; -.
DR   UCSC; uc001rtp.5; human. [Q71U36-1]
DR   CTD; 7846; -.
DR   DisGeNET; 7846; -.
DR   EuPathDB; HostDB:ENSG00000167552.13; -.
DR   GeneCards; TUBA1A; -.
DR   HGNC; HGNC:20766; TUBA1A.
DR   HPA; CAB008686; -.
DR   HPA; HPA039247; -.
DR   HPA; HPA043684; -.
DR   HPA; HPA063394; -.
DR   MalaCards; TUBA1A; -.
DR   MIM; 602529; gene.
DR   MIM; 611603; phenotype.
DR   neXtProt; NX_Q71U36; -.
DR   OpenTargets; ENSG00000167552; -.
DR   Orphanet; 171680; Lissencephaly due to TUBA1A mutation.
DR   PharmGKB; PA162407319; -.
DR   eggNOG; KOG1376; Eukaryota.
DR   eggNOG; COG5023; LUCA.
DR   GeneTree; ENSGT00760000119060; -.
DR   HOGENOM; HOG000165711; -.
DR   HOVERGEN; HBG000089; -.
DR   InParanoid; Q71U36; -.
DR   KO; K07374; -.
DR   OMA; MDSTDGE; -.
DR   OrthoDB; EOG091G0736; -.
DR   PhylomeDB; Q71U36; -.
DR   TreeFam; TF300314; -.
DR   Reactome; R-HSA-1445148; Translocation of GLUT4 to the plasma membrane.
DR   Reactome; R-HSA-190840; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane.
DR   Reactome; R-HSA-190861; Gap junction assembly.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-389957; Prefoldin mediated transfer of substrate to CCT/TriC.
DR   Reactome; R-HSA-389960; Formation of tubulin folding intermediates by CCT/TriC.
DR   Reactome; R-HSA-389977; Post-chaperonin tubulin folding pathway.
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   Reactome; R-HSA-5610787; Hedgehog 'off' state.
DR   Reactome; R-HSA-5617833; Cilium Assembly.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-5620924; Intraflagellar transport.
DR   Reactome; R-HSA-5626467; RHO GTPases activate IQGAPs.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-6807878; COPI-mediated anterograde transport.
DR   Reactome; R-HSA-6811434; COPI-dependent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-6811436; COPI-independent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   Reactome; R-HSA-8955332; Carboxyterminal post-translational modifications of tubulin.
DR   Reactome; R-HSA-983189; Kinesins.
DR   SIGNOR; Q71U36; -.
DR   ChiTaRS; TUBA1A; human.
DR   GeneWiki; TUBA1A; -.
DR   GenomeRNAi; 7846; -.
DR   PMAP-CutDB; Q71U36; -.
DR   PRO; PR:Q71U36; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000167552; -.
DR   CleanEx; HS_TUBA1A; -.
DR   ExpressionAtlas; Q71U36; baseline and differential.
DR   Genevisible; Q71U36; HS.
DR   GO; GO:0005881; C:cytoplasmic microtubule; IEA:Ensembl.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0005874; C:microtubule; IDA:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0055037; C:recycling endosome; IDA:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro.
DR   GO; GO:0005198; F:structural molecule activity; TAS:BHF-UCL.
DR   GO; GO:0051301; P:cell division; TAS:BHF-UCL.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0030705; P:cytoskeleton-dependent intracellular transport; TAS:BHF-UCL.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0007017; P:microtubule-based process; TAS:BHF-UCL.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   Gene3D; 1.10.287.600; -; 1.
DR   Gene3D; 3.30.1330.20; -; 1.
DR   Gene3D; 3.40.50.1440; -; 1.
DR   InterPro; IPR002452; Alpha_tubulin.
DR   InterPro; IPR008280; Tub_FtsZ_C.
DR   InterPro; IPR000217; Tubulin.
DR   InterPro; IPR018316; Tubulin/FtsZ_2-layer-sand-dom.
DR   InterPro; IPR037103; Tubulin/FtsZ_C_sf.
DR   InterPro; IPR036525; Tubulin/FtsZ_GTPase_sf.
DR   InterPro; IPR023123; Tubulin_C.
DR   InterPro; IPR017975; Tubulin_CS.
DR   InterPro; IPR003008; Tubulin_FtsZ_GTPase.
DR   PANTHER; PTHR11588; PTHR11588; 1.
DR   Pfam; PF00091; Tubulin; 1.
DR   Pfam; PF03953; Tubulin_C; 1.
DR   PRINTS; PR01162; ALPHATUBULIN.
DR   PRINTS; PR01161; TUBULIN.
DR   SMART; SM00864; Tubulin; 1.
DR   SMART; SM00865; Tubulin_C; 1.
DR   SUPFAM; SSF52490; SSF52490; 1.
DR   SUPFAM; SSF55307; SSF55307; 1.
DR   PROSITE; PS00227; TUBULIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Direct protein sequencing; Disease mutation;
KW   GTP-binding; Isopeptide bond; Lissencephaly; Methylation; Microtubule;
KW   Nitration; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    451       Tubulin alpha-1A chain.
FT                                /FTId=PRO_0000048111.
FT   CHAIN         1    450       Detyrosinated tubulin alpha-1A chain.
FT                                {ECO:0000305|PubMed:25908662}.
FT                                /FTId=PRO_0000437378.
FT   NP_BIND     142    148       GTP. {ECO:0000255}.
FT   SITE        451    451       Involved in polymerization.
FT                                {ECO:0000250}.
FT   MOD_RES      40     40       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:24906155}.
FT   MOD_RES     282    282       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:P68373}.
FT   MOD_RES     439    439       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P68373}.
FT   MOD_RES     445    445       5-glutamyl polyglutamate.
FT                                {ECO:0000250|UniProtKB:P68369}.
FT   MOD_RES     451    451       3'-nitrotyrosine.
FT                                {ECO:0000269|PubMed:10339593}.
FT   VAR_SEQ       1     35       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_046782.
FT   VARIANT     188    188       I -> L (in LIS3; dbSNP:rs137853045).
FT                                {ECO:0000269|PubMed:17584854}.
FT                                /FTId=VAR_039332.
FT   VARIANT     263    263       P -> T (in LIS3; dbSNP:rs137853046).
FT                                {ECO:0000269|PubMed:17584854}.
FT                                /FTId=VAR_039333.
FT   VARIANT     264    264       R -> C (in LIS3; dbSNP:rs137853043).
FT                                {ECO:0000269|PubMed:17584854}.
FT                                /FTId=VAR_039334.
FT   VARIANT     286    286       L -> F (in LIS3).
FT                                {ECO:0000269|PubMed:17584854}.
FT                                /FTId=VAR_039335.
FT   VARIANT     402    402       R -> C (in LIS3; dbSNP:rs587784483).
FT                                {ECO:0000269|PubMed:17584854}.
FT                                /FTId=VAR_039336.
FT   VARIANT     402    402       R -> H (in LIS3; dbSNP:rs137853044).
FT                                {ECO:0000269|PubMed:17584854}.
FT                                /FTId=VAR_039337.
FT   VARIANT     402    402       R -> L (in LIS3; dbSNP:rs137853044).
FT                                {ECO:0000269|PubMed:25818041}.
FT                                /FTId=VAR_078711.
FT   VARIANT     419    419       S -> L (in LIS3; dbSNP:rs137853047).
FT                                {ECO:0000269|PubMed:17584854}.
FT                                /FTId=VAR_039338.
FT   VARIANT     447    447       E -> K (in dbSNP:rs1065730).
FT                                /FTId=VAR_034540.
FT   CONFLICT    131    131       G -> R (in Ref. 1; CAA25855 and 8;
FT                                AAA91575). {ECO:0000305}.
FT   CONFLICT    290    290       E -> D (in Ref. 8; AAA91575).
FT                                {ECO:0000305}.
FT   CONFLICT    308    308       R -> G (in Ref. 1; CAA25855 and 8;
FT                                AAA91575). {ECO:0000305}.
FT   CONFLICT    438    438       D -> H (in Ref. 1; CAA25855).
FT                                {ECO:0000305}.
SQ   SEQUENCE   451 AA;  50136 MW;  00F8429A4A10E5FE CRC64;
     MRECISIHVG QAGVQIGNAC WELYCLEHGI QPDGQMPSDK TIGGGDDSFN TFFSETGAGK
     HVPRAVFVDL EPTVIDEVRT GTYRQLFHPE QLITGKEDAA NNYARGHYTI GKEIIDLVLD
     RIRKLADQCT GLQGFLVFHS FGGGTGSGFT SLLMERLSVD YGKKSKLEFS IYPAPQVSTA
     VVEPYNSILT THTTLEHSDC AFMVDNEAIY DICRRNLDIE RPTYTNLNRL IGQIVSSITA
     SLRFDGALNV DLTEFQTNLV PYPRIHFPLA TYAPVISAEK AYHEQLSVAE ITNACFEPAN
     QMVKCDPRHG KYMACCLLYR GDVVPKDVNA AIATIKTKRT IQFVDWCPTG FKVGINYQPP
     TVVPGGDLAK VQRAVCMLSN TTAIAEAWAR LDHKFDLMYA KRAFVHWYVG EGMEEGEFSE
     AREDMAALEK DYEEVGVDSV EGEGEEEGEE Y
//
ID   TBB8_HUMAN              Reviewed;         444 AA.
AC   Q3ZCM7; Q5SQX9; Q8WZ78;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   26-FEB-2008, sequence version 2.
DT   25-APR-2018, entry version 120.
DE   RecName: Full=Tubulin beta-8 chain {ECO:0000305};
DE   AltName: Full=Tubulin beta 8 class VIII {ECO:0000312|HGNC:HGNC:20773};
GN   Name=TUBB8 {ECO:0000312|HGNC:HGNC:20773};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11731935; DOI=10.1086/338307;
RA   van Geel M., Eichler E.E., Beck A.F., Shan Z., Haaf T.,
RA   van der Maarel S.M., Frants R.R., de Jong P.J.;
RT   "A cascade of complex subtelomeric duplications during the evolution
RT   of the hominoid and Old World monkey genomes.";
RL   Am. J. Hum. Genet. 70:269-278(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Fetal brain;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4-444.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION AT SER-172.
RX   PubMed=16371510; DOI=10.1091/mbc.E05-07-0621;
RA   Fourest-Lieuvin A., Peris L., Gache V., Garcia-Saez I.,
RA   Juillan-Binard C., Lantez V., Job D.;
RT   "Microtubule regulation in mitosis: tubulin phosphorylation by the
RT   cyclin-dependent kinase Cdk1.";
RL   Mol. Biol. Cell 17:1041-1050(2006).
RN   [7]
RP   GLYCYLATION.
RX   PubMed=19524510; DOI=10.1016/j.cell.2009.05.020;
RA   Rogowski K., Juge F., van Dijk J., Wloga D., Strub J.-M.,
RA   Levilliers N., Thomas D., Bre M.-H., Van Dorsselaer A., Gaertig J.,
RA   Janke C.;
RT   "Evolutionary divergence of enzymatic mechanisms for posttranslational
RT   polyglycylation.";
RL   Cell 137:1076-1087(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   GLUTAMYLATION.
RX   PubMed=26875866; DOI=10.1016/j.cell.2016.01.019;
RA   Valenstein M.L., Roll-Mecak A.;
RT   "Graded control of microtubule severing by tubulin glutamylation.";
RL   Cell 164:911-921(2016).
RN   [10]
RP   INVOLVEMENT IN OOMD2, VARIANTS OOMD2 27-GLU--ALA-33 DEL; LEU-176;
RP   VAL-210; MET-238; MET-255; TRP-262; PRO-285 AND SER-348, AND
RP   CHARACTERIZATION OF VARIANTS OOMD2 27-GLU--ALA-33 DEL; LEU-176;
RP   VAL-210; MET-238; MET-255; TRP-262; PRO-285 AND SER-348.
RX   PubMed=27273344; DOI=10.1136/jmedgenet-2016-103891;
RA   Feng R., Yan Z., Li B., Yu M., Sang Q., Tian G., Xu Y., Chen B.,
RA   Qu R., Sun Z., Sun X., Jin L., He L., Kuang Y., Cowan N.J., Wang L.;
RT   "Mutations in TUBB8 cause a multiplicity of phenotypes in human
RT   oocytes and early embryos.";
RL   J. Med. Genet. 53:662-671(2016).
RN   [11]
RP   FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, INVOLVEMENT IN
RP   OOMD2, VARIANTS OOMD2 LYS-2; LEU-176; ALA-229; GLN-262; ILE-300;
RP   THR-363 AND ASN-417, AND CHARACTERIZATION OF VARIANTS OOMD2 LYS-2;
RP   LEU-176; ALA-229; GLN-262; ILE-300; THR-363 AND ASN-417.
RX   PubMed=26789871; DOI=10.1056/NEJMoa1510791;
RA   Feng R., Sang Q., Kuang Y., Sun X., Yan Z., Zhang S., Shi J., Tian G.,
RA   Luchniak A., Fukuda Y., Li B., Yu M., Chen J., Xu Y., Guo L., Qu R.,
RA   Wang X., Sun Z., Liu M., Shi H., Wang H., Feng Y., Shao R., Chai R.,
RA   Li Q., Xing Q., Zhang R., Nogales E., Jin L., He L., Gupta M.L. Jr.,
RA   Cowan N.J., Wang L.;
RT   "Mutations in TUBB8 and human oocyte meiotic arrest.";
RL   N. Engl. J. Med. 374:223-232(2016).
CC   -!- FUNCTION: Tubulin is the major constituent of microtubules. It
CC       binds two moles of GTP, one at an exchangeable site on the beta
CC       chain and one at a non-exchangeable site on the alpha chain (By
CC       similarity). TUBB8 has a key role in meiotic spindle assembly and
CC       oocyte maturation (PubMed:26789871). {ECO:0000250,
CC       ECO:0000269|PubMed:26789871}.
CC   -!- SUBUNIT: Dimer of alpha and beta chains. A typical microtubule is
CC       a hollow water-filled tube with an outer diameter of 25 nm and an
CC       inner diameter of 15 nM. Alpha-beta heterodimers associate head-
CC       to-tail to form protofilaments running lengthwise along the
CC       microtubule wall with the beta-tubulin subunit facing the
CC       microtubule plus end conferring a structural polarity.
CC       Microtubules usually have 13 protofilaments but different
CC       protofilament numbers can be found in some organisms and
CC       specialized cells.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:26789871}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000269|PubMed:26789871}.
CC   -!- TISSUE SPECIFICITY: Expressed at a high level in oocytes, at
CC       different stages of development. {ECO:0000269|PubMed:26789871}.
CC   -!- PTM: Some glutamate residues at the C-terminus are
CC       polyglutamylated, resulting in polyglutamate chains on the gamma-
CC       carboxyl group (PubMed:26875866). Polyglutamylation plays a key
CC       role in microtubule severing by spastin (SPAST). SPAST
CC       preferentially recognizes and acts on microtubules decorated with
CC       short polyglutamate tails: severing activity by SPAST increases as
CC       the number of glutamates per tubulin rises from one to eight, but
CC       decreases beyond this glutamylation threshold (PubMed:26875866).
CC       {ECO:0000269|PubMed:26875866}.
CC   -!- PTM: Some glutamate residues at the C-terminus are monoglycylated
CC       but not polyglycylated due to the absence of functional TTLL10 in
CC       human. Monoglycylation is mainly limited to tubulin incorporated
CC       into axonemes (cilia and flagella). Both polyglutamylation and
CC       monoglycylation can coexist on the same protein on adjacent
CC       residues, and lowering glycylation levels increases
CC       polyglutamylation, and reciprocally. The precise function of
CC       monoglycylation is still unclear (Probable).
CC       {ECO:0000305|PubMed:19524510}.
CC   -!- PTM: Phosphorylated on Ser-172 by CDK1 during the cell cycle, from
CC       metaphase to telophase, but not in interphase. This
CC       phosphorylation inhibits tubulin incorporation into microtubules.
CC       {ECO:0000269|PubMed:16371510}.
CC   -!- DISEASE: Oocyte maturation defect 2 (OOMD2) [MIM:616780]: An
CC       autosomal dominant infertility disorder caused by defective oocyte
CC       maturation. Oocytes are arrested at metaphase I, and have an
CC       abnormal or no detectable spindle on polarization microscopy.
CC       {ECO:0000269|PubMed:26789871, ECO:0000269|PubMed:27273344}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the tubulin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAI16221.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF355127; AAL32434.1; -; Genomic_DNA.
DR   EMBL; CR590375; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL713922; CAI16221.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471072; EAW86545.1; -; Genomic_DNA.
DR   EMBL; BC101270; AAI01271.1; -; mRNA.
DR   EMBL; BC101271; AAI01272.1; -; mRNA.
DR   CCDS; CCDS7051.1; -.
DR   RefSeq; NP_817124.1; NM_177987.2.
DR   UniGene; Hs.532659; -.
DR   ProteinModelPortal; Q3ZCM7; -.
DR   SMR; Q3ZCM7; -.
DR   BioGrid; 131462; 200.
DR   IntAct; Q3ZCM7; 13.
DR   STRING; 9606.ENSP00000328808; -.
DR   ChEMBL; CHEMBL2095182; -.
DR   iPTMnet; Q3ZCM7; -.
DR   PhosphoSitePlus; Q3ZCM7; -.
DR   SwissPalm; Q3ZCM7; -.
DR   BioMuta; TUBB8; -.
DR   DMDM; 182705285; -.
DR   EPD; Q3ZCM7; -.
DR   MaxQB; Q3ZCM7; -.
DR   PaxDb; Q3ZCM7; -.
DR   PeptideAtlas; Q3ZCM7; -.
DR   PRIDE; Q3ZCM7; -.
DR   DNASU; 347688; -.
DR   Ensembl; ENST00000568584; ENSP00000456206; ENSG00000261456.
DR   GeneID; 347688; -.
DR   KEGG; hsa:347688; -.
DR   UCSC; uc001ifi.3; human.
DR   CTD; 347688; -.
DR   DisGeNET; 347688; -.
DR   EuPathDB; HostDB:ENSG00000261456.5; -.
DR   GeneCards; TUBB8; -.
DR   H-InvDB; HIX0029368; -.
DR   HGNC; HGNC:20773; TUBB8.
DR   HPA; HPA043640; -.
DR   HPA; HPA046280; -.
DR   MalaCards; TUBB8; -.
DR   MIM; 616768; gene.
DR   MIM; 616780; phenotype.
DR   neXtProt; NX_Q3ZCM7; -.
DR   OpenTargets; ENSG00000261456; -.
DR   eggNOG; KOG1375; Eukaryota.
DR   eggNOG; COG5023; LUCA.
DR   GeneTree; ENSGT00760000119061; -.
DR   HOGENOM; HOG000165710; -.
DR   HOVERGEN; HBG000089; -.
DR   InParanoid; Q3ZCM7; -.
DR   KO; K07375; -.
DR   OMA; LTQIGQC; -.
DR   OrthoDB; EOG091G06U2; -.
DR   PhylomeDB; Q3ZCM7; -.
DR   TreeFam; TF300298; -.
DR   Reactome; R-HSA-1445148; Translocation of GLUT4 to the plasma membrane.
DR   Reactome; R-HSA-190840; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane.
DR   Reactome; R-HSA-190861; Gap junction assembly.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   Reactome; R-HSA-5617833; Cilium Assembly.
DR   Reactome; R-HSA-5626467; RHO GTPases activate IQGAPs.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-6807878; COPI-mediated anterograde transport.
DR   Reactome; R-HSA-6811434; COPI-dependent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-6811436; COPI-independent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8955332; Carboxyterminal post-translational modifications of tubulin.
DR   Reactome; R-HSA-983189; Kinesins.
DR   ChiTaRS; TUBB8; human.
DR   GenomeRNAi; 347688; -.
DR   PRO; PR:Q3ZCM7; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000261456; -.
DR   ExpressionAtlas; Q3ZCM7; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0072687; C:meiotic spindle; IDA:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro.
DR   GO; GO:0001556; P:oocyte maturation; IMP:UniProtKB.
DR   GO; GO:0007056; P:spindle assembly involved in female meiosis; IMP:UniProtKB.
DR   Gene3D; 1.10.287.600; -; 1.
DR   Gene3D; 3.30.1330.20; -; 1.
DR   Gene3D; 3.40.50.1440; -; 1.
DR   InterPro; IPR013838; Beta-tubulin_BS.
DR   InterPro; IPR002453; Beta_tubulin.
DR   InterPro; IPR008280; Tub_FtsZ_C.
DR   InterPro; IPR000217; Tubulin.
DR   InterPro; IPR018316; Tubulin/FtsZ_2-layer-sand-dom.
DR   InterPro; IPR037103; Tubulin/FtsZ_C_sf.
DR   InterPro; IPR036525; Tubulin/FtsZ_GTPase_sf.
DR   InterPro; IPR023123; Tubulin_C.
DR   InterPro; IPR017975; Tubulin_CS.
DR   InterPro; IPR003008; Tubulin_FtsZ_GTPase.
DR   PANTHER; PTHR11588; PTHR11588; 1.
DR   PANTHER; PTHR11588:SF256; PTHR11588:SF256; 1.
DR   Pfam; PF00091; Tubulin; 1.
DR   Pfam; PF03953; Tubulin_C; 1.
DR   PRINTS; PR01163; BETATUBULIN.
DR   PRINTS; PR01161; TUBULIN.
DR   SMART; SM00864; Tubulin; 1.
DR   SMART; SM00865; Tubulin_C; 1.
DR   SUPFAM; SSF52490; SSF52490; 1.
DR   SUPFAM; SSF55307; SSF55307; 1.
DR   PROSITE; PS00227; TUBULIN; 1.
DR   PROSITE; PS00228; TUBULIN_B_AUTOREG; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Disease mutation;
KW   GTP-binding; Isopeptide bond; Microtubule; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    444       Tubulin beta-8 chain.
FT                                /FTId=PRO_0000320631.
FT   NP_BIND     140    146       GTP. {ECO:0000255}.
FT   MOD_RES     172    172       Phosphoserine; by CDK1.
FT                                {ECO:0000269|PubMed:16371510}.
FT   MOD_RES     436    436       5-glutamyl polyglutamate.
FT                                {ECO:0000250|UniProtKB:Q2T9S0}.
FT   VARIANT       2      2       R -> K (in OOMD2; loss of function in
FT                                oocyte maturation; decreased alpha/beta-
FT                                tubulin heterodimer assembly;
FT                                dbSNP:rs869025273).
FT                                {ECO:0000269|PubMed:26789871}.
FT                                /FTId=VAR_076898.
FT   VARIANT      27     33       Missing (in OOMD2; loss of alpha/beta-
FT                                tubulin heterodimer assembly; loss of
FT                                function in meiotic spindle assembly).
FT                                {ECO:0000269|PubMed:27273344}.
FT                                /FTId=VAR_076899.
FT   VARIANT     176    176       S -> L (in OOMD2; loss of function in
FT                                oocyte maturation; loss of function in
FT                                meiotic spindle assembly; decreased
FT                                alpha/beta-tubulin heterodimer assembly;
FT                                dbSNP:rs869025609).
FT                                {ECO:0000269|PubMed:26789871,
FT                                ECO:0000269|PubMed:27273344}.
FT                                /FTId=VAR_076900.
FT   VARIANT     210    210       I -> V (in OOMD2; decreased alpha/beta-
FT                                tubulin heterodimer assembly; loss of
FT                                function in meiotic spindle assembly;
FT                                dbSNP:rs781853492).
FT                                {ECO:0000269|PubMed:27273344}.
FT                                /FTId=VAR_076901.
FT   VARIANT     229    229       V -> A (in OOMD2; loss of function in
FT                                oocyte maturation; decreased alpha/beta-
FT                                tubulin heterodimer assembly;
FT                                dbSNP:rs869025271).
FT                                {ECO:0000269|PubMed:26789871}.
FT                                /FTId=VAR_076902.
FT   VARIANT     238    238       T -> M (in OOMD2; decreased alpha/beta-
FT                                tubulin heterodimer assembly; loss of
FT                                function in meiotic spindle assembly).
FT                                {ECO:0000269|PubMed:27273344}.
FT                                /FTId=VAR_076903.
FT   VARIANT     255    255       V -> M (in OOMD2; loss of function in
FT                                meiotic spindle assembly;
FT                                dbSNP:rs782269374).
FT                                {ECO:0000269|PubMed:27273344}.
FT                                /FTId=VAR_076904.
FT   VARIANT     262    262       R -> Q (in OOMD2; loss of function in
FT                                oocyte maturation; decreased alpha/beta-
FT                                tubulin heterodimer assembly;
FT                                dbSNP:rs869025610).
FT                                {ECO:0000269|PubMed:26789871}.
FT                                /FTId=VAR_076905.
FT   VARIANT     262    262       R -> W (in OOMD2; decreased alpha/beta-
FT                                tubulin heterodimer assembly; does not
FT                                affect function in meiotic spindle
FT                                assembly; dbSNP:rs782486119).
FT                                {ECO:0000269|PubMed:27273344}.
FT                                /FTId=VAR_076906.
FT   VARIANT     285    285       T -> P (in OOMD2; loss of function in
FT                                meiotic spindle assembly).
FT                                {ECO:0000269|PubMed:27273344}.
FT                                /FTId=VAR_076907.
FT   VARIANT     300    300       M -> I (in OOMD2; loss of function in
FT                                oocyte maturation; decreased alpha/beta-
FT                                tubulin heterodimer assembly;
FT                                dbSNP:rs869025612).
FT                                {ECO:0000269|PubMed:26789871}.
FT                                /FTId=VAR_076908.
FT   VARIANT     345    345       L -> F (in dbSNP:rs4880608).
FT                                /FTId=VAR_039240.
FT   VARIANT     348    348       N -> S (in OOMD2; loss of function in
FT                                meiotic spindle assembly).
FT                                {ECO:0000269|PubMed:27273344}.
FT                                /FTId=VAR_076909.
FT   VARIANT     363    363       M -> T (in OOMD2; loss of function in
FT                                oocyte maturation; decreased alpha/beta-
FT                                tubulin heterodimer assembly;
FT                                dbSNP:rs869025611).
FT                                {ECO:0000269|PubMed:26789871}.
FT                                /FTId=VAR_076910.
FT   VARIANT     417    417       D -> N (in OOMD2; loss of function in
FT                                oocyte maturation; loss of function in
FT                                meiotic spindle assembly; decreased
FT                                alpha/beta-tubulin heterodimer assembly;
FT                                dbSNP:rs869025272).
FT                                {ECO:0000269|PubMed:26789871}.
FT                                /FTId=VAR_076911.
SQ   SEQUENCE   444 AA;  49776 MW;  3EC4AC10946BF590 CRC64;
     MREIVLTQIG QCGNQIGAKF WEVISDEHAI DSAGTYHGDS HLQLERINVY YNEASGGRYV
     PRAVLVDLEP GTMDSVRSGP FGQVFRPDNF IFGQCGAGNN WAKGHYTEGA ELMESVMDVV
     RKEAESCDCL QGFQLTHSLG GGTGSGMGTL LLSKIREEYP DRIINTFSIL PSPKVSDTVV
     EPYNATLSVH QLIENADETF CIDNEALYDI CSKTLKLPTP TYGDLNHLVS ATMSGVTTCL
     RFPGQLNADL RKLAVNMVPF PRLHFFMPGF APLTSRGSQQ YRALTVAELT QQMFDAKNMM
     AACDPRHGRY LTAAAIFRGR MPMREVDEQM FNIQDKNSSY FADWLPNNVK TAVCDIPPRG
     LKMSATFIGN NTAIQELFKR VSEQFTAMFR RKAFLHWYTG EGMDEMEFTE AESNMNDLVS
     EYQQYQDATA EEEEDEEYAE EEVA
//
ID   A0A087WWG3_HUMAN        Unreviewed;       347 AA.
AC   A0A087WWG3;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   23-MAY-2018, entry version 24.
DE   SubName: Full=COBW domain-containing protein 3 {ECO:0000313|Ensembl:ENSP00000480203};
GN   Name=CBWD3 {ECO:0000313|Ensembl:ENSP00000480203};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000480203, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000480203, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000480203}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL353608; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FQ976557; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_005277697.1; XM_005277640.2.
DR   UniGene; Hs.645337; -.
DR   ProteinModelPortal; A0A087WWG3; -.
DR   STRING; 9606.ENSP00000366612; -.
DR   PaxDb; A0A087WWG3; -.
DR   PeptideAtlas; A0A087WWG3; -.
DR   Ensembl; ENST00000618217; ENSP00000480203; ENSG00000196873.
DR   GeneID; 445571; -.
DR   UCSC; uc004agl.6; human.
DR   CTD; 445571; -.
DR   EuPathDB; HostDB:ENSG00000196873.15; -.
DR   HGNC; HGNC:18519; CBWD3.
DR   OpenTargets; ENSG00000196873; -.
DR   eggNOG; KOG2743; Eukaryota.
DR   eggNOG; COG0523; LUCA.
DR   GeneTree; ENSGT00640000091523; -.
DR   ChiTaRS; CBWD3; human.
DR   GenomeRNAi; 445571; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000196873; -.
DR   ExpressionAtlas; A0A087WWG3; baseline and differential.
DR   Gene3D; 3.30.1220.10; -; 1.
DR   InterPro; IPR011629; Cbl_biosynth_CobW-like_C.
DR   InterPro; IPR036627; CobW-likC_sf.
DR   InterPro; IPR003495; CobW/HypB/UreG_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF02492; cobW; 1.
DR   Pfam; PF07683; CobW_C; 1.
DR   SMART; SM00833; CobW_C; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   4: Predicted;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      226    329       CobW C-terminal.
FT                                {ECO:0000259|SMART:SM00833}.
SQ   SEQUENCE   347 AA;  38697 MW;  43302B134345E3C8 CRC64;
     MLPAVGSVDE EEDPAEEDCP ELVPIETTQS EEEEKSGLGA KIPVTIITGY LGAGKTTLLN
     YILTEQHSKR VAVILNESGE GSALEKSLAV SQGGELYEEW LELRNGCLCC SVKDNGLRAI
     ENLMQKKGKF DDILLETTGL ADPGAVASMF WVDAELGSDI YLDGIITIVD SKYGLKHLTE
     EKPDGLINEA TRSINGLGQI LETQRSSLQK KLQHVPGTQP HLDQSIVTIT FEVPGNAKEE
     HLNMFIQNLL WEKNVRNKDN HCMEVIRLKG LVSIKDKSQQ VIVQGVHELY DLEETPVSWK
     DDTERTNRLV LIGRNLDKDI LKQLFIATVT ETEKQWTTHF KEDQVCT
//
ID   A0A0A0MRU4_HUMAN        Unreviewed;       376 AA.
AC   A0A0A0MRU4;
DT   07-JAN-2015, integrated into UniProtKB/TrEMBL.
DT   07-JAN-2015, sequence version 1.
DT   23-MAY-2018, entry version 26.
DE   SubName: Full=COBW domain-containing protein 3 {ECO:0000313|Ensembl:ENSP00000366559};
GN   Name=CBWD3 {ECO:0000313|Ensembl:ENSP00000366559};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000366559, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000366559, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000366559}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL353608; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FQ976557; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_005277694.1; XM_005277637.2.
DR   UniGene; Hs.645337; -.
DR   ProteinModelPortal; A0A0A0MRU4; -.
DR   PeptideAtlas; A0A0A0MRU4; -.
DR   Ensembl; ENST00000377342; ENSP00000366559; ENSG00000196873.
DR   GeneID; 445571; -.
DR   UCSC; uc064tni.1; human.
DR   CTD; 445571; -.
DR   EuPathDB; HostDB:ENSG00000196873.15; -.
DR   HGNC; HGNC:18519; CBWD3.
DR   OpenTargets; ENSG00000196873; -.
DR   eggNOG; KOG2743; Eukaryota.
DR   eggNOG; COG0523; LUCA.
DR   GeneTree; ENSGT00640000091523; -.
DR   ChiTaRS; CBWD3; human.
DR   GenomeRNAi; 445571; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000196873; -.
DR   ExpressionAtlas; A0A0A0MRU4; baseline and differential.
DR   Gene3D; 3.30.1220.10; -; 1.
DR   InterPro; IPR011629; Cbl_biosynth_CobW-like_C.
DR   InterPro; IPR036627; CobW-likC_sf.
DR   InterPro; IPR003495; CobW/HypB/UreG_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF02492; cobW; 1.
DR   Pfam; PF07683; CobW_C; 1.
DR   SMART; SM00833; CobW_C; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   4: Predicted;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      255    358       CobW C-terminal.
FT                                {ECO:0000259|SMART:SM00833}.
SQ   SEQUENCE   376 AA;  41985 MW;  A1B1D96D0657A8D1 CRC64;
     MLPAVGSVDE EEDPAEEDCP ELVPIETTQS EEEEKSGLGA KIPVTIITGY LGAGKTTLLN
     YILTEQHSKR VAVILNESGE GSALEKSLAV SQGGELYEEW LELRNGCLCC SVKDNGLRAI
     ENLMQKKGKF DDILLETTGL ADPGAVASMF WVDAELGSDI YLDGIITIVD SKYGLKHLTE
     EKPDGLINEA TRQVALADII LINKTDLVPE EDVKKLRTTI RSINGLGQIL ETQRSSLQKK
     LQHVPGTQPH LDQSIVTITF EVPGNAKEEH LNMFIQNLLW EKNVRNKDNH CMEVIRLKGL
     VSIKDKSQQV IVQGVHELYD LEETPVSWKD DTERTNRLVL IGRNLDKDIL KQLFIATVTE
     TEKQWTTHFK EDQVCT
//
ID   A0A0A6YYH9_HUMAN        Unreviewed;       375 AA.
AC   A0A0A6YYH9;
DT   04-FEB-2015, integrated into UniProtKB/TrEMBL.
DT   04-FEB-2015, sequence version 1.
DT   23-MAY-2018, entry version 22.
DE   SubName: Full=COBW domain-containing protein 5 {ECO:0000313|Ensembl:ENSP00000405076};
GN   Name=CBWD5 {ECO:0000313|Ensembl:ENSP00000405076};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000405076, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000405076, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000405076}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (DEC-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX284632; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001278750.1; NM_001291821.1.
DR   RefSeq; XP_005272807.1; XM_005272750.1.
DR   UniGene; Hs.355950; -.
DR   UniGene; Hs.531330; -.
DR   UniGene; Hs.635227; -.
DR   UniGene; Hs.645337; -.
DR   UniGene; Hs.645504; -.
DR   ProteinModelPortal; A0A0A6YYH9; -.
DR   SMR; A0A0A6YYH9; -.
DR   EPD; A0A0A6YYH9; -.
DR   Ensembl; ENST00000429800; ENSP00000405076; ENSG00000147996.
DR   GeneID; 220869; -.
DR   GeneID; 445571; -.
DR   CTD; 220869; -.
DR   CTD; 445571; -.
DR   EuPathDB; HostDB:ENSG00000147996.16; -.
DR   HGNC; HGNC:24584; CBWD5.
DR   OpenTargets; ENSG00000147996; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000147996; -.
DR   ExpressionAtlas; A0A0A6YYH9; baseline and differential.
DR   Gene3D; 3.30.1220.10; -; 1.
DR   InterPro; IPR011629; Cbl_biosynth_CobW-like_C.
DR   InterPro; IPR036627; CobW-likC_sf.
DR   InterPro; IPR003495; CobW/HypB/UreG_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF02492; cobW; 1.
DR   Pfam; PF07683; CobW_C; 1.
DR   SMART; SM00833; CobW_C; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   4: Predicted;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      254    357       CobW C-terminal.
FT                                {ECO:0000259|SMART:SM00833}.
SQ   SEQUENCE   375 AA;  41897 MW;  D2D4CD5D9A8D3963 CRC64;
     MLPAVGSVDE EEDPAEEDCP ELVPIETTQS EEEEKSGLGA KIPVTIITGY LGAGKTTLLN
     YILTEQHSKR VAVILNESGE GSALEKSLAV SQGGELYEEW LELRNGCLCC SVKDNGLRAI
     ENLMQKKGKF DDILLETTGL ADPGIITIVD SKYGLKHLTE EKPDGLINEA TRQVALADII
     LINKTDLVPE EDVKKLRTTI RSINGLGQIL ETQRSRVDLS NVLDLHAFDS LSGISLQKKL
     QHVPGTQPHL DQSIVTITFE VPGNAKEEHL NMFIQNLLWE KNVRNKDNHC MEVIRLKGLV
     SIKDKSQQVI VQGVHELYDL EETPVSWKDD TERTNRLVLI GRNLDKDILK QLFIATVTET
     EKQWTTHFKE DQVCT
//
ID   CBWD3_HUMAN             Reviewed;         395 AA.
AC   Q5JTY5; B4DNG9; Q6VB91;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 1.
DT   28-FEB-2018, entry version 100.
DE   RecName: Full=COBW domain-containing protein 3;
DE   AltName: Full=Cobalamin synthase W domain-containing protein 3;
GN   Name=CBWD3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=15233989; DOI=10.1016/j.ygeno.2004.03.001;
RA   Wong A., Vallender E.J., Heretis K., Ilkin Y., Lahn B.T.,
RA   Lese Martin C., Ledbetter D.H.;
RT   "Diverse fates of paralogs following segmental duplication of
RT   telomeric genes.";
RL   Genomics 84:239-247(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   IDENTIFICATION.
RX   PubMed=12421752; DOI=10.1101/gr.338402;
RA   Fan Y., Newman T., Linardopoulou E., Trask B.J.;
RT   "Gene content and function of the ancestral chromosome fusion site in
RT   human chromosome 2q13-2q14.1 and paralogous regions.";
RL   Genome Res. 12:1663-1672(2002).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q5JTY5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5JTY5-2; Sequence=VSP_055975;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the SIMIBI class G3E GTPase family. CobW
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY344633; AAQ76870.1; -; mRNA.
DR   EMBL; AK297912; BAG60231.1; -; mRNA.
DR   EMBL; AL353608; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX284632; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS35038.2; -. [Q5JTY5-1]
DR   RefSeq; NP_001278750.1; NM_001291821.1. [Q5JTY5-2]
DR   RefSeq; NP_958861.2; NM_201453.3. [Q5JTY5-1]
DR   RefSeq; XP_005272807.1; XM_005272750.1. [Q5JTY5-2]
DR   UniGene; Hs.355950; -.
DR   UniGene; Hs.531330; -.
DR   UniGene; Hs.635227; -.
DR   UniGene; Hs.645337; -.
DR   UniGene; Hs.645504; -.
DR   ProteinModelPortal; Q5JTY5; -.
DR   SMR; Q5JTY5; -.
DR   BioGrid; 128658; 1.
DR   BioGrid; 138650; 24.
DR   IntAct; Q5JTY5; 2.
DR   STRING; 9606.ENSP00000353295; -.
DR   iPTMnet; Q5JTY5; -.
DR   PhosphoSitePlus; Q5JTY5; -.
DR   BioMuta; CBWD3; -.
DR   DMDM; 74742238; -.
DR   MaxQB; Q5JTY5; -.
DR   PaxDb; Q5JTY5; -.
DR   PeptideAtlas; Q5JTY5; -.
DR   PRIDE; Q5JTY5; -.
DR   DNASU; 445571; -.
DR   Ensembl; ENST00000360171; ENSP00000353295; ENSG00000196873. [Q5JTY5-1]
DR   GeneID; 220869; -.
DR   GeneID; 445571; -.
DR   KEGG; hsa:445571; -.
DR   UCSC; uc004agi.6; human. [Q5JTY5-1]
DR   CTD; 220869; -.
DR   CTD; 445571; -.
DR   EuPathDB; HostDB:ENSG00000196873.15; -.
DR   GeneCards; CBWD3; -.
DR   HGNC; HGNC:18519; CBWD3.
DR   HPA; HPA042759; -.
DR   HPA; HPA042813; -.
DR   MIM; 611080; gene.
DR   neXtProt; NX_Q5JTY5; -.
DR   OpenTargets; ENSG00000147996; -.
DR   OpenTargets; ENSG00000196873; -.
DR   PharmGKB; PA134863724; -.
DR   eggNOG; KOG2743; Eukaryota.
DR   eggNOG; COG0523; LUCA.
DR   GeneTree; ENSGT00640000091523; -.
DR   HOGENOM; HOG000182211; -.
DR   HOVERGEN; HBG056297; -.
DR   InParanoid; Q5JTY5; -.
DR   OMA; TFFMDDE; -.
DR   OrthoDB; EOG091G0JUI; -.
DR   PhylomeDB; Q5JTY5; -.
DR   TreeFam; TF332679; -.
DR   ChiTaRS; CBWD3; human.
DR   PRO; PR:Q5JTY5; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000196873; -.
DR   ExpressionAtlas; Q5JTY5; baseline and differential.
DR   Genevisible; Q5JTY5; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.1220.10; -; 1.
DR   InterPro; IPR011629; Cbl_biosynth_CobW-like_C.
DR   InterPro; IPR036627; CobW-likC_sf.
DR   InterPro; IPR003495; CobW/HypB/UreG_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF02492; cobW; 1.
DR   Pfam; PF07683; CobW_C; 1.
DR   SMART; SM00833; CobW_C; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; ATP-binding; Complete proteome;
KW   Nucleotide-binding; Reference proteome.
FT   CHAIN         1    395       COBW domain-containing protein 3.
FT                                /FTId=PRO_0000317238.
FT   DOMAIN      274    377       CobW C-terminal.
FT   NP_BIND      49     56       ATP. {ECO:0000255}.
FT   NP_BIND     110    114       ATP. {ECO:0000255}.
FT   NP_BIND     203    206       ATP. {ECO:0000255}.
FT   VAR_SEQ     145    164       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055975.
FT   CONFLICT    132    132       D -> Y (in Ref. 1; AAQ76870).
FT                                {ECO:0000305}.
SQ   SEQUENCE   395 AA;  44038 MW;  52EE727920F143DE CRC64;
     MLPAVGSVDE EEDPAEEDCP ELVPIETTQS EEEEKSGLGA KIPVTIITGY LGAGKTTLLN
     YILTEQHSKR VAVILNESGE GSALEKSLAV SQGGELYEEW LELRNGCLCC SVKDNGLRAI
     ENLMQKKGKF DDILLETTGL ADPGAVASMF WVDAELGSDI YLDGIITIVD SKYGLKHLTE
     EKPDGLINEA TRQVALADII LINKTDLVPE EDVKKLRTTI RSINGLGQIL ETQRSRVDLS
     NVLDLHAFDS LSGISLQKKL QHVPGTQPHL DQSIVTITFE VPGNAKEEHL NMFIQNLLWE
     KNVRNKDNHC MEVIRLKGLV SIKDKSQQVI VQGVHELYDL EETPVSWKDD TERTNRLVLI
     GRNLDKDILK QLFIATVTET EKQWTTHFKE DQVCT
//
ID   SCPDL_HUMAN             Reviewed;         429 AA.
AC   Q8NBX0; Q8TAR0; Q9Y363;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   28-FEB-2018, entry version 123.
DE   RecName: Full=Saccharopine dehydrogenase-like oxidoreductase;
DE            EC=1.-.-.-;
GN   Name=SCCPDH; ORFNames=CGI-49;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-29; 63-103; 141-167; 199-211; 215-228; 243-257;
RP   330-353; 366-394 AND 417-429, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V.;
RL   Submitted (JAN-2010) to UniProtKB.
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-217, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- SIMILARITY: Belongs to the saccharopine dehydrogenase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF151807; AAD34044.1; -; mRNA.
DR   EMBL; AK075178; BAC11453.1; -; mRNA.
DR   EMBL; AL591848; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC026185; AAH26185.1; -; mRNA.
DR   CCDS; CCDS31084.1; -.
DR   RefSeq; NP_057086.2; NM_016002.2.
DR   UniGene; Hs.498397; -.
DR   ProteinModelPortal; Q8NBX0; -.
DR   SMR; Q8NBX0; -.
DR   BioGrid; 119286; 54.
DR   IntAct; Q8NBX0; 5.
DR   MINT; Q8NBX0; -.
DR   STRING; 9606.ENSP00000355467; -.
DR   iPTMnet; Q8NBX0; -.
DR   PhosphoSitePlus; Q8NBX0; -.
DR   SwissPalm; Q8NBX0; -.
DR   BioMuta; SCCPDH; -.
DR   DMDM; 73919294; -.
DR   EPD; Q8NBX0; -.
DR   MaxQB; Q8NBX0; -.
DR   PaxDb; Q8NBX0; -.
DR   PeptideAtlas; Q8NBX0; -.
DR   PRIDE; Q8NBX0; -.
DR   TopDownProteomics; Q8NBX0; -.
DR   DNASU; 51097; -.
DR   Ensembl; ENST00000366510; ENSP00000355467; ENSG00000143653.
DR   GeneID; 51097; -.
DR   KEGG; hsa:51097; -.
DR   UCSC; uc001ibr.4; human.
DR   CTD; 51097; -.
DR   EuPathDB; HostDB:ENSG00000143653.9; -.
DR   GeneCards; SCCPDH; -.
DR   HGNC; HGNC:24275; SCCPDH.
DR   HPA; HPA050775; -.
DR   neXtProt; NX_Q8NBX0; -.
DR   OpenTargets; ENSG00000143653; -.
DR   PharmGKB; PA142670949; -.
DR   eggNOG; KOG2733; Eukaryota.
DR   eggNOG; COG3268; LUCA.
DR   GeneTree; ENSGT00390000004799; -.
DR   HOGENOM; HOG000251397; -.
DR   HOVERGEN; HBG057028; -.
DR   InParanoid; Q8NBX0; -.
DR   OMA; ICTQVKG; -.
DR   OrthoDB; EOG091G07C9; -.
DR   PhylomeDB; Q8NBX0; -.
DR   TreeFam; TF314904; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   ChiTaRS; SCCPDH; human.
DR   GenomeRNAi; 51097; -.
DR   PRO; PR:Q8NBX0; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143653; -.
DR   CleanEx; HS_SCCPDH; -.
DR   Genevisible; Q8NBX0; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005811; C:lipid droplet; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0030496; C:midbody; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR005097; Sacchrp_dh_NADP.
DR   Pfam; PF03435; Sacchrp_dh_NADP; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Direct protein sequencing;
KW   Oxidoreductase; Phosphoprotein; Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|Ref.5}.
FT   CHAIN         2    429       Saccharopine dehydrogenase-like
FT                                oxidoreductase.
FT                                /FTId=PRO_0000212840.
FT   MOD_RES       2      2       N-acetylalanine. {ECO:0000269|Ref.5}.
FT   MOD_RES     217    217       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     418    418       G -> R (in dbSNP:rs7779).
FT                                /FTId=VAR_034486.
FT   CONFLICT     37     43       SSRLPWA -> TQPALG (in Ref. 1; AAD34044).
FT                                {ECO:0000305}.
FT   CONFLICT    187    187       P -> H (in Ref. 4; AAH26185).
FT                                {ECO:0000305}.
FT   CONFLICT    347    347       Q -> R (in Ref. 4; AAH26185).
FT                                {ECO:0000305}.
SQ   SEQUENCE   429 AA;  47151 MW;  A93EBEDDF128A548 CRC64;
     MATEQRPFHL VVFGASGFTG QFVTEEVARE QVDPERSSRL PWAVAGRSRE KLQRVLEKAA
     LKLGRPTLSS EVGIIICDIA NPASLDEMAK QATVVLNCVG PYRFYGEPVI KACIENGASC
     IDISGEPQFL ELMQLKYHEK AADKGVYIIG SSGFDSIPAD LGVIYTRNKM NGTLTAVESF
     LTIHSGPEGL SIHDGTWKSA IYGFGDQSNL RKLRNVSNLK PVPLIGPKLK RRWPISYCRE
     LKGYSIPFMG SDVSVVRRTQ RYLYENLEES PVQYAAYVTV GGITSVIKLM FAGLFFLFFV
     RFGIGRQLLI KFPWFFSFGY FSKQGPTQKQ IDAASFTLTF FGQGYSQGTG TDKNKPNIKI
     CTQVKGPEAG YVATPIAMVQ AAMTLLSDAS HLPKAGGVFT PGAAFSKTKL IDRLNKHGIE
     FSVISSSEV
//
ID   KCD21_HUMAN             Reviewed;         260 AA.
AC   Q4G0X4; B4DTR0;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   30-AUG-2005, sequence version 1.
DT   28-FEB-2018, entry version 95.
DE   RecName: Full=BTB/POZ domain-containing protein KCTD21;
DE   AltName: Full=KCASH2 protein {ECO:0000303|PubMed:21472142};
DE   AltName: Full=Potassium channel tetramerization domain-containing protein 21;
GN   Name=KCTD21;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   SUBUNIT, FUNCTION, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   85-ASP--TYR-87.
RX   PubMed=21472142;
RA   De Smaele E., Di Marcotullio L., Moretti M., Pelloni M.,
RA   Occhione M.A., Infante P., Cucchi D., Greco A., Pietrosanti L.,
RA   Todorovic J., Coni S., Canettieri G., Ferretti E., Bei R., Maroder M.,
RA   Screpanti I., Gulino A.;
RT   "Identification and characterization of KCASH2 and KCASH3, 2 novel
RT   Cullin3 adaptors suppressing histone deacetylase and Hedgehog activity
RT   in medulloblastoma.";
RL   Neoplasia 13:374-385(2011).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Probable substrate-specific adapter of a BCR (BTB-CUL3-
CC       RBX1) E3 ubiquitin-protein ligase complex mediating the
CC       ubiquitination and subsequent proteasomal degradation of target
CC       proteins. Promotes the ubiquitination of HDAC1. Can function as
CC       antagonist of the Hedgehog pathway by affecting the nuclear
CC       transfer of transcription factor GLI1; the function probably
CC       occurs via HDAC1 down-regulation, keeping GLI1 acetylated and
CC       inactive. Inhibits cell growth and tumorigenicity of
CC       medulloblastoma (MDB) (PubMed:21472142).
CC       {ECO:0000269|PubMed:21472142}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Homopentamer (By similarity). Interacts with KCTD11;
CC       KCTD21 and KCTD11 may associate in pentameric assemblies.
CC       Interacts (via BTB domain) with CUL3; indicative for a
CC       participation in a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase
CC       complex (PubMed:21472142). {ECO:0000250|UniProtKB:Q693B1,
CC       ECO:0000250|UniProtKB:Q8NC69, ECO:0000269|PubMed:21472142,
CC       ECO:0000305}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-11976683, EBI-11976683;
CC       O60437:PPL; NbExp=4; IntAct=EBI-11976683, EBI-368321;
CC   -!- TISSUE SPECIFICITY: Highly expressed in cerebellum and brain.
CC       Expression is down-regulated in medulloblastoma.
CC       {ECO:0000269|PubMed:21472142}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK300320; BAG62072.1; -; mRNA.
DR   EMBL; BC036058; AAH36058.1; -; mRNA.
DR   CCDS; CCDS31645.1; -.
DR   RefSeq; NP_001025030.1; NM_001029859.2.
DR   RefSeq; XP_005273985.1; XM_005273928.1.
DR   RefSeq; XP_006718580.1; XM_006718517.2.
DR   RefSeq; XP_006718581.1; XM_006718518.3.
DR   RefSeq; XP_011543257.1; XM_011544955.2.
DR   UniGene; Hs.528439; -.
DR   ProteinModelPortal; Q4G0X4; -.
DR   SMR; Q4G0X4; -.
DR   BioGrid; 129500; 13.
DR   IntAct; Q4G0X4; 11.
DR   iPTMnet; Q4G0X4; -.
DR   PhosphoSitePlus; Q4G0X4; -.
DR   BioMuta; KCTD21; -.
DR   DMDM; 121943921; -.
DR   EPD; Q4G0X4; -.
DR   MaxQB; Q4G0X4; -.
DR   PaxDb; Q4G0X4; -.
DR   PeptideAtlas; Q4G0X4; -.
DR   PRIDE; Q4G0X4; -.
DR   Ensembl; ENST00000340067; ENSP00000339340; ENSG00000188997.
DR   GeneID; 283219; -.
DR   KEGG; hsa:283219; -.
DR   UCSC; uc001ozb.4; human.
DR   CTD; 283219; -.
DR   DisGeNET; 283219; -.
DR   EuPathDB; HostDB:ENSG00000188997.7; -.
DR   GeneCards; KCTD21; -.
DR   HGNC; HGNC:27452; KCTD21.
DR   HPA; HPA041964; -.
DR   neXtProt; NX_Q4G0X4; -.
DR   OpenTargets; ENSG00000188997; -.
DR   PharmGKB; PA145148689; -.
DR   eggNOG; KOG2723; Eukaryota.
DR   eggNOG; ENOG410Z155; LUCA.
DR   GeneTree; ENSGT00760000119013; -.
DR   HOGENOM; HOG000231837; -.
DR   HOVERGEN; HBG080457; -.
DR   InParanoid; Q4G0X4; -.
DR   KO; K21922; -.
DR   OMA; YTRQNLK; -.
DR   OrthoDB; EOG091G0DC8; -.
DR   PhylomeDB; Q4G0X4; -.
DR   TreeFam; TF315332; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; KCTD21; human.
DR   GenomeRNAi; 283219; -.
DR   PRO; PR:Q4G0X4; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000188997; -.
DR   CleanEx; HS_KCTD21; -.
DR   ExpressionAtlas; Q4G0X4; baseline and differential.
DR   Genevisible; Q4G0X4; HS.
DR   GO; GO:0097602; F:cullin family protein binding; IDA:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway.
DR   GO; GO:0040008; P:regulation of growth; IEA:UniProtKB-KW.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   Pfam; PF02214; BTB_2; 1.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
DR   PROSITE; PS50097; BTB; 1.
PE   1: Evidence at protein level;
KW   Coiled coil; Complete proteome; Growth regulation; Reference proteome;
KW   Tumor suppressor; Ubl conjugation pathway.
FT   CHAIN         1    260       BTB/POZ domain-containing protein KCTD21.
FT                                /FTId=PRO_0000281151.
FT   DOMAIN        3     72       BTB. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00037}.
FT   COILED       88    112       {ECO:0000255}.
FT   COMPBIAS    135    140       Poly-Ser.
FT   MUTAGEN      85     87       DFY->KKK: Abolishes interaction with
FT                                CUL3. {ECO:0000269|PubMed:21472142}.
FT   CONFLICT    152    152       S -> P (in Ref. 1; BAG62072).
FT                                {ECO:0000305}.
SQ   SEQUENCE   260 AA;  29643 MW;  E94BAD422C106070 CRC64;
     MSDPITLNVG GKLYTTSLAT LTSFPDSMLG AMFSGKMPTK RDSQGNCFID RDGKVFRYIL
     NFLRTSHLDL PEDFQEMGLL RREADFYQVQ PLIEALQEKE VELSKAEKNA MLNITLNQRV
     QTVHFTVREA PQIYSLSSSS MEVFNANIFS TSCLFLKLLG SKLFYCSNGN LSSITSHLQD
     PNHLTLDWVA NVEGLPEEEY TKQNLKRLWV VPANKQINSF QVFVEEVLKI ALSDGFCIDS
     SHPHALDFMN NKIIRLIRYR
//
ID   A0A087WV86_HUMAN        Unreviewed;       634 AA.
AC   A0A087WV86;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   23-MAY-2018, entry version 30.
DE   SubName: Full=Protein aurora borealis {ECO:0000313|Ensembl:ENSP00000479266};
GN   Name=BORA {ECO:0000313|Ensembl:ENSP00000479266};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000479266, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000479266, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [4] {ECO:0000213|PubMed:19369195}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [5] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [6] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7] {ECO:0000313|Ensembl:ENSP00000479266}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL138695; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001273675.1; NM_001286746.1.
DR   UniGene; Hs.643464; -.
DR   EPD; A0A087WV86; -.
DR   PeptideAtlas; A0A087WV86; -.
DR   Ensembl; ENST00000613797; ENSP00000479266; ENSG00000136122.
DR   GeneID; 79866; -.
DR   UCSC; uc010aen.2; human.
DR   CTD; 79866; -.
DR   EuPathDB; HostDB:ENSG00000136122.15; -.
DR   HGNC; HGNC:24724; BORA.
DR   OpenTargets; ENSG00000136122; -.
DR   eggNOG; ENOG410IHF2; Eukaryota.
DR   eggNOG; ENOG410ZQ9X; LUCA.
DR   GeneTree; ENSGT00390000013790; -.
DR   OMA; CSPIKNW; -.
DR   OrthoDB; EOG091G0569; -.
DR   ChiTaRS; BORA; human.
DR   GenomeRNAi; 79866; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000136122; -.
DR   ExpressionAtlas; A0A087WV86; baseline and differential.
DR   GO; GO:0072687; C:meiotic spindle; IEA:Ensembl.
DR   InterPro; IPR023252; Aurora_borealis_protein.
DR   PANTHER; PTHR14728; PTHR14728; 1.
DR   Pfam; PF15280; BORA_N; 1.
DR   PRINTS; PR02038; AURORABORA.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A0A087WV86,
KW   ECO:0000213|MaxQB:A0A087WV86, ECO:0000213|PeptideAtlas:A0A087WV86};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   634 AA;  69126 MW;  A0654DD5528C2825 CRC64;
     MERFLFPAPD LPARSPLVNG SSQGVGVEER GTRKSGHVGL GATPPSHSIQ GSRLHLNLPE
     VDSFPPHPAK FSLCAMGDVK ESKMQITPET PGRIPVLNPF ESPSDYSNLH EQTLASPSVF
     KSTKLPTPGK FRWSIDQLAV INPVEIDPED IHRQALYLSH SRIDKDVEDK RQKAIEEFFT
     KDVIVPSPWT DHEGKQLSQC HSSKCTNINS DSPVGKKLTI HSEKSDAACQ TLLSLPVDFN
     LENILGDYFR ADEFADQSPG NLSSSSLRRK LFLDGNGSIS DSLPSASPGS PHSGVQTSLE
     MFYSIDLSPV KCRSPLQTPS SGQFSSSPIQ ASAKKYSLGS ITSPSPISSP TFSPIEFQIG
     ETPLSEQRKF TVHSPDASSG TNSNGITNPC IRSPYIDGCS PIKNWSPMRL QMYSGGTQYR
     TSVIQIPFTL ETQGEDEEDK ENIPSTDVSS PAMDAAGIHL RQFSNEASTH GTHLVVTAMS
     VTQNQSSASE KELALLQDVE REKDNNTVDM VDPIEIADET TWIKEPVDNG SLPMTDFVSG
     IAFSIENSHM CMSPLAESSV IPCESSNIQM DSGYNTQNCG SNIMDTVGAE SYCKESDAQT
     CEVESKSQAF NMKQDHTTQR CWMKTASPFQ CSSP
//
ID   B5LMG6_HUMAN            Unreviewed;       619 AA.
AC   B5LMG6;
DT   14-OCT-2008, integrated into UniProtKB/TrEMBL.
DT   14-OCT-2008, sequence version 1.
DT   23-MAY-2018, entry version 74.
DE   SubName: Full=Aurora borealis {ECO:0000313|EMBL:ACH72049.1};
DE   SubName: Full=FLJ22624 protein, isoform CRA_a {ECO:0000313|EMBL:EAW80514.1};
DE   SubName: Full=Protein aurora borealis {ECO:0000313|Ensembl:ENSP00000375082};
GN   Name=BORA {ECO:0000313|Ensembl:ENSP00000375082};
GN   Synonyms=C13orf34 {ECO:0000313|EMBL:ACH72049.1},
GN   FLJ22624 {ECO:0000313|EMBL:EAW80514.1};
GN   ORFNames=hCG_1781028 {ECO:0000313|EMBL:EAW80514.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACH72049.1};
RN   [1] {ECO:0000313|EMBL:EAW80514.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000375082, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [3] {ECO:0000313|EMBL:EAW80514.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ACH72049.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Osteosarcoma {ECO:0000313|EMBL:ACH72049.1};
RX   PubMed=18615013; DOI=10.1038/nature07185;
RA   Macurek L., Lindqvist A., Lim D., Lampson M.A., Klompmaker R.,
RA   Freire R., Clouin C., Taylor S.S., Yaffe M.B., Medema R.H.;
RT   "Polo-like kinase-1 is activated by aurora A to promote checkpoint
RT   recovery.";
RL   Nature 455:119-123(2008).
RN   [5] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7] {ECO:0000213|PubMed:19369195}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [8] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [9] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10] {ECO:0000313|Ensembl:ENSP00000375082}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL138695; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; EU834129; ACH72049.1; -; mRNA.
DR   EMBL; CH471093; EAW80514.1; -; Genomic_DNA.
DR   RefSeq; NP_079084.3; NM_024808.3.
DR   UniGene; Hs.643464; -.
DR   Ensembl; ENST00000390667; ENSP00000375082; ENSG00000136122.
DR   GeneID; 79866; -.
DR   KEGG; hsa:79866; -.
DR   UCSC; uc001viv.2; human.
DR   CTD; 79866; -.
DR   EuPathDB; HostDB:ENSG00000136122.15; -.
DR   HGNC; HGNC:24724; BORA.
DR   OpenTargets; ENSG00000136122; -.
DR   eggNOG; ENOG410IHF2; Eukaryota.
DR   eggNOG; ENOG410ZQ9X; LUCA.
DR   GeneTree; ENSGT00390000013790; -.
DR   HOGENOM; HOG000074046; -.
DR   HOVERGEN; HBG080904; -.
DR   KO; K16831; -.
DR   ChiTaRS; BORA; human.
DR   GenomeRNAi; 79866; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000136122; -.
DR   InterPro; IPR023252; Aurora_borealis_protein.
DR   PANTHER; PTHR14728; PTHR14728; 1.
DR   Pfam; PF15280; BORA_N; 1.
DR   PRINTS; PR02038; AURORABORA.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:B5LMG6,
KW   ECO:0000213|MaxQB:B5LMG6, ECO:0000213|PeptideAtlas:B5LMG6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   619 AA;  67672 MW;  8F5A462F40660634 CRC64;
     MAGRHDWLVA HKPRALVGPR QRGSGELKSL CLSWKLAWPP ELPGVGTGGF VLYAPFSLCA
     MGDVKESKMQ ITPETPGRIP VLNPFESPSD YSNLHEQTLA SPSVFKSTKL PTPGKFRWSI
     DQLAVINPVE IDPEDIHRQA LYLSHSRIDK DVEDKRQKAI EEFFTKDVIV PSPWTDHEGK
     QLSQCHSSKC TNINSDSPVG KKLTIHSEKS DAACQTLLSL PVDFNLENIL GDYFRADEFA
     DQSPGNLSSS SLRRKLFLDG NGSISDSLPS ASPGSPHSGV QTSLEMFYSI DLSPVKCRSP
     LQTPSSGQFS SSPIQASAKK YSLGSITSPS PISSPTFSPI EFQIGETPLS EQRKFTVHSP
     DASSGTNSNG ITNPCIRSPY IDGCSPIKNW SPMRLQMYSG GTQYRTSVIQ IPFTLETQGE
     DEEDKENIPS TDVSSPAMDA AGIHLRQFSN EASTHGTHLV VTAMSVTQNQ SSASEKELAL
     LQDVEREKDN NTVDMVDPIE IADETTWIKE PVDNGSLPMT DFVSGIAFSI ENSHMCMSPL
     AESSVIPCES SNIQMDSGYN TQNCGSNIMD TVGAESYCKE SDAQTCEVES KSQAFNMKQD
     HTTQRCWMKT ASPFQCSSP
//
ID   BORA_HUMAN              Reviewed;         559 AA.
AC   Q6PGQ7; B4DQ30; Q5W0P3; Q5W0P4; Q86YC6; Q96IW9; Q9H640;
DT   23-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 2.
DT   31-JAN-2018, entry version 115.
DE   RecName: Full=Protein aurora borealis;
DE            Short=HsBora;
GN   Name=BORA; Synonyms=C13orf34;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 135-559 (ISOFORM 1).
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow, Leiomyosarcoma, Rhabdomyosarcoma, and
RC   Testis carcinoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, PHOSPHORYLATION, AND INTERACTION WITH AURKA.
RX   PubMed=16890155; DOI=10.1016/j.devcel.2006.06.002;
RA   Hutterer A., Berdnik D., Wirtz-Peitz F., Zigman M., Schleiffer A.,
RA   Knoblich J.A.;
RT   "Mitotic activation of the kinase Aurora-A requires its binding
RT   partner Bora.";
RL   Dev. Cell 11:147-157(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-270, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-191, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Required for the activation of AURKA at the onset of
CC       mitosis. {ECO:0000269|PubMed:16890155}.
CC   -!- SUBUNIT: Interacts with AURKA. {ECO:0000269|PubMed:16890155}.
CC   -!- INTERACTION:
CC       P53350:PLK1; NbExp=3; IntAct=EBI-719836, EBI-476768;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6PGQ7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6PGQ7-2; Sequence=VSP_055543;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Phosphorylated by AURKA. {ECO:0000269|PubMed:16890155}.
CC   -!- SIMILARITY: Belongs to the BORA family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15426.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK026277; BAB15426.1; ALT_INIT; mRNA.
DR   EMBL; AK298608; BAG60792.1; -; mRNA.
DR   EMBL; AL138695; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471093; EAW80515.1; -; Genomic_DNA.
DR   EMBL; BC007119; AAH07119.1; -; mRNA.
DR   EMBL; BC025367; AAH25367.2; -; mRNA.
DR   EMBL; BC044213; AAH44213.1; -; mRNA.
DR   EMBL; BC056876; AAH56876.2; -; mRNA.
DR   CCDS; CCDS66560.1; -. [Q6PGQ7-2]
DR   RefSeq; NP_001273675.1; NM_001286746.1.
DR   RefSeq; NP_001273676.1; NM_001286747.1. [Q6PGQ7-2]
DR   RefSeq; NP_079084.3; NM_024808.3.
DR   UniGene; Hs.643464; -.
DR   ProteinModelPortal; Q6PGQ7; -.
DR   SMR; Q6PGQ7; -.
DR   BioGrid; 122954; 36.
DR   DIP; DIP-53424N; -.
DR   ELM; Q6PGQ7; -.
DR   IntAct; Q6PGQ7; 12.
DR   STRING; 9606.ENSP00000375082; -.
DR   iPTMnet; Q6PGQ7; -.
DR   PhosphoSitePlus; Q6PGQ7; -.
DR   DMDM; 74737659; -.
DR   MaxQB; Q6PGQ7; -.
DR   PaxDb; Q6PGQ7; -.
DR   PeptideAtlas; Q6PGQ7; -.
DR   PRIDE; Q6PGQ7; -.
DR   DNASU; 79866; -.
DR   Ensembl; ENST00000377815; ENSP00000367046; ENSG00000136122. [Q6PGQ7-2]
DR   GeneID; 79866; -.
DR   KEGG; hsa:79866; -.
DR   UCSC; uc010thr.3; human. [Q6PGQ7-1]
DR   CTD; 79866; -.
DR   EuPathDB; HostDB:ENSG00000136122.15; -.
DR   GeneCards; BORA; -.
DR   HGNC; HGNC:24724; BORA.
DR   HPA; HPA040866; -.
DR   MIM; 610510; gene.
DR   neXtProt; NX_Q6PGQ7; -.
DR   OpenTargets; ENSG00000136122; -.
DR   PharmGKB; PA162378045; -.
DR   eggNOG; ENOG410IHF2; Eukaryota.
DR   eggNOG; ENOG410ZQ9X; LUCA.
DR   GeneTree; ENSGT00390000013790; -.
DR   HOGENOM; HOG000074046; -.
DR   HOVERGEN; HBG080904; -.
DR   InParanoid; Q6PGQ7; -.
DR   KO; K16831; -.
DR   PhylomeDB; Q6PGQ7; -.
DR   TreeFam; TF329674; -.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   SIGNOR; Q6PGQ7; -.
DR   ChiTaRS; BORA; human.
DR   GenomeRNAi; 79866; -.
DR   PRO; PR:Q6PGQ7; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000136122; -.
DR   CleanEx; HS_C13orf34; -.
DR   ExpressionAtlas; Q6PGQ7; baseline and differential.
DR   Genevisible; Q6PGQ7; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0007088; P:regulation of mitotic nuclear division; IMP:UniProtKB.
DR   GO; GO:0060236; P:regulation of mitotic spindle organization; IMP:UniProtKB.
DR   GO; GO:0032880; P:regulation of protein localization; IMP:UniProtKB.
DR   InterPro; IPR023252; Aurora_borealis_protein.
DR   PANTHER; PTHR14728; PTHR14728; 1.
DR   Pfam; PF15280; BORA_N; 1.
DR   PRINTS; PR02038; AURORABORA.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; Cell division; Complete proteome;
KW   Mitosis; Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    559       Protein aurora borealis.
FT                                /FTId=PRO_0000273205.
FT   COMPBIAS    188    278       Ser-rich.
FT   MOD_RES     183    183       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     191    191       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     270    270       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     325    325       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BS90}.
FT   MOD_RES     331    331       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BS90}.
FT   MOD_RES     354    354       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8BS90}.
FT   VAR_SEQ       1     87       MGDVKESKMQITPETPGRIPVLNPFESPSDYSNLHEQTLAS
FT                                PSVFKSTKLPTPGKFRWSIDQLAVINPVEIDPEDIHRQALY
FT                                LSHSR -> MNKLSPVLLFLNQQNYQ (in isoform
FT                                2). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055543.
FT   VARIANT     210    210       S -> L (in dbSNP:rs9543107).
FT                                /FTId=VAR_030110.
FT   VARIANT     308    308       S -> F (in dbSNP:rs1146858).
FT                                /FTId=VAR_030111.
FT   CONFLICT    545    545       R -> K (in Ref. 4; AAH07119).
FT                                {ECO:0000305}.
SQ   SEQUENCE   559 AA;  61203 MW;  F817E6DC2C7600DB CRC64;
     MGDVKESKMQ ITPETPGRIP VLNPFESPSD YSNLHEQTLA SPSVFKSTKL PTPGKFRWSI
     DQLAVINPVE IDPEDIHRQA LYLSHSRIDK DVEDKRQKAI EEFFTKDVIV PSPWTDHEGK
     QLSQCHSSKC TNINSDSPVG KKLTIHSEKS DAACQTLLSL PVDFNLENIL GDYFRADEFA
     DQSPGNLSSS SLRRKLFLDG NGSISDSLPS ASPGSPHSGV QTSLEMFYSI DLSPVKCRSP
     LQTPSSGQFS SSPIQASAKK YSLGSITSPS PISSPTFSPI EFQIGETPLS EQRKFTVHSP
     DASSGTNSNG ITNPCIRSPY IDGCSPIKNW SPMRLQMYSG GTQYRTSVIQ IPFTLETQGE
     DEEDKENIPS TDVSSPAMDA AGIHLRQFSN EASTHGTHLV VTAMSVTQNQ SSASEKELAL
     LQDVEREKDN NTVDMVDPIE IADETTWIKE PVDNGSLPMT DFVSGIAFSI ENSHMCMSPL
     AESSVIPCES SNIQMDSGYN TQNCGSNIMD TVGAESYCKE SDAQTCEVES KSQAFNMKQD
     HTTQRCWMKT ASPFQCSSP
//
ID   B3KXH0_HUMAN            Unreviewed;       991 AA.
AC   B3KXH0;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 44.
DE   SubName: Full=cDNA FLJ45395 fis, clone BRHIP3027191, highly similar to 150 kDa oxygen-regulated protein (Orp150) {ECO:0000313|EMBL:BAG54482.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG54482.1};
RN   [1] {ECO:0000313|EMBL:BAG54482.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Hippocampus {ECO:0000313|EMBL:BAG54482.1};
RA   Kanehori K., Ishibashi T., Chiba Y., Fujimori K., Hiraoka S.,
RA   Tanai H., Watanabe S., Ishida S., Ono Y., Hotuta T., Watanabe M.,
RA   Sugiyama T., Irie R., Otsuki T., Sato H., Wakamatsu A., Ishii S.,
RA   Yamamoto J., Isono Y., Kawai-Hio Y., Saito K., Nishikawa T.,
RA   Kimura K., Matsuo K., Nakamura Y., Sekine M., Kikuchi H., Kanda K.,
RA   Wagatsuma M., Takahashi-Fujii A., Oshima A., Sugiyama A., Kawakami B.,
RA   Suzuki Y., Sugano S., Nagahari K., Masuho Y., Nagai K., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000256|RuleBase:RU003322}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK127324; BAG54482.1; -; mRNA.
DR   RefSeq; NP_001124463.1; NM_001130991.2.
DR   RefSeq; NP_006380.1; NM_006389.4.
DR   UniGene; Hs.277704; -.
DR   ProteinModelPortal; B3KXH0; -.
DR   PeptideAtlas; B3KXH0; -.
DR   PRIDE; B3KXH0; -.
DR   GeneID; 10525; -.
DR   KEGG; hsa:10525; -.
DR   CTD; 10525; -.
DR   eggNOG; KOG0104; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   HOVERGEN; HBG106402; -.
DR   KO; K09486; -.
DR   GenomeRNAi; 10525; -.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100934; SSF100934; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|RuleBase:RU003322};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU003322};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     34       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        35    991       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002790417.
SQ   SEQUENCE   991 AA;  110441 MW;  3513AB15F456DDF5 CRC64;
     MADKVRRQRP RRRVCWALVA VLLADLLALS DTLAVMSVDL GSESMKVAIV LNKESRRKTP
     VIVTLKENER FFGDSAASMA IKNPKATLRY FQHLLGKQAD NPHVALYQAR FPEHELTFDP
     QRQTVHFQIS SQLQFSPEEV LGMVLNYSRS LAEDFAEQPI KDAVITVPVF FNQAERRAVL
     QAARMAGLKV LQLINDNTAT ALSYGVFRRK DINTTAQNIM FYDMGSGSTV CTIVTYQMVK
     TKEAGMQPQL QIRGVGFDRT LGGLEMELRL RERLAGLFNE QRKGQRAKDV RENPRAMAKL
     LREANRLKTV LSANADHMAQ IEGLMDDVDF KAKVTRVEFE ELCADLFERV PGPVQQALQS
     AEMSLDEIEQ VILVGGATRV PRVQEVLLKG VGKEELGKNI NADEAAAMGA VYQAAALSKA
     FKVKPFVVRD AVVYPILVEF TREVEEEPGI HSLKHNKRVL FSRMGPYPQR KVITFNRYSH
     DFNFHINYGD LGFLGPEDLR VFGSQNLTTV KLKGVGDSFK KYPDYESKGI KAHFNLDESG
     VLSLDRVESV FETLVEDSAE EESTLTKLGN TISSLFGGGT TPDAKENGTD TVQEEEESPA
     EGSKDEPGEQ VELKEEAEAP VEDGSQPPPP EPKGDATPEG EKATEKENGD KSEAQKPSEK
     AEAGPEGVAP APEGEKKQKP ARKRRMVEEI GVELVVLDLP DLPEDKLAQS VQKLQDLTLR
     DLEKQEREKA ANSLEAFIFE TQDKLYQPEY QEVSTEEQRE EISGKLSAAS TWLEDEGVGA
     TTVMLKEKLA ELRKLCQGLF FRVEERKKWP ERLSALDNLL NHSSMFLKGA RLIPEMDQIF
     TEVEMTTLEK VINETWAWKN ATLAEQAKLP ATEKPVLLSK DIEAKMMALD REVQYLLNKA
     KFTKPRPRPK DKNGTRAEPP LNASASDQGE KVIPPAGQTE DAEPISEPEK VETAGSEPGD
     TEPLELGGPG AEPEQKEQST GQKRPLKNDE L
//
ID   B7Z602_HUMAN            Unreviewed;       656 AA.
AC   B7Z602;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   28-FEB-2018, entry version 38.
DE   SubName: Full=cDNA FLJ59408, highly similar to 150 kDa oxygen-regulated protein (Orp150) {ECO:0000313|EMBL:BAH13088.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH13088.1};
RN   [1] {ECO:0000313|EMBL:BAH13088.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAH13088.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK299648; BAH13088.1; -; mRNA.
DR   RefSeq; NP_001124463.1; NM_001130991.2.
DR   UniGene; Hs.277704; -.
DR   PeptideAtlas; B7Z602; -.
DR   PRIDE; B7Z602; -.
DR   GeneID; 10525; -.
DR   KEGG; hsa:10525; -.
DR   CTD; 10525; -.
DR   eggNOG; KOG0104; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   HOVERGEN; HBG106402; -.
DR   KO; K09486; -.
DR   GenomeRNAi; 10525; -.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 2.
DR   Pfam; PF00012; HSP70; 1.
DR   SUPFAM; SSF100934; SSF100934; 1.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     34       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        35    656       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002863969.
SQ   SEQUENCE   656 AA;  72847 MW;  AB3D9DFCAC6EC389 CRC64;
     MADKVRRQRP RRRVCWALVA VLLADLLALS DTLAVMSVDL GSESMKVAIV KPGVPMEIVL
     NKESRRKTPV IVTLKENERF FGDSAASMAI KNPKATLRYF QHLLGKQADN PHVALYQARF
     PEHELTFDPQ RQTVHFQISS QLQFSPEEVL GMVLNYSRSL AEDLRVFGSQ NLTTVKLKGV
     GDSFKKYPDY ESKGIKAHFN LDESGVLSLD RVESVFETLV EDSAEEESTL TKLGNTISSL
     FGGGTTPDAK ENGTDTVQEE EESPAEGSKD EPGEQVELKE EAEAPVEDGS QPPPPEPKGD
     ATPEGEKATE KENGDKSEAQ KPSEKAEAGP EGVAPAPEGE KKQKPARKRR MVEEIGVELV
     VLDLPDLPED KLAQSVQKLQ DLTLRDLEKQ EREKAANSLE AFIFETQDKL YQPEYQEVST
     EEQREEISGK LSAASTWLED EGVGATTVML KEKLAELRKL CQGLFFRVEE RKKWPERLSA
     LDNLLNHSSM FLKGARLIPE MDQIFTEVEM TTLEKVINET WAWKNATLAE QAKLPATEKP
     VLLSKDIEAK MMALDREVQY LLNKAKFTKP RPRPKDKNGT RAEPPLNASA SDQGEEVIPP
     AGQTEDAEPI SEPEKVETAG SEPGDTEPLE LGGPGAEPEQ KEQSTGQKRP LKNDEL
//
ID   B7Z766_HUMAN            Unreviewed;       848 AA.
AC   B7Z766;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   28-FEB-2018, entry version 40.
DE   SubName: Full=cDNA FLJ54564, highly similar to 150 kDa oxygen-regulated protein (Orp150) {ECO:0000313|EMBL:BAH13502.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH13502.1};
RN   [1] {ECO:0000313|EMBL:BAH13502.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Synovial membrane tissue {ECO:0000313|EMBL:BAH13502.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000256|RuleBase:RU003322}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK301514; BAH13502.1; -; mRNA.
DR   RefSeq; NP_001124463.1; NM_001130991.2.
DR   RefSeq; NP_006380.1; NM_006389.4.
DR   UniGene; Hs.277704; -.
DR   ProteinModelPortal; B7Z766; -.
DR   PeptideAtlas; B7Z766; -.
DR   PRIDE; B7Z766; -.
DR   GeneID; 10525; -.
DR   KEGG; hsa:10525; -.
DR   CTD; 10525; -.
DR   eggNOG; KOG0104; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   HOVERGEN; HBG106402; -.
DR   KO; K09486; -.
DR   GenomeRNAi; 10525; -.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100934; SSF100934; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|RuleBase:RU003322};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU003322}.
SQ   SEQUENCE   848 AA;  94199 MW;  4AA28D0EEEA9B91B CRC64;
     MVLNYSRSLA EDFAEQPIKD AVITVPVFFN QAERRAVLQA ARMAGLKVLQ LINDNTATAL
     SYGVFRRKDI NTTAQNIMFY DMGSGSTVCT IVTYQMVKTK EAGMQPQLQI RGVGFDRTLG
     GLEMELRLRE RLAGLFNEQR KGQRAKDVRE NPRAMAKLLR EANRLKTVLS ANADHMAQIE
     GLMDDVDFKA KVTRVEFEEL CADLFERVPG PVQQALQSAE MSLDEVEQVI LVGGATRVPR
     VQEVLLKAVG KEELGKNINA DEAAAMGAVY QAAALSKAFK VKPFVVRDAV VYPILVEFTR
     EVEEEPGIHS LKHNKRVLFS RMGPYPQRKV ITFNRYSHDF NFHINYGDLG FLGPEDLRVF
     GSQNLTTVKL KGVGDSFKKY PDYESKGIKA HFNLDESGVL SLDRVESVFE TLVEDSAEEE
     STLTKLGNTI SSLFGGGTTP DAKENGTDTV QEEEESPAEG SKDEPGEQVE LKEEAEAPVE
     DGSQPPPPEP KGDATPEGEK ATEKENGDKS EAQKPSEKAE AGPEGVAPAP EGEKKQKPAR
     KRRMVEEIGV ELVVLGLPDL PEDKLAQSVQ KLQDLTLRDL EKQEREKAAN SLEAFIFETQ
     DKLYQPEYQE VSTEEQREEI SGKLSAASTW LEDEGVGATT VMLKEKLAEL RKLCQGLFFR
     VEERKKWPER LSALDNLLNH SSMFLKGARL IPEMDQIFTE VEMTTLEKVI NETWAWKNAT
     LAEQAKLPAT EKPVLLSKDI EAKMMALDRE VQYLLNKAKF TKPRPRPKDK NGTRAEPPLN
     ASASDQGEKV IPPAGQTEDA EPISEPEKVE TGSEPGDTEP LELGGPGAEP EQKEQSTGQK
     RPLKNDEL
//
ID   Q6IN67_HUMAN            Unreviewed;       678 AA.
AC   Q6IN67;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   28-FEB-2018, entry version 94.
DE   SubName: Full=HYOU1 protein {ECO:0000313|EMBL:AAH72436.1};
GN   Name=HYOU1 {ECO:0000313|EMBL:AAH72436.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH72436.1};
RN   [1] {ECO:0000313|EMBL:AAH72436.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Blood {ECO:0000313|EMBL:AAH72436.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000256|RuleBase:RU003322}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC072436; AAH72436.1; -; mRNA.
DR   RefSeq; NP_001124463.1; NM_001130991.2.
DR   RefSeq; NP_006380.1; NM_006389.4.
DR   UniGene; Hs.277704; -.
DR   ProteinModelPortal; Q6IN67; -.
DR   PeptideAtlas; Q6IN67; -.
DR   PRIDE; Q6IN67; -.
DR   GeneID; 10525; -.
DR   KEGG; hsa:10525; -.
DR   CTD; 10525; -.
DR   PharmGKB; PA38427; -.
DR   eggNOG; KOG0104; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   HOVERGEN; HBG106402; -.
DR   KO; K09486; -.
DR   ChiTaRS; HYOU1; human.
DR   GenomeRNAi; 10525; -.
DR   Genevisible; Q6IN67; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|RuleBase:RU003322};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU003322};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     34       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        35    678       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004274750.
SQ   SEQUENCE   678 AA;  75344 MW;  446F3A4A2DD4B08C CRC64;
     MADKVRRQRP RRRVCWALVA VLLADLLALS DTLAVMSVDL GSESMKVAIV KPGVPMEIVL
     NKESRRKTPV IVTLKENERF FGDSAASMAI KNPKATLRYF QHLLGKQADN PHVALYQARF
     PEHELTFDPQ RQTVHFQISS QLQFSPEEVL GMVLNYSRSL AEDFAEQPIK DAVITVPVFF
     NQAERRAVLQ AARMAGLKVL QLINDNTATA LSYGVFRRKD INTTAQNIMF YDMGSGSTVC
     TIVTYQMVKT KEAGMQPQLQ IRGVGFDRTL GGLEMELRLR ERLAGLFNEQ RKGQRAKDVR
     ENPRAMAKLL REANRLKTVL SANADHMAQI EGLMDDVDFK AKVTRVEFEE LCADLFERVP
     GPVQQALQSA EMSLDEIEQV ILVGGATRVP RVQEVLLKAV GKEELGKNIN ADEAAAMGAV
     YQAAALSKAF KVKPFVVRDA VVYPILVEFT REVEEEPGIH SLKHNKRVLF SRMGPYPQRK
     VITFNRYSHD FNFHINYGDL GFLGPEDLRV FGSQNLTTVK LKGVGDSFKK YPDYESKGIK
     AHFNLDESGV LSLDRVESVF ETLVEDSAEE ESTLTKLGNT ISSLFGGGTT PDAKENGTDT
     VQEEEESPAE GSKDEPGEQV ELKEEAEAPV EDGSQPPPPE PKGDATPEGE KATEKENGDK
     SEAQKPSVCR ASVTRFGF
//
ID   HYOU1_HUMAN             Reviewed;         999 AA.
AC   Q9Y4L1; A8C1Z0; B7Z909; Q2I204; Q53H25;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   23-MAY-2018, entry version 175.
DE   RecName: Full=Hypoxia up-regulated protein 1;
DE   AltName: Full=150 kDa oxygen-regulated protein;
DE            Short=ORP-150;
DE   AltName: Full=170 kDa glucose-regulated protein;
DE            Short=GRP-170;
DE   Flags: Precursor;
GN   Name=HYOU1; Synonyms=GRP170, ORP150;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Astrocytoma;
RX   PubMed=9020069; DOI=10.1006/bbrc.1996.5890;
RA   Ikeda J., Kaneda S., Kuwabara K., Ogawa S., Kobayashi T.,
RA   Matsumoto M., Yura T., Yanagi H.;
RT   "Cloning and expression of cDNA encoding the human 150 kDa oxygen-
RT   regulated protein, ORP150.";
RL   Biochem. Biophys. Res. Commun. 230:94-99(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10965054; DOI=10.1093/oxfordjournals.jbchem.a022783;
RA   Kaneda S., Yura T., Yanagi H.;
RT   "Production of three distinct mRNAs of 150 kDa oxygen-regulated
RT   protein (ORP150) by alternative promoters: preferential induction of
RT   one species under stress conditions.";
RL   J. Biochem. 128:529-538(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=17131193; DOI=10.1007/s10930-006-9038-z;
RA   Takeuchi S.;
RT   "Molecular cloning, sequence, function and structural basis of human
RT   heart 150 kDa oxygen-regulated protein, an ER chaperone.";
RL   Protein J. 25:517-528(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cerebellum, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [8]
RP   PROTEIN SEQUENCE OF 241-256; 541-555; 577-594 AND 754-768, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   FUNCTION.
RX   PubMed=10037731; DOI=10.1074/jbc.274.10.6397;
RA   Ozawa K., Kuwabara K., Tamatani M., Takatsuji K., Tsukamoto Y.,
RA   Kaneda S., Yanagi H., Stern D.M., Eguchi Y., Tsujimoto Y., Ogawa S.,
RA   Tohyama M.;
RT   "150-kDa oxygen-regulated protein (ORP150) suppresses hypoxia-induced
RT   apoptotic cell death.";
RL   J. Biol. Chem. 274:6397-6404(1999).
RN   [10]
RP   COMPONENT OF A CHAPERONE COMPLEX.
RX   PubMed=12475965; DOI=10.1091/mbc.E02-05-0311;
RA   Meunier L., Usherwood Y.-K., Chung K.T., Hendershot L.M.;
RT   "A subset of chaperones and folding enzymes form multiprotein
RT   complexes in endoplasmic reticulum to bind nascent proteins.";
RL   Mol. Biol. Cell 13:4456-4469(2002).
RN   [11]
RP   GLYCOSYLATION AT ASN-155; ASN-515; ASN-596; ASN-830; ASN-862 AND
RP   ASN-931.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-515; ASN-830; ASN-869 AND
RP   ASN-931.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-515.
RC   TISSUE=Platelet;
RX   PubMed=16263699; DOI=10.1074/mcp.M500324-MCP200;
RA   Lewandrowski U., Moebius J., Walter U., Sickmann A.;
RT   "Elucidation of N-glycosylation sites on human platelet proteins: a
RT   glycoproteomic approach.";
RL   Mol. Cell. Proteomics 5:226-233(2006).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-515; ASN-596; ASN-830;
RP   ASN-862 AND ASN-931.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-515.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-567, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   CLEAVAGE OF SIGNAL PEPTIDE [LARGE SCALE ANALYSIS] AFTER THR-32, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Has a pivotal role in cytoprotective cellular mechanisms
CC       triggered by oxygen deprivation. May play a role as a molecular
CC       chaperone and participate in protein folding.
CC       {ECO:0000269|PubMed:10037731}.
CC   -!- SUBUNIT: Part of a large chaperone multiprotein complex comprising
CC       DNAJB11, HSP90B1, HSPA5, HYOU, PDIA2, PDIA4, PDIA6, PPIB, SDF2L1,
CC       UGT1A1 and very small amounts of ERP29, but not, or at very low
CC       levels, CALR nor CANX.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y4L1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y4L1-2; Sequence=VSP_056364, VSP_056365, VSP_056366;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in tissues that contain well-
CC       developed endoplasmic reticulum and synthesize large amounts of
CC       secretory proteins. Highly expressed in liver and pancreas and
CC       lower expression in brain and kidney. Also expressed in
CC       macrophages within aortic atherosclerotic plaques, and in breast
CC       cancers.
CC   -!- INDUCTION: By hypoxia and also by 2-deoxyglucose or tunicamycin.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U65785; AAC50947.1; -; mRNA.
DR   EMBL; AB009979; BAF80348.1; -; Genomic_DNA.
DR   EMBL; DQ350134; ABC75106.1; -; mRNA.
DR   EMBL; DQ372932; ABD14370.1; -; mRNA.
DR   EMBL; AK304264; BAH14145.1; -; mRNA.
DR   EMBL; AK314178; BAG36860.1; -; mRNA.
DR   EMBL; AK222756; BAD96476.1; -; mRNA.
DR   EMBL; EF444986; ACA06002.1; -; Genomic_DNA.
DR   EMBL; AP003392; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS8408.1; -. [Q9Y4L1-1]
DR   PIR; JC5278; JC5278.
DR   RefSeq; NP_001124463.1; NM_001130991.2. [Q9Y4L1-1]
DR   RefSeq; NP_006380.1; NM_006389.4. [Q9Y4L1-1]
DR   RefSeq; XP_016872585.1; XM_017017096.1. [Q9Y4L1-1]
DR   RefSeq; XP_016872586.1; XM_017017097.1. [Q9Y4L1-1]
DR   UniGene; Hs.277704; -.
DR   ProteinModelPortal; Q9Y4L1; -.
DR   SMR; Q9Y4L1; -.
DR   BioGrid; 115780; 116.
DR   IntAct; Q9Y4L1; 44.
DR   MINT; Q9Y4L1; -.
DR   STRING; 9606.ENSP00000384144; -.
DR   ChEMBL; CHEMBL2216741; -.
DR   CarbonylDB; Q9Y4L1; -.
DR   iPTMnet; Q9Y4L1; -.
DR   PhosphoSitePlus; Q9Y4L1; -.
DR   SwissPalm; Q9Y4L1; -.
DR   BioMuta; HYOU1; -.
DR   DMDM; 10720185; -.
DR   REPRODUCTION-2DPAGE; IPI00000877; -.
DR   EPD; Q9Y4L1; -.
DR   PaxDb; Q9Y4L1; -.
DR   PeptideAtlas; Q9Y4L1; -.
DR   PRIDE; Q9Y4L1; -.
DR   Ensembl; ENST00000617285; ENSP00000480150; ENSG00000149428. [Q9Y4L1-1]
DR   Ensembl; ENST00000630669; ENSP00000486825; ENSG00000280682. [Q9Y4L1-1]
DR   GeneID; 10525; -.
DR   KEGG; hsa:10525; -.
DR   UCSC; uc031yhc.2; human. [Q9Y4L1-1]
DR   CTD; 10525; -.
DR   DisGeNET; 10525; -.
DR   EuPathDB; HostDB:ENSG00000149428.18; -.
DR   GeneCards; HYOU1; -.
DR   HGNC; HGNC:16931; HYOU1.
DR   HPA; HPA049296; -.
DR   MIM; 601746; gene.
DR   neXtProt; NX_Q9Y4L1; -.
DR   OpenTargets; ENSG00000149428; -.
DR   PharmGKB; PA38427; -.
DR   eggNOG; KOG0104; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   GeneTree; ENSGT00390000016919; -.
DR   HOGENOM; HOG000007865; -.
DR   HOVERGEN; HBG106402; -.
DR   InParanoid; Q9Y4L1; -.
DR   KO; K09486; -.
DR   OMA; RSLKHNK; -.
DR   OrthoDB; EOG091G025X; -.
DR   PhylomeDB; Q9Y4L1; -.
DR   TreeFam; TF105048; -.
DR   Reactome; R-HSA-3000484; Scavenging by Class F Receptors.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   SIGNOR; Q9Y4L1; -.
DR   ChiTaRS; HYOU1; human.
DR   GeneWiki; HYOU1; -.
DR   GenomeRNAi; 10525; -.
DR   PMAP-CutDB; Q9Y4L1; -.
DR   PRO; PR:Q9Y4L1; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000149428; -.
DR   CleanEx; HS_HYOU1; -.
DR   ExpressionAtlas; Q9Y4L1; baseline and differential.
DR   Genevisible; Q9Y4L1; HS.
DR   GO; GO:0071682; C:endocytic vesicle lumen; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0034663; C:endoplasmic reticulum chaperone complex; IEA:Ensembl.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0051087; F:chaperone binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0071456; P:cellular response to hypoxia; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:1903382; P:negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:1903298; P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; TAS:Reactome.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IEP:ParkinsonsUK-UCL.
DR   GO; GO:0002931; P:response to ischemia; ISS:ParkinsonsUK-UCL.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100934; SSF100934; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Chaperone;
KW   Complete proteome; Direct protein sequencing; Endoplasmic reticulum;
KW   Glycoprotein; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Signal; Stress response.
FT   SIGNAL        1     32       {ECO:0000244|PubMed:25944712}.
FT   CHAIN        33    999       Hypoxia up-regulated protein 1.
FT                                /FTId=PRO_0000013538.
FT   MOTIF       996    999       Prevents secretion from ER.
FT                                {ECO:0000255}.
FT   COMPBIAS    603    606       Poly-Glu.
FT   COMPBIAS    636    641       Poly-Pro.
FT   MOD_RES     567    567       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     883    883       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9JKR6}.
FT   CARBOHYD    155    155       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519}.
FT   CARBOHYD    222    222       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    515    515       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:16263699,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    596    596       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    830    830       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    862    862       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    869    869       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    922    922       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    931    931       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218}.
FT   VAR_SEQ       1     87       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056364.
FT   VAR_SEQ     603    646       EEEESPAEGSKDEPGEQVELKEEAEAPVEDGSQPPPPEPKG
FT                                DAT -> MLFLCPARLPQSKQAIDRFHTAVTCMEPPWGRRC
FT                                RARPAWRLCS (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056365.
FT   VAR_SEQ     647    999       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056366.
FT   CONFLICT     75     75       K -> E (in Ref. 5; BAD96476).
FT                                {ECO:0000305}.
FT   CONFLICT     92     92       N -> D (in Ref. 5; BAD96476).
FT                                {ECO:0000305}.
FT   CONFLICT    255    255       M -> T (in Ref. 5; BAD96476).
FT                                {ECO:0000305}.
FT   CONFLICT    442    442       V -> A (in Ref. 5; BAD96476).
FT                                {ECO:0000305}.
SQ   SEQUENCE   999 AA;  111335 MW;  FCE0F292466AFAB9 CRC64;
     MADKVRRQRP RRRVCWALVA VLLADLLALS DTLAVMSVDL GSESMKVAIV KPGVPMEIVL
     NKESRRKTPV IVTLKENERF FGDSAASMAI KNPKATLRYF QHLLGKQADN PHVALYQARF
     PEHELTFDPQ RQTVHFQISS QLQFSPEEVL GMVLNYSRSL AEDFAEQPIK DAVITVPVFF
     NQAERRAVLQ AARMAGLKVL QLINDNTATA LSYGVFRRKD INTTAQNIMF YDMGSGSTVC
     TIVTYQMVKT KEAGMQPQLQ IRGVGFDRTL GGLEMELRLR ERLAGLFNEQ RKGQRAKDVR
     ENPRAMAKLL REANRLKTVL SANADHMAQI EGLMDDVDFK AKVTRVEFEE LCADLFERVP
     GPVQQALQSA EMSLDEIEQV ILVGGATRVP RVQEVLLKAV GKEELGKNIN ADEAAAMGAV
     YQAAALSKAF KVKPFVVRDA VVYPILVEFT REVEEEPGIH SLKHNKRVLF SRMGPYPQRK
     VITFNRYSHD FNFHINYGDL GFLGPEDLRV FGSQNLTTVK LKGVGDSFKK YPDYESKGIK
     AHFNLDESGV LSLDRVESVF ETLVEDSAEE ESTLTKLGNT ISSLFGGGTT PDAKENGTDT
     VQEEEESPAE GSKDEPGEQV ELKEEAEAPV EDGSQPPPPE PKGDATPEGE KATEKENGDK
     SEAQKPSEKA EAGPEGVAPA PEGEKKQKPA RKRRMVEEIG VELVVLDLPD LPEDKLAQSV
     QKLQDLTLRD LEKQEREKAA NSLEAFIFET QDKLYQPEYQ EVSTEEQREE ISGKLSAAST
     WLEDEGVGAT TVMLKEKLAE LRKLCQGLFF RVEERKKWPE RLSALDNLLN HSSMFLKGAR
     LIPEMDQIFT EVEMTTLEKV INETWAWKNA TLAEQAKLPA TEKPVLLSKD IEAKMMALDR
     EVQYLLNKAK FTKPRPRPKD KNGTRAEPPL NASASDQGEK VIPPAGQTED AEPISEPEKV
     ETGSEPGDTE PLELGGPGAE PEQKEQSTGQ KRPLKNDEL
//
ID   HSP7C_HUMAN             Reviewed;         646 AA.
AC   P11142; Q9H3R6;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   23-MAY-2018, entry version 222.
DE   RecName: Full=Heat shock cognate 71 kDa protein;
DE   AltName: Full=Heat shock 70 kDa protein 8;
DE   AltName: Full=Lipopolysaccharide-associated protein 1;
DE            Short=LAP-1;
DE            Short=LPS-associated protein 1;
GN   Name=HSPA8; Synonyms=HSC70, HSP73, HSPA10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=3037489; DOI=10.1093/nar/15.13.5181;
RA   Dworniczak B.P., Mirault M.-E.;
RT   "Structure and expression of a human gene coding for a 71 kd heat
RT   shock 'cognate' protein.";
RL   Nucleic Acids Res. 15:5181-5197(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=11093761;
RA   Tsukahara F., Yoshioka T., Muraki T.;
RT   "Molecular and functional characterization of HSC54, a novel variant
RT   of human heat shock cognate protein 70.";
RL   Mol. Pharmacol. 58:1257-1263(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Niswonger M.L., Berk L.R., Srivastava P.K.;
RT   "Complete coding sequence of human HSC70.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-49; 57-71; 77-102; 103-155; 160-188; 221-247;
RP   273-311; 326-342; 349-416; 424-447; 452-493; 510-517; 540-550; 570-597
RP   AND 602-646, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [6]
RP   PROTEIN SEQUENCE OF 2-49; 57-72; 78-88; 113-188; 221-247; 300-319;
RP   326-342; 349-357; 362-384; 424-447; 452-469; 510-517; 540-550 AND
RP   584-609, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma, and Ovarian carcinoma;
RA   Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W.,
RA   Bilsland A.E., Keith W.N.;
RL   Submitted (JAN-2010) to UniProtKB.
RN   [7]
RP   PROTEIN SEQUENCE OF 4-49; 57-71; 77-88; 113-126; 129-155; 160-187;
RP   221-246; 300-311; 329-342; 362-384; 424-447; 540-550 AND 574-583, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 50-55; 103-107 AND 580-596.
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [9]
RP   PROTEIN SEQUENCE OF 77-86; 221-236 AND 302-311.
RX   PubMed=8713105; DOI=10.1006/bbrc.1996.1082;
RA   Egerton M., Moritz R.L., Druker B., Kelso A., Simpson R.J.;
RT   "Identification of the 70kD heat shock cognate protein (Hsc70) and
RT   alpha-actinin-1 as novel phosphotyrosine-containing proteins in T
RT   lymphocytes.";
RL   Biochem. Biophys. Res. Commun. 224:666-674(1996).
RN   [10]
RP   PROTEIN SEQUENCE OF 551-567, METHYLATION AT LYS-561, MUTAGENESIS OF
RP   LYS-561, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23349634; DOI=10.1371/journal.pgen.1003210;
RA   Cloutier P., Lavallee-Adam M., Faubert D., Blanchette M., Coulombe B.;
RT   "A newly uncovered group of distantly related lysine
RT   methyltransferases preferentially interact with molecular chaperones
RT   to regulate their activity.";
RL   PLoS Genet. 9:E1003210-E1003210(2013).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=1586970;
RA   Hattori H., Liu Y.-C., Tohnai I., Ueda M., Kaneda T., Kobayashi T.,
RA   Tanabe K., Ohtsuka K.;
RT   "Intracellular localization and partial amino acid sequence of a
RT   stress-inducible 40-kDa protein in HeLa cells.";
RL   Cell Struct. Funct. 17:77-86(1992).
RN   [12]
RP   INTERACTION WITH BAG1, AND DOMAIN.
RX   PubMed=9305631; DOI=10.1093/emboj/16.16.4887;
RA   Takayama S., Bimston D.N., Matsuzawa S.-I., Freeman B.C.,
RA   Aime-Sempe C., Xie Z., Morimoto R.I., Reed J.C.;
RT   "BAG-1 modulates the chaperone activity of Hsp70/Hsc70.";
RL   EMBO J. 16:4887-4896(1997).
RN   [13]
RP   INTERACTION WITH BAG1.
RX   PubMed=9679980;
RA   Takayama S., Krajewski S., Krajewska M., Kitada S., Zapata J.M.,
RA   Kochel K., Knee D., Scudiero D., Tudor G., Miller G.J., Miyashita T.,
RA   Yamada M., Reed J.C.;
RT   "Expression and location of Hsp70/Hsc-binding anti-apoptotic protein
RT   BAG-1 and its variants in normal tissues and tumor cell lines.";
RL   Cancer Res. 58:3116-3131(1998).
RN   [14]
RP   INTERACTION WITH HSF1.
RX   PubMed=9499401; DOI=10.1101/gad.12.5.654;
RA   Shi Y., Mosser D.D., Morimoto R.I.;
RT   "Molecular chaperones as HSF1-specific transcriptional repressors.";
RL   Genes Dev. 12:654-666(1998).
RN   [15]
RP   INTERACTION WITH SV40 VP1.
RX   PubMed=11147964; DOI=10.1379/1466-1268(2000)005<0132:HIWSVP>2.0.CO;2;
RA   Sainis L., Angelidis C., Pagoulatos G.N., Lazaridis L.;
RT   "HSC70 interactions with SV40 viral proteins differ between permissive
RT   and nonpermissive mammalian cells.";
RL   Cell Stress Chaperones 5:132-138(2000).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH CITED1.
RX   PubMed=10722728; DOI=10.1074/jbc.275.12.8825;
RA   Yahata T., de Caestecker M.P., Lechleider R.J., Andriole S.,
RA   Roberts A.B., Isselbacher K.J., Shioda T.;
RT   "The MSG1 non-DNA-binding transactivator binds to the p300/CBP
RT   coactivators, enhancing their functional link to the Smad
RT   transcription factors.";
RL   J. Biol. Chem. 275:8825-8834(2000).
RN   [17]
RP   FUNCTION, IDENTIFICATION AS LPS RECEPTOR, INTERACTION WITH CXCR4; GDF5
RP   AND HSP90AA1, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11276205; DOI=10.1038/86342;
RA   Triantafilou K., Triantafilou M., Dedrick R.L.;
RT   "A CD14-independent LPS receptor cluster.";
RL   Nat. Immunol. 2:338-345(2001).
RN   [18]
RP   INTERACTION WITH PACRG.
RX   PubMed=14532270; DOI=10.1074/jbc.M309655200;
RA   Imai Y., Soda M., Murakami T., Shoji M., Abe K., Takahashi R.;
RT   "A product of the human gene adjacent to parkin is a component of Lewy
RT   bodies and suppresses Pael receptor-induced cell death.";
RL   J. Biol. Chem. 278:51901-51910(2003).
RN   [19]
RP   INTERACTION WITH TTC1.
RX   PubMed=15708368; DOI=10.1016/j.abb.2004.12.020;
RA   Liou S.T., Wang C.;
RT   "Small glutamine-rich tetratricopeptide repeat-containing protein is
RT   composed of three structural units with distinct functions.";
RL   Arch. Biochem. Biophys. 435:253-263(2005).
RN   [20]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [21]
RP   INTERACTION WITH TSC2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15963462; DOI=10.1016/j.bbrc.2005.05.175;
RA   Nellist M., Burgers P.C., van den Ouweland A.M.W., Halley D.J.J.,
RA   Luider T.M.;
RT   "Phosphorylation and binding partner analysis of the TSC1-TSC2
RT   complex.";
RL   Biochem. Biophys. Res. Commun. 333:818-826(2005).
RN   [22]
RP   INTERACTION WITH DNAJB2.
RX   PubMed=15936278; DOI=10.1016/j.cub.2005.04.058;
RA   Westhoff B., Chapple J.P., van der Spuy J., Hoehfeld J.,
RA   Cheetham M.E.;
RT   "HSJ1 is a neuronal shuttling factor for the sorting of chaperone
RT   clients to the proteasome.";
RL   Curr. Biol. 15:1058-1064(2005).
RN   [23]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [24]
RP   INTERACTION WITH HERC5, AND ISGYLATION.
RX   PubMed=16815975; DOI=10.1073/pnas.0600397103;
RA   Wong J.J., Pung Y.F., Sze N.S., Chin K.C.;
RT   "HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates
RT   type I IFN-induced ISGylation of protein targets.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:10735-10740(2006).
RN   [25]
RP   INTERACTION WITH DNAJC9.
RX   PubMed=17182002; DOI=10.1016/j.bbrc.2006.12.013;
RA   Han C., Chen T., Li N., Yang M., Wan T., Cao X.;
RT   "HDJC9, a novel human type C DnaJ/HSP40 member interacts with and
RT   cochaperones HSP70 through the J domain.";
RL   Biochem. Biophys. Res. Commun. 353:280-285(2007).
RN   [26]
RP   IDENTIFICATION IN A MRNP GRANULE COMPLEX, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=17289661; DOI=10.1074/mcp.M600346-MCP200;
RA   Joeson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T., Borup R.,
RA   Johnsen A.H., Christiansen J., Nielsen F.C.;
RT   "Molecular composition of IMP1 ribonucleoprotein granules.";
RL   Mol. Cell. Proteomics 6:798-811(2007).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [28]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [29]
RP   IDENTIFICATION IN A COMPLEX WITH HCFC1; MKI67; EMSY; MATR3; ZNF335;
RP   TUBB2A; CCAR2; ASCL2; RBBP5 AND WDR5.
RX   PubMed=19131338; DOI=10.1074/jbc.M805872200;
RA   Garapaty S., Xu C.F., Trojer P., Mahajan M.A., Neubert T.A.,
RA   Samuels H.H.;
RT   "Identification and characterization of a novel nuclear protein
RT   complex involved in nuclear hormone receptor-mediated gene
RT   regulation.";
RL   J. Biol. Chem. 284:7542-7552(2009).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [31]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-246; LYS-319; LYS-589;
RP   LYS-597 AND LYS-601, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [32]
RP   INTERACTION WITH DNAJB12.
RX   PubMed=21150129; DOI=10.1247/csf.10023;
RA   Yamamoto Y.H., Kimura T., Momohara S., Takeuchi M., Tani T.,
RA   Kimata Y., Kadokura H., Kohno K.;
RT   "A novel ER J-protein DNAJB12 accelerates ER-associated degradation of
RT   membrane proteins including CFTR.";
RL   Cell Struct. Funct. 35:107-116(2010).
RN   [33]
RP   INTERACTION WITH TRIM5.
RX   PubMed=20053985; DOI=10.1074/jbc.M109.040618;
RA   Hwang C.Y., Holl J., Rajan D., Lee Y., Kim S., Um M., Kwon K.S.,
RA   Song B.;
RT   "Hsp70 interacts with the retroviral restriction factor TRIM5alpha and
RT   assists the folding of TRIM5alpha.";
RL   J. Biol. Chem. 285:7827-7837(2010).
RN   [34]
RP   IDENTIFICATION AS A COMPONENT OF THE PRP19-CDC5L COMPLEX, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=20176811; DOI=10.1128/MCB.01505-09;
RA   Grote M., Wolf E., Will C.L., Lemm I., Agafonov D.E., Schomburg A.,
RA   Fischle W., Urlaub H., Luhrmann R.;
RT   "Molecular architecture of the human Prp19/CDC5L complex.";
RL   Mol. Cell. Biol. 30:2105-2119(2010).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [36]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [37]
RP   INTERACTION WITH DNAJB12.
RX   PubMed=21148293; DOI=10.1091/mbc.E10-09-0760;
RA   Grove D.E., Fan C.Y., Ren H.Y., Cyr D.M.;
RT   "The endoplasmic reticulum-associated Hsp40 DNAJB12 and Hsc70
RT   cooperate to facilitate RMA1 E3-dependent degradation of nascent
RT   CFTRDeltaF508.";
RL   Mol. Biol. Cell 22:301-314(2011).
RN   [38]
RP   INTERACTION WITH DNAJB14.
RX   PubMed=23018488; DOI=10.1247/csf.12017;
RA   Sopha P., Kadokura H., Yamamoto Y.H., Takeuchi M., Saito M., Tsuru A.,
RA   Kohno K.;
RT   "A novel mammalian ER-located J-protein, DNAJB14, can accelerate ERAD
RT   of misfolded membrane proteins.";
RL   Cell Struct. Funct. 37:177-187(2012).
RN   [39]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [40]
RP   REVIEW.
RX   PubMed=24121476; DOI=10.4161/auto.26448;
RA   Stricher F., Macri C., Ruff M., Muller S.;
RT   "HSPA8/HSC70 chaperone protein: structure, function, and chemical
RT   targeting.";
RL   Autophagy 9:1937-1954(2013).
RN   [41]
RP   SUBUNIT, AND INTERACTION WITH STUB1.
RX   PubMed=23865999; DOI=10.1021/bi4009209;
RA   Smith M.C., Scaglione K.M., Assimon V.A., Patury S., Thompson A.D.,
RA   Dickey C.A., Southworth D.R., Paulson H.L., Gestwicki J.E.,
RA   Zuiderweg E.R.;
RT   "The E3 ubiquitin ligase CHIP and the molecular chaperone Hsc70 form a
RT   dynamic, tethered complex.";
RL   Biochemistry 52:5354-5364(2013).
RN   [42]
RP   INTERACTION WITH FOXP3.
RX   PubMed=23973223; DOI=10.1016/j.immuni.2013.08.006;
RA   Chen Z., Barbi J., Bu S., Yang H.Y., Li Z., Gao Y., Jinasena D.,
RA   Fu J., Lin F., Chen C., Zhang J., Yu N., Li X., Shan Z., Nie J.,
RA   Gao Z., Tian H., Li Y., Yao Z., Zheng Y., Park B.V., Pan Z., Zhang J.,
RA   Dang E., Li Z., Wang H., Luo W., Li L., Semenza G.L., Zheng S.G.,
RA   Loser K., Tsun A., Greene M.I., Pardoll D.M., Pan F., Li B.;
RT   "The ubiquitin ligase Stub1 negatively modulates regulatory T cell
RT   suppressive activity by promoting degradation of the transcription
RT   factor Foxp3.";
RL   Immunity 39:272-285(2013).
RN   [43]
RP   METHYLATION AT LYS-561, MUTAGENESIS OF LYS-561, AND INTERACTION WITH
RP   METTL21A.
RX   PubMed=23921388; DOI=10.1074/jbc.M113.483248;
RA   Jakobsson M.E., Moen A., Bousset L., Egge-Jacobsen W., Kernstock S.,
RA   Melki R., Falnes P.O.;
RT   "Identification and characterization of a novel human
RT   methyltransferase modulating Hsp70 function through lysine
RT   methylation.";
RL   J. Biol. Chem. 288:27752-27763(2013).
RN   [44]
RP   FUNCTION IN ERAD, AND INTERACTION WITH STUB1.
RX   PubMed=23990462; DOI=10.1074/jbc.M113.479345;
RA   Matsumura Y., Sakai J., Skach W.R.;
RT   "Endoplasmic reticulum protein quality control is determined by
RT   cooperative interactions between Hsp/c70 protein and the CHIP E3
RT   ligase.";
RL   J. Biol. Chem. 288:31069-31079(2013).
RN   [45]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-329 AND SER-541, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [46]
RP   INTERACTION WITH PRKN.
RX   PubMed=24270810; DOI=10.1038/nature12748;
RA   Hasson S.A., Kane L.A., Yamano K., Huang C.H., Sliter D.A.,
RA   Buehler E., Wang C., Heman-Ackah S.M., Hessa T., Guha R., Martin S.E.,
RA   Youle R.J.;
RT   "High-content genome-wide RNAi screens identify regulators of parkin
RT   upstream of mitophagy.";
RL   Nature 504:291-295(2013).
RN   [47]
RP   INTERACTION WITH DNAJC12.
RX   PubMed=24122553; DOI=10.1007/s12192-013-0471-6;
RA   Choi J., Djebbar S., Fournier A., Labrie C.;
RT   "The co-chaperone DNAJC12 binds to Hsc70 and is upregulated by
RT   endoplasmic reticulum stress.";
RL   Cell Stress Chaperones 19:439-446(2014).
RN   [48]
RP   INTERACTION WITH MLLT11.
RX   PubMed=24880125; DOI=10.1016/j.yexcr.2014.05.013;
RA   Li P., Ji M., Lu F., Zhang J., Li H., Cui T., Li Wang X., Tang D.,
RA   Ji C.;
RT   "Degradation of AF1Q by chaperone-mediated autophagy.";
RL   Exp. Cell Res. 327:48-56(2014).
RN   [49]
RP   FUNCTION, AND INTERACTION WITH BAG1; BAG2; BAG3 AND HSPH1.
RX   PubMed=24318877; DOI=10.1074/jbc.M113.521997;
RA   Rauch J.N., Gestwicki J.E.;
RT   "Binding of human nucleotide exchange factors to heat shock protein 70
RT   (Hsp70) generates functionally distinct complexes in vitro.";
RL   J. Biol. Chem. 289:1402-1414(2014).
RN   [50]
RP   INTERACTION WITH RNF207.
RX   PubMed=25281747; DOI=10.1074/jbc.M114.592295;
RA   Roder K., Werdich A.A., Li W., Liu M., Kim T.Y., Organ-Darling L.E.,
RA   Moshal K.S., Hwang J.M., Lu Y., Choi B.R., MacRae C.A., Koren G.;
RT   "RING finger protein RNF207, a novel regulator of cardiac
RT   excitation.";
RL   J. Biol. Chem. 289:33730-33740(2014).
RN   [51]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [52]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-469 AND LYS-561, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [53]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-512, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [54]
RP   INTERACTION WITH DNAJB12 AND DNAJB14.
RX   PubMed=24732912; DOI=10.1371/journal.pone.0094322;
RA   Goodwin E.C., Motamedi N., Lipovsky A., Fernandez-Busnadiego R.,
RA   DiMaio D.;
RT   "Expression of DNAJB12 or DNAJB14 causes coordinate invasion of the
RT   nucleus by membranes associated with a novel nuclear pore structure.";
RL   PLoS ONE 9:E94322-E94322(2014).
RN   [55]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-512, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [56]
RP   INTERACTION WITH HSPA8.
RX   PubMed=25760597; DOI=10.1107/S1399004714026881;
RA   Song J., Kose S., Watanabe A., Son S.Y., Choi S., Hong H.,
RA   Yamashita E., Park I.Y., Imamoto N., Lee S.J.;
RT   "Structural and functional analysis of Hikeshi, a new nuclear
RT   transport receptor of Hsp70s.";
RL   Acta Crystallogr. D 71:473-483(2015).
RN   [57]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [58]
RP   INTERACTION WITH DNAJC21.
RX   PubMed=27346687; DOI=10.1016/j.ajhg.2016.05.002;
RA   Tummala H., Walne A.J., Williams M., Bockett N., Collopy L.,
RA   Cardoso S., Ellison A., Wynn R., Leblanc T., Fitzgibbon J.,
RA   Kelsell D.P., van Heel D.A., Payne E., Plagnol V., Dokal I.,
RA   Vulliamy T.;
RT   "DNAJC21 mutations link a cancer-prone bone marrow failure syndrome to
RT   corruption in 60S ribosome subunit maturation.";
RL   Am. J. Hum. Genet. 99:115-124(2016).
RN   [59]
RP   REVIEW.
RX   PubMed=26865365; DOI=10.1007/s12192-016-0676-6;
RA   Radons J.;
RT   "The human HSP70 family of chaperones: where do we stand?";
RL   Cell Stress Chaperones 21:379-404(2016).
RN   [60]
RP   FUNCTION, INTERACTION WITH BAG1 AND BAG3, REGION NBD, AND REGION SBD.
RX   PubMed=27474739; DOI=10.1074/jbc.M116.742502;
RA   Rauch J.N., Zuiderweg E.R., Gestwicki J.E.;
RT   "Non-canonical interactions between heat shock cognate protein 70
RT   (Hsc70) and Bcl2-associated anthanogene (BAG) co-chaperones are
RT   important for client release.";
RL   J. Biol. Chem. 291:19848-19857(2016).
RN   [61]
RP   INTERACTION WITH HOPX; STUB1; HSP40 AND HSP90.
RX   PubMed=27708256; DOI=10.1038/ncomms12882;
RA   Seo J.H., Park J.H., Lee E.J., Vo T.T., Choi H., Kim J.Y., Jang J.K.,
RA   Wee H.J., Lee H.S., Jang S.H., Park Z.Y., Jeong J., Lee K.J.,
RA   Seok S.H., Park J.Y., Lee B.J., Lee M.N., Oh G.T., Kim K.W.;
RT   "ARD1-mediated Hsp70 acetylation balances stress-induced protein
RT   refolding and degradation.";
RL   Nat. Commun. 7:12882-12882(2016).
RN   [62]
RP   INTERACTION WITH DNAJB12 AND DNAJB14.
RX   PubMed=27916661; DOI=10.1016/j.molcel.2016.10.027;
RA   Li K., Jiang Q., Bai X., Yang Y.F., Ruan M.Y., Cai S.Q.;
RT   "Tetrameric assembly of K(+) channels requires ER-located chaperone
RT   proteins.";
RL   Mol. Cell 65:52-65(2017).
RN   [63]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 1-634.
RX   PubMed=19586912; DOI=10.1074/jbc.M109.033894;
RA   Kajander T., Sachs J.N., Goldman A., Regan L.;
RT   "Electrostatic interactions of Hsp-organizing protein
RT   tetratricopeptide domains with Hsp70 and Hsp90: computational analysis
RT   and protein engineering.";
RL   J. Biol. Chem. 284:25364-25374(2009).
RN   [64]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 4-381 IN COMPLEXES WITH ATP
RP   AND ATP ANALOGS.
RX   PubMed=19256508; DOI=10.1021/jm801627a;
RA   Williamson D.S., Borgognoni J., Clay A., Daniels Z., Dokurno P.,
RA   Drysdale M.J., Foloppe N., Francis G.L., Graham C.J., Howes R.,
RA   Macias A.T., Murray J.B., Parsons R., Shaw T., Surgenor A.E.,
RA   Terry L., Wang Y., Wood M., Massey A.J.;
RT   "Novel adenosine-derived inhibitors of 70 kDa heat shock protein,
RT   discovered through structure-based design.";
RL   J. Med. Chem. 52:1510-1513(2009).
RN   [65]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 4-381 IN COMPLEXES WITH ATP
RP   ANALOGS.
RX   PubMed=21526763; DOI=10.1021/jm101625x;
RA   Macias A.T., Williamson D.S., Allen N., Borgognoni J., Clay A.,
RA   Daniels Z., Dokurno P., Drysdale M.J., Francis G.L., Graham C.J.,
RA   Howes R., Matassova N., Murray J.B., Parsons R., Shaw T.,
RA   Surgenor A.E., Terry L., Wang Y., Wood M., Massey A.J.;
RT   "Adenosine-derived inhibitors of 78 kDa glucose regulated protein
RT   (Grp78) ATPase: insights into isoform selectivity.";
RL   J. Med. Chem. 54:4034-4041(2011).
CC   -!- FUNCTION: Molecular chaperone implicated in a wide variety of
CC       cellular processes, including protection of the proteome from
CC       stress, folding and transport of newly synthesized polypeptides,
CC       activation of proteolysis of misfolded proteins and the formation
CC       and dissociation of protein complexes. Plays a pivotal role in the
CC       protein quality control system, ensuring the correct folding of
CC       proteins, the re-folding of misfolded proteins and controlling the
CC       targeting of proteins for subsequent degradation (PubMed:21150129,
CC       PubMed:21148293, PubMed:24732912, PubMed:27916661,
CC       PubMed:23018488). This is achieved through cycles of ATP binding,
CC       ATP hydrolysis and ADP release, mediated by co-chaperones
CC       (PubMed:21150129, PubMed:21148293, PubMed:24732912,
CC       PubMed:27916661, PubMed:23018488). The co-chaperones have been
CC       shown to not only regulate different steps of the ATPase cycle of
CC       HSP70, but they also have an individual specificity such that one
CC       co-chaperone may promote folding of a substrate while another may
CC       promote degradation (PubMed:21150129, PubMed:21148293,
CC       PubMed:24732912, PubMed:27916661, PubMed:23018488). The affinity
CC       of HSP70 for polypeptides is regulated by its nucleotide bound
CC       state. In the ATP-bound form, it has a low affinity for substrate
CC       proteins. However, upon hydrolysis of the ATP to ADP, it undergoes
CC       a conformational change that increases its affinity for substrate
CC       proteins. HSP70 goes through repeated cycles of ATP hydrolysis and
CC       nucleotide exchange, which permits cycles of substrate binding and
CC       release. The HSP70-associated co-chaperones are of three types: J-
CC       domain co-chaperones HSP40s (stimulate ATPase hydrolysis by
CC       HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3
CC       (facilitate conversion of HSP70 from the ADP-bound to the ATP-
CC       bound state thereby promoting substrate release), and the TPR
CC       domain chaperones such as HOPX and STUB1 (PubMed:24318877,
CC       PubMed:27474739, PubMed:24121476, PubMed:26865365). Acts as a
CC       repressor of transcriptional activation. Inhibits the
CC       transcriptional coactivator activity of CITED1 on Smad-mediated
CC       transcription. Component of the PRP19-CDC5L complex that forms an
CC       integral part of the spliceosome and is required for activating
CC       pre-mRNA splicing. May have a scaffolding role in the spliceosome
CC       assembly as it contacts all other components of the core complex.
CC       Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced
CC       inflammatory response, including TNF secretion by monocytes
CC       (PubMed:10722728, PubMed:11276205). Participates in the ER-
CC       associated degradation (ERAD) quality control pathway in
CC       conjunction with J domain-containing co-chaperones and the E3
CC       ligase STUB1 (PubMed:23990462). {ECO:0000269|PubMed:10722728,
CC       ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:21148293,
CC       ECO:0000269|PubMed:21150129, ECO:0000269|PubMed:23018488,
CC       ECO:0000269|PubMed:23990462, ECO:0000269|PubMed:24318877,
CC       ECO:0000269|PubMed:24732912, ECO:0000269|PubMed:27474739,
CC       ECO:0000269|PubMed:27916661, ECO:0000303|PubMed:24121476,
CC       ECO:0000303|PubMed:26865365}.
CC   -!- SUBUNIT: Identified in a IGF2BP1-dependent mRNP granule complex
CC       containing untranslated mRNAs. Interacts with PACRG. Interacts
CC       with HSPH1/HSP105. Interacts with IRAK1BP1 and BAG1. Interacts
CC       with DNAJC7. Interacts with DNAJB12 (via J domain)
CC       (PubMed:21150129, PubMed:21148293, PubMed:24732912,
CC       PubMed:27916661). Interacts with DNAJB14 (via J domain)
CC       (PubMed:23018488, PubMed:24732912, PubMed:27916661). Interacts
CC       (via C-terminus) with the E3 ligase CHIP forming a 210 kDa complex
CC       of one CHIP and two HSPA8 molecules. Interacts with CITED1 (via N-
CC       terminus); the interaction suppresses the association of CITED1 to
CC       p300/CBP and Smad-mediated transcription transactivation.
CC       Component of the PRP19-CDC5L splicing complex composed of a core
CC       complex comprising a homotetramer of PRPF19, CDC5L, PLRG1 and
CC       BCAS2, and at least three less stably associated proteins CTNNBL1,
CC       CWC15 and HSPA8. Interacts with SV40 VP1. Interacts with TRIM5.
CC       Part of a complex composed at least of ASCL2, EMSY, HCFC1, HSPA8,
CC       CCAR2, MATR3, MKI67, RBBP5, TUBB2A, WDR5 and ZNF335; this complex
CC       may have a histone H3-specific methyltransferase activity.
CC       Interacts with METTL21A. Following LPS binding, may form a complex
CC       with CXCR4, GDF5 and HSP90AA1. Interacts with PRKN. Interacts with
CC       FOXP3. Interacts with DNAJC9 (via J domain) (PubMed:17182002).
CC       Interacts with MLLT11 (PubMed:24880125). Interacts with RNF207
CC       (PubMed:25281747). Interacts with DNAJC21 (PubMed:27346687).
CC       Interacts with DNAJB2 (PubMed:15936278). Interacts with TTC1 (via
CC       TPR repeats) (PubMed:15708368). Interacts with SGTA (via TPR
CC       repeats) (By similarity). Interacts with HSF1 (via transactivation
CC       domain) (PubMed:9499401). Interacts with HOPX, HSP40 and HSP90
CC       (PubMed:27708256). Interacts with STUB1 (PubMed:27708256).
CC       Interacts with BAG2 (PubMed:24318877). Interacts with BAG3
CC       (PubMed:27474739, PubMed:24318877). Interacts with DNAJC12
CC       (PubMed:24122553). Interacts with HSPC138 (PubMed:25760597).
CC       {ECO:0000250|UniProtKB:P63018, ECO:0000269|PubMed:10722728,
CC       ECO:0000269|PubMed:11147964, ECO:0000269|PubMed:11276205,
CC       ECO:0000269|PubMed:14532270, ECO:0000269|PubMed:15708368,
CC       ECO:0000269|PubMed:15936278, ECO:0000269|PubMed:15963462,
CC       ECO:0000269|PubMed:16815975, ECO:0000269|PubMed:17182002,
CC       ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:19131338,
CC       ECO:0000269|PubMed:20053985, ECO:0000269|PubMed:21148293,
CC       ECO:0000269|PubMed:21150129, ECO:0000269|PubMed:23018488,
CC       ECO:0000269|PubMed:23865999, ECO:0000269|PubMed:23921388,
CC       ECO:0000269|PubMed:23973223, ECO:0000269|PubMed:23990462,
CC       ECO:0000269|PubMed:24122553, ECO:0000269|PubMed:24270810,
CC       ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24732912,
CC       ECO:0000269|PubMed:24880125, ECO:0000269|PubMed:25281747,
CC       ECO:0000269|PubMed:25760597, ECO:0000269|PubMed:27346687,
CC       ECO:0000269|PubMed:27474739, ECO:0000269|PubMed:27708256,
CC       ECO:0000269|PubMed:27916661, ECO:0000269|PubMed:9305631,
CC       ECO:0000269|PubMed:9499401, ECO:0000269|PubMed:9679980}.
CC   -!- INTERACTION:
CC       Q99IB8:- (xeno); NbExp=3; IntAct=EBI-351896, EBI-6927928;
CC       P60709:ACTB; NbExp=2; IntAct=EBI-351896, EBI-353944;
CC       Q9GZX7:AICDA; NbExp=2; IntAct=EBI-351896, EBI-3834328;
CC       P49407:ARRB1; NbExp=4; IntAct=EBI-351896, EBI-743313;
CC       P32121:ARRB2; NbExp=4; IntAct=EBI-351896, EBI-714559;
CC       Q9NQ11:ATP13A2; NbExp=2; IntAct=EBI-351896, EBI-6308763;
CC       Q99933:BAG1; NbExp=13; IntAct=EBI-351896, EBI-1030678;
CC       O95816:BAG2; NbExp=7; IntAct=EBI-351896, EBI-355275;
CC       O95429:BAG4; NbExp=3; IntAct=EBI-351896, EBI-2949658;
CC       Q8AZK7:EBNA-LP (xeno); NbExp=3; IntAct=EBI-351896, EBI-1185167;
CC       P00533:EGFR; NbExp=5; IntAct=EBI-351896, EBI-297353;
CC       O14976:GAK; NbExp=6; IntAct=EBI-351896, EBI-714707;
CC       P34932:HSPA4; NbExp=5; IntAct=EBI-351896, EBI-356933;
CC       Q9NZL4:HSPBP1; NbExp=11; IntAct=EBI-351896, EBI-356763;
CC       P05412:JUN; NbExp=3; IntAct=EBI-351896, EBI-852823;
CC       P00338:LDHA; NbExp=4; IntAct=EBI-351896, EBI-372327;
CC       Q5S007:LRRK2; NbExp=5; IntAct=EBI-351896, EBI-5323863;
CC       P03485:M (xeno); NbExp=4; IntAct=EBI-351896, EBI-2547543;
CC       P14598:NCF1; NbExp=2; IntAct=EBI-351896, EBI-395044;
CC       Q9UNE7:STUB1; NbExp=8; IntAct=EBI-351896, EBI-357085;
CC       Q9UNE7-1:STUB1; NbExp=4; IntAct=EBI-351908, EBI-15687717;
CC       P61764:STXBP1; NbExp=2; IntAct=EBI-351896, EBI-960169;
CC       O00635:TRIM38; NbExp=5; IntAct=EBI-351896, EBI-2130415;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Melanosome. Nucleus, nucleolus.
CC       Cell membrane. Note=Localized in cytoplasmic mRNP granules
CC       containing untranslated mRNAs. Translocates rapidly from the
CC       cytoplasm to the nuclei, and especially to the nucleoli, upon heat
CC       shock.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P11142-1; Sequence=Displayed;
CC       Name=2; Synonyms=HSC54;
CC         IsoId=P11142-2; Sequence=VSP_002427;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11276205}.
CC   -!- INDUCTION: Constitutively synthesized.
CC   -!- DOMAIN: The N-terminal nucleotide binding domain (NBD) (also known
CC       as the ATPase domain) is responsible for binding and hydrolyzing
CC       ATP. The C-terminal substrate-binding domain (SBD) (also known as
CC       peptide-binding domain) binds to the client/substrate proteins.
CC       The two domains are allosterically coupled so that, when ATP is
CC       bound to the NBD, the SBD binds relatively weakly to clients. When
CC       ADP is bound in the NBD, a conformational change enhances the
CC       affinity of the SBD for client proteins.
CC       {ECO:0000269|PubMed:9305631}.
CC   -!- PTM: Acetylated. {ECO:0000269|Ref.5, ECO:0000269|Ref.6}.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798,
CC       ECO:0000269|PubMed:16815975}.
CC   -!- PTM: Trimethylation at Lys-561 reduces fibrillar SNCA binding.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y00371; CAA68445.1; -; Genomic_DNA.
DR   EMBL; AB034951; BAB18615.1; -; mRNA.
DR   EMBL; AF352832; AAK17898.1; -; mRNA.
DR   EMBL; BC016179; AAH16179.1; -; mRNA.
DR   EMBL; BC016660; AAH16660.1; -; mRNA.
DR   EMBL; BC019816; AAH19816.1; -; mRNA.
DR   CCDS; CCDS44754.1; -. [P11142-2]
DR   CCDS; CCDS8440.1; -. [P11142-1]
DR   PIR; A27077; A27077.
DR   RefSeq; NP_006588.1; NM_006597.5. [P11142-1]
DR   RefSeq; NP_694881.1; NM_153201.3. [P11142-2]
DR   RefSeq; XP_011541100.1; XM_011542798.1. [P11142-1]
DR   UniGene; Hs.180414; -.
DR   PDB; 3AGY; X-ray; 1.85 A; C/D/F=639-646.
DR   PDB; 3AGZ; X-ray; 2.51 A; C/D/E/F=639-646.
DR   PDB; 3ESK; X-ray; 2.05 A; B=635-646.
DR   PDB; 3FZF; X-ray; 2.20 A; A=4-381.
DR   PDB; 3FZH; X-ray; 2.00 A; A=4-381.
DR   PDB; 3FZK; X-ray; 2.10 A; A=4-381.
DR   PDB; 3FZL; X-ray; 2.20 A; A=4-381.
DR   PDB; 3FZM; X-ray; 2.30 A; A=4-381.
DR   PDB; 3LDQ; X-ray; 1.90 A; A=4-381.
DR   PDB; 3M3Z; X-ray; 2.10 A; A=4-381.
DR   PDB; 4H5N; X-ray; 1.86 A; A/B=2-384.
DR   PDB; 4H5R; X-ray; 1.64 A; A/B=2-384.
DR   PDB; 4H5T; X-ray; 1.90 A; A=2-384.
DR   PDB; 4H5V; X-ray; 1.75 A; A=2-384.
DR   PDB; 4H5W; X-ray; 1.94 A; A/B=2-384.
DR   PDB; 4HWI; X-ray; 2.27 A; A=5-381.
DR   PDB; 4KBQ; X-ray; 2.91 A; C/D=541-646.
DR   PDB; 5AQF; X-ray; 1.88 A; A/C=1-381.
DR   PDB; 5AQG; X-ray; 2.24 A; A/C/E=1-381.
DR   PDB; 5AQH; X-ray; 2.00 A; A=1-381.
DR   PDB; 5AQI; X-ray; 1.98 A; A/C=1-381.
DR   PDB; 5AQJ; X-ray; 1.96 A; A/C/E=1-381.
DR   PDB; 5AQK; X-ray; 2.09 A; A=1-381.
DR   PDB; 5AQL; X-ray; 1.69 A; A/C=1-381.
DR   PDB; 5AQM; X-ray; 1.63 A; A/C=1-381.
DR   PDB; 5AQN; X-ray; 2.45 A; A/C/E=1-381.
DR   PDB; 5AQO; X-ray; 2.12 A; A/C/E=1-381.
DR   PDB; 5AQP; X-ray; 2.08 A; A/C/E=1-381.
DR   PDB; 5AQQ; X-ray; 2.72 A; A/C/E=1-381.
DR   PDB; 5AQR; X-ray; 1.91 A; A/C/E=1-381.
DR   PDB; 5AQS; X-ray; 2.00 A; A/C=1-381.
DR   PDB; 5AQT; X-ray; 1.90 A; A=1-381.
DR   PDB; 5AQU; X-ray; 1.92 A; A=1-381.
DR   PDB; 5AQV; X-ray; 1.75 A; A=1-381.
DR   PDB; 6B1I; X-ray; 2.30 A; A/B=5-381.
DR   PDB; 6B1M; X-ray; 1.90 A; A/B=5-381.
DR   PDB; 6B1N; X-ray; 1.80 A; A/B=5-381.
DR   PDBsum; 3AGY; -.
DR   PDBsum; 3AGZ; -.
DR   PDBsum; 3ESK; -.
DR   PDBsum; 3FZF; -.
DR   PDBsum; 3FZH; -.
DR   PDBsum; 3FZK; -.
DR   PDBsum; 3FZL; -.
DR   PDBsum; 3FZM; -.
DR   PDBsum; 3LDQ; -.
DR   PDBsum; 3M3Z; -.
DR   PDBsum; 4H5N; -.
DR   PDBsum; 4H5R; -.
DR   PDBsum; 4H5T; -.
DR   PDBsum; 4H5V; -.
DR   PDBsum; 4H5W; -.
DR   PDBsum; 4HWI; -.
DR   PDBsum; 4KBQ; -.
DR   PDBsum; 5AQF; -.
DR   PDBsum; 5AQG; -.
DR   PDBsum; 5AQH; -.
DR   PDBsum; 5AQI; -.
DR   PDBsum; 5AQJ; -.
DR   PDBsum; 5AQK; -.
DR   PDBsum; 5AQL; -.
DR   PDBsum; 5AQM; -.
DR   PDBsum; 5AQN; -.
DR   PDBsum; 5AQO; -.
DR   PDBsum; 5AQP; -.
DR   PDBsum; 5AQQ; -.
DR   PDBsum; 5AQR; -.
DR   PDBsum; 5AQS; -.
DR   PDBsum; 5AQT; -.
DR   PDBsum; 5AQU; -.
DR   PDBsum; 5AQV; -.
DR   PDBsum; 6B1I; -.
DR   PDBsum; 6B1M; -.
DR   PDBsum; 6B1N; -.
DR   ProteinModelPortal; P11142; -.
DR   SMR; P11142; -.
DR   BioGrid; 109544; 573.
DR   CORUM; P11142; -.
DR   DIP; DIP-32874N; -.
DR   IntAct; P11142; 216.
DR   MINT; P11142; -.
DR   STRING; 9606.ENSP00000227378; -.
DR   BindingDB; P11142; -.
DR   ChEMBL; CHEMBL1275223; -.
DR   iPTMnet; P11142; -.
DR   PhosphoSitePlus; P11142; -.
DR   SwissPalm; P11142; -.
DR   DMDM; 123648; -.
DR   DOSAC-COBS-2DPAGE; P11142; -.
DR   OGP; P11142; -.
DR   REPRODUCTION-2DPAGE; IPI00003865; -.
DR   SWISS-2DPAGE; P11142; -.
DR   UCD-2DPAGE; P11142; -.
DR   EPD; P11142; -.
DR   PaxDb; P11142; -.
DR   PeptideAtlas; P11142; -.
DR   PRIDE; P11142; -.
DR   TopDownProteomics; P11142-1; -. [P11142-1]
DR   TopDownProteomics; P11142-2; -. [P11142-2]
DR   DNASU; 3312; -.
DR   Ensembl; ENST00000227378; ENSP00000227378; ENSG00000109971. [P11142-1]
DR   Ensembl; ENST00000453788; ENSP00000404372; ENSG00000109971. [P11142-2]
DR   Ensembl; ENST00000532636; ENSP00000437125; ENSG00000109971. [P11142-1]
DR   Ensembl; ENST00000534624; ENSP00000432083; ENSG00000109971. [P11142-1]
DR   GeneID; 3312; -.
DR   KEGG; hsa:3312; -.
DR   UCSC; uc001pyp.5; human. [P11142-1]
DR   CTD; 3312; -.
DR   DisGeNET; 3312; -.
DR   EuPathDB; HostDB:ENSG00000109971.13; -.
DR   GeneCards; HSPA8; -.
DR   H-InvDB; HIX0033867; -.
DR   HGNC; HGNC:5241; HSPA8.
DR   HPA; CAB002056; -.
DR   HPA; HPA052504; -.
DR   MIM; 600816; gene.
DR   neXtProt; NX_P11142; -.
DR   OpenTargets; ENSG00000109971; -.
DR   PharmGKB; PA29507; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   GeneTree; ENSGT00910000144045; -.
DR   HOGENOM; HOG000228135; -.
DR   HOVERGEN; HBG051845; -.
DR   InParanoid; P11142; -.
DR   KO; K03283; -.
DR   OMA; AYTKNQD; -.
DR   OrthoDB; EOG091G03SF; -.
DR   PhylomeDB; P11142; -.
DR   TreeFam; TF105042; -.
DR   BRENDA; 3.6.3.51; 2681.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   Reactome; R-HSA-432720; Lysosome Vesicle Biogenesis.
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-HSA-447041; CHL1 interactions.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8876725; Protein methylation.
DR   Reactome; R-HSA-888590; GABA synthesis, release, reuptake and degradation.
DR   SIGNOR; P11142; -.
DR   ChiTaRS; HSPA8; human.
DR   EvolutionaryTrace; P11142; -.
DR   GeneWiki; HSPA8; -.
DR   GenomeRNAi; 3312; -.
DR   PMAP-CutDB; P11142; -.
DR   PRO; PR:P11142; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000109971; -.
DR   CleanEx; HS_HSPA8; -.
DR   ExpressionAtlas; P11142; baseline and differential.
DR   Genevisible; P11142; HS.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0101031; C:chaperone complex; IPI:ARUK-UCL.
DR   GO; GO:0061202; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0005770; C:late endosome; IEA:Ensembl.
DR   GO; GO:0098575; C:lumenal side of lysosomal membrane; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0005765; C:lysosomal membrane; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0000974; C:Prp19 complex; IDA:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:UniProtKB.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0005681; C:spliceosomal complex; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IDA:BHF-UCL.
DR   GO; GO:0016887; F:ATPase activity; IDA:BHF-UCL.
DR   GO; GO:0042623; F:ATPase activity, coupled; TAS:Reactome.
DR   GO; GO:0055131; F:C3HC4-type RING finger domain binding; IPI:BHF-UCL.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0051087; F:chaperone binding; IPI:ARUK-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0001664; F:G-protein coupled receptor binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:UniProtKB.
DR   GO; GO:0023026; F:MHC class II protein complex binding; HDA:UniProtKB.
DR   GO; GO:0001786; F:phosphatidylserine binding; IEA:Ensembl.
DR   GO; GO:0030674; F:protein binding, bridging; IPI:ARUK-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0046034; P:ATP metabolic process; IDA:BHF-UCL.
DR   GO; GO:0009267; P:cellular response to starvation; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0051085; P:chaperone cofactor-dependent protein refolding; IEA:Ensembl.
DR   GO; GO:0061684; P:chaperone-mediated autophagy; ISS:ParkinsonsUK-UCL.
DR   GO; GO:1904764; P:chaperone-mediated autophagy translocation complex disassembly; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0061741; P:chaperone-mediated protein transport involved in chaperone-mediated autophagy; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0072318; P:clathrin coat disassembly; IEA:Ensembl.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0061738; P:late endosomal microautophagy; IEA:Ensembl.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:1902904; P:negative regulation of supramolecular fiber organization; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0044829; P:positive regulation by host of viral genome replication; IEA:Ensembl.
DR   GO; GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IEA:Ensembl.
DR   GO; GO:0006457; P:protein folding; NAS:UniProtKB.
DR   GO; GO:0042026; P:protein refolding; IDA:UniProtKB.
DR   GO; GO:0061740; P:protein targeting to lysosome involved in chaperone-mediated autophagy; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0051726; P:regulation of cell cycle; IEA:Ensembl.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0043488; P:regulation of mRNA stability; TAS:Reactome.
DR   GO; GO:0043254; P:regulation of protein complex assembly; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0061635; P:regulation of protein complex stability; ISS:ParkinsonsUK-UCL.
DR   GO; GO:1904589; P:regulation of protein import; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0031647; P:regulation of protein stability; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0006986; P:response to unfolded protein; NAS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   SUPFAM; SSF100934; SSF100934; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell membrane; Chaperone; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Host-virus interaction; Isopeptide bond;
KW   Membrane; Methylation; mRNA processing; mRNA splicing;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repressor; Spliceosome; Stress response;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.6}.
FT   CHAIN         2    646       Heat shock cognate 71 kDa protein.
FT                                /FTId=PRO_0000078270.
FT   NP_BIND      12     15       ATP.
FT   NP_BIND     202    204       ATP.
FT   NP_BIND     268    275       ATP.
FT   NP_BIND     339    342       ATP.
FT   REGION        2    386       Nucleotide-binding domain (NBD).
FT                                {ECO:0000305|PubMed:27474739}.
FT   REGION      186    377       Interaction with BAG1.
FT   REGION      394    509       Substrate-binding domain (SBD).
FT                                {ECO:0000305|PubMed:27474739}.
FT   BINDING      71     71       ATP.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.6}.
FT   MOD_RES     108    108       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     153    153       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES     246    246       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     319    319       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     319    319       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     328    328       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     329    329       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     362    362       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     469    469       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     512    512       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     512    512       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     524    524       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     541    541       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     561    561       N6,N6,N6-trimethyllysine; by METTL21A;
FT                                alternate. {ECO:0000269|PubMed:23349634,
FT                                ECO:0000269|PubMed:23921388}.
FT   MOD_RES     561    561       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     589    589       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     597    597       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     601    601       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   CROSSLNK    512    512       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK    512    512       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447}.
FT   VAR_SEQ     464    616       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11093761}.
FT                                /FTId=VSP_002427.
FT   VARIANT      32     32       D -> Y (in dbSNP:rs11551602).
FT                                /FTId=VAR_049619.
FT   VARIANT     459    459       F -> L (in dbSNP:rs11551598).
FT                                /FTId=VAR_049620.
FT   MUTAGEN     561    561       K->R: Complete loss of in vitro
FT                                methylation by METTL21A.
FT                                {ECO:0000269|PubMed:23349634,
FT                                ECO:0000269|PubMed:23921388}.
FT   STRAND        7     10       {ECO:0000244|PDB:5AQM}.
FT   STRAND       13     22       {ECO:0000244|PDB:5AQM}.
FT   STRAND       25     28       {ECO:0000244|PDB:5AQM}.
FT   STRAND       36     39       {ECO:0000244|PDB:5AQM}.
FT   STRAND       42     44       {ECO:0000244|PDB:5AQM}.
FT   STRAND       49     51       {ECO:0000244|PDB:5AQM}.
FT   HELIX        53     57       {ECO:0000244|PDB:5AQM}.
FT   TURN         58     61       {ECO:0000244|PDB:5AQM}.
FT   HELIX        63     65       {ECO:0000244|PDB:5AQM}.
FT   HELIX        70     72       {ECO:0000244|PDB:5AQM}.
FT   TURN         73     75       {ECO:0000244|PDB:5AQM}.
FT   HELIX        81     87       {ECO:0000244|PDB:5AQM}.
FT   STRAND       91     97       {ECO:0000244|PDB:5AQM}.
FT   STRAND      100    107       {ECO:0000244|PDB:5AQM}.
FT   STRAND      110    114       {ECO:0000244|PDB:5AQM}.
FT   HELIX       116    135       {ECO:0000244|PDB:5AQM}.
FT   STRAND      136    138       {ECO:0000244|PDB:5AQF}.
FT   STRAND      141    146       {ECO:0000244|PDB:5AQM}.
FT   HELIX       152    164       {ECO:0000244|PDB:5AQM}.
FT   STRAND      168    174       {ECO:0000244|PDB:5AQM}.
FT   HELIX       175    182       {ECO:0000244|PDB:5AQM}.
FT   HELIX       185    187       {ECO:0000244|PDB:5AQM}.
FT   STRAND      188    191       {ECO:0000244|PDB:5AQL}.
FT   STRAND      193    201       {ECO:0000244|PDB:5AQM}.
FT   STRAND      204    213       {ECO:0000244|PDB:5AQM}.
FT   STRAND      216    225       {ECO:0000244|PDB:5AQM}.
FT   HELIX       230    249       {ECO:0000244|PDB:5AQM}.
FT   HELIX       253    255       {ECO:0000244|PDB:3LDQ}.
FT   HELIX       257    276       {ECO:0000244|PDB:5AQM}.
FT   STRAND      278    288       {ECO:0000244|PDB:5AQM}.
FT   STRAND      291    298       {ECO:0000244|PDB:5AQM}.
FT   HELIX       299    305       {ECO:0000244|PDB:5AQM}.
FT   HELIX       307    312       {ECO:0000244|PDB:5AQM}.
FT   HELIX       314    324       {ECO:0000244|PDB:5AQM}.
FT   HELIX       328    330       {ECO:0000244|PDB:5AQM}.
FT   STRAND      333    338       {ECO:0000244|PDB:5AQM}.
FT   HELIX       339    342       {ECO:0000244|PDB:5AQM}.
FT   HELIX       344    353       {ECO:0000244|PDB:5AQM}.
FT   TURN        354    356       {ECO:0000244|PDB:5AQM}.
FT   STRAND      357    360       {ECO:0000244|PDB:3FZF}.
FT   TURN        365    367       {ECO:0000244|PDB:5AQM}.
FT   HELIX       368    380       {ECO:0000244|PDB:5AQM}.
FT   HELIX       541    556       {ECO:0000244|PDB:4KBQ}.
FT   HELIX       564    582       {ECO:0000244|PDB:4KBQ}.
FT   HELIX       594    612       {ECO:0000244|PDB:4KBQ}.
FT   HELIX       613    616       {ECO:0000244|PDB:4KBQ}.
FT   STRAND      641    644       {ECO:0000244|PDB:3AGY}.
SQ   SEQUENCE   646 AA;  70898 MW;  9AA27B210730670C CRC64;
     MSKGPAVGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA
     MNPTNTVFDA KRLIGRRFDD AVVQSDMKHW PFMVVNDAGR PKVQVEYKGE TKSFYPEEVS
     SMVLTKMKEI AEAYLGKTVT NAVVTVPAYF NDSQRQATKD AGTIAGLNVL RIINEPTAAA
     IAYGLDKKVG AERNVLIFDL GGGTFDVSIL TIEDGIFEVK STAGDTHLGG EDFDNRMVNH
     FIAEFKRKHK KDISENKRAV RRLRTACERA KRTLSSSTQA SIEIDSLYEG IDFYTSITRA
     RFEELNADLF RGTLDPVEKA LRDAKLDKSQ IHDIVLVGGS TRIPKIQKLL QDFFNGKELN
     KSINPDEAVA YGAAVQAAIL SGDKSENVQD LLLLDVTPLS LGIETAGGVM TVLIKRNTTI
     PTKQTQTFTT YSDNQPGVLI QVYEGERAMT KDNNLLGKFE LTGIPPAPRG VPQIEVTFDI
     DANGILNVSA VDKSTGKENK ITITNDKGRL SKEDIERMVQ EAEKYKAEDE KQRDKVSSKN
     SLESYAFNMK ATVEDEKLQG KINDEDKQKI LDKCNEIINW LDKNQTAEKE EFEHQQKELE
     KVCNPIITKL YQSAGGMPGG MPGGFPGGGA PPSGGASSGP TIEEVD
//
ID   Q53HF2_HUMAN            Unreviewed;       493 AA.
AC   Q53HF2;
DT   24-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   24-MAY-2005, sequence version 1.
DT   28-FEB-2018, entry version 82.
DE   SubName: Full=Heat shock 70kDa protein 8 isoform 2 variant {ECO:0000313|EMBL:BAD96348.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD96348.1};
RN   [1] {ECO:0000313|EMBL:BAD96348.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:BAD96348.1};
RX   PubMed=8125298; DOI=10.1016/0378-1119(94)90802-8;
RA   Maruyama K., Sugano S.;
RT   "Oligo-capping: a simple method to replace the cap structure of
RT   eukaryotic mRNAs with oligoribonucleotides.";
RL   Gene 138:171-174(1994).
RN   [2] {ECO:0000313|EMBL:BAD96348.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:BAD96348.1};
RX   PubMed=9373149; DOI=10.1016/S0378-1119(97)00411-3;
RA   Suzuki Y., Yoshitomo K., Maruyama K., Suyama A., Sugano S.;
RT   "Construction and characterization of a full length-enriched and a 5'-
RT   end-enriched cDNA library.";
RL   Gene 200:149-156(1997).
RN   [3] {ECO:0000313|EMBL:BAD96348.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:BAD96348.1};
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- INTERACTION:
CC       Q13387:MAPK8IP2; NbExp=2; IntAct=EBI-877761, EBI-722813;
CC       O14796:SH2D1B; NbExp=3; IntAct=EBI-877761, EBI-3923013;
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000256|RuleBase:RU003322}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK222628; BAD96348.1; -; mRNA.
DR   RefSeq; NP_006588.1; NM_006597.5.
DR   RefSeq; NP_694881.1; NM_153201.3.
DR   UniGene; Hs.180414; -.
DR   IntAct; Q53HF2; 2.
DR   PeptideAtlas; Q53HF2; -.
DR   PRIDE; Q53HF2; -.
DR   DNASU; 3312; -.
DR   GeneID; 3312; -.
DR   KEGG; hsa:3312; -.
DR   CTD; 3312; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   HOGENOM; HOG000228135; -.
DR   HOVERGEN; HBG051845; -.
DR   KO; K03283; -.
DR   GenomeRNAi; 3312; -.
DR   Genevisible; Q53HF2; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 2.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|RuleBase:RU003322};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU003322};
KW   Stress response {ECO:0000313|EMBL:BAD96348.1}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAD96348.1}.
SQ   SEQUENCE   493 AA;  53500 MW;  518CE1F703509AFA CRC64;
     MSKGPAVGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA
     MNPTNTVFDA KRLIGRRFDD AVVQSDMKHW PFMVVNDAGR PKVQVEYKGE TKSFYPEEVS
     SMVLTKMKEI AEAYLGKTVT NAVVTVPAYF NDSQRQATKD AGTIAGLNVL RIINEPTAAA
     IAYGLDKKVG AERNVLIFDL GGGTFDVSIL TIEDGIFEVK STAGDTHLGG EDFDNRMVNH
     FIAEFKRKHK KDISENKRAV RRLRTACERA KRTLSSSTQA SIEIDSLYEG IDFYTSITRA
     RFEELNADLF RGTLDPVEKA LRDAKLDKSQ IHDIVLVGGS TRIPKIQKLL QDFFNGKELN
     KSINPDEAVA YGAAVQAAIL SGDKSENVQD LLLLDVTPLS LGIETAGGVT TVLIKRNTTI
     PIKQTQTFTT YSDNQPGVLI QVYEGERAMT KDNNLLGKFE LTGMPGGMPG GFPGGGAPPS
     GGASSGPTIE EVD
//
ID   V9HW22_HUMAN            Unreviewed;       646 AA.
AC   V9HW22;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   23-MAY-2018, entry version 46.
DE   SubName: Full=Epididymis luminal protein 33 {ECO:0000313|EMBL:ACF94502.1};
DE   SubName: Full=Epididymis secretory sperm binding protein Li 72p {ECO:0000313|EMBL:ACI45986.1};
DE   SubName: Full=Heat shock 70kDa protein 8, isoform CRA_a {ECO:0000313|EMBL:EAW67539.1};
GN   Name=HEL-S-72p {ECO:0000313|EMBL:ACI45986.1};
GN   Synonyms=HEL-33 {ECO:0000313|EMBL:ACF94502.1},
GN   HSPA8 {ECO:0000313|EMBL:EAW67539.1};
GN   ORFNames=hCG_2032950 {ECO:0000313|EMBL:EAW67539.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACI45986.1};
RN   [1] {ECO:0000313|EMBL:EAW67539.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW67539.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ACF94502.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu F.J., Liu J.;
RL   Submitted (APR-2008) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ACI45986.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu J., Liu F.J.;
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000256|RuleBase:RU003322}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU668349; ACF94502.1; -; mRNA.
DR   EMBL; FJ224294; ACI45986.1; -; mRNA.
DR   EMBL; CH471065; EAW67539.1; -; Genomic_DNA.
DR   EMBL; CH471065; EAW67540.1; -; Genomic_DNA.
DR   RefSeq; NP_006588.1; NM_006597.5.
DR   RefSeq; XP_011541100.1; XM_011542798.1.
DR   UniGene; Hs.180414; -.
DR   SMR; V9HW22; -.
DR   MaxQB; V9HW22; -.
DR   PRIDE; V9HW22; -.
DR   GeneID; 3312; -.
DR   KEGG; hsa:3312; -.
DR   UCSC; uc001pyo.5; human.
DR   CTD; 3312; -.
DR   EuPathDB; HostDB:ENSG00000109971.13; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   KO; K03283; -.
DR   OMA; AYTKNQD; -.
DR   OrthoDB; EOG091G03SF; -.
DR   ChiTaRS; HSPA8; human.
DR   GenomeRNAi; 3312; -.
DR   Bgee; ENSG00000109971; -.
DR   ExpressionAtlas; V9HW22; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IEA:Ensembl.
DR   GO; GO:0005770; C:late endosome; IEA:Ensembl.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042623; F:ATPase activity, coupled; IEA:Ensembl.
DR   GO; GO:0001786; F:phosphatidylserine binding; IEA:Ensembl.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:Ensembl.
DR   GO; GO:0051085; P:chaperone cofactor-dependent protein refolding; IEA:Ensembl.
DR   GO; GO:0072318; P:clathrin coat disassembly; IEA:Ensembl.
DR   GO; GO:0061738; P:late endosomal microautophagy; IEA:Ensembl.
DR   GO; GO:0044829; P:positive regulation by host of viral genome replication; IEA:Ensembl.
DR   GO; GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IEA:Ensembl.
DR   GO; GO:0051726; P:regulation of cell cycle; IEA:Ensembl.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   SUPFAM; SSF100934; SSF100934; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|RuleBase:RU003322};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU003322};
KW   Stress response {ECO:0000313|EMBL:EAW67539.1}.
FT   COILED      512    535       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   646 AA;  70898 MW;  9AA27B210730670C CRC64;
     MSKGPAVGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA
     MNPTNTVFDA KRLIGRRFDD AVVQSDMKHW PFMVVNDAGR PKVQVEYKGE TKSFYPEEVS
     SMVLTKMKEI AEAYLGKTVT NAVVTVPAYF NDSQRQATKD AGTIAGLNVL RIINEPTAAA
     IAYGLDKKVG AERNVLIFDL GGGTFDVSIL TIEDGIFEVK STAGDTHLGG EDFDNRMVNH
     FIAEFKRKHK KDISENKRAV RRLRTACERA KRTLSSSTQA SIEIDSLYEG IDFYTSITRA
     RFEELNADLF RGTLDPVEKA LRDAKLDKSQ IHDIVLVGGS TRIPKIQKLL QDFFNGKELN
     KSINPDEAVA YGAAVQAAIL SGDKSENVQD LLLLDVTPLS LGIETAGGVM TVLIKRNTTI
     PTKQTQTFTT YSDNQPGVLI QVYEGERAMT KDNNLLGKFE LTGIPPAPRG VPQIEVTFDI
     DANGILNVSA VDKSTGKENK ITITNDKGRL SKEDIERMVQ EAEKYKAEDE KQRDKVSSKN
     SLESYAFNMK ATVEDEKLQG KINDEDKQKI LDKCNEIINW LDKNQTAEKE EFEHQQKELE
     KVCNPIITKL YQSAGGMPGG MPGGFPGGGA PPSGGASSGP TIEEVD
//
ID   NTRK1_HUMAN             Reviewed;         796 AA.
AC   P04629; B2R6T5; B7ZM34; P08119; Q15655; Q15656; Q5D056; Q5VZS2;
AC   Q7Z5C3; Q9UIU7;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2006, sequence version 4.
DT   23-MAY-2018, entry version 234.
DE   RecName: Full=High affinity nerve growth factor receptor;
DE            EC=2.7.10.1 {ECO:0000269|PubMed:1281417, ECO:0000269|PubMed:2927393};
DE   AltName: Full=Neurotrophic tyrosine kinase receptor type 1;
DE   AltName: Full=TRK1-transforming tyrosine kinase protein;
DE   AltName: Full=Tropomyosin-related kinase A;
DE   AltName: Full=Tyrosine kinase receptor;
DE   AltName: Full=Tyrosine kinase receptor A;
DE            Short=Trk-A;
DE   AltName: Full=gp140trk {ECO:0000303|PubMed:2927393};
DE   AltName: Full=p140-TrkA;
DE   Flags: Precursor;
GN   Name=NTRK1;
GN   Synonyms=MTC, TRK {ECO:0000303|PubMed:2927393},
GN   TRKA {ECO:0000303|PubMed:9290260};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM TRKA-I), CATALYTIC ACTIVITY,
RP   PHOSPHORYLATION, GLYCOSYLATION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Colon;
RX   PubMed=2927393; DOI=10.1128/MCB.9.1.24;
RA   Martin-Zanca D., Oskam R., Mitra G., Copeland T.D., Barbacid M.;
RT   "Molecular and biochemical characterization of the human trk proto-
RT   oncogene.";
RL   Mol. Cell. Biol. 9:24-33(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=7823156;
RA   Shelton D.L., Sutherland J., Gripp J., Camerato T., Armanini M.P.,
RA   Phillips H.S., Carroll K., Spencer S.D., Levinson A.D.;
RT   "Human trks: molecular cloning, tissue distribution, and expression of
RT   extracellular domain immunoadhesins.";
RL   J. Neurosci. 15:477-491(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9290260; DOI=10.1007/BF02766957;
RA   Indo Y., Mardy S., Tsuruta M., Karim M.A., Matsuda I.;
RT   "Structure and organization of the human TRKA gene encoding a high
RT   affinity receptor for nerve growth factor.";
RL   Jpn. J. Hum. Genet. 42:343-351(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM TRKA-II), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-175 (ISOFORM 3).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS TRKA-I AND TRKA-II).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-71.
RX   PubMed=15870692; DOI=10.1038/sj.onc.1208697;
RA   Fujimoto M., Kitazawa R., Maeda S., Kitazawa S.;
RT   "Methylation adjacent to negatively regulating AP-1 site reactivates
RT   TrkA gene expression during cancer progression.";
RL   Oncogene 24:5108-5118(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 399-796, AND CHROMOSOMAL TRANSLOCATION
RP   WITH TPM3.
RX   PubMed=2869410; DOI=10.1038/319743a0;
RA   Martin-Zanca D., Hughes S.H., Barbacid M.;
RT   "A human oncogene formed by the fusion of truncated tropomyosin and
RT   protein tyrosine kinase sequences.";
RL   Nature 319:743-748(1986).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 399-796.
RX   PubMed=2966065;
RA   Kozma S.C., Redmond S.M.S., Saurer S.M., Groner B., Hynes N.E.;
RT   "Activation of the receptor kinase domain of the trk oncogene by
RT   recombination with two different cellular sequences.";
RL   EMBO J. 7:147-154(1988).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 399-796, AND CHROMOSOMAL TRANSLOCATION
RP   WITH TFG.
RX   PubMed=7565764; DOI=10.1128/MCB.15.11.6118;
RA   Greco A., Mariani C., Miranda C., Lupas A., Pagliardini S., Pomati M.,
RA   Pierotti M.A.;
RT   "The DNA rearrangement that generates the TRK-T3 oncogene involves a
RT   novel gene on chromosome 3 whose product has a potential coiled-coil
RT   domain.";
RL   Mol. Cell. Biol. 15:6118-6127(1995).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 486-796, AND CHROMOSOMAL REARRANGEMENT
RP   WITH TPR.
RX   PubMed=1532241;
RA   Greco A., Pierotti M.A., Bongarzone I., Pagliardini S., Lanzi C.,
RA   Della Porta G.;
RT   "TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes
RT   in human papillary thyroid carcinomas.";
RL   Oncogene 7:237-242(1992).
RN   [12]
RP   FUNCTION AS RECEPTOR FOR NGF.
RX   PubMed=1850821; DOI=10.1038/350678a0;
RA   Hempstead B.L., Martin-Zanca D., Kaplan D.R., Parada L.F., Chao M.V.;
RT   "High-affinity NGF binding requires coexpression of the trk proto-
RT   oncogene and the low-affinity NGF receptor.";
RL   Nature 350:678-683(1991).
RN   [13]
RP   FUNCTION IN NGF SIGNALING, AND IDENTIFICATION AS THE HIGH AFFINITY NGF
RP   RECEPTOR.
RX   PubMed=1849459; DOI=10.1016/0092-8674(91)90419-Y;
RA   Klein R., Jing S., Nanduri V., O'Rourke E., Barbacid M.;
RT   "The trk proto-oncogene encodes a receptor for nerve growth factor.";
RL   Cell 65:189-197(1991).
RN   [14]
RP   FUNCTION, SUBUNIT, CATALYTIC ACTIVITY, PHOSPHORYLATION, SUBCELLULAR
RP   LOCATION, AND MUTAGENESIS OF LYS-544.
RX   PubMed=1281417; DOI=10.1016/0896-6273(92)90066-M;
RA   Jing S., Tapley P., Barbacid M.;
RT   "Nerve growth factor mediates signal transduction through trk
RT   homodimer receptors.";
RL   Neuron 9:1067-1079(1992).
RN   [15]
RP   ALTERNATIVE SPLICING (ISOFORMS TRKA-I AND TRKA-II), FUNCTION IN CELL
RP   SURVIVAL, NGF-BINDING, PHOSPHORYLATION, AND TISSUE SPECIFICITY.
RX   PubMed=8325889;
RA   Barker P.A., Lomen-Hoerth C., Gensch E.M., Meakin S.O., Glass D.J.,
RA   Shooter E.M.;
RT   "Tissue-specific alternative splicing generates two isoforms of the
RT   trkA receptor.";
RL   J. Biol. Chem. 268:15150-15157(1993).
RN   [16]
RP   PHOSPHORYLATION AT TYR-791, INTERACTION WITH PLCG1, AND MUTAGENESIS OF
RP   TYR-791.
RX   PubMed=7510697;
RA   Loeb D.M., Stephens R.M., Copeland T.D., Kaplan D.R., Greene L.A.;
RT   "A Trk nerve growth factor (NGF) receptor point mutation affecting
RT   interaction with phospholipase C-gamma 1 abolishes NGF-promoted
RT   peripherin induction but not neurite outgrowth.";
RL   J. Biol. Chem. 269:8901-8910(1994).
RN   [17]
RP   FUNCTION IN NEURONAL DIFFERENTIATION, FUNCTION IN PHOSPHORYLATION OF
RP   SHC1 AND PLCG1, INTERACTION WITH SHC1, MUTAGENESIS OF TYR-496; LYS-544
RP   AND TYR-791, AND PHOSPHORYLATION AT TYR-496; TYR-676; TYR-680; TYR-681
RP   AND TYR-791.
RX   PubMed=8155326; DOI=10.1016/0896-6273(94)90223-2;
RA   Stephens R.M., Loeb D.M., Copeland T.D., Pawson T., Greene L.A.,
RA   Kaplan D.R.;
RT   "Trk receptors use redundant signal transduction pathways involving
RT   SHC and PLC-gamma 1 to mediate NGF responses.";
RL   Neuron 12:691-705(1994).
RN   [18]
RP   FUNCTION IN NF-KAPPA-B ACTIVATION, AND INTERACTION WITH SQSTM1.
RX   PubMed=11244088; DOI=10.1074/jbc.C000869200;
RA   Wooten M.W., Seibenhener M.L., Mamidipudi V., Diaz-Meco M.T.,
RA   Barker P.A., Moscat J.;
RT   "The atypical protein kinase C-interacting protein p62 is a scaffold
RT   for NF-kappaB activation by nerve growth factor.";
RL   J. Biol. Chem. 276:7709-7712(2001).
RN   [19]
RP   FUNCTION IN NEURONAL CELL PROLIFERATION AND DIFFERENTIATION, FUNCTION
RP   IN SIGNALING CASCADE ACTIVATION, NGF-BINDING, SUBCELLULAR LOCATION,
RP   ALTERNATIVE SPLICING (ISOFORM TRKA-III), CHARACTERIZATION OF ISOFORM
RP   TRKA-III, PHOSPHORYLATION AT TYR-496; TYR-680; TYR-681 AND TYR-791,
RP   INTERACTION WITH FRS2; GRB2; PIK3R1; PLCG1; SHC1, GLYCOSYLATION,
RP   TISSUE SPECIFICITY, AND INDUCTION BY HYPOXIA.
RX   PubMed=15488758; DOI=10.1016/j.ccr.2004.09.011;
RA   Tacconelli A., Farina A.R., Cappabianca L., Desantis G., Tessitore A.,
RA   Vetuschi A., Sferra R., Rucci N., Argenti B., Screpanti I., Gulino A.,
RA   Mackay A.R.;
RT   "TrkA alternative splicing: a regulated tumor-promoting switch in
RT   human neuroblastoma.";
RL   Cancer Cell 6:347-360(2004).
RN   [20]
RP   INTERACTION WITH SORT1, AND ENZYME REGULATION.
RX   PubMed=21102451; DOI=10.1038/nn.2689;
RA   Vaegter C.B., Jansen P., Fjorback A.W., Glerup S., Skeldal S.,
RA   Kjolby M., Richner M., Erdmann B., Nyengaard J.R., Tessarollo L.,
RA   Lewin G.R., Willnow T.E., Chao M.V., Nykjaer A.;
RT   "Sortilin associates with Trk receptors to enhance anterograde
RT   transport and neurotrophin signaling.";
RL   Nat. Neurosci. 14:54-61(2011).
RN   [21]
RP   FUNCTION, UBIQUITINATION BY NEDD4L, AND INTERACTION WITH USP36.
RX   PubMed=27445338; DOI=10.1074/jbc.M116.722637;
RA   Anta B., Martin-Rodriguez C., Gomis-Perez C., Calvo L.,
RA   Lopez-Benito S., Calderon-Garcia A.A., Vicente-Garcia C.,
RA   Villarroel A., Arevalo J.C.;
RT   "Ubiquitin-specific Protease 36 (USP36) Controls Neuronal Precursor
RT   Cell-expressed Developmentally Down-regulated 4-2 (Nedd4-2) Actions
RT   over the Neurotrophin Receptor TrkA and Potassium Voltage-gated
RT   Channels 7.2/3 (Kv7.2/3).";
RL   J. Biol. Chem. 291:19132-19145(2016).
RN   [22]
RP   PHOSPHORYLATION, VARIANTS CIPA 235-SER--GLY-796 DEL; ASN-596 AND
RP   TYR-674, AND CHARACTERIZATION OF VARIANTS CIPA 235-SER--GLY-796 DEL
RP   AND ASN-596.
RX   PubMed=28177573; DOI=10.1111/jns.12205;
RA   Nam T.S., Li W., Yoon S., Eom G.H., Kim M.K., Jung S.T., Choi S.Y.;
RT   "Novel NTRK1 mutations associated with congenital insensitivity to
RT   pain with anhidrosis verified by functional studies.";
RL   J. Peripher. Nerv. Syst. 22:92-99(2017).
RN   [23]
RP   STRUCTURE BY NMR OF 489-500.
RX   PubMed=8524391; DOI=10.1038/378584a0;
RA   Zhou M.-M., Ravichandran K.S., Olejniczak E.F., Petros A.M.,
RA   Meadows R.P., Sattler M., Harlan J.E., Wade W.S., Burakoff S.J.,
RA   Fesik S.W.;
RT   "Structure and ligand recognition of the phosphotyrosine binding
RT   domain of Shc.";
RL   Nature 378:584-592(1995).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 278-386, AND DISULFIDE
RP   BONDS.
RX   PubMed=10388563; DOI=10.1006/jmbi.1999.2816;
RA   Ultsch M.H., Wiesmann C., Simmons L.C., Henrich J., Yang M.,
RA   Reilly D., Bass S.H., de Vos A.M.;
RT   "Crystal structures of the neurotrophin-binding domain of TrkA, TrkB
RT   and TrkC.";
RL   J. Mol. Biol. 290:149-159(1999).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 282-382 IN COMPLEX WITH NGF,
RP   SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=10490030; DOI=10.1038/43705;
RA   Wiesmann C., Ultsch M.H., Bass S.H., de Vos A.M.;
RT   "Crystal structure of nerve growth factor in complex with the ligand-
RT   binding domain of the TrkA receptor.";
RL   Nature 401:184-188(1999).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (3.4 ANGSTROMS) OF 36-382 IN COMPLEX WITH NGF,
RP   HOMODIMERIZATION, SUBUNIT, SUBCELLULAR LOCATION, DISULFIDE BONDS, AND
RP   GLYCOSYLATION AT ASN-95; ASN-121; ASN-188; ASN-262; ASN-281 AND
RP   ASN-358.
RX   PubMed=17196528; DOI=10.1016/j.neuron.2006.09.034;
RA   Wehrman T., He X., Raab B., Dukipatti A., Blau H., Garcia K.C.;
RT   "Structural and mechanistic insights into nerve growth factor
RT   interactions with the TrkA and p75 receptors.";
RL   Neuron 53:25-38(2007).
RN   [27]
RP   VARIANT CIPA ARG-577.
RX   PubMed=8696348; DOI=10.1038/ng0896-485;
RA   Indo Y., Tsuruta M., Hayashida Y., Karim M.A., Ohta K., Kawano T.,
RA   Mitsubuchi H., Tonoki H., Awaya Y., Matsuda I.;
RT   "Mutations in the TRKA/NGF receptor gene in patients with congenital
RT   insensitivity to pain with anhidrosis.";
RL   Nat. Genet. 13:485-488(1996).
RN   [28]
RP   VARIANT CIPA PRO-780.
RX   PubMed=10090906; DOI=10.1086/302319;
RA   Greco A., Villa R., Tubino B., Romano L., Penso D., Pierotti M.A.;
RT   "A novel NTRK1 mutation associated with congenital insensitivity to
RT   pain with anhidrosis.";
RL   Am. J. Hum. Genet. 64:1207-1210(1999).
RN   [29]
RP   VARIANTS CIPA PRO-213; TRP-649 AND SER-714, AND VARIANTS SER-85;
RP   TYR-604 AND VAL-613.
RX   PubMed=10330344; DOI=10.1086/302422;
RA   Mardy S., Miura Y., Endo F., Matsuda I., Sztriha L., Frossard P.,
RA   Moosa A., Ismail E.A.R., Macaya A., Andria G., Toscano E., Gibson W.,
RA   Graham G.E., Indo Y.;
RT   "Congenital insensitivity to pain with anhidrosis: novel mutations in
RT   the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve
RT   growth factor.";
RL   Am. J. Hum. Genet. 64:1570-1579(1999).
RN   [30]
RP   VARIANTS TYR-604; VAL-613 AND GLN-780.
RX   PubMed=10443680; DOI=10.1210/jcem.84.8.5901;
RA   Gimm O., Greco A., Hoang-Vu C., Dralle H., Pierotti M.A., Eng C.;
RT   "Mutation analysis reveals novel sequence variants in NTRK1 in
RT   sporadic human medullary thyroid carcinoma.";
RL   J. Clin. Endocrinol. Metab. 84:2784-2787(1999).
RN   [31]
RP   VARIANT CIPA VAL-587.
RX   PubMed=10233776; DOI=10.1046/j.1523-1747.1999.00569.x;
RA   Yotsumoto S., Setoyama M., Hozumi H., Mizoguchi S., Fukumaru S.,
RA   Kobayashi K., Saheki T., Kanzaki T.;
RT   "A novel point mutation affecting the tyrosine kinase domain of the
RT   TRKA gene in a family with congenital insensitivity to pain with
RT   anhidrosis.";
RL   J. Invest. Dermatol. 112:810-814(1999).
RN   [32]
RP   VARIANTS TYR-604 AND VAL-613.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [33]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
RN   [34]
RP   VARIANT CIPA LEU-695, AND VARIANT VAL-613.
RC   TISSUE=Peripheral blood;
RX   PubMed=10861667;
RX   DOI=10.1002/1096-8628(20000619)92:5<353::AID-AJMG12>3.0.CO;2-C;
RA   Shatzky S., Moses S., Levy J., Pinsk V., Hershkovitz E., Herzog L.,
RA   Shorer Z., Luder A., Parvari R.;
RT   "Congenital insensitivity to pain with anhidrosis (CIPA) in Israeli-
RT   Bedouins: genetic heterogeneity, novel mutations in the TRKA/NGF
RT   receptor gene, clinical findings, and results of nerve conduction
RT   studies.";
RL   Am. J. Med. Genet. 92:353-360(2000).
RN   [35]
RP   VARIANTS CIPA PRO-93; ARG-522; ARG-577; CYS-654 AND TYR-674.
RX   PubMed=10982191; DOI=10.1007/s004390051018;
RA   Miura Y., Mardy S., Awaya Y., Nihei K., Endo F., Matsuda I., Indo Y.;
RT   "Mutation and polymorphism analysis of the TRKA (NTRK1) gene encoding
RT   a high-affinity receptor for nerve growth factor in congenital
RT   insensitivity to pain with anhidrosis (CIPA) families.";
RL   Hum. Genet. 106:116-124(2000).
RN   [36]
RP   VARIANT CIPA ARG-577.
RX   PubMed=10567924;
RX   DOI=10.1002/(SICI)1097-4652(200001)182:1<127::AID-JCP14>3.0.CO;2-0;
RA   Greco A., Villa R., Fusetti L., Orlandi R., Pierotti M.A.;
RT   "The Gly571Arg mutation, associated with the autonomic and sensory
RT   disorder congenital insensitivity to pain with anhidrosis, causes the
RT   inactivation of the NTRK1/nerve growth factor receptor.";
RL   J. Cell. Physiol. 182:127-133(2000).
RN   [37]
RP   VARIANT CIPA CYS-359, AND VARIANTS TYR-604 AND VAL-613.
RX   PubMed=11310631; DOI=10.1002/ana.103;
RA   Houlden H., King R.H., Hashemi-Nejad A., Wood N.W., Mathias C.J.,
RA   Reilly M., Thomas P.K.;
RT   "A novel TRK A (NTRK1) mutation associated with hereditary sensory and
RT   autonomic neuropathy type V.";
RL   Ann. Neurol. 49:521-525(2001).
RN   [38]
RP   CHARACTERIZATION OF VARIANTS CIPA PRO-93; PRO-213; ARG-522; ARG-577;
RP   TRP-649; CYS-654 AND SER-714, AND CHARACTERIZATION OF VARIANTS SER-85;
RP   TYR-604; VAL-613 AND TYR-674.
RX   PubMed=11159935; DOI=10.1093/hmg/10.3.179;
RA   Mardy S., Miura Y., Endo F., Matsuda I., Indo Y.;
RT   "Congenital insensitivity to pain with anhidrosis (CIPA): effect of
RT   TRKA (NTRK1) missense mutations on autophosphorylation of the receptor
RT   tyrosine kinase for nerve growth factor.";
RL   Hum. Mol. Genet. 10:179-188(2001).
RN   [39]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-80; VAL-107; MET-237; GLY-238;
RP   GLY-260; GLN-444; CYS-452; THR-566; TYR-604; VAL-613; GLN-780 AND
RP   ILE-790.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [40]
RP   VARIANTS CIPA SER-572 AND ARG-717.
RX   PubMed=18077166; DOI=10.1016/j.nmd.2007.10.005;
RA   Huehne K., Zweier C., Raab K., Odent S., Bonnaure-Mallet M.,
RA   Sixou J.L., Landrieu P., Goizet C., Sarlangue J., Baumann M.,
RA   Eggermann T., Rauch A., Ruppert S., Stettner G.M., Rautenstrauss B.;
RT   "Novel missense, insertion and deletion mutations in the neurotrophic
RT   tyrosine kinase receptor type 1 gene (NTRK1) associated with
RT   congenital insensitivity to pain with anhidrosis.";
RL   Neuromuscul. Disord. 18:159-166(2008).
RN   [41]
RP   VARIANTS CIPA LYS-492 AND CYS-654, AND VARIANT TRP-6.
RX   PubMed=22302274; DOI=10.1007/s00415-011-6397-y;
RA   Davidson G.L., Murphy S.M., Polke J.M., Laura M., Salih M.A.,
RA   Muntoni F., Blake J., Brandner S., Davies N., Horvath R., Price S.,
RA   Donaghy M., Roberts M., Foulds N., Ramdharry G., Soler D., Lunn M.P.,
RA   Manji H., Davis M.B., Houlden H., Reilly M.M.;
RT   "Frequency of mutations in the genes associated with hereditary
RT   sensory and autonomic neuropathy in a UK cohort.";
RL   J. Neurol. 259:1673-1685(2012).
RN   [42]
RP   VARIANTS CIPA ASP-110; 146-SER--GLY-796 DEL; 176-GLN--GLY-796 DEL;
RP   476-LEU--GLY-796 DEL; GLN-649 AND PRO-700.
RX   PubMed=28328124; DOI=10.1002/ajmg.a.38120;
RA   Altassan R., Saud H.A., Masoodi T.A., Dosssari H.A., Khalifa O.,
RA   Al-Zaidan H., Sakati N., Rhabeeni Z., Al-Hassnan Z., Binamer Y.,
RA   Alhashemi N., Wade W., Al-Zayed Z., Al-Sayed M., Al-Muhaizea M.A.,
RA   Meyer B., Al-Owain M., Wakil S.M.;
RT   "Exome sequencing identifies novel NTRK1 mutations in patients with
RT   HSAN-IV phenotype.";
RL   Am. J. Med. Genet. A 173:1009-1016(2017).
RN   [43]
RP   VARIANTS CIPA GLU-517; GLU-522; PRO-657; THR-699; SER-752; SER-763 AND
RP   CYS-771, CHARACTERIZATION OF VARIANTS CIPA GLU-517; GLU-522; PRO-657;
RP   THR-699; SER-752; SER-763 AND CYS-771, GLYCOSYLATION, SUBCELLULAR
RP   LOCATION, AUTOPHOSPHORYLATION AFTER NGF STIMULATION, AND FUNCTION.
RX   PubMed=27676246; DOI=10.1002/humu.23123;
RA   Shaikh S.S., Chen Y.C., Halsall S.A., Nahorski M.S., Omoto K.,
RA   Young G.T., Phelan A., Woods C.G.;
RT   "A comprehensive functional analysis of NTRK1 missense mutations
RT   causing hereditary sensory and autonomic neuropathy type IV (HSAN
RT   IV).";
RL   Hum. Mutat. 38:55-63(2017).
CC   -!- FUNCTION: Receptor tyrosine kinase involved in the development and
CC       the maturation of the central and peripheral nervous systems
CC       through regulation of proliferation, differentiation and survival
CC       of sympathetic and nervous neurons. High affinity receptor for NGF
CC       which is its primary ligand (PubMed:1850821, PubMed:1849459,
CC       PubMed:1281417, PubMed:8325889, PubMed:15488758, PubMed:17196528,
CC       PubMed:27445338). Can also bind and be activated by
CC       NTF3/neurotrophin-3. However, NTF3 only supports axonal extension
CC       through NTRK1 but has no effect on neuron survival (By
CC       similarity). Upon dimeric NGF ligand-binding, undergoes
CC       homodimerization, autophosphorylation and activation
CC       (PubMed:1281417). Recruits, phosphorylates and/or activates
CC       several downstream effectors including SHC1, FRS2, SH2B1, SH2B2
CC       and PLCG1 that regulate distinct overlapping signaling cascades
CC       driving cell survival and differentiation. Through SHC1 and FRS2
CC       activates a GRB2-Ras-MAPK cascade that regulates cell
CC       differentiation and survival. Through PLCG1 controls NF-Kappa-B
CC       activation and the transcription of genes involved in cell
CC       survival. Through SHC1 and SH2B1 controls a Ras-PI3 kinase-AKT1
CC       signaling cascade that is also regulating survival. In absence of
CC       ligand and activation, may promote cell death, making the survival
CC       of neurons dependent on trophic factors.
CC       {ECO:0000250|UniProtKB:P35739, ECO:0000250|UniProtKB:Q3UFB7,
CC       ECO:0000269|PubMed:11244088, ECO:0000269|PubMed:1281417,
CC       ECO:0000269|PubMed:15488758, ECO:0000269|PubMed:17196528,
CC       ECO:0000269|PubMed:1849459, ECO:0000269|PubMed:1850821,
CC       ECO:0000269|PubMed:27445338, ECO:0000269|PubMed:27676246,
CC       ECO:0000269|PubMed:8155326, ECO:0000269|PubMed:8325889}.
CC   -!- FUNCTION: Isoform TrkA-III: Resistant to NGF, it constitutively
CC       activates AKT1 and NF-kappa-B and is unable to activate the Ras-
CC       MAPK signaling cascade. Antagonizes the anti-proliferative NGF-
CC       NTRK1 signaling that promotes neuronal precursors differentiation.
CC       Isoform TrkA-III promotes angiogenesis and has oncogenic activity
CC       when overexpressed. {ECO:0000269|PubMed:15488758}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028, ECO:0000269|PubMed:1281417,
CC       ECO:0000269|PubMed:2927393}.
CC   -!- ENZYME REGULATION: The pro-survival signaling effect of NTRK1 in
CC       neurons requires its endocytosis into signaling early endosomes
CC       and its retrograde axonal transport. This is regulated by
CC       different proteins including CFL1, RAC1 and SORT1. NTF3 is unable
CC       to induce this signaling probably due to the lability of the NTF3-
CC       NTRK1 complex in endosomes. SH2D1A inhibits the
CC       autophosphorylation of the receptor, and alters the recruitment
CC       and activation of downstream effectors and signaling cascades (By
CC       similarity). Regulated by NGFR (By similarity).
CC       {ECO:0000250|UniProtKB:Q3UFB7}.
CC   -!- SUBUNIT: Exists in a dynamic equilibrium between monomeric (low
CC       affinity) and dimeric (high affinity) structures. Homodimerization
CC       is induced by binding of a NGF dimer (PubMed:1281417,
CC       PubMed:10490030, PubMed:17196528). Interacts with SQSTM1; bridges
CC       NTRK1 to NGFR (PubMed:11244088). Forms a ternary complex with NGFR
CC       and KIDINS220; this complex is affected by the expression levels
CC       of KIDINS220 and an increase in KIDINS220 expression leads to a
CC       decreased association of NGFR and NTRK1 (By similarity). Interacts
CC       with SH2D1A; regulates NTRK1 (By similarity). Interacts
CC       (phosphorylated upon activation by NGF) with SHC1; mediates SHC1
CC       phosphorylation and activation (PubMed:8155326, PubMed:15488758).
CC       Interacts (phosphorylated upon activation by NGF) with PLCG1;
CC       mediates PLCG1 phosphorylation and activation (PubMed:7510697,
CC       PubMed:15488758). Interacts (phosphorylated) with SH2B1 and SH2B2
CC       (By similarity). Interacts with GRB2 (PubMed:15488758). Interacts
CC       with PIK3R1 (PubMed:15488758). Interacts with FRS2
CC       (PubMed:15488758). Interacts with SORT1; may regulate NTRK1
CC       anterograde axonal transport (PubMed:21102451). Interacts with
CC       RAB7A (By similarity). Found in a complex, at least composed of
CC       KIDINS220, MAGI2, NTRK1 and RAPGEF2; the complex is mainly formed
CC       at late endosomes in a nerve growth factor (NGF)-dependent manner
CC       (By similarity). Interacts with RAPGEF2; the interaction is
CC       strengthened after NGF stimulation (By similarity). Interacts with
CC       PTPRS (By similarity). Interacts with USP36; USP36 does not
CC       deubiquitinate NTRK1 (PubMed:27445338). {ECO:0000250,
CC       ECO:0000250|UniProtKB:P35739, ECO:0000269|PubMed:10490030,
CC       ECO:0000269|PubMed:11244088, ECO:0000269|PubMed:1281417,
CC       ECO:0000269|PubMed:15488758, ECO:0000269|PubMed:17196528,
CC       ECO:0000269|PubMed:21102451, ECO:0000269|PubMed:27445338,
CC       ECO:0000269|PubMed:7510697, ECO:0000269|PubMed:8155326,
CC       ECO:0000269|PubMed:8325889}.
CC   -!- INTERACTION:
CC       P22681:CBL; NbExp=2; IntAct=EBI-1028226, EBI-518228;
CC       P01138:NGF; NbExp=3; IntAct=EBI-1028226, EBI-1028250;
CC       Q8K4V6:Pirb (xeno); NbExp=2; IntAct=EBI-1028226, EBI-8602514;
CC       P18031:PTPN1; NbExp=2; IntAct=EBI-1028226, EBI-968788;
CC       Q99523:SORT1; NbExp=3; IntAct=EBI-1028226, EBI-1057058;
CC       Q13501:SQSTM1; NbExp=2; IntAct=EBI-1028226, EBI-307104;
CC       O75385:ULK1; NbExp=2; IntAct=EBI-1028226, EBI-908831;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1281417,
CC       ECO:0000269|PubMed:15488758, ECO:0000269|PubMed:17196528,
CC       ECO:0000269|PubMed:27676246, ECO:0000269|PubMed:2927393}; Single-
CC       pass type I membrane protein {ECO:0000269|PubMed:1281417,
CC       ECO:0000269|PubMed:15488758}. Early endosome membrane
CC       {ECO:0000250|UniProtKB:P35739}; Single-pass type I membrane
CC       protein {ECO:0000250|UniProtKB:P35739}. Late endosome membrane
CC       {ECO:0000250|UniProtKB:P35739}; Single-pass type I membrane
CC       protein {ECO:0000250|UniProtKB:P35739}. Note=Rapidly internalized
CC       after NGF binding (PubMed:1281417). Internalized to endosomes upon
CC       binding of NGF or NTF3 and further transported to the cell body
CC       via a retrograde axonal transport. Localized at cell membrane and
CC       early endosomes before nerve growth factor (NGF) stimulation.
CC       Recruited to late endosomes after NGF stimulation. Colocalized
CC       with RAPGEF2 at late endosomes. {ECO:0000250|UniProtKB:P35739,
CC       ECO:0000269|PubMed:1281417}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=TrkA-I and TrkA-II isoforms have similar biological
CC         properties but are differentially expressed.;
CC       Name=TrkA-II; Synonyms=TrkAII;
CC         IsoId=P04629-1; Sequence=Displayed;
CC         Note=Major isoform.;
CC       Name=TrkA-I; Synonyms=TrkAI;
CC         IsoId=P04629-2; Sequence=VSP_002899;
CC         Note=Has enhanced responsiveness to NTF3 neurotrophin.;
CC       Name=3;
CC         IsoId=P04629-3; Sequence=VSP_041905, VSP_002899;
CC       Name=TrkA-III; Synonyms=TrkAIII;
CC         IsoId=P04629-4; Sequence=VSP_042152, VSP_002899;
CC         Note=Constitutively active. Does not bind NGF and does not
CC         interact with GRB2 and FRS2.;
CC   -!- TISSUE SPECIFICITY: Isoform TrkA-I is found in most non-neuronal
CC       tissues. Isoform TrkA-II is primarily expressed in neuronal cells.
CC       TrkA-III is specifically expressed by pluripotent neural stem and
CC       neural crest progenitors. {ECO:0000269|PubMed:15488758,
CC       ECO:0000269|PubMed:8325889}.
CC   -!- INDUCTION: Isoform TrkA-III is up-regulated upon hypoxia in cells
CC       normally expressing it. {ECO:0000269|PubMed:15488758}.
CC   -!- DOMAIN: The transmembrane domain mediates interaction with
CC       KIDINS220. {ECO:0000250|UniProtKB:P35739}.
CC   -!- DOMAIN: The extracellular domain mediates interaction with NGFR.
CC       {ECO:0000250|UniProtKB:P35739}.
CC   -!- PTM: Ligand-mediated autophosphorylation (PubMed:2927393,
CC       PubMed:1281417, PubMed:15488758, PubMed:7510697, PubMed:8155326,
CC       PubMed:8325889, PubMed:27676246, PubMed:28177573). Interaction
CC       with SQSTM1 is phosphotyrosine-dependent. Autophosphorylation at
CC       Tyr-496 mediates interaction and phosphorylation of SHC1
CC       (PubMed:15488758, PubMed:7510697, PubMed:8155326, PubMed:8325889).
CC       {ECO:0000269|PubMed:1281417, ECO:0000269|PubMed:15488758,
CC       ECO:0000269|PubMed:27676246, ECO:0000269|PubMed:28177573,
CC       ECO:0000269|PubMed:2927393, ECO:0000269|PubMed:7510697,
CC       ECO:0000269|PubMed:8155326, ECO:0000269|PubMed:8325889}.
CC   -!- PTM: N-glycosylated (PubMed:2927393). Isoform TrkA-I and isoform
CC       TrkA-II are N-glycosylated. {ECO:0000269|PubMed:15488758,
CC       ECO:0000269|PubMed:17196528, ECO:0000269|PubMed:27676246,
CC       ECO:0000269|PubMed:2927393}.
CC   -!- PTM: Ubiquitinated (PubMed:27445338). Undergoes polyubiquitination
CC       upon activation; regulated by NGFR (PubMed:27445338).
CC       Ubiquitination by NEDD4L leads to degradation (PubMed:27445338).
CC       Ubiquitination regulates the internalization of the receptor (By
CC       similarity). {ECO:0000250|UniProtKB:Q3UFB7,
CC       ECO:0000269|PubMed:27445338}.
CC   -!- DISEASE: Congenital insensitivity to pain with anhidrosis (CIPA)
CC       [MIM:256800]: Characterized by a congenital insensitivity to pain,
CC       anhidrosis (absence of sweating), absence of reaction to noxious
CC       stimuli, self-mutilating behavior, and mental retardation. This
CC       rare autosomal recessive disorder is also known as congenital
CC       sensory neuropathy with anhidrosis or hereditary sensory and
CC       autonomic neuropathy type IV or familial dysautonomia type II.
CC       {ECO:0000269|PubMed:10090906, ECO:0000269|PubMed:10233776,
CC       ECO:0000269|PubMed:10330344, ECO:0000269|PubMed:10567924,
CC       ECO:0000269|PubMed:10861667, ECO:0000269|PubMed:10982191,
CC       ECO:0000269|PubMed:11159935, ECO:0000269|PubMed:11310631,
CC       ECO:0000269|PubMed:18077166, ECO:0000269|PubMed:22302274,
CC       ECO:0000269|PubMed:27676246, ECO:0000269|PubMed:28177573,
CC       ECO:0000269|PubMed:28328124, ECO:0000269|PubMed:8696348}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Note=Chromosomal aberrations involving NTRK1 are found in
CC       papillary thyroid carcinomas (PTCs) (PubMed:2869410,
CC       PubMed:7565764, PubMed:1532241). Translocation t(1;3)(q21;q11)
CC       with TFG generates the TRKT3 (TRK-T3) transcript by fusing TFG to
CC       the 3'-end of NTRK1 (PubMed:7565764). A rearrangement with TPM3
CC       generates the TRK transcript by fusing TPM3 to the 3'-end of NTRK1
CC       (PubMed:2869410). An intrachromosomal rearrangement that links the
CC       protein kinase domain of NTRK1 to the 5'-end of the TPR gene forms
CC       the fusion protein TRK-T1. TRK-T1 is a 55 kDa protein reacting
CC       with antibodies against the C-terminus of the NTRK1 protein
CC       (PubMed:1532241). {ECO:0000269|PubMed:1532241,
CC       ECO:0000269|PubMed:2869410, ECO:0000269|PubMed:7565764}.
CC   -!- MISCELLANEOUS: Trk also stands for tropomyosin-related kinase
CC       since it was first isolated as an oncogenic protein which was the
CC       result of a fusion between the tropomyosin gene TPM3 and NTRK1.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Insulin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA27243.1; Type=Erroneous termination; Positions=786; Note=Translated as Gln.; Evidence={ECO:0000305};
CC       Sequence=CAA27243.1; Type=Frameshift; Positions=769; Evidence={ECO:0000305};
CC       Sequence=CAA27243.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=CAA29888.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=CAA44719.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=CAA59936.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M23102; AAA36770.1; -; mRNA.
DR   EMBL; AB019488; BAA34355.1; -; Genomic_DNA.
DR   EMBL; AK312704; BAG35582.1; -; mRNA.
DR   EMBL; DB265639; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL158169; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC062580; AAH62580.1; -; mRNA.
DR   EMBL; BC136554; AAI36555.1; -; mRNA.
DR   EMBL; BC144239; AAI44240.1; -; mRNA.
DR   EMBL; AY321513; AAP88292.1; -; Genomic_DNA.
DR   EMBL; X03541; CAA27243.1; ALT_SEQ; mRNA.
DR   EMBL; X06704; CAA29888.1; ALT_SEQ; mRNA.
DR   EMBL; X85960; CAA59936.1; ALT_SEQ; mRNA.
DR   EMBL; X62947; CAA44719.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS1161.1; -. [P04629-1]
DR   CCDS; CCDS30890.1; -. [P04629-3]
DR   CCDS; CCDS30891.1; -. [P04629-2]
DR   PIR; A30124; TVHUTT.
DR   PIR; S23741; S23741.
DR   RefSeq; NP_001007793.1; NM_001007792.1. [P04629-3]
DR   RefSeq; NP_001012331.1; NM_001012331.1. [P04629-2]
DR   RefSeq; NP_002520.2; NM_002529.3. [P04629-1]
DR   UniGene; Hs.406293; -.
DR   PDB; 1HE7; X-ray; 2.00 A; A=285-413.
DR   PDB; 1SHC; NMR; -; B=489-500.
DR   PDB; 1WWA; X-ray; 2.50 A; X/Y=278-386.
DR   PDB; 1WWW; X-ray; 2.20 A; X/Y=282-382.
DR   PDB; 2IFG; X-ray; 3.40 A; A/B=36-382.
DR   PDB; 2N90; NMR; -; A/B=410-447.
DR   PDB; 4AOJ; X-ray; 2.75 A; A/B/C=473-796.
DR   PDB; 4CRP; NMR; -; A=282-383.
DR   PDB; 4F0I; X-ray; 2.30 A; A/B=498-796.
DR   PDB; 4GT5; X-ray; 2.40 A; A=498-796.
DR   PDB; 4PMM; X-ray; 2.00 A; A=501-787.
DR   PDB; 4PMP; X-ray; 1.80 A; A=501-787.
DR   PDB; 4PMS; X-ray; 2.80 A; A=501-787.
DR   PDB; 4PMT; X-ray; 2.10 A; A=501-787.
DR   PDB; 4YNE; X-ray; 2.02 A; A=502-796.
DR   PDB; 4YPS; X-ray; 2.10 A; A=502-796.
DR   PDB; 5H3Q; X-ray; 2.10 A; A=473-796.
DR   PDB; 5I8A; X-ray; 2.33 A; A=498-787.
DR   PDB; 5JFS; X-ray; 2.07 A; A=502-796.
DR   PDB; 5JFV; X-ray; 1.59 A; A=502-796.
DR   PDB; 5JFW; X-ray; 1.52 A; A=502-796.
DR   PDB; 5JFX; X-ray; 1.63 A; A=502-796.
DR   PDB; 5KMI; X-ray; 1.87 A; A=474-796.
DR   PDB; 5KMJ; X-ray; 2.04 A; A=474-796.
DR   PDB; 5KMK; X-ray; 2.24 A; A=474-796.
DR   PDB; 5KML; X-ray; 2.01 A; A=474-796.
DR   PDB; 5KMM; X-ray; 2.12 A; A=474-796.
DR   PDB; 5KMN; X-ray; 2.14 A; A=474-796.
DR   PDB; 5KMO; X-ray; 2.67 A; A=474-796.
DR   PDB; 5KVT; X-ray; 2.45 A; A=501-787.
DR   PDB; 5WR7; X-ray; 2.76 A; A=489-792.
DR   PDBsum; 1HE7; -.
DR   PDBsum; 1SHC; -.
DR   PDBsum; 1WWA; -.
DR   PDBsum; 1WWW; -.
DR   PDBsum; 2IFG; -.
DR   PDBsum; 2N90; -.
DR   PDBsum; 4AOJ; -.
DR   PDBsum; 4CRP; -.
DR   PDBsum; 4F0I; -.
DR   PDBsum; 4GT5; -.
DR   PDBsum; 4PMM; -.
DR   PDBsum; 4PMP; -.
DR   PDBsum; 4PMS; -.
DR   PDBsum; 4PMT; -.
DR   PDBsum; 4YNE; -.
DR   PDBsum; 4YPS; -.
DR   PDBsum; 5H3Q; -.
DR   PDBsum; 5I8A; -.
DR   PDBsum; 5JFS; -.
DR   PDBsum; 5JFV; -.
DR   PDBsum; 5JFW; -.
DR   PDBsum; 5JFX; -.
DR   PDBsum; 5KMI; -.
DR   PDBsum; 5KMJ; -.
DR   PDBsum; 5KMK; -.
DR   PDBsum; 5KML; -.
DR   PDBsum; 5KMM; -.
DR   PDBsum; 5KMN; -.
DR   PDBsum; 5KMO; -.
DR   PDBsum; 5KVT; -.
DR   PDBsum; 5WR7; -.
DR   ProteinModelPortal; P04629; -.
DR   SMR; P04629; -.
DR   BioGrid; 110969; 1943.
DR   CORUM; P04629; -.
DR   DIP; DIP-5714N; -.
DR   ELM; P04629; -.
DR   IntAct; P04629; 19.
DR   MINT; P04629; -.
DR   STRING; 9606.ENSP00000431418; -.
DR   BindingDB; P04629; -.
DR   ChEMBL; CHEMBL2815; -.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB00619; Imatinib.
DR   DrugBank; DB08896; Regorafenib.
DR   GuidetoPHARMACOLOGY; 1817; -.
DR   iPTMnet; P04629; -.
DR   PhosphoSitePlus; P04629; -.
DR   BioMuta; NTRK1; -.
DR   DMDM; 94730402; -.
DR   PaxDb; P04629; -.
DR   PeptideAtlas; P04629; -.
DR   PRIDE; P04629; -.
DR   Ensembl; ENST00000368196; ENSP00000357179; ENSG00000198400. [P04629-2]
DR   Ensembl; ENST00000392302; ENSP00000376120; ENSG00000198400. [P04629-3]
DR   Ensembl; ENST00000524377; ENSP00000431418; ENSG00000198400. [P04629-1]
DR   GeneID; 4914; -.
DR   KEGG; hsa:4914; -.
DR   UCSC; uc001fqf.2; human. [P04629-1]
DR   CTD; 4914; -.
DR   DisGeNET; 4914; -.
DR   EuPathDB; HostDB:ENSG00000198400.11; -.
DR   GeneCards; NTRK1; -.
DR   GeneReviews; NTRK1; -.
DR   HGNC; HGNC:8031; NTRK1.
DR   HPA; CAB004606; -.
DR   HPA; HPA035799; -.
DR   HPA; HPA076570; -.
DR   MalaCards; NTRK1; -.
DR   MIM; 164970; gene.
DR   MIM; 191315; gene.
DR   MIM; 256800; phenotype.
DR   neXtProt; NX_P04629; -.
DR   OpenTargets; ENSG00000198400; -.
DR   Orphanet; 99361; Familial medullary thyroid carcinoma.
DR   Orphanet; 642; Hereditary sensory and autonomic neuropathy type 4.
DR   Orphanet; 64752; Hereditary sensory and autonomic neuropathy type 5.
DR   Orphanet; 146; Papillary or follicular thyroid carcinoma.
DR   PharmGKB; PA31817; -.
DR   eggNOG; ENOG410IMMI; Eukaryota.
DR   eggNOG; ENOG410XTGG; LUCA.
DR   GeneTree; ENSGT00760000118818; -.
DR   HOVERGEN; HBG056735; -.
DR   InParanoid; P04629; -.
DR   KO; K03176; -.
DR   OMA; PEVYAIM; -.
DR   OrthoDB; EOG091G01JY; -.
DR   PhylomeDB; P04629; -.
DR   TreeFam; TF106465; -.
DR   BRENDA; 2.7.10.1; 2681.
DR   Reactome; R-HSA-167021; PLC-gamma1 signalling.
DR   Reactome; R-HSA-167044; Signalling to RAS.
DR   Reactome; R-HSA-170968; Frs2-mediated activation.
DR   Reactome; R-HSA-170984; ARMS-mediated activation.
DR   Reactome; R-HSA-177504; Retrograde neurotrophin signalling.
DR   Reactome; R-HSA-187024; NGF-independant TRKA activation.
DR   Reactome; R-HSA-187042; TRKA activation by NGF.
DR   Reactome; R-HSA-187706; Signalling to p38 via RIT and RIN.
DR   Reactome; R-HSA-198203; PI3K/AKT activation.
DR   Reactome; R-HSA-198745; Signalling to STAT3.
DR   SignaLink; P04629; -.
DR   SIGNOR; P04629; -.
DR   ChiTaRS; NTRK1; human.
DR   EvolutionaryTrace; P04629; -.
DR   GenomeRNAi; 4914; -.
DR   PRO; PR:P04629; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000198400; -.
DR   ExpressionAtlas; P04629; baseline and differential.
DR   Genevisible; P04629; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005769; C:early endosome; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005770; C:late endosome; ISS:UniProtKB.
DR   GO; GO:0031902; C:late endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0032991; C:protein-containing complex; ISS:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005004; F:GPI-linked ephrin receptor activity; IEA:Ensembl.
DR   GO; GO:0048406; F:nerve growth factor binding; IDA:UniProtKB.
DR   GO; GO:0010465; F:nerve growth factor receptor activity; IDA:UniProtKB.
DR   GO; GO:0043121; F:neurotrophin binding; TAS:ProtInc.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IDA:MGI.
DR   GO; GO:0000186; P:activation of MAPKK activity; TAS:Reactome.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0007411; P:axon guidance; IEA:Ensembl.
DR   GO; GO:0060385; P:axonogenesis involved in innervation; ISS:UniProtKB.
DR   GO; GO:0030183; P:B cell differentiation; IEA:Ensembl.
DR   GO; GO:0061368; P:behavioral response to formalin induced pain; IEA:Ensembl.
DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IMP:UniProtKB.
DR   GO; GO:0071316; P:cellular response to nicotine; IEA:Ensembl.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; IEA:Ensembl.
DR   GO; GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; IEA:Ensembl.
DR   GO; GO:0007611; P:learning or memory; IEA:Ensembl.
DR   GO; GO:0042490; P:mechanoreceptor differentiation; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:ARUK-UCL.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0038180; P:nerve growth factor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0048666; P:neuron development; IDA:MGI.
DR   GO; GO:0031175; P:neuron projection development; IDA:MGI.
DR   GO; GO:0048011; P:neurotrophin TRK receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0021553; P:olfactory nerve development; IEA:Ensembl.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IDA:MGI.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IDA:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IDA:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0043068; P:positive regulation of programmed cell death; ISS:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; TAS:BHF-UCL.
DR   GO; GO:0046579; P:positive regulation of Ras protein signal transduction; IDA:UniProtKB.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl.
DR   GO; GO:0010623; P:programmed cell death involved in cell development; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0048678; P:response to axon injury; IEA:Ensembl.
DR   GO; GO:0051602; P:response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0051599; P:response to hydrostatic pressure; IEA:Ensembl.
DR   GO; GO:0031667; P:response to nutrient levels; IEA:Ensembl.
DR   GO; GO:0009314; P:response to radiation; IEA:Ensembl.
DR   GO; GO:0060009; P:Sertoli cell development; IEA:Ensembl.
DR   GO; GO:0048485; P:sympathetic nervous system development; ISS:UniProtKB.
DR   Gene3D; 2.60.40.10; -; 2.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR031635; NTRK_C2.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR020461; Tyr_kinase_neurotrophic_rcpt_1.
DR   InterPro; IPR020777; Tyr_kinase_NGF_rcpt.
DR   InterPro; IPR002011; Tyr_kinase_rcpt_2_CS.
DR   Pfam; PF13855; LRR_8; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF16920; TPKR_C2; 1.
DR   PRINTS; PR01939; NTKRECEPTOR.
DR   PRINTS; PR01940; NTKRECEPTOR1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00082; LRRCT; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF48726; SSF48726; 2.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00239; RECEPTOR_TYR_KIN_II; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane;
KW   Chromosomal rearrangement; Complete proteome; Developmental protein;
KW   Differentiation; Disease mutation; Disulfide bond; Endosome;
KW   Glycoprotein; Immunoglobulin domain; Kinase; Leucine-rich repeat;
KW   Membrane; Neurogenesis; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Receptor; Reference proteome; Repeat;
KW   Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase; Ubl conjugation.
FT   SIGNAL        1     32       {ECO:0000255}.
FT   CHAIN        33    796       High affinity nerve growth factor
FT                                receptor.
FT                                /FTId=PRO_0000016724.
FT   TOPO_DOM     33    423       Extracellular. {ECO:0000255}.
FT   TRANSMEM    424    439       Helical. {ECO:0000255}.
FT   TOPO_DOM    440    796       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       90    113       LRR 1.
FT   REPEAT      116    137       LRR 2.
FT   DOMAIN      148    193       LRRCT.
FT   DOMAIN      194    283       Ig-like C2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00114}.
FT   DOMAIN      299    365       Ig-like C2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00114}.
FT   DOMAIN      510    781       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     516    524       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      469    490       Interaction with SQSTM1. {ECO:0000250}.
FT   ACT_SITE    650    650       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     544    544       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   SITE        398    399       Breakpoint for translocation to form TRK
FT                                and TRK-T3.
FT   SITE        486    486       Breakpoint for translocation to form TRK-
FT                                T1.
FT   SITE        496    496       Interaction with SHC1.
FT   SITE        791    791       Interaction with PLCG1.
FT   MOD_RES     496    496       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:15488758,
FT                                ECO:0000269|PubMed:27676246,
FT                                ECO:0000269|PubMed:8155326}.
FT   MOD_RES     676    676       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:8155326}.
FT   MOD_RES     680    680       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:15488758,
FT                                ECO:0000269|PubMed:8155326}.
FT   MOD_RES     681    681       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:15488758,
FT                                ECO:0000269|PubMed:8155326}.
FT   MOD_RES     791    791       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:15488758,
FT                                ECO:0000269|PubMed:7510697,
FT                                ECO:0000269|PubMed:8155326}.
FT   CARBOHYD     67     67       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     95     95       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17196528}.
FT   CARBOHYD    121    121       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17196528}.
FT   CARBOHYD    188    188       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:2IFG,
FT                                ECO:0000269|PubMed:17196528}.
FT   CARBOHYD    202    202       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    253    253       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    262    262       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:2IFG,
FT                                ECO:0000269|PubMed:17196528}.
FT   CARBOHYD    281    281       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:2IFG,
FT                                ECO:0000269|PubMed:17196528}.
FT   CARBOHYD    318    318       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    323    323       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    338    338       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    358    358       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:2IFG,
FT                                ECO:0000269|PubMed:17196528}.
FT   CARBOHYD    401    401       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     36     41       {ECO:0000244|PDB:2IFG}.
FT   DISULFID     40     50       {ECO:0000244|PDB:2IFG}.
FT   DISULFID    154    191       {ECO:0000244|PDB:2IFG,
FT                                ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:17196528}.
FT   DISULFID    215    265       {ECO:0000244|PDB:2IFG,
FT                                ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:17196528}.
FT   DISULFID    300    345       {ECO:0000244|PDB:1HE7,
FT                                ECO:0000244|PDB:1WWA,
FT                                ECO:0000244|PDB:1WWW,
FT                                ECO:0000244|PDB:2IFG,
FT                                ECO:0000244|PDB:4CRP}.
FT   VAR_SEQ       1     71       MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACC
FT                                PHGSSGLRCTRDGALDSLHHLPGAENLTEL -> MKEAALI
FT                                CLAPSVPPILTVKSWDTMQLRAARSRCTNLLAAS (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041905.
FT   VAR_SEQ     192    284       GVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTEL
FT                                EQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGR
FT                                AEVSVQVNVSF -> V (in isoform TrkA-III).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_042152.
FT   VAR_SEQ     393    398       Missing (in isoform TrkA-I, isoform 3 and
FT                                isoform TrkA-III).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:2927393}.
FT                                /FTId=VSP_002899.
FT   VARIANT       6      6       R -> W (in dbSNP:rs201472270).
FT                                {ECO:0000269|PubMed:22302274}.
FT                                /FTId=VAR_068480.
FT   VARIANT      18     18       G -> E (in dbSNP:rs1007211).
FT                                /FTId=VAR_049714.
FT   VARIANT      80     80       Q -> R (in dbSNP:rs55891455).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041461.
FT   VARIANT      85     85       R -> S (in dbSNP:rs543320028).
FT                                {ECO:0000269|PubMed:10330344,
FT                                ECO:0000269|PubMed:11159935}.
FT                                /FTId=VAR_009623.
FT   VARIANT      93     93       L -> P (in CIPA; aberrantly processed;
FT                                shows diminished autophosphorylation in
FT                                neuronal cells).
FT                                {ECO:0000269|PubMed:10982191,
FT                                ECO:0000269|PubMed:11159935}.
FT                                /FTId=VAR_009624.
FT   VARIANT     107    107       A -> V (in an ovarian serous carcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs540521894).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041462.
FT   VARIANT     110    110       A -> D (in CIPA).
FT                                {ECO:0000269|PubMed:28328124}.
FT                                /FTId=VAR_079399.
FT   VARIANT     146    796       Missing (in CIPA).
FT                                {ECO:0000269|PubMed:28328124}.
FT                                /FTId=VAR_079400.
FT   VARIANT     176    796       Missing (in CIPA).
FT                                {ECO:0000269|PubMed:28328124}.
FT                                /FTId=VAR_079401.
FT   VARIANT     213    213       L -> P (in CIPA; aberrantly processed;
FT                                shows diminished autophosphorylation in
FT                                neuronal cells; dbSNP:rs747711259).
FT                                {ECO:0000269|PubMed:10330344,
FT                                ECO:0000269|PubMed:11159935}.
FT                                /FTId=VAR_009625.
FT   VARIANT     235    796       Missing (in CIPA; loss of protein).
FT                                {ECO:0000269|PubMed:28177573}.
FT                                /FTId=VAR_079402.
FT   VARIANT     237    237       T -> M (in dbSNP:rs55909005).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041463.
FT   VARIANT     238    238       V -> G (in dbSNP:rs56000394).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041464.
FT   VARIANT     260    260       R -> G (in dbSNP:rs35116695).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041465.
FT   VARIANT     359    359       Y -> C (in CIPA; dbSNP:rs121964869).
FT                                {ECO:0000269|PubMed:11310631}.
FT                                /FTId=VAR_068481.
FT   VARIANT     444    444       R -> Q (in dbSNP:rs56320207).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041466.
FT   VARIANT     452    452       R -> C (in dbSNP:rs34900547).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041467.
FT   VARIANT     476    796       Missing (in CIPA).
FT                                {ECO:0000269|PubMed:28328124}.
FT                                /FTId=VAR_079403.
FT   VARIANT     492    492       E -> K (in CIPA; dbSNP:rs144901788).
FT                                {ECO:0000269|PubMed:22302274}.
FT                                /FTId=VAR_068482.
FT   VARIANT     517    517       G -> E (in CIPA; following transfection
FT                                in neuroblastoma cells and NGF treatment,
FT                                small decrease in the percentage of cells
FT                                differentiated into neuronal phenotype,
FT                                but in differentiated cells, the average
FT                                neurite length is comparable to wild-
FT                                type; no effect on N-glycosylation,
FT                                subcellular location, nor on basal and
FT                                NGF-induced autophosphorylation; loss of
FT                                NGF-stimulated calcium flux;
FT                                dbSNP:rs606231467).
FT                                {ECO:0000269|PubMed:27676246}.
FT                                /FTId=VAR_077472.
FT   VARIANT     522    522       G -> E (in CIPA; no effect on N-
FT                                glycosylation, nor on subcellular
FT                                location; reduced basal
FT                                autophosphorylation and complete loss of
FT                                NGF-induced autophosphorylation; loss of
FT                                NGF-stimulated calcium flux).
FT                                {ECO:0000269|PubMed:27676246}.
FT                                /FTId=VAR_077473.
FT   VARIANT     522    522       G -> R (in CIPA; processed as wild-type
FT                                but shows significantly diminished
FT                                autophosphorylation in both neuronal and
FT                                non-neuronal cells).
FT                                {ECO:0000269|PubMed:10982191,
FT                                ECO:0000269|PubMed:11159935}.
FT                                /FTId=VAR_009626.
FT   VARIANT     566    566       M -> T (in dbSNP:rs55892037).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041468.
FT   VARIANT     572    572       I -> S (in CIPA).
FT                                {ECO:0000269|PubMed:18077166}.
FT                                /FTId=VAR_077474.
FT   VARIANT     577    577       G -> R (in CIPA; loss of function;
FT                                processed as wild-type but shows
FT                                significantly diminished
FT                                autophosphorylation in both neuronal and
FT                                non-neuronal cells; dbSNP:rs121964866).
FT                                {ECO:0000269|PubMed:10567924,
FT                                ECO:0000269|PubMed:10982191,
FT                                ECO:0000269|PubMed:11159935,
FT                                ECO:0000269|PubMed:8696348}.
FT                                /FTId=VAR_004103.
FT   VARIANT     587    587       M -> V (in CIPA; dbSNP:rs121964870).
FT                                {ECO:0000269|PubMed:10233776}.
FT                                /FTId=VAR_009627.
FT   VARIANT     596    596       D -> N (in CIPA; abolishes
FT                                autophosphorylation).
FT                                {ECO:0000269|PubMed:28177573}.
FT                                /FTId=VAR_079404.
FT   VARIANT     604    604       H -> Y (in dbSNP:rs6336).
FT                                {ECO:0000269|PubMed:10330344,
FT                                ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:10443680,
FT                                ECO:0000269|PubMed:11159935,
FT                                ECO:0000269|PubMed:11310631,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_009628.
FT   VARIANT     613    613       G -> V (in dbSNP:rs6339).
FT                                {ECO:0000269|PubMed:10330344,
FT                                ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:10443680,
FT                                ECO:0000269|PubMed:10861667,
FT                                ECO:0000269|PubMed:11159935,
FT                                ECO:0000269|PubMed:11310631,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_009629.
FT   VARIANT     649    649       R -> Q (in CIPA; dbSNP:rs786205449).
FT                                {ECO:0000269|PubMed:28328124}.
FT                                /FTId=VAR_079405.
FT   VARIANT     649    649       R -> W (in CIPA; processed as wild-type
FT                                but shows significantly diminished
FT                                autophosphorylation in both neuronal and
FT                                non-neuronal cells; dbSNP:rs369353892).
FT                                {ECO:0000269|PubMed:10330344,
FT                                ECO:0000269|PubMed:11159935}.
FT                                /FTId=VAR_009630.
FT   VARIANT     654    654       R -> C (in CIPA; processed as wild-type
FT                                but shows significantly diminished
FT                                autophosphorylation in both neuronal and
FT                                non-neuronal cells; dbSNP:rs764992664).
FT                                {ECO:0000269|PubMed:10982191,
FT                                ECO:0000269|PubMed:11159935,
FT                                ECO:0000269|PubMed:22302274}.
FT                                /FTId=VAR_009631.
FT   VARIANT     657    657       L -> P (in CIPA; following transfection
FT                                in neuroblastoma cells and NGF treatment,
FT                                loss of differentiation into neuronal
FT                                phenotype; partially decreased N-
FT                                glycosylation; reduced expression at the
FT                                plasma membrane; reduced basal
FT                                autophosphorylation and complete loss of
FT                                NGF-induced autophosphorylation; loss of
FT                                NGF-stimulated calcium flux).
FT                                {ECO:0000269|PubMed:27676246}.
FT                                /FTId=VAR_077475.
FT   VARIANT     674    674       D -> Y (in CIPA; might impair the
FT                                function of the enzyme without
FT                                compromising autophosphorylation;
FT                                dbSNP:rs80356677).
FT                                {ECO:0000269|PubMed:10982191,
FT                                ECO:0000269|PubMed:11159935,
FT                                ECO:0000269|PubMed:28177573}.
FT                                /FTId=VAR_009632.
FT   VARIANT     695    695       P -> L (in CIPA; dbSNP:rs121964868).
FT                                {ECO:0000269|PubMed:10861667}.
FT                                /FTId=VAR_009633.
FT   VARIANT     699    699       I -> T (in CIPA; partially decreased N-
FT                                glycosylation; reduced expression at the
FT                                plasma membrane; reduced basal
FT                                autophosphorylation and complete loss of
FT                                NGF-induced autophosphorylation; loss of
FT                                NGF-stimulated calcium flux).
FT                                {ECO:0000269|PubMed:27676246}.
FT                                /FTId=VAR_077476.
FT   VARIANT     700    700       L -> P (in CIPA).
FT                                {ECO:0000269|PubMed:28328124}.
FT                                /FTId=VAR_079406.
FT   VARIANT     714    714       G -> S (in CIPA; processed as wild-type
FT                                but shows significantly diminished
FT                                autophosphorylation in both neuronal and
FT                                non-neuronal cells; dbSNP:rs770727871).
FT                                {ECO:0000269|PubMed:10330344,
FT                                ECO:0000269|PubMed:11159935}.
FT                                /FTId=VAR_009634.
FT   VARIANT     717    717       L -> R (in CIPA; found in a compound
FT                                heterozygote also carrying an premature
FT                                stop codon at position 558).
FT                                {ECO:0000269|PubMed:18077166}.
FT                                /FTId=VAR_077477.
FT   VARIANT     752    752       C -> S (in CIPA; unknown pathological
FT                                significance; following transfection in
FT                                neuroblastoma cells and NGF treatment, no
FT                                effect on neurite outgrowth, nor neurite
FT                                length; no effect on N-glycosylation,
FT                                subcellular location, basal and NGF-
FT                                induced autophosphorylation, nor on NGF-
FT                                stimulated calcium flux).
FT                                {ECO:0000269|PubMed:27676246}.
FT                                /FTId=VAR_077478.
FT   VARIANT     763    763       C -> S (in CIPA; following transfection
FT                                in neuroblastoma cells and NGF treatment,
FT                                decreased percentage of cells
FT                                differentiated into neuronal phenotype
FT                                and reduced neurite length compared with
FT                                wild-type; slightly decreased N-
FT                                glycosylation; reduced expression at the
FT                                plasma membrane; reduced basal and NGF-
FT                                induced autophosphorylation; small
FT                                reduction in NGF-stimulated calcium
FT                                flux). {ECO:0000269|PubMed:27676246}.
FT                                /FTId=VAR_077479.
FT   VARIANT     771    771       R -> C (in CIPA; partially decreased N-
FT                                glycosylation; reduced expression at the
FT                                plasma membrane; reduced basal
FT                                autophosphorylation and complete loss of
FT                                NGF-induced autophosphorylation; loss of
FT                                NGF-stimulated calcium flux).
FT                                {ECO:0000269|PubMed:27676246}.
FT                                /FTId=VAR_077480.
FT   VARIANT     780    780       R -> P (in CIPA; loss of function;
FT                                dbSNP:rs35669708).
FT                                {ECO:0000269|PubMed:10090906}.
FT                                /FTId=VAR_009635.
FT   VARIANT     780    780       R -> Q (in dbSNP:rs35669708).
FT                                {ECO:0000269|PubMed:10443680,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_009636.
FT   VARIANT     790    790       V -> I (in dbSNP:rs55948542).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041469.
FT   MUTAGEN     496    496       Y->F: Loss of interaction with SHC1 and
FT                                altered phosphorylation of SHC1. Altered
FT                                neurite outgrowth and altered activation
FT                                of the MAPK pathway; when associated with
FT                                F-791. {ECO:0000269|PubMed:8155326}.
FT   MUTAGEN     544    544       K->N: Loss of kinase activity.
FT                                {ECO:0000269|PubMed:1281417,
FT                                ECO:0000269|PubMed:8155326}.
FT   MUTAGEN     791    791       Y->F: Loss of interaction with PLCG1 and
FT                                altered phosphorylation of PLCG1. Altered
FT                                neurite outgrowth and altered activation
FT                                of the MAPK pathway; when associated with
FT                                F-496. {ECO:0000269|PubMed:7510697,
FT                                ECO:0000269|PubMed:8155326}.
FT   CONFLICT    263    263       V -> L (in Ref. 1; AAA36770).
FT                                {ECO:0000305}.
FT   CONFLICT    300    300       C -> S (in Ref. 1; AAA36770).
FT                                {ECO:0000305}.
FT   CONFLICT    529    529       C -> S (in Ref. 10; CAA59936).
FT                                {ECO:0000305}.
FT   STRAND       38     40       {ECO:0000244|PDB:2IFG}.
FT   STRAND       43     46       {ECO:0000244|PDB:2IFG}.
FT   TURN         57     61       {ECO:0000244|PDB:2IFG}.
FT   STRAND       69     72       {ECO:0000244|PDB:2IFG}.
FT   HELIX        84     86       {ECO:0000244|PDB:2IFG}.
FT   STRAND       94     97       {ECO:0000244|PDB:2IFG}.
FT   HELIX       110    112       {ECO:0000244|PDB:2IFG}.
FT   STRAND      119    121       {ECO:0000244|PDB:2IFG}.
FT   TURN        133    135       {ECO:0000244|PDB:2IFG}.
FT   STRAND      142    144       {ECO:0000244|PDB:2IFG}.
FT   HELIX       154    156       {ECO:0000244|PDB:2IFG}.
FT   HELIX       157    164       {ECO:0000244|PDB:2IFG}.
FT   HELIX       171    173       {ECO:0000244|PDB:2IFG}.
FT   STRAND      178    181       {ECO:0000244|PDB:2IFG}.
FT   STRAND      195    199       {ECO:0000244|PDB:2IFG}.
FT   STRAND      211    218       {ECO:0000244|PDB:2IFG}.
FT   STRAND      227    230       {ECO:0000244|PDB:2IFG}.
FT   STRAND      234    238       {ECO:0000244|PDB:2IFG}.
FT   STRAND      244    253       {ECO:0000244|PDB:2IFG}.
FT   TURN        257    260       {ECO:0000244|PDB:2IFG}.
FT   STRAND      263    265       {ECO:0000244|PDB:2IFG}.
FT   STRAND      276    278       {ECO:0000244|PDB:2IFG}.
FT   STRAND      284    290       {ECO:0000244|PDB:1WWW}.
FT   STRAND      298    305       {ECO:0000244|PDB:1HE7}.
FT   STRAND      312    317       {ECO:0000244|PDB:1HE7}.
FT   STRAND      326    333       {ECO:0000244|PDB:1HE7}.
FT   STRAND      342    350       {ECO:0000244|PDB:1HE7}.
FT   HELIX       353    355       {ECO:0000244|PDB:1HE7}.
FT   STRAND      357    365       {ECO:0000244|PDB:1HE7}.
FT   STRAND      368    376       {ECO:0000244|PDB:1HE7}.
FT   HELIX       418    441       {ECO:0000244|PDB:2N90}.
FT   STRAND      476    478       {ECO:0000244|PDB:5KML}.
FT   HELIX       490    492       {ECO:0000244|PDB:5KMI}.
FT   TURN        494    496       {ECO:0000244|PDB:1SHC}.
FT   HELIX       507    509       {ECO:0000244|PDB:5JFW}.
FT   STRAND      510    517       {ECO:0000244|PDB:5JFW}.
FT   STRAND      520    522       {ECO:0000244|PDB:5JFW}.
FT   STRAND      524    533       {ECO:0000244|PDB:5JFW}.
FT   TURN        534    536       {ECO:0000244|PDB:5KMI}.
FT   STRAND      537    545       {ECO:0000244|PDB:5JFW}.
FT   HELIX       552    566       {ECO:0000244|PDB:5JFW}.
FT   STRAND      575    579       {ECO:0000244|PDB:5JFW}.
FT   STRAND      581    584       {ECO:0000244|PDB:5JFW}.
FT   STRAND      586    590       {ECO:0000244|PDB:5JFW}.
FT   HELIX       597    603       {ECO:0000244|PDB:5JFW}.
FT   STRAND      605    607       {ECO:0000244|PDB:4F0I}.
FT   HELIX       608    611       {ECO:0000244|PDB:4PMP}.
FT   STRAND      615    617       {ECO:0000244|PDB:4YNE}.
FT   STRAND      619    621       {ECO:0000244|PDB:5KMI}.
FT   HELIX       624    643       {ECO:0000244|PDB:5JFW}.
FT   STRAND      646    648       {ECO:0000244|PDB:5KML}.
FT   HELIX       653    655       {ECO:0000244|PDB:5JFW}.
FT   STRAND      656    659       {ECO:0000244|PDB:5JFW}.
FT   HELIX       660    662       {ECO:0000244|PDB:5JFW}.
FT   STRAND      663    666       {ECO:0000244|PDB:5JFW}.
FT   HELIX       672    675       {ECO:0000244|PDB:5KMI}.
FT   HELIX       677    679       {ECO:0000244|PDB:4PMP}.
FT   STRAND      680    683       {ECO:0000244|PDB:5KMI}.
FT   TURN        684    686       {ECO:0000244|PDB:5KMI}.
FT   STRAND      687    689       {ECO:0000244|PDB:5KMI}.
FT   HELIX       691    693       {ECO:0000244|PDB:5JFW}.
FT   HELIX       696    701       {ECO:0000244|PDB:5JFW}.
FT   HELIX       706    721       {ECO:0000244|PDB:5JFW}.
FT   TURN        722    724       {ECO:0000244|PDB:5JFV}.
FT   TURN        727    730       {ECO:0000244|PDB:5JFW}.
FT   HELIX       733    742       {ECO:0000244|PDB:5JFW}.
FT   HELIX       754    763       {ECO:0000244|PDB:5JFW}.
FT   HELIX       768    770       {ECO:0000244|PDB:5JFW}.
FT   HELIX       774    786       {ECO:0000244|PDB:5JFW}.
FT   HELIX       789    793       {ECO:0000244|PDB:5KMI}.
SQ   SEQUENCE   796 AA;  87497 MW;  6C15C721E336B601 CRC64;
     MLRGGRRGQL GWHSWAAGPG SLLAWLILAS AGAAPCPDAC CPHGSSGLRC TRDGALDSLH
     HLPGAENLTE LYIENQQHLQ HLELRDLRGL GELRNLTIVK SGLRFVAPDA FHFTPRLSRL
     NLSFNALESL SWKTVQGLSL QELVLSGNPL HCSCALRWLQ RWEEEGLGGV PEQKLQCHGQ
     GPLAHMPNAS CGVPTLKVQV PNASVDVGDD VLLRCQVEGR GLEQAGWILT ELEQSATVMK
     SGGLPSLGLT LANVTSDLNR KNVTCWAEND VGRAEVSVQV NVSFPASVQL HTAVEMHHWC
     IPFSVDGQPA PSLRWLFNGS VLNETSFIFT EFLEPAANET VRHGCLRLNQ PTHVNNGNYT
     LLAANPFGQA SASIMAAFMD NPFEFNPEDP IPVSFSPVDT NSTSGDPVEK KDETPFGVSV
     AVGLAVFACL FLSTLLLVLN KCGRRNKFGI NRPAVLAPED GLAMSLHFMT LGGSSLSPTE
     GKGSGLQGHI IENPQYFSDA CVHHIKRRDI VLKWELGEGA FGKVFLAECH NLLPEQDKML
     VAVKALKEAS ESARQDFQRE AELLTMLQHQ HIVRFFGVCT EGRPLLMVFE YMRHGDLNRF
     LRSHGPDAKL LAGGEDVAPG PLGLGQLLAV ASQVAAGMVY LAGLHFVHRD LATRNCLVGQ
     GLVVKIGDFG MSRDIYSTDY YRVGGRTMLP IRWMPPESIL YRKFTTESDV WSFGVVLWEI
     FTYGKQPWYQ LSNTEAIDCI TQGRELERPR ACPPEVYAIM RGCWQREPQQ RHSIKDVHAR
     LQALAQAPPV YLDVLG
//
ID   X5DR71_HUMAN            Unreviewed;       790 AA.
AC   X5DR71;
DT   11-JUN-2014, integrated into UniProtKB/TrEMBL.
DT   11-JUN-2014, sequence version 1.
DT   28-FEB-2018, entry version 34.
DE   RecName: Full=Tyrosine-protein kinase receptor {ECO:0000256|RuleBase:RU000312};
DE            EC=2.7.10.1 {ECO:0000256|RuleBase:RU000312};
DE   Flags: Fragment;
GN   Name=NTRK1 {ECO:0000313|EMBL:AHW56542.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AHW56542.1};
RN   [1] {ECO:0000313|EMBL:AHW56542.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Adult whole brain {ECO:0000313|EMBL:AHW56542.1};
RX   PubMed=24722188;
RA   Corominas R., Yang X., Lin G.N., Kang S., Shen Y., Ghamsari L.,
RA   Broly M., Rodriguez M., Tam S., Wanamaker S.A., Fan C., Yi S.,
RA   Tasan M., Lemmens I., Kuang X., Zhao N., Malhotra D., Michaelson J.J.,
RA   Vacic V., Calderwood M.A., Roth F.P., Tavernier J., Horvath S.,
RA   Salehi-Ashtiani K., Korkin D., Sebat J., Hill D.E., Hao T., Vidal M.,
RA   Iakoucheva L.M.;
RT   "Protein interaction network of alternatively spliced isoforms from
RT   brain links genetic risk factors for autism.";
RL   Nat. Commun. 5:3650-3650(2014).
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000256|RuleBase:RU000312}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Insulin receptor subfamily.
CC       {ECO:0000256|RuleBase:RU000312}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KJ534902; AHW56542.1; -; mRNA.
DR   RefSeq; NP_001012331.1; NM_001012331.1.
DR   UniGene; Hs.406293; -.
DR   ProteinModelPortal; X5DR71; -.
DR   SMR; X5DR71; -.
DR   GeneID; 4914; -.
DR   UCSC; uc001fqi.2; human.
DR   CTD; 4914; -.
DR   EuPathDB; HostDB:ENSG00000198400.11; -.
DR   eggNOG; ENOG410IMMI; Eukaryota.
DR   eggNOG; ENOG410XTGG; LUCA.
DR   ChiTaRS; NTRK1; human.
DR   GenomeRNAi; 4914; -.
DR   Bgee; ENSG00000198400; -.
DR   ExpressionAtlas; X5DR71; baseline and differential.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0005030; F:neurotrophin receptor activity; IEA:InterPro.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 2.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR031635; NTRK_C2.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR020461; Tyr_kinase_neurotrophic_rcpt_1.
DR   InterPro; IPR020777; Tyr_kinase_NGF_rcpt.
DR   InterPro; IPR002011; Tyr_kinase_rcpt_2_CS.
DR   Pfam; PF13855; LRR_8; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF16920; TPKR_C2; 1.
DR   PRINTS; PR01939; NTKRECEPTOR.
DR   PRINTS; PR01940; NTKRECEPTOR1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00082; LRRCT; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF48726; SSF48726; 2.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00239; RECEPTOR_TYR_KIN_II; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS01010727};
KW   Immunoglobulin domain {ECO:0000256|SAAS:SAAS00941986};
KW   Kinase {ECO:0000313|EMBL:AHW56542.1};
KW   Leucine-rich repeat {ECO:0000256|SAAS:SAAS00488662};
KW   Membrane {ECO:0000256|SAAS:SAAS00602683, ECO:0000256|SAM:Phobius};
KW   Phosphoprotein {ECO:0000256|RuleBase:RU000312};
KW   Receptor {ECO:0000256|RuleBase:RU000312,
KW   ECO:0000256|SAAS:SAAS00600436, ECO:0000313|EMBL:AHW56542.1};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transferase {ECO:0000313|EMBL:AHW56542.1};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00602683,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00602683,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     33       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        34    790       Tyrosine-protein kinase receptor.
FT                                {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004955970.
FT   TRANSMEM    410    433       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      194    283       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      504    775       Protein kinase.
FT                                {ECO:0000259|PROSITE:PS50011}.
FT   NON_TER     790    790       {ECO:0000313|EMBL:AHW56542.1}.
SQ   SEQUENCE   790 AA;  86880 MW;  25F05BADA8A2A50C CRC64;
     MLRGGRRGQL GWHSWAAGPG SLLAWLILAS AGAAPCPDAC CPHGSSGLRC TRDGALDSLH
     HLPGAENLTE LYIENQQHLQ HLELRDLRGL GELRNLTIVK SGLRFVAPDA FHFTPRLSRL
     NLSFNALESL SWKTVQGLSL QELVLSGNPL HCSCALRWLQ RWEEEGLGGV PEQKLQCHGQ
     GPLAHMPNAS CGVPTLKVQV PNASVDVGDD VLLRCQVEGR GLEQAGWILT ELEQSATVMK
     SGGLPSLGLT LANVTSDLNR KNVTCWAEND VGRAEVSVQV NVSFPASVQL HTAVEMHHWC
     IPFSVDGQPA PSLRWLFNGS VLNETSFIFT EFLEPAANET VRHGCLRLNQ PTHVNNGNYT
     LLAANPFGQA SASIMAAFMD NPFEFNPEDP IPDTNSTSGD PVEKKDETPF GVSVAVGLAV
     FACLFLSTLL LVLNKCGRRN KFGINRPAVL APEDGLAMSL HFMTLGGSSL SPTEGKGSGL
     QGHIIENPQY FSDACVHHIK RRDIVLKWEL GEGAFGKVFL AECHNLLPEQ DKMLVAVKAL
     KEASESARQD FQREAELLTM LQHQHIVRFF GVCTEGRPLL MVFEYMRHGD LNRFLRSHGP
     DAKLLAGGED VAPGPLGLGQ LLAVASQVAA GMVYLAGLHF VHRDLATRNC LVGQGLVVKI
     GDFGMSRDIY STDYYRVGGR TMLPIRWMPP ESILYRKFTT ESDVWSFGVV LWEIFTYGKQ
     PWYQLSNTEA IDCITQGREL ERPRACPPEV YAIMRGCWQR EPQQRHSIKD VHARLQALAQ
     APPVYLDVLG
//
ID   A8K5I0_HUMAN            Unreviewed;       641 AA.
AC   A8K5I0;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   23-MAY-2018, entry version 105.
DE   SubName: Full=Epididymis secretory protein Li 103 {ECO:0000313|EMBL:ACI45984.1};
DE   SubName: Full=HSPA1A {ECO:0000313|EMBL:AQY76864.1};
DE   SubName: Full=HSPA1B {ECO:0000313|EMBL:AQY76874.1};
DE   SubName: Full=Heat shock 70kDa protein 1A {ECO:0000313|EMBL:EAX03528.1};
DE   SubName: Full=Heat shock 70kDa protein 1B {ECO:0000313|EMBL:EAX03529.1};
DE   SubName: Full=cDNA FLJ75127, highly similar to Homo sapiens heat shock 70kDa protein 1A, mRNA {ECO:0000313|EMBL:BAF83984.1};
GN   Name=HSPA1B {ECO:0000313|EMBL:EAX03529.1};
GN   Synonyms=HEL-S-103 {ECO:0000313|EMBL:ACI45984.1},
GN   HSPA1A {ECO:0000313|EMBL:EAX03528.1};
GN   ORFNames=hCG_1820593 {ECO:0000313|EMBL:EAX03528.1},
GN   hCG_43726 {ECO:0000313|EMBL:EAX03529.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF83984.1};
RN   [1] {ECO:0000313|EMBL:EAX03528.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX03528.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:BAF83984.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Tongue {ECO:0000313|EMBL:BAF83984.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ACI45984.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J., Wang H., Liu J., Liu F.;
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:AQY76864.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Norman P.J., Norberg S.J., Nemat-Gorgani N., Ronaghi M., Parham P.;
RT   "CDS alleles of MHC region genes derived from homozygous
RT   individuals.";
RL   Submitted (JAN-2017) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000256|RuleBase:RU003322}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FJ224292; ACI45984.1; -; mRNA.
DR   EMBL; KY500377; AQY76864.1; -; Genomic_DNA.
DR   EMBL; KY500378; AQY76865.1; -; Genomic_DNA.
DR   EMBL; KY500379; AQY76866.1; -; Genomic_DNA.
DR   EMBL; KY500381; AQY76868.1; -; Genomic_DNA.
DR   EMBL; KY500382; AQY76869.1; -; Genomic_DNA.
DR   EMBL; KY500383; AQY76870.1; -; Genomic_DNA.
DR   EMBL; KY500384; AQY76871.1; -; Genomic_DNA.
DR   EMBL; KY500387; AQY76874.1; -; Genomic_DNA.
DR   EMBL; KY500388; AQY76875.1; -; Genomic_DNA.
DR   EMBL; KY500389; AQY76876.1; -; Genomic_DNA.
DR   EMBL; KY500390; AQY76877.1; -; Genomic_DNA.
DR   EMBL; KY500392; AQY76879.1; -; Genomic_DNA.
DR   EMBL; KY500393; AQY76880.1; -; Genomic_DNA.
DR   EMBL; KY500394; AQY76881.1; -; Genomic_DNA.
DR   EMBL; KY500395; AQY76882.1; -; Genomic_DNA.
DR   EMBL; KY500396; AQY76883.1; -; Genomic_DNA.
DR   EMBL; KY500397; AQY76884.1; -; Genomic_DNA.
DR   EMBL; AK291295; BAF83984.1; -; mRNA.
DR   EMBL; CH471081; EAX03528.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03529.1; -; Genomic_DNA.
DR   RefSeq; NP_005336.3; NM_005345.5.
DR   RefSeq; NP_005337.2; NM_005346.4.
DR   UniGene; Hs.274402; -.
DR   UniGene; Hs.702139; -.
DR   UniGene; Hs.719966; -.
DR   UniGene; Hs.743411; -.
DR   SMR; A8K5I0; -.
DR   IntAct; A8K5I0; 2.
DR   PRIDE; A8K5I0; -.
DR   DNASU; 3303; -.
DR   GeneID; 3303; -.
DR   GeneID; 3304; -.
DR   KEGG; hsa:3303; -.
DR   KEGG; hsa:3304; -.
DR   CTD; 3303; -.
DR   CTD; 3304; -.
DR   EuPathDB; HostDB:ENSG00000204388.6; -.
DR   EuPathDB; HostDB:ENSG00000204389.9; -.
DR   PharmGKB; PA29499; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   HOVERGEN; HBG051845; -.
DR   KO; K03283; -.
DR   OMA; THRTRVE; -.
DR   OrthoDB; EOG093705LK; -.
DR   ChiTaRS; HSPA1A; human.
DR   Bgee; ENSG00000204388; -.
DR   ExpressionAtlas; A8K5I0; baseline and differential.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   SUPFAM; SSF100934; SSF100934; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|RuleBase:RU003322};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU003322};
KW   Stress response {ECO:0000313|EMBL:BAF83984.1}.
FT   COILED      512    535       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   641 AA;  70052 MW;  78F513118C96DE66 CRC64;
     MAKAAAIGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA
     LNPQNTVFDA KRLIGRKFGD PVVQSDMKHW PFQVINDGDK PKVQVSYKGE TKAFYPEEIS
     SMVLTKMKEI AEAYLGYPVT NAVITVPAYF NDSQRQATKD AGVIAGLNVL RIINEPTAAA
     IAYGLDRTGK GERNVLIFDL GGGTFDVSIL TIDDGIFEVK ATAGDTHLGG EDFDNRLVNH
     FVEEFKRKHK KDISQNKRAV RRLRTACERA KRTLSSSTQA SLEIDSLFEG IDFYTSITRA
     RFEELCSDLF RSTLEPVEKA LRDAKLDKAQ IHDLVLVGGS TRIPKVQKLL QDFFNGRDLN
     KSINPDEAVA YGAAVQAAIL MGDKSENVQD LLLLDVAPLS LGLETAGGVM TALIKRNSTI
     PTKQTQIFTT YSDNQPGVLI QVYEGERAMT KDNNLLGRFE LSGIPPAPRG VPQIEVTFDI
     DANGILNVTA TDKSTGKANK ITITNDKGRL SKEEIERMVQ EAEKYKAEDE VQRERVSAKN
     ALESYAFNMK SAVEDEGLKG KISEADKKKV LDKCQEVISW LDANTLAEKD EFEHKRKELE
     QVCNPIISGL YQGAGGPGPG GFGAQGPKGG SGSGPTIEEV D
//
ID   B3KTT5_HUMAN            Unreviewed;       476 AA.
AC   B3KTT5;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 62.
DE   SubName: Full=cDNA FLJ38698 fis, clone KIDNE2002015, highly similar to HEAT SHOCK 70 kDa PROTEIN 1 {ECO:0000313|EMBL:BAG53197.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG53197.1};
RN   [1] {ECO:0000313|EMBL:BAG53197.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Kidney {ECO:0000313|EMBL:BAG53197.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK096017; BAG53197.1; -; mRNA.
DR   RefSeq; NP_005336.3; NM_005345.5.
DR   UniGene; Hs.274402; -.
DR   UniGene; Hs.702139; -.
DR   UniGene; Hs.743411; -.
DR   ProteinModelPortal; B3KTT5; -.
DR   IntAct; B3KTT5; 9.
DR   PeptideAtlas; B3KTT5; -.
DR   PRIDE; B3KTT5; -.
DR   DNASU; 3303; -.
DR   GeneID; 3303; -.
DR   KEGG; hsa:3303; -.
DR   CTD; 3303; -.
DR   PharmGKB; PA29498; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   HOGENOM; HOG000228135; -.
DR   HOVERGEN; HBG051845; -.
DR   KO; K03283; -.
DR   GenomeRNAi; 3303; -.
DR   Genevisible; B3KTT5; HS.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 2.
DR   Pfam; PF00012; HSP70; 1.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   SUPFAM; SSF100934; SSF100934; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Stress response {ECO:0000313|EMBL:BAG53197.1}.
FT   COILED      347    370       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   476 AA;  51917 MW;  24C7844D48228F36 CRC64;
     MAKAAAIGID LGTTYSCVGV FQHGKGERNV LIFDLGGGTF DVSILTIDDG IFEVKATAGD
     THLGGEDFDN RLVNHFVEEF KRKHKKDISQ NKRAVRRLRT ACERAKRTLS SSTQASLEID
     SLFEGIDFYT SITRARFEEL CSDLFRSTLE PVEKALRDAK LDKAQIHDLV LVGGSTRIPK
     VQKLLQDFFN GRDLNKSINP DEAVAYGAAV QAAILMGDKS ENVQDLLLLD VAPLSLGLET
     AGGVMTALIK RNSTIPTKQT QIFTTYSDNQ PGVLIQVYEG ERAMTKDNNL LGRFELSGIP
     PAPRGVPQIE VTFDIDANGI LNVTATDKSA GKANKITITN DKGRLSKEEI ERMVQEAEKY
     KAEDEVQRER VSAKNALESY AFNMKSAVED EGLKGKISEA DKKKVLDKCQ EVISWLDANT
     LAEKDEFEHK RKELEQVCNP IISGLYQGAG GPGPGGFGAQ GPKGGSGSGP TIEEVD
//
ID   HS71A_HUMAN             Reviewed;         641 AA.
AC   P0DMV8; B4E3B6; P08107; P19790; Q5JQI4; Q5SP17; Q9UQL9; Q9UQM0;
DT   27-MAY-2015, integrated into UniProtKB/Swiss-Prot.
DT   27-MAY-2015, sequence version 1.
DT   23-MAY-2018, entry version 34.
DE   RecName: Full=Heat shock 70 kDa protein 1A {ECO:0000312|HGNC:HGNC:5232};
DE   AltName: Full=Heat shock 70 kDa protein 1;
DE            Short=HSP70-1 {ECO:0000303|PubMed:14656967, ECO:0000303|PubMed:2538825};
DE            Short=HSP70.1;
GN   Name=HSPA1A;
GN   Synonyms=HSP72 {ECO:0000303|PubMed:24318877}, HSPA1, HSX70;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING (ISOFORM
RP   1).
RX   PubMed=3931075; DOI=10.1073/pnas.82.19.6455;
RA   Hunt C., Morimoto R.I.;
RT   "Conserved features of eukaryotic hsp70 genes revealed by comparison
RT   with the nucleotide sequence of human hsp70.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:6455-6459(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING (ISOFORM
RP   1).
RX   PubMed=1700760; DOI=10.1007/BF00187095;
RA   Milner C.M., Campbell R.D.;
RT   "Structure and expression of the three MHC-linked HSP70 genes.";
RL   Immunogenetics 32:242-251(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE
RP   SPLICING (ISOFORM 1).
RA   Shiina S., Tamiya G., Oka A., Inoko H.;
RT   "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANT ASP-110, AND
RP   ALTERNATIVE SPLICING (ISOFORM 1).
RX   PubMed=14656967; DOI=10.1101/gr.1736803;
RA   Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S.,
RA   Campbell R.D., Hood L.;
RT   "Analysis of the gene-dense major histocompatibility complex class III
RT   region and its comparison to mouse.";
RL   Genome Res. 13:2621-2636(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORM 1),
RP   AND VARIANT ASP-110.
RG   NIEHS SNPs program;
RL   Submitted (FEB-2006) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, Muscle, Pancreas, PNS, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-36.
RX   PubMed=2538825; DOI=10.1073/pnas.86.6.1968;
RA   Sargent C.A., Dunham I., Trowsdale J., Campbell R.D.;
RT   "Human major histocompatibility complex contains genes for the major
RT   heat shock protein HSP70.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:1968-1972(1989).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22 AND 617-641.
RX   PubMed=3786141; DOI=10.1093/nar/14.22.8933;
RA   Drabent B., Genthe A., Benecke B.-J.;
RT   "In vitro transcription of a human hsp 70 heat shock gene by extracts
RT   prepared from heat-shocked and non-heat-shocked human cells.";
RL   Nucleic Acids Res. 14:8933-8948(1986).
RN   [11]
RP   PROTEIN SEQUENCE OF 4-49; 57-71; 77-155; 160-187; 221-247; 273-311;
RP   326-342; 349-357; 362-416; 424-447; 459-469; 510-517; 540-550; 574-595
RP   AND 598-641, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [12]
RP   PROTEIN SEQUENCE OF 37-49; 57-71; 78-88; 113-126; 160-187; 221-247;
RP   302-311; 329-342; 349-357; 362-384; 540-550 AND 574-589, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [13]
RP   PROTEIN SEQUENCE OF 551-567, METHYLATION AT LYS-561, MUTAGENESIS OF
RP   LYS-561, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23349634; DOI=10.1371/journal.pgen.1003210;
RA   Cloutier P., Lavallee-Adam M., Faubert D., Blanchette M., Coulombe B.;
RT   "A newly uncovered group of distantly related lysine
RT   methyltransferases preferentially interact with molecular chaperones
RT   to regulate their activity.";
RL   PLoS Genet. 9:E1003210-E1003210(2013).
RN   [14]
RP   INTERACTION WITH HSF1.
RX   PubMed=7935376; DOI=10.1128/MCB.14.10.6552;
RA   Rabindran S.K., Wisniewski J., Li L., Li G.C., Wu C.;
RT   "Interaction between heat shock factor and hsp70 is insufficient to
RT   suppress induction of DNA-binding activity in vivo.";
RL   Mol. Cell. Biol. 14:6552-6560(1994).
RN   [15]
RP   FUNCTION, AND INTERACTION WITH HSF1.
RX   PubMed=9499401; DOI=10.1101/gad.12.5.654;
RA   Shi Y., Mosser D.D., Morimoto R.I.;
RT   "Molecular chaperones as HSF1-specific transcriptional repressors.";
RL   Genes Dev. 12:654-666(1998).
RN   [16]
RP   INTERACTION WITH TERT.
RX   PubMed=11274138; DOI=10.1074/jbc.C100055200;
RA   Forsythe H.L., Jarvis J.L., Turner J.W., Elmore L.W., Holt S.E.;
RT   "Stable association of hsp90 and p23, but Not hsp70, with active human
RT   telomerase.";
RL   J. Biol. Chem. 276:15571-15574(2001).
RN   [17]
RP   INTERACTION WITH DNAJC7.
RX   PubMed=12853476; DOI=10.1093/emboj/cdg362;
RA   Brychzy A., Rein T., Winklhofer K.F., Hartl F.U., Young J.C.,
RA   Obermann W.M.;
RT   "Cofactor Tpr2 combines two TPR domains and a J domain to regulate the
RT   Hsp70/Hsp90 chaperone system.";
RL   EMBO J. 22:3613-3623(2003).
RN   [18]
RP   INTERACTION WITH TSC2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15963462; DOI=10.1016/j.bbrc.2005.05.175;
RA   Nellist M., Burgers P.C., van den Ouweland A.M.W., Halley D.J.J.,
RA   Luider T.M.;
RT   "Phosphorylation and binding partner analysis of the TSC1-TSC2
RT   complex.";
RL   Biochem. Biophys. Res. Commun. 333:818-826(2005).
RN   [19]
RP   INTERACTION WITH PPP5C, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15383005; DOI=10.1042/BJ20040690;
RA   Zeke T., Morrice N., Vazquez-Martin C., Cohen P.T.;
RT   "Human protein phosphatase 5 dissociates from heat-shock proteins and
RT   is proteolytically activated in response to arachidonic acid and the
RT   microtubule-depolymerizing drug nocodazole.";
RL   Biochem. J. 385:45-56(2005).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [21]
RP   INTERACTION WITH IRAK1BP1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17233114; DOI=10.1089/dna.2006.25.704;
RA   Haag Breese E., Uversky V.N., Georgiadis M.M., Harrington M.A.;
RT   "The disordered amino-terminus of SIMPL interacts with members of the
RT   70-kDa heat-shock protein family.";
RL   DNA Cell Biol. 25:704-714(2006).
RN   [22]
RP   FUNCTION AS A RECEPTOR FOR ROTAVIRUS A.
RX   PubMed=16537599; DOI=10.1128/JVI.80.7.3322-3331.2006;
RA   Perez-Vargas J., Romero P., Lopez S., Arias C.F.;
RT   "The peptide-binding and ATPase domains of recombinant hsc70 are
RT   required to interact with rotavirus and reduce its infectivity.";
RL   J. Virol. 80:3322-3331(2006).
RN   [23]
RP   INTERACTION WITH DNAJC9.
RX   PubMed=17182002; DOI=10.1016/j.bbrc.2006.12.013;
RA   Han C., Chen T., Li N., Yang M., Wan T., Cao X.;
RT   "HDJC9, a novel human type C DnaJ/HSP40 member interacts with and
RT   cochaperones HSP70 through the J domain.";
RL   Biochem. Biophys. Res. Commun. 353:280-285(2007).
RN   [24]
RP   IDENTIFICATION IN A MRNP GRANULE COMPLEX, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=17289661; DOI=10.1074/mcp.M600346-MCP200;
RA   Joeson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T., Borup R.,
RA   Johnsen A.H., Christiansen J., Nielsen F.C.;
RT   "Molecular composition of IMP1 ribonucleoprotein granules.";
RL   Mol. Cell. Proteomics 6:798-811(2007).
RN   [25]
RP   INTERACTION WITH DNAJC7.
RX   PubMed=18620420; DOI=10.1021/bi800770g;
RA   Moffatt N.S., Bruinsma E., Uhl C., Obermann W.M., Toft D.;
RT   "Role of the cochaperone Tpr2 in Hsp90 chaperoning.";
RL   Biochemistry 47:8203-8213(2008).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [27]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [28]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-108; LYS-246 AND LYS-348,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [29]
RP   INTERACTION WITH TRIM5.
RX   PubMed=20053985; DOI=10.1074/jbc.M109.040618;
RA   Hwang C.Y., Holl J., Rajan D., Lee Y., Kim S., Um M., Kwon K.S.,
RA   Song B.;
RT   "Hsp70 interacts with the retroviral restriction factor TRIM5alpha and
RT   assists the folding of TRIM5alpha.";
RL   J. Biol. Chem. 285:7827-7837(2010).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-631; SER-633 AND
RP   THR-636, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [32]
RP   INTERACTION WITH CHCHD3.
RX   PubMed=21081504; DOI=10.1074/jbc.M110.171975;
RA   Darshi M., Mendiola V.L., Mackey M.R., Murphy A.N., Koller A.,
RA   Perkins G.A., Ellisman M.H., Taylor S.S.;
RT   "ChChd3, an inner mitochondrial membrane protein, is essential for
RT   maintaining crista integrity and mitochondrial function.";
RL   J. Biol. Chem. 286:2918-2932(2011).
RN   [33]
RP   FUNCTION, AND INTERACTION WITH ATF5.
RX   PubMed=22528486; DOI=10.1074/jbc.M112.363622;
RA   Liu X., Liu D., Qian D., Dai J., An Y., Jiang S., Stanley B., Yang J.,
RA   Wang B., Liu X., Liu D.X.;
RT   "Nucleophosmin (NPM1/B23) interacts with activating transcription
RT   factor 5 (ATF5) protein and promotes proteasome- and caspase-dependent
RT   ATF5 degradation in hepatocellular carcinoma cells.";
RL   J. Biol. Chem. 287:19599-19609(2012).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, AND INTERACTION WITH
RP   FOXP3.
RX   PubMed=23973223; DOI=10.1016/j.immuni.2013.08.006;
RA   Chen Z., Barbi J., Bu S., Yang H.Y., Li Z., Gao Y., Jinasena D.,
RA   Fu J., Lin F., Chen C., Zhang J., Yu N., Li X., Shan Z., Nie J.,
RA   Gao Z., Tian H., Li Y., Yao Z., Zheng Y., Park B.V., Pan Z., Zhang J.,
RA   Dang E., Li Z., Wang H., Luo W., Li L., Semenza G.L., Zheng S.G.,
RA   Loser K., Tsun A., Greene M.I., Pardoll D.M., Pan F., Li B.;
RT   "The ubiquitin ligase Stub1 negatively modulates regulatory T cell
RT   suppressive activity by promoting degradation of the transcription
RT   factor Foxp3.";
RL   Immunity 39:272-285(2013).
RN   [36]
RP   METHYLATION AT LYS-561, MUTAGENESIS OF LYS-561, AND INTERACTION WITH
RP   METTL21A.
RX   PubMed=23921388; DOI=10.1074/jbc.M113.483248;
RA   Jakobsson M.E., Moen A., Bousset L., Egge-Jacobsen W., Kernstock S.,
RA   Melki R., Falnes P.O.;
RT   "Identification and characterization of a novel human
RT   methyltransferase modulating Hsp70 function through lysine
RT   methylation.";
RL   J. Biol. Chem. 288:27752-27763(2013).
RN   [37]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [38]
RP   INTERACTION WITH PRKN.
RX   PubMed=24270810; DOI=10.1038/nature12748;
RA   Hasson S.A., Kane L.A., Yamano K., Huang C.H., Sliter D.A.,
RA   Buehler E., Wang C., Heman-Ackah S.M., Hessa T., Guha R., Martin S.E.,
RA   Youle R.J.;
RT   "High-content genome-wide RNAi screens identify regulators of parkin
RT   upstream of mitophagy.";
RL   Nature 504:291-295(2013).
RN   [39]
RP   REVIEW.
RX   PubMed=24012426; DOI=10.1016/j.tibs.2013.08.001;
RA   Mayer M.P.;
RT   "Hsp70 chaperone dynamics and molecular mechanism.";
RL   Trends Biochem. Sci. 38:507-514(2013).
RN   [40]
RP   FUNCTION, AND INTERACTION WITH STUB1 AND SMAD3.
RX   PubMed=24613385; DOI=10.1016/j.bbrc.2014.02.124;
RA   Shang Y., Xu X., Duan X., Guo J., Wang Y., Ren F., He D., Chang Z.;
RT   "Hsp70 and Hsp90 oppositely regulate TGF-beta signaling through
RT   CHIP/Stub1.";
RL   Biochem. Biophys. Res. Commun. 446:387-392(2014).
RN   [41]
RP   FUNCTION, AND INTERACTION WITH BAG1; BAG2; BAG3 AND HSPH1.
RX   PubMed=24318877; DOI=10.1074/jbc.M113.521997;
RA   Rauch J.N., Gestwicki J.E.;
RT   "Binding of human nucleotide exchange factors to heat shock protein 70
RT   (Hsp70) generates functionally distinct complexes in vitro.";
RL   J. Biol. Chem. 289:1402-1414(2014).
RN   [42]
RP   INTERACTION WITH NOD2.
RX   PubMed=24790089; DOI=10.1074/jbc.M114.557686;
RA   Mohanan V., Grimes C.L.;
RT   "The molecular chaperone HSP70 binds to and stabilizes NOD2, an
RT   important protein involved in Crohn disease.";
RL   J. Biol. Chem. 289:18987-18998(2014).
RN   [43]
RP   INTERACTION WITH RNF207.
RX   PubMed=25281747; DOI=10.1074/jbc.M114.592295;
RA   Roder K., Werdich A.A., Li W., Liu M., Kim T.Y., Organ-Darling L.E.,
RA   Moshal K.S., Hwang J.M., Lu Y., Choi B.R., MacRae C.A., Koren G.;
RT   "RING finger protein RNF207, a novel regulator of cardiac
RT   excitation.";
RL   J. Biol. Chem. 289:33730-33740(2014).
RN   [44]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [45]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-469 AND LYS-561, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [46]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [47]
RP   INTERACTION WITH DNAJC8.
RX   PubMed=27133716; DOI=10.1016/j.bbrc.2016.03.152;
RA   Ito N., Kamiguchi K., Nakanishi K., Sokolovskya A., Hirohashi Y.,
RA   Tamura Y., Murai A., Yamamoto E., Kanaseki T., Tsukahara T.,
RA   Kochin V., Chiba S., Shimohama S., Sato N., Torigoe T.;
RT   "A novel nuclear DnaJ protein, DNAJC8, can suppress the formation of
RT   spinocerebellar ataxia 3 polyglutamine aggregation in a J-domain
RT   independent manner.";
RL   Biochem. Biophys. Res. Commun. 474:626-633(2016).
RN   [48]
RP   REVIEW.
RX   PubMed=26865365; DOI=10.1007/s12192-016-0676-6;
RA   Radons J.;
RT   "The human HSP70 family of chaperones: where do we stand?";
RL   Cell Stress Chaperones 21:379-404(2016).
RN   [49]
RP   FUNCTION, INTERACTION WITH NEDD1, AND SUBCELLULAR LOCATION.
RX   PubMed=27137183; DOI=10.1007/s00018-016-2236-8;
RA   Fang C.T., Kuo H.H., Pan T.S., Yu F.C., Yih L.H.;
RT   "HSP70 regulates the function of mitotic centrosomes.";
RL   Cell. Mol. Life Sci. 73:3949-3960(2016).
RN   [50]
RP   FUNCTION, ACETYLATION AT LYS-77, MUTAGENESIS OF LYS-77, AND
RP   INTERACTION WITH NAA10; HSP40; HOPX; STUB1; HSP90 AND HDAC4.
RX   PubMed=27708256; DOI=10.1038/ncomms12882;
RA   Seo J.H., Park J.H., Lee E.J., Vo T.T., Choi H., Kim J.Y., Jang J.K.,
RA   Wee H.J., Lee H.S., Jang S.H., Park Z.Y., Jeong J., Lee K.J.,
RA   Seok S.H., Park J.Y., Lee B.J., Lee M.N., Oh G.T., Kim K.W.;
RT   "ARD1-mediated Hsp70 acetylation balances stress-induced protein
RT   refolding and degradation.";
RL   Nat. Commun. 7:12882-12882(2016).
RN   [51]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-382 IN COMPLEX WITH ADP,
RP   AND ATP-BINDING.
RX   PubMed=10216320; DOI=10.1107/S0907444999002103;
RA   Osipiuk J., Walsh M.A., Freeman B.C., Morimoto R.I., Joachimiak A.;
RT   "Structure of a new crystal form of human hsp70 ATPase domain.";
RL   Acta Crystallogr. D 55:1105-1107(1999).
RN   [52]
RP   X-RAY CRYSTALLOGRAPHY (1.77 ANGSTROMS) OF 389-641 IN COMPLEX WITH ATP
RP   ANALOG, AND ATP-BINDING.
RX   PubMed=20179333; DOI=10.1107/S0907444909053979;
RA   Shida M., Arakawa A., Ishii R., Kishishita S., Takagi T.,
RA   Kukimoto-Niino M., Sugano S., Tanaka A., Shirouzu M., Yokoyama S.;
RT   "Direct inter-subdomain interactions switch between the closed and
RT   open forms of the Hsp70 nucleotide-binding domain in the nucleotide-
RT   free state.";
RL   Acta Crystallogr. D 66:223-232(2010).
RN   [53]
RP   X-RAY CRYSTALLOGRAPHY (2.14 ANGSTROMS) OF 1-387 IN COMPLEX WITH ADP,
RP   AND ATP-BINDING.
RX   PubMed=20072699; DOI=10.1371/journal.pone.0008625;
RA   Wisniewska M., Karlberg T., Lehtio L., Johansson I., Kotenyova T.,
RA   Moche M., Schuler H.;
RT   "Crystal structures of the ATPase domains of four human Hsp70
RT   isoforms: HSPA1L/Hsp70-hom, HSPA2/Hsp70-2, HSPA6/Hsp70B', and
RT   HSPA5/BiP/GRP78.";
RL   PLoS ONE 5:E8625-E8625(2010).
RN   [54]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-388 IN COMPLEX WITH BAG5.
RX   PubMed=20223214; DOI=10.1016/j.str.2010.01.004;
RA   Arakawa A., Handa N., Ohsawa N., Shida M., Kigawa T., Hayashi F.,
RA   Shirouzu M., Yokoyama S.;
RT   "The C-terminal BAG domain of BAG5 induces conformational changes of
RT   the Hsp70 nucleotide-binding domain for ADP-ATP exchange.";
RL   Structure 18:309-319(2010).
RN   [55]
RP   X-RAY CRYSTALLOGRAPHY (1.58 ANGSTROMS) OF 1-388, ATP-BINDING, AND
RP   MUTAGENESIS OF ASP-10 AND ASP-199.
RX   PubMed=21608060; DOI=10.1002/pro.663;
RA   Arakawa A., Handa N., Shirouzu M., Yokoyama S.;
RT   "Biochemical and structural studies on the high affinity of Hsp70 for
RT   ADP.";
RL   Protein Sci. 20:1367-1379(2011).
CC   -!- FUNCTION: Molecular chaperone implicated in a wide variety of
CC       cellular processes, including protection of the proteome from
CC       stress, folding and transport of newly synthesized polypeptides,
CC       activation of proteolysis of misfolded proteins and the formation
CC       and dissociation of protein complexes. Plays a pivotal role in the
CC       protein quality control system, ensuring the correct folding of
CC       proteins, the re-folding of misfolded proteins and controlling the
CC       targeting of proteins for subsequent degradation. This is achieved
CC       through cycles of ATP binding, ATP hydrolysis and ADP release,
CC       mediated by co-chaperones. The co-chaperones have been shown to
CC       not only regulate different steps of the ATPase cycle, but they
CC       also have an individual specificity such that one co-chaperone may
CC       promote folding of a substrate while another may promote
CC       degradation. The affinity for polypeptides is regulated by its
CC       nucleotide bound state. In the ATP-bound form, it has a low
CC       affinity for substrate proteins. However, upon hydrolysis of the
CC       ATP to ADP, it undergoes a conformational change that increases
CC       its affinity for substrate proteins. It goes through repeated
CC       cycles of ATP hydrolysis and nucleotide exchange, which permits
CC       cycles of substrate binding and release. The co-chaperones are of
CC       three types: J-domain co-chaperones such as HSP40s (stimulate
CC       ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF)
CC       such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-
CC       bound to the ATP-bound state thereby promoting substrate release),
CC       and the TPR domain chaperones such as HOPX and STUB1
CC       (PubMed:24012426, PubMed:26865365, PubMed:24318877). Maintains
CC       protein homeostasis during cellular stress through two opposing
CC       mechanisms: protein refolding and degradation. Its
CC       acetylation/deacetylation state determines whether it functions in
CC       protein refolding or protein degradation by controlling the
CC       competitive binding of co-chaperones HOPX and STUB1. During the
CC       early stress response, the acetylated form binds to HOPX which
CC       assists in chaperone-mediated protein refolding, thereafter, it is
CC       deacetylated and binds to ubiquitin ligase STUB1 that promotes
CC       ubiquitin-mediated protein degradation (PubMed:27708256).
CC       Regulates centrosome integrity during mitosis, and is required for
CC       the maintenance of a functional mitotic centrosome that supports
CC       the assembly of a bipolar mitotic spindle (PubMed:27137183).
CC       Enhances STUB1-mediated SMAD3 ubiquitination and degradation and
CC       facilitates STUB1-mediated inhibition of TGF-beta signaling
CC       (PubMed:24613385). Essential for STUB1-mediated ubiquitination and
CC       degradation of FOXP3 in regulatory T-cells (Treg) during
CC       inflammation (PubMed:23973223). Negatively regulates heat shock-
CC       induced HSF1 transcriptional activity during the attenuation and
CC       recovery phase period of the heat shock response (PubMed:9499401).
CC       {ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:23973223,
CC       ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24613385,
CC       ECO:0000269|PubMed:27137183, ECO:0000269|PubMed:27708256,
CC       ECO:0000269|PubMed:9499401, ECO:0000303|PubMed:24012426,
CC       ECO:0000303|PubMed:26865365}.
CC   -!- FUNCTION: (Microbial infection) In case of rotavirus A infection,
CC       serves as a post-attachment receptor for the virus to facilitate
CC       entry into the cell. {ECO:0000269|PubMed:16537599}.
CC   -!- SUBUNIT: Component of the CatSper complex. Identified in a
CC       IGF2BP1-dependent mRNP granule complex containing untranslated
CC       mRNAs (PubMed:17289661). Interacts with CHCHD3, DNAJC7, IRAK1BP1,
CC       PPP5C and TSC2 (PubMed:21081504, PubMed:12853476, PubMed:18620420,
CC       PubMed:17233114, PubMed:15383005, PubMed:15963462). Interacts with
CC       TERT; the interaction occurs in the absence of the RNA component,
CC       TERC, and dissociates once the TERT complex has formed
CC       (PubMed:11274138). Interacts with TRIM5 (via B30.2/SPRY domain)
CC       (PubMed:20053985). Interacts with METTL21A (PubMed:23921388).
CC       Interacts with DNAAF2 (By similarity). Interacts with PRKN
CC       (PubMed:24270810). Interacts with FOXP3 (PubMed:23973223).
CC       Interacts with NOD2; the interaction enhances NOD2 stability
CC       (PubMed:24790089). Interacts with DNAJC9 (via J domain)
CC       (PubMed:17182002). Interacts with ATF5; the interaction protects
CC       ATF5 from degradation via proteasome-dependent and caspase-
CC       dependent processes (PubMed:22528486). Interacts with RNF207 (via
CC       the C-terminus); this interaction additively increases KCNH2
CC       expression (PubMed:25281747). Interacts with HSF1 (via
CC       transactivation domain); this interaction results in the
CC       inhibition of heat shock- and HSF1-induced transcriptional
CC       activity during the attenuation and recovery phase period of the
CC       heat shock response (PubMed:7935376, PubMed:9499401). Interacts
CC       with NAA10, HSP40, HSP90 and HDAC4. The acetylated form and the
CC       non-acetylated form interact with HOPX and STUB1 respectively
CC       (PubMed:27708256). Interacts with NEDD1 (PubMed:27137183).
CC       Interacts (via NBD) with BAG1, BAG2, BAG3 and HSPH1/HSP105
CC       (PubMed:24318877). Interacts with SMAD3 (PubMed:24613385).
CC       Interacts with DNAJC8 (PubMed:27133716).
CC       {ECO:0000250|UniProtKB:Q61696, ECO:0000269|PubMed:10216320,
CC       ECO:0000269|PubMed:11274138, ECO:0000269|PubMed:12853476,
CC       ECO:0000269|PubMed:15383005, ECO:0000269|PubMed:15963462,
CC       ECO:0000269|PubMed:17182002, ECO:0000269|PubMed:17233114,
CC       ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:18620420,
CC       ECO:0000269|PubMed:20053985, ECO:0000269|PubMed:20072699,
CC       ECO:0000269|PubMed:20179333, ECO:0000269|PubMed:20223214,
CC       ECO:0000269|PubMed:21081504, ECO:0000269|PubMed:22528486,
CC       ECO:0000269|PubMed:23921388, ECO:0000269|PubMed:23973223,
CC       ECO:0000269|PubMed:24270810, ECO:0000269|PubMed:24318877,
CC       ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:24790089,
CC       ECO:0000269|PubMed:25281747, ECO:0000269|PubMed:27133716,
CC       ECO:0000269|PubMed:27137183, ECO:0000269|PubMed:27708256,
CC       ECO:0000269|PubMed:7935376, ECO:0000269|PubMed:9499401}.
CC   -!- INTERACTION:
CC       P04663:HA (xeno); NbExp=4; IntAct=EBI-11052499, EBI-13951712;
CC       P13760:HLA-DRB1; NbExp=2; IntAct=EBI-11052499, EBI-1033104;
CC       Q9NUX5:POT1; NbExp=2; IntAct=EBI-11052499, EBI-752420;
CC       O75832:PSMD10; NbExp=2; IntAct=EBI-11052499, EBI-752185;
CC       P04958:tetX (xeno); NbExp=3; IntAct=EBI-11052499, EBI-13951617;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17289661}.
CC       Nucleus {ECO:0000269|PubMed:27137183}. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:27137183}. Note=Localized in cytoplasmic mRNP
CC       granules containing untranslated mRNAs.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P0DMV8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P0DMV8-2; Sequence=VSP_044427;
CC   -!- INDUCTION: By heat shock.
CC   -!- DOMAIN: The N-terminal nucleotide binding domain (NBD) (also known
CC       as the ATPase domain) is responsible for binding and hydrolyzing
CC       ATP. The C-terminal substrate-binding domain (SBD) (also known as
CC       peptide-binding domain) binds to the client/substrate proteins.
CC       The two domains are allosterically coupled so that, when ATP is
CC       bound to the NBD, the SBD binds relatively weakly to clients. When
CC       ADP is bound in the NBD, a conformational change enhances the
CC       affinity of the SBD for client proteins.
CC       {ECO:0000305|PubMed:24012426, ECO:0000305|PubMed:26865365}.
CC   -!- PTM: In response to cellular stress, acetylated at Lys-77 by NA110
CC       and then gradually deacetylated by HDAC4 at later stages.
CC       Acetylation enhances its chaperone activity and also determines
CC       whether it will function as a chaperone for protein refolding or
CC       degradation by controlling its binding to co-chaperones HOPX and
CC       STUB1. The acetylated form and the non-acetylated form bind to
CC       HOPX and STUB1 respectively. Acetylation also protects cells
CC       against various types of cellular stress.
CC       {ECO:0000269|PubMed:27708256}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/hspa1a/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M11717; AAA52697.1; -; Genomic_DNA.
DR   EMBL; M59828; AAA63226.1; -; Genomic_DNA.
DR   EMBL; BA000025; BAB63300.1; -; Genomic_DNA.
DR   EMBL; AF134726; AAD21816.1; -; Genomic_DNA.
DR   EMBL; AK304652; BAG65428.1; -; mRNA.
DR   EMBL; DQ451402; ABD96830.1; -; Genomic_DNA.
DR   EMBL; AL671762; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002453; AAH02453.1; -; mRNA.
DR   EMBL; M24743; AAA59844.1; -; Genomic_DNA.
DR   EMBL; X04676; CAA28381.1; -; Genomic_DNA.
DR   EMBL; X04677; CAA28382.1; -; Genomic_DNA.
DR   CCDS; CCDS34414.1; -. [P0DMV8-1]
DR   PIR; A29160; A29160.
DR   PIR; A45871; A45871.
DR   PIR; I59139; I59139.
DR   PIR; I79540; I79540.
DR   RefSeq; NP_005336.3; NM_005345.5. [P0DMV8-1]
DR   RefSeq; NP_005337.2; NM_005346.4. [P0DMV8-1]
DR   UniGene; Hs.274402; -.
DR   UniGene; Hs.702139; -.
DR   UniGene; Hs.719966; -.
DR   UniGene; Hs.743411; -.
DR   PDB; 1HJO; X-ray; 2.30 A; A=3-382.
DR   PDB; 1S3X; X-ray; 1.84 A; A=1-382.
DR   PDB; 1XQS; X-ray; 2.90 A; C/D=184-371.
DR   PDB; 2E88; X-ray; 1.80 A; A=1-388.
DR   PDB; 2E8A; X-ray; 1.77 A; A=1-388.
DR   PDB; 2LMG; NMR; -; A=537-610.
DR   PDB; 3A8Y; X-ray; 2.30 A; A/B=1-388.
DR   PDB; 3ATU; X-ray; 1.65 A; A=1-388.
DR   PDB; 3ATV; X-ray; 1.58 A; A=1-388.
DR   PDB; 3AY9; X-ray; 1.75 A; A=1-388.
DR   PDB; 3D2E; X-ray; 2.35 A; B/D=1-382.
DR   PDB; 3D2F; X-ray; 2.30 A; B/D=1-382.
DR   PDB; 3JXU; X-ray; 2.14 A; A=1-387.
DR   PDB; 3LOF; X-ray; 2.40 A; A/B/C/D/E/F=534-641.
DR   PDB; 3Q49; X-ray; 1.54 A; C=634-641.
DR   PDB; 4IO8; X-ray; 2.58 A; A=1-382.
DR   PDB; 4J8F; X-ray; 2.70 A; A=1-382.
DR   PDB; 4PO2; X-ray; 2.00 A; A/B=386-613.
DR   PDB; 4WV5; X-ray; 2.04 A; A/B=395-543.
DR   PDB; 4WV7; X-ray; 2.42 A; A/B=395-543.
DR   PDB; 5AQW; X-ray; 1.53 A; A=1-380.
DR   PDB; 5AQX; X-ray; 2.12 A; A=1-380.
DR   PDB; 5AQY; X-ray; 1.56 A; A=1-380.
DR   PDB; 5AQZ; X-ray; 1.65 A; A=1-380.
DR   PDB; 5AR0; X-ray; 1.90 A; A=1-380.
DR   PDB; 5BN8; X-ray; 1.34 A; A=1-388.
DR   PDB; 5BN9; X-ray; 1.69 A; A=1-388.
DR   PDB; 5BPL; X-ray; 1.93 A; A=1-388.
DR   PDB; 5BPM; X-ray; 1.83 A; A=1-388.
DR   PDB; 5BPN; X-ray; 2.10 A; A=1-388.
DR   PDB; 5GJJ; NMR; -; A=385-641.
DR   PDB; 5MKR; X-ray; 1.87 A; A=1-380.
DR   PDB; 5MKS; X-ray; 1.99 A; A=1-380.
DR   PDBsum; 1HJO; -.
DR   PDBsum; 1S3X; -.
DR   PDBsum; 1XQS; -.
DR   PDBsum; 2E88; -.
DR   PDBsum; 2E8A; -.
DR   PDBsum; 2LMG; -.
DR   PDBsum; 3A8Y; -.
DR   PDBsum; 3ATU; -.
DR   PDBsum; 3ATV; -.
DR   PDBsum; 3AY9; -.
DR   PDBsum; 3D2E; -.
DR   PDBsum; 3D2F; -.
DR   PDBsum; 3JXU; -.
DR   PDBsum; 3LOF; -.
DR   PDBsum; 3Q49; -.
DR   PDBsum; 4IO8; -.
DR   PDBsum; 4J8F; -.
DR   PDBsum; 4PO2; -.
DR   PDBsum; 4WV5; -.
DR   PDBsum; 4WV7; -.
DR   PDBsum; 5AQW; -.
DR   PDBsum; 5AQX; -.
DR   PDBsum; 5AQY; -.
DR   PDBsum; 5AQZ; -.
DR   PDBsum; 5AR0; -.
DR   PDBsum; 5BN8; -.
DR   PDBsum; 5BN9; -.
DR   PDBsum; 5BPL; -.
DR   PDBsum; 5BPM; -.
DR   PDBsum; 5BPN; -.
DR   PDBsum; 5GJJ; -.
DR   PDBsum; 5MKR; -.
DR   PDBsum; 5MKS; -.
DR   ProteinModelPortal; P0DMV8; -.
DR   SMR; P0DMV8; -.
DR   CORUM; P0DMV8; -.
DR   IntAct; P0DMV8; 29.
DR   STRING; 9606.ENSP00000364802; -.
DR   BindingDB; P0DMV8; -.
DR   ChEMBL; CHEMBL5460; -.
DR   CarbonylDB; P0DMV8; -.
DR   iPTMnet; P0DMV8; -.
DR   PhosphoSitePlus; P0DMV8; -.
DR   SwissPalm; P0DMV8; -.
DR   DMDM; 147744565; -.
DR   REPRODUCTION-2DPAGE; IPI00304925; -.
DR   PaxDb; P0DMV8; -.
DR   PeptideAtlas; P0DMV8; -.
DR   PRIDE; P0DMV8; -.
DR   DNASU; 3303; -.
DR   Ensembl; ENST00000375651; ENSP00000364802; ENSG00000204389. [P0DMV8-1]
DR   Ensembl; ENST00000400040; ENSP00000382915; ENSG00000215328.
DR   Ensembl; ENST00000430065; ENSP00000404524; ENSG00000235941. [P0DMV8-1]
DR   Ensembl; ENST00000433487; ENSP00000408907; ENSG00000234475. [P0DMV8-1]
DR   Ensembl; ENST00000441618; ENSP00000406359; ENSG00000237724. [P0DMV8-1]
DR   GeneID; 3303; -.
DR   GeneID; 3304; -.
DR   KEGG; hsa:3303; -.
DR   KEGG; hsa:3304; -.
DR   CTD; 3303; -.
DR   CTD; 3304; -.
DR   DisGeNET; 3303; -.
DR   DisGeNET; 3304; -.
DR   EuPathDB; HostDB:ENSG00000204389.9; -.
DR   GeneCards; HSPA1A; -.
DR   H-InvDB; HIX0058169; -.
DR   H-InvDB; HIX0058187; -.
DR   H-InvDB; HIX0166160; -.
DR   HGNC; HGNC:5232; HSPA1A.
DR   HPA; CAB017451; -.
DR   HPA; CAB032815; -.
DR   HPA; HPA052504; -.
DR   MIM; 140550; gene.
DR   MIM; 603012; gene.
DR   neXtProt; NX_P0DMV8; -.
DR   OpenTargets; ENSG00000204388; -.
DR   OpenTargets; ENSG00000204389; -.
DR   HOGENOM; HOG000228135; -.
DR   HOVERGEN; HBG051845; -.
DR   KO; K03283; -.
DR   OMA; THRTRVE; -.
DR   OrthoDB; EOG093705LK; -.
DR   PhylomeDB; P0DMV8; -.
DR   TreeFam; TF105042; -.
DR   Reactome; R-HSA-168330; Viral RNP Complexes in the Host Cell Nucleus.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SIGNOR; P0DMV8; -.
DR   ChiTaRS; HSPA1A; human.
DR   GeneWiki; HSPA1A; -.
DR   PRO; PR:P0DMV8; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000204389; -.
DR   CleanEx; HS_HSPA1A; -.
DR   ExpressionAtlas; P0DMV8; baseline and differential.
DR   GO; GO:0016235; C:aggresome; IDA:UniProtKB.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0005814; C:centriole; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; TAS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0016234; C:inclusion body; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; TAS:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:UniProtKB.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:BHF-UCL.
DR   GO; GO:0016887; F:ATPase activity; IDA:BHF-UCL.
DR   GO; GO:0042623; F:ATPase activity, coupled; IDA:UniProtKB.
DR   GO; GO:0055131; F:C3HC4-type RING finger domain binding; IPI:BHF-UCL.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0031249; F:denatured protein binding; IPI:CAFA.
DR   GO; GO:0097718; F:disordered domain specific binding; IPI:CAFA.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0001664; F:G-protein coupled receptor binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:0044183; F:protein binding involved in protein folding; IDA:BHF-UCL.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0001106; F:RNA polymerase II transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0046034; P:ATP metabolic process; IDA:BHF-UCL.
DR   GO; GO:0070370; P:cellular heat acclimation; IMP:UniProtKB.
DR   GO; GO:0034605; P:cellular response to heat; IDA:UniProtKB.
DR   GO; GO:0034599; P:cellular response to oxidative stress; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0051131; P:chaperone-mediated protein complex assembly; IDA:CAFA.
DR   GO; GO:0006402; P:mRNA catabolic process; IDA:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0060548; P:negative regulation of cell death; IMP:UniProtKB.
DR   GO; GO:0030308; P:negative regulation of cell growth; IMP:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:1902236; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; IDA:ParkinsonsUK-UCL.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:BHF-UCL.
DR   GO; GO:0090084; P:negative regulation of inclusion body assembly; IDA:UniProtKB.
DR   GO; GO:1901029; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0097201; P:negative regulation of transcription from RNA polymerase II promoter in response to stress; IDA:UniProtKB.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:1902380; P:positive regulation of endoribonuclease activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0045648; P:positive regulation of erythrocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; IMP:UniProtKB.
DR   GO; GO:0090063; P:positive regulation of microtubule nucleation; IMP:UniProtKB.
DR   GO; GO:1904722; P:positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB.
DR   GO; GO:0070434; P:positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; IMP:UniProtKB.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:1903265; P:positive regulation of tumor necrosis factor-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0042026; P:protein refolding; IDA:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IDA:CAFA.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:1901673; P:regulation of mitotic spindle assembly; IMP:UniProtKB.
DR   GO; GO:0043488; P:regulation of mRNA stability; TAS:Reactome.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; IDA:BHF-UCL.
DR   GO; GO:0006986; P:response to unfolded protein; IDA:UniProtKB.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   SUPFAM; SSF100934; SSF100934; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Chaperone; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Host cell receptor for virus entry;
KW   Methylation; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Receptor; Reference proteome; Stress response.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    641       Heat shock 70 kDa protein 1A.
FT                                /FTId=PRO_0000078249.
FT   NP_BIND      12     15       ATP.
FT   NP_BIND     202    204       ATP.
FT   NP_BIND     268    275       ATP.
FT   NP_BIND     339    342       ATP.
FT   REGION        2    386       Nucleotide-binding domain (NBD).
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   REGION      394    509       Substrate-binding domain (SBD).
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   BINDING      71     71       ATP.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      77     77       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:27708256}.
FT   MOD_RES     108    108       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     246    246       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     348    348       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     469    469       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     561    561       N6,N6,N6-trimethyllysine; by METTL21A;
FT                                alternate. {ECO:0000244|PubMed:24129315,
FT                                ECO:0000269|PubMed:23349634,
FT                                ECO:0000269|PubMed:23921388}.
FT   MOD_RES     561    561       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     631    631       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     633    633       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     636    636       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   VAR_SEQ      96    150       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044427.
FT   VARIANT     110    110       E -> D (in dbSNP:rs562047).
FT                                {ECO:0000269|PubMed:14656967,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_029053.
FT   MUTAGEN      10     10       D->A: Reduces affinity for ADP.
FT                                {ECO:0000269|PubMed:21608060}.
FT   MUTAGEN      77     77       K->Q: No loss of acetylation and ATPase
FT                                activity. Exhibits normal protein
FT                                refolding activity during the early phase
FT                                but exhibits defects in ubiquitin-
FT                                mediated protein degradation during the
FT                                later phase.
FT                                {ECO:0000269|PubMed:27708256}.
FT   MUTAGEN      77     77       K->R: Significant loss of acetylation and
FT                                ATPase activity. Decreased binding to
FT                                HOPX and HSP90 and increased binding to
FT                                STUB1 and NAA10. Impaired capacity for
FT                                protein refolding during the early phase
FT                                after stress but shows normal protein
FT                                degradation activity in the late phase.
FT                                {ECO:0000269|PubMed:27708256}.
FT   MUTAGEN     199    199       D->A: Reduces affinity for ADP.
FT                                {ECO:0000269|PubMed:21608060}.
FT   MUTAGEN     561    561       K->R: Complete loss of in vitro
FT                                methylation by METTL21A.
FT                                {ECO:0000269|PubMed:23349634,
FT                                ECO:0000269|PubMed:23921388}.
FT   CONFLICT      7      7       I -> V (in Ref. 1; AAA52697 and 10;
FT                                CAA28381). {ECO:0000305}.
FT   CONFLICT    355    355       N -> D (in Ref. 5; BAG65428).
FT                                {ECO:0000305}.
FT   CONFLICT    370    370       A -> G (in Ref. 1; AAA52697).
FT                                {ECO:0000305}.
FT   CONFLICT    469    469       Missing (in Ref. 1; AAA52697).
FT                                {ECO:0000305}.
FT   CONFLICT    497    497       K -> N (in Ref. 5; BAG65428).
FT                                {ECO:0000305}.
FT   STRAND        7     10       {ECO:0000244|PDB:5BN8}.
FT   STRAND       13     22       {ECO:0000244|PDB:5BN8}.
FT   STRAND       25     28       {ECO:0000244|PDB:5BN8}.
FT   STRAND       36     39       {ECO:0000244|PDB:5BN8}.
FT   STRAND       42     44       {ECO:0000244|PDB:5BN8}.
FT   STRAND       49     51       {ECO:0000244|PDB:5BN8}.
FT   HELIX        53     56       {ECO:0000244|PDB:5BN8}.
FT   TURN         57     61       {ECO:0000244|PDB:5BN8}.
FT   HELIX        63     65       {ECO:0000244|PDB:5BN8}.
FT   HELIX        70     72       {ECO:0000244|PDB:5BN8}.
FT   TURN         73     75       {ECO:0000244|PDB:5BN8}.
FT   HELIX        81     86       {ECO:0000244|PDB:5BN8}.
FT   HELIX        87     89       {ECO:0000244|PDB:5BN8}.
FT   STRAND       91     97       {ECO:0000244|PDB:5BN8}.
FT   STRAND      100    107       {ECO:0000244|PDB:5BN8}.
FT   STRAND      110    114       {ECO:0000244|PDB:5BN8}.
FT   HELIX       116    135       {ECO:0000244|PDB:5BN8}.
FT   STRAND      141    146       {ECO:0000244|PDB:5BN8}.
FT   HELIX       152    164       {ECO:0000244|PDB:5BN8}.
FT   STRAND      168    174       {ECO:0000244|PDB:5BN8}.
FT   HELIX       175    182       {ECO:0000244|PDB:5BN8}.
FT   HELIX       185    187       {ECO:0000244|PDB:5BN8}.
FT   STRAND      189    191       {ECO:0000244|PDB:2E8A}.
FT   STRAND      193    200       {ECO:0000244|PDB:5BN8}.
FT   STRAND      205    213       {ECO:0000244|PDB:5BN8}.
FT   STRAND      216    225       {ECO:0000244|PDB:5BN8}.
FT   HELIX       226    228       {ECO:0000244|PDB:2E88}.
FT   HELIX       230    249       {ECO:0000244|PDB:5BN8}.
FT   HELIX       253    255       {ECO:0000244|PDB:2E88}.
FT   HELIX       257    274       {ECO:0000244|PDB:5BN8}.
FT   STRAND      277    288       {ECO:0000244|PDB:5BN8}.
FT   STRAND      291    298       {ECO:0000244|PDB:5BN8}.
FT   HELIX       299    305       {ECO:0000244|PDB:5BN8}.
FT   HELIX       307    312       {ECO:0000244|PDB:5BN8}.
FT   HELIX       314    324       {ECO:0000244|PDB:5BN8}.
FT   HELIX       328    330       {ECO:0000244|PDB:5BN8}.
FT   STRAND      333    338       {ECO:0000244|PDB:5BN8}.
FT   HELIX       339    342       {ECO:0000244|PDB:5BN8}.
FT   HELIX       344    353       {ECO:0000244|PDB:5BN8}.
FT   TURN        354    356       {ECO:0000244|PDB:5BN8}.
FT   TURN        365    367       {ECO:0000244|PDB:5BN8}.
FT   HELIX       368    380       {ECO:0000244|PDB:5BN8}.
FT   HELIX       390    393       {ECO:0000244|PDB:4PO2}.
FT   STRAND      394    396       {ECO:0000244|PDB:4PO2}.
FT   STRAND      401    405       {ECO:0000244|PDB:4PO2}.
FT   TURN        406    408       {ECO:0000244|PDB:4PO2}.
FT   STRAND      409    414       {ECO:0000244|PDB:4PO2}.
FT   STRAND      419    432       {ECO:0000244|PDB:4PO2}.
FT   STRAND      438    449       {ECO:0000244|PDB:4PO2}.
FT   HELIX       450    452       {ECO:0000244|PDB:4PO2}.
FT   STRAND      453    461       {ECO:0000244|PDB:4PO2}.
FT   STRAND      474    480       {ECO:0000244|PDB:4PO2}.
FT   STRAND      486    492       {ECO:0000244|PDB:4PO2}.
FT   TURN        493    495       {ECO:0000244|PDB:4PO2}.
FT   STRAND      498    503       {ECO:0000244|PDB:4PO2}.
FT   HELIX       506    508       {ECO:0000244|PDB:4PO2}.
FT   HELIX       512    524       {ECO:0000244|PDB:4PO2}.
FT   HELIX       526    554       {ECO:0000244|PDB:4PO2}.
FT   HELIX       556    558       {ECO:0000244|PDB:4PO2}.
FT   HELIX       564    583       {ECO:0000244|PDB:4PO2}.
FT   HELIX       589    608       {ECO:0000244|PDB:4PO2}.
FT   HELIX       609    611       {ECO:0000244|PDB:4PO2}.
FT   STRAND      637    639       {ECO:0000244|PDB:3Q49}.
SQ   SEQUENCE   641 AA;  70052 MW;  78F513118C96DE66 CRC64;
     MAKAAAIGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA
     LNPQNTVFDA KRLIGRKFGD PVVQSDMKHW PFQVINDGDK PKVQVSYKGE TKAFYPEEIS
     SMVLTKMKEI AEAYLGYPVT NAVITVPAYF NDSQRQATKD AGVIAGLNVL RIINEPTAAA
     IAYGLDRTGK GERNVLIFDL GGGTFDVSIL TIDDGIFEVK ATAGDTHLGG EDFDNRLVNH
     FVEEFKRKHK KDISQNKRAV RRLRTACERA KRTLSSSTQA SLEIDSLFEG IDFYTSITRA
     RFEELCSDLF RSTLEPVEKA LRDAKLDKAQ IHDLVLVGGS TRIPKVQKLL QDFFNGRDLN
     KSINPDEAVA YGAAVQAAIL MGDKSENVQD LLLLDVAPLS LGLETAGGVM TALIKRNSTI
     PTKQTQIFTT YSDNQPGVLI QVYEGERAMT KDNNLLGRFE LSGIPPAPRG VPQIEVTFDI
     DANGILNVTA TDKSTGKANK ITITNDKGRL SKEEIERMVQ EAEKYKAEDE VQRERVSAKN
     ALESYAFNMK SAVEDEGLKG KISEADKKKV LDKCQEVISW LDANTLAEKD EFEHKRKELE
     QVCNPIISGL YQGAGGPGPG GFGAQGPKGG SGSGPTIEEV D
//
ID   HS71B_HUMAN             Reviewed;         641 AA.
AC   P0DMV9; B4E3B6; P08107; P19790; Q5JQI4; Q5SP17; Q9UQL9; Q9UQM0;
DT   27-MAY-2015, integrated into UniProtKB/Swiss-Prot.
DT   27-MAY-2015, sequence version 1.
DT   23-MAY-2018, entry version 28.
DE   RecName: Full=Heat shock 70 kDa protein 1B {ECO:0000312|HGNC:HGNC:5233};
DE   AltName: Full=Heat shock 70 kDa protein 2;
DE            Short=HSP70-2 {ECO:0000303|PubMed:14656967, ECO:0000303|PubMed:2538825};
DE            Short=HSP70.2;
GN   Name=HSPA1B {ECO:0000312|HGNC:HGNC:5233};
GN   Synonyms=HSP72 {ECO:0000303|PubMed:24318877};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1700760; DOI=10.1007/BF00187095;
RA   Milner C.M., Campbell R.D.;
RT   "Structure and expression of the three MHC-linked HSP70 genes.";
RL   Immunogenetics 32:242-251(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Shiina S., Tamiya G., Oka A., Inoko H.;
RT   "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT SER-499.
RX   PubMed=14656967; DOI=10.1101/gr.1736803;
RA   Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S.,
RA   Campbell R.D., Hood L.;
RT   "Analysis of the gene-dense major histocompatibility complex class III
RT   region and its comparison to mouse.";
RL   Genome Res. 13:2621-2636(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-95; VAL-467 AND
RP   SER-499.
RG   NIEHS SNPs program;
RL   Submitted (FEB-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Muscle, Pancreas, PNS, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 360-424.
RX   PubMed=2538825; DOI=10.1073/pnas.86.6.1968;
RA   Sargent C.A., Dunham I., Trowsdale J., Campbell R.D.;
RT   "Human major histocompatibility complex contains genes for the major
RT   heat shock protein HSP70.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:1968-1972(1989).
RN   [8]
RP   PROTEIN SEQUENCE OF 4-49; 57-71; 77-155; 160-187; 221-247; 273-311;
RP   326-342; 349-357; 362-416; 424-447; 459-469; 510-517; 540-550; 574-595
RP   AND 598-641, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [9]
RP   PROTEIN SEQUENCE OF 37-49; 57-71; 78-88; 113-126; 160-187; 221-247;
RP   302-311; 329-342; 349-357; 362-384; 540-550 AND 574-589, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   PROTEIN SEQUENCE OF 551-567, METHYLATION AT LYS-561, MUTAGENESIS OF
RP   LYS-561, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23349634; DOI=10.1371/journal.pgen.1003210;
RA   Cloutier P., Lavallee-Adam M., Faubert D., Blanchette M., Coulombe B.;
RT   "A newly uncovered group of distantly related lysine
RT   methyltransferases preferentially interact with molecular chaperones
RT   to regulate their activity.";
RL   PLoS Genet. 9:E1003210-E1003210(2013).
RN   [11]
RP   INTERACTION WITH TERT.
RX   PubMed=11274138; DOI=10.1074/jbc.C100055200;
RA   Forsythe H.L., Jarvis J.L., Turner J.W., Elmore L.W., Holt S.E.;
RT   "Stable association of hsp90 and p23, but Not hsp70, with active human
RT   telomerase.";
RL   J. Biol. Chem. 276:15571-15574(2001).
RN   [12]
RP   INTERACTION WITH DNAJC7.
RX   PubMed=12853476; DOI=10.1093/emboj/cdg362;
RA   Brychzy A., Rein T., Winklhofer K.F., Hartl F.U., Young J.C.,
RA   Obermann W.M.;
RT   "Cofactor Tpr2 combines two TPR domains and a J domain to regulate the
RT   Hsp70/Hsp90 chaperone system.";
RL   EMBO J. 22:3613-3623(2003).
RN   [13]
RP   INTERACTION WITH TSC2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15963462; DOI=10.1016/j.bbrc.2005.05.175;
RA   Nellist M., Burgers P.C., van den Ouweland A.M.W., Halley D.J.J.,
RA   Luider T.M.;
RT   "Phosphorylation and binding partner analysis of the TSC1-TSC2
RT   complex.";
RL   Biochem. Biophys. Res. Commun. 333:818-826(2005).
RN   [14]
RP   INTERACTION WITH PPP5C, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15383005; DOI=10.1042/BJ20040690;
RA   Zeke T., Morrice N., Vazquez-Martin C., Cohen P.T.;
RT   "Human protein phosphatase 5 dissociates from heat-shock proteins and
RT   is proteolytically activated in response to arachidonic acid and the
RT   microtubule-depolymerizing drug nocodazole.";
RL   Biochem. J. 385:45-56(2005).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [16]
RP   INTERACTION WITH IRAK1BP1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17233114; DOI=10.1089/dna.2006.25.704;
RA   Haag Breese E., Uversky V.N., Georgiadis M.M., Harrington M.A.;
RT   "The disordered amino-terminus of SIMPL interacts with members of the
RT   70-kDa heat-shock protein family.";
RL   DNA Cell Biol. 25:704-714(2006).
RN   [17]
RP   FUNCTION AS A RECEPTOR FOR ROTAVIRUS A.
RX   PubMed=16537599; DOI=10.1128/JVI.80.7.3322-3331.2006;
RA   Perez-Vargas J., Romero P., Lopez S., Arias C.F.;
RT   "The peptide-binding and ATPase domains of recombinant hsc70 are
RT   required to interact with rotavirus and reduce its infectivity.";
RL   J. Virol. 80:3322-3331(2006).
RN   [18]
RP   INTERACTION WITH DNAJC9.
RX   PubMed=17182002; DOI=10.1016/j.bbrc.2006.12.013;
RA   Han C., Chen T., Li N., Yang M., Wan T., Cao X.;
RT   "HDJC9, a novel human type C DnaJ/HSP40 member interacts with and
RT   cochaperones HSP70 through the J domain.";
RL   Biochem. Biophys. Res. Commun. 353:280-285(2007).
RN   [19]
RP   IDENTIFICATION IN A MRNP GRANULE COMPLEX, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=17289661; DOI=10.1074/mcp.M600346-MCP200;
RA   Joeson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T., Borup R.,
RA   Johnsen A.H., Christiansen J., Nielsen F.C.;
RT   "Molecular composition of IMP1 ribonucleoprotein granules.";
RL   Mol. Cell. Proteomics 6:798-811(2007).
RN   [20]
RP   INTERACTION WITH DNAJC7.
RX   PubMed=18620420; DOI=10.1021/bi800770g;
RA   Moffatt N.S., Bruinsma E., Uhl C., Obermann W.M., Toft D.;
RT   "Role of the cochaperone Tpr2 in Hsp90 chaperoning.";
RL   Biochemistry 47:8203-8213(2008).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-108; LYS-246 AND LYS-348,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [24]
RP   INTERACTION WITH TRIM5.
RX   PubMed=20053985; DOI=10.1074/jbc.M109.040618;
RA   Hwang C.Y., Holl J., Rajan D., Lee Y., Kim S., Um M., Kwon K.S.,
RA   Song B.;
RT   "Hsp70 interacts with the retroviral restriction factor TRIM5alpha and
RT   assists the folding of TRIM5alpha.";
RL   J. Biol. Chem. 285:7827-7837(2010).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-631; SER-633 AND
RP   THR-636, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [27]
RP   INTERACTION WITH CHCHD3.
RX   PubMed=21081504; DOI=10.1074/jbc.M110.171975;
RA   Darshi M., Mendiola V.L., Mackey M.R., Murphy A.N., Koller A.,
RA   Perkins G.A., Ellisman M.H., Taylor S.S.;
RT   "ChChd3, an inner mitochondrial membrane protein, is essential for
RT   maintaining crista integrity and mitochondrial function.";
RL   J. Biol. Chem. 286:2918-2932(2011).
RN   [28]
RP   FUNCTION, AND INTERACTION WITH ATF5.
RX   PubMed=22528486; DOI=10.1074/jbc.M112.363622;
RA   Liu X., Liu D., Qian D., Dai J., An Y., Jiang S., Stanley B., Yang J.,
RA   Wang B., Liu X., Liu D.X.;
RT   "Nucleophosmin (NPM1/B23) interacts with activating transcription
RT   factor 5 (ATF5) protein and promotes proteasome- and caspase-dependent
RT   ATF5 degradation in hepatocellular carcinoma cells.";
RL   J. Biol. Chem. 287:19599-19609(2012).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, AND INTERACTION WITH
RP   FOXP3.
RX   PubMed=23973223; DOI=10.1016/j.immuni.2013.08.006;
RA   Chen Z., Barbi J., Bu S., Yang H.Y., Li Z., Gao Y., Jinasena D.,
RA   Fu J., Lin F., Chen C., Zhang J., Yu N., Li X., Shan Z., Nie J.,
RA   Gao Z., Tian H., Li Y., Yao Z., Zheng Y., Park B.V., Pan Z., Zhang J.,
RA   Dang E., Li Z., Wang H., Luo W., Li L., Semenza G.L., Zheng S.G.,
RA   Loser K., Tsun A., Greene M.I., Pardoll D.M., Pan F., Li B.;
RT   "The ubiquitin ligase Stub1 negatively modulates regulatory T cell
RT   suppressive activity by promoting degradation of the transcription
RT   factor Foxp3.";
RL   Immunity 39:272-285(2013).
RN   [31]
RP   METHYLATION AT LYS-561, MUTAGENESIS OF LYS-561, AND INTERACTION WITH
RP   METTL21A.
RX   PubMed=23921388; DOI=10.1074/jbc.M113.483248;
RA   Jakobsson M.E., Moen A., Bousset L., Egge-Jacobsen W., Kernstock S.,
RA   Melki R., Falnes P.O.;
RT   "Identification and characterization of a novel human
RT   methyltransferase modulating Hsp70 function through lysine
RT   methylation.";
RL   J. Biol. Chem. 288:27752-27763(2013).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [33]
RP   INTERACTION WITH PRKN.
RX   PubMed=24270810; DOI=10.1038/nature12748;
RA   Hasson S.A., Kane L.A., Yamano K., Huang C.H., Sliter D.A.,
RA   Buehler E., Wang C., Heman-Ackah S.M., Hessa T., Guha R., Martin S.E.,
RA   Youle R.J.;
RT   "High-content genome-wide RNAi screens identify regulators of parkin
RT   upstream of mitophagy.";
RL   Nature 504:291-295(2013).
RN   [34]
RP   REVIEW.
RX   PubMed=24012426; DOI=10.1016/j.tibs.2013.08.001;
RA   Mayer M.P.;
RT   "Hsp70 chaperone dynamics and molecular mechanism.";
RL   Trends Biochem. Sci. 38:507-514(2013).
RN   [35]
RP   FUNCTION, AND INTERACTION WITH STUB1 AND SMAD3.
RX   PubMed=24613385; DOI=10.1016/j.bbrc.2014.02.124;
RA   Shang Y., Xu X., Duan X., Guo J., Wang Y., Ren F., He D., Chang Z.;
RT   "Hsp70 and Hsp90 oppositely regulate TGF-beta signaling through
RT   CHIP/Stub1.";
RL   Biochem. Biophys. Res. Commun. 446:387-392(2014).
RN   [36]
RP   FUNCTION, AND INTERACTION WITH BAG1; BAG2; BAG3 AND HSPH1.
RX   PubMed=24318877; DOI=10.1074/jbc.M113.521997;
RA   Rauch J.N., Gestwicki J.E.;
RT   "Binding of human nucleotide exchange factors to heat shock protein 70
RT   (Hsp70) generates functionally distinct complexes in vitro.";
RL   J. Biol. Chem. 289:1402-1414(2014).
RN   [37]
RP   INTERACTION WITH NOD2.
RX   PubMed=24790089; DOI=10.1074/jbc.M114.557686;
RA   Mohanan V., Grimes C.L.;
RT   "The molecular chaperone HSP70 binds to and stabilizes NOD2, an
RT   important protein involved in Crohn disease.";
RL   J. Biol. Chem. 289:18987-18998(2014).
RN   [38]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [39]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-469 AND LYS-561, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [40]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [41]
RP   INTERACTION WITH DNAJC8.
RX   PubMed=27133716; DOI=10.1016/j.bbrc.2016.03.152;
RA   Ito N., Kamiguchi K., Nakanishi K., Sokolovskya A., Hirohashi Y.,
RA   Tamura Y., Murai A., Yamamoto E., Kanaseki T., Tsukahara T.,
RA   Kochin V., Chiba S., Shimohama S., Sato N., Torigoe T.;
RT   "A novel nuclear DnaJ protein, DNAJC8, can suppress the formation of
RT   spinocerebellar ataxia 3 polyglutamine aggregation in a J-domain
RT   independent manner.";
RL   Biochem. Biophys. Res. Commun. 474:626-633(2016).
RN   [42]
RP   REVIEW.
RX   PubMed=26865365; DOI=10.1007/s12192-016-0676-6;
RA   Radons J.;
RT   "The human HSP70 family of chaperones: where do we stand?";
RL   Cell Stress Chaperones 21:379-404(2016).
RN   [43]
RP   FUNCTION, INTERACTION WITH NEDD1, AND SUBCELLULAR LOCATION.
RX   PubMed=27137183; DOI=10.1007/s00018-016-2236-8;
RA   Fang C.T., Kuo H.H., Pan T.S., Yu F.C., Yih L.H.;
RT   "HSP70 regulates the function of mitotic centrosomes.";
RL   Cell. Mol. Life Sci. 73:3949-3960(2016).
RN   [44]
RP   FUNCTION, ACETYLATION AT LYS-77, MUTAGENESIS OF LYS-77, AND
RP   INTERACTION WITH NAA10; HSP40; HOPX; STUB1; HSP90 AND HDAC4.
RX   PubMed=27708256; DOI=10.1038/ncomms12882;
RA   Seo J.H., Park J.H., Lee E.J., Vo T.T., Choi H., Kim J.Y., Jang J.K.,
RA   Wee H.J., Lee H.S., Jang S.H., Park Z.Y., Jeong J., Lee K.J.,
RA   Seok S.H., Park J.Y., Lee B.J., Lee M.N., Oh G.T., Kim K.W.;
RT   "ARD1-mediated Hsp70 acetylation balances stress-induced protein
RT   refolding and degradation.";
RL   Nat. Commun. 7:12882-12882(2016).
RN   [45]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-382 IN COMPLEX WITH ADP,
RP   AND ATP-BINDING.
RX   PubMed=10216320; DOI=10.1107/S0907444999002103;
RA   Osipiuk J., Walsh M.A., Freeman B.C., Morimoto R.I., Joachimiak A.;
RT   "Structure of a new crystal form of human hsp70 ATPase domain.";
RL   Acta Crystallogr. D 55:1105-1107(1999).
RN   [46]
RP   X-RAY CRYSTALLOGRAPHY (1.77 ANGSTROMS) OF 389-641 IN COMPLEX WITH ATP
RP   ANALOG, AND ATP-BINDING.
RX   PubMed=20179333; DOI=10.1107/S0907444909053979;
RA   Shida M., Arakawa A., Ishii R., Kishishita S., Takagi T.,
RA   Kukimoto-Niino M., Sugano S., Tanaka A., Shirouzu M., Yokoyama S.;
RT   "Direct inter-subdomain interactions switch between the closed and
RT   open forms of the Hsp70 nucleotide-binding domain in the nucleotide-
RT   free state.";
RL   Acta Crystallogr. D 66:223-232(2010).
RN   [47]
RP   X-RAY CRYSTALLOGRAPHY (2.14 ANGSTROMS) OF 1-387 IN COMPLEX WITH ADP,
RP   AND ATP-BINDING.
RX   PubMed=20072699; DOI=10.1371/journal.pone.0008625;
RA   Wisniewska M., Karlberg T., Lehtio L., Johansson I., Kotenyova T.,
RA   Moche M., Schuler H.;
RT   "Crystal structures of the ATPase domains of four human Hsp70
RT   isoforms: HSPA1L/Hsp70-hom, HSPA2/Hsp70-2, HSPA6/Hsp70B', and
RT   HSPA5/BiP/GRP78.";
RL   PLoS ONE 5:E8625-E8625(2010).
RN   [48]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-388 IN COMPLEX WITH BAG5.
RX   PubMed=20223214; DOI=10.1016/j.str.2010.01.004;
RA   Arakawa A., Handa N., Ohsawa N., Shida M., Kigawa T., Hayashi F.,
RA   Shirouzu M., Yokoyama S.;
RT   "The C-terminal BAG domain of BAG5 induces conformational changes of
RT   the Hsp70 nucleotide-binding domain for ADP-ATP exchange.";
RL   Structure 18:309-319(2010).
RN   [49]
RP   X-RAY CRYSTALLOGRAPHY (1.58 ANGSTROMS) OF 1-388, ATP-BINDING, AND
RP   MUTAGENESIS OF ASP-10 AND ASP-199.
RX   PubMed=21608060; DOI=10.1002/pro.663;
RA   Arakawa A., Handa N., Shirouzu M., Yokoyama S.;
RT   "Biochemical and structural studies on the high affinity of Hsp70 for
RT   ADP.";
RL   Protein Sci. 20:1367-1379(2011).
CC   -!- FUNCTION: Molecular chaperone implicated in a wide variety of
CC       cellular processes, including protection of the proteome from
CC       stress, folding and transport of newly synthesized polypeptides,
CC       activation of proteolysis of misfolded proteins and the formation
CC       and dissociation of protein complexes. Plays a pivotal role in the
CC       protein quality control system, ensuring the correct folding of
CC       proteins, the re-folding of misfolded proteins and controlling the
CC       targeting of proteins for subsequent degradation. This is achieved
CC       through cycles of ATP binding, ATP hydrolysis and ADP release,
CC       mediated by co-chaperones. The co-chaperones have been shown to
CC       not only regulate different steps of the ATPase cycle, but they
CC       also have an individual specificity such that one co-chaperone may
CC       promote folding of a substrate while another may promote
CC       degradation. The affinity for polypeptides is regulated by its
CC       nucleotide bound state. In the ATP-bound form, it has a low
CC       affinity for substrate proteins. However, upon hydrolysis of the
CC       ATP to ADP, it undergoes a conformational change that increases
CC       its affinity for substrate proteins. It goes through repeated
CC       cycles of ATP hydrolysis and nucleotide exchange, which permits
CC       cycles of substrate binding and release. The co-chaperones are of
CC       three types: J-domain co-chaperones such as HSP40s (stimulate
CC       ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF)
CC       such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-
CC       bound to the ATP-bound state thereby promoting substrate release),
CC       and the TPR domain chaperones such as HOPX and STUB1
CC       (PubMed:24012426, PubMed:26865365, PubMed:24318877). Maintains
CC       protein homeostasis during cellular stress through two opposing
CC       mechanisms: protein refolding and degradation. Its
CC       acetylation/deacetylation state determines whether it functions in
CC       protein refolding or protein degradation by controlling the
CC       competitive binding of co-chaperones HOPX and STUB1. During the
CC       early stress response, the acetylated form binds to HOPX which
CC       assists in chaperone-mediated protein refolding, thereafter, it is
CC       deacetylated and binds to ubiquitin ligase STUB1 that promotes
CC       ubiquitin-mediated protein degradation (PubMed:27708256).
CC       Regulates centrosome integrity during mitosis, and is required for
CC       the maintenance of a functional mitotic centrosome that supports
CC       the assembly of a bipolar mitotic spindle (PubMed:27137183).
CC       Enhances STUB1-mediated SMAD3 ubiquitination and degradation and
CC       facilitates STUB1-mediated inhibition of TGF-beta signaling
CC       (PubMed:24613385). Essential for STUB1-mediated ubiquitination and
CC       degradation of FOXP3 in regulatory T-cells (Treg) during
CC       inflammation (PubMed:23973223). {ECO:0000269|PubMed:22528486,
CC       ECO:0000269|PubMed:23973223, ECO:0000269|PubMed:24318877,
CC       ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:27137183,
CC       ECO:0000269|PubMed:27708256, ECO:0000303|PubMed:24012426,
CC       ECO:0000303|PubMed:26865365}.
CC   -!- FUNCTION: (Microbial infection) In case of rotavirus A infection,
CC       serves as a post-attachment receptor for the virus to facilitate
CC       entry into the cell. {ECO:0000269|PubMed:16537599}.
CC   -!- SUBUNIT: Component of the CatSper complex. Identified in a
CC       IGF2BP1-dependent mRNP granule complex containing untranslated
CC       mRNAs (PubMed:17289661). Interacts with CHCHD3, DNAJC7, IRAK1BP1,
CC       PPP5C and TSC2 (PubMed:21081504, PubMed:12853476, PubMed:18620420,
CC       PubMed:17233114, PubMed:15383005, PubMed:15963462). Interacts with
CC       TERT; the interaction occurs in the absence of the RNA component,
CC       TERC, and dissociates once the TERT complex has formed
CC       (PubMed:11274138). Interacts with TRIM5 (via B30.2/SPRY domain)
CC       (PubMed:20053985). Interacts with METTL21A (PubMed:23921388).
CC       Interacts with PRKN (PubMed:24270810). Interacts with FOXP3
CC       (PubMed:23973223). Interacts with NOD2; the interaction enhances
CC       NOD2 stability (PubMed:24790089). Interacts with DNAJC9 (via J
CC       domain) (PubMed:17182002). Interacts with ATF5; the interaction
CC       protects ATF5 from degradation via proteasome-dependent and
CC       caspase-dependent processes (PubMed:22528486). Interacts with
CC       NAA10, HSP40, HSP90 and HDAC4. The acetylated form and the non-
CC       acetylated form interact with HOPX and STUB1 respectively
CC       (PubMed:27708256). Interacts with NEDD1 (PubMed:27137183).
CC       Interacts (via NBD) with BAG1, BAG2, BAG3 and HSPH1/HSP105
CC       (PubMed:24318877). Interacts with SMAD3 (PubMed:24613385).
CC       Interacts with DNAJC8 (PubMed:27133716).
CC       {ECO:0000269|PubMed:10216320, ECO:0000269|PubMed:11274138,
CC       ECO:0000269|PubMed:12853476, ECO:0000269|PubMed:15383005,
CC       ECO:0000269|PubMed:15963462, ECO:0000269|PubMed:17182002,
CC       ECO:0000269|PubMed:17233114, ECO:0000269|PubMed:17289661,
CC       ECO:0000269|PubMed:18620420, ECO:0000269|PubMed:20053985,
CC       ECO:0000269|PubMed:20072699, ECO:0000269|PubMed:20179333,
CC       ECO:0000269|PubMed:20223214, ECO:0000269|PubMed:21081504,
CC       ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:23921388,
CC       ECO:0000269|PubMed:23973223, ECO:0000269|PubMed:24270810,
CC       ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24613385,
CC       ECO:0000269|PubMed:24790089, ECO:0000269|PubMed:27133716,
CC       ECO:0000269|PubMed:27137183, ECO:0000269|PubMed:27708256}.
CC   -!- INTERACTION:
CC       Q9UL15-1:BAG5; NbExp=3; IntAct=EBI-11820565, EBI-16247256;
CC       P04233:CD74; NbExp=3; IntAct=EBI-11820565, EBI-2622890;
CC       Q93034:CUL5; NbExp=4; IntAct=EBI-11820565, EBI-1057139;
CC       O75460-1:ERN1; NbExp=5; IntAct=EBI-11820565, EBI-15600828;
CC       Q9BZS1:FOXP3; NbExp=4; IntAct=EBI-11820565, EBI-983719;
CC       P69905:HBA2; NbExp=3; IntAct=EBI-11820565, EBI-714680;
CC       P13760:HLA-DRB1; NbExp=8; IntAct=EBI-11820565, EBI-1033104;
CC       P03418:N (xeno); NbExp=3; IntAct=EBI-11820565, EBI-6930799;
CC       P03421:P (xeno); NbExp=3; IntAct=EBI-11820565, EBI-6930954;
CC       P50503:St13 (xeno); NbExp=3; IntAct=EBI-11820565, EBI-917694;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17289661}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:27137183}. Note=Localized in cytoplasmic mRNP
CC       granules containing untranslated mRNAs.
CC   -!- TISSUE SPECIFICITY: HSPA1B is testis-specific.
CC   -!- INDUCTION: By heat shock.
CC   -!- DOMAIN: The N-terminal nucleotide binding domain (NBD) (also known
CC       as the ATPase domain) is responsible for binding and hydrolyzing
CC       ATP. The C-terminal substrate-binding domain (SBD) (also known as
CC       peptide-binding domain) binds to the client/substrate proteins.
CC       The two domains are allosterically coupled so that, when ATP is
CC       bound to the NBD, the SBD binds relatively weakly to clients. When
CC       ADP is bound in the NBD, a conformational change enhances the
CC       affinity of the SBD for client proteins.
CC       {ECO:0000305|PubMed:24012426, ECO:0000305|PubMed:26865365}.
CC   -!- PTM: In response to cellular stress, acetylated at Lys-77 by NA110
CC       and then gradually deacetylated by HDAC4 at later stages.
CC       Acetylation enhances its chaperone activity and also determines
CC       whether it will function as a chaperone for protein refolding or
CC       degradation by controlling its binding to co-chaperones HOPX and
CC       STUB1. The acetylated form and the non-acetylated form bind to
CC       HOPX and STUB1 respectively. Acetylation also protects cells
CC       against various types of cellular stress.
CC       {ECO:0000269|PubMed:27708256}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/hspa1b/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M59830; AAA63227.1; -; Genomic_DNA.
DR   EMBL; BA000025; BAB63299.1; -; Genomic_DNA.
DR   EMBL; AF134726; AAD21815.1; -; Genomic_DNA.
DR   EMBL; DQ388429; ABD48956.1; -; Genomic_DNA.
DR   EMBL; AL671762; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC009322; AAH09322.1; -; mRNA.
DR   EMBL; BC018740; AAH18740.1; -; mRNA.
DR   EMBL; BC057397; AAH57397.1; -; mRNA.
DR   EMBL; BC063507; AAH63507.1; -; mRNA.
DR   EMBL; M24744; AAA59845.1; -; Genomic_DNA.
DR   CCDS; CCDS34415.1; -.
DR   PIR; A29160; A29160.
DR   PIR; A45871; A45871.
DR   PIR; I59139; I59139.
DR   PIR; I79540; I79540.
DR   RefSeq; NP_005336.3; NM_005345.5.
DR   RefSeq; NP_005337.2; NM_005346.4.
DR   UniGene; Hs.274402; -.
DR   UniGene; Hs.702139; -.
DR   UniGene; Hs.719966; -.
DR   UniGene; Hs.743411; -.
DR   PDB; 4J8F; X-ray; 2.70 A; A=1-382, A=384-600.
DR   PDBsum; 4J8F; -.
DR   ProteinModelPortal; P0DMV9; -.
DR   SMR; P0DMV9; -.
DR   CORUM; P0DMV9; -.
DR   IntAct; P0DMV9; 29.
DR   BindingDB; P0DMV9; -.
DR   iPTMnet; P0DMV9; -.
DR   DMDM; 147744565; -.
DR   REPRODUCTION-2DPAGE; IPI00304925; -.
DR   MaxQB; P0DMV9; -.
DR   PRIDE; P0DMV9; -.
DR   DNASU; 3303; -.
DR   Ensembl; ENST00000375650; ENSP00000364801; ENSG00000204388.
DR   Ensembl; ENST00000391548; ENSP00000375391; ENSG00000224501.
DR   Ensembl; ENST00000391555; ENSP00000375399; ENSG00000212866.
DR   Ensembl; ENST00000445736; ENSP00000403530; ENSG00000231555.
DR   Ensembl; ENST00000450744; ENSP00000393087; ENSG00000232804.
DR   GeneID; 3303; -.
DR   GeneID; 3304; -.
DR   KEGG; hsa:3303; -.
DR   KEGG; hsa:3304; -.
DR   CTD; 3303; -.
DR   CTD; 3304; -.
DR   DisGeNET; 3303; -.
DR   DisGeNET; 3304; -.
DR   EuPathDB; HostDB:ENSG00000204388.6; -.
DR   GeneCards; HSPA1B; -.
DR   H-InvDB; HIX0058169; -.
DR   H-InvDB; HIX0058187; -.
DR   H-InvDB; HIX0166160; -.
DR   HGNC; HGNC:5233; HSPA1B.
DR   HPA; CAB008640; -.
DR   HPA; HPA052504; -.
DR   MIM; 140550; gene.
DR   MIM; 603012; gene.
DR   neXtProt; NX_P0DMV9; -.
DR   OpenTargets; ENSG00000204388; -.
DR   OpenTargets; ENSG00000204389; -.
DR   GeneTree; ENSGT00910000144045; -.
DR   HOGENOM; HOG000228135; -.
DR   HOVERGEN; HBG051845; -.
DR   KO; K03283; -.
DR   OrthoDB; EOG093705LK; -.
DR   PhylomeDB; P0DMV9; -.
DR   TreeFam; TF105042; -.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SIGNOR; P0DMV9; -.
DR   ChiTaRS; HSPA1B; human.
DR   GeneWiki; HSPA1A; -.
DR   PRO; PR:P0DMV9; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000204388; -.
DR   CleanEx; HS_HSPA1A; -.
DR   ExpressionAtlas; P0DMV9; baseline and differential.
DR   GO; GO:0016235; C:aggresome; IDA:UniProtKB.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0005814; C:centriole; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; TAS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0016234; C:inclusion body; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; TAS:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:UniProtKB.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:BHF-UCL.
DR   GO; GO:0016887; F:ATPase activity; IDA:BHF-UCL.
DR   GO; GO:0042623; F:ATPase activity, coupled; IDA:UniProtKB.
DR   GO; GO:0055131; F:C3HC4-type RING finger domain binding; IPI:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0001664; F:G-protein coupled receptor binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:0044183; F:protein binding involved in protein folding; IDA:BHF-UCL.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0046034; P:ATP metabolic process; IDA:BHF-UCL.
DR   GO; GO:0070370; P:cellular heat acclimation; IMP:UniProtKB.
DR   GO; GO:0034605; P:cellular response to heat; IDA:UniProtKB.
DR   GO; GO:0034599; P:cellular response to oxidative stress; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0006402; P:mRNA catabolic process; IDA:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0060548; P:negative regulation of cell death; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0030308; P:negative regulation of cell growth; IMP:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:BHF-UCL.
DR   GO; GO:0090084; P:negative regulation of inclusion body assembly; IDA:UniProtKB.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0045648; P:positive regulation of erythrocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; IMP:UniProtKB.
DR   GO; GO:0090063; P:positive regulation of microtubule nucleation; IMP:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB.
DR   GO; GO:0070434; P:positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; IMP:UniProtKB.
DR   GO; GO:1903265; P:positive regulation of tumor necrosis factor-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0042026; P:protein refolding; IDA:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IMP:UniProtKB.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:1901673; P:regulation of mitotic spindle assembly; IMP:UniProtKB.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; IDA:BHF-UCL.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   SUPFAM; SSF100934; SSF100934; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Chaperone; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   Host cell receptor for virus entry; Methylation; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Receptor; Reference proteome;
KW   Stress response.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    641       Heat shock 70 kDa protein 1B.
FT                                /FTId=PRO_0000433115.
FT   NP_BIND      12     15       ATP.
FT   NP_BIND     202    204       ATP.
FT   NP_BIND     268    275       ATP.
FT   NP_BIND     339    342       ATP.
FT   REGION        2    386       Nucleotide-binding domain (NBD).
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   REGION      394    509       Substrate-binding domain (SBD).
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   BINDING      71     71       ATP.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      77     77       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:27708256}.
FT   MOD_RES     108    108       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     246    246       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     348    348       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     469    469       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     561    561       N6,N6,N6-trimethyllysine; by METTL21A;
FT                                alternate. {ECO:0000244|PubMed:24129315,
FT                                ECO:0000269|PubMed:23349634,
FT                                ECO:0000269|PubMed:23921388}.
FT   MOD_RES     561    561       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     631    631       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     633    633       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     636    636       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   VARIANT      95     95       I -> V. {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_032152.
FT   VARIANT     467    467       A -> V (in dbSNP:rs538280104).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_032153.
FT   VARIANT     499    499       N -> S (in dbSNP:rs483638).
FT                                {ECO:0000269|PubMed:14656967,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_029054.
FT   MUTAGEN      10     10       D->A: Reduces affinity for ADP.
FT                                {ECO:0000269|PubMed:21608060}.
FT   MUTAGEN      77     77       K->Q: No loss of acetylation and ATPase
FT                                activity. Exhibits normal protein
FT                                refolding activity during the early phase
FT                                but exhibits defects in ubiquitin-
FT                                mediated protein degradation during the
FT                                later phase.
FT                                {ECO:0000269|PubMed:27708256}.
FT   MUTAGEN      77     77       K->R: Significant loss of acetylation and
FT                                ATPase activity. Decreased binding to
FT                                HOPX and HSP90 and increased binding to
FT                                STUB1 and NAA10. Impaired capacity for
FT                                protein refolding during the early phase
FT                                after stress but shows normal protein
FT                                degradation activity in the late phase.
FT                                {ECO:0000269|PubMed:27708256}.
FT   MUTAGEN     199    199       D->A: Reduces affinity for ADP.
FT                                {ECO:0000269|PubMed:21608060}.
FT   MUTAGEN     561    561       K->R: Complete loss of in vitro
FT                                methylation by METTL21A.
FT                                {ECO:0000269|PubMed:23349634,
FT                                ECO:0000269|PubMed:23921388}.
FT   STRAND        7     11       {ECO:0000244|PDB:4J8F}.
FT   STRAND       13     22       {ECO:0000244|PDB:4J8F}.
FT   STRAND       25     28       {ECO:0000244|PDB:4J8F}.
FT   STRAND       36     39       {ECO:0000244|PDB:4J8F}.
FT   STRAND       42     44       {ECO:0000244|PDB:4J8F}.
FT   STRAND       49     51       {ECO:0000244|PDB:4J8F}.
FT   HELIX        53     57       {ECO:0000244|PDB:4J8F}.
FT   HELIX        59     61       {ECO:0000244|PDB:4J8F}.
FT   HELIX        63     65       {ECO:0000244|PDB:4J8F}.
FT   HELIX        70     73       {ECO:0000244|PDB:4J8F}.
FT   HELIX        81     87       {ECO:0000244|PDB:4J8F}.
FT   STRAND       91     99       {ECO:0000244|PDB:4J8F}.
FT   STRAND      101    107       {ECO:0000244|PDB:4J8F}.
FT   STRAND      110    114       {ECO:0000244|PDB:4J8F}.
FT   HELIX       116    135       {ECO:0000244|PDB:4J8F}.
FT   STRAND      141    146       {ECO:0000244|PDB:4J8F}.
FT   HELIX       152    164       {ECO:0000244|PDB:4J8F}.
FT   STRAND      168    174       {ECO:0000244|PDB:4J8F}.
FT   HELIX       175    182       {ECO:0000244|PDB:4J8F}.
FT   TURN        183    187       {ECO:0000244|PDB:4J8F}.
FT   STRAND      193    200       {ECO:0000244|PDB:4J8F}.
FT   STRAND      205    213       {ECO:0000244|PDB:4J8F}.
FT   STRAND      216    225       {ECO:0000244|PDB:4J8F}.
FT   HELIX       230    249       {ECO:0000244|PDB:4J8F}.
FT   HELIX       257    276       {ECO:0000244|PDB:4J8F}.
FT   STRAND      278    288       {ECO:0000244|PDB:4J8F}.
FT   STRAND      291    298       {ECO:0000244|PDB:4J8F}.
FT   HELIX       299    305       {ECO:0000244|PDB:4J8F}.
FT   HELIX       307    311       {ECO:0000244|PDB:4J8F}.
FT   HELIX       315    324       {ECO:0000244|PDB:4J8F}.
FT   HELIX       328    330       {ECO:0000244|PDB:4J8F}.
FT   STRAND      333    338       {ECO:0000244|PDB:4J8F}.
FT   HELIX       339    342       {ECO:0000244|PDB:4J8F}.
FT   HELIX       344    353       {ECO:0000244|PDB:4J8F}.
FT   TURN        354    356       {ECO:0000244|PDB:4J8F}.
FT   TURN        365    367       {ECO:0000244|PDB:4J8F}.
FT   HELIX       368    382       {ECO:0000244|PDB:4J8F}.
SQ   SEQUENCE   641 AA;  70052 MW;  78F513118C96DE66 CRC64;
     MAKAAAIGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA
     LNPQNTVFDA KRLIGRKFGD PVVQSDMKHW PFQVINDGDK PKVQVSYKGE TKAFYPEEIS
     SMVLTKMKEI AEAYLGYPVT NAVITVPAYF NDSQRQATKD AGVIAGLNVL RIINEPTAAA
     IAYGLDRTGK GERNVLIFDL GGGTFDVSIL TIDDGIFEVK ATAGDTHLGG EDFDNRLVNH
     FVEEFKRKHK KDISQNKRAV RRLRTACERA KRTLSSSTQA SLEIDSLFEG IDFYTSITRA
     RFEELCSDLF RSTLEPVEKA LRDAKLDKAQ IHDLVLVGGS TRIPKVQKLL QDFFNGRDLN
     KSINPDEAVA YGAAVQAAIL MGDKSENVQD LLLLDVAPLS LGLETAGGVM TALIKRNSTI
     PTKQTQIFTT YSDNQPGVLI QVYEGERAMT KDNNLLGRFE LSGIPPAPRG VPQIEVTFDI
     DANGILNVTA TDKSTGKANK ITITNDKGRL SKEEIERMVQ EAEKYKAEDE VQRERVSAKN
     ALESYAFNMK SAVEDEGLKG KISEADKKKV LDKCQEVISW LDANTLAEKD EFEHKRKELE
     QVCNPIISGL YQGAGGPGPG GFGAQGPKGG SGSGPTIEEV D
//
ID   TECT2_HUMAN             Reviewed;         697 AA.
AC   Q96GX1; A8K7Y8; B3KPW5; Q9H966;
DT   04-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   23-MAY-2018, entry version 122.
DE   RecName: Full=Tectonic-2;
DE   Flags: Precursor;
GN   Name=TCTN2; Synonyms=C12orf38, TECT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=16357211; DOI=10.1101/gad.1363606;
RA   Reiter J.F., Skarnes W.C.;
RT   "Tectonic, a novel regulator of the Hedgehog pathway required for both
RT   activation and inhibition.";
RL   Genes Dev. 20:22-27(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Synovium, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INVOLVEMENT IN JBTS24.
RX   PubMed=21565611; DOI=10.1016/j.cell.2011.04.019;
RA   Sang L., Miller J.J., Corbit K.C., Giles R.H., Brauer M.J., Otto E.A.,
RA   Baye L.M., Wen X., Scales S.J., Kwong M., Huntzicker E.G.,
RA   Sfakianos M.K., Sandoval W., Bazan J.F., Kulkarni P.,
RA   Garcia-Gonzalo F.R., Seol A.D., O'Toole J.F., Held S., Reutter H.M.,
RA   Lane W.S., Rafiq M.A., Noor A., Ansar M., Devi A.R., Sheffield V.C.,
RA   Slusarski D.C., Vincent J.B., Doherty D.A., Hildebrandt F.,
RA   Reiter J.F., Jackson P.K.;
RT   "Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease
RT   genes and pathways.";
RL   Cell 145:513-528(2011).
RN   [7]
RP   INVOLVEMENT IN MKS8.
RX   PubMed=21462283; DOI=10.1002/humu.21507;
RA   Shaheen R., Faqeih E., Seidahmed M.Z., Sunker A., Alali F.E.,
RA   Alkuraya F.S.;
RT   "A TCTN2 mutation defines a novel Meckel Gruber syndrome locus.";
RL   Hum. Mutat. 32:573-578(2011).
RN   [8]
RP   INVOLVEMENT IN JBTS24.
RX   PubMed=25118024; DOI=10.1038/ejhg.2014.160;
RA   Huppke P., Wegener E., Boehrer-Rabel H., Bolz H.J., Zoll B.,
RA   Gaertner J., Bergmann C.;
RT   "Tectonic gene mutations in patients with Joubert syndrome.";
RL   Eur. J. Hum. Genet. 23:616-620(2015).
CC   -!- FUNCTION: Component of the tectonic-like complex, a complex
CC       localized at the transition zone of primary cilia and acting as a
CC       barrier that prevents diffusion of transmembrane proteins between
CC       the cilia and plasma membranes. Required for hedgehog signaling
CC       transduction (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Part of the tectonic-like complex (also named B9
CC       complex). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}. Cytoplasm, cytoskeleton, cilium
CC       basal body {ECO:0000250}. Note=Localizes at the transition zone, a
CC       region between the basal body and the ciliary axoneme.
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96GX1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96GX1-2; Sequence=VSP_042776;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Meckel syndrome 8 (MKS8) [MIM:613885]: A disorder
CC       characterized by a combination of renal cysts and variably
CC       associated features including developmental anomalies of the
CC       central nervous system (typically encephalocele), hepatic ductal
CC       dysplasia and cysts, and polydactyly.
CC       {ECO:0000269|PubMed:21462283}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Joubert syndrome 24 (JBTS24) [MIM:616654]: A form of
CC       Joubert syndrome, a disorder presenting with cerebellar ataxia,
CC       oculomotor apraxia, hypotonia, neonatal breathing abnormalities
CC       and psychomotor delay. Neuroradiologically, it is characterized by
CC       cerebellar vermian hypoplasia/aplasia, thickened and reoriented
CC       superior cerebellar peduncles, and an abnormally large
CC       interpeduncular fossa, giving the appearance of a molar tooth on
CC       transaxial slices (molar tooth sign). Additional variable features
CC       include retinal dystrophy, renal disease, liver fibrosis, and
CC       polydactyly. {ECO:0000269|PubMed:21565611,
CC       ECO:0000269|PubMed:25118024}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the tectonic family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14370.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ278870; ABB90562.1; -; mRNA.
DR   EMBL; AK023037; BAB14370.1; ALT_INIT; mRNA.
DR   EMBL; AK056924; BAG51827.1; -; mRNA.
DR   EMBL; AK292153; BAF84842.1; -; mRNA.
DR   EMBL; AC117503; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW98430.1; -; Genomic_DNA.
DR   EMBL; BC009112; AAH09112.1; -; mRNA.
DR   CCDS; CCDS45007.1; -. [Q96GX1-2]
DR   CCDS; CCDS9253.1; -. [Q96GX1-1]
DR   RefSeq; NP_001137322.1; NM_001143850.2. [Q96GX1-2]
DR   RefSeq; NP_079085.2; NM_024809.4. [Q96GX1-1]
DR   UniGene; Hs.167165; -.
DR   ProteinModelPortal; Q96GX1; -.
DR   SMR; Q96GX1; -.
DR   BioGrid; 122955; 288.
DR   IntAct; Q96GX1; 203.
DR   STRING; 9606.ENSP00000304941; -.
DR   iPTMnet; Q96GX1; -.
DR   PhosphoSitePlus; Q96GX1; -.
DR   BioMuta; TCTN2; -.
DR   DMDM; 74731861; -.
DR   EPD; Q96GX1; -.
DR   MaxQB; Q96GX1; -.
DR   PaxDb; Q96GX1; -.
DR   PeptideAtlas; Q96GX1; -.
DR   PRIDE; Q96GX1; -.
DR   Ensembl; ENST00000303372; ENSP00000304941; ENSG00000168778. [Q96GX1-1]
DR   Ensembl; ENST00000426174; ENSP00000395171; ENSG00000168778. [Q96GX1-2]
DR   GeneID; 79867; -.
DR   KEGG; hsa:79867; -.
DR   UCSC; uc001ufp.3; human. [Q96GX1-1]
DR   CTD; 79867; -.
DR   DisGeNET; 79867; -.
DR   EuPathDB; HostDB:ENSG00000168778.11; -.
DR   GeneCards; TCTN2; -.
DR   GeneReviews; TCTN2; -.
DR   HGNC; HGNC:25774; TCTN2.
DR   HPA; HPA039900; -.
DR   MalaCards; TCTN2; -.
DR   MIM; 613846; gene.
DR   MIM; 613885; phenotype.
DR   MIM; 616654; phenotype.
DR   neXtProt; NX_Q96GX1; -.
DR   OpenTargets; ENSG00000168778; -.
DR   Orphanet; 475; Joubert syndrome.
DR   Orphanet; 564; Meckel syndrome.
DR   PharmGKB; PA162405472; -.
DR   eggNOG; ENOG410IJPP; Eukaryota.
DR   eggNOG; ENOG4111MZ0; LUCA.
DR   GeneTree; ENSGT00730000111238; -.
DR   HOGENOM; HOG000013148; -.
DR   HOVERGEN; HBG083562; -.
DR   InParanoid; Q96GX1; -.
DR   KO; K19361; -.
DR   OMA; QFIKIPA; -.
DR   OrthoDB; EOG091G0LKM; -.
DR   PhylomeDB; Q96GX1; -.
DR   TreeFam; TF329169; -.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   ChiTaRS; TCTN2; human.
DR   GenomeRNAi; 79867; -.
DR   PRO; PR:Q96GX1; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000168778; -.
DR   CleanEx; HS_TCTN2; -.
DR   ExpressionAtlas; Q96GX1; baseline and differential.
DR   Genevisible; Q96GX1; HS.
DR   GO; GO:0060170; C:ciliary membrane; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0036038; C:MKS complex; ISS:UniProtKB.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0060271; P:cilium assembly; ISS:UniProtKB.
DR   GO; GO:0007224; P:smoothened signaling pathway; ISS:UniProtKB.
DR   InterPro; IPR011677; DUF1619.
DR   Pfam; PF07773; DUF1619; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell projection; Ciliopathy;
KW   Cilium biogenesis/degradation; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Glycoprotein; Joubert syndrome; Meckel syndrome;
KW   Membrane; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    697       Tectonic-2.
FT                                /FTId=PRO_0000229798.
FT   TOPO_DOM     26    668       Extracellular. {ECO:0000255}.
FT   TRANSMEM    669    689       Helical. {ECO:0000255}.
FT   TOPO_DOM    690    697       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    171    190       Cys-rich.
FT   CARBOHYD    146    146       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    156    156       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    391    391       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    497    497       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ      90     90       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042776.
SQ   SEQUENCE   697 AA;  76871 MW;  4A41EED4972ECFFA CRC64;
     MGFQPPAALL LRLFLLQGIL RLLWGDLAFI PPFIRMSGPA VSASLVGDTE GVTVSLAVLQ
     DEAGILPIPT CGVLNNETED WSVTVIPGAK VLEVTVRWKR GLDWCSSNET DSFSESPCIL
     QTLLVSASHN SSCSAHLLIQ VEIYANSSLT HNASENVTVI PNQVYQPLGP CPCNLTAGAC
     DVRCCCDQEC SSNLTTLFRR SCFTGVFGGD VNPPFDQLCS AGTTTRGVPD WFPFLCVQSP
     LANTPFLGYF YHGAVSPKQD SSFEVYVDTD AKDFADFGYK QGDPIMTVKK AYFTIPQVSL
     AGQCMQNAPV AFLHNFDVKC VTNLELYQER DGIINAKIKN VALGGIVTPK VIYEEATDLD
     KFITNTETPL NNGSTPRIVN VEEHYIFKWN NNTISEINVK IFRAEINAHQ KGIMTQRFVV
     KFLSYNSGNE EELSGNPGYQ LGKPVRALNI NRMNNVTTLH LWQSAGRGLC TSATFKPILF
     GENVLSGCLL EVGINENCTQ LRENAVERLD SLIQATHVAM RGNSDYADLS DGWLEIIRVD
     APDPGADPLA SSVNGMCLDI PAHLSIRILI SDAGAVEGIT QQEILGVETR FSSVNWQYQC
     GLTCEHKADL LPISASVQFI KIPAQLPHPL TRFQINYTEY DCNRNEVCWP QLLYPWTQYY
     QGELHSQCVA KGLLLLLFLT LALFLSNPWT RICKAYS
//
ID   TECT3_HUMAN             Reviewed;         607 AA.
AC   Q6NUS6; A6NIC8; B0QZ90; B4DR81; Q6P7P3; Q6UW27; Q6ZQQ0; Q8N7K1;
AC   Q8NBQ0; Q96GF7; Q9Y3U1;
DT   04-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   04-APR-2006, sequence version 2.
DT   23-MAY-2018, entry version 114.
DE   RecName: Full=Tectonic-3;
DE   Flags: Precursor;
GN   Name=TCTN3; Synonyms=C10orf61, TECT3;
GN   ORFNames=PSEC0041, UNQ1881/PRO4324;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=16357211; DOI=10.1101/gad.1363606;
RA   Reiter J.F., Skarnes W.C.;
RT   "Tectonic, a novel regulator of the Hedgehog pathway required for both
RT   activation and inhibition.";
RL   Genes Dev. 20:22-27(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3; 4 AND 5).
RC   TISSUE=Teratocarcinoma, Testis, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 30-607 (ISOFORM 2).
RC   TISSUE=Lung, Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION.
RX   PubMed=17464193;
RA   Park K.M., Kang E., Jeon Y.-J., Kim N., Kim N.-S., Yoo H.-S.,
RA   Yeom Y.I., Kim S.J.;
RT   "Identification of novel regulators of apoptosis using a high-
RT   throughput cell-based screen.";
RL   Mol. Cells 23:170-174(2007).
RN   [8]
RP   FUNCTION, INVOLVEMENT IN OFDS4, AND VARIANT JBTS18 ARG-314.
RX   PubMed=22883145; DOI=10.1016/j.ajhg.2012.06.017;
RA   Thomas S., Legendre M., Saunier S., Bessieres B., Alby C.,
RA   Bonniere M., Toutain A., Loeuillet L., Szymanska K., Jossic F.,
RA   Gaillard D., Yacoubi M.T., Mougou-Zerelli S., David A., Barthez M.A.,
RA   Ville Y., Bole-Feysot C., Nitschke P., Lyonnet S., Munnich A.,
RA   Johnson C.A., Encha-Razavi F., Cormier-Daire V., Thauvin-Robinet C.,
RA   Vekemans M., Attie-Bitach T.;
RT   "TCTN3 mutations cause Mohr-Majewski syndrome.";
RL   Am. J. Hum. Genet. 91:372-378(2012).
RN   [9]
RP   VARIANT PRO-95.
RX   PubMed=27377014; DOI=10.1016/j.ejmg.2016.06.007;
RA   Bader I., Decker E., Mayr J.A., Lunzer V., Koch J., Boltshauser E.,
RA   Sperl W., Pietsch P., Ertl-Wagner B., Bolz H., Bergmann C.,
RA   Rittinger O.;
RT   "MKS1 mutations cause Joubert syndrome with agenesis of the corpus
RT   callosum.";
RL   Eur. J. Med. Genet. 59:386-391(2016).
CC   -!- FUNCTION: Part of the tectonic-like complex which is required for
CC       tissue-specific ciliogenesis and may regulate ciliary membrane
CC       composition (By similarity). May be involved in apoptosis
CC       regulation. Necessary for signal transduction through the sonic
CC       hedgehog (Shh) signaling pathway. {ECO:0000250,
CC       ECO:0000269|PubMed:17464193, ECO:0000269|PubMed:22883145}.
CC   -!- SUBUNIT: Part of the tectonic-like complex (also named B9
CC       complex). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q6NUS6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6NUS6-2; Sequence=VSP_017795, VSP_017796;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q6NUS6-3; Sequence=VSP_017791, VSP_017794;
CC         Note=No experimental confirmation available. May be produced at
CC         very low levels due to a premature stop codon in the mRNA,
CC         leading to nonsense-mediated mRNA decay.;
CC       Name=4;
CC         IsoId=Q6NUS6-4; Sequence=VSP_017792, VSP_017793;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q6NUS6-5; Sequence=VSP_043266, VSP_043267;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Orofaciodigital syndrome 4 (OFD4) [MIM:258860]: A form of
CC       orofaciodigital syndrome, a group of heterogeneous disorders
CC       characterized by malformations of the oral cavity, face and
CC       digits, and associated phenotypic abnormalities that lead to the
CC       delineation of various subtypes. OFD4 patients have tongue
CC       nodules, multiple frenulae, broad flat nose, hypertelorism, and
CC       short rib polydactyly with tibial dysplasia (Majewski syndrome).
CC       The presence of severe tibial aplasia differentiates OFD4 from
CC       OFD1. Additional features of cystic dysplastic kidneys and brain
CC       malformation, including occipital encephalocele, are observed in
CC       severely affected patients. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Joubert syndrome 18 (JBTS18) [MIM:614815]: A form of
CC       Joubert syndrome, a disorder presenting with cerebellar ataxia,
CC       oculomotor apraxia, hypotonia, neonatal breathing abnormalities
CC       and psychomotor delay. Neuroradiologically, it is characterized by
CC       cerebellar vermian hypoplasia/aplasia, thickened and reoriented
CC       superior cerebellar peduncles, and an abnormally large
CC       interpeduncular fossa, giving the appearance of a molar tooth on
CC       transaxial slices (molar tooth sign). Additional variable features
CC       include retinal dystrophy and renal disease. JBTS18 patients have
CC       vermis agenesis and the molar tooth sign as well as severe
CC       kyphoscoliosis. Other features include intrauterine growth
CC       retardation, oral anomalies, micrognathism, polydactyly and
CC       camptodactyly, joint laxity, horseshoe kidney, and ventricular
CC       septal defect. {ECO:0000269|PubMed:22883145}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC       TCTN3-mutated fibroblasts from JBTS18 patients fail to respond to
CC       Shh agonists suggesting that at least some of the defects in
CC       affected individuals may be secondary to reduced Shh signaling
CC       (PubMed:22883145). {ECO:0000269|PubMed:22883145}.
CC   -!- SIMILARITY: Belongs to the tectonic family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH68449.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=ABB90564.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAC11567.1; Type=Frameshift; Positions=238; Evidence={ECO:0000305};
CC       Sequence=BAC87634.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAI16768.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ278872; ABB90564.1; ALT_INIT; mRNA.
DR   EMBL; AK075357; BAC11567.1; ALT_FRAME; mRNA.
DR   EMBL; AY359022; AAQ89381.1; -; mRNA.
DR   EMBL; AK098295; BAC05278.1; -; mRNA.
DR   EMBL; AK128834; BAC87634.1; ALT_INIT; mRNA.
DR   EMBL; AK299141; BAG61193.1; -; mRNA.
DR   EMBL; AL050022; CAB43242.2; -; mRNA.
DR   EMBL; AL356632; CAI16768.2; ALT_INIT; Genomic_DNA.
DR   EMBL; AL356632; CAQ07589.1; -; Genomic_DNA.
DR   EMBL; BC009494; AAH09494.2; -; mRNA.
DR   EMBL; BC061582; AAH61582.1; -; mRNA.
DR   EMBL; BC068449; AAH68449.2; ALT_INIT; mRNA.
DR   CCDS; CCDS31258.2; -. [Q6NUS6-1]
DR   CCDS; CCDS44461.1; -. [Q6NUS6-5]
DR   PIR; T08708; T08708.
DR   RefSeq; NP_001137445.1; NM_001143973.1. [Q6NUS6-5]
DR   RefSeq; NP_056446.4; NM_015631.5. [Q6NUS6-1]
DR   UniGene; Hs.438991; -.
DR   ProteinModelPortal; Q6NUS6; -.
DR   BioGrid; 117565; 319.
DR   IntAct; Q6NUS6; 307.
DR   STRING; 9606.ENSP00000265993; -.
DR   iPTMnet; Q6NUS6; -.
DR   PhosphoSitePlus; Q6NUS6; -.
DR   BioMuta; TCTN3; -.
DR   DMDM; 91208025; -.
DR   EPD; Q6NUS6; -.
DR   MaxQB; Q6NUS6; -.
DR   PaxDb; Q6NUS6; -.
DR   PeptideAtlas; Q6NUS6; -.
DR   PRIDE; Q6NUS6; -.
DR   Ensembl; ENST00000371209; ENSP00000360253; ENSG00000119977. [Q6NUS6-2]
DR   Ensembl; ENST00000371217; ENSP00000360261; ENSG00000119977. [Q6NUS6-1]
DR   Ensembl; ENST00000430368; ENSP00000387567; ENSG00000119977. [Q6NUS6-5]
DR   Ensembl; ENST00000614499; ENSP00000483364; ENSG00000119977. [Q6NUS6-1]
DR   GeneID; 26123; -.
DR   KEGG; hsa:26123; -.
DR   UCSC; uc001klb.4; human. [Q6NUS6-1]
DR   CTD; 26123; -.
DR   DisGeNET; 26123; -.
DR   EuPathDB; HostDB:ENSG00000119977.20; -.
DR   GeneCards; TCTN3; -.
DR   GeneReviews; TCTN3; -.
DR   HGNC; HGNC:24519; TCTN3.
DR   HPA; HPA026987; -.
DR   MalaCards; TCTN3; -.
DR   MIM; 258860; phenotype.
DR   MIM; 613847; gene.
DR   MIM; 614815; phenotype.
DR   neXtProt; NX_Q6NUS6; -.
DR   OpenTargets; ENSG00000119977; -.
DR   Orphanet; 2754; Joubert syndrome with orofaciodigital defect.
DR   Orphanet; 2753; Orofaciodigital syndrome type 4.
DR   PharmGKB; PA162405513; -.
DR   eggNOG; ENOG410IFR0; Eukaryota.
DR   eggNOG; ENOG4111GX2; LUCA.
DR   GeneTree; ENSGT00570000079101; -.
DR   HOGENOM; HOG000070061; -.
DR   HOVERGEN; HBG094032; -.
DR   InParanoid; Q6NUS6; -.
DR   KO; K19382; -.
DR   PhylomeDB; Q6NUS6; -.
DR   TreeFam; TF329169; -.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   ChiTaRS; TCTN3; human.
DR   GenomeRNAi; 26123; -.
DR   PRO; PR:Q6NUS6; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000119977; -.
DR   CleanEx; HS_TCTN3; -.
DR   ExpressionAtlas; Q6NUS6; baseline and differential.
DR   Genevisible; Q6NUS6; HS.
DR   GO; GO:0060170; C:ciliary membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0060271; P:cilium assembly; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0007224; P:smoothened signaling pathway; IMP:UniProtKB.
DR   InterPro; IPR011677; DUF1619.
DR   Pfam; PF07773; DUF1619; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Ciliopathy;
KW   Cilium biogenesis/degradation; Complete proteome; Disease mutation;
KW   Glycoprotein; Joubert syndrome; Membrane; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    607       Tectonic-3.
FT                                /FTId=PRO_0000229921.
FT   TOPO_DOM     23    581       Extracellular. {ECO:0000255}.
FT   TRANSMEM    582    602       Helical. {ECO:0000255}.
FT   TOPO_DOM    603    607       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS     90    109       Cys-rich.
FT   CARBOHYD     78     78       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    179    179       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    347    347       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    151       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_017791.
FT   VAR_SEQ     167    246       SNLNYFQKLQKVNATNFQALAAEFGGESFTSTFQTQSPPSF
FT                                YRAGDPILTYFPKWSVISLLRQPAGVGAGGLCAESNPAG
FT                                -> C (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043266.
FT   VAR_SEQ     210    211       AG -> VS (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_017792.
FT   VAR_SEQ     212    607       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_017793.
FT   VAR_SEQ     297    365       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043267.
FT   VAR_SEQ     297    323       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_017794.
FT   VAR_SEQ     402    443       MTLLQSQGNGSCSVKRHEVQFGVNAISGCKLRLKKADCSHL
FT                                Q -> VSFLELGGLLQPNEKSCKGFQTYVRLAKGEEFFVHY
FT                                NEVLIY (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_017795.
FT   VAR_SEQ     444    607       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_017796.
FT   VARIANT      95     95       T -> P (found in a patient with Joubert
FT                                syndrome also carrying 2 mutations in
FT                                MKS1 gene, a deletion in intron 15 and a
FT                                missense mutation 'C-80'; unknown
FT                                pathological significance;
FT                                dbSNP:rs749447795).
FT                                {ECO:0000269|PubMed:27377014}.
FT                                /FTId=VAR_077521.
FT   VARIANT     314    314       G -> R (in JBTS18; dbSNP:rs793888508).
FT                                {ECO:0000269|PubMed:22883145}.
FT                                /FTId=VAR_068823.
FT   CONFLICT     30     30       G -> E (in Ref. 3; BAC11567).
FT                                {ECO:0000305}.
FT   CONFLICT    492    492       C -> R (in Ref. 3; BAC11567).
FT                                {ECO:0000305}.
FT   CONFLICT    516    516       H -> Q (in Ref. 4; CAB43242).
FT                                {ECO:0000305}.
SQ   SEQUENCE   607 AA;  66157 MW;  41CE275DEDF358E6 CRC64;
     MRTPQLALLQ VFFLVFPDGV RPQPSSSPSG AVPTSLELQR GTDGGTLQSP SEATATRPAV
     PGLPTVVPTL VTPSAPGNRT VDLFPVLPIC VCDLTPGACD INCCCDRDCY LLHPRTVFSF
     CLPGSVRSSS WVCVDNSVIF RSNSPFPSRV FMDSNGIRQF CVHVNNSNLN YFQKLQKVNA
     TNFQALAAEF GGESFTSTFQ TQSPPSFYRA GDPILTYFPK WSVISLLRQP AGVGAGGLCA
     ESNPAGFLES KSTTCTRFFK NLASSCTLDS ALNAASYYNF TVLKVPRSMT DPQNMEFQVP
     VILTSQANAP LLAGNTCQNV VSQVTYEIET NGTFGIQKVS VSLGQTNLTV EPGASLQQHF
     ILRFRAFQQS TAASLTSPRS GNPGYIVGKP LLALTDDISY SMTLLQSQGN GSCSVKRHEV
     QFGVNAISGC KLRLKKADCS HLQQEIYQTL HGRPRPEYVA IFGNADPAQK GGWTRILNRH
     CSISAINCTS CCLIPVSLEI QVLWAYVGLL SNPQAHVSGV RFLYQCQSIQ DSQQVTEVSL
     TTLVNFVDIT QKPQPPRGQP KMDWKWPFDF FPFKVAFSRG VFSQKCSVSP ILILCLLLLG
     VLNLETM
//
ID   A8MW34_HUMAN            Unreviewed;       409 AA.
AC   A8MW34; B7Z7A7;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   28-JUN-2011, sequence version 2.
DT   31-JAN-2018, entry version 57.
DE   SubName: Full=cDNA FLJ53230, highly similar to Tectonic-1 {ECO:0000313|EMBL:BAH13543.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH13543.1};
RN   [1] {ECO:0000313|EMBL:BAH13543.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:BAH13543.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK301732; BAH13543.1; -; mRNA.
DR   RefSeq; NP_001306610.1; NM_001319681.1.
DR   UniGene; Hs.211511; -.
DR   MaxQB; A8MW34; -.
DR   PeptideAtlas; A8MW34; -.
DR   PRIDE; A8MW34; -.
DR   GeneID; 79600; -.
DR   CTD; 79600; -.
DR   eggNOG; ENOG410IFF2; Eukaryota.
DR   eggNOG; ENOG411028N; LUCA.
DR   HOGENOM; HOG000015332; -.
DR   HOVERGEN; HBG083755; -.
DR   GenomeRNAi; 79600; -.
DR   InterPro; IPR011677; DUF1619.
DR   Pfam; PF07773; DUF1619; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       18    209       DUF1619. {ECO:0000259|Pfam:PF07773}.
SQ   SEQUENCE   409 AA;  44748 MW;  C0258F0F644563FD CRC64;
     MKTSDGFTLN AESYVSFTTK LDIPTAAKYE YGVPLQTSDS FLRFPSSLTS SLCTDNNPAA
     FLVNQAVKCT RKINLEQCEE IEALSMAFYS SPEILRVPDS RKKVPITVQS IVIQSLNKTL
     TRREDTDVLQ PTLVNAGHFS LCVNVVLEVK YSLTYTDAGE VTKADLSFVL GTVSSVVVPL
     QQKFEIHFLQ ENTQPVPLSG NPGYVVGLPL AAGFQPHKGS GIIQTTNRYG QLTILHSTTE
     QDCLALEGVR TPVLFGYTMQ SGCKLRLTGA LPCQLVAQKV KSLLWGQGFP DYVAPFGNSQ
     AQDMLDWVPI HFITQSFNRK DSCQLPGALV IEVKWTKYGS LLNPQAKIVN VTANLISSSF
     PEANSGNERT ILISTAVTFV DVSAPAEAGF RAPPAINARL PFNFFFPFV
//
ID   B4DIB9_HUMAN            Unreviewed;       245 AA.
AC   B4DIB9;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   23-MAY-2018, entry version 55.
DE   SubName: Full=Tectonic-1 {ECO:0000313|Ensembl:ENSP00000473789};
DE   SubName: Full=cDNA FLJ55161, highly similar to Tectonic-1 {ECO:0000313|EMBL:BAG58431.1};
GN   Name=TCTN1 {ECO:0000313|Ensembl:ENSP00000473789};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG58431.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000473789, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RG   Baylor College of Medicine Human Genome Sequencing Center Sequence Production Team;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A., null.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [2] {ECO:0000313|EMBL:BAG58431.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Hippocampus {ECO:0000313|EMBL:BAG58431.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000473789}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2013) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC002350; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC144522; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK295514; BAG58431.1; -; mRNA.
DR   RefSeq; NP_001076006.1; NM_001082537.2.
DR   RefSeq; NP_001076007.1; NM_001082538.2.
DR   RefSeq; NP_001167446.1; NM_001173975.2.
DR   RefSeq; NP_001167447.1; NM_001173976.1.
DR   RefSeq; NP_001306610.1; NM_001319681.1.
DR   RefSeq; NP_001306611.1; NM_001319682.1.
DR   RefSeq; NP_078825.2; NM_024549.5.
DR   UniGene; Hs.211511; -.
DR   PeptideAtlas; B4DIB9; -.
DR   Ensembl; ENST00000550703; ENSP00000473789; ENSG00000204852.
DR   GeneID; 79600; -.
DR   KEGG; hsa:79600; -.
DR   UCSC; uc010syb.3; human.
DR   CTD; 79600; -.
DR   EuPathDB; HostDB:ENSG00000204852.15; -.
DR   HGNC; HGNC:26113; TCTN1.
DR   OpenTargets; ENSG00000204852; -.
DR   eggNOG; ENOG410IFF2; Eukaryota.
DR   eggNOG; ENOG411028N; LUCA.
DR   GeneTree; ENSGT00570000079101; -.
DR   HOVERGEN; HBG082302; -.
DR   KO; K19382; -.
DR   GenomeRNAi; 79600; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000204852; -.
DR   ExpressionAtlas; B4DIB9; baseline and differential.
DR   InterPro; IPR011677; DUF1619.
DR   Pfam; PF07773; DUF1619; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:B4DIB9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     22       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        23    245       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014085093.
FT   DOMAIN       78    208       DUF1619. {ECO:0000259|Pfam:PF07773}.
SQ   SEQUENCE   245 AA;  26395 MW;  7E7D987FFB32F69F CRC64;
     MRPRGLPPLL VVLLGCWASV SAQTDATPAV TTEGLNSTEA ALATFGTFPS TRPPGTPRAP
     GPSSGPRPTP VTDVAVLCVC DLSPAQCDIN CCCDPDCSSV DFSVFSACSV PVVTGDSQFC
     SQKAVIYSLN FTANPPQRVF ELVDQINPSI FCIHITNYKP ALSFINPEVP DENNFDTLMK
     TSDGFTLNAE SYVSFTTKLD IPTAAKYEVS LNLIDSFHPI TNIFPCKLIF KVTRKTGFLE
     TELIL
//
ID   Q05BR9_HUMAN            Unreviewed;       189 AA.
AC   Q05BR9;
DT   14-NOV-2006, integrated into UniProtKB/TrEMBL.
DT   14-NOV-2006, sequence version 1.
DT   31-JAN-2018, entry version 44.
DE   SubName: Full=TCTN1 protein {ECO:0000313|EMBL:AAH33811.1};
GN   Name=TCTN1 {ECO:0000313|EMBL:AAH33811.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH33811.1};
RN   [1] {ECO:0000313|EMBL:AAH33811.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAH33811.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC033811; AAH33811.1; -; mRNA.
DR   RefSeq; NP_001306611.1; NM_001319682.1.
DR   UniGene; Hs.211511; -.
DR   ProteinModelPortal; Q05BR9; -.
DR   PeptideAtlas; Q05BR9; -.
DR   GeneID; 79600; -.
DR   CTD; 79600; -.
DR   eggNOG; ENOG410IFF2; Eukaryota.
DR   eggNOG; ENOG411028N; LUCA.
DR   HOVERGEN; HBG082302; -.
DR   InterPro; IPR011677; DUF1619.
DR   Pfam; PF07773; DUF1619; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       22    153       DUF1619. {ECO:0000259|Pfam:PF07773}.
SQ   SEQUENCE   189 AA;  20844 MW;  0033A5D7B76C53D8 CRC64;
     MCQLLESTVI QPQGDSPVAV LCVCDLSPAQ CDINCCCDPD CSSVDFSVFS ACSVPVVTGD
     SQFCSQKAVI YSLNFTANPP QRVFELVDQI NPSIFCIHIT NYKPALSFIN PEVPDENNFD
     TLMKTSDGFT LNAESYVSFT TKLDIPTAAK YEVSLNLIDS FHPITNIFPC KLIFKVTRKT
     GFLETELIL
//
ID   TECT1_HUMAN             Reviewed;         587 AA.
AC   Q2MV58; A8MX11; Q49A60; Q6P5X1; Q6UXW2; Q8NAE9; Q96N72; Q9H798;
DT   04-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   04-APR-2006, sequence version 2.
DT   23-MAY-2018, entry version 100.
DE   RecName: Full=Tectonic-1;
DE   Flags: Precursor;
GN   Name=TCTN1; Synonyms=TECT1; ORFNames=UNQ9369/PRO34160;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=16357211; DOI=10.1101/gad.1363606;
RA   Reiter J.F., Skarnes W.C.;
RT   "Tectonic, a novel regulator of the Hedgehog pathway required for both
RT   activation and inhibition.";
RL   Genes Dev. 20:22-27(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3; 4 AND 5).
RC   TISSUE=Artery smooth muscle, Mammary gland, and Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 6).
RC   TISSUE=Pancreas, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INVOLVEMENT IN JBTS13, AND SUBCELLULAR LOCATION.
RX   PubMed=21725307; DOI=10.1038/ng.891;
RA   Garcia-Gonzalo F.R., Corbit K.C., Sirerol-Piquer M.S., Ramaswami G.,
RA   Otto E.A., Noriega T.R., Seol A.D., Robinson J.F., Bennett C.L.,
RA   Josifova D.J., Garcia-Verdugo J.M., Katsanis N., Hildebrandt F.,
RA   Reiter J.F.;
RT   "A transition zone complex regulates mammalian ciliogenesis and
RT   ciliary membrane composition.";
RL   Nat. Genet. 43:776-784(2011).
CC   -!- FUNCTION: Component of the tectonic-like complex, a complex
CC       localized at the transition zone of primary cilia and acting as a
CC       barrier that prevents diffusion of transmembrane proteins between
CC       the cilia and plasma membranes. Regulator of Hedgehog (Hh),
CC       required for both activation and inhibition of the Hh pathway in
CC       the patterning of the neural tube. During neural tube development,
CC       it is required for formation of the most ventral cell types and
CC       for full Hh pathway activation. Functions in Hh signal
CC       transduction to fully activate the pathway in the presence of high
CC       Hh levels and to repress the pathway in the absence of Hh signals.
CC       Modulates Hh signal transduction downstream of SMO and RAB23 (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Part of the tectonic-like complex (also named B9
CC       complex). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, cilium basal body
CC       {ECO:0000250}. Secreted {ECO:0000305}. Note=Despite the presence
CC       of a signal sequence, the full-length protein might not be
CC       secreted. Localizes at the transition zone, a region between the
CC       basal body and the ciliary axoneme. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q2MV58-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q2MV58-2; Sequence=VSP_017763;
CC       Name=3;
CC         IsoId=Q2MV58-3; Sequence=VSP_017759;
CC       Name=4;
CC         IsoId=Q2MV58-4; Sequence=VSP_017757;
CC       Name=5;
CC         IsoId=Q2MV58-5; Sequence=VSP_017758, VSP_017761, VSP_017763;
CC       Name=6;
CC         IsoId=Q2MV58-6; Sequence=VSP_017756, VSP_017760, VSP_017762;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay. No
CC         experimental confirmation available.;
CC   -!- DISEASE: Joubert syndrome 13 (JBTS13) [MIM:614173]: A disorder
CC       presenting with cerebellar ataxia, oculomotor apraxia, hypotonia,
CC       neonatal breathing abnormalities and psychomotor delay.
CC       Neuroradiologically, it is characterized by cerebellar vermian
CC       hypoplasia/aplasia, thickened and reoriented superior cerebellar
CC       peduncles, and an abnormally large interpeduncular fossa, giving
CC       the appearance of a molar tooth on transaxial slices (molar tooth
CC       sign). Additional variable features include retinal dystrophy and
CC       renal disease. {ECO:0000269|PubMed:21725307}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the tectonic family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ278868; ABB90560.1; -; mRNA.
DR   EMBL; AY358184; AAQ88551.1; -; mRNA.
DR   EMBL; AK024780; BAB15000.1; -; mRNA.
DR   EMBL; AK055891; BAB71036.1; -; mRNA.
DR   EMBL; AK092775; BAC03973.1; -; mRNA.
DR   EMBL; AC002350; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC144522; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC040113; AAH40113.1; -; mRNA.
DR   EMBL; BC044885; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC062611; AAH62611.1; -; mRNA.
DR   CCDS; CCDS41833.1; -. [Q2MV58-3]
DR   CCDS; CCDS41834.1; -. [Q2MV58-2]
DR   CCDS; CCDS41835.1; -. [Q2MV58-1]
DR   RefSeq; NP_001076006.1; NM_001082537.2. [Q2MV58-1]
DR   RefSeq; NP_001076007.1; NM_001082538.2. [Q2MV58-2]
DR   RefSeq; NP_001167446.1; NM_001173975.2. [Q2MV58-4]
DR   RefSeq; NP_001167447.1; NM_001173976.1.
DR   RefSeq; NP_078825.2; NM_024549.5. [Q2MV58-3]
DR   UniGene; Hs.211511; -.
DR   ProteinModelPortal; Q2MV58; -.
DR   BioGrid; 122738; 133.
DR   IntAct; Q2MV58; 100.
DR   STRING; 9606.ENSP00000380779; -.
DR   iPTMnet; Q2MV58; -.
DR   PhosphoSitePlus; Q2MV58; -.
DR   BioMuta; TCTN1; -.
DR   DMDM; 91208022; -.
DR   MaxQB; Q2MV58; -.
DR   PaxDb; Q2MV58; -.
DR   PeptideAtlas; Q2MV58; -.
DR   PRIDE; Q2MV58; -.
DR   TopDownProteomics; Q2MV58-2; -. [Q2MV58-2]
DR   Ensembl; ENST00000397655; ENSP00000380775; ENSG00000204852. [Q2MV58-3]
DR   Ensembl; ENST00000397659; ENSP00000380779; ENSG00000204852. [Q2MV58-2]
DR   Ensembl; ENST00000551590; ENSP00000448735; ENSG00000204852. [Q2MV58-1]
DR   GeneID; 79600; -.
DR   KEGG; hsa:79600; -.
DR   UCSC; uc001trn.6; human. [Q2MV58-1]
DR   CTD; 79600; -.
DR   DisGeNET; 79600; -.
DR   EuPathDB; HostDB:ENSG00000204852.15; -.
DR   GeneCards; TCTN1; -.
DR   GeneReviews; TCTN1; -.
DR   HGNC; HGNC:26113; TCTN1.
DR   HPA; HPA039687; -.
DR   HPA; HPA040036; -.
DR   MalaCards; TCTN1; -.
DR   MIM; 609863; gene.
DR   MIM; 614173; phenotype.
DR   neXtProt; NX_Q2MV58; -.
DR   OpenTargets; ENSG00000204852; -.
DR   Orphanet; 475; Joubert syndrome.
DR   PharmGKB; PA162405437; -.
DR   eggNOG; ENOG410IFF2; Eukaryota.
DR   eggNOG; ENOG411028N; LUCA.
DR   GeneTree; ENSGT00570000079101; -.
DR   HOVERGEN; HBG083755; -.
DR   InParanoid; Q2MV58; -.
DR   KO; K19382; -.
DR   OMA; VKWTKYG; -.
DR   OrthoDB; EOG091G03CX; -.
DR   PhylomeDB; Q2MV58; -.
DR   TreeFam; TF329169; -.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   GenomeRNAi; 79600; -.
DR   PRO; PR:Q2MV58; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000204852; -.
DR   CleanEx; HS_TCTN1; -.
DR   ExpressionAtlas; Q2MV58; baseline and differential.
DR   Genevisible; Q2MV58; HS.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; IEA:Ensembl.
DR   GO; GO:0036038; C:MKS complex; ISS:UniProtKB.
DR   GO; GO:0021956; P:central nervous system interneuron axonogenesis; IEA:Ensembl.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0060271; P:cilium assembly; ISS:UniProtKB.
DR   GO; GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0001841; P:neural tube formation; IEA:Ensembl.
DR   GO; GO:1904491; P:protein localization to ciliary transition zone; IEA:Ensembl.
DR   GO; GO:0008589; P:regulation of smoothened signaling pathway; IEA:Ensembl.
DR   GO; GO:0021523; P:somatic motor neuron differentiation; IEA:Ensembl.
DR   GO; GO:0021537; P:telencephalon development; IEA:Ensembl.
DR   InterPro; IPR011677; DUF1619.
DR   Pfam; PF07773; DUF1619; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell projection; Ciliopathy;
KW   Cilium biogenesis/degradation; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Developmental protein; Glycoprotein; Joubert syndrome;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    587       Tectonic-1.
FT                                /FTId=PRO_0000229796.
FT   COMPBIAS     78     97       Cys-rich.
FT   CARBOHYD     36     36       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    295    295       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    528    528       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    178       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_017756.
FT   VAR_SEQ       1     73       MRPRGLPPLLVVLLGCWASVSAQTDATPAVTTEGLNSTEAA
FT                                LATFGTFPSTRPPGTPRAPGPSSGPRPTPVTD -> MCQLL
FT                                ESTVIQPQGDSP (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_017757.
FT   VAR_SEQ       1     73       MRPRGLPPLLVVLLGCWASVSAQTDATPAVTTEGLNSTEAA
FT                                LATFGTFPSTRPPGTPRAPGPSSGPRPTPVTD -> MITAH
FT                                CGLDLLGS (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_017758.
FT   VAR_SEQ     238    274       AFLVNQAVKCTRKINLEQCEEIEALSMAFYSSPEILR ->
FT                                GQAYWFTPVIPALWEAEARGSLE (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_017759.
FT   VAR_SEQ     369    438       ENTQPVPLSGNPGYVVGLPLAAGFQPHKGSGIIQTTNRYGQ
FT                                LTILHSTTEQDCLALEGVRTPVLFGYTMQ -> TDWSSPVS
FT                                ARSTEGEEPAVGPGLPRLRGPFWKFPGPGHAGLGAHPLHHP
FT                                VIQQEGFLPAPRGFGYRSEVD (in isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_017760.
FT   VAR_SEQ     398    446       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_017761.
FT   VAR_SEQ     439    587       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_017762.
FT   VAR_SEQ     498    498       K -> KHFVLQ (in isoform 2 and isoform 5).
FT                                {ECO:0000303|PubMed:12975309,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_017763.
FT   CONFLICT     14     14       L -> M (in Ref. 2; AAQ88551).
FT                                {ECO:0000305}.
FT   CONFLICT    330    330       S -> T (in Ref. 1; ABB90560).
FT                                {ECO:0000305}.
FT   CONFLICT    341    341       K -> E (in Ref. 3; BAB15000).
FT                                {ECO:0000305}.
SQ   SEQUENCE   587 AA;  63570 MW;  0FFAD006E3B9160D CRC64;
     MRPRGLPPLL VVLLGCWASV SAQTDATPAV TTEGLNSTEA ALATFGTFPS TRPPGTPRAP
     GPSSGPRPTP VTDVAVLCVC DLSPAQCDIN CCCDPDCSSV DFSVFSACSV PVVTGDSQFC
     SQKAVIYSLN FTANPPQRVF ELVDQINPSI FCIHITNYKP ALSFINPEVP DENNFDTLMK
     TSDGFTLNAE SYVSFTTKLD IPTAAKYEYG VPLQTSDSFL RFPSSLTSSL CTDNNPAAFL
     VNQAVKCTRK INLEQCEEIE ALSMAFYSSP EILRVPDSRK KVPITVQSIV IQSLNKTLTR
     REDTDVLQPT LVNAGHFSLC VNVVLEVKYS LTYTDAGEVT KADLSFVLGT VSSVVVPLQQ
     KFEIHFLQEN TQPVPLSGNP GYVVGLPLAA GFQPHKGSGI IQTTNRYGQL TILHSTTEQD
     CLALEGVRTP VLFGYTMQSG CKLRLTGALP CQLVAQKVKS LLWGQGFPDY VAPFGNSQAQ
     DMLDWVPIHF ITQSFNRKDS CQLPGALVIE VKWTKYGSLL NPQAKIVNVT ANLISSSFPE
     ANSGNERTIL ISTAVTFVDV SAPAEAGFRA PPAINARLPF NFFFPFV
//
ID   TBG1_HUMAN              Reviewed;         451 AA.
AC   P23258; Q53X79; Q9BW59;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2002, sequence version 2.
DT   23-MAY-2018, entry version 192.
DE   RecName: Full=Tubulin gamma-1 chain;
DE   AltName: Full=Gamma-1-tubulin;
DE   AltName: Full=Gamma-tubulin complex component 1;
DE            Short=GCP-1;
GN   Name=TUBG1; Synonyms=TUBG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1904010; DOI=10.1016/0092-8674(91)90389-G;
RA   Zheng Y., Jung M.K., Oakley B.R.;
RT   "Gamma-tubulin is present in Drosophila melanogaster and Homo sapiens
RT   and is associated with the centrosome.";
RL   Cell 65:817-823(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   MASS SPECTROMETRY.
RC   TISSUE=Mammary cancer;
RX   PubMed=11840567;
RX   DOI=10.1002/1615-9861(200202)2:2<212::AID-PROT212>3.0.CO;2-H;
RA   Harris R.A., Yang A., Stein R.C., Lucy K., Brusten L., Herath A.,
RA   Parekh R., Waterfield M.D., O'Hare M.J., Neville M.A., Page M.J.,
RA   Zvelebil M.J.;
RT   "Cluster analysis of an extensive human breast cancer cell line
RT   protein expression map database.";
RL   Proteomics 2:212-223(2002).
RN   [7]
RP   INTERACTION WITH TUBGCP2 AND TUBGCP3, AND SUBCELLULAR LOCATION.
RX   PubMed=9566967; DOI=10.1083/jcb.141.3.663;
RA   Murphy S.M., Urbani L., Stearns T.;
RT   "The mammalian gamma-tubulin complex contains homologues of the yeast
RT   spindle pole body components spc97p and spc98p.";
RL   J. Cell Biol. 141:663-674(1998).
RN   [8]
RP   INTERACTION WITH TUBGCP2, AND SUBCELLULAR LOCATION.
RX   PubMed=9566969; DOI=10.1083/jcb.141.3.689;
RA   Tassin A.-M., Celati C., Moudjou M., Bornens M.;
RT   "Characterization of the human homologue of the yeast spc98p and its
RT   association with gamma-tubulin.";
RL   J. Cell Biol. 141:689-701(1998).
RN   [9]
RP   INTERACTION WITH CDK5RAP2.
RX   PubMed=17959831; DOI=10.1091/mbc.E07-04-0371;
RA   Fong K.W., Choi Y.K., Rattner J.B., Qi R.Z.;
RT   "CDK5RAP2 is a pericentriolar protein that functions in centrosomal
RT   attachment of the gamma-tubulin ring complex.";
RL   Mol. Biol. Cell 19:115-125(2008).
RN   [10]
RP   INTERACTION WITH PIFO.
RX   PubMed=20643351; DOI=10.1016/j.devcel.2010.06.005;
RA   Kinzel D., Boldt K., Davis E.E., Burtscher I., Trumbach D., Diplas B.,
RA   Attie-Bitach T., Wurst W., Katsanis N., Ueffing M., Lickert H.;
RT   "Pitchfork regulates primary cilia disassembly and left-right
RT   asymmetry.";
RL   Dev. Cell 19:66-77(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   INTERACTION WITH SAS6 AND NUP62, AND SUBCELLULAR LOCATION.
RX   PubMed=24107630; DOI=10.4161/cc.26671;
RA   Hashizume C., Moyori A., Kobayashi A., Yamakoshi N., Endo A.,
RA   Wong R.W.;
RT   "Nucleoporin Nup62 maintains centrosome homeostasis.";
RL   Cell Cycle 12:3804-3816(2013).
RN   [13]
RP   VARIANTS CDCBM4 CYS-92; PRO-331 AND PRO-387, AND CHARACTERIZATION OF
RP   VARIANT CDCBM4 PRO-387.
RX   PubMed=23603762; DOI=10.1038/ng.2613;
RA   Poirier K., Lebrun N., Broix L., Tian G., Saillour Y., Boscheron C.,
RA   Parrini E., Valence S., Pierre B.S., Oger M., Lacombe D.,
RA   Genevieve D., Fontana E., Darra F., Cances C., Barth M., Bonneau D.,
RA   Bernadina B.D., N'guyen S., Gitiaux C., Parent P., des Portes V.,
RA   Pedespan J.M., Legrez V., Castelnau-Ptakine L., Nitschke P., Hieu T.,
RA   Masson C., Zelenika D., Andrieux A., Francis F., Guerrini R.,
RA   Cowan N.J., Bahi-Buisson N., Chelly J.;
RT   "Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of
RT   cortical development and microcephaly.";
RL   Nat. Genet. 45:639-647(2013).
CC   -!- FUNCTION: Tubulin is the major constituent of microtubules. The
CC       gamma chain is found at microtubule organizing centers (MTOC) such
CC       as the spindle poles or the centrosome. Pericentriolar matrix
CC       component that regulates alpha/beta chain minus-end nucleation,
CC       centrosome duplication and spindle formation.
CC   -!- SUBUNIT: Interacts with TUBGCP2 and TUBGCP3 (PubMed:9566969,
CC       PubMed:9566969). Interacts with B9D2 (By similarity). Interacts
CC       with CDK5RAP2; the interaction is leading to centrosomal
CC       localization of TUBG1 and CDK5RAP2 (PubMed:17959831). Interacts
CC       with PIFO (PubMed:20643351). Interacts with SAS6 and NUP62 at the
CC       centrosome (PubMed:24107630). {ECO:0000250|UniProtKB:P83887,
CC       ECO:0000269|PubMed:17959831, ECO:0000269|PubMed:20643351,
CC       ECO:0000269|PubMed:24107630, ECO:0000269|PubMed:9566967,
CC       ECO:0000269|PubMed:9566969}.
CC   -!- INTERACTION:
CC       Self; NbExp=6; IntAct=EBI-302589, EBI-302589;
CC       O15169:AXIN1; NbExp=4; IntAct=EBI-302589, EBI-710484;
CC       Q96L34:MARK4; NbExp=4; IntAct=EBI-302589, EBI-302319;
CC       Q08AG7:MZT1; NbExp=3; IntAct=EBI-302589, EBI-2637198;
CC       Q6NZ67:MZT2B; NbExp=3; IntAct=EBI-302589, EBI-1052566;
CC       Q9UGJ1-2:TUBGCP4; NbExp=2; IntAct=EBI-302589, EBI-10964469;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:24107630,
CC       ECO:0000269|PubMed:9566967, ECO:0000269|PubMed:9566969}.
CC   -!- PTM: Phosphorylation at Ser-131 by BRSK1 regulates centrosome
CC       duplication, possibly by mediating relocation of gamma-tubulin and
CC       its associated proteins from the cytoplasm to the centrosome.
CC       {ECO:0000250}.
CC   -!- MASS SPECTROMETRY: Mass=51197.98; Method=MALDI; Range=1-451;
CC       Evidence={ECO:0000269|PubMed:11840567};
CC   -!- DISEASE: Cortical dysplasia, complex, with other brain
CC       malformations 4 (CDCBM4) [MIM:615412]: A disorder of aberrant
CC       neuronal migration and disturbed axonal guidance. Clinical
CC       features include early-onset seizures, microcephaly, spastic
CC       tetraplegia, and various malformations of cortical development,
CC       such as agyria, posterior or frontal pachygyria, thick cortex, and
CC       subcortical band heterotopia and thin corpus callosum in some
CC       patients. {ECO:0000269|PubMed:23603762}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the tubulin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M61764; AAA52620.1; -; mRNA.
DR   EMBL; BT019931; AAV38734.1; -; mRNA.
DR   EMBL; CR407642; CAG28570.1; -; mRNA.
DR   EMBL; AK313339; BAG36143.1; -; mRNA.
DR   EMBL; BC000619; AAH00619.1; -; mRNA.
DR   CCDS; CCDS11433.1; -.
DR   PIR; A39527; UBHUG.
DR   RefSeq; NP_001061.2; NM_001070.4.
DR   UniGene; Hs.279669; -.
DR   PDB; 1Z5V; X-ray; 2.71 A; A=1-449.
DR   PDB; 1Z5W; X-ray; 3.00 A; A=1-449.
DR   PDB; 3CB2; X-ray; 2.30 A; A/B=1-451.
DR   PDBsum; 1Z5V; -.
DR   PDBsum; 1Z5W; -.
DR   PDBsum; 3CB2; -.
DR   ProteinModelPortal; P23258; -.
DR   SMR; P23258; -.
DR   BioGrid; 113134; 246.
DR   CORUM; P23258; -.
DR   DIP; DIP-29890N; -.
DR   IntAct; P23258; 131.
DR   MINT; P23258; -.
DR   STRING; 9606.ENSP00000251413; -.
DR   DrugBank; DB00570; Vinblastine.
DR   iPTMnet; P23258; -.
DR   PhosphoSitePlus; P23258; -.
DR   BioMuta; TUBG1; -.
DR   DMDM; 20455518; -.
DR   REPRODUCTION-2DPAGE; IPI00295081; -.
DR   EPD; P23258; -.
DR   MaxQB; P23258; -.
DR   PaxDb; P23258; -.
DR   PeptideAtlas; P23258; -.
DR   PRIDE; P23258; -.
DR   DNASU; 7283; -.
DR   Ensembl; ENST00000251413; ENSP00000251413; ENSG00000131462.
DR   GeneID; 7283; -.
DR   KEGG; hsa:7283; -.
DR   UCSC; uc002ian.4; human.
DR   CTD; 7283; -.
DR   DisGeNET; 7283; -.
DR   EuPathDB; HostDB:ENSG00000131462.7; -.
DR   GeneCards; TUBG1; -.
DR   HGNC; HGNC:12417; TUBG1.
DR   HPA; CAB004608; -.
DR   MalaCards; TUBG1; -.
DR   MIM; 191135; gene.
DR   MIM; 615412; phenotype.
DR   neXtProt; NX_P23258; -.
DR   OpenTargets; ENSG00000131462; -.
DR   PharmGKB; PA37079; -.
DR   eggNOG; KOG1374; Eukaryota.
DR   eggNOG; COG5023; LUCA.
DR   GeneTree; ENSGT00910000144217; -.
DR   HOGENOM; HOG000165714; -.
DR   HOVERGEN; HBG098558; -.
DR   InParanoid; P23258; -.
DR   KO; K10389; -.
DR   OMA; EGFMLMH; -.
DR   OrthoDB; EOG091G08A9; -.
DR   PhylomeDB; P23258; -.
DR   TreeFam; TF300477; -.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   SIGNOR; P23258; -.
DR   ChiTaRS; TUBG1; human.
DR   EvolutionaryTrace; P23258; -.
DR   GeneWiki; TUBG1; -.
DR   GenomeRNAi; 7283; -.
DR   PMAP-CutDB; P23258; -.
DR   PRO; PR:P23258; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000131462; -.
DR   CleanEx; HS_TUBG1; -.
DR   ExpressionAtlas; P23258; baseline and differential.
DR   Genevisible; P23258; HS.
DR   GO; GO:0045177; C:apical part of cell; IEA:Ensembl.
DR   GO; GO:0031252; C:cell leading edge; IEA:Ensembl.
DR   GO; GO:0005814; C:centriole; IEA:Ensembl.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0036064; C:ciliary basal body; IEA:Ensembl.
DR   GO; GO:0000794; C:condensed nuclear chromosome; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005881; C:cytoplasmic microtubule; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0000930; C:gamma-tubulin complex; TAS:UniProtKB.
DR   GO; GO:0097730; C:non-motile cilium; IEA:Ensembl.
DR   GO; GO:0000242; C:pericentriolar material; IEA:Ensembl.
DR   GO; GO:0005827; C:polar microtubule; IDA:UniProtKB.
DR   GO; GO:0055037; C:recycling endosome; IDA:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc.
DR   GO; GO:0071277; P:cellular response to calcium ion; HEP:ARUK-UCL.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0031122; P:cytoplasmic microtubule organization; IEA:InterPro.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0000212; P:meiotic spindle organization; ISS:UniProtKB.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; TAS:ProtInc.
DR   GO; GO:0007020; P:microtubule nucleation; IEA:InterPro.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   CDD; cd02188; gamma_tubulin; 1.
DR   Gene3D; 1.10.287.600; -; 1.
DR   Gene3D; 3.30.1330.20; -; 1.
DR   Gene3D; 3.40.50.1440; -; 1.
DR   InterPro; IPR002454; Gamma_tubulin.
DR   InterPro; IPR008280; Tub_FtsZ_C.
DR   InterPro; IPR000217; Tubulin.
DR   InterPro; IPR018316; Tubulin/FtsZ_2-layer-sand-dom.
DR   InterPro; IPR037103; Tubulin/FtsZ_C_sf.
DR   InterPro; IPR036525; Tubulin/FtsZ_GTPase_sf.
DR   InterPro; IPR023123; Tubulin_C.
DR   InterPro; IPR017975; Tubulin_CS.
DR   InterPro; IPR003008; Tubulin_FtsZ_GTPase.
DR   PANTHER; PTHR11588; PTHR11588; 1.
DR   Pfam; PF00091; Tubulin; 1.
DR   Pfam; PF03953; Tubulin_C; 1.
DR   PRINTS; PR01164; GAMMATUBULIN.
DR   PRINTS; PR01161; TUBULIN.
DR   SMART; SM00864; Tubulin; 1.
DR   SMART; SM00865; Tubulin_C; 1.
DR   SUPFAM; SSF52490; SSF52490; 1.
DR   SUPFAM; SSF55307; SSF55307; 1.
DR   PROSITE; PS00227; TUBULIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Disease mutation; GTP-binding; Microtubule; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    451       Tubulin gamma-1 chain.
FT                                /FTId=PRO_0000048465.
FT   NP_BIND     142    148       GTP. {ECO:0000255}.
FT   MOD_RES     131    131       Phosphoserine; by BRSK1.
FT                                {ECO:0000250|UniProtKB:P83887}.
FT   VARIANT      92     92       Y -> C (in CDCBM4; dbSNP:rs398123046).
FT                                {ECO:0000269|PubMed:23603762}.
FT                                /FTId=VAR_070577.
FT   VARIANT     331    331       T -> P (in CDCBM4; dbSNP:rs398123047).
FT                                {ECO:0000269|PubMed:23603762}.
FT                                /FTId=VAR_070578.
FT   VARIANT     387    387       L -> P (in CDCBM4; the chaperonin-
FT                                dependent folding and hence the yield of
FT                                monomeric gamma-tubulin is compromised;
FT                                dbSNP:rs398123045).
FT                                {ECO:0000269|PubMed:23603762}.
FT                                /FTId=VAR_070579.
FT   VARIANT     413    413       M -> V (in dbSNP:rs13663).
FT                                /FTId=VAR_052674.
FT   CONFLICT     35     35       G -> A (in Ref. 1; AAA52620).
FT                                {ECO:0000305}.
FT   CONFLICT    202    202       V -> L (in Ref. 1; AAA52620).
FT                                {ECO:0000305}.
FT   STRAND        5     10       {ECO:0000244|PDB:3CB2}.
FT   HELIX        11     28       {ECO:0000244|PDB:3CB2}.
FT   STRAND       33     35       {ECO:0000244|PDB:1Z5V}.
FT   HELIX        48     50       {ECO:0000244|PDB:3CB2}.
FT   STRAND       52     54       {ECO:0000244|PDB:3CB2}.
FT   STRAND       60     62       {ECO:0000244|PDB:3CB2}.
FT   STRAND       64     71       {ECO:0000244|PDB:3CB2}.
FT   HELIX        72     79       {ECO:0000244|PDB:3CB2}.
FT   TURN         81     85       {ECO:0000244|PDB:3CB2}.
FT   HELIX        88     90       {ECO:0000244|PDB:3CB2}.
FT   STRAND       91     93       {ECO:0000244|PDB:3CB2}.
FT   HELIX       104    127       {ECO:0000244|PDB:3CB2}.
FT   STRAND      134    144       {ECO:0000244|PDB:3CB2}.
FT   HELIX       145    160       {ECO:0000244|PDB:3CB2}.
FT   STRAND      164    172       {ECO:0000244|PDB:3CB2}.
FT   HELIX       184    197       {ECO:0000244|PDB:3CB2}.
FT   STRAND      200    206       {ECO:0000244|PDB:3CB2}.
FT   HELIX       207    216       {ECO:0000244|PDB:3CB2}.
FT   HELIX       225    239       {ECO:0000244|PDB:3CB2}.
FT   TURN        240    243       {ECO:0000244|PDB:3CB2}.
FT   STRAND      244    247       {ECO:0000244|PDB:3CB2}.
FT   STRAND      248    250       {ECO:0000244|PDB:1Z5V}.
FT   HELIX       253    260       {ECO:0000244|PDB:3CB2}.
FT   STRAND      262    265       {ECO:0000244|PDB:1Z5V}.
FT   STRAND      268    274       {ECO:0000244|PDB:3CB2}.
FT   HELIX       290    296       {ECO:0000244|PDB:3CB2}.
FT   HELIX       300    302       {ECO:0000244|PDB:3CB2}.
FT   STRAND      303    305       {ECO:0000244|PDB:3CB2}.
FT   STRAND      317    327       {ECO:0000244|PDB:3CB2}.
FT   HELIX       330    342       {ECO:0000244|PDB:3CB2}.
FT   STRAND      350    352       {ECO:0000244|PDB:1Z5V}.
FT   STRAND      356    361       {ECO:0000244|PDB:3CB2}.
FT   STRAND      374    381       {ECO:0000244|PDB:3CB2}.
FT   HELIX       382    384       {ECO:0000244|PDB:3CB2}.
FT   HELIX       385    400       {ECO:0000244|PDB:3CB2}.
FT   HELIX       406    409       {ECO:0000244|PDB:3CB2}.
FT   HELIX       412    414       {ECO:0000244|PDB:3CB2}.
FT   HELIX       419    437       {ECO:0000244|PDB:3CB2}.
FT   HELIX       441    443       {ECO:0000244|PDB:3CB2}.
SQ   SEQUENCE   451 AA;  51170 MW;  E2A4C0179ED0CFE8 CRC64;
     MPREIITLQL GQCGNQIGFE FWKQLCAEHG ISPEGIVEEF ATEGTDRKDV FFYQADDEHY
     IPRAVLLDLE PRVIHSILNS PYAKLYNPEN IYLSEHGGGA GNNWASGFSQ GEKIHEDIFD
     IIDREADGSD SLEGFVLCHS IAGGTGSGLG SYLLERLNDR YPKKLVQTYS VFPNQDEMSD
     VVVQPYNSLL TLKRLTQNAD CVVVLDNTAL NRIATDRLHI QNPSFSQINQ LVSTIMSAST
     TTLRYPGYMN NDLIGLIASL IPTPRLHFLM TGYTPLTTDQ SVASVRKTTV LDVMRRLLQP
     KNVMVSTGRD RQTNHCYIAI LNIIQGEVDP TQVHKSLQRI RERKLANFIP WGPASIQVAL
     SRKSPYLPSA HRVSGLMMAN HTSISSLFER TCRQYDKLRK REAFLEQFRK EDMFKDNFDE
     MDTSREIVQQ LIDEYHAATR PDYISWGTQE Q
//
ID   GTSE1_HUMAN             Reviewed;         720 AA.
AC   Q9NYZ3; B0QYM3; Q20WK2; Q53GX5; Q5R3I6; Q6DHX4; Q9BRE0; Q9UGZ9;
AC   Q9Y557;
DT   26-JUL-2002, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   23-MAY-2018, entry version 143.
DE   RecName: Full=G2 and S phase-expressed protein 1;
DE            Short=GTSE-1;
DE   AltName: Full=Protein B99 homolog;
GN   Name=GTSE1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ARG-506.
RC   TISSUE=Placenta;
RX   PubMed=10974554; DOI=10.1016/S0378-1119(00)00260-2;
RA   Monte M., Collavin L., Lazarevic D., Utrera R., Dragani T.A.,
RA   Schneider C.;
RT   "Cloning, chromosome mapping and functional characterization of a
RT   human homologue of murine Gtse-1 (B99) gene.";
RL   Gene 254:229-236(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-506.
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-506.
RC   TISSUE=Liver, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-506.
RC   TISSUE=Brain, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-168; SER-504 AND
RP   SER-592, VARIANT [LARGE SCALE ANALYSIS] ARG-506, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-592, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-152; SER-168; SER-477;
RP   SER-480; SER-495; SER-501; SER-504; SER-575 AND SER-592, VARIANT
RP   [LARGE SCALE ANALYSIS] ARG-506, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72; SER-138; THR-140;
RP   SER-152; SER-168; SER-189; SER-495; SER-504; SER-509; THR-513;
RP   SER-516; SER-536; SER-575; SER-592; THR-677; SER-688; SER-698;
RP   SER-699; SER-705 AND SER-715, VARIANT [LARGE SCALE ANALYSIS] ARG-506,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-168; SER-228; SER-243;
RP   SER-312; SER-461; SER-495; SER-536; SER-575; SER-592; SER-705 AND
RP   SER-715, VARIANT [LARGE SCALE ANALYSIS] ARG-506, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: May be involved in p53-induced cell cycle arrest in G2/M
CC       phase by interfering with microtubule rearrangements that are
CC       required to enter mitosis. Overexpression delays G2/M phase
CC       progression.
CC   -!- INTERACTION:
CC       P53350:PLK1; NbExp=6; IntAct=EBI-2511327, EBI-476768;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Note=Associated
CC       with microtubules.
CC   -!- DEVELOPMENTAL STAGE: Expressed in G2/M phase. Not detected in
CC       quiescent cells.
CC   -!- PTM: Phosphorylated in mitosis. {ECO:0000250}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAQ09324.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAQ10552.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF223408; AAF31459.1; -; mRNA.
DR   EMBL; CT841519; CAJ86449.1; -; mRNA.
DR   EMBL; AK222806; BAD96526.1; -; mRNA.
DR   EMBL; AK315550; BAG37928.1; -; mRNA.
DR   EMBL; AL031588; CAQ09324.2; ALT_INIT; Genomic_DNA.
DR   EMBL; Z93024; CAQ09324.2; JOINED; Genomic_DNA.
DR   EMBL; Z93024; CAQ10552.2; ALT_INIT; Genomic_DNA.
DR   EMBL; AL031588; CAQ10552.2; JOINED; Genomic_DNA.
DR   EMBL; BC006325; AAH06325.1; -; mRNA.
DR   EMBL; BC075828; AAH75828.1; -; mRNA.
DR   RefSeq; NP_057510.4; NM_016426.6.
DR   UniGene; Hs.386189; -.
DR   UniGene; Hs.439524; -.
DR   ProteinModelPortal; Q9NYZ3; -.
DR   BioGrid; 119580; 139.
DR   IntAct; Q9NYZ3; 130.
DR   MINT; Q9NYZ3; -.
DR   STRING; 9606.ENSP00000415430; -.
DR   iPTMnet; Q9NYZ3; -.
DR   PhosphoSitePlus; Q9NYZ3; -.
DR   BioMuta; GTSE1; -.
DR   DMDM; 317373439; -.
DR   EPD; Q9NYZ3; -.
DR   MaxQB; Q9NYZ3; -.
DR   PaxDb; Q9NYZ3; -.
DR   PeptideAtlas; Q9NYZ3; -.
DR   PRIDE; Q9NYZ3; -.
DR   DNASU; 51512; -.
DR   Ensembl; ENST00000454366; ENSP00000415430; ENSG00000075218.
DR   GeneID; 51512; -.
DR   KEGG; hsa:51512; -.
DR   UCSC; uc011aqy.2; human.
DR   CTD; 51512; -.
DR   DisGeNET; 51512; -.
DR   EuPathDB; HostDB:ENSG00000075218.18; -.
DR   GeneCards; GTSE1; -.
DR   HGNC; HGNC:13698; GTSE1.
DR   HPA; HPA029457; -.
DR   HPA; HPA060544; -.
DR   MIM; 607477; gene.
DR   neXtProt; NX_Q9NYZ3; -.
DR   PharmGKB; PA29061; -.
DR   eggNOG; ENOG410IHTJ; Eukaryota.
DR   eggNOG; ENOG410ZUTK; LUCA.
DR   HOVERGEN; HBG103867; -.
DR   InParanoid; Q9NYZ3; -.
DR   KO; K10129; -.
DR   OrthoDB; EOG091G0890; -.
DR   PhylomeDB; Q9NYZ3; -.
DR   TreeFam; TF332555; -.
DR   Reactome; R-HSA-69481; G2/M Checkpoints.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   SIGNOR; Q9NYZ3; -.
DR   ChiTaRS; GTSE1; human.
DR   GeneWiki; GTSE1; -.
DR   GenomeRNAi; 51512; -.
DR   PRO; PR:Q9NYZ3; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000075218; -.
DR   Genevisible; Q9NYZ3; HS.
DR   GO; GO:0005881; C:cytoplasmic microtubule; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; NAS:UniProtKB.
DR   GO; GO:0007017; P:microtubule-based process; NAS:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; TAS:Reactome.
DR   GO; GO:0046827; P:positive regulation of protein export from nucleus; TAS:Reactome.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; TAS:Reactome.
DR   GO; GO:0050821; P:protein stabilization; TAS:Reactome.
DR   GO; GO:1902749; P:regulation of cell cycle G2/M phase transition; TAS:Reactome.
DR   InterPro; IPR026657; DDA3/GTSE-1.
DR   InterPro; IPR026659; GTSE1.
DR   InterPro; IPR032768; GTSE1_N.
DR   PANTHER; PTHR21584; PTHR21584; 1.
DR   PANTHER; PTHR21584:SF10; PTHR21584:SF10; 1.
DR   Pfam; PF15259; GTSE1_N; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Microtubule;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    720       G2 and S phase-expressed protein 1.
FT                                /FTId=PRO_0000083875.
FT   COMPBIAS     22     27       Poly-Ser.
FT   MOD_RES      72     72       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     138    138       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     140    140       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     152    152       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     168    168       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     189    189       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     228    228       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     243    243       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     312    312       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     461    461       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     466    466       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8R080}.
FT   MOD_RES     477    477       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     480    480       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     495    495       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     501    501       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     504    504       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     509    509       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     513    513       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     516    516       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     536    536       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     575    575       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     592    592       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     677    677       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     688    688       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     698    698       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     699    699       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     705    705       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     715    715       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT     181    181       T -> A (in dbSNP:rs6008600).
FT                                /FTId=VAR_032816.
FT   VARIANT     200    200       A -> V (in dbSNP:rs34404175).
FT                                /FTId=VAR_032817.
FT   VARIANT     274    274       A -> T (in dbSNP:rs35503220).
FT                                /FTId=VAR_032818.
FT   VARIANT     303    303       S -> N (in dbSNP:rs6008622).
FT                                /FTId=VAR_056905.
FT   VARIANT     322    322       S -> N (in dbSNP:rs6008622).
FT                                /FTId=VAR_032819.
FT   VARIANT     463    463       D -> E (in dbSNP:rs6008684).
FT                                /FTId=VAR_032820.
FT   VARIANT     470    470       S -> L (in dbSNP:rs2281192).
FT                                /FTId=VAR_021973.
FT   VARIANT     506    506       W -> R (in dbSNP:rs140054).
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:10974554,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15461802,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_024154.
FT   VARIANT     635    635       A -> T (in dbSNP:rs16995138).
FT                                /FTId=VAR_032821.
FT   CONFLICT      4      4       P -> S (in Ref. 5; AAH75828).
FT                                {ECO:0000305}.
FT   CONFLICT    135    135       M -> V (in Ref. 3; BAD96526).
FT                                {ECO:0000305}.
FT   CONFLICT    259    259       V -> I (in Ref. 1; AAF31459).
FT                                {ECO:0000305}.
FT   CONFLICT    306    306       N -> D (in Ref. 3; BAD96526).
FT                                {ECO:0000305}.
FT   CONFLICT    455    455       K -> R (in Ref. 3; BAD96526).
FT                                {ECO:0000305}.
SQ   SEQUENCE   720 AA;  76645 MW;  DBAC3C9ED528FB29 CRC64;
     MDDPKKEDIL LLADEKFDFD LSLSSSSANE DDEVFFGPFG HKERCIAASL ELNNPVPEQP
     PLPTSESPFA WSPLAGEKFV EVYKEAHLLA LHIESSSRNQ AAQAAKPEDP RSQGVERFIQ
     ESKLKINLFE KEKEMKKSPT SLKRETYYLS DSPLLGPPVG EPRLLASSPA LPSSGAQARL
     TRAPGPPHSA HALPRESCTA HAASQAATQR KPGTKLLLPR AASVRGRSIP GAAEKPKKEI
     PASPSRTKIP AEKESHRDVL PDKPAPGAVN VPAAGSHLGQ GKRAIPVPNK LGLKKTLLKA
     PGSTSNLARK SSSGPVWSGA SSACTSPAVG KAKSSEFASI PANSSRPLSN ISKSGRMGPA
     MLRPALPAGP VGASSWQAKR VDVSELAAEQ LTAPPSASPT QPQTPEGGGQ WLNSSCAWSE
     SSQLNKTRSI RRRDSCLNSK TKVMPTPTNQ FKIPKFSIGD SPDSSTPKLS RAQRPQSCTS
     VGRVTVHSTP VRRSSGPAPQ SLLSAWRVSA LPTPASRRCS GLPPMTPKTM PRAVGSPLCV
     PARRRSSEPR KNSAMRTEPT RESNRKTDSR LVDVSPDRGS PPSRVPQALN FSPEESDSTF
     SKSTATEVAR EEAKPGGDAA PSEALLVDIK LEPLAVTPDA ASQPLIDLPL IDFCDTPEAH
     VAVGSESRPL IDLMTNTPDM NKNVAKPSPV VGQLIDLSSP LIQLSPEADK ENVDSPLLKF
//
ID   E9Q3V6_MOUSE            Unreviewed;       321 AA.
AC   E9Q3V6;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   23-MAY-2018, entry version 68.
DE   SubName: Full=Septin-2 {ECO:0000313|Ensembl:ENSMUSP00000127276};
GN   Name=Sept2 {ECO:0000313|Ensembl:ENSMUSP00000127276,
GN   ECO:0000313|MGI:MGI:97298};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090 {ECO:0000313|Ensembl:ENSMUSP00000127276, ECO:0000313|Proteomes:UP000000589};
RN   [1] {ECO:0000213|PubMed:16452087}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16452087; DOI=10.1074/mcp.T500041-MCP200;
RA   Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R.,
RA   Burlingame A.L.;
RT   "Comprehensive identification of phosphorylation sites in postsynaptic
RT   density preparations.";
RL   Mol. Cell. Proteomics 5:914-922(2006).
RN   [2] {ECO:0000213|PubMed:17242355}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [3] {ECO:0000213|PubMed:18630941}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18630941; DOI=10.1021/pr800223m;
RA   Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.;
RT   "Specific phosphopeptide enrichment with immobilized titanium ion
RT   affinity chromatography adsorbent for phosphoproteome analysis.";
RL   J. Proteome Res. 7:3957-3967(2008).
RN   [4] {ECO:0000213|PubMed:19144319}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [5] {ECO:0000213|PubMed:19131326}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19131326; DOI=10.1074/mcp.M800451-MCP200;
RA   Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.;
RT   "Large scale localization of protein phosphorylation by use of
RT   electron capture dissociation mass spectrometry.";
RL   Mol. Cell. Proteomics 8:904-912(2009).
RN   [6] {ECO:0000313|Ensembl:ENSMUSP00000127276, ECO:0000313|Proteomes:UP000000589}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J {ECO:0000313|Ensembl:ENSMUSP00000127276,
RC   ECO:0000313|Proteomes:UP000000589};
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [7] {ECO:0000213|PubMed:21183079}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [8] {ECO:0000313|Ensembl:ENSMUSP00000127276}
RP   IDENTIFICATION.
RC   STRAIN=C57BL/6J {ECO:0000313|Ensembl:ENSMUSP00000127276};
RG   Ensembl;
RL   Submitted (MAY-2011) to UniProtKB.
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-
CC       like GTPase superfamily. Septin GTPase family.
CC       {ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00534725}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC108412; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001153190.1; NM_001159718.1.
DR   UniGene; Mm.428652; -.
DR   ProteinModelPortal; E9Q3V6; -.
DR   SMR; E9Q3V6; -.
DR   MaxQB; E9Q3V6; -.
DR   PeptideAtlas; E9Q3V6; -.
DR   PRIDE; E9Q3V6; -.
DR   Ensembl; ENSMUST00000172165; ENSMUSP00000127276; ENSMUSG00000026276.
DR   GeneID; 18000; -.
DR   CTD; 4735; -.
DR   MGI; MGI:97298; Sept2.
DR   eggNOG; KOG2655; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   GeneTree; ENSGT00910000144020; -.
DR   ChiTaRS; Sept2; mouse.
DR   Proteomes; UP000000589; Chromosome 1.
DR   Bgee; ENSMUSG00000026276; -.
DR   ExpressionAtlas; E9Q3V6; baseline and differential.
DR   Genevisible; E9Q3V6; MM.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0007049; P:cell cycle; IEA:InterPro.
DR   GO; GO:0051301; P:cell division; IEA:InterPro.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR016491; Septin.
DR   InterPro; IPR008113; Septin2.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   PRINTS; PR01740; SEPTIN2.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000000589};
KW   GTP-binding {ECO:0000256|PIRSR:PIRSR006698-2,
KW   ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00494966};
KW   Nucleotide-binding {ECO:0000256|PIRSR:PIRSR006698-2,
KW   ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00494966};
KW   Proteomics identification {ECO:0000213|EPD:E9Q3V6,
KW   ECO:0000213|MaxQB:E9Q3V6, ECO:0000213|PeptideAtlas:E9Q3V6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000000589}.
FT   DOMAIN        1    266       Septin-type G.
FT                                {ECO:0000259|PROSITE:PS51719}.
FT   COILED      282    302       {ECO:0000256|SAM:Coils}.
FT   SITE        116    116       Important for dimerization.
FT                                {ECO:0000256|PIRSR:PIRSR006698-2}.
SQ   SEQUENCE   321 AA;  36978 MW;  15F2F17FF5797DF5 CRC64;
     MVVGESGLGK STLINSLFLT DLYPERIIPG AAEKIERTVQ IEASTVEIEE RGVKLRLTVV
     DTPGYGDAIN CRDCFKTIIS YIDEQFERYL HDESGLNRRH IIDNRVHCCF YFISPFGHGL
     KPLDVAFMKA IHNKVNIVPV IAKADTLTLK ERERLKKRIL DEIEEHSIKI YHLPDAESDE
     DEDFKEQTRL LKASIPFSVV GSNQLIEAKG KKVRGRLYPW GVVEVENPEH NDFLKLRTML
     ITHMQDLQEV TQDLHYENFR SERLKRGGRK VENEDMNKDQ ILLEKEAELR RMQEMIARMQ
     AQMQMQMQGG DSDSGALGQH V
//
ID   SEPT2_MOUSE             Reviewed;         361 AA.
AC   P42208; B2RRZ2; Q3U9Y5;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   23-MAY-2018, entry version 173.
DE   RecName: Full=Septin-2;
DE   AltName: Full=Neural precursor cell expressed developmentally down-regulated protein 5;
DE            Short=NEDD-5;
GN   Name=Sept2; Synonyms=Nedd-5, Nedd5;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND MUTAGENESIS OF GLY-47;
RP   SER-51 AND GLN-125.
RC   TISSUE=Neural tube;
RX   PubMed=9203580; DOI=10.1101/gad.11.12.1535;
RA   Kinoshita M., Kumar S., Noda M.;
RT   "Nedd5, a mammalian septin, is a novel cytoskeletal component
RT   interacting with actin-based structures.";
RL   Genes Dev. 11:1535-1547(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Bone marrow, and Placenta;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 51-66; 97-112 AND 117-128, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Brain, and Hippocampus;
RA   Lubec G., Klug S., Yang J.W., Zigmond M.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [6]
RP   INTERACTION WITH SEPT5 AND SEPT7, LACK OF INTERACTION WITH SEPT4, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=11739749; DOI=10.1128/MCB.22.1.378-387.2002;
RA   Peng X.-R., Jia Z., Zhang Y., Ware J., Trimble W.S.;
RT   "The septin CDCrel-1 is dispensable for normal development and
RT   neurotransmitter release.";
RL   Mol. Cell. Biol. 22:378-387(2002).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-17, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-218, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=16452087; DOI=10.1074/mcp.T500041-MCP200;
RA   Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R.,
RA   Burlingame A.L.;
RT   "Comprehensive identification of phosphorylation sites in postsynaptic
RT   density preparations.";
RL   Mol. Cell. Proteomics 5:914-922(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-218, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-218, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18630941; DOI=10.1021/pr800223m;
RA   Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.;
RT   "Specific phosphopeptide enrichment with immobilized titanium ion
RT   affinity chromatography adsorbent for phosphoproteome analysis.";
RL   J. Proteome Res. 7:3957-3967(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-218, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-218, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=19131326; DOI=10.1074/mcp.M800451-MCP200;
RA   Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.;
RT   "Large scale localization of protein phosphorylation by use of
RT   electron capture dissociation mass spectrometry.";
RL   Mol. Cell. Proteomics 8:904-912(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-218, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung,
RC   Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [14]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=20558667; DOI=10.1126/science.1191054;
RA   Hu Q., Milenkovic L., Jin H., Scott M.P., Nachury M.V.,
RA   Spiliotis E.T., Nelson W.J.;
RT   "A septin diffusion barrier at the base of the primary cilium
RT   maintains ciliary membrane protein distribution.";
RL   Science 329:436-439(2010).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22179047; DOI=10.1038/ncb2410;
RA   Chih B., Liu P., Chinn Y., Chalouni C., Komuves L.G., Hass P.E.,
RA   Sandoval W., Peterson A.S.;
RT   "A ciliopathy complex at the transition zone protects the cilia as a
RT   privileged membrane domain.";
RL   Nat. Cell Biol. 14:61-72(2012).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 33-306 IN COMPLEX WITH
RP   GPPNHP, AND MUTAGENESIS OF SER-46 AND THR-78.
RX   PubMed=19805342; DOI=10.1073/pnas.0902858106;
RA   Sirajuddin M., Farkasovsky M., Zent E., Wittinghofer A.;
RT   "GTP-induced conformational changes in septins and implications for
RT   function.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:16592-16597(2009).
CC   -!- FUNCTION: Filament-forming cytoskeletal GTPase. Forms a
CC       filamentous structure with SEPT12, SEPT6, SEPT2 and probably SEPT4
CC       at the sperm annulus which is required for the structural
CC       integrity and motility of the sperm tail during postmeiotic
CC       differentiation (By similarity). Required for normal organization
CC       of the actin cytoskeleton. Plays a role in the biogenesis of
CC       polarized columnar-shaped epithelium by maintaining
CC       polyglutamylated microtubules, thus facilitating efficient vesicle
CC       transport, and by impeding MAP4 binding to tubulin. Required for
CC       the progression through mitosis. Forms a scaffold at the midplane
CC       of the mitotic splindle required to maintain CENPE localization at
CC       kinetochores and consequently chromosome congression. During
CC       anaphase, may be required for chromosome segregation and spindle
CC       elongation. Plays a role in ciliogenesis and collective cell
CC       movements (By similarity). In cilia, required for the integrity of
CC       the diffusion barrier at the base of the primary cilium that
CC       prevents diffusion of transmembrane proteins between the cilia and
CC       plasma membranes: probably acts by regulating the assembly of the
CC       tectonic-like complex (also named B9 complex) by localizing
CC       TMEM231 protein. {ECO:0000250, ECO:0000250|UniProtKB:Q15019,
CC       ECO:0000269|PubMed:20558667, ECO:0000269|PubMed:22179047,
CC       ECO:0000269|PubMed:9203580}.
CC   -!- SUBUNIT: Septins polymerize into heterooligomeric protein
CC       complexes that form filaments, and associate with cellular
CC       membranes, actin filaments and microtubules (By similarity).
CC       GTPase activity is required for filament formation (By
CC       similarity). Septin filaments are assembled from asymmetrical
CC       heterotrimers, composed of SEPT2, SEPT6 and SEPT7 that associate
CC       head-to-head to form a hexameric unit (By similarity). Interaction
CC       between SEPT2 and SEPT7 seems indirect (By similarity). Interacts
CC       also with SEPT9 and SEPT5 (PubMed:11739749). Interaction with
CC       SEPT4 not detected (PubMed:11739749). Component of a septin core
CC       octomeric complex consisting of SEPT12, SEPT7, SEPT6 and SEPT2 or
CC       SEPT4 in the order 12-7-6-2-2-6-7-12 or 12-7-6-4-4-6-7-12 and
CC       located in the sperm annulus (By similarity). Interacts with MAP4
CC       (By similarity). Interacts with DZIP1L (By similarity).
CC       {ECO:0000250|UniProtKB:Q15019, ECO:0000269|PubMed:11739749}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton.
CC       Cytoplasm, cytoskeleton, spindle {ECO:0000250}. Chromosome,
CC       centromere, kinetochore {ECO:0000250}. Cleavage furrow
CC       {ECO:0000250}. Midbody {ECO:0000250}. Cytoplasm, cell cortex
CC       {ECO:0000250}. Cell projection, cilium membrane. Cell projection,
CC       cilium, flagellum {ECO:0000250|UniProtKB:Q15019}. Note=In
CC       metaphase cells, localized within the microtubule spindle. At the
CC       metaphase plate, in close apposition to the kinetochores of the
CC       congressed chromosomes. In cells undergoing cytokinesis, localized
CC       to the midbody, the ingressing cleavage furrow, and the central
CC       spindle (By similarity). In interphase and postmitotic cells,
CC       localised to fibrous or granular structures, depending on the
CC       growth state of the cell. Localizes at the base of the cilia near
CC       the morphological distinction between the cilia and plasma
CC       membranes. Found in the sperm annulus. {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q15019}.
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC   -!- DEVELOPMENTAL STAGE: Expressed at 17 dpc in the brain with levels
CC       remaining relatively stable up to adulthood (at protein level).
CC       {ECO:0000269|PubMed:11739749}.
CC   -!- MISCELLANEOUS: Coordinated expression with SEPT6 and SEPT7.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-
CC       like GTPase superfamily. Septin GTPase family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01056}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D49382; BAA08380.1; -; mRNA.
DR   EMBL; AK028072; BAC25737.1; -; mRNA.
DR   EMBL; AK146616; BAE27305.1; -; mRNA.
DR   EMBL; AK151591; BAE30531.1; -; mRNA.
DR   EMBL; AK171331; BAE42396.1; -; mRNA.
DR   EMBL; CH466520; EDL39946.1; -; Genomic_DNA.
DR   EMBL; CH466520; EDL39948.1; -; Genomic_DNA.
DR   EMBL; BC138636; AAI38637.1; -; mRNA.
DR   EMBL; BC138637; AAI38638.1; -; mRNA.
DR   CCDS; CCDS15190.1; -.
DR   RefSeq; NP_001153189.1; NM_001159717.1.
DR   RefSeq; NP_001153190.1; NM_001159718.1.
DR   RefSeq; NP_001153191.1; NM_001159719.1.
DR   RefSeq; NP_035021.1; NM_010891.2.
DR   RefSeq; XP_006529304.1; XM_006529241.2.
DR   RefSeq; XP_006529305.1; XM_006529242.1.
DR   UniGene; Mm.428652; -.
DR   PDB; 3FTQ; X-ray; 2.90 A; A/B/C/D=33-306.
DR   PDBsum; 3FTQ; -.
DR   ProteinModelPortal; P42208; -.
DR   SMR; P42208; -.
DR   BioGrid; 201724; 19.
DR   DIP; DIP-32438N; -.
DR   IntAct; P42208; 21.
DR   MINT; P42208; -.
DR   STRING; 10090.ENSMUSP00000027495; -.
DR   iPTMnet; P42208; -.
DR   PhosphoSitePlus; P42208; -.
DR   SwissPalm; P42208; -.
DR   REPRODUCTION-2DPAGE; IPI00114945; -.
DR   REPRODUCTION-2DPAGE; P42208; -.
DR   EPD; P42208; -.
DR   MaxQB; P42208; -.
DR   PaxDb; P42208; -.
DR   PeptideAtlas; P42208; -.
DR   PRIDE; P42208; -.
DR   Ensembl; ENSMUST00000027495; ENSMUSP00000027495; ENSMUSG00000026276.
DR   Ensembl; ENSMUST00000168776; ENSMUSP00000132850; ENSMUSG00000026276.
DR   Ensembl; ENSMUST00000179353; ENSMUSP00000136366; ENSMUSG00000026276.
DR   GeneID; 18000; -.
DR   KEGG; mmu:18000; -.
DR   UCSC; uc007cea.2; mouse.
DR   CTD; 4735; -.
DR   MGI; MGI:97298; Sept2.
DR   eggNOG; KOG2655; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   GeneTree; ENSGT00910000144020; -.
DR   HOGENOM; HOG000233586; -.
DR   HOVERGEN; HBG065093; -.
DR   InParanoid; P42208; -.
DR   KO; K16942; -.
DR   OMA; QWEQHLI; -.
DR   OrthoDB; EOG091G07TS; -.
DR   PhylomeDB; P42208; -.
DR   TreeFam; TF101079; -.
DR   Reactome; R-MMU-5620912; Anchoring of the basal body to the plasma membrane.
DR   ChiTaRS; Sept2; mouse.
DR   EvolutionaryTrace; P42208; -.
DR   PRO; PR:P42208; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   Bgee; ENSMUSG00000026276; -.
DR   CleanEx; MM_SEPT2; -.
DR   ExpressionAtlas; P42208; baseline and differential.
DR   Genevisible; P42208; MM.
DR   GO; GO:0015629; C:actin cytoskeleton; TAS:MGI.
DR   GO; GO:0005826; C:actomyosin contractile ring; NAS:UniProtKB.
DR   GO; GO:0005930; C:axoneme; ISO:MGI.
DR   GO; GO:0005938; C:cell cortex; TAS:MGI.
DR   GO; GO:0042995; C:cell projection; IDA:MGI.
DR   GO; GO:0009986; C:cell surface; IDA:MGI.
DR   GO; GO:0060170; C:ciliary membrane; IDA:UniProtKB.
DR   GO; GO:0035869; C:ciliary transition zone; IDA:MGI.
DR   GO; GO:0032154; C:cleavage furrow; IEA:UniProtKB-SubCell.
DR   GO; GO:0000777; C:condensed chromosome kinetochore; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; TAS:MGI.
DR   GO; GO:0030496; C:midbody; TAS:MGI.
DR   GO; GO:0043209; C:myelin sheath; IDA:UniProtKB.
DR   GO; GO:0097730; C:non-motile cilium; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0032391; C:photoreceptor connecting cilium; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0031105; C:septin complex; ISO:MGI.
DR   GO; GO:0097227; C:sperm annulus; ISO:MGI.
DR   GO; GO:0005876; C:spindle microtubule; TAS:MGI.
DR   GO; GO:0045202; C:synapse; IDA:MGI.
DR   GO; GO:0045296; F:cadherin binding; ISO:MGI.
DR   GO; GO:0030234; F:enzyme regulator activity; IDA:MGI.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; NAS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0032947; F:protein-containing complex scaffold activity; IDA:MGI.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0060271; P:cilium assembly; IMP:UniProtKB.
DR   GO; GO:0061640; P:cytoskeleton-dependent cytokinesis; NAS:UniProtKB.
DR   GO; GO:0051258; P:protein polymerization; TAS:MGI.
DR   GO; GO:0002036; P:regulation of L-glutamate import across plasma membrane; IDA:MGI.
DR   GO; GO:0032880; P:regulation of protein localization; IDA:MGI.
DR   GO; GO:0007224; P:smoothened signaling pathway; IMP:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR016491; Septin.
DR   InterPro; IPR008113; Septin2.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   PRINTS; PR01740; SEPTIN2.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell cycle; Cell division; Cell membrane;
KW   Cell projection; Centromere; Chromosome; Cilium; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Differentiation; Direct protein sequencing;
KW   Flagellum; GTP-binding; Kinetochore; Membrane; Mitosis;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Spermatogenesis.
FT   CHAIN         1    361       Septin-2.
FT                                /FTId=PRO_0000173516.
FT   DOMAIN       34    306       Septin-type G. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   NP_BIND      44     52       GTP.
FT   NP_BIND     183    186       GTP.
FT   REGION       44     51       G1 motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   REGION      101    104       G3 motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   REGION      182    185       G4 motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   REGION      260    270       Important for dimerization.
FT                                {ECO:0000250}.
FT   BINDING      78     78       GTP.
FT   BINDING     104    104       GTP; via amide nitrogen.
FT   BINDING     241    241       GTP; via amide nitrogen and carbonyl
FT                                oxygen. {ECO:0000250}.
FT   BINDING     256    256       GTP.
FT   BINDING     258    258       GTP. {ECO:0000250}.
FT   SITE        156    156       Important for dimerization.
FT                                {ECO:0000250}.
FT   MOD_RES      17     17       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15592455}.
FT   MOD_RES     190    190       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q15019}.
FT   MOD_RES     211    211       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q15019}.
FT   MOD_RES     218    218       Phosphoserine.
FT                                {ECO:0000244|PubMed:16452087,
FT                                ECO:0000244|PubMed:17242355,
FT                                ECO:0000244|PubMed:18630941,
FT                                ECO:0000244|PubMed:19131326,
FT                                ECO:0000244|PubMed:19144319,
FT                                ECO:0000244|PubMed:21183079}.
FT   MUTAGEN      46     46       S->D: Loss of GTP-binding.
FT                                {ECO:0000269|PubMed:19805342}.
FT   MUTAGEN      47     47       G->V: Loss of GTP-binding activity.
FT                                {ECO:0000269|PubMed:9203580}.
FT   MUTAGEN      51     51       S->N: Loss of GTP-binding activity.
FT                                {ECO:0000269|PubMed:9203580}.
FT   MUTAGEN      78     78       T->G: Reduces affinity for GTP 20-fold.
FT                                {ECO:0000269|PubMed:19805342}.
FT   MUTAGEN     125    125       Q->L: Loss of GTP-binding activity.
FT                                {ECO:0000269|PubMed:9203580}.
FT   STRAND       35     45       {ECO:0000244|PDB:3FTQ}.
FT   HELIX        50     55       {ECO:0000244|PDB:3FTQ}.
FT   STRAND       59     61       {ECO:0000244|PDB:3FTQ}.
FT   STRAND       82     90       {ECO:0000244|PDB:3FTQ}.
FT   STRAND       93    101       {ECO:0000244|PDB:3FTQ}.
FT   STRAND      105    109       {ECO:0000244|PDB:3FTQ}.
FT   HELIX       111    133       {ECO:0000244|PDB:3FTQ}.
FT   STRAND      148    153       {ECO:0000244|PDB:3FTQ}.
FT   STRAND      157    160       {ECO:0000244|PDB:3FTQ}.
FT   HELIX       162    171       {ECO:0000244|PDB:3FTQ}.
FT   TURN        172    174       {ECO:0000244|PDB:3FTQ}.
FT   STRAND      177    182       {ECO:0000244|PDB:3FTQ}.
FT   HELIX       184    186       {ECO:0000244|PDB:3FTQ}.
FT   HELIX       189    205       {ECO:0000244|PDB:3FTQ}.
FT   HELIX       222    233       {ECO:0000244|PDB:3FTQ}.
FT   STRAND      236    238       {ECO:0000244|PDB:3FTQ}.
FT   STRAND      245    247       {ECO:0000244|PDB:3FTQ}.
FT   STRAND      249    258       {ECO:0000244|PDB:3FTQ}.
FT   STRAND      261    264       {ECO:0000244|PDB:3FTQ}.
FT   TURN        268    270       {ECO:0000244|PDB:3FTQ}.
FT   HELIX       273    293       {ECO:0000244|PDB:3FTQ}.
FT   HELIX       295    303       {ECO:0000244|PDB:3FTQ}.
SQ   SEQUENCE   361 AA;  41526 MW;  C4BFFB3F1815E081 CRC64;
     MSKQQPTQFI NPETPGYVGF ANLPNQVHRK SVKKGFEFTL MVVGESGLGK STLINSLFLT
     DLYPERIIPG AAEKIERTVQ IEASTVEIEE RGVKLRLTVV DTPGYGDAIN CRDCFKTIIS
     YIDEQFERYL HDESGLNRRH IIDNRVHCCF YFISPFGHGL KPLDVAFMKA IHNKVNIVPV
     IAKADTLTLK ERERLKKRIL DEIEEHSIKI YHLPDAESDE DEDFKEQTRL LKASIPFSVV
     GSNQLIEAKG KKVRGRLYPW GVVEVENPEH NDFLKLRTML ITHMQDLQEV TQDLHYENFR
     SERLKRGGRK VENEDMNKDQ ILLEKEAELR RMQEMIARMQ AQMQMQMQGG DSDSGALGQH
     V
//
ID   A2A6U3_MOUSE            Unreviewed;       565 AA.
AC   A2A6U3;
DT   20-FEB-2007, integrated into UniProtKB/TrEMBL.
DT   20-FEB-2007, sequence version 1.
DT   23-MAY-2018, entry version 96.
DE   SubName: Full=Septin-9 {ECO:0000313|Ensembl:ENSMUSP00000101961};
GN   Name=Sept9 {ECO:0000313|Ensembl:ENSMUSP00000101961,
GN   ECO:0000313|MGI:MGI:1858222};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090 {ECO:0000313|Ensembl:ENSMUSP00000101961, ECO:0000313|Proteomes:UP000000589};
RN   [1] {ECO:0000213|PubMed:17242355}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [2] {ECO:0000313|Ensembl:ENSMUSP00000101961, ECO:0000313|Proteomes:UP000000589}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J {ECO:0000313|Ensembl:ENSMUSP00000101961,
RC   ECO:0000313|Proteomes:UP000000589};
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3] {ECO:0000213|PubMed:21183079}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [4] {ECO:0000313|Ensembl:ENSMUSP00000101961}
RP   IDENTIFICATION.
RC   STRAIN=C57BL/6J {ECO:0000313|Ensembl:ENSMUSP00000101961};
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [5] {ECO:0000213|PubMed:23806337}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z.,
RA   Zhang Y., Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-
CC       like GTPase superfamily. Septin GTPase family.
CC       {ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00534725}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL603868; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL611935; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL645975; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_006533807.1; XM_006533744.1.
DR   UniGene; Mm.38450; -.
DR   UniGene; Mm.451420; -.
DR   ProteinModelPortal; A2A6U3; -.
DR   SMR; A2A6U3; -.
DR   MaxQB; A2A6U3; -.
DR   PeptideAtlas; A2A6U3; -.
DR   PRIDE; A2A6U3; -.
DR   Ensembl; ENSMUST00000106354; ENSMUSP00000101961; ENSMUSG00000059248.
DR   GeneID; 53860; -.
DR   CTD; 10801; -.
DR   MGI; MGI:1858222; Sept9.
DR   eggNOG; KOG1547; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   GeneTree; ENSGT00910000144020; -.
DR   HOVERGEN; HBG098529; -.
DR   ChiTaRS; Sept9; mouse.
DR   Proteomes; UP000000589; Chromosome 11.
DR   Bgee; ENSMUSG00000059248; -.
DR   ExpressionAtlas; A2A6U3; baseline and differential.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030645; SEPT9.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF47; PTHR18884:SF47; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000000589};
KW   GTP-binding {ECO:0000256|RuleBase:RU004560,
KW   ECO:0000256|SAAS:SAAS00494966};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU004560,
KW   ECO:0000256|SAAS:SAAS00494966};
KW   Proteomics identification {ECO:0000213|EPD:A2A6U3,
KW   ECO:0000213|MaxQB:A2A6U3, ECO:0000213|PeptideAtlas:A2A6U3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000000589}.
FT   DOMAIN      275    547       Septin-type G.
FT                                {ECO:0000259|PROSITE:PS51719}.
SQ   SEQUENCE   565 AA;  63773 MW;  A562151D065B010E CRC64;
     MERDRITALK RSFEVEEIEP PNSTPPRRVQ TPLLRATVAS SSQKFQDLGV KNSEPAARLV
     DSLSQRSPKP SLRRVELAGA KAPEPMSRRT EISIDISSKQ VESTASAAGP SRFGLKRAEV
     LGHKTPEPVP RRTEITIVKP QESVLRRVET PASKIPEGSA VPATDAAPKR VEIQVPKPAE
     APNCPLPSQT LENSEAPMSQ LQSRLEPRPS VAEVPYRNQE DSEVTPSCVG DMADNPRDAM
     LKQAPASRNE KAPMEFGYVG IDSILEQMRR KAMKQGFEFN IMVVGQSGLG KSTLINTLFK
     SKISRKSVQP TSEERIPKTI EIKSITHDIE EKGVRMKLTV IDTPGFGDHI NNENCWQPIM
     KFINDQYEKY LQEEVNINRK KRIPDTRVHC CLYFIPATGH SLRPLDIEFM KRLSKVVNIV
     PVIAKADTLT LEERVYFKQR ITADLLSNGI DVYPQKEFDE DAEDRLVNEK FREMIPFAVV
     GSDHEYQVNG KRILGRKTKW GTIEVENTTH CEFAYLRDLL IRTHMQNIKD ITSNIHFEAY
     RVKRLNEGNS AMANGIEKEP EAQEM
//
ID   SEPT9_MOUSE             Reviewed;         583 AA.
AC   Q80UG5; A2A6U2; A2A6U4; A2A6U6; Q3URP2; Q80TM7; Q9QYX9;
DT   21-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   23-MAY-2018, entry version 133.
DE   RecName: Full=Septin-9;
DE   AltName: Full=SL3-3 integration site 1 protein;
GN   Name=Sept9; Synonyms=Kiaa0991, Sint1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=10666245; DOI=10.1128/JVI.74.5.2161-2168.2000;
RA   Soerensen A.B., Lund A.H., Ethelberg S., Copeland N.G., Jenkins N.A.,
RA   Pedersen F.S.;
RT   "Sint1, a common integration site in SL3-3-induced T-cell lymphomas,
RT   harbors a putative proto-oncogene with homology to the septin gene
RT   family.";
RL   J. Virol. 74:2161-2168(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORM 2),
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=12039034; DOI=10.1016/S0378-1119(02)00406-7;
RA   Soerensen A.B., Warming S., Fuechtbauer E.-M., Pedersen F.S.;
RT   "Alternative splicing, expression, and gene structure of the septin-
RT   like putative proto-oncogene Sint1.";
RL   Gene 285:79-89(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Embryonic tail;
RX   PubMed=12693553; DOI=10.1093/dnares/10.1.35;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Aizawa H., Yuasa S.,
RA   Nakajima D., Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene:
RT   II. The complete nucleotide sequences of 400 mouse KIAA-homologous
RT   cDNAs identified by screening of terminal sequences of cDNA clones
RT   randomly sampled from size-fractionated libraries.";
RL   DNA Res. 10:35-48(2003).
RN   [4]
RP   SEQUENCE REVISION.
RA   Okazaki N., Kikuno R., Nagase T., Ohara O., Koga H.;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J; TISSUE=Head;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=129; TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 548-559, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=OF1; TISSUE=Hippocampus;
RA   Lubec G., Sunyer B., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17546647; DOI=10.1002/humu.20554;
RA   Sudo K., Ito H., Iwamoto I., Morishita R., Asano T., Nagata K.;
RT   "SEPT9 sequence alternations causing hereditary neuralgic amyotrophy
RT   are associated with altered interactions with SEPT4/SEPT11 and
RT   resistance to Rho/Rhotekin-signaling.";
RL   Hum. Mutat. 28:1005-1013(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30; THR-49 AND THR-143,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung,
RC   Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-62, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z.,
RA   Zhang Y., Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
CC   -!- FUNCTION: Filament-forming cytoskeletal GTPase (By similarity).
CC       May play a role in cytokinesis (Potential). {ECO:0000250,
CC       ECO:0000305}.
CC   -!- SUBUNIT: Septins polymerize into heterooligomeric protein
CC       complexes that form filaments, and associate with cellular
CC       membranes, actin filaments, and microtubules. GTPase activity is
CC       required for filament formation. Interacts with SEPT2, SEPT6,
CC       SEPT7, SEPT11 and SEPT14. Interacts with RTKN and ARHGEF18 (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:17546647}. Note=In an epithelial cell line,
CC       concentrates at cell-cell contact areas. After TGF-beta1 treatment
CC       and induction of epithelial to mesenchymal transition, colocalizes
CC       with actin stress fibers.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q80UG5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q80UG5-2; Sequence=VSP_012341;
CC       Name=3;
CC         IsoId=Q80UG5-3; Sequence=VSP_012342;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues examined except
CC       muscle. Isoforms are differentially expressed in testes, kidney,
CC       liver, heart, spleen and brain. {ECO:0000269|PubMed:10666245,
CC       ECO:0000269|PubMed:12039034}.
CC   -!- DEVELOPMENTAL STAGE: At 8 dpc mainly expressed in the lateral
CC       plate mesoderm and the somites. Beginning at 9 dpc the lateral
CC       plate expression is clearly focused in the developing fore- and
CC       hindlimb buds. In the cephalic region, expressed in the first and
CC       second branchial arch, in the nasal process and around the otic
CC       pit. At 9.5 dpc strongest expression is observed in the mesenchyme
CC       of the branchial arches, the limbs, and the developing dorsal root
CC       ganglia. Weak to intermediate expression is found in the neural
CC       epithelium. Expression is seen in the newly formed somites in the
CC       tail bud of older embryos. During formation of the digits,
CC       expression seems to outline the surviving tissue bordering it
CC       towards the apoptotic webbing. Expression is seen in the
CC       developing outer ear and in several areas known to be regulated by
CC       intensive epithelial mesenchymal interactions, like the viscera
CC       follicles and the developing mammary glands.
CC       {ECO:0000269|PubMed:12039034}.
CC   -!- DISEASE: Note=Putative proto-oncogene involved in T-cell
CC       lymphomagenesis. May play a role in leukemogenesis.
CC   -!- MISCELLANEOUS: Targeted by proviral insertion in T-cell lymphomas
CC       induced by the murine retrovirus SL3-3 MuLV.
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-
CC       like GTPase superfamily. Septin GTPase family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01056}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC65697.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ250723; CAB59833.1; -; mRNA.
DR   EMBL; AF450142; AAL50685.1; -; Genomic_DNA.
DR   EMBL; AF450141; AAL50685.1; JOINED; Genomic_DNA.
DR   EMBL; AK031757; BAC27538.1; -; mRNA.
DR   EMBL; AK122415; BAC65697.2; ALT_INIT; mRNA.
DR   EMBL; AK141312; BAE24646.1; -; mRNA.
DR   EMBL; AL603868; CAM13312.1; -; Genomic_DNA.
DR   EMBL; AL611935; CAM13312.1; JOINED; Genomic_DNA.
DR   EMBL; AL645975; CAM13312.1; JOINED; Genomic_DNA.
DR   EMBL; AL645975; CAM15613.1; -; Genomic_DNA.
DR   EMBL; AL603868; CAM15613.1; JOINED; Genomic_DNA.
DR   EMBL; AL611935; CAM15613.1; JOINED; Genomic_DNA.
DR   EMBL; AL611935; CAM19703.1; -; Genomic_DNA.
DR   EMBL; AL603868; CAM19703.1; JOINED; Genomic_DNA.
DR   EMBL; AL645975; CAM19703.1; JOINED; Genomic_DNA.
DR   EMBL; BC046524; AAH46524.1; -; mRNA.
DR   CCDS; CCDS25684.1; -. [Q80UG5-2]
DR   CCDS; CCDS48990.1; -. [Q80UG5-1]
DR   CCDS; CCDS48991.1; -. [Q80UG5-3]
DR   RefSeq; NP_001106958.1; NM_001113486.1. [Q80UG5-1]
DR   RefSeq; NP_001106959.1; NM_001113487.1. [Q80UG5-3]
DR   RefSeq; NP_001106960.1; NM_001113488.1. [Q80UG5-2]
DR   RefSeq; NP_059076.1; NM_017380.2. [Q80UG5-2]
DR   RefSeq; XP_006533808.2; XM_006533745.3. [Q80UG5-2]
DR   RefSeq; XP_006533809.1; XM_006533746.3. [Q80UG5-2]
DR   UniGene; Mm.38450; -.
DR   UniGene; Mm.451420; -.
DR   ProteinModelPortal; Q80UG5; -.
DR   SMR; Q80UG5; -.
DR   BioGrid; 207494; 40.
DR   IntAct; Q80UG5; 41.
DR   STRING; 10090.ENSMUSP00000091435; -.
DR   iPTMnet; Q80UG5; -.
DR   PhosphoSitePlus; Q80UG5; -.
DR   PaxDb; Q80UG5; -.
DR   PeptideAtlas; Q80UG5; -.
DR   PRIDE; Q80UG5; -.
DR   Ensembl; ENSMUST00000019038; ENSMUSP00000019038; ENSMUSG00000059248. [Q80UG5-3]
DR   Ensembl; ENSMUST00000093907; ENSMUSP00000091435; ENSMUSG00000059248. [Q80UG5-1]
DR   Ensembl; ENSMUST00000100193; ENSMUSP00000097767; ENSMUSG00000059248. [Q80UG5-2]
DR   Ensembl; ENSMUST00000106349; ENSMUSP00000101956; ENSMUSG00000059248. [Q80UG5-2]
DR   GeneID; 53860; -.
DR   KEGG; mmu:53860; -.
DR   UCSC; uc007mnd.2; mouse. [Q80UG5-1]
DR   UCSC; uc007mne.2; mouse. [Q80UG5-3]
DR   CTD; 10801; -.
DR   MGI; MGI:1858222; Sept9.
DR   eggNOG; KOG1547; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   GeneTree; ENSGT00910000144020; -.
DR   HOVERGEN; HBG098529; -.
DR   InParanoid; Q80UG5; -.
DR   KO; K16938; -.
DR   OMA; NIHFEAY; -.
DR   OrthoDB; EOG091G08V5; -.
DR   PhylomeDB; Q80UG5; -.
DR   TreeFam; TF101078; -.
DR   ChiTaRS; Sept9; mouse.
DR   PRO; PR:Q80UG5; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   Bgee; ENSMUSG00000059248; -.
DR   CleanEx; MM_SEPT9; -.
DR   ExpressionAtlas; Q80UG5; baseline and differential.
DR   Genevisible; Q80UG5; MM.
DR   GO; GO:0015629; C:actin cytoskeleton; ISO:MGI.
DR   GO; GO:0005930; C:axoneme; ISO:MGI.
DR   GO; GO:0005874; C:microtubule; ISO:MGI.
DR   GO; GO:0097730; C:non-motile cilium; ISO:MGI.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:MGI.
DR   GO; GO:0031105; C:septin complex; ISO:MGI.
DR   GO; GO:0001725; C:stress fiber; ISO:MGI.
DR   GO; GO:0045296; F:cadherin binding; ISO:MGI.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:1902857; P:positive regulation of non-motile cilium assembly; ISO:MGI.
DR   GO; GO:0051291; P:protein heterooligomerization; ISO:MGI.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030645; SEPT9.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF47; PTHR18884:SF47; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell cycle; Cell division;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   GTP-binding; Nucleotide-binding; Phosphoprotein; Reference proteome.
FT   CHAIN         1    583       Septin-9.
FT                                /FTId=PRO_0000173536.
FT   DOMAIN      293    565       Septin-type G. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   NP_BIND     303    310       GTP. {ECO:0000250}.
FT   NP_BIND     443    451       GTP. {ECO:0000250}.
FT   REGION      303    310       G1 motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   REGION      360    363       G3 motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   REGION      442    445       G4 motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   BINDING     337    337       GTP. {ECO:0000250}.
FT   BINDING     363    363       GTP; via amide nitrogen. {ECO:0000250}.
FT   BINDING     499    499       GTP; via amide nitrogen and carbonyl
FT                                oxygen. {ECO:0000250}.
FT   BINDING     514    514       GTP. {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000250|UniProtKB:Q9UHD8}.
FT   MOD_RES      30     30       Phosphoserine.
FT                                {ECO:0000244|PubMed:17242355,
FT                                ECO:0000244|PubMed:21183079}.
FT   MOD_RES      42     42       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9UHD8}.
FT   MOD_RES      49     49       Phosphothreonine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES      62     62       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:23806337}.
FT   MOD_RES      82     82       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9UHD8}.
FT   MOD_RES      85     85       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9UHD8}.
FT   MOD_RES      89     89       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9UHD8}.
FT   MOD_RES     143    143       Phosphothreonine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     276    276       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q9UHD8}.
FT   MOD_RES     325    325       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9UHD8}.
FT   MOD_RES     330    330       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9UHD8}.
FT   VAR_SEQ       1    249       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10666245,
FT                                ECO:0000303|PubMed:16141072}.
FT                                /FTId=VSP_012341.
FT   VAR_SEQ       1     25       MKKSYSGVTRTSSGRLRRLADPTGP -> MSDPAVNAQLDG
FT                                IISDFE (in isoform 3).
FT                                {ECO:0000303|PubMed:12693553}.
FT                                /FTId=VSP_012342.
SQ   SEQUENCE   583 AA;  65575 MW;  174D2F1E8EA382FC CRC64;
     MKKSYSGVTR TSSGRLRRLA DPTGPALKRS FEVEEIEPPN STPPRRVQTP LLRATVASSS
     QKFQDLGVKN SEPAARLVDS LSQRSPKPSL RRVELAGAKA PEPMSRRTEI SIDISSKQVE
     STASAAGPSR FGLKRAEVLG HKTPEPVPRR TEITIVKPQE SVLRRVETPA SKIPEGSAVP
     ATDAAPKRVE IQVPKPAEAP NCPLPSQTLE NSEAPMSQLQ SRLEPRPSVA EVPYRNQEDS
     EVTPSCVGDM ADNPRDAMLK QAPASRNEKA PMEFGYVGID SILEQMRRKA MKQGFEFNIM
     VVGQSGLGKS TLINTLFKSK ISRKSVQPTS EERIPKTIEI KSITHDIEEK GVRMKLTVID
     TPGFGDHINN ENCWQPIMKF INDQYEKYLQ EEVNINRKKR IPDTRVHCCL YFIPATGHSL
     RPLDIEFMKR LSKVVNIVPV IAKADTLTLE ERVYFKQRIT ADLLSNGIDV YPQKEFDEDA
     EDRLVNEKFR EMIPFAVVGS DHEYQVNGKR ILGRKTKWGT IEVENTTHCE FAYLRDLLIR
     THMQNIKDIT SNIHFEAYRV KRLNEGNSAM ANGIEKEPEA QEM
//
ID   ERBB3_HUMAN             Reviewed;        1342 AA.
AC   P21860; A8K6L6; B4DIK7; B4DV32; E9PDT8; Q9BUD7;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1991, sequence version 1.
DT   23-MAY-2018, entry version 209.
DE   RecName: Full=Receptor tyrosine-protein kinase erbB-3;
DE            EC=2.7.10.1;
DE   AltName: Full=Proto-oncogene-like protein c-ErbB-3;
DE   AltName: Full=Tyrosine kinase-type cell surface receptor HER3;
DE   Flags: Precursor;
GN   Name=ERBB3; Synonyms=HER3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2687875; DOI=10.1073/pnas.86.23.9193;
RA   Kraus M.H., Issing W., Miki T., Popescu N.C., Aaronson S.A.;
RT   "Isolation and characterization of ERBB3, a third member of the
RT   ERBB/epidermal growth factor receptor family: evidence for
RT   overexpression in a subset of human mammary tumors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:9193-9197(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2164210; DOI=10.1073/pnas.87.13.4905;
RA   Plowman G.D., Whitney G.S., Neubauer M.G., Green J.M., McDonald V.L.,
RA   Todaro G.J., Shoyab M.;
RT   "Molecular cloning and expression of an additional epidermal growth
RT   factor receptor-related gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:4905-4909(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=7685162; DOI=10.1006/bbrc.1993.1542;
RA   Katoh M., Yazaki Y., Sugimura T., Terada M.;
RT   "c-erbB3 gene encodes secreted as well as transmembrane receptor
RT   tyrosine kinase.";
RL   Biochem. Biophys. Res. Commun. 192:1189-1197(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 4 AND 5).
RC   TISSUE=Hippocampus, Placenta, and Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH GRB7.
RX   PubMed=9516479; DOI=10.1074/jbc.273.13.7717;
RA   Fiddes R.J., Campbell D.H., Janes P.W., Sivertsen S.P., Sasaki H.,
RA   Wallasch C., Daly R.J.;
RT   "Analysis of Grb7 recruitment by heregulin-activated erbB receptors
RT   reveals a novel target selectivity for erbB3.";
RL   J. Biol. Chem. 273:7717-7724(1998).
RN   [9]
RP   INTERACTION WITH PA2G4.
RX   PubMed=11325528; DOI=10.1016/S0303-7207(01)00387-2;
RA   Lessor T.J., Hamburger A.W.;
RT   "Regulation of the ErbB3 binding protein Ebp1 by protein kinase C.";
RL   Mol. Cell. Endocrinol. 175:185-191(2001).
RN   [10]
RP   INTERACTION WITH MUC1.
RX   PubMed=12939402;
RA   Li Y., Yu W.-H., Ren J., Chen W., Huang L., Kharbanda S., Loda M.,
RA   Kufe D.;
RT   "Heregulin targets gamma-catenin to the nucleolus by a mechanism
RT   dependent on the DF3/MUC1 oncoprotein.";
RL   Mol. Cancer Res. 1:765-775(2003).
RN   [11]
RP   INTERACTION WITH CSPG5, AND FUNCTION.
RX   PubMed=15358134; DOI=10.1016/j.bbrc.2004.07.066;
RA   Kinugasa Y., Ishiguro H., Tokita Y., Oohira A., Ohmoto H.,
RA   Higashiyama S.;
RT   "Neuroglycan C, a novel member of the neuregulin family.";
RL   Biochem. Biophys. Res. Commun. 321:1045-1049(2004).
RN   [12]
RP   INTERACTION WITH PA2G4.
RX   PubMed=16832058; DOI=10.1073/pnas.0602923103;
RA   Liu Z., Ahn J.Y., Liu X., Ye K.;
RT   "Ebp1 isoforms distinctively regulate cell survival and
RT   differentiation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:10917-10922(2006).
RN   [13]
RP   INVOLVEMENT IN LCCS2.
RX   PubMed=17701904; DOI=10.1086/520770;
RA   Narkis G., Ofir R., Manor E., Landau D., Elbedour K., Birk O.S.;
RT   "Lethal congenital contractural syndrome type 2 (LCCS2) is caused by a
RT   mutation in ERBB3 (Her3), a modulator of the phosphatidylinositol-3-
RT   kinase/Akt pathway.";
RL   Am. J. Hum. Genet. 81:589-595(2007).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   FUNCTION, BINDING TO NRG1, IDENTIFICATION IN A COMPLEX WITH NRG1 AND
RP   INTEGRINS, AND PHOSPHORYLATION.
RX   PubMed=20682778; DOI=10.1074/jbc.M110.113878;
RA   Ieguchi K., Fujita M., Ma Z., Davari P., Taniguchi Y., Sekiguchi K.,
RA   Wang B., Takada Y.K., Takada Y.;
RT   "Direct binding of the EGF-like domain of neuregulin-1 to integrins
RT   ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB
RT   signaling.";
RL   J. Biol. Chem. 285:31388-31398(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-686, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-686 AND SER-982, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 20-640, DISULFIDE BONDS, AND
RP   GLYCOSYLATION AT ASN-250; ASN-353; ASN-408; ASN-414; ASN-437; ASN-469;
RP   ASN-522 AND ASN-566.
RX   PubMed=12154198; DOI=10.1126/science.1074611;
RA   Cho H.S., Leahy D.J.;
RT   "Structure of the extracellular region of HER3 reveals an interdomain
RT   tether.";
RL   Science 297:1330-1333(2002).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 698-1019 IN COMPLEX WITH
RP   AMP-PNP, AND SUBUNIT.
RX   PubMed=20007378; DOI=10.1073/pnas.0912101106;
RA   Jura N., Shan Y., Cao X., Shaw D.E., Kuriyan J.;
RT   "Structural analysis of the catalytically inactive kinase domain of
RT   the human EGF receptor 3.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:21608-21613(2009).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 684-1020 IN COMPLEX WITH
RP   AMP-PNP, CATALYTIC ACTIVITY, MUTAGENESIS OF LYS-742 AND TYR-868,
RP   AUTOPHOSPHORYLATION, AND SUBUNIT.
RX   PubMed=20351256; DOI=10.1073/pnas.1002753107;
RA   Shi F., Telesco S.E., Liu Y., Radhakrishnan R., Lemmon M.A.;
RT   "ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze
RT   autophosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:7692-7697(2010).
RN   [21]
RP   STRUCTURE BY NMR OF 640-670, AND SUBUNIT.
RX   PubMed=21575594; DOI=10.1016/j.bbamem.2011.04.017;
RA   Mineev K.S., Khabibullina N.F., Lyukmanova E.N., Dolgikh D.A.,
RA   Kirpichnikov M.P., Arseniev A.S.;
RT   "Spatial structure and dimer-monomer equilibrium of the ErbB3
RT   transmembrane domain in DPC micelles.";
RL   Biochim. Biophys. Acta 1808:2081-2088(2011).
RN   [22]
RP   VARIANTS [LARGE SCALE ANALYSIS] TYR-20; LEU-30; MET-104; ILE-204;
RP   TRP-683; LEU-717; THR-744; ARG-998; CYS-1119; HIS-1127; ILE-1177 AND
RP   LYS-1254.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Tyrosine-protein kinase that plays an essential role as
CC       cell surface receptor for neuregulins. Binds to neuregulin-1
CC       (NRG1) and is activated by it; ligand-binding increases
CC       phosphorylation on tyrosine residues and promotes its association
CC       with the p85 subunit of phosphatidylinositol 3-kinase
CC       (PubMed:20682778). May also be activated by CSPG5
CC       (PubMed:15358134). {ECO:0000269|PubMed:15358134,
CC       ECO:0000269|PubMed:20682778}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000269|PubMed:20351256}.
CC   -!- SUBUNIT: Monomer and homodimer. Heterodimer with each of the other
CC       ERBB receptors (Potential). Interacts with CSPG5
CC       (PubMed:15358134). Interacts with GRB7 (PubMed:9516479). Interacts
CC       with MUC1 (PubMed:12939402). Interacts with MYOC (By similarity).
CC       Interacts with isoform 2 of PA2G4 (PubMed:11325528,
CC       PubMed:16832058). Found in a ternary complex with NRG1 and
CC       ITGAV:ITGB3 or ITGA6:ITGB4 (PubMed:20682778).
CC       {ECO:0000250|UniProtKB:Q61526, ECO:0000269|PubMed:11325528,
CC       ECO:0000269|PubMed:12939402, ECO:0000269|PubMed:15358134,
CC       ECO:0000269|PubMed:16832058, ECO:0000269|PubMed:20682778,
CC       ECO:0000269|PubMed:9516479, ECO:0000305}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-720706, EBI-720706;
CC       P42684:ABL2; NbExp=10; IntAct=EBI-720706, EBI-1102694;
CC       P46108:CRK; NbExp=2; IntAct=EBI-720706, EBI-886;
CC       P46109:CRKL; NbExp=3; IntAct=EBI-720706, EBI-910;
CC       P00533:EGFR; NbExp=13; IntAct=EBI-720706, EBI-297353;
CC       P04626:ERBB2; NbExp=29; IntAct=EBI-720706, EBI-641062;
CC       Q15303:ERBB4; NbExp=4; IntAct=EBI-720706, EBI-80371;
CC       P62993:GRB2; NbExp=3; IntAct=EBI-720706, EBI-401755;
CC       Q14451:GRB7; NbExp=7; IntAct=EBI-720706, EBI-970191;
CC       P08631:HCK; NbExp=2; IntAct=EBI-720706, EBI-346340;
CC       P08238:HSP90AB1; NbExp=3; IntAct=EBI-720706, EBI-352572;
CC       O43639:NCK2; NbExp=2; IntAct=EBI-720706, EBI-713635;
CC       Q02297-7:NRG1; NbExp=3; IntAct=EBI-720706, EBI-2460927;
CC       P42336:PIK3CA; NbExp=3; IntAct=EBI-720706, EBI-2116585;
CC       P27986:PIK3R1; NbExp=41; IntAct=EBI-720706, EBI-79464;
CC       O00459:PIK3R2; NbExp=16; IntAct=EBI-720706, EBI-346930;
CC       Q92569:PIK3R3; NbExp=22; IntAct=EBI-720706, EBI-79893;
CC       P19174:PLCG1; NbExp=4; IntAct=EBI-720706, EBI-79387;
CC       P20936:RASA1; NbExp=6; IntAct=EBI-720706, EBI-1026476;
CC       Q9UQQ2:SH2B3; NbExp=2; IntAct=EBI-720706, EBI-7879749;
CC       P29353:SHC1; NbExp=5; IntAct=EBI-720706, EBI-78835;
CC       Q92529:SHC3; NbExp=2; IntAct=EBI-720706, EBI-79084;
CC       P12931:SRC; NbExp=2; IntAct=EBI-720706, EBI-621482;
CC       P43405:SYK; NbExp=6; IntAct=EBI-720706, EBI-78302;
CC       Q63HR2:TNS2; NbExp=3; IntAct=EBI-720706, EBI-949753;
CC       Q68CZ2:TNS3; NbExp=2; IntAct=EBI-720706, EBI-1220488;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=long form;
CC         IsoId=P21860-1; Sequence=Displayed;
CC       Name=2; Synonyms=short form;
CC         IsoId=P21860-2; Sequence=VSP_002893, VSP_002894;
CC       Name=3;
CC         IsoId=P21860-3; Sequence=VSP_041663, VSP_041664;
CC       Name=4;
CC         IsoId=P21860-4; Sequence=VSP_041662;
CC       Name=5;
CC         IsoId=P21860-5; Sequence=VSP_041661;
CC   -!- TISSUE SPECIFICITY: Epithelial tissues and brain.
CC   -!- DEVELOPMENTAL STAGE: Overexpressed in a subset of human mammary
CC       tumors.
CC   -!- DOMAIN: The cytoplasmic part of the receptor may interact with the
CC       SH2 or SH3 domains of many signal-transducing proteins.
CC   -!- PTM: Autophosphorylated (PubMed:20351256). Ligand-binding
CC       increases phosphorylation on tyrosine residues and promotes its
CC       association with the p85 subunit of phosphatidylinositol 3-kinase
CC       (PubMed:20682778). {ECO:0000269|PubMed:20351256,
CC       ECO:0000269|PubMed:20682778}.
CC   -!- DISEASE: Lethal congenital contracture syndrome 2 (LCCS2)
CC       [MIM:607598]: A form of lethal congenital contracture syndrome, an
CC       autosomal recessive disorder characterized by degeneration of
CC       anterior horn neurons, extreme skeletal muscle atrophy, and
CC       congenital non-progressive joint contractures (arthrogryposis).
CC       The contractures can involve the upper or lower limbs and/or the
CC       vertebral column, leading to various degrees of flexion or
CC       extension limitations evident at birth. LCCS2 patients manifest
CC       craniofacial/ocular findings, lack of hydrops, multiple pterygia,
CC       and fractures, as well as a normal duration of pregnancy and a
CC       unique feature of a markedly distended urinary bladder (neurogenic
CC       bladder defect). The phenotype suggests a spinal cord neuropathic
CC       etiology. {ECO:0000269|PubMed:17701904}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. EGF receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ERBB3ID40479ch12q13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M29366; AAA35790.1; -; mRNA.
DR   EMBL; M34309; AAA35979.1; -; mRNA.
DR   EMBL; S61953; AAB26935.1; -; mRNA.
DR   EMBL; BT007226; AAP35890.1; -; mRNA.
DR   EMBL; AK291681; BAF84370.1; -; mRNA.
DR   EMBL; AK295650; BAG58519.1; -; mRNA.
DR   EMBL; AK300909; BAG62544.1; -; mRNA.
DR   EMBL; AC034102; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002706; AAH02706.1; -; mRNA.
DR   EMBL; BC082992; AAH82992.1; -; mRNA.
DR   CCDS; CCDS31833.1; -. [P21860-1]
DR   CCDS; CCDS44918.1; -. [P21860-2]
DR   PIR; A36223; A36223.
DR   PIR; JH0803; JH0803.
DR   RefSeq; NP_001005915.1; NM_001005915.1. [P21860-2]
DR   RefSeq; NP_001973.2; NM_001982.3. [P21860-1]
DR   UniGene; Hs.118681; -.
DR   UniGene; Hs.622058; -.
DR   PDB; 1M6B; X-ray; 2.60 A; A/B=20-640.
DR   PDB; 2L9U; NMR; -; A/B=639-670.
DR   PDB; 3KEX; X-ray; 2.80 A; A/B=698-1019.
DR   PDB; 3LMG; X-ray; 2.80 A; A/B=684-1020.
DR   PDB; 3P11; X-ray; 3.70 A; A=20-532.
DR   PDB; 4LEO; X-ray; 2.64 A; C=20-631.
DR   PDB; 4OTW; X-ray; 2.51 A; A=698-1020.
DR   PDB; 4P59; X-ray; 3.40 A; A=20-640.
DR   PDB; 4RIW; X-ray; 3.10 A; A/C=698-1020.
DR   PDB; 4RIX; X-ray; 3.10 A; A/C=698-1020.
DR   PDB; 4RIY; X-ray; 2.98 A; A/C=698-1020.
DR   PDB; 5CUS; X-ray; 3.20 A; A/B/C/D=20-641.
DR   PDBsum; 1M6B; -.
DR   PDBsum; 2L9U; -.
DR   PDBsum; 3KEX; -.
DR   PDBsum; 3LMG; -.
DR   PDBsum; 3P11; -.
DR   PDBsum; 4LEO; -.
DR   PDBsum; 4OTW; -.
DR   PDBsum; 4P59; -.
DR   PDBsum; 4RIW; -.
DR   PDBsum; 4RIX; -.
DR   PDBsum; 4RIY; -.
DR   PDBsum; 5CUS; -.
DR   ProteinModelPortal; P21860; -.
DR   SMR; P21860; -.
DR   BioGrid; 108377; 186.
DR   CORUM; P21860; -.
DR   DIP; DIP-36441N; -.
DR   ELM; P21860; -.
DR   IntAct; P21860; 93.
DR   MINT; P21860; -.
DR   STRING; 9606.ENSP00000267101; -.
DR   BindingDB; P21860; -.
DR   ChEMBL; CHEMBL5838; -.
DR   GuidetoPHARMACOLOGY; 1798; -.
DR   CarbonylDB; P21860; -.
DR   iPTMnet; P21860; -.
DR   PhosphoSitePlus; P21860; -.
DR   BioMuta; ERBB3; -.
DR   DMDM; 119534; -.
DR   MaxQB; P21860; -.
DR   PaxDb; P21860; -.
DR   PeptideAtlas; P21860; -.
DR   PRIDE; P21860; -.
DR   DNASU; 2065; -.
DR   Ensembl; ENST00000267101; ENSP00000267101; ENSG00000065361. [P21860-1]
DR   Ensembl; ENST00000411731; ENSP00000415753; ENSG00000065361. [P21860-2]
DR   Ensembl; ENST00000415288; ENSP00000408340; ENSG00000065361. [P21860-4]
DR   Ensembl; ENST00000551242; ENSP00000447510; ENSG00000065361. [P21860-3]
DR   GeneID; 2065; -.
DR   KEGG; hsa:2065; -.
DR   UCSC; uc001sjg.4; human. [P21860-1]
DR   CTD; 2065; -.
DR   DisGeNET; 2065; -.
DR   EuPathDB; HostDB:ENSG00000065361.14; -.
DR   GeneCards; ERBB3; -.
DR   HGNC; HGNC:3431; ERBB3.
DR   HPA; CAB025331; -.
DR   HPA; HPA045396; -.
DR   MalaCards; ERBB3; -.
DR   MIM; 190151; gene.
DR   MIM; 607598; phenotype.
DR   neXtProt; NX_P21860; -.
DR   OpenTargets; ENSG00000065361; -.
DR   Orphanet; 137776; Lethal congenital contracture syndrome type 2.
DR   PharmGKB; PA27846; -.
DR   eggNOG; KOG1025; Eukaryota.
DR   eggNOG; ENOG410XNSR; LUCA.
DR   GeneTree; ENSGT00760000118799; -.
DR   HOGENOM; HOG000230982; -.
DR   HOVERGEN; HBG000490; -.
DR   InParanoid; P21860; -.
DR   KO; K05084; -.
DR   OMA; CYHHSLN; -.
DR   OrthoDB; EOG091G00IX; -.
DR   PhylomeDB; P21860; -.
DR   TreeFam; TF106002; -.
DR   BRENDA; 2.7.10.1; 2681.
DR   Reactome; R-HSA-1227986; Signaling by ERBB2.
DR   Reactome; R-HSA-1236394; Signaling by ERBB4.
DR   Reactome; R-HSA-1250196; SHC1 events in ERBB2 signaling.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-1306955; GRB7 events in ERBB2 signaling.
DR   Reactome; R-HSA-1358803; Downregulation of ERBB2:ERBB3 signaling.
DR   Reactome; R-HSA-1963642; PI3K events in ERBB2 signaling.
DR   Reactome; R-HSA-2219530; Constitutive Signaling by Aberrant PI3K in Cancer.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-HSA-6785631; ERBB2 Regulates Cell Motility.
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-HSA-8847993; ERBB2 Activates PTK6 Signaling.
DR   Reactome; R-HSA-8863795; Downregulation of ERBB2 signaling.
DR   SignaLink; P21860; -.
DR   SIGNOR; P21860; -.
DR   ChiTaRS; ERBB3; human.
DR   EvolutionaryTrace; P21860; -.
DR   GeneWiki; ERBB3; -.
DR   GenomeRNAi; 2065; -.
DR   PRO; PR:P21860; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000065361; -.
DR   CleanEx; HS_ERBB3; -.
DR   ExpressionAtlas; P21860; baseline and differential.
DR   Genevisible; P21860; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0016328; C:lateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:BHF-UCL.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019838; F:growth factor binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0038132; F:neuregulin binding; IDA:UniProtKB.
DR   GO; GO:0046934; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; TAS:Reactome.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; NAS:BHF-UCL.
DR   GO; GO:0030296; F:protein tyrosine kinase activator activity; IDA:BHF-UCL.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; TAS:Reactome.
DR   GO; GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; ISS:BHF-UCL.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:CAFA.
DR   GO; GO:0021545; P:cranial nerve development; ISS:BHF-UCL.
DR   GO; GO:0003197; P:endocardial cushion development; IEA:Ensembl.
DR   GO; GO:0038128; P:ERBB2 signaling pathway; TAS:Reactome.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IMP:BHF-UCL.
DR   GO; GO:0007507; P:heart development; ISS:BHF-UCL.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; IDA:BHF-UCL.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISS:BHF-UCL.
DR   GO; GO:0051048; P:negative regulation of secretion; IDA:BHF-UCL.
DR   GO; GO:0009968; P:negative regulation of signal transduction; IDA:BHF-UCL.
DR   GO; GO:0051402; P:neuron apoptotic process; IMP:BHF-UCL.
DR   GO; GO:0007422; P:peripheral nervous system development; ISS:BHF-UCL.
DR   GO; GO:0014065; P:phosphatidylinositol 3-kinase signaling; IDA:BHF-UCL.
DR   GO; GO:0070886; P:positive regulation of calcineurin-NFAT signaling cascade; IEA:Ensembl.
DR   GO; GO:0055025; P:positive regulation of cardiac muscle tissue development; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; TAS:BHF-UCL.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; TAS:Reactome.
DR   GO; GO:0061098; P:positive regulation of protein tyrosine kinase activity; IMP:BHF-UCL.
DR   GO; GO:2000145; P:regulation of cell motility; TAS:Reactome.
DR   GO; GO:0042127; P:regulation of cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0014037; P:Schwann cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; IDA:UniProtKB.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0042060; P:wound healing; NAS:BHF-UCL.
DR   Gene3D; 3.80.20.20; -; 2.
DR   InterPro; IPR006211; Furin-like_Cys-rich_dom.
DR   InterPro; IPR006212; Furin_repeat.
DR   InterPro; IPR032778; GF_recep_IV.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR000494; Rcpt_L-dom.
DR   InterPro; IPR036941; Rcpt_L-dom_sf.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR016245; Tyr_kinase_EGF/ERB/XmrK_rcpt.
DR   Pfam; PF00757; Furin-like; 1.
DR   Pfam; PF14843; GF_recep_IV; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF01030; Recep_L_domain; 2.
DR   PIRSF; PIRSF000619; TyrPK_EGF-R; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00261; FU; 5.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane;
KW   Complete proteome; Disulfide bond; Glycoprotein; Kinase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Receptor;
KW   Reference proteome; Secreted; Signal; Transferase; Transmembrane;
KW   Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20   1342       Receptor tyrosine-protein kinase erbB-3.
FT                                /FTId=PRO_0000016672.
FT   TOPO_DOM     20    643       Extracellular. {ECO:0000255}.
FT   TRANSMEM    644    664       Helical. {ECO:0000255}.
FT   TOPO_DOM    665   1342       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      709    966       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     715    723       ATP.
FT   NP_BIND     788    790       ATP.
FT   NP_BIND     834    839       ATP.
FT   ACT_SITE    834    834       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   BINDING     742    742       ATP.
FT   MOD_RES     686    686       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     982    982       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    126    126       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    250    250       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12154198}.
FT   CARBOHYD    353    353       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12154198}.
FT   CARBOHYD    408    408       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12154198}.
FT   CARBOHYD    414    414       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12154198}.
FT   CARBOHYD    437    437       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12154198}.
FT   CARBOHYD    469    469       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12154198}.
FT   CARBOHYD    522    522       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12154198}.
FT   CARBOHYD    566    566       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12154198}.
FT   CARBOHYD    616    616       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     29     56       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    156    183       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    186    194       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    190    202       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    210    218       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    214    226       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    227    235       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    231    243       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    246    255       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    259    286       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    290    301       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    305    320       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    323    327       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    500    509       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    504    517       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    520    529       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    533    549       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    552    565       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    556    573       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    576    585       {ECO:0000269|PubMed:12154198}.
FT   DISULFID    589    610       {ECO:0000250}.
FT   DISULFID    613    621       {ECO:0000250}.
FT   DISULFID    617    629       {ECO:0000250}.
FT   VAR_SEQ       1    643       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041661.
FT   VAR_SEQ       1     59       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041662.
FT   VAR_SEQ     141    183       EILSGGVYIEKNDKLCHMDTIDWRDIVRDRDAEIVVKDNGR
FT                                SC -> GQFPMVPSGLTPQPAQDWYLLDDDPRLLTLSASSK
FT                                VPVTLAAV (in isoform 2).
FT                                {ECO:0000303|PubMed:7685162}.
FT                                /FTId=VSP_002893.
FT   VAR_SEQ     184   1342       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:7685162}.
FT                                /FTId=VSP_002894.
FT   VAR_SEQ     331    331       C -> F (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_041663.
FT   VAR_SEQ     332   1342       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_041664.
FT   VARIANT      20     20       S -> Y (in dbSNP:rs34379766).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042101.
FT   VARIANT      30     30       P -> L (in dbSNP:rs56017157).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042102.
FT   VARIANT     104    104       V -> M (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042103.
FT   VARIANT     204    204       T -> I (in dbSNP:rs56107455).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042104.
FT   VARIANT     385    385       N -> S (in dbSNP:rs12320176).
FT                                /FTId=VAR_049710.
FT   VARIANT     683    683       R -> W (in dbSNP:rs56387488).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042105.
FT   VARIANT     717    717       S -> L (in dbSNP:rs35961836).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042106.
FT   VARIANT     744    744       I -> T (in dbSNP:rs55787439).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042107.
FT   VARIANT     998    998       K -> R (in dbSNP:rs56259600).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042108.
FT   VARIANT    1119   1119       S -> C (in dbSNP:rs773123).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042109.
FT   VARIANT    1127   1127       R -> H (in dbSNP:rs2271188).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042110.
FT   VARIANT    1177   1177       L -> I (in dbSNP:rs55699040).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042111.
FT   VARIANT    1254   1254       T -> K (in dbSNP:rs55709407).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042112.
FT   VARIANT    1271   1271       G -> S (in dbSNP:rs11171743).
FT                                /FTId=VAR_049711.
FT   MUTAGEN     742    742       K->M: Strongly reduced
FT                                autophosphorylation.
FT                                {ECO:0000269|PubMed:20351256}.
FT   MUTAGEN     868    868       Y->E: Strongly reduced tyrosine
FT                                phosphorylation.
FT                                {ECO:0000269|PubMed:20351256}.
FT   CONFLICT    560    560       E -> G (in Ref. 2; AAA35979).
FT                                {ECO:0000305}.
FT   CONFLICT    684    684       G -> S (in Ref. 5; BAF84370).
FT                                {ECO:0000305}.
FT   CONFLICT   1064   1064       E -> G (in Ref. 2; AAA35979).
FT                                {ECO:0000305}.
FT   CONFLICT   1078   1078       C -> S (in Ref. 5; BAG62544).
FT                                {ECO:0000305}.
FT   CONFLICT   1163   1163       D -> G (in Ref. 5; BAF84370).
FT                                {ECO:0000305}.
FT   STRAND       28     30       {ECO:0000244|PDB:4LEO}.
FT   HELIX        43     53       {ECO:0000244|PDB:4LEO}.
FT   STRAND       58     61       {ECO:0000244|PDB:1M6B}.
FT   STRAND       63     67       {ECO:0000244|PDB:1M6B}.
FT   HELIX        75     79       {ECO:0000244|PDB:1M6B}.
FT   STRAND       82     85       {ECO:0000244|PDB:1M6B}.
FT   STRAND       87     91       {ECO:0000244|PDB:1M6B}.
FT   STRAND       95     98       {ECO:0000244|PDB:1M6B}.
FT   TURN        112    114       {ECO:0000244|PDB:1M6B}.
FT   STRAND      115    120       {ECO:0000244|PDB:1M6B}.
FT   STRAND      125    128       {ECO:0000244|PDB:4LEO}.
FT   STRAND      133    135       {ECO:0000244|PDB:1M6B}.
FT   STRAND      141    144       {ECO:0000244|PDB:5CUS}.
FT   STRAND      146    150       {ECO:0000244|PDB:1M6B}.
FT   TURN        158    160       {ECO:0000244|PDB:1M6B}.
FT   HELIX       163    166       {ECO:0000244|PDB:1M6B}.
FT   STRAND      174    178       {ECO:0000244|PDB:1M6B}.
FT   HELIX       188    190       {ECO:0000244|PDB:4LEO}.
FT   STRAND      194    198       {ECO:0000244|PDB:1M6B}.
FT   STRAND      214    216       {ECO:0000244|PDB:1M6B}.
FT   STRAND      218    222       {ECO:0000244|PDB:1M6B}.
FT   HELIX       223    225       {ECO:0000244|PDB:5CUS}.
FT   STRAND      231    233       {ECO:0000244|PDB:1M6B}.
FT   STRAND      235    239       {ECO:0000244|PDB:1M6B}.
FT   HELIX       240    242       {ECO:0000244|PDB:1M6B}.
FT   STRAND      243    251       {ECO:0000244|PDB:1M6B}.
FT   STRAND      254    258       {ECO:0000244|PDB:1M6B}.
FT   STRAND      262    265       {ECO:0000244|PDB:1M6B}.
FT   TURN        267    269       {ECO:0000244|PDB:1M6B}.
FT   STRAND      270    274       {ECO:0000244|PDB:1M6B}.
FT   STRAND      280    282       {ECO:0000244|PDB:1M6B}.
FT   STRAND      285    289       {ECO:0000244|PDB:1M6B}.
FT   STRAND      295    297       {ECO:0000244|PDB:1M6B}.
FT   STRAND      300    304       {ECO:0000244|PDB:1M6B}.
FT   STRAND      309    314       {ECO:0000244|PDB:1M6B}.
FT   STRAND      317    322       {ECO:0000244|PDB:1M6B}.
FT   STRAND      324    326       {ECO:0000244|PDB:4LEO}.
FT   STRAND      330    332       {ECO:0000244|PDB:1M6B}.
FT   STRAND      338    342       {ECO:0000244|PDB:5CUS}.
FT   TURN        345    347       {ECO:0000244|PDB:1M6B}.
FT   HELIX       348    351       {ECO:0000244|PDB:1M6B}.
FT   STRAND      356    363       {ECO:0000244|PDB:1M6B}.
FT   HELIX       365    369       {ECO:0000244|PDB:1M6B}.
FT   TURN        372    375       {ECO:0000244|PDB:1M6B}.
FT   HELIX       381    389       {ECO:0000244|PDB:1M6B}.
FT   STRAND      392    395       {ECO:0000244|PDB:1M6B}.
FT   STRAND      397    400       {ECO:0000244|PDB:1M6B}.
FT   HELIX       410    412       {ECO:0000244|PDB:1M6B}.
FT   STRAND      425    433       {ECO:0000244|PDB:1M6B}.
FT   STRAND      451    457       {ECO:0000244|PDB:1M6B}.
FT   HELIX       465    467       {ECO:0000244|PDB:4LEO}.
FT   HELIX       470    473       {ECO:0000244|PDB:1M6B}.
FT   STRAND      482    488       {ECO:0000244|PDB:1M6B}.
FT   HELIX       490    493       {ECO:0000244|PDB:1M6B}.
FT   TURN        494    497       {ECO:0000244|PDB:1M6B}.
FT   STRAND      509    513       {ECO:0000244|PDB:1M6B}.
FT   HELIX       514    516       {ECO:0000244|PDB:1M6B}.
FT   STRAND      517    527       {ECO:0000244|PDB:1M6B}.
FT   STRAND      529    531       {ECO:0000244|PDB:1M6B}.
FT   STRAND      534    536       {ECO:0000244|PDB:1M6B}.
FT   STRAND      538    540       {ECO:0000244|PDB:1M6B}.
FT   STRAND      542    545       {ECO:0000244|PDB:1M6B}.
FT   STRAND      548    551       {ECO:0000244|PDB:1M6B}.
FT   STRAND      560    562       {ECO:0000244|PDB:5CUS}.
FT   STRAND      564    570       {ECO:0000244|PDB:1M6B}.
FT   STRAND      573    581       {ECO:0000244|PDB:1M6B}.
FT   STRAND      584    588       {ECO:0000244|PDB:1M6B}.
FT   STRAND      591    594       {ECO:0000244|PDB:4LEO}.
FT   STRAND      600    604       {ECO:0000244|PDB:1M6B}.
FT   STRAND      608    612       {ECO:0000244|PDB:1M6B}.
FT   STRAND      622    625       {ECO:0000244|PDB:1M6B}.
FT   HELIX       626    628       {ECO:0000244|PDB:4LEO}.
FT   HELIX       641    670       {ECO:0000244|PDB:2L9U}.
FT   HELIX       706    708       {ECO:0000244|PDB:4OTW}.
FT   STRAND      709    716       {ECO:0000244|PDB:4OTW}.
FT   STRAND      722    728       {ECO:0000244|PDB:4OTW}.
FT   STRAND      731    733       {ECO:0000244|PDB:3LMG}.
FT   STRAND      737    744       {ECO:0000244|PDB:4OTW}.
FT   TURN        747    749       {ECO:0000244|PDB:4OTW}.
FT   STRAND      753    755       {ECO:0000244|PDB:4RIY}.
FT   HELIX       758    764       {ECO:0000244|PDB:4OTW}.
FT   STRAND      774    778       {ECO:0000244|PDB:4OTW}.
FT   STRAND      780    788       {ECO:0000244|PDB:4OTW}.
FT   HELIX       795    802       {ECO:0000244|PDB:4OTW}.
FT   HELIX       803    805       {ECO:0000244|PDB:4OTW}.
FT   HELIX       808    827       {ECO:0000244|PDB:4OTW}.
FT   HELIX       837    839       {ECO:0000244|PDB:4OTW}.
FT   STRAND      840    846       {ECO:0000244|PDB:4OTW}.
FT   STRAND      848    850       {ECO:0000244|PDB:4OTW}.
FT   HELIX       855    858       {ECO:0000244|PDB:4OTW}.
FT   HELIX       865    868       {ECO:0000244|PDB:4RIY}.
FT   TURN        870    872       {ECO:0000244|PDB:4RIY}.
FT   HELIX       875    877       {ECO:0000244|PDB:4OTW}.
FT   HELIX       880    885       {ECO:0000244|PDB:4OTW}.
FT   HELIX       890    905       {ECO:0000244|PDB:4OTW}.
FT   TURN        911    914       {ECO:0000244|PDB:4OTW}.
FT   HELIX       917    919       {ECO:0000244|PDB:4OTW}.
FT   HELIX       920    925       {ECO:0000244|PDB:4OTW}.
FT   HELIX       938    947       {ECO:0000244|PDB:4OTW}.
FT   TURN        952    954       {ECO:0000244|PDB:4OTW}.
FT   HELIX       958    968       {ECO:0000244|PDB:4OTW}.
FT   HELIX       972    975       {ECO:0000244|PDB:4OTW}.
FT   STRAND      980    983       {ECO:0000244|PDB:3KEX}.
SQ   SEQUENCE   1342 AA;  148098 MW;  7201E7F66CA374BD CRC64;
     MRANDALQVL GLLFSLARGS EVGNSQAVCP GTLNGLSVTG DAENQYQTLY KLYERCEVVM
     GNLEIVLTGH NADLSFLQWI REVTGYVLVA MNEFSTLPLP NLRVVRGTQV YDGKFAIFVM
     LNYNTNSSHA LRQLRLTQLT EILSGGVYIE KNDKLCHMDT IDWRDIVRDR DAEIVVKDNG
     RSCPPCHEVC KGRCWGPGSE DCQTLTKTIC APQCNGHCFG PNPNQCCHDE CAGGCSGPQD
     TDCFACRHFN DSGACVPRCP QPLVYNKLTF QLEPNPHTKY QYGGVCVASC PHNFVVDQTS
     CVRACPPDKM EVDKNGLKMC EPCGGLCPKA CEGTGSGSRF QTVDSSNIDG FVNCTKILGN
     LDFLITGLNG DPWHKIPALD PEKLNVFRTV REITGYLNIQ SWPPHMHNFS VFSNLTTIGG
     RSLYNRGFSL LIMKNLNVTS LGFRSLKEIS AGRIYISANR QLCYHHSLNW TKVLRGPTEE
     RLDIKHNRPR RDCVAEGKVC DPLCSSGGCW GPGPGQCLSC RNYSRGGVCV THCNFLNGEP
     REFAHEAECF SCHPECQPME GTATCNGSGS DTCAQCAHFR DGPHCVSSCP HGVLGAKGPI
     YKYPDVQNEC RPCHENCTQG CKGPELQDCL GQTLVLIGKT HLTMALTVIA GLVVIFMMLG
     GTFLYWRGRR IQNKRAMRRY LERGESIEPL DPSEKANKVL ARIFKETELR KLKVLGSGVF
     GTVHKGVWIP EGESIKIPVC IKVIEDKSGR QSFQAVTDHM LAIGSLDHAH IVRLLGLCPG
     SSLQLVTQYL PLGSLLDHVR QHRGALGPQL LLNWGVQIAK GMYYLEEHGM VHRNLAARNV
     LLKSPSQVQV ADFGVADLLP PDDKQLLYSE AKTPIKWMAL ESIHFGKYTH QSDVWSYGVT
     VWELMTFGAE PYAGLRLAEV PDLLEKGERL AQPQICTIDV YMVMVKCWMI DENIRPTFKE
     LANEFTRMAR DPPRYLVIKR ESGPGIAPGP EPHGLTNKKL EEVELEPELD LDLDLEAEED
     NLATTTLGSA LSLPVGTLNR PRGSQSLLSP SSGYMPMNQG NLGESCQESA VSGSSERCPR
     PVSLHPMPRG CLASESSEGH VTGSEAELQE KVSMCRSRSR SRSPRPRGDS AYHSQRHSLL
     TPVTPLSPPG LEEEDVNGYV MPDTHLKGTP SSREGTLSSV GLSSVLGTEE EDEDEEYEYM
     NRRRRHSPPH PPRPSSLEEL GYEYMDVGSD LSASLGSTQS CPLHPVPIMP TAGTTPDEDY
     EYMNRQRDGG GPGGDYAAMG ACPASEQGYE EMRAFQGPGH QAPHVHYARL KTLRSLEATD
     SAFDNPDYWH SRLFPKANAQ RT
//
ID   PTPRN_HUMAN             Reviewed;         979 AA.
AC   Q16849; B4DK12; F5GZS3; Q08319; Q53QD6; Q6NSL1;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   23-MAY-2018, entry version 167.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase-like N;
DE            Short=R-PTP-N;
DE   AltName: Full=Islet cell antigen 512 {ECO:0000303|PubMed:8144912};
DE            Short=ICA 512 {ECO:0000303|PubMed:8641276};
DE   AltName: Full=Islet cell autoantigen 3;
DE   AltName: Full=PTP IA-2;
DE   Contains:
DE     RecName: Full=ICA512-N-terminal fragment;
DE              Short=ICA512-NTF;
DE   Contains:
DE     RecName: Full=ICA512-transmembrane fragment;
DE              Short=ICA512-TMF;
DE   Contains:
DE     RecName: Full=ICA512-cleaved cytosolic fragment;
DE              Short=ICA512-CCF;
DE   Flags: Precursor;
GN   Name=PTPRN; Synonyms=ICA3, ICA512;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Insulinoma;
RX   PubMed=8024693; DOI=10.1089/dna.1994.13.505;
RA   Lan M.S., Lu J., Goto Y., Notkins A.L.;
RT   "Molecular cloning and identification of a receptor-type protein
RT   tyrosine phosphatase, IA-2, from human insulinoma.";
RL   DNA Cell Biol. 13:505-514(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PRELIMINARY NUCLEOTIDE SEQUENCE OF 389-789, AND ROLE IN DIABETES
RP   MELLITUS.
RC   TISSUE=Pancreatic islet;
RX   PubMed=8144912;
RA   Rabin D.U., Pleasic S.M., Shapiro J.A., Yoo-Warren H., Oles J.,
RA   Hicks J.M., Goldstein D.E., Rae P.M.;
RT   "Islet cell antigen 512 is a diabetes-specific islet autoantigen
RT   related to protein tyrosine phosphatases.";
RL   J. Immunol. 152:3183-3188(1994).
RN   [7]
RP   SEQUENCE REVISION, AND ROLE IN DIABETES MELLITUS.
RX   PubMed=8641276;
RA   Solimena M., Dirkx R. Jr., Hermel J.-M., Pleasic-Williams S.,
RA   Shapiro J.A., Caron L., Rabin D.U.;
RT   "ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane
RT   protein of neurosecretory granules.";
RL   EMBO J. 15:2102-2114(1996).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10457160; DOI=10.1046/j.1460-9568.1999.00677.x;
RA   Hermel J.-M., Dirkx R., Solimena M.;
RT   "Post-translational modifications of ICA512, a receptor tyrosine
RT   phosphatase-like protein of secretory granules.";
RL   Eur. J. Neurosci. 11:2609-2620(1999).
RN   [9]
RP   INTERACTION WITH SNTB2, PROTEOLYTIC PROCESSING, AND PARTIAL PROTEIN
RP   SEQUENCE.
RX   PubMed=11483505; DOI=10.1093/emboj/20.15.4013;
RA   Ort T., Voronov S., Guo J., Zawalich K., Froehner S.C., Zawalich W.,
RA   Solimena M.;
RT   "Dephosphorylation of beta2-syntrophin and Ca2+/mu-calpain-mediated
RT   cleavage of ICA512 upon stimulation of insulin secretion.";
RL   EMBO J. 20:4013-4023(2001).
RN   [10]
RP   FUNCTION, INTERACTION WITH PIAS4, SUBCELLULAR LOCATION, AND
RP   PROTEOLYTIC CLEAVAGE.
RX   PubMed=15596545; DOI=10.1083/jcb.200408172;
RA   Trajkovski M., Mziaut H., Altkrueger A., Ouwendijk J., Knoch K.P.,
RA   Mueller S., Solimena M.;
RT   "Nuclear translocation of an ICA512 cytosolic fragment couples granule
RT   exocytosis and insulin expression in {beta}-cells.";
RL   J. Cell Biol. 167:1063-1074(2004).
RN   [11]
RP   INTERACTION WITH SNX19.
RX   PubMed=16273344; DOI=10.1007/s00125-005-0037-y;
RA   Hu Y.F., Zhang H.L., Cai T., Harashima S., Notkins A.L.;
RT   "The IA-2 interactome.";
RL   Diabetologia 48:2576-2581(2005).
RN   [12]
RP   FUNCTION, INTERACTION WITH STAT5B AND PIAS4, AND SUMOYLATION AT
RP   LYS-754.
RX   PubMed=16622421; DOI=10.1038/ncb1395;
RA   Mziaut H., Trajkovski M., Kersting S., Ehninger A., Altkrueger A.,
RA   Lemaitre R.P., Schmidt D., Saeger H.D., Lee M.S., Drechsel D.N.,
RA   Mueller S., Solimena M.;
RT   "Synergy of glucose and growth hormone signalling in islet cells
RT   through ICA512 and STAT5.";
RL   Nat. Cell Biol. 8:435-445(2006).
RN   [13]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=18824546; DOI=10.1074/jbc.M804928200;
RA   Trajkovski M., Mziaut H., Schubert S., Kalaidzidis Y., Altkrueger A.,
RA   Solimena M.;
RT   "Regulation of insulin granule turnover in pancreatic beta-cells by
RT   cleaved ICA512.";
RL   J. Biol. Chem. 283:33719-33729(2008).
RN   [14]
RP   FUNCTION.
RX   PubMed=18178618; DOI=10.1073/pnas.0710931105;
RA   Mziaut H., Kersting S., Knoch K.P., Fan W.H., Trajkovski M.,
RA   Erdmann K., Bergert H., Ehehalt F., Saeger H.D., Solimena M.;
RT   "ICA512 signaling enhances pancreatic beta-cell proliferation by
RT   regulating cyclins D through STATs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:674-679(2008).
RN   [15]
RP   FUNCTION.
RX   PubMed=20886068; DOI=10.1371/journal.pone.0012929;
RA   Schubert S., Knoch K.P., Ouwendijk J., Mohammed S., Bodrov Y.,
RA   Jaeger M., Altkrueger A., Wegbrod C., Adams M.E., Kim Y.,
RA   Froehner S.C., Jensen O.N., Kalaidzidis Y., Solimena M.;
RT   "beta2-Syntrophin is a Cdk5 substrate that restrains the motility of
RT   insulin secretory granules.";
RL   PLoS ONE 5:E12929-E12929(2010).
RN   [16]
RP   GLYCOSYLATION AT THR-441, STRUCTURE OF CARBOHYDRATES, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=22171320; DOI=10.1074/mcp.M111.013649;
RA   Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.;
RT   "Human urinary glycoproteomics; attachment site specific analysis of
RT   N-and O-linked glycosylations by CID and ECD.";
RL   Mol. Cell. Proteomics 11:1-17(2012).
RN   [17]
RP   FUNCTION.
RX   PubMed=24843546; DOI=10.1111/j.2040-1124.2011.00138.x;
RA   Harashima S., Horiuchi T., Wang Y., Notkins A.L., Seino Y.,
RA   Inagaki N.;
RT   "Sorting nexin 19 regulates the number of dense core vesicles in
RT   pancreatic beta-cells.";
RL   J. Diabetes Investig. 3:52-61(2012).
RN   [18]
RP   GLYCOSYLATION AT THR-441, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23234360; DOI=10.1021/pr300963h;
RA   Halim A., Ruetschi U., Larson G., Nilsson J.;
RT   "LC-MS/MS characterization of O-glycosylation sites and glycan
RT   structures of human cerebrospinal fluid glycoproteins.";
RL   J. Proteome Res. 12:573-584(2013).
RN   [19]
RP   SUBUNIT, SUBCELLULAR LOCATION, MUTAGENESIS OF ASN-506; ASN-524 AND
RP   GLY-553, AND GLYCOSYLATION AT ASN-506 AND ASN-524.
RX   PubMed=25561468; DOI=10.1128/MCB.00994-14;
RA   Torkko J.M., Primo M.E., Dirkx R., Friedrich A., Viehrig A.,
RA   Vergari E., Borgonovo B., Soenmez A., Wegbrod C., Lachnit M.,
RA   Muenster C., Sica M.P., Ermacora M.R., Solimena M.;
RT   "Stability of proICA512/IA-2 and its targeting to insulin secretory
RT   granules require beta4-sheet-mediated dimerization of its ectodomain
RT   in the endoplasmic reticulum.";
RL   Mol. Cell. Biol. 35:914-927(2015).
RN   [20]
RP   SUBUNIT, INTERACTION WITH INSULIN, AND DISULFIDE BONDS.
RX   PubMed=26836020; DOI=10.1016/j.bbapap.2016.01.013;
RA   Sosa L., Torkko J.M., Primo M.E., Llovera R.E., Toledo P.L.,
RA   Rios A.S., Flecha F.L., Trabucchi A., Valdez S.N., Poskus E.,
RA   Solimena M., Ermacora M.R.;
RT   "Biochemical, biophysical, and functional properties of ICA512/IA-2
RT   RESP18 homology domain.";
RL   Biochim. Biophys. Acta 1864:511-522(2016).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.23 ANGSTROMS) OF 681-979.
RX   PubMed=18058037; DOI=10.1007/s10969-007-9036-1;
RA   Almo S.C., Bonanno J.B., Sauder J.M., Emtage S., Dilorenzo T.P.,
RA   Malashkevich V., Wasserman S.R., Swaminathan S., Eswaramoorthy S.,
RA   Agarwal R., Kumaran D., Madegowda M., Ragumani S., Patskovsky Y.,
RA   Alvarado J., Ramagopal U.A., Faber-Barata J., Chance M.R., Sali A.,
RA   Fiser A., Zhang Z.Y., Lawrence D.S., Burley S.K.;
RT   "Structural genomics of protein phosphatases.";
RL   J. Struct. Funct. Genomics 8:121-140(2007).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 468-558.
RX   PubMed=18048354; DOI=10.1074/jbc.M708144200;
RA   Primo M.E., Klinke S., Sica M.P., Goldbaum F.A., Jakoncic J.,
RA   Poskus E., Ermacora M.R.;
RT   "Structure of the mature ectodomain of the human receptor-type
RT   protein-tyrosine phosphatase IA-2.";
RL   J. Biol. Chem. 283:4674-4681(2008).
CC   -!- FUNCTION: Plays a role in vesicle-mediated secretory processes
CC       (PubMed:24843546). Required for normal accumulation of secretory
CC       vesicles in hippocampus, pituitary and pancreatic islets (By
CC       similarity). Required for the accumulation of normal levels of
CC       insulin-containing vesicles and preventing their degradation
CC       (PubMed:24843546). Plays a role in insulin secretion in response
CC       to glucose stimuli (PubMed:24843546). Required for normal
CC       accumulation of the neurotransmitters norepinephrine, dopamine and
CC       serotonin in the brain (By similarity). In females, but not in
CC       males, required for normal accumulation and secretion of pituitary
CC       hormones, such as luteinizing hormone (LH) and follicle-
CC       stimulating hormone (FSH) (By similarity). Required to maintain
CC       normal levels of renin expression and renin release (By
CC       similarity). Seems to lack intrinsic enzyme activity (By
CC       similarity). May regulate catalytic active protein-tyrosine
CC       phosphatases such as PTPRA through dimerization (By similarity).
CC       {ECO:0000250|UniProtKB:Q60673, ECO:0000269|PubMed:24843546}.
CC   -!- FUNCTION: ICA512-transmembrane fragment: ICA512-TMF regulates
CC       dynamics and exocytosis of insulin secretory granules (SGs);
CC       binding of ICA512-TMF to SNTB2/beta-2-syntrophin is proposed to
CC       restrain SGs mobility and exocytosis by tethering them to the
CC       actin cytoskeleton depending on UTRN; the function is inhibited by
CC       cytoplasmic ICA512-CFF dimerizing with ICA512-TMF and displacing
CC       SNTB2. {ECO:0000269|PubMed:18824546, ECO:0000269|PubMed:20886068}.
CC   -!- FUNCTION: ICA512-cleaved cytosolic fragment: ICA512-CCF
CC       translocated to the nucleus promotes expression of insulin and
CC       other granule-related genes; the function implicates binding to
CC       and regulating activity of STAT5B probably by preventing its
CC       dephosphorylation and potentially by inducing its sumoylation by
CC       recruiting PIAS4 (PubMed:15596545, PubMed:16622421,
CC       PubMed:18178618). Enhances pancreatic beta-cell proliferation by
CC       converging with signaling by STAT5B and STAT3 (PubMed:15596545,
CC       PubMed:16622421, PubMed:18178618). ICA512-CCF located in the
CC       cytoplasm regulates dynamics and exocytosis of insulin secretory
CC       granules (SGs) by dimerizing with ICA512-TMF and displacing SNTB2
CC       thus enhancing SGs mobility and exocytosis (PubMed:18824546,
CC       PubMed:20886068). {ECO:0000269|PubMed:15596545,
CC       ECO:0000269|PubMed:16622421, ECO:0000269|PubMed:18178618,
CC       ECO:0000269|PubMed:18824546, ECO:0000269|PubMed:20886068}.
CC   -!- SUBUNIT: Homodimer; shown for the unprocessed protein (proICA512)
CC       in the endoplasmic reticulum and resolved during protein
CC       maturation as ICA512-TMF seems to be predominantly monomeric in
CC       secretory granules; however, ICA512-CCF interacts with ICA512-TMF
CC       disrupting the ICA512-TMF:SNTB2 complex. The isolated lumenal
CC       RESP18 homology domain has been shown to form disulfide-linked
CC       homooligomers (PubMed:25561468, PubMed:18824546, PubMed:26836020).
CC       Interacts (via cytoplasmic domain) with phosphorylated SNTB2; this
CC       protects PTPRN against cleavage by CAPN1 to produce ICA512-CCF.
CC       Dephosphorylation of SNTB2 upon insulin stimulation disrupts the
CC       interaction and results in PTPRN cleavage (PubMed:11483505).
CC       Interacts with SNX19 (PubMed:16273344). ICA512-CCF interacts with
CC       PIAS4; in the nucleus (PubMed:15596545). Interacts with STAT5B
CC       (phosphorylated); down-regulated by ICA512-CCF sumoylation;
CC       ICA512-CCF prevents STAT5B dephosphorylation; ICA512-CCF mediates
CC       interaction of STAT5B with PIAS4 (PubMed:15596545,
CC       PubMed:16622421). Interacts (via RESP18 homology domain) with
CC       insulin and proinsulin (PubMed:26836020). Interacts with PTPRN2,
CC       PTPRA and PTPRE (By similarity). {ECO:0000250|UniProtKB:Q60673,
CC       ECO:0000269|PubMed:11483505, ECO:0000269|PubMed:15596545,
CC       ECO:0000269|PubMed:16273344, ECO:0000269|PubMed:16622421,
CC       ECO:0000269|PubMed:18824546, ECO:0000269|PubMed:25561468,
CC       ECO:0000269|PubMed:26836020}.
CC   -!- INTERACTION:
CC       Q8WXG6:MADD; NbExp=4; IntAct=EBI-728153, EBI-310528;
CC       P21145:MAL; NbExp=3; IntAct=EBI-10200782, EBI-3932027;
CC       P60201:PLP1; NbExp=3; IntAct=EBI-10200782, EBI-8653150;
CC       P60201-2:PLP1; NbExp=8; IntAct=EBI-10200782, EBI-12188331;
CC       P62937:PPIA; NbExp=3; IntAct=EBI-728153, EBI-437708;
CC       Q13332:PTPRS; NbExp=5; IntAct=EBI-728153, EBI-711536;
CC       O14522:PTPRT; NbExp=3; IntAct=EBI-728153, EBI-728180;
CC       Q92543:SNX19; NbExp=4; IntAct=EBI-728153, EBI-728232;
CC       Q9H254:SPTBN4; NbExp=2; IntAct=EBI-728153, EBI-308543;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q63259};
CC       Single-pass type I membrane protein
CC       {ECO:0000250|UniProtKB:Q63259}. Cytoplasmic vesicle, secretory
CC       vesicle membrane {ECO:0000305|PubMed:25561468}; Single-pass type I
CC       membrane protein {ECO:0000305}. Perikaryon
CC       {ECO:0000250|UniProtKB:Q63259}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q63259}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:Q63259}. Cell membrane
CC       {ECO:0000269|PubMed:10457160}; Single-pass type I membrane protein
CC       {ECO:0000250|UniProtKB:Q63259}. Endosome
CC       {ECO:0000250|UniProtKB:Q63259}. Note=Detected on neuronal
CC       secretory vesicles, but not on synaptic vesicles. Colocalizes with
CC       insulin-containing secretory granules (PubMed:25561468). Primarily
CC       detected on secretory vesicle membranes. Transiently found at the
CC       cell membrane, when secretory vesicles fuse with the cell membrane
CC       to release their cargo. Is then endocytosed and recycled to
CC       secretory vesicles via the Golgi apparatus membranes.
CC       {ECO:0000250|UniProtKB:Q63259, ECO:0000269|PubMed:25561468}.
CC   -!- SUBCELLULAR LOCATION: ICA512-transmembrane fragment: Cytoplasmic
CC       vesicle, secretory vesicle membrane
CC       {ECO:0000250|UniProtKB:Q63259}.
CC   -!- SUBCELLULAR LOCATION: ICA512-cleaved cytosolic fragment: Nucleus
CC       {ECO:0000269|PubMed:15596545}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q16849-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16849-2; Sequence=VSP_043654;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q16849-3; Sequence=VSP_045867;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expression is restricted to neuroendocrine
CC       cells. Found in pancreas, brain and pituitary.
CC       {ECO:0000269|PubMed:8024693}.
CC   -!- DOMAIN: The RESP18 homology domain is sufficient for targeting
CC       proICA512 to secretory granules. {ECO:0000269|PubMed:25561468}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:25561468}.
CC   -!- PTM: O-glycosylated with core 1 or possibly core 8 glycans.
CC       {ECO:0000269|PubMed:22171320, ECO:0000269|PubMed:23234360,
CC       ECO:0000269|PubMed:25561468}.
CC   -!- PTM: Subject to proteolytic cleavage at multiple sites
CC       (PubMed:11483505). Subject to cleavage on a pair of basic residues
CC       (By similarity). On exocytosis of secretory granules in pancreatic
CC       beta-cells ICA512-TMF is transiently inserted in the plasma-
CC       membrane and cleaved by mu-type calpain CPN1 to yield ICA512-CCF
CC       (By similarity). {ECO:0000250|UniProtKB:P56722,
CC       ECO:0000250|UniProtKB:Q63259, ECO:0000269|PubMed:11483505,
CC       ECO:0000305|PubMed:15596545}.
CC   -!- PTM: Sumoylated at two sites including Lys-754. Sumoylation
CC       decreases interaction with STAT5. {ECO:0000269|PubMed:16622421}.
CC   -!- DISEASE: Note=Autoantigen in insulin-dependent diabetes mellitus
CC       (IDDM). {ECO:0000269|PubMed:8144912, ECO:0000269|PubMed:8641276}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 8 subfamily. {ECO:0000305}.
CC   -!- CAUTION: Does not possess catalytic activity due to replacement of
CC       highly conserved residues in tyrosine-protein phosphatase domain.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L18983; AAA90974.1; -; mRNA.
DR   EMBL; AK296335; BAG59024.1; -; mRNA.
DR   EMBL; AC114803; AAY24038.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70724.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70726.1; -; Genomic_DNA.
DR   EMBL; BC070053; AAH70053.1; -; mRNA.
DR   EMBL; X62899; CAA44688.2; -; mRNA.
DR   CCDS; CCDS2440.1; -. [Q16849-1]
DR   CCDS; CCDS56167.1; -. [Q16849-3]
DR   CCDS; CCDS56168.1; -. [Q16849-2]
DR   PIR; I37577; I37577.
DR   RefSeq; NP_001186692.1; NM_001199763.1. [Q16849-2]
DR   RefSeq; NP_001186693.1; NM_001199764.1. [Q16849-3]
DR   RefSeq; NP_002837.1; NM_002846.3. [Q16849-1]
DR   UniGene; Hs.89655; -.
DR   PDB; 2I1Y; X-ray; 2.23 A; A/B=681-979.
DR   PDB; 2QT7; X-ray; 1.30 A; A/B=468-558.
DR   PDB; 3N01; X-ray; 1.30 A; A/B=470-558.
DR   PDB; 3N4W; X-ray; 1.45 A; A/B=470-558.
DR   PDB; 3NG8; X-ray; 1.35 A; A/B=470-558.
DR   PDB; 3NP5; X-ray; 1.80 A; A/B/C/D=470-558.
DR   PDBsum; 2I1Y; -.
DR   PDBsum; 2QT7; -.
DR   PDBsum; 3N01; -.
DR   PDBsum; 3N4W; -.
DR   PDBsum; 3NG8; -.
DR   PDBsum; 3NP5; -.
DR   ProteinModelPortal; Q16849; -.
DR   SMR; Q16849; -.
DR   BioGrid; 111762; 86.
DR   IntAct; Q16849; 12.
DR   MINT; Q16849; -.
DR   STRING; 9606.ENSP00000295718; -.
DR   DEPOD; Q16849; -.
DR   GlyConnect; 697; -.
DR   iPTMnet; Q16849; -.
DR   PhosphoSitePlus; Q16849; -.
DR   UniCarbKB; Q16849; -.
DR   BioMuta; PTPRN; -.
DR   DMDM; 2499754; -.
DR   PaxDb; Q16849; -.
DR   PeptideAtlas; Q16849; -.
DR   PRIDE; Q16849; -.
DR   DNASU; 5798; -.
DR   Ensembl; ENST00000295718; ENSP00000295718; ENSG00000054356. [Q16849-1]
DR   Ensembl; ENST00000409251; ENSP00000386638; ENSG00000054356. [Q16849-2]
DR   Ensembl; ENST00000423636; ENSP00000392598; ENSG00000054356. [Q16849-3]
DR   GeneID; 5798; -.
DR   KEGG; hsa:5798; -.
DR   UCSC; uc002vkz.3; human. [Q16849-1]
DR   CTD; 5798; -.
DR   DisGeNET; 5798; -.
DR   EuPathDB; HostDB:ENSG00000054356.13; -.
DR   GeneCards; PTPRN; -.
DR   HGNC; HGNC:9676; PTPRN.
DR   HPA; HPA007152; -.
DR   HPA; HPA007179; -.
DR   MIM; 601773; gene.
DR   neXtProt; NX_Q16849; -.
DR   OpenTargets; ENSG00000054356; -.
DR   PharmGKB; PA34021; -.
DR   eggNOG; KOG0793; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00910000144174; -.
DR   HOGENOM; HOG000243992; -.
DR   HOVERGEN; HBG053762; -.
DR   InParanoid; Q16849; -.
DR   KO; K07817; -.
DR   OMA; FLPYDHA; -.
DR   OrthoDB; EOG091G0LUR; -.
DR   PhylomeDB; Q16849; -.
DR   TreeFam; TF351976; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   ChiTaRS; PTPRN; human.
DR   EvolutionaryTrace; Q16849; -.
DR   GeneWiki; PTPRN; -.
DR   GenomeRNAi; 5798; -.
DR   PMAP-CutDB; Q16849; -.
DR   PRO; PR:Q16849; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000054356; -.
DR   CleanEx; HS_PTPRN; -.
DR   ExpressionAtlas; Q16849; baseline and differential.
DR   Genevisible; Q16849; HS.
DR   GO; GO:0043679; C:axon terminus; ISS:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005768; C:endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043025; C:neuronal cell body; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030141; C:secretory granule; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0030658; C:transport vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030507; F:spectrin binding; IPI:BHF-UCL.
DR   GO; GO:0008134; F:transcription factor binding; IDA:UniProtKB.
DR   GO; GO:0044389; F:ubiquitin-like protein ligase binding; IDA:UniProtKB.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:1990502; P:dense core granule maturation; IGI:GO_Central.
DR   GO; GO:0030073; P:insulin secretion; IGI:GO_Central.
DR   GO; GO:0035773; P:insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB.
DR   GO; GO:0001553; P:luteinization; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:1904692; P:positive regulation of type B pancreatic cell proliferation; IDA:UniProtKB.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0043627; P:response to estrogen; IEA:Ensembl.
DR   GO; GO:0032868; P:response to insulin; IEA:Ensembl.
DR   GO; GO:0000302; P:response to reactive oxygen species; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.70.2470; -; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR033522; IA-2/IA-2_beta.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR021613; Receptor_IA-2_dom.
DR   InterPro; IPR038112; Receptor_IA-2_ectodomain_sf.
DR   InterPro; IPR029403; RESP18_dom.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   PANTHER; PTHR19134:SF2; PTHR19134:SF2; 1.
DR   Pfam; PF11548; Receptor_IA-2; 1.
DR   Pfam; PF14948; RESP18; 1.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Cell projection; Complete proteome; Cytoplasmic vesicle;
KW   Diabetes mellitus; Direct protein sequencing; Disulfide bond;
KW   Endosome; Glycoprotein; Isopeptide bond; Membrane; Nucleus;
KW   Phosphoprotein; Polymorphism; Receptor; Reference proteome; Signal;
KW   Synapse; Transcription; Transcription regulation; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     34       {ECO:0000250}.
FT   CHAIN        35    979       Receptor-type tyrosine-protein
FT                                phosphatase-like N.
FT                                /FTId=PRO_0000025451.
FT   CHAIN        35    448       ICA512-N-terminal fragment.
FT                                {ECO:0000250|UniProtKB:P56722,
FT                                ECO:0000305|PubMed:26836020}.
FT                                /FTId=PRO_0000438079.
FT   CHAIN       449    979       ICA512-transmembrane fragment.
FT                                {ECO:0000250|UniProtKB:P56722,
FT                                ECO:0000305|PubMed:26836020}.
FT                                /FTId=PRO_0000438080.
FT   CHAIN       659    979       ICA512-cleaved cytosolic fragment.
FT                                {ECO:0000305|PubMed:15596545,
FT                                ECO:0000305|PubMed:26836020}.
FT                                /FTId=PRO_0000438081.
FT   TOPO_DOM     35    575       Lumenal. {ECO:0000255}.
FT   TRANSMEM    576    600       Helical. {ECO:0000255}.
FT   TOPO_DOM    601    979       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      709    969       Tyrosine-protein phosphatase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   REGION       35    131       RESP18 homology domain.
FT   REGION      449    575       Sufficient for dimerization of proICA512.
FT                                {ECO:0000269|PubMed:25561468}.
FT   REGION      601    732       Sufficient for dimerization of proICA512.
FT                                {ECO:0000250|UniProtKB:P80560}.
FT   SITE        448    449       Cleavage. {ECO:0000250|UniProtKB:P56722}.
FT   MOD_RES     308    308       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q60673}.
FT   CARBOHYD    441    441       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:22171320,
FT                                ECO:0000269|PubMed:23234360}.
FT   CARBOHYD    506    506       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255,
FT                                ECO:0000269|PubMed:25561468}.
FT   CARBOHYD    524    524       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255,
FT                                ECO:0000269|PubMed:25561468}.
FT   DISULFID     40     40       Interchain (with C-40 or C-47); in
FT                                multimeric form.
FT                                {ECO:0000305|PubMed:26836020}.
FT   DISULFID     47     47       Interchain (with C-40 or C-47); in
FT                                multimeric form.
FT                                {ECO:0000305|PubMed:26836020}.
FT   DISULFID     53     62       {ECO:0000305|PubMed:26836020}.
FT   CROSSLNK    754    754       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:16622421}.
FT   VAR_SEQ       1     90       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045867.
FT   VAR_SEQ     479    508       KPLSLAAGVKLLEILAEHVHMSSGSFINIS -> N (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043654.
FT   VARIANT     419    419       S -> R (in dbSNP:rs35314717).
FT                                /FTId=VAR_051762.
FT   MUTAGEN     506    506       N->A: Reduces N-glycosylation.
FT                                {ECO:0000269|PubMed:25561468}.
FT   MUTAGEN     524    524       N->A: Reduces N-glycosylation.
FT                                {ECO:0000269|PubMed:25561468}.
FT   MUTAGEN     553    553       G->D: Impairs normal processing and leads
FT                                to retention in the endoplasmic reticulum
FT                                and degradation.
FT                                {ECO:0000269|PubMed:25561468}.
FT   CONFLICT    673    673       S -> G (in Ref. 2; BAG59024).
FT                                {ECO:0000305}.
FT   STRAND      471    477       {ECO:0000244|PDB:2QT7}.
FT   HELIX       483    497       {ECO:0000244|PDB:2QT7}.
FT   HELIX       501    503       {ECO:0000244|PDB:2QT7}.
FT   STRAND      504    510       {ECO:0000244|PDB:2QT7}.
FT   STRAND      513    518       {ECO:0000244|PDB:2QT7}.
FT   HELIX       527    536       {ECO:0000244|PDB:2QT7}.
FT   HELIX       538    545       {ECO:0000244|PDB:2QT7}.
FT   STRAND      549    555       {ECO:0000244|PDB:2QT7}.
FT   HELIX       692    704       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       706    717       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       727    730       {ECO:0000244|PDB:2I1Y}.
FT   TURN        732    734       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       735    737       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       755    757       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      766    770       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      780    783       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       788    790       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       791    801       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      805    808       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      812    814       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      826    832       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      835    844       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      846    858       {ECO:0000244|PDB:2I1Y}.
FT   TURN        859    861       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      864    872       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      877    880       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       885    896       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      905    908       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      910    913       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       914    930       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       938    946       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       956    975       {ECO:0000244|PDB:2I1Y}.
SQ   SEQUENCE   979 AA;  105848 MW;  A852B9063D29399D CRC64;
     MRRPRRPGGL GGSGGLRLLL CLLLLSSRPG GCSAVSAHGC LFDRRLCSHL EVCIQDGLFG
     QCQVGVGQAR PLLQVTSPVL QRLQGVLRQL MSQGLSWHDD LTQYVISQEM ERIPRLRPPE
     PRPRDRSGLA PKRPGPAGEL LLQDIPTGSA PAAQHRLPQP PVGKGGAGAS SSLSPLQAEL
     LPPLLEHLLL PPQPPHPSLS YEPALLQPYL FHQFGSRDGS RVSEGSPGMV SVGPLPKAEA
     PALFSRTASK GIFGDHPGHS YGDLPGPSPA QLFQDSGLLY LAQELPAPSR ARVPRLPEQG
     SSSRAEDSPE GYEKEGLGDR GEKPASPAVQ PDAALQRLAA VLAGYGVELR QLTPEQLSTL
     LTLLQLLPKG AGRNPGGVVN VGADIKKTME GPVEGRDTAE LPARTSPMPG HPTASPTSSE
     VQQVPSPVSS EPPKAARPPV TPVLLEKKSP LGQSQPTVAG QPSARPAAEE YGYIVTDQKP
     LSLAAGVKLL EILAEHVHMS SGSFINISVV GPALTFRIRH NEQNLSLADV TQQAGLVKSE
     LEAQTGLQIL QTGVGQREEA AAVLPQTAHS TSPMRSVLLT LVALAGVAGL LVALAVALCV
     RQHARQQDKE RLAALGPEGA HGDTTFEYQD LCRQHMATKS LFNRAEGPPE PSRVSSVSSQ
     FSDAAQASPS SHSSTPSWCE EPAQANMDIS TGHMILAYME DHLRNRDRLA KEWQALCAYQ
     AEPNTCATAQ GEGNIKKNRH PDFLPYDHAR IKLKVESSPS RSDYINASPI IEHDPRMPAY
     IATQGPLSHT IADFWQMVWE SGCTVIVMLT PLVEDGVKQC DRYWPDEGAS LYHVYEVNLV
     SEHIWCEDFL VRSFYLKNVQ TQETRTLTQF HFLSWPAEGT PASTRPLLDF RRKVNKCYRG
     RSCPIIVHCS DGAGRTGTYI LIDMVLNRMA KGVKEIDIAA TLEHVRDQRP GLVRSKDQFE
     FALTAVAEEV NAILKALPQ
//
ID   Q96IA0_HUMAN            Unreviewed;       811 AA.
AC   Q96IA0;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 2.
DT   23-MAY-2018, entry version 106.
DE   SubName: Full=PTPRN protein {ECO:0000313|EMBL:AAH07713.2};
DE   Flags: Fragment;
GN   Name=PTPRN {ECO:0000313|EMBL:AAH07713.2};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH07713.2};
RN   [1] {ECO:0000313|EMBL:AAH07713.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAH07713.2};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC007713; AAH07713.2; -; mRNA.
DR   RefSeq; NP_002837.1; NM_002846.3.
DR   UniGene; Hs.89655; -.
DR   ProteinModelPortal; Q96IA0; -.
DR   SMR; Q96IA0; -.
DR   PeptideAtlas; Q96IA0; -.
DR   PRIDE; Q96IA0; -.
DR   DNASU; 5798; -.
DR   GeneID; 5798; -.
DR   KEGG; hsa:5798; -.
DR   CTD; 5798; -.
DR   PharmGKB; PA34021; -.
DR   eggNOG; KOG0793; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   HOVERGEN; HBG053762; -.
DR   KO; K07817; -.
DR   ChiTaRS; PTPRN; human.
DR   GenomeRNAi; 5798; -.
DR   Genevisible; Q96IA0; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.70.2470; -; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR033522; IA-2/IA-2_beta.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR021613; Receptor_IA-2_dom.
DR   InterPro; IPR038112; Receptor_IA-2_ectodomain_sf.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   PANTHER; PTHR19134:SF2; PTHR19134:SF2; 1.
DR   Pfam; PF11548; Receptor_IA-2; 1.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   2: Evidence at transcript level;
KW   Hydrolase {ECO:0000256|PROSITE-ProRule:PRU00160};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    409    432       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      541    801       Tyrosine-protein phosphatase.
FT                                {ECO:0000259|PROSITE:PS50055}.
FT   DOMAIN      720    792       TYR_PHOSPHATASE_2.
FT                                {ECO:0000259|PROSITE:PS50056}.
FT   ACT_SITE    741    741       Phosphocysteine intermediate.
FT                                {ECO:0000256|PROSITE-ProRule:PRU00160}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAH07713.2}.
SQ   SEQUENCE   811 AA;  87841 MW;  1CC9B2B4F9D2F5B3 CRC64;
     ASSSLSPLQA ELLPPLLEHL LLPPQPPHPS LSYEPALLQP YLFHQFGSRD GSRVSEGSPG
     MVSVGPLPKA EAPALFSRTA SKGIFGDHPG HSYGDLPGPS PAQLFQDSGL LYLAQELPAP
     SRARVPRLPE QGSSSRAEDS PEGYEKEGLG DRGEKPASPA VQPDAALQRL AAVLAGYGVE
     LRQLTPEQLS TLLTLLQLLP KGAGRNPGGV VNVGADIKKT MEGPVEGRDT AELPARTSPM
     PGHPTASPTS SEVQQVPSPV SSEPPKAARP PVTPVLLEKK SPLGQSQPTV AGQPSARPAA
     EEYGYIVTDQ KPLSLAAGVK LLEILAEHVH MSSGSFINIS VVGPALTFRI RHNEQNLSLA
     DVTQQAGLVK SELEAQTGLQ ILQTGVGQRE EAAAVLPQTA HSTSPMRSVL LTLVALAGVA
     GLLVALAVAL CVRQHARQQD KERLAALGPE GAHGDTTFEY QDLCRQHMAT KSLFNRAEGP
     PEPSRVSSVS SQFSDAAQAS PSSHSSTPSW CEEPAQANMD ISTGHMILAY MEDHLRNRDR
     LAKEWQALCA YQAEPNTCAT AQGEGNIKKN RHPDFLPYDH ARIKLKVESS PSRSDYINAS
     PIIEHDPRMP AYIATQGPLS HTIADFWQMV WESGCTVIVM LTPLVEDGVK QCDRYWPDEG
     ASLYHVYEVN LVSEHIWCED FLVRSFYLKN VQTQETRTLT QFHFLSWPAE GTPASTRPLL
     DFRRKVNKCY RGRSCPIIVH CSDGAGRTGT YILIDMVLNR MAKGVKEIDI AATLEHVRDQ
     RPGLVRSKDQ FEFALTAVAE EVNAILKALP Q
//
ID   PTN21_HUMAN             Reviewed;        1174 AA.
AC   Q16825;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   02-MAR-2010, sequence version 2.
DT   23-MAY-2018, entry version 156.
DE   RecName: Full=Tyrosine-protein phosphatase non-receptor type 21;
DE            EC=3.1.3.48;
DE   AltName: Full=Protein-tyrosine phosphatase D1;
GN   Name=PTPN21; Synonyms=PTPD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS PHE-385 AND ALA-936.
RC   TISSUE=Skeletal muscle;
RX   PubMed=7519780; DOI=10.1073/pnas.91.16.7477;
RA   Moeller N.P.H., Moeller K.B., Lammers R., Kharitonenkov A., Sures I.,
RA   Ullrich A.;
RT   "Src kinase associates with a member of a distinct subfamily of
RT   protein-tyrosine phosphatases containing an ezrin-like domain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:7477-7481(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-637, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044}.
CC   -!- INTERACTION:
CC       O08715-5:Akap1 (xeno); NbExp=2; IntAct=EBI-2860264, EBI-9117988;
CC       Q9HC98-4:NEK6; NbExp=4; IntAct=EBI-2860264, EBI-11750983;
CC       P12931:SRC; NbExp=2; IntAct=EBI-2860264, EBI-621482;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Non-receptor class subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PTPN21ID41916ch14q21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X79510; CAA56042.1; -; mRNA.
DR   EMBL; AL162171; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS9884.1; -.
DR   PIR; I38140; I38140.
DR   RefSeq; NP_008970.2; NM_007039.3.
DR   RefSeq; XP_005267344.1; XM_005267287.2.
DR   RefSeq; XP_011534669.1; XM_011536367.2.
DR   UniGene; Hs.437040; -.
DR   ProteinModelPortal; Q16825; -.
DR   SMR; Q16825; -.
DR   BioGrid; 116280; 45.
DR   IntAct; Q16825; 29.
DR   MINT; Q16825; -.
DR   STRING; 9606.ENSP00000330276; -.
DR   BindingDB; Q16825; -.
DR   DEPOD; Q16825; -.
DR   iPTMnet; Q16825; -.
DR   PhosphoSitePlus; Q16825; -.
DR   BioMuta; PTPN21; -.
DR   DMDM; 290457654; -.
DR   EPD; Q16825; -.
DR   MaxQB; Q16825; -.
DR   PaxDb; Q16825; -.
DR   PeptideAtlas; Q16825; -.
DR   PRIDE; Q16825; -.
DR   DNASU; 11099; -.
DR   Ensembl; ENST00000328736; ENSP00000330276; ENSG00000070778.
DR   Ensembl; ENST00000556564; ENSP00000452414; ENSG00000070778.
DR   GeneID; 11099; -.
DR   KEGG; hsa:11099; -.
DR   UCSC; uc001xwv.5; human.
DR   CTD; 11099; -.
DR   DisGeNET; 11099; -.
DR   EuPathDB; HostDB:ENSG00000070778.12; -.
DR   GeneCards; PTPN21; -.
DR   H-InvDB; HIX0037798; -.
DR   HGNC; HGNC:9651; PTPN21.
DR   HPA; CAB011468; -.
DR   HPA; HPA049110; -.
DR   MIM; 603271; gene.
DR   neXtProt; NX_Q16825; -.
DR   OpenTargets; ENSG00000070778; -.
DR   PharmGKB; PA33994; -.
DR   eggNOG; KOG0792; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00910000144001; -.
DR   HOGENOM; HOG000115775; -.
DR   HOVERGEN; HBG053757; -.
DR   InParanoid; Q16825; -.
DR   KO; K18025; -.
DR   OMA; RVDAKKI; -.
DR   OrthoDB; EOG091G00QP; -.
DR   PhylomeDB; Q16825; -.
DR   TreeFam; TF315900; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   SIGNOR; Q16825; -.
DR   ChiTaRS; PTPN21; human.
DR   GeneWiki; PTPN21; -.
DR   GenomeRNAi; 11099; -.
DR   PRO; PR:Q16825; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000070778; -.
DR   CleanEx; HS_PTPN21; -.
DR   ExpressionAtlas; Q16825; baseline and differential.
DR   Genevisible; Q16825; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; TAS:ProtInc.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; TAS:ProtInc.
DR   GO; GO:0006470; P:protein dephosphorylation; TAS:ProtInc.
DR   CDD; cd14473; FERM_B-lobe; 1.
DR   Gene3D; 1.20.80.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_sf.
DR   InterPro; IPR035963; FERM_2.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR019747; FERM_CS.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR018979; FERM_N.
DR   InterPro; IPR018980; FERM_PH-like_C.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR014392; Tyr_Pase_non-rcpt_typ-14/21.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   Pfam; PF09380; FERM_C; 1.
DR   Pfam; PF00373; FERM_M; 1.
DR   Pfam; PF09379; FERM_N; 1.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PIRSF; PIRSF000934; Tyr-Ptase_nr14; 1.
DR   PRINTS; PR00935; BAND41.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM01196; FERM_C; 1.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF47031; SSF47031; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00660; FERM_1; 1.
DR   PROSITE; PS00661; FERM_2; 1.
DR   PROSITE; PS50057; FERM_3; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Hydrolase; Phosphoprotein;
KW   Polymorphism; Protein phosphatase; Reference proteome.
FT   CHAIN         1   1174       Tyrosine-protein phosphatase non-receptor
FT                                type 21.
FT                                /FTId=PRO_0000219439.
FT   DOMAIN       23    308       FERM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00084}.
FT   DOMAIN      896   1167       Tyrosine-protein phosphatase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   REGION     1108   1114       Substrate binding. {ECO:0000250}.
FT   COMPBIAS    340    343       Poly-Pro.
FT   COMPBIAS    565    574       Poly-Pro.
FT   COMPBIAS    712    717       Poly-Glu.
FT   ACT_SITE   1108   1108       Phosphocysteine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160,
FT                                ECO:0000255|PROSITE-ProRule:PRU10044}.
FT   BINDING    1067   1067       Substrate. {ECO:0000255}.
FT   BINDING    1152   1152       Substrate. {ECO:0000250}.
FT   MOD_RES     577    577       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62136}.
FT   MOD_RES     589    589       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62136}.
FT   MOD_RES     590    590       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62136}.
FT   MOD_RES     637    637       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     673    673       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62136}.
FT   MOD_RES     710    710       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62728}.
FT   MOD_RES     711    711       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62728}.
FT   MOD_RES     797    797       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62136}.
FT   MOD_RES     799    799       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62136}.
FT   MOD_RES     804    804       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62136}.
FT   VARIANT     385    385       L -> F (in dbSNP:rs2401751).
FT                                {ECO:0000269|PubMed:7519780}.
FT                                /FTId=VAR_060341.
FT   VARIANT     906    906       K -> N (in dbSNP:rs12879993).
FT                                /FTId=VAR_055539.
FT   VARIANT     936    936       V -> A (in dbSNP:rs2274736).
FT                                {ECO:0000269|PubMed:7519780}.
FT                                /FTId=VAR_060342.
SQ   SEQUENCE   1174 AA;  133281 MW;  5B746C824578F117 CRC64;
     MPLPFGLKLK RTRRYTVSSK SCLVARIQLL NNEFVEFTLS VESTGQESLE AVAQRLELRE
     VTYFSLWYYN KQNQRRWVDL EKPLKKQLDK YALEPTVYFG VVFYVPSVSQ LQQEITRYQY
     YLQLKKDILE GSIPCTLEQA IQLAGLAVQA DFGDFDQYES QDFLQKFALF PVGWLQDEKV
     LEEATQKVAL LHQKYRGLTA PDAEMLYMQE VERMDGYGEE SYPAKDSQGS DISIGACLEG
     IFVKHKNGRH PVVFRWHDIA NMSHNKSFFA LELANKEETI QFQTEDMETA KYIWRLCVAR
     HKFYRLNQCN LQTQTVTVNP IRRRSSSRMS LPKPQPYVMP PPPQLHYNGH YTEPYASSQD
     NLFVPNQNGY YCHSQTSLDR AQIDLNGRIR NGSVYSAHST NSLNNPQPYL QPSPMSSNPS
     ITGSDVMRPD YLPSHRHSAV IPPSYRPTPD YETVMKQLNR GLVHAERQSH SLRNLNIGSS
     YAYSRPAALV YSQPEIREHA QLPSPAAAHC PFSLSYSFHS PSPYPYPAER RPVVGAVSVP
     ELTNAQLQAQ DYPSPNIMRT QVYRPPPPYP PPRPANSTPD LSRHLYISSS NPDLITRRVH
     HSVQTFQEDS LPVAHSLQEV SEPLTAARHA QLHKRNSIEV AGLSHGLEGL RLKERTLSAS
     AAEVAPRAVS VGSQPSVFTE RTQREGPEEA EGLRYGHKKS LSDATMLIHS SEEEEDEDFE
     EESGARAPPA RAREPRPGLA QDPPGCPRVL LAGPLHILEP KAHVPDAEKR MMDSSPVRTT
     AEAQRPWRDG LLMPSMSESD LTTSGRYRAR RDSLKKRPVS DLLSGKKNIV EGLPPLGGMK
     KTRVDAKKIG PLKLAALNGL SLSRVPLPDE GKEVATRATN DERCKILEQR LEQGMVFTEY
     ERILKKRLVD GECSTARLPE NAERNRFQDV LPYDDVRVEL VPTKENNTGY INASHIKVSV
     SGIEWDYIAT QGPLQNTCQD FWQMVWEQGI AIIAMVTAEE EGGREKSFRY WPRLGSRHNT
     VTYGRFKITT RFRTDSGCYA TTGLKMKHLL TGQERTVWHL QYTDWPEHGC PEDLKGFLSY
     LEEIQSVRRH TNSTSDPQSP NPPLLVHCSA GVGRTGVVIL SEIMIACLEH NEVLDIPRVL
     DMLRQQRMML VQTLCQYTFV YRVLIQFLKS SRLI
//
ID   A0A024RAS0_HUMAN        Unreviewed;       377 AA.
AC   A0A024RAS0;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 29.
DE   SubName: Full=Protein tyrosine phosphatase, receptor type, O, isoform CRA_c {ECO:0000313|EMBL:EAW96353.1};
GN   Name=PTPRO {ECO:0000313|EMBL:EAW96353.1};
GN   ORFNames=hCG_25166 {ECO:0000313|EMBL:EAW96353.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW96353.1};
RN   [1] {ECO:0000313|EMBL:EAW96353.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW96353.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000256|SAAS:SAAS00697399}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471094; EAW96353.1; -; Genomic_DNA.
DR   RefSeq; NP_109593.1; NM_030668.2.
DR   RefSeq; NP_109595.1; NM_030670.2.
DR   UniGene; Hs.160871; -.
DR   ProteinModelPortal; A0A024RAS0; -.
DR   SMR; A0A024RAS0; -.
DR   PRIDE; A0A024RAS0; -.
DR   GeneID; 5800; -.
DR   CTD; 5800; -.
DR   EuPathDB; HostDB:ENSG00000151490.13; -.
DR   ChiTaRS; PTPRO; human.
DR   GenomeRNAi; 5800; -.
DR   Bgee; ENSG00000151490; -.
DR   ExpressionAtlas; A0A024RAS0; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   4: Predicted;
KW   Hydrolase {ECO:0000256|SAAS:SAAS01031415};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Protein phosphatase {ECO:0000256|SAAS:SAAS01031415};
KW   Receptor {ECO:0000313|EMBL:EAW96353.1};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     12     33       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       99    356       Tyrosine-protein phosphatase.
FT                                {ECO:0000259|PROSITE:PS50055}.
FT   DOMAIN      273    347       TYR_PHOSPHATASE_2.
FT                                {ECO:0000259|PROSITE:PS50056}.
FT   ACT_SITE    297    297       Phosphocysteine intermediate.
FT                                {ECO:0000256|PROSITE-ProRule:PRU00160}.
SQ   SEQUENCE   377 AA;  43760 MW;  42E10120DBF2D1EF CRC64;
     MVTEMNPNVV VISVLAILST LLIGLLLVTL IILRKKHLQM ARECGAGTFV NFASLERDGK
     LPYNWSKNGL KKRKLTNPVQ LDDFDAYIKD MAKDSDYKFS LQFEELKLIG LDIPHFAADL
     PLNRCKNRYT NILPYDFSRV RLVSMNEEEG ADYINANYIP GYNSPQEYIA TQGPLPETRN
     DFWKMVLQQK SQIIVMLTQC NEKRRVKCDH YWPFTEEPIA YGDITVEMIS EEEQDDWACR
     HFRINYADEM QDVMHFNYTA WPDHGVPTAN AAESILQFVH MVRQQATKSK GPMIIHCSAG
     VGRTGTFIAL DRLLQHIRDH EFVDILGLVS EMRSYRMSMV QTEEQYIFIH QCVQLMWMKK
     KQQFCISDVI YENVSKS
//
ID   A0A024RAS9_HUMAN        Unreviewed;       405 AA.
AC   A0A024RAS9;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 34.
DE   SubName: Full=Protein tyrosine phosphatase, receptor type, O, isoform CRA_d {ECO:0000313|EMBL:EAW96352.1};
GN   Name=PTPRO {ECO:0000313|EMBL:EAW96352.1};
GN   ORFNames=hCG_25166 {ECO:0000313|EMBL:EAW96352.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW96352.1};
RN   [1] {ECO:0000313|EMBL:EAW96352.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW96352.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000256|SAAS:SAAS00697399}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471094; EAW96352.1; -; Genomic_DNA.
DR   RefSeq; NP_109594.1; NM_030669.2.
DR   RefSeq; NP_109596.1; NM_030671.2.
DR   UniGene; Hs.160871; -.
DR   ProteinModelPortal; A0A024RAS9; -.
DR   SMR; A0A024RAS9; -.
DR   PRIDE; A0A024RAS9; -.
DR   GeneID; 5800; -.
DR   CTD; 5800; -.
DR   EuPathDB; HostDB:ENSG00000151490.13; -.
DR   eggNOG; KOG0791; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   ChiTaRS; PTPRO; human.
DR   GenomeRNAi; 5800; -.
DR   Bgee; ENSG00000151490; -.
DR   ExpressionAtlas; A0A024RAS9; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   4: Predicted;
KW   Hydrolase {ECO:0000256|SAAS:SAAS01031415};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Protein phosphatase {ECO:0000256|SAAS:SAAS01031415};
KW   Receptor {ECO:0000313|EMBL:EAW96352.1};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     12     33       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     69     90       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      127    384       Tyrosine-protein phosphatase.
FT                                {ECO:0000259|PROSITE:PS50055}.
FT   DOMAIN      301    375       TYR_PHOSPHATASE_2.
FT                                {ECO:0000259|PROSITE:PS50056}.
FT   ACT_SITE    325    325       Phosphocysteine intermediate.
FT                                {ECO:0000256|PROSITE-ProRule:PRU00160}.
SQ   SEQUENCE   405 AA;  47163 MW;  D7BED5FFF7312782 CRC64;
     MVTEMNPNVV VISVLAILST LLIGLLLVTL IILRKKHLQM ARECGAGTFV NFASLERDGK
     LPYNWRRSIF AFLTLLPSCL WTDYLLAFYI NPWSKNGLKK RKLTNPVQLD DFDAYIKDMA
     KDSDYKFSLQ FEELKLIGLD IPHFAADLPL NRCKNRYTNI LPYDFSRVRL VSMNEEEGAD
     YINANYIPGY NSPQEYIATQ GPLPETRNDF WKMVLQQKSQ IIVMLTQCNE KRRVKCDHYW
     PFTEEPIAYG DITVEMISEE EQDDWACRHF RINYADEMQD VMHFNYTAWP DHGVPTANAA
     ESILQFVHMV RQQATKSKGP MIIHCSAGVG RTGTFIALDR LLQHIRDHEF VDILGLVSEM
     RSYRMSMVQT EEQYIFIHQC VQLMWMKKKQ QFCISDVIYE NVSKS
//
ID   PTPRO_HUMAN             Reviewed;        1216 AA.
AC   Q16827; A0AV39; Q13101; Q8IYG3; Q9UBF0; Q9UBT5;
DT   19-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 2.
DT   23-MAY-2018, entry version 172.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase O;
DE            Short=R-PTP-O;
DE            EC=3.1.3.48;
DE   AltName: Full=Glomerular epithelial protein 1;
DE   AltName: Full=Protein tyrosine phosphatase U2;
DE            Short=PTP-U2;
DE            Short=PTPase U2;
DE   Flags: Precursor;
GN   Name=PTPRO; Synonyms=GLEPP1, PTPU2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=7753550;
RA   Seimiya H., Sawabe T., Inazawa J., Tsuruo T.;
RT   "Cloning, expression and chromosomal localization of a novel gene for
RT   protein tyrosine phosphatase (PTP-U2) induced by various
RT   differentiation-inducing agents.";
RL   Oncogene 10:1731-1738(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=7665166; DOI=10.1006/geno.1995.1021;
RA   Wiggins R.C., Wiggins J.E., Goyal M., Wharram B.L., Thomas P.E.;
RT   "Molecular cloning of cDNAs encoding human GLEPP1, a membrane protein
RT   tyrosine phosphatase: characterization of the GLEPP1 protein
RT   distribution in human kidney and assignment of the GLEPP1 gene to
RT   human chromosome 12p12-p13.";
RL   Genomics 27:174-181(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4), AND TISSUE SPECIFICITY.
RX   PubMed=10498613;
RA   Aguiar R.C., Yakushijin Y., Kharbanda S., Tiwari S., Freeman G.J.,
RA   Shipp M.A.;
RT   "PTPROt: an alternatively spliced and developmentally regulated B-
RT   lymphoid phosphatase that promotes G0/G1 arrest.";
RL   Blood 94:2403-2413(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 5).
RC   TISSUE=Brain, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INVOLVEMENT IN NPHS6.
RX   PubMed=21722858; DOI=10.1016/j.ajhg.2011.05.026;
RA   Ozaltin F., Ibsirlioglu T., Taskiran E.Z., Baydar D.E., Kaymaz F.,
RA   Buyukcelik M., Kilic B.D., Balat A., Iatropoulos P., Asan E.,
RA   Akarsu N.A., Schaefer F., Yilmaz E., Bakkaloglu A.;
RT   "Disruption of PTPRO causes childhood-onset nephrotic syndrome.";
RL   Am. J. Hum. Genet. 89:139-147(2011).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 916-1208, AND FUNCTION.
RX   PubMed=19167335; DOI=10.1016/j.cell.2008.11.038;
RA   Barr A.J., Ugochukwu E., Lee W.H., King O.N.F., Filippakopoulos P.,
RA   Alfano I., Savitsky P., Burgess-Brown N.A., Mueller S., Knapp S.;
RT   "Large-scale structural analysis of the classical human protein
RT   tyrosine phosphatome.";
RL   Cell 136:352-363(2009).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.19 ANGSTROMS) OF 914-1200.
RX   PubMed=18058037; DOI=10.1007/s10969-007-9036-1;
RA   Almo S.C., Bonanno J.B., Sauder J.M., Emtage S., Dilorenzo T.P.,
RA   Malashkevich V., Wasserman S.R., Swaminathan S., Eswaramoorthy S.,
RA   Agarwal R., Kumaran D., Madegowda M., Ragumani S., Patskovsky Y.,
RA   Alvarado J., Ramagopal U.A., Faber-Barata J., Chance M.R., Sali A.,
RA   Fiser A., Zhang Z.Y., Lawrence D.S., Burley S.K.;
RT   "Structural genomics of protein phosphatases.";
RL   J. Struct. Funct. Genomics 8:121-140(2007).
CC   -!- FUNCTION: Possesses tyrosine phosphatase activity. Plays a role in
CC       regulating the glomerular pressure/filtration rate relationship
CC       through an effect on podocyte structure and function (By
CC       similarity). {ECO:0000250, ECO:0000269|PubMed:19167335}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044}.
CC   -!- SUBUNIT: Interacts (phosphorylated form) with FYN and GRB2.
CC       {ECO:0000250|UniProtKB:E9Q612}.
CC   -!- INTERACTION:
CC       P04626:ERBB2; NbExp=2; IntAct=EBI-723739, EBI-641062;
CC       P08581:MET; NbExp=2; IntAct=EBI-723739, EBI-1039152;
CC       Q02763:TEK; NbExp=2; IntAct=EBI-723739, EBI-2257090;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q16827-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16827-2; Sequence=VSP_035586;
CC       Name=3; Synonyms=PTPROt;
CC         IsoId=Q16827-3; Sequence=VSP_043136;
CC         Note=Predominantly expressed in B-lymphoid tissues.;
CC       Name=4;
CC         IsoId=Q16827-4; Sequence=VSP_043136, VSP_035586;
CC       Name=5;
CC         IsoId=Q16827-5; Sequence=VSP_054481, VSP_054482;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Glomerulus of kidney. Also detected in brain,
CC       lung and placenta. {ECO:0000269|PubMed:10498613}.
CC   -!- INDUCTION: By various differentiation-inducing agents.
CC   -!- DISEASE: Nephrotic syndrome 6 (NPHS6) [MIM:614196]: A form of
CC       nephrotic syndrome, a renal disease clinically characterized by
CC       severe proteinuria, resulting in complications such as
CC       hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show
CC       non-specific histologic changes such as focal segmental
CC       glomerulosclerosis and diffuse mesangial proliferation. Some
CC       affected individuals have an inherited steroid-resistant form and
CC       progress to end-stage renal failure.
CC       {ECO:0000269|PubMed:21722858}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 3 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z48541; CAA88425.1; -; mRNA.
DR   EMBL; U20489; AAA82892.1; -; mRNA.
DR   EMBL; AF187043; AAF04086.1; -; mRNA.
DR   EMBL; AF187044; AAF04087.1; -; mRNA.
DR   EMBL; AK290982; BAF83671.1; -; mRNA.
DR   EMBL; AC007542; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022334; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092183; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471094; EAW96349.1; -; Genomic_DNA.
DR   EMBL; CH471094; EAW96350.1; -; Genomic_DNA.
DR   EMBL; CH471094; EAW96351.1; -; Genomic_DNA.
DR   EMBL; BC035960; AAH35960.1; -; mRNA.
DR   EMBL; BC126201; AAI26202.1; -; mRNA.
DR   EMBL; BC126203; AAI26204.1; -; mRNA.
DR   CCDS; CCDS44837.1; -. [Q16827-3]
DR   CCDS; CCDS53754.1; -. [Q16827-4]
DR   CCDS; CCDS8674.1; -. [Q16827-2]
DR   CCDS; CCDS8675.1; -. [Q16827-1]
DR   PIR; A57064; A57064.
DR   PIR; S60613; S60613.
DR   RefSeq; NP_002839.1; NM_002848.3. [Q16827-2]
DR   RefSeq; NP_109592.1; NM_030667.2. [Q16827-1]
DR   RefSeq; NP_109593.1; NM_030668.2. [Q16827-4]
DR   RefSeq; NP_109594.1; NM_030669.2. [Q16827-3]
DR   RefSeq; NP_109595.1; NM_030670.2. [Q16827-4]
DR   RefSeq; NP_109596.1; NM_030671.2. [Q16827-3]
DR   UniGene; Hs.160871; -.
DR   PDB; 2G59; X-ray; 2.19 A; A/B=914-1200.
DR   PDB; 2GJT; X-ray; 2.15 A; A/B=916-1208.
DR   PDBsum; 2G59; -.
DR   PDBsum; 2GJT; -.
DR   ProteinModelPortal; Q16827; -.
DR   SMR; Q16827; -.
DR   BioGrid; 111764; 74.
DR   IntAct; Q16827; 36.
DR   MINT; Q16827; -.
DR   STRING; 9606.ENSP00000281171; -.
DR   DEPOD; Q16827; -.
DR   iPTMnet; Q16827; -.
DR   PhosphoSitePlus; Q16827; -.
DR   BioMuta; PTPRO; -.
DR   DMDM; 209572663; -.
DR   MaxQB; Q16827; -.
DR   PaxDb; Q16827; -.
DR   PeptideAtlas; Q16827; -.
DR   PRIDE; Q16827; -.
DR   DNASU; 5800; -.
DR   Ensembl; ENST00000281171; ENSP00000281171; ENSG00000151490. [Q16827-1]
DR   Ensembl; ENST00000348962; ENSP00000343434; ENSG00000151490. [Q16827-2]
DR   Ensembl; ENST00000442921; ENSP00000404188; ENSG00000151490. [Q16827-3]
DR   Ensembl; ENST00000445537; ENSP00000393449; ENSG00000151490. [Q16827-3]
DR   Ensembl; ENST00000542557; ENSP00000437571; ENSG00000151490. [Q16827-4]
DR   Ensembl; ENST00000543886; ENSP00000444173; ENSG00000151490. [Q16827-5]
DR   Ensembl; ENST00000544244; ENSP00000439234; ENSG00000151490. [Q16827-4]
DR   GeneID; 5800; -.
DR   KEGG; hsa:5800; -.
DR   UCSC; uc001rcu.3; human. [Q16827-1]
DR   CTD; 5800; -.
DR   DisGeNET; 5800; -.
DR   EuPathDB; HostDB:ENSG00000151490.13; -.
DR   GeneCards; PTPRO; -.
DR   HGNC; HGNC:9678; PTPRO.
DR   HPA; HPA034525; -.
DR   MalaCards; PTPRO; -.
DR   MIM; 600579; gene.
DR   MIM; 614196; phenotype.
DR   neXtProt; NX_Q16827; -.
DR   OpenTargets; ENSG00000151490; -.
DR   Orphanet; 93214; Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial proliferation.
DR   Orphanet; 93217; Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis.
DR   Orphanet; 93213; Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis.
DR   Orphanet; 93216; Familial idiopathic steroid-resistant nephrotic syndrome with minimal changes.
DR   PharmGKB; PA34023; -.
DR   eggNOG; KOG0791; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00900000140785; -.
DR   HOGENOM; HOG000115792; -.
DR   HOVERGEN; HBG053763; -.
DR   InParanoid; Q16827; -.
DR   KO; K18035; -.
DR   OMA; SVTACTE; -.
DR   OrthoDB; EOG091G00JF; -.
DR   PhylomeDB; Q16827; -.
DR   TreeFam; TF351926; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   ChiTaRS; PTPRO; human.
DR   EvolutionaryTrace; Q16827; -.
DR   GeneWiki; PTPRO; -.
DR   GenomeRNAi; 5800; -.
DR   PRO; PR:Q16827; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000151490; -.
DR   CleanEx; HS_PTPRO; -.
DR   ExpressionAtlas; Q16827; baseline and differential.
DR   Genevisible; Q16827; HS.
DR   GO; GO:0016324; C:apical plasma membrane; ISS:UniProtKB.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0043197; C:dendritic spine; ISS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0030426; C:growth cone; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; TAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0016328; C:lateral plasma membrane; ISS:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016791; F:phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; NAS:UniProtKB.
DR   GO; GO:0017147; F:Wnt-protein binding; ISS:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; ISS:UniProtKB.
DR   GO; GO:0000902; P:cell morphogenesis; ISS:UniProtKB.
DR   GO; GO:0072112; P:glomerular visceral epithelial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0032835; P:glomerulus development; IMP:UniProtKB.
DR   GO; GO:0030032; P:lamellipodium assembly; ISS:UniProtKB.
DR   GO; GO:0002548; P:monocyte chemotaxis; IMP:UniProtKB.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISS:UniProtKB.
DR   GO; GO:0010812; P:negative regulation of cell-substrate adhesion; ISS:UniProtKB.
DR   GO; GO:0003105; P:negative regulation of glomerular filtration; ISS:UniProtKB.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0090260; P:negative regulation of retinal ganglion cell axon guidance; ISS:UniProtKB.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; IMP:UniProtKB.
DR   GO; GO:0006470; P:protein dephosphorylation; ISS:UniProtKB.
DR   GO; GO:0003093; P:regulation of glomerular filtration; ISS:UniProtKB.
DR   GO; GO:0036060; P:slit diaphragm assembly; ISS:UniProtKB.
DR   CDD; cd00063; FN3; 3.
DR   Gene3D; 2.60.40.10; -; 3.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 4.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS50853; FN3; 5.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Glycoprotein;
KW   Hydrolase; Membrane; Phosphoprotein; Protein phosphatase; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     29       {ECO:0000255}.
FT   CHAIN        30   1216       Receptor-type tyrosine-protein
FT                                phosphatase O.
FT                                /FTId=PRO_0000025458.
FT   TOPO_DOM     30    822       Extracellular. {ECO:0000255}.
FT   TRANSMEM    823    843       Helical. {ECO:0000255}.
FT   TOPO_DOM    844   1216       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       50    124       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      142    211       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      246    306       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      329    425       Fibronectin type-III 4.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      435    531       Fibronectin type-III 5.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      532    628       Fibronectin type-III 6.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      631    724       Fibronectin type-III 7.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      725    817       Fibronectin type-III 8.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      938   1195       Tyrosine-protein phosphatase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   REGION     1136   1142       Substrate binding. {ECO:0000250}.
FT   ACT_SITE   1136   1136       Phosphocysteine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160,
FT                                ECO:0000255|PROSITE-ProRule:PRU10044}.
FT   BINDING    1102   1102       Substrate. {ECO:0000250}.
FT   BINDING    1180   1180       Substrate. {ECO:0000250}.
FT   MOD_RES     865    865       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:E9Q612}.
FT   MOD_RES    1210   1210       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:E9Q612}.
FT   CARBOHYD     75     75       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    154    154       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    189    189       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    201    201       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    227    227       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    278    278       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    287    287       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    323    323       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    324    324       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    370    370       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    461    461       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    490    490       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    700    700       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    712    712       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    733    733       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    811       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:10498613,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043136.
FT   VAR_SEQ     594    597       RIAN -> VIFP (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054481.
FT   VAR_SEQ     598   1216       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054482.
FT   VAR_SEQ     876    903       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:10498613,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:7665166}.
FT                                /FTId=VSP_035586.
FT   CONFLICT    159    159       E -> G (in Ref. 1; CAA88425 and 2;
FT                                AAA82892). {ECO:0000305}.
FT   CONFLICT    196    196       S -> C (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    205    205       L -> V (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    314    314       V -> F (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    441    441       V -> F (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    672    672       A -> T (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    698    698       I -> T (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    705    705       A -> T (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    753    753       E -> K (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    756    758       CQQ -> FQH (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    775    775       S -> P (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    790    790       N -> S (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    861    863       VNF -> ANC (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    876    876       W -> C (in Ref. 1; CAA88425 and 2;
FT                                AAA82892). {ECO:0000305}.
FT   CONFLICT    896    896       L -> P (in Ref. 1; CAA88425 and 2;
FT                                AAA82892). {ECO:0000305}.
FT   HELIX       920    922       {ECO:0000244|PDB:2GJT}.
FT   HELIX       923    946       {ECO:0000244|PDB:2GJT}.
FT   TURN        947    951       {ECO:0000244|PDB:2GJT}.
FT   HELIX       956    958       {ECO:0000244|PDB:2GJT}.
FT   HELIX       960    965       {ECO:0000244|PDB:2GJT}.
FT   TURN        975    977       {ECO:0000244|PDB:2GJT}.
FT   STRAND      978    980       {ECO:0000244|PDB:2GJT}.
FT   TURN        988    991       {ECO:0000244|PDB:2GJT}.
FT   STRAND      992    998       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1007   1010       {ECO:0000244|PDB:2GJT}.
FT   HELIX      1015   1017       {ECO:0000244|PDB:2GJT}.
FT   HELIX      1018   1027       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1032   1035       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1039   1041       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1053   1056       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1058   1060       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1063   1072       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1074   1085       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1088   1097       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1103   1105       {ECO:0000244|PDB:2GJT}.
FT   HELIX      1108   1127       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1132   1140       {ECO:0000244|PDB:2GJT}.
FT   HELIX      1141   1158       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1160   1162       {ECO:0000244|PDB:2GJT}.
FT   HELIX      1164   1172       {ECO:0000244|PDB:2GJT}.
FT   HELIX      1182   1202       {ECO:0000244|PDB:2GJT}.
SQ   SEQUENCE   1216 AA;  138344 MW;  C902B48D1A73BFE1 CRC64;
     MGHLPTGIHG ARRLLPLLWL FVLFKNATAF HVTVQDDNNI VVSLEASDVI SPASVYVVKI
     TGESKNYFFE FEEFNSTLPP PVIFKASYHG LYYIITLVVV NGNVVTKPSR SITVLTKPLP
     VTSVSIYDYK PSPETGVLFE IHYPEKYNVF TRVNISYWEG KDFRTMLYKD FFKGKTVFNH
     WLPGMCYSNI TFQLVSEATF NKSTLVEYSG VSHEPKQHRT APYPPQNISV RIVNLNKNNW
     EEQSGNFPEE SFMRSQDTIG KEKLFHFTEE TPEIPSGNIS SGWPDFNSSD YETTSQPYWW
     DSASAAPESE DEFVSVLPME YENNSTLSET EKSTSGSFSF FPVQMILTWL PPKPPTAFDG
     FHIHIEREEN FTEYLMVDEE AHEFVAELKE PGKYKLSVTT FSSSGSCETR KSQSAKSLSF
     YISPSGEWIE ELTEKPQHVS VHVLSSTTAL MSWTSSQENY NSTIVSVVSL TCQKQKESQR
     LEKQYCTQVN SSKPIIENLV PGAQYQVVIY LRKGPLIGPP SDPVTFAIVP TGIKDLMLYP
     LGPTAVVLSW TRPYLGVFRK YVVEMFYFNP ATMTSEWTTY YEIAATVSLT ASVRIANLLP
     AWYYNFRVTM VTWGDPELSC CDSSTISFIT APVAPEITSV EYFNSLLYIS WTYGDDTTDL
     SHSRMLHWMV VAEGKKKIKK SVTRNVMTAI LSLPPGDIYN LSVTACTERG SNTSMLRLVK
     LEPAPPKSLF AVNKTQTSVT LLWVEEGVAD FFEVFCQQVG SSQKTKLQEP VAVSSHVVTI
     SSLLPATAYN CSVTSFSHDS PSVPTFIAVS TMVTEMNPNV VVISVLAILS TLLIGLLLVT
     LIILRKKHLQ MARECGAGTF VNFASLERDG KLPYNWRRSI FAFLTLLPSC LWTDYLLAFY
     INPWSKNGLK KRKLTNPVQL DDFDAYIKDM AKDSDYKFSL QFEELKLIGL DIPHFAADLP
     LNRCKNRYTN ILPYDFSRVR LVSMNEEEGA DYINANYIPG YNSPQEYIAT QGPLPETRND
     FWKMVLQQKS QIIVMLTQCN EKRRVKCDHY WPFTEEPIAY GDITVEMISE EEQDDWACRH
     FRINYADEMQ DVMHFNYTAW PDHGVPTANA AESILQFVHM VRQQATKSKG PMIIHCSAGV
     GRTGTFIALD RLLQHIRDHE FVDILGLVSE MRSYRMSMVQ TEEQYIFIHQ CVQLMWMKKK
     QQFCISDVIY ENVSKS
//
ID   A0A024R6T1_HUMAN        Unreviewed;       953 AA.
AC   A0A024R6T1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 40.
DE   SubName: Full=Cylindromatosis (Turban tumor syndrome), isoform CRA_a {ECO:0000313|EMBL:EAW82769.1};
GN   Name=CYLD {ECO:0000313|EMBL:EAW82769.1};
GN   ORFNames=hCG_1811700 {ECO:0000313|EMBL:EAW82769.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW82769.1};
RN   [1] {ECO:0000313|EMBL:EAW82769.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW82769.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family.
CC       {ECO:0000256|SAAS:SAAS00549291}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471092; EAW82768.1; -; Genomic_DNA.
DR   EMBL; CH471092; EAW82769.1; -; Genomic_DNA.
DR   EMBL; CH471092; EAW82770.1; -; Genomic_DNA.
DR   EMBL; CH471092; EAW82771.1; -; Genomic_DNA.
DR   RefSeq; NP_001035814.1; NM_001042355.1.
DR   RefSeq; NP_001035877.1; NM_001042412.1.
DR   RefSeq; XP_005255869.1; XM_005255812.2.
DR   RefSeq; XP_006721212.1; XM_006721149.1.
DR   RefSeq; XP_011521209.1; XM_011522907.2.
DR   RefSeq; XP_016878466.1; XM_017022977.1.
DR   RefSeq; XP_016878467.1; XM_017022978.1.
DR   RefSeq; XP_016878468.1; XM_017022979.1.
DR   RefSeq; XP_016878469.1; XM_017022980.1.
DR   UniGene; Hs.578973; -.
DR   SMR; A0A024R6T1; -.
DR   GeneID; 1540; -.
DR   CTD; 1540; -.
DR   EuPathDB; HostDB:ENSG00000083799.17; -.
DR   eggNOG; KOG3556; Eukaryota.
DR   eggNOG; ENOG410XP6I; LUCA.
DR   ChiTaRS; CYLD; human.
DR   GenomeRNAi; 1540; -.
DR   Bgee; ENSG00000083799; -.
DR   ExpressionAtlas; A0A024R6T1; baseline and differential.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; IEA:InterPro.
DR   GO; GO:0016579; P:protein deubiquitination; IEA:InterPro.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 2.30.30.190; -; 3.
DR   InterPro; IPR036859; CAP-Gly_dom_sf.
DR   InterPro; IPR000938; CAP-Gly_domain.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF01302; CAP_GLY; 2.
DR   Pfam; PF00443; UCH; 1.
DR   SMART; SM01052; CAP_GLY; 3.
DR   SUPFAM; SSF74924; SSF74924; 3.
DR   PROSITE; PS00845; CAP_GLY_1; 1.
DR   PROSITE; PS50245; CAP_GLY_2; 2.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   3: Inferred from homology;
FT   DOMAIN      153    198       CAP-Gly. {ECO:0000259|PROSITE:PS50245}.
FT   DOMAIN      489    532       CAP-Gly. {ECO:0000259|PROSITE:PS50245}.
FT   DOMAIN      589    947       USP. {ECO:0000259|PROSITE:PS50235}.
SQ   SEQUENCE   953 AA;  107044 MW;  0CCB3D21E2FF8851 CRC64;
     MSSGLWSQEK VTSPYWEERI FYLLLQECSV TDKQTQKLLK VPKGSIGQYI QDRSVGHSRI
     PSAKGKKNQI GLKILEQPHA VLFVDEKDVV EINEKFTELL LAITNCEERF SLFKNRNRLS
     KGLQIDVGCP VKVQLRSGEE KFPGVVRFRG PLLAERTVSG IFFGVELLEE GRGQGFTDGV
     YQGKQLFQCD EDCGVFVALD KLELIEDDDT ALESDYAGPG DTMQVELPPL EINSRVSLKV
     GETIESGTVI FCDVLPGKES LGYFVGVDMD NPIGNWDGRF DGVQLCSFAC VESTILLHIN
     DIIPESVTQE RRPPKLAFMS RGVGDKGSSS HNKPKATGST SDPGNRNRSE LFYTLNGSSV
     DSQPQSKSKN TWYIDEVAED PAKSLTEIST DFDRSSPPLQ PPPVNSLTTE NRFHSLPFSL
     TKMPNTNGSI GHSPLSLSAQ SVMEELNTAP VQESPPLAMP PGNSHGLEVG SLAEVKENPP
     FYGVIRWIGQ PPGLNEVLAG LELEDECAGC TDGTFRGTRY FTCALKKALF VKLKSCRPDS
     RFASLQPVSN QIERCNSLAF GGYLSEVVEE NTPPKMEKEG LEIMIGKKKG IQGHYNSCYL
     DSTLFCLFAF SSVLDTVLLR PKEKNDVEYY SETQELLRTE IVNPLRIYGY VCATKIMKLR
     KILEKVEAAS GFTSEEKDPE EFLNILFHHI LRVEPLLKIR SAGQKVQDCY FYQIFMEKNE
     KVGVPTIQQL LEWSFINSNL KFAEAPSCLI IQMPRFGKDF KLFKKIFPSL ELNITDLLED
     TPRQCRICGG LAMYECRECY DDPDISAGKI KQFCKTCNTQ VHLHPKRLNH KYNPVSLPKD
     LPDWDWRHGC IPCQNMELFA VLCIETSHYV AFVKYGKDDS AWLFFDSMAD RDGGQNGFNI
     PQVTPCPEVG EYLKMSLEDL HSLDSRRIQG CARRLLCDAY MCMYQSPTMS LYK
//
ID   CYLD_HUMAN              Reviewed;         956 AA.
AC   Q9NQC7; O94934; Q7L3N6; Q96EH0; Q9NZX9;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   23-MAY-2018, entry version 165.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase CYLD;
DE            EC=3.4.19.12 {ECO:0000269|PubMed:18313383};
DE   AltName: Full=Deubiquitinating enzyme CYLD;
DE   AltName: Full=Ubiquitin thioesterase CYLD;
DE   AltName: Full=Ubiquitin-specific-processing protease CYLD;
GN   Name=CYLD {ECO:0000303|PubMed:12917689, ECO:0000312|HGNC:HGNC:2584};
GN   Synonyms=CYLD1, KIAA0849 {ECO:0000303|PubMed:10048485};
GN   ORFNames=HSPC057;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   INVOLVEMENT IN FAMILIAL CYLINDROMATOSIS.
RX   PubMed=10835629; DOI=10.1038/76006;
RA   Bignell G.R., Brown C., Biggs P.J., Lakhani S.R., Jones C., Hansen J.,
RA   Blair E., Hofmann B., Siebert R., Turner G., Evans D.G.,
RA   Schrander-Stumpel C., Beemer F.A., Van Den Ouweland A., Halley D.,
RA   Delpech B., Cleveland M.G., Leigh I., Leisti J., Rasmussen S.,
RA   Wallace M.R., Fenske C., Banerjee P., Oiso N., Chaggar R., Merrett S.,
RA   Leonard N., Huber M., Hohl D., Chapman P., Burn J., Swift S.,
RA   Smith A., Ashworth A., Stratton M.R.;
RT   "Identification of the familial cylindromatosis tumor suppressor
RT   gene.";
RL   Nat. Genet. 25:160-165(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 397-956.
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for
RT   300 previously undefined genes expressed in CD34+ hematopoietic
RT   stem/progenitor cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [6]
RP   FUNCTION, INTERACTION WITH IKBKG/NEMO, AND MUTAGENESIS OF CYS-601.
RX   PubMed=12917689; DOI=10.1038/nature01803;
RA   Trompouki E., Hatzivassiliou E., Tsichritzis T., Farmer H.,
RA   Ashworth A., Mosialos G.;
RT   "CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB
RT   activation by TNFR family members.";
RL   Nature 424:793-796(2003).
RN   [7]
RP   FUNCTION, INTERACTION WITH IKBKG/NEMO, AND MUTAGENESIS OF CYS-601.
RX   PubMed=12917690; DOI=10.1038/nature01811;
RA   Brummelkamp T.R., Nijman S.M.B., Dirac A.M.G., Bernards R.;
RT   "Loss of the cylindromatosis tumour suppressor inhibits apoptosis by
RT   activating NF-kappaB.";
RL   Nature 424:797-801(2003).
RN   [8]
RP   FUNCTION, INTERACTION WITH IKBKG/NEMO AND TRAF2, AND MUTAGENESIS OF
RP   SER-457 AND HIS-871.
RX   PubMed=12917691; DOI=10.1038/nature01802;
RA   Kovalenko A., Chable-Bessia C., Cantarella G., Israeel A., Wallach D.,
RA   Courtois G.;
RT   "The tumour suppressor CYLD negatively regulates NF-kappaB signalling
RT   by deubiquitination.";
RL   Nature 424:801-805(2003).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH TRIP.
RX   PubMed=14676304; DOI=10.1084/jem.20031187;
RA   Regamey A., Hohl D., Liu J.W., Roger T., Kogerman P., Toftgaard R.,
RA   Huber M.;
RT   "The tumor suppressor CYLD interacts with TRIP and regulates
RT   negatively nuclear factor kappaB activation by tumor necrosis
RT   factor.";
RL   J. Exp. Med. 198:1959-1964(2003).
RN   [10]
RP   FUNCTION, INTERACTION WITH TRAF2, ENZYME REGULATION, MUTAGENESIS OF
RP   SER-418; SER-422; SER-432; SER-436; SER-439; SER-441 AND SER-444, AND
RP   PHOSPHORYLATION AT SER-418.
RX   PubMed=15870263; DOI=10.1128/MCB.25.10.3886-3895.2005;
RA   Reiley W., Zhang M., Wu X., Granger E., Sun S.C.;
RT   "Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase
RT   gamma-dependent phosphorylation.";
RL   Mol. Cell. Biol. 25:3886-3895(2005).
RN   [11]
RP   FUNCTION, MUTAGENESIS OF CYS-601, INTERACTION WITH PLK1, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=17495026; DOI=10.1073/pnas.0703268104;
RA   Stegmeier F., Sowa M.E., Nalepa G., Gygi S.P., Harper J.W.,
RA   Elledge S.J.;
RT   "The tumor suppressor CYLD regulates entry into mitosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:8869-8874(2007).
RN   [12]
RP   FUNCTION, SUBUNIT, AND INTERACTION WITH DDX58; MAVS; TBK1 AND IKKE.
RX   PubMed=18636086; DOI=10.1038/embor.2008.136;
RA   Friedman C.S., O'Donnell M.A., Legarda-Addison D., Ng A.,
RA   Cardenas W.B., Yount J.S., Moran T.M., Basler C.F., Komuro A.,
RA   Horvath C.M., Xavier R., Ting A.T.;
RT   "The tumour suppressor CYLD is a negative regulator of RIG-I-mediated
RT   antiviral response.";
RL   EMBO Rep. 9:930-936(2008).
RN   [13]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18222923; DOI=10.1074/jbc.M708470200;
RA   Gao J., Huo L., Sun X., Liu M., Li D., Dong J.T., Zhou J.;
RT   "The tumor suppressor CYLD regulates microtubule dynamics and plays a
RT   role in cell migration.";
RL   J. Biol. Chem. 283:8802-8809(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=20194890; DOI=10.1182/blood-2009-10-248526;
RA   Gao J., Sun L., Huo L., Liu M., Li D., Zhou J.;
RT   "CYLD regulates angiogenesis by mediating vascular endothelial cell
RT   migration.";
RL   Blood 115:4130-4137(2010).
RN   [16]
RP   FUNCTION, INTERACTION WITH HDAC6; BCL3 AND MICROTUBULES, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=19893491; DOI=10.1038/emboj.2009.317;
RA   Wickstrom S.A., Masoumi K.C., Khochbin S., Fassler R., Massoumi R.;
RT   "CYLD negatively regulates cell-cycle progression by inactivating
RT   HDAC6 and increasing the levels of acetylated tubulin.";
RL   EMBO J. 29:131-144(2010).
RN   [17]
RP   FUNCTION, AND INTERACTION WITH DVL1 AND DVL3.
RX   PubMed=20227366; DOI=10.1016/j.molcel.2010.01.035;
RA   Tauriello D.V., Haegebarth A., Kuper I., Edelmann M.J., Henraat M.,
RA   Canninga-van Dijk M.R., Kessler B.M., Clevers H., Maurice M.M.;
RT   "Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling
RT   through K63-linked ubiquitination of Dvl.";
RL   Mol. Cell 37:607-619(2010).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-418 AND SER-422, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-387, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH CEP350.
RX   PubMed=25134987; DOI=10.1038/ncomms5585;
RA   Eguether T., Ermolaeva M.A., Zhao Y., Bonnet M.C., Jain A.,
RA   Pasparakis M., Courtois G., Tassin A.M.;
RT   "The deubiquitinating enzyme CYLD controls apical docking of basal
RT   bodies in ciliated epithelial cells.";
RL   Nat. Commun. 5:4585-4585(2014).
RN   [21]
RP   INVOLVEMENT IN FCYL, AND INVOLVEMENT IN BRSS.
RX   PubMed=12190880; DOI=10.1046/j.1523-1747.2002.01839.x;
RA   Poblete Gutierrez P., Eggermann T., Hoeller D., Jugert F.K.,
RA   Beermann T., Grussendorf-Conen E.-I., Zerres K., Merk H.F., Frank J.;
RT   "Phenotype diversity in familial cylindromatosis: a frameshift
RT   mutation in the tumor suppressor gene CYLD underlies different tumors
RT   of skin appendages.";
RL   J. Invest. Dermatol. 119:527-531(2002).
RN   [22]
RP   INVOLVEMENT IN BRSS.
RX   PubMed=12950348; DOI=10.1046/j.1365-2230.2003.01344.x;
RA   Scheinfeld N., Hu G., Gill M., Austin C., Celebi J.T.;
RT   "Identification of a recurrent mutation in the CYLD gene in Brooke-
RT   Spiegler syndrome.";
RL   Clin. Exp. Dermatol. 28:539-541(2003).
RN   [23]
RP   INVOLVEMENT IN MFT1.
RX   PubMed=16307661; DOI=10.1111/j.1365-2133.2005.06960.x;
RA   Liang Y.H., Gao M., Sun L.D., Liu L.J., Cui Y., Yang S., Fan X.,
RA   Wang J., Xiao F.L., Zhang X.J.;
RT   "Two novel CYLD gene mutations in Chinese families with
RT   trichoepithelioma and a literature review of 16 families with
RT   trichoepithelioma reported in China.";
RL   Br. J. Dermatol. 153:1213-1215(2005).
RN   [24]
RP   INVOLVEMENT IN BRSS.
RX   PubMed=15854031; DOI=10.1111/j.0022-202X.2005.23688.x;
RA   Bowen S., Gill M., Lee D.A., Fisher G., Geronemus R.G., Vazquez M.E.,
RA   Celebi J.T.;
RT   "Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial
RT   cylindromatosis, and multiple familial trichoepithelioma: lack of
RT   genotype-phenotype correlation.";
RL   J. Invest. Dermatol. 124:919-920(2005).
RN   [25]
RP   INVOLVEMENT IN FCYL, AND INVOLVEMENT IN MFT1.
RX   PubMed=16922728; DOI=10.1111/j.1399-0004.2006.00667.x;
RA   Young A.L., Kellermayer R., Szigeti R., Teszas A., Azmi S.,
RA   Celebi J.T.;
RT   "CYLD mutations underlie Brooke-Spiegler, familial cylindromatosis,
RT   and multiple familial trichoepithelioma syndromes.";
RL   Clin. Genet. 70:246-249(2006).
RN   [26]
RP   FUNCTION.
RX   PubMed=26670046; DOI=10.1016/j.celrep.2015.11.009;
RA   Draber P., Kupka S., Reichert M., Draberova H., Lafont E.,
RA   de Miguel D., Spilgies L., Surinova S., Taraborrelli L., Hartwig T.,
RA   Rieser E., Martino L., Rittinger K., Walczak H.;
RT   "LUBAC-recruited CYLD and A20 regulate gene activation and cell death
RT   by exerting opposing effects on linear ubiquitin in signaling
RT   complexes.";
RL   Cell Rep. 13:2258-2272(2015).
RN   [27]
RP   FUNCTION, AND INTERACTION WITH RNF31.
RX   PubMed=26997266; DOI=10.1016/j.celrep.2016.02.062;
RA   Hrdinka M., Fiil B.K., Zucca M., Leske D., Bagola K., Yabal M.,
RA   Elliott P.R., Damgaard R.B., Komander D., Jost P.J., Gyrd-Hansen M.;
RT   "CYLD limits Lys63- and Met1-linked ubiquitin at receptor complexes to
RT   regulate innate immune signaling.";
RL   Cell Rep. 14:2846-2858(2016).
RN   [28]
RP   STRUCTURE BY NMR OF 460-550, AND INTERACTION WITH IKBKG.
RX   PubMed=15341735; DOI=10.1016/j.str.2004.07.012;
RA   Saito K., Kigawa T., Koshiba S., Sato K., Matsuo Y., Sakamoto A.,
RA   Takagi T., Shirouzu M., Yabuki T., Nunokawa E., Seki E., Matsuda T.,
RA   Aoki M., Miyata Y., Hirakawa N., Inoue M., Terada T., Nagase T.,
RA   Kikuno R., Nakayama M., Ohara O., Tanaka A., Yokoyama S.;
RT   "The CAP-Gly domain of CYLD associates with the proline-rich sequence
RT   in NEMO/IKKgamma.";
RL   Structure 12:1719-1728(2004).
RN   [29]
RP   STRUCTURE BY NMR OF 125-304.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the 1st and 2nd CAP-Gly domains in human
RT   cylindromatosis tumor suppressor CYLD.";
RL   Submitted (NOV-2004) to the PDB data bank.
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 583-956 IN COMPLEX WITH ZINC
RP   IONS, FUNCTION, ACTIVE SITE, MUTAGENESIS OF CYS-601, CATALYTIC
RP   ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=18313383; DOI=10.1016/j.molcel.2007.12.018;
RA   Komander D., Lord C.J., Scheel H., Swift S., Hofmann K., Ashworth A.,
RA   Barford D.;
RT   "The structure of the CYLD USP domain explains its specificity for
RT   Lys63-linked polyubiquitin and reveals a B box module.";
RL   Mol. Cell 29:451-464(2008).
RN   [31]
RP   VARIANT MFT1 GLY-747, AND VARIANT BRSS GLY-747.
RX   PubMed=14632188; DOI=10.1046/j.1523-1747.2003.12514.x;
RA   Hu G., Oender M., Gill M., Aksakal B., Oeztas M., Guerer M.A.,
RA   Celebi J.T.;
RT   "A novel missense mutation in CYLD in a family with Brooke-Spiegler
RT   syndrome.";
RL   J. Invest. Dermatol. 121:732-734(2003).
CC   -!- FUNCTION: Deubiquitinase that specifically cleaves 'Lys-63'-linked
CC       polyubiquitin chains. Has endodeubiquitinase activity. Plays an
CC       important role in the regulation of pathways leading to NF-kappa-B
CC       activation (PubMed:12917689, PubMed:12917691). Contributes to the
CC       regulation of cell survival, proliferation and differentiation via
CC       its effects on NF-kappa-B activation (PubMed:12917690). Negative
CC       regulator of Wnt signaling (PubMed:20227366). Inhibits HDAC6 and
CC       thereby promotes acetylation of alpha-tubulin and stabilization of
CC       microtubules (PubMed:19893491). Plays a role in the regulation of
CC       microtubule dynamics, and thereby contributes to the regulation of
CC       cell proliferation, cell polarization, cell migration, and
CC       angiogenesis (PubMed:18222923, PubMed:20194890). Required for
CC       normal cell cycle progress and normal cytokinesis
CC       (PubMed:17495026, PubMed:19893491). Inhibits nuclear translocation
CC       of NF-kappa-B. Plays a role in the regulation of inflammation and
CC       the innate immune response, via its effects on NF-kappa-B
CC       activation (PubMed:18636086). Dispensable for the maturation of
CC       intrathymic natural killer cells, but required for the continued
CC       survival of immature natural killer cells. Negatively regulates
CC       TNFRSF11A signaling and osteoclastogenesis (By similarity).
CC       Involved in the regulation of ciliogenesis, allowing ciliary basal
CC       bodies to migrate and dock to the plasma membrane; this process
CC       does not depend on NF-kappa-B activation (By similarity). Also
CC       able to remove linear ('Met-1'-linked) polyubiquitin chains to
CC       regulate innate immunity: recruited to the LUBAC complex and,
CC       together with OTULIN, restricts linear polyubiquitin formation on
CC       RIPK2 in response to NOD2 stimulation (PubMed:26670046,
CC       PubMed:26997266). {ECO:0000250|UniProtKB:Q80TQ2,
CC       ECO:0000269|PubMed:12917689, ECO:0000269|PubMed:12917690,
CC       ECO:0000269|PubMed:12917691, ECO:0000269|PubMed:14676304,
CC       ECO:0000269|PubMed:17495026, ECO:0000269|PubMed:18222923,
CC       ECO:0000269|PubMed:18636086, ECO:0000269|PubMed:19893491,
CC       ECO:0000269|PubMed:20194890, ECO:0000269|PubMed:20227366,
CC       ECO:0000269|PubMed:26670046, ECO:0000269|PubMed:26997266}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC       {ECO:0000269|PubMed:18313383}.
CC   -!- ENZYME REGULATION: Inhibited by phosphorylation at serine
CC       residues. {ECO:0000269|PubMed:15870263}.
CC   -!- SUBUNIT: Interacts (via CAP-Gly domain) with IKBKG/NEMO (via
CC       proline-rich C-terminal region). Interacts with TRAF2 and TRIP.
CC       Interacts with PLK1, DVL1, DVL3, MAVS, TBK1, IKKE and DDX58.
CC       Interacts (via CAP-Gly domain) with microtubules. Interacts with
CC       HDAC6 and BCL3. Interacts with SQSTM1 and MAP3K7. Identified in a
CC       complex with TRAF6 and SQSTM1 (By similarity). Interacts with
CC       CEP350 (PubMed:25134987). Interacts with RNF31 (PubMed:26997266).
CC       {ECO:0000250, ECO:0000269|PubMed:25134987,
CC       ECO:0000269|PubMed:26997266}.
CC   -!- INTERACTION:
CC       O95786:DDX58; NbExp=2; IntAct=EBI-2117940, EBI-995350;
CC       Q9UBN7:HDAC6; NbExp=4; IntAct=EBI-2117940, EBI-301697;
CC       Q96J02:ITCH; NbExp=3; IntAct=EBI-2117940, EBI-1564678;
CC       Q96J02-2:ITCH; NbExp=2; IntAct=EBI-2117940, EBI-6672198;
CC       Q71U36:TUBA1A; NbExp=6; IntAct=EBI-2117940, EBI-302552;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, perinuclear region.
CC       Cytoplasm, cytoskeleton. Cell membrane; Peripheral membrane
CC       protein; Cytoplasmic side. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:25134987}.
CC       Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:25134987}.
CC       Cytoplasm, cytoskeleton, cilium basal body
CC       {ECO:0000250|UniProtKB:Q80TQ2}. Note=Detected at the microtubule
CC       cytoskeleton during interphase. Detected at the midbody during
CC       telophase. During metaphase, it remains localized to the
CC       centrosome but is also present along the spindle
CC       (PubMed:25134987). {ECO:0000250|UniProtKB:Q80TQ2,
CC       ECO:0000269|PubMed:25134987}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NQC7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NQC7-2; Sequence=VSP_011277;
CC   -!- TISSUE SPECIFICITY: Detected in fetal brain, testis, and skeletal
CC       muscle, and at a lower level in adult brain, leukocytes, liver,
CC       heart, kidney, spleen, ovary and lung. Isoform 2 is found in all
CC       tissues except kidney. {ECO:0000269|PubMed:10835629}.
CC   -!- PTM: Phosphorylated on several serine residues by IKKA and/or IKKB
CC       in response to immune stimuli. Phosphorylation requires IKBKG.
CC       Phosphorylation abolishes TRAF2 deubiquitination, interferes with
CC       the activation of Jun kinases, and strongly reduces CD40-dependent
CC       gene activation by NF-kappa-B. {ECO:0000269|PubMed:15870263}.
CC   -!- DISEASE: Cylindromatosis, familial (FCYL) [MIM:132700]: A disorder
CC       characterized by multiple skin tumors that develop from skin
CC       appendages, such as hair follicles and sweat glands. Affected
CC       individuals typically develop large numbers of tumors called
CC       cylindromas that arise predominantly in hairy parts of the body
CC       with approximately 90% on the head and neck. In severely affected
CC       individuals, cylindromas may combine into a confluent mass which
CC       may ulcerate or become infected (turban tumor syndrome).
CC       Individuals with familial cylindromatosis occasionally develop
CC       other types of tumors including spiradenomas that begin in sweat
CC       glands, and trichoepitheliomas arising from hair follicles.
CC       {ECO:0000269|PubMed:12190880, ECO:0000269|PubMed:16922728}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Multiple familial trichoepithelioma 1 (MFT1)
CC       [MIM:601606]: Autosomal dominant dermatosis characterized by the
CC       presence of many skin tumors predominantly on the face. Since
CC       histologic examination shows dermal aggregates of basaloid cells
CC       with connection to or differentiation toward hair follicles, this
CC       disorder has been thought to represent a benign hamartoma of the
CC       pilosebaceous apparatus. Trichoepitheliomas can degenerate into
CC       basal cell carcinoma. {ECO:0000269|PubMed:14632188,
CC       ECO:0000269|PubMed:16307661, ECO:0000269|PubMed:16922728}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Brooke-Spiegler syndrome (BRSS) [MIM:605041]: An
CC       autosomal dominant disorder characterized by the appearance of
CC       multiple skin appendage tumors such as cylindroma,
CC       trichoepithelioma, and spiradenoma. These tumors are typically
CC       located in the head and neck region, appear in early adulthood,
CC       and gradually increase in size and number throughout life.
CC       {ECO:0000269|PubMed:12190880, ECO:0000269|PubMed:12950348,
CC       ECO:0000269|PubMed:14632188, ECO:0000269|PubMed:15854031}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF29029.1; Type=Frameshift; Positions=776, 808, 932; Evidence={ECO:0000305};
CC       Sequence=BAA74872.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CYLDID40232ch16q12.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ250014; CAB93533.1; -; mRNA.
DR   EMBL; AB020656; BAA74872.2; ALT_INIT; mRNA.
DR   EMBL; BC012342; AAH12342.1; -; mRNA.
DR   EMBL; AF161542; AAF29029.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS42164.1; -. [Q9NQC7-2]
DR   CCDS; CCDS45482.1; -. [Q9NQC7-1]
DR   RefSeq; NP_001035814.1; NM_001042355.1. [Q9NQC7-2]
DR   RefSeq; NP_001035877.1; NM_001042412.1. [Q9NQC7-2]
DR   RefSeq; NP_056062.1; NM_015247.2. [Q9NQC7-1]
DR   RefSeq; XP_005255869.1; XM_005255812.2. [Q9NQC7-2]
DR   RefSeq; XP_006721212.1; XM_006721149.1. [Q9NQC7-2]
DR   RefSeq; XP_011521209.1; XM_011522907.2. [Q9NQC7-2]
DR   RefSeq; XP_016878466.1; XM_017022977.1. [Q9NQC7-2]
DR   RefSeq; XP_016878467.1; XM_017022978.1. [Q9NQC7-2]
DR   RefSeq; XP_016878468.1; XM_017022979.1. [Q9NQC7-2]
DR   RefSeq; XP_016878469.1; XM_017022980.1. [Q9NQC7-2]
DR   UniGene; Hs.578973; -.
DR   PDB; 1IXD; NMR; -; A=460-550.
DR   PDB; 1WHL; NMR; -; A=125-206.
DR   PDB; 1WHM; NMR; -; A=228-304.
DR   PDB; 2VHF; X-ray; 2.80 A; A/B=583-956.
DR   PDBsum; 1IXD; -.
DR   PDBsum; 1WHL; -.
DR   PDBsum; 1WHM; -.
DR   PDBsum; 2VHF; -.
DR   ProteinModelPortal; Q9NQC7; -.
DR   SMR; Q9NQC7; -.
DR   BioGrid; 107920; 615.
DR   CORUM; Q9NQC7; -.
DR   IntAct; Q9NQC7; 32.
DR   MINT; Q9NQC7; -.
DR   STRING; 9606.ENSP00000308928; -.
DR   MEROPS; C67.001; -.
DR   iPTMnet; Q9NQC7; -.
DR   PhosphoSitePlus; Q9NQC7; -.
DR   BioMuta; CYLD; -.
DR   DMDM; 51316104; -.
DR   MaxQB; Q9NQC7; -.
DR   PaxDb; Q9NQC7; -.
DR   PeptideAtlas; Q9NQC7; -.
DR   PRIDE; Q9NQC7; -.
DR   Ensembl; ENST00000311559; ENSP00000308928; ENSG00000083799. [Q9NQC7-1]
DR   Ensembl; ENST00000398568; ENSP00000381574; ENSG00000083799. [Q9NQC7-2]
DR   Ensembl; ENST00000427738; ENSP00000392025; ENSG00000083799. [Q9NQC7-1]
DR   Ensembl; ENST00000564326; ENSP00000454515; ENSG00000083799. [Q9NQC7-2]
DR   Ensembl; ENST00000569418; ENSP00000457576; ENSG00000083799. [Q9NQC7-2]
DR   GeneID; 1540; -.
DR   KEGG; hsa:1540; -.
DR   UCSC; uc002egq.2; human. [Q9NQC7-1]
DR   CTD; 1540; -.
DR   DisGeNET; 1540; -.
DR   EuPathDB; HostDB:ENSG00000083799.17; -.
DR   GeneCards; CYLD; -.
DR   HGNC; HGNC:2584; CYLD.
DR   HPA; CAB011713; -.
DR   HPA; HPA050095; -.
DR   MalaCards; CYLD; -.
DR   MIM; 132700; phenotype.
DR   MIM; 601606; phenotype.
DR   MIM; 605018; gene.
DR   MIM; 605041; phenotype.
DR   neXtProt; NX_Q9NQC7; -.
DR   OpenTargets; ENSG00000083799; -.
DR   Orphanet; 211; Familial cylindromatosis.
DR   Orphanet; 867; Familial multiple trichoepithelioma.
DR   PharmGKB; PA27084; -.
DR   eggNOG; KOG3556; Eukaryota.
DR   eggNOG; ENOG410XP6I; LUCA.
DR   GeneTree; ENSGT00390000018123; -.
DR   HOGENOM; HOG000006796; -.
DR   HOVERGEN; HBG051281; -.
DR   InParanoid; Q9NQC7; -.
DR   KO; K08601; -.
DR   OMA; YWEERIF; -.
DR   OrthoDB; EOG091G015D; -.
DR   PhylomeDB; Q9NQC7; -.
DR   TreeFam; TF318734; -.
DR   Reactome; R-HSA-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-HSA-5357786; TNFR1-induced proapoptotic signaling.
DR   Reactome; R-HSA-5357905; Regulation of TNFR1 signaling.
DR   Reactome; R-HSA-5357956; TNFR1-induced NFkappaB signaling pathway.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-936440; Negative regulators of DDX58/IFIH1 signaling.
DR   SIGNOR; Q9NQC7; -.
DR   ChiTaRS; CYLD; human.
DR   EvolutionaryTrace; Q9NQC7; -.
DR   GeneWiki; CYLD_(gene); -.
DR   GenomeRNAi; 1540; -.
DR   PRO; PR:Q9NQC7; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000083799; -.
DR   CleanEx; HS_CYLD; -.
DR   ExpressionAtlas; Q9NQC7; baseline and differential.
DR   Genevisible; Q9NQC7; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0036064; C:ciliary basal body; ISS:UniProtKB.
DR   GO; GO:0097542; C:ciliary tip; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005819; C:spindle; IDA:UniProtKB.
DR   GO; GO:1990380; F:Lys48-specific deubiquitinase activity; IEA:Ensembl.
DR   GO; GO:0061578; F:Lys63-specific deubiquitinase activity; IDA:UniProtKB.
DR   GO; GO:0070064; F:proline-rich region binding; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; TAS:Reactome.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0043369; P:CD4-positive or CD8-positive, alpha-beta T cell lineage commitment; IEA:Ensembl.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0048872; P:homeostasis of number of cells; IEA:Ensembl.
DR   GO; GO:0045087; P:innate immune response; IDA:UniProtKB.
DR   GO; GO:0070266; P:necroptotic process; IBA:GO_Central.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB.
DR   GO; GO:1901223; P:negative regulation of NIK/NF-kappaB signaling; IDA:UniProtKB.
DR   GO; GO:0045581; P:negative regulation of T cell differentiation; IEA:Ensembl.
DR   GO; GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome.
DR   GO; GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome.
DR   GO; GO:1903829; P:positive regulation of cellular protein localization; IEA:Ensembl.
DR   GO; GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB.
DR   GO; GO:0045582; P:positive regulation of T cell differentiation; IEA:Ensembl.
DR   GO; GO:0050862; P:positive regulation of T cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB.
DR   GO; GO:1990108; P:protein linear deubiquitination; IDA:UniProtKB.
DR   GO; GO:0045577; P:regulation of B cell differentiation; IEA:Ensembl.
DR   GO; GO:1902017; P:regulation of cilium assembly; ISS:UniProtKB.
DR   GO; GO:2001242; P:regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB.
DR   GO; GO:0070507; P:regulation of microtubule cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0007346; P:regulation of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0043393; P:regulation of protein binding; IEA:Ensembl.
DR   GO; GO:0010803; P:regulation of tumor necrosis factor-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:1901026; P:ripoptosome assembly involved in necroptotic process; IEA:Ensembl.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   Gene3D; 2.30.30.190; -; 3.
DR   InterPro; IPR036859; CAP-Gly_dom_sf.
DR   InterPro; IPR000938; CAP-Gly_domain.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF01302; CAP_GLY; 2.
DR   Pfam; PF00443; UCH; 1.
DR   SMART; SM01052; CAP_GLY; 3.
DR   SUPFAM; SSF74924; SSF74924; 3.
DR   PROSITE; PS00845; CAP_GLY_1; 1.
DR   PROSITE; PS50245; CAP_GLY_2; 2.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle; Cell membrane;
KW   Cell projection; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Disease mutation; Hydrolase; Immunity; Innate immunity; Membrane;
KW   Metal-binding; Microtubule; Phosphoprotein; Protease;
KW   Reference proteome; Repeat; Thiol protease; Tumor suppressor;
KW   Ubl conjugation pathway; Wnt signaling pathway; Zinc.
FT   CHAIN         1    956       Ubiquitin carboxyl-terminal hydrolase
FT                                CYLD.
FT                                /FTId=PRO_0000080698.
FT   DOMAIN      153    198       CAP-Gly 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00045}.
FT   DOMAIN      253    286       CAP-Gly 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00045}.
FT   DOMAIN      492    535       CAP-Gly 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00045}.
FT   DOMAIN      592    950       USP.
FT   REGION      106    593       Interaction with TRIP.
FT                                {ECO:0000269|PubMed:14676304}.
FT   REGION      394    469       Interaction with TRAF2.
FT   REGION      470    554       Interaction with IKBKG/NEMO.
FT                                {ECO:0000269|PubMed:15341735}.
FT   ACT_SITE    601    601       Nucleophile. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092,
FT                                ECO:0000269|PubMed:18313383}.
FT   ACT_SITE    871    871       Proton acceptor.
FT                                {ECO:0000305|PubMed:18313383}.
FT   METAL       788    788       Zinc 1.
FT   METAL       791    791       Zinc 1.
FT   METAL       799    799       Zinc 2.
FT   METAL       802    802       Zinc 2.
FT   METAL       817    817       Zinc 1.
FT   METAL       820    820       Zinc 1.
FT   METAL       825    825       Zinc 2.
FT   METAL       833    833       Zinc 2.
FT   MOD_RES     387    387       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     418    418       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:15870263}.
FT   MOD_RES     422    422       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     305    307       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10048485,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_011277.
FT   VARIANT     747    747       E -> G (in MFT1 and BRSS;
FT                                dbSNP:rs121908389).
FT                                {ECO:0000269|PubMed:14632188}.
FT                                /FTId=VAR_045967.
FT   MUTAGEN     418    418       S->A: Reduced phosphorylation; when
FT                                associated with A-422; A-432 and A-436.
FT                                Loss of phosphorylation; when associated
FT                                with A-422; A-432; A-436; A-439; A-441
FT                                and A-444. {ECO:0000269|PubMed:15870263}.
FT   MUTAGEN     418    418       S->E: Abolishes deubiquitination of
FT                                TRAF2; when associated with E-422; E-432;
FT                                E-436; E-439; E-441 and E-444.
FT                                {ECO:0000269|PubMed:15870263}.
FT   MUTAGEN     422    422       S->A: Reduced phosphorylation; when
FT                                associated with A-418; A-432 and A-436.
FT                                Loss of phosphorylation; when associated
FT                                with A-418; A-432; A-436; A-439; A-441
FT                                and A-444. {ECO:0000269|PubMed:15870263}.
FT   MUTAGEN     422    422       S->E: Abolishes deubiquitination of
FT                                TRAF2; when associated with E-418; E-432;
FT                                E-436; E-439; E-441 and E-444.
FT                                {ECO:0000269|PubMed:15870263}.
FT   MUTAGEN     432    432       S->A: Slightly reduced phosphorylation;
FT                                when associated with A-436. Reduced
FT                                phosphorylation; when associated with A-
FT                                418; A-422 and A-436. Loss of
FT                                phosphorylation; when associated with A-
FT                                418; A-422; A-436; A-439; A-441 and A-
FT                                444. {ECO:0000269|PubMed:15870263}.
FT   MUTAGEN     432    432       S->E: Abolishes deubiquitination of
FT                                TRAF2; when associated with E-418; E-422;
FT                                E-436; E-439; E-441 and E-444.
FT                                {ECO:0000269|PubMed:15870263}.
FT   MUTAGEN     436    436       S->A: Slightly reduced phosphorylation;
FT                                when associated with A-432. Reduced
FT                                phosphorylation; when associated with A-
FT                                418; A-422 and A-432. Loss of
FT                                phosphorylation; when associated with A-
FT                                418; A-422; A-432; A-439; A-441 and A-
FT                                444. {ECO:0000269|PubMed:15870263}.
FT   MUTAGEN     436    436       S->E: Abolishes deubiquitination of
FT                                TRAF2; when associated with E-418; E-422;
FT                                E-432; E-439; E-441 and E-444.
FT                                {ECO:0000269|PubMed:15870263}.
FT   MUTAGEN     439    439       S->A: Loss of phosphorylation; when
FT                                associated with A-418; A-422; A-432; A-
FT                                436; A-441 and A-444.
FT                                {ECO:0000269|PubMed:15870263}.
FT   MUTAGEN     439    439       S->E: Abolishes deubiquitination of
FT                                TRAF2; when associated with E-418; E-422;
FT                                E-432; E-436; E-441 and E-444.
FT                                {ECO:0000269|PubMed:15870263}.
FT   MUTAGEN     441    441       S->A: Loss of phosphorylation; when
FT                                associated with A-418; A-422; A-432; A-
FT                                436; A-439 and A-444.
FT                                {ECO:0000269|PubMed:15870263}.
FT   MUTAGEN     441    441       S->E: Abolishes deubiquitination of
FT                                TRAF2; when associated with E-418; E-422;
FT                                E-432; E-436; E-439 and E-444.
FT                                {ECO:0000269|PubMed:15870263}.
FT   MUTAGEN     444    444       S->A: Loss of phosphorylation; when
FT                                associated with A-418; A-422; A-432; A-
FT                                436; A-439 and A-441.
FT                                {ECO:0000269|PubMed:15870263}.
FT   MUTAGEN     444    444       S->E: Abolishes deubiquitination of
FT                                TRAF2; when associated with E-418; E-422;
FT                                E-432; E-436; E-439 and E-441.
FT                                {ECO:0000269|PubMed:15870263}.
FT   MUTAGEN     457    457       S->A: Abolishes binding to TRAF2.
FT                                {ECO:0000269|PubMed:12917691}.
FT   MUTAGEN     601    601       C->A,S: Loss of deubiquitinating
FT                                activity. {ECO:0000269|PubMed:12917689,
FT                                ECO:0000269|PubMed:12917690,
FT                                ECO:0000269|PubMed:17495026,
FT                                ECO:0000269|PubMed:18313383}.
FT   MUTAGEN     871    871       H->N: Loss of deubiquitinating activity.
FT                                {ECO:0000269|PubMed:12917691}.
FT   STRAND      130    134       {ECO:0000244|PDB:1WHL}.
FT   STRAND      136    139       {ECO:0000244|PDB:1WHL}.
FT   STRAND      141    149       {ECO:0000244|PDB:1WHL}.
FT   STRAND      154    157       {ECO:0000244|PDB:1WHL}.
FT   STRAND      163    167       {ECO:0000244|PDB:1WHL}.
FT   STRAND      169    171       {ECO:0000244|PDB:1WHL}.
FT   TURN        191    193       {ECO:0000244|PDB:1WHL}.
FT   STRAND      194    197       {ECO:0000244|PDB:1WHL}.
FT   HELIX       199    201       {ECO:0000244|PDB:1WHL}.
FT   STRAND      202    204       {ECO:0000244|PDB:1WHL}.
FT   STRAND      235    240       {ECO:0000244|PDB:1WHM}.
FT   STRAND      243    253       {ECO:0000244|PDB:1WHM}.
FT   TURN        259    261       {ECO:0000244|PDB:1WHM}.
FT   STRAND      264    272       {ECO:0000244|PDB:1WHM}.
FT   STRAND      278    280       {ECO:0000244|PDB:1WHM}.
FT   STRAND      283    285       {ECO:0000244|PDB:1WHM}.
FT   STRAND      293    298       {ECO:0000244|PDB:1WHM}.
FT   HELIX       299    301       {ECO:0000244|PDB:1WHM}.
FT   STRAND      302    304       {ECO:0000244|PDB:1WHM}.
FT   TURN        463    465       {ECO:0000244|PDB:1IXD}.
FT   STRAND      466    468       {ECO:0000244|PDB:1IXD}.
FT   STRAND      474    478       {ECO:0000244|PDB:1IXD}.
FT   STRAND      480    482       {ECO:0000244|PDB:1IXD}.
FT   STRAND      486    492       {ECO:0000244|PDB:1IXD}.
FT   STRAND      495    497       {ECO:0000244|PDB:1IXD}.
FT   STRAND      501    508       {ECO:0000244|PDB:1IXD}.
FT   STRAND      514    518       {ECO:0000244|PDB:1IXD}.
FT   STRAND      531    535       {ECO:0000244|PDB:1IXD}.
FT   HELIX       536    538       {ECO:0000244|PDB:1IXD}.
FT   STRAND      539    541       {ECO:0000244|PDB:1IXD}.
FT   HELIX       584    586       {ECO:0000244|PDB:2VHF}.
FT   STRAND      588    591       {ECO:0000244|PDB:2VHF}.
FT   HELIX       601    611       {ECO:0000244|PDB:2VHF}.
FT   STRAND      612    614       {ECO:0000244|PDB:2VHF}.
FT   HELIX       615    617       {ECO:0000244|PDB:2VHF}.
FT   HELIX       618    622       {ECO:0000244|PDB:2VHF}.
FT   HELIX       633    642       {ECO:0000244|PDB:2VHF}.
FT   HELIX       645    650       {ECO:0000244|PDB:2VHF}.
FT   STRAND      652    654       {ECO:0000244|PDB:2VHF}.
FT   HELIX       656    669       {ECO:0000244|PDB:2VHF}.
FT   HELIX       682    690       {ECO:0000244|PDB:2VHF}.
FT   TURN        691    694       {ECO:0000244|PDB:2VHF}.
FT   STRAND      699    704       {ECO:0000244|PDB:2VHF}.
FT   STRAND      710    713       {ECO:0000244|PDB:2VHF}.
FT   HELIX       730    741       {ECO:0000244|PDB:2VHF}.
FT   STRAND      743    747       {ECO:0000244|PDB:2VHF}.
FT   STRAND      750    755       {ECO:0000244|PDB:2VHF}.
FT   STRAND      760    764       {ECO:0000244|PDB:2VHF}.
FT   STRAND      773    775       {ECO:0000244|PDB:2VHF}.
FT   HELIX       778    780       {ECO:0000244|PDB:2VHF}.
FT   STRAND      781    784       {ECO:0000244|PDB:2VHF}.
FT   TURN        789    791       {ECO:0000244|PDB:2VHF}.
FT   HELIX       800    802       {ECO:0000244|PDB:2VHF}.
FT   TURN        806    811       {ECO:0000244|PDB:2VHF}.
FT   HELIX       818    824       {ECO:0000244|PDB:2VHF}.
FT   HELIX       828    830       {ECO:0000244|PDB:2VHF}.
FT   HELIX       844    846       {ECO:0000244|PDB:2VHF}.
FT   STRAND      859    868       {ECO:0000244|PDB:2VHF}.
FT   STRAND      871    877       {ECO:0000244|PDB:2VHF}.
FT   STRAND      879    881       {ECO:0000244|PDB:2VHF}.
FT   STRAND      885    889       {ECO:0000244|PDB:2VHF}.
FT   STRAND      905    908       {ECO:0000244|PDB:2VHF}.
FT   HELIX       911    914       {ECO:0000244|PDB:2VHF}.
FT   HELIX       920    925       {ECO:0000244|PDB:2VHF}.
FT   HELIX       928    930       {ECO:0000244|PDB:2VHF}.
FT   HELIX       935    940       {ECO:0000244|PDB:2VHF}.
FT   STRAND      944    948       {ECO:0000244|PDB:2VHF}.
FT   HELIX       950    952       {ECO:0000244|PDB:2VHF}.
SQ   SEQUENCE   956 AA;  107316 MW;  01831F9A83424631 CRC64;
     MSSGLWSQEK VTSPYWEERI FYLLLQECSV TDKQTQKLLK VPKGSIGQYI QDRSVGHSRI
     PSAKGKKNQI GLKILEQPHA VLFVDEKDVV EINEKFTELL LAITNCEERF SLFKNRNRLS
     KGLQIDVGCP VKVQLRSGEE KFPGVVRFRG PLLAERTVSG IFFGVELLEE GRGQGFTDGV
     YQGKQLFQCD EDCGVFVALD KLELIEDDDT ALESDYAGPG DTMQVELPPL EINSRVSLKV
     GETIESGTVI FCDVLPGKES LGYFVGVDMD NPIGNWDGRF DGVQLCSFAC VESTILLHIN
     DIIPALSESV TQERRPPKLA FMSRGVGDKG SSSHNKPKAT GSTSDPGNRN RSELFYTLNG
     SSVDSQPQSK SKNTWYIDEV AEDPAKSLTE ISTDFDRSSP PLQPPPVNSL TTENRFHSLP
     FSLTKMPNTN GSIGHSPLSL SAQSVMEELN TAPVQESPPL AMPPGNSHGL EVGSLAEVKE
     NPPFYGVIRW IGQPPGLNEV LAGLELEDEC AGCTDGTFRG TRYFTCALKK ALFVKLKSCR
     PDSRFASLQP VSNQIERCNS LAFGGYLSEV VEENTPPKME KEGLEIMIGK KKGIQGHYNS
     CYLDSTLFCL FAFSSVLDTV LLRPKEKNDV EYYSETQELL RTEIVNPLRI YGYVCATKIM
     KLRKILEKVE AASGFTSEEK DPEEFLNILF HHILRVEPLL KIRSAGQKVQ DCYFYQIFME
     KNEKVGVPTI QQLLEWSFIN SNLKFAEAPS CLIIQMPRFG KDFKLFKKIF PSLELNITDL
     LEDTPRQCRI CGGLAMYECR ECYDDPDISA GKIKQFCKTC NTQVHLHPKR LNHKYNPVSL
     PKDLPDWDWR HGCIPCQNME LFAVLCIETS HYVAFVKYGK DDSAWLFFDS MADRDGGQNG
     FNIPQVTPCP EVGEYLKMSL EDLHSLDSRR IQGCARRLLC DAYMCMYQSP TMSLYK
//
ID   A0A024QZ30_HUMAN        Unreviewed;       664 AA.
AC   A0A024QZ30;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-MAR-2018, entry version 31.
DE   RecName: Full=Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial {ECO:0000256|RuleBase:RU362051};
DE            EC=1.3.5.1 {ECO:0000256|RuleBase:RU362051};
GN   Name=SDHA {ECO:0000313|EMBL:EAW50984.1};
GN   ORFNames=hCG_1639814 {ECO:0000313|EMBL:EAW50984.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW50984.1};
RN   [1] {ECO:0000313|EMBL:EAW50984.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW50984.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Flavoprotein (FP) subunit of succinate dehydrogenase
CC       (SDH) that is involved in complex II of the mitochondrial electron
CC       transport chain and is responsible for transferring electrons from
CC       succinate to ubiquinone (coenzyme Q).
CC       {ECO:0000256|RuleBase:RU362051}.
CC   -!- CATALYTIC ACTIVITY: Succinate + a quinone = fumarate + a quinol.
CC       {ECO:0000256|RuleBase:RU362051}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000256|RuleBase:RU362051};
CC   -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle;
CC       fumarate from succinate (eukaryal route): step 1/1.
CC       {ECO:0000256|RuleBase:RU362051}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000256|RuleBase:RU362051}; Peripheral membrane protein
CC       {ECO:0000256|RuleBase:RU362051}; Matrix side
CC       {ECO:0000256|RuleBase:RU362051}.
CC   -!- SIMILARITY: Belongs to the FAD-dependent oxidoreductase 2 family.
CC       FRD/SDH subfamily. {ECO:0000256|RuleBase:RU362051}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471235; EAW50984.1; -; Genomic_DNA.
DR   RefSeq; NP_004159.2; NM_004168.3.
DR   UniGene; Hs.440475; -.
DR   ProteinModelPortal; A0A024QZ30; -.
DR   SMR; A0A024QZ30; -.
DR   PRIDE; A0A024QZ30; -.
DR   GeneID; 6389; -.
DR   KEGG; hsa:6389; -.
DR   CTD; 6389; -.
DR   EuPathDB; HostDB:ENSG00000073578.16; -.
DR   eggNOG; KOG2403; Eukaryota.
DR   eggNOG; COG1053; LUCA.
DR   KO; K00234; -.
DR   OMA; GDSPWEH; -.
DR   OrthoDB; EOG091G041Z; -.
DR   PhylomeDB; A0A024QZ30; -.
DR   UniPathway; UPA00223; UER01006.
DR   ChiTaRS; SDHA; human.
DR   GenomeRNAi; 6389; -.
DR   Bgee; ENSG00000073578; -.
DR   ExpressionAtlas; A0A024QZ30; baseline and differential.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0008177; F:succinate dehydrogenase (ubiquinone) activity; IEA:UniProtKB-EC.
DR   GO; GO:0022904; P:respiratory electron transport chain; IEA:Ensembl.
DR   GO; GO:0006105; P:succinate metabolic process; IEA:Ensembl.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.50.50.60; -; 2.
DR   Gene3D; 3.90.700.10; -; 1.
DR   InterPro; IPR003953; FAD-binding_2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR003952; FRD_SDH_FAD_BS.
DR   InterPro; IPR037099; Fum_R/Succ_DH_flav-like_C_sf.
DR   InterPro; IPR015939; Fum_Rdtase/Succ_DH_flav-like_C.
DR   InterPro; IPR027477; Succ_DH/fumarate_Rdtase_cat_sf.
DR   InterPro; IPR011281; Succ_DH_flav_su_fwd.
DR   InterPro; IPR014006; Succ_Dhase_FrdA_Gneg.
DR   Pfam; PF00890; FAD_binding_2; 1.
DR   Pfam; PF02910; Succ_DH_flav_C; 1.
DR   SUPFAM; SSF46977; SSF46977; 1.
DR   SUPFAM; SSF51905; SSF51905; 2.
DR   SUPFAM; SSF56425; SSF56425; 1.
DR   TIGRFAMs; TIGR01816; sdhA_forward; 1.
DR   TIGRFAMs; TIGR01812; sdhA_frdA_Gneg; 1.
DR   PROSITE; PS00504; FRD_SDH_FAD_BINDING; 1.
PE   3: Inferred from homology;
KW   Electron transport {ECO:0000256|RuleBase:RU362051};
KW   FAD {ECO:0000256|RuleBase:RU362051};
KW   Flavoprotein {ECO:0000256|RuleBase:RU362051};
KW   Membrane {ECO:0000256|RuleBase:RU362051};
KW   Oxidoreductase {ECO:0000256|RuleBase:RU362051};
KW   Transit peptide {ECO:0000256|RuleBase:RU362051};
KW   Transport {ECO:0000256|RuleBase:RU362051};
KW   Tricarboxylic acid cycle {ECO:0000256|RuleBase:RU362051}.
FT   DOMAIN       63    457       FAD_binding_2.
FT                                {ECO:0000259|Pfam:PF00890}.
FT   DOMAIN      512    664       Succ_DH_flav_C.
FT                                {ECO:0000259|Pfam:PF02910}.
SQ   SEQUENCE   664 AA;  72692 MW;  180B664E3FFD0B34 CRC64;
     MSGVRGLSRL LSARRLALAK AWPTVLQTGT RGFHFTVDGN KRASAKVSDS ISAQYPVVDH
     EFDAVVVGAG GAGLRAAFGL SEAGFNTACV TKLFPTRSHT VAAQGGINAA LGNMEEDNWR
     WHFYDTVKGS DWLGDQDAIH YMTEQAPAAV VELENYGMPF SRTEDGKIYQ RAFGGQSLKF
     GKGGQAHRCC CVADRTGHSL LHTLYGRSLR YDTSYFVEYF ALDLLMENGE CRGVIALCIE
     DGSIHRIRAK NTVVATGGYG RTYFSCTSAH TSTGDGTAMI TRAGLPCQDL EFVQFHPTGI
     YGAGCLITEG CRGEGGILIN SQGERFMERY APVAKDLASR DVVSRSMTLE IREGRGCGPE
     KDHVYLQLHH LPPEQLATRL PGISETAMIF AGVDVTKEPI PVLPTVHYNM GGIPTNYKGQ
     VLRHVNGQDQ IVPGLYACGE AACASVHGAN RLGANSLLDL VVFGRACALS IEESCRPGDK
     VPPIKPNAGE ESVMNLDKLR FADGSIRTSE LRLSMQKSMQ NHAAVFRVGS VLQEGCGKIS
     KLYGDLKHLK TFDRGMVWNT DLVETLELQN LMLCALQTIY GAEARKESRG AHAREDYKVR
     IDEYDYSKPI QGQQKKPFEE HWRKHTLSYV DVGTGKVTLE YRPVIDKTLN EADCATVPPA
     IRSY
//
ID   D6RFM5_HUMAN            Unreviewed;       583 AA.
AC   D6RFM5;
DT   13-JUL-2010, integrated into UniProtKB/TrEMBL.
DT   13-JUL-2010, sequence version 1.
DT   23-MAY-2018, entry version 68.
DE   RecName: Full=Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial {ECO:0000256|RuleBase:RU362051};
DE            EC=1.3.5.1 {ECO:0000256|RuleBase:RU362051};
GN   Name=SDHA {ECO:0000313|Ensembl:ENSP00000426514};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000426514, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000426514, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [2] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000313|Ensembl:ENSP00000426514}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [5] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Flavoprotein (FP) subunit of succinate dehydrogenase
CC       (SDH) that is involved in complex II of the mitochondrial electron
CC       transport chain and is responsible for transferring electrons from
CC       succinate to ubiquinone (coenzyme Q).
CC       {ECO:0000256|RuleBase:RU362051}.
CC   -!- CATALYTIC ACTIVITY: Succinate + a quinone = fumarate + a quinol.
CC       {ECO:0000256|RuleBase:RU362051}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000256|RuleBase:RU362051};
CC   -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle;
CC       fumarate from succinate (eukaryal route): step 1/1.
CC       {ECO:0000256|RuleBase:RU362051}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000256|RuleBase:RU362051}; Peripheral membrane protein
CC       {ECO:0000256|RuleBase:RU362051}; Matrix side
CC       {ECO:0000256|RuleBase:RU362051}.
CC   -!- SIMILARITY: Belongs to the FAD-dependent oxidoreductase 2 family.
CC       FRD/SDH subfamily. {ECO:0000256|RuleBase:RU362051}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC021087; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001317687.1; NM_001330758.1.
DR   UniGene; Hs.440475; -.
DR   ProteinModelPortal; D6RFM5; -.
DR   SMR; D6RFM5; -.
DR   IntAct; D6RFM5; 1.
DR   MaxQB; D6RFM5; -.
DR   PeptideAtlas; D6RFM5; -.
DR   PRIDE; D6RFM5; -.
DR   Ensembl; ENST00000504309; ENSP00000426514; ENSG00000073578.
DR   GeneID; 6389; -.
DR   UCSC; uc063buv.1; human.
DR   CTD; 6389; -.
DR   EuPathDB; HostDB:ENSG00000073578.16; -.
DR   HGNC; HGNC:10680; SDHA.
DR   OpenTargets; ENSG00000073578; -.
DR   eggNOG; KOG2403; Eukaryota.
DR   eggNOG; COG1053; LUCA.
DR   GeneTree; ENSGT00910000144277; -.
DR   HOGENOM; HOG000160475; -.
DR   UniPathway; UPA00223; UER01006.
DR   ChiTaRS; SDHA; human.
DR   GenomeRNAi; 6389; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000073578; -.
DR   ExpressionAtlas; D6RFM5; baseline and differential.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0008177; F:succinate dehydrogenase (ubiquinone) activity; IEA:UniProtKB-EC.
DR   GO; GO:0022900; P:electron transport chain; IEA:InterPro.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.50.50.60; -; 2.
DR   Gene3D; 3.90.700.10; -; 1.
DR   InterPro; IPR003953; FAD-binding_2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR003952; FRD_SDH_FAD_BS.
DR   InterPro; IPR037099; Fum_R/Succ_DH_flav-like_C_sf.
DR   InterPro; IPR027477; Succ_DH/fumarate_Rdtase_cat_sf.
DR   InterPro; IPR011281; Succ_DH_flav_su_fwd.
DR   InterPro; IPR014006; Succ_Dhase_FrdA_Gneg.
DR   Pfam; PF00890; FAD_binding_2; 1.
DR   SUPFAM; SSF46977; SSF46977; 1.
DR   SUPFAM; SSF51905; SSF51905; 2.
DR   SUPFAM; SSF56425; SSF56425; 1.
DR   TIGRFAMs; TIGR01816; sdhA_forward; 1.
DR   TIGRFAMs; TIGR01812; sdhA_frdA_Gneg; 1.
DR   PROSITE; PS00504; FRD_SDH_FAD_BINDING; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Electron transport {ECO:0000256|RuleBase:RU362051};
KW   FAD {ECO:0000256|RuleBase:RU362051};
KW   Flavoprotein {ECO:0000256|RuleBase:RU362051};
KW   Membrane {ECO:0000256|RuleBase:RU362051};
KW   Oxidoreductase {ECO:0000256|RuleBase:RU362051};
KW   Proteomics identification {ECO:0000213|EPD:D6RFM5,
KW   ECO:0000213|MaxQB:D6RFM5, ECO:0000213|PeptideAtlas:D6RFM5};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transit peptide {ECO:0000256|RuleBase:RU362051};
KW   Transport {ECO:0000256|RuleBase:RU362051};
KW   Tricarboxylic acid cycle {ECO:0000256|RuleBase:RU362051}.
FT   DOMAIN       63    457       FAD_binding_2.
FT                                {ECO:0000259|Pfam:PF00890}.
SQ   SEQUENCE   583 AA;  63567 MW;  0ED1155D7A99BA9A CRC64;
     MSGVRGLSRL LSARRLALAK AWPTVLQTGT RGFHFTVDGN KRASAKVSDS ISAQYPVVDH
     EFDAVVVGAG GAGLRAAFGL SEAGFNTACV TKLFPTRSHT VAAQGGINAA LGNMEEDNWR
     WHFYDTVKGS DWLGDQDAIH YMTEQAPAAV VELENYGMPF SRTEDGKIYQ RAFGGQSLKF
     GKGGQAHRCC CVADRTGHSL LHTLYGRSLR YDTSYFVEYF ALDLLMENGE CRGVIALCIE
     DGSIHRIRAK NTVVATGGYG RTYFSCTSAH TSTGDGTAMI TRAGLPCQDL EFVQFHPTGI
     YGAGCLITEG CRGEGGILIN SQGERFMERY APVAKDLASR DVVSRSMTLE IREGRGCGPE
     KDHVYLQLHH LPPEQLATRL PGISETAMIF AGVDVTKEPI PVLPTVHYNM GGIPTNYKGQ
     VLRHVNGQDQ IVPGLYACGE AACASVHGAN RLGANSLLDL VVFGRACALS IEESCRPGDK
     VPPIKPNAGE ESVMNLDKLR FADGSIRTSE LRLSMQKVRI DEYDYSKPIQ GQQKKPFEEH
     WRKHTLSYVD VGTGKVTLEY RPVIDKTLNE ADCATVPPAI RSY
//
ID   SDHA_HUMAN              Reviewed;         664 AA.
AC   P31040; A8K5J6; B4DJ60; E9PBJ5; Q16395; Q59GW8; Q8IW48; Q9UMY5;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 2.
DT   23-MAY-2018, entry version 205.
DE   RecName: Full=Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial;
DE            EC=1.3.5.1 {ECO:0000305|PubMed:24781757};
DE   AltName: Full=Flavoprotein subunit of complex II;
DE            Short=Fp;
DE   Flags: Precursor;
GN   Name=SDHA; Synonyms=SDH2, SDHF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=7798181;
RA   Hirawake H., Wang H., Kuramochi T., Kojima S., Kita K.;
RT   "Human complex II (succinate-ubiquinone oxidoreductase): cDNA cloning
RT   of the flavoprotein (Fp) subunit of liver mitochondria.";
RL   J. Biochem. 116:221-227(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS PHE-629 AND
RP   ILE-657.
RC   TISSUE=Heart;
RX   PubMed=8142412; DOI=10.1016/0005-2728(94)90203-8;
RA   Morris A.A.M., Farnsworth L., Ackrell B.A.C., Turnbull D.M.,
RA   Birch-MacHin M.A.;
RT   "The cDNA sequence of the flavoprotein subunit of human heart
RT   succinate dehydrogenase.";
RL   Biochim. Biophys. Acta 1185:125-128(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LS VAL-524.
RX   PubMed=10746566; DOI=10.1007/s004390051033;
RA   Parfait B., Chretien D., Roetig A., Marsac C., Munnich A., Rustin P.;
RT   "Compound heterozygous mutations in the flavoprotein gene of the
RT   respiratory chain complex II in a patient with Leigh syndrome.";
RL   Hum. Genet. 106:236-243(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   VAL-38.
RC   TISSUE=Substantia nigra, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   PHE-629.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RT   "Homo sapiens protein coding cDNA.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   PHE-629.
RC   TISSUE=Colon, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PRELIMINARY PARTIAL NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RA   Malcovati M., Marchetti L., Zanelli E., Tenchini M.L.;
RT   "Cloning of the flavoprotein subunit of human succinate
RT   dehydrogenase.";
RL   (In) Curti B., Ronchi S., Zanetti G. (eds.);
RL   Flavins and flavoproteins 1990, pp.727-730, Walter de Gruyter, Berlin
RL   (1991).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 546-562, AND VARIANT LS TRP-554.
RX   PubMed=7550341; DOI=10.1038/ng1095-144;
RA   Bourgeron T., Rustin P., Chretien D., Birch-MacHin M.A., Bourgeois M.,
RA   Viegas-Pequignot E., Munnich A., Roetig A.;
RT   "Mutation of a nuclear succinate dehydrogenase gene results in
RT   mitochondrial respiratory chain deficiency.";
RL   Nat. Genet. 11:144-149(1995).
RN   [11]
RP   PROTEIN SEQUENCE OF 76-92 AND 398-418.
RC   TISSUE=Adipocyte;
RX   PubMed=15242332; DOI=10.1042/BJ20040647;
RA   Aboulaich N., Vainonen J.P., Stralfors P., Vener A.V.;
RT   "Vectorial proteomics reveal targeting, phosphorylation and specific
RT   fragmentation of polymerase I and transcript release factor (PTRF) at
RT   the surface of caveolae in human adipocytes.";
RL   Biochem. J. 383:237-248(2004).
RN   [12]
RP   INTERACTION WITH SDHAF2.
RX   PubMed=19628817; DOI=10.1126/science.1175689;
RA   Hao H.-X., Khalimonchuk O., Schraders M., Dephoure N., Bayley J.-P.,
RA   Kunst H., Devilee P., Cremers C.W.R.J., Schiffman J.D., Bentz B.G.,
RA   Gygi S.P., Winge D.R., Kremer H., Rutter J.;
RT   "SDH5, a gene required for flavination of succinate dehydrogenase, is
RT   mutated in paraganglioma.";
RL   Science 325:1139-1142(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-179; LYS-335; LYS-541 AND
RP   LYS-608, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   FUNCTION, VARIANT PGL5 TRP-589, AND CHARACTERIZATION OF VARIANT PGL5
RP   TRP-589.
RX   PubMed=20484225; DOI=10.1093/hmg/ddq206;
RA   Burnichon N., Briere J.J., Libe R., Vescovo L., Riviere J.,
RA   Tissier F., Jouanno E., Jeunemaitre X., Benit P., Tzagoloff A.,
RA   Rustin P., Bertherat J., Favier J., Gimenez-Roqueplo A.P.;
RT   "SDHA is a tumor suppressor gene causing paraganglioma.";
RL   Hum. Mol. Genet. 19:3011-3020(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION AT TYR-215 BY SRC.
RX   PubMed=22823520; DOI=10.1042/BJ20120509;
RA   Ogura M., Yamaki J., Homma M.K., Homma Y.;
RT   "Mitochondrial c-Src regulates cell survival through phosphorylation
RT   of respiratory chain components.";
RL   Biochem. J. 447:281-289(2012).
RN   [17]
RP   INTERACTION WITH TRAP1.
RX   PubMed=23747254; DOI=10.1016/j.cmet.2013.04.019;
RA   Sciacovelli M., Guzzo G., Morello V., Frezza C., Zheng L., Nannini N.,
RA   Calabrese F., Laudiero G., Esposito F., Landriscina M., Defilippi P.,
RA   Bernardi P., Rasola A.;
RT   "The mitochondrial chaperone TRAP1 promotes neoplastic growth by
RT   inhibiting succinate dehydrogenase.";
RL   Cell Metab. 17:988-999(2013).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20]
RP   VARIANT MT-C2D GLU-555.
RX   PubMed=12794685; DOI=10.1002/ajmg.a.10202;
RA   Van Coster R., Seneca S., Smet J., Van Hecke R., Gerlo E.,
RA   Devreese B., Van Beeumen J., Leroy J.G., De Meirleir L., Lissens W.;
RT   "Homozygous Gly555Glu mutation in the nuclear-encoded 70 kDa
RT   flavoprotein gene causes instability of the respiratory chain complex
RT   II.";
RL   Am. J. Med. Genet. A 120:13-18(2003).
RN   [21]
RP   VARIANT CMD1GG GLU-555.
RX   PubMed=20551992; DOI=10.1038/ejhg.2010.83;
RA   Levitas A., Muhammad E., Harel G., Saada A., Caspi V.C., Manor E.,
RA   Beck J.C., Sheffield V., Parvari R.;
RT   "Familial neonatal isolated cardiomyopathy caused by a mutation in the
RT   flavoprotein subunit of succinate dehydrogenase.";
RL   Eur. J. Hum. Genet. 18:1160-1165(2010).
RN   [22]
RP   VARIANT LS GLY-189, CHARACTERIZATION OF VARIANT LS GLY-189, FUNCTION,
RP   CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=24781757; DOI=10.1038/ejhg.2014.80;
RA   Renkema G.H., Wortmann S.B., Smeets R.J., Venselaar H., Antoine M.,
RA   Visser G., Ben-Omran T., van den Heuvel L.P., Timmers H.J.,
RA   Smeitink J.A., Rodenburg R.J.;
RT   "SDHA mutations causing a multisystem mitochondrial disease: novel
RT   mutations and genetic overlap with hereditary tumors.";
RL   Eur. J. Hum. Genet. 23:202-209(2015).
CC   -!- FUNCTION: Flavoprotein (FP) subunit of succinate dehydrogenase
CC       (SDH) that is involved in complex II of the mitochondrial electron
CC       transport chain and is responsible for transferring electrons from
CC       succinate to ubiquinone (coenzyme Q) (PubMed:24781757). Can act as
CC       a tumor suppressor (PubMed:20484225).
CC       {ECO:0000269|PubMed:20484225, ECO:0000305|PubMed:24781757}.
CC   -!- CATALYTIC ACTIVITY: Succinate + a quinone = fumarate + a quinol.
CC       {ECO:0000305|PubMed:24781757}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000250|UniProtKB:Q0QF01};
CC   -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle;
CC       fumarate from succinate (eukaryal route): step 1/1.
CC       {ECO:0000305|PubMed:24781757}.
CC   -!- SUBUNIT: Component of complex II composed of four subunits: the
CC       flavoprotein (FP) SDHA, iron-sulfur protein (IP) SDHB, and a
CC       cytochrome b560 composed of SDHC and SDHD (By similarity).
CC       Interacts with SDHAF2/SDH5; interaction is required for FAD
CC       attachment (PubMed:19628817). Interacts with TRAP1
CC       (PubMed:23747254). {ECO:0000250|UniProtKB:Q0QF01,
CC       ECO:0000269|PubMed:19628817, ECO:0000269|PubMed:23747254}.
CC   -!- INTERACTION:
CC       P26045:PTPN3; NbExp=2; IntAct=EBI-1057265, EBI-1047946;
CC       Q9NX18:SDHAF2; NbExp=2; IntAct=EBI-1057265, EBI-713250;
CC       P21912:SDHB; NbExp=8; IntAct=EBI-1057265, EBI-1056481;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000250|UniProtKB:Q0QF01}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q0QF01}; Matrix side
CC       {ECO:0000250|UniProtKB:Q0QF01}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P31040-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P31040-2; Sequence=VSP_055077;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P31040-3; Sequence=VSP_055078;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Phosphorylation at Tyr-215 is important for efficient
CC       electron transfer in complex II and the prevention of ROS
CC       generation. {ECO:0000269|PubMed:22823520}.
CC   -!- PTM: Acetylated. Deacetylated by SIRT3.
CC       {ECO:0000250|UniProtKB:Q8K2B3}.
CC   -!- DISEASE: Mitochondrial complex II deficiency (MT-C2D)
CC       [MIM:252011]: A disorder of the mitochondrial respiratory chain
CC       with heterogeneous clinical manifestations. Clinical features
CC       include psychomotor regression in infants, poor growth with lack
CC       of speech development, severe spastic quadriplegia, dystonia,
CC       progressive leukoencephalopathy, muscle weakness, exercise
CC       intolerance, cardiomyopathy. Some patients manifest Leigh syndrome
CC       or Kearns-Sayre syndrome. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC       {ECO:0000269|PubMed:12794685}.
CC   -!- DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset
CC       progressive neurodegenerative disorder characterized by the
CC       presence of focal, bilateral lesions in one or more areas of the
CC       central nervous system including the brainstem, thalamus, basal
CC       ganglia, cerebellum and spinal cord. Clinical features depend on
CC       which areas of the central nervous system are involved and include
CC       subacute onset of psychomotor retardation, hypotonia, ataxia,
CC       weakness, vision loss, eye movement abnormalities, seizures, and
CC       dysphagia. {ECO:0000269|PubMed:10746566,
CC       ECO:0000269|PubMed:24781757, ECO:0000269|PubMed:7550341}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Cardiomyopathy, dilated 1GG (CMD1GG) [MIM:613642]: A
CC       disorder characterized by ventricular dilation and impaired
CC       systolic function, resulting in congestive heart failure and
CC       arrhythmia. Patients are at risk of premature death.
CC       {ECO:0000269|PubMed:20551992}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Paragangliomas 5 (PGL5) [MIM:614165]: A neural crest
CC       tumor usually derived from the chromoreceptor tissue of a
CC       paraganglion. Paragangliomas can develop at various body sites,
CC       including the head, neck, thorax and abdomen. Most commonly, they
CC       are located in the head and neck region, specifically at the
CC       carotid bifurcation, the jugular foramen, the vagal nerve, and in
CC       the middle ear. {ECO:0000269|PubMed:20484225}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the FAD-dependent oxidoreductase 2 family.
CC       FRD/SDH subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92228.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAA37886.1; Type=Miscellaneous discrepancy; Note=Differs extensively from that shown.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=TCA Cycle Gene Mutation Database;
CC       URL="http://databases.lovd.nl/shared/genes/SDHA";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D30648; BAA06332.1; -; mRNA.
DR   EMBL; L21936; AAA20683.1; -; mRNA.
DR   EMBL; AF171030; AAD51006.1; -; Genomic_DNA.
DR   EMBL; AF171017; AAD51006.1; JOINED; Genomic_DNA.
DR   EMBL; AF171018; AAD51006.1; JOINED; Genomic_DNA.
DR   EMBL; AF171019; AAD51006.1; JOINED; Genomic_DNA.
DR   EMBL; AF171020; AAD51006.1; JOINED; Genomic_DNA.
DR   EMBL; AF171021; AAD51006.1; JOINED; Genomic_DNA.
DR   EMBL; AF171022; AAD51006.1; JOINED; Genomic_DNA.
DR   EMBL; AF171023; AAD51006.1; JOINED; Genomic_DNA.
DR   EMBL; AF171024; AAD51006.1; JOINED; Genomic_DNA.
DR   EMBL; AF171025; AAD51006.1; JOINED; Genomic_DNA.
DR   EMBL; AF171026; AAD51006.1; JOINED; Genomic_DNA.
DR   EMBL; AF171027; AAD51006.1; JOINED; Genomic_DNA.
DR   EMBL; AF171028; AAD51006.1; JOINED; Genomic_DNA.
DR   EMBL; AF171029; AAD51006.1; JOINED; Genomic_DNA.
DR   EMBL; AK291311; BAF84000.1; -; mRNA.
DR   EMBL; AK295937; BAG58722.1; -; mRNA.
DR   EMBL; AB208991; BAD92228.1; ALT_INIT; mRNA.
DR   EMBL; AC021087; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471235; EAW50983.1; -; Genomic_DNA.
DR   EMBL; BC001380; AAH01380.1; -; mRNA.
DR   EMBL; BC041016; AAH41016.1; -; mRNA.
DR   EMBL; X53943; CAA37886.1; ALT_SEQ; mRNA.
DR   EMBL; S79641; AAB35332.1; -; Genomic_DNA.
DR   CCDS; CCDS3853.1; -. [P31040-1]
DR   CCDS; CCDS77992.1; -. [P31040-2]
DR   PIR; JX0336; JX0336.
DR   PIR; S21302; S21302.
DR   RefSeq; NP_001281261.1; NM_001294332.1. [P31040-2]
DR   RefSeq; NP_004159.2; NM_004168.3. [P31040-1]
DR   UniGene; Hs.440475; -.
DR   ProteinModelPortal; P31040; -.
DR   SMR; P31040; -.
DR   BioGrid; 112290; 222.
DR   CORUM; P31040; -.
DR   DIP; DIP-45851N; -.
DR   IntAct; P31040; 32.
DR   MINT; P31040; -.
DR   STRING; 9606.ENSP00000264932; -.
DR   ChEMBL; CHEMBL5758; -.
DR   DrugBank; DB04657; Carboxin.
DR   DrugBank; DB00139; Succinic acid.
DR   DrugBank; DB04795; Thenoyltrifluoroacetone.
DR   DrugBank; DB08689; UBIQUINONE-1.
DR   iPTMnet; P31040; -.
DR   PhosphoSitePlus; P31040; -.
DR   SwissPalm; P31040; -.
DR   BioMuta; SDHA; -.
DR   DMDM; 1169337; -.
DR   REPRODUCTION-2DPAGE; IPI00305166; -.
DR   EPD; P31040; -.
DR   MaxQB; P31040; -.
DR   PaxDb; P31040; -.
DR   PeptideAtlas; P31040; -.
DR   PRIDE; P31040; -.
DR   TopDownProteomics; P31040-1; -. [P31040-1]
DR   DNASU; 6389; -.
DR   Ensembl; ENST00000264932; ENSP00000264932; ENSG00000073578. [P31040-1]
DR   Ensembl; ENST00000510361; ENSP00000427703; ENSG00000073578. [P31040-2]
DR   GeneID; 6389; -.
DR   KEGG; hsa:6389; -.
DR   UCSC; uc003jao.5; human. [P31040-1]
DR   CTD; 6389; -.
DR   DisGeNET; 6389; -.
DR   EuPathDB; HostDB:ENSG00000073578.16; -.
DR   GeneCards; SDHA; -.
DR   GeneReviews; SDHA; -.
DR   H-InvDB; HIX0120996; -.
DR   HGNC; HGNC:10680; SDHA.
DR   HPA; CAB034929; -.
DR   HPA; HPA041981; -.
DR   HPA; HPA064582; -.
DR   MalaCards; SDHA; -.
DR   MIM; 252011; phenotype.
DR   MIM; 256000; phenotype.
DR   MIM; 600857; gene.
DR   MIM; 613642; phenotype.
DR   MIM; 614165; phenotype.
DR   neXtProt; NX_P31040; -.
DR   OpenTargets; ENSG00000073578; -.
DR   Orphanet; 154; Familial isolated dilated cardiomyopathy.
DR   Orphanet; 44890; Gastrointestinal stromal tumor.
DR   Orphanet; 29072; Hereditary pheochromocytoma-paraganglioma.
DR   Orphanet; 3208; Isolated succinate-CoQ reductase deficiency.
DR   Orphanet; 255241; Leigh syndrome with leukodystrophy.
DR   PharmGKB; PA35605; -.
DR   eggNOG; KOG2403; Eukaryota.
DR   eggNOG; COG1053; LUCA.
DR   GeneTree; ENSGT00910000144277; -.
DR   HOGENOM; HOG000160475; -.
DR   HOVERGEN; HBG001461; -.
DR   InParanoid; P31040; -.
DR   KO; K00234; -.
DR   OMA; GDSPWEH; -.
DR   OrthoDB; EOG091G041Z; -.
DR   PhylomeDB; P31040; -.
DR   TreeFam; TF300763; -.
DR   BioCyc; MetaCyc:ENSG00000073578-MONOMER; -.
DR   Reactome; R-HSA-611105; Respiratory electron transport.
DR   Reactome; R-HSA-71403; Citric acid cycle (TCA cycle).
DR   SIGNOR; P31040; -.
DR   UniPathway; UPA00223; UER01006.
DR   ChiTaRS; SDHA; human.
DR   GeneWiki; SDHA; -.
DR   GenomeRNAi; 6389; -.
DR   PRO; PR:P31040; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000073578; -.
DR   CleanEx; HS_SDHA; -.
DR   ExpressionAtlas; P31040; baseline and differential.
DR   Genevisible; P31040; HS.
DR   GO; GO:0005743; C:mitochondrial inner membrane; ISS:UniProtKB.
DR   GO; GO:0005749; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0009055; F:electron transfer activity; IBA:GO_Central.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0008177; F:succinate dehydrogenase (ubiquinone) activity; IMP:UniProtKB.
DR   GO; GO:0009061; P:anaerobic respiration; IBA:GO_Central.
DR   GO; GO:0006121; P:mitochondrial electron transport, succinate to ubiquinone; IBA:GO_Central.
DR   GO; GO:0007399; P:nervous system development; IMP:UniProtKB.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:UniProtKB.
DR   GO; GO:0022904; P:respiratory electron transport chain; IDA:UniProtKB.
DR   GO; GO:0006105; P:succinate metabolic process; IDA:UniProtKB.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; TAS:UniProtKB.
DR   Gene3D; 3.50.50.60; -; 2.
DR   Gene3D; 3.90.700.10; -; 1.
DR   InterPro; IPR003953; FAD-binding_2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR003952; FRD_SDH_FAD_BS.
DR   InterPro; IPR037099; Fum_R/Succ_DH_flav-like_C_sf.
DR   InterPro; IPR015939; Fum_Rdtase/Succ_DH_flav-like_C.
DR   InterPro; IPR027477; Succ_DH/fumarate_Rdtase_cat_sf.
DR   InterPro; IPR011281; Succ_DH_flav_su_fwd.
DR   InterPro; IPR014006; Succ_Dhase_FrdA_Gneg.
DR   Pfam; PF00890; FAD_binding_2; 1.
DR   Pfam; PF02910; Succ_DH_flav_C; 1.
DR   SUPFAM; SSF46977; SSF46977; 1.
DR   SUPFAM; SSF51905; SSF51905; 2.
DR   SUPFAM; SSF56425; SSF56425; 1.
DR   TIGRFAMs; TIGR01816; sdhA_forward; 1.
DR   TIGRFAMs; TIGR01812; sdhA_frdA_Gneg; 1.
DR   PROSITE; PS00504; FRD_SDH_FAD_BINDING; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cardiomyopathy; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Electron transport; FAD;
KW   Flavoprotein; Leigh syndrome; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Oxidoreductase; Phosphoprotein;
KW   Polymorphism; Primary mitochondrial disease; Reference proteome;
KW   Transit peptide; Transport; Tricarboxylic acid cycle;
KW   Tumor suppressor.
FT   TRANSIT       1     42       Mitochondrion.
FT                                {ECO:0000250|UniProtKB:Q0QF01}.
FT   CHAIN        43    664       Succinate dehydrogenase [ubiquinone]
FT                                flavoprotein subunit, mitochondrial.
FT                                /FTId=PRO_0000010335.
FT   NP_BIND      68     73       FAD. {ECO:0000250|UniProtKB:Q0QF01}.
FT   NP_BIND      91    106       FAD. {ECO:0000250|UniProtKB:Q0QF01}.
FT   NP_BIND     456    457       FAD. {ECO:0000250|UniProtKB:Q0QF01}.
FT   ACT_SITE    340    340       Proton acceptor.
FT                                {ECO:0000250|UniProtKB:Q9YHT1}.
FT   BINDING     275    275       FAD. {ECO:0000250|UniProtKB:Q0QF01}.
FT   BINDING     296    296       Substrate.
FT                                {ECO:0000250|UniProtKB:Q0QF01}.
FT   BINDING     308    308       Substrate.
FT                                {ECO:0000250|UniProtKB:Q0QF01}.
FT   BINDING     407    407       Substrate.
FT                                {ECO:0000250|UniProtKB:Q0QF01}.
FT   BINDING     440    440       FAD. {ECO:0000250|UniProtKB:Q0QF01}.
FT   BINDING     451    451       Substrate.
FT                                {ECO:0000250|UniProtKB:Q0QF01}.
FT   MOD_RES      99     99       Tele-8alpha-FAD histidine.
FT                                {ECO:0000250|UniProtKB:Q0QF01}.
FT   MOD_RES     167    167       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     179    179       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     179    179       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     182    182       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     215    215       Phosphotyrosine; by SRC.
FT                                {ECO:0000269|PubMed:22823520}.
FT   MOD_RES     250    250       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     250    250       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     335    335       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     335    335       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     480    480       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     485    485       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     485    485       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     498    498       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     498    498       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     517    517       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     538    538       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     538    538       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     541    541       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     547    547       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     547    547       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     550    550       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     598    598       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     608    608       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     615    615       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     624    624       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     636    636       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   MOD_RES     647    647       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8K2B3}.
FT   VAR_SEQ     105    152       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055077.
FT   VAR_SEQ     126    270       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055078.
FT   VARIANT      33     33       F -> V (in dbSNP:rs1061518).
FT                                /FTId=VAR_049214.
FT   VARIANT      38     38       D -> V (in dbSNP:rs34635677).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_049215.
FT   VARIANT     189    189       C -> G (in LS; decrease in succinate
FT                                dehydrogenase activity).
FT                                {ECO:0000269|PubMed:24781757}.
FT                                /FTId=VAR_074022.
FT   VARIANT     240    240       E -> Q (in dbSNP:rs1041946).
FT                                /FTId=VAR_049216.
FT   VARIANT     333    333       V -> I (in dbSNP:rs1062468).
FT                                /FTId=VAR_059307.
FT   VARIANT     524    524       A -> V (in LS; dbSNP:rs137852767).
FT                                {ECO:0000269|PubMed:10746566}.
FT                                /FTId=VAR_016878.
FT   VARIANT     554    554       R -> W (in LS; dbSNP:rs9809219).
FT                                {ECO:0000269|PubMed:7550341}.
FT                                /FTId=VAR_002449.
FT   VARIANT     555    555       G -> E (in MT-C2D and CMD1GG;
FT                                dbSNP:rs137852768).
FT                                {ECO:0000269|PubMed:12794685,
FT                                ECO:0000269|PubMed:20551992}.
FT                                /FTId=VAR_016879.
FT   VARIANT     589    589       R -> W (in PGL5; loss of activity;
FT                                dbSNP:rs387906780).
FT                                {ECO:0000269|PubMed:20484225}.
FT                                /FTId=VAR_065975.
FT   VARIANT     629    629       Y -> F (in dbSNP:rs6960).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8142412,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_071037.
FT   VARIANT     657    657       V -> I (in dbSNP:rs6962).
FT                                {ECO:0000269|PubMed:8142412}.
FT                                /FTId=VAR_049217.
FT   CONFLICT    356    356       G -> D (in Ref. 3; AAD51006).
FT                                {ECO:0000305}.
FT   CONFLICT    398    398       E -> D (in Ref. 3; AAD51006).
FT                                {ECO:0000305}.
FT   CONFLICT    591    591       A -> T (in Ref. 3; AAD51006).
FT                                {ECO:0000305}.
FT   CONFLICT    596    596       D -> G (in Ref. 3; AAD51006).
FT                                {ECO:0000305}.
FT   CONFLICT    600    600       R -> Q (in Ref. 3; AAD51006).
FT                                {ECO:0000305}.
FT   CONFLICT    618    618       F -> L (in Ref. 4; BAG58722).
FT                                {ECO:0000305}.
FT   CONFLICT    640    640       E -> G (in Ref. 3; AAD51006).
FT                                {ECO:0000305}.
SQ   SEQUENCE   664 AA;  72692 MW;  180B664E3FFD0B34 CRC64;
     MSGVRGLSRL LSARRLALAK AWPTVLQTGT RGFHFTVDGN KRASAKVSDS ISAQYPVVDH
     EFDAVVVGAG GAGLRAAFGL SEAGFNTACV TKLFPTRSHT VAAQGGINAA LGNMEEDNWR
     WHFYDTVKGS DWLGDQDAIH YMTEQAPAAV VELENYGMPF SRTEDGKIYQ RAFGGQSLKF
     GKGGQAHRCC CVADRTGHSL LHTLYGRSLR YDTSYFVEYF ALDLLMENGE CRGVIALCIE
     DGSIHRIRAK NTVVATGGYG RTYFSCTSAH TSTGDGTAMI TRAGLPCQDL EFVQFHPTGI
     YGAGCLITEG CRGEGGILIN SQGERFMERY APVAKDLASR DVVSRSMTLE IREGRGCGPE
     KDHVYLQLHH LPPEQLATRL PGISETAMIF AGVDVTKEPI PVLPTVHYNM GGIPTNYKGQ
     VLRHVNGQDQ IVPGLYACGE AACASVHGAN RLGANSLLDL VVFGRACALS IEESCRPGDK
     VPPIKPNAGE ESVMNLDKLR FADGSIRTSE LRLSMQKSMQ NHAAVFRVGS VLQEGCGKIS
     KLYGDLKHLK TFDRGMVWNT DLVETLELQN LMLCALQTIY GAEARKESRG AHAREDYKVR
     IDEYDYSKPI QGQQKKPFEE HWRKHTLSYV DVGTGKVTLE YRPVIDKTLN EADCATVPPA
     IRSY
//
ID   K1_HHV8P                Reviewed;         279 AA.
AC   Q2HRD5;
DT   16-OCT-2013, integrated into UniProtKB/Swiss-Prot.
DT   15-MAY-2007, sequence version 1.
DT   23-MAY-2018, entry version 44.
DE   RecName: Full=Protein K1;
DE   Flags: Precursor;
GN   Name=K1;
OS   Human herpesvirus 8 type P (isolate GK18) (HHV-8) (Kaposi's
OS   sarcoma-associated herpesvirus).
OC   Viruses; dsDNA viruses, no RNA stage; Herpesvirales; Herpesviridae;
OC   Gammaherpesvirinae; Rhadinovirus.
OX   NCBI_TaxID=868565;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10400794;
RA   Glenn M., Rainbow L., Aurade F., Davison A., Schulz T.F.;
RT   "Identification of a spliced gene from Kaposi's sarcoma-associated
RT   herpesvirus encoding a protein with similarities to latent membrane
RT   proteins 1 and 2A of Epstein-Barr virus.";
RL   J. Virol. 73:6953-6963(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16760382; DOI=10.1099/vir.0.81919-0;
RA   Rezaee S.A.R., Cunningham C., Davison A.J., Blackbourn D.J.;
RT   "Kaposi's sarcoma-associated herpesvirus immune modulation: an
RT   overview.";
RL   J. Gen. Virol. 87:1781-1804(2006).
RN   [3]
RP   FUNCTION.
RX   PubMed=9710606; DOI=10.1128/MCB.18.9.5219;
RA   Lee H., Guo J., Li M., Choi J.K., DeMaria M., Rosenzweig M.,
RA   Jung J.U.;
RT   "Identification of an immunoreceptor tyrosine-based activation motif
RT   of K1 transforming protein of Kaposi's sarcoma-associated
RT   herpesvirus.";
RL   Mol. Cell. Biol. 18:5219-5228(1998).
RN   [4]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=10318948; DOI=10.1073/pnas.96.10.5704;
RA   Lagunoff M., Majeti R., Weiss A., Ganem D.;
RT   "Deregulated signal transduction by the K1 gene product of Kaposi's
RT   sarcoma-associated herpesvirus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:5704-5709(1999).
RN   [5]
RP   FUNCTION.
RX   PubMed=14747556; DOI=10.1128/JVI.78.4.1918-1927.2004;
RA   Tomlinson C.C., Damania B.;
RT   "The K1 protein of Kaposi's sarcoma-associated herpesvirus activates
RT   the Akt signaling pathway.";
RL   J. Virol. 78:1918-1927(2004).
CC   -!- FUNCTION: Promotes host cell survival pathways and may contribute
CC       to pathogenesis by preventing infected cells from undergoing
CC       apoptosis. Acts in host B-cells by mimicking the activated B-cell
CC       receptor complex. The cytoplasmic tail of K1 can induce the
CC       phosphorylation of a number of different kinases, leading to the
CC       activation of survival signaling pathways.
CC       {ECO:0000269|PubMed:10318948, ECO:0000269|PubMed:14747556,
CC       ECO:0000269|PubMed:9710606}.
CC   -!- SUBUNIT: Homooligomer. {ECO:0000269|PubMed:10318948}.
CC   -!- SUBCELLULAR LOCATION: Host membrane {ECO:0000305}; Single-pass
CC       type I membrane protein {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF148805; ABD28852.1; -; Genomic_DNA.
DR   RefSeq; YP_001129350.1; NC_009333.1.
DR   ProteinModelPortal; Q2HRD5; -.
DR   SMR; Q2HRD5; -.
DR   BioGrid; 1777014; 9.
DR   PRIDE; Q2HRD5; -.
DR   GeneID; 4961511; -.
DR   KEGG; vg:4961511; -.
DR   KO; K21669; -.
DR   Proteomes; UP000000942; Genome.
DR   GO; GO:0033644; C:host cell membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0039526; P:modulation by virus of host apoptotic process; IEA:UniProtKB-KW.
DR   InterPro; IPR021022; HHSV-8_K1.
DR   InterPro; IPR004121; K1_C.
DR   Pfam; PF02960; K1; 1.
DR   Pfam; PF11049; KSHV_K1; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Host membrane; Host-virus interaction; Membrane;
KW   Modulation of host cell apoptosis by virus; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    279       Protein K1.
FT                                /FTId=PRO_0000423776.
FT   TOPO_DOM     19    220       Extracellular. {ECO:0000255}.
FT   TRANSMEM    221    241       Helical. {ECO:0000255}.
FT   TOPO_DOM    242    279       Cytoplasmic. {ECO:0000255}.
SQ   SEQUENCE   279 AA;  31162 MW;  2AF4EF505D1F3BD5 CRC64;
     MFLYVVCSLA VCFRGLLSLS LQSSPNLCPG VISTPYTLTC PSNTSLPTSW YCNDTRLLRV
     TQGTLTVDTL ICNFSCVGQS GHRYSLWITW YAQPVLQTFC GQPSNTVTCG QHVTLYCSTS
     GNNVTVWHLP NGQNETVSQT KYYNFTLMNQ TEGCYACSNG LSSRLSNRLC FSARCANITP
     ETHTVSVSST TGFRTFATAP TLFVMKEVKS TYLYIQEHLL VFMTLVALIG TMCGILGTII
     FAHCQKQRDS NKTVPQQLQD YYSLHDLCTE DYTQPVDWY
//
ID   Q9WH94_HHV8             Unreviewed;       279 AA.
AC   Q9WH94;
DT   01-NOV-1999, integrated into UniProtKB/TrEMBL.
DT   01-NOV-1999, sequence version 1.
DT   28-FEB-2018, entry version 51.
DE   SubName: Full=K1 glycoprotein {ECO:0000313|EMBL:AAD26378.1};
GN   Name=K1 {ECO:0000313|EMBL:AAD26378.1};
OS   Human herpesvirus 8 (HHV-8) (Kaposi's sarcoma-associated herpesvirus).
OC   Viruses; dsDNA viruses, no RNA stage; Herpesvirales; Herpesviridae;
OC   Gammaherpesvirinae; Rhadinovirus.
OX   NCBI_TaxID=37296 {ECO:0000313|EMBL:AAD26378.1};
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1] {ECO:0000313|EMBL:AAD26378.1}
RP   NUCLEOTIDE SEQUENCE.
RC   STRAIN=GK18 {ECO:0000313|EMBL:AAD26378.1};
RX   PubMed=10416519; DOI=10.1097/00002030-199907090-00004;
RA   Cook P.M., Whitby D., Calabro M.L., Luppi M., Kakoola D.N.,
RA   Hjalgrim H., Ariyoshi K., Ensoli B., Davison A.J., Schulz T.F.;
RT   "Variability and evolution of Kaposi's sarcoma-associated herpesvirus
RT   in Europe and Africa. International Collaborative Group.";
RL   AIDS 13:1165-1176(1999).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF130268; AAD26378.1; -; Genomic_DNA.
DR   RefSeq; YP_001129350.1; NC_009333.1.
DR   ProteinModelPortal; Q9WH94; -.
DR   SMR; Q9WH94; -.
DR   GeneID; 4961511; -.
DR   KEGG; vg:4961511; -.
DR   KO; K21669; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR021022; HHSV-8_K1.
DR   InterPro; IPR004121; K1_C.
DR   Pfam; PF02960; K1; 1.
DR   Pfam; PF11049; KSHV_K1; 1.
PE   4: Predicted;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    219    242       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       36    106       KSHV_K1. {ECO:0000259|Pfam:PF11049}.
FT   DOMAIN      160    279       K1. {ECO:0000259|Pfam:PF02960}.
SQ   SEQUENCE   279 AA;  31162 MW;  2AF4EF505D1F3BD5 CRC64;
     MFLYVVCSLA VCFRGLLSLS LQSSPNLCPG VISTPYTLTC PSNTSLPTSW YCNDTRLLRV
     TQGTLTVDTL ICNFSCVGQS GHRYSLWITW YAQPVLQTFC GQPSNTVTCG QHVTLYCSTS
     GNNVTVWHLP NGQNETVSQT KYYNFTLMNQ TEGCYACSNG LSSRLSNRLC FSARCANITP
     ETHTVSVSST TGFRTFATAP TLFVMKEVKS TYLYIQEHLL VFMTLVALIG TMCGILGTII
     FAHCQKQRDS NKTVPQQLQD YYSLHDLCTE DYTQPVDWY
//
ID   BRAF_HUMAN              Reviewed;         766 AA.
AC   P15056; A4D1T4; B6HY61; B6HY62; B6HY63; B6HY64; B6HY65; B6HY66;
AC   Q13878; Q3MIN6; Q9UDP8; Q9Y6T3;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 4.
DT   23-MAY-2018, entry version 223.
DE   RecName: Full=Serine/threonine-protein kinase B-raf;
DE            EC=2.7.11.1;
DE   AltName: Full=Proto-oncogene B-Raf;
DE   AltName: Full=p94;
DE   AltName: Full=v-Raf murine sarcoma viral oncogene homolog B1;
GN   Name=BRAF; Synonyms=BRAF1, RAFB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND
RP   PHOSPHORYLATION AT THR-373.
RC   TISSUE=Testis;
RX   PubMed=1508179; DOI=10.1128/MCB.12.9.3733;
RA   Stephens R.M., Sithanandam G., Copeland T.D., Kaplan D.R., Rapp U.R.,
RA   Morrison D.K.;
RT   "95-kilodalton B-Raf serine/threonine kinase: identification of the
RT   protein and its major autophosphorylation site.";
RL   Mol. Cell. Biol. 12:3733-3742(1992).
RN   [2]
RP   SEQUENCE REVISION TO 31-33.
RA   Albert S., Wixler L., Rapp U.R.;
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (MAR-2008) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-200.
RC   TISSUE=Placenta;
RX   PubMed=1630826;
RA   Eychene A., Barnier J.V., Apiou F., Dutrillaux B., Calothy G.;
RT   "Chromosomal assignment of two human B-raf(Rmil) proto-oncogene loci:
RT   B-raf-1 encoding the p94Braf/Rmil and B-raf-2, a processed
RT   pseudogene.";
RL   Oncogene 7:1657-1660(1992).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-51; 56-95; 151-158; 189-199; 253-260; 294-354;
RP   361-424; 444-507; 510-522; 559-570; 579-626; 663-680; 692-698;
RP   702-719; 727-735 AND 753-766, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT ALA-2, PHOSPHORYLATION AT SER-365; THR-396; SER-399;
RP   THR-401 AND SER-729, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma, and Hepatoma;
RA   Bienvenut W.V., Boldt K., von Kriegsheim A.F., Zebisch A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 117-766.
RC   TISSUE=Testis;
RX   PubMed=2284096;
RA   Sithanandam G., Kolch W., Duh F.-M., Rapp U.R.;
RT   "Complete coding sequence of a human B-raf cDNA and detection of B-raf
RT   protein kinase with isozyme specific antibodies.";
RL   Oncogene 5:1775-1780(1990).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 381-766, DISEASE, AND CHROMOSOMAL
RP   REARRANGEMENT.
RC   TISSUE=Brain;
RX   PubMed=18974108; DOI=10.1158/0008-5472.CAN-08-2097;
RA   Jones D.T.W., Kocialkowski S., Liu L., Pearson D.M., Backlund L.M.,
RA   Ichimura K., Collins V.P.;
RT   "Tandem duplication producing a novel oncogenic BRAF fusion gene
RT   defines the majority of pilocytic astrocytomas.";
RL   Cancer Res. 68:8673-8677(2008).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 439-766.
RX   PubMed=3043188; DOI=10.1128/MCB.8.6.2651;
RA   Ikawa S., Fukui M., Ueyama Y., Tamaoki N., Yamamoto T., Toyoshima K.;
RT   "B-raf, a new member of the raf family, is activated by DNA
RT   rearrangement.";
RL   Mol. Cell. Biol. 8:2651-2654(1988).
RN   [12]
RP   PHOSPHORYLATION AT SER-365 BY SGK1.
RX   PubMed=11410590; DOI=10.1074/jbc.M102808200;
RA   Zhang B.H., Tang E.D., Zhu T., Greenberg M.E., Vojtek A.B., Guan K.L.;
RT   "Serum- and glucocorticoid-inducible kinase SGK phosphorylates and
RT   negatively regulates B-Raf.";
RL   J. Biol. Chem. 276:31620-31626(2001).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-401, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-401; SER-446; SER-447
RP   AND SER-729, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   SUBUNIT, INTERACTION WITH DGKH, AND PHOSPHORYLATION AT THR-753 BY
RP   MAPK1.
RX   PubMed=19710016; DOI=10.1074/jbc.M109.043604;
RA   Yasuda S., Kai M., Imai S., Takeishi K., Taketomi A., Toyota M.,
RA   Kanoh H., Sakane F.;
RT   "Diacylglycerol kinase eta augments C-Raf activity and B-Raf/C-Raf
RT   heterodimerization.";
RL   J. Biol. Chem. 284:29559-29570(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   INTERACTION WITH AKAP13; MAP2K1 AND KSR1.
RX   PubMed=21102438; DOI=10.1038/ncb2130;
RA   Smith F.D., Langeberg L.K., Cellurale C., Pawson T., Morrison D.K.,
RA   Davis R.J., Scott J.D.;
RT   "AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade.";
RL   Nat. Cell Biol. 12:1242-1249(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   INTERACTION WITH KSR2, SUBUNIT, CATALYTIC ACTIVITY, FUNCTION, AND
RP   MUTAGENESIS OF LYS-483.
RX   PubMed=21441910; DOI=10.1038/nature09860;
RA   Brennan D.F., Dar A.C., Hertz N.T., Chao W.C., Burlingame A.L.,
RA   Shokat K.M., Barford D.;
RT   "A Raf-induced allosteric transition of KSR stimulates phosphorylation
RT   of MEK.";
RL   Nature 472:366-369(2011).
RN   [21]
RP   INTERACTION WITH PRMT5, METHYLATION AT ARG-671, CHARACTERIZATION OF
RP   VARIANT CRC GLU-600, AND MUTAGENESIS OF ARG-671.
RX   PubMed=21917714; DOI=10.1126/scisignal.2001936;
RA   Andreu-Perez P., Esteve-Puig R., de Torre-Minguela C.,
RA   Lopez-Fauqued M., Bech-Serra J.J., Tenbaum S., Garcia-Trevijano E.R.,
RA   Canals F., Merlino G., Avila M.A., Recio J.A.;
RT   "Protein arginine methyltransferase 5 regulates ERK1/2 signal
RT   transduction amplitude and cell fate through CRAF.";
RL   Sci. Signal. 4:RA58-RA58(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-729, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [23]
RP   UBIQUITINATION BY RNF149.
RX   PubMed=22628551; DOI=10.1074/jbc.M111.319822;
RA   Hong S.W., Jin D.H., Shin J.S., Moon J.H., Na Y.S., Jung K.A.,
RA   Kim S.M., Kim J.C., Kim K.P., Hong Y.S., Lee J.L., Choi E.K.,
RA   Lee J.S., Kim T.W.;
RT   "Ring finger protein 149 is an E3 ubiquitin ligase active on wild-type
RT   v-Raf murine sarcoma viral oncogene homolog B1 (BRAF).";
RL   J. Biol. Chem. 287:24017-24025(2012).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151; SER-365; THR-401;
RP   SER-446 AND SER-729, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [25]
RP   UBIQUITINATION AT LYS-578, AND MUTAGENESIS OF LYS-578.
RX   PubMed=23907581; DOI=10.1038/srep02344;
RA   An L., Jia W., Yu Y., Zou N., Liang L., Zhao Y., Fan Y., Cheng J.,
RA   Shi Z., Xu G., Li G., Yang J., Zhang H.;
RT   "Lys63-linked polyubiquitination of BRAF at lysine 578 is required for
RT   BRAF-mediated signaling.";
RL   Sci. Rep. 3:2344-2344(2013).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [27]
RP   INTERACTION WITH FNIP1 AND FNIP2.
RX   PubMed=27353360; DOI=10.1038/ncomms12037;
RA   Woodford M.R., Dunn D.M., Blanden A.R., Capriotti D., Loiselle D.,
RA   Prodromou C., Panaretou B., Hughes P.F., Smith A., Ackerman W.,
RA   Haystead T.A., Loh S.N., Bourboulia D., Schmidt L.S.,
RA   Marston Linehan W., Bratslavsky G., Mollapour M.;
RT   "The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and
RT   enhance drug binding.";
RL   Nat. Commun. 7:12037-12037(2016).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.57 ANGSTROMS) OF 444-719 IN COMPLEX WITH
RP   INHIBITOR.
RX   PubMed=18287029; DOI=10.1073/pnas.0711741105;
RA   Tsai J., Lee J.T., Wang W., Zhang J., Cho H., Mamo S., Bremer R.,
RA   Gillette S., Kong J., Haass N.K., Sproesser K., Li L., Smalley K.S.,
RA   Fong D., Zhu Y.L., Marimuthu A., Nguyen H., Lam B., Liu J., Cheung I.,
RA   Rice J., Suzuki Y., Luu C., Settachatgul C., Shellooe R., Cantwell J.,
RA   Kim S.H., Schlessinger J., Zhang K.Y., West B.L., Powell B.,
RA   Habets G., Zhang C., Ibrahim P.N., Hirth P., Artis D.R., Herlyn M.,
RA   Bollag G.;
RT   "Discovery of a selective inhibitor of oncogenic B-Raf kinase with
RT   potent antimelanoma activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3041-3046(2008).
RN   [29]
RP   VARIANTS LNCR VAL-466 AND ARG-597.
RX   PubMed=12460919;
RA   Naoki K., Chen T.-H., Richards W.G., Sugarbaker D.J., Meyerson M.;
RT   "Missense mutations of the BRAF gene in human lung adenocarcinoma.";
RL   Cancer Res. 62:7001-7003(2002).
RN   [30]
RP   VARIANTS CANCER GLU-464; VAL-464; ALA-466; GLU-466; VAL-466; ALA-469;
RP   GLU-469; LYS-586; LEU-595; ARG-596; ARG-597; VAL-597; GLU-600 AND
RP   ASP-600, AND CHARACTERIZATION OF VARIANTS CANCER VAL-464; ALA-469;
RP   VAL-597 AND GLU-600.
RX   PubMed=12068308; DOI=10.1038/nature00766;
RA   Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S.,
RA   Teague J., Woffendin H., Garnett M.J., Bottomley W., Davis N.,
RA   Dicks E., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J.,
RA   Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S.,
RA   Hooper S., Wilson R., Jayatilake H., Gusterson B.A., Cooper C.,
RA   Shipley J., Hargrave D., Pritchard-Jones K., Maitland N.,
RA   Chenevix-Trench G., Riggins G.J., Bigner D.D., Palmieri G., Cossu A.,
RA   Flanagan A., Nicholson A., Ho J.W.C., Leung S.Y., Yuen S.T.,
RA   Weber B.L., Seigler H.F., Darrow T.L., Paterson H., Marais R.,
RA   Marshall C.J., Wooster R., Stratton M.R., Futreal P.A.;
RT   "Mutations of the BRAF gene in human cancer.";
RL   Nature 417:949-954(2002).
RN   [31]
RP   VARIANTS CRC ILE-462; SER-463; GLU-464; GLU-600 AND GLU-601.
RX   PubMed=12198537; DOI=10.1038/418934a;
RA   Rajagopalan H., Bardelli A., Lengauer C., Kinzler K.W., Vogelstein B.,
RA   Velculescu V.E.;
RT   "Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status.";
RL   Nature 418:934-934(2002).
RN   [32]
RP   VARIANTS NHL ALA-469; ARG-469 AND GLY-594.
RX   PubMed=14612909; DOI=10.1038/sj.bjc.6601371;
RA   Lee J.W., Yoo N.J., Soung Ark W.S., Kim S.Y., Lee J.H., Park J.Y.,
RA   Cho Y.G., Kim C.J., Ko Y.H., Kim S.H., Nam S.W., Lee J.Y., Lee S.H.;
RT   "BRAF mutations in non-Hodgkin's lymphoma.";
RL   Br. J. Cancer 89:1958-1960(2003).
RN   [33]
RP   CHARACTERIZATION OF VARIANT MELANOMA GLU-600.
RX   PubMed=14500344;
RA   Hingorani S.R., Jacobetz M.A., Robertson G.P., Herlyn M.,
RA   Tuveson D.A.;
RT   "Suppression of BRAF(V599E) in human melanoma abrogates
RT   transformation.";
RL   Cancer Res. 63:5198-5202(2003).
RN   [34]
RP   VARIANTS CFC1 PRO-246; ARG-257; GLU-469; PHE-485; GLU-499; LYS-501;
RP   GLY-501 AND ASP-581.
RX   PubMed=16474404; DOI=10.1038/ng1749;
RA   Niihori T., Aoki Y., Narumi Y., Neri G., Cave H., Verloes A.,
RA   Okamoto N., Hennekam R.C.M., Gillessen-Kaesbach G., Wieczorek D.,
RA   Kavamura M.I., Kurosawa K., Ohashi H., Wilson L., Heron D.,
RA   Bonneau D., Corona G., Kaname T., Naritomi K., Baumann C.,
RA   Matsumoto N., Kato K., Kure S., Matsubara Y.;
RT   "Germline KRAS and BRAF mutations in cardio-facio-cutaneous
RT   syndrome.";
RL   Nat. Genet. 38:294-296(2006).
RN   [35]
RP   VARIANT [LARGE SCALE ANALYSIS] GLU-600.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [36]
RP   VARIANTS CFC1 ARG-257; ALA-467; SER-468; GLU-469; PHE-485; GLU-499;
RP   LYS-501; GLY-501; ASP-581; LEU-595 AND VAL-596.
RX   PubMed=16439621; DOI=10.1126/science.1124642;
RA   Rodriguez-Viciana P., Tetsu O., Tidyman W.E., Estep A.L., Conger B.A.,
RA   Cruz M.S., McCormick F., Rauen K.A.;
RT   "Germline mutations in genes within the MAPK pathway cause cardio-
RT   facio-cutaneous syndrome.";
RL   Science 311:1287-1290(2006).
RN   [37]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-301; ALA-469; VAL-469; SER-581;
RP   ARG-596; ARG-597; VAL-597 AND GLU-600.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [38]
RP   VARIANTS CFC1 PRO-241; PRO-244; PRO-246; ARG-257; LYS-262; SER-468;
RP   GLU-469; GLU-499; ASN-499; ASP-580; ASP-581 AND LEU-595.
RX   PubMed=18042262; DOI=10.1111/j.1399-0004.2007.00931.x;
RA   Schulz A.L., Albrecht B., Arici C., van der Burgt I., Buske A.,
RA   Gillessen-Kaesbach G., Heller R., Horn D., Hubner C.A., Korenke G.C.,
RA   Konig R., Kress W., Kruger G., Meinecke P., Mucke J., Plecko B.,
RA   Rossier E., Schinzel A., Schulze A., Seemanova E., Seidel H.,
RA   Spranger S., Tuysuz B., Uhrig S., Wieczorek D., Kutsche K., Zenker M.;
RT   "Mutation and phenotypic spectrum in patients with cardio-facio-
RT   cutaneous and Costello syndrome.";
RL   Clin. Genet. 73:62-70(2008).
RN   [39]
RP   VARIANT LPRD3 PRO-241, VARIANTS NS7 CYS-531 AND VAL-597, VARIANTS CFC1
RP   PHE-245; PRO-246; ARG-257; LYS-275; GLU-469; PHE-485; ASN-499;
RP   LYS-501; PRO-525; LEU-595; ARG-599; GLN-601; GLU-638 AND ARG-709, AND
RP   VARIANTS ARG-241 AND MET-241.
RX   PubMed=19206169; DOI=10.1002/humu.20955;
RA   Sarkozy A., Carta C., Moretti S., Zampino G., Digilio M.C.,
RA   Pantaleoni F., Scioletti A.P., Esposito G., Cordeddu V., Lepri F.,
RA   Petrangeli V., Dentici M.L., Mancini G.M., Selicorni A., Rossi C.,
RA   Mazzanti L., Marino B., Ferrero G.B., Silengo M.C., Memo L.,
RA   Stanzial F., Faravelli F., Stuppia L., Puxeddu E., Gelb B.D.,
RA   Dallapiccola B., Tartaglia M.;
RT   "Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous
RT   syndromes: molecular diversity and associated phenotypic spectrum.";
RL   Hum. Mutat. 30:695-702(2009).
RN   [40]
RP   VARIANT CRC GLU-600.
RX   PubMed=23263490; DOI=10.1038/ng.2503;
RG   CORGI Consortium;
RG   WGS500 Consortium;
RA   Palles C., Cazier J.B., Howarth K.M., Domingo E., Jones A.M.,
RA   Broderick P., Kemp Z., Spain S.L., Guarino Almeida E., Salguero I.,
RA   Sherborne A., Chubb D., Carvajal-Carmona L.G., Ma Y., Kaur K.,
RA   Dobbins S., Barclay E., Gorman M., Martin L., Kovac M.B., Humphray S.,
RA   Lucassen A., Holmes C.C., Bentley D., Donnelly P., Taylor J.,
RA   Petridis C., Roylance R., Sawyer E.J., Kerr D.J., Clark S., Grimes J.,
RA   Kearsey S.E., Thomas H.J., McVean G., Houlston R.S., Tomlinson I.;
RT   "Germline mutations affecting the proofreading domains of POLE and
RT   POLD1 predispose to colorectal adenomas and carcinomas.";
RL   Nat. Genet. 45:136-144(2013).
RN   [41]
RP   VARIANT CRC GLU-600.
RX   PubMed=24455489; DOI=10.3389/fonc.2013.00333;
RA   D'mello S.A., Flanagan J.U., Green T.N., Leung E.Y.,
RA   Askarian-Amiri M.E., Joseph W.R., McCrystal M.R., Isaacs R.J.,
RA   Shaw J.H., Furneaux C.E., During M.J., Finlay G.J., Baguley B.C.,
RA   Kalev-Zylinska M.L.;
RT   "Evidence that GRIN2A mutations in melanoma correlate with decreased
RT   survival.";
RL   Front. Oncol. 3:333-333(2014).
CC   -!- FUNCTION: Protein kinase involved in the transduction of mitogenic
CC       signals from the cell membrane to the nucleus. May play a role in
CC       the postsynaptic responses of hippocampal neuron. Phosphorylates
CC       MAP2K1, and thereby contributes to the MAP kinase signal
CC       transduction pathway. {ECO:0000269|PubMed:21441910}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:21441910}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000250};
CC   -!- ENZYME REGULATION: Activity is increased by EGF and HGF.
CC   -!- SUBUNIT: Monomer. Homodimer. Heterodimerizes with RAF1, and the
CC       heterodimer possesses a highly increased kinase activity compared
CC       to the respective homodimers or monomers. Heterodimerization is
CC       mitogen-regulated and enhanced by 14-3-3 proteins. MAPK1/ERK2
CC       activation can induce a negative feedback that promotes the
CC       dissociation of the heterodimer by phosphorylating BRAF at Thr-
CC       753. Found in a complex with at least BRAF, HRAS, MAP2K1, MAPK3
CC       and RGS14. Interacts with RIT1. Interacts (via N-terminus) with
CC       RGS14 (via RBD domains); the interaction mediates the formation of
CC       a ternary complex with RAF1, a ternary complex inhibited by GNAI1
CC       (By similarity). Interacts with DGKH (PubMed:19710016). Interacts
CC       with PRMT5 (PubMed:21917714). Interacts with KSR2
CC       (PubMed:21441910). Interacts with AKAP13, MAP2K1 and KSR1.
CC       Identified in a complex with AKAP13, MAP2K1 and KSR1
CC       (PubMed:21102438). Interacts with FNIP1 and FNIP2
CC       (PubMed:27353360). {ECO:0000250, ECO:0000269|PubMed:18287029,
CC       ECO:0000269|PubMed:19710016, ECO:0000269|PubMed:21102438,
CC       ECO:0000269|PubMed:21441910, ECO:0000269|PubMed:21917714,
CC       ECO:0000269|PubMed:27353360}.
CC   -!- INTERACTION:
CC       Self; NbExp=13; IntAct=EBI-365980, EBI-365980;
CC       P10398:ARAF; NbExp=3; IntAct=EBI-365980, EBI-365961;
CC       P01112:HRAS; NbExp=4; IntAct=EBI-365980, EBI-350145;
CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-365980, EBI-352572;
CC       P46940:IQGAP1; NbExp=4; IntAct=EBI-365980, EBI-297509;
CC       Q61097:Ksr1 (xeno); NbExp=3; IntAct=EBI-365980, EBI-1536336;
CC       P29678:MAP2K1 (xeno); NbExp=2; IntAct=EBI-365980, EBI-1631983;
CC       Q02750:MAP2K1; NbExp=58; IntAct=EBI-365980, EBI-492564;
CC       P36507:MAP2K2; NbExp=6; IntAct=EBI-365980, EBI-1056930;
CC       Q13233:MAP3K1; NbExp=2; IntAct=EBI-365980, EBI-49776;
CC       P01111:NRAS; NbExp=3; IntAct=EBI-365980, EBI-721993;
CC       P04049:RAF1; NbExp=55; IntAct=EBI-365980, EBI-365996;
CC       Q99N57:Raf1 (xeno); NbExp=3; IntAct=EBI-365980, EBI-397757;
CC       Q8CGE9:Rgs12 (xeno); NbExp=2; IntAct=EBI-365980, EBI-7340552;
CC       Q15349:RPS6KA2; NbExp=2; IntAct=EBI-365980, EBI-1384149;
CC       Q13114:TRAF3; NbExp=2; IntAct=EBI-365980, EBI-357631;
CC       P31946:YWHAB; NbExp=3; IntAct=EBI-365980, EBI-359815;
CC       P63104:YWHAZ; NbExp=4; IntAct=EBI-365980, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm. Cell
CC       membrane {ECO:0000250}. Note=Colocalizes with RGS14 and RAF1 in
CC       both the cytoplasm and membranes. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Brain and testis.
CC   -!- PTM: Phosphorylation at Ser-365 by SGK1 inhibits its activity.
CC       {ECO:0000269|PubMed:11410590, ECO:0000269|PubMed:1508179,
CC       ECO:0000269|PubMed:19710016, ECO:0000269|Ref.8}.
CC   -!- PTM: Methylation at Arg-671 decreases stability and kinase
CC       activity. {ECO:0000269|PubMed:21917714}.
CC   -!- PTM: Ubiquitinated by RNF149; which leads to proteasomal
CC       degradation. Polyubiquitinated at Lys-578 in response to EGF.
CC       {ECO:0000269|PubMed:22628551, ECO:0000269|PubMed:23907581}.
CC   -!- DISEASE: Note=Defects in BRAF are found in a wide range of
CC       cancers. {ECO:0000269|PubMed:18974108}.
CC   -!- DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease
CC       characterized by malignant lesions arising from the inner wall of
CC       the large intestine (the colon) and the rectum. Genetic
CC       alterations are often associated with progression from
CC       premalignant lesion (adenoma) to invasive adenocarcinoma. Risk
CC       factors for cancer of the colon and rectum include colon polyps,
CC       long-standing ulcerative colitis, and genetic family history.
CC       {ECO:0000269|PubMed:12198537, ECO:0000269|PubMed:21917714,
CC       ECO:0000269|PubMed:23263490, ECO:0000269|PubMed:24455489}.
CC       Note=The disease may be caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy
CC       affecting tissues of the lung. The most common form of lung cancer
CC       is non-small cell lung cancer (NSCLC) that can be divided into 3
CC       major histologic subtypes: squamous cell carcinoma,
CC       adenocarcinoma, and large cell lung cancer. NSCLC is often
CC       diagnosed at an advanced stage and has a poor prognosis.
CC       {ECO:0000269|PubMed:12460919}. Note=The gene represented in this
CC       entry is involved in disease pathogenesis.
CC   -!- DISEASE: Familial non-Hodgkin lymphoma (NHL) [MIM:605027]: Cancer
CC       that starts in cells of the lymph system, which is part of the
CC       body's immune system. NHLs can occur at any age and are often
CC       marked by enlarged lymph nodes, fever and weight loss.
CC       {ECO:0000269|PubMed:14612909}. Note=The gene represented in this
CC       entry is involved in disease pathogenesis.
CC   -!- DISEASE: Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]: A
CC       multiple congenital anomaly disorder characterized by a
CC       distinctive facial appearance, heart defects and mental
CC       retardation. Heart defects include pulmonic stenosis, atrial
CC       septal defects and hypertrophic cardiomyopathy. Some affected
CC       individuals present with ectodermal abnormalities such as sparse,
CC       friable hair, hyperkeratotic skin lesions and a generalized
CC       ichthyosis-like condition. Typical facial features are similar to
CC       Noonan syndrome. They include high forehead with bitemporal
CC       constriction, hypoplastic supraorbital ridges, downslanting
CC       palpebral fissures, a depressed nasal bridge, and posteriorly
CC       angulated ears with prominent helices.
CC       {ECO:0000269|PubMed:16439621, ECO:0000269|PubMed:16474404,
CC       ECO:0000269|PubMed:18042262, ECO:0000269|PubMed:19206169}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Noonan syndrome 7 (NS7) [MIM:613706]: A form of Noonan
CC       syndrome, a disease characterized by short stature, facial
CC       dysmorphic features such as hypertelorism, a downward eyeslant and
CC       low-set posteriorly rotated ears, and a high incidence of
CC       congenital heart defects and hypertrophic cardiomyopathy. Other
CC       features can include a short neck with webbing or redundancy of
CC       skin, deafness, motor delay, variable intellectual deficits,
CC       multiple skeletal defects, cryptorchidism, and bleeding diathesis.
CC       Individuals with Noonan syndrome are at risk of juvenile
CC       myelomonocytic leukemia, a myeloproliferative disorder
CC       characterized by excessive production of myelomonocytic cells.
CC       {ECO:0000269|PubMed:19206169}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: LEOPARD syndrome 3 (LPRD3) [MIM:613707]: A disorder
CC       characterized by lentigines, electrocardiographic conduction
CC       abnormalities, ocular hypertelorism, pulmonic stenosis,
CC       abnormalities of genitalia, retardation of growth, and
CC       sensorineural deafness. {ECO:0000269|PubMed:19206169}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving BRAF is found in
CC       pilocytic astrocytomas. A tandem duplication of 2 Mb at 7q34 leads
CC       to the expression of a KIAA1549-BRAF fusion protein with a
CC       constitutive kinase activity and inducing cell transformation.
CC       {ECO:0000269|PubMed:18974108}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. RAF subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD43193.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAQ43111.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAQ43112.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAQ43113.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAQ43114.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAQ43115.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAQ43116.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/BRAFID828.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M95712; AAA35609.2; -; mRNA.
DR   EMBL; AC006344; AAD43193.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; EU600171; ACD11489.1; -; Genomic_DNA.
DR   EMBL; AC006347; AAD15551.1; -; Genomic_DNA.
DR   EMBL; CH236950; EAL24023.1; -; Genomic_DNA.
DR   EMBL; BC101757; AAI01758.1; -; mRNA.
DR   EMBL; BC112079; AAI12080.1; -; mRNA.
DR   EMBL; X65187; CAA46301.1; -; Genomic_DNA.
DR   EMBL; M21001; AAA96495.1; -; mRNA.
DR   EMBL; AM989472; CAQ43111.1; ALT_INIT; mRNA.
DR   EMBL; AM989473; CAQ43112.1; ALT_INIT; mRNA.
DR   EMBL; AM989474; CAQ43113.1; ALT_INIT; mRNA.
DR   EMBL; AM989475; CAQ43114.1; ALT_INIT; mRNA.
DR   EMBL; AM989476; CAQ43115.1; ALT_INIT; mRNA.
DR   EMBL; AM989477; CAQ43116.1; ALT_INIT; mRNA.
DR   CCDS; CCDS5863.1; -.
DR   PIR; A57977; TVHUBF.
DR   RefSeq; NP_004324.2; NM_004333.4.
DR   UniGene; Hs.324250; -.
DR   UniGene; Hs.550061; -.
DR   UniGene; Hs.600998; -.
DR   UniGene; Hs.605380; -.
DR   UniGene; Hs.659507; -.
DR   UniGene; Hs.684552; -.
DR   PDB; 1UWH; X-ray; 2.95 A; A/B=448-723.
DR   PDB; 1UWJ; X-ray; 3.50 A; A/B=448-723.
DR   PDB; 2FB8; X-ray; 2.90 A; A/B=445-723.
DR   PDB; 2L05; NMR; -; A=149-232.
DR   PDB; 3C4C; X-ray; 2.57 A; A/B=444-721.
DR   PDB; 3D4Q; X-ray; 2.80 A; A/B=433-726.
DR   PDB; 3IDP; X-ray; 2.70 A; A/B=434-727.
DR   PDB; 3II5; X-ray; 2.79 A; A/B=432-726.
DR   PDB; 3NY5; X-ray; 1.99 A; A/B/C/D=153-237.
DR   PDB; 3OG7; X-ray; 2.45 A; A/B=448-720.
DR   PDB; 3PPJ; X-ray; 3.70 A; A/B=432-726.
DR   PDB; 3PPK; X-ray; 3.00 A; A/B=432-726.
DR   PDB; 3PRF; X-ray; 2.90 A; A/B=432-726.
DR   PDB; 3PRI; X-ray; 3.50 A; A/B=432-726.
DR   PDB; 3PSB; X-ray; 3.40 A; A/B=433-726.
DR   PDB; 3PSD; X-ray; 3.60 A; A/B=433-726.
DR   PDB; 3Q4C; X-ray; 3.20 A; A/B=432-726.
DR   PDB; 3Q96; X-ray; 3.10 A; A/B=446-727.
DR   PDB; 3SKC; X-ray; 3.20 A; A/B=432-726.
DR   PDB; 3TV4; X-ray; 3.40 A; A/B=432-726.
DR   PDB; 3TV6; X-ray; 3.30 A; A/B=432-726.
DR   PDB; 4CQE; X-ray; 2.30 A; A/B=448-723.
DR   PDB; 4DBN; X-ray; 3.15 A; A/B=445-726.
DR   PDB; 4E26; X-ray; 2.55 A; A/B=432-726.
DR   PDB; 4E4X; X-ray; 3.60 A; A/B=432-726.
DR   PDB; 4EHE; X-ray; 3.30 A; A/B=432-726.
DR   PDB; 4EHG; X-ray; 3.50 A; A/B=432-726.
DR   PDB; 4FC0; X-ray; 2.95 A; A/B=445-726.
DR   PDB; 4FK3; X-ray; 2.65 A; A/B=444-723.
DR   PDB; 4G9C; X-ray; 3.50 A; A/B=432-726.
DR   PDB; 4G9R; X-ray; 3.20 A; A/B=432-726.
DR   PDB; 4H58; X-ray; 3.10 A; A/B/C=448-722.
DR   PDB; 4JVG; X-ray; 3.09 A; A/B/C/D=444-723.
DR   PDB; 4KSP; X-ray; 2.93 A; A/B=445-726.
DR   PDB; 4KSQ; X-ray; 3.30 A; A/B=445-726.
DR   PDB; 4MBJ; X-ray; 3.60 A; A/B=432-723.
DR   PDB; 4MNE; X-ray; 2.85 A; B/C/F/G=432-726.
DR   PDB; 4MNF; X-ray; 2.80 A; A/B=432-736.
DR   PDB; 4PP7; X-ray; 3.40 A; A/B=432-726.
DR   PDB; 4R5Y; X-ray; 3.50 A; A/B=444-723.
DR   PDB; 4RZV; X-ray; 2.99 A; A/B=443-723.
DR   PDB; 4RZW; X-ray; 3.49 A; A/B=443-723.
DR   PDB; 4WO5; X-ray; 2.83 A; A/B=444-723.
DR   PDB; 4XV1; X-ray; 2.47 A; A/B=444-705.
DR   PDB; 4XV2; X-ray; 2.50 A; A/B=444-705.
DR   PDB; 4XV3; X-ray; 2.80 A; A/B=444-705.
DR   PDB; 4XV9; X-ray; 2.00 A; A=442-705.
DR   PDB; 4YHT; X-ray; 3.05 A; A/B=449-720.
DR   PDB; 5C9C; X-ray; 2.70 A; A/B=432-726.
DR   PDB; 5CSW; X-ray; 2.66 A; A/B=442-721.
DR   PDB; 5CSX; X-ray; 2.51 A; A=442-721.
DR   PDB; 5CT7; X-ray; 3.17 A; A/B=445-723.
DR   PDB; 5FD2; X-ray; 2.89 A; A/B=433-726.
DR   PDB; 5HI2; X-ray; 2.51 A; A=444-737.
DR   PDB; 5HID; X-ray; 2.50 A; A/B=444-737.
DR   PDB; 5HIE; X-ray; 3.00 A; A/B/C/D=432-726.
DR   PDB; 5ITA; X-ray; 1.95 A; A/B=448-723.
DR   PDB; 5J17; NMR; -; A=151-232.
DR   PDB; 5J18; NMR; -; A=151-232.
DR   PDB; 5J2R; NMR; -; A=151-232.
DR   PDB; 5JRQ; X-ray; 2.29 A; A/B=448-723.
DR   PDB; 5JSM; X-ray; 2.19 A; A/B/C/D=448-723.
DR   PDB; 5JT2; X-ray; 2.70 A; A/B/C/D=448-723.
DR   PDB; 5VAL; X-ray; 2.26 A; A/B=445-723.
DR   PDB; 5VAM; X-ray; 2.10 A; A/B=445-723.
DR   PDB; 5VYK; X-ray; 1.75 A; A/C=36-110.
DR   PDB; 6B8U; X-ray; 2.68 A; A/B=445-723.
DR   PDB; 6CAD; X-ray; 2.55 A; A/B=444-723.
DR   PDBsum; 1UWH; -.
DR   PDBsum; 1UWJ; -.
DR   PDBsum; 2FB8; -.
DR   PDBsum; 2L05; -.
DR   PDBsum; 3C4C; -.
DR   PDBsum; 3D4Q; -.
DR   PDBsum; 3IDP; -.
DR   PDBsum; 3II5; -.
DR   PDBsum; 3NY5; -.
DR   PDBsum; 3OG7; -.
DR   PDBsum; 3PPJ; -.
DR   PDBsum; 3PPK; -.
DR   PDBsum; 3PRF; -.
DR   PDBsum; 3PRI; -.
DR   PDBsum; 3PSB; -.
DR   PDBsum; 3PSD; -.
DR   PDBsum; 3Q4C; -.
DR   PDBsum; 3Q96; -.
DR   PDBsum; 3SKC; -.
DR   PDBsum; 3TV4; -.
DR   PDBsum; 3TV6; -.
DR   PDBsum; 4CQE; -.
DR   PDBsum; 4DBN; -.
DR   PDBsum; 4E26; -.
DR   PDBsum; 4E4X; -.
DR   PDBsum; 4EHE; -.
DR   PDBsum; 4EHG; -.
DR   PDBsum; 4FC0; -.
DR   PDBsum; 4FK3; -.
DR   PDBsum; 4G9C; -.
DR   PDBsum; 4G9R; -.
DR   PDBsum; 4H58; -.
DR   PDBsum; 4JVG; -.
DR   PDBsum; 4KSP; -.
DR   PDBsum; 4KSQ; -.
DR   PDBsum; 4MBJ; -.
DR   PDBsum; 4MNE; -.
DR   PDBsum; 4MNF; -.
DR   PDBsum; 4PP7; -.
DR   PDBsum; 4R5Y; -.
DR   PDBsum; 4RZV; -.
DR   PDBsum; 4RZW; -.
DR   PDBsum; 4WO5; -.
DR   PDBsum; 4XV1; -.
DR   PDBsum; 4XV2; -.
DR   PDBsum; 4XV3; -.
DR   PDBsum; 4XV9; -.
DR   PDBsum; 4YHT; -.
DR   PDBsum; 5C9C; -.
DR   PDBsum; 5CSW; -.
DR   PDBsum; 5CSX; -.
DR   PDBsum; 5CT7; -.
DR   PDBsum; 5FD2; -.
DR   PDBsum; 5HI2; -.
DR   PDBsum; 5HID; -.
DR   PDBsum; 5HIE; -.
DR   PDBsum; 5ITA; -.
DR   PDBsum; 5J17; -.
DR   PDBsum; 5J18; -.
DR   PDBsum; 5J2R; -.
DR   PDBsum; 5JRQ; -.
DR   PDBsum; 5JSM; -.
DR   PDBsum; 5JT2; -.
DR   PDBsum; 5VAL; -.
DR   PDBsum; 5VAM; -.
DR   PDBsum; 5VYK; -.
DR   PDBsum; 6B8U; -.
DR   PDBsum; 6CAD; -.
DR   ProteinModelPortal; P15056; -.
DR   SMR; P15056; -.
DR   BioGrid; 107141; 65.
DR   CORUM; P15056; -.
DR   DIP; DIP-1045N; -.
DR   IntAct; P15056; 49.
DR   MINT; P15056; -.
DR   STRING; 9606.ENSP00000288602; -.
DR   BindingDB; P15056; -.
DR   ChEMBL; CHEMBL5145; -.
DR   DrugBank; DB08912; Dabrafenib.
DR   DrugBank; DB05238; PLX4032.
DR   DrugBank; DB08896; Regorafenib.
DR   DrugBank; DB00398; Sorafenib.
DR   DrugBank; DB08881; Vemurafenib.
DR   DrugBank; DB05190; XL281.
DR   GuidetoPHARMACOLOGY; 1943; -.
DR   iPTMnet; P15056; -.
DR   PhosphoSitePlus; P15056; -.
DR   BioMuta; BRAF; -.
DR   DMDM; 50403720; -.
DR   EPD; P15056; -.
DR   MaxQB; P15056; -.
DR   PaxDb; P15056; -.
DR   PeptideAtlas; P15056; -.
DR   PRIDE; P15056; -.
DR   DNASU; 673; -.
DR   Ensembl; ENST00000288602; ENSP00000288602; ENSG00000157764.
DR   GeneID; 673; -.
DR   KEGG; hsa:673; -.
DR   UCSC; uc003vwc.5; human.
DR   CTD; 673; -.
DR   DisGeNET; 673; -.
DR   EuPathDB; HostDB:ENSG00000157764.12; -.
DR   GeneCards; BRAF; -.
DR   GeneReviews; BRAF; -.
DR   H-InvDB; HIX0167822; -.
DR   HGNC; HGNC:1097; BRAF.
DR   HPA; CAB004552; -.
DR   HPA; HPA001328; -.
DR   HPA; HPA071048; -.
DR   MalaCards; BRAF; -.
DR   MIM; 114500; phenotype.
DR   MIM; 115150; phenotype.
DR   MIM; 164757; gene.
DR   MIM; 211980; phenotype.
DR   MIM; 605027; phenotype.
DR   MIM; 613706; phenotype.
DR   MIM; 613707; phenotype.
DR   neXtProt; NX_P15056; -.
DR   OpenTargets; ENSG00000157764; -.
DR   Orphanet; 1340; Cardiofaciocutaneous syndrome.
DR   Orphanet; 54595; Craniopharyngioma.
DR   Orphanet; 58017; Hairy cell leukemia.
DR   Orphanet; 99872; Hashimoto-Pritzker syndrome.
DR   Orphanet; 500; LEOPARD syndrome.
DR   Orphanet; 648; Noonan syndrome.
DR   Orphanet; 251612; Pilocytic astrocytoma.
DR   PharmGKB; PA25408; -.
DR   eggNOG; KOG0193; Eukaryota.
DR   eggNOG; ENOG410Y4UP; LUCA.
DR   GeneTree; ENSGT00900000140880; -.
DR   HOVERGEN; HBG001886; -.
DR   InParanoid; P15056; -.
DR   KO; K04365; -.
DR   OMA; IVFDFEP; -.
DR   OrthoDB; EOG091G09SB; -.
DR   PhylomeDB; P15056; -.
DR   TreeFam; TF317006; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-1295596; Spry regulation of FGF signaling.
DR   Reactome; R-HSA-170968; Frs2-mediated activation.
DR   Reactome; R-HSA-170984; ARMS-mediated activation.
DR   Reactome; R-HSA-187706; Signalling to p38 via RIT and RIN.
DR   Reactome; R-HSA-442742; CREB phosphorylation through the activation of Ras.
DR   Reactome; R-HSA-5673000; RAF activation.
DR   Reactome; R-HSA-5674135; MAP2K and MAPK activation.
DR   Reactome; R-HSA-5674499; Negative feedback regulation of MAPK pathway.
DR   Reactome; R-HSA-5675221; Negative regulation of MAPK pathway.
DR   Reactome; R-HSA-6802946; Signaling by moderate kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802948; Signaling by high-kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802949; Signaling by RAS mutants.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF fusions.
DR   Reactome; R-HSA-6802955; Paradoxical activation of RAF signaling by kinase inactive BRAF.
DR   SignaLink; P15056; -.
DR   SIGNOR; P15056; -.
DR   ChiTaRS; BRAF; human.
DR   EvolutionaryTrace; P15056; -.
DR   GeneWiki; BRAF_(gene); -.
DR   GenomeRNAi; 673; -.
DR   PMAP-CutDB; P15056; -.
DR   PRO; PR:P15056; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000157764; -.
DR   CleanEx; HS_BRAF; -.
DR   ExpressionAtlas; P15056; baseline and differential.
DR   Genevisible; P15056; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005622; C:intracellular; IBA:GO_Central.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IBA:GO_Central.
DR   GO; GO:0031434; F:mitogen-activated protein kinase kinase binding; IBA:GO_Central.
DR   GO; GO:0004672; F:protein kinase activity; IDA:BHF-UCL.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0071277; P:cellular response to calcium ion; IDA:BHF-UCL.
DR   GO; GO:0090150; P:establishment of protein localization to membrane; IDA:CACAO.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0009968; P:negative regulation of signal transduction; IBA:GO_Central.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL.
DR   GO; GO:0010828; P:positive regulation of glucose transmembrane transport; IDA:CACAO.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0070413; P:trehalose metabolism in response to stress; IMP:SGD.
DR   CDD; cd00029; C1; 1.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR003116; RBD_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF02196; RBD; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00455; RBD; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50898; RBD; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Cardiomyopathy; Cell membrane;
KW   Chromosomal rearrangement; Complete proteome; Cytoplasm; Deafness;
KW   Direct protein sequencing; Disease mutation; Ectodermal dysplasia;
KW   Isopeptide bond; Kinase; Membrane; Mental retardation; Metal-binding;
KW   Methylation; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   INIT_MET      1      1       Removed. {ECO:0000269|Ref.8}.
FT   CHAIN         2    766       Serine/threonine-protein kinase B-raf.
FT                                /FTId=PRO_0000085665.
FT   DOMAIN      155    227       RBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00262}.
FT   DOMAIN      457    717       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ZN_FING     234    280       Phorbol-ester/DAG-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   NP_BIND     463    471       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COMPBIAS      6     11       Poly-Gly.
FT   COMPBIAS    122    129       Poly-Ser.
FT   COMPBIAS    428    432       Poly-Ser.
FT   ACT_SITE    576    576       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   METAL       235    235       Zinc 1. {ECO:0000250}.
FT   METAL       248    248       Zinc 2. {ECO:0000250}.
FT   METAL       251    251       Zinc 2. {ECO:0000250}.
FT   METAL       261    261       Zinc 1. {ECO:0000250}.
FT   METAL       264    264       Zinc 1. {ECO:0000250}.
FT   METAL       269    269       Zinc 2. {ECO:0000250}.
FT   METAL       272    272       Zinc 2. {ECO:0000250}.
FT   METAL       280    280       Zinc 1. {ECO:0000250}.
FT   BINDING     483    483       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   SITE        380    381       Breakpoint for translocation to form
FT                                KIAA1549-BRAF fusion protein.
FT   SITE        438    439       Breakpoint for translocation to form
FT                                KIAA1549-BRAF fusion protein.
FT   MOD_RES       2      2       N-acetylalanine. {ECO:0000269|Ref.8}.
FT   MOD_RES     151    151       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     333    333       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P28028}.
FT   MOD_RES     365    365       Phosphoserine; by SGK1.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:11410590,
FT                                ECO:0000269|Ref.8}.
FT   MOD_RES     373    373       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000269|PubMed:1508179}.
FT   MOD_RES     396    396       Phosphothreonine. {ECO:0000269|Ref.8}.
FT   MOD_RES     399    399       Phosphoserine. {ECO:0000269|Ref.8}.
FT   MOD_RES     401    401       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|Ref.8}.
FT   MOD_RES     446    446       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     447    447       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     671    671       Omega-N-methylarginine; by PRMT5.
FT                                {ECO:0000269|PubMed:21917714}.
FT   MOD_RES     729    729       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|Ref.8}.
FT   MOD_RES     750    750       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P28028}.
FT   MOD_RES     753    753       Phosphothreonine; by MAPK1.
FT                                {ECO:0000269|PubMed:19710016}.
FT   CROSSLNK    578    578       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:23907581}.
FT   VARIANT     241    241       T -> M (in a patient with Noonan
FT                                syndrome; dbSNP:rs387906660).
FT                                {ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_058620.
FT   VARIANT     241    241       T -> P (in CFC1 and LPRD3;
FT                                dbSNP:rs387906661).
FT                                {ECO:0000269|PubMed:18042262,
FT                                ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_058621.
FT   VARIANT     241    241       T -> R (in a patient with Noonan
FT                                syndrome; dbSNP:rs387906660).
FT                                {ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_058622.
FT   VARIANT     244    244       T -> P (in CFC1; dbSNP:rs397507465).
FT                                {ECO:0000269|PubMed:18042262}.
FT                                /FTId=VAR_065171.
FT   VARIANT     245    245       L -> F (in CFC1; dbSNP:rs397507466).
FT                                {ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_058623.
FT   VARIANT     246    246       A -> P (in CFC1; dbSNP:rs180177034).
FT                                {ECO:0000269|PubMed:16474404,
FT                                ECO:0000269|PubMed:18042262,
FT                                ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_026113.
FT   VARIANT     257    257       Q -> R (in CFC1; dbSNP:rs180177035).
FT                                {ECO:0000269|PubMed:16439621,
FT                                ECO:0000269|PubMed:16474404,
FT                                ECO:0000269|PubMed:18042262,
FT                                ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_026114.
FT   VARIANT     262    262       Q -> K (in CFC1; dbSNP:rs397507470).
FT                                {ECO:0000269|PubMed:18042262}.
FT                                /FTId=VAR_065172.
FT   VARIANT     275    275       E -> K (in CFC1).
FT                                {ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_058624.
FT   VARIANT     301    301       P -> S (in dbSNP:rs34776339).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040391.
FT   VARIANT     462    462       R -> I (in CRC; dbSNP:rs180177032).
FT                                {ECO:0000269|PubMed:12198537}.
FT                                /FTId=VAR_018613.
FT   VARIANT     463    463       I -> S (in CRC; dbSNP:rs180177033).
FT                                {ECO:0000269|PubMed:12198537}.
FT                                /FTId=VAR_018614.
FT   VARIANT     464    464       G -> E (in CRC; dbSNP:rs121913348).
FT                                {ECO:0000269|PubMed:12068308,
FT                                ECO:0000269|PubMed:12198537}.
FT                                /FTId=VAR_018615.
FT   VARIANT     464    464       G -> V (in a colorectal cancer cell line;
FT                                elevated kinase activity; efficiently
FT                                induces cell transformation;
FT                                dbSNP:rs121913348).
FT                                {ECO:0000269|PubMed:12068308}.
FT                                /FTId=VAR_018616.
FT   VARIANT     466    466       G -> A (in melanoma; dbSNP:rs121913351).
FT                                {ECO:0000269|PubMed:12068308}.
FT                                /FTId=VAR_018617.
FT   VARIANT     466    466       G -> E (in melanoma; dbSNP:rs121913351).
FT                                {ECO:0000269|PubMed:12068308}.
FT                                /FTId=VAR_018618.
FT   VARIANT     466    466       G -> V (in LNCR; dbSNP:rs121913351).
FT                                {ECO:0000269|PubMed:12068308,
FT                                ECO:0000269|PubMed:12460919}.
FT                                /FTId=VAR_018512.
FT   VARIANT     467    467       S -> A (in CFC1; dbSNP:rs869025606).
FT                                {ECO:0000269|PubMed:16439621}.
FT                                /FTId=VAR_035096.
FT   VARIANT     468    468       F -> S (in CFC1; dbSNP:rs397507473).
FT                                {ECO:0000269|PubMed:16439621,
FT                                ECO:0000269|PubMed:18042262}.
FT                                /FTId=VAR_035097.
FT   VARIANT     469    469       G -> A (in NHL; also in a lung
FT                                adenocarcinoma sample; somatic mutation;
FT                                elevated kinase activity; efficiently
FT                                induces cell transformation;
FT                                dbSNP:rs121913355).
FT                                {ECO:0000269|PubMed:12068308,
FT                                ECO:0000269|PubMed:14612909,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_018620.
FT   VARIANT     469    469       G -> E (in CFC1 and colon cancer;
FT                                dbSNP:rs121913355).
FT                                {ECO:0000269|PubMed:12068308,
FT                                ECO:0000269|PubMed:16439621,
FT                                ECO:0000269|PubMed:16474404,
FT                                ECO:0000269|PubMed:18042262,
FT                                ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_018621.
FT   VARIANT     469    469       G -> R (in NHL; dbSNP:rs121913357).
FT                                {ECO:0000269|PubMed:14612909}.
FT                                /FTId=VAR_018622.
FT   VARIANT     469    469       G -> V (in a colorectal adenocarcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs121913355).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040392.
FT   VARIANT     485    485       L -> F (in CFC1; dbSNP:rs180177036).
FT                                {ECO:0000269|PubMed:16439621,
FT                                ECO:0000269|PubMed:16474404,
FT                                ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_026115.
FT   VARIANT     499    499       K -> E (in CFC1; dbSNP:rs180177037).
FT                                {ECO:0000269|PubMed:16439621,
FT                                ECO:0000269|PubMed:16474404,
FT                                ECO:0000269|PubMed:18042262}.
FT                                /FTId=VAR_026116.
FT   VARIANT     499    499       K -> N (in CFC1; dbSNP:rs397507476).
FT                                {ECO:0000269|PubMed:18042262,
FT                                ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_058625.
FT   VARIANT     501    501       E -> G (in CFC1; dbSNP:rs180177039).
FT                                {ECO:0000269|PubMed:16439621,
FT                                ECO:0000269|PubMed:16474404}.
FT                                /FTId=VAR_026117.
FT   VARIANT     501    501       E -> K (in CFC1; dbSNP:rs180177038).
FT                                {ECO:0000269|PubMed:16439621,
FT                                ECO:0000269|PubMed:16474404,
FT                                ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_026118.
FT   VARIANT     525    525       L -> P (in CFC1; dbSNP:rs869025340).
FT                                {ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_058626.
FT   VARIANT     531    531       W -> C (in NS7; dbSNP:rs606231228).
FT                                {ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_058627.
FT   VARIANT     580    580       N -> D (in CFC1).
FT                                {ECO:0000269|PubMed:18042262}.
FT                                /FTId=VAR_065173.
FT   VARIANT     581    581       N -> D (in CFC1; dbSNP:rs180177040).
FT                                {ECO:0000269|PubMed:16439621,
FT                                ECO:0000269|PubMed:16474404,
FT                                ECO:0000269|PubMed:18042262}.
FT                                /FTId=VAR_026119.
FT   VARIANT     581    581       N -> S (in a colorectal adenocarcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs121913370).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040393.
FT   VARIANT     586    586       E -> K (in ovarian cancer;
FT                                dbSNP:rs121913340).
FT                                {ECO:0000269|PubMed:12068308}.
FT                                /FTId=VAR_018623.
FT   VARIANT     594    594       D -> G (in NHL; dbSNP:rs121913338).
FT                                {ECO:0000269|PubMed:14612909}.
FT                                /FTId=VAR_018624.
FT   VARIANT     595    595       F -> L (in colon cancer and CFC1;
FT                                dbSNP:rs121913341).
FT                                {ECO:0000269|PubMed:12068308,
FT                                ECO:0000269|PubMed:16439621,
FT                                ECO:0000269|PubMed:18042262,
FT                                ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_018625.
FT   VARIANT     596    596       G -> R (in a colorectal adenocarcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs121913361).
FT                                {ECO:0000269|PubMed:12068308,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_018626.
FT   VARIANT     596    596       G -> V (in CFC1; dbSNP:rs397507483).
FT                                {ECO:0000269|PubMed:16439621}.
FT                                /FTId=VAR_035098.
FT   VARIANT     597    597       L -> R (in LNCR; also found in an ovarian
FT                                serous carcinoma sample; somatic
FT                                mutation; dbSNP:rs121913366).
FT                                {ECO:0000269|PubMed:12068308,
FT                                ECO:0000269|PubMed:12460919,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_018513.
FT   VARIANT     597    597       L -> V (in NS7; also in a lung
FT                                adenocarcinoma sample; somatic mutation;
FT                                elevated kinase activity; efficiently
FT                                induces cell transformation;
FT                                dbSNP:rs121913369).
FT                                {ECO:0000269|PubMed:12068308,
FT                                ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_018627.
FT   VARIANT     599    599       T -> R (in CFC1; dbSNP:rs121913375).
FT                                {ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_058628.
FT   VARIANT     600    600       V -> D (in a melanoma cell line; requires
FT                                2 nucleotide substitutions;
FT                                dbSNP:rs121913377).
FT                                {ECO:0000269|PubMed:12068308}.
FT                                /FTId=VAR_018628.
FT   VARIANT     600    600       V -> E (in CRC; also found in sarcoma,
FT                                metastatic melanoma, ovarian serous
FT                                carcinoma, pilocytic astrocytoma; somatic
FT                                mutation; most common mutation;
FT                                constitutive and elevated kinase
FT                                activity; efficiently induces cell
FT                                transformation; suppression of mutation
FT                                in melanoma causes growth arrest and
FT                                promotes apoptosis; loss of regulation by
FT                                PMRT5; dbSNP:rs113488022).
FT                                {ECO:0000269|PubMed:12068308,
FT                                ECO:0000269|PubMed:12198537,
FT                                ECO:0000269|PubMed:14500344,
FT                                ECO:0000269|PubMed:16959974,
FT                                ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:21917714,
FT                                ECO:0000269|PubMed:23263490,
FT                                ECO:0000269|PubMed:24455489}.
FT                                /FTId=VAR_018629.
FT   VARIANT     601    601       K -> E (in CRC; dbSNP:rs121913364).
FT                                {ECO:0000269|PubMed:12198537}.
FT                                /FTId=VAR_018630.
FT   VARIANT     601    601       K -> Q (in CFC1; dbSNP:rs121913364).
FT                                {ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_058629.
FT   VARIANT     638    638       D -> E (in CFC1; dbSNP:rs180177042).
FT                                {ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_058630.
FT   VARIANT     709    709       Q -> R (in CFC1; dbSNP:rs397507486).
FT                                {ECO:0000269|PubMed:19206169}.
FT                                /FTId=VAR_058631.
FT   MUTAGEN     483    483       K->S: Reduces kinase activity with
FT                                MAP2K1. {ECO:0000269|PubMed:21441910}.
FT   MUTAGEN     578    578       K->R: Blocks EGF-induced ubiquitination
FT                                and ERK activation.
FT                                {ECO:0000269|PubMed:23907581}.
FT   MUTAGEN     671    671       R->K: Increased kinase activity and
FT                                stability in response to EGF treatment.
FT                                {ECO:0000269|PubMed:21917714}.
FT   CONFLICT    766    766       H -> D (in Ref. 11; AAA96495).
FT                                {ECO:0000305}.
FT   HELIX        43     68       {ECO:0000244|PDB:5VYK}.
FT   HELIX        76    103       {ECO:0000244|PDB:5VYK}.
FT   STRAND      156    161       {ECO:0000244|PDB:3NY5}.
FT   TURN        162    164       {ECO:0000244|PDB:3NY5}.
FT   STRAND      165    170       {ECO:0000244|PDB:3NY5}.
FT   HELIX       177    186       {ECO:0000244|PDB:3NY5}.
FT   TURN        187    189       {ECO:0000244|PDB:3NY5}.
FT   HELIX       192    194       {ECO:0000244|PDB:3NY5}.
FT   STRAND      195    199       {ECO:0000244|PDB:3NY5}.
FT   STRAND      206    208       {ECO:0000244|PDB:3NY5}.
FT   HELIX       214    217       {ECO:0000244|PDB:3NY5}.
FT   STRAND      221    226       {ECO:0000244|PDB:3NY5}.
FT   HELIX       448    450       {ECO:0000244|PDB:5JRQ}.
FT   HELIX       454    456       {ECO:0000244|PDB:5JRQ}.
FT   STRAND      458    466       {ECO:0000244|PDB:5ITA}.
FT   STRAND      469    486       {ECO:0000244|PDB:5ITA}.
FT   STRAND      487    489       {ECO:0000244|PDB:4E26}.
FT   HELIX       492    506       {ECO:0000244|PDB:5ITA}.
FT   STRAND      516    520       {ECO:0000244|PDB:5ITA}.
FT   STRAND      522    524       {ECO:0000244|PDB:5ITA}.
FT   STRAND      526    530       {ECO:0000244|PDB:5ITA}.
FT   STRAND      534    536       {ECO:0000244|PDB:5VAM}.
FT   HELIX       537    542       {ECO:0000244|PDB:5ITA}.
FT   STRAND      543    545       {ECO:0000244|PDB:4RZW}.
FT   HELIX       550    569       {ECO:0000244|PDB:5ITA}.
FT   HELIX       579    581       {ECO:0000244|PDB:5ITA}.
FT   STRAND      582    585       {ECO:0000244|PDB:5ITA}.
FT   TURN        586    588       {ECO:0000244|PDB:5ITA}.
FT   STRAND      589    592       {ECO:0000244|PDB:5ITA}.
FT   TURN        598    600       {ECO:0000244|PDB:5JSM}.
FT   TURN        602    605       {ECO:0000244|PDB:4RZV}.
FT   HELIX       611    613       {ECO:0000244|PDB:4WO5}.
FT   TURN        614    616       {ECO:0000244|PDB:5HID}.
FT   HELIX       617    619       {ECO:0000244|PDB:5ITA}.
FT   HELIX       622    625       {ECO:0000244|PDB:5ITA}.
FT   STRAND      629    631       {ECO:0000244|PDB:5VAM}.
FT   HELIX       635    651       {ECO:0000244|PDB:5ITA}.
FT   TURN        655    659       {ECO:0000244|PDB:5ITA}.
FT   HELIX       662    670       {ECO:0000244|PDB:5ITA}.
FT   HELIX       678    680       {ECO:0000244|PDB:5ITA}.
FT   STRAND      683    685       {ECO:0000244|PDB:5JRQ}.
FT   HELIX       687    696       {ECO:0000244|PDB:5ITA}.
FT   HELIX       701    703       {ECO:0000244|PDB:5ITA}.
FT   HELIX       707    717       {ECO:0000244|PDB:5ITA}.
FT   TURN        718    720       {ECO:0000244|PDB:4RZV}.
SQ   SEQUENCE   766 AA;  84437 MW;  0798C2AAB487E813 CRC64;
     MAALSGGGGG GAEPGQALFN GDMEPEAGAG AGAAASSAAD PAIPEEVWNI KQMIKLTQEH
     IEALLDKFGG EHNPPSIYLE AYEEYTSKLD ALQQREQQLL ESLGNGTDFS VSSSASMDTV
     TSSSSSSLSV LPSSLSVFQN PTDVARSNPK SPQKPIVRVF LPNKQRTVVP ARCGVTVRDS
     LKKALMMRGL IPECCAVYRI QDGEKKPIGW DTDISWLTGE ELHVEVLENV PLTTHNFVRK
     TFFTLAFCDF CRKLLFQGFR CQTCGYKFHQ RCSTEVPLMC VNYDQLDLLF VSKFFEHHPI
     PQEEASLAET ALTSGSSPSA PASDSIGPQI LTSPSPSKSI PIPQPFRPAD EDHRNQFGQR
     DRSSSAPNVH INTIEPVNID DLIRDQGFRG DGGSTTGLSA TPPASLPGSL TNVKALQKSP
     GPQRERKSSS SSEDRNRMKT LGRRDSSDDW EIPDGQITVG QRIGSGSFGT VYKGKWHGDV
     AVKMLNVTAP TPQQLQAFKN EVGVLRKTRH VNILLFMGYS TKPQLAIVTQ WCEGSSLYHH
     LHIIETKFEM IKLIDIARQT AQGMDYLHAK SIIHRDLKSN NIFLHEDLTV KIGDFGLATV
     KSRWSGSHQF EQLSGSILWM APEVIRMQDK NPYSFQSDVY AFGIVLYELM TGQLPYSNIN
     NRDQIIFMVG RGYLSPDLSK VRSNCPKAMK RLMAECLKKK RDERPLFPQI LASIELLARS
     LPKIHRSASE PSLNRAGFQT EDFSLYACAS PKTPIQAGGY GAFPVH
//
